Citrus Sinensis ID: 021711

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------31
Protein Sequence
MEKKEDSCSPVGVLEDYFRSEDSETCSSKEPCSETKPESKSNSRWHLFYDLFRNKSKKSLVTLYPLKLSIRRSSSMREGIDMPRNLFVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS
Secondary Structure (PSIPRED)
cccccccccccEEEEccccccccccccccccccccccccccccccEEEEEEEEccccEEEEEEccEEEEEcccccccccccccccccccccccccccccccHHHHHHHHcccccccccccccccccEEEEEccccEEEEEEcccccHHHHHHHHHHHHHHHHHccccccccEEEEEEEcccEEEEEcccccccHHHHccccccccHHHHHHHHHHHHHHHHHHcccccccEEEccccccccccccccccccccccccEEcccccEEEEEEEEEEEcccccccccccccccccccccEEEEEEEEEEEc
Secondary Structure Prediction (SSPRO)
cccEEcccccccEEEEEEEEcccccccccccccccccccccccccEEEEEEHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccEEcHHHHHHHHccccHHccccccccccEEEcEcccccEEEEEEEccccccccHHHHHHHHHHHHHHHHHcHHHEEEEEEcccEEEEEEEcccccHHHHHccccccccHHHHHHHHHHHHHHHHHHHHHcHcccccccccHHHEEEcccccEEEccccHHHEcccccccEEEEEEEEccccccHHHHHcccccccccHHHHHHHHEHHHcc
Coil and Loop (DISEMBL)
mekkedscspvgvledyfrsedsetcsskepcsetkpesksnsrWHLFYDLFRNKSKKSLVTLYPlklsirrsssmregidmprnlfvnsydsqspqKIFSLYELqsatnnfsfenligkggyaeVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGimahvdhpntakLLGYGIEGGMHIVlelspngslASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANIlltedfepqicdfglakwlpeqwthhtiskvegtfglvklnlpplvilKRCFTCIFigfsqlqlscs
Flexible Loop (DISEMBL)
mekkedscspvgvledyfrsedsetcsskepcsetkpesksnsrWHLFYDLfrnkskkslvtlyplklsirrsssmregidMPRNLFVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS
Low Complexity Region (SEG)
MEKKEDSCSPVGVLEDYFRSEDSETCSSKEPCSETKPESKSNSRWHLFYDLFRNKSKKSLVTLYPLKLSIRRSSSMREGIDMPRNLFVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS
Disordered region (IsUnstruct)
*******************************************RWHLFYDLFRNKSKKSLVTLYPLKLSI**************NLFVNSY*****QKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQ****
Disordered Region (DISOPRED)
************VLEDYF******************************YDLFRNKSKKSLVTLYPLK*****************************QKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAI****************SELGIMAHVDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS
Disordered Region (DISEMBL)
**********VGVLEDYF************************SRWHLFYDLFRNKSKKSLVTLYPLKLSIRRSSSMREGIDMPRNLFVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS
Disordered Region (DISPRO)
*EKKEDSCSPVGVLEDYFRSEDSETCSSKEPCSE*******NSRWHLFYDLFRNKSKKSLVTLYPLKLSIRRSS********************SPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHoooo
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MEKKEDSCSPVGVLEDYFRSEDSETCSSKEPCSETKPESKSNSRWHLFYDLFRNKSKKSLVTLYPLKLSIRRSSSMREGIDMPRNLFVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	308	2.2.26 [Sep-21-2011]
Q8RXC8	460	Receptor-like cytosolic s	no	no	0.772	0.517	0.593	6e-77
Q8H1D6	467	Receptor-like cytosolic s	no	no	0.577	0.381	0.616	2e-61
Q5XF57	579	Probable receptor-like se	no	no	0.577	0.307	0.544	5e-53
C0LGG7	953	Probable LRR receptor-lik	no	no	0.571	0.184	0.461	3e-38
O65405	683	Cysteine-rich receptor-li	no	no	0.600	0.270	0.446	4e-37
P93050	617	Probable LRR receptor-lik	no	no	0.577	0.288	0.475	5e-37
Q9LDT0	700	Putative cysteine-rich re	no	no	0.587	0.258	0.437	6e-37
Q9XEC8	648	Cysteine-rich receptor-li	no	no	0.646	0.307	0.418	2e-36
Q9T0J1	665	Cysteine-rich receptor-li	no	no	0.574	0.266	0.450	7e-36
Q9XEC7	646	Cysteine-rich receptor-li	no	no	0.603	0.287	0.432	9e-36

>sp|Q8RXC8|RBK2_ARATH Receptor-like cytosolic serine/threonine-protein kinase RBK2 OS=Arabidopsis thaliana GN=RBK2 PE=1 SV=1

 Score =  287 bits (735), Expect = 6e-77,   Method: Compositional matrix adjust.
 Identities = 143/241 (59%), Positives = 179/241 (74%), Gaps = 3/241 (1%)

Query: 40  KSNSRWHLFYDLFRNKSKKSLVTLYPLKLSIRRSSSMREGIDMPRNLFV--NSYDSQSPQ 97
           +++S W  F+ L++ +S K L +  PL  +        +  D   N  V  + YD QS  
Sbjct: 69  RASSNWGKFFKLWKRRSMKRLSSFPPLSGAAPPIIKQNKSADPNMNGMVLHDIYDFQSSL 128

Query: 98  KIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSE 157
           + FS+ +++ AT+NFS EN+IG+GGYA+VY+G L  G+L+A+KRLT+GT DE  A+FLSE
Sbjct: 129 QNFSISDIEIATDNFSPENIIGRGGYADVYQGILPEGKLIAVKRLTKGTPDEQTAEFLSE 188

Query: 158 LGIMAHVDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYG-MKEKLKWGIRYKIALGV 216
           LGI+AHVDHPNTAK +G  IEGGMH+V  LSP GSL SLL+G  K KL W  RY +ALG 
Sbjct: 189 LGIIAHVDHPNTAKFIGCCIEGGMHLVFRLSPLGSLGSLLHGPSKYKLTWSRRYNVALGT 248

Query: 217 AEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTF 276
           A+GL+YLHEGCQRRIIHRDIKA NILLTEDF+PQICDFGLAKWLP+Q THH +SK EGTF
Sbjct: 249 ADGLVYLHEGCQRRIIHRDIKADNILLTEDFQPQICDFGLAKWLPKQLTHHNVSKFEGTF 308

Query: 277 G 277
           G
Sbjct: 309 G 309

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q8H1D6|RBK1_ARATH Receptor-like cytosolic serine/threonine-protein kinase RBK1 OS=Arabidopsis thaliana GN=RBK1 PE=1 SV=1

 Score =  236 bits (602), Expect = 2e-61,   Method: Compositional matrix adjust.
 Identities = 111/180 (61%), Positives = 139/180 (77%), Gaps = 2/180 (1%)

Query: 100 FSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADE--IIADFLSE 157
           F+  EL  AT+ F+ EN+IGKGG+AEVYKG L NG+ VAIK+L     +E   ++DFLSE
Sbjct: 141 FTYEELAVATDYFNPENMIGKGGHAEVYKGVLINGETVAIKKLMSHAKEEEERVSDFLSE 200

Query: 158 LGIMAHVDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVA 217
           LGI+AHV+HPN A+L G+  + G+H VLE +P GSLAS+L+G +E L+W IRYK+ALG+A
Sbjct: 201 LGIIAHVNHPNAARLRGFSSDRGLHFVLEYAPYGSLASMLFGSEECLEWKIRYKVALGIA 260

Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFG 277
           +GL YLH  C RRIIHRDIKA+NILL  D+E QI DFGLAKWLPE W HH +  +EGTFG
Sbjct: 261 DGLSYLHNACPRRIIHRDIKASNILLNHDYEAQISDFGLAKWLPENWPHHVVFPIEGTFG 320

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q5XF57|Y5576_ARATH Probable receptor-like serine/threonine-protein kinase At5g57670 OS=Arabidopsis thaliana GN=At5g57670 PE=2 SV=1

 Score =  207 bits (528), Expect = 5e-53,   Method: Compositional matrix adjust.
 Identities = 98/180 (54%), Positives = 131/180 (72%), Gaps = 2/180 (1%)

Query: 100 FSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTAD-EIIADFLSEL 158
           F+  E+  ATN+F   N++G GGY+EVY+G L +G+ +A+KRL + + D     +FL+EL
Sbjct: 255 FTYNEISKATNDFHQGNIVGIGGYSEVYRGDLWDGRRIAVKRLAKESGDMNKEKEFLTEL 314

Query: 159 GIMAHVDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKE-KLKWGIRYKIALGVA 217
           GI++HV HPNTA LLG  +E G+++V   S NG+L S L+  +   L W +RYKIA+GVA
Sbjct: 315 GIISHVSHPNTALLLGCCVEKGLYLVFRFSENGTLYSALHENENGSLDWPVRYKIAVGVA 374

Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFG 277
            GL YLH+ C  RIIHRDIK++N+LL  D+EPQI DFGLAKWLP +WTHH +  VEGTFG
Sbjct: 375 RGLHYLHKRCNHRIIHRDIKSSNVLLGPDYEPQITDFGLAKWLPNKWTHHAVIPVEGTFG 434

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGG7|Y1534_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g53420 OS=Arabidopsis thaliana GN=At1g53420 PE=2 SV=2

 Score =  159 bits (402), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 84/182 (46%), Positives = 123/182 (67%), Gaps = 6/182 (3%)

Query: 100 FSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELG 159
           FSL +++ ATNNF   N IG+GG+  VYKG+L +G ++A+K+L+ G+  +   +FL+E+G
Sbjct: 612 FSLRQIKIATNNFDSANRIGEGGFGPVYKGKLFDGTIIAVKQLSTGSK-QGNREFLNEIG 670

Query: 160 IMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKE---KLKWGIRYKIALG 215
           +++ + HPN  KL G  +EGG + +V E   N SLA  L+G +E   +L W  R KI +G
Sbjct: 671 MISALHHPNLVKLYGCCVEGGQLLLVYEFVENNSLARALFGPQETQLRLDWPTRRKICIG 730

Query: 216 VAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGT 275
           VA GL YLHE  + +I+HRDIKA N+LL +   P+I DFGLAK L E+ + H  +++ GT
Sbjct: 731 VARGLAYLHEESRLKIVHRDIKATNVLLDKQLNPKISDFGLAK-LDEEDSTHISTRIAGT 789

Query: 276 FG 277
           FG
Sbjct: 790 FG 791

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O65405|CRK28_ARATH Cysteine-rich receptor-like protein kinase 28 OS=Arabidopsis thaliana GN=CRK28 PE=3 SV=2

 Score =  155 bits (391), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 87/195 (44%), Positives = 123/195 (63%), Gaps = 10/195 (5%)

Query: 92  DSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRL--TRGTADE 149
           D  S   +     L++AT+NFS EN +G+GG+  VYKG    GQ +A+KRL  T G  D 
Sbjct: 341 DEFSDSLVVDFETLKAATDNFSPENELGRGGFGSVYKGVFSGGQEIAVKRLSCTSGQGD- 399

Query: 150 IIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHI-VLELSPNGSLASLLYGMKEK--LKW 206
             ++F +E+ ++A + H N  +LLG+ IEG   I V E   N SL + ++ +K++  L W
Sbjct: 400 --SEFKNEILLLAKLQHRNLVRLLGFCIEGQERILVYEFIKNASLDNFIFDLKKRQLLDW 457

Query: 207 GIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKW--LPEQW 264
           G+RYK+  GVA GLLYLHE  + RIIHRD+KA+NILL ++  P+I DFGLAK     +  
Sbjct: 458 GVRYKMIGGVARGLLYLHEDSRYRIIHRDLKASNILLDQEMNPKIADFGLAKLYDTDQTS 517

Query: 265 THHTISKVEGTFGLV 279
           TH   SK+ GT+G +
Sbjct: 518 THRFTSKIAGTYGYM 532

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|P93050|RKF3_ARATH Probable LRR receptor-like serine/threonine-protein kinase RKF3 OS=Arabidopsis thaliana GN=RKF3 PE=1 SV=1

 Score =  155 bits (391), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 89/187 (47%), Positives = 118/187 (63%), Gaps = 9/187 (4%)

Query: 100 FSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELG 159
           FS  E++ ATNNFS  N+IG+GGY  V+KG L +G  VA KR    +A    A+F  E+ 
Sbjct: 271 FSFDEIKKATNNFSRHNIIGRGGYGNVFKGALPDGTQVAFKRFKNCSAGGD-ANFAHEVE 329

Query: 160 IMAHVDHPNTAKLLGYGI-----EGGMHIVL-ELSPNGSLASLLYG-MKEKLKWGIRYKI 212
           ++A + H N   L GY       EG   I++ +L  NGSL   L+G ++ +L W +R +I
Sbjct: 330 VIASIRHVNLLALRGYCTATTPYEGHQRIIVCDLVSNGSLHDHLFGDLEAQLAWPLRQRI 389

Query: 213 ALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKV 272
           ALG+A GL YLH G Q  IIHRDIKA+NILL E FE ++ DFGLAK+ PE  TH + ++V
Sbjct: 390 ALGMARGLAYLHYGAQPSIIHRDIKASNILLDERFEAKVADFGLAKFNPEGMTHMS-TRV 448

Query: 273 EGTFGLV 279
            GT G V
Sbjct: 449 AGTMGYV 455

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LDT0|CRK30_ARATH Putative cysteine-rich receptor-like protein kinase 30 OS=Arabidopsis thaliana GN=CRK30 PE=3 SV=1

 Score =  154 bits (390), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 84/192 (43%), Positives = 119/192 (61%), Gaps = 11/192 (5%)

Query: 100 FSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELG 159
           F + ++++AT+NF   N IG+GG+ EVYKG L NG  VA+KRL+R T+D+   +F +E+ 
Sbjct: 334 FDIKDIEAATSNFLASNKIGQGGFGEVYKGTLSNGTEVAVKRLSR-TSDQGELEFKNEVL 392

Query: 160 IMAHVDHPNTAKLLGYGIEGGMHI-VLELSPNGSLASLLYG-----MKEKLKWGIRYKIA 213
           ++A + H N  +LLG+ ++G   I V E  PN SL   L+G      K +L W  RY I 
Sbjct: 393 LVAKLQHRNLVRLLGFALQGEEKILVFEFVPNKSLDYFLFGSTNPTKKGQLDWTRRYNII 452

Query: 214 LGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVE 273
            G+  GLLYLH+  +  IIHRDIKA+NILL  D  P+I DFG+A+   +  T  +  +V 
Sbjct: 453 GGITRGLLYLHQDSRLTIIHRDIKASNILLDADMNPKIADFGMARNFRDHQTEDSTGRVV 512

Query: 274 GTFGLVKLNLPP 285
           GTFG     +PP
Sbjct: 513 GTFGY----MPP 520

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9XEC8|CRK38_ARATH Cysteine-rich receptor-like protein kinase 38 OS=Arabidopsis thaliana GN=CRK38 PE=3 SV=1

 Score =  152 bits (385), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 87/208 (41%), Positives = 123/208 (59%), Gaps = 9/208 (4%)

Query: 91  YDSQSPQKI-FSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADE 149
           YD     K+ F    + +AT++FSFEN IG+GG+  VYKG+L  G+ +A+KRLTRG+   
Sbjct: 317 YDYGGQSKLRFDFRMILTATDDFSFENKIGQGGFGSVYKGKLPGGEEIAVKRLTRGSGQG 376

Query: 150 IIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHI-VLELSPNGSLASLLYGMKEKL--KW 206
            I +F +E+ ++  + H N  KLLG+  EG   I V E  PN SL   ++  +++L   W
Sbjct: 377 EI-EFRNEVLLLTRLQHRNLVKLLGFCNEGDEEILVYEFVPNSSLDHFIFDEEKRLLLTW 435

Query: 207 GIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH 266
            +R +I  GVA GL+YLHE  Q RIIHRD+KA+NILL     P++ DFG+A+      T 
Sbjct: 436 DMRARIIEGVARGLVYLHEDSQLRIIHRDLKASNILLDAYMNPKVADFGMARLFNMDQTR 495

Query: 267 HTISKVEGTFGLVKLNLPPLVILKRCFT 294
               KV GTFG     + P  +  R F+
Sbjct: 496 AVTRKVVGTFGY----MAPEYVRNRTFS 519

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9T0J1|CRK26_ARATH Cysteine-rich receptor-like protein kinase 26 OS=Arabidopsis thaliana GN=CRK26 PE=2 SV=1

 Score =  151 bits (381), Expect = 7e-36,   Method: Compositional matrix adjust.
 Identities = 82/182 (45%), Positives = 116/182 (63%), Gaps = 5/182 (2%)

Query: 100 FSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELG 159
           F    LQ AT++FS EN +G+GG+  VYKG L +GQ +A+KRL++  A +   +F +E  
Sbjct: 332 FDFSVLQDATSHFSLENKLGEGGFGAVYKGVLSDGQKIAVKRLSK-NAQQGETEFKNEFL 390

Query: 160 IMAHVDHPNTAKLLGYGIEGGMHI-VLELSPNGSLASLLYG--MKEKLKWGIRYKIALGV 216
           ++A + H N  KLLGY IEG   + V E  P+ SL   ++      +L+W IRYKI  GV
Sbjct: 391 LVAKLQHRNLVKLLGYSIEGTERLLVYEFLPHTSLDKFIFDPIQGNELEWEIRYKIIGGV 450

Query: 217 AEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP-EQWTHHTISKVEGT 275
           A GLLYLH+  + RIIHRD+KA+NILL E+  P+I DFG+A+    +  T    +++ GT
Sbjct: 451 ARGLLYLHQDSRLRIIHRDLKASNILLDEEMTPKIADFGMARLFDIDHTTQRYTNRIVGT 510

Query: 276 FG 277
           FG
Sbjct: 511 FG 512

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9XEC7|CRK37_ARATH Cysteine-rich receptor-like protein kinase 37 OS=Arabidopsis thaliana GN=CRK37 PE=3 SV=1

 Score =  150 bits (380), Expect = 9e-36,   Method: Compositional matrix adjust.
 Identities = 83/192 (43%), Positives = 119/192 (61%), Gaps = 6/192 (3%)

Query: 91  YDSQSPQKI--FSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTAD 148
           +DS + Q +  F L  + +ATNNFS EN +G+GG+  VYKG L +GQ +A+KRL +G+  
Sbjct: 322 FDSNNGQSMLRFDLRMIVTATNNFSLENKLGQGGFGSVYKGILPSGQEIAVKRLRKGSGQ 381

Query: 149 EIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHI-VLELSPNGSLASLLYGMKEK--LK 205
             + +F +E+ ++  + H N  KLLG+  E    I V E  PN SL   ++  +++  L 
Sbjct: 382 GGM-EFKNEVLLLTRLQHRNLVKLLGFCNEKDEEILVYEFVPNSSLDHFIFDEEKRRVLT 440

Query: 206 WGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT 265
           W +RY I  GVA GLLYLHE  Q RIIHRD+KA+NILL  +  P++ DFG+A+      T
Sbjct: 441 WDVRYTIIEGVARGLLYLHEDSQLRIIHRDLKASNILLDAEMNPKVADFGMARLFDMDET 500

Query: 266 HHTISKVEGTFG 277
               S+V GT+G
Sbjct: 501 RGQTSRVVGTYG 512

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	308
224131288	421	predicted protein [Populus trichocarpa]	0.889	0.650	0.769	1e-119
255567596	462	ATP binding protein, putative [Ricinus c	0.889	0.593	0.721	1e-109
356500232	423	PREDICTED: receptor-like cytosolic serin	0.886	0.645	0.665	1e-100
15239245	429	protein kinase-like protein [Arabidopsis	0.850	0.610	0.657	2e-97
356535678	411	PREDICTED: receptor-like cytosolic serin	0.886	0.664	0.711	6e-97
297805146	404	hypothetical protein ARALYDRAFT_355584 [	0.850	0.648	0.632	1e-96
226815616	413	Rop-interacting receptor-like cytoplasmi	0.886	0.661	0.678	4e-96
449463832	414	PREDICTED: receptor-like cytosolic serin	0.889	0.661	0.628	4e-95
296086669	434	unnamed protein product [Vitis vinifera]	0.892	0.633	0.641	4e-95
359479848	440	PREDICTED: LOW QUALITY PROTEIN: receptor	0.892	0.625	0.641	5e-95

>gi|224131288|ref|XP_002321047.1| predicted protein [Populus trichocarpa] gi|222861820|gb|EEE99362.1| predicted protein [Populus trichocarpa]

 Score =  434 bits (1117), Expect = e-119,   Method: Compositional matrix adjust.
 Identities = 217/282 (76%), Positives = 243/282 (86%), Gaps = 8/282 (2%)

Query: 1   MEKKEDSCSPVGVLEDYFRSEDSETCSSKEPCSETKPESKSNSRWHLFYDLFRNKSKKSL 60
           MEKKED+ SPVGVLEDYF+SEDSE+CSSK+P S+ +  SK  SRWH F  L R++SKKSL
Sbjct: 1   MEKKEDASSPVGVLEDYFKSEDSESCSSKDPSSDAEV-SKHASRWHGFVKLLRSRSKKSL 59

Query: 61  VTLYPL---KLSIRRSSSMREGIDMPRNLFVNSYDS--QSPQKIFSLYELQSATNNFSFE 115
            TL+PL   KLS+R+SSSMRE I    NLF NS  S  +SP+  F+L ELQ+ATNNFS E
Sbjct: 60  ATLHPLGVLKLSMRKSSSMRENI--ITNLFANSDSSNFKSPRINFTLSELQAATNNFSQE 117

Query: 116 NLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGY 175
           NLIGKGGYAEVYKG L+NG++VAIKRLTRGT DEII DFLSE+GIMAHV+HPNTAKL+GY
Sbjct: 118 NLIGKGGYAEVYKGCLQNGKIVAIKRLTRGTTDEIIGDFLSEMGIMAHVNHPNTAKLIGY 177

Query: 176 GIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRD 235
           GIEGGMH+VLELSP+GSLAS+LYG KE+L W IRYKIALG A GLLYLHEGCQRRIIHRD
Sbjct: 178 GIEGGMHLVLELSPHGSLASVLYGSKERLTWHIRYKIALGTAHGLLYLHEGCQRRIIHRD 237

Query: 236 IKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFG 277
           IKAANILLTEDFEPQICDFGLAKWLPE WTHHT+SK EGTFG
Sbjct: 238 IKAANILLTEDFEPQICDFGLAKWLPEHWTHHTVSKFEGTFG 279

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255567596|ref|XP_002524777.1| ATP binding protein, putative [Ricinus communis] gi|223535961|gb|EEF37620.1| ATP binding protein, putative [Ricinus communis]

 Score =  401 bits (1030), Expect = e-109,   Method: Compositional matrix adjust.
 Identities = 205/284 (72%), Positives = 238/284 (83%), Gaps = 10/284 (3%)

Query: 1   MEKKEDSCSPVGVLEDYFRSEDSETCSSKEPCSE--TKPESKSNSRWHLFYDLFRNKSKK 58
           MEKK D+ SPVGVLEDYFRSE+SE+ SSKEP S+  ++  SK  SRW  F+ L ++++KK
Sbjct: 36  MEKKGDTSSPVGVLEDYFRSEESESSSSKEPTSDFDSQKSSKPVSRWRGFFQLLKSRTKK 95

Query: 59  SLVTLYPL---KLSIRRSSSMREGIDMPRNLFVNS--YDSQSPQKIFSLYELQSATNNFS 113
            L TL+PL   KLS+RRSSSMRE   M  NLF +S  Y+   P+  F+L ELQ+ATN+FS
Sbjct: 96  PLATLHPLSVLKLSLRRSSSMRE---MVPNLFADSDSYNLNCPRMSFTLSELQAATNDFS 152

Query: 114 FENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLL 173
            ENLIGKGGYAEVYKG L+NG+LVAIKRL RGTADEI+ DFLSE+GIMAHV+HPNTA+L+
Sbjct: 153 QENLIGKGGYAEVYKGCLKNGKLVAIKRLIRGTADEIVGDFLSEMGIMAHVNHPNTARLI 212

Query: 174 GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIH 233
           GYGIEGGMH+VLELSP+GSLAS+L G KE LKW IRYKIA+G AEG+ YLHE CQRRIIH
Sbjct: 213 GYGIEGGMHLVLELSPHGSLASVLSGSKETLKWDIRYKIAVGTAEGIRYLHEDCQRRIIH 272

Query: 234 RDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFG 277
           RDIKAANILLTEDFEPQICDFGLAKWLP+QWTHH +SK EGTFG
Sbjct: 273 RDIKAANILLTEDFEPQICDFGLAKWLPQQWTHHVVSKFEGTFG 316

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356500232|ref|XP_003518937.1| PREDICTED: receptor-like cytosolic serine/threonine-protein kinase RBK2-like [Glycine max]

 Score =  371 bits (953), Expect = e-100,   Method: Compositional matrix adjust.
 Identities = 195/293 (66%), Positives = 221/293 (75%), Gaps = 20/293 (6%)

Query: 4   KEDSCSPVGVLEDYFR---------------SEDSETCSSKEPCSETKPESKSNSRWHLF 48
           KE   SPV VLEDYFR               SE  E   S     E++  SKS SRWH F
Sbjct: 2   KEKVDSPVTVLEDYFRSSDSESSSSKEPSADSESREFSKSASRWHESREFSKSASRWHAF 61

Query: 49  YDLFRNKSKKSLVTLYPL---KLSIRRSSSMREGIDMPRNLF-VNSYDSQSPQKIFSLYE 104
             L R+ SKK + TL+PL   KLS R S+SMRE I +P  L    +   +SP KIF+ +E
Sbjct: 62  LQLLRSGSKKQMNTLHPLSVLKLSKRMSTSMRESI-LPSCLLDATASPCRSPWKIFTHHE 120

Query: 105 LQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHV 164
           +Q ATN+FS ENLIGKGGYAEVYKG L N QLVA+KRLTRGTADEII DFLSELG+MAHV
Sbjct: 121 IQVATNSFSQENLIGKGGYAEVYKGCLPNRQLVAVKRLTRGTADEIIGDFLSELGVMAHV 180

Query: 165 DHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
           +HPNTAKL+GYG++GGM++VLELS  GSLAS+LYG KEK  W IR+KIALG A+G+LYLH
Sbjct: 181 NHPNTAKLVGYGVDGGMYLVLELSEKGSLASVLYGSKEKPPWFIRHKIALGTAKGILYLH 240

Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFG 277
           EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE WTHHT+SK EGTFG
Sbjct: 241 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPENWTHHTVSKFEGTFG 293

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|15239245|ref|NP_198445.1| protein kinase-like protein [Arabidopsis thaliana] gi|9758799|dbj|BAB09252.1| serine/threonine protein kinase-like [Arabidopsis thaliana] gi|332006650|gb|AED94033.1| protein kinase-like protein [Arabidopsis thaliana]

 Score =  361 bits (926), Expect = 2e-97,   Method: Compositional matrix adjust.
 Identities = 188/286 (65%), Positives = 216/286 (75%), Gaps = 24/286 (8%)

Query: 3   KKEDSCSPVGVLEDYFRSEDSETCSSKEPCSETKPESKSNSRWHLFYDLFRNKSKKSLVT 62
           K  DS SP GVLE++FR+E  E  SS E       ++ S+SR+     L R+KSKKSL  
Sbjct: 27  KVPDSSSPTGVLEEFFRTE--EFNSSSETV-----KNPSSSRFRKMVQLLRSKSKKSLEN 79

Query: 63  LY-------PLKLSIRRSSSMREGIDMPRNLFVNSYDSQ----SPQKIFSLYELQSATNN 111
           +         +K S RR SSMRE      NL  +S DS     SP++IF+  +L+SATNN
Sbjct: 80  VKIPFHNNGVIKSSFRRCSSMRE------NLRFSSNDSHFLLHSPRRIFTFSDLKSATNN 133

Query: 112 FSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAK 171
           FS ENLIGKGGYAEVYKG L NGQ+VAIKRL RG ++EII DFLSE+GIMAHV+HPN AK
Sbjct: 134 FSLENLIGKGGYAEVYKGMLPNGQMVAIKRLMRGNSEEIIVDFLSEMGIMAHVNHPNIAK 193

Query: 172 LLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRI 231
           LLGYG+EGGMH+VLELSP+GSLAS+LY  KEK+KW IRYKIALGVAEGL+YLH GC RRI
Sbjct: 194 LLGYGVEGGMHLVLELSPHGSLASMLYSSKEKMKWSIRYKIALGVAEGLVYLHRGCHRRI 253

Query: 232 IHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFG 277
           IHRDIKAANILLT DF PQICDFGLAKWLPE WTHH +SK EGTFG
Sbjct: 254 IHRDIKAANILLTHDFSPQICDFGLAKWLPENWTHHIVSKFEGTFG 299

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356535678|ref|XP_003536371.1| PREDICTED: receptor-like cytosolic serine/threonine-protein kinase RBK2-like [Glycine max]

 Score =  360 bits (923), Expect = 6e-97,   Method: Compositional matrix adjust.
 Identities = 200/281 (71%), Positives = 227/281 (80%), Gaps = 8/281 (2%)

Query: 4   KEDSCSPVGVLEDYFRSEDSETCSSKEPC--SETKPESKSNSRWHLFYDLFRNKSKKSLV 61
           KE   SPV VLEDYFRS DSE+ SSKEP   SE++  SK  SRWH F  L R+ SKK + 
Sbjct: 2   KEKLDSPVTVLEDYFRSSDSESSSSKEPSADSESQELSKPASRWHSFIQLLRSGSKKQMN 61

Query: 62  -TLYPL---KLSIRRSSSMREGIDMPRNLF-VNSYDSQSPQKIFSLYELQSATNNFSFEN 116
            TL+PL   KLS R S+SMRE I +P  L    +   +SP KIF+ +E+Q ATN+FS EN
Sbjct: 62  NTLHPLSVLKLSKRMSTSMRESI-LPICLLDATASPCRSPWKIFTHHEIQVATNSFSQEN 120

Query: 117 LIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYG 176
           LIGKGGYAEVYKG L N QLVAIKRLTRGTADEII DFLSELG+MAHV+H NTAKL+GYG
Sbjct: 121 LIGKGGYAEVYKGCLPNRQLVAIKRLTRGTADEIIGDFLSELGVMAHVNHTNTAKLVGYG 180

Query: 177 IEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDI 236
           ++GGM++VLELS  GSLAS+LYG KEKL W IR+KIALG A+G+LYLHEGCQRRIIHRDI
Sbjct: 181 VDGGMYLVLELSEKGSLASVLYGSKEKLPWCIRHKIALGTAKGILYLHEGCQRRIIHRDI 240

Query: 237 KAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFG 277
           KAANILLT+DFEPQICDFGLAKWLPE WTHHT+SK EGTFG
Sbjct: 241 KAANILLTKDFEPQICDFGLAKWLPENWTHHTVSKFEGTFG 281

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297805146|ref|XP_002870457.1| hypothetical protein ARALYDRAFT_355584 [Arabidopsis lyrata subsp. lyrata] gi|297316293|gb|EFH46716.1| hypothetical protein ARALYDRAFT_355584 [Arabidopsis lyrata subsp. lyrata]

 Score =  358 bits (920), Expect = 1e-96,   Method: Compositional matrix adjust.
 Identities = 181/286 (63%), Positives = 217/286 (75%), Gaps = 24/286 (8%)

Query: 3   KKEDSCSPVGVLEDYFRSEDSETCSSKEPCSETKPESKSNSRWHLFYDLFRNKSKKSLVT 62
           K  DS SP GVLE++FR+E+  +       SET  E  S+SR+     L R++SKKS+  
Sbjct: 2   KAPDSSSPTGVLEEFFRTEEFGS-------SETVKEYPSSSRFRKMVQLLRSRSKKSIEN 54

Query: 63  LY-------PLKLSIRRSSSMREGIDMPRNLFVNSYDSQ----SPQKIFSLYELQSATNN 111
           L         ++ S+RR SSMR+      NL   S D+Q    SP++IF+  +L++ATNN
Sbjct: 55  LKIPFHNNGVIQSSLRRCSSMRD------NLRFGSSDAQFLLLSPRRIFTFSDLKTATNN 108

Query: 112 FSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAK 171
           F+ ENLIGKGGYAEVYKG L NGQ+VAIKRL RG ++EII DFLSE+GIMAHV+HPN AK
Sbjct: 109 FALENLIGKGGYAEVYKGMLPNGQMVAIKRLMRGNSEEIIVDFLSEMGIMAHVNHPNIAK 168

Query: 172 LLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRI 231
           LLGYG+EGGMH+VLELSP+GSLAS+LY  KEK+KW IRYKIALGVAEGL+YLH GC RRI
Sbjct: 169 LLGYGVEGGMHLVLELSPHGSLASMLYNSKEKMKWSIRYKIALGVAEGLVYLHRGCHRRI 228

Query: 232 IHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFG 277
           IHRD+KAANILLT DF PQICDFGL+KWLPE WTHH +SK EGTFG
Sbjct: 229 IHRDVKAANILLTHDFSPQICDFGLSKWLPENWTHHIVSKFEGTFG 274

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|226815616|emb|CAT79821.1| Rop-interacting receptor-like cytoplasmic kinase 2 [Medicago truncatula]

 Score =  357 bits (916), Expect = 4e-96,   Method: Compositional matrix adjust.
 Identities = 192/283 (67%), Positives = 224/283 (79%), Gaps = 10/283 (3%)

Query: 4   KEDSCSPVGVLEDYFRSEDSETCSSKEPCSETKPE---SKSNSRWHLFYDLFRNKSKKSL 60
           KE   SP+ VLEDYFRS DSE+ SSKEP  +++     SK  SRWH F  L +++SKK L
Sbjct: 2   KEKVDSPITVLEDYFRSSDSESSSSKEPTLDSESNDDISKPVSRWHSFLQLLKSRSKKQL 61

Query: 61  VTL-YPL--KLSIRRSSSMREGIDMPRNLFVNSYDS---QSPQKIFSLYELQSATNNFSF 114
             L +PL  + S R S SMRE I +P  L + +  S   +SP KIFS +++Q ATNNFS 
Sbjct: 62  PALNHPLNGQFSRRMSRSMRETI-LPSCLTLANATSTPCRSPWKIFSHHDIQVATNNFSQ 120

Query: 115 ENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLG 174
           ENLIGKGGYAEVYKG L N +LVAIKRLTRGT DEII DFLSELG+MAHV+HPNTAKL+G
Sbjct: 121 ENLIGKGGYAEVYKGCLPNHRLVAIKRLTRGTPDEIIGDFLSELGVMAHVNHPNTAKLVG 180

Query: 175 YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHR 234
           YG++GGM++VLELS  GSLAS+LYG KEK++W IR KIALG A+G+LYLHEGCQ+R IHR
Sbjct: 181 YGVDGGMYLVLELSEKGSLASVLYGSKEKVQWCIRQKIALGTAKGILYLHEGCQKRFIHR 240

Query: 235 DIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFG 277
           DIKAANILLTEDFEPQICDFGLAKWLPE WTHH +SK EGTFG
Sbjct: 241 DIKAANILLTEDFEPQICDFGLAKWLPENWTHHNVSKFEGTFG 283

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449463832|ref|XP_004149635.1| PREDICTED: receptor-like cytosolic serine/threonine-protein kinase RBK2-like [Cucumis sativus] gi|449515774|ref|XP_004164923.1| PREDICTED: receptor-like cytosolic serine/threonine-protein kinase RBK2-like [Cucumis sativus]

 Score =  353 bits (907), Expect = 4e-95,   Method: Compositional matrix adjust.
 Identities = 181/288 (62%), Positives = 222/288 (77%), Gaps = 14/288 (4%)

Query: 1   MEKKEDSCSPVGVLEDYFRSEDSETCSSKEPCSETKPESKSNSRWHLFYDLFRNKSKKSL 60
           M++K +S SP GVLEDYFRS   E+ SS+      KP   + S W   + +  +KS+K +
Sbjct: 1   MKEKVNSFSPTGVLEDYFRSSGPESTSSEL----AKP---AGSFWRGIFKILGSKSRKPV 53

Query: 61  VTLYP---LKLSIRRSSSMREGIDMPRNLFVNSYDSQSPQKIFSLYELQSATNNFSFENL 117
             L+P   LKLS R S+SMRE + +      +  +  SP K F+L EL++ATN FS EN+
Sbjct: 54  SKLHPQSVLKLSKRLSNSMRETLHLHFGFDSDVCNFNSPWKNFTLRELEAATNYFSPENV 113

Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGI 177
           IGKGGYAEVY+G L++GQ+VAIKRLTRG+ DE + DFL ELGIMAH++HPNTAKL+GYGI
Sbjct: 114 IGKGGYAEVYRGCLKSGQVVAIKRLTRGSFDENVGDFLLELGIMAHLNHPNTAKLIGYGI 173

Query: 178 EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIK 237
           +GGMH+VLE  P+GSLAS L+G+KEKL+W IRYKIA+G+AEGL YLHEGCQRRIIHRDIK
Sbjct: 174 QGGMHLVLEFFPHGSLASTLHGLKEKLEWSIRYKIAIGIAEGLRYLHEGCQRRIIHRDIK 233

Query: 238 AANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPP 285
           AANILLT+DFEPQICDFGLAKWLP+QWTHH +SK EGTFG     LPP
Sbjct: 234 AANILLTQDFEPQICDFGLAKWLPKQWTHHIVSKFEGTFGY----LPP 277

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|296086669|emb|CBI32304.3| unnamed protein product [Vitis vinifera]

 Score =  353 bits (907), Expect = 4e-95,   Method: Compositional matrix adjust.
 Identities = 179/279 (64%), Positives = 211/279 (75%), Gaps = 4/279 (1%)

Query: 3   KKEDSCSPVGVLEDYFRSEDSETCSSKEPCSETKPESKSNSRWHLFYDLFRNKSKKSLVT 62
           +K+ S SP  VLEDY    +SET SSKE  S +     +   W     L R +SK+ L T
Sbjct: 4   RKQASSSPNCVLEDYLSRLESETSSSKEGTSGSGSSQNTKPTWRGLIQLLRTQSKRRLAT 63

Query: 63  LYP---LKLSIRRSSSMREGIDMPRNLFVNSYD-SQSPQKIFSLYELQSATNNFSFENLI 118
           L P    K S+R+  SMR    + RNL   +   S+S  K F+L ELQ AT NFS ENLI
Sbjct: 64  LDPRNVWKYSVRKCRSMRFSNGVGRNLDGETVSYSRSGWKNFTLSELQRATKNFSHENLI 123

Query: 119 GKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE 178
           GKGGYAEVYKG L++GQLVA+KRL RG  +E   +FLSELGIMAHV+HPNTAKL+GYG+E
Sbjct: 124 GKGGYAEVYKGCLQDGQLVAVKRLVRGKPEERTGNFLSELGIMAHVNHPNTAKLIGYGVE 183

Query: 179 GGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKA 238
           GG+H+VLELSP+GSLASLL+G + KLKW +RY++ALG+AEGLLYLHEGCQRR IHRDIKA
Sbjct: 184 GGLHLVLELSPHGSLASLLHGGRVKLKWSMRYQVALGIAEGLLYLHEGCQRRFIHRDIKA 243

Query: 239 ANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFG 277
           +NILLTEDF+PQICDFGLAKWLPEQWTHHTIS  EGTFG
Sbjct: 244 SNILLTEDFQPQICDFGLAKWLPEQWTHHTISSFEGTFG 282

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359479848|ref|XP_002270886.2| PREDICTED: LOW QUALITY PROTEIN: receptor-like cytosolic serine/threonine-protein kinase RBK2-like [Vitis vinifera]

 Score =  353 bits (906), Expect = 5e-95,   Method: Compositional matrix adjust.
 Identities = 179/279 (64%), Positives = 211/279 (75%), Gaps = 4/279 (1%)

Query: 3   KKEDSCSPVGVLEDYFRSEDSETCSSKEPCSETKPESKSNSRWHLFYDLFRNKSKKSLVT 62
           +K+ S SP  VLEDY    +SET SSKE  S +     +   W     L R +SK+ L T
Sbjct: 4   RKQASSSPNCVLEDYLSRLESETSSSKEGTSGSGSSQNTKPTWRGLIQLLRTQSKRRLAT 63

Query: 63  LYP---LKLSIRRSSSMREGIDMPRNLFVNSYD-SQSPQKIFSLYELQSATNNFSFENLI 118
           L P    K S+R+  SMR    + RNL   +   S+S  K F+L ELQ AT NFS ENLI
Sbjct: 64  LDPRNVWKYSVRKCRSMRFSNGVGRNLDGETVSYSRSGWKNFTLSELQRATKNFSHENLI 123

Query: 119 GKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE 178
           GKGGYAEVYKG L++GQLVA+KRL RG  +E   +FLSELGIMAHV+HPNTAKL+GYG+E
Sbjct: 124 GKGGYAEVYKGCLQDGQLVAVKRLVRGKPEERTGNFLSELGIMAHVNHPNTAKLIGYGVE 183

Query: 179 GGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKA 238
           GG+H+VLELSP+GSLASLL+G + KLKW +RY++ALG+AEGLLYLHEGCQRR IHRDIKA
Sbjct: 184 GGLHLVLELSPHGSLASLLHGGRVKLKWSMRYQVALGIAEGLLYLHEGCQRRFIHRDIKA 243

Query: 239 ANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFG 277
           +NILLTEDF+PQICDFGLAKWLPEQWTHHTIS  EGTFG
Sbjct: 244 SNILLTEDFQPQICDFGLAKWLPEQWTHHTISSFEGTFG 282

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	308
TAIR|locus:2162848	429	AT5G35960 [Arabidopsis thalian	0.863	0.620	0.659	9.3e-91
TAIR|locus:2144970	511	AT5G18910 [Arabidopsis thalian	0.782	0.471	0.600	5.7e-75
TAIR|locus:2096209	460	RBK2 "ROP binding protein kina	0.772	0.517	0.593	6.7e-72
TAIR|locus:2142514	467	RBK1 "ROP binding protein kina	0.834	0.550	0.486	4.2e-63
TAIR|locus:2155700	456	AT5G65530 [Arabidopsis thalian	0.873	0.589	0.482	2.7e-61
TAIR|locus:2044420	392	AT2G18890 [Arabidopsis thalian	0.597	0.469	0.582	4.2e-56
TAIR|locus:2172555	579	AT5G57670 [Arabidopsis thalian	0.577	0.307	0.544	9.5e-50
TAIR|locus:2141762	665	CRK26 "cysteine-rich RLK (RECE	0.805	0.372	0.377	8.6e-37
TAIR|locus:2009630	953	AT1G53420 [Arabidopsis thalian	0.571	0.184	0.461	1.4e-36
TAIR|locus:2195975	794	AT1G77280 [Arabidopsis thalian	0.733	0.284	0.393	1.7e-36

TAIR|locus:2162848 AT5G35960 [Arabidopsis thaliana (taxid:3702)]

 Score = 905 (323.6 bits), Expect = 9.3e-91, P = 9.3e-91
 Identities = 186/282 (65%), Positives = 217/282 (76%)

Query:     3 KKEDSCSPVGVLEDYFRSEDSETCSSKEPCSETKPESKSNSRWHLFYDLFRNKSKKSLVT 62
             K  DS SP GVLE++FR+E+    SS    SET  ++ S+SR+     L R+KSKKSL  
Sbjct:    27 KVPDSSSPTGVLEEFFRTEEFN--SS----SETV-KNPSSSRFRKMVQLLRSKSKKSLEN 79

Query:    63 L-YP------LKLSIRRSSSMREGIDMPRNLFVNSYDSQSPQKIFSLYELQSATNNFSFE 115
             +  P      +K S RR SSMRE +    N   + +   SP++IF+  +L+SATNNFS E
Sbjct:    80 VKIPFHNNGVIKSSFRRCSSMRENLRFSSN--DSHFLLHSPRRIFTFSDLKSATNNFSLE 137

Query:   116 NLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGY 175
             NLIGKGGYAEVYKG L NGQ+VAIKRL RG ++EII DFLSE+GIMAHV+HPN AKLLGY
Sbjct:   138 NLIGKGGYAEVYKGMLPNGQMVAIKRLMRGNSEEIIVDFLSEMGIMAHVNHPNIAKLLGY 197

Query:   176 GIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRD 235
             G+EGGMH+VLELSP+GSLAS+LY  KEK+KW IRYKIALGVAEGL+YLH GC RRIIHRD
Sbjct:   198 GVEGGMHLVLELSPHGSLASMLYSSKEKMKWSIRYKIALGVAEGLVYLHRGCHRRIIHRD 257

Query:   236 IKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFG 277
             IKAANILLT DF PQICDFGLAKWLPE WTHH +SK EGTFG
Sbjct:   258 IKAANILLTHDFSPQICDFGLAKWLPENWTHHIVSKFEGTFG 299

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2144970 AT5G18910 [Arabidopsis thaliana (taxid:3702)]

 Score = 756 (271.2 bits), Expect = 5.7e-75, P = 5.7e-75
 Identities = 152/253 (60%), Positives = 191/253 (75%)

Query:    41 SNSRWHL-FYDLFRN-KSKKSLVTLYPLK----LSIRRSSSMREG-IDMPRNLFVNSYDS 93
             +N  W   F+ L +   S     T  PLK    L+ R+S  +R+  + +   L  +    
Sbjct:   113 NNGHWRRGFFRLLKKGSSAMPFNTFTPLKGVPKLTRRKSKRIRDNMVPVIPALDTDHLFY 172

Query:    94 QSPQ-KIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIA 152
               P  + FSL ++Q+ATN++S ENLIG+GGYAEVYKG++ +GQ+VAIK+LTRG+A+E+  
Sbjct:   173 FKPSWRNFSLRDIQTATNDYSRENLIGEGGYAEVYKGQMADGQIVAIKKLTRGSAEEMTM 232

Query:   153 DFLSELGIMAHVDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKI 212
             D+LSELGI+ HVDHPN AKL+GY +EGGMH+VLELSPNGSLASLLY  KEKL W +RYK+
Sbjct:   233 DYLSELGIIVHVDHPNIAKLIGYCVEGGMHLVLELSPNGSLASLLYEAKEKLNWSMRYKV 292

Query:   213 ALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKV 272
             A+G AEGL YLHEGCQRRIIH+DIKA+NILLT++FE QI DFGLAKWLP+QWTHHT+SKV
Sbjct:   293 AMGTAEGLYYLHEGCQRRIIHKDIKASNILLTQNFEAQISDFGLAKWLPDQWTHHTVSKV 352

Query:   273 EGTFGLVKLNLPP 285
             EGTFG     LPP
Sbjct:   353 EGTFGY----LPP 361

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005777 "peroxisome" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2096209 RBK2 "ROP binding protein kinases 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 727 (261.0 bits), Expect = 6.7e-72, P = 6.7e-72
 Identities = 143/241 (59%), Positives = 179/241 (74%)

Query:    40 KSNSRWHLFYDLFRNKSKKSLVTLYPLKLSIRRSSSMREGIDMPRNLFV--NSYDSQSPQ 97
             +++S W  F+ L++ +S K L +  PL  +        +  D   N  V  + YD QS  
Sbjct:    69 RASSNWGKFFKLWKRRSMKRLSSFPPLSGAAPPIIKQNKSADPNMNGMVLHDIYDFQSSL 128

Query:    98 KIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSE 157
             + FS+ +++ AT+NFS EN+IG+GGYA+VY+G L  G+L+A+KRLT+GT DE  A+FLSE
Sbjct:   129 QNFSISDIEIATDNFSPENIIGRGGYADVYQGILPEGKLIAVKRLTKGTPDEQTAEFLSE 188

Query:   158 LGIMAHVDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYG-MKEKLKWGIRYKIALGV 216
             LGI+AHVDHPNTAK +G  IEGGMH+V  LSP GSL SLL+G  K KL W  RY +ALG 
Sbjct:   189 LGIIAHVDHPNTAKFIGCCIEGGMHLVFRLSPLGSLGSLLHGPSKYKLTWSRRYNVALGT 248

Query:   217 AEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTF 276
             A+GL+YLHEGCQRRIIHRDIKA NILLTEDF+PQICDFGLAKWLP+Q THH +SK EGTF
Sbjct:   249 ADGLVYLHEGCQRRIIHRDIKADNILLTEDFQPQICDFGLAKWLPKQLTHHNVSKFEGTF 308

Query:   277 G 277
             G
Sbjct:   309 G 309

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005737 "cytoplasm" evidence=IDA

GO:0051020 "GTPase binding" evidence=IPI

TAIR|locus:2142514 RBK1 "ROP binding protein kinases 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 609 (219.4 bits), Expect = 4.2e-63, Sum P(2) = 4.2e-63
 Identities = 131/269 (48%), Positives = 178/269 (66%)

Query:    20 SEDSETCSSKEPCSET-KPESKSNS--RWHLFYDLFRNKSKKSLVTLYPLKLS--IRRSS 74
             S D ++ S+  P S T K  S S+   +W+   +  + KS +   ++ PL  S  + R +
Sbjct:    53 SSDDKSSSTSSPFSNTTKTVSSSHHGLQWNKMIESIKKKSMRRF-SVIPLLASYELTRKN 111

Query:    75 SMREGIDM-P-RNLFV-NSYDSQSPQ-KIFSLYELQSATNNFSFENLIGKGGYAEVYKGR 130
               R+   + P  + F   ++    P  + F+  EL  AT+ F+ EN+IGKGG+AEVYKG 
Sbjct:   112 LRRKQPKLTPSESAFTCEAFFMAKPSWRNFTYEELAVATDYFNPENMIGKGGHAEVYKGV 171

Query:   131 LRNGQLVAIKRLTRGTADEI--IADFLSELGIMAHVDHPNTAKLLGYGIEGGMHIVLELS 188
             L NG+ VAIK+L     +E   ++DFLSELGI+AHV+HPN A+L G+  + G+H VLE +
Sbjct:   172 LINGETVAIKKLMSHAKEEEERVSDFLSELGIIAHVNHPNAARLRGFSSDRGLHFVLEYA 231

Query:   189 PNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFE 248
             P GSLAS+L+G +E L+W IRYK+ALG+A+GL YLH  C RRIIHRDIKA+NILL  D+E
Sbjct:   232 PYGSLASMLFGSEECLEWKIRYKVALGIADGLSYLHNACPRRIIHRDIKASNILLNHDYE 291

Query:   249 PQICDFGLAKWLPEQWTHHTISKVEGTFG 277
              QI DFGLAKWLPE W HH +  +EGTFG
Sbjct:   292 AQISDFGLAKWLPENWPHHVVFPIEGTFG 320

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005737 "cytoplasm" evidence=IDA

GO:0005829 "cytosol" evidence=IDA

GO:0009623 "response to parasitic fungus" evidence=IEP

GO:0009814 "defense response, incompatible interaction" evidence=IEP

GO:0012505 "endomembrane system" evidence=IDA

GO:0051020 "GTPase binding" evidence=IPI

GO:0071369 "cellular response to ethylene stimulus" evidence=IEP

GO:0009612 "response to mechanical stimulus" evidence=RCA

GO:0019722 "calcium-mediated signaling" evidence=RCA

TAIR|locus:2155700 AT5G65530 [Arabidopsis thaliana (taxid:3702)]

 Score = 627 (225.8 bits), Expect = 2.7e-61, P = 2.7e-61
 Identities = 140/290 (48%), Positives = 186/290 (64%)

Query:     5 EDSCSPVGVLEDYFRSEDSE---TCSS------KEPCSETKPESKSNSRWHLFYDLFRNK 55
             ED  SP  VLE    S DS+   +CSS        P S T P   S  +W+   +  + K
Sbjct:    26 EDP-SPRCVLEIPVMSSDSDNSSSCSSCSPDKSSSPLSTTPPNVSSFHQWNKMIESIKKK 84

Query:    56 SKKSLVTLYPLKLSIRRSSSMREGIDMPRNLFVNSYDSQS-----PQ-KIFSLYELQSAT 109
             S +   ++ PL  S   +   ++    P +   N +D        P  + F+  EL +AT
Sbjct:    85 SIRRF-SVIPLLASYELTRKKKQPKLSPCS--ENDFDCDQILVAKPSWRNFTFDELVAAT 141

Query:   110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDHP 167
             +NF+ EN+IGKGG+AEVYKG L +G+ VAIK+LTR     +E ++DFLSELGI+AHV+HP
Sbjct:   142 DNFNPENMIGKGGHAEVYKGVLPDGETVAIKKLTRHAKEVEERVSDFLSELGIIAHVNHP 201

Query:   168 NTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
             N A+L G+  + G+H VLE S +GSLASLL+G +E L W  RYK+A+G+A+GL YLH  C
Sbjct:   202 NAARLRGFSCDRGLHFVLEYSSHGSLASLLFGSEECLDWKKRYKVAMGIADGLSYLHNDC 261

Query:   228 QRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFG 277
              RRIIHRDIKA+NILL++D+E QI DFGLAKWLPE W HH +  +EGTFG
Sbjct:   262 PRRIIHRDIKASNILLSQDYEAQISDFGLAKWLPEHWPHHIVFPIEGTFG 311

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2044420 AT2G18890 [Arabidopsis thaliana (taxid:3702)]

 Score = 578 (208.5 bits), Expect = 4.2e-56, P = 4.2e-56
 Identities = 110/189 (58%), Positives = 143/189 (75%)

Query:    94 QSPQ-KIFSLYELQSATNNFSFENLIGKGGYAEVYKGRL-RNGQLVAIKRLTRGTADEII 151
             Q P+ K FS  E+  ATN FS ENL+G+GG+AEVYKG L +NG+ +A+KR+TRG  D+  
Sbjct:    49 QRPKWKCFSFQEIYDATNGFSSENLVGRGGFAEVYKGILGKNGEEIAVKRITRGGRDDER 108

Query:   152 AD--FLSELGIMAHVDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEK-LKWGI 208
              +  FL E+G + HV HPN   LLG  I+ G+++V   S  GSLASLL+ + +  L+W  
Sbjct:   109 REKEFLMEIGTIGHVSHPNVLSLLGCCIDNGLYLVFIFSSRGSLASLLHDLNQAPLEWET 168

Query:   209 RYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT 268
             RYKIA+G A+GL YLH+GCQRRIIHRDIK++N+LL +DFEPQI DFGLAKWLP QW+HH+
Sbjct:   169 RYKIAIGTAKGLHYLHKGCQRRIIHRDIKSSNVLLNQDFEPQISDFGLAKWLPSQWSHHS 228

Query:   269 ISKVEGTFG 277
             I+ +EGTFG
Sbjct:   229 IAPIEGTFG 237

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2172555 AT5G57670 [Arabidopsis thaliana (taxid:3702)]

 Score = 518 (187.4 bits), Expect = 9.5e-50, P = 9.5e-50
 Identities = 98/180 (54%), Positives = 131/180 (72%)

Query:   100 FSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTAD-EIIADFLSEL 158
             F+  E+  ATN+F   N++G GGY+EVY+G L +G+ +A+KRL + + D     +FL+EL
Sbjct:   255 FTYNEISKATNDFHQGNIVGIGGYSEVYRGDLWDGRRIAVKRLAKESGDMNKEKEFLTEL 314

Query:   159 GIMAHVDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKE-KLKWGIRYKIALGVA 217
             GI++HV HPNTA LLG  +E G+++V   S NG+L S L+  +   L W +RYKIA+GVA
Sbjct:   315 GIISHVSHPNTALLLGCCVEKGLYLVFRFSENGTLYSALHENENGSLDWPVRYKIAVGVA 374

Query:   218 EGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFG 277
              GL YLH+ C  RIIHRDIK++N+LL  D+EPQI DFGLAKWLP +WTHH +  VEGTFG
Sbjct:   375 RGLHYLHKRCNHRIIHRDIKSSNVLLGPDYEPQITDFGLAKWLPNKWTHHAVIPVEGTFG 434

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002238 "response to molecule of fungal origin" evidence=RCA

TAIR|locus:2141762 CRK26 "cysteine-rich RLK (RECEPTOR-like protein kinase) 26" [Arabidopsis thaliana (taxid:3702)]

 Score = 401 (146.2 bits), Expect = 8.6e-37, P = 8.6e-37
 Identities = 96/254 (37%), Positives = 144/254 (56%)

Query:    28 SKEPCSETKPESKSNSRWHLFYDLFRNKSKKSLVTLYPLKLSIRRSSSMREGIDMPRNLF 87
             S+ P +ET+  ++ +    +   L    +  ++V L+ + L +      +E I    N  
Sbjct:   261 SRPPKNETRSVTQGDKNRGVPKALIFASASVAIVVLFIVLLVVFLKLRRKENIRNSENKH 320

Query:    88 VNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTA 147
              N   S    K F    LQ AT++FS EN +G+GG+  VYKG L +GQ +A+KRL++  A
Sbjct:   321 ENENISTDSMK-FDFSVLQDATSHFSLENKLGEGGFGAVYKGVLSDGQKIAVKRLSKN-A 378

Query:   148 DEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHI-VLELSPNGSLASLLYG--MKEKL 204
              +   +F +E  ++A + H N  KLLGY IEG   + V E  P+ SL   ++      +L
Sbjct:   379 QQGETEFKNEFLLVAKLQHRNLVKLLGYSIEGTERLLVYEFLPHTSLDKFIFDPIQGNEL 438

Query:   205 KWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP-EQ 263
             +W IRYKI  GVA GLLYLH+  + RIIHRD+KA+NILL E+  P+I DFG+A+    + 
Sbjct:   439 EWEIRYKIIGGVARGLLYLHQDSRLRIIHRDLKASNILLDEEMTPKIADFGMARLFDIDH 498

Query:   264 WTHHTISKVEGTFG 277
              T    +++ GTFG
Sbjct:   499 TTQRYTNRIVGTFG 512

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006826 "iron ion transport" evidence=RCA

GO:0010106 "cellular response to iron ion starvation" evidence=RCA

GO:0010167 "response to nitrate" evidence=RCA

GO:0015706 "nitrate transport" evidence=RCA

TAIR|locus:2009630 AT1G53420 [Arabidopsis thaliana (taxid:3702)]

 Score = 404 (147.3 bits), Expect = 1.4e-36, P = 1.4e-36
 Identities = 84/182 (46%), Positives = 122/182 (67%)

Query:   100 FSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELG 159
             FSL +++ ATNNF   N IG+GG+  VYKG+L +G ++A+K+L+ G+      +FL+E+G
Sbjct:   612 FSLRQIKIATNNFDSANRIGEGGFGPVYKGKLFDGTIIAVKQLSTGSKQGN-REFLNEIG 670

Query:   160 IMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKE---KLKWGIRYKIALG 215
             +++ + HPN  KL G  +EGG + +V E   N SLA  L+G +E   +L W  R KI +G
Sbjct:   671 MISALHHPNLVKLYGCCVEGGQLLLVYEFVENNSLARALFGPQETQLRLDWPTRRKICIG 730

Query:   216 VAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGT 275
             VA GL YLHE  + +I+HRDIKA N+LL +   P+I DFGLAK L E+ + H  +++ GT
Sbjct:   731 VARGLAYLHEESRLKIVHRDIKATNVLLDKQLNPKISDFGLAK-LDEEDSTHISTRIAGT 789

Query:   276 FG 277
             FG
Sbjct:   790 FG 791

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009506 "plasmodesma" evidence=IDA

TAIR|locus:2195975 AT1G77280 [Arabidopsis thaliana (taxid:3702)]

 Score = 389 (142.0 bits), Expect = 1.7e-36, Sum P(2) = 1.7e-36
 Identities = 94/239 (39%), Positives = 139/239 (58%)

Query:    47 LFYDLFRNKSKKSLVTLYPLKLSIRRSSSMREGIDMPRNL---FVNSYDS-QSPQKIFSL 102
             L YD   + +  +L  L P  ++   + S+ +  + PR L       Y+   S  + F  
Sbjct:   379 LGYDSSED-NLSTLNALVPFGINSITNKSIPD--NSPRKLPEELEGLYERFSSTCRFFKY 435

Query:   103 YELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMA 162
              EL S T+NFS +N IGKGG + V++G L NG++VA+K L +   ++++ DF++E+ I+ 
Sbjct:   436 KELVSVTSNFSADNFIGKGGSSRVFRGCLSNGRVVAVKILKQ--TEDVLNDFVAEIEIIT 493

Query:   163 HVDHPNTAKLLGYGIEG-GMHIVLELSPNGSLASLLYG-MKEKLK--WGIRYKIALGVAE 218
              + H N   LLG+  E   + +V      GSL   L+G  K+ L   W  RYK+A+GVAE
Sbjct:   494 TLHHKNIISLLGFCFEDHNLLLVYNYLSRGSLEENLHGNKKDPLAFCWSERYKVAVGVAE 553

Query:   219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFG 277
              L YLH    + +IHRD+K++NILL++DFEPQ+ DFGLA+W     TH   S V GTFG
Sbjct:   554 ALDYLHNTASQPVIHRDVKSSNILLSDDFEPQLSDFGLARWASISTTHIICSDVAGTFG 612

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002238 "response to molecule of fungal origin" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.766

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: eugene3.00140825 hypothetical protein (422 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	308
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	1e-40
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	6e-39
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	1e-37
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	7e-37
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	4e-36
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	6e-36
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	7e-34
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	3e-32
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-31
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	5e-31
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-25
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	6e-25
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	3e-24
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	2e-23
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	2e-23
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	3e-23
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	4e-23
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	4e-23
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	1e-22
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	1e-22
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	5e-22
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	3e-21
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	9e-21
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	1e-20
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	1e-20
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	2e-20
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	3e-20
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	9e-20
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-19
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	1e-19
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	1e-19
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	1e-19
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	2e-19
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-19
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	2e-19
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	3e-19
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	3e-19
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	3e-19
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	4e-19
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	6e-19
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	7e-19
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	9e-19
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	1e-18
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	1e-18
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	2e-18
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	2e-18
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	7e-18
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	7e-18
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-17
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	1e-17
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	1e-17
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	1e-17
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	2e-17
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	2e-17
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	4e-17
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	6e-17
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	6e-17
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	6e-17
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	7e-17
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	1e-16
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	1e-16
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-16
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	2e-16
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-16
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	2e-16
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	3e-16
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	3e-16
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	4e-16
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	4e-16
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	5e-16
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	5e-16
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	6e-16
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	7e-16
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	7e-16
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-15
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	2e-15
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-15
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	2e-15
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	2e-15
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	3e-15
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	6e-15
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	7e-15
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	9e-15
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	1e-14
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	1e-14
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	1e-14
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-14
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	2e-14
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	4e-14
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	8e-14
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	8e-14
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	8e-14
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	9e-14
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	1e-13
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	2e-13
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-13
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-13
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	2e-13
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	3e-13
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	3e-13
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	3e-13
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	7e-13
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	9e-13
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	1e-12
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	1e-12
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	1e-12
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	1e-12
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-12
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-12
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-12
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-12
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	3e-12
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	3e-12
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	4e-12
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	5e-12
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	8e-12
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-11
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-11
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	2e-11
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	3e-11
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	3e-11
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	6e-11
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	6e-11
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	7e-11
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	1e-10
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	1e-10
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	1e-10
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	1e-10
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	1e-10
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	1e-10
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	1e-10
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	1e-10
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	1e-10
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	2e-10
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-10
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	2e-10
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-10
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	3e-10
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	3e-10
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	3e-10
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	4e-10
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	5e-10
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	6e-10
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	6e-10
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	6e-10
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	6e-10
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	6e-10
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	7e-10
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	1e-09
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-09
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	2e-09
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	2e-09
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-09
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	2e-09
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	2e-09
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	3e-09
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	4e-09
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	4e-09
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	4e-09
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	6e-09
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	6e-09
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	6e-09
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	7e-09
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	1e-08
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	2e-08
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	2e-08
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	2e-08
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	2e-08
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	3e-08
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	4e-08
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	5e-08
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	6e-08
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	6e-08
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	6e-08
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	7e-08
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	8e-08
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	8e-08
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	1e-07
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	1e-07
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	1e-07
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	1e-07
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	1e-07
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	2e-07
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	2e-07
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	2e-07
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	2e-07
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-07
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	3e-07
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	3e-07
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	4e-07
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	4e-07
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	4e-07
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	4e-07
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	5e-07
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	6e-07
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	6e-07
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	7e-07
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	7e-07
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	7e-07
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	7e-07
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	8e-07
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	8e-07
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	9e-07
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	1e-06
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	1e-06
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	1e-06
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	1e-06
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	1e-06
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-06
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-06
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-06
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	2e-06
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-06
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	3e-06
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	3e-06
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	4e-06
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	4e-06
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	5e-06
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	5e-06
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	5e-06
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	6e-06
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	6e-06
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	6e-06
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	8e-06
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	9e-06
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	9e-06
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	1e-05
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	1e-05
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	1e-05
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	1e-05
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	1e-05
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	1e-05
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	2e-05
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	2e-05
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-05
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	2e-05
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	3e-05
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	3e-05
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	3e-05
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	3e-05
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	3e-05
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	3e-05
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	4e-05
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	4e-05
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	5e-05
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	5e-05
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	5e-05
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	5e-05
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	5e-05
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	6e-05
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	6e-05
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	7e-05
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	8e-05
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	8e-05
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	1e-04
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	1e-04
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	2e-04
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	3e-04
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	3e-04
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	4e-04
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	5e-04
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	6e-04
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	6e-04
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	6e-04
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	7e-04
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	7e-04
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	7e-04
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	8e-04
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	8e-04
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	0.001
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	0.001
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	0.001
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	0.001
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	0.001
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	0.002
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	0.002
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	0.002
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	0.002
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	0.002
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	0.003
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	0.003
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	0.004
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	0.004
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	0.004

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  141 bits (358), Expect = 1e-40
 Identities = 61/191 (31%), Positives = 88/191 (46%), Gaps = 20/191 (10%)

Query: 113 SFENLIGKGGYAEVYKGRLR-----NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHP 167
           +    +G+G + EVYKG+L+         VA+K L    +++ I +FL E  IM  +DHP
Sbjct: 2   TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61

Query: 168 NTAKLLGYGIEGGMH-IVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEG 226
           N  KLLG   E     IV+E    G L S L   + KL        AL +A G+ YL   
Sbjct: 62  NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLES- 120

Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLN---L 283
             +  IHRD+ A N L+ E+   +I DFGL++            +  G     KL    +
Sbjct: 121 --KNFIHRDLAARNCLVGENLVVKISDFGLSR----DLYDDDYYRKRGG----KLPIRWM 170

Query: 284 PPLVILKRCFT 294
            P  + +  FT
Sbjct: 171 APESLKEGKFT 181

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  137 bits (347), Expect = 6e-39
 Identities = 55/153 (35%), Positives = 79/153 (51%), Gaps = 9/153 (5%)

Query: 112 FSFENLIGKGGYAEVYKGRLR-----NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDH 166
                 +G+G + EVYKG L+         VA+K L  G ++E   +FL E  IM  + H
Sbjct: 1   LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSH 60

Query: 167 PNTAKLLGYGIEGGMH-IVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHE 225
           PN  +LLG   +G    IV E  P G L   L    EKL      ++AL +A+G+ YL  
Sbjct: 61  PNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLES 120

Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
              +  +HRD+ A N L+TE+   +I DFGL++
Sbjct: 121 ---KNFVHRDLAARNCLVTENLVVKISDFGLSR 150

Length = 258

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  133 bits (338), Expect = 1e-37
 Identities = 63/192 (32%), Positives = 89/192 (46%), Gaps = 21/192 (10%)

Query: 113 SFENLIGKGGYAEVYKGRLRNG-----QLVAIKRLTRGTADEIIADFLSELGIMAHVDHP 167
           +    +G+G + EVYKG L+         VA+K L    +++ I +FL E  IM  +DHP
Sbjct: 2   TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61

Query: 168 NTAKLLGYGIEGGMH-IVLELSPNGSLASLLYGMKEK-LKWGIRYKIALGVAEGLLYLHE 225
           N  KLLG   E     IV+E  P G L   L   + K L        AL +A G+ YL  
Sbjct: 62  NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES 121

Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLN--- 282
              +  IHRD+ A N L+ E+   +I DFGL++            KV+G     KL    
Sbjct: 122 ---KNFIHRDLAARNCLVGENLVVKISDFGLSR----DLYDDDYYKVKGG----KLPIRW 170

Query: 283 LPPLVILKRCFT 294
           + P  + +  FT
Sbjct: 171 MAPESLKEGKFT 182

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  130 bits (330), Expect = 7e-37
 Identities = 54/149 (36%), Positives = 82/149 (55%), Gaps = 6/149 (4%)

Query: 118 IGKGGYAEVYKGRLRN-GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYG 176
           +G+GG+  VY  R +  G+ VAIK + +  +  ++ + L E+ I+  ++HPN  KL G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 177 IEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRD 235
            +   +++V+E    GSL  LL   + KL      +I L + EGL YLH      IIHRD
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHS---NGIIHRD 117

Query: 236 IKAANILLTED-FEPQICDFGLAKWLPEQ 263
           +K  NILL  D  + ++ DFGL+K L   
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLTSD 146

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  129 bits (328), Expect = 4e-36
 Identities = 51/160 (31%), Positives = 79/160 (49%), Gaps = 16/160 (10%)

Query: 116 NLIGKGGYAEVYKGRLRNGQ----LVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAK 171
             +G+G + EVYKG+L+        VA+K L    ++E   DFL E  +M  + HPN  +
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 172 LLGYGIEGG-MHIVLELSPNGSLASLL--------YGMKEKLKWGIRYKIALGVAEGLLY 222
           LLG   E   +++VLE    G L   L           K  L        A+ +A+G+ Y
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE 262
           L     ++ +HRD+ A N L+ ED   +I DFGL++ + +
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  129 bits (327), Expect = 6e-36
 Identities = 48/163 (29%), Positives = 76/163 (46%), Gaps = 12/163 (7%)

Query: 112 FSFENLIGKGGYAEVYKGRLRN-GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTA 170
           +     +G+G + +VY  R +  G+LVAIK + +    +     L E+ I+  + HPN  
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 171 KLLGYGIEGG-MHIVLELSPNGSLASLL---YGMKEKLKWGIRYKIALGVAEGLLYLHEG 226
           +L     +   +++V+E    G L  LL     + E      R+     +   L YLH  
Sbjct: 61  RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDE---ARF-YLRQILSALEYLH-- 114

Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTI 269
             + I+HRD+K  NILL ED   ++ DFGLA+ L       T 
Sbjct: 115 -SKGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTF 156

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  124 bits (313), Expect = 7e-34
 Identities = 50/150 (33%), Positives = 73/150 (48%), Gaps = 7/150 (4%)

Query: 112 FSFENLIGKGGYAEVYKGRLRN-GQLVAIKRL-TRGTADEIIADFLSELGIMAHVDHPNT 169
           +     +G G +  VYK + +  G++VA+K L  R    +       E+ I+  + HPN 
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60

Query: 170 AKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQ 228
            +L+    +   +++V+E    G L   L      L      KIAL +  GL YLH    
Sbjct: 61  VRLIDAFEDKDHLYLVMEYCEGGDLFDYLS-RGGPLSEDEAKKIALQILRGLEYLHS--- 116

Query: 229 RRIIHRDIKAANILLTEDFEPQICDFGLAK 258
             IIHRD+K  NILL E+   +I DFGLAK
Sbjct: 117 NGIIHRDLKPENILLDENGVVKIADFGLAK 146

Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  120 bits (302), Expect = 3e-32
 Identities = 62/149 (41%), Positives = 81/149 (54%), Gaps = 8/149 (5%)

Query: 114 FENL--IGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTA 170
           FE L  IGKGG+ EVYK R  R G+ VAIK + +  + E     ++E+ I+    HPN  
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVI-KLESKEKKEKIINEIQILKKCKHPNIV 60

Query: 171 KLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQR 229
           K  G Y  +  + IV+E    GSL  LL    + L       +   + +GL YLH     
Sbjct: 61  KYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHS---N 117

Query: 230 RIIHRDIKAANILLTEDFEPQICDFGLAK 258
            IIHRDIKAANILLT D E ++ DFGL+ 
Sbjct: 118 GIIHRDIKAANILLTSDGEVKLIDFGLSA 146

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  118 bits (298), Expect = 1e-31
 Identities = 57/169 (33%), Positives = 85/169 (50%), Gaps = 17/169 (10%)

Query: 116 NLIGKGGYAEVYKGRLR-NGQLVAIK--RLTRGTADEIIADFLSELGIMAHVDHPNTAKL 172
            L+G+G +  VY    +  G+L+A+K   L+  + +E+      E+ I++ + HPN  + 
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEEL-EALEREIRILSSLQHPNIVRY 64

Query: 173 LGYGIE---GGMHIVLELSPNGSLASLLY---GMKEKLKWGIRYKIALGVAEGLLYLHEG 226
            G   +     ++I LE    GSL+SLL     + E +   IR K    + EGL YLH  
Sbjct: 65  YGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPV---IR-KYTRQILEGLAYLHS- 119

Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGT 275
               I+HRDIK ANIL+  D   ++ DFG AK L +  T      V GT
Sbjct: 120 --NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGT 166

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  116 bits (293), Expect = 5e-31
 Identities = 61/171 (35%), Positives = 94/171 (54%), Gaps = 15/171 (8%)

Query: 111 NFSFENLIGKGGYAEVYKG-RLRNGQLVAIKRLTR-GTADEIIADFLSELGIMAHVDHPN 168
           N+   +LIG+G +  VYKG  L  G  VAIK+++     +E +   + E+ ++ ++ HPN
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 169 TAKLLG-YGIEGGMHIVLELSPNGSLASLL--YG-MKEKLKWGIRYKIALGVAEGLLYLH 224
             K +G       ++I+LE + NGSL  ++  +G   E L     Y +   V +GL YLH
Sbjct: 61  IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLV--AVY-VY-QVLQGLAYLH 116

Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGT 275
           E   + +IHRDIKAANIL T+D   ++ DFG+A  L +       + V GT
Sbjct: 117 E---QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDV--SKDDASVVGT 162

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  102 bits (255), Expect = 2e-25
 Identities = 48/160 (30%), Positives = 80/160 (50%), Gaps = 11/160 (6%)

Query: 111 NFSFENLIGKGGYAEVYKGRLRN-----GQLVAIKRLTRGTADEIIADFLSELGIMAHVD 165
           +  F   +G+G + +V   R        G+ VA+K L     ++  +DF  E+ I+  +D
Sbjct: 5   HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLD 64

Query: 166 HPNTAKLLGYGIEGG---MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLY 222
           H N  K  G   + G   + +++E  P+GSL   L   ++++        +  + +G+ Y
Sbjct: 65  HENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDY 124

Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE 262
           L     +R IHRD+ A NIL+  +   +I DFGLAK LPE
Sbjct: 125 LGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPE 161

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  100 bits (251), Expect = 6e-25
 Identities = 55/154 (35%), Positives = 81/154 (52%), Gaps = 8/154 (5%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLR-NGQ---LVAIKRLTRGTADEIIADFLSELGIMAHVD 165
           +  + E +IG G + EV +GRL+  G+    VAIK L  G++D+   DFL+E  IM   D
Sbjct: 4   SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFD 63

Query: 166 HPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
           HPN  +L G   +   + I+ E   NGSL   L     K   G    +  G+A G+ YL 
Sbjct: 64  HPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLS 123

Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           E      +HRD+ A NIL+  +   ++ DFGL++
Sbjct: 124 EMN---YVHRDLAARNILVNSNLVCKVSDFGLSR 154

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 98.8 bits (247), Expect = 3e-24
 Identities = 55/150 (36%), Positives = 78/150 (52%), Gaps = 11/150 (7%)

Query: 112 FSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTA 170
           F+    IGKG + EVYK    R  Q+VAIK +    A++ I D   E+  ++    P   
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62

Query: 171 KLLGYGIEG-GMHIVLELSPNGSLASLL--YGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
           K  G  ++G  + I++E    GS   LL    + E     I + I   V  GL YLHE  
Sbjct: 63  KYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETY---IAF-ILREVLLGLEYLHEE- 117

Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLA 257
               IHRDIKAANILL+E+ + ++ DFG++
Sbjct: 118 --GKIHRDIKAANILLSEEGDVKLADFGVS 145

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 96.1 bits (240), Expect = 2e-23
 Identities = 54/147 (36%), Positives = 76/147 (51%), Gaps = 13/147 (8%)

Query: 118 IGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYG 176
           +G+G    VYK R +  G++ A+K++     +E     L EL  +   + P   K   YG
Sbjct: 9   LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKC--YG 66

Query: 177 I---EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRY--KIALGVAEGLLYLHEGCQRRI 231
               EG + IVLE    GSLA LL   K+  K        IA  + +GL YLH   +R I
Sbjct: 67  AFYKEGEISIVLEYMDGGSLADLL---KKVGKIPEPVLAYIARQILKGLDYLHT--KRHI 121

Query: 232 IHRDIKAANILLTEDFEPQICDFGLAK 258
           IHRDIK +N+L+    E +I DFG++K
Sbjct: 122 IHRDIKPSNLLINSKGEVKIADFGISK 148

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 96.7 bits (241), Expect = 2e-23
 Identities = 50/155 (32%), Positives = 81/155 (52%), Gaps = 9/155 (5%)

Query: 118 IGKGGYAEVYKGRLRN-GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLL-GY 175
           +G G + +VYK + +  G   A K +   + +E+  DF+ E+ I++   HPN   L   Y
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEEL-EDFMVEIDILSECKHPNIVGLYEAY 71

Query: 176 GIEGGMHIVLELSPNGSLASLLYGMKEKLKWG-IRYKIALGVAEGLLYLHEGCQRRIIHR 234
             E  + I++E    G+L S++  ++  L    IRY +   + E L +LH     ++IHR
Sbjct: 72  FYENKLWILIEFCDGGALDSIMLELERGLTEPQIRY-VCRQMLEALNFLHS---HKVIHR 127

Query: 235 DIKAANILLTEDFEPQICDFGL-AKWLPEQWTHHT 268
           D+KA NILLT D + ++ DFG+ AK         T
Sbjct: 128 DLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT 162

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 96.2 bits (240), Expect = 3e-23
 Identities = 61/169 (36%), Positives = 86/169 (50%), Gaps = 25/169 (14%)

Query: 105 LQSATNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLSELGIMA- 162
           L   T  F    +IG+G Y +VYK R  + GQLVAIK +     DE   +   E  I+  
Sbjct: 1   LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIK-IMDIIEDEE-EEIKEEYNILRK 58

Query: 163 HVDHPNTAKLLG-------YGIEGGMHIVLELSPNGSLASLLYG-------MKEKLKWGI 208
           + +HPN A   G        G +  + +V+EL   GS+  L+ G       +KE+    I
Sbjct: 59  YSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEW---I 115

Query: 209 RYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLA 257
            Y I      GL YLHE    ++IHRDIK  NILLT++ E ++ DFG++
Sbjct: 116 AY-ILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGVS 160

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 95.4 bits (238), Expect = 4e-23
 Identities = 59/176 (33%), Positives = 80/176 (45%), Gaps = 26/176 (14%)

Query: 101 SLYELQSATNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLSELG 159
             YEL            IG G Y +VYK R +  G+LVAIK + +    +       E+ 
Sbjct: 3   EDYELIQR---------IGSGTYGDVYKARDIATGELVAIK-VIKLEPGDDFEIIQQEIS 52

Query: 160 IMAHVDHPNTAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE 218
           ++    HPN     G Y     + IV+E    GSL  +    +  L      +IA    E
Sbjct: 53  MLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLS---ELQIAYVCRE 109

Query: 219 ---GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK 271
              GL YLH   +   IHRDIK ANILLTED + ++ DFG++  L       TI+K
Sbjct: 110 TLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLT-----ATIAK 157

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 95.2 bits (237), Expect = 4e-23
 Identities = 51/143 (35%), Positives = 78/143 (54%), Gaps = 4/143 (2%)

Query: 117 LIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYG 176
            IGKG + +VYKG L+    VA+K        ++   FL E  I+   DHPN  KL+G  
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61

Query: 177 IEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRD 235
           ++   ++IV+EL P GSL + L   K +L      +++L  A G+ YL     +  IHRD
Sbjct: 62  VQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRD 118

Query: 236 IKAANILLTEDFEPQICDFGLAK 258
           + A N L+ E+   +I DFG+++
Sbjct: 119 LAARNCLVGENNVLKISDFGMSR 141

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 94.3 bits (234), Expect = 1e-22
 Identities = 59/163 (36%), Positives = 84/163 (51%), Gaps = 17/163 (10%)

Query: 117 LIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYG 176
           L+GKG + EV+KG L++   VA+K        E+   FLSE  I+   DHPN  KL+G  
Sbjct: 2   LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61

Query: 177 IE-GGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRD 235
            +   ++IV+EL P G   S L   K++LK     K AL  A G+ YL     +  IHRD
Sbjct: 62  TQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLE---SKNCIHRD 118

Query: 236 IKAANILLTEDFEPQICDFGLA-------------KWLPEQWT 265
           + A N L+ E+   +I DFG++             K +P +WT
Sbjct: 119 LAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWT 161

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 93.7 bits (234), Expect = 1e-22
 Identities = 49/153 (32%), Positives = 77/153 (50%), Gaps = 17/153 (11%)

Query: 116 NLIGKGGYAEVYKGR-LRNGQLVAIKR--LTRGTADEIIADFLSELGIMAHVDHPNTAKL 172
             IGKG + +VY  R   +G+L  +K   L+  +  E   D L+E+ I+  ++HPN  K 
Sbjct: 6   KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKER-EDALNEVKILKKLNHPNIIKY 64

Query: 173 LGYGIEGGM-HIVLELSPNGSLASLLYGMKEKLKWGIRY------KIALGVAEGLLYLHE 225
                E G   IV+E +  G L+     +K++ K G  +         + +   L YLH 
Sbjct: 65  YESFEEKGKLCIVMEYADGGDLSQK---IKKQKKEGKPFPEEQILDWFVQLCLALKYLHS 121

Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
              R+I+HRDIK  NI LT +   ++ DFG++K
Sbjct: 122 ---RKILHRDIKPQNIFLTSNGLVKLGDFGISK 151

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 92.4 bits (230), Expect = 5e-22
 Identities = 49/152 (32%), Positives = 78/152 (51%), Gaps = 6/152 (3%)

Query: 113 SFENL--IGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
             E L  +G G    V K   R  G+++A+K +     + I    L EL I+   + P  
Sbjct: 2   DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYI 61

Query: 170 AKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQ 228
               G +   G + I +E    GSL  +L  ++ ++   I  KIA+ V +GL YLHE  +
Sbjct: 62  VGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHE--K 119

Query: 229 RRIIHRDIKAANILLTEDFEPQICDFGLAKWL 260
            +IIHRD+K +NIL+    + ++CDFG++  L
Sbjct: 120 HKIIHRDVKPSNILVNSRGQIKLCDFGVSGQL 151

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 90.6 bits (225), Expect = 3e-21
 Identities = 57/178 (32%), Positives = 89/178 (50%), Gaps = 20/178 (11%)

Query: 109 TNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLT--RGTADEIIADFLSELGIMAHVD 165
             NF  E  IGKG ++ VYK   L +G++VA+K++        +   D L E+ ++  +D
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 166 HPNTAKLLGYGIEGGM-HIVLELSPNGSLASLLYGMK-------EKLKWGIRYKIALGVA 217
           HPN  K L   IE    +IVLEL+  G L+ ++   K       E+  W    K  + + 
Sbjct: 61  HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIW----KYFVQLC 116

Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGT 275
             L ++H    +RI+HRDIK AN+ +T     ++ D GL ++   + T    S V GT
Sbjct: 117 SALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK-TTAAHSLV-GT 169

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 89.0 bits (221), Expect = 9e-21
 Identities = 55/161 (34%), Positives = 81/161 (50%), Gaps = 12/161 (7%)

Query: 117 LIGKGGYAEVYKGRLRN--GQL--VAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKL 172
            +G G +  V +G      G++  VA+K L      +I+ DFL E  IM  +DH N  +L
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61

Query: 173 LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKW---GIRYKIALGVAEGLLYLHEGCQR 229
            G  +   + +V EL+P GSL   L   K+ L           A+ +A G+ YL     +
Sbjct: 62  YGVVLTHPLMMVTELAPLGSLLDRLR--KDALGHFLISTLCDYAVQIANGMRYLE---SK 116

Query: 230 RIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTIS 270
           R IHRD+ A NILL  D + +I DFGL + LP+   H+ + 
Sbjct: 117 RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVME 157

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 88.6 bits (220), Expect = 1e-20
 Identities = 58/162 (35%), Positives = 82/162 (50%), Gaps = 21/162 (12%)

Query: 117 LIGKGGYAEVYKGRLRNGQLVAIKRLTR--GTADEIIADFLSELGIMAHVDHPNTAKLLG 174
            IGKG + +V  G  R GQ VA+K L      A      FL+E  +M  + HPN  +LLG
Sbjct: 13  TIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQA----FLAEASVMTTLRHPNLVQLLG 67

Query: 175 YGIEG-GMHIVLELSPNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEGCQRRII 232
             ++G  ++IV E    GSL   L    +  +    +   AL V EG+ YL E   +  +
Sbjct: 68  VVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEE---KNFV 124

Query: 233 HRDIKAANILLTEDFEPQICDFGLAK---------WLPEQWT 265
           HRD+ A N+L++ED   ++ DFGLAK          LP +WT
Sbjct: 125 HRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWT 166

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 88.5 bits (220), Expect = 1e-20
 Identities = 48/148 (32%), Positives = 74/148 (50%), Gaps = 8/148 (5%)

Query: 112 FSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTA 170
           F     +G+G Y  VYK   +  GQ+VAIK +     +E + + + E+ I+   D P   
Sbjct: 5   FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVP---VEEDLQEIIKEISILKQCDSPYIV 61

Query: 171 KLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQR 229
           K  G Y     + IV+E    GS++ ++    + L       I     +GL YLH     
Sbjct: 62  KYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH---SN 118

Query: 230 RIIHRDIKAANILLTEDFEPQICDFGLA 257
           + IHRDIKA NILL E+ + ++ DFG++
Sbjct: 119 KKIHRDIKAGNILLNEEGQAKLADFGVS 146

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 88.2 bits (219), Expect = 2e-20
 Identities = 50/151 (33%), Positives = 79/151 (52%), Gaps = 7/151 (4%)

Query: 117 LIGKGGYAEVYKG---RLRNGQL-VAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKL 172
            IG+G + +VY+G      N ++ VA+K     T+  +   FL E  IM   DHP+  KL
Sbjct: 13  CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72

Query: 173 LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRII 232
           +G   E  + IV+EL+P G L S L   K  L        +  ++  L YL     +R +
Sbjct: 73  IGVITENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE---SKRFV 129

Query: 233 HRDIKAANILLTEDFEPQICDFGLAKWLPEQ 263
           HRDI A N+L++     ++ DFGL+++L ++
Sbjct: 130 HRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 88.3 bits (219), Expect = 3e-20
 Identities = 58/179 (32%), Positives = 83/179 (46%), Gaps = 28/179 (15%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQLV-AIKRLTRGTADEIIADFLSELGIMAHVDHPN 168
                 + +G+G    V K RL+N  ++ A+K +T     ++    L EL I      P 
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60

Query: 169 TAKLLGYGI-----EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRY------KIALGVA 217
             K   YG         + I +E    GSL S+    K+  K G R       KIA  V 
Sbjct: 61  IVKY--YGAFLDESSSSIGIAMEYCEGGSLDSIY---KKVKKRGGRIGEKVLGKIAESVL 115

Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTF 276
           +GL YLH    R+IIHRDIK +NILLT   + ++CDFG++  L        ++ + GTF
Sbjct: 116 KGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGEL--------VNSLAGTF 163

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 86.3 bits (214), Expect = 9e-20
 Identities = 52/156 (33%), Positives = 75/156 (48%), Gaps = 7/156 (4%)

Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGI 177
           +G G +  V+ G+ R    VAIK +  G   E   DF+ E  +M  + HPN  +L G   
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSE--DDFIEEAKVMMKLSHPNLVQLYGVCT 69

Query: 178 EGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDI 236
           +   + IV E   NG L + L   K KL       +   V E + YL        IHRD+
Sbjct: 70  KQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDL 126

Query: 237 KAANILLTEDFEPQICDFGLAKW-LPEQWTHHTISK 271
            A N L+ ED   ++ DFGLA++ L +Q+T    +K
Sbjct: 127 AARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTK 162

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 86.6 bits (215), Expect = 1e-19
 Identities = 48/154 (31%), Positives = 80/154 (51%), Gaps = 17/154 (11%)

Query: 114 FENL--IGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADF-LSELGIMAHVDHPNT 169
           ++ L  IG+G Y  VYK R    G++VAIK++      E I    L E+ ++  ++HPN 
Sbjct: 1   YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60

Query: 170 AKLLG-YGIEGGMHIVLELSPNGSLASLL----YGMKEKLKWGIRYKIALGVAEGLLYLH 224
            KLL  +  +G +++V E   +  L  L+     G+ E L     Y++  G+A    + H
Sbjct: 61  IKLLDVFRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLA----FCH 115

Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
                 I+HRD+K  N+L+  +   ++ DFGLA+
Sbjct: 116 ---SHGILHRDLKPENLLINTEGVLKLADFGLAR 146

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 86.3 bits (214), Expect = 1e-19
 Identities = 54/158 (34%), Positives = 74/158 (46%), Gaps = 13/158 (8%)

Query: 110 NNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPN 168
           +++    +IG G  A VY    L N + VAIKR+        + +   E+  M+  +HPN
Sbjct: 1   DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPN 60

Query: 169 TAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGI--RYKIAL---GVAEGLLY 222
             K     + G  + +V+     GSL  +   MK     G      IA     V +GL Y
Sbjct: 61  VVKYYTSFVVGDELWLVMPYLSGGSLLDI---MKSSYPRGGLDEAIIATVLKEVLKGLEY 117

Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL 260
           LH   Q   IHRDIKA NILL ED   +I DFG++  L
Sbjct: 118 LHSNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASL 152

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 86.1 bits (213), Expect = 1e-19
 Identities = 49/155 (31%), Positives = 75/155 (48%), Gaps = 16/155 (10%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
                   +G G + EV+ G       VAIK L +G+       FL+E  +M  + HP  
Sbjct: 6   ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS--PEAFLAEANLMKQLQHPRL 63

Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKI------ALGVAEGLLYL 223
            +L     +  ++I+ E   NGSL   L     K   GI+  I      A  +AEG+ ++
Sbjct: 64  VRLYAVVTQEPIYIITEYMENGSLVDFL-----KTPEGIKLTINKLIDMAAQIAEGMAFI 118

Query: 224 HEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
               ++  IHRD++AANIL++E    +I DFGLA+
Sbjct: 119 E---RKNYIHRDLRAANILVSETLCCKIADFGLAR 150

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 85.8 bits (213), Expect = 1e-19
 Identities = 52/151 (34%), Positives = 71/151 (47%), Gaps = 7/151 (4%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
            +   E  +G G + EV+ G       VA+K L  GT       FL E  IM  + H   
Sbjct: 6   ESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS--PEAFLQEAQIMKKLRHDKL 63

Query: 170 AKLLGYGIEGG-MHIVLELSPNGSLASLLY-GMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
            +L     E   ++IV E    GSL   L  G  +KL+      +A  +AEG+ YL    
Sbjct: 64  VQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLES-- 121

Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
            R  IHRD+ A NIL+ E+   +I DFGLA+
Sbjct: 122 -RNYIHRDLAARNILVGENLVCKIADFGLAR 151

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 86.1 bits (213), Expect = 2e-19
 Identities = 56/158 (35%), Positives = 79/158 (50%), Gaps = 18/158 (11%)

Query: 115 ENLIGKGGYAEVYKGRL----RNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTA 170
           E +IG G + EV +GRL    +    VAIK L  G  ++   DFLSE  IM   DHPN  
Sbjct: 9   EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68

Query: 171 KLLGYGIEG-GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIAL-----GVAEGLLYLH 224
            L G   +   + I+ E   NG+L S L     +   G    I L     G+A G+ YL 
Sbjct: 69  HLEGVVTKSRPVMIITEFMENGALDSFL-----RQNDGQFTVIQLVGMLRGIAAGMKYLS 123

Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE 262
           E      +HRD+ A NIL+  +   ++ DFGL+++L +
Sbjct: 124 E---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 85.6 bits (212), Expect = 2e-19
 Identities = 55/156 (35%), Positives = 80/156 (51%), Gaps = 16/156 (10%)

Query: 117 LIGKGGYAEVYKG-RLRNGQLVAIKR----LTRGTADEIIADFLSELGIMAHVDHPNTAK 171
           L+G G +  VY+G  L +G   A+K         T  E +     E+ +++ + HPN  +
Sbjct: 7   LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66

Query: 172 LLGYGIEGG-MHIVLELSPNGSLASLL--YG-MKEKLKWGIRYKIALGVAEGLLYLHEGC 227
            LG   E   ++I LEL P GSLA LL  YG   E +      +I LG+     YLH+  
Sbjct: 67  YLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLE----YLHD-- 120

Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ 263
            R  +HRDIK ANIL+  +   ++ DFG+AK + E 
Sbjct: 121 -RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF 155

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 85.7 bits (212), Expect = 2e-19
 Identities = 49/159 (30%), Positives = 81/159 (50%), Gaps = 16/159 (10%)

Query: 117 LIGKGGYAEVYKGR-LRNGQLVAIK-----RLTRGTADEIIADFLSELGIMAHVDHPNTA 170
            +G G ++  Y+ R ++ G L+A+K     R T    +E++     E+ +MA ++HP+  
Sbjct: 7   QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66

Query: 171 KLLGYGIEGG-MHIVLELSPNGSLASLL--YGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
           ++LG   E    ++ +E    GS++ LL  YG     K  +       +  GL YLHE  
Sbjct: 67  RMLGATCEDSHFNLFVEWMAGGSVSHLLSKYG---AFKEAVIINYTEQLLRGLSYLHE-- 121

Query: 228 QRRIIHRDIKAANILL-TEDFEPQICDFGLAKWLPEQWT 265
             +IIHRD+K AN+L+ +     +I DFG A  L  + T
Sbjct: 122 -NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGT 159

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 85.3 bits (212), Expect = 3e-19
 Identities = 51/167 (30%), Positives = 81/167 (48%), Gaps = 12/167 (7%)

Query: 97  QKIFSLYELQSA---TNNFSFENLIGKGGYAEVYKGRLRN-GQLVAIKRLT-RGTADEII 151
           +   +L ++ S       +     IG+G   EVYK   R  G+ VAIK++  R    E+I
Sbjct: 3   ELKAALKDIVSEGDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELI 62

Query: 152 ADFLSELGIMAHVDHPNTAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRY 210
              ++E+ IM    HPN       Y +   + +V+E    GSL  ++     ++      
Sbjct: 63  ---INEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIA 119

Query: 211 KIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLA 257
            +   V +GL YLH    + +IHRDIK+ NILL++D   ++ DFG A
Sbjct: 120 YVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFA 163

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 84.8 bits (210), Expect = 3e-19
 Identities = 55/149 (36%), Positives = 78/149 (52%), Gaps = 11/149 (7%)

Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGI 177
           +G G + EV++G   N   VA+K L  GT D    DFL+E  IM  + HP   +L  Y +
Sbjct: 14  LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDP--KDFLAEAQIMKKLRHPKLIQL--YAV 69

Query: 178 ---EGGMHIVLELSPNGSLASLLYGMKEK-LKWGIRYKIALGVAEGLLYLHEGCQRRIIH 233
              E  ++IV EL   GSL   L G   + LK      +A  VA G+ YL     +  IH
Sbjct: 70  CTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIH 126

Query: 234 RDIKAANILLTEDFEPQICDFGLAKWLPE 262
           RD+ A N+L+ E+   ++ DFGLA+ + E
Sbjct: 127 RDLAARNVLVGENNICKVADFGLARVIKE 155

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 85.2 bits (211), Expect = 3e-19
 Identities = 50/155 (32%), Positives = 79/155 (50%), Gaps = 20/155 (12%)

Query: 118 IGKGGYAEVYKG----RLRNGQL-VAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKL 172
           +G G +  VYKG         ++ VAIK L   T+ +   + L E  +MA VDHP+  +L
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74

Query: 173 LGYGIEGGMHIVLELSPNGSLASLL------YGMKEKLKWGIRYKIALGVAEGLLYLHEG 226
           LG  +   + ++ +L P G L   +       G +  L W ++      +A+G+ YL E 
Sbjct: 75  LGICLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ------IAKGMSYLEE- 127

Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP 261
             +R++HRD+ A N+L+      +I DFGLAK L 
Sbjct: 128 --KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 84.6 bits (209), Expect = 4e-19
 Identities = 55/158 (34%), Positives = 84/158 (53%), Gaps = 17/158 (10%)

Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGI 177
           IG+G +  V +G    GQ VA+K +     D     FL E  +M  + H N  +LLG  +
Sbjct: 14  IGEGEFGAVLQGEY-TGQKVAVKNIK---CDVTAQAFLEETAVMTKLHHKNLVRLLGVIL 69

Query: 178 EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRY-KIALGVAEGLLYLHEGCQRRIIHRDI 236
             G++IV+EL   G+L + L      L   I+  + +L VAEG+ YL     ++++HRD+
Sbjct: 70  HNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDL 126

Query: 237 KAANILLTEDFEPQICDFGLAK---------WLPEQWT 265
            A NIL++ED   ++ DFGLA+          LP +WT
Sbjct: 127 AARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWT 164

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 84.7 bits (209), Expect = 6e-19
 Identities = 44/141 (31%), Positives = 80/141 (56%), Gaps = 4/141 (2%)

Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLG-YG 176
           +G G + +VYK + +    +A  ++    ++E + D++ E+ I+A  +HP   KLLG + 
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79

Query: 177 IEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDI 236
            +G + I++E  P G++ +++  +   L       I   + E L YLH     +IIHRD+
Sbjct: 80  WDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLH---SMKIIHRDL 136

Query: 237 KAANILLTEDFEPQICDFGLA 257
           KA N+LLT D + ++ DFG++
Sbjct: 137 KAGNVLLTLDGDIKLADFGVS 157

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 84.1 bits (208), Expect = 7e-19
 Identities = 55/162 (33%), Positives = 80/162 (49%), Gaps = 22/162 (13%)

Query: 116 NLIGKGGYAEVYKGRLRN-------GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPN 168
           N +G G + EVY+G   +          VA+K L +G  D+   +FL E  +M++ +HPN
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60

Query: 169 TAKLLGYGIEG-GMHIVLELSPNGSLASLLYGMKEK------LKWGIRYKIALGVAEGLL 221
             KLLG  +     +I++EL   G L S L   + +      L       I L VA+G +
Sbjct: 61  IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120

Query: 222 YLHEGCQRRIIHRDIKAANILLTE-----DFEPQICDFGLAK 258
           YL    Q   IHRD+ A N L++E     D   +I DFGLA+
Sbjct: 121 YLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 84.3 bits (208), Expect = 9e-19
 Identities = 50/149 (33%), Positives = 83/149 (55%), Gaps = 8/149 (5%)

Query: 117 LIGKGGYAEVYKG-RLRNGQLV----AIKRLTRGTADEIIADFLSELGIMAHVDHPNTAK 171
           ++G G +  VYKG  +  G+ V    AIK L   T  +   +F+ E  IMA +DHP+  +
Sbjct: 14  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73

Query: 172 LLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRI 231
           LLG  +   + +V +L P+G L   ++  K+ +   +     + +A+G++YL E   RR+
Sbjct: 74  LLGVCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEE---RRL 130

Query: 232 IHRDIKAANILLTEDFEPQICDFGLAKWL 260
           +HRD+ A N+L+      +I DFGLA+ L
Sbjct: 131 VHRDLAARNVLVKSPNHVKITDFGLARLL 159

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 85.2 bits (209), Expect = 1e-18
 Identities = 59/159 (37%), Positives = 83/159 (52%), Gaps = 12/159 (7%)

Query: 111 NFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTAD--EIIADFLSELGIMAHVDHP- 167
           ++     +G+G + EVY  R R  +LVA+K L +      + +  FL E+ I+A ++HP 
Sbjct: 1   SYRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58

Query: 168 NTAKLLGYGI-EGGMHIVLELSPNGSLASLL--YGMKEKLKWGIRYKIALGVAEGLLYLH 224
           N  KL  +   EG +++V+E    GSL  LL   G K  L       I   +   L YLH
Sbjct: 59  NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118

Query: 225 EGCQRRIIHRDIKAANILLTED-FEPQICDFGLAKWLPE 262
               + IIHRDIK  NILL  D    ++ DFGLAK LP+
Sbjct: 119 S---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPD 154

Length = 384

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 83.2 bits (206), Expect = 1e-18
 Identities = 48/151 (31%), Positives = 78/151 (51%), Gaps = 16/151 (10%)

Query: 118 IGKGGYAEVYKG--RLRNGQL--VAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLL 173
           +G G +  V KG   +++G+   VA+K L +        +FL E  +MA +DHP   +L+
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 174 GYGIEGGMHIVLELSPNGSLASLLYGMKE----KLKWGIRYKIALGVAEGLLYLHEGCQR 229
           G      + +V+EL+P G L   L   +E     LK     ++A  VA G+ YL     +
Sbjct: 63  GVCKGEPLMLVMELAPLGPLLKYLKKRREIPVSDLK-----ELAHQVAMGMAYLES---K 114

Query: 230 RIIHRDIKAANILLTEDFEPQICDFGLAKWL 260
             +HRD+ A N+LL    + +I DFG+++ L
Sbjct: 115 HFVHRDLAARNVLLVNRHQAKISDFGMSRAL 145

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 82.9 bits (205), Expect = 2e-18
 Identities = 52/154 (33%), Positives = 78/154 (50%), Gaps = 8/154 (5%)

Query: 112 FSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIA-DFLSELGIMAHVDHPNTA 170
           F+ E  +G G + EV++G  +N   VAIK L     D +   DF  E+  +  + H +  
Sbjct: 8   FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKS--DDLLKQQDFQKEVQALKRLRHKHLI 65

Query: 171 KLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEK-LKWGIRYKIALGVAEGLLYLHEGCQ 228
            L      G  ++I+ EL   GSL + L   + + L       +A  VAEG+ YL E   
Sbjct: 66  SLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE--- 122

Query: 229 RRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE 262
           +  IHRD+ A NIL+ ED   ++ DFGLA+ + E
Sbjct: 123 QNSIHRDLAARNILVGEDLVCKVADFGLARLIKE 156

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 83.0 bits (206), Expect = 2e-18
 Identities = 51/158 (32%), Positives = 79/158 (50%), Gaps = 19/158 (12%)

Query: 114 FENL--IGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADE---IIADFLSELGIMAHVDHP 167
           +E +  IG+G Y +VYK R  + G+LVA+K++      E   I A  + E+ ++  + HP
Sbjct: 1   YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITA--IREIKLLQKLRHP 58

Query: 168 NTAKLLGYGI-----EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLY 222
           N  +L    I     +G +++V E   +  L  LL   + K            + EGL Y
Sbjct: 59  NIVRL--KEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQY 115

Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL 260
           LH      I+HRDIK +NIL+  D   ++ DFGLA+  
Sbjct: 116 LH---SNGILHRDIKGSNILINNDGVLKLADFGLARPY 150

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 81.5 bits (202), Expect = 7e-18
 Identities = 51/160 (31%), Positives = 81/160 (50%), Gaps = 26/160 (16%)

Query: 116 NLIGKGGYAEVYKGR-LRNGQLVAIKRL-TRGTADEIIADFLSELGIMAHVD---HPNTA 170
             IG+G Y  VYK R L  G+ VA+K++    + + I    L E+ ++  ++   HPN  
Sbjct: 5   AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIV 64

Query: 171 KLL----GYGIEGGMHI--VLELSPNGSLASLL-----YGM-KEKLKWGIRYKIALGVAE 218
           +LL    G   +  + +  V E   +  LA+ L      G+  E +K  +R      +  
Sbjct: 65  RLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIKDLMRQ-----LLR 118

Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           G+ +LH     RI+HRD+K  NIL+T D + +I DFGLA+
Sbjct: 119 GVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLAR 155

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 81.2 bits (201), Expect = 7e-18
 Identities = 53/160 (33%), Positives = 73/160 (45%), Gaps = 21/160 (13%)

Query: 116 NLIGKGGYAEVYKG-RLRNGQLVAIK-----RLTRGTADEIIADFLSELGIMAHVDHPNT 169
           N IG G + +VY    L  G+L+A+K          T  EI      E+ ++  + HPN 
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIA----DEMKVLELLKHPNL 61

Query: 170 AKLLGYGIE---GGMHIVLELSPNGSLASLL-YGMKEKLKWGIRYKIALGVAEGLLYLHE 225
            K   YG+E     ++I +E    G+L  LL +G          Y + L   EGL YLH 
Sbjct: 62  VKY--YGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQL--LEGLAYLHS 117

Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT 265
                I+HRDIK ANI L  +   ++ DFG A  L    T
Sbjct: 118 ---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 81.0 bits (201), Expect = 1e-17
 Identities = 47/150 (31%), Positives = 73/150 (48%), Gaps = 7/150 (4%)

Query: 112 FSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADE-IIADFLSELGIMAHVDHPNT 169
           +     +G+G Y  VYK R  + G++VA+K++     +E I +  L E+ ++  + HPN 
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNI 60

Query: 170 AKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQ 228
            KLL     E  +++V E      L   L      L   +   I   +  GL Y H    
Sbjct: 61  VKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH---S 116

Query: 229 RRIIHRDIKAANILLTEDFEPQICDFGLAK 258
            RI+HRD+K  NIL+  D   ++ DFGLA+
Sbjct: 117 HRILHRDLKPQNILINRDGVLKLADFGLAR 146

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 80.8 bits (200), Expect = 1e-17
 Identities = 46/156 (29%), Positives = 76/156 (48%), Gaps = 11/156 (7%)

Query: 118 IGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNTAKLLGY 175
           IG+G +  V+K + R  G+ VA+K++     +  I +  L E+  +    HP   KLL  
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67

Query: 176 GIEG-GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHR 234
              G G  +V+E  P   L+ +L   +  L           + +G+ Y+H      I+HR
Sbjct: 68  FPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHA---NGIMHR 123

Query: 235 DIKAANILLTEDFEPQICDFGLAKWL----PEQWTH 266
           D+K AN+L++ D   +I DFGLA+      P  ++H
Sbjct: 124 DLKPANLLISADGVLKIADFGLARLFSEEEPRLYSH 159

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 80.8 bits (199), Expect = 1e-17
 Identities = 44/141 (31%), Positives = 79/141 (56%), Gaps = 4/141 (2%)

Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLL-GYG 176
           +G G + +VYK + +   ++A  ++    ++E + D++ E+ I+A  DHPN  KLL  + 
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72

Query: 177 IEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDI 236
            E  + I++E    G++ +++  ++  L       +     E L YLHE    +IIHRD+
Sbjct: 73  YENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDL 129

Query: 237 KAANILLTEDFEPQICDFGLA 257
           KA NIL T D + ++ DFG++
Sbjct: 130 KAGNILFTLDGDIKLADFGVS 150

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 79.9 bits (198), Expect = 1e-17
 Identities = 50/149 (33%), Positives = 76/149 (51%), Gaps = 16/149 (10%)

Query: 118 IGKGGYAEVYKGRLRN-GQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDHPNTAKLLG 174
           +GKG + +V   R ++ G+L A+K L +      + +   L+E  I++ ++HP   KL  
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59

Query: 175 YGI--EGGMHIVLELSPNGSLASLLY---GMKEKLKWGIRYKIALGVAEGLLYLHEGCQR 229
           Y    E  +++VLE +P G L S L       E+     R+  A  +   L YLH     
Sbjct: 60  YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEER---ARFYAA-EIVLALEYLHS---L 112

Query: 230 RIIHRDIKAANILLTEDFEPQICDFGLAK 258
            II+RD+K  NILL  D   ++ DFGLAK
Sbjct: 113 GIIYRDLKPENILLDADGHIKLTDFGLAK 141

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 79.9 bits (197), Expect = 2e-17
 Identities = 44/161 (27%), Positives = 79/161 (49%), Gaps = 15/161 (9%)

Query: 111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEII-ADFLSELGIMAHVDHPN 168
           +F   N IGKG +  V+K   + + ++ A+K++     +     + + E  ++A +D   
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60

Query: 169 TAKLLGYGIEGG-MHIVLELSPNGSLASLLYG-----MKEKLKWGIRYKIALGVAEGLLY 222
             +     ++ G ++IV+E + NG L  LL       + E   W    +I LG+A    +
Sbjct: 61  IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLA----H 116

Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ 263
           LH    ++I+HRDIK+ N+ L      +I D G+AK L + 
Sbjct: 117 LH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN 154

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 79.7 bits (196), Expect = 2e-17
 Identities = 47/143 (32%), Positives = 72/143 (50%), Gaps = 5/143 (3%)

Query: 118 IGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYG 176
           IG+G + EV+ GRLR +   VA+K        ++ A FL E  I+    HPN  +L+G  
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62

Query: 177 IEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRD 235
            +   ++IV+EL   G   + L     +LK     ++    A G+ YL        IHRD
Sbjct: 63  TQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CIHRD 119

Query: 236 IKAANILLTEDFEPQICDFGLAK 258
           + A N L+TE    +I DFG+++
Sbjct: 120 LAARNCLVTEKNVLKISDFGMSR 142

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 79.5 bits (196), Expect = 4e-17
 Identities = 53/165 (32%), Positives = 74/165 (44%), Gaps = 22/165 (13%)

Query: 112 FSFENLIGKGGYAEVYKGRLRNG----QLVAIK--RLTRGTADEIIADFLSELGIMAHVD 165
                ++G+G +  V +G+L         VA+K  +L   T  EI  +FLSE   M   D
Sbjct: 1   LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEI-EEFLSEAACMKDFD 59

Query: 166 HPNTAKLLGYGIEGGMH-------IVLELSPNGSLASLLYGMK-----EKLKWGIRYKIA 213
           HPN  KL+G   E           ++L    +G L S L   +     EKL      K  
Sbjct: 60  HPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFM 119

Query: 214 LGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           + +A G+ YL     R  IHRD+ A N +L ED    + DFGL+K
Sbjct: 120 VDIALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSK 161

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 79.1 bits (195), Expect = 6e-17
 Identities = 54/177 (30%), Positives = 78/177 (44%), Gaps = 31/177 (17%)

Query: 110 NNFSFENLIGKGGYAEVYKGRL------RNGQLVAIKRLTRGTADEIIADFLSELGIMAH 163
           NN  +   IG+G +  V++ R           +VA+K L    + ++ ADF  E  +MA 
Sbjct: 5   NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 64

Query: 164 VDHPNTAKLLGYGIEGG-MHIVLELSPNGSL------------ASLLYGMKEKLKWGIRY 210
            DHPN  KLLG    G  M ++ E    G L             SL +      K G+  
Sbjct: 65  FDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNP 124

Query: 211 ---------KIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
                     IA  VA G+ YL E   R+ +HRD+   N L+ E+   +I DFGL++
Sbjct: 125 LPLSCTEQLCIAKQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSR 178

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 78.6 bits (194), Expect = 6e-17
 Identities = 49/149 (32%), Positives = 85/149 (57%), Gaps = 16/149 (10%)

Query: 117 LIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLSELGIMA---HVDHPNTAKL 172
           LIG+G Y  VY+G+ +  G++VA+K +   T D+ ++D   E+ +++       PN  K 
Sbjct: 8   LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67

Query: 173 LGYGIEG-GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLL---YLHEGCQ 228
            G  ++G  + I++E +  GS+ +L+       K+     I++ + E L+   Y+H   +
Sbjct: 68  YGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKY-----ISVIIREVLVALKYIH---K 119

Query: 229 RRIIHRDIKAANILLTEDFEPQICDFGLA 257
             +IHRDIKAANIL+T     ++CDFG+A
Sbjct: 120 VGVIHRDIKAANILVTNTGNVKLCDFGVA 148

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 78.9 bits (195), Expect = 6e-17
 Identities = 46/161 (28%), Positives = 76/161 (47%), Gaps = 15/161 (9%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRN-GQLVAIKRLTRGTADEIIADF-LSELGIMAHVDHP 167
           N +    ++G+G Y  V K R +  G++VAIK+      DE +    L E+ ++  + H 
Sbjct: 1   NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60

Query: 168 NTAKLL-GYGIEGGMHIVLELSPNGSLASLL----YGMKEKLKWGIRYKIALGVAEGLLY 222
           N   L   +  +G +++V E     +L  LL     G+         +++   +A    Y
Sbjct: 61  NIVNLKEAFRRKGRLYLVFEYVER-TLLELLEASPGGLPPDAVRSYIWQLLQAIA----Y 115

Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ 263
            H      IIHRDIK  NIL++E    ++CDFG A+ L  +
Sbjct: 116 CH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRAR 153

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 78.3 bits (193), Expect = 7e-17
 Identities = 49/156 (31%), Positives = 84/156 (53%), Gaps = 9/156 (5%)

Query: 111 NFSFENLIGKGGYAEVYK-GRLRNGQLVAIKRLT-RGTADEIIADFLSELGIMAHVDHPN 168
           +F     +GKG Y  VYK  RL + Q  A+K +     + +   D ++E+ I+A V+HPN
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 169 TAKLLGYGIEGG-MHIVLELSPNGSLASLL---YGMKEKLKWGIRYKIALGVAEGLLYLH 224
                   ++G  + IV+E +P G L+  +      ++ +     ++I + +  GL  LH
Sbjct: 61  IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120

Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL 260
           E   ++I+HRD+K+ANILL  +   +I D G++K L
Sbjct: 121 E---QKILHRDLKSANILLVANDLVKIGDLGISKVL 153

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 77.9 bits (192), Expect = 1e-16
 Identities = 55/156 (35%), Positives = 82/156 (52%), Gaps = 21/156 (13%)

Query: 117 LIGKGGYAEVYKG-RLRNGQLVAIKR--LTRGTADE-------IIADFLSELGIMAHVDH 166
           LIGKG Y  VY    +  G+++A+K+  L    A         ++    SE+  +  +DH
Sbjct: 8   LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67

Query: 167 PNTAKLLGY-GIEGGMHIVLELSPNGSLASLL--YG-MKEKLKWGIRYKIALGVAEGLLY 222
            N  + LG+   E  + I LE  P GS+ S L  YG  +E+L   +R+     V EGL Y
Sbjct: 68  LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQL---VRF-FTEQVLEGLAY 123

Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           LH    + I+HRD+KA N+L+  D   +I DFG++K
Sbjct: 124 LH---SKGILHRDLKADNLLVDADGICKISDFGISK 156

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 78.5 bits (193), Expect = 1e-16
 Identities = 54/156 (34%), Positives = 84/156 (53%), Gaps = 12/156 (7%)

Query: 112 FSFENLIGKGGYAEVYKGR-LRNGQ----LVAIKRLTRGTADEIIADFLSELGIMAHVDH 166
           F    ++G G +  VYKG  +  G+     VAIK L   T+ +   + L E  +MA VD+
Sbjct: 9   FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68

Query: 167 PNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKI--ALGVAEGLLYLH 224
           P+  +LLG  +   + ++ +L P G L  L Y  + K   G +Y +   + +A+G+ YL 
Sbjct: 69  PHVCRLLGICLTSTVQLITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 126

Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL 260
           E   RR++HRD+ A N+L+      +I DFGLAK L
Sbjct: 127 E---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 77.3 bits (190), Expect = 2e-16
 Identities = 51/172 (29%), Positives = 89/172 (51%), Gaps = 18/172 (10%)

Query: 116 NLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIAD-----FLSELGIMAHVDHPNTA 170
            ++GKG Y  VY G    GQL+A+K++   T++ + A+        E+ ++  + H N  
Sbjct: 6   EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65

Query: 171 KLLGYGIEGG-MHIVLELSPNGSLASLL--YGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
           + LG  ++   + I +E  P GS++S+L  +G    L   +  K    + +G+ YLH  C
Sbjct: 66  QYLGTCLDDNTISIFMEFVPGGSISSILNRFG---PLPEPVFCKYTKQILDGVAYLHNNC 122

Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAK---WLPEQWTHHTISK-VEGT 275
              ++HRDIK  N++L  +   ++ DFG A+   W+    TH  + K + GT
Sbjct: 123 ---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGT 171

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 77.5 bits (191), Expect = 2e-16
 Identities = 47/165 (28%), Positives = 77/165 (46%), Gaps = 26/165 (15%)

Query: 117 LIGKGGYAEVYKGRLR------NGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNT 169
            +G+G + +V K              VA+K L     ++ ++D +SE+ +M  +  H N 
Sbjct: 19  PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78

Query: 170 AKLLGYGIEGG-MHIVLELSPNGSLASLLY-----GMK----------EKLKWGIRYKIA 213
             LLG   + G +++V+E + +G+L   L      G            E L        A
Sbjct: 79  INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138

Query: 214 LGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
             VA G+ +L     ++ IHRD+ A N+L+TED   +I DFGLA+
Sbjct: 139 YQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLAR 180

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 76.8 bits (189), Expect = 2e-16
 Identities = 46/163 (28%), Positives = 83/163 (50%), Gaps = 9/163 (5%)

Query: 113 SFENLIGKGGYAEVYKGRL-RNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAK 171
           + ++ +G G Y EVY+G   +    VA+K L   T +  + +FL E  +M  + HPN  +
Sbjct: 9   TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQ 66

Query: 172 LLGY-GIEGGMHIVLELSPNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEGCQR 229
           LLG    E   +I+ E    G+L   L    ++++   +   +A  ++  + YL    ++
Sbjct: 67  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KK 123

Query: 230 RIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ-WTHHTISK 271
             IHRD+ A N L+ E+   ++ DFGL++ +    +T H  +K
Sbjct: 124 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK 166

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 76.9 bits (189), Expect = 2e-16
 Identities = 54/158 (34%), Positives = 79/158 (50%), Gaps = 12/158 (7%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLR----NGQLVAIKRLTRGTADEIIADFLSELGIMAHVD 165
           +    E +IG G + EV  GRL+        VAIK L  G  ++   DFLSE  IM   D
Sbjct: 4   SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFD 63

Query: 166 HPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIAL--GVAEGLLY 222
           HPN   L G   +   + IV E   NGSL + L   K   ++ +   + +  G+A G+ Y
Sbjct: 64  HPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFL--RKHDGQFTVIQLVGMLRGIASGMKY 121

Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL 260
           L +      +HRD+ A NIL+  +   ++ DFGL++ L
Sbjct: 122 LSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVL 156

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 76.7 bits (189), Expect = 3e-16
 Identities = 58/176 (32%), Positives = 80/176 (45%), Gaps = 33/176 (18%)

Query: 106 QSATNNFSFENLIGKGGYAEVYKG--RLRNG----QLVAIKRLTRGTADEIIADFLSELG 159
           +   ++ +    +G G + EVY+G  R R+G      VA+K L    +++  +DFL E  
Sbjct: 2   EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEAL 61

Query: 160 IMAHVDHPNTAKLLGYGIEG-GMHIVLELSPNGSLASLL------------YGMKEKLKW 206
           IM+  +H N  +L+G   E     I+LEL   G L S L              MK+ L  
Sbjct: 62  IMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLL-- 119

Query: 207 GIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQ----ICDFGLAK 258
                 A  VA+G  YL E      IHRDI A N LLT    P     I DFG+A+
Sbjct: 120 ----FCARDVAKGCKYLEE---NHFIHRDIAARNCLLTCK-GPGRVAKIADFGMAR 167

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 76.8 bits (190), Expect = 3e-16
 Identities = 50/172 (29%), Positives = 75/172 (43%), Gaps = 37/172 (21%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHV---- 164
           ++F F  +IG+G ++ V   + +   +  AIK L +          L +   + +V    
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDK--------RQLIKEKKVKYVKIEK 52

Query: 165 -------DHPNTAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWG------IRY 210
                   HP   KL   +  E  ++ VLE +PNG L   +       K+G       R+
Sbjct: 53  EVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYI------RKYGSLDEKCTRF 106

Query: 211 KIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE 262
             A  +   L YLH    + IIHRD+K  NILL +D   +I DFG AK L  
Sbjct: 107 YAAE-ILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 76.1 bits (187), Expect = 4e-16
 Identities = 48/156 (30%), Positives = 75/156 (48%), Gaps = 7/156 (4%)

Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGI 177
           IG G +  V+ G     + VAIK +  G   E   DF+ E  +M  + HP   +L G   
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSE--EDFIEEAQVMMKLSHPKLVQLYGVCT 69

Query: 178 EGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDI 236
           E   + +V E   +G L+  L   + K        + L V EG+ YL       +IHRD+
Sbjct: 70  ERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDL 126

Query: 237 KAANILLTEDFEPQICDFGLAKW-LPEQWTHHTISK 271
            A N L+ E+   ++ DFG+ ++ L +Q+T  T +K
Sbjct: 127 AARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTK 162

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 76.3 bits (187), Expect = 4e-16
 Identities = 59/168 (35%), Positives = 87/168 (51%), Gaps = 19/168 (11%)

Query: 105 LQSATNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRL-TRGTADEIIADFLSELGIMA 162
           L+     F    L+G G Y +VYKGR ++ GQL AIK +   G  +E I   ++ L   +
Sbjct: 1   LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYS 60

Query: 163 HVDHPNTAKLLGY-------GIEGGMHIVLELSPNGSLASLLYGMKE---KLKWGIRYKI 212
           H  H N A   G        G++  + +V+E    GS+  L+   K    K +W I Y I
Sbjct: 61  H--HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEW-IAY-I 116

Query: 213 ALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL 260
              +  GL +LH   Q ++IHRDIK  N+LLTE+ E ++ DFG++  L
Sbjct: 117 CREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 161

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 76.6 bits (189), Expect = 5e-16
 Identities = 50/154 (32%), Positives = 78/154 (50%), Gaps = 19/154 (12%)

Query: 118 IGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADE---IIADFLSELGIMAHVDHPNTAKLL 173
           IG+G + EV+K R +   Q+VA+K++      E   I A  L E+ I+  + H N   L+
Sbjct: 20  IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITA--LREIKILQLLKHENVVNLI 77

Query: 174 ---------GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
                        +G  ++V E   +  LA LL     K       K+   +  GL Y+H
Sbjct: 78  EICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIH 136

Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
              + +I+HRD+KAANIL+T+D   ++ DFGLA+
Sbjct: 137 ---RNKILHRDMKAANILITKDGILKLADFGLAR 167

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 76.0 bits (187), Expect = 5e-16
 Identities = 51/168 (30%), Positives = 81/168 (48%), Gaps = 26/168 (15%)

Query: 111 NFSFENLIGKGGYAEVYKGRLRNG--QLVAIK---------RLTRGTADEIIADFLSELG 159
            ++    +G G +  VYK R +N    L+A+K            +   D+ I D +SE+ 
Sbjct: 1   EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVT 60

Query: 160 IM-AHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLK-------WGIRY 210
           I+   + HPN  +     +E   ++IV++L     L      +KEK +       W I  
Sbjct: 61  IIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFV 120

Query: 211 KIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           ++ L     L YLH+  ++RI+HRD+   NI+L ED +  I DFGLAK
Sbjct: 121 QMVLA----LRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAK 162

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 76.8 bits (190), Expect = 6e-16
 Identities = 49/160 (30%), Positives = 74/160 (46%), Gaps = 23/160 (14%)

Query: 112 FSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           +     IG G Y  V      R G+ VAIK+++    D I A   L E+ ++ H+ H N 
Sbjct: 2   YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENI 61

Query: 170 AKLL------GYGIEGGMHIVLELSPNGSLASLLYGMKEKL-----KWGIRYKIALGVAE 218
             LL             ++IV EL     L  ++    + L     ++   Y+I  G   
Sbjct: 62  IGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIK-SPQPLTDDHIQY-FLYQILRG--- 115

Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
            L YLH      +IHRD+K +NIL+  + + +ICDFGLA+
Sbjct: 116 -LKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLAR 151

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 75.6 bits (186), Expect = 7e-16
 Identities = 52/151 (34%), Positives = 73/151 (48%), Gaps = 13/151 (8%)

Query: 116 NLIGKGGYAEVYKGRL----RNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAK 171
            +IGKG +  VY G L          A+K L R T  E +  FL E  IM    HPN   
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60

Query: 172 LLGYGI--EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALG--VAEGLLYLHEGC 227
           LLG  +  EG   +VL    +G L + +    E     ++  I  G  VA+G+ YL    
Sbjct: 61  LLGICLPSEGSPLVVLPYMKHGDLRNFI--RSETHNPTVKDLIGFGLQVAKGMEYL---A 115

Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
            ++ +HRD+ A N +L E F  ++ DFGLA+
Sbjct: 116 SKKFVHRDLAARNCMLDESFTVKVADFGLAR 146

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 76.3 bits (188), Expect = 7e-16
 Identities = 53/154 (34%), Positives = 80/154 (51%), Gaps = 11/154 (7%)

Query: 111 NFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRL-TRGTADEIIADFLSELGIMAHVDHPN 168
            F   N IG+G Y  VY+ R   +G++VA+K++      D I    L E+ ++ ++ HPN
Sbjct: 8   EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPN 67

Query: 169 TAKLL----GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
             +L     G  ++  + +V+E      LASLL  M           + L +  GL YLH
Sbjct: 68  IVELKEVVVGKHLDS-IFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLH 125

Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           E     IIHRD+K +N+LLT+    +I DFGLA+
Sbjct: 126 ENF---IIHRDLKVSNLLLTDKGCLKIADFGLAR 156

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 75.8 bits (187), Expect = 1e-15
 Identities = 53/164 (32%), Positives = 81/164 (49%), Gaps = 17/164 (10%)

Query: 107 SATNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADE---IIADFLSELGIMA 162
           S   ++     +G+G + EVYK R ++ G++VA+K++      +   I A  L E+ I+ 
Sbjct: 5   SKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITA--LREIKILK 62

Query: 163 HVDHPNTAKLLGYGIE------GGMHIVLELSP--NGSLASLLYGMKEKLKWGIRYKIAL 214
            + HPN   L+   +E           V  ++P  +  L+ LL     KL         L
Sbjct: 63  KLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYML 122

Query: 215 GVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
            + EG+ YLHE     I+HRDIKAANIL+      +I DFGLA+
Sbjct: 123 QLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADFGLAR 163

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 74.9 bits (185), Expect = 2e-15
 Identities = 52/165 (31%), Positives = 82/165 (49%), Gaps = 32/165 (19%)

Query: 111 NFSFENLIGKGGYAEVYKGRLRN-GQLVAIKRL---TRGTADEIIA-DFLSELGIMAHVD 165
            +     +G+G YA VYK R +  G++VAIK++    R  A + I    L E+ ++  + 
Sbjct: 1   RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60

Query: 166 HPNTAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYK-IALGVAE----- 218
           HPN   LL  +G +  +++V E      + + L    EK+   I+ K I L  A+     
Sbjct: 61  HPNIIGLLDVFGHKSNINLVFEF-----METDL----EKV---IKDKSIVLTPADIKSYM 108

Query: 219 -----GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
                GL YLH      I+HRD+K  N+L+  D   ++ DFGLA+
Sbjct: 109 LMTLRGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLAR 150

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 74.8 bits (184), Expect = 2e-15
 Identities = 50/157 (31%), Positives = 76/157 (48%), Gaps = 12/157 (7%)

Query: 114 FENLIGKGGYAEVYKGRL-----RNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPN 168
           F   +GKG +  V   R        G++VA+K+L   TA+ +  DF  E+ I+  + H N
Sbjct: 8   FIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHL-RDFEREIEILKSLQHDN 66

Query: 169 TAKLLGYGIEGG---MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHE 225
             K  G     G   + +V+E  P GSL   L   +E+L        A  + +G+ YL  
Sbjct: 67  IVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGS 126

Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE 262
              +R +HRD+   NIL+  +   +I DFGL K LP+
Sbjct: 127 ---KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ 160

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 74.4 bits (183), Expect = 2e-15
 Identities = 52/198 (26%), Positives = 86/198 (43%), Gaps = 27/198 (13%)

Query: 118 IGKGGYAEVYKGRLRNGQ------LVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAK 171
           +G+G + +V+ G   + +      LVA+K L    +++   DF  E  ++ +  H N  K
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 172 LLGYGIEGGMHI-VLELSPNGSL----------ASLLYGMKEK---LKWGIRYKIALGVA 217
             G   EG   I V E   +G L          A+ L         L      +IA+ +A
Sbjct: 73  FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132

Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFG 277
            G++YL     +  +HRD+   N L+  D   +I DFG+++   + +T     +V G   
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR---DVYTTDYY-RVGGHTM 185

Query: 278 LVKLNLPPLVILKRCFTC 295
           L    +PP  I+ R FT 
Sbjct: 186 LPIRWMPPESIMYRKFTT 203

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 73.9 bits (181), Expect = 2e-15
 Identities = 55/167 (32%), Positives = 77/167 (46%), Gaps = 19/167 (11%)

Query: 111 NFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTA 170
                  IGKG + +V  G  R G  VA+K +     D     FL+E  +M  + H N  
Sbjct: 7   ELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKN---DATAQAFLAEASVMTQLRHSNLV 62

Query: 171 KLLGYGIE--GGMHIVLELSPNGSLASLLYGMKEKLKWGIRY-KIALGVAEGLLYLHEGC 227
           +LLG  +E  GG++IV E    GSL   L      +  G    K +L V E + YL    
Sbjct: 63  QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE--- 119

Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAKW---------LPEQWT 265
               +HRD+ A N+L++ED   ++ DFGL K          LP +WT
Sbjct: 120 ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT 166

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 74.5 bits (183), Expect = 3e-15
 Identities = 57/172 (33%), Positives = 85/172 (49%), Gaps = 22/172 (12%)

Query: 91  YDSQSPQKIFS-LYELQSATNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRL--TRGT 146
           +    P+K+F+ L E             IG G +  VY  R +R  ++VAIK++  +   
Sbjct: 8   FSKDDPEKLFTDLRE-------------IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQ 54

Query: 147 ADEIIADFLSELGIMAHVDHPNTAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLK 205
           ++E   D + E+  +  + HPNT +  G Y  E    +V+E    GS + +L   K+ L+
Sbjct: 55  SNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDILEVHKKPLQ 113

Query: 206 WGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLA 257
                 I  G  +GL YLH   +   IHRDIKA NILLTE    ++ DFG A
Sbjct: 114 EVEIAAICHGALQGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSA 162

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 73.1 bits (179), Expect = 6e-15
 Identities = 47/162 (29%), Positives = 87/162 (53%), Gaps = 10/162 (6%)

Query: 111 NFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIA--DFLSELGIMAHVDHP 167
           NF  E  IG+G ++EVY+   L + + VA+K++      +  A  D + E+ ++  ++HP
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62

Query: 168 NTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKW---GIRYKIALGVAEGLLYL 223
           N  K L   IE   ++IVLEL+  G L+ ++   K++ +       +K  + +   + ++
Sbjct: 63  NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122

Query: 224 HEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT 265
           H    RR++HRDIK AN+ +T     ++ D GL ++   + T
Sbjct: 123 H---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 73.2 bits (180), Expect = 7e-15
 Identities = 48/149 (32%), Positives = 75/149 (50%), Gaps = 13/149 (8%)

Query: 118 IGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADF-LSELGIMAHVDHPNTAKLLG- 174
           IG+G Y  V+K R R  GQ+VAIK+      D +I    L E+ ++  + HPN   L+  
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68

Query: 175 YGIEGGMHIVLELSPNGSLASL---LYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRI 231
           +  +  +H+V E   +  L  L     G+ E L   I ++    V     + H   +   
Sbjct: 69  FRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVN----FCH---KHNC 121

Query: 232 IHRDIKAANILLTEDFEPQICDFGLAKWL 260
           IHRD+K  NIL+T+  + ++CDFG A+ L
Sbjct: 122 IHRDVKPENILITKQGQIKLCDFGFARIL 150

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 72.8 bits (178), Expect = 9e-15
 Identities = 53/147 (36%), Positives = 79/147 (53%), Gaps = 7/147 (4%)

Query: 118 IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYG 176
           IGKG + EVYKG   R  ++VAIK +    A++ I D   E+ +++  D P   +  G  
Sbjct: 12  IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71

Query: 177 IEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRD 235
           ++G  + I++E    GS   LL      L+      I   + +GL YLH     R IHRD
Sbjct: 72  LKGTKLWIIMEYLGGGSALDLL--KPGPLEETYIATILREILKGLDYLH---SERKIHRD 126

Query: 236 IKAANILLTEDFEPQICDFGLAKWLPE 262
           IKAAN+LL+E  + ++ DFG+A  L +
Sbjct: 127 IKAANVLLSEQGDVKLADFGVAGQLTD 153

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 72.6 bits (178), Expect = 1e-14
 Identities = 51/155 (32%), Positives = 75/155 (48%), Gaps = 21/155 (13%)

Query: 117 LIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGY 175
           ++GKG Y  VY  R L     +AIK +        +     E+ + +++ H N  + LG 
Sbjct: 15  VLGKGTYGIVYAARDLSTQVRIAIKEIPE-RDSRYVQPLHEEIALHSYLKHRNIVQYLGS 73

Query: 176 GIEGG-MHIVLELSPNGSLASLLYGMKEKLKWG--------IRYKIALGVAEGLLYLHEG 226
             E G   I +E  P GSL++LL     + KWG        I +     + EGL YLH+ 
Sbjct: 74  DSENGFFKIFMEQVPGGSLSALL-----RSKWGPLKDNEQTIIF-YTKQILEGLKYLHD- 126

Query: 227 CQRRIIHRDIKAANILL-TEDFEPQICDFGLAKWL 260
              +I+HRDIK  N+L+ T     +I DFG +K L
Sbjct: 127 --NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 159

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 72.3 bits (177), Expect = 1e-14
 Identities = 49/156 (31%), Positives = 76/156 (48%), Gaps = 8/156 (5%)

Query: 110 NNFSFENLIGKGGYAEVYKGRL----RNGQLVAIKRLTRGTADEIIADFLSELGIMAHVD 165
           ++ + + +IG G + EV++G L    R    VAIK L  G  ++   DFLSE  IM    
Sbjct: 5   SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFS 64

Query: 166 HPNTAKLLGYGIE-GGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
           H N  +L G   +     I+ E   NG+L   L     +        +  G+A G+ YL 
Sbjct: 65  HHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS 124

Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL 260
           +      +HRD+ A NIL+  + E ++ DFGL++ L
Sbjct: 125 D---MNYVHRDLAARNILVNSNLECKVSDFGLSRVL 157

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 72.4 bits (177), Expect = 1e-14
 Identities = 54/148 (36%), Positives = 81/148 (54%), Gaps = 9/148 (6%)

Query: 118 IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYG 176
           IGKG + EV+KG   R  Q+VAIK +    A++ I D   E+ +++  D P   K  G  
Sbjct: 12  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71

Query: 177 IEGG-MHIVLELSPNGSLASLLY-GMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHR 234
           ++G  + I++E    GS   LL  G  ++ +     K  L   +GL YLH     + IHR
Sbjct: 72  LKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEIL---KGLDYLH---SEKKIHR 125

Query: 235 DIKAANILLTEDFEPQICDFGLAKWLPE 262
           DIKAAN+LL+E  + ++ DFG+A  L +
Sbjct: 126 DIKAANVLLSEQGDVKLADFGVAGQLTD 153

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 72.3 bits (177), Expect = 2e-14
 Identities = 51/169 (30%), Positives = 86/169 (50%), Gaps = 23/169 (13%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQL---VAIKRLTRGTADEIIADFLSELGIMAHV-D 165
           N+  F+++IG+G + +V K R++   L    AIKR+    + +   DF  EL ++  +  
Sbjct: 7   NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 66

Query: 166 HPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYG---MKEKLKWGIRYKIA-------- 213
           HPN   LLG     G +++ +E +P+G+L   L     ++    + I    A        
Sbjct: 67  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126

Query: 214 ----LGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
                 VA G+ YL    Q++ IHRD+ A NIL+ E++  +I DFGL++
Sbjct: 127 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR 172

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 71.9 bits (176), Expect = 2e-14
 Identities = 47/132 (35%), Positives = 67/132 (50%), Gaps = 8/132 (6%)

Query: 134 GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG---MHIVLELSPN 190
           G++VA+K L R    +  + +  E+ I+  + H N  K  G   E G   + +++E  P 
Sbjct: 33  GEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPL 92

Query: 191 GSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQ 250
           GSL    Y  K KL        A  + EG+ YLH    +  IHRD+ A N+LL  D   +
Sbjct: 93  GSL--RDYLPKHKLNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVK 147

Query: 251 ICDFGLAKWLPE 262
           I DFGLAK +PE
Sbjct: 148 IGDFGLAKAVPE 159

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 70.8 bits (173), Expect = 4e-14
 Identities = 57/175 (32%), Positives = 86/175 (49%), Gaps = 20/175 (11%)

Query: 99  IFSLYELQSATNNFSFENLIGKGGYAEVYK-GRLRNGQLVAIKRL--TRGTADEIIADFL 155
           +  L  L   T+ +     IGKG Y +VYK    ++G L A+K L       +EI A++ 
Sbjct: 11  MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEY- 69

Query: 156 SELGIMAHV-DHPNTAKLLG------YGIEGGMHIVLELSPNGSLASLLYGM---KEKLK 205
               I+  + +HPN  K  G        + G + +VLEL   GS+  L+ G+    ++L 
Sbjct: 70  ---NILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLD 126

Query: 206 WGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL 260
             +   I  G   GL +LH     RIIHRD+K  NILLT +   ++ DFG++  L
Sbjct: 127 EAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQL 178

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 70.0 bits (171), Expect = 8e-14
 Identities = 47/160 (29%), Positives = 81/160 (50%), Gaps = 11/160 (6%)

Query: 118 IGKGGYAEVYKGRL-----RNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKL 172
           +G+G + +V   R        G+ VA+K L   +    IAD   E+ I+ ++ H N  K 
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71

Query: 173 LGYGIEGG---MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQR 229
            G   E G   + +++E  P+GSL   L   K K+    + K A+ + +G+ YL     R
Sbjct: 72  KGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG---SR 128

Query: 230 RIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTI 269
           + +HRD+ A N+L+  + + +I DFGL K +     ++T+
Sbjct: 129 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTV 168

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 69.6 bits (170), Expect = 8e-14
 Identities = 43/146 (29%), Positives = 74/146 (50%), Gaps = 6/146 (4%)

Query: 118 IGKGGYAEVYKG--RLRNGQL-VAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLG 174
           +G G +  V KG  ++R  Q+ VAIK L       +  + + E  IM  +D+P   +++G
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62

Query: 175 YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHR 234
                 + +V+E++  G L   L G K+++      ++   V+ G+ YL     +  +HR
Sbjct: 63  VCEAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEG---KNFVHR 119

Query: 235 DIKAANILLTEDFEPQICDFGLAKWL 260
           D+ A N+LL      +I DFGL+K L
Sbjct: 120 DLAARNVLLVNQHYAKISDFGLSKAL 145

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 70.5 bits (172), Expect = 8e-14
 Identities = 51/144 (35%), Positives = 77/144 (53%), Gaps = 8/144 (5%)

Query: 118 IGKGGYAEVYKGR-LRNGQLVAIKRLTRG--TADEIIADFLSELGIMAHVDHPNTAKLLG 174
           IG G +  VY  R +RN ++VAIK+++     ++E   D + E+  +  + HPNT +  G
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82

Query: 175 -YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIH 233
            Y  E    +V+E    GS + LL   K+ L+      +  G  +GL YLH      +IH
Sbjct: 83  CYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIH 138

Query: 234 RDIKAANILLTEDFEPQICDFGLA 257
           RD+KA NILL+E    ++ DFG A
Sbjct: 139 RDVKAGNILLSEPGLVKLGDFGSA 162

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 69.7 bits (170), Expect = 9e-14
 Identities = 55/169 (32%), Positives = 87/169 (51%), Gaps = 24/169 (14%)

Query: 111 NFSFENLIGKGGYAEVYKGR-LRNGQLVAIKR-----LTRGTADEIIADFLSELGIMAHV 164
           NF  E  IG+G ++EVY+   L +G  VA+K+     L    A    AD + E+ ++  +
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKAR---ADCIKEIDLLKQL 59

Query: 165 DHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMK-------EKLKWGIRYKIALGV 216
           +HPN  K     IE   ++IVLEL+  G L+ ++   K       EK  W  +Y + L  
Sbjct: 60  NHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVW--KYFVQLCS 117

Query: 217 AEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT 265
           A  L ++H    RR++HRDIK AN+ +T     ++ D GL ++   + T
Sbjct: 118 A--LEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 69.4 bits (170), Expect = 1e-13
 Identities = 47/154 (30%), Positives = 77/154 (50%), Gaps = 19/154 (12%)

Query: 118 IGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGI-MAHVDHPNTAKLLGY 175
           +G+G Y  V K R    G ++A+KR+      +     L +L I M  VD P T     Y
Sbjct: 9   LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTF--Y 66

Query: 176 GI---EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRY------KIALGVAEGLLYLHEG 226
           G    EG + I +E+  + SL       K+    G+        KIA+ + + L YLH  
Sbjct: 67  GALFREGDVWICMEVM-DTSLDKF---YKKVYDKGLTIPEDILGKIAVSIVKALEYLHS- 121

Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL 260
            +  +IHRD+K +N+L+  + + ++CDFG++ +L
Sbjct: 122 -KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYL 154

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 69.3 bits (169), Expect = 2e-13
 Identities = 58/172 (33%), Positives = 86/172 (50%), Gaps = 21/172 (12%)

Query: 102 LYELQSATNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIK--RLTRGTADEIIADFLSEL 158
           L  L+     F    ++G G Y +VYKGR ++ GQL AIK   +T    +EI  + ++ L
Sbjct: 8   LSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLE-INML 66

Query: 159 GIMAHVDHPNTAKLLGY-------GIEGGMHIVLELSPNGSLASLLYGMKE---KLKWGI 208
              +H  H N A   G        G +  + +V+E    GS+  L+   K    K  W I
Sbjct: 67  KKYSH--HRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDW-I 123

Query: 209 RYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL 260
            Y I   +  GL +LH     ++IHRDIK  N+LLTE+ E ++ DFG++  L
Sbjct: 124 AY-ICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 171

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 69.0 bits (168), Expect = 2e-13
 Identities = 53/148 (35%), Positives = 80/148 (54%), Gaps = 9/148 (6%)

Query: 118 IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLG-Y 175
           IGKG + EV+KG   R  ++VAIK +    A++ I D   E+ +++  D P   K  G Y
Sbjct: 12  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71

Query: 176 GIEGGMHIVLELSPNGSLASLLY-GMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHR 234
             +  + I++E    GS   LL  G  ++ +      I   + +GL YLH     + IHR
Sbjct: 72  LKDTKLWIIMEYLGGGSALDLLEPGPLDETQIA---TILREILKGLDYLH---SEKKIHR 125

Query: 235 DIKAANILLTEDFEPQICDFGLAKWLPE 262
           DIKAAN+LL+E  E ++ DFG+A  L +
Sbjct: 126 DIKAANVLLSEHGEVKLADFGVAGQLTD 153

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 68.7 bits (168), Expect = 2e-13
 Identities = 51/156 (32%), Positives = 81/156 (51%), Gaps = 22/156 (14%)

Query: 117 LIGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADE--------IIADFLSELGIMAHVDHP 167
           LIG G +  VY G    +G+L+A+K++   +           ++     E+ ++  + H 
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66

Query: 168 NTAKLLGYGI-EGGMHIVLELSPNGSLASLL--YGMKEK--LKWGIRYKIALGVAEGLLY 222
           N  + LG  +    ++I LE  P GS+A+LL  YG  E+  ++  +R      + +GL Y
Sbjct: 67  NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQ-----ILKGLNY 121

Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           LH    R IIHRDIK ANIL+      +I DFG++K
Sbjct: 122 LH---NRGIIHRDIKGANILVDNKGGIKISDFGISK 154

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 68.5 bits (167), Expect = 2e-13
 Identities = 50/151 (33%), Positives = 80/151 (52%), Gaps = 12/151 (7%)

Query: 117 LIGKGGYAEVYKG-RLRNGQ----LVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAK 171
           ++G G +  VYKG  + +G+     VAIK L   T+ +   + L E  +MA V  P   +
Sbjct: 14  VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73

Query: 172 LLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIA--LGVAEGLLYLHEGCQR 229
           LLG  +   + +V +L P G L  L Y  + K + G +  +   + +A+G+ YL E    
Sbjct: 74  LLGICLTSTVQLVTQLMPYGCL--LDYVRENKDRIGSQDLLNWCVQIAKGMSYLEE---V 128

Query: 230 RIIHRDIKAANILLTEDFEPQICDFGLAKWL 260
           R++HRD+ A N+L+      +I DFGLA+ L
Sbjct: 129 RLVHRDLAARNVLVKSPNHVKITDFGLARLL 159

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 68.0 bits (166), Expect = 3e-13
 Identities = 46/155 (29%), Positives = 76/155 (49%), Gaps = 7/155 (4%)

Query: 113 SFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKL 172
           +F   +G G +  V+ G+ R    VAIK +  G   E   DF+ E  +M  + HP   +L
Sbjct: 7   TFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSE--EDFIEEAKVMMKLSHPKLVQL 64

Query: 173 LGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRI 231
            G   +   ++IV E   NG L + L   + KL   +   +   V EG+ YL    +   
Sbjct: 65  YGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE---RNSF 121

Query: 232 IHRDIKAANILLTEDFEPQICDFGLAKW-LPEQWT 265
           IHRD+ A N L++     ++ DFG+ ++ L +++T
Sbjct: 122 IHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT 156

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 68.6 bits (167), Expect = 3e-13
 Identities = 52/144 (36%), Positives = 77/144 (53%), Gaps = 8/144 (5%)

Query: 118 IGKGGYAEVYKGR-LRNGQLVAIKRLTRG--TADEIIADFLSELGIMAHVDHPNTAKLLG 174
           IG G +  VY  R +R  ++VAIK+++     ++E   D + E+  +  + HPN+ +  G
Sbjct: 33  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92

Query: 175 -YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIH 233
            Y  E    +V+E    GS + LL   K+ L+      I  G  +GL YLH      +IH
Sbjct: 93  CYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIH 148

Query: 234 RDIKAANILLTEDFEPQICDFGLA 257
           RDIKA NILLTE  + ++ DFG A
Sbjct: 149 RDIKAGNILLTEPGQVKLADFGSA 172

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 68.5 bits (167), Expect = 3e-13
 Identities = 49/168 (29%), Positives = 80/168 (47%), Gaps = 23/168 (13%)

Query: 111 NFSFENLIGKGGYAEVYKGRLR---NGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DH 166
           +  FE++IG+G + +V +  ++        AIK L    ++    DF  EL ++  +  H
Sbjct: 3   DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHH 62

Query: 167 PNTAKLLGYGIEGG-MHIVLELSPNGSLASLL---------------YGMKEKLKWGIRY 210
           PN   LLG     G ++I +E +P G+L   L               +G    L      
Sbjct: 63  PNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLL 122

Query: 211 KIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           + A  VA G+ YL E   ++ IHRD+ A N+L+ E+   +I DFGL++
Sbjct: 123 QFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLASKIADFGLSR 167

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 67.0 bits (163), Expect = 7e-13
 Identities = 49/147 (33%), Positives = 75/147 (51%), Gaps = 15/147 (10%)

Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGI 177
           +G G + EV+ G   N   VA+K L  GT    +  FL E  +M  + H    +L  Y +
Sbjct: 14  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS--VQAFLEEANLMKTLQHDKLVRL--YAV 69

Query: 178 ---EGGMHIVLELSPNGSLASLLY---GMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRI 231
              E  ++I+ E    GSL   L    G K  L   I +  +  +AEG+ Y+    ++  
Sbjct: 70  VTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDF--SAQIAEGMAYIE---RKNY 124

Query: 232 IHRDIKAANILLTEDFEPQICDFGLAK 258
           IHRD++AAN+L++E    +I DFGLA+
Sbjct: 125 IHRDLRAANVLVSESLMCKIADFGLAR 151

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 66.6 bits (163), Expect = 9e-13
 Identities = 42/159 (26%), Positives = 73/159 (45%), Gaps = 23/159 (14%)

Query: 118 IGKGGYAEVYKGRLRN------GQLVAIKRLT-RGTADEIIADFLSELGIMAHVDHPNTA 170
           +G+G +  VY+G  +          VAIK +    +  E I  FL+E  +M   +  +  
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIE-FLNEASVMKEFNCHHVV 72

Query: 171 KLLGYGIEGGMH--IVLELSPNGSLASLLYGMKEK---------LKWGIRYKIALGVAEG 219
           +LLG  +  G    +V+EL   G L S L   + +                ++A  +A+G
Sbjct: 73  RLLGV-VSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADG 131

Query: 220 LLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           + YL     ++ +HRD+ A N ++ ED   +I DFG+ +
Sbjct: 132 MAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTR 167

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 66.6 bits (162), Expect = 1e-12
 Identities = 48/153 (31%), Positives = 74/153 (48%), Gaps = 6/153 (3%)

Query: 111 NFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTA 170
           +   E  +G+G + EV+ G       VAIK L  GT       FL E  +M  + H    
Sbjct: 7   SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP--EAFLQEAQVMKKLRHEKLV 64

Query: 171 KLLGYGIEGGMHIVLELSPNGSLASLLYGMKEK-LKWGIRYKIALGVAEGLLYLHEGCQR 229
           +L     E  ++IV E    GSL   L G   K L+      +A  +A G+ Y+    + 
Sbjct: 65  QLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RM 121

Query: 230 RIIHRDIKAANILLTEDFEPQICDFGLAKWLPE 262
             +HRD++AANIL+ E+   ++ DFGLA+ + +
Sbjct: 122 NYVHRDLRAANILVGENLVCKVADFGLARLIED 154

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 66.9 bits (163), Expect = 1e-12
 Identities = 54/164 (32%), Positives = 78/164 (47%), Gaps = 23/164 (14%)

Query: 115 ENLIGKGGYAEVY---KGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVD-HPNTA 170
           E   G+   AE Y   K R      VA+K L     D+ +AD +SE+ +M  +  H N  
Sbjct: 22  EGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNII 81

Query: 171 KLLGYGI-EGGMHIVLELSPNGSLASLLYGMK---------------EKLKWGIRYKIAL 214
            LLG    EG +++++E +  G+L   L   +               E+L +      A 
Sbjct: 82  NLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAY 141

Query: 215 GVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
            VA G+ YL     RR IHRD+ A N+L+TED   +I DFGLA+
Sbjct: 142 QVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLAR 182

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 66.2 bits (161), Expect = 1e-12
 Identities = 49/146 (33%), Positives = 72/146 (49%), Gaps = 6/146 (4%)

Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGI 177
           +G+G + EV+ G       VAIK L  GT       FL E  IM  + H     L     
Sbjct: 14  LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMP--EAFLQEAQIMKKLRHDKLVPLYAVVS 71

Query: 178 EGGMHIVLELSPNGSLASLLY-GMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDI 236
           E  ++IV E    GSL   L  G  + LK      +A  +A+G+ Y+    +   IHRD+
Sbjct: 72  EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDL 128

Query: 237 KAANILLTEDFEPQICDFGLAKWLPE 262
           +AANIL+ ++   +I DFGLA+ + +
Sbjct: 129 RAANILVGDNLVCKIADFGLARLIED 154

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 66.2 bits (161), Expect = 1e-12
 Identities = 48/142 (33%), Positives = 67/142 (47%), Gaps = 6/142 (4%)

Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGI 177
           +G G + EV+ G       VA+K L  GT       FL E  IM  + H    +L     
Sbjct: 14  LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSP--ESFLEEAQIMKKLRHDKLVQLYAVVS 71

Query: 178 EGGMHIVLELSPNGSLASLLY-GMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDI 236
           E  ++IV E    GSL   L  G    LK      +A  VA G+ Y+    +   IHRD+
Sbjct: 72  EEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDL 128

Query: 237 KAANILLTEDFEPQICDFGLAK 258
           ++ANIL+ +    +I DFGLA+
Sbjct: 129 RSANILVGDGLVCKIADFGLAR 150

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 66.8 bits (163), Expect = 2e-12
 Identities = 55/184 (29%), Positives = 83/184 (45%), Gaps = 13/184 (7%)

Query: 82  MPRNLFVNSYDSQSPQKIFSLYELQSATNNFS-FE--NLIGKGGYAEVYKGRLR-NGQLV 137
           +P  L   S  S S     +     SA  + S  E  N IG G    VYK   R  G+L 
Sbjct: 43  VPLPLPPPSSSSSSSSSSSASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLY 102

Query: 138 AIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLG-YGIEGGMHIVLELSPNGSLASL 196
           A+K +     D +      E+ I+  V+HPN  K    +   G + ++LE    GSL   
Sbjct: 103 ALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGT 162

Query: 197 LYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGL 256
               ++ L       +A  +  G+ YLH   +R I+HRDIK +N+L+      +I DFG+
Sbjct: 163 HIADEQFLA-----DVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGV 214

Query: 257 AKWL 260
           ++ L
Sbjct: 215 SRIL 218

Length = 353

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 66.1 bits (161), Expect = 2e-12
 Identities = 47/156 (30%), Positives = 74/156 (47%), Gaps = 20/156 (12%)

Query: 117 LIGKGGYAEVYKG-RLRNGQL----VAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAK 171
           L+G G +  V+KG  +  G      VAIK +   +  +   +    +  M  +DH    +
Sbjct: 14  LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73

Query: 172 LLGYGIEGGMHIVLELSPNGSLASLLYGMKEK------LKWGIRYKIALGVAEGLLYLHE 225
           LLG      + +V +LSP GSL   +   ++       L W ++      +A+G+ YL E
Sbjct: 74  LLGICPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQ------IAKGMYYLEE 127

Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP 261
               R++HR++ A NILL  D   QI DFG+A  L 
Sbjct: 128 ---HRMVHRNLAARNILLKSDSIVQIADFGVADLLY 160

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 65.3 bits (160), Expect = 2e-12
 Identities = 50/152 (32%), Positives = 76/152 (50%), Gaps = 22/152 (14%)

Query: 118 IGKGGYAEVYKGRLRN-GQLVAIKRLTRGTADEIIAD-----FLSELGIMAHVDHPNTAK 171
           I KG Y  V+  + ++ G + AIK + +    ++I        L+E  I++    P   K
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKK---ADMIRKNQVDQVLTERDILSQAQSPYVVK 57

Query: 172 LLGYGIEG--GMHIVLELSPNGSLASLL--YG-MKEKLKWGIRYKIALGVAEGLLYLHEG 226
           L  Y  +G   +++V+E  P G LASLL   G + E +    R  IA  +   L YLH  
Sbjct: 58  LY-YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDV---ARIYIA-EIVLALEYLH-- 110

Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
               IIHRD+K  NIL+  +   ++ DFGL+K
Sbjct: 111 -SNGIIHRDLKPDNILIDSNGHLKLTDFGLSK 141

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 65.3 bits (160), Expect = 2e-12
 Identities = 44/156 (28%), Positives = 72/156 (46%), Gaps = 10/156 (6%)

Query: 118 IGKGGYAEVYK-GRLRNGQLVAIKRLTRGTADEIIADFL-SELGIMAHVDHPNTAKLLGY 175
           IGKG +  V K  R  +G+++  K +  G   E     L SE+ I+  + HPN  +    
Sbjct: 8   IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDR 67

Query: 176 GIEGG---MHIVLELSPNGSLASLL---YGMKEKLKWGIRYKIALGVAEGLLYLHEGCQ- 228
            I+     ++IV+E    G LA L+      ++ ++    ++I   +   L   H     
Sbjct: 68  IIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDP 127

Query: 229 -RRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ 263
              ++HRD+K ANI L  +   ++ DFGLAK L   
Sbjct: 128 GNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHD 163

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 65.8 bits (160), Expect = 3e-12
 Identities = 50/144 (34%), Positives = 73/144 (50%), Gaps = 8/144 (5%)

Query: 118 IGKGGYAEVY-KGRLRNGQLVAIKRLTRG--TADEIIADFLSELGIMAHVDHPNTAKLLG 174
           IG G +  VY        ++VA+K+++      +E   D + E+  +  + HPNT +  G
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88

Query: 175 -YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIH 233
            Y  E    +V+E    GS + LL   K+ L+      I  G  +GL YLH      +IH
Sbjct: 89  CYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIH 144

Query: 234 RDIKAANILLTEDFEPQICDFGLA 257
           RDIKA NILLTE  + ++ DFG A
Sbjct: 145 RDIKAGNILLTEPGQVKLADFGSA 168

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 65.3 bits (159), Expect = 3e-12
 Identities = 44/144 (30%), Positives = 71/144 (49%), Gaps = 6/144 (4%)

Query: 118 IGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLG-Y 175
           +GKG Y  VYK   R  G  +A+K +     +      + EL I+     P      G +
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68

Query: 176 GIEGGMHIVLELSPNGSLASLLYG--MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIH 233
            IEG +++ +E    GSL  L  G    E +   +  +I   V +GL +L E  +  IIH
Sbjct: 69  FIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIH 126

Query: 234 RDIKAANILLTEDFEPQICDFGLA 257
           RD+K  N+L+  + + ++CDFG++
Sbjct: 127 RDVKPTNVLVNGNGQVKLCDFGVS 150

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 64.6 bits (158), Expect = 4e-12
 Identities = 48/161 (29%), Positives = 73/161 (45%), Gaps = 11/161 (6%)

Query: 111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEI--IADFLSELGIMAHVDHP 167
           +F    +IGKG + +V   + R   ++ A+K + +    E   + + L+E  I+  ++HP
Sbjct: 1   HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60

Query: 168 NTAKLLGYGIEGG--MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHE 225
               L  Y  +    M++V++L   G L   L   K K            +   L YLH 
Sbjct: 61  FLVNLW-YSFQDEENMYLVVDLLLGGDLRYHL-SQKVKFSEEQVKFWICEIVLALEYLHS 118

Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLA-KWLPEQWT 265
              + IIHRDIK  NILL E     I DF +A K  P+  T
Sbjct: 119 ---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT 156

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 64.7 bits (157), Expect = 5e-12
 Identities = 46/151 (30%), Positives = 74/151 (49%), Gaps = 10/151 (6%)

Query: 111 NFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTA 170
           +   E  +G G + EV+         VA+K +  G+    +  FL+E  +M  + H    
Sbjct: 7   SLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS--VEAFLAEANVMKTLQHDKLV 64

Query: 171 KLLGYGIEGGMHIVLELSPNGSLASLLY---GMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
           KL     +  ++I+ E    GSL   L    G K+ L   I +  +  +AEG+ ++    
Sbjct: 65  KLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDF--SAQIAEGMAFIE--- 119

Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           QR  IHRD++AANIL++     +I DFGLA+
Sbjct: 120 QRNYIHRDLRAANILVSASLVCKIADFGLAR 150

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 64.3 bits (156), Expect = 8e-12
 Identities = 54/154 (35%), Positives = 78/154 (50%), Gaps = 16/154 (10%)

Query: 118 IGKGGYAEVYK-GRLRNGQLVAIKRLTRGTADEIIADFLSELGIM-AHVDHPNTAKLLGY 175
           IGKG Y +V+K    +NG   A+K L      +I  +  +E  I+ A  DHPN  K  G 
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVKILD--PIHDIDEEIEAEYNILKALSDHPNVVKFYGM 83

Query: 176 ----GIEGG--MHIVLELSPNGSLASLLYGMKEKLKWGIRYK---IALGVAEGLLYLHEG 226
                ++ G  + +VLEL   GS+  L+ G    LK G R +   IA  + E L+ L   
Sbjct: 84  YYKKDVKNGDQLWLVLELCNGGSVTDLVKGF---LKRGERMEEPIIAYILHEALMGLQHL 140

Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL 260
              + IHRD+K  NILLT +   ++ DFG++  L
Sbjct: 141 HVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQL 174

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 63.2 bits (153), Expect = 2e-11
 Identities = 48/163 (29%), Positives = 79/163 (48%), Gaps = 23/163 (14%)

Query: 116 NLIGKGGYAEVYKGRLRNGQL---VAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAK 171
           ++IG+G + +V K R++   L    AIKR+    + +   DF  EL ++  +  HPN   
Sbjct: 1   DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60

Query: 172 LLGYGIEGG-MHIVLELSPNGSLASLL---------------YGMKEKLKWGIRYKIALG 215
           LLG     G +++ +E +P+G+L   L                     L        A  
Sbjct: 61  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120

Query: 216 VAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           VA G+ YL +   ++ IHRD+ A NIL+ E++  +I DFGL++
Sbjct: 121 VARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR 160

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 63.9 bits (156), Expect = 2e-11
 Identities = 54/186 (29%), Positives = 83/186 (44%), Gaps = 28/186 (15%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEI----IADFLSELGIMAHV 164
           ++F    +IG+G + EV+  R +  GQ+ A+K L +  +D I    IA   +E  I+A  
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRK--SDMIKRNQIAHVRAERDILADA 58

Query: 165 DHPNTAKLLGYGIEGGMHI--VLELSPNGSLASLLYGMKEKLKWGIRYKI------ALGV 216
           D P   KL  Y  +   H+  V+E  P G L +LL          IR  +         +
Sbjct: 59  DSPWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLL----------IRKDVFPEETARFYI 107

Query: 217 AEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTF 276
           AE +L L    +   IHRDIK  NIL+  D   ++ DFGL K +           +  + 
Sbjct: 108 AELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMN--KAKDREYYLNDSH 165

Query: 277 GLVKLN 282
            L+  +
Sbjct: 166 NLLFRD 171

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 62.8 bits (152), Expect = 2e-11
 Identities = 48/151 (31%), Positives = 73/151 (48%), Gaps = 11/151 (7%)

Query: 111 NFSFENLIGKGGYAEVYKGR-LRNGQLVAIK--RLTRGTADEIIADFLSELGIMAHVDHP 167
           +F     IG G Y +VYK R +  G+L AIK  +L  G    ++     E+ +M    H 
Sbjct: 10  DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQ---QEIIMMKDCKHS 66

Query: 168 NTAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEG 226
           N     G Y     + I +E    GSL  + +      +  I Y ++    +GL YLH  
Sbjct: 67  NIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAY-VSRETLQGLYYLH-- 123

Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLA 257
             +  +HRDIK ANILLT++   ++ DFG++
Sbjct: 124 -SKGKMHRDIKGANILLTDNGHVKLADFGVS 153

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 62.6 bits (152), Expect = 3e-11
 Identities = 45/158 (28%), Positives = 79/158 (50%), Gaps = 11/158 (6%)

Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGI 177
           +G G +  V  G+ R    VAIK +  G+  E   +F+ E  +M  + H    +L  YG+
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE--DEFIEEAKVMMKLSHEKLVQL--YGV 67

Query: 178 ---EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHR 234
              +  ++IV E   NG L + L    ++ +     ++   V EG+ YL     ++ IHR
Sbjct: 68  CTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHR 124

Query: 235 DIKAANILLTEDFEPQICDFGLAKW-LPEQWTHHTISK 271
           D+ A N L+ +    ++ DFGL+++ L +++T    SK
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSK 162

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 62.5 bits (152), Expect = 3e-11
 Identities = 46/148 (31%), Positives = 69/148 (46%), Gaps = 13/148 (8%)

Query: 118 IGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEI--IADFLSELGI-MAHVDHPNTAKLL 173
           I KG +  VY  + R  G   AIK L +        + +  +E  I M   + P  AKL 
Sbjct: 4   ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63

Query: 174 GYGIEGG--MHIVLELSPNGSLASLLYGMKE-KLKWGIRYKIALGVAEGLLYLHEGCQRR 230
            Y  +    +++V+E    G  ASL+  +      W  +Y     V  G+  LH   QR 
Sbjct: 64  -YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQY--IAEVVLGVEDLH---QRG 117

Query: 231 IIHRDIKAANILLTEDFEPQICDFGLAK 258
           IIHRDIK  N+L+ +    ++ DFGL++
Sbjct: 118 IIHRDIKPENLLIDQTGHLKLTDFGLSR 145

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 61.5 bits (149), Expect = 6e-11
 Identities = 47/164 (28%), Positives = 77/164 (46%), Gaps = 20/164 (12%)

Query: 112 FSFENLIGKGGYAEVYKGRLR----NGQLVAIKRL-TRGTADEIIADFLSELGIMAHVDH 166
           F+   ++GKG +  V + +L+    + Q VA+K L     +   I +FL E   M   DH
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60

Query: 167 PNTAKLLGYGI----EGGMHIVLELSP---NGSLASLLYGMKE-----KLKWGIRYKIAL 214
           PN  KL+G  +    +G + I + + P   +G L + L   +       L      +  +
Sbjct: 61  PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120

Query: 215 GVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
            +A G+ YL     +  IHRD+ A N +L E+    + DFGL+K
Sbjct: 121 DIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSK 161

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 62.0 bits (150), Expect = 6e-11
 Identities = 45/139 (32%), Positives = 72/139 (51%), Gaps = 20/139 (14%)

Query: 137 VAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGIEGG-MHIVLELSPNGSLA 194
           VA+K L     D+ ++D +SE+ +M  +  H N   LLG   + G +++++E +  G+L 
Sbjct: 47  VAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLR 106

Query: 195 SLLY-----GM----------KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAA 239
             L      GM          +E+L +      A  VA G+ YL     ++ IHRD+ A 
Sbjct: 107 EYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRDLAAR 163

Query: 240 NILLTEDFEPQICDFGLAK 258
           N+L+TED   +I DFGLA+
Sbjct: 164 NVLVTEDNVMKIADFGLAR 182

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 61.4 bits (149), Expect = 7e-11
 Identities = 45/142 (31%), Positives = 66/142 (46%), Gaps = 9/142 (6%)

Query: 119 GKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLG-YGI 177
           G GG     K  +  G ++A K +  G    +    L EL IM     P      G +  
Sbjct: 16  GNGGSVSKVK-HIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLN 74

Query: 178 EGGMHIVLELSPNGSLASLL--YGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRD 235
           E  + + +E    GSL  +    G    +   I  KIA+ V EGL YL+     RI+HRD
Sbjct: 75  ENNICMCMEFMDCGSLDRIYKKGG---PIPVEILGKIAVAVVEGLTYLYN--VHRIMHRD 129

Query: 236 IKAANILLTEDFEPQICDFGLA 257
           IK +NIL+    + ++CDFG++
Sbjct: 130 IKPSNILVNSRGQIKLCDFGVS 151

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 61.1 bits (148), Expect = 1e-10
 Identities = 47/178 (26%), Positives = 79/178 (44%), Gaps = 33/178 (18%)

Query: 111 NFSFENLIGKGGYAEVYKG-----RLRNG-QLVAIKRLTRGTADEIIADFLSELGIMAHV 164
           N      +G+G + +V K      + R G   VA+K L    +   + D LSE  ++  V
Sbjct: 1   NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60

Query: 165 DHPNTAKLLGY-GIEGGMHIVLELSPNGSLASLLYGMK---------------------- 201
           +HP+  KL G    +G + +++E +  GSL S L   +                      
Sbjct: 61  NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120

Query: 202 -EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
              L  G     A  ++ G+ YL E    +++HRD+ A N+L+ E  + +I DFGL++
Sbjct: 121 ERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSR 175

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 61.0 bits (149), Expect = 1e-10
 Identities = 45/154 (29%), Positives = 73/154 (47%), Gaps = 26/154 (16%)

Query: 118 IGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSEL-GIMAHVDHPNTAKLL 173
           +G G +  VY  R +  G+LVAIK++ +     +E +   L E+  +    +HPN  KL 
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMN--LREVKSLRKLNEHPNIVKLK 64

Query: 174 GYGIEGG-MHIVLE-LSPNGSLASLLYGMKEKLKWG------IRYKIALGVAEGLLYLHE 225
               E   ++ V E +  N      LY + +  K        IR  I   + +GL ++H+
Sbjct: 65  EVFRENDELYFVFEYMEGN------LYQLMKDRKGKPFSESVIRS-IIYQILQGLAHIHK 117

Query: 226 -GCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
            G      HRD+K  N+L++     +I DFGLA+
Sbjct: 118 HG----FFHRDLKPENLLVSGPEVVKIADFGLAR 147

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 61.1 bits (149), Expect = 1e-10
 Identities = 47/151 (31%), Positives = 79/151 (52%), Gaps = 15/151 (9%)

Query: 116 NLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADE---IIADFLSELGIMAHVDHPNTAK 171
           N I +G Y  VY+ R  + G++VA+K+L      E   I +  L E+ I+  + HPN   
Sbjct: 11  NRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITS--LREINILLKLQHPNIVT 68

Query: 172 L----LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
           +    +G  ++  +++V+E   +  L SL+  MK+         + L +  G+ +LH   
Sbjct: 69  VKEVVVGSNLDK-IYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLH--- 123

Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
              I+HRD+K +N+LL      +ICDFGLA+
Sbjct: 124 DNWILHRDLKTSNLLLNNRGILKICDFGLAR 154

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 61.4 bits (150), Expect = 1e-10
 Identities = 52/166 (31%), Positives = 78/166 (46%), Gaps = 50/166 (30%)

Query: 118 IGKGGYAEVYKGR-LRNGQLVAIKRL---------TRGTADEIIADFLSELGIMAHVDHP 167
           +GKG Y  V+K    R  ++VA+K++          + T  EI+  FL ELG     DHP
Sbjct: 15  LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIM--FLQELG-----DHP 67

Query: 168 NTAKLLG---------------YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKI 212
           N  KLL                Y +E  +H V+        A++L   ++  K  I Y++
Sbjct: 68  NIVKLLNVIKAENDKDIYLVFEY-METDLHAVIR-------ANIL---EDVHKRYIMYQL 116

Query: 213 ALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
              +     Y+H G    +IHRD+K +NILL  D   ++ DFGLA+
Sbjct: 117 LKALK----YIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLAR 155

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 61.0 bits (148), Expect = 1e-10
 Identities = 52/162 (32%), Positives = 78/162 (48%), Gaps = 20/162 (12%)

Query: 110 NNFSFENLIGKGGYAEVYK------GRLRNGQLVAIKRL-TRGTADEIIADFLSELGIMA 162
           NN SF   +G G + +V +       +      VA+K L     + E  A  +SEL IM+
Sbjct: 35  NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREA-LMSELKIMS 93

Query: 163 HV-DHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALG----V 216
           H+ +H N   LLG    GG + ++ E    G L + L   +E     +  +  L     V
Sbjct: 94  HLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESF---LTLEDLLSFSYQV 150

Query: 217 AEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           A+G+ +L     +  IHRD+ A N+LLT     +ICDFGLA+
Sbjct: 151 AKGMAFL---ASKNCIHRDLAARNVLLTHGKIVKICDFGLAR 189

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 60.5 bits (147), Expect = 1e-10
 Identities = 38/146 (26%), Positives = 70/146 (47%), Gaps = 11/146 (7%)

Query: 118 IGKGGYAEVYKGRLRN-GQLVAIKRLTRGTADEIIADF-LSELGIMAHVDHPNTAKLLGY 175
           IG+G Y  V+K + R   ++VA+KR+     DE +    L E+ ++  + H N  +L  Y
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRL--Y 65

Query: 176 GI---EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRII 232
            +   +  + +V E   +  L          +   I       + +GL + H      ++
Sbjct: 66  DVLHSDKKLTLVFEYC-DQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH---SHNVL 121

Query: 233 HRDIKAANILLTEDFEPQICDFGLAK 258
           HRD+K  N+L+ ++ E ++ DFGLA+
Sbjct: 122 HRDLKPQNLLINKNGELKLADFGLAR 147

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 60.6 bits (147), Expect = 1e-10
 Identities = 49/176 (27%), Positives = 75/176 (42%), Gaps = 17/176 (9%)

Query: 110 NNFSFENLIGKGGYAEVY------KGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAH 163
            N+    L+G+G +  VY       GR    + V     +  T  E+ A    E+ ++ +
Sbjct: 2   TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNA-LECEIQLLKN 60

Query: 164 VDHPNTAKLLG-YGIEGGMHIVLELSPNGSLASLL--YGMKEKLKWGIRYKIALGVAEGL 220
           + H    +  G    +  + I +E  P GS+   L  YG    L   +  K    + EG+
Sbjct: 61  LQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYG---ALTETVTRKYTRQILEGV 117

Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT-ISKVEGT 275
            YLH      I+HRDIK ANIL       ++ DFG +K L    +  T +  V GT
Sbjct: 118 EYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGT 170

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 60.5 bits (147), Expect = 1e-10
 Identities = 47/163 (28%), Positives = 73/163 (44%), Gaps = 25/163 (15%)

Query: 118 IGKGGYAEVYKGRL------RNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAK 171
           +G+G + +VYKG L       +   VAIK L      ++  +F  E  +M+ + HPN   
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72

Query: 172 LLG-------------YGIEGGMH-IVLELSPNGSL--ASLLYGMKEKLKWGIRYKIALG 215
           LLG             Y   G +H  ++  SP+  +   S    +K  L       IA+ 
Sbjct: 73  LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132

Query: 216 VAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           +A G+ YL        +HRD+ A N L+ E    +I DFGL++
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSR 172

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 60.4 bits (146), Expect = 1e-10
 Identities = 50/167 (29%), Positives = 76/167 (45%), Gaps = 25/167 (14%)

Query: 114 FENLIGKGGYAEVYKGRL-----RNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPN 168
           F   +G+  + ++YKG L      + QLVAIK L      +   +F  E  +MA + HPN
Sbjct: 9   FMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPN 68

Query: 169 TAKLLG-------------YGIEGGMHIVLEL-SPN---GSLASLLYGMKEKLKWGIRYK 211
              LLG             Y  +G +H  L + SP+   G  +     +K  L  G    
Sbjct: 69  IVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLH 128

Query: 212 IALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           IA+ +A G+ YL        +H+D+ A NIL+ E    +I D GL++
Sbjct: 129 IAIQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSR 172

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 60.3 bits (146), Expect = 2e-10
 Identities = 46/157 (29%), Positives = 71/157 (45%), Gaps = 10/157 (6%)

Query: 104 ELQSATNNFSFENLIGKGGYAEVYKGRL----RNGQLVAIKRLTRGTADEIIADFLSELG 159
           EL + +     E ++G G + E+ +G L    +    VAI  L  G +D+    FL+E  
Sbjct: 1   ELDNKS--IKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEAL 58

Query: 160 IMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE 218
            +   DH N  +L G    G  M IV E   NG+L S L   + +L  G    +  G+A 
Sbjct: 59  TLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLAS 118

Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFG 255
           G+ YL E      +H+ + A  +L+  D   +I  F 
Sbjct: 119 GMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFR 152

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 60.5 bits (147), Expect = 2e-10
 Identities = 43/160 (26%), Positives = 70/160 (43%), Gaps = 24/160 (15%)

Query: 116 NLIGKGGYAEVYKGR-LRNGQLVAIKRL-----------TRGTADEIIADF--LSELGIM 161
             +G+G Y +V K      G++VAIK++            R         F  L EL IM
Sbjct: 15  AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74

Query: 162 AHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYK--IALGVAE 218
             + H N   L+   +EG  +++V+++     L  ++     K++        I L +  
Sbjct: 75  NEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVV---DRKIRLTESQVKCILLQILN 130

Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           GL  LH   +   +HRD+  ANI +      +I DFGLA+
Sbjct: 131 GLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLAR 167

Length = 335

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 60.6 bits (147), Expect = 2e-10
 Identities = 50/181 (27%), Positives = 88/181 (48%), Gaps = 19/181 (10%)

Query: 84  RNLFVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLV-AIKRL 142
           +N  ++++ S+  +    + +L+    +F    +IG+G + EV   R ++ + V A+K L
Sbjct: 17  KNKNIDNFLSRYEKAAEKITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLL 76

Query: 143 TRGTADEII-----ADFLSELGIMAHVDHPNTAKL-LGYGIEGGMHIVLELSPNGSLASL 196
           ++    E+I     A F  E  IMAH +     +L   +  +  +++V+E  P G L +L
Sbjct: 77  SK---FEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNL 133

Query: 197 L--YGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDF 254
           +  Y + EK  W   Y      AE +L L        IHRD+K  N+LL +    ++ DF
Sbjct: 134 MSNYDIPEK--WARFY-----TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADF 186

Query: 255 G 255
           G
Sbjct: 187 G 187

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 59.7 bits (144), Expect = 2e-10
 Identities = 47/152 (30%), Positives = 74/152 (48%), Gaps = 11/152 (7%)

Query: 110 NNFSFENLIGKGGYAEVYKGR-LRNGQLVAIK--RLTRGTADEIIADFLSELGIMAHVDH 166
           +++     +G G Y +VYK R L  G+L A+K  +L  G    +I     E+ ++    H
Sbjct: 9   HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQ---QEIFMVKECKH 65

Query: 167 PNTAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHE 225
            N     G Y     + I +E    GSL  + +      +  I Y +     +GL YLH 
Sbjct: 66  CNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAY-VCRETLQGLAYLH- 123

Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLA 257
              +  +HRDIK ANILLT++ + ++ DFG+A
Sbjct: 124 --SKGKMHRDIKGANILLTDNGDVKLADFGVA 153

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 59.7 bits (145), Expect = 3e-10
 Identities = 48/154 (31%), Positives = 80/154 (51%), Gaps = 12/154 (7%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTR-GTADE---IIADFLSELGIMAHV 164
           N+      IG G   +VYK R +  G ++A+K++ R G  +E   I+ D   ++ + +H 
Sbjct: 15  NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDL--DVVLKSH- 71

Query: 165 DHPNTAKLLGYGI-EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYL 223
           D P   K  GY I +  + I +EL     L  LL  ++  +   I  K+ + + + L YL
Sbjct: 72  DCPYIVKCYGYFITDSDVFICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYL 130

Query: 224 HEGCQRRIIHRDIKAANILLTEDFEPQICDFGLA 257
            E  +  +IHRD+K +NILL      ++CDFG++
Sbjct: 131 KE--KHGVIHRDVKPSNILLDASGNVKLCDFGIS 162

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 59.5 bits (145), Expect = 3e-10
 Identities = 48/166 (28%), Positives = 78/166 (46%), Gaps = 19/166 (11%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEII-----ADFLSELGIMAH 163
           ++F F   +G G +  V   R + +G+  A+K L++    +I+        L+E  I+  
Sbjct: 1   DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSK---AKIVKLKQVEHVLNEKRILQS 57

Query: 164 VDHPNTAKLLG-YGIEGGMHIVLELSPNGSLASLL--YGMKEKLKWGIRYKIALGVAEGL 220
           + HP    L G +  +  +++V+E  P G L S L   G +        Y  A  V   L
Sbjct: 58  IRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSG-RFPEPVARFY--AAQVVLAL 114

Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ-WT 265
            YLH      I++RD+K  N+LL  D   +I DFG AK +  + +T
Sbjct: 115 EYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYT 157

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 59.4 bits (144), Expect = 3e-10
 Identities = 47/156 (30%), Positives = 80/156 (51%), Gaps = 16/156 (10%)

Query: 111 NFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADE-IIADFLSELGIMAHVDHPN 168
           NF     IG+G Y  VYK R    G++VA+K++   T  E + +  + E+ ++  ++HPN
Sbjct: 1   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60

Query: 169 TAKLLGY-GIEGGMHIVLELSPNGSL-----ASLLYGMKEKLKWGIRYKIALGVAEGLLY 222
             KLL     E  +++V E   +  L     AS L G+   L     +++  G+A    +
Sbjct: 61  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLA----F 115

Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
            H     R++HRD+K  N+L+  +   ++ DFGLA+
Sbjct: 116 CH---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 148

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 59.6 bits (145), Expect = 4e-10
 Identities = 44/150 (29%), Positives = 73/150 (48%), Gaps = 16/150 (10%)

Query: 118 IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNTAKLL-- 173
           IG G Y  V      R+G+ VAIK++        +A   L EL I+ H  H N   +   
Sbjct: 13  IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDI 72

Query: 174 -----GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQ 228
                    +  +++V++L  +  L  +++  +   +  IRY     +  GL Y+H    
Sbjct: 73  LRPPGADFKD--VYVVMDLMES-DLHHIIHSDQPLTEEHIRY-FLYQLLRGLKYIHSAN- 127

Query: 229 RRIIHRDIKAANILLTEDFEPQICDFGLAK 258
             +IHRD+K +N+L+ ED E +I DFG+A+
Sbjct: 128 --VIHRDLKPSNLLVNEDCELRIGDFGMAR 155

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 59.2 bits (144), Expect = 5e-10
 Identities = 49/168 (29%), Positives = 80/168 (47%), Gaps = 21/168 (12%)

Query: 112 FSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           +   + +G G Y +V        G+ VAIK+L+R     I A     EL ++ H+DH N 
Sbjct: 17  YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENV 76

Query: 170 AKLL-----GYGIEG--GMHIVLELSPNGSLASLLYGMKEKLKWG---IRYKIALGVAEG 219
             LL        +E    +++V  L     + + L  + +  K     I++ +   +  G
Sbjct: 77  IGLLDVFTPASSLEDFQDVYLVTHL-----MGADLNNIVKCQKLSDDHIQF-LVYQILRG 130

Query: 220 LLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH 267
           L Y+H      IIHRD+K +NI + ED E +I DFGLA+   ++ T +
Sbjct: 131 LKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGY 175

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 58.6 bits (142), Expect = 6e-10
 Identities = 44/156 (28%), Positives = 79/156 (50%), Gaps = 29/156 (18%)

Query: 118 IGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADE-IIADFLSELGIMAHVDHPNTAKLLGY 175
           IG+G Y  VYKGR  + GQ+VA+K++   + +E + +  + E+ ++  + HPN   L   
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67

Query: 176 GI-EGGMHIVLE------------LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLY 222
            + E  ++++ E            L     + + L  +K  L     Y+I     +G+L+
Sbjct: 68  LMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAEL--VKSYL-----YQI----LQGILF 116

Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
            H    RR++HRD+K  N+L+      ++ DFGLA+
Sbjct: 117 CH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLAR 149

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 58.5 bits (142), Expect = 6e-10
 Identities = 53/163 (32%), Positives = 80/163 (49%), Gaps = 19/163 (11%)

Query: 112 FSFENL-----IGKGGYAEVYKGRLRN-GQLVAIKRLTRGTADEI-IADFLSEL-GIMAH 163
           F+ E+L     IG+G +  V K   +  G ++A+KR+ R T DE      L +L  +M  
Sbjct: 1   FTAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRI-RSTVDEKEQKRLLMDLDVVMRS 59

Query: 164 VDHPNTAKLLGYGI---EGGMHIVLEL--SPNGSLASLLYGMKEK-LKWGIRYKIALGVA 217
            D P   K   YG    EG   I +EL           +Y + +  +   I  KIA+   
Sbjct: 60  SDCPYIVKF--YGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATV 117

Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL 260
           + L YL E  + +IIHRD+K +NILL  +   ++CDFG++  L
Sbjct: 118 KALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQL 158

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 58.5 bits (142), Expect = 6e-10
 Identities = 38/131 (29%), Positives = 62/131 (47%), Gaps = 14/131 (10%)

Query: 136 LVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGI-EGGMHIVLELSPNGSLA 194
           LVA+K L    +D    DFL E+ I++ +  PN A+LLG    +  + +++E   NG L 
Sbjct: 48  LVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLN 107

Query: 195 SLLY-------GMKEKLK---WGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLT 244
             L        G+    K   +     +A  +A G+ YL        +HRD+   N L+ 
Sbjct: 108 QFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRNCLVG 164

Query: 245 EDFEPQICDFG 255
           +++  +I DFG
Sbjct: 165 KNYTIKIADFG 175

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 58.5 bits (141), Expect = 6e-10
 Identities = 48/158 (30%), Positives = 74/158 (46%), Gaps = 21/158 (13%)

Query: 118 IGKGGYAEVYKGRLRNGQL---VAIK--RLTRGTADEIIADFLSELGIMAHVDHPNTAKL 172
           +G+G +  V +G+L        VA+K  ++   T  E+  DFLSE   M   DHPN  +L
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEM-EDFLSEAVCMKEFDHPNVMRL 65

Query: 173 LGYGIEGGMH-------IVLELSPNGSLAS-LLYG----MKEKLKWGIRYKIALGVAEGL 220
           +G  ++           ++L    +G L S LLY       + L   +  K    +A G+
Sbjct: 66  IGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGM 125

Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
            YL     +  IHRD+ A N +L E+    + DFGL+K
Sbjct: 126 EYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 58.6 bits (142), Expect = 6e-10
 Identities = 44/186 (23%), Positives = 76/186 (40%), Gaps = 36/186 (19%)

Query: 112 FSFENL-----IGKGGYAEVYKGRLRNG------QLVAIKRLTRGTADEIIADFLSELGI 160
           F   NL     +G+G + EV+  + +         LV +K L +   + + ++F  EL +
Sbjct: 2   FPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDM 61

Query: 161 MAHVDHPNTAKLLGYGIEGGMH-IVLELSPNGSLASLLYGMKEK--------LKWGIRYK 211
              + H N  +LLG   E   H ++LE +  G L   L   K K        L    +  
Sbjct: 62  FRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVA 121

Query: 212 IALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK------------- 258
           +   +A G+ +L      R +HRD+ A N L++   E ++    L+K             
Sbjct: 122 LCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNA 178

Query: 259 WLPEQW 264
            +P +W
Sbjct: 179 LIPLRW 184

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 58.4 bits (141), Expect = 7e-10
 Identities = 48/151 (31%), Positives = 74/151 (49%), Gaps = 13/151 (8%)

Query: 118 IGKGGYAEVYKG-RLRNGQLVAIKR--LTRGTADEIIADFLSELGIMAHVDHPNTAKLL- 173
           IG+G    VY    +  GQ VAIK+  L +    E+I   ++E+ +M    HPN    L 
Sbjct: 27  IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELI---INEILVMRENKHPNIVNYLD 83

Query: 174 GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIH 233
            Y +   + +V+E    GSL  ++   +  +  G    +     + L +LH     ++IH
Sbjct: 84  SYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLH---SNQVIH 138

Query: 234 RDIKAANILLTEDFEPQICDFGL-AKWLPEQ 263
           RDIK+ NILL  D   ++ DFG  A+  PEQ
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 58.1 bits (140), Expect = 1e-09
 Identities = 44/139 (31%), Positives = 72/139 (51%), Gaps = 20/139 (14%)

Query: 137 VAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGIEGG-MHIVLELSPNGSLA 194
           VA+K L     ++ ++D +SE+ +M  +  H N   LLG   + G +++++E +  G+L 
Sbjct: 53  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 112

Query: 195 SLLY-----GMK----------EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAA 239
             L      GM+          E+L +      A  VA G+ YL     ++ IHRD+ A 
Sbjct: 113 EYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAAR 169

Query: 240 NILLTEDFEPQICDFGLAK 258
           N+L+TED   +I DFGLA+
Sbjct: 170 NVLVTEDNVMKIADFGLAR 188

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 57.1 bits (138), Expect = 2e-09
 Identities = 47/158 (29%), Positives = 71/158 (44%), Gaps = 14/158 (8%)

Query: 118 IGKGGYAEVYKGRLRN-GQLVAIKRLTRG----TADEIIADFLSELGIMAHVDHPNTAKL 172
           +GKGG+ EV   +++  G++ A K+L +        E +A  L+E  I+  V       L
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMA--LNEKKILEKVSSRFIVSL 58

Query: 173 LGYGIEGGMHI--VLELSPNGSLASLLYGMKEKLKWGIRYKI-ALGVAEGLLYLHEGCQR 229
             Y  E    +  V+ L   G L   +Y + E      R    A  +  GL +LH   QR
Sbjct: 59  -AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLH---QR 114

Query: 230 RIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH 267
           RI++RD+K  N+LL +    +I D GLA  L       
Sbjct: 115 RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIK 152

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 57.3 bits (138), Expect = 2e-09
 Identities = 45/166 (27%), Positives = 81/166 (48%), Gaps = 28/166 (16%)

Query: 118 IGKGGYAEVY--------KGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPN 168
           +G+G + +V         K + +    VA+K L     ++ ++D +SE+ +M  +  H N
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82

Query: 169 TAKLLGYGIEGG-MHIVLELSPNGSLASLLY-----GMK----------EKLKWGIRYKI 212
              LLG   + G +++++E +  G+L   L      GM+          E++ +      
Sbjct: 83  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142

Query: 213 ALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
              VA G+ YL     ++ IHRD+ A N+L+TE+   +I DFGLA+
Sbjct: 143 TYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 185

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 57.2 bits (138), Expect = 2e-09
 Identities = 49/170 (28%), Positives = 70/170 (41%), Gaps = 25/170 (14%)

Query: 118 IGKGGYAEVYKGRLRNGQLVA---IKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLG 174
           IG G + +V  G    G   A   +K L      +    FL E+     ++HPN  + LG
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62

Query: 175 YGIEG-GMHIVLELSPNGSLASLLYGMKEKLKWG----IRYKIALGVAEGLLYLHEGCQR 229
             IE     +VLE  P G L + L   +  +       +  ++A  VA GLL+LH   Q 
Sbjct: 63  QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QA 119

Query: 230 RIIHRDIKAANILLTEDFEPQICDFGLA--------------KWLPEQWT 265
             IH D+   N  LT D   +I D+GLA                +P +W 
Sbjct: 120 DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWL 169

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 57.0 bits (138), Expect = 2e-09
 Identities = 45/156 (28%), Positives = 77/156 (49%), Gaps = 17/156 (10%)

Query: 114 FENL--IGKGGYAEVYKGRLRN-GQLVAIKRLTRGTADEIIADF-LSELGIMAHVDHPNT 169
           +ENL  +G+G Y  V K + +  GQ+VAIK+      D+++    + E+ ++  + H N 
Sbjct: 3   YENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENL 62

Query: 170 AKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRY----KIALGVAEGLLYLH 224
             L+  +  +  +++V E   +  L  L     EK   G+      K    +  G+ + H
Sbjct: 63  VNLIEVFRRKKRLYLVFEFVDHTVLDDL-----EKYPNGLDESRVRKYLFQILRGIEFCH 117

Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL 260
                 IIHRDIK  NIL+++    ++CDFG A+ L
Sbjct: 118 ---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTL 150

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 56.9 bits (137), Expect = 2e-09
 Identities = 47/157 (29%), Positives = 81/157 (51%), Gaps = 23/157 (14%)

Query: 118 IGKGGYAEVYKGR-LRNG-QLVAIKRLTRGTADE-IIADFLSELGIMAHVD---HPNTAK 171
           IG+G Y +V+K R L+NG + VA+KR+   T +E +    + E+ ++ H++   HPN  +
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68

Query: 172 LLGYGI------EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYK----IALGVAEGLL 221
           L           E  + +V E   +  L + L  + E    G+  +    +   +  GL 
Sbjct: 69  LFDVCTVSRTDRETKLTLVFE-HVDQDLTTYLDKVPEP---GVPTETIKDMMFQLLRGLD 124

Query: 222 YLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           +LH     R++HRD+K  NIL+T   + ++ DFGLA+
Sbjct: 125 FLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLAR 158

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 56.8 bits (137), Expect = 2e-09
 Identities = 42/149 (28%), Positives = 74/149 (49%), Gaps = 10/149 (6%)

Query: 114 FENLIGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKL 172
           ++ ++G G    VYK   L   +++A+K +      E+    +SEL I+   D P     
Sbjct: 5   YQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGF 64

Query: 173 LG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRI 231
            G + +E  + I  E    GSL      +  K+   +  +IA+ V +GL YL      +I
Sbjct: 65  YGAFFVENRISICTEFMDGGSL-----DVYRKIPEHVLGRIAVAVVKGLTYL---WSLKI 116

Query: 232 IHRDIKAANILLTEDFEPQICDFGLAKWL 260
           +HRD+K +N+L+    + ++CDFG++  L
Sbjct: 117 LHRDVKPSNMLVNTRGQVKLCDFGVSTQL 145

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 56.3 bits (136), Expect = 3e-09
 Identities = 37/157 (23%), Positives = 71/157 (45%), Gaps = 17/157 (10%)

Query: 116 NLIGKGGYAEVYKGRLRNG-----QLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTA 170
           +L+ +G +  ++ G L +      + V +K +    ++  +   L E  ++  + H N  
Sbjct: 12  DLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNIL 71

Query: 171 KLLGYGIE-GGMHIVLELSPN-GSLASLLYGMKEKLKWGIR-------YKIALGVAEGLL 221
            +L   IE G    VL    N G+L   L   +       +         +A+ +A G+ 
Sbjct: 72  PILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMS 131

Query: 222 YLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           YLH   +R +IH+DI A N ++ E+ + +I D  L++
Sbjct: 132 YLH---KRGVIHKDIAARNCVIDEELQVKITDNALSR 165

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 56.5 bits (136), Expect = 4e-09
 Identities = 52/171 (30%), Positives = 82/171 (47%), Gaps = 29/171 (16%)

Query: 107 SATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVD 165
           +AT+  + E L G+G YA VYKG  R NGQLVA+K ++  T + +    + E  ++  + 
Sbjct: 3   AATSYLNLEKL-GEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLK 61

Query: 166 HPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKW-------GIR-YKIAL--- 214
           H N   L         H ++      +L  +   M   L         G+  Y + L   
Sbjct: 62  HANIVLL---------HDIIHTKE--TLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMF 110

Query: 215 GVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLA--KWLPEQ 263
            +  GL Y+H    + I+HRD+K  N+L++   E ++ DFGLA  K +P Q
Sbjct: 111 QLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ 158

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 56.1 bits (135), Expect = 4e-09
 Identities = 44/149 (29%), Positives = 70/149 (46%), Gaps = 8/149 (5%)

Query: 118 IGKGGYAEVYKG---RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNTAKLL 173
           +G G +  V KG     ++ + VA+K L     D  + D  L E  +M  +D+P   +++
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 174 GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIH 233
           G        +V+EL+  G L   L   K   +  I  ++   V+ G+ YL E      +H
Sbjct: 63  GICEAESWMLVMELAELGPLNKFLQKNKHVTEKNIT-ELVHQVSMGMKYLEE---TNFVH 118

Query: 234 RDIKAANILLTEDFEPQICDFGLAKWLPE 262
           RD+ A N+LL      +I DFGL+K L  
Sbjct: 119 RDLAARNVLLVTQHYAKISDFGLSKALGA 147

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 56.6 bits (136), Expect = 4e-09
 Identities = 50/186 (26%), Positives = 90/186 (48%), Gaps = 18/186 (9%)

Query: 80  IDMP---RNLFVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQL 136
           +D P   +N  ++++ ++  + +  + +LQ    ++    +IG+G + EV   R ++ Q 
Sbjct: 10  LDFPALRKNKNIDNFLNRYEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQK 69

Query: 137 V-AIKRLTRGTADEII-----ADFLSELGIMAHVDHPNTAKLL-GYGIEGGMHIVLELSP 189
           V A+K L++    E+I     A F  E  IMA  + P   +L   +  +  +++V+E  P
Sbjct: 70  VYAMKLLSKF---EMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMP 126

Query: 190 NGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEP 249
            G L +L+       KW   Y      AE +L L       +IHRD+K  N+LL +    
Sbjct: 127 GGDLVNLMSNYDVPEKWAKFY-----TAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHL 181

Query: 250 QICDFG 255
           ++ DFG
Sbjct: 182 KLADFG 187

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 55.8 bits (135), Expect = 6e-09
 Identities = 43/172 (25%), Positives = 66/172 (38%), Gaps = 38/172 (22%)

Query: 112 FSFENLIGKGGYAEVYKGRLRN---GQLVAIKRL--TRGTADEIIADFLSELGIMAHVDH 166
           +  E  IG+G Y  VYK + +N   G+  AIK+    +     I      E+ ++  + H
Sbjct: 2   YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61

Query: 167 PNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGI----RYKIALGVAE---- 218
            N   L+          V  L        LL+   E   W I    R    + +      
Sbjct: 62  ENVVSLVE---------VF-LEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVK 111

Query: 219 --------GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQ----ICDFGLAK 258
                   G+ YLH      ++HRD+K ANIL+  +   +    I D GLA+
Sbjct: 112 SLLWQILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDLGLAR 160

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 55.6 bits (134), Expect = 6e-09
 Identities = 43/154 (27%), Positives = 80/154 (51%), Gaps = 14/154 (9%)

Query: 113 SFENL--IGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           +F+ L  +G+G YA VYKGR R  G++VA+K +     +   +  + E+ +M  + H N 
Sbjct: 1   NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60

Query: 170 AKLLGYGI---EGGMHIVLELSPNGSLASLL--YGMKEKLKWGIRYKIALGVAEGLLYLH 224
            +L  + +   E  + +V E   +  L   +  +G++  L           + +G+ + H
Sbjct: 61  VRL--HDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH 117

Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           E    R++HRD+K  N+L+ +  E ++ DFGLA+
Sbjct: 118 E---NRVLHRDLKPQNLLINKRGELKLADFGLAR 148

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 55.4 bits (134), Expect = 6e-09
 Identities = 46/155 (29%), Positives = 77/155 (49%), Gaps = 28/155 (18%)

Query: 118 IGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADE-IIADFLSELGIMAHVDHPNTAKLLGY 175
           IG+G Y  VYK R    G++VA+K++   T DE + +  + E+ ++  ++HPN  +LL  
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66

Query: 176 GIEGG-MHIVLEL-----------SPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYL 223
                 +++V E            SP   L   L  +K  L     Y++  G+A    Y 
Sbjct: 67  VHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPL--IKSYL-----YQLLQGIA----YC 115

Query: 224 HEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           H     R++HRD+K  N+L+  +   ++ DFGLA+
Sbjct: 116 H---SHRVLHRDLKPQNLLIDREGALKLADFGLAR 147

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 55.1 bits (133), Expect = 7e-09
 Identities = 46/160 (28%), Positives = 80/160 (50%), Gaps = 21/160 (13%)

Query: 118 IGKGGYAE--VYKGRLRNGQLVAIKR--LTRGTADEIIADFLSELGIMAHVDHPNTAKLL 173
           +GKG + E  +Y+ R  +  LV  K   LTR +  E   D L+E+ I++ + HPN     
Sbjct: 8   LGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKER-RDALNEIVILSLLQHPNIIAYY 65

Query: 174 GYGIEGG-MHIVLELSPNGSLASLLYGMKEKL------KWGIRYKIALGVAEGLLYLHEG 226
            + ++   + I +E +  G+L   +   K +L       W   ++I   V+    Y+H  
Sbjct: 66  NHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLW-YLFQIVSAVS----YIH-- 118

Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH 266
            +  I+HRDIK  NI LT+    ++ DFG++K L  +++ 
Sbjct: 119 -KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSM 157

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 55.1 bits (132), Expect = 1e-08
 Identities = 41/145 (28%), Positives = 72/145 (49%), Gaps = 5/145 (3%)

Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNTAKLLG-Y 175
           +G G    V K + +   L+  ++L        I +  + EL ++   + P      G +
Sbjct: 13  LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72

Query: 176 GIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRD 235
             +G + I +E    GSL  +L   K ++   I  K+++ V  GL YL E  + +I+HRD
Sbjct: 73  YSDGEISICMEHMDGGSLDQVLKEAK-RIPEEILGKVSIAVLRGLAYLRE--KHQIMHRD 129

Query: 236 IKAANILLTEDFEPQICDFGLAKWL 260
           +K +NIL+    E ++CDFG++  L
Sbjct: 130 VKPSNILVNSRGEIKLCDFGVSGQL 154

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 54.4 bits (131), Expect = 2e-08
 Identities = 47/162 (29%), Positives = 77/162 (47%), Gaps = 21/162 (12%)

Query: 112 FSFENLIGKGGYAEVYKGRLRN-GQLVAIKRLTRGTADE---IIADFLSELGIMAHVDHP 167
           F     IG+G Y +VYK R ++ G+LVA+K++      E   I A  + E+ I+  ++H 
Sbjct: 9   FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITA--IREIKILRQLNHR 66

Query: 168 NTAKLLGYGIE-----------GGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGV 216
           N   L     +           G  ++V E   +  +  L  G+    +  I+      +
Sbjct: 67  NIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIK-SFMKQL 125

Query: 217 AEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
            EGL Y H   ++  +HRDIK +NILL    + ++ DFGLA+
Sbjct: 126 LEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLAR 164

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 54.4 bits (131), Expect = 2e-08
 Identities = 47/154 (30%), Positives = 76/154 (49%), Gaps = 10/154 (6%)

Query: 109 TNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDH 166
           TN +     +G G +  V   R    GQ VAIK++ +  +  ++A     EL ++ H+ H
Sbjct: 9   TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68

Query: 167 PNTAKLLGYGIE--GGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
            N   L    I     ++ V EL     L  LL     + ++ I+Y     +  GL Y+H
Sbjct: 69  ENIISLSDIFISPLEDIYFVTELLGT-DLHRLLTSRPLEKQF-IQY-FLYQILRGLKYVH 125

Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
                 ++HRD+K +NIL+ E+ + +ICDFGLA+
Sbjct: 126 SA---GVVHRDLKPSNILINENCDLKICDFGLAR 156

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 54.5 bits (131), Expect = 2e-08
 Identities = 49/171 (28%), Positives = 78/171 (45%), Gaps = 30/171 (17%)

Query: 117 LIGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNTAKLLG 174
            +G G Y  V      R G+ VAIK+L+R    EI A     EL ++ H+ H N   LL 
Sbjct: 22  QVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLD 81

Query: 175 --------------YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGL 220
                         Y +   M   L+      L+      ++K+++ + Y++      GL
Sbjct: 82  VFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLS------EDKVQYLV-YQML----CGL 130

Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK 271
            Y+H      IIHRD+K  N+ + ED E +I DFGLA+    + T + +++
Sbjct: 131 KYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR 178

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 53.9 bits (129), Expect = 2e-08
 Identities = 41/161 (25%), Positives = 78/161 (48%), Gaps = 19/161 (11%)

Query: 118 IGKGGYAEVYKGRLRN------GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAK 171
           +G+G +  VY+G  +          VAIK +    +     +FL+E  +M   +  +  +
Sbjct: 14  LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 172 LLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLK---------WGIRYKIALGVAEGLL 221
           LLG   +G    +++EL   G L S L  ++ +++              ++A  +A+G+ 
Sbjct: 74  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133

Query: 222 YLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE 262
           YL+     + +HRD+ A N ++ EDF  +I DFG+ + + E
Sbjct: 134 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 171

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 53.5 bits (128), Expect = 3e-08
 Identities = 57/181 (31%), Positives = 84/181 (46%), Gaps = 24/181 (13%)

Query: 117 LIGKGGYAEVYKGRLR-NGQLVAIKRL----TRGTADEIIADFLSELGIMAHVDHPNTAK 171
           ++GKGG+ EV   ++R  G++ A K+L     +    E +A  L+E  I+  V+      
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMA--LNEKQILEKVNSRFVVS 64

Query: 172 L-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE----GLLYLHEG 226
           L   Y  +  + +VL L   G L   +Y M E    G     A+  A     GL  LH  
Sbjct: 65  LAYAYETKDALCLVLTLMNGGDLKFHIYHMGEA---GFEEGRAVFYAAEICCGLEDLH-- 119

Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPL 286
            Q RI++RD+K  NILL +    +I D GLA  +PE  T      ++G  G V    P +
Sbjct: 120 -QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT------IKGRVGTVGYMAPEV 172

Query: 287 V 287
           V
Sbjct: 173 V 173

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 53.6 bits (129), Expect = 4e-08
 Identities = 30/86 (34%), Positives = 45/86 (52%), Gaps = 20/86 (23%)

Query: 211 KIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL---------- 260
           KI++ V  GL YL E  + +I+HRD+K +NIL+    E ++CDFG++  L          
Sbjct: 103 KISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVG 160

Query: 261 ------PE--QWTHHTISKVEGTFGL 278
                 PE  Q TH+T+     + GL
Sbjct: 161 TRSYMSPERLQGTHYTVQSDIWSLGL 186

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 53.2 bits (128), Expect = 5e-08
 Identities = 43/148 (29%), Positives = 73/148 (49%), Gaps = 14/148 (9%)

Query: 118 IGKGGYAEVYKGRLRN-GQLVAIKRLTRGT---ADEIIADFLSELGIMAHVDHPNTAKLL 173
           +G+GGY +V+  + ++ G++VA+KR+ +      +E+    L+E  I+         KLL
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEV-RHVLTERDILTTTKSEWLVKLL 67

Query: 174 GYGIEGGMHIVL--ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHE-GCQRR 230
            Y  +   ++ L  E  P G   +LL  +    +   R+ +A    E +  LHE G    
Sbjct: 68  -YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMF-EAVDALHELG---- 121

Query: 231 IIHRDIKAANILLTEDFEPQICDFGLAK 258
            IHRD+K  N L+      ++ DFGL+K
Sbjct: 122 YIHRDLKPENFLIDASGHIKLTDFGLSK 149

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 52.7 bits (126), Expect = 6e-08
 Identities = 43/159 (27%), Positives = 80/159 (50%), Gaps = 23/159 (14%)

Query: 118 IGKGGYAEVYKGRLRN---GQL---VAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAK 171
           +G+G +  VY+G  R+   G+    VA+K +    +     +FL+E  +M      +  +
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73

Query: 172 LLGYGIEGG-MHIVLELSPNGSLASLLYGMKEK-----------LKWGIRYKIALGVAEG 219
           LLG   +G    +V+EL  +G L S L  ++ +           L+  I  ++A  +A+G
Sbjct: 74  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI--QMAAEIADG 131

Query: 220 LLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           + YL+    ++ +HRD+ A N ++  DF  +I DFG+ +
Sbjct: 132 MAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR 167

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 52.7 bits (126), Expect = 6e-08
 Identities = 43/163 (26%), Positives = 72/163 (44%), Gaps = 36/163 (22%)

Query: 118 IGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADE-IIADFLSELGIM---AHVDHPNTAKL 172
           IG G Y  VYK R   +G  VA+K +   T ++ +    + E+ ++      DHPN  +L
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 173 LGY-----------------GIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALG 215
           +                    ++  +   L+  P   L      +K+ ++  +R      
Sbjct: 68  MDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLP--AETIKDLMRQFLR------ 119

Query: 216 VAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
              GL +LH  C   I+HRD+K  NIL+T   + ++ DFGLA+
Sbjct: 120 ---GLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLAR 156

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 52.3 bits (125), Expect = 6e-08
 Identities = 52/169 (30%), Positives = 76/169 (44%), Gaps = 32/169 (18%)

Query: 112 FSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTAD-------EIIADFLSELGIMAH 163
           + F  ++GKG Y EV   R R +G+   IK+L    A        E  A  LS+L     
Sbjct: 2   YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQL----- 56

Query: 164 VDHPN--TAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKL-------KWGIRYKIAL 214
             HPN    +    G +G ++IV+     G L   L   K KL       +W ++     
Sbjct: 57  -KHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQ----- 110

Query: 215 GVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ 263
            +A  L YLHE   + I+HRD+K  N+ LT     ++ D G+A+ L  Q
Sbjct: 111 -IAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ 155

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 52.4 bits (125), Expect = 7e-08
 Identities = 51/183 (27%), Positives = 86/183 (46%), Gaps = 13/183 (7%)

Query: 92  DSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKG-RLRNGQLVAIKR--LTRGTAD 148
           D +  +K+ S+  +      ++    IG+G    VY    +  GQ VAIK+  L +    
Sbjct: 1   DEEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKK 60

Query: 149 EIIADFLSELGIMAHVDHPNTAKLL-GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWG 207
           E+I   ++E+ +M    +PN    L  Y +   + +V+E    GSL  ++   +  +  G
Sbjct: 61  ELI---INEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEG 115

Query: 208 IRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGL-AKWLPEQWTH 266
               +     + L +LH     ++IHRDIK+ NILL  D   ++ DFG  A+  PEQ   
Sbjct: 116 QIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 172

Query: 267 HTI 269
            T+
Sbjct: 173 STM 175

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 53.3 bits (128), Expect = 8e-08
 Identities = 38/140 (27%), Positives = 70/140 (50%), Gaps = 11/140 (7%)

Query: 115 ENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLL 173
           EN+I +G     YKG+ ++NG    +K +     + I +  ++++G    + HPN  KL+
Sbjct: 695 ENVISRGKKGASYKGKSIKNGMQFVVKEIND--VNSIPSSEIADMG---KLQHPNIVKLI 749

Query: 174 GY-GIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRII 232
           G    E G +++ E     +L+ +L      L W  R KIA+G+A+ L +LH  C   ++
Sbjct: 750 GLCRSEKGAYLIHEYIEGKNLSEVLRN----LSWERRRKIAIGIAKALRFLHCRCSPAVV 805

Query: 233 HRDIKAANILLTEDFEPQIC 252
             ++    I++    EP + 
Sbjct: 806 VGNLSPEKIIIDGKDEPHLR 825

Length = 968

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 52.1 bits (125), Expect = 8e-08
 Identities = 32/138 (23%), Positives = 58/138 (42%), Gaps = 12/138 (8%)

Query: 118 IGKGGYAEVYKGRLRN---------GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPN 168
           +G+G +  +YKG LR          GQ V++     G+       F     +M+ + H +
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 169 TAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQ 228
             KL G  +     +V E    G L   L+  K  +    +  +A  +A  L YL +   
Sbjct: 63  LVKLYGVCVRDENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLED--- 119

Query: 229 RRIIHRDIKAANILLTED 246
           ++++H ++   NIL+   
Sbjct: 120 KKLVHGNVCGKNILVARY 137

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 52.0 bits (125), Expect = 1e-07
 Identities = 49/166 (29%), Positives = 70/166 (42%), Gaps = 31/166 (18%)

Query: 111 NFSFENLIGKGGYAEV----YKGRLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHV- 164
            +     +G+G Y  V            + VAIK++T   + +I+A   L EL ++ H  
Sbjct: 1   RYELIKELGQGAYGIVCSARNAET-SEEETVAIKKITNVFSKKILAKRALRELKLLRHFR 59

Query: 165 DHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYG--MKEKLKWGIRYKIALGVAE---- 218
            H N   L        M IV   + N      LY   M+  L   IR    L  A     
Sbjct: 60  GHKNITCLYD------MDIVFPGNFNELY---LYEELMEADLHQIIRSGQPLTDAHFQSF 110

Query: 219 ------GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
                 GL Y+H      ++HRD+K  N+L+  D E +ICDFGLA+
Sbjct: 111 IYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLAR 153

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 51.9 bits (124), Expect = 1e-07
 Identities = 49/186 (26%), Positives = 88/186 (47%), Gaps = 18/186 (9%)

Query: 80  IDMP---RNLFVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQL 136
           +D P   +N  ++++ ++    I  + +L+    ++    +IG+G + EV   R ++ + 
Sbjct: 10  LDFPALRKNKNIDNFLNRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRK 69

Query: 137 V-AIKRLTRGTADEII-----ADFLSELGIMAHVDHPNTAKLL-GYGIEGGMHIVLELSP 189
           V A+K L++    E+I     A F  E  IMA  + P   +L   +  +  +++V+E  P
Sbjct: 70  VYAMKLLSKF---EMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMP 126

Query: 190 NGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEP 249
            G L +L+       KW   Y      AE +L L        IHRD+K  N+LL +    
Sbjct: 127 GGDLVNLMSNYDVPEKWARFY-----TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHL 181

Query: 250 QICDFG 255
           ++ DFG
Sbjct: 182 KLADFG 187

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 52.0 bits (124), Expect = 1e-07
 Identities = 42/151 (27%), Positives = 75/151 (49%), Gaps = 7/151 (4%)

Query: 114 FENL--IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNTA 170
           FE +  +G G    V+K   +   L+  ++L        I +  + EL ++   + P   
Sbjct: 7   FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 66

Query: 171 KLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQR 229
              G +  +G + I +E    GSL  +L     ++   I  K+++ V +GL YL E  + 
Sbjct: 67  GFYGAFYSDGEISICMEHMDGGSLDQVL-KKAGRIPEQILGKVSIAVIKGLTYLRE--KH 123

Query: 230 RIIHRDIKAANILLTEDFEPQICDFGLAKWL 260
           +I+HRD+K +NIL+    E ++CDFG++  L
Sbjct: 124 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 154

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 52.0 bits (125), Expect = 1e-07
 Identities = 49/159 (30%), Positives = 78/159 (49%), Gaps = 20/159 (12%)

Query: 113 SFENL--IGKGGYAEVYKGRL----RNGQLVAIKRLTRGTA--DEIIADFLSELGIMAHV 164
            FE++  IG+G + EV   RL      G + A+K+L +      E +A   +E  I+A  
Sbjct: 2   DFESIKVIGRGAFGEV---RLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEA 58

Query: 165 DHPNTAKLL-GYGIEGGMHIVLELSPNGSLASLLYGMKEKL--KWGIRYKIALGVAEGLL 221
           D+P   KL   +  E  +++++E  P G + +LL  MK+    +   R+ IA    E +L
Sbjct: 59  DNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLL--MKKDTFTEEETRFYIA----ETIL 112

Query: 222 YLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL 260
            +    +   IHRDIK  N+LL      ++ DFGL   L
Sbjct: 113 AIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGL 151

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 51.1 bits (122), Expect = 1e-07
 Identities = 44/163 (26%), Positives = 79/163 (48%), Gaps = 24/163 (14%)

Query: 111 NFSFENLIGKGGYAEVY--KGRLRNGQLVAIKR--LTRGTADEIIADFLSELGIMAHVDH 166
            +     IG+G + ++Y  K +  +   V IK   LT+    E  A    E+ ++A + H
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAKSDSEHCV-IKEIDLTKMPVKEKEAS-KKEVILLAKMKH 58

Query: 167 PNTAKLLG-YGIEGGMHIVLELSPNGSLAS-------LLYGMKEKLKWGIRYKIALGVAE 218
           PN       +   G + IV+E    G L         +L+   + L W ++      ++ 
Sbjct: 59  PNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQ------ISL 112

Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTED-FEPQICDFGLAKWL 260
           GL ++H+   R+I+HRDIK+ NI L+++    ++ DFG+A+ L
Sbjct: 113 GLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQL 152

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 51.3 bits (123), Expect = 2e-07
 Identities = 37/130 (28%), Positives = 66/130 (50%), Gaps = 17/130 (13%)

Query: 132 RNGQLVAIKR--LTRGTADEIIADFLSELGIMAHVDHPNTAKLLG-YGIEGGMHIVLELS 188
             G+ VA+K+  L +    E++    +E+ IM    HPN  ++   Y +   + +V+E  
Sbjct: 42  STGRQVAVKKMDLRKQQRRELL---FNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFL 98

Query: 189 PNGSLASLLYGMK---EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTE 245
             G+L  ++   +   E++       + L V + L +LH    + +IHRDIK+ +ILLT 
Sbjct: 99  EGGALTDIVTHTRMNEEQIA-----TVCLAVLKALSFLH---AQGVIHRDIKSDSILLTS 150

Query: 246 DFEPQICDFG 255
           D   ++ DFG
Sbjct: 151 DGRVKLSDFG 160

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 51.5 bits (123), Expect = 2e-07
 Identities = 46/161 (28%), Positives = 75/161 (46%), Gaps = 11/161 (6%)

Query: 118 IGKGGYAEV-YKGRLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNTAKLLGY 175
           +G G Y  V      R G  VAIK+L R    E+ A     EL ++ H+ H N   LL  
Sbjct: 23  VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82

Query: 176 -----GIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRR 230
                 ++      L +   G+    L   ++  +  I++ +   + +GL Y+H      
Sbjct: 83  FTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQF-LVYQMLKGLKYIHAA---G 138

Query: 231 IIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK 271
           IIHRD+K  N+ + ED E +I DFGLA+    + T + +++
Sbjct: 139 IIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTR 179

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 51.6 bits (123), Expect = 2e-07
 Identities = 51/169 (30%), Positives = 83/169 (49%), Gaps = 17/169 (10%)

Query: 114 FENL--IGKGGYAEV---YKGRLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHP 167
           ++NL  +G G Y  V   Y  RLR  Q VA+K+L+R     I A     EL ++ H+ H 
Sbjct: 17  YQNLTPVGSGAYGSVCSAYDTRLR--QKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHE 74

Query: 168 NTAKLL-----GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLY 222
           N   LL        IE    + L  +  G+  + +   ++     +++ I   +  GL Y
Sbjct: 75  NVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLI-YQLLRGLKY 133

Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK 271
           +H      IIHRD+K +N+ + ED E +I DFGLA+   ++ T +  ++
Sbjct: 134 IHSA---GIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR 179

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 50.9 bits (121), Expect = 2e-07
 Identities = 49/177 (27%), Positives = 84/177 (47%), Gaps = 13/177 (7%)

Query: 92  DSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKR--LTRGTAD 148
           D +  +K+ S+  +      ++    IG+G    VY    +  GQ VAI++  L +    
Sbjct: 2   DEEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK 61

Query: 149 EIIADFLSELGIMAHVDHPNTAKLL-GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWG 207
           E+I   ++E+ +M    +PN    L  Y +   + +V+E    GSL  ++   +  +  G
Sbjct: 62  ELI---INEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEG 116

Query: 208 IRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGL-AKWLPEQ 263
               +     + L +LH     ++IHRDIK+ NILL  D   ++ DFG  A+  PEQ
Sbjct: 117 QIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 50.8 bits (121), Expect = 2e-07
 Identities = 46/161 (28%), Positives = 75/161 (46%), Gaps = 18/161 (11%)

Query: 111 NFSFENLIGKGGYAEVYKG-RLRNGQLVAIKRL-----TRGTADEIIADFLSELGIMAHV 164
           N+    L+G+G +  VY       G+ +A+K++     +  T+ E+ A    E+ ++ ++
Sbjct: 3   NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNA-LECEIQLLKNL 61

Query: 165 DHPNTAKLLGY---GIEGGMHIVLELSPNGSLASLL--YGMKEKLKWGIRYKIALGVAEG 219
            H    +  G     +E  + I +E  P GS+   L  YG    L   +  K    + EG
Sbjct: 62  LHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYG---ALTENVTRKYTRQILEG 118

Query: 220 LLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL 260
           + YLH      I+HRDIK ANIL       ++ DFG +K L
Sbjct: 119 VSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRL 156

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 50.9 bits (122), Expect = 3e-07
 Identities = 23/51 (45%), Positives = 30/51 (58%), Gaps = 4/51 (7%)

Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLA-KWLPEQWTHHT 268
           GL YLH      I+HRDIK  N+L+  +   +ICDFGLA    P++  H T
Sbjct: 115 GLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMT 162

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 51.0 bits (122), Expect = 3e-07
 Identities = 42/153 (27%), Positives = 75/153 (49%), Gaps = 9/153 (5%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDH 166
            +F  ++L+G+G + EV   R +  G + A+K + +    A E ++ F  E  I++  + 
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60

Query: 167 PNTAKLLGYGIEGGMHI--VLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
           P   +L  Y  +   ++  V+E  P G L SLL   +++    +       +AE +L +H
Sbjct: 61  PWIPQLQ-YAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDM---AQFYLAELVLAIH 116

Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLA 257
              Q   +HRDIK  N+L+      ++ DFG A
Sbjct: 117 SVHQMGYVHRDIKPENVLIDRTGHIKLADFGSA 149

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 50.5 bits (120), Expect = 4e-07
 Identities = 47/158 (29%), Positives = 78/158 (49%), Gaps = 24/158 (15%)

Query: 113 SFENL--IGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           S+E L  +G+G YA VYKG+ + NG+LVA+K +     +      + E  ++  + H N 
Sbjct: 6   SYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANI 65

Query: 170 AKLLGYGIEGGMHIVLELSPNGSLA-----SLLYGMKEKLKWGIR---YKIAL-GVAEGL 220
             L         H ++      +L      + L    +K   G+     K+ L  +  GL
Sbjct: 66  VLL---------HDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGL 116

Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
            Y+H   QR I+HRD+K  N+L+++  E ++ DFGLA+
Sbjct: 117 SYIH---QRYILHRDLKPQNLLISDTGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 50.3 bits (120), Expect = 4e-07
 Identities = 49/183 (26%), Positives = 80/183 (43%), Gaps = 39/183 (21%)

Query: 114 FENLIGKGGYAEVYKGRLRNGQ-----------------LVAIKRLTRGTADEIIADFLS 156
           F+  +G+G + EV+   + N Q                 LVA+K L          DFL 
Sbjct: 9   FKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLK 68

Query: 157 ELGIMAHVDHPNTAKLLGYGI-EGGMHIVLELSPNGSLASLL--YGMKEKLKWG------ 207
           E+ I++ +  PN  +LLG  + E  + ++ E   NG L   L  + + +K + G      
Sbjct: 69  EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPP 128

Query: 208 ------IRYK----IALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLA 257
                 I Y     +AL +A G+ YL        +HRD+   N L+ E+   +I DFG++
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMS 185

Query: 258 KWL 260
           + L
Sbjct: 186 RNL 188

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 50.4 bits (121), Expect = 4e-07
 Identities = 47/150 (31%), Positives = 71/150 (47%), Gaps = 14/150 (9%)

Query: 117 LIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEI--IADFLSELGIMAHVDHPNTAKLL 173
           L+GKG    V+  RL+  G+L A+K L +    +   +   L+E  I+A +DHP    L 
Sbjct: 8   LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLY 67

Query: 174 GYGIEGGMHI--VLELSPNGSLASLLYGMKEKL--KWGIRYKIALGVAEGLLYLH-EGCQ 228
               +   ++  V++  P G L  LL     K   +   R+  A  +   L YLH  G  
Sbjct: 68  A-SFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLL-ALEYLHLLG-- 123

Query: 229 RRIIHRDIKAANILLTEDFEPQICDFGLAK 258
             I++RD+K  NILL E     + DF L+K
Sbjct: 124 --IVYRDLKPENILLHESGHIMLSDFDLSK 151

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 50.0 bits (119), Expect = 4e-07
 Identities = 37/137 (27%), Positives = 61/137 (44%), Gaps = 15/137 (10%)

Query: 136 LVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLA 194
           LVA+K L          DFL E+ IM+ + +PN  +LLG  +    + ++ E   NG L 
Sbjct: 46  LVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLN 105

Query: 195 SLLYGMKEKLKWGIRYKI-----------ALGVAEGLLYLHEGCQRRIIHRDIKAANILL 243
             L   + +  +     I           A+ +A G+ YL        +HRD+   N L+
Sbjct: 106 QFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLV 162

Query: 244 TEDFEPQICDFGLAKWL 260
              +  +I DFG+++ L
Sbjct: 163 GNHYTIKIADFGMSRNL 179

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 50.1 bits (120), Expect = 5e-07
 Identities = 46/157 (29%), Positives = 71/157 (45%), Gaps = 18/157 (11%)

Query: 112 FSFENLIGKGGYAEVYKGRLRN-GQLVAIKRLTRGTADEIIAD-----FLSELGIMAHVD 165
           F    ++G+G + +V     +  G+L AIK L +G   +IIA       + E  I    +
Sbjct: 1   FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKG---DIIARDEVESLMCEKRIFETAN 57

Query: 166 ---HPNTAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLL 221
              HP    L   +  E  +  V+E +  G L   ++         + Y  A  V  GL 
Sbjct: 58  SERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFY--AACVVLGLQ 115

Query: 222 YLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           YLHE    +I++RD+K  N+LL  +   +I DFGL K
Sbjct: 116 YLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCK 149

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 49.6 bits (118), Expect = 6e-07
 Identities = 45/173 (26%), Positives = 74/173 (42%), Gaps = 41/173 (23%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADF-LSELGIMAHVDHP 167
           N F    ++G+G Y  V K R +   ++VAIK+      +E + +  L EL ++  +   
Sbjct: 1   NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60

Query: 168 NTAKL-------------LGYGIEGGMHIVLELSPNGSLA----SLLYGMKEKLKWGIRY 210
           N  +L               Y +E  M  +LE  PNG       S +Y + + + W    
Sbjct: 61  NIVELKEAFRRRGKLYLVFEY-VEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHW---- 115

Query: 211 KIALGVAEGLLYLHEGCQRR-IIHRDIKAANILLTEDFEPQICDFGLAKWLPE 262
                           C +  I+HRDIK  N+L++ +   ++CDFG A+ L E
Sbjct: 116 ----------------CHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSE 152

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 49.8 bits (119), Expect = 6e-07
 Identities = 43/163 (26%), Positives = 72/163 (44%), Gaps = 29/163 (17%)

Query: 112 FSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIAD---FLSELGIMAHVDHP 167
           +  + +IGKG Y  V        G+ VAIK++      E ++D    L E+ ++  + HP
Sbjct: 2   YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIN--DVFEHVSDATRILREIKLLRLLRHP 59

Query: 168 NTAKLLGYGIEGGMHIVLELSPN--GSLASLLYGMKEKLKWGIR---------YKIAL-G 215
           +  ++         HI+L  S      +  +   M+  L   I+         ++  L  
Sbjct: 60  DIVEIK--------HIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQ 111

Query: 216 VAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           +   L Y+H      + HRD+K  NIL   D + +ICDFGLA+
Sbjct: 112 LLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLAR 151

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 49.6 bits (118), Expect = 7e-07
 Identities = 51/170 (30%), Positives = 85/170 (50%), Gaps = 21/170 (12%)

Query: 118 IGKGGYAEVYKGRLRN-GQLVAIKRLTRG----TADEIIADFLSELGIMAHVDHPNTAKL 172
           +GKGG+ EV   +++N G++ A K+L +      + E +A  L E  I+  V+ P    L
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMA--LLEKEILEKVNSPFIVNL 58

Query: 173 LGYGIEGGMHI--VLELSPNGSLASLLYGMKEK---LKWGIRYKIALGVAEGLLYLHEGC 227
             Y  E   H+  V+ L   G L   +Y + E+   ++  I Y  +  +  G+L+LH   
Sbjct: 59  -AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHY--SAQITCGILHLHS-- 113

Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFG 277
              I++RD+K  N+LL +    ++ D GLA  L +     TI++  GT G
Sbjct: 114 -MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG---KTITQRAGTNG 159

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 49.6 bits (118), Expect = 7e-07
 Identities = 43/156 (27%), Positives = 72/156 (46%), Gaps = 15/156 (9%)

Query: 111 NFSFENLIGKGGYAEVYKGRLRNGQL--VAIKRLTRGT--ADEIIADFLSELGIMAHVDH 166
           +F+F   +G G +  V     +N     VAIKR  +      + +    SE  I+ +++H
Sbjct: 31  DFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINH 90

Query: 167 PNTAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGV--AEGLLYL 223
           P    L G +  E  +++VLE    G   + L   K       R+   +G   A  ++ +
Sbjct: 91  PFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNK-------RFPNDVGCFYAAQIVLI 143

Query: 224 HEGCQR-RIIHRDIKAANILLTEDFEPQICDFGLAK 258
            E  Q   I++RD+K  N+LL +D   ++ DFG AK
Sbjct: 144 FEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAK 179

Length = 340

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 49.2 bits (118), Expect = 7e-07
 Identities = 40/151 (26%), Positives = 72/151 (47%), Gaps = 16/151 (10%)

Query: 118 IGKGGYAEVYKGRLRN-GQLVAIKRLTRGTADEIIAD-----FLSELGIMAHVDHPNTAK 171
           +G GG+  V   ++++  +  A+K + +     I+         SE  I+   +HP   K
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKK---RHIVETGQQEHIFSEKEILEECNHPFIVK 57

Query: 172 LL-GYGIEGGMHIVLELSPNGSLASLLYGMKEKL-KWGIRYKIALGVAEGLLYLHEGCQR 229
           L   +  +  +++++E    G L ++L   +    ++  R+ IA  V     YLH    R
Sbjct: 58  LYRTFKDKKYIYMLMEYCLGGELWTILR-DRGLFDEYTARFYIA-CVVLAFEYLHN---R 112

Query: 230 RIIHRDIKAANILLTEDFEPQICDFGLAKWL 260
            II+RD+K  N+LL  +   ++ DFG AK L
Sbjct: 113 GIIYRDLKPENLLLDSNGYVKLVDFGFAKKL 143

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 49.1 bits (117), Expect = 7e-07
 Identities = 46/161 (28%), Positives = 81/161 (50%), Gaps = 14/161 (8%)

Query: 117 LIGKGGYAEVYKGRLRNGQ-LVAIKRLT--RGTADEIIADFLSELGIMAHVDHPNTAKLL 173
           ++G+G +  V+  R +  Q LV IK++   + T DE +A   +E  ++  + HPN  +  
Sbjct: 7   VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLA-AQNECQVLKLLSHPNIIEYY 65

Query: 174 GYGIE-GGMHIVLELSPNGSLASLLYGMKEKL---KWGIRYKIALGVAEGLLYLHEGCQR 229
              +E   + IV+E +P G+LA  +      L      + + + +     LL LH    +
Sbjct: 66  ENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQI-----LLALHHVHTK 120

Query: 230 RIIHRDIKAANILLTE-DFEPQICDFGLAKWLPEQWTHHTI 269
            I+HRD+K  NILL +     +I DFG++K L  +   +T+
Sbjct: 121 LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTV 161

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 49.3 bits (118), Expect = 8e-07
 Identities = 44/159 (27%), Positives = 68/159 (42%), Gaps = 33/159 (20%)

Query: 118 IGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNTAKL--- 172
           IG+G Y  V   +     + VAIK++     + I A   L E+ ++ H+DH N   +   
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDI 72

Query: 173 ---LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALG----------VAEG 219
                      ++IV EL            M   L   IR    L           +  G
Sbjct: 73  MPPPHREAFNDVYIVYEL------------MDTDLHQIIRSSQTLSDDHCQYFLYQLLRG 120

Query: 220 LLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           L Y+H      ++HRD+K +N+LL  + + +ICDFGLA+
Sbjct: 121 LKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLAR 156

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 49.4 bits (118), Expect = 8e-07
 Identities = 48/152 (31%), Positives = 80/152 (52%), Gaps = 18/152 (11%)

Query: 117 LIGKGGYAEVYKGR----LRNGQLVAIKRLTRGT---ADEIIADFLSELGIMAHVDHPNT 169
           ++G+G + +V+  R       GQL A+K L + T    D +      E  I+A V+HP  
Sbjct: 3   VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKM--ERDILAEVNHPFI 60

Query: 170 AKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKL--KWGIRYKIALGVAEGLLYLHEG 226
            KL   +  EG ++++L+    G L + L   KE +  +  +++ +A  +A  L +LH  
Sbjct: 61  VKLHYAFQTEGKLYLILDFLRGGDLFTRL--SKEVMFTEEDVKFYLA-ELALALDHLH-- 115

Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
               II+RD+K  NILL E+   ++ DFGL+K
Sbjct: 116 -SLGIIYRDLKPENILLDEEGHIKLTDFGLSK 146

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 49.2 bits (118), Expect = 9e-07
 Identities = 41/153 (26%), Positives = 78/153 (50%), Gaps = 24/153 (15%)

Query: 118 IGKGGYAEVYKGR-LRNGQLVAIKRLTR--GTADEIIADFLSELGIMAHV-DHPNTAKLL 173
           IG+G ++EV K +  + G+  AIK + +   + +++    L E+  +  +  HPN  +L+
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNN--LREIQALRRLSPHPNILRLI 64

Query: 174 GYGIE---GGMHIVLELSPNGSLASLLYGMK-----EKLKWGIRYKIALGVAEGLLYLHE 225
               +   G + +V EL  + +L  L+ G K     +++K  + Y++       L ++H 
Sbjct: 65  EVLFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEKRVKSYM-YQLLKS----LDHMH- 117

Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
             +  I HRDIK  NIL+ +D   ++ DFG  +
Sbjct: 118 --RNGIFHRDIKPENILIKDD-ILKLADFGSCR 147

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 48.9 bits (116), Expect = 1e-06
 Identities = 52/204 (25%), Positives = 88/204 (43%), Gaps = 27/204 (13%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRN------GQLVAIKRLTRGTADEIIADFLSELGIMAH 163
           +N   +  +G+G + +V+     N        LVA+K L +  +D    DF  E  ++ +
Sbjct: 5   HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTL-KDASDNARKDFHREAELLTN 63

Query: 164 VDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYG-------MKE-----KLKWGIRY 210
           + H +  K  G  +EG  + +V E   +G L   L         M E     +L      
Sbjct: 64  LQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQML 123

Query: 211 KIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTIS 270
            IA  +A G++YL     +  +HRD+   N L+ E+   +I DFG+++ +          
Sbjct: 124 HIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYST----DYY 176

Query: 271 KVEGTFGLVKLNLPPLVILKRCFT 294
           +V G   L    +PP  I+ R FT
Sbjct: 177 RVGGHTMLPIRWMPPESIMYRKFT 200

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 49.8 bits (119), Expect = 1e-06
 Identities = 41/135 (30%), Positives = 60/135 (44%), Gaps = 11/135 (8%)

Query: 134 GQLVAIK--RLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGI--EGGMHIVLELSP 189
           G  VAIK  R      +   A F  E  + A + HPN   LL  G    G +  V E  P
Sbjct: 3   GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62

Query: 190 NGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTE-DFE 248
             +L  +L      L  G   ++ L V + L   H    + I+HRD+K  NI++++    
Sbjct: 63  GRTLREVL-AADGALPAGETGRLMLQVLDALACAHN---QGIVHRDLKPQNIMVSQTGVR 118

Query: 249 P--QICDFGLAKWLP 261
           P  ++ DFG+   LP
Sbjct: 119 PHAKVLDFGIGTLLP 133

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 48.3 bits (115), Expect = 1e-06
 Identities = 31/112 (27%), Positives = 60/112 (53%), Gaps = 17/112 (15%)

Query: 157 ELGIMAHVDHPNTAKLL-GYGIEGGMHIVLELSPNGSLASLLYGMK-------EKLKWGI 208
           E+ +++++ HPN  +    +   G ++IV++    G L   +   +       + L W +
Sbjct: 49  EVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFV 108

Query: 209 RYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL 260
           +  +AL       ++H+   R+I+HRDIK+ NI LT+D   ++ DFG+A+ L
Sbjct: 109 QICLALK------HVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVL 151

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 48.7 bits (116), Expect = 1e-06
 Identities = 55/176 (31%), Positives = 81/176 (46%), Gaps = 21/176 (11%)

Query: 112 FSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTAD----EIIADFLSELGIMAHVDH 166
           F    ++GKGG+ EV   ++R  G++ A K+L +        E +A  L+E  I+  V+ 
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKQILEKVNS 59

Query: 167 PNTAKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE----GLL 221
                L   Y  +  + +VL L   G L   +Y M      G   + A+  A     GL 
Sbjct: 60  RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNP---GFDEERAVFYAAEITCGLE 116

Query: 222 YLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFG 277
            LH   + RI++RD+K  NILL +    +I D GLA  +PE     TI    GT G
Sbjct: 117 DLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPE---GETIRGRVGTVG 166

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 48.0 bits (114), Expect = 1e-06
 Identities = 38/134 (28%), Positives = 68/134 (50%), Gaps = 17/134 (12%)

Query: 135 QLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLL-GYGIEGGMHIVLELSPNGSL 193
           Q  A+K +    +   + D   E  ++A + HPN       +  +G ++IV+E    G L
Sbjct: 26  QKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDL 85

Query: 194 ASLLYGMKEKL-------KWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTED 246
              +   + KL       +W +  ++ LGV     ++HE   +R++HRDIK+ NI LT++
Sbjct: 86  MQKIKLQRGKLFPEDTILQWFV--QMCLGVQ----HIHE---KRVLHRDIKSKNIFLTQN 136

Query: 247 FEPQICDFGLAKWL 260
            + ++ DFG A+ L
Sbjct: 137 GKVKLGDFGSARLL 150

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 48.2 bits (114), Expect = 2e-06
 Identities = 50/185 (27%), Positives = 86/185 (46%), Gaps = 17/185 (9%)

Query: 92  DSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKR--LTRGTAD 148
           D +  +K+ ++  +      ++    IG+G    V+    +  GQ VAIK+  L +    
Sbjct: 1   DEEIMEKLRTIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKK 60

Query: 149 EIIADFLSELGIMAHVDHPNTAKLL-GYGIEGGMHIVLELSPNGSLASLLYG--MKEKLK 205
           E+I   ++E+ +M  + +PN    L  + +   + +V+E    GSL  ++    M E   
Sbjct: 61  ELI---INEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEA-- 115

Query: 206 WGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGL-AKWLPEQW 264
                +IA    E L  L      ++IHRDIK+ N+LL  D   ++ DFG  A+  PEQ 
Sbjct: 116 -----QIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS 170

Query: 265 THHTI 269
              T+
Sbjct: 171 KRSTM 175

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 47.9 bits (114), Expect = 2e-06
 Identities = 44/157 (28%), Positives = 71/157 (45%), Gaps = 13/157 (8%)

Query: 111 NFSFENLIGKGGYAEVY----KGRLRNGQLVAIKRLTRGT---ADEIIADFLSELGIMAH 163
           NF    ++G G Y +V+     G    G+L A+K L + T     +      +E  ++  
Sbjct: 1   NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60

Query: 164 VDHPNTAKLLGYGI--EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLL 221
           V        L Y    +  +H++L+    G L + LY  +E        ++ + +AE +L
Sbjct: 61  VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLY-QREHFT---ESEVRVYIAEIVL 116

Query: 222 YLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
            L    Q  II+RDIK  NILL  +    + DFGL+K
Sbjct: 117 ALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSK 153

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 48.1 bits (114), Expect = 2e-06
 Identities = 46/167 (27%), Positives = 79/167 (47%), Gaps = 13/167 (7%)

Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 19  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 78

Query: 170 AKLL-----GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
             LL        +E    + L     G+  + +   ++     +++ I   +  GL Y+H
Sbjct: 79  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH 137

Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK 271
                 IIHRD+K +N+ + ED E +I DFGLA+   ++ T +  ++
Sbjct: 138 SA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 181

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 48.1 bits (115), Expect = 2e-06
 Identities = 36/162 (22%), Positives = 64/162 (39%), Gaps = 27/162 (16%)

Query: 133 NGQLVAIKRLTRGTADEIIADFL-SELGIMAHVDHPNTAKLLGYGIEGG-MHIVLELSPN 190
              LVA+K++   +  +     L  E+     + HPN    +   I    +++V  L   
Sbjct: 24  TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY 83

Query: 191 GSLASLL-----YGMKEKLKWGIRYKIALGVAEGLLYLH-EGCQRRIIHRDIKAANILLT 244
           GS   LL      G+ E     I + I   V   L Y+H +G     IHR +KA++ILL+
Sbjct: 84  GSCEDLLKTHFPEGLPELA---IAF-ILKDVLNALDYIHSKGF----IHRSVKASHILLS 135

Query: 245 EDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPL 286
            D +  +               +++S ++       ++  P 
Sbjct: 136 GDGKVVLSGL-----------RYSVSMIKHGKRQRVVHDFPK 166

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 47.7 bits (113), Expect = 2e-06
 Identities = 44/152 (28%), Positives = 74/152 (48%), Gaps = 24/152 (15%)

Query: 118 IGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGY- 175
           +G+G YA V+KGR +    LVA+K +     +      + E+ ++ ++ H N   L    
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72

Query: 176 GIEGGMHIVLE---------LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEG 226
             E  + +V E         L   G+L S+ + +K  +   +R         GL Y H+ 
Sbjct: 73  HTERCLTLVFEYLDSDLKQYLDNCGNLMSM-HNVKIFMFQLLR---------GLSYCHK- 121

Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
             R+I+HRD+K  N+L+ E  E ++ DFGLA+
Sbjct: 122 --RKILHRDLKPQNLLINEKGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 47.7 bits (113), Expect = 3e-06
 Identities = 46/154 (29%), Positives = 72/154 (46%), Gaps = 14/154 (9%)

Query: 117 LIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIAD--FLSELGIMAHVDHPNTAKL- 172
           ++GKGG+ EV   ++R  G++ A KRL +    +   +   L+E  I+  V+      L 
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLA 66

Query: 173 LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE----GLLYLHEGCQ 228
             Y  +  + +VL +   G L   +Y M      G   + AL  A     GL  LH   +
Sbjct: 67  YAYETKDALCLVLTIMNGGDLKFHIYNMGNP---GFEEERALFYAAEILCGLEDLH---R 120

Query: 229 RRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE 262
              ++RD+K  NILL +    +I D GLA  +PE
Sbjct: 121 ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPE 154

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 47.9 bits (114), Expect = 3e-06
 Identities = 30/106 (28%), Positives = 50/106 (47%), Gaps = 7/106 (6%)

Query: 155 LSELGIMAHVDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIAL 214
           L E  ++ +V+HP+  ++    + G +  ++    +  L + L      L       I  
Sbjct: 105 LIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEK 164

Query: 215 GVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQIC--DFGLAK 258
            + EGL YLH    +RIIHRD+K  NI +  +   Q+C  D G A+
Sbjct: 165 QILEGLRYLH---AQRIIHRDVKTENIFI--NDVDQVCIGDLGAAQ 205

Length = 357

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 47.4 bits (113), Expect = 4e-06
 Identities = 41/152 (26%), Positives = 73/152 (48%), Gaps = 19/152 (12%)

Query: 117 LIGKGGYAEVYKGRLRN-GQLVAIKRLTRGTADEIIAD-----FLSELGIMAHV-DHPNT 169
           ++GKG + +V    L+   +L A+K L +   D I+ D      ++E  ++A    HP  
Sbjct: 2   VLGKGSFGKVLLAELKGTDELYAVKVLKK---DVILQDDDVECTMTEKRVLALAGKHPFL 58

Query: 170 AKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKI--ALGVAEGLLYLHEG 226
            +L   +  +  +  V+E    G L   ++ ++   ++        A  +  GL +LHE 
Sbjct: 59  TQLHSCFQTKDRLFFVMEYVNGGDL---MFHIQRSGRFDEPRARFYAAEIVLGLQFLHE- 114

Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
             R II+RD+K  N+LL  +   +I DFG+ K
Sbjct: 115 --RGIIYRDLKLDNVLLDSEGHIKIADFGMCK 144

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 47.5 bits (113), Expect = 4e-06
 Identities = 48/158 (30%), Positives = 74/158 (46%), Gaps = 20/158 (12%)

Query: 118 IGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEI----IADFLSELGIMAHVDHPNTAKL 172
           IG G + EV   R +    L A+K L +  AD +     A   +E  I+A  D+    KL
Sbjct: 9   IGIGAFGEVCLVRKVDTNALYAMKTLRK--ADVLMRNQAAHVKAERDILAEADNEWVVKL 66

Query: 173 L-GYGIEGGMHIVLELSPNGSLASLLYGM---KEKLKWGIRYKIALGVAEGLLYLHEGCQ 228
              +  +  ++ V++  P G + SLL  +   +E L    R+ IA  +   +  +H   +
Sbjct: 67  YYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLA---RFYIA-ELTCAIESVH---K 119

Query: 229 RRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH 266
              IHRDIK  NIL+  D   ++ DFGL      +WTH
Sbjct: 120 MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGF--RWTH 155

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 46.9 bits (111), Expect = 5e-06
 Identities = 55/183 (30%), Positives = 83/183 (45%), Gaps = 18/183 (9%)

Query: 112 FSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTAD----EIIADFLSELGIMAHVDH 166
           F    ++GKGG+ EV   ++R  G++ A K+L +        E +A  L+E  I+  V+ 
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKRILEKVNS 59

Query: 167 PNTAKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHE 225
                L   Y  +  + +VL +   G L   +Y M      G   + A+  A  L    E
Sbjct: 60  RFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNP---GFDEQRAIFYAAELCCGLE 116

Query: 226 GCQR-RIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNLP 284
             QR RI++RD+K  NILL +    +I D GLA  +PE  T      V G  G V    P
Sbjct: 117 DLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET------VRGRVGTVGYMAP 170

Query: 285 PLV 287
            ++
Sbjct: 171 EVI 173

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 46.9 bits (112), Expect = 5e-06
 Identities = 42/158 (26%), Positives = 70/158 (44%), Gaps = 19/158 (12%)

Query: 111 NFSFENLIGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
            +   + IG+G Y  V        G  VAIK+++           L E+ I+    H N 
Sbjct: 6   RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENI 65

Query: 170 AKLLGYGIEGG------MHIVLELSPNGSLASLLYGMK---EKLKWGIRYKIALGVAEGL 220
             +L             ++IV EL     L  L+       + +++ + Y+I      GL
Sbjct: 66  IGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQHLSNDHIQYFL-YQIL----RGL 119

Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
            Y+H      ++HRD+K +N+LL  + + +ICDFGLA+
Sbjct: 120 KYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLAR 154

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 47.1 bits (112), Expect = 5e-06
 Identities = 44/158 (27%), Positives = 74/158 (46%), Gaps = 19/158 (12%)

Query: 111 NFSFENLIGKGGYAEVYKGRLRNG-QLVAIKRLTRGTADEIIAD-----FLSELGIMAHV 164
           +F+F  ++GKG + +V     +   +L AIK L +   D II D      + E  ++A  
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKK---DVIIQDDDVECTMVEKRVLALP 57

Query: 165 DHPN--TAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKE--KLKWGIRYKIALGVAEGL 220
             P   T     +     ++ V+E    G L   +Y +++  K K       A  +A GL
Sbjct: 58  GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL---MYHIQQVGKFKEPHAVFYAAEIAIGL 114

Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
            +LH    + II+RD+K  N++L  +   +I DFG+ K
Sbjct: 115 FFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCK 149

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 46.7 bits (111), Expect = 6e-06
 Identities = 42/166 (25%), Positives = 72/166 (43%), Gaps = 26/166 (15%)

Query: 111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIA-----DFLSELGIMAHV 164
           +F     +G G +  V   + +  G+  AIK L +    EI+          E  I+  +
Sbjct: 19  DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKK---REILKMKQVQHVAQEKSILMEL 75

Query: 165 DHPNTAKLL-GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALG---VAEGL 220
            HP    ++  +  E  ++ +LE    G L +        L+   R+   +     AE +
Sbjct: 76  SHPFIVNMMCSFQDENRVYFLLEFVVGGELFT-------HLRKAGRFPNDVAKFYHAELV 128

Query: 221 L---YLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ 263
           L   YLH    + II+RD+K  N+LL      ++ DFG AK +P++
Sbjct: 129 LAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171

Length = 329

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 46.8 bits (111), Expect = 6e-06
 Identities = 41/159 (25%), Positives = 71/159 (44%), Gaps = 22/159 (13%)

Query: 110 NNFSFENLIGKGGYAEV-YKGRLRNGQLVAIKRL--TRGTADEIIADFLSELGIMAHVDH 166
            +F    +IGKG + EV    +   G++ A+K L  +     + +A   +E  ++A  D 
Sbjct: 1   EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60

Query: 167 PNTAKLLGYGIEGG--MHIVLELSPNGSLASLLYGMKEKLKWGIRYKI------ALGVAE 218
           P    L  Y  +    +++++E  P G L ++L          I+Y           +AE
Sbjct: 61  PWVVSLY-YSFQDAQYLYLIMEFLPGGDLMTML----------IKYDTFSEDVTRFYMAE 109

Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLA 257
            +L +    +   IHRDIK  NIL+      ++ DFGL+
Sbjct: 110 CVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLS 148

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 46.5 bits (110), Expect = 6e-06
 Identities = 42/153 (27%), Positives = 72/153 (47%), Gaps = 26/153 (16%)

Query: 118 IGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYG 176
           +G+G YA V+KGR +    LVA+K +     +      + E+ ++  + H N   L    
Sbjct: 14  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTL---- 69

Query: 177 IEGGMHIVLELSPNGSLASLLYGMKEKLKWGI----------RYKIAL-GVAEGLLYLHE 225
                H ++    + SL  +   + + LK  +            KI L  +  GL Y H 
Sbjct: 70  -----HDIVH--TDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH- 121

Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
             +R+++HRD+K  N+L+ E  E ++ DFGLA+
Sbjct: 122 --RRKVLHRDLKPQNLLINERGELKLADFGLAR 152

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 46.2 bits (109), Expect = 8e-06
 Identities = 49/177 (27%), Positives = 77/177 (43%), Gaps = 19/177 (10%)

Query: 111 NFSFENLIGKGGYAEVY------KGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHV 164
           N+    L+G+G + EVY       GR    + V     ++ T+ E+ A    E+ ++ ++
Sbjct: 3   NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNA-LECEIQLLKNL 61

Query: 165 DHPNTAKLLGY---GIEGGMHIVLELSPNGSLASLL--YGMKEKLKWGIRYKIALGVAEG 219
            H    +  G      E  + I +E  P GS+   L  YG    L   +  +    + +G
Sbjct: 62  RHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYG---ALTENVTRRYTRQILQG 118

Query: 220 LLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT-ISKVEGT 275
           + YLH      I+HRDIK ANIL       ++ DFG +K +       T I  V GT
Sbjct: 119 VSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGT 172

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 46.4 bits (110), Expect = 9e-06
 Identities = 22/46 (47%), Positives = 31/46 (67%), Gaps = 3/46 (6%)

Query: 213 ALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           +  VA G+ +L     R+ IHRD+ A NILL+E+   +ICDFGLA+
Sbjct: 179 SFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLAR 221

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 46.2 bits (110), Expect = 9e-06
 Identities = 20/40 (50%), Positives = 29/40 (72%), Gaps = 3/40 (7%)

Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           GL Y H   QRR++HRD+K  N+L++E  E ++ DFGLA+
Sbjct: 115 GLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 46.0 bits (109), Expect = 1e-05
 Identities = 48/149 (32%), Positives = 71/149 (47%), Gaps = 14/149 (9%)

Query: 118 IGKGGYAEVYKGRLR-NGQLVAIKRLT--RGTADEIIADFLSELGIMAHVDHPNTAKLLG 174
           +GKGG+ EV   ++R  G+L A K+L   R    +     + E  I+A V H      L 
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-HSRFIVSLA 59

Query: 175 YGIE--GGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIAL----GVAEGLLYLHEGCQ 228
           Y  +    + +V+ +   G L   +Y + E+   G     A      +  GL +LH   Q
Sbjct: 60  YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEE-NPGFPEPRACFYTAQIISGLEHLH---Q 115

Query: 229 RRIIHRDIKAANILLTEDFEPQICDFGLA 257
           RRII+RD+K  N+LL  D   +I D GLA
Sbjct: 116 RRIIYRDLKPENVLLDNDGNVRISDLGLA 144

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 45.9 bits (109), Expect = 1e-05
 Identities = 44/150 (29%), Positives = 71/150 (47%), Gaps = 12/150 (8%)

Query: 117 LIGKGGYAEVYKGRL----RNGQLVAIKRLTRGT---ADEIIADFLSELGIMAHVDHPNT 169
           ++GKGGY +V++ R       G++ A+K L + T     +  A   +E  I+  V HP  
Sbjct: 3   VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62

Query: 170 AKLL-GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQ 228
             L+  +   G ++++LE    G L   L    E+    +       ++E  L L    Q
Sbjct: 63  VDLIYAFQTGGKLYLILEYLSGGELFMHL----EREGIFMEDTACFYLSEISLALEHLHQ 118

Query: 229 RRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           + II+RD+K  NILL      ++ DFGL K
Sbjct: 119 QGIIYRDLKPENILLDAQGHVKLTDFGLCK 148

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 46.1 bits (109), Expect = 1e-05
 Identities = 22/43 (51%), Positives = 30/43 (69%), Gaps = 3/43 (6%)

Query: 216 VAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           VA G+ +L     R+ IHRD+ A NILL+E+   +ICDFGLA+
Sbjct: 183 VARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLAR 222

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 46.2 bits (109), Expect = 1e-05
 Identities = 44/155 (28%), Positives = 72/155 (46%), Gaps = 10/155 (6%)

Query: 118 IGKGGYAEV-YKGRLRNGQLVAIKRLTRGTA--DEIIADFLSELGIMAHVDHPNTAKLL- 173
           +G G + EV    ++    L A+K L +        +A   +E  I+A  D+    KL  
Sbjct: 9   LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68

Query: 174 GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIH 233
            +  +  ++ V++  P G + SLL  M+   +   R+ IA    E  L +    +   IH
Sbjct: 69  SFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIA----ELTLAIESVHKMGFIH 124

Query: 234 RDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT 268
           RDIK  NIL+  D   ++ DFGL      +WTH++
Sbjct: 125 RDIKPDNILIDLDGHIKLTDFGLCTGF--RWTHNS 157

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 46.0 bits (109), Expect = 1e-05
 Identities = 42/161 (26%), Positives = 70/161 (43%), Gaps = 30/161 (18%)

Query: 118 IGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADE--IIADFLSELGIMAHVDH-PNTAKLL 173
           IG+G Y +VYK R    G+LVA+K+ TR   DE  I    L E+ ++  +       +LL
Sbjct: 9   IGEGTYGKVYKARDKNTGKLVALKK-TRLEMDEEGIPPTALREISLLQMLSESIYIVRLL 67

Query: 174 GY------GIEGGMHIVLE---------LSPNGSLASLLYGMKEKLKWGIRYKIALGVAE 218
                     +  +++V E         +  NG        +  K      Y++  GVA 
Sbjct: 68  DVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPG--RPLPAKTIKSFMYQLLKGVA- 124

Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEP-QICDFGLAK 258
              + H   +  ++HRD+K  N+L+ +     +I D GL +
Sbjct: 125 ---HCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR 159

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 45.8 bits (108), Expect = 1e-05
 Identities = 43/152 (28%), Positives = 72/152 (47%), Gaps = 24/152 (15%)

Query: 118 IGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGY- 175
           +G+G YA VYKGR +    LVA+K +     +      + E+ ++  + H N   L    
Sbjct: 14  LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73

Query: 176 GIEGGMHIVLE---------LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEG 226
             E  + +V E         L   G+  ++ + +K  L   +R         GL Y H  
Sbjct: 74  HTEKSLTLVFEYLDKDLKQYLDDCGNSINM-HNVKLFLFQLLR---------GLNYCH-- 121

Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
            +R+++HRD+K  N+L+ E  E ++ DFGLA+
Sbjct: 122 -RRKVLHRDLKPQNLLINERGELKLADFGLAR 152

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 45.3 bits (107), Expect = 2e-05
 Identities = 36/136 (26%), Positives = 61/136 (44%), Gaps = 14/136 (10%)

Query: 136 LVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLA 194
           LVA+K L          DFL E+ IM+ +  PN  +LL   I    + ++ E   NG L 
Sbjct: 48  LVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLN 107

Query: 195 SLLYGMKEK----------LKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLT 244
             L   + +          + +     +A  +A G+ YL        +HRD+   N L+ 
Sbjct: 108 QFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVG 164

Query: 245 EDFEPQICDFGLAKWL 260
           +++  +I DFG+++ L
Sbjct: 165 KNYTIKIADFGMSRNL 180

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 45.4 bits (107), Expect = 2e-05
 Identities = 22/43 (51%), Positives = 31/43 (72%), Gaps = 3/43 (6%)

Query: 216 VAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           VA+G+ +L     R+ IHRD+ A NILL+E+   +ICDFGLA+
Sbjct: 188 VAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLAR 227

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 45.0 bits (106), Expect = 2e-05
 Identities = 41/146 (28%), Positives = 73/146 (50%), Gaps = 18/146 (12%)

Query: 118 IGKGGYAEVYKGRLRN-GQLVAIKR--LTRGTADEIIADFLSELGIMAHVDHPNTAKLL- 173
           IG+G    V    +++ G+LVA+K+  L +    E++    +E+ IM    H N  ++  
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELL---FNEVVIMRDYQHENVVEMYN 84

Query: 174 GYGIEGGMHIVLELSPNGSLASLLYGMK---EKLKWGIRYKIALGVAEGLLYLHEGCQRR 230
            Y +   + +V+E    G+L  ++   +   E++       + L V + L  LH    + 
Sbjct: 85  SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----AVCLAVLKALSVLH---AQG 136

Query: 231 IIHRDIKAANILLTEDFEPQICDFGL 256
           +IHRDIK+ +ILLT D   ++ DFG 
Sbjct: 137 VIHRDIKSDSILLTHDGRVKLSDFGF 162

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 45.1 bits (106), Expect = 2e-05
 Identities = 45/155 (29%), Positives = 68/155 (43%), Gaps = 18/155 (11%)

Query: 117 LIGKGGYAEVY------KGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTA 170
           L+G+G +  VY       GR    + V     +  T+ E+ A    E+ ++ ++ H    
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSA-LECEIQLLKNLQHERIV 67

Query: 171 KLLGY---GIEGGMHIVLELSPNGSLASLL--YGMKEKLKWGIRYKIALGVAEGLLYLHE 225
           +  G      E  + I +E  P GS+   L  YG    L   +  K    + EG+ YLH 
Sbjct: 68  QYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYG---ALTESVTRKYTRQILEGMSYLH- 123

Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL 260
                I+HRDIK ANIL       ++ DFG +K L
Sbjct: 124 --SNMIVHRDIKGANILRDSAGNVKLGDFGASKRL 156

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 45.1 bits (106), Expect = 3e-05
 Identities = 41/147 (27%), Positives = 73/147 (49%), Gaps = 10/147 (6%)

Query: 117 LIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDHPNTAKL- 172
           L+GKG + +V   R + +G+  A+K L +    A + +A  L+E  ++ +  HP    L 
Sbjct: 2   LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61

Query: 173 LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKI-ALGVAEGLLYLHEGCQRRI 231
             +  +  +  V+E    G L    +  +E++    R +     +   L YLH G   +I
Sbjct: 62  YSFQTKDRLCFVMEYVNGGEL--FFHLSRERVFSEDRTRFYGAEIVSALDYLHSG---KI 116

Query: 232 IHRDIKAANILLTEDFEPQICDFGLAK 258
           ++RD+K  N++L +D   +I DFGL K
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCK 143

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 44.9 bits (106), Expect = 3e-05
 Identities = 32/94 (34%), Positives = 41/94 (43%), Gaps = 21/94 (22%)

Query: 220 LLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL------------------- 260
           LL +H    + +IHRDIK+ANILL  +   ++ DFG +K                     
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYV 212

Query: 261 -PEQWTHHTISKVEGTFGLVKLNLPPLVILKRCF 293
            PE W     SK    F L  L L  L+ LKR F
Sbjct: 213 APEIWRRKPYSKKADMFSLGVL-LYELLTLKRPF 245

Length = 496

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 44.6 bits (105), Expect = 3e-05
 Identities = 42/155 (27%), Positives = 74/155 (47%), Gaps = 13/155 (8%)

Query: 111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELGIMAHVDHP 167
           +F+F  ++GKG + +V     +   +L AIK L +     D+ +   + E  ++A  D P
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60

Query: 168 NTAKLLG--YGIEGGMHIVLELSPNGSLASLLYGMKE--KLKWGIRYKIALGVAEGLLYL 223
                L   +     ++ V+E    G L   +Y +++  K K       A  ++ GL +L
Sbjct: 61  PFLTQLHSCFQTVDRLYFVMEYVNGGDL---MYHIQQVGKFKEPQAVFYAAEISVGLFFL 117

Query: 224 HEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           H    R II+RD+K  N++L  +   +I DFG+ K
Sbjct: 118 HR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCK 149

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 44.2 bits (104), Expect = 3e-05
 Identities = 46/169 (27%), Positives = 71/169 (42%), Gaps = 25/169 (14%)

Query: 118 IGKGGYAEVYKGRLRNG---QLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLG 174
           IG G + +V  G + +G     V +K L    + +    FL E      + H N  + LG
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62

Query: 175 YGIEGGMHI-VLELSPNGSLASLLYGMK--EKLKWGIR--YKIALGVAEGLLYLHEGCQR 229
              E   ++ V+E  P G L   L   +  E +        ++A  +A GLL+LH   + 
Sbjct: 63  QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KN 119

Query: 230 RIIHRDIKAANILLTEDFEPQICDFGLA--------------KWLPEQW 264
             IH D+   N LLT D   +I D+GL+               W+P +W
Sbjct: 120 NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRW 168

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 44.5 bits (105), Expect = 3e-05
 Identities = 20/43 (46%), Positives = 29/43 (67%), Gaps = 3/43 (6%)

Query: 216 VAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           VA+G+ +L     +  IHRD+ A N+LLT+    +ICDFGLA+
Sbjct: 221 VAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLAR 260

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 44.2 bits (104), Expect = 3e-05
 Identities = 42/157 (26%), Positives = 72/157 (45%), Gaps = 13/157 (8%)

Query: 111 NFSFENLIGKGGYAEVYKGRL----RNGQLVAIKRLTRGT---ADEIIADFLSELGIMAH 163
           NF    ++G G Y +V+  R      +G+L A+K L + T     +      +E  ++ H
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60

Query: 164 VDHPNTAKLLGYGI--EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLL 221
           +        L Y    +  +H++L+    G L + L   +E+ K     ++ +   E +L
Sbjct: 61  IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHL-SQRERFK---EQEVQIYSGEIVL 116

Query: 222 YLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
            L    +  II+RDIK  NILL  +    + DFGL+K
Sbjct: 117 ALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK 153

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 44.2 bits (104), Expect = 4e-05
 Identities = 43/153 (28%), Positives = 72/153 (47%), Gaps = 10/153 (6%)

Query: 114 FENL--IGKGGYAEVYKGRLRN-GQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDHPN 168
           FE+L  IG+G + EV   + ++ G + A+K L +      E +A   +E  I+   D   
Sbjct: 3   FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW 62

Query: 169 TAKLL-GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
             K+   +  +  +++++E  P G + +LL   K+ L           +AE +L +    
Sbjct: 63  VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLM-KKDTLS---EEATQFYIAETVLAIDAIH 118

Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAKWL 260
           Q   IHRDIK  N+LL      ++ DFGL   L
Sbjct: 119 QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGL 151

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 44.2 bits (104), Expect = 4e-05
 Identities = 38/153 (24%), Positives = 75/153 (49%), Gaps = 13/153 (8%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQLV-AIKRLTRGTADEII-----ADFLSELGIMAH 163
           ++F    +IG+G + EV   ++++ + + A+K L +    E++     A F  E  ++ +
Sbjct: 1   DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKW---EMLKRAETACFREERNVLVN 57

Query: 164 VD-HPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLY 222
            D    T     +  E  +++V++    G L +LL   +++L   +       +AE +L 
Sbjct: 58  GDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMA---RFYIAEMVLA 114

Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFG 255
           +H   Q   +HRDIK  N+LL  +   ++ DFG
Sbjct: 115 IHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFG 147

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 44.8 bits (106), Expect = 5e-05
 Identities = 47/158 (29%), Positives = 69/158 (43%), Gaps = 21/158 (13%)

Query: 117 LIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADE--IIADFLSELGIMAHVDHPNTAKLL 173
           LIGKGG  EVY        + VA+K++    ++   +   FL E  I A + HP    + 
Sbjct: 9   LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPV- 67

Query: 174 GYGIEGGMHIVLELSP---NGSLASLLYGM--KEKLKWGIRYKIALG--------VAEGL 220
            Y I      V    P     +L SLL  +  KE L   +  K ++G        +   +
Sbjct: 68  -YSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATI 126

Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
            Y+H    + ++HRD+K  NILL    E  I D+G A 
Sbjct: 127 EYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAI 161

Length = 932

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 43.9 bits (103), Expect = 5e-05
 Identities = 38/165 (23%), Positives = 64/165 (38%), Gaps = 25/165 (15%)

Query: 114 FENLIGKGGYAEVYKGRL------RNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHP 167
           F   +G+  + +VYKG L         Q VAIK L       +  +F  E  + + + HP
Sbjct: 9   FMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHP 68

Query: 168 NTAKLLGYGI-EGGMHIVLELSPNGSLASLLY---------------GMKEKLKWGIRYK 211
           N   LLG    E  + ++     +  L   L                 +K  L+      
Sbjct: 69  NIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVH 128

Query: 212 IALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGL 256
           I   +A G+ +L       ++H+D+   N+L+ +    +I D GL
Sbjct: 129 IVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKLNVKISDLGL 170

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 44.0 bits (104), Expect = 5e-05
 Identities = 40/163 (24%), Positives = 73/163 (44%), Gaps = 15/163 (9%)

Query: 111 NFSFENLIGKGGYAEVYKGRLRNG------QLVAIKRLTRGTADEIIADFLSELGIMAHV 164
           +      +G G +  V+  R R        +++AI  + R   ++ +    +E  ++  V
Sbjct: 2   DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVH---NEKRVLKEV 58

Query: 165 DHPNTAKLL-GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYL 223
            HP   +L      +  +++++E  P G L S L     +         A  +   L YL
Sbjct: 59  SHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSG-RFSNSTGLFYASEIVCALEYL 117

Query: 224 HEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ-WT 265
           H    + I++RD+K  NILL ++   ++ DFG AK L ++ WT
Sbjct: 118 H---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWT 157

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 43.8 bits (103), Expect = 5e-05
 Identities = 38/145 (26%), Positives = 69/145 (47%), Gaps = 8/145 (5%)

Query: 118 IGKGGYAEVYKGRLRNGQLV-AIKRLTRG--TADEIIADFLSELGIMAHVDHPNTAKL-L 173
           IGKG + +V + R R+ Q + A+K + +    +   +   L+E  ++A V+ P    L  
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60

Query: 174 GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIH 233
            +     +++VL     G L    + ++ + ++ +  +     AE L  L    +  +I+
Sbjct: 61  SFQSPEKLYLVLAFINGGEL---FHHLQREGRFDL-SRARFYTAELLCALENLHKFNVIY 116

Query: 234 RDIKAANILLTEDFEPQICDFGLAK 258
           RD+K  NILL       +CDFGL K
Sbjct: 117 RDLKPENILLDYQGHIALCDFGLCK 141

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 44.1 bits (104), Expect = 5e-05
 Identities = 21/43 (48%), Positives = 28/43 (65%), Gaps = 3/43 (6%)

Query: 216 VAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           VA+G+ +L     +  IHRD+ A NILLT     +ICDFGLA+
Sbjct: 223 VAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR 262

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 43.4 bits (102), Expect = 6e-05
 Identities = 50/198 (25%), Positives = 84/198 (42%), Gaps = 29/198 (14%)

Query: 118 IGKGGYAEVYKGRLRN------GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAK 171
           +G+G + +V+     N        LVA+K L   + +    DF  E  ++  + H +  +
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTVLQHQHIVR 71

Query: 172 LLGYGIEGG-MHIVLELSPNGSL----------ASLLYGMKE----KLKWGIRYKIALGV 216
             G   EG  + +V E   +G L          A +L G ++    +L  G    IA  +
Sbjct: 72  FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131

Query: 217 AEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTF 276
           A G++YL        +HRD+   N L+ +    +I DFG+++ +          +V G  
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYST----DYYRVGGRT 184

Query: 277 GLVKLNLPPLVILKRCFT 294
            L    +PP  IL R FT
Sbjct: 185 MLPIRWMPPESILYRKFT 202

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 43.5 bits (102), Expect = 6e-05
 Identities = 37/130 (28%), Positives = 63/130 (48%), Gaps = 17/130 (13%)

Query: 133 NGQLVAIKR--LTRGTADEIIADFLSELGIMAHVDHPNTAKLL-GYGIEGGMHIVLELSP 189
            G+ VA+K+  L +    E++    +E+ IM    H N   +   Y +   + +V+E   
Sbjct: 46  TGKQVAVKKMDLRKQQRRELL---FNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE 102

Query: 190 NGSLASLLYGMK---EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTED 246
            G+L  ++   +   E++       + L V   L YLH    + +IHRDIK+ +ILLT D
Sbjct: 103 GGALTDIVTHTRMNEEQIA-----TVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSD 154

Query: 247 FEPQICDFGL 256
              ++ DFG 
Sbjct: 155 GRIKLSDFGF 164

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 43.5 bits (102), Expect = 7e-05
 Identities = 42/154 (27%), Positives = 71/154 (46%), Gaps = 12/154 (7%)

Query: 114 FENL--IGKGGYAEVYKGRLRN-GQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDHPN 168
           FE+L  IG+G + EV   + ++ G + A+K L +      E +    +E  I+   D   
Sbjct: 3   FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW 62

Query: 169 TAKLLGYGIEGGM--HIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEG 226
             K+  Y  +  +  ++++E  P G + +LL       +   ++ IA    E +L +   
Sbjct: 63  VVKMF-YSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIA----ETVLAIDSI 117

Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL 260
            Q   IHRDIK  N+LL      ++ DFGL   L
Sbjct: 118 HQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGL 151

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 43.3 bits (102), Expect = 8e-05
 Identities = 29/78 (37%), Positives = 36/78 (46%), Gaps = 6/78 (7%)

Query: 212 IALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK 271
           I   + E L YLH    R IIHRD+K  NI L E     + DFG A  L     H    +
Sbjct: 190 IQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDA---HPDTPQ 243

Query: 272 VEGTFGLVKLNLPPLVIL 289
             G  G ++ N P L+ L
Sbjct: 244 CYGWSGTLETNSPELLAL 261

Length = 392

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 43.2 bits (102), Expect = 8e-05
 Identities = 20/49 (40%), Positives = 31/49 (63%), Gaps = 4/49 (8%)

Query: 219 GLLYLHEGCQRRIIHRDIKAANILL-TEDFEPQICDFGLAKWLPEQWTH 266
           GL Y+H      ++HRD+K AN+ + TED   +I DFGLA+ +   ++H
Sbjct: 126 GLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSH 171

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 43.1 bits (101), Expect = 1e-04
 Identities = 45/158 (28%), Positives = 70/158 (44%), Gaps = 16/158 (10%)

Query: 118 IGKGGYAEVYKGR-LRNGQLVAIKRLTRGTA--DEIIADFLSELGIMAHVDHPNTAKLL- 173
           +G G + EV   R +    L A+K L +        +A   +E  I+A  D+    +L  
Sbjct: 9   LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYY 68

Query: 174 GYGIEGGMHIVLELSPNGSLASLLYGM---KEKLKWGIRYKIALGVAEGLLYLHEGCQRR 230
            +  +  ++ V++  P G + SLL  M    E L    R+ IA    E    +    +  
Sbjct: 69  SFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLA---RFYIA----ELTCAVESVHKMG 121

Query: 231 IIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT 268
            IHRDIK  NIL+  D   ++ DFGL      +WTH +
Sbjct: 122 FIHRDIKPDNILIDRDGHIKLTDFGLCTGF--RWTHDS 157

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 42.9 bits (101), Expect = 1e-04
 Identities = 52/183 (28%), Positives = 76/183 (41%), Gaps = 23/183 (12%)

Query: 118 IGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMA-------HVDHPNT 169
           IGKG + +V   + + +G+  A+K L +    + I     +  IMA       +V HP  
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQK----KAILKKKEQKHIMAERNVLLKNVKHPFL 58

Query: 170 AKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQ 228
             L   +     ++ VL+    G L   L   +   +   R+  A  +A  L YLH    
Sbjct: 59  VGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARF-YAAEIASALGYLHS--- 114

Query: 229 RRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPLVI 288
             II+RD+K  NILL       + DFGL K   E       SK   TF      L P V+
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIE------HSKTTSTFCGTPEYLAPEVL 168

Query: 289 LKR 291
            K+
Sbjct: 169 RKQ 171

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 42.6 bits (100), Expect = 2e-04
 Identities = 48/156 (30%), Positives = 81/156 (51%), Gaps = 18/156 (11%)

Query: 112 FSFENLIGKGGYAEVYKGRLRN-GQLVAIKRLTRGTADEI----IADFLSELGIMAHVDH 166
           F     I +G + +VY GR +N  +L A+K + +  AD I    +    +E   +A    
Sbjct: 6   FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKK--ADMINKNMVHQVQAERDALALSKS 63

Query: 167 PNTAKLLGYGIEGG--MHIVLELSPNGSLASLL--YGMKEKLKWGIRYKIALGVAEGLLY 222
           P    L  Y ++    +++V+E    G + SLL  YG  ++ +  ++Y I+  VA  L Y
Sbjct: 64  PFIVHLY-YSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDE-EMAVKY-IS-EVALALDY 119

Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           LH   +  IIHRD+K  N+L++ +   ++ DFGL+K
Sbjct: 120 LH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 41.5 bits (97), Expect = 3e-04
 Identities = 41/147 (27%), Positives = 72/147 (48%), Gaps = 10/147 (6%)

Query: 117 LIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDHPN-TAKL 172
           L+GKG + +V   R +  G+  A+K L +    A + +A  ++E  ++ +  HP  TA  
Sbjct: 2   LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61

Query: 173 LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKI-ALGVAEGLLYLHEGCQRRI 231
             +     +  V+E +  G L    +  +E++    R +     +   L YLH    R +
Sbjct: 62  YAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSALEYLH---SRDV 116

Query: 232 IHRDIKAANILLTEDFEPQICDFGLAK 258
           ++RDIK  N++L +D   +I DFGL K
Sbjct: 117 VYRDIKLENLMLDKDGHIKITDFGLCK 143

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 41.5 bits (97), Expect = 3e-04
 Identities = 43/169 (25%), Positives = 72/169 (42%), Gaps = 13/169 (7%)

Query: 111 NFSFENLIGKGGYAEVYKGRLRNG----QLVAIKRLTRGT---ADEIIADFLSELGIMAH 163
           NF    ++G G Y +V+  R   G    +L A+K L +       + +    +E  ++ H
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60

Query: 164 VDHPNTAKLLGYGI--EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLL 221
           V        L Y    E  +H++L+    G + + LY      +  +R+       E +L
Sbjct: 61  VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFY----SGEIIL 116

Query: 222 YLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTIS 270
            L    +  I++RDIK  NILL  +    + DFGL+K    +    T S
Sbjct: 117 ALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS 165

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 41.3 bits (97), Expect = 4e-04
 Identities = 41/155 (26%), Positives = 75/155 (48%), Gaps = 17/155 (10%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRN-GQLVAIK------RLTRGTADEIIADFLSELGIMA 162
           ++F    +IG+G + EV   +++N GQ+ A+K       L R       A F  E  ++ 
Sbjct: 1   DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAE----TACFREERDVLV 56

Query: 163 HVDHPNTAKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGI-RYKIALGVAEGL 220
           + D      L   +  E  +++V++    G L +LL   +++L   + R+ +A    E +
Sbjct: 57  NGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLA----EMV 112

Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFG 255
           L +    Q   +HRDIK  N+LL ++   ++ DFG
Sbjct: 113 LAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFG 147

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 40.6 bits (95), Expect = 5e-04
 Identities = 43/158 (27%), Positives = 73/158 (46%), Gaps = 33/158 (20%)

Query: 118 IGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADE-IIADFLSELGIMAHVDHPNTAKLLGY 175
           IG+G Y  VYK R R   + +A+K++     DE + +  + E+ ++  + H N  +L   
Sbjct: 10  IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRL--Q 67

Query: 176 GI---EGGMHIVLEL-----------SPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLL 221
            +   E  +++V E            SP+   A     +K  L     Y+I  G+A    
Sbjct: 68  DVVHSEKRLYLVFEYLDLDLKKHMDSSPD--FAKNPRLIKTYL-----YQILRGIA---- 116

Query: 222 YLHEGCQRRIIHRDIKAANILLTEDFEP-QICDFGLAK 258
           Y H     R++HRD+K  N+L+       ++ DFGLA+
Sbjct: 117 YCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLAR 151

Length = 294

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 40.8 bits (95), Expect = 6e-04
 Identities = 43/151 (28%), Positives = 67/151 (44%), Gaps = 17/151 (11%)

Query: 117 LIGKGGYAEVY-KGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMA-------HVDHPN 168
           +IGKG + +V    R  +G+  A+K L +    +I+ +   +  IMA       +V HP 
Sbjct: 2   VIGKGSFGKVLLAKRKLDGKCYAVKVLQK----KIVLNRKEQKHIMAERNVLLKNVKHPF 57

Query: 169 TAKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
              L   +     ++ VL+    G L   L   +   +   R+  A  +A  L YLH   
Sbjct: 58  LVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAA-EIASALGYLH--- 113

Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
              I++RD+K  NILL       + DFGL K
Sbjct: 114 SINIVYRDLKPENILLDSQGHVVLTDFGLCK 144

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 40.7 bits (95), Expect = 6e-04
 Identities = 36/148 (24%), Positives = 75/148 (50%), Gaps = 11/148 (7%)

Query: 118 IGKGGYAEVYKGRLRN-GQLVAIKRLTRG--TADEIIADFLSELGIMAHVDHPNTAKLLG 174
           IGKG + +VY+ R ++  ++ A+K L++    A + +A  + E  I+       +  ++G
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 175 ----YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRR 230
               +  +  +++V +    G L    + ++++ ++    +    +AE +L L    +  
Sbjct: 61  LKFSFQTDSDLYLVTDYMSGGEL---FWHLQKEGRFS-EDRAKFYIAELVLALEHLHKYD 116

Query: 231 IIHRDIKAANILLTEDFEPQICDFGLAK 258
           I++RD+K  NILL       +CDFGL+K
Sbjct: 117 IVYRDLKPENILLDATGHIALCDFGLSK 144

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 40.2 bits (95), Expect = 6e-04
 Identities = 34/109 (31%), Positives = 49/109 (44%), Gaps = 11/109 (10%)

Query: 156 SELGIMAHV---DHPNTAKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYK 211
           + +  M H    D+PN  KL        G  ++++   +G L  LL   + KL      K
Sbjct: 55  NAIEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLK-KEGKLSEAEVKK 113

Query: 212 IALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQI--CDFGLAK 258
           I   + E L  LH   +  IIH DIK  N+L     + +I  CD+GL K
Sbjct: 114 IIRQLVEALNDLH---KHNIIHNDIKLENVLYDR-AKDRIYLCDYGLCK 158

Length = 267

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 40.4 bits (94), Expect = 7e-04
 Identities = 39/130 (30%), Positives = 63/130 (48%), Gaps = 15/130 (11%)

Query: 137 VAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNTAKLLGY-----GIE--GGMHIVLELS 188
           VAIK+L+R   ++  A     EL +M  V+H N   LL        +E    ++IV+EL 
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111

Query: 189 PNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFE 248
                  +   +  +    + Y++  G+     +LH      IIHRD+K +NI++  D  
Sbjct: 112 DANLCQVIQMELDHERMSYLLYQMLCGIK----HLHSA---GIIHRDLKPSNIVVKSDCT 164

Query: 249 PQICDFGLAK 258
            +I DFGLA+
Sbjct: 165 LKILDFGLAR 174

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 40.4 bits (94), Expect = 7e-04
 Identities = 39/147 (26%), Positives = 73/147 (49%), Gaps = 9/147 (6%)

Query: 117 LIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDHPN-TAKL 172
           L+GKG + +V   + +  G+  A+K L +    A + +A  L+E  ++ +  HP  TA  
Sbjct: 2   LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 61

Query: 173 LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKI-ALGVAEGLLYLHEGCQRRI 231
             +     +  V+E +  G L    +  +E++    R +     +   L YLH   ++ +
Sbjct: 62  YSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIVSALDYLHS--EKNV 117

Query: 232 IHRDIKAANILLTEDFEPQICDFGLAK 258
           ++RD+K  N++L +D   +I DFGL K
Sbjct: 118 VYRDLKLENLMLDKDGHIKITDFGLCK 144

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 40.2 bits (94), Expect = 7e-04
 Identities = 39/147 (26%), Positives = 69/147 (46%), Gaps = 10/147 (6%)

Query: 117 LIGKGGYAEVYKGR-LRNGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDHPNTAKL- 172
           L+GKG + +V   R    G+  A+K L +    A + +A  L+E  ++ +  HP    L 
Sbjct: 2   LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALK 61

Query: 173 LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKI-ALGVAEGLLYLHEGCQRRI 231
             +     +  V+E +  G L    +  +E++    R +     +   L YLH      +
Sbjct: 62  YSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIVSALGYLHS---CDV 116

Query: 232 IHRDIKAANILLTEDFEPQICDFGLAK 258
           ++RD+K  N++L +D   +I DFGL K
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCK 143

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 40.3 bits (94), Expect = 8e-04
 Identities = 37/150 (24%), Positives = 73/150 (48%), Gaps = 15/150 (10%)

Query: 117 LIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA---DEIIADFLSELGIMAHVDHPNTAKL 172
           ++GKG + +V    L+  G+  A+K L +      D++    + +  +    ++P    L
Sbjct: 2   VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61

Query: 173 L-GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE---GLLYLHEGCQ 228
              +  +  +  V+E    G L   ++ +++K ++ + Y+     AE   GL +LH    
Sbjct: 62  YCTFQTKEHLFFVMEFLNGGDL---MFHIQDKGRFDL-YRATFYAAEIVCGLQFLH---S 114

Query: 229 RRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           + II+RD+K  N++L  D   +I DFG+ K
Sbjct: 115 KGIIYRDLKLDNVMLDRDGHIKIADFGMCK 144

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 40.1 bits (94), Expect = 8e-04
 Identities = 43/145 (29%), Positives = 62/145 (42%), Gaps = 39/145 (26%)

Query: 134 GQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNTAKLLGY-----GIEGGMH--IVL 185
           GQ VAIK+L+R   +   A     EL +M  V+H N   LL        +E      +V+
Sbjct: 41  GQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVM 100

Query: 186 ELSP------------NGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIH 233
           EL              +  ++ LLY M   +K                +LH      IIH
Sbjct: 101 ELMDANLCQVIQMDLDHERMSYLLYQMLCGIK----------------HLHSA---GIIH 141

Query: 234 RDIKAANILLTEDFEPQICDFGLAK 258
           RD+K +NI++  D   +I DFGLA+
Sbjct: 142 RDLKPSNIVVKSDCTLKILDFGLAR 166

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 40.0 bits (93), Expect = 0.001
 Identities = 38/149 (25%), Positives = 69/149 (46%), Gaps = 13/149 (8%)

Query: 117 LIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA---DEIIADFLSELGIMAHVDHPNTAKL 172
           ++GKG + +V+   L+   Q  AIK L +      D++    + +  +    +HP    L
Sbjct: 2   MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61

Query: 173 L-GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKI--ALGVAEGLLYLHEGCQR 229
              +  +  +  V+E    G L   ++ ++   K+ +      A  +  GL +LH    +
Sbjct: 62  YCTFQTKENLFFVMEYLNGGDL---MFHIQSCHKFDLPRATFYAAEIICGLQFLH---SK 115

Query: 230 RIIHRDIKAANILLTEDFEPQICDFGLAK 258
            I++RD+K  NILL  D   +I DFG+ K
Sbjct: 116 GIVYRDLKLDNILLDTDGHIKIADFGMCK 144

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 39.6 bits (92), Expect = 0.001
 Identities = 40/143 (27%), Positives = 70/143 (48%), Gaps = 12/143 (8%)

Query: 118 IGKGGYAEVYKGRLR-NGQLVAIKR--LTRGTADEIIADFLSELGIMAHVDHPNTAKLL- 173
           IG+G    V   R + +G+ VA+K   L +    E++    +E+ IM    H N  ++  
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELL---FNEVVIMRDYQHQNVVEMYK 85

Query: 174 GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIH 233
            Y +   + +++E    G+L  ++   + +L       +   V + L YLH    + +IH
Sbjct: 86  SYLVGEELWVLMEFLQGGALTDIV--SQTRLNEEQIATVCESVLQALCYLH---SQGVIH 140

Query: 234 RDIKAANILLTEDFEPQICDFGL 256
           RDIK+ +ILLT D   ++ DFG 
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGF 163

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 39.6 bits (92), Expect = 0.001
 Identities = 42/151 (27%), Positives = 72/151 (47%), Gaps = 17/151 (11%)

Query: 117 LIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELGIMAHVDHPNTAKLL 173
           +IG+G YA+V   RL+ N Q+ A+K + +     DE I    +E  +       +   L+
Sbjct: 2   VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQAS--SNPFLV 59

Query: 174 G----YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYK--IALGVAEGLLYLHEGC 227
           G    +     + +V+E    G L   ++ M+ + K    +    A  +   L +LHE  
Sbjct: 60  GLHSCFQTTSRLFLVIEYVNGGDL---MFHMQRQRKLPEEHARFYAAEICIALNFLHE-- 114

Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
            R II+RD+K  N+LL  D   ++ D+G+ K
Sbjct: 115 -RGIIYRDLKLDNVLLDADGHIKLTDYGMCK 144

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 39.7 bits (92), Expect = 0.001
 Identities = 38/150 (25%), Positives = 73/150 (48%), Gaps = 9/150 (6%)

Query: 111 NFSFENLIGKGGYAEVYKGRLRNG-QLVAIKRLTRGT--ADEIIADFLSELGIMAHVDHP 167
           +F    +IG+G + EV   +L+N  ++ A+K L +         A F  E  ++ + D+ 
Sbjct: 2   DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQ 61

Query: 168 NTAKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGI-RYKIALGVAEGLLYLHE 225
               L   +  E  +++V++    G L +LL   +++L   + R+ +A    E ++ +  
Sbjct: 62  WITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLA----EMVIAIDS 117

Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFG 255
             Q   +HRDIK  NIL+  +   ++ DFG
Sbjct: 118 VHQLHYVHRDIKPDNILMDMNGHIRLADFG 147

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 39.3 bits (91), Expect = 0.001
 Identities = 37/130 (28%), Positives = 61/130 (46%), Gaps = 15/130 (11%)

Query: 137 VAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNTAKLLGYGIEG-------GMHIVLELS 188
           VAIK+L+R   ++  A     EL +M  V+H N   LL              +++V+EL 
Sbjct: 45  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM 104

Query: 189 PNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFE 248
                  +   +  +    + Y++  G+     +LH      IIHRD+K +NI++  D  
Sbjct: 105 DANLCQVIQMELDHERMSYLLYQMLCGIK----HLHSA---GIIHRDLKPSNIVVKSDCT 157

Query: 249 PQICDFGLAK 258
            +I DFGLA+
Sbjct: 158 LKILDFGLAR 167

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 39.0 bits (91), Expect = 0.002
 Identities = 43/154 (27%), Positives = 64/154 (41%), Gaps = 10/154 (6%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRNG-QLVAIKRLTRGTA--DEIIADFLSELGIMAHVDH 166
            +F    LI  G Y  VY  R +   Q  A+K++ +        I     E  I+   ++
Sbjct: 1   EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAEN 60

Query: 167 PNTAKLLGYGIEGGMHI--VLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
           P    +     E   H+  V+E    G  A+LL  +        R   A  V   L YLH
Sbjct: 61  PFVVSMFC-SFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVL-ALEYLH 118

Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
                 I+HRD+K  N+L+T     ++ DFGL+K
Sbjct: 119 ---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSK 149

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 38.8 bits (90), Expect = 0.002
 Identities = 20/42 (47%), Positives = 29/42 (69%), Gaps = 4/42 (9%)

Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL 260
           G+ Y+H   QRRI+HRD+KA NI L  +   +I DFG+++ L
Sbjct: 118 GVHYMH---QRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLL 155

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 39.2 bits (91), Expect = 0.002
 Identities = 39/133 (29%), Positives = 72/133 (54%), Gaps = 21/133 (15%)

Query: 137 VAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNTAKLLGY-----GIE--GGMHIVLELS 188
           VA+K+L+R   ++  A     EL ++  V+H N   LL        +E    +++V+EL 
Sbjct: 49  VAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM 108

Query: 189 PNGSLASLLYGMK---EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTE 245
            + +L  +++ M+   E++ + + Y++  G+     +LH      IIHRD+K +NI++  
Sbjct: 109 -DANLCQVIH-MELDHERMSY-LLYQMLCGIK----HLHSA---GIIHRDLKPSNIVVKS 158

Query: 246 DFEPQICDFGLAK 258
           D   +I DFGLA+
Sbjct: 159 DCTLKILDFGLAR 171

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 39.0 bits (91), Expect = 0.002
 Identities = 39/149 (26%), Positives = 71/149 (47%), Gaps = 13/149 (8%)

Query: 117 LIGKGGYAEVYKGRLR-NGQLVAIKRLTRG--TADEIIADFLSELGIM-AHVDHPNTAKL 172
           +IG+G YA+V    L+   ++ A+K + +     DE I    +E  +     +HP    L
Sbjct: 2   VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGL 61

Query: 173 LG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYK--IALGVAEGLLYLHEGCQR 229
              +  E  +  V+E    G L   ++ M+ + K    +    +  ++  L +LHE   R
Sbjct: 62  HSCFQTESRLFFVIEFVSGGDL---MFHMQRQRKLPEEHARFYSAEISLALNFLHE---R 115

Query: 230 RIIHRDIKAANILLTEDFEPQICDFGLAK 258
            II+RD+K  N+LL  +   ++ D+G+ K
Sbjct: 116 GIIYRDLKLDNVLLDAEGHIKLTDYGMCK 144

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 38.9 bits (90), Expect = 0.002
 Identities = 41/147 (27%), Positives = 71/147 (48%), Gaps = 9/147 (6%)

Query: 117 LIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELGIMAHV-DHPNTAKL 172
           +IG+G YA+V   RL+   ++ A+K + +     DE I    +E  +     +HP    L
Sbjct: 2   VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61

Query: 173 LG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRI 231
              +  E  +  V+E    G L   +   ++  +   R+  A  ++  L YLHE   R I
Sbjct: 62  HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNYLHE---RGI 117

Query: 232 IHRDIKAANILLTEDFEPQICDFGLAK 258
           I+RD+K  N+LL  +   ++ D+G+ K
Sbjct: 118 IYRDLKLDNVLLDSEGHIKLTDYGMCK 144

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 38.4 bits (89), Expect = 0.003
 Identities = 42/140 (30%), Positives = 58/140 (41%), Gaps = 19/140 (13%)

Query: 118 IGKG--GYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLL 173
           IG+G      VY  R    G LV ++        E     L    +++H   HPN     
Sbjct: 6   IGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSW 65

Query: 174 GYGIEGG-MHIVLELSPNGSLASLLY-----GMKEKLKWGIRYKIALGVAEGLLYLHE-G 226
                G  + ++      GS  SLL      GM E L   I +    G   GL YLH+ G
Sbjct: 66  TVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILF----GALRGLNYLHQNG 121

Query: 227 CQRRIIHRDIKAANILLTED 246
                IHR+IKA++IL++ D
Sbjct: 122 Y----IHRNIKASHILISGD 137

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 38.4 bits (89), Expect = 0.003
 Identities = 39/163 (23%), Positives = 67/163 (41%), Gaps = 26/163 (15%)

Query: 118 IGKGGYAEVYKGRLRN------GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAK 171
           +G+G + +V+     N        LVA+K L   T      DF  E  ++ ++ H +  K
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAAR-KDFQREAELLTNLQHEHIVK 71

Query: 172 LLGYGIEGG-MHIVLELSPNGSLASLLYG---------------MKEKLKWGIRYKIALG 215
             G   +G  + +V E   +G L   L                  K +L       IA  
Sbjct: 72  FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131

Query: 216 VAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           +A G++YL     +  +HRD+   N L+  +   +I DFG+++
Sbjct: 132 IASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 171

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 38.1 bits (88), Expect = 0.004
 Identities = 44/168 (26%), Positives = 78/168 (46%), Gaps = 15/168 (8%)

Query: 117 LIGKGGYAEVYKGRLRN-GQLVAIK-----RLTRGTADEIIADFLSELGIMAHVDHPNTA 170
           +IG+GG+ EVY  R  + G++ A+K     R+     + +  +    L +++  D P   
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 171 KL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQR 229
            +   +     +  +L+L   G L   L       +  +R+  A  +  GL ++H    R
Sbjct: 61  CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRF-YATEIILGLEHMH---NR 116

Query: 230 RIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFG 277
            +++RD+K ANILL E    +I D GLA    ++  H ++    GT G
Sbjct: 117 FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHG 160

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 38.0 bits (88), Expect = 0.004
 Identities = 42/152 (27%), Positives = 76/152 (50%), Gaps = 19/152 (12%)

Query: 117 LIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIAD-----FLSELGIM--AHVDHPN 168
           ++GKG + +V   RL+ +G+L A+K L +   D I+ D      ++E  I+  A  +HP 
Sbjct: 2   VLGKGSFGKVMLARLKESGRLYAVKVLKK---DVILQDDDVECTMTEKRILSLAR-NHPF 57

Query: 169 TAKLL-GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKI-ALGVAEGLLYLHEG 226
             +L   +     +  V+E    G L  + +  K +     R +  A  +   L++LH+ 
Sbjct: 58  LTQLYCCFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFDEARARFYAAEITSALMFLHD- 114

Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
             + II+RD+K  N+LL  +   ++ DFG+ K
Sbjct: 115 --KGIIYRDLKLDNVLLDHEGHCKLADFGMCK 144

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 38.1 bits (88), Expect = 0.004
 Identities = 18/43 (41%), Positives = 27/43 (62%), Gaps = 3/43 (6%)

Query: 216 VAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           VA G+ +L     +  +HRD+ A N+L+ E    +ICDFGLA+
Sbjct: 248 VANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLAR 287

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	308
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.98
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	99.98
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	99.98
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	99.98
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	99.98
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.98
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.98
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	99.98
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	99.98
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.98
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	99.98
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.98
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	99.98
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.98
PHA03210	501	serine/threonine kinase US3; Provisional	99.98
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.98
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.98
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.98
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	99.98
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.98
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	99.98
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	99.98
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.98
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	99.98
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.98
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.98
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	99.98
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	99.98
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	99.98
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.97
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	99.97
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.97
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	99.97
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	99.97
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.97
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.97
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	99.97
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	99.97
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.97
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.97
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.97
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.97
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.97
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	99.97
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.97
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.97
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.97
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.97
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.97
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.97
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.97
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.97
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	99.97
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.97
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	99.97
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.97
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.97
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.97
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.97
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.97
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	99.97
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.97
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.97
PLN00009	294	cyclin-dependent kinase A; Provisional	99.97
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.97
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.97
PHA02882	294	putative serine/threonine kinase; Provisional	99.97
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.97
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.97
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.97
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.97
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.97
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.97
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.97
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.97
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.97
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.97
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.97
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.97
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.97
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.97
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.97
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.97
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.97
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.97
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.97
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.97
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.97
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.97
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.97
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.97
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.97
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.97
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.97
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.97
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.97
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.97
KOG1152	772	consensus Signal transduction serine/threonine kin	99.97
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.97
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.97
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.97
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.97
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.96
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.96
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.96
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.96
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.96
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.96
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.96
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.96
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.96
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.96
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.96
PRK09188	365	serine/threonine protein kinase; Provisional	99.96
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.95
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.95
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.95
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.95
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.95
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.94
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.94
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.94
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.94
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.94
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.93
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.93
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.93
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.93
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.92
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.91
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.91
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.91
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.91
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.9
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.89
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.88
PLN00181	793	protein SPA1-RELATED; Provisional	99.87
PRK10345	210	hypothetical protein; Provisional	99.86
smart00090	237	RIO RIO-like kinase.	99.85
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.83
PRK12274	218	serine/threonine protein kinase; Provisional	99.83
PRK14879	211	serine/threonine protein kinase; Provisional	99.82
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.8
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.8
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.8
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.77
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.77
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.75
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.74
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.72
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.71
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.68
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.61
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.58
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.58
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.58
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.57
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.55
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.54
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.5
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.48
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.46
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.34
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.31
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.23
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.21
KOG3087	229	consensus Serine/threonine protein kinase [General	99.2
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.18
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.12
KOG1243	690	consensus Protein kinase [General function predict	99.09
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.07
KOG1266	458	consensus Protein kinase [Signal transduction mech	98.99
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.85
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.83
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.74
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.73
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.7
PRK09902	216	hypothetical protein; Provisional	98.65
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.49
PF01636	239	APH: Phosphotransferase enzyme family This family	98.46
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.4
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.39
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	98.34
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.32
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.26
PLN02876	822	acyl-CoA dehydrogenase	98.24
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.19
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.18
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.18
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.16
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.11
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.03
COG4248	637	Uncharacterized protein with protein kinase and he	97.96
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.95
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.75
PRK10593	297	hypothetical protein; Provisional	97.71
PRK05231	319	homoserine kinase; Provisional	97.58
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.5
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.46
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.38
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.32
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.3
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.12
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.01
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.75
PLN02236	344	choline kinase	96.68
KOG2270	520	consensus Serine/threonine protein kinase involved	96.55
PRK06148	1013	hypothetical protein; Provisional	96.44
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	96.34
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.32
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.21
PLN02756	418	S-methyl-5-thioribose kinase	96.21
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	95.83
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	95.72
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	95.72
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	95.47
PRK12396	409	5-methylribose kinase; Reviewed	95.46
PRK11768	325	serine/threonine protein kinase; Provisional	95.0
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	94.21
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	94.11
KOG1236	565	consensus Predicted unusual protein kinase [Genera	93.76
PF03109	119	ABC1: ABC1 family; InterPro: IPR004147 This entry	93.67
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	93.15
PRK10271	188	thiK thiamine kinase; Provisional	93.12
COG2334	331	Putative homoserine kinase type II (protein kinase	93.11

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-49  Score=362.21  Aligned_cols=209  Identities=48%  Similarity=0.768  Sum_probs=189.4

Q ss_pred             CccccCHHHHHhhcCCccccceeeccCceEEEEEEECCCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeE
Q 021711           96 PQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGY  175 (308)
Q Consensus        96 ~~~~~~~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~  175 (308)
                      +.+.|++.++..+|++|.-.++||+|+||.||+|...+|..||||++....... ..+|.+|+.++.+++|||+|+|+||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~-~~eF~~Ei~~ls~l~H~Nlv~LlGy  139 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG-EREFLNEVEILSRLRHPNLVKLLGY  139 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc-hhHHHHHHHHHhcCCCcCcccEEEE
Confidence            577899999999999999999999999999999999989999999887655432 3569999999999999999999999


Q ss_pred             EEeCc--EEEEEEecCCCCHHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEe
Q 021711          176 GIEGG--MHIVLELSPNGSLASLLYGMKE-KLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQIC  252 (308)
Q Consensus       176 ~~~~~--~~lv~e~~~~gsL~~~l~~~~~-~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~  252 (308)
                      |.+.+  ..||+||+++|+|.+.|+.... .++|..+++|+.++|.||+|||+.+...||||||||+|||||+++++||+
T Consensus       140 C~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls  219 (361)
T KOG1187|consen  140 CLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS  219 (361)
T ss_pred             EecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence            99875  7999999999999999987666 89999999999999999999999887789999999999999999999999


Q ss_pred             ccccceecCC-CCceeEeece-eccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          253 DFGLAKWLPE-QWTHHTISKV-EGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       253 DFGla~~~~~-~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      |||+|+..+. ...   .... .||++|+|||+......+.++||||||++|+||.+|
T Consensus       220 DFGLa~~~~~~~~~---~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitg  274 (361)
T KOG1187|consen  220 DFGLAKLGPEGDTS---VSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITG  274 (361)
T ss_pred             CccCcccCCccccc---eeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhC
Confidence            9999987766 322   1222 899999999999888899999999999999999876

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-46  Score=332.77  Aligned_cols=193  Identities=27%  Similarity=0.393  Sum_probs=172.8

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCC-hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVL  185 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~  185 (308)
                      ..+|.+.+.||+|+||+||+|+++ ++..||||.+.... ..+..+.+..|+.+|+.++|||||.+++++..+ .+||||
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM   88 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM   88 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence            467888899999999999999977 58999999996553 456678899999999999999999999987765 579999


Q ss_pred             EecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCC------CcEEEecccccee
Q 021711          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTED------FEPQICDFGLAKW  259 (308)
Q Consensus       186 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~------~~~kl~DFGla~~  259 (308)
                      |||.||+|.++++. .+.+++..+..++.|++.||++||+   ++||||||||.||||+..      -.+||+|||+||.
T Consensus        89 EyC~gGDLs~yi~~-~~~l~e~t~r~Fm~QLA~alq~L~~---~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~  164 (429)
T KOG0595|consen   89 EYCNGGDLSDYIRR-RGRLPEATARHFMQQLASALQFLHE---NNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF  164 (429)
T ss_pred             EeCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence            99999999999965 4579999999999999999999999   999999999999999875      3589999999999


Q ss_pred             cCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          260 LPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       260 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      +.+..   .....+|++-|||||......++.++|+||.|.+||++++|
T Consensus       165 L~~~~---~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g  210 (429)
T KOG0595|consen  165 LQPGS---MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTG  210 (429)
T ss_pred             CCchh---HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhC
Confidence            97652   34578999999999999999999999999999999999886

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-44  Score=319.98  Aligned_cols=191  Identities=29%  Similarity=0.400  Sum_probs=171.9

Q ss_pred             CccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEe-Cc-EEEEEEe
Q 021711          111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GG-MHIVLEL  187 (308)
Q Consensus       111 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~-~~lv~e~  187 (308)
                      +.+..+.||+|..|+||+++++ +++.+|+|.+.........++..+|+++++.++||+||.+||.+.. +. ..++|||
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY  159 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY  159 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence            4456789999999999999987 5889999999777777788999999999999999999999995554 43 8999999


Q ss_pred             cCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCcee
Q 021711          188 SPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH  267 (308)
Q Consensus       188 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~  267 (308)
                      |.+|+|.+++.. .+++++...-.++.+|++||.|||+  .++||||||||+|||++..|++||||||.++.+...    
T Consensus       160 MDgGSLd~~~k~-~g~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS----  232 (364)
T KOG0581|consen  160 MDGGSLDDILKR-VGRIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS----  232 (364)
T ss_pred             cCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh----
Confidence            999999999864 3679999999999999999999995  289999999999999999999999999999987554    


Q ss_pred             EeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          268 TISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ...++.||..|||||.+.+..++-++||||||++++|+|-|
T Consensus       233 ~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~G  273 (364)
T KOG0581|consen  233 IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIG  273 (364)
T ss_pred             hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhC
Confidence            34678999999999999999999999999999999999865

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.9e-43  Score=311.66  Aligned_cols=194  Identities=24%  Similarity=0.304  Sum_probs=164.8

Q ss_pred             hcCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHH------HHHHHHHHHHHHhcCCCCeeeeeeeEEEeCc
Q 021711          108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADE------IIADFLSELGIMAHVDHPNTAKLLGYGIEGG  180 (308)
Q Consensus       108 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  180 (308)
                      ..+.|.+.+.||+|+||.|-+|..+ +|+.||||++.+.....      ......+|+++|++|+|||||++++++....
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            4567888899999999999999865 69999999996542211      1234579999999999999999999888765


Q ss_pred             -EEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCC---CcEEEecccc
Q 021711          181 -MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTED---FEPQICDFGL  256 (308)
Q Consensus       181 -~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~---~~~kl~DFGl  256 (308)
                       .|+||||+.||+|.+++.. .+.+.+..-..++.|++.|+.|||+   +||+||||||+|||+..+   ..+||+|||+
T Consensus       250 s~YmVlE~v~GGeLfd~vv~-nk~l~ed~~K~~f~Qll~avkYLH~---~GI~HRDiKPeNILl~~~~e~~llKItDFGl  325 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVVA-NKYLREDLGKLLFKQLLTAVKYLHS---QGIIHRDIKPENILLSNDAEDCLLKITDFGL  325 (475)
T ss_pred             ceEEEEEEecCccHHHHHHh-ccccccchhHHHHHHHHHHHHHHHH---cCcccccCCcceEEeccCCcceEEEecccch
Confidence             5999999999999999865 4557777778899999999999999   999999999999999876   6899999999


Q ss_pred             ceecCCCCceeEeeceeccccccccccCchhh---cCccceeEEEeeEEEeeccC
Q 021711          257 AKWLPEQWTHHTISKVEGTFGLVKLNLPPLVI---LKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       257 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Di~s~g~~l~el~c~  308 (308)
                      |+...+.   ..+.+.+||+.|.|||.+....   ...+.|+||+||+||-.+||
T Consensus       326 AK~~g~~---sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG  377 (475)
T KOG0615|consen  326 AKVSGEG---SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSG  377 (475)
T ss_pred             hhccccc---eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEecc
Confidence            9988654   3567899999999999875443   23478999999999999987

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-43  Score=323.61  Aligned_cols=193  Identities=31%  Similarity=0.470  Sum_probs=168.7

Q ss_pred             CccccceeeccCceEEEEEEECCCcEEEEEEeccCC-hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeCc--EEEEEEe
Q 021711          111 NFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG--MHIVLEL  187 (308)
Q Consensus       111 ~~~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~lv~e~  187 (308)
                      .....+.||+|+||+||+|.++....||||++.... ..+..+.|.+|+.+|.+++|||||+++|+|.+..  +++||||
T Consensus        42 ~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy  121 (362)
T KOG0192|consen   42 ELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEY  121 (362)
T ss_pred             HhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEe
Confidence            344556799999999999999754449999997543 2233679999999999999999999999999875  8999999


Q ss_pred             cCCCCHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-ceecCCCCCCEEECCCC-cEEEeccccceecCCCC
Q 021711          188 SPNGSLASLLYG-MKEKLKWGIRYKIALGVAEGLLYLHEGCQRR-IIHRDIKAANILLTEDF-EPQICDFGLAKWLPEQW  264 (308)
Q Consensus       188 ~~~gsL~~~l~~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~-iiHrDlKp~NILl~~~~-~~kl~DFGla~~~~~~~  264 (308)
                      +++|+|.++++. .+..+++..++.++.|||+||.|||+   .+ ||||||||+|||++.++ ++||+|||+++......
T Consensus       122 ~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~---~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~  198 (362)
T KOG0192|consen  122 MPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHS---EGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK  198 (362)
T ss_pred             CCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhc---CCCeeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence            999999999987 47789999999999999999999998   67 99999999999999998 99999999999765432


Q ss_pred             ceeEeeceeccccccccccCc--hhhcCccceeEEEeeEEEeeccC
Q 021711          265 THHTISKVEGTFGLVKLNLPP--LVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                        .......||+.|||||.+.  ...++.++||||||++||||.++
T Consensus       199 --~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~  242 (362)
T KOG0192|consen  199 --TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTG  242 (362)
T ss_pred             --ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHC
Confidence              2334589999999999998  55899999999999999999875

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-43  Score=312.06  Aligned_cols=195  Identities=23%  Similarity=0.312  Sum_probs=171.5

Q ss_pred             hcCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCCh--HHHHHHHHHHHHHHhcCCCCeeeeeee-EEEeCcEEE
Q 021711          108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELGIMAHVDHPNTAKLLG-YGIEGGMHI  183 (308)
Q Consensus       108 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~-~~~~~~~~l  183 (308)
                      ..++|++.++||+|+||+||.++.+ +++.+|+|.+++..-  ....+....|..||..++||+||+++- |.+...+|+
T Consensus        23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl  102 (357)
T KOG0598|consen   23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL  102 (357)
T ss_pred             ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence            3468999999999999999999866 589999999976432  223567889999999999999999975 667778999


Q ss_pred             EEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCC
Q 021711          184 VLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ  263 (308)
Q Consensus       184 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  263 (308)
                      |+||+.||.|...|.. .+.+++..+.-++.+|+.||.|||+   ++||||||||+|||||.+|+++|+||||++.....
T Consensus       103 Vld~~~GGeLf~hL~~-eg~F~E~~arfYlaEi~lAL~~LH~---~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~  178 (357)
T KOG0598|consen  103 VLDYLNGGELFYHLQR-EGRFSEDRARFYLAEIVLALGYLHS---KGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD  178 (357)
T ss_pred             EEeccCCccHHHHHHh-cCCcchhHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHeeecCCCcEEEeccccchhcccC
Confidence            9999999999999953 5678999888899999999999999   99999999999999999999999999999965444


Q ss_pred             CceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          264 WTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ..  ....++||+.|||||++.+..+++..|-||+|+++|||.||
T Consensus       179 ~~--~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G  221 (357)
T KOG0598|consen  179 GD--ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTG  221 (357)
T ss_pred             CC--ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhC
Confidence            32  33468999999999999999999999999999999999987

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.6e-42  Score=322.01  Aligned_cols=193  Identities=28%  Similarity=0.379  Sum_probs=174.2

Q ss_pred             CCccccceeeccCceEEEEEEE-CCCcEEEEEEeccCC--hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRL-RNGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVL  185 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~  185 (308)
                      ..|...++||+|||+.||.++. .+|+.||+|.+.+..  ....++...+|++|.+.|+|||||++++++.+. ++|+|+
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            4799999999999999999997 679999999996532  234578899999999999999999999988765 689999


Q ss_pred             EecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCc
Q 021711          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (308)
Q Consensus       186 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~  265 (308)
                      |+|..++|..++. ....+++..+..++.||+.||.|||+   ++|||||||..|+||+++.++||+|||||..+..+..
T Consensus        98 ELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH~---~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E  173 (592)
T KOG0575|consen   98 ELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLHS---LGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE  173 (592)
T ss_pred             EecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHHh---cCceecccchhheeecCcCcEEecccceeeeecCccc
Confidence            9999999999986 57789999999999999999999999   9999999999999999999999999999999875532


Q ss_pred             eeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          266 HHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                        ...+.+||+.|+|||.+.....+-.+||||+||+||.|++|
T Consensus       174 --rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G  214 (592)
T KOG0575|consen  174 --RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVG  214 (592)
T ss_pred             --ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhC
Confidence              23468999999999999988899999999999999999886

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2e-42  Score=319.09  Aligned_cols=195  Identities=26%  Similarity=0.342  Sum_probs=170.3

Q ss_pred             hhcCCccccceeeccCceEEEEEEECCCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeCc-EEEEE
Q 021711          107 SATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIVL  185 (308)
Q Consensus       107 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~  185 (308)
                      .....+.+++.||+|.||+||.|.++....||+|.++.....  .+.|.+|+++|++|+|+|||+++++|..++ ++|||
T Consensus       203 i~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~--~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVt  280 (468)
T KOG0197|consen  203 IPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMS--PEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVT  280 (468)
T ss_pred             ecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccC--hhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEE
Confidence            334456678899999999999999987779999999876443  378899999999999999999999999865 89999


Q ss_pred             EecCCCCHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCC
Q 021711          186 ELSPNGSLASLLYG-MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (308)
Q Consensus       186 e~~~~gsL~~~l~~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  264 (308)
                      ||++.|+|.++|.. .+..+...+.+.++.|||+||+||++   +++|||||.++||||+++..+||+||||||...++.
T Consensus       281 E~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes---~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~  357 (468)
T KOG0197|consen  281 EYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLES---KNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDE  357 (468)
T ss_pred             EecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHh---CCccchhhhhhheeeccCceEEEcccccccccCCCc
Confidence            99999999999986 56678999999999999999999999   999999999999999999999999999999554432


Q ss_pred             ceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          265 THHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                       ........=..-|.|||++....++.++||||||++|||+++
T Consensus       358 -Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT  399 (468)
T KOG0197|consen  358 -YTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFT  399 (468)
T ss_pred             -eeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhc
Confidence             222233444578999999999999999999999999999874

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.6e-44  Score=307.02  Aligned_cols=195  Identities=25%  Similarity=0.376  Sum_probs=168.8

Q ss_pred             CCccccceeeccCceEEEEEEE-CCCcEEEEEEeccCC-hHHHHHHHHHHHHHHhcCCCCeeeeeee--EEEeCc-EEEE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRL-RNGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLG--YGIEGG-MHIV  184 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~--~~~~~~-~~lv  184 (308)
                      .+|+++++||+|.||+||++.. .+|..||.|.++-.. +...+++...|+.+|++|+|||||++++  +..++. ++||
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            3688899999999999999974 479999999987432 3345788999999999999999999998  334444 7899


Q ss_pred             EEecCCCCHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-ceecCCCCCCEEECCCCcEEEeccccceec
Q 021711          185 LELSPNGSLASLLYG---MKEKLKWGIRYKIALGVAEGLLYLHEGCQRR-IIHRDIKAANILLTEDFEPQICDFGLAKWL  260 (308)
Q Consensus       185 ~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~-iiHrDlKp~NILl~~~~~~kl~DFGla~~~  260 (308)
                      ||+|.+|+|...+..   .+..+++..+++++.|++.||.++|.-.+++ |+||||||.||+|+.+|.+||+||||++.+
T Consensus        99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l  178 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL  178 (375)
T ss_pred             HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence            999999999998853   4567999999999999999999999732222 999999999999999999999999999998


Q ss_pred             CCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeec
Q 021711          261 PEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLS  306 (308)
Q Consensus       261 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~  306 (308)
                      ....+  ...+.+||+.||+||...+..++.++|+||+|+++|||+
T Consensus       179 ~s~~t--fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMc  222 (375)
T KOG0591|consen  179 SSKTT--FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMC  222 (375)
T ss_pred             cchhH--HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHH
Confidence            66533  335789999999999999999999999999999999986

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=2.3e-42  Score=298.52  Aligned_cols=193  Identities=23%  Similarity=0.294  Sum_probs=168.8

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCCh-HHHHHHHHHHHHHHhcCCCCeeeeeeeEEEe-CcEEEEEE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA-DEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLE  186 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~lv~e  186 (308)
                      +.|+.+.++|+|+||.||+|+++ +|+.||||++..... +...+-.+||+++|++++|+|+|.+++.|.. ..++||+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            46777889999999999999987 499999999976554 3455668999999999999999999996654 56899999


Q ss_pred             ecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCce
Q 021711          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH  266 (308)
Q Consensus       187 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~  266 (308)
                      ||.. ++.+-|......++...+..++.|++.|+.|+|+   +++|||||||+|||++.+|.+||||||+|+.+..... 
T Consensus        82 ~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk---~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd-  156 (396)
T KOG0593|consen   82 YCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHK---NNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGD-  156 (396)
T ss_pred             ecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhh---cCeecccCChhheEEecCCcEEeccchhhHhhcCCcc-
Confidence            9987 5555565667779999999999999999999999   8999999999999999999999999999999875432 


Q ss_pred             eEeeceeccccccccccCch-hhcCccceeEEEeeEEEeeccC
Q 021711          267 HTISKVEGTFGLVKLNLPPL-VILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~s~g~~l~el~c~  308 (308)
                       ..+.++.|.+|.|||++.+ ..++.+.|+|+.||++.||+.|
T Consensus       157 -~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G  198 (396)
T KOG0593|consen  157 -NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTG  198 (396)
T ss_pred             -hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcC
Confidence             4578899999999998876 6789999999999999999876

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4e-41  Score=307.59  Aligned_cols=195  Identities=26%  Similarity=0.324  Sum_probs=169.8

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCC-hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC---cEEE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG---GMHI  183 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---~~~l  183 (308)
                      .+.|+.++.||+|+||.||+|+.. +|+.||+|++.-.. .+.......|||.||++|+||||++|.+...+.   .+|+
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl  195 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL  195 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence            356888899999999999999854 69999999996544 334456678999999999999999999976654   6899


Q ss_pred             EEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCC
Q 021711          184 VLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ  263 (308)
Q Consensus       184 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  263 (308)
                      |+|||++ +|.-++....-.++..++..++.|++.||.|+|.   ++|+|||||.+|||||.+|.+||+|||||+++...
T Consensus       196 VFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~---~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~  271 (560)
T KOG0600|consen  196 VFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHS---RGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS  271 (560)
T ss_pred             EEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhh---cCeeeccccccceEEcCCCCEEeccccceeeccCC
Confidence            9999976 8988887767789999999999999999999999   99999999999999999999999999999987665


Q ss_pred             CceeEeeceeccccccccccCchh-hcCccceeEEEeeEEEeeccC
Q 021711          264 WTHHTISKVEGTFGLVKLNLPPLV-ILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ... ..+..+-|.+|.|||++.+. .++...|+||.||+|.||+.|
T Consensus       272 ~~~-~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~g  316 (560)
T KOG0600|consen  272 GSA-PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLG  316 (560)
T ss_pred             CCc-ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcC
Confidence            432 36677889999999987654 589999999999999999865

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-40  Score=287.12  Aligned_cols=190  Identities=24%  Similarity=0.295  Sum_probs=170.4

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCCh--HHHHHHHHHHHHHHhcCCCCeeeeeeeEE-EeCcEEEEE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELGIMAHVDHPNTAKLLGYG-IEGGMHIVL  185 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~lv~  185 (308)
                      ++|+..+.||.|+||.|.+++.+ +|..+|+|.+.+...  -++.+...+|..+|+.+.||+++++++-+ ..+.+++||
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm  123 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM  123 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence            47888899999999999999977 589999999976432  24567788999999999999999999754 455689999


Q ss_pred             EecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCc
Q 021711          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (308)
Q Consensus       186 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~  265 (308)
                      ||.+||.|.++++. .+++++..+.-++.||+.||+|||+   .+|++|||||+|||+|.+|.+||+|||+|+.+...  
T Consensus       124 eyv~GGElFS~Lrk-~~rF~e~~arFYAAeivlAleylH~---~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r--  197 (355)
T KOG0616|consen  124 EYVPGGELFSYLRK-SGRFSEPHARFYAAEIVLALEYLHS---LDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR--  197 (355)
T ss_pred             eccCCccHHHHHHh-cCCCCchhHHHHHHHHHHHHHHHHh---cCeeeccCChHHeeeccCCcEEEEeccceEEecCc--
Confidence            99999999999975 4679999999999999999999999   99999999999999999999999999999987553  


Q ss_pred             eeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          266 HHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                         .-+.+||+.|+|||......++++.|=|+||+++||++||
T Consensus       198 ---T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG  237 (355)
T KOG0616|consen  198 ---TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAG  237 (355)
T ss_pred             ---EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcC
Confidence               3468999999999999999999999999999999999997

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2e-39  Score=290.51  Aligned_cols=195  Identities=28%  Similarity=0.438  Sum_probs=165.9

Q ss_pred             CCccccceeeccCceEEEEEEECC-CcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeE-EEeC--cEEEEE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLRN-GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGY-GIEG--GMHIVL  185 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~~-g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~-~~~~--~~~lv~  185 (308)
                      .+|...+.||+|+||.||++...+ |...|||.+....... .+.+.+|+.+|.+++|||||+++|. ....  .+++.|
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m   95 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM   95 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence            467788999999999999999764 8999999987653333 5778999999999999999999996 3333  478999


Q ss_pred             EecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECC-CCcEEEeccccceecCCCC
Q 021711          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTE-DFEPQICDFGLAKWLPEQW  264 (308)
Q Consensus       186 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~-~~~~kl~DFGla~~~~~~~  264 (308)
                      ||+++|+|.+++...+..+++..+..+++||++||.|||+   ++||||||||+|||++. ++.+||+|||+++......
T Consensus        96 Ey~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs---~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~  172 (313)
T KOG0198|consen   96 EYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHS---KGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG  172 (313)
T ss_pred             eccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence            9999999999997755579999999999999999999998   99999999999999999 7999999999998776311


Q ss_pred             c-eeEeeceeccccccccccCchh-hcCccceeEEEeeEEEeeccC
Q 021711          265 T-HHTISKVEGTFGLVKLNLPPLV-ILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       265 ~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~s~g~~l~el~c~  308 (308)
                      . ........||+.|||||..... ...+.+|+||+|++++||+.|
T Consensus       173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg  218 (313)
T KOG0198|consen  173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTG  218 (313)
T ss_pred             ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCC
Confidence            1 1223468999999999998753 344589999999999999875

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=2e-40  Score=306.23  Aligned_cols=192  Identities=27%  Similarity=0.422  Sum_probs=173.1

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccC-ChHHHHHHHHHHHHHHhcCCCCeeeeeeeEE-EeCcEEEEEE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRG-TADEIIADFLSELGIMAHVDHPNTAKLLGYG-IEGGMHIVLE  186 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~lv~e  186 (308)
                      ++|.+.+.||+|+||.||||+.+ +.+.||+|.+.+. ..++....+.+|++|++.++|||||.+++++ ...++++|+|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            57888999999999999999866 5899999999654 3445678899999999999999999999955 4567999999


Q ss_pred             ecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCce
Q 021711          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH  266 (308)
Q Consensus       187 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~  266 (308)
                      |+.| +|..++.. .+.+++..+..++.+++.||.|||+   ++|+|||+||.|||++..+.+|+||||+|+.+...  .
T Consensus        82 ~a~g-~L~~il~~-d~~lpEe~v~~~a~~LVsaL~yLhs---~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~--t  154 (808)
T KOG0597|consen   82 YAVG-DLFTILEQ-DGKLPEEQVRAIAYDLVSALYYLHS---NRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN--T  154 (808)
T ss_pred             hhhh-hHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHh---cCcccccCCcceeeecCCCceeechhhhhhhcccC--c
Confidence            9987 99999954 6789999999999999999999999   99999999999999999999999999999988664  3


Q ss_pred             eEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          267 HTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ...+.+.||+-|||||+..+..++..+|+||+|+++||++.|
T Consensus       155 ~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G  196 (808)
T KOG0597|consen  155 SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVG  196 (808)
T ss_pred             eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcC
Confidence            467889999999999999999999999999999999999876

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-39  Score=300.37  Aligned_cols=196  Identities=24%  Similarity=0.343  Sum_probs=169.4

Q ss_pred             hhcCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCC----hHHHHHHHHHHHHHHhcCC-CCeeeeeeeEEE-eC
Q 021711          107 SATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT----ADEIIADFLSELGIMAHVD-HPNTAKLLGYGI-EG  179 (308)
Q Consensus       107 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~----~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~-~~  179 (308)
                      ...++|.+.+.||+|+||+|+.|... +|+.||+|++.+..    .....+.+.+|+.+++.++ ||||++++++.. ..
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            34578999999999999999999865 68999999776531    1123456668999999999 999999999655 45


Q ss_pred             cEEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCC-CcEEEeccccce
Q 021711          180 GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTED-FEPQICDFGLAK  258 (308)
Q Consensus       180 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~-~~~kl~DFGla~  258 (308)
                      .+++||||+.||+|.+++.. .+++.+..+..++.|++.|+.|||+   ++|+||||||+|||++.+ +++||+|||++.
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~---~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~  169 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHS---RGIVHRDLKPENILLDGNEGNLKLSDFGLSA  169 (370)
T ss_pred             eEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEecCCCCCEEEecccccc
Confidence            68999999999999999977 7789999999999999999999998   999999999999999999 999999999999


Q ss_pred             ecCCCCceeEeeceeccccccccccCchhh-c-CccceeEEEeeEEEeeccC
Q 021711          259 WLPEQWTHHTISKVEGTFGLVKLNLPPLVI-L-KRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       259 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~-~~~~Di~s~g~~l~el~c~  308 (308)
                      ...  .........+||+.|+|||++.+.. + +.++|+||+|++||.|+||
T Consensus       170 ~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G  219 (370)
T KOG0583|consen  170 ISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCG  219 (370)
T ss_pred             ccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhC
Confidence            874  1122456789999999999987755 4 6889999999999999997

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=5e-40  Score=302.67  Aligned_cols=198  Identities=29%  Similarity=0.363  Sum_probs=170.4

Q ss_pred             hhcCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCCh--HHHHHHHHHHHHHHhcC-CCCeeeeeee-EEEeCcE
Q 021711          107 SATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELGIMAHV-DHPNTAKLLG-YGIEGGM  181 (308)
Q Consensus       107 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~-~~~~~~~  181 (308)
                      ...++|.+++.||.|+|++|++|+.. ++..+|||++.+..-  +.-..-..+|-.+|..| .||.|++|+- |..+..+
T Consensus        70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL  149 (604)
T KOG0592|consen   70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL  149 (604)
T ss_pred             CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence            44578999999999999999999865 589999999864321  11234466788889999 8999999986 6666789


Q ss_pred             EEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecC
Q 021711          182 HIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP  261 (308)
Q Consensus       182 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~  261 (308)
                      |+|+||+++|+|.+++.. .+.+++.....++.||+.||+|||+   +|||||||||+|||||.++++||+|||.|+.++
T Consensus       150 YFvLe~A~nGdll~~i~K-~Gsfde~caR~YAAeIldAleylH~---~GIIHRDlKPENILLd~dmhikITDFGsAK~l~  225 (604)
T KOG0592|consen  150 YFVLEYAPNGDLLDLIKK-YGSFDETCARFYAAEILDALEYLHS---NGIIHRDLKPENILLDKDGHIKITDFGSAKILS  225 (604)
T ss_pred             EEEEEecCCCcHHHHHHH-hCcchHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeEcCCCcEEEeeccccccCC
Confidence            999999999999999965 4679999999999999999999999   999999999999999999999999999999886


Q ss_pred             CCCce---------eE--eeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          262 EQWTH---------HT--ISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       262 ~~~~~---------~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      +....         ..  ...++||..|++||++.+...+..+|+|+|||+||++..|
T Consensus       226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG  283 (604)
T KOG0592|consen  226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAG  283 (604)
T ss_pred             hhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcC
Confidence            54322         11  2459999999999999999999999999999999998865

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=1.7e-39  Score=276.29  Aligned_cols=192  Identities=26%  Similarity=0.334  Sum_probs=166.2

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChH-HHHHHHHHHHHHHhcCCCCeeeeeeeEE-EeCcEEEEEE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTAD-EIIADFLSELGIMAHVDHPNTAKLLGYG-IEGGMHIVLE  186 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~lv~e  186 (308)
                      ++|..+++||+|.||.||+|++. +|+.||||+++..... ..-...+||+..|+.++|+||+.+++.+ ..+++.||+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            46778899999999999999865 6999999999765433 2345688999999999999999999955 4567899999


Q ss_pred             ecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCce
Q 021711          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH  266 (308)
Q Consensus       187 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~  266 (308)
                      |++. +|..+++.....+...++..++.++++||+|||.   +.|+||||||.|+|++.+|.+||+|||+|+.+......
T Consensus        82 fm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~---~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~  157 (318)
T KOG0659|consen   82 FMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHS---KWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI  157 (318)
T ss_pred             eccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHh---hhhhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence            9975 8999998888889999999999999999999998   89999999999999999999999999999998766543


Q ss_pred             eEeeceeccccccccccCchh-hcCccceeEEEeeEEEeecc
Q 021711          267 HTISKVEGTFGLVKLNLPPLV-ILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~s~g~~l~el~c  307 (308)
                      .+  ..+-|.+|.|||++-+. .++...|+||.||++.||.-
T Consensus       158 ~~--~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELll  197 (318)
T KOG0659|consen  158 QT--HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLL  197 (318)
T ss_pred             cc--cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHc
Confidence            32  22679999999976554 58899999999999999863

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=8.9e-40  Score=285.74  Aligned_cols=192  Identities=27%  Similarity=0.336  Sum_probs=167.2

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHH-HHHHHHHHHHHHhcCCCCeeeeeeeEEEe---CcEEEE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADE-IIADFLSELGIMAHVDHPNTAKLLGYGIE---GGMHIV  184 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~---~~~~lv  184 (308)
                      ++|+.++.|++|+||.||+|+++ +++.||+|+++.....+ ..-.-+||+.+|.+++|||||.+-.+...   +.+|+|
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V  155 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV  155 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence            46778899999999999999976 58999999997544322 23356899999999999999999886554   358999


Q ss_pred             EEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCC
Q 021711          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (308)
Q Consensus       185 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  264 (308)
                      ||||++ +|..++....+++....+..++.|++.|+.|||.   +.|+||||||+|+|+++.|.+||+|||+||.+....
T Consensus       156 Me~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~---~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~  231 (419)
T KOG0663|consen  156 MEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHD---NWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL  231 (419)
T ss_pred             HHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhh---ceeEecccchhheeeccCCcEEecccchhhhhcCCc
Confidence            999976 8999999888899999999999999999999998   899999999999999999999999999999987764


Q ss_pred             ceeEeeceeccccccccccCchh-hcCccceeEEEeeEEEeecc
Q 021711          265 THHTISKVEGTFGLVKLNLPPLV-ILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~s~g~~l~el~c  307 (308)
                      .  .++..+-|.+|.|||++.+. .++.+.|+||+||++.|+..
T Consensus       232 k--~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~  273 (419)
T KOG0663|consen  232 K--PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLT  273 (419)
T ss_pred             c--cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHh
Confidence            3  45677889999999987665 48999999999999998764

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-40  Score=298.76  Aligned_cols=193  Identities=21%  Similarity=0.255  Sum_probs=167.3

Q ss_pred             hcCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCC-CCeeeeeeeEEEeC--cEEE
Q 021711          108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVD-HPNTAKLLGYGIEG--GMHI  183 (308)
Q Consensus       108 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~l  183 (308)
                      ..++|.+.+.||.|+||.||+|+.. +|..||||++++....-..-.-+||+..|++|+ |||||++.+.+.++  .+|+
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f   87 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF   87 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence            4568999999999999999999855 699999999986543321233478999999999 99999999966554  4899


Q ss_pred             EEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCC
Q 021711          184 VLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ  263 (308)
Q Consensus       184 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  263 (308)
                      |||||.. +|.+++..++..+++..+..|+.||++||.|+|.   +|+.|||+||+|||+.....+||+|||+||.+...
T Consensus        88 VfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk---~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk  163 (538)
T KOG0661|consen   88 VFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHK---HGFFHRDLKPENILISGNDVIKIADFGLAREVRSK  163 (538)
T ss_pred             eHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHh---cCcccccCChhheEecccceeEecccccccccccC
Confidence            9999965 9999998888889999999999999999999998   99999999999999998889999999999987543


Q ss_pred             CceeEeeceeccccccccccCc-hhhcCccceeEEEeeEEEeecc
Q 021711          264 WTHHTISKVEGTFGLVKLNLPP-LVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~s~g~~l~el~c  307 (308)
                         ...+.++.|.+|+|||.+. ...++.+.|+|++|++++||+.
T Consensus       164 ---pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~s  205 (538)
T KOG0661|consen  164 ---PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYS  205 (538)
T ss_pred             ---CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHH
Confidence               3456789999999999764 5568999999999999999863

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.1e-38  Score=293.03  Aligned_cols=198  Identities=23%  Similarity=0.330  Sum_probs=164.6

Q ss_pred             hhcCCccccceeeccCceEEEEEEEC------CCcEEEEEEeccCChHHHHHHHHHHHHHHhcC-CCCeeeeeeeEEEeC
Q 021711          107 SATNNFSFENLIGKGGYAEVYKGRLR------NGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGIEG  179 (308)
Q Consensus       107 ~~~~~~~~~~~LG~G~fg~Vy~~~~~------~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  179 (308)
                      ...++|++.+.||+|+||.||+|.+.      ++..||+|.+...........+.+|+.++..+ +||||+++++++...
T Consensus         4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~   83 (338)
T cd05102           4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP   83 (338)
T ss_pred             cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence            34568999999999999999999742      35689999997655444567899999999999 899999999977653


Q ss_pred             --cEEEEEEecCCCCHHHHHhccC--------------------------------------------------------
Q 021711          180 --GMHIVLELSPNGSLASLLYGMK--------------------------------------------------------  201 (308)
Q Consensus       180 --~~~lv~e~~~~gsL~~~l~~~~--------------------------------------------------------  201 (308)
                        .+++||||+++|+|.+++....                                                        
T Consensus        84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (338)
T cd05102          84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET  163 (338)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence              4789999999999999986421                                                        


Q ss_pred             -----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCceeEeeceeccc
Q 021711          202 -----EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTF  276 (308)
Q Consensus       202 -----~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~  276 (308)
                           ..+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++.+.............++.
T Consensus       164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~  240 (338)
T cd05102         164 DDLWKSPLTMEDLICYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL  240 (338)
T ss_pred             cccccCCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence                 236778888999999999999998   899999999999999999999999999998764432222223445678


Q ss_pred             cccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          277 GLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       277 ~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      .|+|||.+.....+.++|+||||++||||++
T Consensus       241 ~y~aPE~~~~~~~~~~sDiwslG~il~el~~  271 (338)
T cd05102         241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFS  271 (338)
T ss_pred             cccCcHHhhcCCCCcccCHHHHHHHHHHHHh
Confidence            9999999877778899999999999999874

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=5e-39  Score=310.02  Aligned_cols=199  Identities=23%  Similarity=0.335  Sum_probs=171.9

Q ss_pred             HhhcCCccccceeeccCceEEEEEEEC------CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC
Q 021711          106 QSATNNFSFENLIGKGGYAEVYKGRLR------NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG  179 (308)
Q Consensus       106 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~------~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  179 (308)
                      .....+..+.+.||+|+||+||+|+..      +.+.||||.++.....+..++|.||++++..++|||||+|+|.|.++
T Consensus       482 ~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~  561 (774)
T KOG1026|consen  482 EIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREG  561 (774)
T ss_pred             EechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC
Confidence            344567777889999999999999854      24689999999888777889999999999999999999999999887


Q ss_pred             c-EEEEEEecCCCCHHHHHhcc-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECC
Q 021711          180 G-MHIVLELSPNGSLASLLYGM-------------KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTE  245 (308)
Q Consensus       180 ~-~~lv~e~~~~gsL~~~l~~~-------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~  245 (308)
                      + +++|+|||..|+|.++|..+             ..+++..+.+.||.|||.||.||-+   +.+|||||.++|+||.+
T Consensus       562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~---~~FVHRDLATRNCLVge  638 (774)
T KOG1026|consen  562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS---HHFVHRDLATRNCLVGE  638 (774)
T ss_pred             CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh---Ccccccchhhhhceecc
Confidence            6 67999999999999999642             1237888999999999999999998   89999999999999999


Q ss_pred             CCcEEEeccccceecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          246 DFEPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       246 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      +..|||+||||+|..-............-.+.||+||.+....++..+||||||++|||++.
T Consensus       639 ~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFs  700 (774)
T KOG1026|consen  639 NLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFS  700 (774)
T ss_pred             ceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhc
Confidence            99999999999997654433332223344689999999999999999999999999999974

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-37  Score=290.66  Aligned_cols=195  Identities=21%  Similarity=0.267  Sum_probs=163.7

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCC--hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVL  185 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~  185 (308)
                      ++|++.+.||+|+||.||++... +++.||||.+....  ..+....+.+|+.++..++||||+++++++.++ ..|+||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            47889999999999999999865 68999999986432  223456788999999999999999999977665 478999


Q ss_pred             EecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCc
Q 021711          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (308)
Q Consensus       186 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~  265 (308)
                      ||+++|+|.+++.. ...+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++.+.....
T Consensus        81 E~~~gg~L~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~---~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~  156 (377)
T cd05629          81 EFLPGGDLMTMLIK-YDTFSEDVTRFYMAECVLAIEAVHK---LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHD  156 (377)
T ss_pred             eCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEEeecccccccccccc
Confidence            99999999999864 4568888999999999999999998   8999999999999999999999999999964321100


Q ss_pred             e------------e---------------------------------EeeceeccccccccccCchhhcCccceeEEEee
Q 021711          266 H------------H---------------------------------TISKVEGTFGLVKLNLPPLVILKRCFTCIFIGF  300 (308)
Q Consensus       266 ~------------~---------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~  300 (308)
                      .            .                                 ......||+.|+|||.+....++.++|+||+|+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv  236 (377)
T cd05629         157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA  236 (377)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecch
Confidence            0            0                                 001246999999999988778899999999999


Q ss_pred             EEEeeccC
Q 021711          301 SQLQLSCS  308 (308)
Q Consensus       301 ~l~el~c~  308 (308)
                      ++|||++|
T Consensus       237 il~elltG  244 (377)
T cd05629         237 IMFECLIG  244 (377)
T ss_pred             hhhhhhcC
Confidence            99999876

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.8e-38  Score=292.33  Aligned_cols=199  Identities=25%  Similarity=0.373  Sum_probs=168.3

Q ss_pred             HHHhhcCCccccceeeccCceEEEEEEECC--C--cE-EEEEEecc--CChHHHHHHHHHHHHHHhcCCCCeeeeeeeEE
Q 021711          104 ELQSATNNFSFENLIGKGGYAEVYKGRLRN--G--QL-VAIKRLTR--GTADEIIADFLSELGIMAHVDHPNTAKLLGYG  176 (308)
Q Consensus       104 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~--g--~~-vAvK~~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  176 (308)
                      .|+...++..+.++||+|+||.||+|+++.  +  .. ||||..+.  ....+...+|++|+++|+.++|||||+++|++
T Consensus       151 ~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa  230 (474)
T KOG0194|consen  151 KWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVA  230 (474)
T ss_pred             ccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            344555677777999999999999998753  2  23 89999874  34456788999999999999999999999987


Q ss_pred             EeC-cEEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccc
Q 021711          177 IEG-GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFG  255 (308)
Q Consensus       177 ~~~-~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFG  255 (308)
                      ... .+++|||+|.||+|.++|......++..+...++.+.|.||+|||+   +++|||||.++|+|++.++.+||+|||
T Consensus       231 ~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~---k~~IHRDIAARNcL~~~~~~vKISDFG  307 (474)
T KOG0194|consen  231 VLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHS---KNCIHRDIAARNCLYSKKGVVKISDFG  307 (474)
T ss_pred             cCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHH---CCCcchhHhHHHheecCCCeEEeCccc
Confidence            765 5789999999999999998777679999999999999999999998   999999999999999999999999999


Q ss_pred             cceecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          256 LAKWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       256 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      +++.-.. ... ......-...|+|||.+....++.++||||||+++||++.
T Consensus       308 Ls~~~~~-~~~-~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~  357 (474)
T KOG0194|consen  308 LSRAGSQ-YVM-KKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFE  357 (474)
T ss_pred             cccCCcc-eee-ccccccCcceecChhhhccCccccccchhheeeeEEeeec
Confidence            9986431 110 1111234689999999998899999999999999999974

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-39  Score=298.13  Aligned_cols=203  Identities=26%  Similarity=0.361  Sum_probs=176.9

Q ss_pred             CHHHHHhhcCCccccceeeccCceEEEEEEECCCcEEEEEEeccCC-hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC
Q 021711          101 SLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG  179 (308)
Q Consensus       101 ~~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  179 (308)
                      +.++|.+..+.+.+...||+|.||+||+|++..  .||||.+.... .++..+.|.+|+..+++-+|.||+-+.|||..+
T Consensus       383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p  460 (678)
T KOG0193|consen  383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP  460 (678)
T ss_pred             cccccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence            446677777788889999999999999999863  59999997543 345789999999999999999999999999999


Q ss_pred             cEEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEecccccee
Q 021711          180 GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKW  259 (308)
Q Consensus       180 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~  259 (308)
                      ...+|+.+|+|-+|..+++.....++......|+.||++||.|||.   ++|||||||..||++.+++.|||+||||+..
T Consensus       461 ~~AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHA---K~IIHrDLKSnNIFl~~~~kVkIgDFGLatv  537 (678)
T KOG0193|consen  461 PLAIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHA---KNIIHRDLKSNNIFLHEDLKVKIGDFGLATV  537 (678)
T ss_pred             ceeeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhh---hhhhhhhccccceEEccCCcEEEecccceee
Confidence            9999999999999999999888889999999999999999999998   9999999999999999999999999999975


Q ss_pred             cCCCCceeEeeceeccccccccccCc---hhhcCccceeEEEeeEEEeeccC
Q 021711          260 LPEQWTHHTISKVEGTFGLVKLNLPP---LVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       260 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      -......+......|...|||||++.   ...++..+||||||+++|||.||
T Consensus       538 k~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg  589 (678)
T KOG0193|consen  538 KTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTG  589 (678)
T ss_pred             eeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhC
Confidence            43332223344567889999999864   33478889999999999999986

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-37  Score=289.43  Aligned_cols=195  Identities=22%  Similarity=0.288  Sum_probs=165.5

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCC--hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVL  185 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~  185 (308)
                      ++|++.+.||+|+||.||+|+.. +|+.||||.+....  .......+.+|+.++..++||||+++++++..+ ..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            47899999999999999999976 58999999996432  223456788999999999999999999876655 578999


Q ss_pred             EecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCc
Q 021711          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (308)
Q Consensus       186 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~  265 (308)
                      ||+++|+|.+++.. ...+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.++|+|||+++.+.....
T Consensus        81 E~~~~g~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~  156 (364)
T cd05599          81 EYLPGGDMMTLLMK-KDTFTEEETRFYIAETILAIDSIHK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHR  156 (364)
T ss_pred             CCCCCcHHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEeecccceecccccc
Confidence            99999999999864 4568999999999999999999998   8999999999999999999999999999986543211


Q ss_pred             ee------------------------------------EeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          266 HH------------------------------------TISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       266 ~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ..                                    ......||+.|+|||.+....++.++|+||+|+++|||++|
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G  235 (364)
T cd05599         157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG  235 (364)
T ss_pred             ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC
Confidence            00                                    01124699999999998888889999999999999999876

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=2.7e-38  Score=291.18  Aligned_cols=198  Identities=22%  Similarity=0.310  Sum_probs=168.9

Q ss_pred             hhcCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCCh--HHHHHHHHHHHHHHhcCCCCeeeeeee-EEEeCcEE
Q 021711          107 SATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELGIMAHVDHPNTAKLLG-YGIEGGMH  182 (308)
Q Consensus       107 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~-~~~~~~~~  182 (308)
                      ...++|+++++||+|+||.||+|+-+ +|..+|+|++++...  ....+..+.|-.+|...++|+||+|+- |.....+|
T Consensus       138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LY  217 (550)
T KOG0605|consen  138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLY  217 (550)
T ss_pred             CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeE
Confidence            35679999999999999999999866 599999999987543  234677889999999999999999986 55556799


Q ss_pred             EEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCC
Q 021711          183 IVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE  262 (308)
Q Consensus       183 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~  262 (308)
                      |||||++||++..+|.. ...|++..+..++.+++.|+.-||.   .|+|||||||+|+|||..|++||+||||++-+..
T Consensus       218 LiMEylPGGD~mTLL~~-~~~L~e~~arfYiaE~vlAI~~iH~---~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~  293 (550)
T KOG0605|consen  218 LIMEYLPGGDMMTLLMR-KDTLTEDWARFYIAETVLAIESIHQ---LGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDK  293 (550)
T ss_pred             EEEEecCCccHHHHHHh-cCcCchHHHHHHHHHHHHHHHHHHH---cCcccccCChhheeecCCCCEeeccccccchhhh
Confidence            99999999999999954 6679999999999999999999998   9999999999999999999999999999863311


Q ss_pred             -----------------------CCc------e----------------eEeeceeccccccccccCchhhcCccceeEE
Q 021711          263 -----------------------QWT------H----------------HTISKVEGTFGLVKLNLPPLVILKRCFTCIF  297 (308)
Q Consensus       263 -----------------------~~~------~----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s  297 (308)
                                             +..      .                ......+|||.|||||.+.+..++...|-||
T Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWS  373 (550)
T KOG0605|consen  294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWS  373 (550)
T ss_pred             hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHH
Confidence                                   000      0                0012478999999999999999999999999


Q ss_pred             EeeEEEeeccC
Q 021711          298 IGFSQLQLSCS  308 (308)
Q Consensus       298 ~g~~l~el~c~  308 (308)
                      +|++|||++-|
T Consensus       374 LG~ImyEmLvG  384 (550)
T KOG0605|consen  374 LGCIMYEMLVG  384 (550)
T ss_pred             HHHHHHHHHhC
Confidence            99999999765

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=3.6e-37  Score=287.27  Aligned_cols=195  Identities=22%  Similarity=0.225  Sum_probs=162.6

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCC--hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVL  185 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~  185 (308)
                      ++|++.+.||+|+||.||+|+.. +++.||+|.+....  .......+.+|+.++..++||||+++++.+.++ .+++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            37899999999999999999876 58999999986432  122346788999999999999999999866554 578999


Q ss_pred             EecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCc
Q 021711          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (308)
Q Consensus       186 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~  265 (308)
                      ||+++|+|.+++.. ...++...+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+|..+.....
T Consensus        81 E~~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~  156 (376)
T cd05598          81 DYIPGGDMMSLLIR-LGIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD  156 (376)
T ss_pred             eCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccc
Confidence            99999999999865 4467888888999999999999998   9999999999999999999999999999853310000


Q ss_pred             -----------------------------------------eeEeeceeccccccccccCchhhcCccceeEEEeeEEEe
Q 021711          266 -----------------------------------------HHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQ  304 (308)
Q Consensus       266 -----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~e  304 (308)
                                                               ........||+.|+|||.+....++.++|+||+|+++||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye  236 (376)
T cd05598         157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE  236 (376)
T ss_pred             ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence                                                     000123579999999999888888899999999999999


Q ss_pred             eccC
Q 021711          305 LSCS  308 (308)
Q Consensus       305 l~c~  308 (308)
                      |++|
T Consensus       237 ll~G  240 (376)
T cd05598         237 MLVG  240 (376)
T ss_pred             hhhC
Confidence            9876

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-37  Score=281.29  Aligned_cols=199  Identities=23%  Similarity=0.315  Sum_probs=171.8

Q ss_pred             hhcCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeee-EEEeCcEEEE
Q 021711          107 SATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLG-YGIEGGMHIV  184 (308)
Q Consensus       107 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~-~~~~~~~~lv  184 (308)
                      ...+.|.+.++||.|.-++||+|+.. .++.||||++.-..-......+.+|+..|+.++||||++++. |..+..+|+|
T Consensus        23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvV  102 (516)
T KOG0582|consen   23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVV  102 (516)
T ss_pred             CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEe
Confidence            44568999999999999999999865 589999999976554445788999999999999999999998 5556679999


Q ss_pred             EEecCCCCHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCC
Q 021711          185 LELSPNGSLASLLYG-MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ  263 (308)
Q Consensus       185 ~e~~~~gsL~~~l~~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  263 (308)
                      |.||.+|++.+++.. ....+++..+..|++++++||.|||.   +|-||||||+.||||+.+|.|||+|||.+..+...
T Consensus       103 mpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~---~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~  179 (516)
T KOG0582|consen  103 MPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQ---NGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDS  179 (516)
T ss_pred             ehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHh---cCceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence            999999999999965 34569999999999999999999998   99999999999999999999999999998887665


Q ss_pred             CceeE-e-eceeccccccccccCchh--hcCccceeEEEeeEEEeeccC
Q 021711          264 WTHHT-I-SKVEGTFGLVKLNLPPLV--ILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       264 ~~~~~-~-~~~~gt~~y~aPE~~~~~--~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ..... . ..+.||+.|||||.+.+.  .++.++||||||++.+|||.|
T Consensus       180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G  228 (516)
T KOG0582|consen  180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHG  228 (516)
T ss_pred             CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcC
Confidence            43222 1 567999999999984433  378899999999999999876

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=8e-38  Score=290.45  Aligned_cols=195  Identities=21%  Similarity=0.273  Sum_probs=165.4

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCC--hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVL  185 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~  185 (308)
                      ++|++.+.||+|+||.||+|... +++.||+|.+....  .......+.+|+.++..++||||+++++.+.+. .+++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            47889999999999999999876 58999999986432  123356788899999999999999999876654 578999


Q ss_pred             EecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCc
Q 021711          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (308)
Q Consensus       186 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~  265 (308)
                      ||+++|+|.+++.. ...+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++.+.....
T Consensus        81 E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~---~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~  156 (363)
T cd05628          81 EFLPGGDMMTLLMK-KDTLTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHR  156 (363)
T ss_pred             cCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCCEEEeeccCccccccccc
Confidence            99999999999864 4578999999999999999999998   9999999999999999999999999999986532110


Q ss_pred             e---------------------------------eEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          266 H---------------------------------HTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       266 ~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      .                                 .......||+.|+|||.+.+..++.++|+||+|+++|||++|
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G  232 (363)
T cd05628         157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG  232 (363)
T ss_pred             ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhC
Confidence            0                                 001245799999999998887888999999999999999876

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=2.1e-37  Score=289.48  Aligned_cols=194  Identities=21%  Similarity=0.214  Sum_probs=163.1

Q ss_pred             CccccceeeccCceEEEEEEEC-CCcEEEEEEeccCC--hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEEE
Q 021711          111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLE  186 (308)
Q Consensus       111 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e  186 (308)
                      .|++.+.||+|+||.||+|+.. +++.||+|.+....  .......+.+|+.++..++||||+++++++.+. .+++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            6888999999999999999875 58899999986532  223456789999999999999999999976654 5789999


Q ss_pred             ecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCce
Q 021711          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH  266 (308)
Q Consensus       187 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~  266 (308)
                      |+++|+|.+++.. ...+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++.+......
T Consensus        82 ~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~aL~~LH~---~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~  157 (381)
T cd05626          82 YIPGGDMMSLLIR-MEVFPEVLARFYIAELTLAIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNS  157 (381)
T ss_pred             cCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccc
Confidence            9999999999864 4468888888999999999999998   89999999999999999999999999998643211000


Q ss_pred             ---------------------------------------------eEeeceeccccccccccCchhhcCccceeEEEeeE
Q 021711          267 ---------------------------------------------HTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFS  301 (308)
Q Consensus       267 ---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~  301 (308)
                                                                   .......||+.|+|||.+....++.++|+||+|++
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i  237 (381)
T cd05626         158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI  237 (381)
T ss_pred             ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence                                                         00123579999999999887778899999999999


Q ss_pred             EEeeccC
Q 021711          302 QLQLSCS  308 (308)
Q Consensus       302 l~el~c~  308 (308)
                      +|||++|
T Consensus       238 l~elltG  244 (381)
T cd05626         238 LFEMLVG  244 (381)
T ss_pred             HHHHHhC
Confidence            9999876

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=6.7e-37  Score=280.37  Aligned_cols=195  Identities=21%  Similarity=0.278  Sum_probs=166.9

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCCh--HHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVL  185 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~  185 (308)
                      ++|++.+.||+|+||.||++... +|+.||+|.+.....  .+....+.+|+.+++.++||||+++++++.+. ..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            47899999999999999999876 589999999875422  23456788999999999999999999866554 578999


Q ss_pred             EecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCc
Q 021711          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (308)
Q Consensus       186 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~  265 (308)
                      ||+++|+|.+++......+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++.+.....
T Consensus        81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~  157 (330)
T cd05601          81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM  157 (330)
T ss_pred             CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence            9999999999997665679999999999999999999998   8999999999999999999999999999988755432


Q ss_pred             eeEeeceeccccccccccCc------hhhcCccceeEEEeeEEEeeccC
Q 021711          266 HHTISKVEGTFGLVKLNLPP------LVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      . ......||+.|+|||.+.      ...++.++|+||+|+++|||++|
T Consensus       158 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g  205 (330)
T cd05601         158 V-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYG  205 (330)
T ss_pred             e-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccC
Confidence            2 223457999999999875      34567889999999999999876

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=3.3e-37  Score=281.85  Aligned_cols=187  Identities=24%  Similarity=0.273  Sum_probs=160.1

Q ss_pred             ceeeccCceEEEEEEEC-CCcEEEEEEeccCC--hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEEEecCCC
Q 021711          116 NLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLELSPNG  191 (308)
Q Consensus       116 ~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~~~g  191 (308)
                      ++||+|+||.||+|... +|+.||+|.+....  .......+.+|+.+++.++||||+++++++..+ ..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            47999999999999875 68999999987532  223356788999999999999999999866554 578999999999


Q ss_pred             CHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCceeEeec
Q 021711          192 SLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK  271 (308)
Q Consensus       192 sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~  271 (308)
                      +|.+++.. ...+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++.......  ....
T Consensus        81 ~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~--~~~~  154 (323)
T cd05571          81 ELFFHLSR-ERVFSEDRARFYGAEIVSALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKT  154 (323)
T ss_pred             cHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC--cccc
Confidence            99988864 4568999999999999999999998   8999999999999999999999999999986432211  2345


Q ss_pred             eeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          272 VEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       272 ~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ..||+.|+|||.+.+..++.++|+||+|+++|||++|
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg  191 (323)
T cd05571         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG  191 (323)
T ss_pred             eecCccccChhhhcCCCCCccccCcccchhhhhhhcC
Confidence            6799999999999888889999999999999999876

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-37  Score=283.19  Aligned_cols=190  Identities=23%  Similarity=0.306  Sum_probs=165.9

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCCh--HHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVL  185 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~  185 (308)
                      ++|++.+.||+|+||.||+|++. +++.||+|.+.....  ......+.+|+.++..++||||+++++++..+ ..++||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            47899999999999999999976 589999999865321  22356788999999999999999999876655 578999


Q ss_pred             EecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCc
Q 021711          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (308)
Q Consensus       186 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~  265 (308)
                      ||+++|+|.+++.. ...+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++....   
T Consensus        81 e~~~g~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---  153 (333)
T cd05600          81 EYVPGGDFRTLLNN-LGVLSEDHARFYMAEMFEAVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---  153 (333)
T ss_pred             eCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEEEeCcCCccccc---
Confidence            99999999999854 4568899999999999999999998   8999999999999999999999999999986543   


Q ss_pred             eeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          266 HHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                        ......||+.|+|||.+.+..++.++|+||+|+++|||++|
T Consensus       154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g  194 (333)
T cd05600         154 --YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCG  194 (333)
T ss_pred             --ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhC
Confidence              22356799999999998888889999999999999999886

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=8.7e-37  Score=280.09  Aligned_cols=195  Identities=19%  Similarity=0.225  Sum_probs=165.1

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCC--hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVL  185 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~  185 (308)
                      ++|++.+.||+|+||.||+++.. +++.||+|.+....  .......+.+|..++..++|+||+++++++.+. ..++||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            47899999999999999999976 58899999986421  122345678899999999999999999876654 578999


Q ss_pred             EecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCc
Q 021711          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (308)
Q Consensus       186 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~  265 (308)
                      ||+++|+|.+++......+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++.+.....
T Consensus        81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~---~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  157 (331)
T cd05624          81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ---LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT  157 (331)
T ss_pred             eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence            9999999999997655678999999999999999999998   9999999999999999999999999999987754432


Q ss_pred             eeEeeceeccccccccccCch-----hhcCccceeEEEeeEEEeeccC
Q 021711          266 HHTISKVEGTFGLVKLNLPPL-----VILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      . ......||++|+|||.+..     ...+.++|+||+|+++|||++|
T Consensus       158 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g  204 (331)
T cd05624         158 V-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYG  204 (331)
T ss_pred             e-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhC
Confidence            1 2234679999999998754     3467789999999999999886

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=6.8e-37  Score=283.87  Aligned_cols=195  Identities=21%  Similarity=0.286  Sum_probs=165.0

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCC--hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVL  185 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~  185 (308)
                      ++|++.+.||+|+||.||++... +++.||+|.+....  ..+....+.+|+.++..++||||+++++.+.+. ..++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46889999999999999999876 58999999986432  223456788899999999999999999866554 578999


Q ss_pred             EecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCc
Q 021711          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (308)
Q Consensus       186 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~  265 (308)
                      ||+++|+|.+++.. ...+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.++|+|||+++.+.....
T Consensus        81 E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~~L~~lH~---~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~  156 (360)
T cd05627          81 EFLPGGDMMTLLMK-KDTLSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHR  156 (360)
T ss_pred             eCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEeeccCCcccccccc
Confidence            99999999999864 4568899999999999999999998   9999999999999999999999999999876532110


Q ss_pred             e---------------------------------eEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          266 H---------------------------------HTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       266 ~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      .                                 .......||+.|+|||.+.+..++.++|+||+|+++|||++|
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG  232 (360)
T cd05627         157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG  232 (360)
T ss_pred             cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccC
Confidence            0                                 001235799999999998888889999999999999999986

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=3.9e-37  Score=276.38  Aligned_cols=192  Identities=26%  Similarity=0.287  Sum_probs=163.9

Q ss_pred             CccccceeeccCceEEEEEEEC-CCcEEEEEEeccCCh--HHHHHHHHHHHHHHhcCCCCeeeeeeeEEEe-CcEEEEEE
Q 021711          111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLE  186 (308)
Q Consensus       111 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~lv~e  186 (308)
                      .|+..+.||+|+||.||+|... +|+.||+|.+.....  ......+.+|+.++..++|+||+++++++.+ +..++|||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            3778899999999999999865 689999999864322  1223567899999999999999999986655 45789999


Q ss_pred             ecCCCCHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCc
Q 021711          187 LSPNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (308)
Q Consensus       187 ~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~  265 (308)
                      |+++|+|...+... ...+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.++|+|||+++...... 
T Consensus        81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-  156 (285)
T cd05631          81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE-  156 (285)
T ss_pred             ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-
Confidence            99999998887543 3468899999999999999999998   899999999999999999999999999998865432 


Q ss_pred             eeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          266 HHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                        ......||..|+|||.+.+..++.++|+||+|+++|||++|
T Consensus       157 --~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g  197 (285)
T cd05631         157 --TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQG  197 (285)
T ss_pred             --eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhC
Confidence              22356799999999999888889999999999999999875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=3.3e-37  Score=287.20  Aligned_cols=197  Identities=22%  Similarity=0.253  Sum_probs=165.2

Q ss_pred             HhhcCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCC--hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cE
Q 021711          106 QSATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GM  181 (308)
Q Consensus       106 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~  181 (308)
                      ....++|++.+.||+|+||.||+++.. +++.+|+|.+....  .......+.+|+.+++.++||||+++++++..+ ..
T Consensus        39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~  118 (370)
T cd05621          39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL  118 (370)
T ss_pred             CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence            344578999999999999999999976 58899999986421  122345678899999999999999999866554 57


Q ss_pred             EEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecC
Q 021711          182 HIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP  261 (308)
Q Consensus       182 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~  261 (308)
                      ++||||+++|+|.+++..  ..++...+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+|+.+.
T Consensus       119 ~lv~Ey~~gg~L~~~l~~--~~~~~~~~~~~~~qil~aL~~LH~---~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~  193 (370)
T cd05621         119 YMVMEYMPGGDLVNLMSN--YDVPEKWAKFYTAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMD  193 (370)
T ss_pred             EEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEEecccceecc
Confidence            899999999999999854  458888999999999999999998   999999999999999999999999999998764


Q ss_pred             CCCceeEeeceeccccccccccCchh----hcCccceeEEEeeEEEeeccC
Q 021711          262 EQWTHHTISKVEGTFGLVKLNLPPLV----ILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       262 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Di~s~g~~l~el~c~  308 (308)
                      .... .......||+.|+|||.+...    .++.++|+||+|+++|||++|
T Consensus       194 ~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G  243 (370)
T cd05621         194 ETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG  243 (370)
T ss_pred             cCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhC
Confidence            4322 122456799999999987543    367889999999999999886

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-38  Score=296.62  Aligned_cols=195  Identities=24%  Similarity=0.315  Sum_probs=170.2

Q ss_pred             hhcCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCC--hHHHHHHHHHHHHHHhcC-CCCeeeeeee-EEEeCcE
Q 021711          107 SATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHV-DHPNTAKLLG-YGIEGGM  181 (308)
Q Consensus       107 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~-~~~~~~~  181 (308)
                      ...++|.++++||+|.||+|+++..+ +++.+|||.+++..  .++..+..+.|.+|+... +||+++.++. |.+...+
T Consensus       365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l  444 (694)
T KOG0694|consen  365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL  444 (694)
T ss_pred             ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence            34578999999999999999999987 58899999998753  234467888999988777 5999999998 5566789


Q ss_pred             EEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecC
Q 021711          182 HIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP  261 (308)
Q Consensus       182 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~  261 (308)
                      |+||||+.||++..+  .....+++..+.-++..|+.||+|||+   ++|||||||.+|||||.+|.+||+|||+++...
T Consensus       445 ~fvmey~~Ggdm~~~--~~~~~F~e~rarfyaAev~l~L~fLH~---~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m  519 (694)
T KOG0694|consen  445 FFVMEYVAGGDLMHH--IHTDVFSEPRARFYAAEVVLGLQFLHE---NGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM  519 (694)
T ss_pred             EEEEEecCCCcEEEE--EecccccHHHHHHHHHHHHHHHHHHHh---cCceeeecchhheEEcccCcEEecccccccccC
Confidence            999999999994333  345779999999999999999999999   999999999999999999999999999999754


Q ss_pred             CCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          262 EQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       262 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      -...  ..++++||+.|||||.+.+..+++..|=|+||++||||++|
T Consensus       520 ~~g~--~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~G  564 (694)
T KOG0694|consen  520 GQGD--RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVG  564 (694)
T ss_pred             CCCC--ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcC
Confidence            3222  45789999999999999999999999999999999999886

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=4.7e-37  Score=287.11  Aligned_cols=194  Identities=21%  Similarity=0.225  Sum_probs=162.7

Q ss_pred             CccccceeeccCceEEEEEEEC-CCcEEEEEEeccCC--hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEEE
Q 021711          111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLE  186 (308)
Q Consensus       111 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e  186 (308)
                      +|++.+.||+|+||.||+|+.. +++.||+|.+....  .......+.+|+.+++.++||||+++++.+.++ .+++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            5888999999999999999875 58899999986432  223456788999999999999999999876654 5789999


Q ss_pred             ecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCc-
Q 021711          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT-  265 (308)
Q Consensus       187 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~-  265 (308)
                      |+++|+|.+++.. ...+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++.+..... 
T Consensus        82 ~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~al~~lH~---~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~  157 (382)
T cd05625          82 YIPGGDMMSLLIR-MGIFPEDLARFYIAELTCAVESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS  157 (382)
T ss_pred             CCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEeECCCCccccccccc
Confidence            9999999999864 3468888889999999999999998   8999999999999999999999999999864311000 


Q ss_pred             --------------------------------------------eeEeeceeccccccccccCchhhcCccceeEEEeeE
Q 021711          266 --------------------------------------------HHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFS  301 (308)
Q Consensus       266 --------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~  301 (308)
                                                                  ........||+.|+|||.+.+..++.++|+||+|++
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi  237 (382)
T cd05625         158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI  237 (382)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence                                                        000123579999999999888888899999999999


Q ss_pred             EEeeccC
Q 021711          302 QLQLSCS  308 (308)
Q Consensus       302 l~el~c~  308 (308)
                      ||||++|
T Consensus       238 l~elltG  244 (382)
T cd05625         238 LYEMLVG  244 (382)
T ss_pred             HHHHHhC
Confidence            9999876

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=2.3e-37  Score=281.86  Aligned_cols=195  Identities=28%  Similarity=0.407  Sum_probs=169.3

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCc----EEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeCcEEEE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQ----LVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHIV  184 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~----~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~lv  184 (308)
                      .+|++.+.||+|+||.||+|.+. ++.    .||+|.+.........+++.+|+.+++.++||||+++++++..+..+++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~~~~~v   86 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLI   86 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCCCceee
Confidence            57899999999999999999864 333    4899998765555556789999999999999999999999988888999


Q ss_pred             EEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCC
Q 021711          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (308)
Q Consensus       185 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  264 (308)
                      +||+++|+|.+++......+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++.+....
T Consensus        87 ~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~  163 (316)
T cd05108          87 TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADE  163 (316)
T ss_pred             eecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEecCCCcEEEccccccccccCCC
Confidence            99999999999997766678999999999999999999998   899999999999999999999999999999876544


Q ss_pred             ceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          265 THHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      .........++..|+|||.+.....+.++|+||||+++|||.+
T Consensus       164 ~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t  206 (316)
T cd05108         164 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT  206 (316)
T ss_pred             cceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHc
Confidence            3333333445778999999888888999999999999999764

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=3.5e-37  Score=278.90  Aligned_cols=194  Identities=23%  Similarity=0.362  Sum_probs=163.3

Q ss_pred             CCccccceeeccCceEEEEEEECC-----------------CcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeee
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLRN-----------------GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKL  172 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~~-----------------g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  172 (308)
                      ++|.+.+.||+|+||.||+|.+.+                 +..||+|.+...........|.+|+.++..++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            578899999999999999997532                 347999998765555556789999999999999999999


Q ss_pred             eeEEEeC-cEEEEEEecCCCCHHHHHhccC------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCcee
Q 021711          173 LGYGIEG-GMHIVLELSPNGSLASLLYGMK------------------EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIH  233 (308)
Q Consensus       173 ~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~------------------~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH  233 (308)
                      ++++.+. ..++||||+++|+|.+++....                  ..+++..+..++.||+.||.|||+   .+|+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~ivH  161 (304)
T cd05096          85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNFVH  161 (304)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH---CCccc
Confidence            9977654 5789999999999999885421                  236778889999999999999998   89999


Q ss_pred             cCCCCCCEEECCCCcEEEeccccceecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeec
Q 021711          234 RDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLS  306 (308)
Q Consensus       234 rDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~  306 (308)
                      |||||+|||++.++.+||+|||+++.+.............++..|+|||.......+.++|+||||+++|||+
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~  234 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL  234 (304)
T ss_pred             cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHH
Confidence            9999999999999999999999998765443322223455688999999987777889999999999999975

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=2.8e-37  Score=283.08  Aligned_cols=190  Identities=20%  Similarity=0.293  Sum_probs=165.7

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCC--hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVL  185 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~  185 (308)
                      ++|++.+.||+|+||.||+|++. +++.||+|.+....  .....+.+.+|+.++..++||||+++++++..+ ..++||
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            57899999999999999999976 58999999986432  123356788999999999999999999966554 578999


Q ss_pred             EecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCc
Q 021711          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (308)
Q Consensus       186 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~  265 (308)
                      ||+++|+|.+++.. ...+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++...... 
T Consensus        98 e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-  172 (329)
T PTZ00263         98 EFVVGGELFTHLRK-AGRFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT-  172 (329)
T ss_pred             cCCCCChHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc-
Confidence            99999999999864 4568888889999999999999998   899999999999999999999999999998775432 


Q ss_pred             eeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          266 HHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                          ....||+.|+|||.+.....+.++|+||+|+++|||++|
T Consensus       173 ----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg  211 (329)
T PTZ00263        173 ----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAG  211 (329)
T ss_pred             ----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcC
Confidence                235799999999998888888999999999999999875

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-37  Score=283.19  Aligned_cols=195  Identities=28%  Similarity=0.355  Sum_probs=161.5

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHH-------------HHHHHHHHHHHHhcCCCCeeeeeee
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADE-------------IIADFLSELGIMAHVDHPNTAKLLG  174 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~-------------~~~~~~~E~~~l~~l~h~niv~l~~  174 (308)
                      .++|++.+.||+|.||.|-+|+.. +++.||||++.+.....             -.+...+|+.||++|+|||||+|+.
T Consensus        96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiE  175 (576)
T KOG0585|consen   96 LNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIE  175 (576)
T ss_pred             hhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEE
Confidence            478999999999999999999976 69999999996432110             1357889999999999999999999


Q ss_pred             EEEeC---cEEEEEEecCCCCHHHHHhccCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEE
Q 021711          175 YGIEG---GMHIVLELSPNGSLASLLYGMKEK-LKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQ  250 (308)
Q Consensus       175 ~~~~~---~~~lv~e~~~~gsL~~~l~~~~~~-l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~k  250 (308)
                      +..+.   .+|||+|||..|.+...=  .... +...++..+++++..||+|||.   ++||||||||+|+||+.+|++|
T Consensus       176 vLDDP~s~~~YlVley~s~G~v~w~p--~d~~els~~~Ar~ylrDvv~GLEYLH~---QgiiHRDIKPsNLLl~~~g~VK  250 (576)
T KOG0585|consen  176 VLDDPESDKLYLVLEYCSKGEVKWCP--PDKPELSEQQARKYLRDVVLGLEYLHY---QGIIHRDIKPSNLLLSSDGTVK  250 (576)
T ss_pred             eecCcccCceEEEEEeccCCccccCC--CCcccccHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEEcCCCcEE
Confidence            87654   589999999988775432  2333 8899999999999999999998   9999999999999999999999


Q ss_pred             EeccccceecCCCCc---eeEeeceeccccccccccCch----hhcCccceeEEEeeEEEeeccC
Q 021711          251 ICDFGLAKWLPEQWT---HHTISKVEGTFGLVKLNLPPL----VILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       251 l~DFGla~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      |+|||.+...+....   ........||+.|+|||+..+    ..-+.+.||||+|++||-|..|
T Consensus       251 IsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG  315 (576)
T KOG0585|consen  251 ISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFG  315 (576)
T ss_pred             eeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhc
Confidence            999999987744321   123446899999999998765    2347789999999999977654

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.2e-37  Score=275.61  Aligned_cols=192  Identities=20%  Similarity=0.292  Sum_probs=163.4

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChH-HHHHHHHHHHHHHhcCCCCe-eeeeeeEEEeC-------
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTAD-EIIADFLSELGIMAHVDHPN-TAKLLGYGIEG-------  179 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~-~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~-------  179 (308)
                      ..|...+.||+|+||+||+|+.+ +|+.||+|++.-...+ .......+|+.+++.++|+| ||.+++++...       
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            35666778999999999999965 6899999999755432 23456789999999999999 99999976553       


Q ss_pred             cEEEEEEecCCCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEecccc
Q 021711          180 GMHIVLELSPNGSLASLLYGMK---EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGL  256 (308)
Q Consensus       180 ~~~lv~e~~~~gsL~~~l~~~~---~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGl  256 (308)
                      .+++|+||+.. +|..++....   ..++...+..++.||+.||.|||+   ++|+||||||.|||++++|.+||+|||+
T Consensus        91 ~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~---~~IlHRDLKPQNlLi~~~G~lKlaDFGl  166 (323)
T KOG0594|consen   91 KLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHS---HGILHRDLKPQNLLISSSGVLKLADFGL  166 (323)
T ss_pred             eEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCcceEEECCCCcEeeeccch
Confidence            46799999965 8999997655   467888999999999999999999   9999999999999999999999999999


Q ss_pred             ceecCCCCceeEeeceeccccccccccCchh-hcCccceeEEEeeEEEeecc
Q 021711          257 AKWLPEQWTHHTISKVEGTFGLVKLNLPPLV-ILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       257 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~s~g~~l~el~c  307 (308)
                      |+.+.-+..  ..+...+|..|.|||.+.+. .++...|+||+|+++.||++
T Consensus       167 Ara~~ip~~--~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~  216 (323)
T KOG0594|consen  167 ARAFSIPMR--TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFT  216 (323)
T ss_pred             HHHhcCCcc--cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHh
Confidence            997654332  35677899999999987665 68999999999999999976

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=4.8e-37  Score=282.99  Aligned_cols=191  Identities=23%  Similarity=0.302  Sum_probs=165.2

Q ss_pred             cCCccccceeeccCceEEEEEEECC--CcEEEEEEeccCC--hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLRN--GQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHI  183 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~~--g~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l  183 (308)
                      .++|++.+.||+|+||.||+|.+..  +..||+|.+....  .....+.+.+|+.++..++||||+++++++.+. ..++
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l  108 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL  108 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence            4579999999999999999998653  3689999986432  223456788999999999999999999977665 4789


Q ss_pred             EEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCC
Q 021711          184 VLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ  263 (308)
Q Consensus       184 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  263 (308)
                      ||||+++|+|.+++.. ...+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++.+...
T Consensus       109 v~Ey~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~  184 (340)
T PTZ00426        109 VLEFVIGGEFFTFLRR-NKRFPNDVGCFYAAQIVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR  184 (340)
T ss_pred             EEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC
Confidence            9999999999999864 4568999999999999999999998   89999999999999999999999999999876432


Q ss_pred             CceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          264 WTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                           .....||+.|+|||.+.+...+.++|+||+|+++|||++|
T Consensus       185 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G  224 (340)
T PTZ00426        185 -----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVG  224 (340)
T ss_pred             -----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcC
Confidence                 1346799999999998887788999999999999999876

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=3e-36  Score=275.66  Aligned_cols=188  Identities=23%  Similarity=0.280  Sum_probs=159.1

Q ss_pred             ceeeccCceEEEEEEEC-CCcEEEEEEeccCC--hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEEEecCCC
Q 021711          116 NLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLELSPNG  191 (308)
Q Consensus       116 ~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~~~g  191 (308)
                      +.||+|+||.||++... +|+.||+|.+....  .......+.+|+.++..++||||+++++++... ..++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999865 68999999986532  223356778899999999999999999866554 578999999999


Q ss_pred             CHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCceeEeec
Q 021711          192 SLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK  271 (308)
Q Consensus       192 sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~  271 (308)
                      +|..++.. ...+++..+..++.||+.||.|||+  ..+|+||||||+|||++.++.+||+|||+++.......  ....
T Consensus        81 ~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~--~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~~~  155 (325)
T cd05594          81 ELFFHLSR-ERVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMKT  155 (325)
T ss_pred             cHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc--cccc
Confidence            99988854 4568999999999999999999995  16899999999999999999999999999986433221  2234


Q ss_pred             eeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          272 VEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       272 ~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ..||+.|+|||.+.+..++.++|+||+|+++|||++|
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG  192 (325)
T cd05594         156 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG  192 (325)
T ss_pred             ccCCcccCCHHHHccCCCCCccccccccceeeeeccC
Confidence            6799999999998888889999999999999999986

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=8.9e-37  Score=284.39  Aligned_cols=200  Identities=21%  Similarity=0.243  Sum_probs=166.9

Q ss_pred             HHHHhhcCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCC--hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC
Q 021711          103 YELQSATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG  179 (308)
Q Consensus       103 ~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  179 (308)
                      .++....++|++.+.||+|+||.||+|+.. +++.+|+|.+....  .......+.+|+.+++.++||||+++++.+..+
T Consensus        36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~  115 (371)
T cd05622          36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD  115 (371)
T ss_pred             hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence            344555689999999999999999999976 58899999986421  122345678899999999999999999876654


Q ss_pred             -cEEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccce
Q 021711          180 -GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK  258 (308)
Q Consensus       180 -~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~  258 (308)
                       ..++||||+++|+|.+++..  ..++...+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++
T Consensus       116 ~~~~lv~Ey~~gg~L~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NIll~~~~~ikL~DfG~a~  190 (371)
T cd05622         116 RYLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCM  190 (371)
T ss_pred             CEEEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHEEECCCCCEEEEeCCcee
Confidence             47899999999999999854  457888888999999999999998   999999999999999999999999999998


Q ss_pred             ecCCCCceeEeeceeccccccccccCchh----hcCccceeEEEeeEEEeeccC
Q 021711          259 WLPEQWTHHTISKVEGTFGLVKLNLPPLV----ILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       259 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Di~s~g~~l~el~c~  308 (308)
                      .+..... .......||+.|+|||.+...    .++.++|+||+|+++|||++|
T Consensus       191 ~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G  243 (371)
T cd05622         191 KMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG  243 (371)
T ss_pred             EcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhC
Confidence            7754322 122356799999999987543    367889999999999999876

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-37  Score=279.65  Aligned_cols=190  Identities=21%  Similarity=0.262  Sum_probs=164.6

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCCh--HHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVL  185 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~  185 (308)
                      ++|++.+.||+|+||.||+|... +|+.||+|.+.....  .+..+.+.+|+.+++.++||||+++++++.+. ..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            47889999999999999999976 589999999864321  22356788999999999999999999866554 578999


Q ss_pred             EecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCc
Q 021711          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (308)
Q Consensus       186 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~  265 (308)
                      ||+++|+|.+++.. ...+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++.+...  
T Consensus        81 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~--  154 (291)
T cd05612          81 EYVPGGELFSYLRN-SGRFSNSTGLFYASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR--  154 (291)
T ss_pred             eCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEEecCcchhccCC--
Confidence            99999999999864 4568899999999999999999998   99999999999999999999999999999876432  


Q ss_pred             eeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          266 HHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                         .....||+.|+|||.+.+...+.++|+||+|+++|+|++|
T Consensus       155 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g  194 (291)
T cd05612         155 ---TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVG  194 (291)
T ss_pred             ---cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhC
Confidence               1235799999999998887788999999999999999875

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.9e-37  Score=281.39  Aligned_cols=195  Identities=25%  Similarity=0.295  Sum_probs=167.5

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCC--hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEe-CcEEEEE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVL  185 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~lv~  185 (308)
                      ++|.+.+.||+|+||.||+|... +|+.||+|.+....  .......+.+|+.++..++||||+++++++.+ +..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            47899999999999999999976 68999999986432  11335678899999999999999999986655 4578999


Q ss_pred             EecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCC-
Q 021711          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW-  264 (308)
Q Consensus       186 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~-  264 (308)
                      ||+++++|.+++... ..++...+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++.+.... 
T Consensus        81 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~---~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~  156 (350)
T cd05573          81 EYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKD  156 (350)
T ss_pred             cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCc
Confidence            999999999998654 678999999999999999999998   999999999999999999999999999998765432 


Q ss_pred             --------------------------ceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          265 --------------------------THHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       265 --------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                                                .........||+.|+|||.+.+...+.++|+||+|+++|||++|
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g  226 (350)
T cd05573         157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG  226 (350)
T ss_pred             ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccC
Confidence                                      00122346799999999998888889999999999999999876

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-37  Score=308.71  Aligned_cols=196  Identities=29%  Similarity=0.414  Sum_probs=168.7

Q ss_pred             cCCccccceeeccCceEEEEEEECC--Cc----EEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeCc-E
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLRN--GQ----LVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG-M  181 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~~--g~----~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~  181 (308)
                      ..+.++.+.||+|+||.||.|...+  |.    .||||.+.+....+...+|++|..+|++++|||||+++|++.+.. .
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~  770 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP  770 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence            4567778899999999999998653  43    499999998877777899999999999999999999999888764 6


Q ss_pred             EEEEEecCCCCHHHHHhcc------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccc
Q 021711          182 HIVLELSPNGSLASLLYGM------KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFG  255 (308)
Q Consensus       182 ~lv~e~~~~gsL~~~l~~~------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFG  255 (308)
                      ++++|||++|+|..+|+..      ...+.....+.++.|||+|+.||++   +++|||||.++|+||+....+||+|||
T Consensus       771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~---~~fvHRDLAaRNCLL~~~r~VKIaDFG  847 (1025)
T KOG1095|consen  771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES---KHFVHRDLAARNCLLDERRVVKIADFG  847 (1025)
T ss_pred             EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh---CCCcCcchhhhheeecccCcEEEcccc
Confidence            7899999999999999876      5668899999999999999999999   999999999999999999999999999


Q ss_pred             cceecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          256 LAKWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       256 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      +|+.+.............-...|||||.+.+.+++.++||||||++||||+.
T Consensus       848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifs  899 (1025)
T KOG1095|consen  848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFS  899 (1025)
T ss_pred             hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHh
Confidence            9994433221111111233478999999999999999999999999999874

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-37  Score=287.46  Aligned_cols=192  Identities=28%  Similarity=0.375  Sum_probs=169.3

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeee-EEEeCcEEEEEE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLG-YGIEGGMHIVLE  186 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~-~~~~~~~~lv~e  186 (308)
                      ...|.....||+|+.|.||.+... +++.||||++....... .+-.++|+.+|+..+|+|||.+++ |...+.+|.|||
T Consensus       272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~-keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVME  350 (550)
T KOG0578|consen  272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK-KELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVME  350 (550)
T ss_pred             hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc-hhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEe
Confidence            346777889999999999999854 68999999986544322 466789999999999999999997 666778999999


Q ss_pred             ecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCce
Q 021711          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH  266 (308)
Q Consensus       187 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~  266 (308)
                      |++||+|.+++..  ..+++.++..|+++++.||+|||.   ++|+|||||.+|||++.+|.+||+|||++..+..... 
T Consensus       351 ym~ggsLTDvVt~--~~~~E~qIA~Icre~l~aL~fLH~---~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-  424 (550)
T KOG0578|consen  351 YMEGGSLTDVVTK--TRMTEGQIAAICREILQGLKFLHA---RGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-  424 (550)
T ss_pred             ecCCCchhhhhhc--ccccHHHHHHHHHHHHHHHHHHHh---cceeeeccccceeEeccCCcEEEeeeeeeeccccccC-
Confidence            9999999999854  458999999999999999999998   9999999999999999999999999999998866543 


Q ss_pred             eEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          267 HTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                       ...+..||+.|||||......++.+.||||||+.++||.-|
T Consensus       425 -KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveG  465 (550)
T KOG0578|consen  425 -KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEG  465 (550)
T ss_pred             -ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcC
Confidence             34578999999999999999999999999999999998754

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.5e-36  Score=278.16  Aligned_cols=187  Identities=24%  Similarity=0.281  Sum_probs=159.9

Q ss_pred             ceeeccCceEEEEEEEC-CCcEEEEEEeccCC--hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEe-CcEEEEEEecCCC
Q 021711          116 NLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLELSPNG  191 (308)
Q Consensus       116 ~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~lv~e~~~~g  191 (308)
                      +.||+|+||.||++... +|+.||+|.+....  .......+.+|+.+++.++||||+++++++.. +..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999875 58999999986532  22345678899999999999999999986655 4578999999999


Q ss_pred             CHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCceeEeec
Q 021711          192 SLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK  271 (308)
Q Consensus       192 sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~  271 (308)
                      +|...+.. ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++......  .....
T Consensus        81 ~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~~~  154 (328)
T cd05593          81 ELFFHLSR-ERVFSEDRTRFYGAEIVSALDYLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--ATMKT  154 (328)
T ss_pred             CHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc--ccccc
Confidence            99988854 4568999999999999999999998   899999999999999999999999999998643321  12345


Q ss_pred             eeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          272 VEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       272 ~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ..||+.|+|||.+.....+.++|+||+|+++|+|++|
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG  191 (328)
T cd05593         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG  191 (328)
T ss_pred             ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhC
Confidence            6799999999998887889999999999999999876

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.4e-37  Score=285.79  Aligned_cols=194  Identities=25%  Similarity=0.340  Sum_probs=171.1

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCC-hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEe-Cc-EEEE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GG-MHIV  184 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~-~~lv  184 (308)
                      .++|.+.+++|+|+||.++.++++ ++..+++|.+.-.. .+..+.....|+.++++++|||||.+.+.+.+ +. ++||
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv   82 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV   82 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence            357889999999999999999876 57899999986432 33345678899999999999999999995554 44 6899


Q ss_pred             EEecCCCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCC
Q 021711          185 LELSPNGSLASLLYGMK-EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ  263 (308)
Q Consensus       185 ~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  263 (308)
                      |+||+||+|.+.+...+ ..+++..+..++.|++.|+.|||+   ++|+|||||+.||+++.++.|||+|||+|+.+..+
T Consensus        83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~---~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~  159 (426)
T KOG0589|consen   83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHE---NRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE  159 (426)
T ss_pred             EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHh---hhhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence            99999999999997655 568999999999999999999998   89999999999999999999999999999998776


Q ss_pred             CceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          264 WTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      ..  ....+.||+.||+||.+.+..++.++|+||+|+++||++|
T Consensus       160 ~~--~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~  201 (426)
T KOG0589|consen  160 DS--LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCT  201 (426)
T ss_pred             hh--hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHh
Confidence            42  3467899999999999999999999999999999999986

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=5e-37  Score=276.03  Aligned_cols=194  Identities=22%  Similarity=0.290  Sum_probs=163.8

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEEE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLE  186 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e  186 (308)
                      .++|++.+.||+|+||.||+|... +++.||+|.+...........+.+|+.+++.++||||+++++++... ..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (288)
T cd07871           4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE   83 (288)
T ss_pred             cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence            357999999999999999999876 58999999986543333345678999999999999999999976654 4789999


Q ss_pred             ecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCce
Q 021711          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH  266 (308)
Q Consensus       187 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~  266 (308)
                      |+.+ +|.+++......+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++....... 
T Consensus        84 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~-  158 (288)
T cd07871          84 YLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK-  158 (288)
T ss_pred             CCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc-
Confidence            9975 8998886655668899999999999999999998   9999999999999999999999999999987543321 


Q ss_pred             eEeeceeccccccccccCch-hhcCccceeEEEeeEEEeeccC
Q 021711          267 HTISKVEGTFGLVKLNLPPL-VILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~s~g~~l~el~c~  308 (308)
                       ......||+.|+|||.+.+ ..++.++|+||+|+++|||++|
T Consensus       159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g  200 (288)
T cd07871         159 -TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATG  200 (288)
T ss_pred             -cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhC
Confidence             2234578999999998754 4578889999999999999876

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=9.6e-37  Score=278.89  Aligned_cols=187  Identities=24%  Similarity=0.286  Sum_probs=159.5

Q ss_pred             ceeeccCceEEEEEEEC-CCcEEEEEEeccCC--hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEe-CcEEEEEEecCCC
Q 021711          116 NLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLELSPNG  191 (308)
Q Consensus       116 ~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~lv~e~~~~g  191 (308)
                      +.||+|+||.||++... +|..||+|.+....  .......+.+|+.+++.++||||+++++++.. +..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            46999999999999875 58999999986532  22335677899999999999999999986655 4578999999999


Q ss_pred             CHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCceeEeec
Q 021711          192 SLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK  271 (308)
Q Consensus       192 sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~  271 (308)
                      +|..++.. ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++.......  ....
T Consensus        81 ~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~~~  154 (323)
T cd05595          81 ELFFHLSR-ERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKT  154 (323)
T ss_pred             cHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC--cccc
Confidence            99888854 4568999999999999999999998   8999999999999999999999999999986433211  2235


Q ss_pred             eeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          272 VEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       272 ~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ..||+.|+|||.+.+..++.++|+||+|+++|||++|
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g  191 (323)
T cd05595         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG  191 (323)
T ss_pred             ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhC
Confidence            6799999999999888889999999999999999876

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=2.9e-36  Score=276.68  Aligned_cols=195  Identities=21%  Similarity=0.235  Sum_probs=163.9

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCC--hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEe-CcEEEEE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVL  185 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~lv~  185 (308)
                      ++|++.+.||+|+||.||+++.+ +++.+|+|.+.+..  .......+.+|+.++..++|+||+++++.+.+ +..++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            47889999999999999999976 47889999985421  12234557889999999999999999986655 4578999


Q ss_pred             EecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCc
Q 021711          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (308)
Q Consensus       186 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~  265 (308)
                      ||+++|+|.+++......+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++.+.....
T Consensus        81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~---~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~  157 (332)
T cd05623          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT  157 (332)
T ss_pred             eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEeecchheecccCCc
Confidence            9999999999997656678999999999999999999998   9999999999999999999999999999987644322


Q ss_pred             eeEeeceeccccccccccCch-----hhcCccceeEEEeeEEEeeccC
Q 021711          266 HHTISKVEGTFGLVKLNLPPL-----VILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      . ......||+.|+|||++..     ..++.++|+||+|+++|||++|
T Consensus       158 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g  204 (332)
T cd05623         158 V-QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYG  204 (332)
T ss_pred             c-eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcC
Confidence            1 2234579999999998752     3467789999999999999876

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1e-36  Score=283.84  Aligned_cols=196  Identities=22%  Similarity=0.230  Sum_probs=163.7

Q ss_pred             hhcCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCC--hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEE
Q 021711          107 SATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMH  182 (308)
Q Consensus       107 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~  182 (308)
                      ...++|++.+.||+|+||.||+++.. +++.||+|.+....  .......+.+|+.+++.++||||+++++++.++ ..+
T Consensus        40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~  119 (370)
T cd05596          40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY  119 (370)
T ss_pred             CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence            34568999999999999999999876 58899999986421  112345578899999999999999999876654 478


Q ss_pred             EEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCC
Q 021711          183 IVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE  262 (308)
Q Consensus       183 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~  262 (308)
                      +||||+++|+|.+++..  ..++...+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++.+..
T Consensus       120 lv~Ey~~gg~L~~~l~~--~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~  194 (370)
T cd05596         120 MVMEYMPGGDLVNLMSN--YDIPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA  194 (370)
T ss_pred             EEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence            99999999999998854  457888888999999999999998   8999999999999999999999999999987654


Q ss_pred             CCceeEeeceeccccccccccCchh----hcCccceeEEEeeEEEeeccC
Q 021711          263 QWTHHTISKVEGTFGLVKLNLPPLV----ILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       263 ~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Di~s~g~~l~el~c~  308 (308)
                      .... ......||+.|+|||.+...    ..+.++|+||+|+++|||++|
T Consensus       195 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG  243 (370)
T cd05596         195 NGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG  243 (370)
T ss_pred             CCcc-cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhC
Confidence            3221 12346799999999986543    367889999999999999876

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-36  Score=276.73  Aligned_cols=195  Identities=20%  Similarity=0.242  Sum_probs=164.1

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCC--hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVL  185 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~  185 (308)
                      ++|++.+.||+|+||.||+++.. +++.||+|.+....  .....+.+.+|+.++..++|+||+++++++.++ ..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            47899999999999999999976 58999999986421  122346688999999999999999999866554 578999


Q ss_pred             EecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCc
Q 021711          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (308)
Q Consensus       186 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~  265 (308)
                      ||+++|+|.+++......+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||++..+.....
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  157 (331)
T cd05597          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQ---LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT  157 (331)
T ss_pred             ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence            9999999999997656678999999999999999999998   9999999999999999999999999999987654322


Q ss_pred             eeEeeceeccccccccccCch-----hhcCccceeEEEeeEEEeeccC
Q 021711          266 HHTISKVEGTFGLVKLNLPPL-----VILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      . ......||+.|+|||.+..     ...+.++|+||+|+++|||++|
T Consensus       158 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g  204 (331)
T cd05597         158 V-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYG  204 (331)
T ss_pred             c-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhC
Confidence            1 1223569999999998753     3356789999999999999875

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-36  Score=276.03  Aligned_cols=185  Identities=22%  Similarity=0.247  Sum_probs=158.7

Q ss_pred             eeccCceEEEEEEEC-CCcEEEEEEeccCC--hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEe-CcEEEEEEecCCCCH
Q 021711          118 IGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLELSPNGSL  193 (308)
Q Consensus       118 LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~lv~e~~~~gsL  193 (308)
                      ||+|+||.||+|+.. +++.||+|.+....  .......+.+|+.++..++||||+++++++.. +..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            799999999999976 58899999986432  22345678899999999999999999986655 457899999999999


Q ss_pred             HHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCceeEeecee
Q 021711          194 ASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVE  273 (308)
Q Consensus       194 ~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~  273 (308)
                      .+++.. ...+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++.......  ......
T Consensus        81 ~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~  154 (312)
T cd05585          81 FHHLQR-EGRFDLSRARFYTAELLCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD--KTNTFC  154 (312)
T ss_pred             HHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC--cccccc
Confidence            999864 4568999999999999999999998   9999999999999999999999999999986433221  224567


Q ss_pred             ccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          274 GTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       274 gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ||+.|+|||.+.+..++.++|+||+|+++|||++|
T Consensus       155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg  189 (312)
T cd05585         155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTG  189 (312)
T ss_pred             CCcccCCHHHHcCCCCCCccceechhHHHHHHHhC
Confidence            99999999998888888999999999999999875

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=4.1e-36  Score=275.42  Aligned_cols=193  Identities=22%  Similarity=0.285  Sum_probs=161.4

Q ss_pred             CccccceeeccCceEEEEEEEC----CCcEEEEEEeccCC---hHHHHHHHHHHHHHHhcC-CCCeeeeeeeEEEeC-cE
Q 021711          111 NFSFENLIGKGGYAEVYKGRLR----NGQLVAIKRLTRGT---ADEIIADFLSELGIMAHV-DHPNTAKLLGYGIEG-GM  181 (308)
Q Consensus       111 ~~~~~~~LG~G~fg~Vy~~~~~----~g~~vAvK~~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~~  181 (308)
                      +|++.+.||+|+||.||+++..    +++.||+|.+....   .....+.+.+|+.++..+ +||||+++++++... ..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            5888999999999999999753    57899999986432   123356788899999999 599999999866554 57


Q ss_pred             EEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecC
Q 021711          182 HIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP  261 (308)
Q Consensus       182 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~  261 (308)
                      ++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++.+.
T Consensus        81 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~  156 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQ-RDNFSEDEVRFYSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFL  156 (332)
T ss_pred             EEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence            899999999999998854 4568999999999999999999998   899999999999999999999999999998754


Q ss_pred             CCCceeEeeceeccccccccccCchhh-cCccceeEEEeeEEEeeccC
Q 021711          262 EQWTHHTISKVEGTFGLVKLNLPPLVI-LKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       262 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~s~g~~l~el~c~  308 (308)
                      ..... ......||+.|+|||.+.+.. .+.++|+||+|+++|||++|
T Consensus       157 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg  203 (332)
T cd05614         157 SEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTG  203 (332)
T ss_pred             ccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcC
Confidence            33221 223467999999999876543 67889999999999999875

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.7e-37  Score=277.41  Aligned_cols=193  Identities=21%  Similarity=0.323  Sum_probs=169.8

Q ss_pred             cCCccccceeeccCceEEEEEEE-CCCcEEEEEEeccCCh--HHHHHHHHHHHHHHhcCCCCeeeeeeeEEEe-CcEEEE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRL-RNGQLVAIKRLTRGTA--DEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIV  184 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~lv  184 (308)
                      ..+|++.+.||+|.||+|-+|.. ..|+.||||.+.+..-  +...-...+|++||..|+||||+.++.++.+ +.+.||
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv  131 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV  131 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence            35788899999999999999985 5799999999976532  3345678899999999999999999996655 568899


Q ss_pred             EEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCC
Q 021711          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (308)
Q Consensus       185 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  264 (308)
                      |||..+|.|.+++.. .+.+++.....+++||..|+.|+|.   ++++|||||.+|||||.++++||+||||+..+....
T Consensus       132 MEYaS~GeLYDYiSe-r~~LsErEaRhfFRQIvSAVhYCHk---nrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~k  207 (668)
T KOG0611|consen  132 MEYASGGELYDYISE-RGSLSEREARHFFRQIVSAVHYCHK---NRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKK  207 (668)
T ss_pred             EEecCCccHHHHHHH-hccccHHHHHHHHHHHHHHHHHHhh---ccceecccchhheeecCCCCeeeeccchhhhhcccc
Confidence            999999999999964 5679999999999999999999998   899999999999999999999999999999876552


Q ss_pred             ceeEeeceeccccccccccCchhhc-CccceeEEEeeEEEeeccC
Q 021711          265 THHTISKVEGTFGLVKLNLPPLVIL-KRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~s~g~~l~el~c~  308 (308)
                         -..+++|++-|.+||...+..+ ++..|.||+|++||.|.+|
T Consensus       208 ---fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyG  249 (668)
T KOG0611|consen  208 ---FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYG  249 (668)
T ss_pred             ---HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhc
Confidence               3467999999999999887765 6789999999999998775

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=8.8e-37  Score=276.27  Aligned_cols=194  Identities=24%  Similarity=0.319  Sum_probs=163.5

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEEE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLE  186 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e  186 (308)
                      .++|++.+.||+|+||.||+|... +++.||+|.+...........+.+|+.+++.++||||+++++++... ..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            468999999999999999999976 68999999986543333345678899999999999999999976654 4789999


Q ss_pred             ecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCce
Q 021711          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH  266 (308)
Q Consensus       187 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~  266 (308)
                      |+. ++|.+++......++...+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++......  
T Consensus        84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--  157 (303)
T cd07869          84 YVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS--  157 (303)
T ss_pred             CCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC--
Confidence            995 68888886666678999999999999999999998   999999999999999999999999999998654322  


Q ss_pred             eEeeceeccccccccccCch-hhcCccceeEEEeeEEEeeccC
Q 021711          267 HTISKVEGTFGLVKLNLPPL-VILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      .......||+.|+|||.+.+ ..++.++|+||+|+++|||++|
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g  200 (303)
T cd07869         158 HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQG  200 (303)
T ss_pred             ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhC
Confidence            12344678999999998754 3467889999999999999876

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-36  Score=289.95  Aligned_cols=196  Identities=28%  Similarity=0.384  Sum_probs=174.7

Q ss_pred             hhcCCccccceeeccCceEEEEEEECC----CcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeCc-E
Q 021711          107 SATNNFSFENLIGKGGYAEVYKGRLRN----GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG-M  181 (308)
Q Consensus       107 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~----g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~  181 (308)
                      .......++++||.|.||+|++|+++-    ...||||.++..-.++.+.+|+.|+.||.+++||||++|-|..+... +
T Consensus       626 Id~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~Pv  705 (996)
T KOG0196|consen  626 IDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPV  705 (996)
T ss_pred             cChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCcee
Confidence            344567888999999999999999872    45799999999888888999999999999999999999999988876 5


Q ss_pred             EEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecC
Q 021711          182 HIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP  261 (308)
Q Consensus       182 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~  261 (308)
                      .+|+|||++|+|..+|+.+.+.+.+.+...++++|+.||.||-+   .++|||||.++|||++.+..+|++||||+|.+.
T Consensus       706 MIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsd---m~YVHRDLAARNILVNsnLvCKVsDFGLSRvle  782 (996)
T KOG0196|consen  706 MIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  782 (996)
T ss_pred             EEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhh---cCchhhhhhhhheeeccceEEEeccccceeecc
Confidence            68999999999999999988999999999999999999999999   999999999999999999999999999999887


Q ss_pred             CCCceeEeecee--ccccccccccCchhhcCccceeEEEeeEEEeec
Q 021711          262 EQWTHHTISKVE--GTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLS  306 (308)
Q Consensus       262 ~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~  306 (308)
                      ++.. ...+...  -...|.|||++....++.++|+||||++|||+.
T Consensus       783 dd~~-~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVm  828 (996)
T KOG0196|consen  783 DDPE-AAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVM  828 (996)
T ss_pred             cCCC-ccccccCCccceeecChhHhhhcccCchhhccccceEEEEec
Confidence            6642 2222222  347899999999999999999999999999975

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.2e-37  Score=274.03  Aligned_cols=186  Identities=28%  Similarity=0.347  Sum_probs=155.1

Q ss_pred             CccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC----cE--EE
Q 021711          111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG----GM--HI  183 (308)
Q Consensus       111 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----~~--~l  183 (308)
                      .|...+++|.|+||.||+|... +++.||||+.-......     -+|+++|+.++|||||++.-++...    ..  .+
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k-----nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl   99 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK-----NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL   99 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC-----cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence            5667799999999999999866 57999999986544321     2799999999999999998755432    23  47


Q ss_pred             EEEecCCCCHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCC-CcEEEecccccee
Q 021711          184 VLELSPNGSLASLLYG---MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTED-FEPQICDFGLAKW  259 (308)
Q Consensus       184 v~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~-~~~kl~DFGla~~  259 (308)
                      ||||++. +|..+++.   .+..++.-.+.-++.||.+||.|||+   .+|+||||||.|+|+|.+ |.+||||||.|+.
T Consensus       100 VleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~---~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~  175 (364)
T KOG0658|consen  100 VLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS---HGICHRDIKPQNLLVDPDTGVLKICDFGSAKV  175 (364)
T ss_pred             HHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh---cCcccCCCChheEEEcCCCCeEEeccCCccee
Confidence            9999986 89888863   35667888888899999999999999   999999999999999977 8999999999999


Q ss_pred             cCCCCceeEeeceeccccccccccCchh-hcCccceeEEEeeEEEeeccC
Q 021711          260 LPEQWTHHTISKVEGTFGLVKLNLPPLV-ILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       260 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~s~g~~l~el~c~  308 (308)
                      +..+...   ....-|..|+|||++.+. .++.+.|+||.||++.||.-|
T Consensus       176 L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g  222 (364)
T KOG0658|consen  176 LVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKG  222 (364)
T ss_pred             eccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcC
Confidence            8765432   457789999999986655 589999999999999998744

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.2e-36  Score=283.98  Aligned_cols=199  Identities=23%  Similarity=0.276  Sum_probs=164.7

Q ss_pred             HhhcCCccccceeeccCceEEEEEEEC------CCcEEEEEEeccCChHHHHHHHHHHHHHHhcC-CCCeeeeeeeEEEe
Q 021711          106 QSATNNFSFENLIGKGGYAEVYKGRLR------NGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGIE  178 (308)
Q Consensus       106 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~------~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  178 (308)
                      ....++|++.+.||+|+||.||+|.+.      ++..||||.++........+.+.+|+.++..+ +||||+++++++..
T Consensus        31 ~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~  110 (375)
T cd05104          31 EFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTV  110 (375)
T ss_pred             ccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeecc
Confidence            344568999999999999999999641      35689999987554444457789999999999 89999999998766


Q ss_pred             C-cEEEEEEecCCCCHHHHHhccC--------------------------------------------------------
Q 021711          179 G-GMHIVLELSPNGSLASLLYGMK--------------------------------------------------------  201 (308)
Q Consensus       179 ~-~~~lv~e~~~~gsL~~~l~~~~--------------------------------------------------------  201 (308)
                      + ..++||||+++|+|.+++....                                                        
T Consensus       111 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  190 (375)
T cd05104         111 GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVR  190 (375)
T ss_pred             CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccc
Confidence            5 4789999999999999885421                                                        


Q ss_pred             ------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCC
Q 021711          202 ------------------EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ  263 (308)
Q Consensus       202 ------------------~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  263 (308)
                                        ..+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++.+...
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~  267 (375)
T cd05104         191 SGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIRND  267 (375)
T ss_pred             cceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCchhhEEEECCCcEEEecCccceeccCc
Confidence                              146788889999999999999998   89999999999999999999999999999877544


Q ss_pred             CceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          264 WTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      ..........++..|+|||...+..++.++|+||||+++|||++
T Consensus       268 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt  311 (375)
T cd05104         268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS  311 (375)
T ss_pred             ccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHh
Confidence            32222223445678999999888888999999999999999875

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=4.2e-36  Score=274.60  Aligned_cols=187  Identities=25%  Similarity=0.280  Sum_probs=157.8

Q ss_pred             ceeeccCceEEEEEEEC----CCcEEEEEEeccCC---hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEe-CcEEEEEEe
Q 021711          116 NLIGKGGYAEVYKGRLR----NGQLVAIKRLTRGT---ADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLEL  187 (308)
Q Consensus       116 ~~LG~G~fg~Vy~~~~~----~g~~vAvK~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~lv~e~  187 (308)
                      +.||+|+||.||+++..    +++.||+|.+....   .......+.+|+.+++.++||||+++++++.. +..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            68999999999999853    47899999986532   12234567889999999999999999986655 457899999


Q ss_pred             cCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCcee
Q 021711          188 SPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH  267 (308)
Q Consensus       188 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~  267 (308)
                      +++++|.+++.. ...+.+..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++.......  
T Consensus        82 ~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--  155 (323)
T cd05584          82 LSGGELFMHLER-EGIFMEDTACFYLSEISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT--  155 (323)
T ss_pred             CCCchHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC--
Confidence            999999998854 4567888888899999999999998   8999999999999999999999999999986433222  


Q ss_pred             EeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          268 TISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ......||+.|+|||.+.+...+.++|+||+|+++|||++|
T Consensus       156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G  196 (323)
T cd05584         156 VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTG  196 (323)
T ss_pred             cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcC
Confidence            12346799999999998887788999999999999999876

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-37  Score=291.64  Aligned_cols=192  Identities=24%  Similarity=0.343  Sum_probs=166.1

Q ss_pred             CccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeCc-------EE
Q 021711          111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG-------MH  182 (308)
Q Consensus       111 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-------~~  182 (308)
                      .|...+.||+|+||.||+|+++ +|+.||||.+........+++..+|+++|++++|+|||++++...+..       ..
T Consensus        14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v   93 (732)
T KOG4250|consen   14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV   93 (732)
T ss_pred             ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence            4455678999999999999966 699999999876544445688999999999999999999998654332       46


Q ss_pred             EEEEecCCCCHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECC--CC--cEEEecccc
Q 021711          183 IVLELSPNGSLASLLYG--MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTE--DF--EPQICDFGL  256 (308)
Q Consensus       183 lv~e~~~~gsL~~~l~~--~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~--~~--~~kl~DFGl  256 (308)
                      +|||||.+|||...|..  +...+++..++.++.+++.||.|||+   ++|+||||||.||++-.  +|  .-||+|||.
T Consensus        94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrE---n~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~  170 (732)
T KOG4250|consen   94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRE---NGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA  170 (732)
T ss_pred             EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHH---cCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence            89999999999999975  33469999999999999999999999   99999999999999853  33  469999999


Q ss_pred             ceecCCCCceeEeeceeccccccccccCch-hhcCccceeEEEeeEEEeeccC
Q 021711          257 AKWLPEQWTHHTISKVEGTFGLVKLNLPPL-VILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       257 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ||.++++.   ....+.||..|++||++++ ..++.-.|.||||+++||.++|
T Consensus       171 Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG  220 (732)
T KOG4250|consen  171 ARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATG  220 (732)
T ss_pred             cccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhcc
Confidence            99987764   5678999999999999985 7788889999999999999987

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=2.6e-36  Score=276.85  Aligned_cols=193  Identities=24%  Similarity=0.336  Sum_probs=168.3

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEEE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLE  186 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e  186 (308)
                      .++|++.+.||+|+||.||+++.. +|..+|+|.+...........+.+|+++++.++||||+++++++..+ ..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            468999999999999999999976 58899999987655455567899999999999999999999976554 5789999


Q ss_pred             ecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCce
Q 021711          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH  266 (308)
Q Consensus       187 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~  266 (308)
                      |+++++|.+++.. ...+++..+..++.|++.||.|||+  ..+|+||||||+|||++.++.+||+|||+++.+....  
T Consensus        84 ~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--  158 (331)
T cd06649          84 HMDGGSLDQVLKE-AKRIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--  158 (331)
T ss_pred             cCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhh--cCCEEcCCCChhhEEEcCCCcEEEccCcccccccccc--
Confidence            9999999999864 3468899999999999999999997  1369999999999999999999999999998764432  


Q ss_pred             eEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          267 HTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                        .....||..|+|||.+.+...+.++|+||+|+++|||++|
T Consensus       159 --~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg  198 (331)
T cd06649         159 --ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIG  198 (331)
T ss_pred             --cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhC
Confidence              2345799999999998888888999999999999999875

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.3e-35  Score=270.61  Aligned_cols=187  Identities=24%  Similarity=0.217  Sum_probs=159.1

Q ss_pred             ceeeccCceEEEEEEE----CCCcEEEEEEeccCCh-HHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEEEecC
Q 021711          116 NLIGKGGYAEVYKGRL----RNGQLVAIKRLTRGTA-DEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLELSP  189 (308)
Q Consensus       116 ~~LG~G~fg~Vy~~~~----~~g~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~~  189 (308)
                      +.||+|+||.||+++.    .+|+.||+|.+..... ......+.+|+.++++++||||+++++++..+ ..++||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            5799999999999875    2578999999865322 12345678899999999999999999876554 5789999999


Q ss_pred             CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCceeEe
Q 021711          190 NGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTI  269 (308)
Q Consensus       190 ~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  269 (308)
                      +|+|.+++.. ...+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++.......  ..
T Consensus        82 ~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~--~~  155 (318)
T cd05582          82 GGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK--KA  155 (318)
T ss_pred             CCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC--ce
Confidence            9999998854 4568999999999999999999998   8999999999999999999999999999986544322  22


Q ss_pred             eceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          270 SKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       270 ~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ....||+.|+|||.......+.++|+||+|+++|||++|
T Consensus       156 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg  194 (318)
T cd05582         156 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG  194 (318)
T ss_pred             ecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccC
Confidence            356799999999998877788899999999999999876

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-38  Score=272.93  Aligned_cols=190  Identities=26%  Similarity=0.382  Sum_probs=171.5

Q ss_pred             CccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeee-EEEeCcEEEEEEec
Q 021711          111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLG-YGIEGGMHIVLELS  188 (308)
Q Consensus       111 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~-~~~~~~~~lv~e~~  188 (308)
                      -|.+..+||+|+||.||++.++ .|+.+|||.+....   ..+...+|+.||.+++.|++|++|| |+...++|+|||||
T Consensus        34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s---DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC  110 (502)
T KOG0574|consen   34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT---DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC  110 (502)
T ss_pred             HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc---hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence            3567789999999999999876 59999999986543   3577889999999999999999998 77788999999999


Q ss_pred             CCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCceeE
Q 021711          189 PNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT  268 (308)
Q Consensus       189 ~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  268 (308)
                      ..|+..++++.++.++.+..+..+++..+.||+|||.   ..-||||||+.||||+.+|.+||+|||.|..+.+.-.  .
T Consensus       111 GAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~---~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA--K  185 (502)
T KOG0574|consen  111 GAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHD---LKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA--K  185 (502)
T ss_pred             CCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHH---HHHHHhhcccccEEEcccchhhhhhccccchhhhhHH--h
Confidence            9999999999888999999999999999999999998   8889999999999999999999999999987754321  2


Q ss_pred             eeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          269 ISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       269 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ...+.||+.|||||.+++..++..+|+||+|++.+|++-|
T Consensus       186 RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG  225 (502)
T KOG0574|consen  186 RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEG  225 (502)
T ss_pred             hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcC
Confidence            3568999999999999999999999999999999999865

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=2.7e-36  Score=269.99  Aligned_cols=195  Identities=25%  Similarity=0.339  Sum_probs=168.1

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCc----EEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeCcEEEE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQ----LVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHIV  184 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~----~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~lv  184 (308)
                      ++|++.+.||+|+||.||+|.+. +++    .+++|.+..........++..|+.++++++||||+++++++.....+++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~~~~~~i   86 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPGASLQLV   86 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECCCccEEE
Confidence            46788899999999999999864 344    4788887654444455778889999999999999999999887778899


Q ss_pred             EEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCC
Q 021711          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (308)
Q Consensus       185 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  264 (308)
                      +||+++|+|.+++......+++..+..++.||+.||.|||+   ++++||||||+|||++.++.+||+|||+++.+....
T Consensus        87 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~  163 (279)
T cd05111          87 TQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEE---HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDD  163 (279)
T ss_pred             EEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEEcCCccceeccCCC
Confidence            99999999999997666778999999999999999999998   899999999999999999999999999999876544


Q ss_pred             ceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          265 THHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      .........++..|+|||.......+.++|+||||+++||+++
T Consensus       164 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t  206 (279)
T cd05111         164 KKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMS  206 (279)
T ss_pred             cccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHc
Confidence            3333345668889999999887778899999999999999874

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=6e-36  Score=273.48  Aligned_cols=192  Identities=22%  Similarity=0.279  Sum_probs=161.8

Q ss_pred             CccccceeeccCceEEEEEEEC-CCcEEEEEEeccCCh--HHHHHHHHHHHHHHhcC-CCCeeeeeeeEEEe-CcEEEEE
Q 021711          111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELGIMAHV-DHPNTAKLLGYGIE-GGMHIVL  185 (308)
Q Consensus       111 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-~~~~lv~  185 (308)
                      +|++.+.||+|+||.||+|... +++.||+|.+.....  ......+..|..++..+ +|++|+++++++.. +.+++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            5788999999999999999876 478999999875321  22345677788888777 58999999886655 4578999


Q ss_pred             EecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCc
Q 021711          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (308)
Q Consensus       186 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~  265 (308)
                      ||+++|+|...+.. ...+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++.......
T Consensus        81 E~~~~g~L~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~  156 (323)
T cd05616          81 EYVNGGDLMYQIQQ-VGRFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV  156 (323)
T ss_pred             cCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCC
Confidence            99999999988854 4568899999999999999999998   8999999999999999999999999999986533221


Q ss_pred             eeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          266 HHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                        ......||+.|+|||.+....++.++|+||+|+++|||++|
T Consensus       157 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg  197 (323)
T cd05616         157 --TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAG  197 (323)
T ss_pred             --ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhC
Confidence              23456799999999998888889999999999999999876

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=5.7e-36  Score=273.76  Aligned_cols=192  Identities=23%  Similarity=0.276  Sum_probs=161.4

Q ss_pred             CccccceeeccCceEEEEEEEC-CCcEEEEEEeccCC--hHHHHHHHHHHHHHHhcCCCC-eeeeeeeEEEe-CcEEEEE
Q 021711          111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDHP-NTAKLLGYGIE-GGMHIVL  185 (308)
Q Consensus       111 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~h~-niv~l~~~~~~-~~~~lv~  185 (308)
                      +|++.+.||+|+||.||+|... +++.||+|.+....  .....+.+..|..++..++|+ +|+++++++.. +.+++||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            5788999999999999999876 47899999986532  223456788999999999765 57788876554 4588999


Q ss_pred             EecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCc
Q 021711          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (308)
Q Consensus       186 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~  265 (308)
                      ||+++|+|.+++.. ...+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++.......
T Consensus        81 E~~~~g~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~  156 (324)
T cd05587          81 EYVNGGDLMYHIQQ-VGKFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK  156 (324)
T ss_pred             cCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCC
Confidence            99999999998854 4568899999999999999999998   8999999999999999999999999999975432211


Q ss_pred             eeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          266 HHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                        ......||+.|+|||.+.+..++.++|+||+|+++|||++|
T Consensus       157 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG  197 (324)
T cd05587         157 --TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAG  197 (324)
T ss_pred             --ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhC
Confidence              23456799999999998887788999999999999999876

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.9e-36  Score=282.51  Aligned_cols=198  Identities=24%  Similarity=0.306  Sum_probs=164.3

Q ss_pred             hhcCCccccceeeccCceEEEEEEEC------CCcEEEEEEeccCChHHHHHHHHHHHHHHhcC-CCCeeeeeeeEEEeC
Q 021711          107 SATNNFSFENLIGKGGYAEVYKGRLR------NGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGIEG  179 (308)
Q Consensus       107 ~~~~~~~~~~~LG~G~fg~Vy~~~~~------~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  179 (308)
                      ...++|++.+.||+|+||.||+|...      ++..||+|.+......+....+.+|+.+++.+ +|+||+++++++...
T Consensus        35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~  114 (374)
T cd05106          35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHG  114 (374)
T ss_pred             ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence            34458899999999999999999742      24589999997655555567889999999999 899999999977664


Q ss_pred             -cEEEEEEecCCCCHHHHHhccC---------------------------------------------------------
Q 021711          180 -GMHIVLELSPNGSLASLLYGMK---------------------------------------------------------  201 (308)
Q Consensus       180 -~~~lv~e~~~~gsL~~~l~~~~---------------------------------------------------------  201 (308)
                       ..++||||+++|+|.+++....                                                         
T Consensus       115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (374)
T cd05106         115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS  194 (374)
T ss_pred             CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence             5789999999999999885321                                                         


Q ss_pred             ------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCceeEe
Q 021711          202 ------------EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTI  269 (308)
Q Consensus       202 ------------~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  269 (308)
                                  .++++..+..++.||+.||.|||+   ++|+||||||+|||+++++.+||+|||+++.+.........
T Consensus       195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~  271 (374)
T cd05106         195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK  271 (374)
T ss_pred             ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeec
Confidence                        236778889999999999999998   89999999999999999999999999999876544322222


Q ss_pred             eceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          270 SKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       270 ~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      ....++..|+|||.......+.++|+||||+++|||++
T Consensus       272 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt  309 (374)
T cd05106         272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS  309 (374)
T ss_pred             cCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHh
Confidence            23345678999999888888999999999999999873

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=3.9e-36  Score=274.81  Aligned_cols=190  Identities=25%  Similarity=0.311  Sum_probs=158.9

Q ss_pred             ccccceeeccCceEEEEEEEC-CCcEEEEEEeccCC--hHHHHHHHHHHHHHH---hcCCCCeeeeeeeEEEeC-cEEEE
Q 021711          112 FSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIM---AHVDHPNTAKLLGYGIEG-GMHIV  184 (308)
Q Consensus       112 ~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~-~~~lv  184 (308)
                      |++.+.||+|+||.||+|... +|+.||||.+....  .....+.+.+|+.++   ..++||||+++++++..+ ..++|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            667899999999999999876 58999999986432  122345566666554   567899999999976654 57899


Q ss_pred             EEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCC
Q 021711          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (308)
Q Consensus       185 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  264 (308)
                      |||+++++|...+.  ...+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++......
T Consensus        81 ~E~~~~~~L~~~~~--~~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  155 (324)
T cd05589          81 MEYAAGGDLMMHIH--TDVFSEPRAVFYAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG  155 (324)
T ss_pred             EcCCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC
Confidence            99999999998874  3568999999999999999999998   899999999999999999999999999987543221


Q ss_pred             ceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          265 THHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                        .......||+.|+|||...+...+.++|+||+|+++|||++|
T Consensus       156 --~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G  197 (324)
T cd05589         156 --DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVG  197 (324)
T ss_pred             --CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhC
Confidence              122456799999999998888888899999999999999876

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-36  Score=285.76  Aligned_cols=192  Identities=24%  Similarity=0.273  Sum_probs=167.5

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccC--ChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEE-eCcEEEEE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRG--TADEIIADFLSELGIMAHVDHPNTAKLLGYGI-EGGMHIVL  185 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~lv~  185 (308)
                      +-|++++.||.|+.|.|.+|++. +|+.+|||++.+.  ..+.......+|+-+|+-+.|||++++|+.+. ...+|+|+
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl   91 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL   91 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence            46788999999999999999875 7999999999654  22333556789999999999999999999555 45789999


Q ss_pred             EecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCc
Q 021711          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (308)
Q Consensus       186 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~  265 (308)
                      ||+++|.|.+++.. ++++++....+++.||+.|+.|+|.   .+|+||||||+|+||+..+++||+|||+|..-.++  
T Consensus        92 Eyv~gGELFdylv~-kG~l~e~eaa~ff~QIi~gv~yCH~---~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g--  165 (786)
T KOG0588|consen   92 EYVPGGELFDYLVR-KGPLPEREAAHFFRQILDGVSYCHA---FNICHRDLKPENLLLDVKNNIKIADFGMASLEVPG--  165 (786)
T ss_pred             EecCCchhHHHHHh-hCCCCCHHHHHHHHHHHHHHHHHhh---hcceeccCCchhhhhhcccCEeeeccceeecccCC--
Confidence            99999999999854 6789999999999999999999998   99999999999999999999999999999876554  


Q ss_pred             eeEeeceeccccccccccCchhh-cCccceeEEEeeEEEeeccC
Q 021711          266 HHTISKVEGTFGLVKLNLPPLVI-LKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~s~g~~l~el~c~  308 (308)
                       ....+.+|.+.|.|||...+.. .++++||||.|++||.|+.|
T Consensus       166 -klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG  208 (786)
T KOG0588|consen  166 -KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTG  208 (786)
T ss_pred             -ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhC
Confidence             2445689999999999887665 58899999999999998876

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-37  Score=285.43  Aligned_cols=180  Identities=25%  Similarity=0.368  Sum_probs=159.9

Q ss_pred             cccceeeccCceEEEEEEECCCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeCc-EEEEEEecCCC
Q 021711          113 SFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNG  191 (308)
Q Consensus       113 ~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~~~~g  191 (308)
                      .-++.||+|+.|.||+|+++ ++.||||+++...        ..+++-|++|+||||+.+.|+|.+.. +|||||||..|
T Consensus       127 sELeWlGSGaQGAVF~Grl~-netVAVKKV~elk--------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~G  197 (904)
T KOG4721|consen  127 SELEWLGSGAQGAVFLGRLH-NETVAVKKVRELK--------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQG  197 (904)
T ss_pred             hhhhhhccCcccceeeeecc-CceehhHHHhhhh--------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccc
Confidence            34578999999999999986 6789999875322        24678899999999999999999876 56999999999


Q ss_pred             CHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCceeEeec
Q 021711          192 SLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK  271 (308)
Q Consensus       192 sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~  271 (308)
                      -|..+|+. ...+.......+..+||.||.|||.   +.|||||||.-||||..+..+||+|||.++.+.+.   .+...
T Consensus       198 qL~~VLka-~~~itp~llv~Wsk~IA~GM~YLH~---hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkMS  270 (904)
T KOG4721|consen  198 QLYEVLKA-GRPITPSLLVDWSKGIAGGMNYLHL---HKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKMS  270 (904)
T ss_pred             cHHHHHhc-cCccCHHHHHHHHHHhhhhhHHHHH---hhHhhhccCCCceEeeccceEEeccccchHhhhhh---hhhhh
Confidence            99999964 5678888999999999999999998   89999999999999999999999999999987654   34567


Q ss_pred             eeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          272 VEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       272 ~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      +.||..|||||.+.....+.+.||||||++||||+++
T Consensus       271 FaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~  307 (904)
T KOG4721|consen  271 FAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTG  307 (904)
T ss_pred             hhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhc
Confidence            9999999999999988999999999999999999864

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-36  Score=282.35  Aligned_cols=195  Identities=23%  Similarity=0.339  Sum_probs=174.2

Q ss_pred             cCCccccceeeccCceEEEEEEECCCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeCc-EEEEEEe
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLEL  187 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~  187 (308)
                      .+...+.++||+|.||.|.+|....+..||||.++.......+.+|.+|+++|.+|+|||||+++|.|..++ +++++||
T Consensus       537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY  616 (807)
T KOG1094|consen  537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY  616 (807)
T ss_pred             hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence            445667789999999999999998789999999998777777899999999999999999999999998765 6799999


Q ss_pred             cCCCCHHHHHhccCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCce
Q 021711          188 SPNGSLASLLYGMKEK-LKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH  266 (308)
Q Consensus       188 ~~~gsL~~~l~~~~~~-l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~  266 (308)
                      +++|+|.+++..+..+ +.......|+.||+.||+||.+   .++|||||.++|+|++.++++||+|||+++.+-....+
T Consensus       617 mEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes---~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy  693 (807)
T KOG1094|consen  617 MENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLES---LNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY  693 (807)
T ss_pred             HhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHh---hchhhccccccceeecCcccEEecCcccccccccCCce
Confidence            9999999999765433 3555667899999999999999   89999999999999999999999999999988777666


Q ss_pred             eEeeceeccccccccccCchhhcCccceeEEEeeEEEeec
Q 021711          267 HTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLS  306 (308)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~  306 (308)
                      +..-+..-...|||||.+....++.++|+|+||++|||++
T Consensus       694 ~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~  733 (807)
T KOG1094|consen  694 RVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVF  733 (807)
T ss_pred             eeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHH
Confidence            6656677789999999999999999999999999999986

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=2.1e-35  Score=270.07  Aligned_cols=187  Identities=23%  Similarity=0.246  Sum_probs=155.5

Q ss_pred             ceeeccCceEEEEEEEC-CCcEEEEEEeccCC--hHHHHHHHHHHHH-HHhcCCCCeeeeeeeEEEe-CcEEEEEEecCC
Q 021711          116 NLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELG-IMAHVDHPNTAKLLGYGIE-GGMHIVLELSPN  190 (308)
Q Consensus       116 ~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~-~~~~lv~e~~~~  190 (308)
                      ++||+|+||.||+|+.. +|+.+|+|.+....  .......+..|.. +++.++||||+++++++.. +..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            46999999999999875 68999999986432  1222345566655 4677999999999986654 467899999999


Q ss_pred             CCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCceeEee
Q 021711          191 GSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTIS  270 (308)
Q Consensus       191 gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~  270 (308)
                      |+|...+.. ...+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++.......  ...
T Consensus        81 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~---~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~~  154 (325)
T cd05604          81 GELFFHLQR-ERSFPEPRARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD--TTT  154 (325)
T ss_pred             CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC--Ccc
Confidence            999988854 4578999999999999999999998   8999999999999999999999999999985432211  234


Q ss_pred             ceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          271 KVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       271 ~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ...||+.|+|||.+.+..++.++|+||+|+++|||++|
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G  192 (325)
T cd05604         155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYG  192 (325)
T ss_pred             cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcC
Confidence            56799999999999888888999999999999999876

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.6e-35  Score=270.42  Aligned_cols=187  Identities=25%  Similarity=0.253  Sum_probs=155.0

Q ss_pred             ceeeccCceEEEEEEEC-CCcEEEEEEeccCCh--HHHHHHHHHHHH-HHhcCCCCeeeeeeeEEEe-CcEEEEEEecCC
Q 021711          116 NLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELG-IMAHVDHPNTAKLLGYGIE-GGMHIVLELSPN  190 (308)
Q Consensus       116 ~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~--~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~-~~~~lv~e~~~~  190 (308)
                      ++||+|+||.||+|+.. +++.||+|.+.....  ......+.+|.. +++.++||||+++++++.. +..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            47999999999999976 588999999864321  222345566654 5788999999999986655 457899999999


Q ss_pred             CCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCceeEee
Q 021711          191 GSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTIS  270 (308)
Q Consensus       191 gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~  270 (308)
                      |+|...+.. ...++...+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++......  ....
T Consensus        81 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~  154 (321)
T cd05603          81 GELFFHLQR-ERCFLEPRARFYAAEVASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--ETTS  154 (321)
T ss_pred             CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--Cccc
Confidence            999888754 4568888888999999999999998   899999999999999999999999999998642221  1234


Q ss_pred             ceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          271 KVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       271 ~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ...||+.|+|||.+....++.++|+||+|+++|||++|
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g  192 (321)
T cd05603         155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYG  192 (321)
T ss_pred             cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcC
Confidence            56799999999998877788899999999999999876

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1.9e-35  Score=270.15  Aligned_cols=187  Identities=25%  Similarity=0.269  Sum_probs=155.3

Q ss_pred             ceeeccCceEEEEEEEC-CCcEEEEEEeccCCh--HHHHHHHHHHHH-HHhcCCCCeeeeeeeEEEe-CcEEEEEEecCC
Q 021711          116 NLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELG-IMAHVDHPNTAKLLGYGIE-GGMHIVLELSPN  190 (308)
Q Consensus       116 ~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~--~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~-~~~~lv~e~~~~  190 (308)
                      ++||+|+||+||+|... +|+.||+|.+.....  ......++.|.. +++.++||||+++++.+.. +..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            47999999999999976 689999999864321  122345556655 4578999999999986655 457899999999


Q ss_pred             CCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCceeEee
Q 021711          191 GSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTIS  270 (308)
Q Consensus       191 gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~  270 (308)
                      |+|..++.. ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++.......  ...
T Consensus        81 g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~~~  154 (323)
T cd05575          81 GELFFHLQR-ERSFPEPRARFYAAEIASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK--TTS  154 (323)
T ss_pred             CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC--ccc
Confidence            999998854 4568899999999999999999998   8999999999999999999999999999986432211  234


Q ss_pred             ceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          271 KVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       271 ~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ...||+.|+|||.+.+...+.++|+||+|+++|||++|
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g  192 (323)
T cd05575         155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYG  192 (323)
T ss_pred             cccCChhhcChhhhcCCCCCccccccccchhhhhhhcC
Confidence            56799999999998887888899999999999999875

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=1.1e-35  Score=272.47  Aligned_cols=187  Identities=23%  Similarity=0.260  Sum_probs=159.2

Q ss_pred             ceeeccCceEEEEEEEC-CCcEEEEEEeccCC--hHHHHHHHHHHHHHHhcC-CCCeeeeeeeEEEeC-cEEEEEEecCC
Q 021711          116 NLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHV-DHPNTAKLLGYGIEG-GMHIVLELSPN  190 (308)
Q Consensus       116 ~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~~~lv~e~~~~  190 (308)
                      ++||+|+||.||+|... +++.||+|.++...  ..+....+.+|..++..+ +||||+++++++... .+++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            47999999999999876 58899999997532  223356688899999888 799999999976654 57899999999


Q ss_pred             CCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCceeEee
Q 021711          191 GSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTIS  270 (308)
Q Consensus       191 gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~  270 (308)
                      |+|..++.. ...+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++......  ....
T Consensus        81 g~L~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--~~~~  154 (329)
T cd05588          81 GDLMFHMQR-QRKLPEEHARFYSAEISLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG--DTTS  154 (329)
T ss_pred             CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEECcCccccccccCC--Cccc
Confidence            999988754 4579999999999999999999998   899999999999999999999999999997532221  1234


Q ss_pred             ceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          271 KVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       271 ~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ...||+.|+|||.+.+..++.++|+||+|+++|+|++|
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g  192 (329)
T cd05588         155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAG  192 (329)
T ss_pred             cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHC
Confidence            56899999999998888888899999999999999875

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=4.5e-36  Score=269.00  Aligned_cols=194  Identities=23%  Similarity=0.304  Sum_probs=164.0

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCCh-HHHHHHHHHHHHHHhcCCCCeeeeeeeEEEe-CcEEEEEE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA-DEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLE  186 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~lv~e  186 (308)
                      ++|++.+.||+|+||.||+|+.+ +++.||+|.+..... ....+.+.+|+.+++.++||||+++++++.. +..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            47899999999999999999986 588999999865432 2345678899999999999999999986655 45789999


Q ss_pred             ecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCce
Q 021711          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH  266 (308)
Q Consensus       187 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~  266 (308)
                      |++++.+..+. .....+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.+||+|||+++.+..... 
T Consensus        81 ~~~~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-  155 (287)
T cd07848          81 YVEKNMLELLE-EMPNGVPPEKVRSYIYQLIKAIHWCHK---NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN-  155 (287)
T ss_pred             cCCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc-
Confidence            99987666544 345568999999999999999999998   8999999999999999999999999999987654322 


Q ss_pred             eEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          267 HTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      .......||+.|+|||...+...+.++|+||+|+++|||++|
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g  197 (287)
T cd07848         156 ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDG  197 (287)
T ss_pred             ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhC
Confidence            122346799999999998777788999999999999999876

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.2e-35  Score=271.33  Aligned_cols=187  Identities=22%  Similarity=0.271  Sum_probs=158.2

Q ss_pred             ceeeccCceEEEEEEEC-CCcEEEEEEeccCC--hHHHHHHHHHHHHHHhcC-CCCeeeeeeeEEEeC-cEEEEEEecCC
Q 021711          116 NLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHV-DHPNTAKLLGYGIEG-GMHIVLELSPN  190 (308)
Q Consensus       116 ~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~~~lv~e~~~~  190 (308)
                      ++||+|+||.||+|+.. +++.||+|.+....  ..+....+..|..++..+ +||||+++++++... ..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46999999999999876 47899999986532  223356678899998866 799999999976654 57899999999


Q ss_pred             CCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCceeEee
Q 021711          191 GSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTIS  270 (308)
Q Consensus       191 gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~  270 (308)
                      |+|...+.. ...+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++.......  ...
T Consensus        81 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~~~  154 (321)
T cd05591          81 GDLMFQIQR-SRKFDEPRSRFYAAEVTLALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--TTT  154 (321)
T ss_pred             CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeecccceecccCCc--ccc
Confidence            999988854 4568899999999999999999998   8999999999999999999999999999986433221  234


Q ss_pred             ceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          271 KVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       271 ~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ...||+.|+|||.+.+..++.++|+||+|+++|||++|
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg  192 (321)
T cd05591         155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAG  192 (321)
T ss_pred             ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcC
Confidence            56799999999998888888999999999999999876

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1.5e-35  Score=271.73  Aligned_cols=187  Identities=24%  Similarity=0.270  Sum_probs=158.1

Q ss_pred             ceeeccCceEEEEEEEC-CCcEEEEEEeccCC--hHHHHHHHHHHHHHHhcC-CCCeeeeeeeEEEe-CcEEEEEEecCC
Q 021711          116 NLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHV-DHPNTAKLLGYGIE-GGMHIVLELSPN  190 (308)
Q Consensus       116 ~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-~~~~lv~e~~~~  190 (308)
                      +.||+|+||.||+|... +++.||+|.+....  .......+.+|+.++..+ +||||+++++++.. +..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            47999999999999976 58899999987532  223355678899888776 89999999996655 457899999999


Q ss_pred             CCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCceeEee
Q 021711          191 GSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTIS  270 (308)
Q Consensus       191 gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~  270 (308)
                      |+|..++.. ...+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++.......  ...
T Consensus        81 ~~L~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~--~~~  154 (329)
T cd05618          81 GDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTS  154 (329)
T ss_pred             CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC--ccc
Confidence            999888754 4578999999999999999999998   8999999999999999999999999999986432211  223


Q ss_pred             ceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          271 KVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       271 ~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ...||+.|+|||.+.+..++.++|+||+|+++|||++|
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g  192 (329)
T cd05618         155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAG  192 (329)
T ss_pred             cccCCccccCHHHHcCCCCCCccceecccHHHHHHhhC
Confidence            56799999999998888888899999999999999875

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=7.3e-36  Score=272.25  Aligned_cols=187  Identities=22%  Similarity=0.278  Sum_probs=156.2

Q ss_pred             ceeeccCceEEEEEEEC-CCcEEEEEEeccCC--hHHHHHHHHHHHHHHhc-CCCCeeeeeeeEEEeC-cEEEEEEecCC
Q 021711          116 NLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAH-VDHPNTAKLLGYGIEG-GMHIVLELSPN  190 (308)
Q Consensus       116 ~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~-~~~lv~e~~~~  190 (308)
                      ++||+|+||.||+|... +++.||+|.+....  .....+.+..|..++.. .+||||+++++++..+ ..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            47999999999999876 58899999986532  12234556667777765 4899999999866554 57899999999


Q ss_pred             CCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCceeEee
Q 021711          191 GSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTIS  270 (308)
Q Consensus       191 gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~  270 (308)
                      |+|..++.. ...++...+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++......  ....
T Consensus        81 g~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~~  154 (316)
T cd05592          81 GDLMFHIQS-SGRFDEARARFYAAEIICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKAS  154 (316)
T ss_pred             CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cccc
Confidence            999988854 4568999999999999999999999   899999999999999999999999999998654332  1234


Q ss_pred             ceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          271 KVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       271 ~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ...||+.|+|||.+.+..++.++|+||+|+++|||++|
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G  192 (316)
T cd05592         155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIG  192 (316)
T ss_pred             cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhC
Confidence            56799999999998877788999999999999999876

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=7.8e-36  Score=274.05  Aligned_cols=193  Identities=23%  Similarity=0.343  Sum_probs=167.1

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEEE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLE  186 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e  186 (308)
                      .++|++.+.||+|+||.||++.+. ++..+|+|.+...........+.+|+++++.++||||+++++++..+ ..++|||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            468999999999999999999976 58899999887655455567899999999999999999999976655 5789999


Q ss_pred             ecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCce
Q 021711          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH  266 (308)
Q Consensus       187 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~  266 (308)
                      |+++|+|.+++.. ...+++..+..++.|++.||.|||+  ..+|+||||||+|||++.++.+||+|||++..+...   
T Consensus        84 ~~~~~~L~~~l~~-~~~~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~---  157 (333)
T cd06650          84 HMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---  157 (333)
T ss_pred             cCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh---
Confidence            9999999999864 4468889999999999999999997  147999999999999999999999999999865432   


Q ss_pred             eEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          267 HTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                       ......||..|+|||...+...+.++|+||+|+++|++++|
T Consensus       158 -~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g  198 (333)
T cd06650         158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIG  198 (333)
T ss_pred             -ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHC
Confidence             12345799999999998877788899999999999999875

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1e-35  Score=285.88  Aligned_cols=194  Identities=19%  Similarity=0.156  Sum_probs=164.7

Q ss_pred             CccccceeeccCceEEEEEEEC-C-CcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEEEe
Q 021711          111 NFSFENLIGKGGYAEVYKGRLR-N-GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLEL  187 (308)
Q Consensus       111 ~~~~~~~LG~G~fg~Vy~~~~~-~-g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~  187 (308)
                      .|.+.+.||+|+||.||+|... + ++.||+|.+..... .....+.+|+.+++.++|||||++++++..+ ..++||||
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~-~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~  146 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDE-RQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY  146 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCH-HHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence            4889999999999999999754 3 67889997754433 3345678899999999999999999976654 57899999


Q ss_pred             cCCCCHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCC
Q 021711          188 SPNGSLASLLYG---MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (308)
Q Consensus       188 ~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  264 (308)
                      +++|+|.+++..   ....+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++.+....
T Consensus       147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~  223 (478)
T PTZ00267        147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS---RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV  223 (478)
T ss_pred             CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence            999999988753   23458888999999999999999998   899999999999999999999999999999875443


Q ss_pred             ceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          265 THHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      .........||++|+|||.+....++.++|+||+|+++|||++|
T Consensus       224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg  267 (478)
T PTZ00267        224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTL  267 (478)
T ss_pred             ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhC
Confidence            22233456799999999998888889999999999999999875

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=6e-36  Score=274.28  Aligned_cols=193  Identities=22%  Similarity=0.283  Sum_probs=160.2

Q ss_pred             CccccceeeccCceEEEEEEEC-CCcEEEEEEeccCC-hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC------cEE
Q 021711          111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG------GMH  182 (308)
Q Consensus       111 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~  182 (308)
                      +|++.++||+|+||.||+|... +|+.||||.+.... .......+.+|+.+++.++||||+++++++...      ..+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            5888999999999999999976 58999999986432 122345788999999999999999999876432      368


Q ss_pred             EEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCC
Q 021711          183 IVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE  262 (308)
Q Consensus       183 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~  262 (308)
                      +||||+. ++|.+++.. ...+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++....
T Consensus        81 lv~e~~~-~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~  155 (338)
T cd07859          81 VVFELME-SDLHQVIKA-NDDLTPEHHQFFLYQLLRALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVAFN  155 (338)
T ss_pred             EEEecCC-CCHHHHHHh-cccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEccCcccccccc
Confidence            9999995 689888854 4468999999999999999999999   8999999999999999999999999999986533


Q ss_pred             CCc-eeEeeceeccccccccccCch--hhcCccceeEEEeeEEEeeccC
Q 021711          263 QWT-HHTISKVEGTFGLVKLNLPPL--VILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       263 ~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ... ........||..|+|||....  ...+.++|+||+|+++|||++|
T Consensus       156 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg  204 (338)
T cd07859         156 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG  204 (338)
T ss_pred             ccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcC
Confidence            221 112235679999999998755  4578889999999999999875

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-36  Score=267.44  Aligned_cols=195  Identities=24%  Similarity=0.358  Sum_probs=165.5

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCCh-HHHHHHHHHHHHHHhcCCCCeeeeeeeEEEe------Cc
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA-DEIIADFLSELGIMAHVDHPNTAKLLGYGIE------GG  180 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~  180 (308)
                      ...|...+.||+|+||.|..+..+ +|+.||||++.+... .-..++-+||+.+|++++|+||+.+++....      .+
T Consensus        21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D  100 (359)
T KOG0660|consen   21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND  100 (359)
T ss_pred             cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence            446666789999999999999876 689999999975432 2346788999999999999999999986654      34


Q ss_pred             EEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceec
Q 021711          181 MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL  260 (308)
Q Consensus       181 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~  260 (308)
                      +|+|+|+| +.+|...++. +..++......++.|+++||.|+|+   .+|+||||||+|+|++.+..+||+|||+|+..
T Consensus       101 vYiV~elM-etDL~~iik~-~~~L~d~H~q~f~YQiLrgLKyiHS---AnViHRDLKPsNll~n~~c~lKI~DFGLAR~~  175 (359)
T KOG0660|consen  101 VYLVFELM-ETDLHQIIKS-QQDLTDDHAQYFLYQILRGLKYIHS---ANVIHRDLKPSNLLLNADCDLKICDFGLARYL  175 (359)
T ss_pred             eEEehhHH-hhHHHHHHHc-CccccHHHHHHHHHHHHHhcchhhc---ccccccccchhheeeccCCCEEeccccceeec
Confidence            89999999 4588888854 4458999999999999999999999   89999999999999999999999999999998


Q ss_pred             CCCCceeEeeceeccccccccccCchh-hcCccceeEEEeeEEEeeccC
Q 021711          261 PEQWTHHTISKVEGTFGLVKLNLPPLV-ILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       261 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ........++...-|.+|.|||.+... .+++..|+||.||++.||..|
T Consensus       176 ~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~g  224 (359)
T KOG0660|consen  176 DKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTG  224 (359)
T ss_pred             cccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcC
Confidence            654233345788999999999987544 478999999999999998764

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=9.3e-36  Score=272.03  Aligned_cols=187  Identities=23%  Similarity=0.343  Sum_probs=158.3

Q ss_pred             ceeeccCceEEEEEEEC-CCcEEEEEEeccCC--hHHHHHHHHHHHHHHhcC-CCCeeeeeeeEEEeC-cEEEEEEecCC
Q 021711          116 NLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHV-DHPNTAKLLGYGIEG-GMHIVLELSPN  190 (308)
Q Consensus       116 ~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~~~lv~e~~~~  190 (308)
                      ++||+|+||.||+|+.. +++.||+|.+....  .....+.+..|..++..+ +||||+++++++... .+++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999976 58899999986432  123356778888888776 699999999876654 57899999999


Q ss_pred             CCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCceeEee
Q 021711          191 GSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTIS  270 (308)
Q Consensus       191 gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~  270 (308)
                      |+|..++.. ...+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++.......  ...
T Consensus        81 g~L~~~i~~-~~~l~~~~~~~~~~ql~~~L~~lH~---~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~--~~~  154 (320)
T cd05590          81 GDLMFHIQK-SRRFDEARARFYAAEITSALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK--TTS  154 (320)
T ss_pred             chHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC--ccc
Confidence            999988854 4568999999999999999999998   9999999999999999999999999999986432221  234


Q ss_pred             ceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          271 KVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       271 ~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ...||+.|+|||.+.+...+.++|+||+|+++|||++|
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g  192 (320)
T cd05590         155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCG  192 (320)
T ss_pred             ccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhC
Confidence            56799999999998888888899999999999999876

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5e-37  Score=257.70  Aligned_cols=193  Identities=26%  Similarity=0.375  Sum_probs=168.8

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChH--HHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTAD--EIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIV  184 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv  184 (308)
                      .++|++++.||+|.||.||.|+.+ ++-.||+|.+.+..-.  ....++.+|++|-.+|+||||+++++|+.+. ..||+
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence            367889999999999999999966 5789999998654321  2356788999999999999999999988776 58999


Q ss_pred             EEecCCCCHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCC
Q 021711          185 LELSPNGSLASLLYG-MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ  263 (308)
Q Consensus       185 ~e~~~~gsL~~~l~~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  263 (308)
                      +||.+.|+|...|.. ...+++......++.|+|.||.|+|.   +++|||||||+|+|++.++.+||+|||-+..-+..
T Consensus       101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~---k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~~  177 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHL---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSN  177 (281)
T ss_pred             EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhcc---CCcccCCCCHHHhccCCCCCeeccCCCceeecCCC
Confidence            999999999999964 34458888899999999999999998   99999999999999999999999999999876643


Q ss_pred             CceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          264 WTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      .    ....+||+.|.+||+..+...+...|+|++|++.||+.-|
T Consensus       178 k----R~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg  218 (281)
T KOG0580|consen  178 K----RKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVG  218 (281)
T ss_pred             C----ceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhc
Confidence            2    3468999999999999999999999999999999987654

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.9e-35  Score=270.39  Aligned_cols=187  Identities=25%  Similarity=0.244  Sum_probs=153.9

Q ss_pred             ceeeccCceEEEEEEEC-CCcEEEEEEeccCCh--HHHHHHHHHHHH-HHhcCCCCeeeeeeeEEEe-CcEEEEEEecCC
Q 021711          116 NLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELG-IMAHVDHPNTAKLLGYGIE-GGMHIVLELSPN  190 (308)
Q Consensus       116 ~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~--~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~-~~~~lv~e~~~~  190 (308)
                      +.||+|+||.||+|+.. +++.||+|.+.....  ......+..|.. +++.++||||+++++++.. +..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            47999999999999976 578999999864321  122234455544 4678899999999986655 457899999999


Q ss_pred             CCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCceeEee
Q 021711          191 GSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTIS  270 (308)
Q Consensus       191 gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~  270 (308)
                      |+|.+++.. ...+....+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++......  ....
T Consensus        81 ~~L~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~---~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~--~~~~  154 (325)
T cd05602          81 GELFYHLQR-ERCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--GTTS  154 (325)
T ss_pred             CcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEEccCCCCcccccCC--CCcc
Confidence            999998864 4567788888899999999999998   999999999999999999999999999998643221  1234


Q ss_pred             ceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          271 KVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       271 ~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ...||+.|+|||.+.+..++.++|+||+|+++|||++|
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g  192 (325)
T cd05602         155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG  192 (325)
T ss_pred             cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcC
Confidence            56799999999998888888999999999999999876

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=1.1e-35  Score=279.29  Aligned_cols=199  Identities=23%  Similarity=0.269  Sum_probs=165.5

Q ss_pred             HhhcCCccccceeeccCceEEEEEEEC------CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCC-CCeeeeeeeEEEe
Q 021711          106 QSATNNFSFENLIGKGGYAEVYKGRLR------NGQLVAIKRLTRGTADEIIADFLSELGIMAHVD-HPNTAKLLGYGIE  178 (308)
Q Consensus       106 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~------~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~  178 (308)
                      ....++|.+.++||+|+||.||+|.+.      .+..||||.+.........+.+++|+.++.+++ ||||+++++++..
T Consensus        33 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~  112 (400)
T cd05105          33 EFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTK  112 (400)
T ss_pred             eccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc
Confidence            344678999999999999999999853      134799999976555555678999999999996 9999999998766


Q ss_pred             C-cEEEEEEecCCCCHHHHHhccC--------------------------------------------------------
Q 021711          179 G-GMHIVLELSPNGSLASLLYGMK--------------------------------------------------------  201 (308)
Q Consensus       179 ~-~~~lv~e~~~~gsL~~~l~~~~--------------------------------------------------------  201 (308)
                      . ..++||||+++|+|.+++....                                                        
T Consensus       113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (400)
T cd05105         113 SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML  192 (400)
T ss_pred             CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence            4 5789999999999998875421                                                        


Q ss_pred             ---------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEE
Q 021711          202 ---------------------------------------EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANIL  242 (308)
Q Consensus       202 ---------------------------------------~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NIL  242 (308)
                                                             ..+++..+..++.|++.||.|||+   .+|+||||||+|||
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dikp~Nil  269 (400)
T cd05105         193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVL  269 (400)
T ss_pred             hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHhEE
Confidence                                                   236777888999999999999998   89999999999999


Q ss_pred             ECCCCcEEEeccccceecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          243 LTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       243 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      ++.++.+||+|||+++.+.............++..|+|||.+.+...+.++|+||||+++|||++
T Consensus       270 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt  334 (400)
T cd05105         270 LAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS  334 (400)
T ss_pred             EeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHH
Confidence            99999999999999987654332222233457788999999887778899999999999999863

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.1e-35  Score=265.53  Aligned_cols=196  Identities=26%  Similarity=0.362  Sum_probs=168.3

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCc----EEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeCcEEE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQ----LVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHI  183 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~----~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l  183 (308)
                      .++|++.+.||+|+||.||+|.+. +|+    .||+|.+...........+.+|+.++..++||||+++++++.....++
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~l   85 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTSTVQL   85 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCCCcEE
Confidence            357888999999999999999854 444    489999876555555678899999999999999999999998888899


Q ss_pred             EEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCC
Q 021711          184 VLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ  263 (308)
Q Consensus       184 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  263 (308)
                      ++||+++|+|.+++......+++..++.++.|++.||.|||+   ++|+||||||+|||+++++.+||+|||+++.+...
T Consensus        86 ~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~  162 (279)
T cd05109          86 VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDID  162 (279)
T ss_pred             EEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEcCCCcEEECCCCceeecccc
Confidence            999999999999997656678999999999999999999998   89999999999999999999999999999987654


Q ss_pred             CceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          264 WTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      ..........++..|+|||.......+.++|+||||+++||+..
T Consensus       163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t  206 (279)
T cd05109         163 ETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMT  206 (279)
T ss_pred             cceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHc
Confidence            33222233455788999999877778889999999999999753

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=9.2e-36  Score=264.59  Aligned_cols=194  Identities=24%  Similarity=0.310  Sum_probs=164.3

Q ss_pred             cCCccccceeeccCceEEEEEEEC----CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR----NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHI  183 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~----~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l  183 (308)
                      .++|++.+.||+|+||.||+|.+.    .+..||+|.++..........|.+|+.++..++||||+++++++..+ ..++
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   83 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI   83 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence            357889999999999999999754    36789999998765555567899999999999999999999976654 5789


Q ss_pred             EEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCC
Q 021711          184 VLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ  263 (308)
Q Consensus       184 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  263 (308)
                      ||||+++|+|.+++......+++..++.++.|++.||.|||+   ++++||||||+|||++.++.++++|||.+......
T Consensus        84 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~  160 (266)
T cd05064          84 VTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE  160 (266)
T ss_pred             EEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence            999999999999997655678999999999999999999998   89999999999999999999999999987754322


Q ss_pred             CceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeec
Q 021711          264 WTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLS  306 (308)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~  306 (308)
                      .. .......++..|+|||.+....++.++|+||||+++||+.
T Consensus       161 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell  202 (266)
T cd05064         161 AI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVM  202 (266)
T ss_pred             ch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHh
Confidence            11 1112334567899999988888899999999999999954

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-35  Score=264.96  Aligned_cols=192  Identities=27%  Similarity=0.294  Sum_probs=164.0

Q ss_pred             CccccceeeccCceEEEEEEEC-CCcEEEEEEeccCCh--HHHHHHHHHHHHHHhcCCCCeeeeeeeEEEe-CcEEEEEE
Q 021711          111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLE  186 (308)
Q Consensus       111 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~lv~e  186 (308)
                      +|++.++||+|+||.||++... +++.||+|.+.....  ......+.+|+.+++.++||||+++++.+.. +..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            4788899999999999999875 588999999865322  2223567889999999999999999987655 45889999


Q ss_pred             ecCCCCHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCc
Q 021711          187 LSPNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (308)
Q Consensus       187 ~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~  265 (308)
                      |+++|+|.+++... ...+++..+..++.|++.||.|||+   .+|+||||||+||++++++.++|+|||+++...... 
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-  156 (285)
T cd05605          81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE-  156 (285)
T ss_pred             ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC-
Confidence            99999999888543 3468999999999999999999998   899999999999999999999999999998765432 


Q ss_pred             eeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          266 HHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                        ......||..|+|||.+....++.++|+||+|+++||+++|
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g  197 (285)
T cd05605         157 --TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEG  197 (285)
T ss_pred             --ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHC
Confidence              22345789999999998877788899999999999999875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=8.9e-36  Score=287.21  Aligned_cols=200  Identities=18%  Similarity=0.172  Sum_probs=168.6

Q ss_pred             HhhcCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCC-hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC----
Q 021711          106 QSATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG----  179 (308)
Q Consensus       106 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----  179 (308)
                      ....++|++.+.||+|+||.||+|+.. +|+.||||.+.... .......+.+|+.++..++|+||++++..+...    
T Consensus        28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~  107 (496)
T PTZ00283         28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN  107 (496)
T ss_pred             cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence            344579999999999999999999865 68999999986542 334456788999999999999999998744321    


Q ss_pred             -----cEEEEEEecCCCCHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEE
Q 021711          180 -----GMHIVLELSPNGSLASLLYGM---KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQI  251 (308)
Q Consensus       180 -----~~~lv~e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl  251 (308)
                           .+++||||+++|+|.+++...   ...+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||
T Consensus       108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~---~~IiHrDLKP~NILl~~~~~vkL  184 (496)
T PTZ00283        108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS---KHMIHRDIKSANILLCSNGLVKL  184 (496)
T ss_pred             cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEeCCCCEEE
Confidence                 157899999999999988642   3468889999999999999999998   89999999999999999999999


Q ss_pred             eccccceecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          252 CDFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       252 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      +|||+++.+.............||+.|+|||.+....++.++|+||+|+++|||++|
T Consensus       185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG  241 (496)
T PTZ00283        185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTL  241 (496)
T ss_pred             EecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHC
Confidence            999999876543332233456899999999999888889999999999999999875

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=6e-36  Score=276.79  Aligned_cols=189  Identities=26%  Similarity=0.355  Sum_probs=157.9

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEEEe
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLEL  187 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~  187 (308)
                      ++|+..+.||+|+||.||+|.+. +++.||||.+...........+.+|+.+++.++|+||+++++++..+ .+++||||
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  153 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF  153 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence            45667889999999999999876 58999999997655555567899999999999999999999976654 57899999


Q ss_pred             cCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCcee
Q 021711          188 SPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH  267 (308)
Q Consensus       188 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~  267 (308)
                      +.+|+|...     ....+..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++.+.....  
T Consensus       154 ~~~~~L~~~-----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--  223 (353)
T PLN00034        154 MDGGSLEGT-----HIADEQFLADVARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD--  223 (353)
T ss_pred             CCCCccccc-----ccCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEcccccceecccccc--
Confidence            999998643     235667788899999999999998   8999999999999999999999999999987654321  


Q ss_pred             EeeceeccccccccccCch-----hhcCccceeEEEeeEEEeeccC
Q 021711          268 TISKVEGTFGLVKLNLPPL-----VILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~-----~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ......||..|+|||.+..     ...+.++|+||||+++|||++|
T Consensus       224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g  269 (353)
T PLN00034        224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLG  269 (353)
T ss_pred             cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhC
Confidence            1234579999999998632     2234578999999999999875

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-37  Score=277.87  Aligned_cols=193  Identities=29%  Similarity=0.356  Sum_probs=170.2

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEE-EeCcEEEEEEe
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYG-IEGGMHIVLEL  187 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~lv~e~  187 (308)
                      ..|+..+.||+|.||.||+|.+. .++.||+|++.-...++..++..+|+.++..++++||.++|+.+ ....++++|||
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey   92 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY   92 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence            35667789999999999999865 68999999998776666678899999999999999999999844 45568999999


Q ss_pred             cCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCcee
Q 021711          188 SPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH  267 (308)
Q Consensus       188 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~  267 (308)
                      |.||++.+.+.. ...+.+..+.-++++++.||.|||.   .+.+|||||+.|||+..+|.+|++|||.+..+...... 
T Consensus        93 ~~gGsv~~lL~~-~~~~~E~~i~~ilre~l~~l~ylH~---~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r-  167 (467)
T KOG0201|consen   93 CGGGSVLDLLKS-GNILDEFEIAVILREVLKGLDYLHS---EKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR-  167 (467)
T ss_pred             hcCcchhhhhcc-CCCCccceeeeehHHHHHHhhhhhh---cceecccccccceeEeccCcEEEEecceeeeeechhhc-
Confidence            999999999853 4445777888889999999999998   89999999999999999999999999999988665332 


Q ss_pred             EeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          268 TISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                       ..++.||+.|||||......++.++||||+|++.+||+.|
T Consensus       168 -r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~G  207 (467)
T KOG0201|consen  168 -RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKG  207 (467)
T ss_pred             -cccccccccccchhhhccccccchhhhhhhhHHHHHHhcC
Confidence             2679999999999999988899999999999999999976

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-35  Score=274.38  Aligned_cols=193  Identities=24%  Similarity=0.317  Sum_probs=169.8

Q ss_pred             hcCCccccceeeccCceEEEEEEECC-CcEEEEEEeccCChH--HHHHHHHHHHHHHhcCC-CCeeeeeeeEEEe-CcEE
Q 021711          108 ATNNFSFENLIGKGGYAEVYKGRLRN-GQLVAIKRLTRGTAD--EIIADFLSELGIMAHVD-HPNTAKLLGYGIE-GGMH  182 (308)
Q Consensus       108 ~~~~~~~~~~LG~G~fg~Vy~~~~~~-g~~vAvK~~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~-~~~~  182 (308)
                      ....|++.+.||+|.||.||+|+.+. |+.+|+|.+.+....  .....+.+|+.+|+++. |||||.+++.+.. ..++
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~  112 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY  112 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence            34678899999999999999999774 999999999654332  23568899999999998 9999999996554 5689


Q ss_pred             EEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCC----CcEEEeccccce
Q 021711          183 IVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTED----FEPQICDFGLAK  258 (308)
Q Consensus       183 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~----~~~kl~DFGla~  258 (308)
                      +|||++.||.|.+.+...  .+++..+..++.|++.++.|||+   .+|+||||||+|+|+...    +.+|++|||+|.
T Consensus       113 lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~---~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~  187 (382)
T KOG0032|consen  113 LVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHS---LGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAK  187 (382)
T ss_pred             EEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHh---CCceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence            999999999999998654  39999999999999999999999   999999999999999754    479999999999


Q ss_pred             ecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          259 WLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       259 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      .....   ......+||+.|+|||......++...|+||.|+++|.|.||
T Consensus       188 ~~~~~---~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G  234 (382)
T KOG0032|consen  188 FIKPG---ERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSG  234 (382)
T ss_pred             EccCC---ceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhC
Confidence            98763   345678999999999999888899999999999999999997

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1.6e-35  Score=270.78  Aligned_cols=192  Identities=23%  Similarity=0.292  Sum_probs=160.5

Q ss_pred             CccccceeeccCceEEEEEEEC-CCcEEEEEEeccCC--hHHHHHHHHHHHHHHhcCC-CCeeeeeeeEEEe-CcEEEEE
Q 021711          111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVD-HPNTAKLLGYGIE-GGMHIVL  185 (308)
Q Consensus       111 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~-~~~~lv~  185 (308)
                      +|+..++||+|+||.||+|... +|+.||+|.+....  .....+.+..|..++..+. |++|+++++++.. +.+++||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            4678899999999999999876 58999999986532  1233466788999998885 5777788876554 4578999


Q ss_pred             EecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCc
Q 021711          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (308)
Q Consensus       186 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~  265 (308)
                      ||+++|+|.+++.. ...+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++.......
T Consensus        81 Ey~~~g~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~lH~---~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~  156 (323)
T cd05615          81 EYVNGGDLMYHIQQ-VGKFKEPQAVFYAAEISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV  156 (323)
T ss_pred             cCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeccccccccCCCCc
Confidence            99999999998854 4568999999999999999999998   8999999999999999999999999999986433221


Q ss_pred             eeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          266 HHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                        ......||+.|+|||.+.....+.++|+||+|+++|||++|
T Consensus       157 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG  197 (323)
T cd05615         157 --TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAG  197 (323)
T ss_pred             --cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhC
Confidence              22346799999999998877788899999999999999875

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=4.1e-35  Score=268.55  Aligned_cols=187  Identities=25%  Similarity=0.271  Sum_probs=159.0

Q ss_pred             ceeeccCceEEEEEEEC-CCcEEEEEEeccCC--hHHHHHHHHHHHHHHhcC-CCCeeeeeeeEEEe-CcEEEEEEecCC
Q 021711          116 NLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHV-DHPNTAKLLGYGIE-GGMHIVLELSPN  190 (308)
Q Consensus       116 ~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-~~~~lv~e~~~~  190 (308)
                      ++||+|+||.||+|... +++.||+|.+....  ..+....+.+|+.++..+ +||||+++++++.. +.+++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            47999999999999876 57899999997542  223456788999999888 69999999986655 457899999999


Q ss_pred             CCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCceeEee
Q 021711          191 GSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTIS  270 (308)
Q Consensus       191 gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~  270 (308)
                      |+|..++.. ...+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++.......  ...
T Consensus        81 ~~L~~~~~~-~~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~~  154 (327)
T cd05617          81 GDLMFHMQR-QRKLPEEHARFYAAEICIALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD--TTS  154 (327)
T ss_pred             CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC--cee
Confidence            999988753 4568999999999999999999998   8999999999999999999999999999986432211  234


Q ss_pred             ceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          271 KVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       271 ~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ...||+.|+|||.+.+..++.++|+||+|+++|||++|
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g  192 (327)
T cd05617         155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAG  192 (327)
T ss_pred             cccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhC
Confidence            56799999999998888888999999999999999875

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=2e-35  Score=265.16  Aligned_cols=192  Identities=24%  Similarity=0.364  Sum_probs=158.0

Q ss_pred             CCccccceeeccCceEEEEEEEC--CCcEEEEEEeccCChH-HHHHHHHHHHHHHhcC---CCCeeeeeeeEEE------
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR--NGQLVAIKRLTRGTAD-EIIADFLSELGIMAHV---DHPNTAKLLGYGI------  177 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~--~g~~vAvK~~~~~~~~-~~~~~~~~E~~~l~~l---~h~niv~l~~~~~------  177 (308)
                      ++|++.+.||+|+||.||+|+..  ++..||+|.+...... .....+.+|+.+++.+   +||||+++++++.      
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            36889999999999999999863  4688999988643321 2234566777777665   6999999999764      


Q ss_pred             eCcEEEEEEecCCCCHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEecccc
Q 021711          178 EGGMHIVLELSPNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGL  256 (308)
Q Consensus       178 ~~~~~lv~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGl  256 (308)
                      ...+++|+||+. ++|.+++... ...+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~iiH~dlkp~Nil~~~~~~~kl~Dfg~  156 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGL  156 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEcCCCCEEEccccc
Confidence            234789999996 5898888643 3458899999999999999999998   8999999999999999999999999999


Q ss_pred             ceecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          257 AKWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       257 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ++.....   .......||+.|+|||.+.+...+.++|+||+|+++|||+.|
T Consensus       157 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g  205 (290)
T cd07862         157 ARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRR  205 (290)
T ss_pred             eEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcC
Confidence            9876543   123456799999999998877888899999999999998754

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.3e-35  Score=278.21  Aligned_cols=187  Identities=22%  Similarity=0.200  Sum_probs=159.5

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEEE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLE  186 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e  186 (308)
                      ..+|++.+.||+|+||.||+|... +++.||+|...       ...+.+|+.+++.++||||+++++++..+ ..++|+|
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e  163 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILP  163 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEe
Confidence            468999999999999999999875 58899999643       23467899999999999999999976655 4688999


Q ss_pred             ecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCce
Q 021711          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH  266 (308)
Q Consensus       187 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~  266 (308)
                      ++. ++|..++.. ...+++..++.++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+|+...... .
T Consensus       164 ~~~-~~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~ylH~---~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~-~  237 (391)
T PHA03212        164 RYK-TDLYCYLAA-KRNIAICDILAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN-A  237 (391)
T ss_pred             cCC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHhEEEcCCCCEEEEeCCccccccccc-c
Confidence            985 688888754 4568899999999999999999998   899999999999999999999999999997543221 1


Q ss_pred             eEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          267 HTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      .......||+.|+|||.+....++.++|+||+|+++|||++|
T Consensus       238 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg  279 (391)
T PHA03212        238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATC  279 (391)
T ss_pred             cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHC
Confidence            123456899999999998888889999999999999999875

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=7.7e-36  Score=274.61  Aligned_cols=197  Identities=23%  Similarity=0.337  Sum_probs=164.7

Q ss_pred             hcCCccccceeeccCceEEEEEEEC------CCcEEEEEEeccCChHHHHHHHHHHHHHHhcC-CCCeeeeeeeEEEeC-
Q 021711          108 ATNNFSFENLIGKGGYAEVYKGRLR------NGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGIEG-  179 (308)
Q Consensus       108 ~~~~~~~~~~LG~G~fg~Vy~~~~~------~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-  179 (308)
                      ..++|++.++||+|+||.||+|...      +++.||+|++...........+.+|+.++.++ +|+||+++++++... 
T Consensus         5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~   84 (337)
T cd05054           5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG   84 (337)
T ss_pred             CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence            3457999999999999999999642      24789999987554444456788999999999 899999999977543 


Q ss_pred             -cEEEEEEecCCCCHHHHHhccC---------------------------------------------------------
Q 021711          180 -GMHIVLELSPNGSLASLLYGMK---------------------------------------------------------  201 (308)
Q Consensus       180 -~~~lv~e~~~~gsL~~~l~~~~---------------------------------------------------------  201 (308)
                       .+++++||+++++|.+++....                                                         
T Consensus        85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (337)
T cd05054          85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE  164 (337)
T ss_pred             CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence             4789999999999999885321                                                         


Q ss_pred             ---CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCceeEeeceeccccc
Q 021711          202 ---EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGL  278 (308)
Q Consensus       202 ---~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y  278 (308)
                         ..+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.++|+|||+++.+.............++..|
T Consensus       165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y  241 (337)
T cd05054         165 LYKEPLTLEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW  241 (337)
T ss_pred             HhhcCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccc
Confidence               257888999999999999999998   89999999999999999999999999999876543322222345667889


Q ss_pred             cccccCchhhcCccceeEEEeeEEEeecc
Q 021711          279 VKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       279 ~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      +|||++....++.++|+||+|++++|+++
T Consensus       242 ~aPE~~~~~~~~~~~Di~SlGv~l~el~t  270 (337)
T cd05054         242 MAPESIFDKVYTTQSDVWSFGVLLWEIFS  270 (337)
T ss_pred             cCcHHhcCCCCCccccHHHHHHHHHHHHH
Confidence            99999888889999999999999999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=2.1e-35  Score=269.19  Aligned_cols=187  Identities=22%  Similarity=0.269  Sum_probs=157.0

Q ss_pred             ceeeccCceEEEEEEEC-CCcEEEEEEeccCCh--HHHHHHHHHHHHHHhc-CCCCeeeeeeeEEEeC-cEEEEEEecCC
Q 021711          116 NLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELGIMAH-VDHPNTAKLLGYGIEG-GMHIVLELSPN  190 (308)
Q Consensus       116 ~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~--~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~-~~~lv~e~~~~  190 (308)
                      ++||+|+||.||+|++. +|+.||+|.++....  ......+..|..++.. ++||||+++++++... ..++||||+.+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            47999999999999976 588999999875321  1234566778888865 4899999999876554 57899999999


Q ss_pred             CCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCceeEee
Q 021711          191 GSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTIS  270 (308)
Q Consensus       191 gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~  270 (308)
                      |+|..++.. ...+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.++|+|||+++.......  ...
T Consensus        81 g~L~~~i~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~  154 (316)
T cd05620          81 GDLMFHIQD-KGRFDLYRATFYAAEIVCGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN--RAS  154 (316)
T ss_pred             CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC--cee
Confidence            999988854 4568899999999999999999998   8999999999999999999999999999985432211  234


Q ss_pred             ceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          271 KVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       271 ~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ...||+.|+|||.+.+..++.++|+||+|+++|||++|
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g  192 (316)
T cd05620         155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIG  192 (316)
T ss_pred             ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhC
Confidence            56799999999999888889999999999999999876

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1.9e-35  Score=264.72  Aligned_cols=186  Identities=25%  Similarity=0.313  Sum_probs=158.3

Q ss_pred             eeccCceEEEEEEEC-CCcEEEEEEeccCCh--HHHHHHHHHHHHHHhcCCCCeeeeeeeEEEe-CcEEEEEEecCCCCH
Q 021711          118 IGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLELSPNGSL  193 (308)
Q Consensus       118 LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~lv~e~~~~gsL  193 (308)
                      ||+|+||+||++... +++.||+|.+.....  ....+.+..|+.+++.++|+||+++.+++.. ...++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            699999999999876 688999999864322  2234677889999999999999999986654 457899999999999


Q ss_pred             HHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCceeEee
Q 021711          194 ASLLYG---MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTIS  270 (308)
Q Consensus       194 ~~~l~~---~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~  270 (308)
                      ...+..   ....+++..+..++.|++.||.|||+   ++|+||||||+||+++.++.++|+|||+++.+.....  ...
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~  155 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK  155 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence            887743   23468999999999999999999998   8999999999999999999999999999987654322  223


Q ss_pred             ceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          271 KVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       271 ~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ...||+.|+|||.+.+..++.++|+||+|+++|||++|
T Consensus       156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g  193 (280)
T cd05608         156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAA  193 (280)
T ss_pred             ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhC
Confidence            46799999999999888888999999999999999875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-34  Score=266.03  Aligned_cols=185  Identities=23%  Similarity=0.270  Sum_probs=152.5

Q ss_pred             eeccCceEEEEEEEC-CCcEEEEEEeccCC--hHHHHHHHHHHHHHHhcC---CCCeeeeeeeEEEe-CcEEEEEEecCC
Q 021711          118 IGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHV---DHPNTAKLLGYGIE-GGMHIVLELSPN  190 (308)
Q Consensus       118 LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~-~~~~lv~e~~~~  190 (308)
                      ||+|+||.||+|+.. +++.||+|.+....  .......+..|..++..+   +||||+++++.+.. ...++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            799999999999876 58999999986432  112234566677777665   69999999986654 458899999999


Q ss_pred             CCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCceeEee
Q 021711          191 GSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTIS  270 (308)
Q Consensus       191 gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~  270 (308)
                      |+|..++.. ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++.......  ...
T Consensus        81 g~L~~~l~~-~~~~~~~~~~~~~~qil~al~~LH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~--~~~  154 (330)
T cd05586          81 GELFWHLQK-EGRFSEDRAKFYIAELVLALEHLHK---YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK--TTN  154 (330)
T ss_pred             ChHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC--Ccc
Confidence            999988854 4568999999999999999999998   8999999999999999999999999999976433221  224


Q ss_pred             ceeccccccccccCchh-hcCccceeEEEeeEEEeeccC
Q 021711          271 KVEGTFGLVKLNLPPLV-ILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       271 ~~~gt~~y~aPE~~~~~-~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ...||+.|+|||.+.+. .++.++|+||+|+++|+|++|
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG  193 (330)
T cd05586         155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCG  193 (330)
T ss_pred             CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccC
Confidence            56799999999987654 368889999999999999886

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=4e-35  Score=267.45  Aligned_cols=187  Identities=22%  Similarity=0.271  Sum_probs=156.6

Q ss_pred             ceeeccCceEEEEEEEC-CCcEEEEEEeccCC--hHHHHHHHHHHHHHHhc-CCCCeeeeeeeEEEeC-cEEEEEEecCC
Q 021711          116 NLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAH-VDHPNTAKLLGYGIEG-GMHIVLELSPN  190 (308)
Q Consensus       116 ~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~-~~~lv~e~~~~  190 (308)
                      +.||+|+||.||+|... +++.||+|.+....  .+.....+..|..++.. ++||||+++++++.+. .+++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999976 47899999987542  12234566778888875 4899999999976554 57899999999


Q ss_pred             CCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCceeEee
Q 021711          191 GSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTIS  270 (308)
Q Consensus       191 gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~  270 (308)
                      |+|..++.. ...+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++.......  ...
T Consensus        81 g~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~  154 (316)
T cd05619          81 GDLMFHIQS-CHKFDLPRATFYAAEIICGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA--KTC  154 (316)
T ss_pred             CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC--cee
Confidence            999998854 3568899999999999999999998   8999999999999999999999999999986432211  224


Q ss_pred             ceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          271 KVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       271 ~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ...||+.|+|||.+.+...+.++|+||+|+++|||++|
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G  192 (316)
T cd05619         155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIG  192 (316)
T ss_pred             eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhC
Confidence            56799999999998877888999999999999999875

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=9.1e-35  Score=261.31  Aligned_cols=199  Identities=23%  Similarity=0.322  Sum_probs=166.2

Q ss_pred             HhhcCCccccceeeccCceEEEEEEECC------CcEEEEEEeccCChHHHHHHHHHHHHHHhcC-CCCeeeeeeeEEEe
Q 021711          106 QSATNNFSFENLIGKGGYAEVYKGRLRN------GQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGIE  178 (308)
Q Consensus       106 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~------g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  178 (308)
                      ....++|++.+.||+|+||.||++....      ...+|+|.+......+....+.+|+.++..+ +|+||+++++++..
T Consensus         8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   87 (293)
T cd05053           8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ   87 (293)
T ss_pred             ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC
Confidence            3445688999999999999999998642      3689999987654444557789999999999 89999999997765


Q ss_pred             C-cEEEEEEecCCCCHHHHHhcc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEE
Q 021711          179 G-GMHIVLELSPNGSLASLLYGM---------------KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANIL  242 (308)
Q Consensus       179 ~-~~~lv~e~~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NIL  242 (308)
                      + ..+++|||+++|+|..++...               ...+++..++.++.|++.||.|||+   ++|+||||||+|||
T Consensus        88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~Nil  164 (293)
T cd05053          88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS---KKCIHRDLAARNVL  164 (293)
T ss_pred             CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCccccccceeeEE
Confidence            5 578999999999999998532               3458889999999999999999998   89999999999999


Q ss_pred             ECCCCcEEEeccccceecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          243 LTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       243 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      ++.++.+||+|||+++.+.............++..|+|||.......+.++|+||||+++|||++
T Consensus       165 ~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~  229 (293)
T cd05053         165 VTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT  229 (293)
T ss_pred             EcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhc
Confidence            99999999999999987755432222223345678999999877788889999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=2.3e-35  Score=261.41  Aligned_cols=191  Identities=29%  Similarity=0.450  Sum_probs=163.1

Q ss_pred             ccceeeccCceEEEEEEEC-----CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEe-CcEEEEEEe
Q 021711          114 FENLIGKGGYAEVYKGRLR-----NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLEL  187 (308)
Q Consensus       114 ~~~~LG~G~fg~Vy~~~~~-----~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~lv~e~  187 (308)
                      +.+.||.|.||.||+|.+.     .+..|+||.++.....+..+.|.+|++.+.+++||||++++|++.. +..++|+||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            5678999999999999876     2578999999765555557899999999999999999999999885 457899999


Q ss_pred             cCCCCHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCce
Q 021711          188 SPNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH  266 (308)
Q Consensus       188 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~  266 (308)
                      +++|+|.+++... ...+++..+..++.||+.||.|||+   ++|+|+||+++|||++.++.+||+|||+++........
T Consensus        83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~---~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~  159 (259)
T PF07714_consen   83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHS---NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY  159 (259)
T ss_dssp             -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHH---TTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred             ccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccccc
Confidence            9999999999775 5679999999999999999999999   89999999999999999999999999999987443333


Q ss_pred             eEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          267 HTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      .......+...|+|||.......+.++||||||+++||+++
T Consensus       160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~  200 (259)
T PF07714_consen  160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILT  200 (259)
T ss_dssp             EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHT
T ss_pred             ccccccccccccccccccccccccccccccccccccccccc
Confidence            33445678889999999888889999999999999999986

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.5e-34  Score=259.05  Aligned_cols=195  Identities=25%  Similarity=0.346  Sum_probs=166.1

Q ss_pred             CCccccceeeccCceEEEEEEEC-----CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC---cE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-----NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG---GM  181 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-----~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---~~  181 (308)
                      ..|++.+.||+|+||.||++.+.     ++..||+|.+...........+.+|+.+++.++||||+++++++...   ..
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            45788899999999999999742     47889999987655455567899999999999999999999977653   47


Q ss_pred             EEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecC
Q 021711          182 HIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP  261 (308)
Q Consensus       182 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~  261 (308)
                      ++||||+++++|.+++......+++..+..++.|++.||.|||+   ++|+||||||+||+++.++.++|+|||+++.+.
T Consensus        84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~  160 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE  160 (284)
T ss_pred             EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccchheEEEcCCCCEEECCCccccccc
Confidence            89999999999999986555568999999999999999999998   999999999999999999999999999998775


Q ss_pred             CCCcee-EeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          262 EQWTHH-TISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       262 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      ...... ......|+..|+|||...+...+.++|+||+|+++|||++
T Consensus       161 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt  207 (284)
T cd05079         161 TDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT  207 (284)
T ss_pred             cCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhc
Confidence            433221 1224567778999998877778889999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=5.2e-35  Score=262.62  Aligned_cols=184  Identities=19%  Similarity=0.246  Sum_probs=158.2

Q ss_pred             ceeeccCceEEEEEEECCCcEEEEEEeccCCh--HHHHHHHHHHHHHHhcCCCCeeeeeeeEEEe-----CcEEEEEEec
Q 021711          116 NLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTA--DEIIADFLSELGIMAHVDHPNTAKLLGYGIE-----GGMHIVLELS  188 (308)
Q Consensus       116 ~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~~~lv~e~~  188 (308)
                      ..||+|++|.||+|.+ +|+.||||.+.....  ....+.|.+|+.+|.+++||||+++++++.+     ...++||||+
T Consensus        26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~  104 (283)
T PHA02988         26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC  104 (283)
T ss_pred             eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence            6799999999999998 688999999865432  2345788899999999999999999998766     2478999999


Q ss_pred             CCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCceeE
Q 021711          189 PNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT  268 (308)
Q Consensus       189 ~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  268 (308)
                      ++|+|.+++.. ...+++.....++.|++.||.|||+.  .+++||||||+|||++.++.+||+|||+++.+....    
T Consensus       105 ~~g~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~----  177 (283)
T PHA02988        105 TRGYLREVLDK-EKDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP----  177 (283)
T ss_pred             CCCcHHHHHhh-CCCCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc----
Confidence            99999999965 45688999999999999999999971  378899999999999999999999999998764321    


Q ss_pred             eeceeccccccccccCch--hhcCccceeEEEeeEEEeeccC
Q 021711          269 ISKVEGTFGLVKLNLPPL--VILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       269 ~~~~~gt~~y~aPE~~~~--~~~~~~~Di~s~g~~l~el~c~  308 (308)
                       ....||..|+|||.+.+  ..++.++|+||||+++|||++|
T Consensus       178 -~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g  218 (283)
T PHA02988        178 -FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTG  218 (283)
T ss_pred             -ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHC
Confidence             23468999999999876  4678899999999999999876

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=5.1e-35  Score=261.83  Aligned_cols=195  Identities=25%  Similarity=0.333  Sum_probs=164.2

Q ss_pred             CCccccceeeccCceEEEEEEEC-----CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEe-CcEEE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-----NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHI  183 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-----~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~l  183 (308)
                      ++|++.+.||+|+||.||+|.+.     .+..||+|.+...........+.+|+.+++.++||||+++++++.. ...++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            46788899999999999999842     4678999999765544556788999999999999999999997655 45789


Q ss_pred             EEEecCCCCHHHHHhcc----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCC
Q 021711          184 VLELSPNGSLASLLYGM----------------KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDF  247 (308)
Q Consensus       184 v~e~~~~gsL~~~l~~~----------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~  247 (308)
                      ||||+++++|.+++...                ...+++..++.++.|++.||.|||+   ++|+||||||+|||++.++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS---HFFVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---cCeehhccccceEEEcCCC
Confidence            99999999999998532                1247788889999999999999998   8999999999999999999


Q ss_pred             cEEEeccccceecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          248 EPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       248 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      .+||+|||+++.+.............++..|+|||+......+.++|+||||++++||++
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~  221 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS  221 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHc
Confidence            999999999987654332223344556788999999877778899999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=2.8e-35  Score=262.73  Aligned_cols=197  Identities=22%  Similarity=0.335  Sum_probs=163.7

Q ss_pred             hcCCccccceeeccCceEEEEEEEC------CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-c
Q 021711          108 ATNNFSFENLIGKGGYAEVYKGRLR------NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-G  180 (308)
Q Consensus       108 ~~~~~~~~~~LG~G~fg~Vy~~~~~------~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~  180 (308)
                      ..++|++.+.||+|+||.||+|.+.      .+..||+|.+...........+.+|+.+++.++||||+++++++..+ .
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4568999999999999999999753      24679999986544333456789999999999999999999977654 5


Q ss_pred             EEEEEEecCCCCHHHHHhccC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEE
Q 021711          181 MHIVLELSPNGSLASLLYGMK---------EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQI  251 (308)
Q Consensus       181 ~~lv~e~~~~gsL~~~l~~~~---------~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl  251 (308)
                      .++||||+++++|.+++....         ..+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCcchheEEEcCCCCEEE
Confidence            789999999999999986422         235677888999999999999998   89999999999999999999999


Q ss_pred             eccccceecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          252 CDFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       252 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      +|||+++.+.............+++.|+|||.+.....+.++|+||||+++|||++
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~  216 (277)
T cd05062         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT  216 (277)
T ss_pred             CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHc
Confidence            99999987654332222223456789999999887778899999999999999975

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=7.3e-35  Score=257.67  Aligned_cols=188  Identities=23%  Similarity=0.330  Sum_probs=160.4

Q ss_pred             eeeccCceEEEEEEEC---CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeCcEEEEEEecCCCCH
Q 021711          117 LIGKGGYAEVYKGRLR---NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHIVLELSPNGSL  193 (308)
Q Consensus       117 ~LG~G~fg~Vy~~~~~---~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~lv~e~~~~gsL  193 (308)
                      .||+|+||.||+|.+.   .+..||+|.+.........+.+.+|+.+++.++||||+++++++.....++||||+++++|
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~lv~e~~~~~~L   81 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAEALMLVMEMASGGPL   81 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcCCCeEEEEEeCCCCCH
Confidence            3899999999999764   3557999998766555556789999999999999999999999887788999999999999


Q ss_pred             HHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCceeE-eece
Q 021711          194 ASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT-ISKV  272 (308)
Q Consensus       194 ~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~-~~~~  272 (308)
                      .+++......+++..++.++.|++.||.|||+   ++++||||||+|||++.++.+||+|||+++.+........ ....
T Consensus        82 ~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  158 (257)
T cd05115          82 NKFLSGKKDEITVSNVVELMHQVSMGMKYLEG---KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAG  158 (257)
T ss_pred             HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---cCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCC
Confidence            99997666678999999999999999999998   8999999999999999999999999999987654432211 1222


Q ss_pred             eccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          273 EGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       273 ~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      .++..|+|||.......+.++|+||||+++||+++
T Consensus       159 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~  193 (257)
T cd05115         159 KWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFS  193 (257)
T ss_pred             CCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhc
Confidence            34578999998877778889999999999999874

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=5.4e-35  Score=257.80  Aligned_cols=192  Identities=23%  Similarity=0.342  Sum_probs=163.9

Q ss_pred             CCccccceeeccCceEEEEEEECCCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEEEec
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLELS  188 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~  188 (308)
                      ++|++.+.||+|+||.||++.++++..+|+|.+......  ...+.+|+.+++.++||||+++++++... ..++||||+
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~   81 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMS--EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFM   81 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCcc--HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcC
Confidence            467888999999999999999888888999988654322  35788999999999999999999977654 578999999


Q ss_pred             CCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCceeE
Q 021711          189 PNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT  268 (308)
Q Consensus       189 ~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  268 (308)
                      ++|+|.+++......+++..+..++.|++.||.|||+   ++|+||||||+||+++.++.+||+|||+++....... ..
T Consensus        82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~-~~  157 (256)
T cd05114          82 ENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLER---NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY-TS  157 (256)
T ss_pred             CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcceEEEcCCCeEEECCCCCccccCCCce-ec
Confidence            9999999987655568999999999999999999998   8999999999999999999999999999987644322 11


Q ss_pred             eeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          269 ISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       269 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      .....++..|+|||.......+.++|+||||+++||+++
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~  196 (256)
T cd05114         158 SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFT  196 (256)
T ss_pred             cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHc
Confidence            223345678999999877778889999999999999886

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=9e-35  Score=257.78  Aligned_cols=194  Identities=29%  Similarity=0.416  Sum_probs=166.1

Q ss_pred             CCccccceeeccCceEEEEEEECC----CcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLRN----GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIV  184 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~~----g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv  184 (308)
                      ++|++.+.||+|+||.||+|.+..    ...||+|.+...........|.+|+.+++.++||||+++++++..+ ..+++
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   83 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII   83 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence            578899999999999999998752    4589999987665555567899999999999999999999976654 57899


Q ss_pred             EEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCC
Q 021711          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (308)
Q Consensus       185 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  264 (308)
                      |||+++++|.+++......+++..+..++.|++.||.|||+   ++|+|+||||+|||++.++.++|+|||+++.+....
T Consensus        84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~  160 (266)
T cd05033          84 TEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE  160 (266)
T ss_pred             EEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence            99999999999997666678999999999999999999998   899999999999999999999999999999875322


Q ss_pred             ceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeec
Q 021711          265 THHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLS  306 (308)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~  306 (308)
                      .........++..|+|||.......+.++|+||+|+++|++.
T Consensus       161 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~  202 (266)
T cd05033         161 ATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVM  202 (266)
T ss_pred             cceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHH
Confidence            222222344567899999988778888999999999999975

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.3e-35  Score=281.16  Aligned_cols=188  Identities=20%  Similarity=0.222  Sum_probs=160.7

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEEE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLE  186 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e  186 (308)
                      ...|.+.+.||+|+||.||+|.+. .++.||||...       ...+.+|+.++++++|+|||++++++..+ ..++|||
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~-------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e  240 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW-------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLP  240 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc-------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEE
Confidence            347999999999999999999976 47899999632       23456899999999999999999977665 4689999


Q ss_pred             ecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCce
Q 021711          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH  266 (308)
Q Consensus       187 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~  266 (308)
                      ++. ++|..++......+++..++.++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++.+......
T Consensus       241 ~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~  316 (461)
T PHA03211        241 KYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST  316 (461)
T ss_pred             ccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence            985 68888886655679999999999999999999998   89999999999999999999999999999876543322


Q ss_pred             eEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          267 HTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      .......||..|+|||++.+..++.++|+||||++|||++.
T Consensus       317 ~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~  357 (461)
T PHA03211        317 PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAV  357 (461)
T ss_pred             ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHH
Confidence            22234679999999999988888999999999999999864

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.9e-35  Score=259.43  Aligned_cols=195  Identities=27%  Similarity=0.396  Sum_probs=168.0

Q ss_pred             CCccccceeeccCceEEEEEEECC-Cc----EEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeCcEEEE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLRN-GQ----LVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHIV  184 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~~-g~----~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~lv  184 (308)
                      .+|++.+.||+|+||.||+|.+.. |.    .+|+|.+...........+.+|+.+++.++||||+++++++.....++|
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~v   86 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLSSQVQLI   86 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCceEEE
Confidence            578889999999999999998652 33    6899988766555556789999999999999999999999888888999


Q ss_pred             EEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCC
Q 021711          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (308)
Q Consensus       185 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  264 (308)
                      +||+++|+|.+++......+++..++.++.|++.||.|||+   ++|+||||||+||+++.++.+||+|||+++.+....
T Consensus        87 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~  163 (279)
T cd05057          87 TQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDE  163 (279)
T ss_pred             EecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecccCcceEEEcCCCeEEECCCcccccccCcc
Confidence            99999999999997766679999999999999999999998   899999999999999999999999999999876443


Q ss_pred             ceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          265 THHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      .........++..|+|||.......+.++|+||+|++++|+++
T Consensus       164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~  206 (279)
T cd05057         164 KEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMT  206 (279)
T ss_pred             cceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhc
Confidence            3222222334678999998877778889999999999999875

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=3.6e-35  Score=266.43  Aligned_cols=193  Identities=21%  Similarity=0.289  Sum_probs=162.6

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEe-CcEEEEEEe
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLEL  187 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~lv~e~  187 (308)
                      ++|.+.+.||+|+||.||+|+.. +++.||+|.+...........+.+|+.+++.++||||+++++++.. +..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            57999999999999999999876 5889999998754433334567889999999999999999997665 457899999


Q ss_pred             cCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCcee
Q 021711          188 SPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH  267 (308)
Q Consensus       188 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~  267 (308)
                      +++ +|.+++......++...+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++.......  
T Consensus        86 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--  159 (309)
T cd07872          86 LDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK--  159 (309)
T ss_pred             CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECccccceecCCCcc--
Confidence            975 8888886656668899999999999999999998   8999999999999999999999999999986543321  


Q ss_pred             EeeceeccccccccccCch-hhcCccceeEEEeeEEEeeccC
Q 021711          268 TISKVEGTFGLVKLNLPPL-VILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ......+|+.|+|||.+.+ ...+.++|+||+|+++|+|++|
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg  201 (309)
T cd07872         160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASG  201 (309)
T ss_pred             ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhC
Confidence            2234568999999998754 3467889999999999999876

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=6.3e-35  Score=260.88  Aligned_cols=195  Identities=25%  Similarity=0.339  Sum_probs=165.1

Q ss_pred             CCccccceeeccCceEEEEEEECC------CcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLRN------GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMH  182 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~~------g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~  182 (308)
                      ++|++.+.||+|+||.||+|....      ...||+|.+...........|.+|+.++..++||||+++++++... ..+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            468889999999999999998643      2579999987665555667899999999999999999999977654 478


Q ss_pred             EEEEecCCCCHHHHHhccC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCC
Q 021711          183 IVLELSPNGSLASLLYGMK---------------EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDF  247 (308)
Q Consensus       183 lv~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~  247 (308)
                      +++||+++++|.+++....               ..+++..+..++.|++.||.|||+   ++++||||||+||++++++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccccceEEEcCCC
Confidence            9999999999999986421               457888899999999999999998   8999999999999999999


Q ss_pred             cEEEeccccceecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          248 EPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       248 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      .++|+|||+++...............+++.|+|||.......+.++|+||||+++|||++
T Consensus       162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~  221 (283)
T cd05048         162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFS  221 (283)
T ss_pred             cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHc
Confidence            999999999987644332222334567889999998877778899999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=7.1e-35  Score=265.92  Aligned_cols=187  Identities=24%  Similarity=0.291  Sum_probs=158.3

Q ss_pred             ceeeccCceEEEEEEEC-CCcEEEEEEeccCC--hHHHHHHHHHHHHHHhcC-CCCeeeeeeeEEEeC-cEEEEEEecCC
Q 021711          116 NLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHV-DHPNTAKLLGYGIEG-GMHIVLELSPN  190 (308)
Q Consensus       116 ~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~~~lv~e~~~~  190 (308)
                      +.||+|+||.||+|... +++.||+|.+....  .......+.+|..++..+ +||||+++++++... ..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999876 47899999987532  123356678899999887 799999999976554 57899999999


Q ss_pred             CCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCceeEee
Q 021711          191 GSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTIS  270 (308)
Q Consensus       191 gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~  270 (308)
                      |+|..++.. ...+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++.......  ...
T Consensus        81 ~~L~~~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~  154 (318)
T cd05570          81 GDLMFHIQR-SGRFDEPRARFYAAEIVLGLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV--TTS  154 (318)
T ss_pred             CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC--ccc
Confidence            999988854 4578999999999999999999998   8999999999999999999999999999976432221  223


Q ss_pred             ceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          271 KVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       271 ~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ...||+.|+|||.+.+..++.++|+||+|+++|+|++|
T Consensus       155 ~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G  192 (318)
T cd05570         155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAG  192 (318)
T ss_pred             ceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhC
Confidence            45799999999999888888999999999999999876

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=7.9e-35  Score=269.84  Aligned_cols=190  Identities=23%  Similarity=0.213  Sum_probs=160.6

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCC-hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-------
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-------  179 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-------  179 (308)
                      .++|++.+.||+|+||.||++... +|+.||+|.+.... .......+.+|+.+++.++||||+++++++...       
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   99 (359)
T cd07876          20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ   99 (359)
T ss_pred             hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence            468999999999999999999875 58999999986532 223456788999999999999999999976533       


Q ss_pred             cEEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEecccccee
Q 021711          180 GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKW  259 (308)
Q Consensus       180 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~  259 (308)
                      ..++||||+.+ +|...+.   ..++...+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++.
T Consensus       100 ~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~---~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~  172 (359)
T cd07876         100 DVYLVMELMDA-NLCQVIH---MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART  172 (359)
T ss_pred             eeEEEEeCCCc-CHHHHHh---ccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEecCCCccc
Confidence            36899999975 5666553   347888888999999999999998   8999999999999999999999999999986


Q ss_pred             cCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          260 LPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       260 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      .....   ......||..|+|||.+.+..++.++|+||+|+++|+|++|
T Consensus       173 ~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg  218 (359)
T cd07876         173 ACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG  218 (359)
T ss_pred             cccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhC
Confidence            53321   22456789999999999888888999999999999999875

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=5.7e-35  Score=260.61  Aligned_cols=195  Identities=21%  Similarity=0.313  Sum_probs=165.5

Q ss_pred             CCccccceeeccCceEEEEEEECC------CcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLRN------GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMH  182 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~~------g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~  182 (308)
                      ++|.+.+.||+|+||.||+|...+      +..||+|.+......+..+.+.+|+++++.++|+||+++++++..+ ..+
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   84 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI   84 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence            468889999999999999998642      4789999997665555568899999999999999999999976654 578


Q ss_pred             EEEEecCCCCHHHHHhccC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcE
Q 021711          183 IVLELSPNGSLASLLYGMK-------------EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEP  249 (308)
Q Consensus       183 lv~e~~~~gsL~~~l~~~~-------------~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~  249 (308)
                      +||||+++++|.+++....             ..+++..+..++.|++.||.|||+   ++++||||||+||+++.++.+
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS---QHFVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeeccccccceEEEcCCCeE
Confidence            9999999999999986432             347888899999999999999998   899999999999999999999


Q ss_pred             EEeccccceecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          250 QICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       250 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      +|+|||+++.+.............+++.|+|||.......+.++|+||+|+++||+++
T Consensus       162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~  219 (280)
T cd05049         162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT  219 (280)
T ss_pred             EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHh
Confidence            9999999987644322222234456789999999888888999999999999999985

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=8.7e-35  Score=290.82  Aligned_cols=196  Identities=25%  Similarity=0.274  Sum_probs=164.4

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCC--hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVL  185 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~  185 (308)
                      ++|++.++||+|+||.||+|.+. +|+.||+|.+....  .....++|.+|+.+++.++||||+++++++.++ ..++||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            57999999999999999999976 58999999986532  233467899999999999999999999987665 478999


Q ss_pred             EecCCCCHHHHHhcc----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccc
Q 021711          186 ELSPNGSLASLLYGM----------KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFG  255 (308)
Q Consensus       186 e~~~~gsL~~~l~~~----------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFG  255 (308)
                      ||++||+|.+++...          ....++..++.++.||+.||.|||+   ++|+||||||+|||++.++.++|+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs---~GIIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH---CCccccCCchheEEEcCCCCEEEEecC
Confidence            999999999988531          1235567788899999999999998   899999999999999999999999999


Q ss_pred             cceecCCCCce----------------eEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          256 LAKWLPEQWTH----------------HTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       256 la~~~~~~~~~----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      +++........                .......||+.|+|||...+...+.++|+||+|+++|||++|
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG  227 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTL  227 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHC
Confidence            99876221100                011235799999999998888889999999999999999876

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=9e-35  Score=255.61  Aligned_cols=189  Identities=26%  Similarity=0.341  Sum_probs=159.2

Q ss_pred             ceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEEEecCCCCH
Q 021711          116 NLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLELSPNGSL  193 (308)
Q Consensus       116 ~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~~~gsL  193 (308)
                      +.||+|+||.||+|... +++.+|+|.+......+....+.+|+++++.++||||+++++++... ..++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            36899999999999875 68999999887655555567899999999999999999999977654 47899999999999


Q ss_pred             HHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCceeEeecee
Q 021711          194 ASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVE  273 (308)
Q Consensus       194 ~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~  273 (308)
                      .+++......+++..++.++.|++.||.|||+   ++|+||||||+||+++.++.+||+|||+++...............
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  157 (252)
T cd05084          81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLES---KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ  157 (252)
T ss_pred             HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence            99987655668999999999999999999998   899999999999999999999999999998654321111111223


Q ss_pred             ccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          274 GTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       274 gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      ++..|+|||.+.....+.++|+||+|+++||+++
T Consensus       158 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~  191 (252)
T cd05084         158 IPVKWTAPEALNYGRYSSESDVWSFGILLWEAFS  191 (252)
T ss_pred             CceeecCchhhcCCCCChHHHHHHHHHHHHHHHh
Confidence            3567999999887778888999999999999874

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.1e-35  Score=262.33  Aligned_cols=196  Identities=21%  Similarity=0.322  Sum_probs=163.6

Q ss_pred             cCCccccceeeccCceEEEEEEECC---------------CcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeee
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLRN---------------GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLL  173 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~~---------------g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  173 (308)
                      .++|++.+.||+|+||.||+|....               ...||+|.+...........|.+|+++++.++|+|+++++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~   83 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL   83 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence            3578999999999999999987532               2358999987654455567899999999999999999999


Q ss_pred             eEEEeC-cEEEEEEecCCCCHHHHHhccC-----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCE
Q 021711          174 GYGIEG-GMHIVLELSPNGSLASLLYGMK-----------EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANI  241 (308)
Q Consensus       174 ~~~~~~-~~~lv~e~~~~gsL~~~l~~~~-----------~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NI  241 (308)
                      +++... ..++||||+++++|.+++....           ..+++..++.++.|++.||.|||+   .+++||||||+||
T Consensus        84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Ni  160 (295)
T cd05097          84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATRNC  160 (295)
T ss_pred             EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh---cCeeccccChhhE
Confidence            976554 5789999999999999985421           136788899999999999999998   8999999999999


Q ss_pred             EECCCCcEEEeccccceecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          242 LLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       242 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      +++.++.+||+|||+++.+.............++..|+|||.......+.++|+||||+++++|++
T Consensus       161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~  226 (295)
T cd05097         161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT  226 (295)
T ss_pred             EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHH
Confidence            999999999999999987654432222234456789999999887778999999999999999875

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=2.2e-34  Score=258.99  Aligned_cols=196  Identities=23%  Similarity=0.345  Sum_probs=166.6

Q ss_pred             cCCccccceeeccCceEEEEEEECC-----------------CcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeee
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLRN-----------------GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAK  171 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~~-----------------g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  171 (308)
                      ..+|++.+.||+|+||.||+|....                 +..||+|.+.........+.+.+|++++..++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            3578999999999999999987542                 24689999876655555678999999999999999999


Q ss_pred             eeeEEEe-CcEEEEEEecCCCCHHHHHhccC----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCC
Q 021711          172 LLGYGIE-GGMHIVLELSPNGSLASLLYGMK----------EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAAN  240 (308)
Q Consensus       172 l~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~----------~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~N  240 (308)
                      +++++.. +..++++|++++++|.+++....          ..+++..++.++.|++.||.|||+   .+|+||||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~---~~i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH---cCccccccchhc
Confidence            9997766 45789999999999999986533          258899999999999999999998   899999999999


Q ss_pred             EEECCCCcEEEeccccceecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          241 ILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       241 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      |+++.++.++|+|||+++.+.............++..|+|||.......+.++|+||||+++|||++
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~  227 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT  227 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHh
Confidence            9999999999999999987654433233334567889999999877778899999999999999875

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=5e-35  Score=269.70  Aligned_cols=196  Identities=23%  Similarity=0.332  Sum_probs=162.2

Q ss_pred             cCCccccceeeccCceEEEEEEE------CCCcEEEEEEeccCChHHHHHHHHHHHHHHhcC-CCCeeeeeeeEEEeC--
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRL------RNGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGIEG--  179 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~------~~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~--  179 (308)
                      .++|++.+.||+|+||.||+|.+      .+++.||||.+......+....+.+|+.++.++ +||||+++++++...  
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   85 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence            45899999999999999999974      246889999997655444567789999999999 689999999976543  


Q ss_pred             cEEEEEEecCCCCHHHHHhccC----------------------------------------------------------
Q 021711          180 GMHIVLELSPNGSLASLLYGMK----------------------------------------------------------  201 (308)
Q Consensus       180 ~~~lv~e~~~~gsL~~~l~~~~----------------------------------------------------------  201 (308)
                      ..+++|||+++|+|.+++....                                                          
T Consensus        86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (343)
T cd05103          86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  165 (343)
T ss_pred             ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence            4689999999999999985421                                                          


Q ss_pred             --------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCceeEeecee
Q 021711          202 --------EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVE  273 (308)
Q Consensus       202 --------~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~  273 (308)
                              ..+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++.+.............
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  242 (343)
T cd05103         166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR  242 (343)
T ss_pred             hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence                    235777888899999999999998   899999999999999999999999999998764432211222345


Q ss_pred             ccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          274 GTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       274 gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      +++.|+|||......++.++|+||+|+++|++++
T Consensus       243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~  276 (343)
T cd05103         243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS  276 (343)
T ss_pred             CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHH
Confidence            6778999999877788889999999999999874

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=1.2e-34  Score=258.94  Aligned_cols=197  Identities=20%  Similarity=0.254  Sum_probs=168.8

Q ss_pred             hcCCccccceeeccCceEEEEEEECC-----CcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEe--Cc
Q 021711          108 ATNNFSFENLIGKGGYAEVYKGRLRN-----GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE--GG  180 (308)
Q Consensus       108 ~~~~~~~~~~LG~G~fg~Vy~~~~~~-----g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~  180 (308)
                      ..++|++.++||+|+||.||+|.+..     +..|++|.+...........+.+|+.+++.++||||+++++++..  ..
T Consensus         4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   83 (280)
T cd05043           4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP   83 (280)
T ss_pred             chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            35689999999999999999998765     688999998766555557789999999999999999999998766  45


Q ss_pred             EEEEEEecCCCCHHHHHhccC-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEec
Q 021711          181 MHIVLELSPNGSLASLLYGMK-------EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICD  253 (308)
Q Consensus       181 ~~lv~e~~~~gsL~~~l~~~~-------~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~D  253 (308)
                      .+++++|+++++|.+++....       ..+++..++.++.|++.||.|||+   ++++||||||+||+++.++.+||+|
T Consensus        84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kl~d  160 (280)
T cd05043          84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITD  160 (280)
T ss_pred             CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCHhhEEEcCCCcEEECC
Confidence            789999999999999986532       458899999999999999999998   8999999999999999999999999


Q ss_pred             cccceecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          254 FGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       254 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      ||+++.+.....+.......++..|+|||.......+.++|+||+|+++||+++
T Consensus       161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~  214 (280)
T cd05043         161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMT  214 (280)
T ss_pred             CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhc
Confidence            999987654433322334567788999999887778899999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=2.3e-34  Score=257.36  Aligned_cols=185  Identities=24%  Similarity=0.318  Sum_probs=156.1

Q ss_pred             eeccCceEEEEEEEC-CCcEEEEEEeccCChH--HHHHHHHHHHHHHhcCCCCeeeeeeeEEEe-CcEEEEEEecCCCCH
Q 021711          118 IGKGGYAEVYKGRLR-NGQLVAIKRLTRGTAD--EIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLELSPNGSL  193 (308)
Q Consensus       118 LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~lv~e~~~~gsL  193 (308)
                      ||+|+||.||+++.. +|+.+|+|.+......  .....+..|+++++.++||||+++++++.. ...++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            699999999999876 5899999998643211  123445679999999999999999986654 457899999999999


Q ss_pred             HHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCceeEeece
Q 021711          194 ASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKV  272 (308)
Q Consensus       194 ~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~  272 (308)
                      .+++... ...+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.++|+|||++.......   .....
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~~  154 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQR  154 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH---CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeecc
Confidence            9887543 3358889999999999999999998   999999999999999999999999999998775432   22345


Q ss_pred             eccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          273 EGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       273 ~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      .||..|+|||++.....+.++|+||+|+++|||++|
T Consensus       155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g  190 (277)
T cd05607         155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAG  190 (277)
T ss_pred             CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhC
Confidence            799999999998887889999999999999999875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=7.4e-35  Score=277.21  Aligned_cols=189  Identities=22%  Similarity=0.268  Sum_probs=155.1

Q ss_pred             hcCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-------
Q 021711          108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-------  179 (308)
Q Consensus       108 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-------  179 (308)
                      ...+|++.+.||+|+||.||+|... +++.||||.+.....     ...+|+.+|+.++||||+++++++...       
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~-----~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~  138 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQ-----YKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK  138 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcc-----hHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence            3468999999999999999999875 588999998864321     234799999999999999998865321       


Q ss_pred             --cEEEEEEecCCCCHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCC-cEEEec
Q 021711          180 --GMHIVLELSPNGSLASLLYG---MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDF-EPQICD  253 (308)
Q Consensus       180 --~~~lv~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~-~~kl~D  253 (308)
                        .+++||||+++ +|.+++..   ....+++..+..++.||+.||.|||+   ++|+||||||+|||++.++ .+||+|
T Consensus       139 ~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~---~~IiHrDLKp~NILl~~~~~~vkL~D  214 (440)
T PTZ00036        139 NIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS---KFICHRDLKPQNLLIDPNTHTLKLCD  214 (440)
T ss_pred             ceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCcCHHHEEEcCCCCceeeec
Confidence              25689999975 67666542   34568999999999999999999998   8999999999999999664 799999


Q ss_pred             cccceecCCCCceeEeeceeccccccccccCchh-hcCccceeEEEeeEEEeeccC
Q 021711          254 FGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPLV-ILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       254 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ||+|+.+.....   .....||+.|+|||.+.+. .++.++|+||+|++||||++|
T Consensus       215 FGla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG  267 (440)
T PTZ00036        215 FGSAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILG  267 (440)
T ss_pred             cccchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhC
Confidence            999987654322   2345789999999987654 578889999999999999886

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=2.3e-34  Score=257.28  Aligned_cols=187  Identities=24%  Similarity=0.356  Sum_probs=161.8

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEEEe
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLEL  187 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~  187 (308)
                      ++|++.++||+|+||.||+|.+. +++.||+|.+......+....+.+|+.+++.++||||+++++++... ..++|+||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            36788899999999999999865 68899999987654444557799999999999999999999966554 57899999


Q ss_pred             cCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCcee
Q 021711          188 SPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH  267 (308)
Q Consensus       188 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~  267 (308)
                      +++++|..+.     .+++..+..++.|++.||.|||+   .+|+|+||||+|||++.++.++|+|||++..+...    
T Consensus        81 ~~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~----  148 (279)
T cd06619          81 MDGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS----  148 (279)
T ss_pred             CCCCChHHhh-----cCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc----
Confidence            9999996542     46788888999999999999998   99999999999999999999999999999876443    


Q ss_pred             EeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          268 TISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ......||..|+|||.+.+...+.++|+||+|+++|++++|
T Consensus       149 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g  189 (279)
T cd06619         149 IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALG  189 (279)
T ss_pred             cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhC
Confidence            22346799999999999888888999999999999999875

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.5e-34  Score=255.48  Aligned_cols=192  Identities=21%  Similarity=0.318  Sum_probs=164.2

Q ss_pred             CCccccceeeccCceEEEEEEECCCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEEEec
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLELS  188 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~  188 (308)
                      ++|.+.+.||+|+||.||+|.+.++..+|+|.+......  ...|.+|+.++..++||||+++++++... ..+++|||+
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYM   81 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCccc--HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcC
Confidence            467888999999999999998877777999988754322  35688999999999999999999987654 468999999


Q ss_pred             CCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCceeE
Q 021711          189 PNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT  268 (308)
Q Consensus       189 ~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  268 (308)
                      .+|+|.+++......+++..++.++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||+++....... ..
T Consensus        82 ~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-~~  157 (256)
T cd05113          82 SNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLES---KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-TS  157 (256)
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCCEEECCCccceecCCCce-ee
Confidence            9999999987655578999999999999999999998   8999999999999999999999999999987654322 12


Q ss_pred             eeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          269 ISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       269 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      .....++..|+|||.......+.++|+||||+++|+|++
T Consensus       158 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~  196 (256)
T cd05113         158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYS  196 (256)
T ss_pred             cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhc
Confidence            223456788999999877778889999999999999875

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.6e-34  Score=268.67  Aligned_cols=195  Identities=25%  Similarity=0.307  Sum_probs=170.4

Q ss_pred             hhcCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChH-HHHHHHHHHHHHHhcCCCCeeeeeeeEEE-eCcEEE
Q 021711          107 SATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTAD-EIIADFLSELGIMAHVDHPNTAKLLGYGI-EGGMHI  183 (308)
Q Consensus       107 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~l  183 (308)
                      .....|.+.+.||+|.|+.|.++++. ++..||||.+.+...+ ..++.+.+|+++|+.|+|||||+++.+.. +..+|+
T Consensus        53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl  132 (596)
T KOG0586|consen   53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL  132 (596)
T ss_pred             ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence            34568999999999999999999866 5899999999776443 34566999999999999999999999655 667999


Q ss_pred             EEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCC
Q 021711          184 VLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ  263 (308)
Q Consensus       184 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  263 (308)
                      ||||+.+|.+.+++.... +........++.|+..+++|||.   +.|+|||||++||||+.+.++||+|||++..+...
T Consensus       133 V~eya~~ge~~~yl~~~g-r~~e~~ar~~F~q~vsaveYcH~---k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~  208 (596)
T KOG0586|consen  133 VMEYASGGELFDYLVKHG-RMKEKEARAKFRQIVSAVEYCHS---KNIVHRDLKAENILLDENMNIKIADFGFSTFFDYG  208 (596)
T ss_pred             EEEeccCchhHHHHHhcc-cchhhhhhhhhHHHHHHHHHHhh---cceeccccchhhcccccccceeeeccccceeeccc
Confidence            999999999999997644 45557888899999999999998   99999999999999999999999999999988654


Q ss_pred             CceeEeeceeccccccccccCchhh-cCccceeEEEeeEEEeeccC
Q 021711          264 WTHHTISKVEGTFGLVKLNLPPLVI-LKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~s~g~~l~el~c~  308 (308)
                         .......|++.|.|||++.+.. .+...|+||+|++||-|.||
T Consensus       209 ---~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~G  251 (596)
T KOG0586|consen  209 ---LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEG  251 (596)
T ss_pred             ---ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeec
Confidence               2446789999999999987766 47789999999999999987

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=1.1e-34  Score=260.64  Aligned_cols=198  Identities=22%  Similarity=0.328  Sum_probs=163.0

Q ss_pred             hhcCCccccceeeccCceEEEEEEEC------CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-
Q 021711          107 SATNNFSFENLIGKGGYAEVYKGRLR------NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-  179 (308)
Q Consensus       107 ~~~~~~~~~~~LG~G~fg~Vy~~~~~------~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-  179 (308)
                      ...++|++.+.||+|+||.||+|..+      .+..||+|.+...........+.+|+.+++.++||||+++++++..+ 
T Consensus         3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   82 (288)
T cd05061           3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ   82 (288)
T ss_pred             ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            34578999999999999999999753      24589999886554434456788999999999999999999976554 


Q ss_pred             cEEEEEEecCCCCHHHHHhccC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEE
Q 021711          180 GMHIVLELSPNGSLASLLYGMK---------EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQ  250 (308)
Q Consensus       180 ~~~lv~e~~~~gsL~~~l~~~~---------~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~k  250 (308)
                      ..++||||+++|+|.+++....         ..+.+..+..++.|++.||.|||+   ++|+||||||+|||++.++.++
T Consensus        83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dikp~nili~~~~~~~  159 (288)
T cd05061          83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVK  159 (288)
T ss_pred             CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCCChheEEEcCCCcEE
Confidence            4789999999999999996421         234567788899999999999998   8999999999999999999999


Q ss_pred             EeccccceecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          251 ICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       251 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      |+|||+++...............++..|+|||...+...+.++|+||||+++||+++
T Consensus       160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~  216 (288)
T cd05061         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS  216 (288)
T ss_pred             ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHh
Confidence            999999987644332222223345778999999888888999999999999999876

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=2e-34  Score=261.65  Aligned_cols=192  Identities=25%  Similarity=0.344  Sum_probs=165.9

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEe-CcEEEEEEe
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLEL  187 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~lv~e~  187 (308)
                      ++|++.+.||+|+||.||++.+. ++..+|+|.+......+...++.+|++++.+++||||+++++++.. +..++|+||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            46889999999999999999876 5888999998765555556778999999999999999999996655 457899999


Q ss_pred             cCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCcee
Q 021711          188 SPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH  267 (308)
Q Consensus       188 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~  267 (308)
                      +++++|.+++.. ...+++..+..++.|++.||.|||+  ..+++||||||+|||++.++.+||+|||++..+....   
T Consensus        81 ~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~---  154 (308)
T cd06615          81 MDGGSLDQVLKK-AGRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---  154 (308)
T ss_pred             cCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEccCCCcccccccc---
Confidence            999999999865 3568899999999999999999996  2489999999999999999999999999998664331   


Q ss_pred             EeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          268 TISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                       .....|+..|+|||...+...+.++|+||+|++++++++|
T Consensus       155 -~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g  194 (308)
T cd06615         155 -ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIG  194 (308)
T ss_pred             -cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhC
Confidence             2345789999999998777788899999999999999875

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=2.5e-34  Score=270.93  Aligned_cols=187  Identities=24%  Similarity=0.315  Sum_probs=162.6

Q ss_pred             CccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCC-C-----CeeeeeeeEEE-eCcEE
Q 021711          111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVD-H-----PNTAKLLGYGI-EGGMH  182 (308)
Q Consensus       111 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~~~~~-~~~~~  182 (308)
                      +|.+.++||+|+||.|.+|.+. +++.||||++++..  ....+...|+.+|..|+ |     -|+|++++++. .+++|
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k--~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlc  264 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK--RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLC  264 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh--HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccccee
Confidence            6788999999999999999865 69999999998764  34567788999999996 3     49999999654 56799


Q ss_pred             EEEEecCCCCHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCC--CcEEEecccccee
Q 021711          183 IVLELSPNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTED--FEPQICDFGLAKW  259 (308)
Q Consensus       183 lv~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~--~~~kl~DFGla~~  259 (308)
                      ||+|.+. .+|.+++..+ ...++...+..++.||+.||.+||+   .+|||+||||+||||.+.  ..+||+|||.|..
T Consensus       265 iVfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~---l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~  340 (586)
T KOG0667|consen  265 IVFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHE---LGIIHCDLKPENILLKDPKRSRIKVIDFGSSCF  340 (586)
T ss_pred             eeehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCChhheeeccCCcCceeEEecccccc
Confidence            9999995 5999999764 3568999999999999999999998   999999999999999865  3799999999987


Q ss_pred             cCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          260 LPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       260 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ....     .....-+..|.|||.+.+..++.+.|+|||||++.||+.|
T Consensus       341 ~~q~-----vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG  384 (586)
T KOG0667|consen  341 ESQR-----VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTG  384 (586)
T ss_pred             cCCc-----ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcC
Confidence            5432     2367788999999999999999999999999999999876

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=2e-34  Score=254.76  Aligned_cols=193  Identities=23%  Similarity=0.339  Sum_probs=164.8

Q ss_pred             cCCccccceeeccCceEEEEEEECCCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEEEe
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLEL  187 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~  187 (308)
                      .++|++.+.||+|+||.||+|...++..||+|.+.....  ..+.+.+|+.+++.++|+||+++++.+... ..++++||
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   82 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM--SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY   82 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch--hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence            467899999999999999999988888899998865432  246789999999999999999999866554 47899999


Q ss_pred             cCCCCHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCce
Q 021711          188 SPNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH  266 (308)
Q Consensus       188 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~  266 (308)
                      +++++|.+++... ...+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||+++....... 
T Consensus        83 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-  158 (261)
T cd05072          83 MAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY-  158 (261)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEecCCCcEEECCCccceecCCCce-
Confidence            9999999998653 3568888999999999999999998   8999999999999999999999999999988754322 


Q ss_pred             eEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          267 HTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      .......++..|+|||.......+.++|+||+|+++|+|++
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t  199 (261)
T cd05072         159 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVT  199 (261)
T ss_pred             eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHc
Confidence            12233456788999999877778888999999999999975

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1.7e-34  Score=255.13  Aligned_cols=194  Identities=25%  Similarity=0.355  Sum_probs=167.4

Q ss_pred             hcCCccccceeeccCceEEEEEEECCCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeCcEEEEEEe
Q 021711          108 ATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHIVLEL  187 (308)
Q Consensus       108 ~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~lv~e~  187 (308)
                      ..++|++.++||+|+||.||+|...+++.||+|.+......  ...+.+|+.+++.++|+||++++++...+..++++||
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~   81 (260)
T cd05067           4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS--PEAFLAEANLMKQLQHPRLVRLYAVVTQEPIYIITEY   81 (260)
T ss_pred             chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCc--HHHHHHHHHHHHhcCCcCeeeEEEEEccCCcEEEEEc
Confidence            34688999999999999999999888899999998754432  3578899999999999999999998877788999999


Q ss_pred             cCCCCHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCce
Q 021711          188 SPNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH  266 (308)
Q Consensus       188 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~  266 (308)
                      +++++|.+++... ...+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||+++....... 
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-  157 (260)
T cd05067          82 MENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIER---KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY-  157 (260)
T ss_pred             CCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHHhEEEcCCCCEEEccCcceeecCCCCc-
Confidence            9999999988643 3468899999999999999999998   8999999999999999999999999999987753322 


Q ss_pred             eEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          267 HTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      .......++..|+|||.+.....+.++|+||||++++|+++
T Consensus       158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~  198 (260)
T cd05067         158 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT  198 (260)
T ss_pred             ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHh
Confidence            12223456789999999877778889999999999999986

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.2e-34  Score=256.38  Aligned_cols=196  Identities=22%  Similarity=0.311  Sum_probs=164.5

Q ss_pred             cCCccccceeeccCceEEEEEEECC------CcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLRN------GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GM  181 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~~------g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~  181 (308)
                      .++|++.+.||+|+||.||+|....      +..||+|.+...........+.+|+.+++.++||||+++++++..+ ..
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   84 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT   84 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence            4688999999999999999998642      3689999987655444456789999999999999999999976655 47


Q ss_pred             EEEEEecCCCCHHHHHhccC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEe
Q 021711          182 HIVLELSPNGSLASLLYGMK---------EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQIC  252 (308)
Q Consensus       182 ~lv~e~~~~gsL~~~l~~~~---------~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~  252 (308)
                      ++||||+++|+|.+++....         ..+++..++.++.|++.||.|||+   .+|+||||||+|||++.++.+||+
T Consensus        85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccChheEEEcCCCCEEEC
Confidence            89999999999999986421         236788899999999999999998   899999999999999999999999


Q ss_pred             ccccceecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          253 DFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       253 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      |||+++.+.............+|..|+|||...+...+.++|+||||+++||+++
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t  216 (277)
T cd05032         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT  216 (277)
T ss_pred             CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhc
Confidence            9999987644322122234457889999999877778889999999999999986

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=3e-34  Score=256.81  Aligned_cols=192  Identities=27%  Similarity=0.360  Sum_probs=161.7

Q ss_pred             ccccceeeccCceEEEEEEE-----CCCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC---cEEE
Q 021711          112 FSFENLIGKGGYAEVYKGRL-----RNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG---GMHI  183 (308)
Q Consensus       112 ~~~~~~LG~G~fg~Vy~~~~-----~~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---~~~l  183 (308)
                      |++.+.||+|+||+||++..     .++..||+|.+...........|.+|+++++.++||||+++++++...   ..++
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL   85 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence            48889999999999988753     247889999987654444567888999999999999999999976543   3789


Q ss_pred             EEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCC
Q 021711          184 VLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ  263 (308)
Q Consensus       184 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  263 (308)
                      +|||+++++|.+++..  ..+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.++|+|||+++.+...
T Consensus        86 v~e~~~~~~l~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~  160 (283)
T cd05080          86 IMEYVPLGSLRDYLPK--HKLNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG  160 (283)
T ss_pred             EecCCCCCCHHHHHHH--cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccChheEEEcCCCcEEEeecccccccCCc
Confidence            9999999999999854  458999999999999999999998   89999999999999999999999999999877543


Q ss_pred             CceeE-eeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          264 WTHHT-ISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       264 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ..... .....++..|+|||...+...+.++|+||||++++||++|
T Consensus       161 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg  206 (283)
T cd05080         161 HEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTH  206 (283)
T ss_pred             chhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhC
Confidence            22111 1223456779999998877888999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-35  Score=259.05  Aligned_cols=195  Identities=26%  Similarity=0.344  Sum_probs=170.3

Q ss_pred             hcCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCC--hHHHHHHHHHHHHHHhcCCCCeeeee-eeEEEeCcEEE
Q 021711          108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDHPNTAKL-LGYGIEGGMHI  183 (308)
Q Consensus       108 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l-~~~~~~~~~~l  183 (308)
                      ..++|..+++||+|.||+|.+|+.+ +|+.+|+|++++..  ..+....-+.|-++|+..+||.+..| +.|...+.+|+
T Consensus       166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF  245 (516)
T KOG0690|consen  166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF  245 (516)
T ss_pred             ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence            4578999999999999999999876 69999999997652  22335667789999999999999988 46778888999


Q ss_pred             EEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCC
Q 021711          184 VLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ  263 (308)
Q Consensus       184 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  263 (308)
                      ||||..||.|...|.. ...+++.....+...|+.||.|||+   ++||.||||.+|+|+|.+|++||+|||+++.--..
T Consensus       246 VMeyanGGeLf~HLsr-er~FsE~RtRFYGaEIvsAL~YLHs---~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~  321 (516)
T KOG0690|consen  246 VMEYANGGELFFHLSR-ERVFSEDRTRFYGAEIVSALGYLHS---RNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY  321 (516)
T ss_pred             EEEEccCceEeeehhh-hhcccchhhhhhhHHHHHHhhhhhh---CCeeeeechhhhheeccCCceEeeecccchhcccc
Confidence            9999999999887743 4567777777889999999999999   99999999999999999999999999999854333


Q ss_pred             CceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          264 WTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      .  .....++||+.|+|||.+...-++++.|-|.+|++|||+.||
T Consensus       322 g--~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCG  364 (516)
T KOG0690|consen  322 G--DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCG  364 (516)
T ss_pred             c--ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhc
Confidence            2  245689999999999999999999999999999999999997

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=3.4e-34  Score=257.21  Aligned_cols=191  Identities=25%  Similarity=0.278  Sum_probs=162.1

Q ss_pred             ccccceeeccCceEEEEEEEC-CCcEEEEEEeccCCh--HHHHHHHHHHHHHHhcCCCCeeeeeeeEEEe-CcEEEEEEe
Q 021711          112 FSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLEL  187 (308)
Q Consensus       112 ~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~lv~e~  187 (308)
                      |+..+.||+|+||+||++... +++.+|+|.+.....  ......+.+|+.+++.++|+||+.+++.+.. +..+++|||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            667789999999999999875 588999999865422  2234567889999999999999999876554 457899999


Q ss_pred             cCCCCHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCce
Q 021711          188 SPNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH  266 (308)
Q Consensus       188 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~  266 (308)
                      +++++|.+++... ...+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.++|+|||++.......  
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~---~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~--  156 (285)
T cd05632          82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE--  156 (285)
T ss_pred             ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC--
Confidence            9999999888643 3468999999999999999999998   899999999999999999999999999998764432  


Q ss_pred             eEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          267 HTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                       ......|+..|+|||...+..++.++|+||+|+++|||++|
T Consensus       157 -~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g  197 (285)
T cd05632         157 -SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEG  197 (285)
T ss_pred             -cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhC
Confidence             12345799999999998877888999999999999999865

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-34  Score=263.07  Aligned_cols=188  Identities=23%  Similarity=0.336  Sum_probs=160.5

Q ss_pred             cceeeccCceEEEEEEEC-CCcEEEEEEeccCC-hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEE-eCcEEEEEEecCCC
Q 021711          115 ENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGI-EGGMHIVLELSPNG  191 (308)
Q Consensus       115 ~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~lv~e~~~~g  191 (308)
                      .++||+|.||+||-|.++ +|+.||||.+.+.. ..+....+.+|+.||.+++||.||.+--.+. .+.++.|||-+.|.
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD  648 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD  648 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence            478999999999999876 69999999996542 2223367889999999999999999987554 45688999999765


Q ss_pred             CHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCC---CcEEEeccccceecCCCCceeE
Q 021711          192 SLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTED---FEPQICDFGLAKWLPEQWTHHT  268 (308)
Q Consensus       192 sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~---~~~kl~DFGla~~~~~~~~~~~  268 (308)
                      -|.-+|...++++++.....++.||+.||.|||.   ++|+|+||||+|||+...   -++||||||+|+.+++..-   
T Consensus       649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~---knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF---  722 (888)
T KOG4236|consen  649 MLEMILSSEKGRLPERITKFLVTQILVALRYLHF---KNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF---  722 (888)
T ss_pred             HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhh---cceeeccCCchheeeccCCCCCceeeccccceeecchhhh---
Confidence            5566666678889999999999999999999998   999999999999999754   3799999999999987632   


Q ss_pred             eeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          269 ISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       269 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ...+.||+.|+|||.+....++++-|+||.|+++|--+.|
T Consensus       723 RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSG  762 (888)
T KOG4236|consen  723 RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSG  762 (888)
T ss_pred             hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecc
Confidence            3568999999999999999999999999999999976544

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.5e-34  Score=269.34  Aligned_cols=192  Identities=21%  Similarity=0.247  Sum_probs=160.4

Q ss_pred             CccccceeeccCceEEEEEEEC-CCcEEEEEEeccCC-hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC------cEE
Q 021711          111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG------GMH  182 (308)
Q Consensus       111 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~  182 (308)
                      +|++.+.||+|+||.||++... +|+.||+|.+.... ......++.+|+.+++.++||||+++++++...      ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            4778899999999999999975 68999999986532 223356788999999999999999999977654      478


Q ss_pred             EEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCC
Q 021711          183 IVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE  262 (308)
Q Consensus       183 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~  262 (308)
                      +|+||+. ++|.+.+.. ...+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++....
T Consensus        81 lv~e~~~-~~l~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~  155 (372)
T cd07853          81 VVTELMQ-SDLHKIIVS-PQPLSSDHVKVFLYQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEP  155 (372)
T ss_pred             EEeeccc-cCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence            9999986 578877743 4578999999999999999999998   8999999999999999999999999999987644


Q ss_pred             CCceeEeeceeccccccccccCchh-hcCccceeEEEeeEEEeeccC
Q 021711          263 QWTHHTISKVEGTFGLVKLNLPPLV-ILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       263 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ... .......+|..|+|||.+.+. .++.++|+||+|+++|||++|
T Consensus       156 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g  201 (372)
T cd07853         156 DES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGR  201 (372)
T ss_pred             Ccc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcC
Confidence            322 223345789999999987654 367889999999999999875

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=9.6e-35  Score=263.04  Aligned_cols=195  Identities=27%  Similarity=0.426  Sum_probs=165.6

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCc----EEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeCcEEEE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQ----LVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHIV  184 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~----~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~lv  184 (308)
                      ++|+..+.||+|+||.||+|.+. +|.    .||+|.+...........+.+|+.+++.++||||+++++++.....+++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~v   86 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQLV   86 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCCCceee
Confidence            46778899999999999999864 343    5799988765544445578999999999999999999998887778899


Q ss_pred             EEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCC
Q 021711          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (308)
Q Consensus       185 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  264 (308)
                      +||+++|+|.+++......+++..++.++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++.+....
T Consensus        87 ~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~  163 (303)
T cd05110          87 TQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDE  163 (303)
T ss_pred             ehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhh---cCeeccccccceeeecCCCceEEccccccccccCcc
Confidence            99999999999987656678999999999999999999998   899999999999999999999999999998775433


Q ss_pred             ceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          265 THHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      .........++..|+|||.......+.++|+||||+++||+++
T Consensus       164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t  206 (303)
T cd05110         164 KEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMT  206 (303)
T ss_pred             cccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHh
Confidence            2222233456789999999887778889999999999999864

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=3.9e-34  Score=256.04  Aligned_cols=194  Identities=27%  Similarity=0.388  Sum_probs=163.6

Q ss_pred             CCccccceeeccCceEEEEEEEC-----CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEe---CcE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-----NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE---GGM  181 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-----~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---~~~  181 (308)
                      .+|++.+.||+|+||.||+|...     ++..||+|.+..... ...+.+.+|++++..++||||+++++++..   ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   82 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTA-EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   82 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCH-HHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence            57888999999999999999743     478999999875543 345788999999999999999999997643   247


Q ss_pred             EEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecC
Q 021711          182 HIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP  261 (308)
Q Consensus       182 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~  261 (308)
                      ++|+||+++++|.+++......+++..+..++.|++.||.|||+   ++|+||||||+||+++.++.+||+|||+++.++
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~  159 (284)
T cd05081          83 RLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGS---KRYVHRDLATRNILVESENRVKIGDFGLTKVLP  159 (284)
T ss_pred             EEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHhhEEECCCCeEEECCCccccccc
Confidence            89999999999999997655678999999999999999999998   899999999999999999999999999999876


Q ss_pred             CCCceeEe-eceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          262 EQWTHHTI-SKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       262 ~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      ........ ....++..|+|||...+...+.++|+||+|++++||++
T Consensus       160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~  206 (284)
T cd05081         160 QDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT  206 (284)
T ss_pred             CCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhh
Confidence            54322111 12234556999999887778899999999999999976

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.2e-34  Score=259.31  Aligned_cols=195  Identities=19%  Similarity=0.260  Sum_probs=163.4

Q ss_pred             CCccccceeeccCceEEEEEEEC------CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR------NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMH  182 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~------~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~  182 (308)
                      .+|++.+.||+|+||.||+|...      .++.||+|.+.........+.+.+|+.++..++||||+++++++... ..+
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~   84 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS   84 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence            35778899999999999999863      25789999997655555567789999999999999999999977654 578


Q ss_pred             EEEEecCCCCHHHHHhcc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCC
Q 021711          183 IVLELSPNGSLASLLYGM---------------KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDF  247 (308)
Q Consensus       183 lv~e~~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~  247 (308)
                      +++||+.+++|.+++...               ...+++..+..++.|++.||.|||+   ++|+||||||+|||+++++
T Consensus        85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~---~gi~H~dlkp~Nil~~~~~  161 (283)
T cd05091          85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDKL  161 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---cCccccccchhheEecCCC
Confidence            999999999999998521               2347888889999999999999998   8999999999999999999


Q ss_pred             cEEEeccccceecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          248 EPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       248 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      .+||+|||+++.+.............+++.|+|||.......+.++|+||+|+++|||++
T Consensus       162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~  221 (283)
T cd05091         162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS  221 (283)
T ss_pred             ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHc
Confidence            999999999987654432222334456789999999877778889999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-34  Score=254.51  Aligned_cols=191  Identities=26%  Similarity=0.340  Sum_probs=162.1

Q ss_pred             CccccceeeccCceEEEEEEECCCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEEEecC
Q 021711          111 NFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLELSP  189 (308)
Q Consensus       111 ~~~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~~  189 (308)
                      +|++.+.||+|+||.||+|.++++..+|+|.+......  ...+.+|+.+++.++||||+++++++... ..++|+||++
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMS--EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA   82 (256)
T ss_pred             HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCC--HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence            57788999999999999999877778999998654322  25688899999999999999999976654 4789999999


Q ss_pred             CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCceeEe
Q 021711          190 NGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTI  269 (308)
Q Consensus       190 ~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  269 (308)
                      +++|.+++......+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.+||+|||+++........ ..
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~-~~  158 (256)
T cd05059          83 NGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLES---NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT-SS  158 (256)
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHhhEEECCCCcEEECCcccceeccccccc-cc
Confidence            999999997655678999999999999999999998   89999999999999999999999999999876543211 11


Q ss_pred             eceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          270 SKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       270 ~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      ....++..|+|||.......+.++|+||||+++|++++
T Consensus       159 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~  196 (256)
T cd05059         159 QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFS  196 (256)
T ss_pred             CCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhc
Confidence            22234568999999887788889999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=5e-34  Score=256.24  Aligned_cols=192  Identities=27%  Similarity=0.327  Sum_probs=162.6

Q ss_pred             CccccceeeccCceEEEEEEEC-CCcEEEEEEeccCCh--HHHHHHHHHHHHHHhcCCCCeeeeeeeEEEe-CcEEEEEE
Q 021711          111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLE  186 (308)
Q Consensus       111 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~lv~e  186 (308)
                      .|+..++||+|+||.||++... +++.||+|.+.....  ......+.+|+.+++.++|+||+.+++.+.. +..++|||
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence            3677789999999999999876 588999999864322  2223567889999999999999999986654 45789999


Q ss_pred             ecCCCCHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCc
Q 021711          187 LSPNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (308)
Q Consensus       187 ~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~  265 (308)
                      |+++++|.+++... ...+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.++|+|||++........
T Consensus        81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  157 (285)
T cd05630          81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT  157 (285)
T ss_pred             ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence            99999999888543 3458899999999999999999998   9999999999999999999999999999987654322


Q ss_pred             eeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          266 HHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                         .....||..|+|||......++.++|+||+|+++|+|++|
T Consensus       158 ---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g  197 (285)
T cd05630         158 ---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAG  197 (285)
T ss_pred             ---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhC
Confidence               2345799999999998887888999999999999999875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=2e-34  Score=254.69  Aligned_cols=193  Identities=25%  Similarity=0.324  Sum_probs=165.7

Q ss_pred             cCCccccceeeccCceEEEEEEECCCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeCcEEEEEEec
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHIVLELS  188 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~lv~e~~  188 (308)
                      .++|++.+.||+|+||.||+|...++..+|+|.+......  .+.+.+|+.+++.++|+|++++++++.....+++|||+
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~--~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e~~   82 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS--PESFLEEAQIMKKLRHDKLVQLYAVVSEEPIYIVTEYM   82 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCC--HHHHHHHHHHHHhcCCCceEEEEeEECCCCcEEEEEec
Confidence            3578899999999999999999887888999998754332  35688999999999999999999988777789999999


Q ss_pred             CCCCHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCcee
Q 021711          189 PNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH  267 (308)
Q Consensus       189 ~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~  267 (308)
                      ++++|.+++... ...+++..+..++.|++.||.|||+   ++|+||||||+||++++++.++|+|||++..+...... 
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~-  158 (260)
T cd05070          83 SKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT-  158 (260)
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEEeCCceEEeCCceeeeeccCcccc-
Confidence            999999998653 3458999999999999999999998   89999999999999999999999999999876543221 


Q ss_pred             EeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          268 TISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      ......++..|+|||.......+.++|+||||+++|++++
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~  198 (260)
T cd05070         159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVT  198 (260)
T ss_pred             cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHh
Confidence            1223346678999998877778889999999999999976

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1.9e-33  Score=247.68  Aligned_cols=193  Identities=20%  Similarity=0.237  Sum_probs=165.5

Q ss_pred             CccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEEEec
Q 021711          111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLELS  188 (308)
Q Consensus       111 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~  188 (308)
                      +|++.+.||+|+||.||++... +++.+|+|.+.........+.+.+|+.+++.++|+||+++++.+..+ .+++++||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            4788899999999999999876 58899999986544444567788999999999999999999866554 578999999


Q ss_pred             CCCCHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCcee
Q 021711          189 PNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH  267 (308)
Q Consensus       189 ~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~  267 (308)
                      ++++|.+++... ...++...+..++.|++.||.|||+   ++|+|+||||+||+++.++.++|+|||+++.+.....  
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~--  155 (255)
T cd08219          81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA--  155 (255)
T ss_pred             CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEECCCCcEEEcccCcceeeccccc--
Confidence            999999988643 3457889999999999999999998   8999999999999999999999999999987754322  


Q ss_pred             EeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          268 TISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ......|+..|+|||.......+.++|+||+|+++++++.|
T Consensus       156 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g  196 (255)
T cd08219         156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTL  196 (255)
T ss_pred             ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhc
Confidence            12346789999999998887888899999999999999865

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.6e-34  Score=254.09  Aligned_cols=194  Identities=28%  Similarity=0.348  Sum_probs=164.0

Q ss_pred             hcCCccccceeeccCceEEEEEEECCCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEEE
Q 021711          108 ATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLE  186 (308)
Q Consensus       108 ~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e  186 (308)
                      ..++|++.+.||+|+||.||+|.+.+++.||+|.+......  .+.+.+|+.+++.++||||+++++++... ..+++||
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (261)
T cd05068           4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD--PKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE   81 (261)
T ss_pred             chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCccc--HHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence            34678999999999999999999877888999998754322  46688999999999999999999976654 5789999


Q ss_pred             ecCCCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCc
Q 021711          187 LSPNGSLASLLYGMK-EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (308)
Q Consensus       187 ~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~  265 (308)
                      |+++++|.+++.... ..+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.++|+|||+++.+.....
T Consensus        82 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  158 (261)
T cd05068          82 LMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY  158 (261)
T ss_pred             cccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence            999999999986533 468999999999999999999998   8999999999999999999999999999998764321


Q ss_pred             eeEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          266 HHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      . ......++..|+|||.......+.++|+||||++++||++
T Consensus       159 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t  199 (261)
T cd05068         159 E-AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVT  199 (261)
T ss_pred             c-ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHh
Confidence            1 1122233468999999887778889999999999999875

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-35  Score=272.77  Aligned_cols=186  Identities=31%  Similarity=0.379  Sum_probs=161.7

Q ss_pred             CccccceeeccCceEEEEEEEC-CCcEEEEEEeccCC--hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEe-CcEEEEEE
Q 021711          111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLE  186 (308)
Q Consensus       111 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~lv~e  186 (308)
                      -|.-++.||.|+||.||-+++. +.+.||||++.-..  ..+-.++.++|+..|.+++|||++.+-|++.. ...|||||
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME  106 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME  106 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence            3555678999999999999865 68899999986432  23457889999999999999999999996655 45789999


Q ss_pred             ecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCce
Q 021711          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH  266 (308)
Q Consensus       187 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~  266 (308)
                      ||- |+-.+++.-.+.++.+-.+..|+.+.+.||.|||+   ++.||||||+.||||++.|.|||+|||.|....+.   
T Consensus       107 YCl-GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS---~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA---  179 (948)
T KOG0577|consen  107 YCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS---HNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA---  179 (948)
T ss_pred             HHh-ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHH---hhHHhhhccccceEecCCCeeeeccccchhhcCch---
Confidence            995 58888887778889999999999999999999999   99999999999999999999999999999876543   


Q ss_pred             eEeeceecccccccccc---CchhhcCccceeEEEeeEEEeec
Q 021711          267 HTISKVEGTFGLVKLNL---PPLVILKRCFTCIFIGFSQLQLS  306 (308)
Q Consensus       267 ~~~~~~~gt~~y~aPE~---~~~~~~~~~~Di~s~g~~l~el~  306 (308)
                         ..++||+.|||||.   +.++.++-+.||||+|++-+|||
T Consensus       180 ---nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELA  219 (948)
T KOG0577|consen  180 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA  219 (948)
T ss_pred             ---hcccCCccccchhHheeccccccCCccceeeccchhhhhh
Confidence               56899999999996   45777889999999999998886

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=3.5e-34  Score=254.56  Aligned_cols=194  Identities=27%  Similarity=0.385  Sum_probs=166.4

Q ss_pred             cCCccccceeeccCceEEEEEEECC----CcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeCcEEEE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLRN----GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHIV  184 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~~----g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~lv  184 (308)
                      .++|.+.++||+|+||.||+|.+.+    ...||+|........+..+.+.+|+.+++.++||||+++++++.....++|
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~lv   84 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITENPVWIV   84 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcCCCcEEE
Confidence            3568889999999999999998643    246899988766545556789999999999999999999999888888999


Q ss_pred             EEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCC
Q 021711          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (308)
Q Consensus       185 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  264 (308)
                      |||+++|+|.+++......+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||+++......
T Consensus        85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~  161 (270)
T cd05056          85 MELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES  161 (270)
T ss_pred             EEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccChheEEEecCCCeEEccCceeeeccccc
Confidence            99999999999997655568999999999999999999998   899999999999999999999999999998775442


Q ss_pred             ceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeec
Q 021711          265 THHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLS  306 (308)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~  306 (308)
                      . .......++..|+|||.......+.++|+||+|++++|++
T Consensus       162 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~  202 (270)
T cd05056         162 Y-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL  202 (270)
T ss_pred             c-eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHH
Confidence            2 1222334567899999887777888999999999999976

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=3.9e-34  Score=251.09  Aligned_cols=188  Identities=30%  Similarity=0.402  Sum_probs=160.7

Q ss_pred             ceeeccCceEEEEEEECCCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEEEecCCCCHH
Q 021711          116 NLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLELSPNGSLA  194 (308)
Q Consensus       116 ~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~~~gsL~  194 (308)
                      ++||+|+||.||+|...++..+|+|.+......+....+.+|+.+++.++||||+++++++... ..++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            3689999999999998788999999987665555566799999999999999999999977654 478999999999999


Q ss_pred             HHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCceeEeeceec
Q 021711          195 SLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEG  274 (308)
Q Consensus       195 ~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g  274 (308)
                      +++......+++..+..++.|++.||.|||+   ++++||||||+||+++.++.+||+|||++......... ......+
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~  156 (250)
T cd05085          81 SFLRKKKDELKTKQLVKFALDAAAGMAYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSGLKQI  156 (250)
T ss_pred             HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccChheEEEcCCCeEEECCCccceeccccccc-cCCCCCC
Confidence            9987655678999999999999999999998   89999999999999999999999999999865433211 1122345


Q ss_pred             cccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          275 TFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       275 t~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      ++.|+|||+......+.++|+||||+++|++++
T Consensus       157 ~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~  189 (250)
T cd05085         157 PIKWTAPEALNYGRYSSESDVWSYGILLWETFS  189 (250)
T ss_pred             cccccCHHHhccCCCCchhHHHHHHHHHHHHhc
Confidence            678999999877778888999999999999876

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=1.9e-34  Score=267.79  Aligned_cols=190  Identities=24%  Similarity=0.211  Sum_probs=160.7

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCC-hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEe-------C
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-------G  179 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-------~  179 (308)
                      .++|++.+.||+|+||.||++... .++.||||.+.... .......+.+|+.+++.++||||+++++++..       .
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~  102 (364)
T cd07875          23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  102 (364)
T ss_pred             hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence            468999999999999999999875 58899999986542 22345678899999999999999999986543       2


Q ss_pred             cEEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEecccccee
Q 021711          180 GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKW  259 (308)
Q Consensus       180 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~  259 (308)
                      ..++||||+.+ +|...+.   ..+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++.
T Consensus       103 ~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~  175 (364)
T cd07875         103 DVYIVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART  175 (364)
T ss_pred             eEEEEEeCCCC-CHHHHHH---hcCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEECCCCcEEEEeCCCccc
Confidence            36899999975 6777663   347888899999999999999998   8999999999999999999999999999987


Q ss_pred             cCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          260 LPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       260 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      .....   ......||..|+|||.+.+..++.++|+||+|+++|||++|
T Consensus       176 ~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g  221 (364)
T cd07875         176 AGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG  221 (364)
T ss_pred             cCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhC
Confidence            64332   22346789999999999888888999999999999999875

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.4e-34  Score=267.72  Aligned_cols=191  Identities=23%  Similarity=0.213  Sum_probs=161.1

Q ss_pred             hcCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCC-hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC------
Q 021711          108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG------  179 (308)
Q Consensus       108 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  179 (308)
                      ..++|++.+.||+|+||.||++... .++.||+|.+.... .......+.+|+.+++.++||||+++++++...      
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            3468999999999999999999865 58899999987543 233456788999999999999999999966432      


Q ss_pred             -cEEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccce
Q 021711          180 -GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK  258 (308)
Q Consensus       180 -~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~  258 (308)
                       ..++||||+.+ +|.+.+.   ..+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++
T Consensus        95 ~~~~lv~e~~~~-~l~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDikp~Nill~~~~~~kl~Dfg~~~  167 (355)
T cd07874          95 QDVYLVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR  167 (355)
T ss_pred             ceeEEEhhhhcc-cHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEECCCCCEEEeeCcccc
Confidence             36899999975 6666663   357888889999999999999998   899999999999999999999999999998


Q ss_pred             ecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          259 WLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       259 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ......   ......||..|+|||.+.+..++.++|+||+|+++|+|++|
T Consensus       168 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g  214 (355)
T cd07874         168 TAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH  214 (355)
T ss_pred             cCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhC
Confidence            754331   22456799999999998887888999999999999999865

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=3.1e-34  Score=259.62  Aligned_cols=197  Identities=21%  Similarity=0.311  Sum_probs=164.2

Q ss_pred             hcCCccccceeeccCceEEEEEEEC--------CCcEEEEEEeccCChHHHHHHHHHHHHHHhcC-CCCeeeeeeeEEEe
Q 021711          108 ATNNFSFENLIGKGGYAEVYKGRLR--------NGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGIE  178 (308)
Q Consensus       108 ~~~~~~~~~~LG~G~fg~Vy~~~~~--------~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  178 (308)
                      ..++|.+.+.||+|+||.||+|+..        ++..||+|.+...........+.+|+.++..+ +||||+++++++..
T Consensus        13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   92 (304)
T cd05101          13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ   92 (304)
T ss_pred             cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence            3467889999999999999999742        24579999987554444467889999999999 89999999997665


Q ss_pred             C-cEEEEEEecCCCCHHHHHhccC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEE
Q 021711          179 G-GMHIVLELSPNGSLASLLYGMK---------------EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANIL  242 (308)
Q Consensus       179 ~-~~~lv~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NIL  242 (308)
                      . ..+++|||+++|+|.+++....               ..+++..+..++.|++.||.|||+   ++|+||||||+|||
T Consensus        93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nil  169 (304)
T cd05101          93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS---QKCIHRDLAARNVL  169 (304)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH---CCeeecccccceEE
Confidence            4 5789999999999999986531               247788899999999999999998   89999999999999


Q ss_pred             ECCCCcEEEeccccceecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          243 LTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       243 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      ++.++.+||+|||+++.+.............++..|+|||......++.++|+||||+++|++++
T Consensus       170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~  234 (304)
T cd05101         170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT  234 (304)
T ss_pred             EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHc
Confidence            99999999999999998755433222233456788999999877778889999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.8e-34  Score=270.71  Aligned_cols=189  Identities=22%  Similarity=0.211  Sum_probs=160.3

Q ss_pred             cCCccccceeeccCceEEEEEEEC---CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEe-CcEEEE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR---NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIV  184 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~---~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~lv  184 (308)
                      ..+|.+.+.||+|+||.||+|...   .+..||+|.+....      .+.+|+.+++.++||||+++++++.. ...++|
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~------~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv  164 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK------TPGREIDILKTISHRAIINLIHAYRWKSTVCMV  164 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc------cHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence            457999999999999999999754   35789999876432      34579999999999999999986654 457899


Q ss_pred             EEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCC
Q 021711          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (308)
Q Consensus       185 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  264 (308)
                      ||++. ++|.+++. ....+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.++|+|||+++.+....
T Consensus       165 ~e~~~-~~l~~~l~-~~~~l~~~~~~~i~~ql~~aL~~LH~---~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~  239 (392)
T PHA03207        165 MPKYK-CDLFTYVD-RSGPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP  239 (392)
T ss_pred             ehhcC-CCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence            99985 68888883 45678999999999999999999998   899999999999999999999999999998765543


Q ss_pred             ceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          265 THHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      .........||+.|+|||++....++.++|+||+|+++|||++|
T Consensus       240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g  283 (392)
T PHA03207        240 DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVK  283 (392)
T ss_pred             ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHC
Confidence            32233356799999999998877788999999999999999865

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.6e-34  Score=266.41  Aligned_cols=186  Identities=22%  Similarity=0.256  Sum_probs=159.1

Q ss_pred             hcCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeCc-EEEEE
Q 021711          108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIVL  185 (308)
Q Consensus       108 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~  185 (308)
                      ...+|.+.+.||+|+||.||+|... +++.||+|.....       ....|+.+++.++||||+++++++.... .++|+
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  136 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL  136 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence            3468999999999999999999976 4788999975432       2346899999999999999999776654 67899


Q ss_pred             EecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCc
Q 021711          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (308)
Q Consensus       186 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~  265 (308)
                      |++. ++|.+++......+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++...... 
T Consensus       137 e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-  211 (357)
T PHA03209        137 PHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP-  211 (357)
T ss_pred             EccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEecCccccccccCc-
Confidence            9985 68888887666779999999999999999999998   899999999999999999999999999998543221 


Q ss_pred             eeEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          266 HHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                        ......||+.|+|||.+....++.++|+||+|+++|||++
T Consensus       212 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~  251 (357)
T PHA03209        212 --AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA  251 (357)
T ss_pred             --ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHH
Confidence              2234679999999999988888999999999999999864

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=3.2e-34  Score=254.68  Aligned_cols=188  Identities=26%  Similarity=0.306  Sum_probs=152.3

Q ss_pred             eeeccCceEEEEEEECC---CcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEEEecCCCC
Q 021711          117 LIGKGGYAEVYKGRLRN---GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLELSPNGS  192 (308)
Q Consensus       117 ~LG~G~fg~Vy~~~~~~---g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~~~gs  192 (308)
                      .||+|+||.||+|...+   ...+|+|.+...........|.+|+.+++.++||||+++++.+... ..++||||+++|+
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD   81 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence            58999999999997543   4578999876554444557789999999999999999999977654 5789999999999


Q ss_pred             HHHHHhccCC----CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCceeE
Q 021711          193 LASLLYGMKE----KLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT  268 (308)
Q Consensus       193 L~~~l~~~~~----~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  268 (308)
                      |.+++.....    ..++.....++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++..........
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~  158 (269)
T cd05042          82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT  158 (269)
T ss_pred             HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh---cCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence            9999865332    24577788999999999999998   8999999999999999999999999999976543322222


Q ss_pred             eeceeccccccccccCch-------hhcCccceeEEEeeEEEeecc
Q 021711          269 ISKVEGTFGLVKLNLPPL-------VILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       269 ~~~~~gt~~y~aPE~~~~-------~~~~~~~Di~s~g~~l~el~c  307 (308)
                      .....++..|+|||....       ...+.++|+||+|+++|||++
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~  204 (269)
T cd05042         159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT  204 (269)
T ss_pred             cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHh
Confidence            233456778999998532       345778999999999999876

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-36  Score=255.55  Aligned_cols=193  Identities=22%  Similarity=0.260  Sum_probs=163.2

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCC-hHHHHHHHHHHHHHHhcCCCCeeeeeeeEE-EeCcEEEEE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYG-IEGGMHIVL  185 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~lv~  185 (308)
                      +++|++.++||+|.|+.||++.+. +|+.+|+|++.... .....+.+.+|+.|.+.|+|||||+|.+-. .++-.|+|+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF   89 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   89 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence            467888899999999999999865 58999999885332 223467889999999999999999999844 445568999


Q ss_pred             EecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCC---CcEEEeccccceecCC
Q 021711          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTED---FEPQICDFGLAKWLPE  262 (308)
Q Consensus       186 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~---~~~kl~DFGla~~~~~  262 (308)
                      |++.|++|..-+-.+ ...++..+-.+++||+++|.|+|.   ++|||||+||.|+|+...   --+||+|||+|..+..
T Consensus        90 e~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~---n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~  165 (355)
T KOG0033|consen   90 DLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCHS---NGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVND  165 (355)
T ss_pred             ecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeeeeccCCCceeecccceEEEeCC
Confidence            999999997666432 446777888899999999999999   999999999999999754   3589999999999873


Q ss_pred             CCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          263 QWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       263 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      +   .......||++|||||....-.++.+.|+|+.|++||-|+.|
T Consensus       166 g---~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G  208 (355)
T KOG0033|consen  166 G---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG  208 (355)
T ss_pred             c---cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhC
Confidence            3   345678999999999999999999999999999999988754

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=2.5e-34  Score=254.85  Aligned_cols=193  Identities=25%  Similarity=0.344  Sum_probs=165.1

Q ss_pred             cCCccccceeeccCceEEEEEEECCCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeCcEEEEEEec
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHIVLELS  188 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~lv~e~~  188 (308)
                      .++|++.+.||+|+||.||+|.+.++..||+|.+......  .+.|.+|+.+++.++||||+++++++.+...++||||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~--~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e~~   82 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYM   82 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccC--HHHHHHHHHHHHhCCCCCcceEEEEECCCCcEEEEEcC
Confidence            4579999999999999999998876677999998754332  35788999999999999999999987777789999999


Q ss_pred             CCCCHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCcee
Q 021711          189 PNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH  267 (308)
Q Consensus       189 ~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~  267 (308)
                      ++|+|.+++... ...+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.++|+|||+++.+..... .
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~-~  158 (262)
T cd05071          83 SKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-T  158 (262)
T ss_pred             CCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcccEEEcCCCcEEeccCCceeecccccc-c
Confidence            999999999653 3457889999999999999999998   8999999999999999999999999999987654322 1


Q ss_pred             EeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          268 TISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      ......++..|+|||.......+.++|+||+|+++||++.
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt  198 (262)
T cd05071         159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT  198 (262)
T ss_pred             cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHc
Confidence            1223456788999998877778889999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=2.5e-34  Score=260.67  Aligned_cols=196  Identities=23%  Similarity=0.314  Sum_probs=162.1

Q ss_pred             cCCccccceeeccCceEEEEEEEC--------CCcEEEEEEeccCChHHHHHHHHHHHHHHhcC-CCCeeeeeeeEEEeC
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR--------NGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGIEG  179 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~--------~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  179 (308)
                      .++|.+.+.||+|+||.||++...        ++..+|+|.+...........+.+|+.++..+ +||||+++++++...
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            467999999999999999999753        23579999987654444457788999999999 799999999977654


Q ss_pred             -cEEEEEEecCCCCHHHHHhccC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEE
Q 021711          180 -GMHIVLELSPNGSLASLLYGMK---------------EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILL  243 (308)
Q Consensus       180 -~~~lv~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl  243 (308)
                       ..++||||+++|+|.+++....               ..+++..++.++.|++.||.|||+   ++++||||||+|||+
T Consensus        97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill  173 (307)
T cd05098          97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLV  173 (307)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHHheEE
Confidence             5789999999999999996532               247889999999999999999998   899999999999999


Q ss_pred             CCCCcEEEeccccceecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          244 TEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       244 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      +.++.+||+|||+++...............++..|+|||...+...+.++|+||+|+++|||++
T Consensus       174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~  237 (307)
T cd05098         174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT  237 (307)
T ss_pred             cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHc
Confidence            9999999999999987643221111122334578999998877778889999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.5e-34  Score=263.77  Aligned_cols=190  Identities=24%  Similarity=0.281  Sum_probs=160.1

Q ss_pred             hcCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChH-HHHHHHHHHHHHHhcCCCCeeeeeeeEEEe-------
Q 021711          108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTAD-EIIADFLSELGIMAHVDHPNTAKLLGYGIE-------  178 (308)
Q Consensus       108 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-------  178 (308)
                      ..++|++.+.||+|+||.||+|... +++.||||.+...... .....+.+|+.+++.++||||+++++++..       
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07878          13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF   92 (343)
T ss_pred             hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence            3578999999999999999999865 5889999998654322 234567899999999999999999986543       


Q ss_pred             CcEEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccce
Q 021711          179 GGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK  258 (308)
Q Consensus       179 ~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~  258 (308)
                      ...+++++++ +++|..++.  ...+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++
T Consensus        93 ~~~~~~~~~~-~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~  166 (343)
T cd07878          93 NEVYLVTNLM-GADLNNIVK--CQKLSDEHVQFLIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLAR  166 (343)
T ss_pred             CcEEEEeecC-CCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhhEEECCCCCEEEcCCccce
Confidence            2357888877 789988774  3568999999999999999999998   899999999999999999999999999998


Q ss_pred             ecCCCCceeEeeceeccccccccccCch-hhcCccceeEEEeeEEEeeccC
Q 021711          259 WLPEQWTHHTISKVEGTFGLVKLNLPPL-VILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       259 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      .....     .....||..|+|||.+.+ ..++.++|+||+|+++|+|++|
T Consensus       167 ~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g  212 (343)
T cd07878         167 QADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKG  212 (343)
T ss_pred             ecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHC
Confidence            76442     234578999999998765 4578889999999999999875

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=6.1e-34  Score=252.73  Aligned_cols=194  Identities=28%  Similarity=0.372  Sum_probs=164.1

Q ss_pred             CCccccceeeccCceEEEEEEEC-C---CcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-N---GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIV  184 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~---g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv  184 (308)
                      .+|++.+.||+|+||.||+|.+. +   +..+|+|.+...........+.+|+.+++.++||||+++++++..+ ..++|
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            47888999999999999999864 2   3479999987655455567899999999999999999999977654 57899


Q ss_pred             EEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCC
Q 021711          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (308)
Q Consensus       185 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  264 (308)
                      |||+++++|.+++......+++..+..++.|++.||.|||+   .+++||||||+|||++.++.++|+|||+++.+....
T Consensus        84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd05066          84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP  160 (267)
T ss_pred             EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence            99999999999997666678999999999999999999998   899999999999999999999999999999775543


Q ss_pred             ceeE-eeceeccccccccccCchhhcCccceeEEEeeEEEeec
Q 021711          265 THHT-ISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLS  306 (308)
Q Consensus       265 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~  306 (308)
                      .... .....++..|+|||.......+.++|+||||++++|+.
T Consensus       161 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell  203 (267)
T cd05066         161 EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVM  203 (267)
T ss_pred             ceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHh
Confidence            2211 12233457899999988777889999999999999954

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=2.5e-34  Score=270.18  Aligned_cols=199  Identities=23%  Similarity=0.299  Sum_probs=164.0

Q ss_pred             HhhcCCccccceeeccCceEEEEEEEC------CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCC-CCeeeeeeeEEEe
Q 021711          106 QSATNNFSFENLIGKGGYAEVYKGRLR------NGQLVAIKRLTRGTADEIIADFLSELGIMAHVD-HPNTAKLLGYGIE  178 (308)
Q Consensus       106 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~------~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~  178 (308)
                      ....++|.+.+.||+|+||.||+|++.      .+..||+|.+.........+.+++|+.++..+. ||||+++++++..
T Consensus        33 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~  112 (401)
T cd05107          33 EMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK  112 (401)
T ss_pred             eecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc
Confidence            344557888999999999999999864      246899999976544444567999999999997 9999999997766


Q ss_pred             C-cEEEEEEecCCCCHHHHHhccC--------------------------------------------------------
Q 021711          179 G-GMHIVLELSPNGSLASLLYGMK--------------------------------------------------------  201 (308)
Q Consensus       179 ~-~~~lv~e~~~~gsL~~~l~~~~--------------------------------------------------------  201 (308)
                      . ..++|+||+++|+|.++++...                                                        
T Consensus       113 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (401)
T cd05107         113 GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM  192 (401)
T ss_pred             CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence            4 5789999999999999986421                                                        


Q ss_pred             -----------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCC
Q 021711          202 -----------------------------------------EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAAN  240 (308)
Q Consensus       202 -----------------------------------------~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~N  240 (308)
                                                               ..+++..+..++.|++.||.|||+   .+|+||||||+|
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrdlkp~N  269 (401)
T cd05107         193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAARN  269 (401)
T ss_pred             hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCcCcccCCcce
Confidence                                                     125667788899999999999998   899999999999


Q ss_pred             EEECCCCcEEEeccccceecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          241 ILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       241 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      ||++.++.+||+|||+++.+.............++..|+|||.+.....+.++|+||||+++||+++
T Consensus       270 iLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~  336 (401)
T cd05107         270 VLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT  336 (401)
T ss_pred             EEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHH
Confidence            9999999999999999987643322112223457789999999887778889999999999999874

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=4.1e-34  Score=256.88  Aligned_cols=195  Identities=21%  Similarity=0.311  Sum_probs=163.7

Q ss_pred             cCCccccceeeccCceEEEEEEEC------CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR------NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GM  181 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~------~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~  181 (308)
                      .++|.+.+.||+|+||.||++...      ++..+|+|.+..... .....+.+|+.++++++||||+++++++... ..
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   82 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASD-NARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL   82 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCH-HHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence            357889999999999999999742      245689998865443 3457799999999999999999999977654 57


Q ss_pred             EEEEEecCCCCHHHHHhccC------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcE
Q 021711          182 HIVLELSPNGSLASLLYGMK------------EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEP  249 (308)
Q Consensus       182 ~lv~e~~~~gsL~~~l~~~~------------~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~  249 (308)
                      ++|+||+++++|.+++....            ..+++..+..++.|++.||.|||+   ++++||||||+|||++.++.+
T Consensus        83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~---~~i~H~dlkp~Nili~~~~~~  159 (288)
T cd05093          83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLV  159 (288)
T ss_pred             EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcE
Confidence            89999999999999986432            248999999999999999999998   899999999999999999999


Q ss_pred             EEeccccceecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          250 QICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       250 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      +|+|||+++...............++..|+|||.......+.++|+||||+++++|++
T Consensus       160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t  217 (288)
T cd05093         160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT  217 (288)
T ss_pred             EeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHh
Confidence            9999999987654332222233456789999999888788899999999999999975

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=4.9e-34  Score=253.53  Aligned_cols=193  Identities=23%  Similarity=0.358  Sum_probs=158.5

Q ss_pred             ccccceeeccCceEEEEEEECC-Cc--EEEEEEeccCC-hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-------c
Q 021711          112 FSFENLIGKGGYAEVYKGRLRN-GQ--LVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-------G  180 (308)
Q Consensus       112 ~~~~~~LG~G~fg~Vy~~~~~~-g~--~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-------~  180 (308)
                      |.+.++||+|+||.||+|.+.. +.  .+|+|.++... .....+.+.+|+.+++.++||||+++++++...       .
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            3467899999999999998764 33  68999886542 233467889999999999999999999976431       3


Q ss_pred             EEEEEEecCCCCHHHHHhc-----cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccc
Q 021711          181 MHIVLELSPNGSLASLLYG-----MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFG  255 (308)
Q Consensus       181 ~~lv~e~~~~gsL~~~l~~-----~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFG  255 (308)
                      .++++||+++|+|.+++..     ....+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhheEEcCCCCEEECCCC
Confidence            5799999999999988742     22347899999999999999999998   899999999999999999999999999


Q ss_pred             cceecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          256 LAKWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       256 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      +++.+.............+++.|+|||.......+.++|+||||+++||+++
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~  209 (272)
T cd05075         158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIAT  209 (272)
T ss_pred             cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHc
Confidence            9997754332212223346778999999888888999999999999999976

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=3.3e-34  Score=259.64  Aligned_cols=198  Identities=25%  Similarity=0.301  Sum_probs=166.1

Q ss_pred             hhcCCccccceeeccCceEEEEEEEC------CCcEEEEEEeccCChHHHHHHHHHHHHHHhcC-CCCeeeeeeeEEEeC
Q 021711          107 SATNNFSFENLIGKGGYAEVYKGRLR------NGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGIEG  179 (308)
Q Consensus       107 ~~~~~~~~~~~LG~G~fg~Vy~~~~~------~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  179 (308)
                      ...++|.+.+.||+|+||.||++...      .+..||+|.+.........+.+.+|+.+++++ +||||+++++++...
T Consensus        32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~  111 (302)
T cd05055          32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG  111 (302)
T ss_pred             ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence            34457999999999999999999742      24589999987654445567899999999999 799999999976654


Q ss_pred             -cEEEEEEecCCCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccc
Q 021711          180 -GMHIVLELSPNGSLASLLYGMK-EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLA  257 (308)
Q Consensus       180 -~~~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla  257 (308)
                       ..++||||+++|+|.+++.... ..+++..+..++.|++.||.|||+   ++|+|+||||+|||++.++.++|+|||++
T Consensus       112 ~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~dfg~~  188 (302)
T cd05055         112 GPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNVLLTHGKIVKICDFGLA  188 (302)
T ss_pred             CceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeehhhhccceEEEcCCCeEEECCCccc
Confidence             5789999999999999986533 338999999999999999999998   89999999999999999999999999999


Q ss_pred             eecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          258 KWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      +.+.............++..|+|||...+...+.++|+||+|+++||+++
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t  238 (302)
T cd05055         189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS  238 (302)
T ss_pred             ccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHh
Confidence            87655433222223456788999999888888899999999999999874

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=4.1e-34  Score=256.29  Aligned_cols=191  Identities=24%  Similarity=0.319  Sum_probs=156.0

Q ss_pred             CccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChH-HHHHHHHHHHHHHhcC---CCCeeeeeeeEEEe------C
Q 021711          111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTAD-EIIADFLSELGIMAHV---DHPNTAKLLGYGIE------G  179 (308)
Q Consensus       111 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~-~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~------~  179 (308)
                      +|++.+.||+|+||.||+|... +++.||+|.+...... .....+.+|+.+++.+   +||||+++++++..      .
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4788899999999999999876 5899999988643221 1123455677666655   79999999997653      2


Q ss_pred             cEEEEEEecCCCCHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccce
Q 021711          180 GMHIVLELSPNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK  258 (308)
Q Consensus       180 ~~~lv~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~  258 (308)
                      ..++++||+.+ +|.+++... ...+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~kl~dfg~~~  156 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGQVKLADFGLAR  156 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccCccc
Confidence            36899999975 888887543 3458999999999999999999998   899999999999999999999999999998


Q ss_pred             ecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          259 WLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       259 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ......   ......||..|+|||.+.....+.++|+||+|+++|+|++|
T Consensus       157 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g  203 (288)
T cd07863         157 IYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRR  203 (288)
T ss_pred             cccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhC
Confidence            765332   22345789999999998877889999999999999999764

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=8.1e-34  Score=252.07  Aligned_cols=194  Identities=29%  Similarity=0.451  Sum_probs=162.7

Q ss_pred             CCccccceeeccCceEEEEEEECC-C---cEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLRN-G---QLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIV  184 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~~-g---~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv  184 (308)
                      ..|++.+.||+|+||.||+|.... +   ..||+|.+...........|..|+.+++.++||||+++++++..+ ..++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            357889999999999999998653 3   369999987654455567899999999999999999999977655 47899


Q ss_pred             EEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCC
Q 021711          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (308)
Q Consensus       185 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  264 (308)
                      |||+++++|.+++......+++..+..++.|++.||.|||+   ++++|+||||+||+++.++.+||+|||+++......
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~---~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~  160 (269)
T cd05065          84 TEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT  160 (269)
T ss_pred             EecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence            99999999999997656678999999999999999999998   899999999999999999999999999998765432


Q ss_pred             ceeEee-ceec--cccccccccCchhhcCccceeEEEeeEEEeec
Q 021711          265 THHTIS-KVEG--TFGLVKLNLPPLVILKRCFTCIFIGFSQLQLS  306 (308)
Q Consensus       265 ~~~~~~-~~~g--t~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~  306 (308)
                      ...... ...|  +..|+|||.......+.++|+||+|+++||+.
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l  205 (269)
T cd05065         161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVM  205 (269)
T ss_pred             cccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHh
Confidence            211111 1222  45799999988777888999999999999965

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=4.3e-34  Score=256.85  Aligned_cols=194  Identities=25%  Similarity=0.353  Sum_probs=161.3

Q ss_pred             CccccceeeccCceEEEEEEEC------CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEE
Q 021711          111 NFSFENLIGKGGYAEVYKGRLR------NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHI  183 (308)
Q Consensus       111 ~~~~~~~LG~G~fg~Vy~~~~~------~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l  183 (308)
                      +|++.+.||+|+||.||+|...      ....+|+|.+..........++.+|+.+++.++||||+++++.+... ..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            4778899999999999999853      13578999887655444467899999999999999999999976654 4789


Q ss_pred             EEEecCCCCHHHHHhccC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCC
Q 021711          184 VLELSPNGSLASLLYGMK-----------------------EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAAN  240 (308)
Q Consensus       184 v~e~~~~gsL~~~l~~~~-----------------------~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~N  240 (308)
                      ++||+.+++|.+++....                       ..+++..++.++.|++.||.|||+   .+|+||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH---CCeehhhhhhhe
Confidence            999999999999875321                       247788899999999999999998   899999999999


Q ss_pred             EEECCCCcEEEeccccceecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          241 ILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       241 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      ||+++++.+||+|||+++...............++..|+|||.......+.++|+||||++++||++
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t  224 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT  224 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHh
Confidence            9999999999999999987644322222233456788999998877778899999999999999875

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-35  Score=277.47  Aligned_cols=192  Identities=26%  Similarity=0.392  Sum_probs=164.5

Q ss_pred             CCccccceeeccCceEEEEEEECC-CcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeee-EEEeCcEEEEEEe
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLRN-GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLG-YGIEGGMHIVLEL  187 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~~-g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~-~~~~~~~~lv~e~  187 (308)
                      +.|.++..||.|+||.||+|..+. +-..|.|.+.... .+..++|+-|++||..++||+||+|++ |+.++.+|++.||
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetks-eEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF  110 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKS-EEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF  110 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccc-hhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence            345567789999999999999775 5566777775544 345789999999999999999999997 8889999999999


Q ss_pred             cCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCcee
Q 021711          188 SPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH  267 (308)
Q Consensus       188 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~  267 (308)
                      |.||-...++-.....+.+.++..+++|++.||.|||+   ++|||||||+.|||++-+|.++|+|||.+......  ..
T Consensus       111 C~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs---~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t--~q  185 (1187)
T KOG0579|consen  111 CGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHS---QNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST--RQ  185 (1187)
T ss_pred             cCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhh---cchhhhhccccceEEEecCcEeeecccccccchhH--Hh
Confidence            99999998887778889999999999999999999999   99999999999999999999999999998754322  22


Q ss_pred             EeeceeccccccccccCch-----hhcCccceeEEEeeEEEeecc
Q 021711          268 TISKVEGTFGLVKLNLPPL-----VILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~-----~~~~~~~Di~s~g~~l~el~c  307 (308)
                      ....+.||+.|||||...+     ..++.++||||||++|+|||-
T Consensus       186 kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAq  230 (1187)
T KOG0579|consen  186 KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQ  230 (1187)
T ss_pred             hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhc
Confidence            3467999999999997543     346677899999999999874

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=1.4e-33  Score=253.85  Aligned_cols=194  Identities=26%  Similarity=0.399  Sum_probs=164.4

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEE-eCcEEEEEE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGI-EGGMHIVLE  186 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~lv~e  186 (308)
                      .+.|++.+.||+|+||.||+|... ++..+|+|.+..... +..+.+.+|+.+++.++||||+++++.+. ++..++|||
T Consensus        11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   89 (292)
T cd06644          11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSE-EELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIE   89 (292)
T ss_pred             chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCH-HHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEe
Confidence            367899999999999999999976 488999999876543 34678899999999999999999999654 455889999


Q ss_pred             ecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCce
Q 021711          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH  266 (308)
Q Consensus       187 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~  266 (308)
                      |+++++|..++......+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++........ 
T Consensus        90 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~-  165 (292)
T cd06644          90 FCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ-  165 (292)
T ss_pred             cCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhc---CCeeecCCCcceEEEcCCCCEEEccCccceecccccc-
Confidence            999999998886656678999999999999999999998   8999999999999999999999999999876533211 


Q ss_pred             eEeeceeccccccccccCc-----hhhcCccceeEEEeeEEEeeccC
Q 021711          267 HTISKVEGTFGLVKLNLPP-----LVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                       ......++..|+|||...     ...++.++|+||+|+++|||++|
T Consensus       166 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g  211 (292)
T cd06644         166 -RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQI  211 (292)
T ss_pred             -ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcC
Confidence             223456889999999874     23356789999999999999875

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.8e-35  Score=266.13  Aligned_cols=193  Identities=21%  Similarity=0.316  Sum_probs=170.0

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHH-HHHHHHHHHHHHhcCCCCeeeeeeeEEEe-CcEEEEEE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADE-IIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLE  186 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~lv~e  186 (308)
                      .-|.+++.||+|.|++|-+|++- +|..||||++.+...++ ....+..|++.|+-++|||||+||++... ..+|||+|
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE   97 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE   97 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence            45778899999999999999854 79999999997765443 35678899999999999999999996554 46999999


Q ss_pred             ecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEEC-CCCcEEEeccccceecCCCCc
Q 021711          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLT-EDFEPQICDFGLAKWLPEQWT  265 (308)
Q Consensus       187 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~-~~~~~kl~DFGla~~~~~~~~  265 (308)
                      +=.+|+|.+++.++...+.+....+++.||+.|+.|+|.   ..+|||||||+|+.+- .-|.+||+|||++..+.+.. 
T Consensus        98 LGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHq---LHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~-  173 (864)
T KOG4717|consen   98 LGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQ---LHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK-  173 (864)
T ss_pred             ecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhh---hhhhcccCCcceeEEeeecCceEeeeccccccCCCcc-
Confidence            999999999998888899999999999999999999998   8999999999998775 45899999999998887663 


Q ss_pred             eeEeeceeccccccccccCchhhcC-ccceeEEEeeEEEeeccC
Q 021711          266 HHTISKVEGTFGLVKLNLPPLVILK-RCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~s~g~~l~el~c~  308 (308)
                        .....+|...|-|||.+.+-.+. +..||||+|++||.|.||
T Consensus       174 --kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCG  215 (864)
T KOG4717|consen  174 --KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCG  215 (864)
T ss_pred             --hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhC
Confidence              34678999999999998877765 568999999999999998

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.3e-35  Score=273.70  Aligned_cols=189  Identities=24%  Similarity=0.377  Sum_probs=157.7

Q ss_pred             cccceeeccCceEEEEEEEC-CCcEEEEEEe---ccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-c--EEEEE
Q 021711          113 SFENLIGKGGYAEVYKGRLR-NGQLVAIKRL---TRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-G--MHIVL  185 (308)
Q Consensus       113 ~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~---~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~--~~lv~  185 (308)
                      +...+||+|+|-+||+|.+. +|-.||--.+   ......+..++|..|+.+|+.|+||||++++.++.+. .  +.+|+
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT  122 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT  122 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence            44578999999999999875 4777774333   2233445678999999999999999999999965543 3  67899


Q ss_pred             EecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCC-CcEEEeccccceecCCCC
Q 021711          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTED-FEPQICDFGLAKWLPEQW  264 (308)
Q Consensus       186 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~-~~~kl~DFGla~~~~~~~  264 (308)
                      |.+..|+|..++.. .+..+...+..|++||+.||.|||+.. .+|||||||.+||+|+.+ |.|||+|+|||+.+... 
T Consensus       123 EL~TSGtLr~Y~kk-~~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s-  199 (632)
T KOG0584|consen  123 ELFTSGTLREYRKK-HRRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS-  199 (632)
T ss_pred             ecccCCcHHHHHHH-hccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhcc-
Confidence            99999999999865 456888899999999999999999843 579999999999999855 89999999999987554 


Q ss_pred             ceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          265 THHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                         ....+.|||.|||||+++ -.++...||||||++|+||+++
T Consensus       200 ---~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~  239 (632)
T KOG0584|consen  200 ---HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTS  239 (632)
T ss_pred             ---ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhc
Confidence               223479999999999987 5678889999999999999865

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=4.2e-34  Score=260.09  Aligned_cols=197  Identities=25%  Similarity=0.348  Sum_probs=162.8

Q ss_pred             hcCCccccceeeccCceEEEEEEEC--------CCcEEEEEEeccCChHHHHHHHHHHHHHHhcC-CCCeeeeeeeEEEe
Q 021711          108 ATNNFSFENLIGKGGYAEVYKGRLR--------NGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGIE  178 (308)
Q Consensus       108 ~~~~~~~~~~LG~G~fg~Vy~~~~~--------~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  178 (308)
                      ..++|.+.+.||+|+||.||+|...        ....+|+|.+...........+.+|+.+++.+ +||||+++++++..
T Consensus        10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~   89 (314)
T cd05099          10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ   89 (314)
T ss_pred             cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence            3457889999999999999999742        24579999987654445567889999999999 69999999997765


Q ss_pred             C-cEEEEEEecCCCCHHHHHhccC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEE
Q 021711          179 G-GMHIVLELSPNGSLASLLYGMK---------------EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANIL  242 (308)
Q Consensus       179 ~-~~~lv~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NIL  242 (308)
                      . ..++++||+++|+|.+++....               ..+++..+..++.|++.||.|||+   ++|+||||||+|||
T Consensus        90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nil  166 (314)
T cd05099          90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHRDLAARNVL  166 (314)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeeccccceeEE
Confidence            5 4789999999999999986421               347888899999999999999998   89999999999999


Q ss_pred             ECCCCcEEEeccccceecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          243 LTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       243 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      ++.++.+||+|||+++...............++..|+|||...+...+.++|+||+|+++||+++
T Consensus       167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~  231 (314)
T cd05099         167 VTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT  231 (314)
T ss_pred             EcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHh
Confidence            99999999999999987654322111122334568999999877778889999999999999886

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1.7e-33  Score=251.87  Aligned_cols=191  Identities=26%  Similarity=0.375  Sum_probs=161.8

Q ss_pred             ccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEEEecC
Q 021711          112 FSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLELSP  189 (308)
Q Consensus       112 ~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~~  189 (308)
                      |++.+.||+|+||.||+|... ++..+|+|.+..... ...+.+.+|+.+++.++||||+++++++..+ ..++|+||++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~   85 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSE-EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA   85 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCH-HHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence            567789999999999999976 478889998865443 3457789999999999999999999866554 5789999999


Q ss_pred             CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCceeEe
Q 021711          190 NGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTI  269 (308)
Q Consensus       190 ~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  269 (308)
                      +++|..++......+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.++|+|||++.......  ...
T Consensus        86 ~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~~~  160 (282)
T cd06643          86 GGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHE---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QRR  160 (282)
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEccCCCEEEccccccccccccc--ccc
Confidence            999998886656678999999999999999999998   899999999999999999999999999997654322  123


Q ss_pred             eceeccccccccccCc-----hhhcCccceeEEEeeEEEeeccC
Q 021711          270 SKVEGTFGLVKLNLPP-----LVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       270 ~~~~gt~~y~aPE~~~-----~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ....||..|+|||.+.     ...++.++|+||+|+++|||++|
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g  204 (282)
T cd06643         161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQI  204 (282)
T ss_pred             ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccC
Confidence            4467899999999863     34466789999999999999865

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=5.7e-34  Score=256.89  Aligned_cols=195  Identities=22%  Similarity=0.340  Sum_probs=161.0

Q ss_pred             CCccccceeeccCceEEEEEEEC-----------------CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeee
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-----------------NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKL  172 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-----------------~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  172 (308)
                      ++|++.+.||+|+||.||++...                 ++..+|+|.+...........+.+|+.+++.++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            57899999999999999998532                 2346899998765545556789999999999999999999


Q ss_pred             eeEEEeC-cEEEEEEecCCCCHHHHHhccC----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCE
Q 021711          173 LGYGIEG-GMHIVLELSPNGSLASLLYGMK----------EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANI  241 (308)
Q Consensus       173 ~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~----------~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NI  241 (308)
                      ++++..+ ..++||||+++++|.+++....          ..+++..+..++.|++.||.|||+   .+|+||||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dlkp~Ni  161 (296)
T cd05095          85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRNC  161 (296)
T ss_pred             EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCeecccCChheE
Confidence            9977654 5789999999999999986532          236678899999999999999998   8999999999999


Q ss_pred             EECCCCcEEEeccccceecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          242 LLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       242 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      |++.++.++|+|||+++.+.............++..|++||......++.++|+||||+++||+++
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~  227 (296)
T cd05095         162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT  227 (296)
T ss_pred             EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHH
Confidence            999999999999999987644322211223345678999998766678889999999999999875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=1.2e-33  Score=248.44  Aligned_cols=193  Identities=23%  Similarity=0.305  Sum_probs=166.5

Q ss_pred             CccccceeeccCceEEEEEEEC-CCcEEEEEEeccC-ChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEEEe
Q 021711          111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRG-TADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLEL  187 (308)
Q Consensus       111 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~  187 (308)
                      +|++.+.||+|+||.||+|... +++.|++|.+... ........+.+|+.+++.++||||+++++++.+. ..++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            4778899999999999999876 5899999998643 2234467889999999999999999999976654 57899999


Q ss_pred             cCCCCHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCce
Q 021711          188 SPNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH  266 (308)
Q Consensus       188 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~  266 (308)
                      +++++|.+++... ...+++..+..++.|++.||.|||+   .+|+|+||||+||+++.++.++|+|||+++.+..... 
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~---~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~-  156 (256)
T cd08529          81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN-  156 (256)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEeCCCCEEEcccccceeccCccc-
Confidence            9999999998764 4568899999999999999999998   8999999999999999999999999999997765432 


Q ss_pred             eEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          267 HTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                       ......|+..|+|||+......+.++|+||||+++++|++|
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g  197 (256)
T cd08529         157 -FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTG  197 (256)
T ss_pred             -hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhC
Confidence             12345688999999998888888899999999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-34  Score=270.16  Aligned_cols=186  Identities=27%  Similarity=0.396  Sum_probs=160.0

Q ss_pred             eeeccCceEEEEEEECC-CcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeCcEE-EEEEecCCCCHH
Q 021711          117 LIGKGGYAEVYKGRLRN-GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMH-IVLELSPNGSLA  194 (308)
Q Consensus       117 ~LG~G~fg~Vy~~~~~~-g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-lv~e~~~~gsL~  194 (308)
                      +||+|.||+||-|++.+ ...+|||-+...... ..+-+..|+.+-++|+|.|||+++|.+.+++.+ +.||.++||+|.
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr-~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS  660 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSR-EVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS  660 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccch-hhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence            79999999999999775 557899998755443 356688899999999999999999988877754 789999999999


Q ss_pred             HHHhccCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECC-CCcEEEeccccceecCCCCceeEeec
Q 021711          195 SLLYGMKEKL--KWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTE-DFEPQICDFGLAKWLPEQWTHHTISK  271 (308)
Q Consensus       195 ~~l~~~~~~l--~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~~~  271 (308)
                      ++|+..-+++  ++.++-.+..||++||.|||+   +.|||||||-+|+|++. .|.+||+|||.++.+.-- +. ...+
T Consensus       661 sLLrskWGPlKDNEstm~fYtkQILeGLkYLHe---n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi-nP-~TET  735 (1226)
T KOG4279|consen  661 SLLRSKWGPLKDNESTMNFYTKQILEGLKYLHE---NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI-NP-CTET  735 (1226)
T ss_pred             HHHHhccCCCccchhHHHHHHHHHHHHhhhhhh---cceeeccccCCcEEEeeccceEEecccccchhhccC-Cc-cccc
Confidence            9998877777  778888899999999999999   89999999999999985 589999999999877432 11 2357


Q ss_pred             eeccccccccccCchhh--cCccceeEEEeeEEEeeccC
Q 021711          272 VEGTFGLVKLNLPPLVI--LKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       272 ~~gt~~y~aPE~~~~~~--~~~~~Di~s~g~~l~el~c~  308 (308)
                      +.||..|||||.+..+.  +++++|||||||++.|||+|
T Consensus       736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATG  774 (1226)
T KOG4279|consen  736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATG  774 (1226)
T ss_pred             cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccC
Confidence            89999999999986553  78899999999999999987

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.7e-34  Score=257.51  Aligned_cols=196  Identities=23%  Similarity=0.238  Sum_probs=166.0

Q ss_pred             CCccccceeeccCceEEEEEEECC-CcEEEEEEeccCCh--HHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLRN-GQLVAIKRLTRGTA--DEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVL  185 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~~-g~~vAvK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~  185 (308)
                      +.|++.+.||+|.-|+||++++++ +..+|+|.+.+...  .+...+...|.+||+.++||.++.||+.+..+ ..||||
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m  156 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM  156 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence            567888999999999999999874 68999999976533  23456778899999999999999999866555 578999


Q ss_pred             EecCCCCHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCC--
Q 021711          186 ELSPNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE--  262 (308)
Q Consensus       186 e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~--  262 (308)
                      |||+||+|..+++.+ ...+++..+.-++.+|+.||+|||-   .|||+|||||+||||.++|++.|+||.|+....-  
T Consensus       157 eyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHm---lGivYRDLKPENILvredGHIMLsDFDLS~~~~~~P  233 (459)
T KOG0610|consen  157 EYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHM---LGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP  233 (459)
T ss_pred             ecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHh---hceeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence            999999999988653 4568999999999999999999998   9999999999999999999999999998653210  


Q ss_pred             -------------------------------CCce---------------------eEeeceeccccccccccCchhhcC
Q 021711          263 -------------------------------QWTH---------------------HTISKVEGTFGLVKLNLPPLVILK  290 (308)
Q Consensus       263 -------------------------------~~~~---------------------~~~~~~~gt~~y~aPE~~~~~~~~  290 (308)
                                                     ..+.                     .....++||-.|+|||.+.+...+
T Consensus       234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg  313 (459)
T KOG0610|consen  234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG  313 (459)
T ss_pred             eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC
Confidence                                           0000                     012357899999999999999999


Q ss_pred             ccceeEEEeeEEEeeccC
Q 021711          291 RCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       291 ~~~Di~s~g~~l~el~c~  308 (308)
                      ...|=|+||+.||||.+|
T Consensus       314 sAVDWWtfGIflYEmLyG  331 (459)
T KOG0610|consen  314 SAVDWWTFGIFLYEMLYG  331 (459)
T ss_pred             chhhHHHHHHHHHHHHhC
Confidence            999999999999999986

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=4.2e-34  Score=258.36  Aligned_cols=193  Identities=23%  Similarity=0.294  Sum_probs=162.2

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEEEe
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLEL  187 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~  187 (308)
                      ++|.+.+.||+|+||.||+|... +++.||+|.+...........+.+|+.+++.++||||+++++++... ..++|+||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            57899999999999999999876 58899999986543333345678899999999999999999977654 57899999


Q ss_pred             cCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCcee
Q 021711          188 SPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH  267 (308)
Q Consensus       188 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~  267 (308)
                      +. ++|.+++......+++..+..++.|++.||.|||+   .+|+|+||||+|||++.++.++|+|||+++.......  
T Consensus        86 ~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~--  159 (301)
T cd07873          86 LD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK--  159 (301)
T ss_pred             cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC--
Confidence            97 58988887666678899999999999999999998   8999999999999999999999999999986543221  


Q ss_pred             EeeceeccccccccccCchh-hcCccceeEEEeeEEEeeccC
Q 021711          268 TISKVEGTFGLVKLNLPPLV-ILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ......+++.|+|||.+.+. ..+.++|+||+|+++|||++|
T Consensus       160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg  201 (301)
T cd07873         160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTG  201 (301)
T ss_pred             cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhC
Confidence            22345678999999986543 467789999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=6.1e-34  Score=259.02  Aligned_cols=187  Identities=22%  Similarity=0.321  Sum_probs=151.5

Q ss_pred             cceeeccCceEEEEEEEC---CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEe---CcEEEEEEec
Q 021711          115 ENLIGKGGYAEVYKGRLR---NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE---GGMHIVLELS  188 (308)
Q Consensus       115 ~~~LG~G~fg~Vy~~~~~---~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---~~~~lv~e~~  188 (308)
                      .+.||+|+||.||+|+..   +++.||+|.+.....   ...+.+|+.++++++||||+++++++..   ...++++||+
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~   82 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI---SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA   82 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC---cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc
Confidence            368999999999999865   467899999865432   2456789999999999999999987643   2468899998


Q ss_pred             CCCCHHHHHhcc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEE----CCCCcEEEecccc
Q 021711          189 PNGSLASLLYGM--------KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILL----TEDFEPQICDFGL  256 (308)
Q Consensus       189 ~~gsL~~~l~~~--------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl----~~~~~~kl~DFGl  256 (308)
                      . ++|.+++...        ...++...+..++.||+.||.|||+   .+|+||||||+|||+    +.++.+||+|||+
T Consensus        83 ~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~  158 (317)
T cd07868          83 E-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGF  158 (317)
T ss_pred             C-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence            5 4888776421        1247888899999999999999998   899999999999999    4567899999999


Q ss_pred             ceecCCCCce-eEeeceeccccccccccCchh-hcCccceeEEEeeEEEeeccC
Q 021711          257 AKWLPEQWTH-HTISKVEGTFGLVKLNLPPLV-ILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       257 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ++.+...... .......||+.|+|||.+.+. .++.++|+||+|++++||++|
T Consensus       159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g  212 (317)
T cd07868         159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS  212 (317)
T ss_pred             eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhC
Confidence            9876543221 123457889999999987654 478889999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-33  Score=250.67  Aligned_cols=193  Identities=26%  Similarity=0.383  Sum_probs=160.0

Q ss_pred             ccccceeeccCceEEEEEEECC----CcEEEEEEeccCC-hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeCc------
Q 021711          112 FSFENLIGKGGYAEVYKGRLRN----GQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG------  180 (308)
Q Consensus       112 ~~~~~~LG~G~fg~Vy~~~~~~----g~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  180 (308)
                      |++.+.||+|+||.||+|....    +..||+|.++... .......+.+|+.+++.++||||+++++++....      
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            5678899999999999998642    3689999987543 2334578999999999999999999999765433      


Q ss_pred             -EEEEEEecCCCCHHHHHhcc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEecc
Q 021711          181 -MHIVLELSPNGSLASLLYGM-----KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDF  254 (308)
Q Consensus       181 -~~lv~e~~~~gsL~~~l~~~-----~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DF  254 (308)
                       .++++||+++|+|..++...     ...+++..+..++.|++.||.|||+   .+|+||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchheEEECCCCeEEECCc
Confidence             57999999999999888432     2358889999999999999999998   89999999999999999999999999


Q ss_pred             ccceecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          255 GLAKWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       255 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      |+++.+.............++..|+|||.......+.++|+||+|+++|||+.
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~  210 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT  210 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHh
Confidence            99997754433222223345778999999887788999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=3.5e-34  Score=252.20  Aligned_cols=191  Identities=30%  Similarity=0.432  Sum_probs=165.0

Q ss_pred             ccccceeeccCceEEEEEEECC-CcEEEEEEeccCChHHH-HHHHHHHHHHHhcCCCCeeeeeeeEEEe-CcEEEEEEec
Q 021711          112 FSFENLIGKGGYAEVYKGRLRN-GQLVAIKRLTRGTADEI-IADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLELS  188 (308)
Q Consensus       112 ~~~~~~LG~G~fg~Vy~~~~~~-g~~vAvK~~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~lv~e~~  188 (308)
                      |++.+.||+|+||.||++.... ++.+|+|.+........ .....+|+.++++++||||+++++++.. ...++|||++
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            6788999999999999999874 67899999987654432 3345679999999999999999997765 4578999999


Q ss_pred             CCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCceeE
Q 021711          189 PNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT  268 (308)
Q Consensus       189 ~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  268 (308)
                      .+++|.+++. ....+++..+..++.|++.||.|||+   .+|+|+||||+||+++.++.++|+|||.+......  ...
T Consensus        81 ~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~Lh~---~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~--~~~  154 (260)
T PF00069_consen   81 PGGSLQDYLQ-KNKPLSEEEILKIAYQILEALAYLHS---KGIVHRDIKPENILLDENGEVKLIDFGSSVKLSEN--NEN  154 (260)
T ss_dssp             TTEBHHHHHH-HHSSBBHHHHHHHHHHHHHHHHHHHH---TTEEESSBSGGGEEESTTSEEEESSGTTTEESTST--TSE
T ss_pred             cccccccccc-cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc--ccc
Confidence            9999999996 35678999999999999999999999   89999999999999999999999999999875222  224


Q ss_pred             eeceeccccccccccCc-hhhcCccceeEEEeeEEEeeccC
Q 021711          269 ISKVEGTFGLVKLNLPP-LVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       269 ~~~~~gt~~y~aPE~~~-~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      .....+|..|+|||... ....+.++|+||+|+++++|++|
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~  195 (260)
T PF00069_consen  155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTG  195 (260)
T ss_dssp             BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHS
T ss_pred             ccccccccccccccccccccccccccccccccccccccccc
Confidence            45678999999999987 77889999999999999999875

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=9.8e-34  Score=251.68  Aligned_cols=189  Identities=24%  Similarity=0.261  Sum_probs=153.5

Q ss_pred             ceeeccCceEEEEEEECC---CcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEEEecCCC
Q 021711          116 NLIGKGGYAEVYKGRLRN---GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLELSPNG  191 (308)
Q Consensus       116 ~~LG~G~fg~Vy~~~~~~---g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~~~g  191 (308)
                      +.||+|+||.||+|...+   +..+|+|.+...........+.+|+.+++.++||||+++++++.+. ..++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            368999999999998643   4679999887654444446789999999999999999999977654 478999999999


Q ss_pred             CHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCcee
Q 021711          192 SLASLLYGMK----EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH  267 (308)
Q Consensus       192 sL~~~l~~~~----~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~  267 (308)
                      +|.+++....    ...++..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||+++.........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK---NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            9999986422    245667788899999999999998   899999999999999999999999999997654332222


Q ss_pred             EeeceeccccccccccCchh-------hcCccceeEEEeeEEEeecc
Q 021711          268 TISKVEGTFGLVKLNLPPLV-------ILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~-------~~~~~~Di~s~g~~l~el~c  307 (308)
                      ......|+..|+|||.....       ..+.++|+||||+++|||++
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~  204 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFE  204 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHh
Confidence            22345678899999987543       24678999999999999864

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=7.5e-34  Score=255.27  Aligned_cols=195  Identities=25%  Similarity=0.266  Sum_probs=161.7

Q ss_pred             hcCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEE
Q 021711          108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVL  185 (308)
Q Consensus       108 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~  185 (308)
                      ++++|.+.+.||+|+||.||+|... +|+.||+|.+...........+.+|+.+++.++|+||+++++++..+ ..++|+
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            3578999999999999999999865 58899999986544333334677899999999999999999977655 478999


Q ss_pred             EecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCc
Q 021711          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (308)
Q Consensus       186 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~  265 (308)
                      ||+. ++|.+.+......+++..+..++.|++.||.|||+   .+|+|+||||+|||++.++.++|+|||+++.......
T Consensus        83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  158 (291)
T cd07870          83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ  158 (291)
T ss_pred             eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEEcCCCcEEEeccccccccCCCCC
Confidence            9996 67777765545567888888999999999999998   8999999999999999999999999999986543221


Q ss_pred             eeEeeceeccccccccccCchh-hcCccceeEEEeeEEEeeccC
Q 021711          266 HHTISKVEGTFGLVKLNLPPLV-ILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~s~g~~l~el~c~  308 (308)
                        ......++..|+|||...+. ..+.++|+||+|+++|||++|
T Consensus       159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g  200 (291)
T cd07870         159 --TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQG  200 (291)
T ss_pred             --CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhC
Confidence              22345679999999987653 367789999999999999876

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4e-35  Score=288.54  Aligned_cols=203  Identities=23%  Similarity=0.247  Sum_probs=175.4

Q ss_pred             CHHHHHhhcCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCCh--HHHHHHHHHHHHHHhcCCCCeeeeee-eEE
Q 021711          101 SLYELQSATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELGIMAHVDHPNTAKLL-GYG  176 (308)
Q Consensus       101 ~~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~-~~~  176 (308)
                      ...++....++|.+.++||+|+||.|..++++ +++.+|+|++.+-..  .....-|..|-.+|..-+.+-|+.++ +|.
T Consensus        66 ~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQ  145 (1317)
T KOG0612|consen   66 KVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQ  145 (1317)
T ss_pred             HHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhc
Confidence            34566667789999999999999999999987 588999999865211  11246788999999999999999996 577


Q ss_pred             EeCcEEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEecccc
Q 021711          177 IEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGL  256 (308)
Q Consensus       177 ~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGl  256 (308)
                      .+.++|+||||++||+|..++.... ++++..+..++..|+.||.-||+   .|+|||||||+|||||..|++||+|||.
T Consensus       146 D~~~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~---mgyVHRDiKPDNvLld~~GHikLADFGs  221 (1317)
T KOG0612|consen  146 DERYLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHS---MGYVHRDIKPDNVLLDKSGHIKLADFGS  221 (1317)
T ss_pred             CccceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHh---ccceeccCCcceeEecccCcEeeccchh
Confidence            7778999999999999999997655 79999999999999999999998   9999999999999999999999999999


Q ss_pred             ceecCCCCceeEeeceeccccccccccCch-----hhcCccceeEEEeeEEEeeccC
Q 021711          257 AKWLPEQWTHHTISKVEGTFGLVKLNLPPL-----VILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       257 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      +-.+..++.. .....+|||.|++||.+..     ..+++..|-||+|+++|||+||
T Consensus       222 Clkm~~dG~V-~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG  277 (1317)
T KOG0612|consen  222 CLKMDADGTV-RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYG  277 (1317)
T ss_pred             HHhcCCCCcE-EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcC
Confidence            9888876654 3457889999999998632     3577889999999999999997

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=1.3e-33  Score=250.15  Aligned_cols=195  Identities=23%  Similarity=0.315  Sum_probs=163.7

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCC----hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC---cE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT----ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG---GM  181 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---~~  181 (308)
                      .+|++.+.||+|+||.||+|... ++..||+|.+....    .....+.+.+|+.++..++||||+++++++.+.   .+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            57899999999999999999875 58999999875321    123456888999999999999999999976543   36


Q ss_pred             EEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecC
Q 021711          182 HIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP  261 (308)
Q Consensus       182 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~  261 (308)
                      ++++||+++++|.+++.. ...+++.....++.|++.||.|||+   .+|+|+||||+||+++.++.++|+|||+++.+.
T Consensus        82 ~~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~  157 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKS-YGALTENVTRKYTRQILEGVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQ  157 (265)
T ss_pred             EEEEEecCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEecCCCCEEECcCccccccc
Confidence            799999999999998864 3457888899999999999999998   899999999999999999999999999998654


Q ss_pred             CCCce-eEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          262 EQWTH-HTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       262 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ..... .......|+..|+|||...+...+.++|+||||+++|||++|
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g  205 (265)
T cd06652         158 TICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTE  205 (265)
T ss_pred             cccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhC
Confidence            32111 122345689999999998777788899999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=1.1e-33  Score=254.21  Aligned_cols=190  Identities=25%  Similarity=0.338  Sum_probs=165.4

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCCh--HHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVL  185 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~  185 (308)
                      ++|++.+.||+|+||.||++... +++.||+|.+.....  .+....+.+|+++++.++||||+++++++..+ ..++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            47889999999999999999876 589999999865321  23456789999999999999999999976654 578999


Q ss_pred             EecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCc
Q 021711          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (308)
Q Consensus       186 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~  265 (308)
                      ||+++++|.+++.. ...++...+..++.|++.||.|||+   .+|+|+||+|+|||++.++.+||+|||+++.....  
T Consensus        81 e~~~~~~L~~~~~~-~~~l~~~~~~~~~~qil~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--  154 (290)
T cd05580          81 EYVPGGELFSHLRK-SGRFPEPVARFYAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--  154 (290)
T ss_pred             ecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--
Confidence            99999999999865 3578999999999999999999998   89999999999999999999999999999876544  


Q ss_pred             eeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          266 HHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                         .....|++.|+|||...+...+.++|+||+|+++++|++|
T Consensus       155 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g  194 (290)
T cd05580         155 ---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAG  194 (290)
T ss_pred             ---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhC
Confidence               2345789999999998777778889999999999999876

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=6.3e-34  Score=251.70  Aligned_cols=192  Identities=26%  Similarity=0.337  Sum_probs=164.3

Q ss_pred             CCccccceeeccCceEEEEEEECCCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeCcEEEEEEecC
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHIVLELSP  189 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~lv~e~~~  189 (308)
                      ++|.+...||+|+||.||+|.+..+..+|+|.+.....  ..+.+.+|+.+++.++|||++++++++..+..+++|||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~   83 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM--MPEAFLQEAQIMKKLRHDKLVPLYAVVSEEPIYIVTEFMG   83 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc--cHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCcEEEEEcCC
Confidence            56888999999999999999987777899998865432  2367889999999999999999999887777899999999


Q ss_pred             CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCceeE
Q 021711          190 NGSLASLLYGMK-EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT  268 (308)
Q Consensus       190 ~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  268 (308)
                      +++|.+++.... ..+++..+..++.|++.||.|||+   .+|+|+||||+||++++++.++|+|||+++....... ..
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~-~~  159 (260)
T cd05069          84 KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY-TA  159 (260)
T ss_pred             CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCeEEECCCccceEccCCcc-cc
Confidence            999999996533 347899999999999999999998   8999999999999999999999999999987644321 11


Q ss_pred             eeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          269 ISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       269 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      .....++..|+|||.......+.++|+||+|+++||+++
T Consensus       160 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t  198 (260)
T cd05069         160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVT  198 (260)
T ss_pred             cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHh
Confidence            223456788999998877778889999999999999976

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1.2e-33  Score=256.06  Aligned_cols=193  Identities=26%  Similarity=0.412  Sum_probs=158.8

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCc--EEEEEEeccCChHHHHHHHHHHHHHHhcC-CCCeeeeeeeEEEeC-cEEE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQ--LVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGIEG-GMHI  183 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~--~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~~~l  183 (308)
                      .++|++.+.||+|+||.||+|.++ ++.  .+|+|.+...........+.+|+.++.++ +||||+++++++..+ ..++
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l   85 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   85 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence            357889999999999999999875 344  46888776544444567888999999999 899999999977654 4789


Q ss_pred             EEEecCCCCHHHHHhccC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCc
Q 021711          184 VLELSPNGSLASLLYGMK---------------EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFE  248 (308)
Q Consensus       184 v~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~  248 (308)
                      |+||+++++|.+++....               ..+++..++.++.|++.||.|||+   ++|+||||||+|||++.++.
T Consensus        86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dlkp~Nili~~~~~  162 (303)
T cd05088          86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYV  162 (303)
T ss_pred             EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEecCCCc
Confidence            999999999999986432               257888999999999999999998   89999999999999999999


Q ss_pred             EEEeccccceecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          249 PQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       249 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      +||+|||+++......   ......++..|+|||.......+.++|+||||++++|++.
T Consensus       163 ~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt  218 (303)
T cd05088         163 AKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS  218 (303)
T ss_pred             EEeCccccCcccchhh---hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHh
Confidence            9999999987432111   1112234678999998877778889999999999999974

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=7.8e-34  Score=260.61  Aligned_cols=198  Identities=23%  Similarity=0.307  Sum_probs=163.5

Q ss_pred             hhcCCccccceeeccCceEEEEEEECC--------CcEEEEEEeccCChHHHHHHHHHHHHHHhcC-CCCeeeeeeeEEE
Q 021711          107 SATNNFSFENLIGKGGYAEVYKGRLRN--------GQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGI  177 (308)
Q Consensus       107 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~--------g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  177 (308)
                      ....+|++.+.||+|+||.||+|....        +..||+|.+...........+.+|+.+++++ +||||+++++++.
T Consensus         9 ~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~   88 (334)
T cd05100           9 LSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACT   88 (334)
T ss_pred             cCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc
Confidence            334578999999999999999997421        2368999887655455567899999999999 7999999999776


Q ss_pred             eC-cEEEEEEecCCCCHHHHHhccC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCE
Q 021711          178 EG-GMHIVLELSPNGSLASLLYGMK---------------EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANI  241 (308)
Q Consensus       178 ~~-~~~lv~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NI  241 (308)
                      .. ..++++||+++|+|.+++....               ..+++..+..++.|++.||.|||+   ++|+||||||+||
T Consensus        89 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Ni  165 (334)
T cd05100          89 QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKCIHRDLAARNV  165 (334)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceE
Confidence            65 4789999999999999986421               247788899999999999999998   8999999999999


Q ss_pred             EECCCCcEEEeccccceecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          242 LLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       242 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      |++.++.+||+|||+++...............++..|+|||...+...+.++|+||||+++|||++
T Consensus       166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~  231 (334)
T cd05100         166 LVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT  231 (334)
T ss_pred             EEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHh
Confidence            999999999999999987654322212223344678999999888888889999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-35  Score=263.79  Aligned_cols=195  Identities=27%  Similarity=0.361  Sum_probs=169.6

Q ss_pred             hcCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChH--HHHHHHHHHHHHHhcCCCCeeeee-eeEEEeCcEEE
Q 021711          108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTAD--EIIADFLSELGIMAHVDHPNTAKL-LGYGIEGGMHI  183 (308)
Q Consensus       108 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l-~~~~~~~~~~l  183 (308)
                      ..+.|+.-++||+|+||.||-|+.+ +|..+|.|.+.+....  ....-.++|-.||.+++.++||.+ |+|.+.+.+++
T Consensus       183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LCl  262 (591)
T KOG0986|consen  183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCL  262 (591)
T ss_pred             cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEE
Confidence            4567888899999999999999866 5999999988543211  122446789999999999999998 56888888999


Q ss_pred             EEEecCCCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCC
Q 021711          184 VLELSPNGSLASLLYGMK-EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE  262 (308)
Q Consensus       184 v~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~  262 (308)
                      |+..|.||+|...|.+.+ ..+++..+.-++.+|+.||++||.   .+||+|||||+|||||+.|+++|+|+|||..+++
T Consensus       263 VLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~---~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~  339 (591)
T KOG0986|consen  263 VLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHR---RRIVYRDLKPENILLDDHGHVRISDLGLAVEIPE  339 (591)
T ss_pred             EEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHh---cceeeccCChhheeeccCCCeEeeccceEEecCC
Confidence            999999999998887654 458999999999999999999998   8999999999999999999999999999999988


Q ss_pred             CCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          263 QWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       263 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ...   ....+||.||||||...+..++-+.|-||+|++||||.-|
T Consensus       340 g~~---~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G  382 (591)
T KOG0986|consen  340 GKP---IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAG  382 (591)
T ss_pred             CCc---cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcc
Confidence            743   3456999999999999888899999999999999998754

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-33  Score=248.15  Aligned_cols=195  Identities=23%  Similarity=0.321  Sum_probs=164.7

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCCh----HHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA----DEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHI  183 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l  183 (308)
                      ++|.+.+.||+|+||.||+|... +++.||+|.+.....    ......+.+|+.++++++||||+++++++..+ ..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            57889999999999999999865 589999998864321    12345788999999999999999999976654 5789


Q ss_pred             EEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCC
Q 021711          184 VLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ  263 (308)
Q Consensus       184 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  263 (308)
                      |+||+++++|.+.+.. ...++...+..++.|++.||.|||+   .+|+||||+|+||+++.++.++|+|||+++.....
T Consensus        82 v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~  157 (263)
T cd06625          82 FMEYMPGGSVKDQLKA-YGALTETVTRKYTRQILEGVEYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI  157 (263)
T ss_pred             EEEECCCCcHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecccc
Confidence            9999999999998854 3468888899999999999999998   89999999999999999999999999999876443


Q ss_pred             Ccee-EeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          264 WTHH-TISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       264 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      .... ......|+..|+|||...+...+.++|+||+|+++||+++|
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g  203 (263)
T cd06625         158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTE  203 (263)
T ss_pred             ccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhC
Confidence            2111 11345688999999998887788999999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=1.1e-33  Score=250.50  Aligned_cols=194  Identities=25%  Similarity=0.354  Sum_probs=164.5

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccC--ChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEe-CcEEEEE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRG--TADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVL  185 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~lv~  185 (308)
                      ++|++.+.||+|+||.||+|+.. +++.||||.+...  ...+....+.+|+.+++.++||||+++++++.. +..++++
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            57899999999999999999865 6899999987542  223445678999999999999999999986655 4578999


Q ss_pred             EecCCCCHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCC
Q 021711          186 ELSPNGSLASLLYG---MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE  262 (308)
Q Consensus       186 e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~  262 (308)
                      ||+++++|.+++..   ....++...+..++.|++.||.|||+   ++++|+||||+||+++.++.++|+|||++..+..
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            99999999988753   23457888999999999999999998   8999999999999999999999999999987754


Q ss_pred             CCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          263 QWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       263 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ...  ......|+..|+|||...+...+.++|+||+|+++|||+.|
T Consensus       159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g  202 (267)
T cd08228         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAAL  202 (267)
T ss_pred             hhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcC
Confidence            322  12345688999999998877788889999999999999764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=8.4e-34  Score=250.66  Aligned_cols=190  Identities=28%  Similarity=0.367  Sum_probs=157.3

Q ss_pred             ceeeccCceEEEEEEEC----CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEe--CcEEEEEEecC
Q 021711          116 NLIGKGGYAEVYKGRLR----NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE--GGMHIVLELSP  189 (308)
Q Consensus       116 ~~LG~G~fg~Vy~~~~~----~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~lv~e~~~  189 (308)
                      +.||+|+||.||+|.+.    .+..||+|.+...........+.+|+.+++.++||||+++++++..  +..++++||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            46899999999999853    2457999998654444446788999999999999999999997653  34789999999


Q ss_pred             CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCce--e
Q 021711          190 NGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH--H  267 (308)
Q Consensus       190 ~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~--~  267 (308)
                      +|+|.+++......+.+..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++.+......  .
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~  157 (262)
T cd05058          81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH  157 (262)
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence            999999997655567788888999999999999998   89999999999999999999999999999866443211  1


Q ss_pred             EeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          268 TISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ......++..|+|||.......+.++|+||||+++|||+++
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~  198 (262)
T cd05058         158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTR  198 (262)
T ss_pred             ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcC
Confidence            11234567889999998777788899999999999999763

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-34  Score=279.24  Aligned_cols=200  Identities=23%  Similarity=0.310  Sum_probs=162.6

Q ss_pred             HhhcCCccccceeeccCceEEEEEEECCC-cEEEEEEeccCChHHHHHHHHHHHHHHhcCC-CCeeeeeee-EEE---e-
Q 021711          106 QSATNNFSFENLIGKGGYAEVYKGRLRNG-QLVAIKRLTRGTADEIIADFLSELGIMAHVD-HPNTAKLLG-YGI---E-  178 (308)
Q Consensus       106 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~g-~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~-~~~---~-  178 (308)
                      .....++++.++|.+|||+.||+|....+ ..||+|++-.. ++...+...+|+++|+.|+ |+|||.+++ ...   . 
T Consensus        33 ~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~-de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~  111 (738)
T KOG1989|consen   33 TVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN-DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSN  111 (738)
T ss_pred             EECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC-CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCC
Confidence            34556888999999999999999998765 99999998766 4556788999999999997 999999998 322   1 


Q ss_pred             C---cEEEEEEecCCCCHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEecc
Q 021711          179 G---GMHIVLELSPNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDF  254 (308)
Q Consensus       179 ~---~~~lv~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DF  254 (308)
                      +   ++.|.||||.||.|.+++..+ ...|++..+++|+.|+++|+.+||. ++.+|||||||.+||||+.+++.|||||
T Consensus       112 ~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g~~KLCDF  190 (738)
T KOG1989|consen  112 NGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADGNYKLCDF  190 (738)
T ss_pred             CceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCCCEEeCcc
Confidence            1   256899999999999999642 3459999999999999999999997 4467999999999999999999999999


Q ss_pred             ccceecCCCC-ceeEe------eceeccccccccccC---chhhcCccceeEEEeeEEEeecc
Q 021711          255 GLAKWLPEQW-THHTI------SKVEGTFGLVKLNLP---PLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       255 Gla~~~~~~~-~~~~~------~~~~gt~~y~aPE~~---~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      |-|...-..- +....      -..-.|+.|+|||++   -+...+.++|||++||+||.|++
T Consensus       191 GSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy  253 (738)
T KOG1989|consen  191 GSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCY  253 (738)
T ss_pred             cccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHH
Confidence            9986432211 11111      123468999999975   35557899999999999998864

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-34  Score=269.86  Aligned_cols=192  Identities=28%  Similarity=0.437  Sum_probs=171.5

Q ss_pred             CccccceeeccCceEEEEEEECC---C--cEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeCcEEEEE
Q 021711          111 NFSFENLIGKGGYAEVYKGRLRN---G--QLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHIVL  185 (308)
Q Consensus       111 ~~~~~~~LG~G~fg~Vy~~~~~~---g--~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~lv~  185 (308)
                      ...+.+.||.|.||.||+|.+.+   |  -.||||..+.+...+..+.|+.|..+|++++|||||+++|.|.+...|+||
T Consensus       390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~P~Wivm  469 (974)
T KOG4257|consen  390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQPMWIVM  469 (974)
T ss_pred             hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeeccceeEEE
Confidence            34456789999999999998643   2  469999998876666689999999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCc
Q 021711          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (308)
Q Consensus       186 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~  265 (308)
                      |.++-|.|..+|..++..++......++.||+.+|.|||+   .++|||||.++|||+....-+||+|||++|++.++..
T Consensus       470 EL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeS---krfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~y  546 (974)
T KOG4257|consen  470 ELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLES---KRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAY  546 (974)
T ss_pred             ecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHh---hchhhhhhhhhheeecCcceeeecccchhhhccccch
Confidence            9999999999999888899999999999999999999999   9999999999999999999999999999999977644


Q ss_pred             eeEeeceeccccccccccCchhhcCccceeEEEeeEEEeec
Q 021711          266 HHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLS  306 (308)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~  306 (308)
                      .+ .+...-.+-|||||-..-..++..+|+|=||++|||++
T Consensus       547 Yk-aS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl  586 (974)
T KOG4257|consen  547 YK-ASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEIL  586 (974)
T ss_pred             hh-ccccccceeecCccccchhcccchhhHHHHHHHHHHHH
Confidence            32 23555568899999988888899999999999999986

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=1.2e-33  Score=254.25  Aligned_cols=194  Identities=20%  Similarity=0.279  Sum_probs=162.6

Q ss_pred             CCccccceeeccCceEEEEEEEC------CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR------NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMH  182 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~------~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~  182 (308)
                      .+|.+.+.||+|+||.||+|...      ++..+++|.+..... .....+.+|+.+++.++||||+++++++... ..+
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL-AARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI   83 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccH-HHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceE
Confidence            46888899999999999999743      345689998865443 2346788999999999999999999977665 478


Q ss_pred             EEEEecCCCCHHHHHhccC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCC
Q 021711          183 IVLELSPNGSLASLLYGMK---------------EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDF  247 (308)
Q Consensus       183 lv~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~  247 (308)
                      +||||+++++|.+++....               ..+++..++.++.|++.||.|||+   ++|+||||||+|||++.++
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil~~~~~  160 (291)
T cd05094          84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS---QHFVHRDLATRNCLVGANL  160 (291)
T ss_pred             EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCC
Confidence            9999999999999986422               347889999999999999999998   8999999999999999999


Q ss_pred             cEEEeccccceecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          248 EPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       248 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      .++|+|||+++...............++..|+|||.......+.++|+||+|+++|||++
T Consensus       161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t  220 (291)
T cd05094         161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT  220 (291)
T ss_pred             cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHh
Confidence            999999999987654332222234557889999999888888889999999999999986

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=7.3e-34  Score=252.43  Aligned_cols=194  Identities=27%  Similarity=0.388  Sum_probs=162.7

Q ss_pred             hcCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcC-CCCeeeeeeeEEEe-------
Q 021711          108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGIE-------  178 (308)
Q Consensus       108 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-------  178 (308)
                      +++.|++.+.||+|+||.||+|... +++.||+|.+......  ...+.+|+.++..+ +|+||+++++++..       
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~--~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE--EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCcc--HHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            4567888899999999999999876 5889999998654322  35678899999998 79999999997654       


Q ss_pred             CcEEEEEEecCCCCHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccc
Q 021711          179 GGMHIVLELSPNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLA  257 (308)
Q Consensus       179 ~~~~lv~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla  257 (308)
                      ...+++|||+++++|.+++... ...+++..+..++.|++.||.|||+   ++|+||||||+||+++.++.++|+|||++
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivh~dl~~~nili~~~~~~~l~Dfg~~  158 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVS  158 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHEEECCCCCEEEccCCCc
Confidence            2368999999999999998753 3468899999999999999999999   89999999999999999999999999999


Q ss_pred             eecCCCCceeEeeceeccccccccccCc-----hhhcCccceeEEEeeEEEeeccC
Q 021711          258 KWLPEQWTHHTISKVEGTFGLVKLNLPP-----LVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      +.+.....  ......|+..|+|||.+.     ...++.++|+||+|+++|||++|
T Consensus       159 ~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g  212 (272)
T cd06637         159 AQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG  212 (272)
T ss_pred             eecccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhC
Confidence            87643221  234567999999999864     33467789999999999999875

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=6.2e-34  Score=254.16  Aligned_cols=196  Identities=28%  Similarity=0.331  Sum_probs=161.3

Q ss_pred             cCCccccceeeccCceEEEEEEECC------CcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLRN------GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GM  181 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~~------g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~  181 (308)
                      .++|++.+.||+|+||.||+|.+..      +..||+|.+...........|.+|+.+++.++|+||+++++++.+. ..
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   84 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR   84 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence            4678999999999999999998753      5679999886554444456799999999999999999999966554 57


Q ss_pred             EEEEEecCCCCHHHHHhccC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCC---cEEEe
Q 021711          182 HIVLELSPNGSLASLLYGMK------EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDF---EPQIC  252 (308)
Q Consensus       182 ~lv~e~~~~gsL~~~l~~~~------~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~---~~kl~  252 (308)
                      ++||||+++++|.+++....      ..+++..+..++.||+.||.|||+   ++++||||||+||+++.++   .+||+
T Consensus        85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~nil~~~~~~~~~~kl~  161 (277)
T cd05036          85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKIA  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchheEEEeccCCCcceEec
Confidence            89999999999999986532      258899999999999999999998   8999999999999998754   59999


Q ss_pred             ccccceecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          253 DFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       253 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      |||+++.+.............++..|+|||.+.....+.++|+||||+++|||++
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~  216 (277)
T cd05036         162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS  216 (277)
T ss_pred             cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHc
Confidence            9999987643221111122334578999999887888999999999999999875

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=4.7e-35  Score=250.21  Aligned_cols=193  Identities=25%  Similarity=0.329  Sum_probs=165.1

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccC-------ChHHHHHHHHHHHHHHhcC-CCCeeeeeeeEEEeC
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRG-------TADEIIADFLSELGIMAHV-DHPNTAKLLGYGIEG  179 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~-------~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  179 (308)
                      -++|.-.+.||.|..++|.+|..+ +|+.+|+|++...       ...+.++.-.+|+.||+++ .||+|+++.+++..+
T Consensus        16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~   95 (411)
T KOG0599|consen   16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD   95 (411)
T ss_pred             HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence            356777889999999999999866 5888999988532       1234567778899999998 699999999976665


Q ss_pred             c-EEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccce
Q 021711          180 G-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK  258 (308)
Q Consensus       180 ~-~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~  258 (308)
                      . +++|+|.|+.|.|.++|.. .-.+++....+|++|+.+|+.|||.   ++||||||||+|||++++.++||+|||+|.
T Consensus        96 sF~FlVFdl~prGELFDyLts-~VtlSEK~tR~iMrqlfegVeylHa---~~IVHRDLKpENILlddn~~i~isDFGFa~  171 (411)
T KOG0599|consen   96 AFVFLVFDLMPRGELFDYLTS-KVTLSEKETRRIMRQLFEGVEYLHA---RNIVHRDLKPENILLDDNMNIKISDFGFAC  171 (411)
T ss_pred             chhhhhhhhcccchHHHHhhh-heeecHHHHHHHHHHHHHHHHHHHH---hhhhhcccChhheeeccccceEEeccceee
Confidence            4 6789999999999999954 5568889999999999999999998   999999999999999999999999999999


Q ss_pred             ecCCCCceeEeeceeccccccccccCchh------hcCccceeEEEeeEEEeeccC
Q 021711          259 WLPEQWTHHTISKVEGTFGLVKLNLPPLV------ILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       259 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~Di~s~g~~l~el~c~  308 (308)
                      .++++..   ....+||+||+|||.+...      .++...|+|+.|++||.|+.|
T Consensus       172 ~l~~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaG  224 (411)
T KOG0599|consen  172 QLEPGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAG  224 (411)
T ss_pred             ccCCchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcC
Confidence            9988743   4578999999999986544      356779999999999988765

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=1.3e-33  Score=254.79  Aligned_cols=192  Identities=26%  Similarity=0.395  Sum_probs=158.3

Q ss_pred             CCccccceeeccCceEEEEEEECC-Cc--EEEEEEeccCChHHHHHHHHHHHHHHhcC-CCCeeeeeeeEEEeC-cEEEE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLRN-GQ--LVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGIEG-GMHIV  184 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~~-g~--~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~~~lv  184 (308)
                      ++|++.++||+|+||.||+|...+ +.  .+++|.++........+.+.+|+.++.++ +||||+++++++... ..+++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            578999999999999999998753 33  47888887544444467899999999999 799999999977654 47899


Q ss_pred             EEecCCCCHHHHHhccC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcE
Q 021711          185 LELSPNGSLASLLYGMK---------------EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEP  249 (308)
Q Consensus       185 ~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~  249 (308)
                      +||+++++|.+++....               ..+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCcCCcceEEECCCCeE
Confidence            99999999999986422               247888999999999999999998   899999999999999999999


Q ss_pred             EEeccccceecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          250 QICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       250 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      ||+|||++.......   .......+..|+|||.......+.++|+||||+++|||++
T Consensus       159 kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t  213 (297)
T cd05089         159 KIADFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS  213 (297)
T ss_pred             EECCcCCCcccccee---ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHc
Confidence            999999987432211   1111233567999999887778899999999999999974

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=1e-33  Score=254.24  Aligned_cols=193  Identities=24%  Similarity=0.316  Sum_probs=161.6

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEEEe
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLEL  187 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~  187 (308)
                      ++|++.+.||+|+||.||+|..+ +++.||+|.+...........+.+|+.+++.++|+||+++++++..+ ..++||||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            67899999999999999999976 58999999986543322234567899999999999999999977655 47899999


Q ss_pred             cCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCcee
Q 021711          188 SPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH  267 (308)
Q Consensus       188 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~  267 (308)
                      +.+ +|.+++......+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.+||+|||+++.......  
T Consensus        85 ~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~--  158 (291)
T cd07844          85 LDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK--  158 (291)
T ss_pred             CCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCHHHEEEcCCCCEEECccccccccCCCCc--
Confidence            975 8999887655678999999999999999999998   8999999999999999999999999999976533211  


Q ss_pred             EeeceeccccccccccCch-hhcCccceeEEEeeEEEeeccC
Q 021711          268 TISKVEGTFGLVKLNLPPL-VILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ......++..|+|||...+ ...+.++|+||+|+++|+|++|
T Consensus       159 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g  200 (291)
T cd07844         159 TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATG  200 (291)
T ss_pred             cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhC
Confidence            1233457889999998764 3467889999999999999876

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.2e-33  Score=253.21  Aligned_cols=193  Identities=25%  Similarity=0.377  Sum_probs=162.3

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEE-eCcEEEEEEe
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGI-EGGMHIVLEL  187 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~lv~e~  187 (308)
                      ++|++.+.||+|+||.||++... ++..||+|.+...........+.+|+.+++.++||||+++++.+. .+..++|+||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            36888999999999999999976 689999998875544444578999999999999999999998554 4567899999


Q ss_pred             cCCCCHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCc
Q 021711          188 SPNGSLASLLYGM--KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (308)
Q Consensus       188 ~~~gsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~  265 (308)
                      +++++|..++...  ...+++..+..++.|++.||.|||+  ..+|+||||||+||+++.++.++|+|||++..+.... 
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-  157 (286)
T cd06622          81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL-  157 (286)
T ss_pred             cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc-
Confidence            9999999888653  2368999999999999999999996  2589999999999999999999999999998764332 


Q ss_pred             eeEeeceeccccccccccCchh------hcCccceeEEEeeEEEeeccC
Q 021711          266 HHTISKVEGTFGLVKLNLPPLV------ILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~------~~~~~~Di~s~g~~l~el~c~  308 (308)
                         .....|+..|+|||.....      ..+.++|+||+|+++|++++|
T Consensus       158 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g  203 (286)
T cd06622         158 ---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALG  203 (286)
T ss_pred             ---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhC
Confidence               2334688999999987433      246789999999999999865

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=8.9e-34  Score=249.73  Aligned_cols=181  Identities=20%  Similarity=0.281  Sum_probs=154.5

Q ss_pred             ceeeccCceEEEEEEECC-C----------cEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeCcEEEE
Q 021711          116 NLIGKGGYAEVYKGRLRN-G----------QLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHIV  184 (308)
Q Consensus       116 ~~LG~G~fg~Vy~~~~~~-g----------~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~lv  184 (308)
                      +.||+|+||.||+|.+.+ +          ..+++|.+......  ...|.+|+.+++.++||||+++++++..+..++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD--SLAFFETASLMSQLSHKHLVKLYGVCVRDENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh--HHHHHHHHHHHHcCCCcchhheeeEEecCCcEEE
Confidence            468999999999998764 3          25788876544322  5788899999999999999999998777778999


Q ss_pred             EEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCC-------cEEEeccccc
Q 021711          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDF-------EPQICDFGLA  257 (308)
Q Consensus       185 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~-------~~kl~DFGla  257 (308)
                      +||+++|+|.+++......+++..+..++.|++.||.|||+   ++|+||||||+|||++.++       .+||+|||++
T Consensus        79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a  155 (259)
T cd05037          79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLED---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP  155 (259)
T ss_pred             EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhh---CCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence            99999999999997655578999999999999999999998   8999999999999999887       7999999999


Q ss_pred             eecCCCCceeEeeceeccccccccccCchh--hcCccceeEEEeeEEEeecc
Q 021711          258 KWLPEQWTHHTISKVEGTFGLVKLNLPPLV--ILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~s~g~~l~el~c  307 (308)
                      +.+...      ....++..|+|||++...  ..+.++|+||+|+++|||++
T Consensus       156 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~  201 (259)
T cd05037         156 ITVLSR------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICS  201 (259)
T ss_pred             cccccc------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHh
Confidence            876441      234577889999998765  67888999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-33  Score=248.02  Aligned_cols=188  Identities=24%  Similarity=0.315  Sum_probs=159.7

Q ss_pred             ceeeccCceEEEEEEECC----CcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeCcEEEEEEecCCC
Q 021711          116 NLIGKGGYAEVYKGRLRN----GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHIVLELSPNG  191 (308)
Q Consensus       116 ~~LG~G~fg~Vy~~~~~~----g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~lv~e~~~~g  191 (308)
                      +.||+|+||.||+|.+..    +..+|+|.+.........+.+.+|+.+++.++||||+++++++.....++||||+++|
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~~   80 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKGEPLMLVMELAPLG   80 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcCCceEEEEEeCCCC
Confidence            469999999999997542    2689999987655444457889999999999999999999988878889999999999


Q ss_pred             CHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCceeE-ee
Q 021711          192 SLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT-IS  270 (308)
Q Consensus       192 sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~-~~  270 (308)
                      +|.+++... ..+++..+..++.|++.||.|||.   .+++|+||||+|||++.++.+||+|||+++.+........ ..
T Consensus        81 ~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~  156 (257)
T cd05060          81 PLLKYLKKR-REIPVSDLKELAHQVAMGMAYLES---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATT  156 (257)
T ss_pred             cHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhh---cCeeccCcccceEEEcCCCcEEeccccccceeecCCccccccc
Confidence            999999653 368999999999999999999998   8999999999999999999999999999987754432211 11


Q ss_pred             ceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          271 KVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       271 ~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      ...++..|+|||.......+.++|+||||+++|++++
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~  193 (257)
T cd05060         157 AGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFS  193 (257)
T ss_pred             CccccccccCHHHhcCCCCCccchHHHHHHHHHHHHc
Confidence            2234568999999887788899999999999999985

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.9e-33  Score=249.27  Aligned_cols=193  Identities=24%  Similarity=0.324  Sum_probs=161.8

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEEE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLE  186 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e  186 (308)
                      .++|++.+.||+|+||.||+|... +++.||+|.+...... ....+.+|+.++..++||||+++++++... ..++|+|
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~-~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e   86 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGD-DFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICME   86 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccc-hHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEe
Confidence            357999999999999999999975 6889999998654322 235678899999999999999999976554 5789999


Q ss_pred             ecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCce
Q 021711          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH  266 (308)
Q Consensus       187 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~  266 (308)
                      |+++++|.+++.. ...+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.++|+|||+++.+..... 
T Consensus        87 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-  161 (267)
T cd06646          87 YCGGGSLQDIYHV-TGPLSELQIAYVCRETLQGLAYLHS---KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA-  161 (267)
T ss_pred             CCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEECcCccceeeccccc-
Confidence            9999999998854 4568999999999999999999998   8999999999999999999999999999987643321 


Q ss_pred             eEeeceeccccccccccCc---hhhcCccceeEEEeeEEEeeccC
Q 021711          267 HTISKVEGTFGLVKLNLPP---LVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                       ......|+..|+|||.+.   ....+.++|+||+|++++||+.|
T Consensus       162 -~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g  205 (267)
T cd06646         162 -KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAEL  205 (267)
T ss_pred             -ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhC
Confidence             123457899999999863   33467789999999999998764

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=2.2e-33  Score=248.21  Aligned_cols=194  Identities=22%  Similarity=0.332  Sum_probs=165.6

Q ss_pred             hcCCccccceeeccCceEEEEEEECCCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeCcEEEEEEe
Q 021711          108 ATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHIVLEL  187 (308)
Q Consensus       108 ~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~lv~e~  187 (308)
                      ..++|++.+.||+|+||.||++...++..+|+|.+.....  ....+.+|+.+++.++|+||+++++++.....+++|||
T Consensus         4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~v~e~   81 (260)
T cd05073           4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM--SVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEF   81 (260)
T ss_pred             cccceeEEeEecCccceEEEEEEecCCccEEEEecCCChh--HHHHHHHHHHHHHhcCCCCcceEEEEEcCCCeEEEEEe
Confidence            4568999999999999999999977778899998875432  34678999999999999999999998777778999999


Q ss_pred             cCCCCHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCce
Q 021711          188 SPNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH  266 (308)
Q Consensus       188 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~  266 (308)
                      +++++|.+++... ...+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||++..+......
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~  158 (260)
T cd05073          82 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT  158 (260)
T ss_pred             CCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCCcceeeccCCCcc
Confidence            9999999998653 3457888899999999999999998   89999999999999999999999999999876543221


Q ss_pred             eEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          267 HTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                       ......++..|+|||.+.....+.++|+||+|++++++++
T Consensus       159 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t  198 (260)
T cd05073         159 -AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVT  198 (260)
T ss_pred             -cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHh
Confidence             2223456788999999877778889999999999999875

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.3e-33  Score=248.78  Aligned_cols=189  Identities=29%  Similarity=0.428  Sum_probs=162.0

Q ss_pred             ceeeccCceEEEEEEECC--C--cEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeCcEEEEEEecCCC
Q 021711          116 NLIGKGGYAEVYKGRLRN--G--QLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHIVLELSPNG  191 (308)
Q Consensus       116 ~~LG~G~fg~Vy~~~~~~--g--~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~lv~e~~~~g  191 (308)
                      ++||+|++|.||+|.+.+  +  ..||+|.+.........+.+.+|+.++++++||||+++++++.....++|+||++++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~~   80 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLTHPLMMVTELAPLG   80 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcCCeEEEEEEecCCC
Confidence            468999999999998653  3  369999997765545578899999999999999999999977777788999999999


Q ss_pred             CHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCceeE-e
Q 021711          192 SLASLLYGMK-EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT-I  269 (308)
Q Consensus       192 sL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~-~  269 (308)
                      +|.+.+.... ..+++..+..++.|++.||.|||+   ++++|+||||+||+++.++.+||+|||+++.+........ .
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  157 (257)
T cd05040          81 SLLDRLRKDALGHFLISTLCDYAVQIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVME  157 (257)
T ss_pred             cHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHh---CCccccccCcccEEEecCCEEEeccccccccccccccceecc
Confidence            9999997644 568999999999999999999998   8999999999999999999999999999998755332211 1


Q ss_pred             eceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          270 SKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       270 ~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      ....++.+|+|||.......+.++|+||+|++++||+.
T Consensus       158 ~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t  195 (257)
T cd05040         158 EHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFT  195 (257)
T ss_pred             cCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHh
Confidence            23567889999999888888899999999999999864

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=9.4e-34  Score=250.99  Aligned_cols=192  Identities=22%  Similarity=0.361  Sum_probs=162.7

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEEEe
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLEL  187 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~  187 (308)
                      .+|.+.+.||+|+||.||+|... ++..||+|.+.....  ....+.+|+.+++.++||||+++++++... ..+++|||
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF   83 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCch--HHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEe
Confidence            46888899999999999999865 488999999875432  246789999999999999999999976654 57899999


Q ss_pred             cCCCCHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCce
Q 021711          188 SPNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH  266 (308)
Q Consensus       188 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~  266 (308)
                      +++++|.+++... ...+++..++.++.|++.||.|||+   ++++||||||+||++++++.+||+|||+++........
T Consensus        84 ~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~  160 (263)
T cd05052          84 MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT  160 (263)
T ss_pred             CCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence            9999999998653 3458999999999999999999998   89999999999999999999999999999876543221


Q ss_pred             eEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          267 HTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                       ......++..|+|||.......+.++|+||||+++|||++
T Consensus       161 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t  200 (263)
T cd05052         161 -AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT  200 (263)
T ss_pred             -ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHc
Confidence             1123345678999999887788889999999999999975

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=5.3e-33  Score=248.02  Aligned_cols=196  Identities=26%  Similarity=0.355  Sum_probs=166.3

Q ss_pred             CCccccceeeccCceEEEEEEEC-----CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEe---CcE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-----NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE---GGM  181 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-----~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---~~~  181 (308)
                      +.|++.+.||+|+||.||++.+.     ++..+|+|.+...........|.+|+.+++.++||||+++++++..   ...
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            46778899999999999999854     3678999999765544456789999999999999999999998765   247


Q ss_pred             EEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecC
Q 021711          182 HIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP  261 (308)
Q Consensus       182 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~  261 (308)
                      +++|||+++++|.+++......+++..+..++.|++.||.|||+   .+|+|+||||+||+++.++.++|+|||++....
T Consensus        84 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  160 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVLP  160 (284)
T ss_pred             EEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence            89999999999999997666579999999999999999999998   899999999999999999999999999999876


Q ss_pred             CCCceeE-eeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          262 EQWTHHT-ISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       262 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ....... .....++..|+|||.......+.++|+||+|++++||++|
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg  208 (284)
T cd05038         161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTY  208 (284)
T ss_pred             cCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeecc
Confidence            4322111 1233456779999988777788899999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.9e-33  Score=251.72  Aligned_cols=200  Identities=27%  Similarity=0.363  Sum_probs=164.4

Q ss_pred             HHHHHhhcCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcC-CCCeeeeeeeEEEe-
Q 021711          102 LYELQSATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGIE-  178 (308)
Q Consensus       102 ~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-  178 (308)
                      +..+....++|++.+.||+|+||.||++... +++.+|+|.+.....  ....+.+|+.++..+ +||||+++++++.. 
T Consensus        10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~--~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   87 (286)
T cd06638          10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD--IDEEIEAEYNILKALSDHPNVVKFYGMYYKK   87 (286)
T ss_pred             eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc--hHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence            3445567789999999999999999999875 588999998764322  235677899999999 69999999997632 


Q ss_pred             -----CcEEEEEEecCCCCHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEE
Q 021711          179 -----GGMHIVLELSPNGSLASLLYG---MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQ  250 (308)
Q Consensus       179 -----~~~~lv~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~k  250 (308)
                           +..++||||+++++|.+++..   ....+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.++
T Consensus        88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~k  164 (286)
T cd06638          88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV---NKTIHRDVKGNNILLTTEGGVK  164 (286)
T ss_pred             ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHh---CCccccCCCHHhEEECCCCCEE
Confidence                 347899999999999988753   23468888899999999999999998   8999999999999999999999


Q ss_pred             EeccccceecCCCCceeEeeceeccccccccccCch-----hhcCccceeEEEeeEEEeeccC
Q 021711          251 ICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPL-----VILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       251 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      |+|||+++.+.....  ......|++.|+|||.+..     ..++.++|+||+|+++|||++|
T Consensus       165 l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g  225 (286)
T cd06638         165 LVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG  225 (286)
T ss_pred             EccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcC
Confidence            999999987654321  2234579999999998642     3357789999999999999875

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-34  Score=271.27  Aligned_cols=195  Identities=27%  Similarity=0.415  Sum_probs=172.8

Q ss_pred             CCccccceeeccCceEEEEEEECC--Cc--EEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeCcEEEEE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLRN--GQ--LVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHIVL  185 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~~--g~--~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~lv~  185 (308)
                      .+..+.++||+|.||.|++|.|..  |.  .||||.+..........+|++|+.+|.+|+|+|+++|||...+..+.+|+
T Consensus       110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~qp~mMV~  189 (1039)
T KOG0199|consen  110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLDQPAMMVF  189 (1039)
T ss_pred             HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeeccchhhHHh
Confidence            345567899999999999998873  43  68999998766555788999999999999999999999999988889999


Q ss_pred             EecCCCCHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCC
Q 021711          186 ELSPNGSLASLLYG-MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (308)
Q Consensus       186 e~~~~gsL~~~l~~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  264 (308)
                      |+++.|+|.+.|+. ....+.......++.|||.||.||..   +++|||||.++|+||.....+||+||||.+.++...
T Consensus       190 ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLes---krlvHRDLAARNlllasprtVKI~DFGLmRaLg~ne  266 (1039)
T KOG0199|consen  190 ELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLES---KRLVHRDLAARNLLLASPRTVKICDFGLMRALGENE  266 (1039)
T ss_pred             hhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence            99999999999987 45568888899999999999999998   999999999999999999999999999999998876


Q ss_pred             ceeEee-ceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          265 THHTIS-KVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       265 ~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      ....+. ...-.+.|.|||.+....++.++|+|+||++|||++.
T Consensus       267 d~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFt  310 (1039)
T KOG0199|consen  267 DMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFT  310 (1039)
T ss_pred             cceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhc
Confidence            655443 2344688999999999999999999999999999986

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=1.8e-33  Score=248.38  Aligned_cols=187  Identities=22%  Similarity=0.301  Sum_probs=158.8

Q ss_pred             eeeccCceEEEEEEEC---CCcEEEEEEeccCCh-HHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeCcEEEEEEecCCCC
Q 021711          117 LIGKGGYAEVYKGRLR---NGQLVAIKRLTRGTA-DEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHIVLELSPNGS  192 (308)
Q Consensus       117 ~LG~G~fg~Vy~~~~~---~g~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~lv~e~~~~gs  192 (308)
                      .||+|+||.||+|.++   ++..+|+|++..... ....+.+.+|+.+++.++||||+++++++.....++||||+++|+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~   81 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEAESWMLVMELAELGP   81 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCcEEEEecCCCCc
Confidence            5899999999999753   478899999865432 334678999999999999999999999988888899999999999


Q ss_pred             HHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCceeE-eec
Q 021711          193 LASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT-ISK  271 (308)
Q Consensus       193 L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~-~~~  271 (308)
                      |.+++.. ...+++..+..++.|++.||.|||+   ++|+||||||.||+++.++.+||+|||+++.+........ ...
T Consensus        82 L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  157 (257)
T cd05116          82 LNKFLQK-NKHVTEKNITELVHQVSMGMKYLEE---TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTH  157 (257)
T ss_pred             HHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCC
Confidence            9999854 3568999999999999999999998   8999999999999999999999999999987755433211 122


Q ss_pred             eeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          272 VEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       272 ~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      ..++..|+|||.......+.++|+||||+++||+++
T Consensus       158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t  193 (257)
T cd05116         158 GKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFS  193 (257)
T ss_pred             CCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHh
Confidence            334678999998877778889999999999999874

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=2.1e-33  Score=249.17  Aligned_cols=196  Identities=26%  Similarity=0.363  Sum_probs=164.0

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CC---cEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NG---QLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHI  183 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g---~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l  183 (308)
                      .++|+..+.||+|+||.||+|... ++   ..+|+|.+.........+.+..|+.+++.++||||+++++++... ..++
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI   83 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence            357888899999999999999875 23   379999987654444567899999999999999999999976654 5789


Q ss_pred             EEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCC
Q 021711          184 VLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ  263 (308)
Q Consensus       184 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  263 (308)
                      ||||+++++|.+++......+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++......
T Consensus        84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~  160 (268)
T cd05063          84 ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD  160 (268)
T ss_pred             EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence            999999999999997656678999999999999999999998   89999999999999999999999999999877543


Q ss_pred             CceeE-eeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          264 WTHHT-ISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       264 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      ..... ......+..|+|||.......+.++|+||+|+++||+++
T Consensus       161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~  205 (268)
T cd05063         161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMS  205 (268)
T ss_pred             cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHh
Confidence            22111 112233567999998877778889999999999999764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-34  Score=270.66  Aligned_cols=199  Identities=22%  Similarity=0.347  Sum_probs=170.5

Q ss_pred             HHHHhhcCCccccceeeccCceEEEEEEECC-CcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-c
Q 021711          103 YELQSATNNFSFENLIGKGGYAEVYKGRLRN-GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-G  180 (308)
Q Consensus       103 ~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~-g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~  180 (308)
                      ++|+....+....++||-|.||.||.|.|+. .-.||||.++....+  .++|+.|+.+|+.++|||+|+|+|+|+.. .
T Consensus       260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMe--veEFLkEAAvMKeikHpNLVqLLGVCT~EpP  337 (1157)
T KOG4278|consen  260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP  337 (1157)
T ss_pred             chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchh--HHHHHHHHHHHHhhcCccHHHHhhhhccCCC
Confidence            3455556677788899999999999999875 678999999876654  68999999999999999999999999765 5


Q ss_pred             EEEEEEecCCCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEecccccee
Q 021711          181 MHIVLELSPNGSLASLLYGMK-EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKW  259 (308)
Q Consensus       181 ~~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~  259 (308)
                      +|||+|||..|+|.++|+... ..++.-..+.++.||..||.||..   +++|||||.++|+|+.++..+||+||||++.
T Consensus       338 FYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEk---knFIHRDLAARNCLVgEnhiVKvADFGLsRl  414 (1157)
T KOG4278|consen  338 FYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHIVKVADFGLSRL  414 (1157)
T ss_pred             eEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHH---hhhhhhhhhhhhccccccceEEeeccchhhh
Confidence            889999999999999998744 446777788899999999999998   9999999999999999999999999999999


Q ss_pred             cCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          260 LPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       260 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      +..+.. .......=.+-|.|||-+.-..++.++|+|+||++|||++.
T Consensus       415 MtgDTY-TAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIAT  461 (1157)
T KOG4278|consen  415 MTGDTY-TAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIAT  461 (1157)
T ss_pred             hcCCce-ecccCccCcccccCcccccccccccchhhHHHHHHHHHHHh
Confidence            876522 11122233578999999988889999999999999999974

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=2.1e-33  Score=249.03  Aligned_cols=192  Identities=26%  Similarity=0.355  Sum_probs=162.1

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEe-CcEEEEEEe
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLEL  187 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~lv~e~  187 (308)
                      ++|++.+.||+|+||.||+|... +++.||+|.+...... ....+.+|+.+++.++||||+++++.+.. +..++|+||
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~   87 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGE-DFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF   87 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchh-HHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence            47888999999999999999865 5889999998755432 34567889999999999999999996655 457899999


Q ss_pred             cCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCcee
Q 021711          188 SPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH  267 (308)
Q Consensus       188 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~  267 (308)
                      +++++|.+++.. ...+++..+..++.|++.||.|||+   .+|+|+||||+||+++.++.++|+|||++..+....  .
T Consensus        88 ~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~--~  161 (267)
T cd06645          88 CGGGSLQDIYHV-TGPLSESQIAYVSRETLQGLYYLHS---KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI--A  161 (267)
T ss_pred             cCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc--c
Confidence            999999998854 4578999999999999999999998   899999999999999999999999999998764321  1


Q ss_pred             EeeceeccccccccccCc---hhhcCccceeEEEeeEEEeeccC
Q 021711          268 TISKVEGTFGLVKLNLPP---LVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ......|+..|+|||.+.   ....+.++|+||+|+++|+|+.|
T Consensus       162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~  205 (267)
T cd06645         162 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAEL  205 (267)
T ss_pred             ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcC
Confidence            223467999999999863   33467789999999999998653

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=8.8e-34  Score=271.87  Aligned_cols=193  Identities=19%  Similarity=0.198  Sum_probs=155.3

Q ss_pred             HHhhcCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCC------CCeeeeeeeEEE
Q 021711          105 LQSATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVD------HPNTAKLLGYGI  177 (308)
Q Consensus       105 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~l~~~~~  177 (308)
                      +...+++|++.++||+|+||.||+|.+. +++.||||++....  .....+..|+.++..++      |.+++++++++.
T Consensus       124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~  201 (467)
T PTZ00284        124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP--KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ  201 (467)
T ss_pred             cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch--hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence            3445688999999999999999999875 58899999986432  12334556776666664      456888888776


Q ss_pred             eC--cEEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCC--------
Q 021711          178 EG--GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDF--------  247 (308)
Q Consensus       178 ~~--~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~--------  247 (308)
                      ..  ..++|||++ +++|.+++.. ...+++..+..++.||+.||.|||+  ..+||||||||+|||++.++        
T Consensus       202 ~~~~~~~iv~~~~-g~~l~~~l~~-~~~l~~~~~~~i~~qi~~aL~yLH~--~~gIiHrDlKP~NILl~~~~~~~~~~~~  277 (467)
T PTZ00284        202 NETGHMCIVMPKY-GPCLLDWIMK-HGPFSHRHLAQIIFQTGVALDYFHT--ELHLMHTDLKPENILMETSDTVVDPVTN  277 (467)
T ss_pred             cCCceEEEEEecc-CCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHh--cCCeecCCCCHHHEEEecCCcccccccc
Confidence            53  467888887 7788888854 3578999999999999999999996  14899999999999998765        


Q ss_pred             --------cEEEeccccceecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          248 --------EPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       248 --------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                              .+||+|||++.....     ......||+.|+|||.+.+..++.++|+||+|+++|||++|
T Consensus       278 ~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG  341 (467)
T PTZ00284        278 RALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTG  341 (467)
T ss_pred             cccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhC
Confidence                    499999999864322     22456899999999999888889999999999999999986

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=2.3e-33  Score=246.63  Aligned_cols=189  Identities=28%  Similarity=0.399  Sum_probs=164.0

Q ss_pred             ceeeccCceEEEEEEECC----CcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEEEecCC
Q 021711          116 NLIGKGGYAEVYKGRLRN----GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLELSPN  190 (308)
Q Consensus       116 ~~LG~G~fg~Vy~~~~~~----g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~~~  190 (308)
                      +.||+|+||.||+|....    +..||+|.+...........+.+|+.++..++|+||+++++++... ..++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            469999999999998753    7889999997665444567899999999999999999999977664 57899999999


Q ss_pred             CCHHHHHhcc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCC
Q 021711          191 GSLASLLYGM--------KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE  262 (308)
Q Consensus       191 gsL~~~l~~~--------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~  262 (308)
                      ++|.+++...        ...+++..+..++.|++.||.|||+   ++++||||||+||+++.++.++|+|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc---CCcccCccCcceEEECCCCcEEEccccccccccc
Confidence            9999999765        4678999999999999999999998   9999999999999999999999999999998765


Q ss_pred             CCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          263 QWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       263 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      ...........++..|+|||.......+.++|+||+|++++++++
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~  202 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFT  202 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHh
Confidence            432223345678899999998877778889999999999999875

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=4e-33  Score=247.36  Aligned_cols=195  Identities=24%  Similarity=0.315  Sum_probs=163.7

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCC----hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEe---CcE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT----ADEIIADFLSELGIMAHVDHPNTAKLLGYGIE---GGM  181 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---~~~  181 (308)
                      .+|+..+.||+|+||.||+|... ++..||+|.+....    ..+....+.+|+.+++.++||||+++++++..   ...
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            47889999999999999999875 58899999885432    12345678899999999999999999997654   346


Q ss_pred             EEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecC
Q 021711          182 HIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP  261 (308)
Q Consensus       182 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~  261 (308)
                      ++++||+++++|.+++.. ...+++.....++.|++.||.|||+   .+|+||||||+||+++.++.++|+|||+++.+.
T Consensus        82 ~l~~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~LH~---~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~  157 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKA-YGALTESVTRKYTRQILEGMSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ  157 (266)
T ss_pred             EEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence            899999999999999864 3458889999999999999999998   899999999999999999999999999998664


Q ss_pred             CCCce-eEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          262 EQWTH-HTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       262 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ..... .......++..|+|||.......+.++|+||+|+++|||++|
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g  205 (266)
T cd06651         158 TICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTE  205 (266)
T ss_pred             cccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHC
Confidence            32111 112345689999999998877788899999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.1e-33  Score=284.01  Aligned_cols=199  Identities=20%  Similarity=0.253  Sum_probs=162.9

Q ss_pred             hhcCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCC-hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEe---CcE
Q 021711          107 SATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGIE---GGM  181 (308)
Q Consensus       107 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---~~~  181 (308)
                      ...++|.+.+.||+|+||.||+|... .+..||+|.+.... .......|..|+.++..|+|||||++++++..   ..+
T Consensus        10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l   89 (1021)
T PTZ00266         10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL   89 (1021)
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence            34568999999999999999999976 47889999886432 33446789999999999999999999997643   247


Q ss_pred             EEEEEecCCCCHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCC----CCCceecCCCCCCEEECC---------
Q 021711          182 HIVLELSPNGSLASLLYGM---KEKLKWGIRYKIALGVAEGLLYLHEGC----QRRIIHRDIKAANILLTE---------  245 (308)
Q Consensus       182 ~lv~e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~yLH~~~----~~~iiHrDlKp~NILl~~---------  245 (308)
                      |+||||+++|+|.+++...   ...+++..++.|+.||+.||.|||...    ..+||||||||+||||+.         
T Consensus        90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~  169 (1021)
T PTZ00266         90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT  169 (1021)
T ss_pred             EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence            8999999999999998642   356899999999999999999999721    135999999999999964         


Q ss_pred             --------CCcEEEeccccceecCCCCceeEeeceeccccccccccCch--hhcCccceeEEEeeEEEeeccC
Q 021711          246 --------DFEPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPL--VILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       246 --------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~s~g~~l~el~c~  308 (308)
                              .+.+||+|||+++.+....   ......||+.|+|||++..  ..++.++|+||||++||||++|
T Consensus       170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTG  239 (1021)
T PTZ00266        170 AQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSG  239 (1021)
T ss_pred             ccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHC
Confidence                    2358999999998764432   1234579999999998743  3467889999999999999886

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-34  Score=261.52  Aligned_cols=191  Identities=27%  Similarity=0.406  Sum_probs=161.7

Q ss_pred             CCccccceeeccCceEEEEEEECCCcEEEEEEeccCChHHHHHHHHHHHHHHhc--CCCCeeeeeeeEEEe-----CcEE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAH--VDHPNTAKLLGYGIE-----GGMH  182 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~-----~~~~  182 (308)
                      ...++.++||+|.||.||+|.+. ++.||||++..    +..+.|..|-+|..-  ++|+||++++++...     .+++
T Consensus       210 ~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~----~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw  284 (534)
T KOG3653|consen  210 DPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE----QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW  284 (534)
T ss_pred             CchhhHHHhhcCccceeehhhcc-CceeEEEecCH----HHHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence            45667789999999999999985 59999999863    335778888888765  589999999986433     2578


Q ss_pred             EEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC------CCCceecCCCCCCEEECCCCcEEEecccc
Q 021711          183 IVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC------QRRIIHRDIKAANILLTEDFEPQICDFGL  256 (308)
Q Consensus       183 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~------~~~iiHrDlKp~NILl~~~~~~kl~DFGl  256 (308)
                      ||++|.+.|+|.++|..  ..++|....+++.-+++||+|||+..      ...|+|||||..|||+..++++.|+||||
T Consensus       285 LVt~fh~kGsL~dyL~~--ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL  362 (534)
T KOG3653|consen  285 LVTEFHPKGSLCDYLKA--NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL  362 (534)
T ss_pred             EEeeeccCCcHHHHHHh--ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence            99999999999999954  56899999999999999999999854      24699999999999999999999999999


Q ss_pred             ceecCCCCceeEeeceeccccccccccCchhhcC------ccceeEEEeeEEEeecc
Q 021711          257 AKWLPEQWTHHTISKVEGTFGLVKLNLPPLVILK------RCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       257 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~------~~~Di~s~g~~l~el~c  307 (308)
                      |..+............+||..|||||.+++...-      ++.|+||+|.+|||++.
T Consensus       363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~S  419 (534)
T KOG3653|consen  363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIAS  419 (534)
T ss_pred             eEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHh
Confidence            9998766554444568999999999998776532      35899999999999873

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-33  Score=249.25  Aligned_cols=192  Identities=31%  Similarity=0.389  Sum_probs=166.9

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEEEe
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLEL  187 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~  187 (308)
                      ++|++.+.||.|+||.||+|... +++.||+|.+...........+.+|+.+++.++|+||+++++++.++ ..++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            36888899999999999999876 58899999987554344456788999999999999999999976654 57899999


Q ss_pred             cCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCcee
Q 021711          188 SPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH  267 (308)
Q Consensus       188 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~  267 (308)
                      +++++|.+++..  ..+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||+++.+.....  
T Consensus        81 ~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~--  153 (274)
T cd06609          81 CGGGSCLDLLKP--GKLDETYIAFILREVLLGLEYLHE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS--  153 (274)
T ss_pred             eCCCcHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEcccccceeeccccc--
Confidence            999999999864  378999999999999999999998   8999999999999999999999999999988764321  


Q ss_pred             EeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          268 TISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ......|+..|+|||...+...+.++|+||||+++|++++|
T Consensus       154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg  194 (274)
T cd06609         154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKG  194 (274)
T ss_pred             ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhC
Confidence            22345788999999998877789999999999999999876

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.5e-33  Score=249.73  Aligned_cols=194  Identities=26%  Similarity=0.370  Sum_probs=165.2

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCC--hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEe-CcEEEEE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVL  185 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~lv~  185 (308)
                      ++|++.+.||+|+||.||++... ++..+|||.+....  ......++.+|+.+++.++||||+++++++.. +..++++
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            47888999999999999999864 68999999876432  22345688999999999999999999996655 4578999


Q ss_pred             EecCCCCHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCC
Q 021711          186 ELSPNGSLASLLYG---MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE  262 (308)
Q Consensus       186 e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~  262 (308)
                      ||+++++|.+++..   ....+++..+..++.|++.||.|||+   ++++|+||||+||+++.++.++|+|||++..+..
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            99999999998853   23458899999999999999999998   8999999999999999999999999999987654


Q ss_pred             CCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          263 QWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       263 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ...  ......|+..|+|||...+...+.++|+||+|+++|+|++|
T Consensus       159 ~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g  202 (267)
T cd08229         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAAL  202 (267)
T ss_pred             CCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhC
Confidence            322  12345789999999998777788889999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=5e-33  Score=244.91  Aligned_cols=193  Identities=22%  Similarity=0.278  Sum_probs=165.6

Q ss_pred             CccccceeeccCceEEEEEEEC-CCcEEEEEEeccCC-hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEEEe
Q 021711          111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLEL  187 (308)
Q Consensus       111 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~  187 (308)
                      +|++.++||+|+||.||.++.. +++.+++|.+.... ......++.+|+.++++++|+||+++++++.+. ..++++||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            5888999999999999999865 58899999886432 234456789999999999999999999976655 46889999


Q ss_pred             cCCCCHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCce
Q 021711          188 SPNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH  266 (308)
Q Consensus       188 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~  266 (308)
                      +++++|.+++... ...+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.+||+|||+++....... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~-  156 (256)
T cd08221          81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK---AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS-  156 (256)
T ss_pred             cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence            9999999998654 3468899999999999999999998   8999999999999999999999999999987755432 


Q ss_pred             eEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          267 HTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                       ......|+..|+|||...+...+.++|+||+|++++|+++|
T Consensus       157 -~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g  197 (256)
T cd08221         157 -MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTL  197 (256)
T ss_pred             -cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHC
Confidence             22456789999999998777778889999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=1.3e-33  Score=253.35  Aligned_cols=196  Identities=27%  Similarity=0.356  Sum_probs=163.8

Q ss_pred             cCCccccceeeccCceEEEEEEEC------CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR------NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GM  181 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~------~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~  181 (308)
                      .++|++.+.||+|+||.||+|...      ++..||+|.+...........+.+|+.+++.++||||+++++++..+ ..
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            467899999999999999999863      36789999987655555567799999999999999999999977654 57


Q ss_pred             EEEEEecCCCCHHHHHhccC---------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCC
Q 021711          182 HIVLELSPNGSLASLLYGMK---------------------EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAAN  240 (308)
Q Consensus       182 ~lv~e~~~~gsL~~~l~~~~---------------------~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~N  240 (308)
                      ++++||+++|+|.+++....                     ..+++..++.++.|++.||.|||+   ++++||||||+|
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~---~~i~H~dl~p~n  160 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE---RKFVHRDLATRN  160 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCeecccccHhh
Confidence            89999999999999986321                     246788889999999999999998   899999999999


Q ss_pred             EEECCCCcEEEeccccceecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          241 ILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       241 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      |+++.++.++|+|||+++.+.............++..|+|||.......+.++|+||||+++|||++
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~  227 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS  227 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHh
Confidence            9999999999999999986644322122223345678999998877778889999999999999874

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-33  Score=250.61  Aligned_cols=194  Identities=24%  Similarity=0.349  Sum_probs=165.0

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEEE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLE  186 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e  186 (308)
                      .++|++.+.||+|+||.||++... ++..+|+|.+..... ...+.|.+|+.+++.++||||+++++++..+ ..++|||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESE-EELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE   82 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCH-HHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence            357889999999999999999875 588999999875543 3457899999999999999999999976654 5789999


Q ss_pred             ecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCce
Q 021711          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH  266 (308)
Q Consensus       187 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~  266 (308)
                      |+++++|.+++......+++..+..++.|++.||.|||+   .+|+|+||||+||+++.++.++|+|||++........ 
T Consensus        83 ~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-  158 (280)
T cd06611          83 FCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHS---HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ-  158 (280)
T ss_pred             ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEECCCCCEEEccCccchhhccccc-
Confidence            999999999987656679999999999999999999998   8999999999999999999999999999876543322 


Q ss_pred             eEeeceeccccccccccCc-----hhhcCccceeEEEeeEEEeeccC
Q 021711          267 HTISKVEGTFGLVKLNLPP-----LVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                       ......||+.|+|||...     ....+.++|+||+|+++|++++|
T Consensus       159 -~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g  204 (280)
T cd06611         159 -KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQM  204 (280)
T ss_pred             -ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhC
Confidence             223467899999999864     23356789999999999998875

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-33  Score=245.70  Aligned_cols=194  Identities=28%  Similarity=0.379  Sum_probs=166.8

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEEE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLE  186 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e  186 (308)
                      .++|++.+.||+|+||.||+|... ++..+|+|.+...... ..+.+.+|+.+++.++||||+++++++... .++++||
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e   80 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD-DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVME   80 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh-hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEe
Confidence            367899999999999999999875 5788999998765433 457889999999999999999999966554 5789999


Q ss_pred             ecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCce
Q 021711          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH  266 (308)
Q Consensus       187 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~  266 (308)
                      |+++++|.+++......++...+..++.|++.||.|||+   ++|+|+||||+||+++.++.++|+|||++..+..... 
T Consensus        81 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-  156 (262)
T cd06613          81 YCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA-  156 (262)
T ss_pred             CCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHh---CCceecCCChhhEEECCCCCEEECccccchhhhhhhh-
Confidence            999999999987655679999999999999999999998   8999999999999999999999999999987654321 


Q ss_pred             eEeeceeccccccccccCchh---hcCccceeEEEeeEEEeeccC
Q 021711          267 HTISKVEGTFGLVKLNLPPLV---ILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~~---~~~~~~Di~s~g~~l~el~c~  308 (308)
                       ......++..|+|||.....   ..+.++|+||+|++++||++|
T Consensus       157 -~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg  200 (262)
T cd06613         157 -KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAEL  200 (262)
T ss_pred             -ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhC
Confidence             22345789999999998666   677889999999999999765

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=3.9e-33  Score=246.68  Aligned_cols=194  Identities=27%  Similarity=0.378  Sum_probs=165.6

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccC--ChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRG--TADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVL  185 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~  185 (308)
                      ++|++.+.||+|+||.||+|... +|+.||+|.++..  ........+.+|+.+++.++|+|++++++++..+ ..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            58999999999999999999977 7899999988632  2233467889999999999999999999966554 578999


Q ss_pred             EecCCCCHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCC
Q 021711          186 ELSPNGSLASLLYG---MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE  262 (308)
Q Consensus       186 e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~  262 (308)
                      ||+++++|..++..   ....+++..+..++.|++.||.|||+   .+|+||||+|+||+++.++.++|+|||+++.+..
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            99999999998853   23458899999999999999999998   8999999999999999999999999999987654


Q ss_pred             CCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          263 QWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       263 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ...  ......|+..|+|||...+...+.++|+||+|+++|+|+.|
T Consensus       159 ~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g  202 (267)
T cd08224         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAAL  202 (267)
T ss_pred             CCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHC
Confidence            322  12345689999999998777788899999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=2.8e-33  Score=248.88  Aligned_cols=188  Identities=20%  Similarity=0.243  Sum_probs=150.8

Q ss_pred             eeeccCceEEEEEEECCC---cEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEEEecCCCC
Q 021711          117 LIGKGGYAEVYKGRLRNG---QLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLELSPNGS  192 (308)
Q Consensus       117 ~LG~G~fg~Vy~~~~~~g---~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~~~gs  192 (308)
                      .||+|+||.||+|...++   ..+++|.+.........+.|.+|+.+++.++||||+++++.+... ..++||||+++|+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   81 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD   81 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence            589999999999975433   356777776554444567899999999999999999999977655 4789999999999


Q ss_pred             HHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCceeEe
Q 021711          193 LASLLYGMK---EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTI  269 (308)
Q Consensus       193 L~~~l~~~~---~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  269 (308)
                      |.+++....   ...+...+..++.||+.||.|||+   .+++||||||+|||++.++.++|+|||++............
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  158 (268)
T cd05086          82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE  158 (268)
T ss_pred             HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence            999986532   345667778899999999999998   89999999999999999999999999998653322111122


Q ss_pred             eceeccccccccccCch-------hhcCccceeEEEeeEEEeecc
Q 021711          270 SKVEGTFGLVKLNLPPL-------VILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       270 ~~~~gt~~y~aPE~~~~-------~~~~~~~Di~s~g~~l~el~c  307 (308)
                      ....|+..|+|||+...       ...+.++|+||||+++|||++
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~  203 (268)
T cd05086         159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFE  203 (268)
T ss_pred             cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHh
Confidence            34568899999998643       234678999999999999864

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.8e-33  Score=244.93  Aligned_cols=189  Identities=28%  Similarity=0.367  Sum_probs=160.5

Q ss_pred             ceeeccCceEEEEEEECCCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEEEecCCCCHH
Q 021711          116 NLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLELSPNGSLA  194 (308)
Q Consensus       116 ~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~~~gsL~  194 (308)
                      ++||+|+||.||++...+++.||+|.+......+....+.+|+.+++.++|+||+++++++... ..++|+||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            4689999999999998779999999987655544567899999999999999999999976654 578999999999999


Q ss_pred             HHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCceeEeeceec
Q 021711          195 SLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEG  274 (308)
Q Consensus       195 ~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g  274 (308)
                      +++......+++..+..++.+++.||.|||+   ++++||||||+|||++.++.++|+|||+++...............+
T Consensus        81 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~  157 (251)
T cd05041          81 TFLRKKKNRLTVKKLLQMSLDAAAGMEYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI  157 (251)
T ss_pred             HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence            9997655678899999999999999999998   8999999999999999999999999999986643221111112334


Q ss_pred             cccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          275 TFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       275 t~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      +..|+|||.......+.++|+||+|++++|+++
T Consensus       158 ~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t  190 (251)
T cd05041         158 PIKWTAPEALNYGRYTSESDVWSYGILLWETFS  190 (251)
T ss_pred             eeccCChHhhccCCCCcchhHHHHHHHHHHHHh
Confidence            678999999877778899999999999999875

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=3.3e-33  Score=247.42  Aligned_cols=194  Identities=25%  Similarity=0.393  Sum_probs=164.4

Q ss_pred             CccccceeeccCceEEEEEEECCCcEEEEEEeccCC-----hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEE
Q 021711          111 NFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGT-----ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIV  184 (308)
Q Consensus       111 ~~~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv  184 (308)
                      +|++.+.||+|+||.||+|...+++.+|+|.+....     ..+....+.+|+.+++.++|+||+++++++.+. ..+++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            477889999999999999998789999999886432     123346788999999999999999999987665 46899


Q ss_pred             EEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCC
Q 021711          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (308)
Q Consensus       185 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  264 (308)
                      +||+++++|.+++.. ...+++..+..++.|++.||.|||+   .+|+|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  156 (265)
T cd06631          81 MEFVPGGSISSILNR-FGPLPEPVFCKYTKQILDGVAYLHN---NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG  156 (265)
T ss_pred             EecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcc
Confidence            999999999999854 3468889999999999999999998   899999999999999999999999999998653321


Q ss_pred             c----eeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          265 T----HHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       265 ~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      .    ........|+..|+|||.......+.++|+||+|+++++|++|
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g  204 (265)
T cd06631         157 LHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATG  204 (265)
T ss_pred             ccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhC
Confidence            1    1122345789999999998887788999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-33  Score=248.30  Aligned_cols=194  Identities=27%  Similarity=0.357  Sum_probs=165.5

Q ss_pred             hcCCccccceeeccCceEEEEEEECCCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEe-CcEEEEEE
Q 021711          108 ATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLE  186 (308)
Q Consensus       108 ~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~lv~e  186 (308)
                      ..++|.+.+.||+|+||.||+|...+++.+|+|.+......  ..++.+|+.+++.++|+||+++++++.. ...++|||
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   81 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS--PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE   81 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccC--HHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence            45689999999999999999999877888999998754332  3678899999999999999999997766 56789999


Q ss_pred             ecCCCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCc
Q 021711          187 LSPNGSLASLLYGMK-EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (308)
Q Consensus       187 ~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~  265 (308)
                      |+++++|.+++.... ..+++..+..++.|++.||.|||+   ++++|+||||+||+++.++.++|+|||+++.+.....
T Consensus        82 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~  158 (261)
T cd05034          82 YMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLES---RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY  158 (261)
T ss_pred             ccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence            999999999996543 468999999999999999999998   8999999999999999999999999999987754211


Q ss_pred             eeEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          266 HHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                       .......++..|+|||...+...+.++|+||+|++++++++
T Consensus       159 -~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t  199 (261)
T cd05034         159 -TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVT  199 (261)
T ss_pred             -hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHh
Confidence             11122345678999999887778889999999999999876

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=9.4e-34  Score=250.23  Aligned_cols=193  Identities=27%  Similarity=0.352  Sum_probs=165.4

Q ss_pred             cCCccccceeeccCceEEEEEEECCCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEEEe
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLEL  187 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~  187 (308)
                      ..+|++.+.||+|+||.||+|...++..+|+|.+...... ....+.+|+.+++.++||||+++++++... ..++||||
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   83 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLL-KQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL   83 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchh-hHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence            3578899999999999999999888899999998765432 346788999999999999999999977665 46899999


Q ss_pred             cCCCCHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCce
Q 021711          188 SPNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH  266 (308)
Q Consensus       188 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~  266 (308)
                      +++++|.+++... ...+++..+..++.|++.||.|||+   ++|+|+||||+||+++.++.+||+|||++.........
T Consensus        84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~  160 (261)
T cd05148          84 MEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL  160 (261)
T ss_pred             cccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccCcceEEEcCCceEEEccccchhhcCCcccc
Confidence            9999999999653 3458999999999999999999998   89999999999999999999999999999876543221


Q ss_pred             eEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          267 HTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                        .....++..|+|||.......+.++|+||+|++++++++
T Consensus       161 --~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~  199 (261)
T cd05148         161 --SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFT  199 (261)
T ss_pred             --ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHc
Confidence              124456788999998877778889999999999999875

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=3e-33  Score=250.29  Aligned_cols=194  Identities=20%  Similarity=0.295  Sum_probs=162.0

Q ss_pred             CCccccceeeccCceEEEEEEEC------CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR------NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMH  182 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~------~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~  182 (308)
                      ++|++.+.||+|+||.||++...      ++..+|+|.+..... .....+.+|+++++.++|+||+++++++... ..+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASE-SARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL   83 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCH-HHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence            57788899999999999999642      356899998865443 3457899999999999999999999977664 478


Q ss_pred             EEEEecCCCCHHHHHhccC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCc
Q 021711          183 IVLELSPNGSLASLLYGMK--------------EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFE  248 (308)
Q Consensus       183 lv~e~~~~gsL~~~l~~~~--------------~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~  248 (308)
                      +++||+++++|.+++....              ..+++..++.++.|++.||.|||+   .+|+||||||+|||+++++.
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~nil~~~~~~  160 (280)
T cd05092          84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS---LHFVHRDLATRNCLVGQGLV  160 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH---CCeecccccHhhEEEcCCCC
Confidence            9999999999999986532              247889999999999999999998   89999999999999999999


Q ss_pred             EEEeccccceecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          249 PQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       249 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      +||+|||+++...............+++.|+|||.......+.++|+||||+++|||++
T Consensus       161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~  219 (280)
T cd05092         161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFT  219 (280)
T ss_pred             EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHc
Confidence            99999999987654322222223445788999999887778889999999999999874

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.8e-33  Score=246.05  Aligned_cols=195  Identities=22%  Similarity=0.319  Sum_probs=164.0

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccC----ChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC---cE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRG----TADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG---GM  181 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~----~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---~~  181 (308)
                      .+|++.+.||+|+||.||+|.+. ++..||+|.+...    ........+.+|+.+++.++|+||+++++++.+.   .+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            47899999999999999999875 5899999987532    1223456889999999999999999999977653   36


Q ss_pred             EEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecC
Q 021711          182 HIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP  261 (308)
Q Consensus       182 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~  261 (308)
                      ++++||+++++|.+++.. ...+++.....++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||+++...
T Consensus        82 ~~v~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~  157 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKA-YGALTENVTRRYTRQILQGVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQ  157 (264)
T ss_pred             EEEEEeCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECccccccccc
Confidence            799999999999998864 3458888999999999999999998   899999999999999999999999999998653


Q ss_pred             CCCce-eEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          262 EQWTH-HTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       262 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ..... .......|+..|+|||.......+.++|+||||+++++|++|
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g  205 (264)
T cd06653         158 TICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTE  205 (264)
T ss_pred             cccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhC
Confidence            32111 122345689999999998877788899999999999999876

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=6.6e-33  Score=246.09  Aligned_cols=197  Identities=24%  Similarity=0.317  Sum_probs=162.4

Q ss_pred             HhhcCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEE
Q 021711          106 QSATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHI  183 (308)
Q Consensus       106 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l  183 (308)
                      +.+++++.....||+|+||.||+|.+. ++..||+|.+...... ..+.+.+|+.+++.++|+||+++++++..+ ..++
T Consensus         4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   82 (268)
T cd06624           4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSR-YVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI   82 (268)
T ss_pred             ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHH-HHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence            345566666679999999999999865 5788999988755433 356789999999999999999999977665 4789


Q ss_pred             EEEecCCCCHHHHHhccCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECC-CCcEEEeccccceec
Q 021711          184 VLELSPNGSLASLLYGMKEKL--KWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTE-DFEPQICDFGLAKWL  260 (308)
Q Consensus       184 v~e~~~~gsL~~~l~~~~~~l--~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~-~~~~kl~DFGla~~~  260 (308)
                      |+||+++++|.+++......+  +...+..++.|++.||.|||+   .+|+||||||+||+++. ++.++|+|||++...
T Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~  159 (268)
T cd06624          83 FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL  159 (268)
T ss_pred             EEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence            999999999999987544445  788888899999999999998   89999999999999986 679999999999876


Q ss_pred             CCCCceeEeeceeccccccccccCchhh--cCccceeEEEeeEEEeeccC
Q 021711          261 PEQWTHHTISKVEGTFGLVKLNLPPLVI--LKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       261 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Di~s~g~~l~el~c~  308 (308)
                      .....  ......|+..|+|||......  .+.++|+||+|+++|+|++|
T Consensus       160 ~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g  207 (268)
T cd06624         160 AGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATG  207 (268)
T ss_pred             ccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhC
Confidence            43221  223456899999999875443  67789999999999999865

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=4.3e-33  Score=247.13  Aligned_cols=182  Identities=19%  Similarity=0.264  Sum_probs=151.4

Q ss_pred             ceeeccCceEEEEEEECC-------------CcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cE
Q 021711          116 NLIGKGGYAEVYKGRLRN-------------GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GM  181 (308)
Q Consensus       116 ~~LG~G~fg~Vy~~~~~~-------------g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~  181 (308)
                      +.||+|+||.||+|....             ...||+|.+.... .+....|.+|+.++..++||||+++++++... ..
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~   79 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH-RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVEN   79 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh-hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence            368999999999997532             2358888876543 23456788999999999999999999987665 46


Q ss_pred             EEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCc-------EEEecc
Q 021711          182 HIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFE-------PQICDF  254 (308)
Q Consensus       182 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~-------~kl~DF  254 (308)
                      ++||||+++|+|..++......+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.       ++++||
T Consensus        80 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~  156 (262)
T cd05077          80 IMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLED---KDLVHGNVCTKNILLAREGIDGECGPFIKLSDP  156 (262)
T ss_pred             EEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhh---CCeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence            89999999999999887656678999999999999999999998   89999999999999987654       899999


Q ss_pred             ccceecCCCCceeEeeceeccccccccccCc-hhhcCccceeEEEeeEEEeecc
Q 021711          255 GLAKWLPEQWTHHTISKVEGTFGLVKLNLPP-LVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       255 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      |++......      ....|+..|+|||... ....+.++|+||||+++|||++
T Consensus       157 g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~  204 (262)
T cd05077         157 GIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICY  204 (262)
T ss_pred             CCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHh
Confidence            998765322      2346789999999876 4557888999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=6.7e-33  Score=247.62  Aligned_cols=192  Identities=24%  Similarity=0.375  Sum_probs=156.7

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHH-HhcCCCCeeeeeeeEEEe-CcEEEEEE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGI-MAHVDHPNTAKLLGYGIE-GGMHIVLE  186 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~-~~~~lv~e  186 (308)
                      ++|++.+.||+|+||.||++.+. +|+.||+|.+......+....+..|+.+ ++.++||||+++++++.. +..++++|
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            47889999999999999999976 5899999998765433333456667665 566789999999997654 45899999


Q ss_pred             ecCCCCHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCC-CceecCCCCCCEEECCCCcEEEeccccceecCC
Q 021711          187 LSPNGSLASLLYG---MKEKLKWGIRYKIALGVAEGLLYLHEGCQR-RIIHRDIKAANILLTEDFEPQICDFGLAKWLPE  262 (308)
Q Consensus       187 ~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~-~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~  262 (308)
                      |++ |+|.+++..   ....+++..++.++.|++.||.|||+   + +++||||||+||+++.++.+||+|||+++.+..
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS---KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD  156 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            996 688877753   23468999999999999999999998   6 899999999999999999999999999987643


Q ss_pred             CCceeEeeceeccccccccccCch----hhcCccceeEEEeeEEEeeccC
Q 021711          263 QWTHHTISKVEGTFGLVKLNLPPL----VILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       263 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ..   ......|+..|+|||.+..    ...+.++|+||+|+++|++++|
T Consensus       157 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g  203 (283)
T cd06617         157 SV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATG  203 (283)
T ss_pred             cc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhC
Confidence            32   1233568999999998754    3357789999999999999875

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=4.5e-33  Score=253.01  Aligned_cols=186  Identities=22%  Similarity=0.317  Sum_probs=150.6

Q ss_pred             ceeeccCceEEEEEEEC---CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEe---CcEEEEEEecC
Q 021711          116 NLIGKGGYAEVYKGRLR---NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE---GGMHIVLELSP  189 (308)
Q Consensus       116 ~~LG~G~fg~Vy~~~~~---~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---~~~~lv~e~~~  189 (308)
                      ..||+|+||.||+|...   ++..||+|.+.....   ...+.+|+.+++.++||||+++++++..   ...++|+||+.
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI---SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE   83 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC---cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence            58999999999999865   357899998865432   2457789999999999999999997643   34689999986


Q ss_pred             CCCHHHHHhcc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEE----CCCCcEEEeccccc
Q 021711          190 NGSLASLLYGM--------KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILL----TEDFEPQICDFGLA  257 (308)
Q Consensus       190 ~gsL~~~l~~~--------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl----~~~~~~kl~DFGla  257 (308)
                      + +|.+++...        ...+++..+..++.|++.||.|||+   .+|+||||||+|||+    +.++.+||+|||++
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07867          84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence            5 777776421        2247888899999999999999998   899999999999999    45678999999999


Q ss_pred             eecCCCCce-eEeeceeccccccccccCchh-hcCccceeEEEeeEEEeeccC
Q 021711          258 KWLPEQWTH-HTISKVEGTFGLVKLNLPPLV-ILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       258 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~s~g~~l~el~c~  308 (308)
                      +........ .......||+.|+|||.+.+. ..+.++|+||+|+++|||++|
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg  212 (317)
T cd07867         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS  212 (317)
T ss_pred             eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhC
Confidence            876543221 123456789999999987653 468889999999999999875

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=8.9e-33  Score=243.26  Aligned_cols=193  Identities=24%  Similarity=0.289  Sum_probs=164.3

Q ss_pred             CccccceeeccCceEEEEEEEC-CCcEEEEEEeccCC-hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEe-C-cEEEEEE
Q 021711          111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-G-GMHIVLE  186 (308)
Q Consensus       111 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~-~~~lv~e  186 (308)
                      +|++.+.||+|++|.||++... +++.||+|.+.... .....+.+.+|+.+++.++|+|++++++.+.. + ..++++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            4888999999999999999876 47899999986433 23345678899999999999999999986543 3 3689999


Q ss_pred             ecCCCCHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCc
Q 021711          187 LSPNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (308)
Q Consensus       187 ~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~  265 (308)
                      |+++++|.+++... ...+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.++|+|||+++.+.....
T Consensus        81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~---~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~  157 (257)
T cd08223          81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD  157 (257)
T ss_pred             ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence            99999999988653 3458999999999999999999998   8999999999999999999999999999987754322


Q ss_pred             eeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          266 HHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                        ......|++.|+|||.......+.++|+||+|++++++++|
T Consensus       158 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g  198 (257)
T cd08223         158 --MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATL  198 (257)
T ss_pred             --ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcC
Confidence              22346789999999998888888899999999999999865

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.9e-33  Score=245.78  Aligned_cols=188  Identities=28%  Similarity=0.413  Sum_probs=162.8

Q ss_pred             cCCccccceeeccCceEEEEEEECCCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEE-eCcEEEEEEe
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGI-EGGMHIVLEL  187 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~lv~e~  187 (308)
                      .++|++.+.||+|+||.||+|... |+.||+|.+.....  ..+++.+|+.+++.++|+||+++++++. .+..++||||
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   81 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST--AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY   81 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh--HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence            457889999999999999999875 78999999976543  3578899999999999999999999776 4568899999


Q ss_pred             cCCCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCce
Q 021711          188 SPNGSLASLLYGMK-EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH  266 (308)
Q Consensus       188 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~  266 (308)
                      +++++|.+++.... ..+++..+..++.|++.||.|||+   ++|+||||||+||+++.++.++|+|||+++......  
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~--  156 (256)
T cd05039          82 MAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEE---KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ--  156 (256)
T ss_pred             cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccchhcccceEEEeCCCCEEEccccccccccccc--
Confidence            99999999986533 268999999999999999999998   999999999999999999999999999998774321  


Q ss_pred             eEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          267 HTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                         ....++..|+|||.+.....+.++|+||+|++++|+++
T Consensus       157 ---~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~  194 (256)
T cd05039         157 ---DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS  194 (256)
T ss_pred             ---ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHh
Confidence               13345678999999877778888999999999999864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=7.8e-33  Score=248.64  Aligned_cols=202  Identities=29%  Similarity=0.409  Sum_probs=166.3

Q ss_pred             cCHHHHHhhcCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcC-CCCeeeeeeeEEE
Q 021711          100 FSLYELQSATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGI  177 (308)
Q Consensus       100 ~~~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  177 (308)
                      +...++...+++|++.+.||+|+||.||++... +++.+|+|.+.....  ....+.+|+.++..+ +|||++++++++.
T Consensus        12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~--~~~~~~~e~~~l~~l~~h~ni~~~~~~~~   89 (291)
T cd06639          12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD--VDEEIEAEYNILQSLPNHPNVVKFYGMFY   89 (291)
T ss_pred             hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc--HHHHHHHHHHHHHHhcCCCCeEEEEEEEE
Confidence            344455566789999999999999999999875 588999999865322  235677899999988 8999999999765


Q ss_pred             eC------cEEEEEEecCCCCHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCc
Q 021711          178 EG------GMHIVLELSPNGSLASLLYG---MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFE  248 (308)
Q Consensus       178 ~~------~~~lv~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~  248 (308)
                      ..      ..++|+||+++++|.+++..   ....+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.
T Consensus        90 ~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~nili~~~~~  166 (291)
T cd06639          90 KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEGG  166 (291)
T ss_pred             eccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCC
Confidence            42      37899999999999998753   34568999999999999999999998   89999999999999999999


Q ss_pred             EEEeccccceecCCCCceeEeeceeccccccccccCchh-----hcCccceeEEEeeEEEeeccC
Q 021711          249 PQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPLV-----ILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       249 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Di~s~g~~l~el~c~  308 (308)
                      +||+|||+++.+.....  ......|+..|+|||.+...     ..+.++|+||+|+++|||++|
T Consensus       167 ~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g  229 (291)
T cd06639         167 VKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG  229 (291)
T ss_pred             EEEeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhC
Confidence            99999999987654321  11235689999999986432     357889999999999999875

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=4.2e-33  Score=245.74  Aligned_cols=187  Identities=27%  Similarity=0.386  Sum_probs=159.6

Q ss_pred             cCCccccceeeccCceEEEEEEECCCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEe--CcEEEEEE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE--GGMHIVLE  186 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~lv~e  186 (308)
                      .++|++.+.||+|+||.||++... |..+|+|.+.....   .+.+.+|+.+++.++|+|++++++++..  +..++++|
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (256)
T cd05082           5 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT---AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE   80 (256)
T ss_pred             HHhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCch---HHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEE
Confidence            357889999999999999999874 78899998865432   4578899999999999999999986543  35789999


Q ss_pred             ecCCCCHHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCc
Q 021711          187 LSPNGSLASLLYGMKE-KLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (308)
Q Consensus       187 ~~~~gsL~~~l~~~~~-~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~  265 (308)
                      |+++++|.+++..... .+++..+..++.|++.||.|||+   ++|+||||||+||+++.++.+||+|||+++...... 
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-  156 (256)
T cd05082          81 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEA---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-  156 (256)
T ss_pred             CCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccccchheEEEcCCCcEEecCCccceeccccC-
Confidence            9999999999865433 47889999999999999999998   899999999999999999999999999998654321 


Q ss_pred             eeEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          266 HHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                          ....++..|+|||+......+.++|+||+|+++|||++
T Consensus       157 ----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~  194 (256)
T cd05082         157 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS  194 (256)
T ss_pred             ----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHh
Confidence                23345678999999877778889999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=6.8e-33  Score=251.03  Aligned_cols=195  Identities=23%  Similarity=0.266  Sum_probs=162.7

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCCh--HHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVL  185 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~  185 (308)
                      ++|++.+.||+|+||.||++... .++.||+|.+.....  ......+.+|+.+++.++||||+++++.+..+ ..++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            47889999999999999999876 478999999865432  23356788999999999999999999876654 478999


Q ss_pred             EecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCc
Q 021711          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (308)
Q Consensus       186 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~  265 (308)
                      ||+++++|.+++.. ...+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||+++.......
T Consensus        81 e~~~g~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~  156 (305)
T cd05609          81 EYVEGGDCATLLKN-IGALPVDMARMYFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT  156 (305)
T ss_pred             ecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHEEECCCCCEEEeeCCCccccCcCcc
Confidence            99999999999865 3568899999999999999999998   8999999999999999999999999999874211100


Q ss_pred             -------------eeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          266 -------------HHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       266 -------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                                   ........|+..|+|||.+.+...+.++|+||||+++||+++|
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g  212 (305)
T cd05609         157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG  212 (305)
T ss_pred             ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhC
Confidence                         0011234678899999998887889999999999999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=9.3e-33  Score=244.67  Aligned_cols=194  Identities=26%  Similarity=0.420  Sum_probs=163.0

Q ss_pred             CccccceeeccCceEEEEEEEC-CCcEEEEEEeccCCh--------HHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-c
Q 021711          111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--------DEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-G  180 (308)
Q Consensus       111 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~  180 (308)
                      +|.+...||+|+||.||+|... +++.+|+|.+.....        .+..+.+.+|+.+++.++||||+++++++.+. .
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            4677899999999999999865 588999998854321        12346788999999999999999999976654 5


Q ss_pred             EEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceec
Q 021711          181 MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL  260 (308)
Q Consensus       181 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~  260 (308)
                      .++++||+++++|.+++.. ...+++..+..++.|++.||.|||+   .+++||||+|+||+++.++.++|+|||+++.+
T Consensus        81 ~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~~l~~~l~~lH~---~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~  156 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNN-YGAFEETLVRNFVRQILKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISKKL  156 (267)
T ss_pred             cEEEEEecCCCCHHHHHHh-ccCccHHHHHHHHHHHHHHHHHHHh---cCcccccCCHHHEEEcCCCCEEecccCCCccc
Confidence            7899999999999999964 3568888999999999999999998   89999999999999999999999999999877


Q ss_pred             CCCCcee----EeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          261 PEQWTHH----TISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       261 ~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      .......    ......|+..|+|||...+...+.++|+||+|+++|+|++|
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g  208 (267)
T cd06628         157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTG  208 (267)
T ss_pred             ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhC
Confidence            5322111    11235688999999998877788889999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=7.5e-33  Score=243.77  Aligned_cols=192  Identities=22%  Similarity=0.364  Sum_probs=163.0

Q ss_pred             CCccccceeeccCceEEEEEEECCCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEEEec
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLELS  188 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~  188 (308)
                      .+|++.+.||+|+||.||++.+.++..+|+|.+......  ...|.+|+++++.++|||++++++++... ..++|+||+
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   81 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS--EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM   81 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCC--HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcC
Confidence            467888999999999999998877889999988754332  25688999999999999999999976554 578999999


Q ss_pred             CCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCceeE
Q 021711          189 PNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT  268 (308)
Q Consensus       189 ~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  268 (308)
                      ++++|.+++......+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||+++....... ..
T Consensus        82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~  157 (256)
T cd05112          82 EHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLES---SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY-TS  157 (256)
T ss_pred             CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccccceEEEcCCCeEEECCCcceeecccCcc-cc
Confidence            9999999987656678999999999999999999998   8999999999999999999999999999987644321 11


Q ss_pred             eeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          269 ISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       269 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      .....++.+|+|||.......+.++|+||+|+++|||++
T Consensus       158 ~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~  196 (256)
T cd05112         158 STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFS  196 (256)
T ss_pred             cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHc
Confidence            123345678999998877778888999999999999875

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=7e-33  Score=246.67  Aligned_cols=194  Identities=20%  Similarity=0.270  Sum_probs=163.9

Q ss_pred             CCccccceeeccCceEEEEEEEC------CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR------NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMH  182 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~------~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~  182 (308)
                      .+|+....||+|+||.||+|+.+      +.+.||+|.+...........+.+|+.++++++|+||+++++++.+. ..+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            57888999999999999999864      24679999887655544677899999999999999999999987664 478


Q ss_pred             EEEEecCCCCHHHHHhccC--------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEecc
Q 021711          183 IVLELSPNGSLASLLYGMK--------EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDF  254 (308)
Q Consensus       183 lv~e~~~~gsL~~~l~~~~--------~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DF  254 (308)
                      +||||+++|+|.+++....        ..+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.++|+||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh---cCcccCcCccceEEEeCCCcEEEccc
Confidence            9999999999999986433        158999999999999999999998   89999999999999999999999999


Q ss_pred             ccceecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          255 GLAKWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       255 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      |+++....... .......++..|+|||.......+.++|+||+|++++++++
T Consensus       162 ~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~  213 (275)
T cd05046         162 SLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT  213 (275)
T ss_pred             ccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHh
Confidence            99876533211 12234567888999998877777888999999999999875

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=1.4e-32  Score=242.98  Aligned_cols=196  Identities=27%  Similarity=0.351  Sum_probs=167.0

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEe-CcEEEEEEe
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLEL  187 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~lv~e~  187 (308)
                      ++|++.+.||.|+||.||+|... ++..+|+|.+...........+.+|+.+++.++|+||+++++.+.. ...++|+|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            47899999999999999999865 5889999998755433356788999999999999999999986555 457899999


Q ss_pred             cCCCCHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCc
Q 021711          188 SPNGSLASLLYGM--KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (308)
Q Consensus       188 ~~~gsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~  265 (308)
                      +++++|.+++...  ...+++..+..++.|++.||.|||+   .+|+||||+|+||++++++.++|+|||++..+.....
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~---~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~  157 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS---NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD  157 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence            9999999998653  2468999999999999999999998   8999999999999999999999999999987765433


Q ss_pred             ee--EeeceeccccccccccCchh-hcCccceeEEEeeEEEeeccC
Q 021711          266 HH--TISKVEGTFGLVKLNLPPLV-ILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       266 ~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ..  ......|+..|+|||.+... ..+.++|+||+|+++++|+.|
T Consensus       158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g  203 (267)
T cd06610         158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATG  203 (267)
T ss_pred             ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhC
Confidence            21  22345789999999987766 678889999999999999875

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.7e-33  Score=258.62  Aligned_cols=197  Identities=19%  Similarity=0.260  Sum_probs=168.1

Q ss_pred             hhcCCccccceeeccCceEEEEEEECCCcEEEEEEecc-CChHHHHHHHHHHHHHHhcCC-CCeeeeeeeEEEeCc-EEE
Q 021711          107 SATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTR-GTADEIIADFLSELGIMAHVD-HPNTAKLLGYGIEGG-MHI  183 (308)
Q Consensus       107 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~-~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~-~~l  183 (308)
                      .....|++++.||+||.+.||++...+.+.+|+|++.. ..+......|..|+..|.+|+ |.+||+|++|...++ +|+
T Consensus       358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm  437 (677)
T KOG0596|consen  358 VKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM  437 (677)
T ss_pred             ECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence            44567999999999999999999988778888887754 344556788999999999995 999999999987654 789


Q ss_pred             EEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCC
Q 021711          184 VLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ  263 (308)
Q Consensus       184 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  263 (308)
                      ||||= ..+|..+|......++...+..+..|++.++.++|.   +||||.||||.|+|+.. |.+||+|||+|..+..+
T Consensus       438 vmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~---~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~D  512 (677)
T KOG0596|consen  438 VMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQ---HGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPD  512 (677)
T ss_pred             Eeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHH---hceeecCCCcccEEEEe-eeEEeeeechhcccCcc
Confidence            99975 459999997765555544777889999999999998   99999999999999986 58999999999999988


Q ss_pred             CceeEeeceeccccccccccCchhh-----------cCccceeEEEeeEEEeeccC
Q 021711          264 WTHHTISKVEGTFGLVKLNLPPLVI-----------LKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~~~-----------~~~~~Di~s~g~~l~el~c~  308 (308)
                      .+.-....-+||+.||+||++....           .++++|+||+||+||+|.+|
T Consensus       513 TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYg  568 (677)
T KOG0596|consen  513 TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYG  568 (677)
T ss_pred             ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhc
Confidence            7766667889999999999875543           45789999999999999876

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.6e-33  Score=252.10  Aligned_cols=196  Identities=26%  Similarity=0.275  Sum_probs=165.5

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChH--HHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTAD--EIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVL  185 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~  185 (308)
                      ++|++.+.||+|+||.||+|... +++.+|+|.+......  .....+..|++++..++||||+++++.+..+ ..++||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            36889999999999999999876 4899999998765332  2456789999999999999999999876654 478999


Q ss_pred             EecCCCCHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCC
Q 021711          186 ELSPNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (308)
Q Consensus       186 e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  264 (308)
                      ||+.+++|.+++... ...+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||++.......
T Consensus        81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~  157 (316)
T cd05574          81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP  157 (316)
T ss_pred             EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence            999999999998643 3568999999999999999999998   899999999999999999999999999987653321


Q ss_pred             ce---------------------------eEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          265 TH---------------------------HTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       265 ~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ..                           .......||..|+|||...+...+.++|+||+|+++|+|++|
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g  228 (316)
T cd05574         158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYG  228 (316)
T ss_pred             cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhC
Confidence            10                           011235689999999998877788899999999999999876

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=2.2e-33  Score=250.53  Aligned_cols=191  Identities=30%  Similarity=0.396  Sum_probs=164.0

Q ss_pred             CccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEEEec
Q 021711          111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLELS  188 (308)
Q Consensus       111 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~  188 (308)
                      .|+..+.||+|+||.||+|.+. ++..||+|.+.........+.+.+|+.+++.++||||+++++++..+ ..++|+||+
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence            4667788999999999999865 57899999987555445567899999999999999999999966554 578999999


Q ss_pred             CCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCceeE
Q 021711          189 PNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT  268 (308)
Q Consensus       189 ~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  268 (308)
                      ++++|.+++.  ...+++..+..++.|++.||.|||+   ++++|+||+|+||+++.++.++|+|||+++.+.....  .
T Consensus        85 ~~~~L~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~--~  157 (277)
T cd06642          85 GGGSALDLLK--PGPLEETYIATILREILKGLDYLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--K  157 (277)
T ss_pred             CCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhc---CCeeccCCChheEEEeCCCCEEEccccccccccCcch--h
Confidence            9999999884  3568899999999999999999998   8999999999999999999999999999987654321  2


Q ss_pred             eeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          269 ISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       269 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      .....|+..|+|||.......+.++|+||||++++|+++|
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg  197 (277)
T cd06642         158 RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKG  197 (277)
T ss_pred             hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhC
Confidence            2335689999999998887788899999999999999875

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=9e-33  Score=246.65  Aligned_cols=192  Identities=29%  Similarity=0.384  Sum_probs=165.8

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEEEe
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLEL  187 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~  187 (308)
                      ..|+..+.||+|+||.||+|.+. ++..||+|.+...........+.+|+.+++.++||||+++++++.++ ..++||||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence            35777889999999999999876 58899999987654444567899999999999999999999977665 47899999


Q ss_pred             cCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCcee
Q 021711          188 SPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH  267 (308)
Q Consensus       188 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~  267 (308)
                      +++++|.+++..  ..+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++..+.....  
T Consensus        84 ~~~~~L~~~i~~--~~l~~~~~~~~~~~l~~~l~~lh~---~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--  156 (277)
T cd06640          84 LGGGSALDLLRA--GPFDEFQIATMLKEILKGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--  156 (277)
T ss_pred             CCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc--
Confidence            999999998853  468888999999999999999998   8999999999999999999999999999987654321  


Q ss_pred             EeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          268 TISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ......++..|+|||.......+.++|+||||+++||+++|
T Consensus       157 ~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg  197 (277)
T cd06640         157 KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKG  197 (277)
T ss_pred             ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHC
Confidence            22345689999999998777788899999999999999876

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=4.9e-33  Score=245.01  Aligned_cols=186  Identities=26%  Similarity=0.405  Sum_probs=161.1

Q ss_pred             CCccccceeeccCceEEEEEEECCCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeCcEEEEEEecC
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHIVLELSP  189 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~lv~e~~~  189 (308)
                      ++|++.+.||+|+||.||++.. +++.||+|.+....   ....+.+|+.++..++|||++++++++..+..+++|||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~---~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~v~e~~~   81 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV---TAQAFLEETAVMTKLHHKNLVRLLGVILHNGLYIVMELMS   81 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc---hHHHHHHHHHHHHhCCCCCcCeEEEEEcCCCcEEEEECCC
Confidence            4688999999999999999975 57889999986543   2357889999999999999999999888888999999999


Q ss_pred             CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCceeE
Q 021711          190 NGSLASLLYGMK-EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT  268 (308)
Q Consensus       190 ~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  268 (308)
                      +++|.+++.... ..+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||+++.....     
T Consensus        82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-----  153 (254)
T cd05083          82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES---KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-----  153 (254)
T ss_pred             CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCcEEECCCccceecccc-----
Confidence            999999986533 357899999999999999999998   89999999999999999999999999999865432     


Q ss_pred             eeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          269 ISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       269 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      ......+..|+|||.......+.+.|+||+|++++||++
T Consensus       154 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~  192 (254)
T cd05083         154 VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFS  192 (254)
T ss_pred             CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHh
Confidence            122344678999999887788889999999999999875

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.6e-33  Score=250.10  Aligned_cols=192  Identities=26%  Similarity=0.317  Sum_probs=165.2

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEEEe
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLEL  187 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~  187 (308)
                      ++|++.+.||+|+||.||++... +|+.||+|.+...........+.+|++++..++||||+++++++... ..++|+||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            57888999999999999999865 58899999887655455567899999999999999999999976654 57899999


Q ss_pred             cCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCcee
Q 021711          188 SPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH  267 (308)
Q Consensus       188 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~  267 (308)
                      +++++|.+++.. .+.+++..+..++.+++.||.|||+  .++++||||||+||+++.++.++|+|||++.......   
T Consensus        85 ~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~---  158 (284)
T cd06620          85 MDCGSLDRIYKK-GGPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI---  158 (284)
T ss_pred             CCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc---
Confidence            999999998854 4568999999999999999999996  2579999999999999999999999999987653321   


Q ss_pred             EeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          268 TISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                       .....|+..|+|||.+.....+.++|+||+|+++|++++|
T Consensus       159 -~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg  198 (284)
T cd06620         159 -ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALG  198 (284)
T ss_pred             -cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhC
Confidence             1245789999999998777788899999999999999865

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=5.9e-33  Score=250.64  Aligned_cols=192  Identities=22%  Similarity=0.291  Sum_probs=164.5

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEe-CcEEEEEE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLE  186 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~lv~e  186 (308)
                      ..+|++.+.||+|+||.||+|... +++.||+|.+....... .+.+.+|+.+++.++|+||+++++.+.. ...++|+|
T Consensus        19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~-~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e   97 (296)
T cd06654          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK-KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   97 (296)
T ss_pred             ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcch-HHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeec
Confidence            458899999999999999999865 58899999987544332 4678899999999999999999986655 45789999


Q ss_pred             ecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCce
Q 021711          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH  266 (308)
Q Consensus       187 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~  266 (308)
                      |+++++|.+++..  ..+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.++|+|||++........ 
T Consensus        98 ~~~~~~L~~~~~~--~~~~~~~~~~i~~ql~~aL~~LH~---~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~-  171 (296)
T cd06654          98 YLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-  171 (296)
T ss_pred             ccCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEECccccchhcccccc-
Confidence            9999999998853  457889999999999999999998   8999999999999999999999999999886543321 


Q ss_pred             eEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          267 HTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                       ......|++.|+|||.......+.++|+||||+++|++++|
T Consensus       172 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g  212 (296)
T cd06654         172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG  212 (296)
T ss_pred             -ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhC
Confidence             12345789999999998877788899999999999999865

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=8.7e-33  Score=245.67  Aligned_cols=194  Identities=26%  Similarity=0.394  Sum_probs=162.5

Q ss_pred             CccccceeeccCceEEEEEEEC-CCcEEEEEEeccCCh---------HHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-
Q 021711          111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA---------DEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-  179 (308)
Q Consensus       111 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~---------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-  179 (308)
                      +|.+.+.||+|+||.||+|... +|+.+|+|.+.....         ....+.+.+|+.+++.++|||++++++++... 
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            4778899999999999999865 589999998753211         12345688899999999999999999977664 


Q ss_pred             cEEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEecccccee
Q 021711          180 GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKW  259 (308)
Q Consensus       180 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~  259 (308)
                      ..++|+||+++++|.+++... ..+++..+..++.|++.||.|||+   .+++||||+|+||+++.++.++|+|||+++.
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~  157 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHS---KGILHRDLKADNLLVDADGICKISDFGISKK  157 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhh---CCeeecCCChhhEEEcCCCeEEEeecccccc
Confidence            478999999999999998654 568899999999999999999998   8999999999999999999999999999987


Q ss_pred             cCCCCceeEeeceeccccccccccCchhh--cCccceeEEEeeEEEeeccC
Q 021711          260 LPEQWTHHTISKVEGTFGLVKLNLPPLVI--LKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       260 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Di~s~g~~l~el~c~  308 (308)
                      ..............|+..|+|||......  .+.++|+||+|++++++++|
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g  208 (272)
T cd06629         158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAG  208 (272)
T ss_pred             ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhC
Confidence            65433222234567899999999876544  67889999999999998875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=6.3e-33  Score=248.01  Aligned_cols=192  Identities=21%  Similarity=0.340  Sum_probs=159.4

Q ss_pred             CccccceeeccCceEEEEEEEC-CCcEEEEEEeccCCh-HHHHHHHHHHHHHHhcCCCCeeeeeeeEEEe-CcEEEEEEe
Q 021711          111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA-DEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLEL  187 (308)
Q Consensus       111 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~lv~e~  187 (308)
                      +|++.+.||+|+||.||+|... +++.||+|.+..... ......+.+|+.++..++||||+++++++.. +..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            4788899999999999999876 589999999864322 2234567889999999999999999997765 457899999


Q ss_pred             cCCCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCc
Q 021711          188 SPNGSLASLLYGMK--EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (308)
Q Consensus       188 ~~~gsL~~~l~~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~  265 (308)
                      +. ++|.+++....  ..+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.++|+|||++........
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  156 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR  156 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence            97 58888875422  568999999999999999999998   8999999999999999999999999999986643321


Q ss_pred             eeEeeceeccccccccccCchh-hcCccceeEEEeeEEEeeccC
Q 021711          266 HHTISKVEGTFGLVKLNLPPLV-ILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~s~g~~l~el~c~  308 (308)
                        ......+++.|+|||.+.+. ..+.++|+||+|+++++|++|
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg  198 (285)
T cd07861         157 --VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATK  198 (285)
T ss_pred             --cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHC
Confidence              22344678999999987544 357789999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=8.8e-33  Score=252.92  Aligned_cols=192  Identities=18%  Similarity=0.216  Sum_probs=156.1

Q ss_pred             ccceeecc--CceEEEEEEEC-CCcEEEEEEeccCC-hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEEEec
Q 021711          114 FENLIGKG--GYAEVYKGRLR-NGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLELS  188 (308)
Q Consensus       114 ~~~~LG~G--~fg~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~  188 (308)
                      +.++||+|  +|++||++..+ +|+.||+|.+.... ..+....+.+|+.+++.++||||+++++++..+ ..++|+||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            45789999  78999999875 68999999986543 233456677899999999999999999977665 578999999


Q ss_pred             CCCCHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCcee
Q 021711          189 PNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH  267 (308)
Q Consensus       189 ~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~  267 (308)
                      ++|+|.+++... ...+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.++++|||.+..........
T Consensus        82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~  158 (327)
T cd08227          82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL  158 (327)
T ss_pred             CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence            999999998643 3458999999999999999999998   899999999999999999999999998765432211100


Q ss_pred             -----EeeceeccccccccccCchh--hcCccceeEEEeeEEEeeccC
Q 021711          268 -----TISKVEGTFGLVKLNLPPLV--ILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       268 -----~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~s~g~~l~el~c~  308 (308)
                           ......++..|+|||.+...  .++.++|+||+|++++||++|
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g  206 (327)
T cd08227         159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANG  206 (327)
T ss_pred             cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHC
Confidence                 01223577889999998653  467889999999999999875

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=8.1e-33  Score=243.19  Aligned_cols=192  Identities=27%  Similarity=0.400  Sum_probs=167.4

Q ss_pred             cCCccccceeeccCceEEEEEEECC-CcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEEE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLRN-GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLE  186 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~~-g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e  186 (308)
                      .++|++.+.||+|+||.||+|.... ++.+|+|.+.....   .+.+.+|+.+++.++||||+++++++... ..++++|
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e   78 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED---LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVME   78 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH---HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEe
Confidence            3678999999999999999999774 78999999865432   57899999999999999999999976554 5789999


Q ss_pred             ecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCce
Q 021711          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH  266 (308)
Q Consensus       187 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~  266 (308)
                      |+++++|.+++......+++..+..++.|++.||.|||+   .+|+|+||+|+||+++.++.++|+|||++........ 
T Consensus        79 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-  154 (256)
T cd06612          79 YCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-  154 (256)
T ss_pred             cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence            999999999997666778999999999999999999998   8999999999999999999999999999987654422 


Q ss_pred             eEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          267 HTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                       ......|+..|+|||...+...+.++|+||+|+++++|+.|
T Consensus       155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g  195 (256)
T cd06612         155 -KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEG  195 (256)
T ss_pred             -ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhC
Confidence             22345689999999998777788899999999999998764

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=9.1e-33  Score=246.94  Aligned_cols=193  Identities=25%  Similarity=0.308  Sum_probs=164.7

Q ss_pred             CccccceeeccCceEEEEEEEC-CCcEEEEEEeccCCh-HHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEEEe
Q 021711          111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA-DEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLEL  187 (308)
Q Consensus       111 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~  187 (308)
                      +|++.+.||+|+||.||+|... +|..||+|.+..... ......+.+|+.+++.++||||+++++++..+ ..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            4788899999999999999975 689999999875432 33456789999999999999999999976654 57899999


Q ss_pred             cCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCcee
Q 021711          188 SPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH  267 (308)
Q Consensus       188 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~  267 (308)
                      + +++|.+++......+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||++........ .
T Consensus        81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~  155 (286)
T cd07832          81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-R  155 (286)
T ss_pred             c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-C
Confidence            9 999999987656779999999999999999999998   8999999999999999999999999999987754422 1


Q ss_pred             EeeceeccccccccccCchh-hcCccceeEEEeeEEEeeccC
Q 021711          268 TISKVEGTFGLVKLNLPPLV-ILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ......|+..|+|||.+.+. ..+.++|+||+|++++||++|
T Consensus       156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg  197 (286)
T cd07832         156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNG  197 (286)
T ss_pred             ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcC
Confidence            22345789999999987544 357889999999999999875

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=9.6e-33  Score=249.33  Aligned_cols=192  Identities=21%  Similarity=0.293  Sum_probs=164.9

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEEE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLE  186 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e  186 (308)
                      ..+|++.+.||.|+||.||+|... +++.||+|.+...... ..+.+.+|+.+++.++||||+++++++... ..++|+|
T Consensus        18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   96 (296)
T cd06655          18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQP-KKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVME   96 (296)
T ss_pred             cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCc-hHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEE
Confidence            357999999999999999999864 6899999988654332 246788999999999999999999976554 5789999


Q ss_pred             ecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCce
Q 021711          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH  266 (308)
Q Consensus       187 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~  266 (308)
                      |+++++|..++..  ..+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++..+..... 
T Consensus        97 ~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~---~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~-  170 (296)
T cd06655          97 YLAGGSLTDVVTE--TCMDEAQIAAVCRECLQALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-  170 (296)
T ss_pred             ecCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccchhcccccc-
Confidence            9999999998853  468999999999999999999998   8999999999999999999999999999987654322 


Q ss_pred             eEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          267 HTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                       ......|+..|+|||.......+.++|+||||+++|++++|
T Consensus       171 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg  211 (296)
T cd06655         171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG  211 (296)
T ss_pred             -cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhC
Confidence             12345789999999998877788899999999999999875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-34  Score=244.80  Aligned_cols=192  Identities=26%  Similarity=0.329  Sum_probs=157.6

Q ss_pred             CccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHH-hcCCCCeeeeeee-EEEeCcEEEEEEe
Q 021711          111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIM-AHVDHPNTAKLLG-YGIEGGMHIVLEL  187 (308)
Q Consensus       111 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~-~~~~~~~~lv~e~  187 (308)
                      +.+-+..||.|+||+|++-.++ .|+..|||++.....+....+++.|.+.. +.=+.||||+++| .+.++..|+.||+
T Consensus        65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMEL  144 (361)
T KOG1006|consen   65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMEL  144 (361)
T ss_pred             hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHH
Confidence            4445678999999999999876 59999999998766666678899998865 4457999999999 5667788999999


Q ss_pred             cCCCCHHHHHh---c-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCC
Q 021711          188 SPNGSLASLLY---G-MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ  263 (308)
Q Consensus       188 ~~~gsL~~~l~---~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  263 (308)
                      |. .||..+..   . .+..+++...-.|+.....||.||-+.  ..|||||+||+|||++..|.+||||||++..+...
T Consensus       145 Md-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S  221 (361)
T KOG1006|consen  145 MD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS  221 (361)
T ss_pred             Hh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecccchHhHHHH
Confidence            85 36655432   1 345688888888998999999999983  78999999999999999999999999999877543


Q ss_pred             CceeEeeceeccccccccccCc--hhhcCccceeEEEeeEEEeeccC
Q 021711          264 WTHHTISKVEGTFGLVKLNLPP--LVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                         -..+...|...|||||.+.  +..+.-++|+||+|++|+|+|.|
T Consensus       222 ---iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG  265 (361)
T KOG1006|consen  222 ---IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATG  265 (361)
T ss_pred             ---HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecC
Confidence               2334578999999999753  33478899999999999999987

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=6.3e-33  Score=247.73  Aligned_cols=180  Identities=23%  Similarity=0.295  Sum_probs=149.2

Q ss_pred             eeeccCceEEEEEEECC-------------------------CcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeee
Q 021711          117 LIGKGGYAEVYKGRLRN-------------------------GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAK  171 (308)
Q Consensus       117 ~LG~G~fg~Vy~~~~~~-------------------------g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  171 (308)
                      .||+|+||.||+|.+..                         ...||+|.+..... +....|.+|+.+++.++||||++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~-~~~~~~~~~~~~~~~l~h~niv~   80 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHR-DIALAFFETASLMSQVSHIHLAF   80 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHH-HHHHHHHHHHHHHhcCCCCCeee
Confidence            69999999999997421                         13588998865432 34567889999999999999999


Q ss_pred             eeeEEEeCc-EEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCC---
Q 021711          172 LLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDF---  247 (308)
Q Consensus       172 l~~~~~~~~-~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~---  247 (308)
                      +++++..+. .++||||+++|+|..++......+++..+..++.|++.||.|||+   ++|+||||||+|||++..+   
T Consensus        81 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~Nill~~~~~~~  157 (274)
T cd05076          81 VHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLED---KNLVHGNVCAKNILLARLGLAE  157 (274)
T ss_pred             EEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHc---CCccCCCCCcccEEEeccCccc
Confidence            999887654 689999999999999987656678999999999999999999998   8999999999999998643   


Q ss_pred             ----cEEEeccccceecCCCCceeEeeceeccccccccccCch-hhcCccceeEEEeeEEEeec
Q 021711          248 ----EPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPL-VILKRCFTCIFIGFSQLQLS  306 (308)
Q Consensus       248 ----~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~s~g~~l~el~  306 (308)
                          .+|++|||++......      ....++..|+|||.+.+ ..++.++|+||||+++||++
T Consensus       158 ~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~  215 (274)
T cd05076         158 GTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEIC  215 (274)
T ss_pred             CccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHH
Confidence                3899999998654322      22357889999998765 45788999999999999984

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=9.7e-33  Score=249.33  Aligned_cols=192  Identities=23%  Similarity=0.295  Sum_probs=165.0

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEEE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLE  186 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e  186 (308)
                      ..+|++.+.||+|+||.||+|... +++.||+|.+...... ..+.+.+|+.+++.++|+||+++++++..+ ..++|||
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e   96 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   96 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc-hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeec
Confidence            368999999999999999999864 6899999998654433 246688999999999999999999976654 5789999


Q ss_pred             ecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCce
Q 021711          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH  266 (308)
Q Consensus       187 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~  266 (308)
                      |+++++|.+++..  ..+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.++|+|||++........ 
T Consensus        97 ~~~~~~L~~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~---~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~-  170 (297)
T cd06656          97 YLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-  170 (297)
T ss_pred             ccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc-
Confidence            9999999999853  457889999999999999999998   8999999999999999999999999999987654322 


Q ss_pred             eEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          267 HTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                       ......|++.|+|||...+...+.++|+||+|+++|+++.|
T Consensus       171 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg  211 (297)
T cd06656         171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG  211 (297)
T ss_pred             -CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhC
Confidence             12345789999999998877788899999999999998765

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=2.1e-32  Score=244.31  Aligned_cols=191  Identities=29%  Similarity=0.379  Sum_probs=164.0

Q ss_pred             CccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEEEec
Q 021711          111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLELS  188 (308)
Q Consensus       111 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~  188 (308)
                      -|++.+.||+|+||.||+|... ++..||+|.+...........+.+|+.++..++||||+++++++..+ ..++|+||+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL   84 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence            3667789999999999999865 68899999886554444567889999999999999999999977665 478999999


Q ss_pred             CCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCceeE
Q 021711          189 PNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT  268 (308)
Q Consensus       189 ~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  268 (308)
                      ++++|.+++..  ..+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||+++.+.....  .
T Consensus        85 ~~~~l~~~i~~--~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~--~  157 (277)
T cd06641          85 GGGSALDLLEP--GPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--K  157 (277)
T ss_pred             CCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHcc---CCeecCCCCHHhEEECCCCCEEEeecccceecccchh--h
Confidence            99999998853  468899999999999999999998   8999999999999999999999999999987654321  1


Q ss_pred             eeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          269 ISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       269 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      .....|+..|+|||.......+.++|+||+|++++++++|
T Consensus       158 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g  197 (277)
T cd06641         158 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKG  197 (277)
T ss_pred             hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcC
Confidence            2345689999999998877788899999999999999875

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1.2e-32  Score=246.20  Aligned_cols=193  Identities=25%  Similarity=0.322  Sum_probs=162.0

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCCh-HHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEEE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA-DEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLE  186 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e  186 (308)
                      ++|++.+.||+|+||.||+|... +|+.||+|.+..... ....+.+.+|+.+++.++|||++++++++..+ ..++|+|
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            46889999999999999999976 589999998864332 22345678999999999999999999976655 5789999


Q ss_pred             ecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCce
Q 021711          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH  266 (308)
Q Consensus       187 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~  266 (308)
                      |+++++|..++.. ...+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.++|+|||++..+..... 
T Consensus        81 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~ql~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-  155 (286)
T cd07847          81 YCDHTVLNELEKN-PRGVPEHLIKKIIWQTLQAVNFCHK---HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-  155 (286)
T ss_pred             ccCccHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCChhhEEEcCCCcEEECccccceecCCCcc-
Confidence            9999888777643 4468999999999999999999998   8999999999999999999999999999998755432 


Q ss_pred             eEeeceeccccccccccCch-hhcCccceeEEEeeEEEeeccC
Q 021711          267 HTISKVEGTFGLVKLNLPPL-VILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~s~g~~l~el~c~  308 (308)
                       ......++..|+|||.+.+ ...+.++|+||+|+++++|++|
T Consensus       156 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g  197 (286)
T cd07847         156 -DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTG  197 (286)
T ss_pred             -cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhC
Confidence             1234567899999998754 3467889999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.98  E-value=1.7e-33  Score=227.64  Aligned_cols=190  Identities=23%  Similarity=0.331  Sum_probs=163.4

Q ss_pred             CccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHH-HHHHHHHHHHHHhcCCCCeeeeeeeEEE-eCcEEEEEEe
Q 021711          111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADE-IIADFLSELGIMAHVDHPNTAKLLGYGI-EGGMHIVLEL  187 (308)
Q Consensus       111 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~lv~e~  187 (308)
                      +|...++||+|.||+||+|+.+ +++.||+|++.-...++ .....++|+.+++.++|.|||++++... +..+.+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            5666789999999999999966 58999999987544332 3567889999999999999999999654 4568899999


Q ss_pred             cCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCcee
Q 021711          188 SPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH  267 (308)
Q Consensus       188 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~  267 (308)
                      |. .+|..+....++.++......++.|+++||.|+|+   ++++||||||.|+|++.+|+.|++|||+|+.+.-.-.  
T Consensus        83 cd-qdlkkyfdslng~~d~~~~rsfmlqllrgl~fchs---hnvlhrdlkpqnllin~ngelkladfglarafgipvr--  156 (292)
T KOG0662|consen   83 CD-QDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHS---HNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR--  156 (292)
T ss_pred             hh-HHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhh---hhhhhccCCcceEEeccCCcEEecccchhhhcCCceE--
Confidence            95 48999888888889999999999999999999999   9999999999999999999999999999998866532  


Q ss_pred             EeeceeccccccccccCc-hhhcCccceeEEEeeEEEeec
Q 021711          268 TISKVEGTFGLVKLNLPP-LVILKRCFTCIFIGFSQLQLS  306 (308)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~s~g~~l~el~  306 (308)
                      -.+...-|..|.+|..+- ...++.+.|+||-|+++.||+
T Consensus       157 cysaevvtlwyrppdvlfgakly~tsidmwsagcifaela  196 (292)
T KOG0662|consen  157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELA  196 (292)
T ss_pred             eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHh
Confidence            335567799999999765 445799999999999999886

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=99.98  E-value=1.6e-32  Score=244.20  Aligned_cols=186  Identities=26%  Similarity=0.403  Sum_probs=152.9

Q ss_pred             ceeeccCceEEEEEEECC-Cc--EEEEEEeccCChHHHHHHHHHHHHHHhcC-CCCeeeeeeeEEEeC-cEEEEEEecCC
Q 021711          116 NLIGKGGYAEVYKGRLRN-GQ--LVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGIEG-GMHIVLELSPN  190 (308)
Q Consensus       116 ~~LG~G~fg~Vy~~~~~~-g~--~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~~~lv~e~~~~  190 (308)
                      ++||+|+||.||+|.+.+ +.  .+|+|.+.........+.+.+|+.++.++ +||||+++++++... ..++||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            368999999999998753 43  57888887544444567889999999999 899999999977665 47899999999


Q ss_pred             CCHHHHHhccC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccc
Q 021711          191 GSLASLLYGMK---------------EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFG  255 (308)
Q Consensus       191 gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFG  255 (308)
                      |+|.+++....               ..+++..+..++.|++.||.|||+   ++++||||||+|||++.++.+||+|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccccceEEEcCCCeEEECCCC
Confidence            99999986422               247888999999999999999998   899999999999999999999999999


Q ss_pred             cceecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          256 LAKWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       256 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      +++......   .......+..|+|||.......+.++|+||||++++||++
T Consensus       158 l~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~  206 (270)
T cd05047         158 LSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS  206 (270)
T ss_pred             Cccccchhh---hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHc
Confidence            986432111   1111234667999999877778889999999999999974

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=99.98  E-value=1.4e-32  Score=245.72  Aligned_cols=200  Identities=27%  Similarity=0.377  Sum_probs=164.2

Q ss_pred             HHHHHhhcCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcC-CCCeeeeeeeEEEe-
Q 021711          102 LYELQSATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGIE-  178 (308)
Q Consensus       102 ~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-  178 (308)
                      +.++....+.|++.+.||+|+||.||+|... +++.+|+|.+.....  ....+..|+.++..+ +|+||+++++++.. 
T Consensus         8 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   85 (282)
T cd06636           8 LSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED--EEEEIKLEINMLKKYSHHRNIATYYGAFIKK   85 (282)
T ss_pred             hhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChH--HHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence            3444456678999999999999999999975 588999998865432  235678899999988 79999999997642 


Q ss_pred             ------CcEEEEEEecCCCCHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEE
Q 021711          179 ------GGMHIVLELSPNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQI  251 (308)
Q Consensus       179 ------~~~~lv~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl  251 (308)
                            ...+++|||+++|+|.+++... ...+++..+..++.|++.||.|||+   .+|+|+||||+||+++.++.++|
T Consensus        86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dl~~~nili~~~~~~~l  162 (282)
T cd06636          86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHA---HKVIHRDIKGQNVLLTENAEVKL  162 (282)
T ss_pred             cccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEE
Confidence                  3468999999999999988653 3457888889999999999999998   89999999999999999999999


Q ss_pred             eccccceecCCCCceeEeeceeccccccccccCc-----hhhcCccceeEEEeeEEEeeccC
Q 021711          252 CDFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPP-----LVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       252 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      +|||++........  ......|+..|+|||.+.     ...++.++|+||+|+++|||++|
T Consensus       163 ~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g  222 (282)
T cd06636         163 VDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG  222 (282)
T ss_pred             eeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhC
Confidence            99999986543211  223467899999999864     33467789999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=99.98  E-value=3.4e-33  Score=249.85  Aligned_cols=192  Identities=20%  Similarity=0.299  Sum_probs=159.7

Q ss_pred             CccccceeeccCceEEEEEEEC-CCcEEEEEEeccCCh-HHHHHHHHHHHHHHhcCCCCeeeeeeeEEEe-CcEEEEEEe
Q 021711          111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA-DEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLEL  187 (308)
Q Consensus       111 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~lv~e~  187 (308)
                      +|++.+.||+|+||.||+|... +|+.||+|.+..... ......+.+|+.+++.++||||+++++++.+ ...++++||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            4788899999999999999976 589999999864322 2223567789999999999999999996554 457899999


Q ss_pred             cCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCcee
Q 021711          188 SPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH  267 (308)
Q Consensus       188 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~  267 (308)
                      +. ++|.+++......+++..+..++.||+.||.|||+   .+|+||||||+||+++.++.++|+|||+++.+.....  
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~--  154 (284)
T cd07839          81 CD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR--  154 (284)
T ss_pred             CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC--
Confidence            97 58888876556678999999999999999999998   8999999999999999999999999999987644322  


Q ss_pred             EeeceeccccccccccCchh-hcCccceeEEEeeEEEeeccC
Q 021711          268 TISKVEGTFGLVKLNLPPLV-ILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ......++..|+|||.+.+. ..+.++|+||+|+++|||++|
T Consensus       155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg  196 (284)
T cd07839         155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANA  196 (284)
T ss_pred             CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhc
Confidence            22345678999999986553 467889999999999999764

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=99.98  E-value=5.2e-33  Score=248.71  Aligned_cols=193  Identities=23%  Similarity=0.307  Sum_probs=162.3

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChH-HHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEEE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTAD-EIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLE  186 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e  186 (308)
                      ++|++.+.||+|+||.||+|.+. +++.||+|.+...... ...+.+.+|+.+++.++||||+++++++..+ ..++|+|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            46889999999999999999986 5899999988643322 2356788999999999999999999976654 4789999


Q ss_pred             ecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCce
Q 021711          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH  266 (308)
Q Consensus       187 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~  266 (308)
                      |+++++|..+... ...+++..+..++.|++.||.|||+   .+|+|+||+|+||++++++.++|+|||++..+..... 
T Consensus        81 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-  155 (286)
T cd07846          81 FVDHTVLDDLEKY-PNGLDESRVRKYLFQILRGIEFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE-  155 (286)
T ss_pred             cCCccHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc-
Confidence            9999888877643 3458999999999999999999998   8999999999999999999999999999987654322 


Q ss_pred             eEeeceeccccccccccCch-hhcCccceeEEEeeEEEeeccC
Q 021711          267 HTISKVEGTFGLVKLNLPPL-VILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~s~g~~l~el~c~  308 (308)
                       ......++..|+|||.... ...+.++|+||||++++||++|
T Consensus       156 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g  197 (286)
T cd07846         156 -VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTG  197 (286)
T ss_pred             -ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcC
Confidence             2234568999999998754 3357789999999999999876

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.98  E-value=3.6e-33  Score=230.05  Aligned_cols=193  Identities=25%  Similarity=0.358  Sum_probs=160.1

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhc-CCCCeeeeeee-EEEeCcEEEEEE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAH-VDHPNTAKLLG-YGIEGGMHIVLE  186 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~-~~~~~~~~lv~e  186 (308)
                      +.......||+|++|.|-+-++. +|+..|+|.+......+...+.++|+.+..+ ...|.+|.++| ++.+++.|+.||
T Consensus        46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME  125 (282)
T KOG0984|consen   46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICME  125 (282)
T ss_pred             hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHH
Confidence            44455678999999999988865 6999999999876656667889999998655 57999999998 778889999999


Q ss_pred             ecCCCCHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCC
Q 021711          187 LSPNGSLASLLYG---MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ  263 (308)
Q Consensus       187 ~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  263 (308)
                      .|. .||..+...   .+..+++..+-+|+..+..||.|||+  +..+||||+||+|||++.+|++|+||||++..+.+.
T Consensus       126 ~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dS  202 (282)
T KOG0984|consen  126 LMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDS  202 (282)
T ss_pred             Hhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeehhh
Confidence            995 477766543   56678999999999999999999998  478999999999999999999999999999988553


Q ss_pred             CceeEeeceeccccccccccCch-h---hcCccceeEEEeeEEEeeccC
Q 021711          264 WTHHTISKVEGTFGLVKLNLPPL-V---ILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~-~---~~~~~~Di~s~g~~l~el~c~  308 (308)
                      -   ..+-..|.-.|||||.... .   .++-++|+||+|++++|||.+
T Consensus       203 i---Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~l  248 (282)
T KOG0984|consen  203 I---AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAIL  248 (282)
T ss_pred             h---HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhc
Confidence            1   2233678999999997632 2   356789999999999999853

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.98  E-value=7.9e-33  Score=254.13  Aligned_cols=194  Identities=23%  Similarity=0.314  Sum_probs=161.3

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC------cE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG------GM  181 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~  181 (308)
                      .++|++.+.||+|+||.||+|... +|+.||+|.+...........+.+|+.+++.++||||+++++++...      ..
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            468999999999999999999865 68999999986543334456788999999999999999999875543      36


Q ss_pred             EEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecC
Q 021711          182 HIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP  261 (308)
Q Consensus       182 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~  261 (308)
                      ++++||+.+ +|...+.  ...+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.+||+|||+++...
T Consensus        84 ~lv~e~~~~-~l~~~~~--~~~l~~~~~~~i~~ql~~aL~~LH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~  157 (336)
T cd07849          84 YIVQELMET-DLYKLIK--TQHLSNDHIQYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIAD  157 (336)
T ss_pred             EEEehhccc-CHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEECcccceeecc
Confidence            899999964 8887774  3568999999999999999999998   899999999999999999999999999998764


Q ss_pred             CCCcee-EeeceeccccccccccCch-hhcCccceeEEEeeEEEeeccC
Q 021711          262 EQWTHH-TISKVEGTFGLVKLNLPPL-VILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       262 ~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ...... ......||..|+|||.+.. ...+.++|+||+|+++++|++|
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G  206 (336)
T cd07849         158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN  206 (336)
T ss_pred             ccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhC
Confidence            432211 1234578999999997643 4578889999999999999875

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=99.98  E-value=5.6e-33  Score=245.64  Aligned_cols=193  Identities=27%  Similarity=0.401  Sum_probs=167.2

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEe-CcEEEEEEe
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLEL  187 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~lv~e~  187 (308)
                      ++|+..+.||+|+||.||++.+. +++.+|+|.+...........+.+|+++++.++||||+++++++.. ...++++||
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            36778899999999999999976 5899999998776555556789999999999999999999986654 457899999


Q ss_pred             cCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCcee
Q 021711          188 SPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH  267 (308)
Q Consensus       188 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~  267 (308)
                      +++++|.+++......++...+..++.|++.||.|||+  ..+++|+||||+||+++.++.++|+|||++........  
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~--~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--  156 (265)
T cd06605          81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA--  156 (265)
T ss_pred             cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcC--CCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh--
Confidence            99999999997655778999999999999999999996  36899999999999999999999999999976643322  


Q ss_pred             EeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          268 TISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                        ....|+..|+|||.......+.++|+||+|++++++++|
T Consensus       157 --~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g  195 (265)
T cd06605         157 --KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATG  195 (265)
T ss_pred             --hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhC
Confidence              126789999999998877888899999999999999875

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=99.98  E-value=1.9e-32  Score=240.75  Aligned_cols=192  Identities=29%  Similarity=0.402  Sum_probs=163.5

Q ss_pred             ccccceeeccCceEEEEEEECC-----CcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEe-CcEEEEE
Q 021711          112 FSFENLIGKGGYAEVYKGRLRN-----GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVL  185 (308)
Q Consensus       112 ~~~~~~LG~G~fg~Vy~~~~~~-----g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~lv~  185 (308)
                      +++.+.||.|+||.||++....     +..||+|.+......+....+..|+.++..++|+||+++++++.. +..+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            3567899999999999998763     388999999766554456789999999999999999999997765 4578999


Q ss_pred             EecCCCCHHHHHhccCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCC
Q 021711          186 ELSPNGSLASLLYGMKEK-LKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (308)
Q Consensus       186 e~~~~gsL~~~l~~~~~~-l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  264 (308)
                      ||+++++|.+++...... +++..+..++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||+++......
T Consensus        81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~---~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  157 (258)
T smart00219       81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD  157 (258)
T ss_pred             eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhc---CCeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence            999999999998654443 8999999999999999999998   899999999999999999999999999998776542


Q ss_pred             ceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          265 THHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      .... ....+++.|+|||.......+.++|+||+|+++++|++
T Consensus       158 ~~~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~  199 (258)
T smart00219      158 YYKK-KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFT  199 (258)
T ss_pred             cccc-ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHh
Confidence            2211 12347889999999877788999999999999999875

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.98  E-value=1.1e-32  Score=243.15  Aligned_cols=191  Identities=24%  Similarity=0.286  Sum_probs=165.3

Q ss_pred             CccccceeeccCceEEEEEEEC-CCcEEEEEEeccCC--hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEe-CcEEEEEE
Q 021711          111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLE  186 (308)
Q Consensus       111 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~lv~e  186 (308)
                      +|++.+.||+|+||.||+|... +++.||+|.+....  .....+.+.+|++++++++||||+++++++.+ ...++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            5888999999999999999976 58999999986532  22346789999999999999999999986554 45789999


Q ss_pred             ecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCce
Q 021711          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH  266 (308)
Q Consensus       187 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~  266 (308)
                      |+.+++|.+++... ..+++..+..++.|+++||.|||+   .+++|+||+|+||+++.++.++|+|||++.......  
T Consensus        81 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--  154 (258)
T cd05578          81 LLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--  154 (258)
T ss_pred             CCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc--
Confidence            99999999998653 578999999999999999999998   899999999999999999999999999998765442  


Q ss_pred             eEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          267 HTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                       ......|+..|+|||.......+.++|+||+|+++|++++|
T Consensus       155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g  195 (258)
T cd05578         155 -LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRG  195 (258)
T ss_pred             -cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhC
Confidence             22346789999999998777788999999999999999865

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.98  E-value=4.2e-33  Score=246.27  Aligned_cols=183  Identities=19%  Similarity=0.250  Sum_probs=152.8

Q ss_pred             ceeeccCceEEEEEEECC-C-------cEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEe-CcEEEEEE
Q 021711          116 NLIGKGGYAEVYKGRLRN-G-------QLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLE  186 (308)
Q Consensus       116 ~~LG~G~fg~Vy~~~~~~-g-------~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~lv~e  186 (308)
                      +.||+|+||.||+|.... +       ..+|+|.+.... ....+.+..|+.+++.++||||+++++++.. ...++|||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e   79 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH-RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQE   79 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchh-HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEe
Confidence            368999999999998642 2       348888775432 2345678899999999999999999997765 56789999


Q ss_pred             ecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCc--------EEEeccccce
Q 021711          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFE--------PQICDFGLAK  258 (308)
Q Consensus       187 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~--------~kl~DFGla~  258 (308)
                      |+++|+|.+++......+++..++.++.||+.||.|||+   ++|+||||||+||+++.++.        ++++|||++.
T Consensus        80 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~  156 (258)
T cd05078          80 YVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLED---KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI  156 (258)
T ss_pred             cCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence            999999999997666678999999999999999999998   99999999999999987765        6999999987


Q ss_pred             ecCCCCceeEeeceeccccccccccCchh-hcCccceeEEEeeEEEeeccC
Q 021711          259 WLPEQWTHHTISKVEGTFGLVKLNLPPLV-ILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       259 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~s~g~~l~el~c~  308 (308)
                      .....      ....++..|+|||.+... ..+.++|+||+|+++||+++|
T Consensus       157 ~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g  201 (258)
T cd05078         157 TVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSG  201 (258)
T ss_pred             ccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcC
Confidence            65432      235688999999988653 468889999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.98  E-value=1.3e-33  Score=279.70  Aligned_cols=195  Identities=26%  Similarity=0.376  Sum_probs=159.7

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEE-----------
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGI-----------  177 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-----------  177 (308)
                      .+|+...+||+||||.||+++++ +|+.+|||+|.-...+.......+|+..+++|+|||||+++..+.           
T Consensus       479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei  558 (1351)
T KOG1035|consen  479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEI  558 (1351)
T ss_pred             hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccc
Confidence            47788899999999999999987 899999999976665666788999999999999999999875210           


Q ss_pred             ---------------------------------------------e----------------------------------
Q 021711          178 ---------------------------------------------E----------------------------------  178 (308)
Q Consensus       178 ---------------------------------------------~----------------------------------  178 (308)
                                                                   .                                  
T Consensus       559 ~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~  638 (1351)
T KOG1035|consen  559 VASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEG  638 (1351)
T ss_pred             cccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCC
Confidence                                                         0                                  


Q ss_pred             ------------------------------CcEEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 021711          179 ------------------------------GGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQ  228 (308)
Q Consensus       179 ------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~  228 (308)
                                                    .-+||-||||+..+|.++++.+...-.....++++++|++||.|+|+   
T Consensus       639 ~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~---  715 (1351)
T KOG1035|consen  639 SVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHD---  715 (1351)
T ss_pred             ccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHh---
Confidence                                          01367789998877777775433222466788999999999999999   


Q ss_pred             CCceecCCCCCCEEECCCCcEEEeccccceecC----------C------CCceeEeeceeccccccccccCchhh---c
Q 021711          229 RRIIHRDIKAANILLTEDFEPQICDFGLAKWLP----------E------QWTHHTISKVEGTFGLVKLNLPPLVI---L  289 (308)
Q Consensus       229 ~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~----------~------~~~~~~~~~~~gt~~y~aPE~~~~~~---~  289 (308)
                      .+||||||||.||++++++.|||+|||+|+...          .      .......+..+||.-|+|||++.+..   +
T Consensus       716 ~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Y  795 (1351)
T KOG1035|consen  716 QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKY  795 (1351)
T ss_pred             CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccc
Confidence            899999999999999999999999999998721          0      01112346789999999999987665   8


Q ss_pred             CccceeEEEeeEEEeecc
Q 021711          290 KRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       290 ~~~~Di~s~g~~l~el~c  307 (308)
                      +.+.|+||+|++++||+.
T Consensus       796 n~KiDmYSLGIVlFEM~y  813 (1351)
T KOG1035|consen  796 NSKIDMYSLGIVLFEMLY  813 (1351)
T ss_pred             cchhhhHHHHHHHHHHhc
Confidence            999999999999999874

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=99.98  E-value=6.5e-33  Score=245.90  Aligned_cols=189  Identities=29%  Similarity=0.359  Sum_probs=156.5

Q ss_pred             ceeeccCceEEEEEEECC-------CcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEEEe
Q 021711          116 NLIGKGGYAEVYKGRLRN-------GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLEL  187 (308)
Q Consensus       116 ~~LG~G~fg~Vy~~~~~~-------g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~  187 (308)
                      +.||+|+||.||+|...+       ++.+|+|.+...........+.+|+.+++.++||||+++++++..+ ..++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            368999999999998642       2679999886654444467899999999999999999999976654 57899999


Q ss_pred             cCCCCHHHHHhcc------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCC-----cEEEecccc
Q 021711          188 SPNGSLASLLYGM------KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDF-----EPQICDFGL  256 (308)
Q Consensus       188 ~~~gsL~~~l~~~------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~-----~~kl~DFGl  256 (308)
                      +++++|.+++...      ...+++..++.++.|++.||.|||+   .+++|+||||+||+++.++     .++|+|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh---CCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence            9999999998642      2347888999999999999999998   8999999999999999887     899999999


Q ss_pred             ceecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          257 AKWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       257 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      ++.+.............++..|+|||.......+.++|+||||+++|||++
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt  208 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT  208 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHH
Confidence            987644322222223456789999999888888999999999999999875

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.98  E-value=2e-32  Score=243.92  Aligned_cols=191  Identities=28%  Similarity=0.430  Sum_probs=163.3

Q ss_pred             CccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCC---CCeeeeeeeEEEeC-cEEEEE
Q 021711          111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVD---HPNTAKLLGYGIEG-GMHIVL  185 (308)
Q Consensus       111 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~-~~~lv~  185 (308)
                      .|+..+.||+|+||.||+|.+. +++.||+|.+...........+.+|+.+++.++   |||++++++++..+ ..++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            5778899999999999999965 689999999876544445677889999999986   99999999976655 478999


Q ss_pred             EecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCc
Q 021711          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (308)
Q Consensus       186 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~  265 (308)
                      ||+++++|.+++..  ..+++..+..++.|++.||.|||+   .+|+|+||+|+||+++.++.++|+|||++..+.....
T Consensus        82 e~~~~~~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06917          82 EYAEGGSVRTLMKA--GPIAEKYISVIIREVLVALKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS  156 (277)
T ss_pred             ecCCCCcHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc
Confidence            99999999998854  478999999999999999999998   8999999999999999999999999999988765432


Q ss_pred             eeEeeceeccccccccccCchh-hcCccceeEEEeeEEEeeccC
Q 021711          266 HHTISKVEGTFGLVKLNLPPLV-ILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~s~g~~l~el~c~  308 (308)
                        ......|+..|+|||...+. ..+.++|+||+|+++|+|++|
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g  198 (277)
T cd06917         157 --KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATG  198 (277)
T ss_pred             --ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhC
Confidence              22345789999999987543 467889999999999999875

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.98  E-value=6.7e-33  Score=267.73  Aligned_cols=195  Identities=17%  Similarity=0.172  Sum_probs=151.7

Q ss_pred             cCCccccceeeccCceEEEEEEECC--CcEEEEEEe--------------cc--CChHHHHHHHHHHHHHHhcCCCCeee
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLRN--GQLVAIKRL--------------TR--GTADEIIADFLSELGIMAHVDHPNTA  170 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~~--g~~vAvK~~--------------~~--~~~~~~~~~~~~E~~~l~~l~h~niv  170 (308)
                      .++|++.+.||+|+||+||+|..+.  +...++|.+              .+  .........+.+|+.+|.+++||||+
T Consensus       147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv  226 (501)
T PHA03210        147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL  226 (501)
T ss_pred             hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence            4689999999999999999987542  222222211              00  01122345688999999999999999


Q ss_pred             eeeeEEEeC-cEEEEEEecCCCCHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECC
Q 021711          171 KLLGYGIEG-GMHIVLELSPNGSLASLLYGMK----EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTE  245 (308)
Q Consensus       171 ~l~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~----~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~  245 (308)
                      ++++++... ..++|++++. ++|..++....    .......+..++.||+.||.|||+   ++|+||||||+|||++.
T Consensus       227 ~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~---~gIiHrDLKP~NILl~~  302 (501)
T PHA03210        227 KIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD---KKLIHRDIKLENIFLNC  302 (501)
T ss_pred             cEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECC
Confidence            999977665 4678999885 57777664321    123345677899999999999998   89999999999999999


Q ss_pred             CCcEEEeccccceecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          246 DFEPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       246 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ++.+||+|||+++.+...... ......||..|+|||.+.+..++.++|+||+|++||||+++
T Consensus       303 ~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~  364 (501)
T PHA03210        303 DGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSH  364 (501)
T ss_pred             CCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHC
Confidence            999999999999987544221 22346799999999999888889999999999999999763

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.98  E-value=4.6e-33  Score=238.01  Aligned_cols=192  Identities=24%  Similarity=0.393  Sum_probs=161.4

Q ss_pred             CccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCC-CCeeeeeeeEEEeC-cEEEEEEe
Q 021711          111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVD-HPNTAKLLGYGIEG-GMHIVLEL  187 (308)
Q Consensus       111 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~-~~~lv~e~  187 (308)
                      +.+.+..||.|+-|.|++++.+ +|...|||.+.+....+..++.+..+.++...+ .|+||+.+||+..+ ++++.||.
T Consensus        93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMel  172 (391)
T KOG0983|consen   93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMEL  172 (391)
T ss_pred             HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHH
Confidence            4445678999999999999977 589999999988776667788899999876664 89999999977654 57788888


Q ss_pred             cCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCcee
Q 021711          188 SPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH  267 (308)
Q Consensus       188 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~  267 (308)
                      |.. -+..++....+++++..+-++..-+..||.||.+  .++|||||+||+|||+|+.|++|+||||++..+-+..   
T Consensus       173 Ms~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk---  246 (391)
T KOG0983|consen  173 MST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK---  246 (391)
T ss_pred             HHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeeccc---
Confidence            743 4566666667789999999999999999999998  4789999999999999999999999999998886653   


Q ss_pred             EeeceeccccccccccCc---hhhcCccceeEEEeeEEEeeccC
Q 021711          268 TISKVEGTFGLVKLNLPP---LVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ..++..|.+.|||||.+.   .-.+.-++|+||||++|+||++|
T Consensus       247 AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg  290 (391)
T KOG0983|consen  247 AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATG  290 (391)
T ss_pred             ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcc
Confidence            335778999999999753   22467789999999999999986

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.98  E-value=1.5e-33  Score=280.63  Aligned_cols=197  Identities=26%  Similarity=0.320  Sum_probs=165.0

Q ss_pred             hcCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCC-hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEE
Q 021711          108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIV  184 (308)
Q Consensus       108 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv  184 (308)
                      .+-+++....||.|.||.||.|... +|...|+|-+.-.. .........+|+.++..++|||+|+++|+..+. .++|.
T Consensus      1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred             ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence            3456777889999999999999854 69999999875432 234456678899999999999999999987765 57899


Q ss_pred             EEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCC
Q 021711          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (308)
Q Consensus       185 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  264 (308)
                      ||||.+|+|.+++. ...-.++.....+..|++.|+.|||+   ++||||||||+||+|+.+|.+|++|||.|..+....
T Consensus      1313 MEyC~~GsLa~ll~-~gri~dE~vt~vyt~qll~gla~LH~---~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~ 1388 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLE-HGRIEDEMVTRVYTKQLLEGLAYLHE---HGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNA 1388 (1509)
T ss_pred             HHHhccCcHHHHHH-hcchhhhhHHHHHHHHHHHHHHHHHh---cCceecCCCccceeeecCCcEEeecccceeEecCch
Confidence            99999999999984 34446666667788999999999999   999999999999999999999999999999876542


Q ss_pred             ce--eEeeceeccccccccccCchhh---cCccceeEEEeeEEEeeccC
Q 021711          265 TH--HTISKVEGTFGLVKLNLPPLVI---LKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       265 ~~--~~~~~~~gt~~y~aPE~~~~~~---~~~~~Di~s~g~~l~el~c~  308 (308)
                      ..  .......||+.|||||.+.+..   ...+.||||+||+.+||++|
T Consensus      1389 ~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tG 1437 (1509)
T KOG4645|consen 1389 QTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATG 1437 (1509)
T ss_pred             hcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecC
Confidence            11  2344688999999999987654   56778999999999999987

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=4e-33  Score=251.81  Aligned_cols=192  Identities=24%  Similarity=0.331  Sum_probs=159.1

Q ss_pred             cCCccccceeeccCceEEEEEEECCCcEEEEEEeccCChHHHHHHHHHHHHHHhc--CCCCeeeeeeeEEEeC-----cE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAH--VDHPNTAKLLGYGIEG-----GM  181 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~-----~~  181 (308)
                      ..+..+.+.||+|.||+||+|.++ |+.||||++.....    ..+.+|.+|...  |+|+||+.+++.-..+     .+
T Consensus       210 arqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srdE----~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQL  284 (513)
T KOG2052|consen  210 ARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRDE----RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQL  284 (513)
T ss_pred             hheeEEEEEecCccccceeecccc-CCceEEEEecccch----hhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEE
Confidence            457888999999999999999995 88999999865432    567788888876  5999999999753322     37


Q ss_pred             EEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC-----CCCCceecCCCCCCEEECCCCcEEEecccc
Q 021711          182 HIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEG-----CQRRIIHRDIKAANILLTEDFEPQICDFGL  256 (308)
Q Consensus       182 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~-----~~~~iiHrDlKp~NILl~~~~~~kl~DFGl  256 (308)
                      |||++|-+.|||.++|.  ...++....++++..+|.||+|||..     ....|.|||||..|||+..++.+.|+|+||
T Consensus       285 wLvTdYHe~GSL~DyL~--r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGL  362 (513)
T KOG2052|consen  285 WLVTDYHEHGSLYDYLN--RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL  362 (513)
T ss_pred             EEeeecccCCcHHHHHh--hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeecee
Confidence            89999999999999994  46799999999999999999999952     124599999999999999999999999999


Q ss_pred             ceecCCCCce--eEeeceeccccccccccCchhhc------CccceeEEEeeEEEeecc
Q 021711          257 AKWLPEQWTH--HTISKVEGTFGLVKLNLPPLVIL------KRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       257 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~------~~~~Di~s~g~~l~el~c  307 (308)
                      |-....+...  -..+..+||-.|||||.+.+.+.      -+.+||||||.++||+|+
T Consensus       363 Av~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiar  421 (513)
T KOG2052|consen  363 AVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIAR  421 (513)
T ss_pred             eEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHH
Confidence            9876554221  12346789999999999877653      356899999999999985

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=99.98  E-value=2.5e-32  Score=240.68  Aligned_cols=196  Identities=23%  Similarity=0.345  Sum_probs=164.6

Q ss_pred             CccccceeeccCceEEEEEEEC-CCcEEEEEEeccCC-hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEe---CcEEEEE
Q 021711          111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGIE---GGMHIVL  185 (308)
Q Consensus       111 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---~~~~lv~  185 (308)
                      +|++.+.||.|+||.||++... +++.+|+|.+.... .....+.+..|+.+++.++||||+++++++..   ...++++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            4788899999999999999865 58899999986432 33445778899999999999999999986643   2368999


Q ss_pred             EecCCCCHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCceecCCCCCCEEECCCCcEEEeccccceec
Q 021711          186 ELSPNGSLASLLYGM---KEKLKWGIRYKIALGVAEGLLYLHEGC--QRRIIHRDIKAANILLTEDFEPQICDFGLAKWL  260 (308)
Q Consensus       186 e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~yLH~~~--~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~  260 (308)
                      ||+++++|.+++...   ...+++..++.++.|++.||.|||..+  ..+|+|+||||+||+++.++.+||+|||++...
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~  160 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL  160 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence            999999999998643   457899999999999999999999211  189999999999999999999999999999987


Q ss_pred             CCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          261 PEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       261 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      .....  ......|+..|+|||.......+.++|+||+|++++++++|
T Consensus       161 ~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g  206 (265)
T cd08217         161 GHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCAL  206 (265)
T ss_pred             cCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHC
Confidence            55432  12345789999999998777788889999999999998865

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.98  E-value=6.2e-32  Score=244.99  Aligned_cols=190  Identities=28%  Similarity=0.363  Sum_probs=160.8

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccC--ChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRG--TADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIV  184 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv  184 (308)
                      ...|+..+.||+|+||.||+|... +++.||+|.+...  ...+....+.+|+.+++.++||||+++++++..+ ..++|
T Consensus        14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv   93 (307)
T cd06607          14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV   93 (307)
T ss_pred             chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence            356888899999999999999876 5899999988543  2234456789999999999999999999977664 57899


Q ss_pred             EEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCC
Q 021711          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (308)
Q Consensus       185 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  264 (308)
                      +||+. |++.+++......+++..+..++.|++.||.|||+   .+|+||||+|+||+++.++.++|+|||++...... 
T Consensus        94 ~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~---~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~-  168 (307)
T cd06607          94 MEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA-  168 (307)
T ss_pred             HHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEECCCCCEEEeecCcceecCCC-
Confidence            99997 57777776555678999999999999999999998   89999999999999999999999999999876443 


Q ss_pred             ceeEeeceeccccccccccCc---hhhcCccceeEEEeeEEEeeccC
Q 021711          265 THHTISKVEGTFGLVKLNLPP---LVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                           ....|+..|+|||...   ....+.++|+||||+++|||++|
T Consensus       169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg  210 (307)
T cd06607         169 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER  210 (307)
T ss_pred             -----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcC
Confidence                 2346889999999863   34567789999999999999775

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=99.98  E-value=3.7e-32  Score=239.02  Aligned_cols=191  Identities=27%  Similarity=0.407  Sum_probs=163.4

Q ss_pred             CccccceeeccCceEEEEEEEC-CCcEEEEEEeccCC----hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEE
Q 021711          111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT----ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIV  184 (308)
Q Consensus       111 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv  184 (308)
                      +|+..+.||+|+||.||+|... +++.|++|.+....    ..+..+.+.+|+.+++.++|+||+++++++..+ ..+++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4677899999999999999976 68999999885432    133467889999999999999999999977654 57899


Q ss_pred             EEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCC
Q 021711          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (308)
Q Consensus       185 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  264 (308)
                      +||+++++|.+++.. ...+++..+..++.|++.||.|||+   .+|+|+||+|+||+++.++.+||+|||++.......
T Consensus        81 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~  156 (258)
T cd06632          81 LELVPGGSLAKLLKK-YGSFPEPVIRLYTRQILLGLEYLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS  156 (258)
T ss_pred             EEecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccceeccccc
Confidence            999999999999864 3458899999999999999999998   899999999999999999999999999998764432


Q ss_pred             ceeEeeceeccccccccccCchhh-cCccceeEEEeeEEEeeccC
Q 021711          265 THHTISKVEGTFGLVKLNLPPLVI-LKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~s~g~~l~el~c~  308 (308)
                         ......|+..|++||.+.... .+.++|+||+|+++|+|+.|
T Consensus       157 ---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g  198 (258)
T cd06632         157 ---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATG  198 (258)
T ss_pred             ---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhC
Confidence               223567899999999876655 78889999999999999864

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=99.98  E-value=1.9e-32  Score=246.73  Aligned_cols=192  Identities=26%  Similarity=0.304  Sum_probs=161.2

Q ss_pred             CccccceeeccCceEEEEEEEC-CCcEEEEEEeccCCh----HHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEE
Q 021711          111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA----DEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIV  184 (308)
Q Consensus       111 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv  184 (308)
                      +|++.+.||+|+||.||+|... +|+.||+|.+.....    ......+..|+.+++.++|+||+++++++.+. ..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            4778899999999999999976 589999999865432    22345677899999999999999999977664 57899


Q ss_pred             EEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCC
Q 021711          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (308)
Q Consensus       185 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  264 (308)
                      |||+ +++|.+++......+++..+..++.||+.||.|||+   ++|+|+||||+||+++.++.++|+|||+++......
T Consensus        81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~  156 (298)
T cd07841          81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN  156 (298)
T ss_pred             Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence            9999 899999996544478999999999999999999998   899999999999999999999999999998775532


Q ss_pred             ceeEeeceeccccccccccCch-hhcCccceeEEEeeEEEeeccC
Q 021711          265 THHTISKVEGTFGLVKLNLPPL-VILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      .  ......+++.|+|||.+.. ...+.++|+||+|++++|+++|
T Consensus       157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g  199 (298)
T cd07841         157 R--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLR  199 (298)
T ss_pred             c--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcC
Confidence            2  1233457889999998743 3457789999999999998865

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.98  E-value=3e-32  Score=242.15  Aligned_cols=193  Identities=24%  Similarity=0.366  Sum_probs=158.2

Q ss_pred             ccccceeeccCceEEEEEEEC----CCcEEEEEEeccCC-hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeCc------
Q 021711          112 FSFENLIGKGGYAEVYKGRLR----NGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG------  180 (308)
Q Consensus       112 ~~~~~~LG~G~fg~Vy~~~~~----~g~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  180 (308)
                      |.+.++||+|+||.||+|.+.    +++.||||.+.... .....+++.+|+.+++.++||||+++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            567789999999999999854    36889999986543 2334677899999999999999999999765421      


Q ss_pred             -EEEEEEecCCCCHHHHHhcc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEecc
Q 021711          181 -MHIVLELSPNGSLASLLYGM-----KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDF  254 (308)
Q Consensus       181 -~~lv~e~~~~gsL~~~l~~~-----~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DF  254 (308)
                       .+++++|+.+|+|..++...     ...+++.....++.|++.||.|||+   .+|+||||||+||+++.++.+||+||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccchhhEEEcCCCCEEECcc
Confidence             36788999999998877431     1247888899999999999999998   89999999999999999999999999


Q ss_pred             ccceecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          255 GLAKWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       255 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      |+++.+.............++..|++||.......+.++|+||+|+++|||++
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~  210 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMT  210 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhh
Confidence            99987654332222233456678999998877778889999999999999876

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=99.98  E-value=4.5e-32  Score=238.81  Aligned_cols=193  Identities=19%  Similarity=0.246  Sum_probs=164.0

Q ss_pred             CccccceeeccCceEEEEEEEC-CCcEEEEEEeccCC-hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEEEe
Q 021711          111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLEL  187 (308)
Q Consensus       111 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~  187 (308)
                      +|++.+.||+|+||.||++... +|+.||+|.+.... .......+.+|+.+++.++||||+++++++... ..++|+||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            4788999999999999999865 58899999986432 223356789999999999999999999976654 57899999


Q ss_pred             cCCCCHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCce
Q 021711          188 SPNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH  266 (308)
Q Consensus       188 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~  266 (308)
                      +++++|.+++... ...+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++.........
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~  157 (256)
T cd08218          81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL  157 (256)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh
Confidence            9999999988653 3357889999999999999999998   89999999999999999999999999999876543221


Q ss_pred             eEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          267 HTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                        .....|+..|+|||...+...+.++|+||||++++++++|
T Consensus       158 --~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g  197 (256)
T cd08218         158 --ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTL  197 (256)
T ss_pred             --hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcC
Confidence              1235688999999998877788899999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.98  E-value=2.2e-32  Score=244.38  Aligned_cols=192  Identities=23%  Similarity=0.335  Sum_probs=160.6

Q ss_pred             CccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEEEec
Q 021711          111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLELS  188 (308)
Q Consensus       111 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~  188 (308)
                      +|++.+.||+|++|.||+|... +|+.||+|.+...........+.+|+.+++.++||||+++++++... ..++|+||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            5888999999999999999976 58899999987554333346677899999999999999999976654 578999999


Q ss_pred             CCCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCce
Q 021711          189 PNGSLASLLYGMK--EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH  266 (308)
Q Consensus       189 ~~gsL~~~l~~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~  266 (308)
                      ++ +|.+++....  ..+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||+++.+..... 
T Consensus        81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-  155 (284)
T cd07836          81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-  155 (284)
T ss_pred             Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence            85 8888875433  458999999999999999999998   8999999999999999999999999999986644322 


Q ss_pred             eEeeceeccccccccccCchh-hcCccceeEEEeeEEEeeccC
Q 021711          267 HTISKVEGTFGLVKLNLPPLV-ILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~s~g~~l~el~c~  308 (308)
                       ......+|..|++||.+.+. ..+.++|+||+|+++|++++|
T Consensus       156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g  197 (284)
T cd07836         156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITG  197 (284)
T ss_pred             -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhC
Confidence             22345678999999987543 467889999999999999865

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.98  E-value=3.7e-32  Score=244.04  Aligned_cols=192  Identities=28%  Similarity=0.372  Sum_probs=164.4

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC---cEEEEE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG---GMHIVL  185 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---~~~lv~  185 (308)
                      ++|...+.||.|++|.||+|.+. +++.+|+|.+...........+.+|+++++.++||||+++++++...   .+++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            46788899999999999999975 58899999987654445567899999999999999999999976542   478999


Q ss_pred             EecCCCCHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCC
Q 021711          186 ELSPNGSLASLLYG---MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE  262 (308)
Q Consensus       186 e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~  262 (308)
                      ||+++++|.+++..   ....++...+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence            99999999887643   34558888999999999999999998   8999999999999999999999999999876543


Q ss_pred             CCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          263 QWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       263 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ...    ....++..|+|||.......+.+.|+||+|+++|+|++|
T Consensus       158 ~~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g  199 (287)
T cd06621         158 SLA----GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQN  199 (287)
T ss_pred             ccc----ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhC
Confidence            221    245688999999988777788899999999999999875

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=99.98  E-value=2.5e-33  Score=236.53  Aligned_cols=200  Identities=24%  Similarity=0.295  Sum_probs=164.9

Q ss_pred             hhcCCccccceeeccCceEEEEEE-ECCCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEe------C
Q 021711          107 SATNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE------G  179 (308)
Q Consensus       107 ~~~~~~~~~~~LG~G~fg~Vy~~~-~~~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~  179 (308)
                      .+.++|.+.+.||+|||+.||+++ ..++..+|+|++.-... +..+..++|++..++++|||++++++++..      .
T Consensus        18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~-~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~   96 (302)
T KOG2345|consen   18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQ-EDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH   96 (302)
T ss_pred             EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccch-HHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence            556799999999999999999998 45789999999976553 346888999999999999999999986432      2


Q ss_pred             cEEEEEEecCCCCHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEecccc
Q 021711          180 GMHIVLELSPNGSLASLLYGM---KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGL  256 (308)
Q Consensus       180 ~~~lv~e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGl  256 (308)
                      ..|+++.|...|+|.+.+...   +..+++.+++.|+.+|++||++||+.- ....||||||.|||+.+.+.++|.|||.
T Consensus        97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS  175 (302)
T KOG2345|consen   97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGS  175 (302)
T ss_pred             eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccC
Confidence            378999999999999998652   346899999999999999999999822 2499999999999999999999999999


Q ss_pred             ceecCCCCc-------eeEeeceeccccccccccCchh---hcCccceeEEEeeEEEeeccC
Q 021711          257 AKWLPEQWT-------HHTISKVEGTFGLVKLNLPPLV---ILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       257 a~~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Di~s~g~~l~el~c~  308 (308)
                      +...+..-.       .+.......|..|.|||++...   ..+.+.||||+|++||++.+|
T Consensus       176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~  237 (302)
T KOG2345|consen  176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFG  237 (302)
T ss_pred             ccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHc
Confidence            876543211       1223356789999999997544   467899999999999988654

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=99.98  E-value=3.5e-32  Score=241.22  Aligned_cols=194  Identities=31%  Similarity=0.455  Sum_probs=163.1

Q ss_pred             hcCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcC-CCCeeeeeeeEEEeCc-----
Q 021711          108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGIEGG-----  180 (308)
Q Consensus       108 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~-----  180 (308)
                      .+++|++.+.||+|+||.||+|... +++.+++|.+......  ...+.+|+.+++.+ +|+||+++++++....     
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE--EEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND   81 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchh--HHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence            4678999999999999999999976 5789999998755432  36788999999998 7999999999876533     


Q ss_pred             --EEEEEEecCCCCHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccc
Q 021711          181 --MHIVLELSPNGSLASLLYGM---KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFG  255 (308)
Q Consensus       181 --~~lv~e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFG  255 (308)
                        .++||||+++++|.+++...   ...+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~~l~p~ni~~~~~~~~~l~d~~  158 (275)
T cd06608          82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFG  158 (275)
T ss_pred             eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEEccCCeEEECCCc
Confidence              68999999999999988542   3578999999999999999999998   899999999999999999999999999


Q ss_pred             cceecCCCCceeEeeceeccccccccccCch-----hhcCccceeEEEeeEEEeeccC
Q 021711          256 LAKWLPEQWTHHTISKVEGTFGLVKLNLPPL-----VILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       256 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ++........  ......|+..|+|||.+..     ...+.++|+||+|++|+++++|
T Consensus       159 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g  214 (275)
T cd06608         159 VSAQLDSTLG--RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADG  214 (275)
T ss_pred             cceecccchh--hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhC
Confidence            9987644322  2234568999999997532     2356779999999999999865

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=99.98  E-value=3e-32  Score=241.34  Aligned_cols=194  Identities=26%  Similarity=0.415  Sum_probs=162.6

Q ss_pred             CccccceeeccCceEEEEEEEC-CCcEEEEEEeccCC-----hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEE
Q 021711          111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT-----ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHI  183 (308)
Q Consensus       111 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l  183 (308)
                      +|+..+.||+|+||.||++... +++.||+|.+....     .......+.+|+.+++.++|+||+++++++.++ ..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            4778899999999999999864 68999999886432     122457889999999999999999999976654 5789


Q ss_pred             EEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCC-cEEEeccccceecCC
Q 021711          184 VLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDF-EPQICDFGLAKWLPE  262 (308)
Q Consensus       184 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~-~~kl~DFGla~~~~~  262 (308)
                      |+||+++++|.+++.. ...+++..+..++.|++.||.|||+   ++++|+||||+||+++.++ .++|+|||++..+..
T Consensus        81 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~ql~~al~~LH~---~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~  156 (268)
T cd06630          81 FVEWMAGGSVSHLLSK-YGAFKEAVIINYTEQLLRGLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAA  156 (268)
T ss_pred             EEeccCCCcHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccccccccccc
Confidence            9999999999999864 4568899999999999999999998   8999999999999998775 599999999987754


Q ss_pred             CCcee--EeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          263 QWTHH--TISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       263 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      .....  ......||..|+|||.......+.++|+||+|+++++|++|
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g  204 (268)
T cd06630         157 KGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATA  204 (268)
T ss_pred             ccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhC
Confidence            32111  11235689999999988777788899999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.97  E-value=2.7e-32  Score=246.66  Aligned_cols=196  Identities=25%  Similarity=0.307  Sum_probs=160.2

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCCh-HHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-------
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA-DEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-------  179 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-------  179 (308)
                      .++|++.+.||+|+||.||+|... +++.||+|.+..... ......+.+|+.+++.++||||+++++++...       
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            357999999999999999999876 589999998864322 22234567899999999999999999976543       


Q ss_pred             --cEEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccc
Q 021711          180 --GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLA  257 (308)
Q Consensus       180 --~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla  257 (308)
                        ..++|+||+. ++|.+.+......+++..+..++.|++.||.|||+   ++++|+||||+||+++.++.+||+|||++
T Consensus        91 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~  166 (310)
T cd07865          91 KGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHR---NKILHRDMKAANILITKDGILKLADFGLA  166 (310)
T ss_pred             CceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEECCCCcEEECcCCCc
Confidence              2489999996 48888886655578999999999999999999998   89999999999999999999999999999


Q ss_pred             eecCCCCce--eEeeceeccccccccccCchhh-cCccceeEEEeeEEEeeccC
Q 021711          258 KWLPEQWTH--HTISKVEGTFGLVKLNLPPLVI-LKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       258 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~s~g~~l~el~c~  308 (308)
                      ..+......  .......++..|+|||...+.. .+.++|+||+|+++|||++|
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~  220 (310)
T cd07865         167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTR  220 (310)
T ss_pred             ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhC
Confidence            876443221  1122356788999999875443 57789999999999999764

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=99.97  E-value=1e-32  Score=248.67  Aligned_cols=189  Identities=21%  Similarity=0.286  Sum_probs=159.8

Q ss_pred             ccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEe-CcEEEEEEecC
Q 021711          112 FSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLELSP  189 (308)
Q Consensus       112 ~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~lv~e~~~  189 (308)
                      |.....||+|+||.||++... ++..||||.+..... ...+.+.+|+.+++.++|+||+++++.+.. +..++||||++
T Consensus        24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~  102 (292)
T cd06658          24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQ-QRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE  102 (292)
T ss_pred             HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchH-HHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence            334467999999999999875 588999999865432 335678899999999999999999986554 45789999999


Q ss_pred             CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCceeEe
Q 021711          190 NGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTI  269 (308)
Q Consensus       190 ~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  269 (308)
                      +++|.+++..  ..+++..+..++.|++.||.|||+   ++|+||||||+||+++.++.++|+|||++........  ..
T Consensus       103 ~~~L~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~--~~  175 (292)
T cd06658         103 GGALTDIVTH--TRMNEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP--KR  175 (292)
T ss_pred             CCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--cC
Confidence            9999998743  468899999999999999999998   8999999999999999999999999999976543321  22


Q ss_pred             eceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          270 SKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       270 ~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ....|+..|+|||.......+.++|+||+|+++||++.|
T Consensus       176 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g  214 (292)
T cd06658         176 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDG  214 (292)
T ss_pred             ceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhC
Confidence            345789999999998877788899999999999999875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.97  E-value=3e-32  Score=245.07  Aligned_cols=193  Identities=25%  Similarity=0.346  Sum_probs=162.2

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCCh-HHHHHHHHHHHHHHhcCCCCeeeeeeeEEEe---CcEEEE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA-DEIIADFLSELGIMAHVDHPNTAKLLGYGIE---GGMHIV  184 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---~~~~lv  184 (308)
                      ++|++.+.||+|+||.||+|... +++.+|+|.+..... +.....+.+|+.++..++||||+++++++..   ...++|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            47888999999999999999976 588999999865432 2233467789999999999999999997654   458899


Q ss_pred             EEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCC
Q 021711          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (308)
Q Consensus       185 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  264 (308)
                      +||+.+ +|.+++......+++..+..++.|++.||.|||+   .+|+|+||||+||+++.++.++|+|||+++.+....
T Consensus        85 ~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~  160 (293)
T cd07843          85 MEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL  160 (293)
T ss_pred             ehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence            999974 9998886655578999999999999999999998   899999999999999999999999999998775542


Q ss_pred             ceeEeeceeccccccccccCchhh-cCccceeEEEeeEEEeeccC
Q 021711          265 THHTISKVEGTFGLVKLNLPPLVI-LKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~s~g~~l~el~c~  308 (308)
                      .  ......++..|+|||.+.+.. .+.++|+||+|+++++|.+|
T Consensus       161 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g  203 (293)
T cd07843         161 K--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTK  203 (293)
T ss_pred             c--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhC
Confidence            2  223456789999999875443 57889999999999998765

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=99.97  E-value=3.1e-32  Score=243.70  Aligned_cols=194  Identities=24%  Similarity=0.291  Sum_probs=163.8

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCCh-HHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEEE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA-DEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLE  186 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e  186 (308)
                      ++|++.+.||+|+||.||+|.+. +++.||+|.+..... ......+.+|+++++.++|+||+++++++..+ ..++++|
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            36889999999999999999876 588999998865322 23457789999999999999999999977654 4789999


Q ss_pred             ecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCce
Q 021711          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH  266 (308)
Q Consensus       187 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~  266 (308)
                      |++++.+..+.. ....+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.+||+|||++........ 
T Consensus        81 ~~~~~~l~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~-  155 (288)
T cd07833          81 YVERTLLELLEA-SPGGLPPDAVRSYIWQLLQAIAYCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA-  155 (288)
T ss_pred             cCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc-
Confidence            999876665553 34568999999999999999999998   8999999999999999999999999999987765432 


Q ss_pred             eEeeceeccccccccccCchh-hcCccceeEEEeeEEEeeccC
Q 021711          267 HTISKVEGTFGLVKLNLPPLV-ILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~s~g~~l~el~c~  308 (308)
                      .......++..|+|||+.... ..+.++|+||+|+++|++++|
T Consensus       156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g  198 (288)
T cd07833         156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDG  198 (288)
T ss_pred             ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhC
Confidence            122346788999999998777 678899999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=99.97  E-value=5.2e-32  Score=238.04  Aligned_cols=192  Identities=23%  Similarity=0.305  Sum_probs=162.8

Q ss_pred             CccccceeeccCceEEEEEEEC-CCcEEEEEEeccCC-hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEe-CcEEEEEEe
Q 021711          111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLEL  187 (308)
Q Consensus       111 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~lv~e~  187 (308)
                      +|+..+.||+|+||.||++... +++.+|+|.+.... ..+....+.+|+.+++.++|||++++++.+.. +..++|+||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            5788899999999999999865 58899999986542 23346788999999999999999999986554 457899999


Q ss_pred             cCCCCHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCC-CcEEEeccccceecCCCCc
Q 021711          188 SPNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTED-FEPQICDFGLAKWLPEQWT  265 (308)
Q Consensus       188 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~-~~~kl~DFGla~~~~~~~~  265 (308)
                      +++++|.+++... ...+++..+..++.|++.||.|||+   ++|+|+||||+||+++.+ +.++|+|||+++.......
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~  157 (256)
T cd08220          81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK  157 (256)
T ss_pred             CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence            9999999999653 3458899999999999999999998   899999999999999865 4689999999998754422


Q ss_pred             eeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          266 HHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                         .....|+..|+|||.......+.++|+||+|+++++|++|
T Consensus       158 ---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~  197 (256)
T cd08220         158 ---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASL  197 (256)
T ss_pred             ---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhC
Confidence               2345689999999998877788899999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.97  E-value=4.3e-32  Score=250.99  Aligned_cols=190  Identities=24%  Similarity=0.221  Sum_probs=160.9

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCC-hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-------
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-------  179 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-------  179 (308)
                      .++|++.+.||+|+||.||+|... +|+.||+|.+.... .......+.+|+.+++.++||||+++++++...       
T Consensus        15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   94 (353)
T cd07850          15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ   94 (353)
T ss_pred             hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence            468999999999999999999876 68999999986432 223456778899999999999999999876432       


Q ss_pred             cEEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEecccccee
Q 021711          180 GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKW  259 (308)
Q Consensus       180 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~  259 (308)
                      ..++|+||+. ++|.+.+..   .++...+..++.|++.||.|||+   .+|+||||||+||+++.++.+||+|||+++.
T Consensus        95 ~~~lv~e~~~-~~l~~~~~~---~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~  167 (353)
T cd07850          95 DVYLVMELMD-ANLCQVIQM---DLDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART  167 (353)
T ss_pred             cEEEEEeccC-CCHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCcccee
Confidence            3689999996 488887743   28888899999999999999998   8999999999999999999999999999987


Q ss_pred             cCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          260 LPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       260 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ......   .....||..|+|||.+.+...+.++|+||+|+++++|++|
T Consensus       168 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g  213 (353)
T cd07850         168 AGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRG  213 (353)
T ss_pred             CCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHC
Confidence            654321   2345689999999998888888999999999999999865

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.97  E-value=4e-32  Score=246.33  Aligned_cols=194  Identities=29%  Similarity=0.369  Sum_probs=161.7

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCCh-HHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC---cEEE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA-DEIIADFLSELGIMAHVDHPNTAKLLGYGIEG---GMHI  183 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---~~~l  183 (308)
                      .++|++.+.||+|+||.||+|... +|+.||+|.+..... ......+.+|+.+++.++|+||+++++++.+.   ..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            468999999999999999999976 589999999864322 12234567899999999999999999977543   4789


Q ss_pred             EEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCC
Q 021711          184 VLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ  263 (308)
Q Consensus       184 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  263 (308)
                      ||||+.+ +|.+++......+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||+++.+...
T Consensus        86 v~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~  161 (309)
T cd07845          86 VMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP  161 (309)
T ss_pred             EEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence            9999964 8888886655678999999999999999999998   89999999999999999999999999999877543


Q ss_pred             CceeEeeceeccccccccccCch-hhcCccceeEEEeeEEEeeccC
Q 021711          264 WTHHTISKVEGTFGLVKLNLPPL-VILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ..  ......++..|+|||...+ ...+.++|+||+|+++|||++|
T Consensus       162 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g  205 (309)
T cd07845         162 AK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAH  205 (309)
T ss_pred             cC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhC
Confidence            21  2233456889999998754 4467889999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=99.97  E-value=1.9e-32  Score=247.58  Aligned_cols=188  Identities=21%  Similarity=0.269  Sum_probs=159.5

Q ss_pred             cccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEe-CcEEEEEEecCC
Q 021711          113 SFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLELSPN  190 (308)
Q Consensus       113 ~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~lv~e~~~~  190 (308)
                      .....||+|+||.||++... +++.||+|.+...... ..+.+.+|+.++..++||||+++++++.. +..++++||+++
T Consensus        24 ~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~  102 (297)
T cd06659          24 ENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQ-RRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG  102 (297)
T ss_pred             HhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccc-hHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence            33457999999999999875 5899999998654322 24668899999999999999999986554 457899999999


Q ss_pred             CCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCceeEee
Q 021711          191 GSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTIS  270 (308)
Q Consensus       191 gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~  270 (308)
                      ++|..++..  ..+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.++|+|||+++.+.....  ...
T Consensus       103 ~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~  175 (297)
T cd06659         103 GALTDIVSQ--TRLNEEQIATVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KRK  175 (297)
T ss_pred             CCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc--ccc
Confidence            999987743  568899999999999999999998   8999999999999999999999999999986644322  223


Q ss_pred             ceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          271 KVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       271 ~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ...|+..|+|||.+.+...+.++|+||+|++++||+.|
T Consensus       176 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g  213 (297)
T cd06659         176 SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDG  213 (297)
T ss_pred             ceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhC
Confidence            46789999999998777788899999999999999865

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=99.97  E-value=1.5e-31  Score=235.90  Aligned_cols=194  Identities=28%  Similarity=0.391  Sum_probs=168.2

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEEEe
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLEL  187 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~  187 (308)
                      ++|++.+.||+|++|.||+|... +++.||+|.+...........+.+|+.++..++|+||+++++++..+ ..++|+||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            46888999999999999999977 48999999987665434567899999999999999999999976654 57899999


Q ss_pred             cCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCcee
Q 021711          188 SPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH  267 (308)
Q Consensus       188 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~  267 (308)
                      +++++|.+++... ..++...++.++.|++.||.|||+.  .+++|+||+|+||+++.++.++|+|||++......... 
T Consensus        81 ~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~--~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~-  156 (264)
T cd06623          81 MDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ-  156 (264)
T ss_pred             cCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhcc--CCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc-
Confidence            9999999999643 6789999999999999999999952  68999999999999999999999999999877544322 


Q ss_pred             EeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          268 TISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                       .....++..|+|||.......+.++|+||||+++|++++|
T Consensus       157 -~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg  196 (264)
T cd06623         157 -CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALG  196 (264)
T ss_pred             -ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhC
Confidence             1345789999999998887888899999999999999875

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=7e-33  Score=241.32  Aligned_cols=188  Identities=20%  Similarity=0.300  Sum_probs=157.7

Q ss_pred             ceeeccCceEEEEEE-ECCCcEEEEEEeccCChHHHHHHHHHHHHHHhcCC-CCeeeeeeeEEEeC-cEEEEEEecCCCC
Q 021711          116 NLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVD-HPNTAKLLGYGIEG-GMHIVLELSPNGS  192 (308)
Q Consensus       116 ~~LG~G~fg~Vy~~~-~~~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~-~~~lv~e~~~~gs  192 (308)
                      ++||+|+|+.|-.|. ..+|..+|||++.+.. ...+.+..+|++++.+++ |+||++|++|+.++ .+|||||-+.||+
T Consensus        84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~-gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp  162 (463)
T KOG0607|consen   84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP-GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP  162 (463)
T ss_pred             HHhcCccceeeeeeeeeccchhhhhhhhhcCC-chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence            689999999999997 5689999999997663 345788999999999995 99999999987665 5899999999999


Q ss_pred             HHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCC---cEEEeccccceecCCCC-----
Q 021711          193 LASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDF---EPQICDFGLAKWLPEQW-----  264 (308)
Q Consensus       193 L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~---~~kl~DFGla~~~~~~~-----  264 (308)
                      |...+.. ...+++..+..++.+|+.||.|||.   ++|.||||||+|||-....   -+|||||.|+.-+....     
T Consensus       163 lLshI~~-~~~F~E~EAs~vvkdia~aLdFlH~---kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spa  238 (463)
T KOG0607|consen  163 LLSHIQK-RKHFNEREASRVVKDIASALDFLHT---KGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPA  238 (463)
T ss_pred             HHHHHHH-hhhccHHHHHHHHHHHHHHHHHHhh---cCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCC
Confidence            9999965 4568899999999999999999998   9999999999999987654   48999998876443221     


Q ss_pred             ceeEeeceeccccccccccC-----chhhcCccceeEEEeeEEEeeccC
Q 021711          265 THHTISKVEGTFGLVKLNLP-----PLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ......+..|+..|||||..     ....++++.|.||+|++||.|+||
T Consensus       239 stP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsG  287 (463)
T KOG0607|consen  239 STPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSG  287 (463)
T ss_pred             CCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhC
Confidence            11234467899999999974     233578889999999999999987

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=4.9e-33  Score=266.19  Aligned_cols=192  Identities=27%  Similarity=0.362  Sum_probs=172.3

Q ss_pred             cccceeeccCceEEEEEEEC-C----CcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeCcEEEEEEe
Q 021711          113 SFENLIGKGGYAEVYKGRLR-N----GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHIVLEL  187 (308)
Q Consensus       113 ~~~~~LG~G~fg~Vy~~~~~-~----g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~lv~e~  187 (308)
                      ...++||+|+||+||+|.+- .    ..+||||.+......+...+++.|+-+|.+++|||+++|+++|..+.+.||++|
T Consensus       699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~~qlvtq~  778 (1177)
T KOG1025|consen  699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLSTLQLVTQL  778 (1177)
T ss_pred             hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccchHHHHHHh
Confidence            45689999999999999864 2    357999999777666667889999999999999999999999999888999999


Q ss_pred             cCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCcee
Q 021711          188 SPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH  267 (308)
Q Consensus       188 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~  267 (308)
                      ++.|+|.++++.++..+.....+.|..|||+||.|||+   ++++||||.++|||+..-..+||+|||+|+.+..+....
T Consensus       779 mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~---qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey  855 (1177)
T KOG1025|consen  779 MPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEE---QRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEY  855 (1177)
T ss_pred             cccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHh---cchhhhhhhhhheeecCCCeEEEEecchhhccCcccccc
Confidence            99999999999988999999999999999999999998   999999999999999999999999999999998877655


Q ss_pred             EeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          268 TISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      ......-.+.|||-|.+....++..+||||||+++|||.+
T Consensus       856 ~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmT  895 (1177)
T KOG1025|consen  856 SAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMT  895 (1177)
T ss_pred             cccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHh
Confidence            5555555678999998888889999999999999999863

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.97  E-value=6.6e-32  Score=240.90  Aligned_cols=189  Identities=22%  Similarity=0.246  Sum_probs=155.8

Q ss_pred             ccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCC-CCeeeeeeeEEEeC---cEEEEEE
Q 021711          112 FSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVD-HPNTAKLLGYGIEG---GMHIVLE  186 (308)
Q Consensus       112 ~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~---~~~lv~e  186 (308)
                      |++.+.||+|+||.||+|... +++.||+|.+.............+|+.++.++. |+|++++++++.++   ..++|+|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            567889999999999999865 588999999875432222234567999999885 99999999976654   5789999


Q ss_pred             ecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCce
Q 021711          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH  266 (308)
Q Consensus       187 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~  266 (308)
                      |+. ++|.+.+......+++..+..++.|++.||.|||+   .+|+||||||+||+++. +.+||+|||+++.+..... 
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~-  154 (282)
T cd07831          81 LMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHR---NGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP-  154 (282)
T ss_pred             cCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEcC-CCeEEEecccccccccCCC-
Confidence            997 58888886655678999999999999999999998   89999999999999999 9999999999987644322 


Q ss_pred             eEeeceeccccccccccC-chhhcCccceeEEEeeEEEeeccC
Q 021711          267 HTISKVEGTFGLVKLNLP-PLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~-~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                        .....++..|+|||.. .....+.++|+||+|+++|||++|
T Consensus       155 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~  195 (282)
T cd07831         155 --YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSL  195 (282)
T ss_pred             --cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcC
Confidence              1235688999999965 344567889999999999999864

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.97  E-value=2.2e-33  Score=243.66  Aligned_cols=195  Identities=23%  Similarity=0.310  Sum_probs=161.2

Q ss_pred             cCCccccceeeccCceEEEEEEECC-----CcEEEEEEeccCChH-HHHHHHHHHHHHHhcCCCCeeeeeeeEEEe--Cc
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLRN-----GQLVAIKRLTRGTAD-EIIADFLSELGIMAHVDHPNTAKLLGYGIE--GG  180 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~~-----g~~vAvK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~  180 (308)
                      ...|+....||+|+||.||+|.-.+     ...+|||.++...+. ..-....||+.+++.++|||++.|..++..  ..
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~  102 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK  102 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence            3578888999999999999996432     237999999765332 234567899999999999999999885544  46


Q ss_pred             EEEEEEecCCCCHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCC----CcEEEe
Q 021711          181 MHIVLELSPNGSLASLLYGM----KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTED----FEPQIC  252 (308)
Q Consensus       181 ~~lv~e~~~~gsL~~~l~~~----~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~----~~~kl~  252 (308)
                      +++++||.++ +|..+++-+    ...++...+..|+.||+.|+.|||+   +-|+||||||+|||+..+    |.|||+
T Consensus       103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~---NWvlHRDLKPaNIlvmgdgperG~VKIa  178 (438)
T KOG0666|consen  103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS---NWVLHRDLKPANILVMGDGPERGRVKIA  178 (438)
T ss_pred             EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh---hheeeccCCcceEEEeccCCccCeeEee
Confidence            8999999976 888888542    2458889999999999999999998   789999999999999877    899999


Q ss_pred             ccccceecCCCCcee-EeeceeccccccccccCchhh-cCccceeEEEeeEEEeecc
Q 021711          253 DFGLAKWLPEQWTHH-TISKVEGTFGLVKLNLPPLVI-LKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       253 DFGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~s~g~~l~el~c  307 (308)
                      |||+||.+......- ....++-|++|.|||++.+.. ++...|+|+.||+..||..
T Consensus       179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLt  235 (438)
T KOG0666|consen  179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLT  235 (438)
T ss_pred             cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHc
Confidence            999999886654432 446788999999999877665 7889999999999988864

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.97  E-value=6.5e-32  Score=242.79  Aligned_cols=193  Identities=19%  Similarity=0.233  Sum_probs=157.1

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChH-HHHHHHHHHHHHHhcCC-CCeeeeeeeEEEeC-c-----
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTAD-EIIADFLSELGIMAHVD-HPNTAKLLGYGIEG-G-----  180 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~-~-----  180 (308)
                      ++|++.+.||+|+||.||+|.+. +++.||+|.+...... .....+.+|+.+++.++ ||||+++++++... .     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            46889999999999999999976 5899999987643322 23456888999999995 69999999866543 2     


Q ss_pred             EEEEEEecCCCCHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECC-CCcEEEeccc
Q 021711          181 MHIVLELSPNGSLASLLYGM----KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTE-DFEPQICDFG  255 (308)
Q Consensus       181 ~~lv~e~~~~gsL~~~l~~~----~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~-~~~~kl~DFG  255 (308)
                      .++||||+++ +|.+++...    ...+++..+..++.||+.||.|||+   ++|+||||||+||+++. ++.+||+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEecCCCeEEEeecc
Confidence            6899999985 788887542    2357999999999999999999998   89999999999999998 8899999999


Q ss_pred             cceecCCCCceeEeeceeccccccccccCch-hhcCccceeEEEeeEEEeeccC
Q 021711          256 LAKWLPEQWTHHTISKVEGTFGLVKLNLPPL-VILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       256 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      +++.+.....  ......+++.|+|||.+.+ ...+.++|+||+|+++|+|++|
T Consensus       157 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g  208 (295)
T cd07837         157 LGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK  208 (295)
T ss_pred             cceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcC
Confidence            9986643221  1223457889999998754 3467889999999999999875

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=99.97  E-value=1e-31  Score=242.22  Aligned_cols=191  Identities=24%  Similarity=0.308  Sum_probs=163.4

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEEEe
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLEL  187 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~  187 (308)
                      ++|.+.+.||+|+||.||++... ++..||+|.+...... ..+.+.+|+.+++.++||||+++++++... ..++|+||
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~   97 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQP-KKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY   97 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccch-HHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence            58889999999999999999865 5789999998643322 246788999999999999999999976554 57899999


Q ss_pred             cCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCcee
Q 021711          188 SPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH  267 (308)
Q Consensus       188 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~  267 (308)
                      +++++|.+++..  ..+++..+..++.|++.||.|||+   ++++|+||||+||+++.++.++|+|||++........  
T Consensus        98 ~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~---~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~--  170 (293)
T cd06647          98 LAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--  170 (293)
T ss_pred             CCCCcHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHh---CCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc--
Confidence            999999999853  457888999999999999999998   8999999999999999999999999999987654322  


Q ss_pred             EeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          268 TISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ......|++.|+|||.......+.++|+||||+++|++++|
T Consensus       171 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g  211 (293)
T cd06647         171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG  211 (293)
T ss_pred             ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhC
Confidence            22345789999999998777788899999999999999865

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.97  E-value=1.4e-31  Score=236.37  Aligned_cols=194  Identities=27%  Similarity=0.371  Sum_probs=165.0

Q ss_pred             CccccceeeccCceEEEEEEEC-CCcEEEEEEeccCCh-HHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEEEe
Q 021711          111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA-DEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLEL  187 (308)
Q Consensus       111 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~  187 (308)
                      +|++.+.||+|+||.||+|... +++.||+|.+..... ......+.+|+.+++.++|+||+++++++... ..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            5788899999999999999865 688999999875543 24567899999999999999999999976554 57899999


Q ss_pred             cCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCcee
Q 021711          188 SPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH  267 (308)
Q Consensus       188 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~  267 (308)
                      +++++|.+++.. ...+++..+..++.|++.||.|||+   .+|+|+||+|+||+++.++.+||+|||++..........
T Consensus        81 ~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~  156 (264)
T cd06626          81 CSGGTLEELLEH-GRILDEHVIRVYTLQLLEGLAYLHS---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM  156 (264)
T ss_pred             CCCCcHHHHHhh-cCCCChHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc
Confidence            999999999864 3457888999999999999999998   899999999999999999999999999998775543321


Q ss_pred             E--eeceeccccccccccCchhh---cCccceeEEEeeEEEeeccC
Q 021711          268 T--ISKVEGTFGLVKLNLPPLVI---LKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       268 ~--~~~~~gt~~y~aPE~~~~~~---~~~~~Di~s~g~~l~el~c~  308 (308)
                      .  .....++..|+|||......   .+.++|+||||++++++++|
T Consensus       157 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g  202 (264)
T cd06626         157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATG  202 (264)
T ss_pred             cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhC
Confidence            1  12457889999999987665   77889999999999999865

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.97  E-value=9.3e-32  Score=241.54  Aligned_cols=193  Identities=24%  Similarity=0.281  Sum_probs=159.8

Q ss_pred             CccccceeeccCceEEEEEEEC----CCcEEEEEEeccCCh---HHHHHHHHHHHHHHhcC-CCCeeeeeeeEEEeC-cE
Q 021711          111 NFSFENLIGKGGYAEVYKGRLR----NGQLVAIKRLTRGTA---DEIIADFLSELGIMAHV-DHPNTAKLLGYGIEG-GM  181 (308)
Q Consensus       111 ~~~~~~~LG~G~fg~Vy~~~~~----~g~~vAvK~~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~~  181 (308)
                      +|++.+.||+|+||.||++...    +|..||+|.+.....   ....+.+.+|+.++..+ +|+||+++++.+..+ ..
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            4788899999999999999863    688999999865322   12346778899999999 599999999866554 46


Q ss_pred             EEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecC
Q 021711          182 HIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP  261 (308)
Q Consensus       182 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~  261 (308)
                      ++|+||+++++|.+++.. ...+++..+..++.|++.||.|||+   .+++||||+|+|||++.++.+||+|||+++...
T Consensus        81 ~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~  156 (290)
T cd05613          81 HLILDYINGGELFTHLSQ-RERFKEQEVQIYSGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH  156 (290)
T ss_pred             EEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEECCCCCEEEeeCccceecc
Confidence            899999999999999864 4568888999999999999999998   899999999999999999999999999998764


Q ss_pred             CCCceeEeeceeccccccccccCchh--hcCccceeEEEeeEEEeeccC
Q 021711          262 EQWTHHTISKVEGTFGLVKLNLPPLV--ILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       262 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~s~g~~l~el~c~  308 (308)
                      .... .......|+..|+|||.....  ..+.+.|+||+|+++|+|++|
T Consensus       157 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g  204 (290)
T cd05613         157 EDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTG  204 (290)
T ss_pred             cccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcC
Confidence            4321 112345689999999987643  356789999999999999876

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.97  E-value=5.4e-32  Score=248.60  Aligned_cols=194  Identities=23%  Similarity=0.302  Sum_probs=161.1

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCC-hHHHHHHHHHHHHHHhcC-CCCeeeeeeeEEEeC---cEE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT-ADEIIADFLSELGIMAHV-DHPNTAKLLGYGIEG---GMH  182 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~---~~~  182 (308)
                      .++|++.+.||+|+||.||+|.+. +|+.+|+|.+.... .......+.+|+.++.++ +||||+++++++...   ..+
T Consensus         6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~   85 (337)
T cd07852           6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY   85 (337)
T ss_pred             hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence            467889999999999999999976 58899999885431 222345677899999999 999999999976543   378


Q ss_pred             EEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCC
Q 021711          183 IVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE  262 (308)
Q Consensus       183 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~  262 (308)
                      +|+||+. ++|..++..  ..+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.+||+|||+++.+..
T Consensus        86 lv~e~~~-~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~---~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~  159 (337)
T cd07852          86 LVFEYME-TDLHAVIRA--NILEDVHKRYIMYQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSLSE  159 (337)
T ss_pred             EEecccc-cCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccchhcccc
Confidence            9999997 589888854  278888999999999999999998   8999999999999999999999999999987754


Q ss_pred             CCce---eEeeceeccccccccccCch-hhcCccceeEEEeeEEEeeccC
Q 021711          263 QWTH---HTISKVEGTFGLVKLNLPPL-VILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       263 ~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ....   .......||..|+|||.+.. ...+.++|+||+|+++|+|++|
T Consensus       160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg  209 (337)
T cd07852         160 LEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLG  209 (337)
T ss_pred             ccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhC
Confidence            4321   12345678999999997654 4467889999999999999875

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.97  E-value=1.2e-31  Score=240.39  Aligned_cols=195  Identities=26%  Similarity=0.324  Sum_probs=167.4

Q ss_pred             hhcCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEe-CcEEEE
Q 021711          107 SATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIV  184 (308)
Q Consensus       107 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~lv  184 (308)
                      ..++.|+..+.||+|+||.||+|.+. +++.+|+|.+.....  ..+.+.+|+.+++.++|+|++++++.+.. ...+++
T Consensus        16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   93 (286)
T cd06614          16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ--NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVV   93 (286)
T ss_pred             CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch--hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEE
Confidence            44567888899999999999999977 588999999875543  35678899999999999999999996655 457899


Q ss_pred             EEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCC
Q 021711          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (308)
Q Consensus       185 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  264 (308)
                      +||+++++|.+++......+++..+..++.|++.||.|||+   .+|+|+||+|+||+++.++.++|+|||++.......
T Consensus        94 ~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~---~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  170 (286)
T cd06614          94 MEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK  170 (286)
T ss_pred             EeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence            99999999999997654479999999999999999999998   999999999999999999999999999987654332


Q ss_pred             ceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          265 THHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      .  ......++..|++||...+...+.++|+||+|+++|+|+.|
T Consensus       171 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g  212 (286)
T cd06614         171 S--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEG  212 (286)
T ss_pred             h--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhC
Confidence            1  12334688999999998777788899999999999999865

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.97  E-value=1.2e-31  Score=247.48  Aligned_cols=196  Identities=23%  Similarity=0.279  Sum_probs=162.1

Q ss_pred             HHHHHhhcCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCCh-HHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC
Q 021711          102 LYELQSATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA-DEIIADFLSELGIMAHVDHPNTAKLLGYGIEG  179 (308)
Q Consensus       102 ~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  179 (308)
                      ..++...+++|.+.+.||+|+||.||+|... +++.||+|++..... ....+.+.+|+.++.+++||||+++++++...
T Consensus         9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~   88 (345)
T cd07877           9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA   88 (345)
T ss_pred             HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence            3455667789999999999999999999864 689999999875432 22346788999999999999999999866432


Q ss_pred             -------cEEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEe
Q 021711          180 -------GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQIC  252 (308)
Q Consensus       180 -------~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~  252 (308)
                             ..+++++++ +++|.+++..  ..+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.+||+
T Consensus        89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~  162 (345)
T cd07877          89 RSLEEFNDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKIL  162 (345)
T ss_pred             ccccccccEEEEehhc-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEcCCCCEEEe
Confidence                   256677765 7899888743  468999999999999999999998   899999999999999999999999


Q ss_pred             ccccceecCCCCceeEeeceeccccccccccCch-hhcCccceeEEEeeEEEeeccC
Q 021711          253 DFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPL-VILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       253 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      |||+++.....     .....||..|+|||...+ ...+.++|+||+|+++++|++|
T Consensus       163 dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g  214 (345)
T cd07877         163 DFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG  214 (345)
T ss_pred             ccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhC
Confidence            99999865332     234578999999998755 4567889999999999999865

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.97  E-value=8.7e-32  Score=240.30  Aligned_cols=185  Identities=24%  Similarity=0.296  Sum_probs=156.3

Q ss_pred             eeccCceEEEEEEEC-CCcEEEEEEeccCCh--HHHHHHHHHHHHHHhcCCCCeeeeeeeEEEe-CcEEEEEEecCCCCH
Q 021711          118 IGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLELSPNGSL  193 (308)
Q Consensus       118 LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~lv~e~~~~gsL  193 (308)
                      ||+|+||.||+|... +|+.||+|.+.....  ......+.+|+.+++.++||||+++++.+.. +..++|+||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            689999999999865 588999999864321  2234567889999999999999999986654 457899999999999


Q ss_pred             HHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCceeEeece
Q 021711          194 ASLLYGMK-EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKV  272 (308)
Q Consensus       194 ~~~l~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~  272 (308)
                      .+++.... ..+++..+..++.|++.||.|||+   .+++||||+|+||+++.++.++|+|||++.......   .....
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~  154 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKGR  154 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC---ccccc
Confidence            99986533 368999999999999999999998   899999999999999999999999999998764421   22345


Q ss_pred             eccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          273 EGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       273 ~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      .++..|+|||.......+.++|+||+|+++++|++|
T Consensus       155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g  190 (277)
T cd05577         155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAG  190 (277)
T ss_pred             cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhC
Confidence            688999999998777788889999999999999875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.97  E-value=1.1e-31  Score=240.40  Aligned_cols=184  Identities=24%  Similarity=0.254  Sum_probs=148.2

Q ss_pred             eeeccCceEEEEEEEC-CCcEEEEEEeccCCh--HHHHHHHHHHHH---HHhcCCCCeeeeeeeEEEe-CcEEEEEEecC
Q 021711          117 LIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELG---IMAHVDHPNTAKLLGYGIE-GGMHIVLELSP  189 (308)
Q Consensus       117 ~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~--~~~~~~~~~E~~---~l~~l~h~niv~l~~~~~~-~~~~lv~e~~~  189 (308)
                      +||+|+||.||++... +++.+|+|.+.....  ......+.+|..   ++...+||||+.+++++.. +..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999875 588999998865322  111223344443   3344579999999886654 56789999999


Q ss_pred             CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCceeEe
Q 021711          190 NGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTI  269 (308)
Q Consensus       190 ~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  269 (308)
                      +++|.+++.. ...+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.++|+|||++.......    .
T Consensus        81 ~~~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~----~  152 (279)
T cd05633          81 GGDLHYHLSQ-HGVFSEKEMRFYATEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----P  152 (279)
T ss_pred             CCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC----c
Confidence            9999988854 4568999999999999999999998   899999999999999999999999999997654332    1


Q ss_pred             eceeccccccccccCc-hhhcCccceeEEEeeEEEeeccC
Q 021711          270 SKVEGTFGLVKLNLPP-LVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       270 ~~~~gt~~y~aPE~~~-~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ....||..|+|||... +...+.++|+||+|+++++|+.|
T Consensus       153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g  192 (279)
T cd05633         153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRG  192 (279)
T ss_pred             cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhC
Confidence            2357999999999875 34578889999999999999865

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.97  E-value=2.3e-31  Score=235.23  Aligned_cols=184  Identities=22%  Similarity=0.238  Sum_probs=158.2

Q ss_pred             eeccCceEEEEEEEC-CCcEEEEEEeccCCh--HHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEEEecCCCCH
Q 021711          118 IGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLELSPNGSL  193 (308)
Q Consensus       118 LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~~~gsL  193 (308)
                      ||.|+||.||+|... +++.+|+|.+.....  ....+.+.+|+.+++.++||||+++++++.++ ..++++||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            699999999999976 488999999865432  23456789999999999999999999976554 57899999999999


Q ss_pred             HHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCceeEeecee
Q 021711          194 ASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVE  273 (308)
Q Consensus       194 ~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~  273 (308)
                      .+++.. ...++...+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||+++......   ......
T Consensus        81 ~~~l~~-~~~l~~~~~~~~~~~i~~~l~~lH~---~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~~  153 (262)
T cd05572          81 WTILRD-RGLFDEYTARFYIACVVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFC  153 (262)
T ss_pred             HHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccccc
Confidence            999865 3458889999999999999999998   899999999999999999999999999998775542   112357


Q ss_pred             ccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          274 GTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       274 gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      |+..|++||.......+.++|+||+|+++|++++|
T Consensus       154 ~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g  188 (262)
T cd05572         154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTG  188 (262)
T ss_pred             CCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhC
Confidence            89999999998777788899999999999999865

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=99.97  E-value=5.5e-32  Score=241.97  Aligned_cols=192  Identities=22%  Similarity=0.345  Sum_probs=159.2

Q ss_pred             CccccceeeccCceEEEEEEEC-CCcEEEEEEeccCCh-HHHHHHHHHHHHHHhcCCCCeeeeeeeEEEe-CcEEEEEEe
Q 021711          111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA-DEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLEL  187 (308)
Q Consensus       111 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~lv~e~  187 (308)
                      +|+..+.||+|+||.||+|... +|+.||||.+..... ......+.+|++++++++||||+++++++.+ ...++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            5788899999999999999876 589999998864322 2234578899999999999999999997655 457899999


Q ss_pred             cCCCCHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCce
Q 021711          188 SPNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH  266 (308)
Q Consensus       188 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~  266 (308)
                      +. ++|..++... ...+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.+||+|||+++.+..... 
T Consensus        81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~---~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~-  155 (284)
T cd07860          81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-  155 (284)
T ss_pred             cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc-
Confidence            96 5888887543 3568999999999999999999998   8999999999999999999999999999987644322 


Q ss_pred             eEeeceeccccccccccCchhh-cCccceeEEEeeEEEeeccC
Q 021711          267 HTISKVEGTFGLVKLNLPPLVI-LKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~s~g~~l~el~c~  308 (308)
                       ......++..|+|||...+.. .+.++|+||+|+++|||++|
T Consensus       156 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg  197 (284)
T cd07860         156 -TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR  197 (284)
T ss_pred             -ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHC
Confidence             223345789999999875543 57789999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.97  E-value=3e-31  Score=241.75  Aligned_cols=188  Identities=29%  Similarity=0.371  Sum_probs=159.4

Q ss_pred             CccccceeeccCceEEEEEEEC-CCcEEEEEEeccCC--hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEEE
Q 021711          111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLE  186 (308)
Q Consensus       111 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e  186 (308)
                      .|...+.||+|+||.||++... ++..+|+|.+....  ..+....+.+|+.+++.++|||++++++++..+ ..++|||
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  105 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME  105 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence            4677889999999999999865 58899999986432  234456789999999999999999999977665 4689999


Q ss_pred             ecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCce
Q 021711          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH  266 (308)
Q Consensus       187 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~  266 (308)
                      |+. |+|.+.+......+++..+..++.|++.||.|||+   ++|+||||+|+||+++.++.++|+|||++......   
T Consensus       106 ~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~---~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~---  178 (317)
T cd06635         106 YCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA---  178 (317)
T ss_pred             CCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcccEEECCCCCEEEecCCCccccCCc---
Confidence            997 47888776656778999999999999999999998   89999999999999999999999999998765432   


Q ss_pred             eEeeceeccccccccccCc---hhhcCccceeEEEeeEEEeeccC
Q 021711          267 HTISKVEGTFGLVKLNLPP---LVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                         ....|++.|+|||...   ....+.++|+||+|+++|||++|
T Consensus       179 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g  220 (317)
T cd06635         179 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER  220 (317)
T ss_pred             ---ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhC
Confidence               2356899999999863   34567889999999999999865

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=99.97  E-value=1.5e-31  Score=237.37  Aligned_cols=193  Identities=27%  Similarity=0.384  Sum_probs=161.3

Q ss_pred             CccccceeeccCceEEEEEEECC--CcEEEEEEeccC---------ChHHHHHHHHHHHHHHhc-CCCCeeeeeeeEEEe
Q 021711          111 NFSFENLIGKGGYAEVYKGRLRN--GQLVAIKRLTRG---------TADEIIADFLSELGIMAH-VDHPNTAKLLGYGIE  178 (308)
Q Consensus       111 ~~~~~~~LG~G~fg~Vy~~~~~~--g~~vAvK~~~~~---------~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~  178 (308)
                      +|++.+.||+|+||.||+|.+..  ++.+|+|.+...         .......++.+|+.++.. ++||||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47888999999999999999764  688999987532         122345678889998865 799999999997665


Q ss_pred             C-cEEEEEEecCCCCHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEecc
Q 021711          179 G-GMHIVLELSPNGSLASLLYG---MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDF  254 (308)
Q Consensus       179 ~-~~~lv~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DF  254 (308)
                      + ..+++|||+++++|.+++..   ....+++..++.++.|++.||.|||+  ..+++|+||+|+||+++.++.++|+||
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~df  158 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDF  158 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEecc
Confidence            4 57899999999999988743   34568899999999999999999995  157999999999999999999999999


Q ss_pred             ccceecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          255 GLAKWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       255 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      |++.......   ......|+..|+|||...+...+.++|+||+|+++|+|++|
T Consensus       159 g~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g  209 (269)
T cd08528         159 GLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTL  209 (269)
T ss_pred             cceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhC
Confidence            9998765432   23456789999999998877788999999999999999764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.97  E-value=2.8e-31  Score=231.68  Aligned_cols=191  Identities=33%  Similarity=0.442  Sum_probs=166.7

Q ss_pred             CccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEEEec
Q 021711          111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLELS  188 (308)
Q Consensus       111 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~  188 (308)
                      +|++.+.||+|++|.||++... +++.+++|.+..... .....+.+|+.+++.++|+|++++++++..+ ..++++||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~   79 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFC   79 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch-hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecC
Confidence            4778899999999999999976 688999999876543 3457889999999999999999999976554 578999999


Q ss_pred             CCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCceeE
Q 021711          189 PNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT  268 (308)
Q Consensus       189 ~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  268 (308)
                      ++++|.+++......+++..+..++.|++.||.|||.   .+++|+||+|+||+++.++.++|+|||++........   
T Consensus        80 ~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---  153 (253)
T cd05122          80 SGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---  153 (253)
T ss_pred             CCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhc---CCEecCCCCHHHEEEccCCeEEEeecccccccccccc---
Confidence            9999999987655678999999999999999999998   8999999999999999999999999999987765432   


Q ss_pred             eeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          269 ISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       269 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      .....|+..|+|||.......+.++|+||+|+++++++.|
T Consensus       154 ~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g  193 (253)
T cd05122         154 RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEG  193 (253)
T ss_pred             ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhC
Confidence            2356789999999998777788899999999999998765

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.97  E-value=2e-31  Score=238.37  Aligned_cols=184  Identities=25%  Similarity=0.276  Sum_probs=148.5

Q ss_pred             eeeccCceEEEEEEEC-CCcEEEEEEeccCChH--HHHHHHHHH---HHHHhcCCCCeeeeeeeEEEe-CcEEEEEEecC
Q 021711          117 LIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTAD--EIIADFLSE---LGIMAHVDHPNTAKLLGYGIE-GGMHIVLELSP  189 (308)
Q Consensus       117 ~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~--~~~~~~~~E---~~~l~~l~h~niv~l~~~~~~-~~~~lv~e~~~  189 (308)
                      +||+|+||.||++... +++.||+|.+......  .....+..|   +..++..+||||+++++++.. +..++|+||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            4899999999999865 5889999988643211  111223333   344555689999999986655 45789999999


Q ss_pred             CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCceeEe
Q 021711          190 NGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTI  269 (308)
Q Consensus       190 ~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  269 (308)
                      +++|..++.. ...+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.++|+|||+++.+....    .
T Consensus        81 g~~L~~~l~~-~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~----~  152 (278)
T cd05606          81 GGDLHYHLSQ-HGVFSEAEMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----P  152 (278)
T ss_pred             CCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC----C
Confidence            9999988854 4568999999999999999999998   899999999999999999999999999998654322    1


Q ss_pred             eceeccccccccccCchh-hcCccceeEEEeeEEEeeccC
Q 021711          270 SKVEGTFGLVKLNLPPLV-ILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       270 ~~~~gt~~y~aPE~~~~~-~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ....|+..|+|||..... .++.++|+||+|+++|||++|
T Consensus       153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g  192 (278)
T cd05606         153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG  192 (278)
T ss_pred             cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhC
Confidence            235799999999997643 578889999999999999875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.97  E-value=7.2e-32  Score=244.66  Aligned_cols=194  Identities=22%  Similarity=0.311  Sum_probs=157.9

Q ss_pred             CccccceeeccCceEEEEEEEC---CCcEEEEEEeccCC--hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC---cEE
Q 021711          111 NFSFENLIGKGGYAEVYKGRLR---NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG---GMH  182 (308)
Q Consensus       111 ~~~~~~~LG~G~fg~Vy~~~~~---~g~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---~~~  182 (308)
                      +|++.+.||+|+||.||+|...   +++.||+|.+....  .....+.+.+|+.++..++||||+++++++...   ..+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            4778899999999999999875   37899999987632  122346678899999999999999999977655   378


Q ss_pred             EEEEecCCCCHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECC----CCcEEEecc
Q 021711          183 IVLELSPNGSLASLLYGM----KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTE----DFEPQICDF  254 (308)
Q Consensus       183 lv~e~~~~gsL~~~l~~~----~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~----~~~~kl~DF  254 (308)
                      +||||+++ +|.+++...    ...++...+..++.|++.||.|||+   .+|+||||||+||+++.    ++.+||+||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999975 676666421    2367889999999999999999998   89999999999999999    899999999


Q ss_pred             ccceecCCCCc-eeEeeceeccccccccccCchh-hcCccceeEEEeeEEEeeccC
Q 021711          255 GLAKWLPEQWT-HHTISKVEGTFGLVKLNLPPLV-ILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       255 Gla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~s~g~~l~el~c~  308 (308)
                      |+++.+..... ........+|+.|+|||...+. ..+.++|+||+|+++++|++|
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~  212 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTL  212 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhc
Confidence            99987654322 1122356789999999976553 467889999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=6.5e-31  Score=253.62  Aligned_cols=197  Identities=28%  Similarity=0.412  Sum_probs=165.3

Q ss_pred             HHhhcCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcC-CCCeeeeeeeEEE-----
Q 021711          105 LQSATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGI-----  177 (308)
Q Consensus       105 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~-----  177 (308)
                      +...++.|.+.++||+|.+|.||+++.. +++.+|+|++......+  +....|.++++.+ +|||++.++|++.     
T Consensus        14 lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d--eEiE~eynil~~~~~hpnv~~fyg~~~k~~~~   91 (953)
T KOG0587|consen   14 LPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE--EEIELEYNMLKKYSHHPNVATFYGAFIKKDPG   91 (953)
T ss_pred             CCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc--HHHHHHHHHHHhccCCCCcceEEEEEEEecCC
Confidence            3445678899999999999999999855 68999999987654433  4455678888776 6999999999653     


Q ss_pred             -eCcEEEEEEecCCCCHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccc
Q 021711          178 -EGGMHIVLELSPNGSLASLLYG-MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFG  255 (308)
Q Consensus       178 -~~~~~lv~e~~~~gsL~~~l~~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFG  255 (308)
                       .+.+|||||||.+||..+++.+ .+.++.|..+..|++.++.||.+||.   +.++|||||-.|||++.++.|||+|||
T Consensus        92 ~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~---nkviHRDikG~NiLLT~e~~VKLvDFG  168 (953)
T KOG0587|consen   92 NGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHN---NKVIHRDIKGQNVLLTENAEVKLVDFG  168 (953)
T ss_pred             CCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhh---cceeeecccCceEEEeccCcEEEeeee
Confidence             3458999999999999999875 35679999999999999999999998   899999999999999999999999999


Q ss_pred             cceecCCCCceeEeeceeccccccccccCch-----hhcCccceeEEEeeEEEeeccC
Q 021711          256 LAKWLPEQWTHHTISKVEGTFGLVKLNLPPL-----VILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       256 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ++..+...  ........||+.|||||...+     ..++.++|+||+|++.+||+-|
T Consensus       169 vSaQldsT--~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG  224 (953)
T KOG0587|consen  169 VSAQLDST--VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEG  224 (953)
T ss_pred             eeeeeecc--cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCC
Confidence            99987543  234467899999999998533     3467788999999999999865

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.97  E-value=1.2e-31  Score=241.87  Aligned_cols=196  Identities=24%  Similarity=0.308  Sum_probs=161.3

Q ss_pred             hcCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCCh-HHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC------
Q 021711          108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA-DEIIADFLSELGIMAHVDHPNTAKLLGYGIEG------  179 (308)
Q Consensus       108 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  179 (308)
                      ..++|++.+.||+|+||.||+|... +|+.||+|.+..... ......+.+|+.+++.++||||+++++++.+.      
T Consensus         5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~   84 (302)
T cd07864           5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF   84 (302)
T ss_pred             hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence            3468999999999999999999976 588999999865332 22335677899999999999999999876543      


Q ss_pred             -----cEEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEecc
Q 021711          180 -----GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDF  254 (308)
Q Consensus       180 -----~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DF  254 (308)
                           .+++|+||+++ ++...+......+++..+..++.|++.||.|||+   .+|+|+||||+||+++.++.+||+||
T Consensus        85 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~kl~df  160 (302)
T cd07864          85 KKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADF  160 (302)
T ss_pred             cccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCcEEeCcc
Confidence                 47899999976 7777776555578999999999999999999998   89999999999999999999999999


Q ss_pred             ccceecCCCCceeEeeceeccccccccccCch-hhcCccceeEEEeeEEEeeccC
Q 021711          255 GLAKWLPEQWTHHTISKVEGTFGLVKLNLPPL-VILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       255 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      |++..+..... .......++..|+|||.... ...+.++|+||+|++++||++|
T Consensus       161 g~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g  214 (302)
T cd07864         161 GLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTK  214 (302)
T ss_pred             cccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhC
Confidence            99987754432 12223456889999997654 3457889999999999999765

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=99.97  E-value=2.8e-31  Score=238.28  Aligned_cols=189  Identities=21%  Similarity=0.298  Sum_probs=160.5

Q ss_pred             ccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEe-CcEEEEEEecC
Q 021711          112 FSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLELSP  189 (308)
Q Consensus       112 ~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~lv~e~~~  189 (308)
                      |...+.||+|++|.||++... +++.+|+|.+..... ...+.+.+|+.+++.++||||+++++++.. +..++++||++
T Consensus        21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~   99 (285)
T cd06648          21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQ-QRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE   99 (285)
T ss_pred             hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccch-hHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence            444579999999999999865 688999998864332 234668899999999999999999996654 45789999999


Q ss_pred             CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCceeEe
Q 021711          190 NGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTI  269 (308)
Q Consensus       190 ~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  269 (308)
                      +++|.+++..  ..+++..+..++.|++.||.|||+   ++|+||||+|+||+++.++.++|+|||++........  ..
T Consensus       100 ~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--~~  172 (285)
T cd06648         100 GGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--RR  172 (285)
T ss_pred             CCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc--cc
Confidence            9999999865  568899999999999999999998   8999999999999999999999999999876544321  12


Q ss_pred             eceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          270 SKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       270 ~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ....|++.|+|||.......+.++|+||+|++++||++|
T Consensus       173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g  211 (285)
T cd06648         173 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDG  211 (285)
T ss_pred             ccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhC
Confidence            345689999999998777788889999999999999875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.97  E-value=8.6e-32  Score=241.38  Aligned_cols=192  Identities=24%  Similarity=0.358  Sum_probs=156.1

Q ss_pred             CccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCC-CCeeeeeeeEEEe-CcEEEEEEe
Q 021711          111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVD-HPNTAKLLGYGIE-GGMHIVLEL  187 (308)
Q Consensus       111 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~-~~~~lv~e~  187 (308)
                      +|...+.||+|+||.||++... +++.+|+|.+...........+.+|+.++.++. |+||+++++++.. ...+++|||
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~   84 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL   84 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence            5666789999999999999876 589999999875544445677899999999996 9999999996654 457899999


Q ss_pred             cCCCCHHHHH---hc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCC
Q 021711          188 SPNGSLASLL---YG-MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ  263 (308)
Q Consensus       188 ~~~gsL~~~l---~~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  263 (308)
                      +.. ++.++.   .. ....+++..+..++.|++.||.|||+  ..+|+||||||+||+++.++.++|+|||+++.+...
T Consensus        85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  161 (288)
T cd06616          85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS  161 (288)
T ss_pred             ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence            864 555433   21 23568999999999999999999996  148999999999999999999999999999866443


Q ss_pred             CceeEeeceeccccccccccCchh---hcCccceeEEEeeEEEeeccC
Q 021711          264 WTHHTISKVEGTFGLVKLNLPPLV---ILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ..   .....|++.|+|||.+...   ..+.++|+||+|+++||+++|
T Consensus       162 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g  206 (288)
T cd06616         162 IA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATG  206 (288)
T ss_pred             Cc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhC
Confidence            21   1334689999999987655   577889999999999999865

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.97  E-value=2.1e-31  Score=237.86  Aligned_cols=192  Identities=26%  Similarity=0.321  Sum_probs=161.2

Q ss_pred             ccccceeeccCceEEEEEEEC-CCcEEEEEEeccCC-hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC---cEEEEEE
Q 021711          112 FSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG---GMHIVLE  186 (308)
Q Consensus       112 ~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---~~~lv~e  186 (308)
                      |++.+.||+|+||.||+|... +++.+|+|.+.... .......+.+|+.+++.++|+|++++++++...   ..++|+|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            567889999999999999876 48899999997653 223356788999999999999999999977655   5789999


Q ss_pred             ecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCce
Q 021711          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH  266 (308)
Q Consensus       187 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~  266 (308)
                      |+++ +|.+++......+++..+..++.|++.||.|||+   .+++|+||||+||++++++.++|+|||++........ 
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~---~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~-  155 (287)
T cd07840          81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS-  155 (287)
T ss_pred             cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc-
Confidence            9975 8988886654678999999999999999999998   8999999999999999999999999999987755421 


Q ss_pred             eEeeceeccccccccccCch-hhcCccceeEEEeeEEEeeccC
Q 021711          267 HTISKVEGTFGLVKLNLPPL-VILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      .......++..|+|||.+.+ ...+.++|+||||++++||++|
T Consensus       156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~  198 (287)
T cd07840         156 ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLG  198 (287)
T ss_pred             ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhC
Confidence            12234467889999997654 3467889999999999999865

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.97  E-value=2.3e-31  Score=239.47  Aligned_cols=193  Identities=19%  Similarity=0.250  Sum_probs=156.8

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCCh-HHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEEE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA-DEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLE  186 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e  186 (308)
                      ++|++.+.||+|++|.||+|... +|+.||+|.+..... ......+.+|+.+++.++||||+++++++..+ ..++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            57889999999999999999876 688999998864322 23346788999999999999999999977654 5789999


Q ss_pred             ecCCCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECC-CCcEEEeccccceecCCCC
Q 021711          187 LSPNGSLASLLYGMK-EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTE-DFEPQICDFGLAKWLPEQW  264 (308)
Q Consensus       187 ~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~-~~~~kl~DFGla~~~~~~~  264 (308)
                      |++ ++|.+.+.... ..+++..+..++.||+.||.|||+   ++++||||+|+||+++. ++.+||+|||++.......
T Consensus        82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~  157 (294)
T PLN00009         82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV  157 (294)
T ss_pred             ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence            996 57877774432 236778888999999999999998   89999999999999985 4579999999998664332


Q ss_pred             ceeEeeceeccccccccccCchh-hcCccceeEEEeeEEEeeccC
Q 021711          265 THHTISKVEGTFGLVKLNLPPLV-ILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~s~g~~l~el~c~  308 (308)
                      .  ......+++.|+|||...+. ..+.++|+||+|+++|+|++|
T Consensus       158 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg  200 (294)
T PLN00009        158 R--TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQ  200 (294)
T ss_pred             c--ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhC
Confidence            1  22345678999999987553 467789999999999999875

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.97  E-value=1.4e-31  Score=235.88  Aligned_cols=187  Identities=25%  Similarity=0.335  Sum_probs=158.5

Q ss_pred             eeccCceEEEEEEECC-CcEEEEEEeccCCh--HHHHHHHHHHHHHHhcCCCCeeeeeeeEEEe-CcEEEEEEecCCCCH
Q 021711          118 IGKGGYAEVYKGRLRN-GQLVAIKRLTRGTA--DEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLELSPNGSL  193 (308)
Q Consensus       118 LG~G~fg~Vy~~~~~~-g~~vAvK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~lv~e~~~~gsL  193 (308)
                      ||+|+||.||++.... |+.+|+|.+.....  ......+.+|+.++..++||||+++++.+.. ...++++||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            6899999999999874 89999999865432  2346778999999999999999999986554 457899999999999


Q ss_pred             HHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCc------ee
Q 021711          194 ASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT------HH  267 (308)
Q Consensus       194 ~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~------~~  267 (308)
                      .+++... ..+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++........      ..
T Consensus        81 ~~~l~~~-~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  156 (265)
T cd05579          81 ASLLENV-GSLDEDVARIYIAEIVLALEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEK  156 (265)
T ss_pred             HHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccc
Confidence            9998653 378999999999999999999998   8999999999999999999999999999886543321      11


Q ss_pred             EeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          268 TISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ......++..|+|||.......+.++|+||+|+++++|++|
T Consensus       157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g  197 (265)
T cd05579         157 EDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVG  197 (265)
T ss_pred             cccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhC
Confidence            23456788999999998777788899999999999999865

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.97  E-value=5e-31  Score=230.99  Aligned_cols=194  Identities=29%  Similarity=0.421  Sum_probs=167.7

Q ss_pred             CccccceeeccCceEEEEEEEC-CCcEEEEEEeccCCh-HHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC---cEEEEE
Q 021711          111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA-DEIIADFLSELGIMAHVDHPNTAKLLGYGIEG---GMHIVL  185 (308)
Q Consensus       111 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---~~~lv~  185 (308)
                      +|+..+.||+|++|.||+|... ++..|++|.+..... ....+.+.+|+.+++.++||||+++++.+...   ..++++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4778899999999999999977 688999999865432 23467889999999999999999999977665   578999


Q ss_pred             EecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCc
Q 021711          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (308)
Q Consensus       186 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~  265 (308)
                      ||+++++|.+++.... .+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||.+........
T Consensus        81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~---~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  156 (260)
T cd06606          81 EYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET  156 (260)
T ss_pred             EecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence            9999999999986543 78999999999999999999998   8999999999999999999999999999998766532


Q ss_pred             eeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          266 HHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ........++..|+|||.......+.++|+||+|+++++|++|
T Consensus       157 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g  199 (260)
T cd06606         157 GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATG  199 (260)
T ss_pred             cccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhC
Confidence            1113456789999999998777788999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.97  E-value=1.5e-31  Score=241.35  Aligned_cols=195  Identities=21%  Similarity=0.235  Sum_probs=146.8

Q ss_pred             cCCccccceeeccCceEEEEEEECC----CcEEEEEEeccCChH---HH-------HHHHHHHHHHHhcCCCCeeeeeee
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLRN----GQLVAIKRLTRGTAD---EI-------IADFLSELGIMAHVDHPNTAKLLG  174 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~~----g~~vAvK~~~~~~~~---~~-------~~~~~~E~~~l~~l~h~niv~l~~  174 (308)
                      .++|++.++||+|+||.||+|...+    +..+|+|........   +.       ......+...+..++|+|++++++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   90 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG   90 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence            4689999999999999999998754    345666654322111   00       112234445566779999999998


Q ss_pred             EEEeCc-----EEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcE
Q 021711          175 YGIEGG-----MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEP  249 (308)
Q Consensus       175 ~~~~~~-----~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~  249 (308)
                      .+....     .+++++++. .++.+.+.. ....++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiHrDiKp~Nill~~~~~~  165 (294)
T PHA02882         91 CGSFKRCRMYYRFILLEKLV-ENTKEIFKR-IKCKNKKLIKNIMKDMLTTLEYIHE---HGISHGDIKPENIMVDGNNRG  165 (294)
T ss_pred             eeeEecCCceEEEEEEehhc-cCHHHHHHh-hccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCcE
Confidence            654432     246677664 366666543 2346788889999999999999998   899999999999999999999


Q ss_pred             EEeccccceecCCCCce-----eEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          250 QICDFGLAKWLPEQWTH-----HTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       250 kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      +|+|||+|+.+......     .......||+.|+|||...+..++.++|+||+|++|+||++|
T Consensus       166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g  229 (294)
T PHA02882        166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGI  229 (294)
T ss_pred             EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhC
Confidence            99999999877543221     112235799999999998888889999999999999999865

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=6.6e-31  Score=230.35  Aligned_cols=192  Identities=30%  Similarity=0.455  Sum_probs=165.7

Q ss_pred             CccccceeeccCceEEEEEEEC-CCcEEEEEEeccCCh-HHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEEEe
Q 021711          111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA-DEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLEL  187 (308)
Q Consensus       111 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~  187 (308)
                      +|++.+.||+|++|.||++... +++.||+|.+..... ......+.+|++++.+++|||++++++++..+ ..++++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            4778899999999999999876 578999999875532 23467899999999999999999999976654 57899999


Q ss_pred             cCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCcee
Q 021711          188 SPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH  267 (308)
Q Consensus       188 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~  267 (308)
                      +++++|.+++... ..+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.++|+|||++......... 
T Consensus        81 ~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-  155 (254)
T cd06627          81 AENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHE---QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD-  155 (254)
T ss_pred             CCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc-
Confidence            9999999998643 678999999999999999999998   89999999999999999999999999999987654321 


Q ss_pred             EeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          268 TISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                       .....|+..|+|||.......+.+.|+|++|++++++++|
T Consensus       156 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g  195 (254)
T cd06627         156 -DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTG  195 (254)
T ss_pred             -ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhC
Confidence             2456789999999988766688899999999999999875

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.97  E-value=1.3e-31  Score=245.88  Aligned_cols=194  Identities=23%  Similarity=0.282  Sum_probs=160.6

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCCh-HHHHHHHHHHHHHHhcCCCCeeeeeeeEEEe-----CcEE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA-DEIIADFLSELGIMAHVDHPNTAKLLGYGIE-----GGMH  182 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~~~  182 (308)
                      ++|++.+.||+|+||.||+|... +|+.||+|.+..... ......+.+|+.+++.++||||+++++++..     ...+
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY   84 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence            68999999999999999999865 589999999865422 2345677889999999999999999886532     3478


Q ss_pred             EEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCC
Q 021711          183 IVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE  262 (308)
Q Consensus       183 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~  262 (308)
                      +|+||+. ++|.+++.. ...+++..+..++.|++.||.|||+   ++|+||||||+||+++.++.+||+|||+++....
T Consensus        85 lv~e~~~-~~l~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  159 (334)
T cd07855          85 VVMDLME-SDLHHIIHS-DQPLTEEHIRYFLYQLLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSS  159 (334)
T ss_pred             EEEehhh-hhHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEecccccceeecc
Confidence            9999995 689888854 4558999999999999999999998   8999999999999999999999999999987644


Q ss_pred             CCce--eEeeceeccccccccccCch-hhcCccceeEEEeeEEEeeccC
Q 021711          263 QWTH--HTISKVEGTFGLVKLNLPPL-VILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       263 ~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ....  .......|+..|+|||.+.. ...+.++|+||+|+++|||++|
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g  208 (334)
T cd07855         160 SPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGR  208 (334)
T ss_pred             cCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcC
Confidence            3221  11234578999999998754 3468889999999999998764

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.97  E-value=5.7e-31  Score=230.86  Aligned_cols=193  Identities=26%  Similarity=0.347  Sum_probs=166.3

Q ss_pred             CccccceeeccCceEEEEEEEC-CCcEEEEEEeccCCh-HHHHHHHHHHHHHHhcCCCCeeeeeeeEEEe-CcEEEEEEe
Q 021711          111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA-DEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLEL  187 (308)
Q Consensus       111 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~lv~e~  187 (308)
                      +|++.+.||+|+||.||++... +++.+|+|.+..... ......+.+|+++++.++|||++++++.+.. ...++|+|+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            5788899999999999999976 588999999875432 2445678899999999999999999986555 457899999


Q ss_pred             cCCCCHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCC
Q 021711          188 SPNGSLASLLYGM---KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (308)
Q Consensus       188 ~~~gsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  264 (308)
                      +++++|.+++...   ...+++..+..++.+++.||.|||+   .+++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            9999999998664   3678999999999999999999998   899999999999999999999999999998775543


Q ss_pred             ceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          265 THHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                        .......|++.|+|||.......+.+.|+||+|++++++++|
T Consensus       158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g  199 (258)
T cd08215         158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTL  199 (258)
T ss_pred             --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcC
Confidence              123345789999999988777788899999999999999865

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.97  E-value=3e-31  Score=244.57  Aligned_cols=190  Identities=25%  Similarity=0.313  Sum_probs=160.1

Q ss_pred             hcCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCC-hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC------
Q 021711          108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG------  179 (308)
Q Consensus       108 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  179 (308)
                      ..++|++.+.||+|+||.||++... ++..||||.+.... .......+.+|+.+++.++||||+++++++..+      
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF   92 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence            4678999999999999999999865 68999999986432 233456788999999999999999999876543      


Q ss_pred             -cEEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccce
Q 021711          180 -GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK  258 (308)
Q Consensus       180 -~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~  258 (308)
                       ..++|+||+ +++|..++.  ...+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.++|+|||+++
T Consensus        93 ~~~~lv~e~~-~~~l~~~~~--~~~l~~~~~~~i~~qi~~al~~LH~---~gi~H~dlkp~Nill~~~~~~kl~dfg~~~  166 (343)
T cd07880          93 HDFYLVMPFM-GTDLGKLMK--HEKLSEDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR  166 (343)
T ss_pred             ceEEEEEecC-CCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeccccc
Confidence             247899998 779988874  3568999999999999999999998   899999999999999999999999999998


Q ss_pred             ecCCCCceeEeeceeccccccccccCch-hhcCccceeEEEeeEEEeeccC
Q 021711          259 WLPEQWTHHTISKVEGTFGLVKLNLPPL-VILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       259 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      .....     .....+++.|+|||.+.. ...+.++|+||+|++++++++|
T Consensus       167 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g  212 (343)
T cd07880         167 QTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTG  212 (343)
T ss_pred             ccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhC
Confidence            66432     124567899999998765 3467889999999999999875

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.97  E-value=2.7e-31  Score=239.42  Aligned_cols=195  Identities=26%  Similarity=0.389  Sum_probs=159.5

Q ss_pred             hcCCccccceeeccCceEEEEEEECC-CcEEEEEEeccCChHHHHHHHHHHHHHHhcCC-CCeeeeeeeEEEeC-cEEEE
Q 021711          108 ATNNFSFENLIGKGGYAEVYKGRLRN-GQLVAIKRLTRGTADEIIADFLSELGIMAHVD-HPNTAKLLGYGIEG-GMHIV  184 (308)
Q Consensus       108 ~~~~~~~~~~LG~G~fg~Vy~~~~~~-g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~-~~~lv  184 (308)
                      ..++|++.+.||+|+||.||+|.+.+ ++.||||.+...........+.+|+.++.... ||||+++++++... ..+++
T Consensus        13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v   92 (296)
T cd06618          13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC   92 (296)
T ss_pred             CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence            34678899999999999999999874 89999999976544444566777888776664 99999999977655 57899


Q ss_pred             EEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCC
Q 021711          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (308)
Q Consensus       185 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  264 (308)
                      |||+. ++|.+++......+++..+..++.|++.||.|||+  ..+|+||||+|+||+++.++.+||+|||++..+....
T Consensus        93 ~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~--~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~  169 (296)
T cd06618          93 MELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK  169 (296)
T ss_pred             eeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--hCCEecCCCcHHHEEEcCCCCEEECccccchhccCCC
Confidence            99985 57777775555678999999999999999999996  1489999999999999999999999999998764432


Q ss_pred             ceeEeeceeccccccccccCchhh----cCccceeEEEeeEEEeeccC
Q 021711          265 THHTISKVEGTFGLVKLNLPPLVI----LKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Di~s~g~~l~el~c~  308 (308)
                      .   .....++..|+|||.+....    .+.++|+||||+++|+|++|
T Consensus       170 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g  214 (296)
T cd06618         170 A---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATG  214 (296)
T ss_pred             c---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhC
Confidence            2   12345788999999875442    67789999999999999875

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.97  E-value=2.7e-31  Score=244.15  Aligned_cols=193  Identities=23%  Similarity=0.289  Sum_probs=160.4

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCC-hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC------c
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG------G  180 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~  180 (308)
                      .++|.+.+.||+|+||.||+|... ++..||||.+.... .......+.+|+.+++.++|+||+++++++...      .
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            357999999999999999999865 58999999986532 222345677899999999999999999866533      3


Q ss_pred             EEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceec
Q 021711          181 MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL  260 (308)
Q Consensus       181 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~  260 (308)
                      .++|+||+. ++|.+++.. ...++...+..++.|++.||.|||+   ++++||||||+||+++.++.+||+|||+++..
T Consensus        84 ~~lv~e~~~-~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~  158 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRS-SQTLSDDHCQYFLYQLLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTT  158 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcCcccccc
Confidence            689999996 688888754 4568999999999999999999998   89999999999999999999999999999876


Q ss_pred             CCCCceeEeeceeccccccccccCch-hhcCccceeEEEeeEEEeeccC
Q 021711          261 PEQWTHHTISKVEGTFGLVKLNLPPL-VILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       261 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      .....  ......++..|+|||.+.. ...+.++|+||+|+++|+|++|
T Consensus       159 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g  205 (337)
T cd07858         159 SEKGD--FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGR  205 (337)
T ss_pred             CCCcc--cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcC
Confidence            54321  2234568999999998654 4578889999999999999765

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.97  E-value=2.2e-31  Score=240.82  Aligned_cols=196  Identities=28%  Similarity=0.336  Sum_probs=159.5

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCCh-HHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-------
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA-DEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-------  179 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-------  179 (308)
                      .++|++.+.||+|+||.||+|... +++.+|+|.+..... +.....+.+|+++++.++||||+++++++...       
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            478999999999999999999976 588999998864322 12234667899999999999999999865322       


Q ss_pred             --cEEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccc
Q 021711          180 --GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLA  257 (308)
Q Consensus       180 --~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla  257 (308)
                        .+++|+||+.+ +|...+......+++..+..++.|+++||.|||+   .+|+|+||||+||+++.++.++|+|||++
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~  162 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADFGLA  162 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECcCccc
Confidence              25899999865 7777776555679999999999999999999998   89999999999999999999999999999


Q ss_pred             eecCCCCce---------eEeeceeccccccccccCchh-hcCccceeEEEeeEEEeeccC
Q 021711          258 KWLPEQWTH---------HTISKVEGTFGLVKLNLPPLV-ILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       258 ~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~s~g~~l~el~c~  308 (308)
                      +........         .......|++.|+|||...+. ..+.++|+||+|+++|||+.|
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g  223 (311)
T cd07866         163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTR  223 (311)
T ss_pred             hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhC
Confidence            866433211         112345778999999986543 467889999999999998765

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.97  E-value=2.4e-31  Score=233.91  Aligned_cols=193  Identities=20%  Similarity=0.289  Sum_probs=161.8

Q ss_pred             CccccceeeccCceEEEEEEEC-CCcEEEEEEeccCCh-HHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEEEe
Q 021711          111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA-DEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLEL  187 (308)
Q Consensus       111 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~  187 (308)
                      +|++.+.||+|+||.||+|... +|..+|+|.+..... ....+.+.+|+.+++.++|+||+++++.+..+ ..++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            5788899999999999999976 588999999865321 12345778999999999999999999876554 57899999


Q ss_pred             cCCCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCC-cEEEeccccceecCCCCc
Q 021711          188 SPNGSLASLLYGMK-EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDF-EPQICDFGLAKWLPEQWT  265 (308)
Q Consensus       188 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~-~~kl~DFGla~~~~~~~~  265 (308)
                      +++++|.+++.... ..+++..+..++.|++.||.|||+   .+++|+||||+||++++++ .++|+|||.+........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~  157 (257)
T cd08225          81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME  157 (257)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence            99999999986533 357899999999999999999998   8999999999999999885 569999999987654322


Q ss_pred             eeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          266 HHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                        ......|++.|+|||.......+.++|+||+|++++|+++|
T Consensus       158 --~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g  198 (257)
T cd08225         158 --LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTL  198 (257)
T ss_pred             --cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhC
Confidence              12335689999999998877788899999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.97  E-value=3.5e-31  Score=236.68  Aligned_cols=191  Identities=23%  Similarity=0.320  Sum_probs=158.3

Q ss_pred             ccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChH-HHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEEEec
Q 021711          112 FSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTAD-EIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLELS  188 (308)
Q Consensus       112 ~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~  188 (308)
                      |++.+.||.|++|.||+|... +|..||+|.+...... .....+.+|+.+++.++|||++++++++.++ ..++++||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            567789999999999999875 6899999998654322 2345688899999999999999999977654 478999999


Q ss_pred             CCCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCcee
Q 021711          189 PNGSLASLLYGMK-EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH  267 (308)
Q Consensus       189 ~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~  267 (308)
                      . ++|.+++.... ..+++..+..++.|++.||.|||+   ++++||||+|+||+++.++.++|+|||+++.+.....  
T Consensus        81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~---~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--  154 (283)
T cd07835          81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR--  154 (283)
T ss_pred             C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc--
Confidence            5 68998886533 368999999999999999999998   8999999999999999999999999999986643322  


Q ss_pred             EeeceeccccccccccCchh-hcCccceeEEEeeEEEeeccC
Q 021711          268 TISKVEGTFGLVKLNLPPLV-ILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ......++..|+|||.+.+. ..+.++|+||+|+++|+|++|
T Consensus       155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g  196 (283)
T cd07835         155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNR  196 (283)
T ss_pred             ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhC
Confidence            12234578999999976543 457889999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.97  E-value=1.2e-30  Score=233.10  Aligned_cols=190  Identities=27%  Similarity=0.351  Sum_probs=157.2

Q ss_pred             ccccceeeccCceEEEEEEECC-CcEEEEEEeccCChH-HHHHHHHHHHHHHhcC---CCCeeeeeeeEEEeCc------
Q 021711          112 FSFENLIGKGGYAEVYKGRLRN-GQLVAIKRLTRGTAD-EIIADFLSELGIMAHV---DHPNTAKLLGYGIEGG------  180 (308)
Q Consensus       112 ~~~~~~LG~G~fg~Vy~~~~~~-g~~vAvK~~~~~~~~-~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~------  180 (308)
                      |++.+.||+|+||.||+|.++. ++.+|+|.+...... .....+.+|+.++.++   +|||++++++++....      
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            5678899999999999999874 899999998643322 2234566787777665   6999999999766543      


Q ss_pred             EEEEEEecCCCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEecccccee
Q 021711          181 MHIVLELSPNGSLASLLYGMK-EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKW  259 (308)
Q Consensus       181 ~~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~  259 (308)
                      .++++||+.+ +|.+++.... ..+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++..
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~---~~i~h~~l~~~nili~~~~~~~l~dfg~~~~  156 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLARI  156 (287)
T ss_pred             eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhEEEccCCCEEEeccCccee
Confidence            7899999974 8988886533 358999999999999999999998   8999999999999999999999999999987


Q ss_pred             cCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          260 LPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       260 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      +....   ......++..|+|||.......+.++|+||+|+++++|++|
T Consensus       157 ~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~  202 (287)
T cd07838         157 YSFEM---ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRR  202 (287)
T ss_pred             ccCCc---ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhC
Confidence            75432   12344688999999998888888899999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.97  E-value=5.2e-31  Score=237.63  Aligned_cols=186  Identities=22%  Similarity=0.305  Sum_probs=158.5

Q ss_pred             cceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEe-CcEEEEEEecCCCC
Q 021711          115 ENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLELSPNGS  192 (308)
Q Consensus       115 ~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~lv~e~~~~gs  192 (308)
                      ...||+|+||.||++... +++.||+|.+..... .....+.+|+.+++.++|+||+++++++.. +..++||||+++++
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~  103 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQ-QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA  103 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccch-hHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCc
Confidence            357999999999999875 689999998864332 235678999999999999999999987665 45789999999999


Q ss_pred             HHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCceeEeece
Q 021711          193 LASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKV  272 (308)
Q Consensus       193 L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~  272 (308)
                      |.+++.  ...+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++........  .....
T Consensus       104 L~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~---~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~~  176 (292)
T cd06657         104 LTDIVT--HTRMNEEQIAAVCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSL  176 (292)
T ss_pred             HHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEcccccceecccccc--ccccc
Confidence            999874  3468899999999999999999998   8999999999999999999999999999887654322  22345


Q ss_pred             eccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          273 EGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       273 ~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      .|++.|+|||.......+.++|+||+|+++|+|++|
T Consensus       177 ~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg  212 (292)
T cd06657         177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG  212 (292)
T ss_pred             ccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhC
Confidence            789999999988777788899999999999999865

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.9e-31  Score=239.79  Aligned_cols=197  Identities=25%  Similarity=0.306  Sum_probs=162.0

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCC--h----HHHHHHHHHHHHHHhcCCCCeeeeeeeEEEe--Cc
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--A----DEIIADFLSELGIMAHVDHPNTAKLLGYGIE--GG  180 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~--~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~  180 (308)
                      ++|-++++||+|||+.||++.+- ..+.||+|+-..+.  .    +...+...+|..|-+.|+||-||++|+|+.-  +.
T Consensus       463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds  542 (775)
T KOG1151|consen  463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS  542 (775)
T ss_pred             HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence            46778889999999999999854 57889999864322  1    2245667899999999999999999998754  45


Q ss_pred             EEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCC---CcEEEeccccc
Q 021711          181 MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTED---FEPQICDFGLA  257 (308)
Q Consensus       181 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~---~~~kl~DFGla  257 (308)
                      +|-|+|||+|.+|..+|.. ...+++..+..|+.||+.||.||.+- ..+|||-||||.||||...   |.+||+||||+
T Consensus       543 FCTVLEYceGNDLDFYLKQ-hklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGLS  620 (775)
T KOG1151|consen  543 FCTVLEYCEGNDLDFYLKQ-HKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGLS  620 (775)
T ss_pred             ceeeeeecCCCchhHHHHh-hhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecchh
Confidence            7899999999999999965 45688899999999999999999974 3679999999999999654   78999999999


Q ss_pred             eecCCCCcee-----EeeceeccccccccccCchh----hcCccceeEEEeeEEEeeccC
Q 021711          258 KWLPEQWTHH-----TISKVEGTFGLVKLNLPPLV----ILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       258 ~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~----~~~~~~Di~s~g~~l~el~c~  308 (308)
                      +.+..+...+     ..+...||++|++||.+--.    ..+.+.||||.|+++|...+|
T Consensus       621 KIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYG  680 (775)
T KOG1151|consen  621 KIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYG  680 (775)
T ss_pred             hhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhcc
Confidence            9987654331     23468899999999987543    256789999999999988775

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.97  E-value=1.1e-30  Score=237.05  Aligned_cols=189  Identities=29%  Similarity=0.366  Sum_probs=158.4

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccC--ChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRG--TADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVL  185 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~  185 (308)
                      +.|+..+.||+|+||.||+|+.. +++.+|+|.+...  .......++.+|+.+++.++|+|++++++++... ..++|+
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   94 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence            34677789999999999999976 5789999988642  2233456788999999999999999999976655 468999


Q ss_pred             EecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCc
Q 021711          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (308)
Q Consensus       186 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~  265 (308)
                      ||+. |+|.+.+......+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++......  
T Consensus        95 e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--  168 (308)
T cd06634          95 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--  168 (308)
T ss_pred             EccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHhEEECCCCcEEECCcccceeecCc--
Confidence            9996 58888776556678999999999999999999998   89999999999999999999999999999876443  


Q ss_pred             eeEeeceeccccccccccCc---hhhcCccceeEEEeeEEEeeccC
Q 021711          266 HHTISKVEGTFGLVKLNLPP---LVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                          ....|++.|+|||.+.   ....+.++|+||+|+++++|++|
T Consensus       169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g  210 (308)
T cd06634         169 ----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER  210 (308)
T ss_pred             ----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcC
Confidence                2346889999999864   23467789999999999999865

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.97  E-value=8.4e-31  Score=233.16  Aligned_cols=185  Identities=23%  Similarity=0.245  Sum_probs=151.3

Q ss_pred             hcCCcccccee--eccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhc-CCCCeeeeeeeEEEe-CcEE
Q 021711          108 ATNNFSFENLI--GKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAH-VDHPNTAKLLGYGIE-GGMH  182 (308)
Q Consensus       108 ~~~~~~~~~~L--G~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~-~~~~  182 (308)
                      ..++|.+.+.+  |+|+||.||++..+ ++..+|+|.+.......      .|+..... .+||||+++++.+.. +..+
T Consensus        12 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~------~e~~~~~~~~~h~~iv~~~~~~~~~~~~~   85 (267)
T PHA03390         12 FLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA------IEPMVHQLMKDNPNFIKLYYSVTTLKGHV   85 (267)
T ss_pred             HHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch------hhHHHHHHhhcCCCEEEEEEEEecCCeeE
Confidence            34566776666  99999999999865 58889999886432211      12222221 279999999986654 4578


Q ss_pred             EEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCC-cEEEeccccceecC
Q 021711          183 IVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDF-EPQICDFGLAKWLP  261 (308)
Q Consensus       183 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~-~~kl~DFGla~~~~  261 (308)
                      +||||+++++|.+++... ..+++..+..++.|++.||.|||+   .+++||||||+||+++.++ .++|+|||+++...
T Consensus        86 iv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~  161 (267)
T PHA03390         86 LIMDYIKDGDLFDLLKKE-GKLSEAEVKKIIRQLVEALNDLHK---HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG  161 (267)
T ss_pred             EEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEeCCCCeEEEecCccceecC
Confidence            999999999999998653 478999999999999999999998   8999999999999999998 99999999998765


Q ss_pred             CCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          262 EQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       262 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ..      ....|+..|+|||.+.....+.++|+||+|++++|+++|
T Consensus       162 ~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g  202 (267)
T PHA03390        162 TP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTG  202 (267)
T ss_pred             CC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHC
Confidence            43      234689999999998877788899999999999999875

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=1e-30  Score=230.89  Aligned_cols=183  Identities=27%  Similarity=0.288  Sum_probs=151.8

Q ss_pred             ceeeccCceEEEEEEEC-CCcEEEEEEeccCCh--HHHHHHHHHHHHHH-hcCCCCeeeeeeeEEEeC-cEEEEEEecCC
Q 021711          116 NLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELGIM-AHVDHPNTAKLLGYGIEG-GMHIVLELSPN  190 (308)
Q Consensus       116 ~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~--~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~~-~~~lv~e~~~~  190 (308)
                      +.||+|+||.||+|... +|+.||+|.+.....  ......+..|..++ ...+|+|++++++++..+ ..++|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            57999999999999875 589999999865422  12233445555544 455899999999977654 57899999999


Q ss_pred             CCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCceeEee
Q 021711          191 GSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTIS  270 (308)
Q Consensus       191 gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~  270 (308)
                      ++|.+++.. ...++...+..++.|++.||.|||+   .+++||||+|+||+++.++.++|+|||+++.....      .
T Consensus        82 ~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~------~  151 (260)
T cd05611          82 GDCASLIKT-LGGLPEDWAKQYIAEVVLGVEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN------K  151 (260)
T ss_pred             CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEeecccceecccc------c
Confidence            999999854 3568899999999999999999998   89999999999999999999999999999865432      2


Q ss_pred             ceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          271 KVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       271 ~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ...|+..|+|||...+...+.++|+||+|+++|++++|
T Consensus       152 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g  189 (260)
T cd05611         152 KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFG  189 (260)
T ss_pred             cCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHC
Confidence            35688999999998777788899999999999998865

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.97  E-value=6.9e-31  Score=234.58  Aligned_cols=190  Identities=23%  Similarity=0.289  Sum_probs=157.7

Q ss_pred             ccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCC-CCeeeeeeeEEEe-CcEEEEEEec
Q 021711          112 FSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVD-HPNTAKLLGYGIE-GGMHIVLELS  188 (308)
Q Consensus       112 ~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~-~~~~lv~e~~  188 (308)
                      |++.+.||+|+||.||+|... +++.||||.+.............+|+..+..++ |+||+++++++.. +..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            567889999999999999976 478999999865433222234567999999999 9999999986554 4578999999


Q ss_pred             CCCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCcee
Q 021711          189 PNGSLASLLYGMK-EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH  267 (308)
Q Consensus       189 ~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~  267 (308)
                       +|+|.+.+.... ..+++..+..++.|++.+|.|||+   ++++|+||+|+||+++.++.++|+|||+++.......  
T Consensus        81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~--  154 (283)
T cd07830          81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP--  154 (283)
T ss_pred             -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC--
Confidence             789998886543 468999999999999999999998   8999999999999999999999999999987654322  


Q ss_pred             EeeceeccccccccccCch-hhcCccceeEEEeeEEEeeccC
Q 021711          268 TISKVEGTFGLVKLNLPPL-VILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~s~g~~l~el~c~  308 (308)
                       .....|+..|+|||.+.. ...+.++|+||||++++||++|
T Consensus       155 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g  195 (283)
T cd07830         155 -YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTL  195 (283)
T ss_pred             -cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhC
Confidence             234568899999998743 3467889999999999998764

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.97  E-value=3.8e-31  Score=241.98  Aligned_cols=193  Identities=24%  Similarity=0.295  Sum_probs=163.6

Q ss_pred             CccccceeeccCceEEEEEEEC-CCcEEEEEEeccCCh-HHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC------cEE
Q 021711          111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA-DEIIADFLSELGIMAHVDHPNTAKLLGYGIEG------GMH  182 (308)
Q Consensus       111 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~  182 (308)
                      +|++.+.||+|+||.||+|... +++.||+|.+..... ....+.+.+|+.+++.++|+||+++++++...      ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            5788899999999999999976 489999999876432 33456789999999999999999999976554      478


Q ss_pred             EEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCC
Q 021711          183 IVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE  262 (308)
Q Consensus       183 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~  262 (308)
                      ++|||++ ++|.+++.. ...+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.++|+|||++.....
T Consensus        81 lv~e~~~-~~l~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~---~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~  155 (330)
T cd07834          81 IVTELME-TDLHKVIKS-PQPLTDDHIQYFLYQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARGVDP  155 (330)
T ss_pred             EEecchh-hhHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccCceEeecc
Confidence            9999997 488888854 3478999999999999999999998   8999999999999999999999999999998755


Q ss_pred             CCce-eEeeceeccccccccccCchh-hcCccceeEEEeeEEEeeccC
Q 021711          263 QWTH-HTISKVEGTFGLVKLNLPPLV-ILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       263 ~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~s~g~~l~el~c~  308 (308)
                      .... .......+|..|+|||.+.+. ..+.++|+||+|++++++++|
T Consensus       156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g  203 (330)
T cd07834         156 DEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTR  203 (330)
T ss_pred             cccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcC
Confidence            4211 123345689999999998777 688899999999999999875

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.97  E-value=3.5e-31  Score=235.57  Aligned_cols=195  Identities=27%  Similarity=0.349  Sum_probs=165.1

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCC--hHHHHHHHHHHHHHHhcCC-CCeeeeeeeEEEe-CcEEEE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVD-HPNTAKLLGYGIE-GGMHIV  184 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~-~~~~lv  184 (308)
                      ++|.+.+.||+|+||.||+|... +++.||+|.+....  .......+.+|+.++.+++ ||||+++++++.. ...++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            47889999999999999999876 68999999986532  2233467889999999998 9999999986554 457899


Q ss_pred             EEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCC
Q 021711          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (308)
Q Consensus       185 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  264 (308)
                      ||++++++|.+++.. ...+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~Lh~---~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~  156 (280)
T cd05581          81 LEYAPNGELLQYIRK-YGSLDEKCTRFYAAEILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNS  156 (280)
T ss_pred             EcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEecCCccccccCCcc
Confidence            999999999999865 3479999999999999999999998   899999999999999999999999999998765432


Q ss_pred             ce------------------eEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          265 TH------------------HTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       265 ~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ..                  .......|+..|+|||.......+.++|+||+|++++++++|
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g  218 (280)
T cd05581         157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTG  218 (280)
T ss_pred             ccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhC
Confidence            21                  122345688999999988777788899999999999998765

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.97  E-value=2.1e-30  Score=235.81  Aligned_cols=187  Identities=28%  Similarity=0.365  Sum_probs=157.1

Q ss_pred             ccccceeeccCceEEEEEEEC-CCcEEEEEEeccCC--hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEEEe
Q 021711          112 FSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLEL  187 (308)
Q Consensus       112 ~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~  187 (308)
                      |...+.||+|+||.||+|... +++.||+|.+....  .......+.+|+.+++.++|||++++++++.+. ..++||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            556678999999999999875 58899999986432  223456788999999999999999999977665 47899999


Q ss_pred             cCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCcee
Q 021711          188 SPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH  267 (308)
Q Consensus       188 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~  267 (308)
                      +. |+|.+++......+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.+||+|||++......    
T Consensus       103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~----  174 (313)
T cd06633         103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA----  174 (313)
T ss_pred             CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChhhEEECCCCCEEEeecCCCcccCCC----
Confidence            96 57888776656678999999999999999999998   89999999999999999999999999998754322    


Q ss_pred             EeeceeccccccccccCc---hhhcCccceeEEEeeEEEeeccC
Q 021711          268 TISKVEGTFGLVKLNLPP---LVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                        ....|+..|+|||.+.   ....+.++|+||+|+++|+|++|
T Consensus       175 --~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g  216 (313)
T cd06633         175 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER  216 (313)
T ss_pred             --CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhC
Confidence              3457899999999874   34567789999999999999765

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.97  E-value=7.1e-32  Score=233.23  Aligned_cols=189  Identities=21%  Similarity=0.228  Sum_probs=156.2

Q ss_pred             hcCCcccc-ceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcC-CCCeeeeeeeEEEeC-----
Q 021711          108 ATNNFSFE-NLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGIEG-----  179 (308)
Q Consensus       108 ~~~~~~~~-~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-----  179 (308)
                      .+++|++. ++||-|-.|.|-.|..+ +|+.+|+|.+...      ....+|++.--.. .|||||.+++++.+.     
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rk  132 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS------PKARREVELHWMASGHPHIVSIIDVYENSYQGRK  132 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCce
Confidence            45667664 68999999999999876 6899999988643      2344677764444 699999999855432     


Q ss_pred             cEEEEEEecCCCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCC---CcEEEeccc
Q 021711          180 GMHIVLELSPNGSLASLLYGMK-EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTED---FEPQICDFG  255 (308)
Q Consensus       180 ~~~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~---~~~kl~DFG  255 (308)
                      .+.+|||.++||.|.+.+..++ ..+++..+..|+.||+.|+.|||+   .+|.||||||+|+|....   -.+||+|||
T Consensus       133 cLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~---~nIAHRDlKpENLLyt~t~~na~lKLtDfG  209 (400)
T KOG0604|consen  133 CLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHS---MNIAHRDLKPENLLYTTTSPNAPLKLTDFG  209 (400)
T ss_pred             eeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHh---cchhhccCChhheeeecCCCCcceEecccc
Confidence            2568999999999999997643 458999999999999999999999   999999999999999754   469999999


Q ss_pred             cceecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          256 LAKWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       256 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      +|+.-..   +....+.+-|+.|.|||.+....++.+.|+||+|++||.|+||
T Consensus       210 FAK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCG  259 (400)
T KOG0604|consen  210 FAKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG  259 (400)
T ss_pred             cccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcC
Confidence            9997543   2345667889999999998777799999999999999999998

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.97  E-value=8e-31  Score=241.55  Aligned_cols=188  Identities=23%  Similarity=0.311  Sum_probs=157.1

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCCh-HHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-------
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA-DEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-------  179 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-------  179 (308)
                      .++|.+.+.||+|+||.||+|... +|+.||+|.+..... +.....+.+|+.+++.++||||+++++++...       
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            468999999999999999999865 689999999865322 23345688999999999999999999876543       


Q ss_pred             cEEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEecccccee
Q 021711          180 GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKW  259 (308)
Q Consensus       180 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~  259 (308)
                      ..++|+||+.. +|..++   ...+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.++|+|||+++.
T Consensus        94 ~~~lv~e~~~~-~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~  166 (342)
T cd07879          94 DFYLVMPYMQT-DLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLARH  166 (342)
T ss_pred             eEEEEeccccc-CHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCCCCcC
Confidence            35899999864 776655   3468899999999999999999998   8999999999999999999999999999986


Q ss_pred             cCCCCceeEeeceeccccccccccCch-hhcCccceeEEEeeEEEeeccC
Q 021711          260 LPEQWTHHTISKVEGTFGLVKLNLPPL-VILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       260 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ....     .....+|..|+|||...+ ...+.++|+||+|++++||++|
T Consensus       167 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g  211 (342)
T cd07879         167 ADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTG  211 (342)
T ss_pred             CCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhC
Confidence            5432     234567899999998765 3477889999999999999875

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=6.9e-31  Score=258.33  Aligned_cols=199  Identities=23%  Similarity=0.313  Sum_probs=167.1

Q ss_pred             HHhhcCCccccceeeccCceEEEEEEEC----C----CcEEEEEEeccCChHHHHHHHHHHHHHHhcC-CCCeeeeeeeE
Q 021711          105 LQSATNNFSFENLIGKGGYAEVYKGRLR----N----GQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLGY  175 (308)
Q Consensus       105 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~----~----g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~  175 (308)
                      ++...++..+.+.||+|.||.|++|...    .    ...||||.++........+.+..|+.+|..+ +|+||+.++|+
T Consensus       291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~  370 (609)
T KOG0200|consen  291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGA  370 (609)
T ss_pred             eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheee
Confidence            4444556667779999999999999743    1    3579999998776666678999999999998 69999999999


Q ss_pred             EEeC-cEEEEEEecCCCCHHHHHhccC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCC
Q 021711          176 GIEG-GMHIVLELSPNGSLASLLYGMK---------------EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAA  239 (308)
Q Consensus       176 ~~~~-~~~lv~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~  239 (308)
                      |... ..++|+||+..|+|.++++..+               ..+.....+.++.|||.||+||++   .++|||||.++
T Consensus       371 ~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~---~~~vHRDLAaR  447 (609)
T KOG0200|consen  371 CTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS---VPCVHRDLAAR  447 (609)
T ss_pred             eccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh---CCccchhhhhh
Confidence            8884 5789999999999999997755               348888999999999999999998   89999999999


Q ss_pred             CEEECCCCcEEEeccccceecCCCCceeEeeceec--cccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          240 NILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEG--TFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       240 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      |||+..+..+||+|||+|+........ ....-.|  ...|||||.+.+..++.++|+||||++|||++.
T Consensus       448 NVLi~~~~~~kIaDFGlar~~~~~~~y-~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~Eifs  516 (609)
T KOG0200|consen  448 NVLITKNKVIKIADFGLARDHYNKDYY-RTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFT  516 (609)
T ss_pred             hEEecCCCEEEEccccceeccCCCCce-EecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhh
Confidence            999999999999999999976554322 1122222  345999999999999999999999999999864

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.97  E-value=9.5e-31  Score=239.83  Aligned_cols=191  Identities=25%  Similarity=0.308  Sum_probs=159.9

Q ss_pred             hhcCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCC-hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEe--CcEE
Q 021711          107 SATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGIE--GGMH  182 (308)
Q Consensus       107 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~  182 (308)
                      ..+++|++.+.||+|+||.||++... +++.||+|.+.... .....+.+.+|+.++..++||||+++++++..  ...+
T Consensus         7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   86 (328)
T cd07856           7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY   86 (328)
T ss_pred             ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence            45788999999999999999999866 68999999885432 22335678899999999999999999997654  3578


Q ss_pred             EEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCC
Q 021711          183 IVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE  262 (308)
Q Consensus       183 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~  262 (308)
                      +++||+ +++|..++..  ..++...+..++.|++.||.|||+   .+|+||||+|+||+++.++.++|+|||+++....
T Consensus        87 lv~e~~-~~~L~~~~~~--~~~~~~~~~~~~~ql~~aL~~LH~---~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~  160 (328)
T cd07856          87 FVTELL-GTDLHRLLTS--RPLEKQFIQYFLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLARIQDP  160 (328)
T ss_pred             EEeehh-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEeECCCCCEEeCccccccccCC
Confidence            999998 5689888743  457888888899999999999998   8999999999999999999999999999986533


Q ss_pred             CCceeEeeceeccccccccccCch-hhcCccceeEEEeeEEEeeccC
Q 021711          263 QWTHHTISKVEGTFGLVKLNLPPL-VILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       263 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      .     .....++..|+|||.+.. ...+.++|+||+|++++++++|
T Consensus       161 ~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg  202 (328)
T cd07856         161 Q-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEG  202 (328)
T ss_pred             C-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhC
Confidence            2     123467889999998654 4578889999999999999875

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.97  E-value=7.4e-31  Score=230.50  Aligned_cols=191  Identities=26%  Similarity=0.360  Sum_probs=163.1

Q ss_pred             CccccceeeccCceEEEEEEEC-CCcEEEEEEeccCC-hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEe-CcEEEEEEe
Q 021711          111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLEL  187 (308)
Q Consensus       111 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~lv~e~  187 (308)
                      +|++.+.||+|+||.||++... +++.+|+|.+.... .......+.+|+.+++.++|+||+++++++.. ...++|+||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            4788899999999999999865 68899999986532 23345678899999999999999999986544 557899999


Q ss_pred             cCCCCHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCC
Q 021711          188 SPNGSLASLLYGM---KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (308)
Q Consensus       188 ~~~gsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  264 (308)
                      +++++|.+++...   ...+++..++.++.|++.||.|||+   .+++|+||+|+||+++.++.+||+|||+++......
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~---~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~  157 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKNM  157 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence            9999999988542   3568889999999999999999998   899999999999999999999999999998776542


Q ss_pred             ceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          265 THHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                          .....|+..|++||...+...+.++|+||+|+++++|.+|
T Consensus       158 ----~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g  197 (256)
T cd08530         158 ----AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATF  197 (256)
T ss_pred             ----cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhC
Confidence                1235688999999998777788889999999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.97  E-value=8.8e-31  Score=234.94  Aligned_cols=193  Identities=24%  Similarity=0.274  Sum_probs=159.2

Q ss_pred             CccccceeeccCceEEEEEEEC----CCcEEEEEEeccCCh---HHHHHHHHHHHHHHhcC-CCCeeeeeeeEEEeC-cE
Q 021711          111 NFSFENLIGKGGYAEVYKGRLR----NGQLVAIKRLTRGTA---DEIIADFLSELGIMAHV-DHPNTAKLLGYGIEG-GM  181 (308)
Q Consensus       111 ~~~~~~~LG~G~fg~Vy~~~~~----~g~~vAvK~~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~~  181 (308)
                      +|++.+.||+|+||.||++...    ++..||||.+.....   ......+.+|+.++..+ +||||+++++.+..+ ..
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            4778899999999999999743    468899999864321   22346788999999999 599999998865544 57


Q ss_pred             EEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecC
Q 021711          182 HIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP  261 (308)
Q Consensus       182 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~  261 (308)
                      ++||||+++|+|.+.+.. ...+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||+++.+.
T Consensus        81 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~---~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  156 (288)
T cd05583          81 HLILDYVNGGELFTHLYQ-REHFTESEVRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFL  156 (288)
T ss_pred             EEEEecCCCCcHHHHHhh-cCCcCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEEECccccccc
Confidence            899999999999998854 3468888999999999999999998   899999999999999999999999999998764


Q ss_pred             CCCceeEeeceeccccccccccCchhh--cCccceeEEEeeEEEeeccC
Q 021711          262 EQWTHHTISKVEGTFGLVKLNLPPLVI--LKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       262 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Di~s~g~~l~el~c~  308 (308)
                      ..... ......|+..|+|||...+..  .+.++|+||+|++++||++|
T Consensus       157 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg  204 (288)
T cd05583         157 AEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG  204 (288)
T ss_pred             ccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhC
Confidence            43221 123456899999999876554  67789999999999999865

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.97  E-value=8.3e-31  Score=233.72  Aligned_cols=191  Identities=25%  Similarity=0.311  Sum_probs=161.7

Q ss_pred             ccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChH-HHHHHHHHHHHHHhcCCCCeeeeeeeEEEe-CcEEEEEEec
Q 021711          112 FSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTAD-EIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLELS  188 (308)
Q Consensus       112 ~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~lv~e~~  188 (308)
                      |++.+.||+|++|.||+|... +++.+|+|.+...... .....+.+|+.+++.++|+||+++++++.. ...++|+||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            566789999999999999875 6899999998654322 335678899999999999999999986554 4578999999


Q ss_pred             CCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCceeE
Q 021711          189 PNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT  268 (308)
Q Consensus       189 ~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  268 (308)
                      ++ +|.+++......+++..+..++.|++.||.|||+   .+|+|+||||+||+++.++.++|+|||.+.......  ..
T Consensus        81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~~  154 (283)
T cd05118          81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHS---HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--RP  154 (283)
T ss_pred             CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHH---CCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--cc
Confidence            75 8888886655678999999999999999999998   899999999999999999999999999998876543  12


Q ss_pred             eeceeccccccccccCchh-hcCccceeEEEeeEEEeeccC
Q 021711          269 ISKVEGTFGLVKLNLPPLV-ILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       269 ~~~~~gt~~y~aPE~~~~~-~~~~~~Di~s~g~~l~el~c~  308 (308)
                      .....++..|+|||..... ..+.++|+||+|+++|++++|
T Consensus       155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg  195 (283)
T cd05118         155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSR  195 (283)
T ss_pred             ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhC
Confidence            2345688999999987665 578889999999999999875

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.97  E-value=1.4e-30  Score=238.88  Aligned_cols=193  Identities=23%  Similarity=0.319  Sum_probs=156.2

Q ss_pred             CccccceeeccCceEEEEEEEC-C--CcEEEEEEeccCCh-HHHHHHHHHHHHHHhcC-CCCeeeeeeeEEEe-----Cc
Q 021711          111 NFSFENLIGKGGYAEVYKGRLR-N--GQLVAIKRLTRGTA-DEIIADFLSELGIMAHV-DHPNTAKLLGYGIE-----GG  180 (308)
Q Consensus       111 ~~~~~~~LG~G~fg~Vy~~~~~-~--g~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-----~~  180 (308)
                      +|++.+.||+|+||.||++... .  +..||+|.+..... ....+.+.+|+.+++++ +||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            4788899999999999999975 3  77899999864322 22356788999999999 59999999985432     23


Q ss_pred             EEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceec
Q 021711          181 MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL  260 (308)
Q Consensus       181 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~  260 (308)
                      .+++++++. ++|.+.+.. ...+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++.+
T Consensus        81 ~~~~~e~~~-~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~---~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~  155 (332)
T cd07857          81 LYLYEELME-ADLHQIIRS-GQPLTDAHFQSFIYQILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARGF  155 (332)
T ss_pred             EEEEEeccc-CCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence            577888875 689888854 4568999999999999999999998   89999999999999999999999999999876


Q ss_pred             CCCCce--eEeeceeccccccccccCch-hhcCccceeEEEeeEEEeeccC
Q 021711          261 PEQWTH--HTISKVEGTFGLVKLNLPPL-VILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       261 ~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ......  .......||..|+|||...+ ...+.++|+||+|+++++++.|
T Consensus       156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g  206 (332)
T cd07857         156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGR  206 (332)
T ss_pred             ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhC
Confidence            543221  11234578999999998654 3467889999999999998754

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=2.8e-31  Score=248.32  Aligned_cols=203  Identities=21%  Similarity=0.257  Sum_probs=166.5

Q ss_pred             HHHHHhhcCCccccceeeccCceEEEEEE-ECCCcEEEEEEeccCCh--HHHHHHHHHHHHHHhcCCCCeeeeeee-EEE
Q 021711          102 LYELQSATNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTA--DEIIADFLSELGIMAHVDHPNTAKLLG-YGI  177 (308)
Q Consensus       102 ~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~-~~~g~~vAvK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~-~~~  177 (308)
                      +..-+.....|..++.||-|+||+|.+++ .++..++|+|.+.+...  .........|-.||...+.+-||+||- |..
T Consensus       621 LkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQD  700 (1034)
T KOG0608|consen  621 LKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQD  700 (1034)
T ss_pred             HHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEecc
Confidence            33344455678888999999999999997 44578899999865432  233556778999999999999999975 666


Q ss_pred             eCcEEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccc
Q 021711          178 EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLA  257 (308)
Q Consensus       178 ~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla  257 (308)
                      .+.+|+||+|++||++..+|.. .+-+++..+..++.++..|+++.|.   .|+|||||||+|||||.+|++||+||||+
T Consensus       701 kdnLYFVMdYIPGGDmMSLLIr-mgIFeE~LARFYIAEltcAiesVHk---mGFIHRDiKPDNILIDrdGHIKLTDFGLC  776 (1034)
T KOG0608|consen  701 KDNLYFVMDYIPGGDMMSLLIR-MGIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLC  776 (1034)
T ss_pred             CCceEEEEeccCCccHHHHHHH-hccCHHHHHHHHHHHHHHHHHHHHh---ccceecccCccceEEccCCceeeeecccc
Confidence            6789999999999999999865 4567888888889999999999998   99999999999999999999999999998


Q ss_pred             eecCC--------CCce--------------------------------eEeeceeccccccccccCchhhcCccceeEE
Q 021711          258 KWLPE--------QWTH--------------------------------HTISKVEGTFGLVKLNLPPLVILKRCFTCIF  297 (308)
Q Consensus       258 ~~~~~--------~~~~--------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s  297 (308)
                      .-+..        ...|                                ......+||..|+|||.+....++...|-||
T Consensus       777 TGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws  856 (1034)
T KOG0608|consen  777 TGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWS  856 (1034)
T ss_pred             ccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhH
Confidence            63310        0000                                0112478999999999999999999999999


Q ss_pred             EeeEEEeeccC
Q 021711          298 IGFSQLQLSCS  308 (308)
Q Consensus       298 ~g~~l~el~c~  308 (308)
                      .|++||||..|
T Consensus       857 ~gvil~em~~g  867 (1034)
T KOG0608|consen  857 VGVILYEMLVG  867 (1034)
T ss_pred             hhHHHHHHhhC
Confidence            99999999765

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=4.8e-32  Score=242.98  Aligned_cols=194  Identities=23%  Similarity=0.297  Sum_probs=163.4

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCCh--HHHHHHHHHHHHHHhcC-CCCeeeeeee-EEEeCcEEE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELGIMAHV-DHPNTAKLLG-YGIEGGMHI  183 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~-~~~~~~~~l  183 (308)
                      ..+|.++.+||+|+||.|.++..+ +.+.+|||++++...  ++..+--+.|-++|.-. +-|.+++++. |.+-+.+|+
T Consensus       348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF  427 (683)
T KOG0696|consen  348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF  427 (683)
T ss_pred             ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence            357889999999999999999866 478999999976531  22234455677777665 5788999987 445577999


Q ss_pred             EEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCC
Q 021711          184 VLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ  263 (308)
Q Consensus       184 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  263 (308)
                      ||||+.||+|...+.+ -+++.++.+.-++.+||-||-|||+   ++||+||||.+||||+.+|++||+|||+++.---+
T Consensus       428 VMEyvnGGDLMyhiQQ-~GkFKEp~AvFYAaEiaigLFFLh~---kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~  503 (683)
T KOG0696|consen  428 VMEYVNGGDLMYHIQQ-VGKFKEPVAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD  503 (683)
T ss_pred             EEEEecCchhhhHHHH-hcccCCchhhhhhHHHHHHhhhhhc---CCeeeeeccccceEeccCCceEeeecccccccccC
Confidence            9999999999988854 4578888888999999999999999   99999999999999999999999999999854333


Q ss_pred             CceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          264 WTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      .  .+..++.||+.|+|||...-..++.+.|-||+|++|||+..|
T Consensus       504 ~--~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaG  546 (683)
T KOG0696|consen  504 G--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAG  546 (683)
T ss_pred             C--cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcC
Confidence            2  245679999999999999888899999999999999999865

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.97  E-value=8.8e-31  Score=241.26  Aligned_cols=193  Identities=22%  Similarity=0.256  Sum_probs=156.8

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC--------
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG--------  179 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------  179 (308)
                      ..+|.+.+.||.|+||.||+|... +|+.||+|.+..... ...+.+.+|+.+++.++||||+++++++...        
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~-~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP-QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDV   82 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC-chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccc
Confidence            368999999999999999999875 589999999865443 3356788999999999999999998754332        


Q ss_pred             -------cEEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECC-CCcEEE
Q 021711          180 -------GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTE-DFEPQI  251 (308)
Q Consensus       180 -------~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~-~~~~kl  251 (308)
                             ..++|+||+. ++|.+++.  ...+++..+..++.|++.||.|||+   .+|+||||||+||+++. ++.++|
T Consensus        83 ~~~~~~~~~~lv~e~~~-~~L~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~---~givH~dikp~Nili~~~~~~~kl  156 (342)
T cd07854          83 GSLTELNSVYIVQEYME-TDLANVLE--QGPLSEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANVFINTEDLVLKI  156 (342)
T ss_pred             ccccccceEEEEeeccc-ccHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCceEEE
Confidence                   3689999997 58888874  3468899999999999999999998   89999999999999984 557899


Q ss_pred             eccccceecCCCCcee-EeeceeccccccccccCch-hhcCccceeEEEeeEEEeeccC
Q 021711          252 CDFGLAKWLPEQWTHH-TISKVEGTFGLVKLNLPPL-VILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       252 ~DFGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      +|||+++.+....... ......|+..|+|||.... ...+.++|+||+|+++|+|++|
T Consensus       157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g  215 (342)
T cd07854         157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG  215 (342)
T ss_pred             CCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhC
Confidence            9999998764332211 1123467899999997543 4567889999999999999875

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.97  E-value=7.9e-31  Score=243.22  Aligned_cols=190  Identities=22%  Similarity=0.274  Sum_probs=159.4

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCCh--HH-----HHHHHHHHHHHHhcCC---CCeeeeeeeEEEe
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DE-----IIADFLSELGIMAHVD---HPNTAKLLGYGIE  178 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~--~~-----~~~~~~~E~~~l~~l~---h~niv~l~~~~~~  178 (308)
                      .+|...+.+|+|+||.|++|.++ +...|+||.+.+..-  +.     ..-..-.|++||..++   |+||+++++|+.+
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED  640 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence            46888999999999999999987 467899998865421  10     1122346999999997   9999999998888


Q ss_pred             Cc-EEEEEEec-CCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEecccc
Q 021711          179 GG-MHIVLELS-PNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGL  256 (308)
Q Consensus       179 ~~-~~lv~e~~-~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGl  256 (308)
                      ++ +||+||-- ++-+|.+++. .+..+++.....|+.||+.|+++||+   .+|||||||-+|+.++.+|-+||+|||.
T Consensus       641 dd~yyl~te~hg~gIDLFd~IE-~kp~m~E~eAk~IFkQV~agi~hlh~---~~ivhrdikdenvivd~~g~~klidfgs  716 (772)
T KOG1152|consen  641 DDYYYLETEVHGEGIDLFDFIE-FKPRMDEPEAKLIFKQVVAGIKHLHD---QGIVHRDIKDENVIVDSNGFVKLIDFGS  716 (772)
T ss_pred             CCeeEEEecCCCCCcchhhhhh-ccCccchHHHHHHHHHHHhccccccc---cCceecccccccEEEecCCeEEEeeccc
Confidence            76 45777753 5668999885 46679999999999999999999999   9999999999999999999999999999


Q ss_pred             ceecCCCCceeEeeceeccccccccccCchhh-cCccceeEEEeeEEEeecc
Q 021711          257 AKWLPEQWTHHTISKVEGTFGLVKLNLPPLVI-LKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       257 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~s~g~~l~el~c  307 (308)
                      |.....+    ....+.||.+|.|||.+.+.. .+++.|||++|++||.+.+
T Consensus       717 aa~~ksg----pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivy  764 (772)
T KOG1152|consen  717 AAYTKSG----PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVY  764 (772)
T ss_pred             hhhhcCC----CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEe
Confidence            9877554    456789999999999987654 6889999999999998754

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.97  E-value=1.6e-30  Score=236.15  Aligned_cols=191  Identities=18%  Similarity=0.148  Sum_probs=152.4

Q ss_pred             ccceeeccCceEEEEEEECCCcEEEEEEeccC-ChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEe-CcEEEEEEecCCC
Q 021711          114 FENLIGKGGYAEVYKGRLRNGQLVAIKRLTRG-TADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLELSPNG  191 (308)
Q Consensus       114 ~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~lv~e~~~~g  191 (308)
                      +.+.+|.|+++.|+++.. +++.||+|.+... ...+....+.+|+.+++.++|+||+++++++.. ...+++|||+++|
T Consensus         6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~   84 (314)
T cd08216           6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG   84 (314)
T ss_pred             hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence            344455555555555544 6899999998754 233456789999999999999999999986655 4578999999999


Q ss_pred             CHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCce----
Q 021711          192 SLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH----  266 (308)
Q Consensus       192 sL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~----  266 (308)
                      +|.+++... ...+++..+..++.|++.||.|||+   ++|+||||||+||+++.++.+||+|||.+..+......    
T Consensus        85 ~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~---~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~  161 (314)
T cd08216          85 SCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV  161 (314)
T ss_pred             CHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence            999998653 3458888999999999999999998   89999999999999999999999999998766432211    


Q ss_pred             -eEeeceeccccccccccCchh--hcCccceeEEEeeEEEeeccC
Q 021711          267 -HTISKVEGTFGLVKLNLPPLV--ILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       267 -~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~s~g~~l~el~c~  308 (308)
                       .......++..|+|||.+...  .++.++|+||+|++++|+++|
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g  206 (314)
T cd08216         162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANG  206 (314)
T ss_pred             ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhC
Confidence             112345678899999987653  367889999999999999865

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.97  E-value=2.8e-30  Score=236.41  Aligned_cols=190  Identities=22%  Similarity=0.240  Sum_probs=152.3

Q ss_pred             ceeecc--CceEEEEEEEC-CCcEEEEEEeccCC-hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEEEecCC
Q 021711          116 NLIGKG--GYAEVYKGRLR-NGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLELSPN  190 (308)
Q Consensus       116 ~~LG~G--~fg~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~~~  190 (308)
                      ..||+|  +||+||++.+. +|+.||+|.+.... ..+..+.+.+|+.+++.++||||+++++++..+ ..++|+||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            456766  99999999875 69999999986433 334457889999999999999999999977654 57899999999


Q ss_pred             CCHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCcee--
Q 021711          191 GSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH--  267 (308)
Q Consensus       191 gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~--  267 (308)
                      ++|.+++... ...+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.++++|||.+..........  
T Consensus        84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (328)
T cd08226          84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQ---NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV  160 (328)
T ss_pred             CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence            9999988653 2458889999999999999999998   899999999999999999999999998654332211110  


Q ss_pred             ---EeeceeccccccccccCchh--hcCccceeEEEeeEEEeeccC
Q 021711          268 ---TISKVEGTFGLVKLNLPPLV--ILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       268 ---~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~s~g~~l~el~c~  308 (308)
                         ......++..|+|||.+.+.  .++.++|+||+|++++||++|
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g  206 (328)
T cd08226         161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATG  206 (328)
T ss_pred             cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhC
Confidence               01112356779999987653  367889999999999999875

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.97  E-value=6.6e-30  Score=227.32  Aligned_cols=189  Identities=21%  Similarity=0.266  Sum_probs=159.3

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCC--C----eeeeeeeEEE-eCc
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDH--P----NTAKLLGYGI-EGG  180 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h--~----niv~l~~~~~-~~~  180 (308)
                      +++|.+...+|+|+||.|-.|.++ .+..||||+++.-  ...++..+-|++++.++.+  |    -+|++.+|+. .+.
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V--~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh  165 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV--DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH  165 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH--HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence            678999999999999999999876 4789999998753  3456788899999999932  1    2556666554 567


Q ss_pred             EEEEEEecCCCCHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECC--------------
Q 021711          181 MHIVLELSPNGSLASLLYG-MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTE--------------  245 (308)
Q Consensus       181 ~~lv~e~~~~gsL~~~l~~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~--------------  245 (308)
                      .|+|+|.+ |-|+.+++.. ...+++..++..++.|+++++.|||+   .+++|-||||+|||+..              
T Consensus       166 iCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~---~kl~HTDLKPENILfvss~~~~~~~~k~~~~  241 (415)
T KOG0671|consen  166 ICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHD---LKLTHTDLKPENILFVSSEYFKTYNPKKKVC  241 (415)
T ss_pred             eEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHh---cceeecCCChheEEEeccceEEEeccCCccc
Confidence            89999988 6699999976 34568999999999999999999999   99999999999999842              


Q ss_pred             ------CCcEEEeccccceecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          246 ------DFEPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       246 ------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                            +..++|+|||.|+.-.+.     .+.++.|..|.|||.+.++.++.+.|+||+|++|+||+.|
T Consensus       242 ~~r~~ks~~I~vIDFGsAtf~~e~-----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG  305 (415)
T KOG0671|consen  242 FIRPLKSTAIKVIDFGSATFDHEH-----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTG  305 (415)
T ss_pred             eeccCCCcceEEEecCCcceeccC-----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeecc
Confidence                  235899999999975443     2567899999999999999999999999999999999876

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.97  E-value=3.8e-30  Score=266.62  Aligned_cols=183  Identities=24%  Similarity=0.355  Sum_probs=154.0

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEEEe
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLEL  187 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~  187 (308)
                      ..|...++||+|+||.||+|... ++..||||.+......     ...|++++++++|||||++++++.+. ..++||||
T Consensus       690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey  764 (968)
T PLN00113        690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI-----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY  764 (968)
T ss_pred             hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc-----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence            45777889999999999999974 6899999998643321     12468889999999999999988765 47899999


Q ss_pred             cCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCcee
Q 021711          188 SPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH  267 (308)
Q Consensus       188 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~  267 (308)
                      +++|+|.++++    .++|..+..++.|++.||.|||..+..+|+||||||+||+++.++.+++. ||.+......    
T Consensus       765 ~~~g~L~~~l~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~----  835 (968)
T PLN00113        765 IEGKNLSEVLR----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD----  835 (968)
T ss_pred             CCCCcHHHHHh----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC----
Confidence            99999999984    38899999999999999999996555799999999999999999888876 6666543222    


Q ss_pred             EeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          268 TISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                        ....||++|+|||+.....++.++||||||+++|||++|
T Consensus       836 --~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg  874 (968)
T PLN00113        836 --TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTG  874 (968)
T ss_pred             --CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhC
Confidence              223689999999999888889999999999999999875

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.96  E-value=2.9e-30  Score=236.83  Aligned_cols=194  Identities=24%  Similarity=0.268  Sum_probs=156.3

Q ss_pred             CCcc-ccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHH-------------HHHHHHHHHHHHhcCCCCeeeeeee
Q 021711          110 NNFS-FENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADE-------------IIADFLSELGIMAHVDHPNTAKLLG  174 (308)
Q Consensus       110 ~~~~-~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~-------------~~~~~~~E~~~l~~l~h~niv~l~~  174 (308)
                      ++|. +.+.||+|+||.||+|... +++.||+|.+.......             ....+.+|+.++..++|+||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            4554 4578999999999999976 58999999886432211             0124778999999999999999999


Q ss_pred             EEEeC-cEEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEec
Q 021711          175 YGIEG-GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICD  253 (308)
Q Consensus       175 ~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~D  253 (308)
                      ++... ..++||||+. |+|.+++.. ...++......++.|++.||.|||+   .+|+|+||+|+||+++.++.++|+|
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~---~~i~H~dl~~~nill~~~~~~kl~d  162 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVDR-KIRLTESQVKCILLQILNGLNVLHK---WYFMHRDLSPANIFINSKGICKIAD  162 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHeEECCCCCEEECC
Confidence            76654 5789999996 589888853 4568999999999999999999998   8999999999999999999999999


Q ss_pred             cccceecCCCC------------ceeEeeceeccccccccccCchhh-cCccceeEEEeeEEEeeccC
Q 021711          254 FGLAKWLPEQW------------THHTISKVEGTFGLVKLNLPPLVI-LKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       254 FGla~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~s~g~~l~el~c~  308 (308)
                      ||+++......            .........++..|+|||.+.+.. .+.++|+||+|++++||++|
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg  230 (335)
T PTZ00024        163 FGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG  230 (335)
T ss_pred             ccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhC
Confidence            99998765111            011223345788999999876543 57889999999999999875

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=2.9e-32  Score=249.55  Aligned_cols=192  Identities=21%  Similarity=0.224  Sum_probs=166.6

Q ss_pred             CCccccceeeccCceEEEEEEECCCc-EEEEEEeccCC--hHHHHHHHHHHHHHHhcCCCCeeeeeee-EEEeCcEEEEE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLRNGQ-LVAIKRLTRGT--ADEIIADFLSELGIMAHVDHPNTAKLLG-YGIEGGMHIVL  185 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~~g~-~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~-~~~~~~~~lv~  185 (308)
                      .+++....||-|+||.|-++..+... .+|+|++++..  ..+..+....|-.||..++.|.||++|. |-.+..+|++|
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm  499 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM  499 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence            45666778999999999999876433 48999886542  2344577889999999999999999997 44455678999


Q ss_pred             EecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCc
Q 021711          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (308)
Q Consensus       186 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~  265 (308)
                      |-|-||.|...|+. ++.++..+...++..+++|+.|||.   ++||+|||||+|++|+.+|-+||.|||+|+.+.....
T Consensus       500 EaClGGElWTiLrd-Rg~Fdd~tarF~~acv~EAfeYLH~---k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~K  575 (732)
T KOG0614|consen  500 EACLGGELWTILRD-RGSFDDYTARFYVACVLEAFEYLHR---KGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRK  575 (732)
T ss_pred             HhhcCchhhhhhhh-cCCcccchhhhhHHHHHHHHHHHHh---cCceeccCChhheeeccCCceEEeehhhHHHhccCCc
Confidence            99999999999965 5678888888899999999999998   9999999999999999999999999999999987765


Q ss_pred             eeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          266 HHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      .+   +++||+.|.|||...+...+.+.|.|++|++++||+.|
T Consensus       576 Tw---TFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G  615 (732)
T KOG0614|consen  576 TW---TFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTG  615 (732)
T ss_pred             ee---eecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcC
Confidence            44   58999999999999999999999999999999999876

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.96  E-value=2.3e-30  Score=230.73  Aligned_cols=191  Identities=25%  Similarity=0.335  Sum_probs=160.8

Q ss_pred             ccccceeeccCceEEEEEEEC-CCcEEEEEEeccCC-hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEe-CcEEEEEEec
Q 021711          112 FSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLELS  188 (308)
Q Consensus       112 ~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~lv~e~~  188 (308)
                      |+..+.||+|+||.||+|... +++.+|+|.+.... .+...+.+..|+.+++.++|+|++++++++.. +..++|+||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            566788999999999999976 48999999987653 22335677889999999999999999996655 4678999999


Q ss_pred             CCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCceeE
Q 021711          189 PNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT  268 (308)
Q Consensus       189 ~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  268 (308)
                      + ++|.+++......+++..+..++.|++.||.|||+   .+|+||||+|+||+++.++.++|+|||+++.......  .
T Consensus        81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--~  154 (282)
T cd07829          81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR--T  154 (282)
T ss_pred             C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc--c
Confidence            7 58999997654578999999999999999999999   8999999999999999999999999999987654322  2


Q ss_pred             eeceeccccccccccCchh-hcCccceeEEEeeEEEeeccC
Q 021711          269 ISKVEGTFGLVKLNLPPLV-ILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       269 ~~~~~gt~~y~aPE~~~~~-~~~~~~Di~s~g~~l~el~c~  308 (308)
                      .....++..|+|||..... ..+.++|+||+|++++|++.|
T Consensus       155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~  195 (282)
T cd07829         155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITG  195 (282)
T ss_pred             cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhC
Confidence            2344567889999987655 678889999999999998764

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.96  E-value=3.2e-30  Score=227.67  Aligned_cols=192  Identities=21%  Similarity=0.274  Sum_probs=155.4

Q ss_pred             CccccceeeccCceEEEEEEECC-CcEEEEEEeccCC----hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEe-CcEEEE
Q 021711          111 NFSFENLIGKGGYAEVYKGRLRN-GQLVAIKRLTRGT----ADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIV  184 (308)
Q Consensus       111 ~~~~~~~LG~G~fg~Vy~~~~~~-g~~vAvK~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~lv  184 (308)
                      +|.+.+.||+|+||.||++.... +..+++|.++...    .......+.+|+.+++.++||||+++++++.+ ...++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            47888999999999999998653 4555566554321    11223456789999999999999999986554 457899


Q ss_pred             EEecCCCCHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecC
Q 021711          185 LELSPNGSLASLLYG---MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP  261 (308)
Q Consensus       185 ~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~  261 (308)
                      +||+++++|.+++..   ....+++..+..++.|++.||.|||+   .+++|+||||+||+++. +.++|+|||+++.+.
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ---RRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH---cCccccCCChhheEeec-CCEeecccCceeecC
Confidence            999999999988853   34568999999999999999999998   89999999999999986 569999999998765


Q ss_pred             CCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          262 EQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       262 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ....  ......|+..|+|||.......+.++|+||+|+++++|++|
T Consensus       157 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~  201 (260)
T cd08222         157 GSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCL  201 (260)
T ss_pred             CCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhC
Confidence            4322  22346789999999988777778889999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.96  E-value=3.5e-30  Score=237.34  Aligned_cols=190  Identities=25%  Similarity=0.327  Sum_probs=159.2

Q ss_pred             hcCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCC-hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC------
Q 021711          108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG------  179 (308)
Q Consensus       108 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  179 (308)
                      ..++|++.+.||+|+||.||+|+.. +++.||+|.+.... .......+.+|+.+++.++||||+++++++...      
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            3568999999999999999999976 58899999886532 223346678899999999999999998854432      


Q ss_pred             -cEEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccce
Q 021711          180 -GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK  258 (308)
Q Consensus       180 -~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~  258 (308)
                       ..++|+||+ +++|.+++..  ..+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.++|+|||++.
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nill~~~~~~kL~dfg~~~  166 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLAR  166 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEccccccc
Confidence             278999998 6799998853  568999999999999999999998   899999999999999999999999999998


Q ss_pred             ecCCCCceeEeeceeccccccccccCch-hhcCccceeEEEeeEEEeeccC
Q 021711          259 WLPEQWTHHTISKVEGTFGLVKLNLPPL-VILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       259 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      .....     .....++..|+|||.... ...+.++|+||+|+++||++.|
T Consensus       167 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg  212 (343)
T cd07851         167 HTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG  212 (343)
T ss_pred             ccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhC
Confidence            76443     234568899999998654 3567889999999999998765

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.96  E-value=1.3e-29  Score=222.10  Aligned_cols=185  Identities=27%  Similarity=0.314  Sum_probs=157.9

Q ss_pred             eeccCceEEEEEEEC-CCcEEEEEEeccCCh--HHHHHHHHHHHHHHhcCCCCeeeeeeeEEEe-CcEEEEEEecCCCCH
Q 021711          118 IGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLELSPNGSL  193 (308)
Q Consensus       118 LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~lv~e~~~~gsL  193 (308)
                      ||+|+||.||++... +++.+|+|.+.....  ......+..|+.+++.++||||+++++.+.. ...+++|||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            699999999999876 489999999865432  2245678899999999999999999986544 457899999999999


Q ss_pred             HHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCceeEeecee
Q 021711          194 ASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVE  273 (308)
Q Consensus       194 ~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~  273 (308)
                      .+++.. ...+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++........  ......
T Consensus        81 ~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lh~---~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~  154 (250)
T cd05123          81 FSHLSK-EGRFSEERARFYAAEIVLALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS--RTNTFC  154 (250)
T ss_pred             HHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcceEEEcCCCcEEEeecCcceecccCCC--cccCCc
Confidence            999864 3468999999999999999999998   8999999999999999999999999999987654321  224567


Q ss_pred             ccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          274 GTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       274 gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ++..|++||...+...+.++|+||+|+++|++++|
T Consensus       155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g  189 (250)
T cd05123         155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTG  189 (250)
T ss_pred             CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHC
Confidence            89999999998777788889999999999998865

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.96  E-value=1.9e-29  Score=241.24  Aligned_cols=196  Identities=21%  Similarity=0.269  Sum_probs=145.8

Q ss_pred             hcCCccccceeeccCceEEEEEEE-----------------CCCcEEEEEEeccCChHHHHH--------------HHHH
Q 021711          108 ATNNFSFENLIGKGGYAEVYKGRL-----------------RNGQLVAIKRLTRGTADEIIA--------------DFLS  156 (308)
Q Consensus       108 ~~~~~~~~~~LG~G~fg~Vy~~~~-----------------~~g~~vAvK~~~~~~~~~~~~--------------~~~~  156 (308)
                      ..++|++.++||+|+||.||+|..                 ..++.||||++...... ..+              .+..
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~-~~~~fl~e~~~~~~~~e~~~v  221 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQG-VRQDFLKTGTLAKGSAETGMV  221 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchh-hHHHHHhhhhhhhcccchhHH
Confidence            467999999999999999999964                 13568999998643221 122              2345


Q ss_pred             HHHHHhcCCCCee-----eeeeeEEE---------eCcEEEEEEecCCCCHHHHHhccC---------------------
Q 021711          157 ELGIMAHVDHPNT-----AKLLGYGI---------EGGMHIVLELSPNGSLASLLYGMK---------------------  201 (308)
Q Consensus       157 E~~~l~~l~h~ni-----v~l~~~~~---------~~~~~lv~e~~~~gsL~~~l~~~~---------------------  201 (308)
                      |+.++..++|.++     +++++|+.         .+..++|+||+++++|.++++...                     
T Consensus       222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~  301 (507)
T PLN03224        222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM  301 (507)
T ss_pred             HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence            6777777766654     56666654         245789999999999999886421                     


Q ss_pred             --CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCceeEeeceecccccc
Q 021711          202 --EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGLV  279 (308)
Q Consensus       202 --~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~  279 (308)
                        ..+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++.+...... ......+|+.|+
T Consensus       302 ~~~~~~~~~~~~i~~ql~~aL~~lH~---~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~  377 (507)
T PLN03224        302 PQDKRDINVIKGVMRQVLTGLRKLHR---IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYS  377 (507)
T ss_pred             ccccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCccee
Confidence              123567788899999999999998   89999999999999999999999999999765443211 111233478999


Q ss_pred             ccccCchhh--------------------c--CccceeEEEeeEEEeeccC
Q 021711          280 KLNLPPLVI--------------------L--KRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       280 aPE~~~~~~--------------------~--~~~~Di~s~g~~l~el~c~  308 (308)
                      |||.+....                    +  ...+|+||+|+++++|+++
T Consensus       378 aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~  428 (507)
T PLN03224        378 PPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVP  428 (507)
T ss_pred             ChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhC
Confidence            999753211                    1  2347999999999998763

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=2.6e-32  Score=231.09  Aligned_cols=194  Identities=25%  Similarity=0.342  Sum_probs=158.6

Q ss_pred             CCccccceeeccCceEEEEEEECC-CcEEEEEEe-ccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEe---------
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLRN-GQLVAIKRL-TRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE---------  178 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~~-g~~vAvK~~-~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---------  178 (308)
                      +.|....+||+|.||.||+|+.++ |+.||+|++ ..+.....-...++|+.+|..|+|+|++.+++.|..         
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            356667899999999999998764 778898865 322222234567899999999999999999886532         


Q ss_pred             CcEEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccce
Q 021711          179 GGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK  258 (308)
Q Consensus       179 ~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~  258 (308)
                      ..+|+|+.+|++ +|.-+|.+...+++...+.+++.++..||.|+|.   ..|+|||+||+|+|++.+|.+||+|||+|+
T Consensus        97 ~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr---~kilHRDmKaaNvLIt~dgilklADFGlar  172 (376)
T KOG0669|consen   97 ATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHR---NKILHRDMKAANVLITKDGILKLADFGLAR  172 (376)
T ss_pred             ceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHH---hhHHhhcccHhhEEEcCCceEEeecccccc
Confidence            237899999976 8999998777889999999999999999999998   899999999999999999999999999998


Q ss_pred             ecCCCCce--eEeeceeccccccccccCchh-hcCccceeEEEeeEEEeecc
Q 021711          259 WLPEQWTH--HTISKVEGTFGLVKLNLPPLV-ILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       259 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~s~g~~l~el~c  307 (308)
                      .+......  ...+..+-|..|.+||.+.+. .++++.|+|.-||+|.|++.
T Consensus       173 ~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwt  224 (376)
T KOG0669|consen  173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWT  224 (376)
T ss_pred             ceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHc
Confidence            76433221  123445569999999986554 57999999999999998875

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.96  E-value=1.4e-29  Score=246.92  Aligned_cols=192  Identities=21%  Similarity=0.205  Sum_probs=135.9

Q ss_pred             hcCCccccceeeccCceEEEEEEEC-C----CcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeee-E------
Q 021711          108 ATNNFSFENLIGKGGYAEVYKGRLR-N----GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLG-Y------  175 (308)
Q Consensus       108 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~----g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~-~------  175 (308)
                      ..++|++.+.||+|+||.||+|.+. +    +..||+|++......+   .+..|  .+.+..+.+++.++. +      
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e---~~~~e--~l~~~~~~~~~~~~~~~~~~~~~  204 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVE---IWMNE--RVRRACPNSCADFVYGFLEPVSS  204 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhH---HHHHH--HHHhhchhhHHHHHHhhhccccc
Confidence            5679999999999999999999975 4    6899999876433221   11111  112222222222221 1      


Q ss_pred             EEeCcEEEEEEecCCCCHHHHHhccCCC-------------------CCHHHHHHHHHHHHHHHHHHHhCCCCCceecCC
Q 021711          176 GIEGGMHIVLELSPNGSLASLLYGMKEK-------------------LKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDI  236 (308)
Q Consensus       176 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~-------------------l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDl  236 (308)
                      ......++|+||+.+++|.+++......                   .....+..++.|++.||.|||+   ++|+||||
T Consensus       205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~---~gIiHRDL  281 (566)
T PLN03225        205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS---TGIVHRDV  281 (566)
T ss_pred             ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH---CCEEeCcC
Confidence            1234578999999999999988643211                   1123355789999999999998   89999999


Q ss_pred             CCCCEEECC-CCcEEEeccccceecCCCCceeEeeceeccccccccccCchhh----------------------cCccc
Q 021711          237 KAANILLTE-DFEPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPLVI----------------------LKRCF  293 (308)
Q Consensus       237 Kp~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----------------------~~~~~  293 (308)
                      ||+|||++. ++.+||+|||+|+.+..... .......||+.|+|||.+....                      +..++
T Consensus       282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~  360 (566)
T PLN03225        282 KPQNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF  360 (566)
T ss_pred             CHHHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence            999999986 57999999999987644322 1234568899999999543221                      23456


Q ss_pred             eeEEEeeEEEeeccC
Q 021711          294 TCIFIGFSQLQLSCS  308 (308)
Q Consensus       294 Di~s~g~~l~el~c~  308 (308)
                      |+||+|++||||+++
T Consensus       361 DVwSlGviL~el~~~  375 (566)
T PLN03225        361 DIYSAGLIFLQMAFP  375 (566)
T ss_pred             ccHHHHHHHHHHHhC
Confidence            999999999998753

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.96  E-value=2.3e-29  Score=219.95  Aligned_cols=173  Identities=17%  Similarity=0.104  Sum_probs=144.1

Q ss_pred             cCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEe-CcEEEEEEecCCCCHHHHHh
Q 021711          121 GGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLELSPNGSLASLLY  198 (308)
Q Consensus       121 G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~lv~e~~~~gsL~~~l~  198 (308)
                      |.||.||++++. +++.+|+|.+....      .+.+|...+....||||+++++++.+ ...+++|||+++|+|.+++.
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   77 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHIS   77 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHH
Confidence            899999999976 58999999986542      12244455556679999999996655 45789999999999999885


Q ss_pred             ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCceeEeeceeccccc
Q 021711          199 GMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGL  278 (308)
Q Consensus       199 ~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y  278 (308)
                      . ...+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.++++|||++..+...     .....++..|
T Consensus        78 ~-~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~y  148 (237)
T cd05576          78 K-FLNIPEECVKRWAAEMVVALDALHR---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENMY  148 (237)
T ss_pred             H-hcCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCccc
Confidence            4 3468999999999999999999998   89999999999999999999999999988765432     1234567789


Q ss_pred             cccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          279 VKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       279 ~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      +|||.......+.++|+||+|+++||+++|
T Consensus       149 ~aPE~~~~~~~~~~~DvwslG~il~el~~g  178 (237)
T cd05576         149 CAPEVGGISEETEACDWWSLGAILFELLTG  178 (237)
T ss_pred             cCCcccCCCCCCchhhHHHHHHHHHHHHHC
Confidence            999988766778889999999999999875

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=3.6e-30  Score=225.84  Aligned_cols=194  Identities=24%  Similarity=0.288  Sum_probs=165.1

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCC--hHHHHHHHHHHHHHHhcC-CCCeeeeeee-EEEeCcEEE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHV-DHPNTAKLLG-YGIEGGMHI  183 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~-~~~~~~~~l  183 (308)
                      .++|.++++||+|+|++|.++++. +.+.+|+|++++..  .++.......|-.+.... +||.+|.++. |.++..+++
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff  328 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF  328 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence            468999999999999999999876 58899999987642  223345566777777665 7999999998 556677899


Q ss_pred             EEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCC
Q 021711          184 VLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ  263 (308)
Q Consensus       184 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  263 (308)
                      |.||++||+|...+. ...++++..+..+...|+.||.|||+   ++||.||||.+|+|+|..|++||+|+|+++.--.+
T Consensus       329 vieyv~ggdlmfhmq-rqrklpeeharfys~ei~lal~flh~---rgiiyrdlkldnvlldaeghikltdygmcke~l~~  404 (593)
T KOG0695|consen  329 VIEYVNGGDLMFHMQ-RQRKLPEEHARFYSAEICLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGP  404 (593)
T ss_pred             EEEEecCcceeeehh-hhhcCcHHHhhhhhHHHHHHHHHHhh---cCeeeeeccccceEEccCCceeecccchhhcCCCC
Confidence            999999999987764 35679999999999999999999999   99999999999999999999999999999864332


Q ss_pred             CceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          264 WTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ..  +.++++||+.|+|||.+.+..++-+.|-|++|++|+|+..|
T Consensus       405 gd--~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmag  447 (593)
T KOG0695|consen  405 GD--TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAG  447 (593)
T ss_pred             Cc--ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcC
Confidence            22  45689999999999999999999999999999999998754

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.96  E-value=6.2e-28  Score=222.08  Aligned_cols=166  Identities=17%  Similarity=0.109  Sum_probs=131.3

Q ss_pred             hcCCccccceeeccCceEEEEEEEC--CCcEEEEEEeccCC----hHHHHHHHHHHHHHHhcCCCCeeee-eeeEEEeCc
Q 021711          108 ATNNFSFENLIGKGGYAEVYKGRLR--NGQLVAIKRLTRGT----ADEIIADFLSELGIMAHVDHPNTAK-LLGYGIEGG  180 (308)
Q Consensus       108 ~~~~~~~~~~LG~G~fg~Vy~~~~~--~g~~vAvK~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~-l~~~~~~~~  180 (308)
                      ..++|.+.+.||+|+||+||+|.+.  +++.||||++....    .......|.+|+.+|+.++|+|++. ++++   +.
T Consensus        16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---~~   92 (365)
T PRK09188         16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---GK   92 (365)
T ss_pred             ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---CC
Confidence            4568999999999999999999865  47788999875331    2234567999999999999999985 4432   45


Q ss_pred             EEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCC-CCCCEEECCCCcEEEecccccee
Q 021711          181 MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDI-KAANILLTEDFEPQICDFGLAKW  259 (308)
Q Consensus       181 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDl-Kp~NILl~~~~~~kl~DFGla~~  259 (308)
                      .++||||++|++|.. +.  .  ..   ...++.|++.+|.|||+   ++|+|||| ||+|||++.++.+||+|||+|+.
T Consensus        93 ~~LVmE~~~G~~L~~-~~--~--~~---~~~~~~~i~~aL~~lH~---~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~  161 (365)
T PRK09188         93 DGLVRGWTEGVPLHL-AR--P--HG---DPAWFRSAHRALRDLHR---AGITHNDLAKPQNWLMGPDGEAAVIDFQLASV  161 (365)
T ss_pred             cEEEEEccCCCCHHH-hC--c--cc---hHHHHHHHHHHHHHHHH---CCCeeCCCCCcceEEEcCCCCEEEEECcccee
Confidence            799999999999963 21  1  11   14578899999999998   99999999 99999999999999999999998


Q ss_pred             cCCCCcee------EeeceeccccccccccCchh
Q 021711          260 LPEQWTHH------TISKVEGTFGLVKLNLPPLV  287 (308)
Q Consensus       260 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~  287 (308)
                      +.......      ......+++.|+|||++...
T Consensus       162 ~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        162 FRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             cccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            76543211      12467889999999987544

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.95  E-value=1.1e-27  Score=238.59  Aligned_cols=185  Identities=24%  Similarity=0.291  Sum_probs=151.1

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCC--hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEe-CcEEEEE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVL  185 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~lv~  185 (308)
                      ++|.+.+.||+|+||.||+|.+. +++.||||++....  .......+.+|+.++..++||||+++++++.. ...++||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            68999999999999999999976 58999999986432  23345778899999999999999999986654 4578999


Q ss_pred             EecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCc
Q 021711          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (308)
Q Consensus       186 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~  265 (308)
                      ||+.+++|.+++.. ...+++..++.++.||+.||.|||.   ++|+||||||+|||++.++.+||+|||+++.......
T Consensus        84 Ey~~g~~L~~li~~-~~~l~~~~~~~i~~qil~aL~yLH~---~gIiHrDLKP~NILl~~~g~vkL~DFGls~~~~~~~~  159 (669)
T cd05610          84 EYLIGGDVKSLLHI-YGYFDEEMAVKYISEVALALDYLHR---HGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNREL  159 (669)
T ss_pred             eCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCccHHHEEEcCCCCEEEEeCCCCccccCCcc
Confidence            99999999999864 3468888999999999999999998   8999999999999999999999999999997644322


Q ss_pred             eeEeeceeccccccccccCchh-hcCccceeEEEee
Q 021711          266 HHTISKVEGTFGLVKLNLPPLV-ILKRCFTCIFIGF  300 (308)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~s~g~  300 (308)
                        ......+|+.|++||..... .....+++|++|+
T Consensus       160 --~~~~~~~t~~~~~pe~~~~~~~~~~~s~~~s~g~  193 (669)
T cd05610         160 --NMMDILTTPSMAKPKNDYSRTPGQVLSLISSLGF  193 (669)
T ss_pred             --cccccccCccccCccccccCCCCceeeeeeecCc
Confidence              33457899999999853211 1223355666664

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=2.2e-30  Score=221.77  Aligned_cols=190  Identities=22%  Similarity=0.274  Sum_probs=155.0

Q ss_pred             CccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChH-HHHHHHHHHHHHHhcCCCCeeeeeeeEEEeCc------EE
Q 021711          111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTAD-EIIADFLSELGIMAHVDHPNTAKLLGYGIEGG------MH  182 (308)
Q Consensus       111 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~  182 (308)
                      +.+-.+.||-|+||.||.+.+. +|+.||+|++.+-... ...+++.+|+.++..++|.|++..++.-...+      +|
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY  133 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY  133 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence            3445688999999999999865 6999999988653322 23578899999999999999999988655443      45


Q ss_pred             EEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCC
Q 021711          183 IVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE  262 (308)
Q Consensus       183 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~  262 (308)
                      .++|.+. .+|..++- ....++...+.-++.||++||.|||+   .+|+||||||.|+|++.+..+||||||+|+.-..
T Consensus       134 V~TELmQ-SDLHKIIV-SPQ~Ls~DHvKVFlYQILRGLKYLHs---A~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~  208 (449)
T KOG0664|consen  134 VLTELMQ-SDLHKIIV-SPQALTPDHVKVFVYQILRGLKYLHT---ANILHRDIKPGNLLVNSNCILKICDFGLARTWDQ  208 (449)
T ss_pred             HHHHHHH-hhhhheec-cCCCCCcchhhhhHHHHHhhhHHHhh---cchhhccCCCccEEeccCceEEecccccccccch
Confidence            6777774 46776663 45678888888999999999999999   8999999999999999999999999999997654


Q ss_pred             CCceeEeeceeccccccccccCchhh-cCccceeEEEeeEEEeec
Q 021711          263 QWTHHTISKVEGTFGLVKLNLPPLVI-LKRCFTCIFIGFSQLQLS  306 (308)
Q Consensus       263 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~s~g~~l~el~  306 (308)
                      +.. ..++...-|..|.|||.+.+.. ++...|+||.|+++.||+
T Consensus       209 d~~-~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELL  252 (449)
T KOG0664|consen  209 RDR-LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELL  252 (449)
T ss_pred             hhh-hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHH
Confidence            433 3456677899999999887665 788999999999988874

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.95  E-value=9.8e-28  Score=206.05  Aligned_cols=193  Identities=27%  Similarity=0.389  Sum_probs=163.0

Q ss_pred             ccccceeeccCceEEEEEEECC-CcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEe-CcEEEEEEecC
Q 021711          112 FSFENLIGKGGYAEVYKGRLRN-GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLELSP  189 (308)
Q Consensus       112 ~~~~~~LG~G~fg~Vy~~~~~~-g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~lv~e~~~  189 (308)
                      |.+.+.||+|++|.||++.... ++.+|+|.+.........+.+.+|+..+..++|+|++++++++.. ...++++|+++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            5567899999999999999875 889999998765433246788999999999999999999997665 45789999999


Q ss_pred             CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCceeEe
Q 021711          190 NGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTI  269 (308)
Q Consensus       190 ~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  269 (308)
                      +++|.+++......+++.....++.+++.++.|||+   .+++|+||+|.||+++.++.++|+|||++........ ...
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-~~~  156 (225)
T smart00221       81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHS---LGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-ALL  156 (225)
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-ccc
Confidence            999999986543338899999999999999999998   8999999999999999999999999999998765421 122


Q ss_pred             eceeccccccccccC-chhhcCccceeEEEeeEEEeeccC
Q 021711          270 SKVEGTFGLVKLNLP-PLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       270 ~~~~gt~~y~aPE~~-~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ....++..|++||.. .....+.++|+|++|+++++|++|
T Consensus       157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g  196 (225)
T smart00221      157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWG  196 (225)
T ss_pred             cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHC
Confidence            346788899999987 455566789999999999999865

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.95  E-value=2e-28  Score=230.40  Aligned_cols=185  Identities=23%  Similarity=0.281  Sum_probs=154.6

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcC-CCCeeeeeeeEEEeC-cEEEEE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGIEG-GMHIVL  185 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~~~lv~  185 (308)
                      +..|.+...+|.|+|+.|..|... +++..++|++.+...+     -.+|+.++... +||||+++.+.+.++ ..|+||
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~-----~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~  395 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD-----NQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM  395 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheeccccccc-----cccccchhhhhcCCCcceeecceecCCceeeeee
Confidence            567888888999999999999866 5888999999765222     23566555444 799999999976655 689999


Q ss_pred             EecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEE-CCCCcEEEeccccceecCCCC
Q 021711          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILL-TEDFEPQICDFGLAKWLPEQW  264 (308)
Q Consensus       186 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl-~~~~~~kl~DFGla~~~~~~~  264 (308)
                      |.+.|+-+.+.+....  .....+..|+.+|+.++.|||+   +++|||||||+|||+ +..++++|+|||.++.++.. 
T Consensus       396 e~l~g~ell~ri~~~~--~~~~e~~~w~~~lv~Av~~LH~---~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-  469 (612)
T KOG0603|consen  396 ELLDGGELLRRIRSKP--EFCSEASQWAAELVSAVDYLHE---QGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-  469 (612)
T ss_pred             hhccccHHHHHHHhcc--hhHHHHHHHHHHHHHHHHHHHh---cCeeecCCChhheeecCCCCcEEEEEechhhhCchh-
Confidence            9999998888775432  2236777899999999999999   999999999999999 58899999999999987665 


Q ss_pred             ceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          265 THHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                          ..+.+-|..|.|||......++.+.|+||+|++||+|+||
T Consensus       470 ----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G  509 (612)
T KOG0603|consen  470 ----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTG  509 (612)
T ss_pred             ----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhC
Confidence                2345668999999999888899999999999999999997

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.95  E-value=1.4e-27  Score=219.40  Aligned_cols=190  Identities=22%  Similarity=0.255  Sum_probs=161.5

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCC------CCeeeeeee-EEEeCc
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVD------HPNTAKLLG-YGIEGG  180 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~l~~-~~~~~~  180 (308)
                      ..+|.+....|+|-|++|..|.+. .|+.||||+|.++..  ..+.=++|++||++|+      --++++|+. |...++
T Consensus       431 D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~--M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknH  508 (752)
T KOG0670|consen  431 DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV--MHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNH  508 (752)
T ss_pred             cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH--HhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcce
Confidence            467888888999999999999976 488999999986532  2455678999999994      347788875 677788


Q ss_pred             EEEEEEecCCCCHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCC-CcEEEeccccc
Q 021711          181 MHIVLELSPNGSLASLLYGM--KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTED-FEPQICDFGLA  257 (308)
Q Consensus       181 ~~lv~e~~~~gsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~-~~~kl~DFGla  257 (308)
                      +|||+|.+. -+|.++|...  .-.|....+..++.|+..||..|-.   .+|+|.||||+|||+++. ..+||||||.|
T Consensus       509 LClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~---c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA  584 (752)
T KOG0670|consen  509 LCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKK---CGVLHADIKPDNILVNESKNILKLCDFGSA  584 (752)
T ss_pred             eEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHh---cCeeecccCccceEeccCcceeeeccCccc
Confidence            999999885 4899999653  3457778888999999999999998   899999999999999976 46899999999


Q ss_pred             eecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          258 KWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      -...++    .++.+.-+..|.|||.+.+..++.+.|+||.||+||||++|
T Consensus       585 ~~~~en----eitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtG  631 (752)
T KOG0670|consen  585 SFASEN----EITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTG  631 (752)
T ss_pred             cccccc----cccHHHHHHhccCcceeecCcccCCccceeeceeeEEeecc
Confidence            887665    45666777889999999999999999999999999999986

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.94  E-value=2.2e-27  Score=205.43  Aligned_cols=180  Identities=28%  Similarity=0.361  Sum_probs=155.3

Q ss_pred             CceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEe-CcEEEEEEecCCCCHHHHHhc
Q 021711          122 GYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLELSPNGSLASLLYG  199 (308)
Q Consensus       122 ~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~lv~e~~~~gsL~~~l~~  199 (308)
                      +||.||+|... +|+.+|+|.+...........+.+|+..++.++|+|++++++++.. ...++++|++++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999987 4899999998765443325788999999999999999999997766 457899999999999999865


Q ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCceeEeeceecccccc
Q 021711          200 MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGLV  279 (308)
Q Consensus       200 ~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~  279 (308)
                      .. .+++..+..++.+++.++.|||+   .+++|+||+|+||+++.++.++|+|||++.......   ......++..|+
T Consensus        81 ~~-~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~  153 (244)
T smart00220       81 RG-RLSEDEARFYARQILSALEYLHS---NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEYM  153 (244)
T ss_pred             cc-CCCHHHHHHHHHHHHHHHHHHHH---cCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCCC
Confidence            33 38889999999999999999998   899999999999999999999999999999876542   234567889999


Q ss_pred             ccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          280 KLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       280 aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      +||.......+.++|+|++|+++++++++
T Consensus       154 ~pE~~~~~~~~~~~Di~slG~~l~~l~~~  182 (244)
T smart00220      154 APEVLLGKGYGKAVDVWSLGVILYELLTG  182 (244)
T ss_pred             CHHHHccCCCCchhhHHHHHHHHHHHHhC
Confidence            99988777778899999999999999875

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.94  E-value=4.3e-27  Score=226.34  Aligned_cols=188  Identities=26%  Similarity=0.329  Sum_probs=150.7

Q ss_pred             ccccceeeccCce-EEEEEEECCCcEEEEEEeccCChHHHHHHHHHHHHHHhcC-CCCeeeeeeeEEEeCc-EEEEEEec
Q 021711          112 FSFENLIGKGGYA-EVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGIEGG-MHIVLELS  188 (308)
Q Consensus       112 ~~~~~~LG~G~fg-~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~-~~lv~e~~  188 (308)
                      |.-.+++|.|+.| .||+|.. .|+.||||++-..    ......+|+..+..- +|||||++++...+.. .|+.+|.|
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e----~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC  585 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEE----FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC  585 (903)
T ss_pred             eccHHHcccCCCCcEEEEEee-CCceehHHHHhhH----hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence            4445789999886 5799998 4889999988543    334567899998877 5999999998766654 68899999


Q ss_pred             CCCCHHHHHhccCCC---CCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECC---C--CcEEEeccccceec
Q 021711          189 PNGSLASLLYGMKEK---LKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTE---D--FEPQICDFGLAKWL  260 (308)
Q Consensus       189 ~~gsL~~~l~~~~~~---l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~---~--~~~kl~DFGla~~~  260 (308)
                      . .+|.+++......   ........+..|++.||++||+   .+||||||||.||||+.   +  ..++|+|||+++.+
T Consensus       586 ~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHs---l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl  661 (903)
T KOG1027|consen  586 A-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHS---LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL  661 (903)
T ss_pred             h-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHh---cccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence            5 5999999663111   1113346678999999999999   89999999999999986   3  47899999999998


Q ss_pred             CCCCce-eEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          261 PEQWTH-HTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       261 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ..+... .......||-||+|||++.+....++.|++|+||++|....|
T Consensus       662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltg  710 (903)
T KOG1027|consen  662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTG  710 (903)
T ss_pred             CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecC
Confidence            765443 235678999999999999988889999999999999988754

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.94  E-value=2.3e-28  Score=230.10  Aligned_cols=192  Identities=26%  Similarity=0.415  Sum_probs=163.2

Q ss_pred             hcCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeee-EEEeCcEEEEE
Q 021711          108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLG-YGIEGGMHIVL  185 (308)
Q Consensus       108 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~-~~~~~~~~lv~  185 (308)
                      ..++|.+...+|.|+||.||++++. .+++.|+|.++-...++ ..-...|+.+++.++|||||.+++ |-..+.++++|
T Consensus        13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd-~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM   91 (829)
T KOG0576|consen   13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDD-FSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM   91 (829)
T ss_pred             CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCcc-ccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence            3468889999999999999999976 58999999987654433 456678999999999999999998 66677899999


Q ss_pred             EecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCc
Q 021711          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (308)
Q Consensus       186 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~  265 (308)
                      |||.+|+|.+..+ ..+.+++.++...++..+.||.|||+   .+-+|||||-.|||+++.|.+|++|||.+..+..-- 
T Consensus        92 EycgggslQdiy~-~TgplselqiayvcRetl~gl~ylhs---~gk~hRdiKGanilltd~gDvklaDfgvsaqitati-  166 (829)
T KOG0576|consen   92 EYCGGGSLQDIYH-VTGPLSELQIAYVCRETLQGLKYLHS---QGKIHRDIKGANILLTDEGDVKLADFGVSAQITATI-  166 (829)
T ss_pred             EecCCCcccceee-ecccchhHHHHHHHhhhhccchhhhc---CCcccccccccceeecccCceeecccCchhhhhhhh-
Confidence            9999999998764 46789999999999999999999998   899999999999999999999999999987664321 


Q ss_pred             eeEeeceeccccccccccCc---hhhcCccceeEEEeeEEEeec
Q 021711          266 HHTISKVEGTFGLVKLNLPP---LVILKRCFTCIFIGFSQLQLS  306 (308)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~s~g~~l~el~  306 (308)
                       .....+.||+.|||||...   ...++...|+|+.|++..||+
T Consensus       167 -~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~  209 (829)
T KOG0576|consen  167 -AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELG  209 (829)
T ss_pred             -hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhh
Confidence             1224689999999999753   334678899999999988875

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.94  E-value=6.2e-27  Score=200.28  Aligned_cols=188  Identities=19%  Similarity=0.330  Sum_probs=152.3

Q ss_pred             cCCccccceeeccCceEEEEEEECC-CcEEEEEEeccCChHHHHHHHHHHHHHHhcC-CCCeeeeeee--EEEeCcEEEE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLRN-GQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLG--YGIEGGMHIV  184 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~~-g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~--~~~~~~~~lv  184 (308)
                      .+.|.+.+.||+|.||.+-+|+++. .+.+++|.+.....  ...+|.+|...--.| .|.||+.-|+  |...+.+.++
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t--t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~  100 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT--TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV  100 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh--hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence            3578899999999999999999874 78899999876543  357899998877667 4899999886  4444445579


Q ss_pred             EEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEEC--CCCcEEEeccccceecCC
Q 021711          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLT--EDFEPQICDFGLAKWLPE  262 (308)
Q Consensus       185 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~--~~~~~kl~DFGla~~~~~  262 (308)
                      +||++.|+|.+-+.  ...+.+.....++.|++.|+.|+|+   .++||||||.+|||+-  +...+||||||+.+..+.
T Consensus       101 qE~aP~gdL~snv~--~~GigE~~~K~v~~ql~SAi~fMHs---knlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~  175 (378)
T KOG1345|consen  101 QEFAPRGDLRSNVE--AAGIGEANTKKVFAQLLSAIEFMHS---KNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT  175 (378)
T ss_pred             eccCccchhhhhcC--cccccHHHHHHHHHHHHHHHHHhhc---cchhhcccccceEEEecCCccEEEeeecccccccCc
Confidence            99999999998774  3557777888899999999999999   9999999999999984  335899999999986432


Q ss_pred             CCceeEeeceeccccccccccCchh-----hcCccceeEEEeeEEEeeccC
Q 021711          263 QWTHHTISKVEGTFGLVKLNLPPLV-----ILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       263 ~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Di~s~g~~l~el~c~  308 (308)
                           +.....-+..|-+||.....     ...+..|+|.||++++....|
T Consensus       176 -----tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG  221 (378)
T KOG1345|consen  176 -----TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTG  221 (378)
T ss_pred             -----eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecC
Confidence                 33456677889999975433     246789999999999988765

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.94  E-value=3.7e-26  Score=192.74  Aligned_cols=183  Identities=31%  Similarity=0.480  Sum_probs=156.6

Q ss_pred             eeccCceEEEEEEECC-CcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEe-CcEEEEEEecCCCCHHH
Q 021711          118 IGKGGYAEVYKGRLRN-GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLELSPNGSLAS  195 (308)
Q Consensus       118 LG~G~fg~Vy~~~~~~-g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~lv~e~~~~gsL~~  195 (308)
                      ||+|++|.||++.... ++.+++|.+...........+.+|+..++.++|++++++++++.. ...++++|++.+++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999999764 899999998766543235678999999999999999999997766 45789999999999999


Q ss_pred             HHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECC-CCcEEEeccccceecCCCCceeEeeceec
Q 021711          196 LLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTE-DFEPQICDFGLAKWLPEQWTHHTISKVEG  274 (308)
Q Consensus       196 ~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~g  274 (308)
                      ++......+++..+..++.+++.+|.+||+   .+++|+||+|.||+++. ++.++|+|||.+........  ......+
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~  155 (215)
T cd00180          81 LLKENEGKLSEDEILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVG  155 (215)
T ss_pred             HHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccC
Confidence            986543568999999999999999999998   89999999999999999 89999999999987755421  1234568


Q ss_pred             cccccccccCchh-hcCccceeEEEeeEEEee
Q 021711          275 TFGLVKLNLPPLV-ILKRCFTCIFIGFSQLQL  305 (308)
Q Consensus       275 t~~y~aPE~~~~~-~~~~~~Di~s~g~~l~el  305 (308)
                      ...|++||..... ..+...|+|++|++++++
T Consensus       156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l  187 (215)
T cd00180         156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL  187 (215)
T ss_pred             CCCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence            8999999988776 677889999999998875

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.93  E-value=2.9e-27  Score=206.27  Aligned_cols=188  Identities=25%  Similarity=0.236  Sum_probs=155.8

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCCh-HHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-------c
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA-DEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-------G  180 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-------~  180 (308)
                      .+|.-...+|.|.- .|-.+-+. .++.||+|++..... ....++..+|...+..++|+||++++.+++..       +
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e   95 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE   95 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence            46666778888887 55555433 588999998854422 12346778999999999999999999987653       3


Q ss_pred             EEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceec
Q 021711          181 MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL  260 (308)
Q Consensus       181 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~  260 (308)
                      .|+|||++. ++|...+.   ..++...+..|+.|++.|++|||+   .+|+||||||+||++..+..+||.|||+|+.-
T Consensus        96 ~y~v~e~m~-~nl~~vi~---~elDH~tis~i~yq~~~~ik~lhs---~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e  168 (369)
T KOG0665|consen   96 VYLVMELMD-ANLCQVIL---MELDHETISYILYQMLCGIKHLHS---AGIIHRDLKPSNIVVNSDCTLKILDFGLARTE  168 (369)
T ss_pred             HHHHHHhhh-hHHHHHHH---HhcchHHHHHHHHHHHHHHHHHHh---cceeecccCcccceecchhheeeccchhhccc
Confidence            689999995 58888875   457778888999999999999999   99999999999999999999999999999864


Q ss_pred             CCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          261 PEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       261 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ...   ...+....|..|.|||...+..++...|+||.||++.||..|
T Consensus       169 ~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~  213 (369)
T KOG0665|consen  169 DTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILG  213 (369)
T ss_pred             Ccc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhc
Confidence            433   356788999999999999988899999999999999998754

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=5.6e-26  Score=207.62  Aligned_cols=130  Identities=25%  Similarity=0.328  Sum_probs=109.5

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCC--------CCeeeeeeeEEEeC
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVD--------HPNTAKLLGYGIEG  179 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~~~~~~~  179 (308)
                      ..+|.+.++||-|.|++||+|.+. +.+.||+|+.+..  +...+..+.||.+|++++        -..||+|++++...
T Consensus        77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA--qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs  154 (590)
T KOG1290|consen   77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA--QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS  154 (590)
T ss_pred             CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh--hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec
Confidence            468999999999999999999976 5789999998743  345678889999999883        35799999976543


Q ss_pred             -----cEEEEEEecCCCCHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEE
Q 021711          180 -----GMHIVLELSPNGSLASLLYG-MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILL  243 (308)
Q Consensus       180 -----~~~lv~e~~~~gsL~~~l~~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl  243 (308)
                           ++++|+|++ |.+|..++.. ..+.++...+..|+.||+.||.|||..  .+|||-||||+|||+
T Consensus       155 GpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~e--cgIIHTDlKPENvLl  221 (590)
T KOG1290|consen  155 GPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRE--CGIIHTDLKPENVLL  221 (590)
T ss_pred             CCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHh--cCccccCCCcceeee
Confidence                 378999998 6688888865 345699999999999999999999985  689999999999999

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.93  E-value=4.1e-27  Score=197.12  Aligned_cols=184  Identities=20%  Similarity=0.253  Sum_probs=153.7

Q ss_pred             hcCCccccceeeccCceEEEEEEE-CCCcEEEEEEeccCChHHHHHHHHHHHHHHhcCC-CCeeeeeeeEEEeCc---EE
Q 021711          108 ATNNFSFENLIGKGGYAEVYKGRL-RNGQLVAIKRLTRGTADEIIADFLSELGIMAHVD-HPNTAKLLGYGIEGG---MH  182 (308)
Q Consensus       108 ~~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~---~~  182 (308)
                      ..++|++.+.+|+|.|++||.|.. .+++.++||++++-..    +...+|+.||..|. ||||+++++...++.   ..
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkk----kKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktpa  111 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKK----KKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPS  111 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHH----HHHHHHHHHHHhccCCCCeeehhhhhcCccccCch
Confidence            457899999999999999999984 4688999999986443    45779999999997 999999999766543   56


Q ss_pred             EEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCC-CcEEEeccccceecC
Q 021711          183 IVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTED-FEPQICDFGLAKWLP  261 (308)
Q Consensus       183 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~-~~~kl~DFGla~~~~  261 (308)
                      |++||+.+.+...+.    ..++...+..++.+++.||.|+|+   .||+|||+||.|+++|.. ..++|+|+|+|.+..
T Consensus       112 LiFE~v~n~Dfk~ly----~tl~d~dIryY~~elLkALdyCHS---~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH  184 (338)
T KOG0668|consen  112 LIFEYVNNTDFKQLY----PTLTDYDIRYYIYELLKALDYCHS---MGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  184 (338)
T ss_pred             hHhhhhccccHHHHh----hhhchhhHHHHHHHHHHHHhHHHh---cCcccccCCcceeeechhhceeeeeecchHhhcC
Confidence            999999988776654    457777888899999999999999   999999999999999965 579999999999886


Q ss_pred             CCCceeEeeceeccccccccccCchhh-cCccceeEEEeeEEEee
Q 021711          262 EQWTHHTISKVEGTFGLVKLNLPPLVI-LKRCFTCIFIGFSQLQL  305 (308)
Q Consensus       262 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~s~g~~l~el  305 (308)
                      +...   .+-...+..|-.||++-+.. +.-+-|+||||+.+..|
T Consensus       185 p~~e---YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~m  226 (338)
T KOG0668|consen  185 PGKE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASM  226 (338)
T ss_pred             CCce---eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHH
Confidence            6533   33446677889999887664 67889999999987655

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.93  E-value=7e-27  Score=208.64  Aligned_cols=203  Identities=20%  Similarity=0.223  Sum_probs=173.7

Q ss_pred             HHHHHhhcCCccccceeeccCceEEEEEEECC------CcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeE
Q 021711          102 LYELQSATNNFSFENLIGKGGYAEVYKGRLRN------GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGY  175 (308)
Q Consensus       102 ~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~------g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~  175 (308)
                      ..++.....++++..++-+|.||.||.|.+++      .+.|-+|.++....+-....++.|...+..+.|||+..+.+.
T Consensus       276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V  355 (563)
T KOG1024|consen  276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV  355 (563)
T ss_pred             HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence            34555666788888999999999999997652      456778888877776667889999999999999999999997


Q ss_pred             EEeCc--EEEEEEecCCCCHHHHHhcc-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCC
Q 021711          176 GIEGG--MHIVLELSPNGSLASLLYGM-------KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTED  246 (308)
Q Consensus       176 ~~~~~--~~lv~e~~~~gsL~~~l~~~-------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~  246 (308)
                      +.+..  .+.++.++.-|+|..+|...       .+.+...+...++.|++.||.|||.   +++||.||.++|+++++.
T Consensus       356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~---~~ViHkDiAaRNCvIdd~  432 (563)
T KOG1024|consen  356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN---HGVIHKDIAARNCVIDDQ  432 (563)
T ss_pred             EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh---cCcccchhhhhcceehhh
Confidence            76653  56778888899999999732       2346677788899999999999998   999999999999999999


Q ss_pred             CcEEEeccccceecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          247 FEPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       247 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      .++||+|-.++|.+-+...+..-........||+||.+.+..++..+|+||||++||||..
T Consensus       433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmt  493 (563)
T KOG1024|consen  433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMT  493 (563)
T ss_pred             eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHh
Confidence            9999999999998877767666666777889999999999999999999999999999853

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.92  E-value=3e-25  Score=187.19  Aligned_cols=192  Identities=23%  Similarity=0.308  Sum_probs=159.2

Q ss_pred             hcCCccccceeeccCceEEEEEEE-CCCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCC-CeeeeeeeEEEeCcE-EEE
Q 021711          108 ATNNFSFENLIGKGGYAEVYKGRL-RNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDH-PNTAKLLGYGIEGGM-HIV  184 (308)
Q Consensus       108 ~~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~-~lv  184 (308)
                      ..++|.+.+.||+|+||.+|.|.. .+|+.||||.-......   ..+..|..+...|++ ..|..+..|..+... .+|
T Consensus        13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h---pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlV   89 (341)
T KOG1163|consen   13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH---PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLV   89 (341)
T ss_pred             eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC---cchhHHHHHHHHhccCCCCchhhhhccccccceee
Confidence            457899999999999999999984 57999999987654432   356678888888864 566666667666553 588


Q ss_pred             EEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCC---CcEEEeccccceecC
Q 021711          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTED---FEPQICDFGLAKWLP  261 (308)
Q Consensus       185 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~---~~~kl~DFGla~~~~  261 (308)
                      |+.+ |.+|.+++.-....++..+++.++-|++.-++|+|.   +++|||||||+|+|+.-+   ..+.++|||+|+.+-
T Consensus        90 MdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~---r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~  165 (341)
T KOG1163|consen   90 MDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHL---RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR  165 (341)
T ss_pred             eecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHh---hccccccCCccceeeccccccceEEEEeccchhhhc
Confidence            8887 789999997778889999999999999999999998   999999999999999744   468999999999875


Q ss_pred             CCCcee-----EeeceeccccccccccCchhhcCccceeEEEeeEEEeec
Q 021711          262 EQWTHH-----TISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLS  306 (308)
Q Consensus       262 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~  306 (308)
                      +..+..     .-....||..|.+-.+..+..++++.|+-|+|++|+.+-
T Consensus       166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfn  215 (341)
T KOG1163|consen  166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFN  215 (341)
T ss_pred             cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeee
Confidence            543322     234678999999999999999999999999999998753

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.91  E-value=8.9e-25  Score=196.87  Aligned_cols=192  Identities=24%  Similarity=0.272  Sum_probs=154.5

Q ss_pred             HhhcCCccccceeeccCceEEEEEEEC----CCcEEEEEEeccCChHHHHHHHHHHHHHHhcC-CCCeeeeeeeEEEe-C
Q 021711          106 QSATNNFSFENLIGKGGYAEVYKGRLR----NGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGIE-G  179 (308)
Q Consensus       106 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~----~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-~  179 (308)
                      ....+.|.++++||+|.|++||++.+.    .++.||+|.+......   .+...|++.|..+ .+.||+++.++... +
T Consensus        32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p---~ri~~El~~L~~~gG~~ni~~~~~~~rnnd  108 (418)
T KOG1167|consen   32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP---SRILNELEMLYRLGGSDNIIKLNGCFRNND  108 (418)
T ss_pred             hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc---hHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence            344578899999999999999999754    3678999998765443   4678999999988 48999999986554 5


Q ss_pred             cEEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCC-CcEEEeccccce
Q 021711          180 GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTED-FEPQICDFGLAK  258 (308)
Q Consensus       180 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~-~~~kl~DFGla~  258 (308)
                      ...+|+||+++....++...    ++...+..+++.++.||.++|.   +|||||||||.|+|.+.. +.-.|.|||+|.
T Consensus       109 ~v~ivlp~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h~---~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~  181 (418)
T KOG1167|consen  109 QVAIVLPYFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHLHK---NGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQ  181 (418)
T ss_pred             eeEEEecccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhhhc---cCccccCCCccccccccccCCceEEechhHH
Confidence            68899999999999888743    6678888899999999999998   999999999999999965 578899999997


Q ss_pred             ecCCCC------------------------------------------ceeEeeceeccccccccccCchh-hcCcccee
Q 021711          259 WLPEQW------------------------------------------THHTISKVEGTFGLVKLNLPPLV-ILKRCFTC  295 (308)
Q Consensus       259 ~~~~~~------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di  295 (308)
                      ......                                          .........||+||.|||.+... .++.+.|+
T Consensus       182 ~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDi  261 (418)
T KOG1167|consen  182 RYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDI  261 (418)
T ss_pred             HHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccce
Confidence            221000                                          00111246799999999987655 47889999


Q ss_pred             EEEeeEEEeecc
Q 021711          296 IFIGFSQLQLSC  307 (308)
Q Consensus       296 ~s~g~~l~el~c  307 (308)
                      ||.|++++-+..
T Consensus       262 ws~GVI~Lslls  273 (418)
T KOG1167|consen  262 WSAGVILLSLLS  273 (418)
T ss_pred             eeccceeehhhc
Confidence            999999987764

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.91  E-value=3.5e-24  Score=181.33  Aligned_cols=141  Identities=18%  Similarity=0.143  Sum_probs=109.1

Q ss_pred             cceeeccCceEEEEEEECCCcEEEEEEeccCChH--H-----------------------HHHHHHHHHHHHhcCCCCee
Q 021711          115 ENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTAD--E-----------------------IIADFLSELGIMAHVDHPNT  169 (308)
Q Consensus       115 ~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~--~-----------------------~~~~~~~E~~~l~~l~h~ni  169 (308)
                      ...||+|+||.||+|...+|+.||||.++.....  .                       ......+|+.++..+.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            4689999999999999878999999998654211  0                       01122459999999987776


Q ss_pred             eeeeeEEEeCcEEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCceecCCCCCCEEECCCCc
Q 021711          170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYL-HEGCQRRIIHRDIKAANILLTEDFE  248 (308)
Q Consensus       170 v~l~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yL-H~~~~~~iiHrDlKp~NILl~~~~~  248 (308)
                      .....+... ..++||||++++++..... ....++...+..++.|++.+|.|+ |+   .+|+||||||+|||++ ++.
T Consensus        82 ~~p~~~~~~-~~~iVmE~i~g~~l~~~~~-~~~~~~~~~~~~i~~qi~~~L~~l~H~---~giiHrDlkP~NIli~-~~~  155 (190)
T cd05147          82 PCPEPILLK-SHVLVMEFIGDDGWAAPRL-KDAPLSESKARELYLQVIQIMRILYQD---CRLVHADLSEYNLLYH-DGK  155 (190)
T ss_pred             CCCcEEEec-CCEEEEEEeCCCCCcchhh-hcCCCCHHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEE-CCc
Confidence            443333222 3389999999887765432 235688899999999999999999 66   7999999999999998 478


Q ss_pred             EEEeccccceecC
Q 021711          249 PQICDFGLAKWLP  261 (308)
Q Consensus       249 ~kl~DFGla~~~~  261 (308)
                      ++|+|||+|....
T Consensus       156 v~LiDFG~a~~~~  168 (190)
T cd05147         156 LYIIDVSQSVEHD  168 (190)
T ss_pred             EEEEEccccccCC
Confidence            9999999998653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.91  E-value=3e-24  Score=188.50  Aligned_cols=191  Identities=23%  Similarity=0.279  Sum_probs=157.3

Q ss_pred             cCCccccceeeccCceEEEEEE-ECCCcEEEEEEeccCChHHHHHHHHHHHHHHhcC-CCCeeeeeeeEEEeCcE-EEEE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGIEGGM-HIVL  185 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~-~~~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~-~lv~  185 (308)
                      .-+|.+.++||+|+||+.+.|. +-+++.||||.-.......   ++..|....+.| ..++|..++-|..++-. .||+
T Consensus        27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~AP---QLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi  103 (449)
T KOG1165|consen   27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAP---QLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI  103 (449)
T ss_pred             cccceeccccccCcceeeecccccccCceEEEEeccccCCcc---hHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence            3489999999999999999997 4479999999875544332   344555555555 46888888877666543 4788


Q ss_pred             EecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCC-----CcEEEeccccceec
Q 021711          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTED-----FEPQICDFGLAKWL  260 (308)
Q Consensus       186 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~-----~~~kl~DFGla~~~  260 (308)
                      |++ |.||.+++.-++..++..+++.+|.|++.-++|+|+   +.+|.|||||+|+||..-     ..+.|+|||+|+.+
T Consensus       104 dLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~---k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y  179 (449)
T KOG1165|consen  104 DLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHE---KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY  179 (449)
T ss_pred             hhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHh---cceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence            877 889999998888999999999999999999999999   999999999999999754     35899999999988


Q ss_pred             CCCCcee-----EeeceeccccccccccCchhhcCccceeEEEeeEEEeec
Q 021711          261 PEQWTHH-----TISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLS  306 (308)
Q Consensus       261 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~  306 (308)
                      .+..+..     ......||..||+-..+.+..++++.|+-|+|-+++..+
T Consensus       180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFL  230 (449)
T KOG1165|consen  180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFL  230 (449)
T ss_pred             cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhc
Confidence            7665432     234688999999999999999999999999998776554

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.91  E-value=2.6e-24  Score=196.79  Aligned_cols=193  Identities=22%  Similarity=0.242  Sum_probs=153.3

Q ss_pred             CccccceeeccCceEEEEEEECCC--cEEEEEEeccCChHHHHHHHHHHHHHHhcCCC----CeeeeeeeEEE-eCc-EE
Q 021711          111 NFSFENLIGKGGYAEVYKGRLRNG--QLVAIKRLTRGTADEIIADFLSELGIMAHVDH----PNTAKLLGYGI-EGG-MH  182 (308)
Q Consensus       111 ~~~~~~~LG~G~fg~Vy~~~~~~g--~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~~~~~-~~~-~~  182 (308)
                      +|.+.+.||+|+||.||.|.....  ..+|+|.......... ..+..|..++..+..    +++..+++.+. ... .+
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~-~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~   97 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP-SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNF   97 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC-ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeE
Confidence            899999999999999999997653  4788888765432211 256678888888863    58888888773 443 46


Q ss_pred             EEEEecCCCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCC-----CcEEEecccc
Q 021711          183 IVLELSPNGSLASLLYGMK-EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTED-----FEPQICDFGL  256 (308)
Q Consensus       183 lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~-----~~~kl~DFGl  256 (308)
                      +||+.+ |.+|.++..... +.++..+.+.++.|++.+|.+||+   .+++||||||+|+++...     ..+.|.|||+
T Consensus        98 iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~---~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl  173 (322)
T KOG1164|consen   98 IVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHS---KGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGL  173 (322)
T ss_pred             EEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHh---cCcccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence            777766 789999885544 779999999999999999999999   999999999999999865     4699999999


Q ss_pred             ce--ecCCCCce----e-E-eeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          257 AK--WLPEQWTH----H-T-ISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       257 a~--~~~~~~~~----~-~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      |+  .+......    . . .....||..|.++.++.+...+++.|+||++|++.|+..|
T Consensus       174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g  233 (322)
T KOG1164|consen  174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKG  233 (322)
T ss_pred             CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcC
Confidence            98  32222110    0 1 2346699999999999999999999999999999998754

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.90  E-value=1.2e-22  Score=172.13  Aligned_cols=144  Identities=20%  Similarity=0.182  Sum_probs=112.1

Q ss_pred             cceeeccCceEEEEEEECCCcEEEEEEeccCChH------------------------H-HHHHHHHHHHHHhcCCCCee
Q 021711          115 ENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTAD------------------------E-IIADFLSELGIMAHVDHPNT  169 (308)
Q Consensus       115 ~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~------------------------~-~~~~~~~E~~~l~~l~h~ni  169 (308)
                      ...||+|+||.||+|...+|+.||||.+......                        . ....+.+|...+..+.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            4689999999999999878999999998754210                        0 12234678999999999987


Q ss_pred             eeeeeEEEeCcEEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcE
Q 021711          170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEP  249 (308)
Q Consensus       170 v~l~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~  249 (308)
                      .....+... ..++||||++++++..... ....++......++.|++.+|.++|+  ..+|+||||||+|||++ ++.+
T Consensus        82 ~~p~~~~~~-~~~lVmE~~~g~~~~~~~l-~~~~~~~~~~~~i~~~l~~~l~~lH~--~~givHrDlkP~NIll~-~~~~  156 (190)
T cd05145          82 PVPEPILLK-KNVLVMEFIGDDGSPAPRL-KDVPLEEEEAEELYEQVVEQMRRLYQ--EAGLVHGDLSEYNILYH-DGKP  156 (190)
T ss_pred             CCceEEEec-CCEEEEEEecCCCchhhhh-hhccCCHHHHHHHHHHHHHHHHHHHH--hCCEecCCCChhhEEEE-CCCE
Confidence            554443333 3489999999886543321 23457778889999999999999996  26999999999999999 7899


Q ss_pred             EEeccccceecCCC
Q 021711          250 QICDFGLAKWLPEQ  263 (308)
Q Consensus       250 kl~DFGla~~~~~~  263 (308)
                      +|+|||+|+.++..
T Consensus       157 ~liDFG~a~~~~~~  170 (190)
T cd05145         157 YIIDVSQAVELDHP  170 (190)
T ss_pred             EEEEcccceecCCC
Confidence            99999999877543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.89  E-value=6.4e-23  Score=176.80  Aligned_cols=170  Identities=9%  Similarity=0.051  Sum_probs=130.4

Q ss_pred             hhcCCccccceeeccCceEEEEEEECCCcEEEEEEeccCCh--HHHHHH------HHHHHHHHhcCCCCeeeeeeeEEEe
Q 021711          107 SATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTA--DEIIAD------FLSELGIMAHVDHPNTAKLLGYGIE  178 (308)
Q Consensus       107 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~--~~~~~~------~~~E~~~l~~l~h~niv~l~~~~~~  178 (308)
                      ...++|+..++||.|+||.||+... ++..+|+|.+.....  +...+.      +.+|+..+.+++|++|..+..++..
T Consensus        28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~  106 (232)
T PRK10359         28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL  106 (232)
T ss_pred             HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence            3468999999999999999999765 567899999965432  222333      5789999999999999999886442


Q ss_pred             ---------CcEEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcE
Q 021711          179 ---------GGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEP  249 (308)
Q Consensus       179 ---------~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~  249 (308)
                               +..+++|||++|.+|.++..     ++.    ....+++.+|..+|.   .+++|||+||+||+++.++ +
T Consensus       107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH~---~gi~H~Dikp~Nili~~~g-i  173 (232)
T PRK10359        107 AERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLHQ---HGMVSGDPHKGNFIVSKNG-L  173 (232)
T ss_pred             cccccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHHH---cCCccCCCChHHEEEeCCC-E
Confidence                     24689999999999987641     222    245689999999998   9999999999999999988 9


Q ss_pred             EEeccccceecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEe
Q 021711          250 QICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQ  304 (308)
Q Consensus       250 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~e  304 (308)
                      +|+|||..+...+....   ..           +..+..+..+.|+|++||++..
T Consensus       174 ~liDfg~~~~~~e~~a~---d~-----------~vler~y~~~~di~~lg~~~~~  214 (232)
T PRK10359        174 RIIDLSGKRCTAQRKAK---DR-----------IDLERHYGIKNEIKDLGYYLLI  214 (232)
T ss_pred             EEEECCCcccccchhhH---HH-----------HHHHhHhcccccccceeEeehH
Confidence            99999998866433111   00           2223334467899999998864

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.88  E-value=1.4e-22  Score=180.77  Aligned_cols=191  Identities=32%  Similarity=0.455  Sum_probs=159.7

Q ss_pred             ccccceeeccCceEEEEEEECCCcEEEEEEeccCChHH--HHHHHHHHHHHHhcCCCC-eeeeeeeEEEeCc-EEEEEEe
Q 021711          112 FSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADE--IIADFLSELGIMAHVDHP-NTAKLLGYGIEGG-MHIVLEL  187 (308)
Q Consensus       112 ~~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~--~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~-~~lv~e~  187 (308)
                      |.+.+.||.|+||.||++...  ..+++|.+.......  ....+.+|+.++..+.|+ +++++.+++.... .++++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            667789999999999999976  788999987554332  467899999999999988 7999998776555 5899999


Q ss_pred             cCCCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCC-cEEEeccccceecCCCC
Q 021711          188 SPNGSLASLLYGMK--EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDF-EPQICDFGLAKWLPEQW  264 (308)
Q Consensus       188 ~~~gsL~~~l~~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~-~~kl~DFGla~~~~~~~  264 (308)
                      +.++++.+++....  ..+.......++.|++.++.|+|.   .+++|||+||+||+++..+ .++++|||+++.+....
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~---~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence            99999997775433  268889999999999999999998   8899999999999999988 79999999998766543


Q ss_pred             cee----EeeceeccccccccccCch---hhcCccceeEEEeeEEEeecc
Q 021711          265 THH----TISKVEGTFGLVKLNLPPL---VILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       265 ~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~~Di~s~g~~l~el~c  307 (308)
                      ...    ......||..|++||....   .......|+||+|++++++..
T Consensus       157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~  206 (384)
T COG0515         157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLT  206 (384)
T ss_pred             ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHh
Confidence            322    3467899999999999887   467888999999977766543

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.87  E-value=1.8e-23  Score=212.52  Aligned_cols=141  Identities=12%  Similarity=0.061  Sum_probs=106.0

Q ss_pred             CCC-CeeeeeeeEEE-------e-CcEEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceec
Q 021711          164 VDH-PNTAKLLGYGI-------E-GGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHR  234 (308)
Q Consensus       164 l~h-~niv~l~~~~~-------~-~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHr  234 (308)
                      ++| +||..+++++.       + ..+.+++|++ +++|.+++......+++..++.++.||+.||.|||+   ++|+||
T Consensus        29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~gIvHr  104 (793)
T PLN00181         29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHS---QGIVVH  104 (793)
T ss_pred             hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHh---CCeeec
Confidence            344 46777776541       1 2345677776 669999997655679999999999999999999998   999999


Q ss_pred             CCCCCCEEECC-------------------CCcEEEeccccceecCCCCc--------------eeEeeceecccccccc
Q 021711          235 DIKAANILLTE-------------------DFEPQICDFGLAKWLPEQWT--------------HHTISKVEGTFGLVKL  281 (308)
Q Consensus       235 DlKp~NILl~~-------------------~~~~kl~DFGla~~~~~~~~--------------~~~~~~~~gt~~y~aP  281 (308)
                      ||||+||||+.                   ++.+|++|||+++.......              ........||+.||||
T Consensus       105 DlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP  184 (793)
T PLN00181        105 NVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSP  184 (793)
T ss_pred             cCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceECh
Confidence            99999999954                   34566777777664321000              0001124689999999


Q ss_pred             ccCchhhcCccceeEEEeeEEEeeccC
Q 021711          282 NLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       282 E~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      |++.+..++.++||||||++||||+|+
T Consensus       185 E~~~~~~~~~~sDVwSlGviL~ELl~~  211 (793)
T PLN00181        185 EEDNGSSSNCASDVYRLGVLLFELFCP  211 (793)
T ss_pred             hhhccCCCCchhhhhhHHHHHHHHhhC
Confidence            998888889999999999999999874

>PRK10345 hypothetical protein; Provisional

Probab=99.86  E-value=5.8e-21  Score=163.60  Aligned_cols=137  Identities=20%  Similarity=0.285  Sum_probs=104.0

Q ss_pred             ccceeeccCceEEEEEEECCCcEEEEEEeccCChHHHHHHHHHHHHHHhcC-----CCCeeeeeeeEEEeCc----EE-E
Q 021711          114 FENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHV-----DHPNTAKLLGYGIEGG----MH-I  183 (308)
Q Consensus       114 ~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~----~~-l  183 (308)
                      -.++||+|+||.||. ...++.. +||++...... ..+.+.+|+.+++.+     +||||+++++++..+.    ++ +
T Consensus         6 ~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~-~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~   82 (210)
T PRK10345          6 EQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDG-GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV   82 (210)
T ss_pred             CcceecCCCceEEEE-CCCCcCe-EEEEEeccccc-hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence            347899999999996 2223444 68987654322 246789999999999     6799999999776652    23 7


Q ss_pred             EEEe--cCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHH-HHHHhCCCCCceecCCCCCCEEECCC----CcEEEec-cc
Q 021711          184 VLEL--SPNGSLASLLYGMKEKLKWGIRYKIALGVAEGL-LYLHEGCQRRIIHRDIKAANILLTED----FEPQICD-FG  255 (308)
Q Consensus       184 v~e~--~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L-~yLH~~~~~~iiHrDlKp~NILl~~~----~~~kl~D-FG  255 (308)
                      |+||  +.+|+|.+++..  ..+++.  ..++.|++.++ .|||+   ++|+||||||+|||++..    +.++|+| ||
T Consensus        83 I~e~~G~~~~tL~~~l~~--~~~~e~--~~~~~~~L~~l~~yLh~---~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G  155 (210)
T PRK10345         83 IADFDGKPSITLTEFAEQ--CRYEED--VAQLRQLLKKLKRYLLD---NRIVTMELKPQNILCQRISESEVIPVVCDNIG  155 (210)
T ss_pred             EecCCCCcchhHHHHHHc--ccccHh--HHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence            8999  557999999954  345555  35577888777 99998   999999999999999743    4799999 55


Q ss_pred             cceec
Q 021711          256 LAKWL  260 (308)
Q Consensus       256 la~~~  260 (308)
                      ....+
T Consensus       156 ~~~~i  160 (210)
T PRK10345        156 ESTFI  160 (210)
T ss_pred             Cccee
Confidence            54443

>smart00090 RIO RIO-like kinase

Probab=99.85  E-value=1.3e-20  Score=164.87  Aligned_cols=154  Identities=19%  Similarity=0.174  Sum_probs=116.8

Q ss_pred             HHHHHhhcCCccccceeeccCceEEEEEE--ECCCcEEEEEEeccCChH-----------------------HHHHHHHH
Q 021711          102 LYELQSATNNFSFENLIGKGGYAEVYKGR--LRNGQLVAIKRLTRGTAD-----------------------EIIADFLS  156 (308)
Q Consensus       102 ~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~--~~~g~~vAvK~~~~~~~~-----------------------~~~~~~~~  156 (308)
                      .+.+.....-|.+.+.||+|+||.||+|.  ..+|+.||+|.+......                       .....+.+
T Consensus        20 ~~~~~~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   99 (237)
T smart00090       20 LYSLLNRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEK   99 (237)
T ss_pred             HHHHHhcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHH
Confidence            34444444468899999999999999998  457999999998643210                       01234668


Q ss_pred             HHHHHhcCCCCe--eeeeeeEEEeCcEEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-cee
Q 021711          157 ELGIMAHVDHPN--TAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRR-IIH  233 (308)
Q Consensus       157 E~~~l~~l~h~n--iv~l~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~-iiH  233 (308)
                      |+.++..+.+.+  +.+++++   ...++||||+++++|...... ...+.......++.|++.+|.+||.   .+ |+|
T Consensus       100 E~~~L~~L~~~~i~~p~~~~~---~~~~lV~E~~~g~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~---~g~iiH  172 (237)
T smart00090      100 EFRNLQRLYEAGVPVPKPIAW---RRNVLVMEFIGGDGLPAPRLK-DVEPEEEEEFELYDDILEEMRKLYK---EGELVH  172 (237)
T ss_pred             HHHHHHHHHhcCCCCCeeeEe---cCceEEEEEecCCcccccccc-cCCcchHHHHHHHHHHHHHHHHHHh---cCCEEe
Confidence            999999997532  3444443   345899999999888665422 2345556667899999999999998   88 999


Q ss_pred             cCCCCCCEEECCCCcEEEeccccceecCCC
Q 021711          234 RDIKAANILLTEDFEPQICDFGLAKWLPEQ  263 (308)
Q Consensus       234 rDlKp~NILl~~~~~~kl~DFGla~~~~~~  263 (308)
                      |||||+||+++ ++.++|+|||.|......
T Consensus       173 ~Dikp~NIli~-~~~i~LiDFg~a~~~~~~  201 (237)
T smart00090      173 GDLSEYNILVH-DGKVVIIDVSQSVELDHP  201 (237)
T ss_pred             CCCChhhEEEE-CCCEEEEEChhhhccCCc
Confidence            99999999999 789999999999876543

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.83  E-value=6e-20  Score=156.42  Aligned_cols=146  Identities=20%  Similarity=0.133  Sum_probs=112.6

Q ss_pred             HHHhhcCCccccceeeccCceEEEEEEECCCcEEEEEEeccCChH---------------------HHHHHHHHHHHHHh
Q 021711          104 ELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTAD---------------------EIIADFLSELGIMA  162 (308)
Q Consensus       104 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~---------------------~~~~~~~~E~~~l~  162 (308)
                      ++......|.+.+.||+|+||.||++...+|+.||||.+......                     .....+.+|..++.
T Consensus         9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   88 (198)
T cd05144           9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK   88 (198)
T ss_pred             HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence            344444458888999999999999999888999999987543210                     01123677888898


Q ss_pred             cCCCCe--eeeeeeEEEeCcEEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCC
Q 021711          163 HVDHPN--TAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAAN  240 (308)
Q Consensus       163 ~l~h~n--iv~l~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~N  240 (308)
                      .+.|++  ++..++   ....++||||+++++|......       .....++.+++.++.++|+   .+|+||||||+|
T Consensus        89 ~l~~~~i~v~~~~~---~~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh~---~gi~H~Dl~p~N  155 (198)
T cd05144          89 ALYEEGFPVPKPID---WNRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAYK---HGIIHGDLSEFN  155 (198)
T ss_pred             HHHHcCCCCCceee---cCCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHHH---CCCCcCCCCccc
Confidence            887774  444443   3445899999999998765421       2345688899999999998   899999999999


Q ss_pred             EEECCCCcEEEeccccceecCC
Q 021711          241 ILLTEDFEPQICDFGLAKWLPE  262 (308)
Q Consensus       241 ILl~~~~~~kl~DFGla~~~~~  262 (308)
                      |+++.++.++|+|||++..+..
T Consensus       156 ill~~~~~~~liDfg~~~~~~~  177 (198)
T cd05144         156 ILVDDDEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             EEEcCCCcEEEEECCccccCCC
Confidence            9999999999999999976644

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.83  E-value=1.1e-19  Score=153.84  Aligned_cols=135  Identities=19%  Similarity=0.162  Sum_probs=106.9

Q ss_pred             cccceeeccCceEEEEEEECCCcEEEEEEeccCCh--HH-HHHHHHHHHHHHhcCC-CCeeeeeeeEEEeCcEEEEEEec
Q 021711          113 SFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTA--DE-IIADFLSELGIMAHVD-HPNTAKLLGYGIEGGMHIVLELS  188 (308)
Q Consensus       113 ~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~--~~-~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~lv~e~~  188 (308)
                      .+...|++|+||+||.+.. .+..++.+.+.....  .. ....|.+|+++|++|+ |+++++++++   ++.+++|||+
T Consensus         5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~---~~~~lvmeyI   80 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW---DGRHLDRSYL   80 (218)
T ss_pred             ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE---cCEEEEEeee
Confidence            3567899999999997765 677888777654332  11 1235789999999995 5889999886   4569999999


Q ss_pred             CCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCC-CCCCEEECCCCcEEEeccccceecCC
Q 021711          189 PNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDI-KAANILLTEDFEPQICDFGLAKWLPE  262 (308)
Q Consensus       189 ~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDl-Kp~NILl~~~~~~kl~DFGla~~~~~  262 (308)
                      .|.+|...+..        ....++.|++.+|.++|.   .+|+|||| ||+|||++.++.++|+|||+|.....
T Consensus        81 ~G~~L~~~~~~--------~~~~~~~qi~~~L~~lH~---~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~  144 (218)
T PRK12274         81 AGAAMYQRPPR--------GDLAYFRAARRLLQQLHR---CGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNP  144 (218)
T ss_pred             cCccHHhhhhh--------hhHHHHHHHHHHHHHHHH---CcCccCCCCCcceEEEcCCCCEEEEECCCceecCC
Confidence            99998654311        113467899999999998   99999999 79999999999999999999986554

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.82  E-value=2.2e-19  Score=154.04  Aligned_cols=136  Identities=24%  Similarity=0.251  Sum_probs=110.8

Q ss_pred             ceeeccCceEEEEEEECCCcEEEEEEeccCCh--H-----HHHHHHHHHHHHHhcCCCCeeeeeeeEE-EeCcEEEEEEe
Q 021711          116 NLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTA--D-----EIIADFLSELGIMAHVDHPNTAKLLGYG-IEGGMHIVLEL  187 (308)
Q Consensus       116 ~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~--~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~lv~e~  187 (308)
                      +.||+|++|.||+|.. .|..+++|.......  .     ....++.+|+.++..++|+++.....++ .....+++|||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5799999999999987 677899997653221  1     1134688899999999999887666554 34567899999


Q ss_pred             cCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecC
Q 021711          188 SPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP  261 (308)
Q Consensus       188 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~  261 (308)
                      ++|++|.+++....    . ....++.+++.+|.++|.   .+++|+|++|.|||++ ++.++|+|||+++...
T Consensus        81 ~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~---~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~~  145 (211)
T PRK14879         81 IEGEPLKDLINSNG----M-EELELSREIGRLVGKLHS---AGIIHGDLTTSNMILS-GGKIYLIDFGLAEFSK  145 (211)
T ss_pred             eCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHh---CCcccCCCCcccEEEE-CCCEEEEECCcccCCC
Confidence            99999999885321    2 777899999999999998   8999999999999999 7899999999998643

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.80  E-value=4.5e-20  Score=180.41  Aligned_cols=191  Identities=24%  Similarity=0.267  Sum_probs=148.4

Q ss_pred             cccceeeccCceEEEEEEEC-CCcEEEEEEec----cCCh-HHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEE
Q 021711          113 SFENLIGKGGYAEVYKGRLR-NGQLVAIKRLT----RGTA-DEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVL  185 (308)
Q Consensus       113 ~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~----~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~  185 (308)
                      ....++|.|++|.|+..... .....+.|...    .... ......+..|..+-..+.|||++..+....+. ...-.|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            35678999999988877643 23334444322    2211 22223366788888889999998877644433 333459


Q ss_pred             EecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCc
Q 021711          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (308)
Q Consensus       186 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~  265 (308)
                      |||++ +|..++.. ...+....+..++.|++.|+.|+|+   .+|.|||||++|+++..+|.+||+|||.+..+.-++.
T Consensus       401 E~~~~-Dlf~~~~~-~~~~~~~e~~c~fKqL~~Gv~y~h~---~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e  475 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMS-NGKLTPLEADCFFKQLLRGVKYLHS---MGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE  475 (601)
T ss_pred             hcccH-HHHHHHhc-ccccchhhhhHHHHHHHHHHHHHHh---cCceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence            99999 99998854 3468888888999999999999999   9999999999999999999999999999988766665


Q ss_pred             e--eEeeceeccccccccccCchhhcC-ccceeEEEeeEEEeeccC
Q 021711          266 H--HTISKVEGTFGLVKLNLPPLVILK-RCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       266 ~--~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~s~g~~l~el~c~  308 (308)
                      .  .....+.|+-.|+|||......+. +..|+||.|++++-|.++
T Consensus       476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~  521 (601)
T KOG0590|consen  476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILG  521 (601)
T ss_pred             hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecC
Confidence            5  556789999999999998877764 568999999999988765

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.80  E-value=5.8e-19  Score=172.03  Aligned_cols=138  Identities=23%  Similarity=0.317  Sum_probs=109.3

Q ss_pred             CCccccceeeccCceEEEEEEECCCcEEEEEEe-ccC-Ch-----HHHHHHHHHHHHHHhcCCCCeeeeeeeEEEe-CcE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRL-TRG-TA-----DEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGM  181 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~-~~~-~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~  181 (308)
                      ..|...+.||+|+||.||+|.+.... +++|.. ... ..     ....+++.+|+.++..++|++++....++.. ...
T Consensus       333 ~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~  411 (535)
T PRK09605        333 RRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK  411 (535)
T ss_pred             cccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence            34566789999999999999875443 444432 211 11     1124578899999999999999887665544 456


Q ss_pred             EEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecC
Q 021711          182 HIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP  261 (308)
Q Consensus       182 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~  261 (308)
                      ++||||+++++|.+++.         ....++.+++.+|.|||+   .+++||||||+|||+ .++.++|+|||+++...
T Consensus       412 ~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~---~giiHrDlkp~NILl-~~~~~~liDFGla~~~~  478 (535)
T PRK09605        412 TIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHK---AGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYSD  478 (535)
T ss_pred             EEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHh---CCCccCCCChHHEEE-ECCcEEEEeCcccccCC
Confidence            89999999999999884         345789999999999998   899999999999999 57799999999998754

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.80  E-value=8.4e-19  Score=149.12  Aligned_cols=133  Identities=23%  Similarity=0.306  Sum_probs=104.9

Q ss_pred             eeeccCceEEEEEEECCCcEEEEEEeccCCh-----H--HHHHHHHHHHHHHhcCCCCeeeeeeeEE-EeCcEEEEEEec
Q 021711          117 LIGKGGYAEVYKGRLRNGQLVAIKRLTRGTA-----D--EIIADFLSELGIMAHVDHPNTAKLLGYG-IEGGMHIVLELS  188 (308)
Q Consensus       117 ~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~-----~--~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~lv~e~~  188 (308)
                      .||+|+||.||+|.+ +|..+++|.......     +  ....++.+|+.++..++|+++.....++ .....++||||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            489999999999986 577899998643211     1  1235678899999999888755444333 344568999999


Q ss_pred             CCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCC
Q 021711          189 PNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE  262 (308)
Q Consensus       189 ~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~  262 (308)
                      +|++|.+++.....        .++.+++.+|.+||+   .+++|+|++|.||+++ ++.++++|||+++....
T Consensus        80 ~g~~l~~~~~~~~~--------~~~~~i~~~l~~lH~---~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~~~  141 (199)
T TIGR03724        80 EGKPLKDVIEEGND--------ELLREIGRLVGKLHK---AGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYSDE  141 (199)
T ss_pred             CCccHHHHHhhcHH--------HHHHHHHHHHHHHHH---CCeecCCCCcceEEEE-CCcEEEEECCCCcCCCc
Confidence            99999988743211        678999999999998   9999999999999999 78999999999987543

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.77  E-value=1.1e-19  Score=151.29  Aligned_cols=100  Identities=18%  Similarity=0.041  Sum_probs=88.7

Q ss_pred             CCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCceeEee
Q 021711          191 GSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTIS  270 (308)
Q Consensus       191 gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~  270 (308)
                      |+|.+++...+..+++..++.++.|++.||.|||+   .+      ||+|||++.++.+|+  ||+++......      
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~---~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~------   63 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHR---QA------KSGNILLTWDGLLKL--DGSVAFKTPEQ------   63 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh---cC------CcccEeEcCccceee--ccceEeecccc------
Confidence            68999997666779999999999999999999998   55      999999999999999  99998765431      


Q ss_pred             ceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          271 KVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       271 ~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                       ..||+.|+|||.+.+..++.++||||+|+++|||++|
T Consensus        64 -~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg  100 (176)
T smart00750       64 -SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDY  100 (176)
T ss_pred             -CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhC
Confidence             2689999999999888888999999999999999875

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.77  E-value=1.6e-19  Score=180.87  Aligned_cols=194  Identities=21%  Similarity=0.196  Sum_probs=146.7

Q ss_pred             HHhhcCCccccceeeccCceEEEEEEECCCcEEEEEEeccCChHHHHHHHHHHHHHHhcCC---CCeeeeeee-EEEeCc
Q 021711          105 LQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVD---HPNTAKLLG-YGIEGG  180 (308)
Q Consensus       105 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~-~~~~~~  180 (308)
                      .+.....|.+.+.||+|+||.||+|...+|+.||+|.-+....-+    |.--.+++.+|+   -+.|..+.. +...+.
T Consensus       693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE----fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~  768 (974)
T KOG1166|consen  693 FEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE----FYICLQVMERLKPQMLPSIMHISSAHVFQNA  768 (974)
T ss_pred             eeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee----eeehHHHHHhhchhhhcchHHHHHHHccCCc
Confidence            334456788889999999999999998889999999877655432    222233344444   122333332 344556


Q ss_pred             EEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECC-------CCcEEEec
Q 021711          181 MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTE-------DFEPQICD  253 (308)
Q Consensus       181 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~-------~~~~kl~D  253 (308)
                      .+||+||.+.|+|.+++. ..+.+++...+.++.|++.-+..||.   .+|||+||||+|+||..       ..-++|+|
T Consensus       769 S~lv~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH~---~~IIHgDiKPDNfll~~~~~~~~~~~~l~lID  844 (974)
T KOG1166|consen  769 SVLVSEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLHA---MGIIHGDIKPDNFLLRREICADSDSKGLYLID  844 (974)
T ss_pred             ceeeeeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHHh---cceecccCCcceeEeecccCCCCcccceEEEe
Confidence            789999999999999996 56679999999999999999999998   99999999999999953       23589999


Q ss_pred             cccceecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeec
Q 021711          254 FGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLS  306 (308)
Q Consensus       254 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~  306 (308)
                      ||.+--+.--..........+|-++-.+|+..+..++-..|.|.++-+++-|+
T Consensus       845 fG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mL  897 (974)
T KOG1166|consen  845 FGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVML  897 (974)
T ss_pred             cccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHH
Confidence            99985442211113556788999999999999888888888887766655444

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.75  E-value=3.2e-20  Score=175.21  Aligned_cols=180  Identities=24%  Similarity=0.232  Sum_probs=144.8

Q ss_pred             eeeccCceEEEEEE----ECCCcEEEEEEeccCChH-HHHHHHHHHHHHHhcCC-CCeeeeeee-EEEeCcEEEEEEecC
Q 021711          117 LIGKGGYAEVYKGR----LRNGQLVAIKRLTRGTAD-EIIADFLSELGIMAHVD-HPNTAKLLG-YGIEGGMHIVLELSP  189 (308)
Q Consensus       117 ~LG~G~fg~Vy~~~----~~~g~~vAvK~~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~-~~~~~~~~lv~e~~~  189 (308)
                      ++|+|+||.|++++    .+.|..+|+|.+++.... ........|..++..++ ||.+|++.- +..+...++++++..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            47999999999875    234788999988654321 11224556788888887 999999975 666778999999999


Q ss_pred             CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCceeEe
Q 021711          190 NGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTI  269 (308)
Q Consensus       190 ~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  269 (308)
                      +|.|...+.. ...+.......+...++.++.++|+   .+|+|||+|++||+++.+|++++.|||+++..-+...    
T Consensus        81 gg~lft~l~~-~~~f~~~~~~~~~aelaLald~lh~---l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~----  152 (612)
T KOG0603|consen   81 GGDLFTRLSK-EVMFDELDVAFYLAELALALDHLHK---LGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI----  152 (612)
T ss_pred             cchhhhcccc-CCchHHHHHHHHHHHHHHHHhhcch---hHHHHhcccccceeecccCccccCCchhhhHhHhhhh----
Confidence            9999887754 3345555666677789999999998   9999999999999999999999999999997655422    


Q ss_pred             eceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          270 SKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       270 ~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                        .+||..|||||...  ......|.||||++++|+..|
T Consensus       153 --~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg  187 (612)
T KOG0603|consen  153 --ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTG  187 (612)
T ss_pred             --cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhC
Confidence              28999999999876  556778999999999999765

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.74  E-value=1.9e-17  Score=139.36  Aligned_cols=139  Identities=20%  Similarity=0.200  Sum_probs=97.1

Q ss_pred             cceeeccCceEEEEEEECCCcEEEEEEeccCChH-HHHHH----------------------HHHHHHHHhcCCCCe--e
Q 021711          115 ENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTAD-EIIAD----------------------FLSELGIMAHVDHPN--T  169 (308)
Q Consensus       115 ~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~-~~~~~----------------------~~~E~~~l~~l~h~n--i  169 (308)
                      .+.||+|+||.||+|...+|+.||||.+...... .....                      ...|...+..+.+..  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            4689999999999999878999999988653211 00111                      134555565554332  3


Q ss_pred             eeeeeEEEeCcEEEEEEecCCCCHHH-HHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCc
Q 021711          170 AKLLGYGIEGGMHIVLELSPNGSLAS-LLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFE  248 (308)
Q Consensus       170 v~l~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~  248 (308)
                      .+.++.   ...++||||++++++.. .+....  .. .....++.+++.++.++|.  ..+|+||||||+||+++ ++.
T Consensus        82 ~~~~~~---~~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh~--~~~ivH~Dl~p~Nili~-~~~  152 (187)
T cd05119          82 PKPIDL---NRHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLYR--EAGLVHGDLSEYNILVD-DGK  152 (187)
T ss_pred             CceEec---CCCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHhh--ccCcCcCCCChhhEEEE-CCc
Confidence            333332   34589999999854321 111111  11 5567789999999999996  26899999999999999 889


Q ss_pred             EEEeccccceecCC
Q 021711          249 PQICDFGLAKWLPE  262 (308)
Q Consensus       249 ~kl~DFGla~~~~~  262 (308)
                      ++|+|||.+.....
T Consensus       153 ~~liDfg~a~~~~~  166 (187)
T cd05119         153 VYIIDVPQAVEIDH  166 (187)
T ss_pred             EEEEECcccccccC
Confidence            99999999976543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.72  E-value=6.5e-17  Score=129.85  Aligned_cols=136  Identities=23%  Similarity=0.185  Sum_probs=109.8

Q ss_pred             ccceeeccCceEEEEEEECCCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCC--CeeeeeeeEEEe-CcEEEEEEecCC
Q 021711          114 FENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDH--PNTAKLLGYGIE-GGMHIVLELSPN  190 (308)
Q Consensus       114 ~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~-~~~~lv~e~~~~  190 (308)
                      +.+.||+|.++.||++...+ ..+++|.......   ...+.+|+.++..++|  .++++++.+... +..++++||+.+
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~---~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g   77 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK---GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG   77 (155)
T ss_pred             cceecccccccceEEEEecC-CeEEEEecCCCCc---hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence            34689999999999999854 7899998865443   3568889999999976  588888876554 347899999988


Q ss_pred             CCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecC
Q 021711          191 GSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP  261 (308)
Q Consensus       191 gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~  261 (308)
                      +.+..+        +......++.+++.+|.++|.....+++|+|++|.||+++..+.++++|||.++..+
T Consensus        78 ~~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~~  140 (155)
T cd05120          78 ETLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYGP  140 (155)
T ss_pred             eecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCCC
Confidence            766543        455667788999999999997433479999999999999998999999999998643

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.71  E-value=1.3e-16  Score=139.83  Aligned_cols=136  Identities=18%  Similarity=0.240  Sum_probs=104.6

Q ss_pred             ceee-ccCceEEEEEEECCCcEEEEEEeccCCh------------HHHHHHHHHHHHHHhcCCCCee--eeeeeEEEeC-
Q 021711          116 NLIG-KGGYAEVYKGRLRNGQLVAIKRLTRGTA------------DEIIADFLSELGIMAHVDHPNT--AKLLGYGIEG-  179 (308)
Q Consensus       116 ~~LG-~G~fg~Vy~~~~~~g~~vAvK~~~~~~~------------~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~-  179 (308)
                      ..|| .|+.|+||.+... +..++||.......            .....++.+|+.++..|+|++|  +..+++.... 
T Consensus        37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~  115 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH  115 (239)
T ss_pred             ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence            5687 7889999998874 67889998753210            1123568899999999998875  6666653322 


Q ss_pred             c----EEEEEEecCC-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEecc
Q 021711          180 G----MHIVLELSPN-GSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDF  254 (308)
Q Consensus       180 ~----~~lv~e~~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DF  254 (308)
                      .    .++|+|+++| .+|.+++..  ..++..    .+.+++.+|.+||+   .+|+||||||.|||++.++.++|+||
T Consensus       116 ~~~~~~~lV~e~l~G~~~L~~~l~~--~~l~~~----~~~~i~~~l~~lH~---~GI~HrDlkp~NILv~~~~~v~LIDf  186 (239)
T PRK01723        116 GLFYRADILIERIEGARDLVALLQE--APLSEE----QWQAIGQLIARFHD---AGVYHADLNAHNILLDPDGKFWLIDF  186 (239)
T ss_pred             CcceeeeEEEEecCCCCCHHHHHhc--CCCCHH----HHHHHHHHHHHHHH---CCCCCCCCCchhEEEcCCCCEEEEEC
Confidence            1    2499999997 689888743  344443    35689999999998   99999999999999999889999999


Q ss_pred             ccceecC
Q 021711          255 GLAKWLP  261 (308)
Q Consensus       255 Gla~~~~  261 (308)
                      |.+....
T Consensus       187 g~~~~~~  193 (239)
T PRK01723        187 DRGELRT  193 (239)
T ss_pred             CCcccCC
Confidence            9998654

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.68  E-value=5.2e-17  Score=144.23  Aligned_cols=189  Identities=18%  Similarity=0.227  Sum_probs=122.3

Q ss_pred             CccccceeeccCceEEEEEEEC-CCcEEEEEEeccC--ChHHHHHHHHHHHHHHhcCCC-----------Cee-----ee
Q 021711          111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRG--TADEIIADFLSELGIMAHVDH-----------PNT-----AK  171 (308)
Q Consensus       111 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l~h-----------~ni-----v~  171 (308)
                      .+.....||.|+++.||.+.+. +|+.+|+|.....  ......+++.+|.-....+.+           ..+     ++
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            4456789999999999999987 4899999987432  222346667776644444322           111     12


Q ss_pred             eee---EEEeC---------cEEEEEEecCCCCHHHHHhc---cCCC---CCHHHHHHHHHHHHHHHHHHHhCCCCCcee
Q 021711          172 LLG---YGIEG---------GMHIVLELSPNGSLASLLYG---MKEK---LKWGIRYKIALGVAEGLLYLHEGCQRRIIH  233 (308)
Q Consensus       172 l~~---~~~~~---------~~~lv~e~~~~gsL~~~l~~---~~~~---l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH  233 (308)
                      +-+   +....         +.+++|+-+ .++|.+++..   ....   +....++.+..|+++.+++||.   .+++|
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~---~GlVH  168 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS---YGLVH  168 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEEE
T ss_pred             EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh---cceEe
Confidence            111   11111         224556655 5688777532   2222   3334456677899999999999   99999


Q ss_pred             cCCCCCCEEECCCCcEEEeccccceecCCCCceeEeeceeccccccccccCchh--------hcCccceeEEEeeEEEee
Q 021711          234 RDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPLV--------ILKRCFTCIFIGFSQLQL  305 (308)
Q Consensus       234 rDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~~Di~s~g~~l~el  305 (308)
                      +||||+|++++.+|.++|+||+........    . .....+..|.+||.....        ..+.+.|.|++|+++|.|
T Consensus       169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~----~-~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l  243 (288)
T PF14531_consen  169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTR----Y-RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL  243 (288)
T ss_dssp             ST-SGGGEEE-TTS-EEE--GGGEEETTEE----E-EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred             cccceeeEEEcCCCCEEEcChHHHeecCce----e-eccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence            999999999999999999999988765432    1 113456889999976443        457788999999999999


Q ss_pred             ccC
Q 021711          306 SCS  308 (308)
Q Consensus       306 ~c~  308 (308)
                      +|+
T Consensus       244 WC~  246 (288)
T PF14531_consen  244 WCG  246 (288)
T ss_dssp             HHS
T ss_pred             HHc
Confidence            996

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.61  E-value=5.6e-15  Score=140.23  Aligned_cols=143  Identities=22%  Similarity=0.229  Sum_probs=100.0

Q ss_pred             cceeeccCceEEEEEEECCCcEEEEEEeccCChHHHH---------------------------------------HHHH
Q 021711          115 ENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEII---------------------------------------ADFL  155 (308)
Q Consensus       115 ~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~---------------------------------------~~~~  155 (308)
                      .+.||.|++|.||+|++++|+.||||...........                                       -+|.
T Consensus       122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            3679999999999999999999999998654321100                                       0245


Q ss_pred             HHHHHHhcC----CCCeeeeeeeEE--EeCcEEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHH-HHHHHHhCCC
Q 021711          156 SELGIMAHV----DHPNTAKLLGYG--IEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE-GLLYLHEGCQ  228 (308)
Q Consensus       156 ~E~~~l~~l----~h~niv~l~~~~--~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~-~L~yLH~~~~  228 (308)
                      +|+..+..+    +|.+-+.+-..+  .....++||||++|++|.++........+   ...++.+++. .+..+|.   
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~---  275 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLR---  275 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHh---
Confidence            566655554    222222222211  22346899999999999887643222222   2345555555 4677887   


Q ss_pred             CCceecCCCCCCEEECCCCcEEEeccccceecCCC
Q 021711          229 RRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ  263 (308)
Q Consensus       229 ~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  263 (308)
                      .+++|+|++|.||+++.++.++++|||++..+.+.
T Consensus       276 ~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~~  310 (437)
T TIGR01982       276 DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSEE  310 (437)
T ss_pred             CCceeCCCCcccEEECCCCcEEEEeCCCeeECCHH
Confidence            89999999999999999999999999999887643

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.58  E-value=7.3e-16  Score=145.28  Aligned_cols=144  Identities=23%  Similarity=0.339  Sum_probs=118.0

Q ss_pred             HhcCCCCeeeeeeeEEEeCc-EEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCc-eecCCCC
Q 021711          161 MAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRI-IHRDIKA  238 (308)
Q Consensus       161 l~~l~h~niv~l~~~~~~~~-~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~i-iHrDlKp  238 (308)
                      |+.+.|.|+.+++|.+.++. ...|.+||..|+|.+.+......+++.....++++++.||.|||.   ..| .|+.|++
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~---s~i~~hg~l~s   77 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHN---SPIGYHGALKS   77 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhc---Ccceeeeeecc
Confidence            45789999999999877764 678999999999999998877889999999999999999999998   444 9999999


Q ss_pred             CCEEECCCCcEEEeccccceecCCCCceeEeeceeccccccccccCchh-------hcCccceeEEEeeEEEeecc
Q 021711          239 ANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPLV-------ILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       239 ~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~Di~s~g~~l~el~c  307 (308)
                      .|++++..+.+||+|||+....+............-..-|.|||.....       ..+++.|+||||++++|++.
T Consensus        78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~  153 (484)
T KOG1023|consen   78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILF  153 (484)
T ss_pred             ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHh
Confidence            9999999999999999999877542111122233456788999986543       14667999999999998863

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.58  E-value=9.6e-17  Score=138.15  Aligned_cols=184  Identities=18%  Similarity=0.248  Sum_probs=139.4

Q ss_pred             ccccceeeccCceEEEEEEECCCcEEEEEEeccC-ChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEEEecC
Q 021711          112 FSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRG-TADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLELSP  189 (308)
Q Consensus       112 ~~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~~  189 (308)
                      ..+..+|.+...|+.|+|++. |..+++|++... .......+|..|.-.++-+.||||+.+++.|... ++.++..|++
T Consensus       192 lnl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp  270 (448)
T KOG0195|consen  192 LNLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMP  270 (448)
T ss_pred             hhhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeecc
Confidence            345567888999999999996 445666777532 2334456788999889999999999999988765 5788999999


Q ss_pred             CCCHHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCc-eecCCCCCCEEECCCCcEEEe--ccccceecCCCCc
Q 021711          190 NGSLASLLYGMKE-KLKWGIRYKIALGVAEGLLYLHEGCQRRI-IHRDIKAANILLTEDFEPQIC--DFGLAKWLPEQWT  265 (308)
Q Consensus       190 ~gsL~~~l~~~~~-~l~~~~~~~i~~qi~~~L~yLH~~~~~~i-iHrDlKp~NILl~~~~~~kl~--DFGla~~~~~~~~  265 (308)
                      .|+|..+|+.... ..+..+..+++.++++|+.|||+.  .++ .---|....+++|++.+++|+  |--++-  .+   
T Consensus       271 ~gslynvlhe~t~vvvd~sqav~faldiargmaflhsl--ep~ipr~~lns~hvmidedltarismad~kfsf--qe---  343 (448)
T KOG0195|consen  271 FGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL--EPMIPRFYLNSKHVMIDEDLTARISMADTKFSF--QE---  343 (448)
T ss_pred             chHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc--chhhhhhhcccceEEecchhhhheecccceeee--ec---
Confidence            9999999986433 367788999999999999999983  344 444788999999999888775  322221  11   


Q ss_pred             eeEeeceeccccccccccCchh---hcCccceeEEEeeEEEeecc
Q 021711          266 HHTISKVEGTFGLVKLNLPPLV---ILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Di~s~g~~l~el~c  307 (308)
                          ....-.+.||+||.+...   ..-+..|+|||+++||||.+
T Consensus       344 ----~gr~y~pawmspealqrkped~n~raadmwsfaillwel~t  384 (448)
T KOG0195|consen  344 ----VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNT  384 (448)
T ss_pred             ----cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhc
Confidence                122346899999986543   45567899999999999853

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.58  E-value=7.7e-17  Score=160.01  Aligned_cols=190  Identities=19%  Similarity=0.185  Sum_probs=139.4

Q ss_pred             CccccceeeccCceEEEEEEECCCcEEEEEEeccCChH---HHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEEE
Q 021711          111 NFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTAD---EIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLE  186 (308)
Q Consensus       111 ~~~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e  186 (308)
                      ++...+.||++.|=+|.+|+++.|. |+||.+-+..+.   +...+.++|++ ...++|||.+++.-+...+ -.|+|-+
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq  101 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ  101 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence            6778899999999999999998887 888988654432   12334445555 5566899999886543333 2466777


Q ss_pred             ecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccce--ecCCCC
Q 021711          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK--WLPEQW  264 (308)
Q Consensus       187 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~--~~~~~~  264 (308)
                      |..+ +|.+.+.. +..+......=|+.|++.||.-+|.   .+|+|+|||.+|||++.-+-+.|+||.--+  +++++.
T Consensus       102 yvkh-nLyDRlST-RPFL~~iEKkWiaFQLL~al~qcH~---~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN  176 (1431)
T KOG1240|consen  102 YVKH-NLYDRLST-RPFLVLIEKKWIAFQLLKALSQCHK---LGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN  176 (1431)
T ss_pred             HHhh-hhhhhhcc-chHHHHHHHHHHHHHHHHHHHHHHH---cCccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence            7754 89888843 3335555666689999999999998   999999999999999998889999997654  344442


Q ss_pred             cee---EeeceeccccccccccCchhh-----------cCccceeEEEeeEEEeecc
Q 021711          265 THH---TISKVEGTFGLVKLNLPPLVI-----------LKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       265 ~~~---~~~~~~gt~~y~aPE~~~~~~-----------~~~~~Di~s~g~~l~el~c  307 (308)
                      -..   -..+-..-..|+|||.+-...           ++++=||+|.||++.||+|
T Consensus       177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~  233 (1431)
T KOG1240|consen  177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFL  233 (1431)
T ss_pred             cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHh
Confidence            211   112333446799999864422           5667899999999999986

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.57  E-value=9.1e-16  Score=138.29  Aligned_cols=135  Identities=20%  Similarity=0.260  Sum_probs=98.9

Q ss_pred             CCCeeeeeeeEEEe----------------------------CcEEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHH
Q 021711          165 DHPNTAKLLGYGIE----------------------------GGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGV  216 (308)
Q Consensus       165 ~h~niv~l~~~~~~----------------------------~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi  216 (308)
                      +|||||++++++.+                            ..+|+||.-++ .+|..++..  ...+.....-++.|+
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~--~~~s~r~~~~~laQl  350 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWT--RHRSYRTGRVILAQL  350 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhc--CCCchHHHHHHHHHH
Confidence            59999999874321                            12578887664 489888854  345666667788999


Q ss_pred             HHHHHHHHhCCCCCceecCCCCCCEEEC--CCC--cEEEeccccceecCC-----CCceeEeeceeccccccccccCchh
Q 021711          217 AEGLLYLHEGCQRRIIHRDIKAANILLT--EDF--EPQICDFGLAKWLPE-----QWTHHTISKVEGTFGLVKLNLPPLV  287 (308)
Q Consensus       217 ~~~L~yLH~~~~~~iiHrDlKp~NILl~--~~~--~~kl~DFGla~~~~~-----~~~~~~~~~~~gt~~y~aPE~~~~~  287 (308)
                      ++|+.|||.   ++|.|||+|.+|||+.  +++  .+.|+|||.+-.-..     +..++ .....|...-||||.+...
T Consensus       351 LEav~hL~~---hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~-~Vd~GGNa~lmAPEi~ta~  426 (598)
T KOG4158|consen  351 LEAVTHLHK---HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESD-EVDLGGNAKLMAPEIATAV  426 (598)
T ss_pred             HHHHHHHHH---ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccc-cccCCCcceecchhhhhcC
Confidence            999999998   9999999999999984  443  467999998854322     11111 2345688889999986433


Q ss_pred             ------hcCccceeEEEeeEEEeec
Q 021711          288 ------ILKRCFTCIFIGFSQLQLS  306 (308)
Q Consensus       288 ------~~~~~~Di~s~g~~l~el~  306 (308)
                            ..-.++|.|+.|-+.||++
T Consensus       427 PGp~avvny~kAD~WA~GalaYEIf  451 (598)
T KOG4158|consen  427 PGPNAVVNYEKADTWAAGALAYEIF  451 (598)
T ss_pred             CCCceeeccchhhhhhhhhhHHHHh
Confidence                  2345689999999999986

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.55  E-value=5e-16  Score=152.07  Aligned_cols=195  Identities=21%  Similarity=0.212  Sum_probs=154.0

Q ss_pred             CCccccceeeccCceEEEEEEEC--CCcEEEEEEeccCC-hHHHHHHHHHHHHHHhcCC-CCeeeeeeeEEEeCc-EEEE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR--NGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVD-HPNTAKLLGYGIEGG-MHIV  184 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~--~g~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~-~~lv  184 (308)
                      ..|.+.+.||+|+|+.|-.....  ....+|+|.+.... ......+...|..+-..+. |+|++.+++...+.. .++.
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~   99 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS   99 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence            46677788999999999888753  35567777775443 2223344445777777776 999999999766654 5688


Q ss_pred             EEecCCCCHHHHH-hccCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCceecCCCCCCEEECCCC-cEEEeccccceecC
Q 021711          185 LELSPNGSLASLL-YGMKEKLKWGIRYKIALGVAEGLLYLH-EGCQRRIIHRDIKAANILLTEDF-EPQICDFGLAKWLP  261 (308)
Q Consensus       185 ~e~~~~gsL~~~l-~~~~~~l~~~~~~~i~~qi~~~L~yLH-~~~~~~iiHrDlKp~NILl~~~~-~~kl~DFGla~~~~  261 (308)
                      ++|..++++.+.+ .......+....-.++.|+..++.|+| +   .++.|||+||+|.+++..+ ..+++|||+|..+.
T Consensus       100 ~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~---~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~  176 (601)
T KOG0590|consen  100 LSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPE---NGVTHRDIKPSNSLLDESGSALKIADFGLATAYR  176 (601)
T ss_pred             cCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcc---cccccCCCCCccchhccCCCcccCCCchhhcccc
Confidence            9999999998877 433324555666778999999999999 7   8999999999999999999 99999999999887


Q ss_pred             C-CCceeEeeceec-cccccccccCch-hhcCccceeEEEeeEEEeecc
Q 021711          262 E-QWTHHTISKVEG-TFGLVKLNLPPL-VILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       262 ~-~~~~~~~~~~~g-t~~y~aPE~~~~-~~~~~~~Di~s~g~~l~el~c  307 (308)
                      . ...........| ++.|+|||...+ .....+.|+||.|+++.-+..
T Consensus       177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~  225 (601)
T KOG0590|consen  177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLT  225 (601)
T ss_pred             ccCCcceeeecccCCCCCCCCcccccchhhcCCCccccccccccccccc
Confidence            7 555556667788 999999999887 467888999999999887654

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.54  E-value=7.4e-16  Score=152.80  Aligned_cols=158  Identities=26%  Similarity=0.311  Sum_probs=114.6

Q ss_pred             hcCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeCcEEEEEE
Q 021711          108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHIVLE  186 (308)
Q Consensus       108 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~lv~e  186 (308)
                      ...+|..+++|..|+||.||..+++ ..+.+|+|+-+++..       +|-  ++.....|.+|                
T Consensus        81 ~e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~li-------lRn--ilt~a~npfvv----------------  135 (1205)
T KOG0606|consen   81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNLI-------LRN--ILTFAGNPFVV----------------  135 (1205)
T ss_pred             CccccceeEeeccCCCCceeeeeccccccchhhcccccchh-------hhc--cccccCCccee----------------
Confidence            3468999999999999999999987 478899954332211       111  22333334333                


Q ss_pred             ecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCC--
Q 021711          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW--  264 (308)
Q Consensus       187 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~--  264 (308)
                          |+-...+.. -+.++..        ++.+++|||+   .+|+|||+||+|.|+..-|++|++|||+++..-...  
T Consensus       136 ----gDc~tllk~-~g~lPvd--------mvla~Eylh~---ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at  199 (1205)
T KOG0606|consen  136 ----GDCATLLKN-IGPLPVD--------MVLAVEYLHS---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT  199 (1205)
T ss_pred             ----chhhhhccc-CCCCcch--------hhHHhHhhcc---CCeecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence                455555533 2233322        2678999998   999999999999999999999999999987532111  


Q ss_pred             ----------cee-EeeceeccccccccccCchhhcCccceeEEEeeEEEeec
Q 021711          265 ----------THH-TISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLS  306 (308)
Q Consensus       265 ----------~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~  306 (308)
                                ++. ....+.||+.|+|||+.....++++.|=|++|+++||..
T Consensus       200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFL  252 (1205)
T KOG0606|consen  200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFL  252 (1205)
T ss_pred             hhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHh
Confidence                      111 112468999999999999999999999999999999864

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.50  E-value=8.9e-14  Score=114.84  Aligned_cols=128  Identities=16%  Similarity=0.102  Sum_probs=94.7

Q ss_pred             ceeeccCceEEEEEEECCCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeee-eeeeEEEeCcEEEEEEecCCCCHH
Q 021711          116 NLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTA-KLLGYGIEGGMHIVLELSPNGSLA  194 (308)
Q Consensus       116 ~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~lv~e~~~~gsL~  194 (308)
                      +.|+.|.++.||++... +..+++|........  ...+.+|+.++..+.+.+++ +++.+. ....++|||+++|.++.
T Consensus         4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~~--~~~~~~E~~~l~~l~~~~~~P~~~~~~-~~~~~lv~e~i~G~~l~   79 (170)
T cd05151           4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTEL--LINRENEAENSKLAAEAGIGPKLYYFD-PETGVLITEFIEGSELL   79 (170)
T ss_pred             eecCCcccCceEEEEEC-CeEEEEEeCCCCccc--ccCHHHHHHHHHHHHHhCCCCceEEEe-CCCCeEEEEecCCCccc
Confidence            56889999999999875 778999987554321  23456888888888655544 444443 33457999999998775


Q ss_pred             HHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-----ceecCCCCCCEEECCCCcEEEeccccceec
Q 021711          195 SLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRR-----IIHRDIKAANILLTEDFEPQICDFGLAKWL  260 (308)
Q Consensus       195 ~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~-----iiHrDlKp~NILl~~~~~~kl~DFGla~~~  260 (308)
                      ...      .   ....++.+++.+|..||.   .+     ++|+|++|.||+++ ++.++++|||.+..-
T Consensus        80 ~~~------~---~~~~~~~~l~~~l~~LH~---~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~~  137 (170)
T cd05151          80 TED------F---SDPENLEKIAKLLKKLHS---SPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGMN  137 (170)
T ss_pred             ccc------c---cCHHHHHHHHHHHHHHhC---CCCCCceeecCCCCcCcEEEE-CCeEEEEecccccCC
Confidence            420      1   112356789999999998   55     59999999999999 668999999998753

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.48  E-value=1.4e-13  Score=132.70  Aligned_cols=143  Identities=17%  Similarity=0.153  Sum_probs=92.9

Q ss_pred             CCccccceeeccCceEEEEEEECC-CcEEEEEEeccCChH---------------------------------HHHH---
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLRN-GQLVAIKRLTRGTAD---------------------------------EIIA---  152 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~~-g~~vAvK~~~~~~~~---------------------------------~~~~---  152 (308)
                      ..|+. +.||+|++|.||+|++++ |+.||||.+.++..+                                 +..+   
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~  198 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH  198 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence            35665 789999999999999987 999999998754211                                 1111   


Q ss_pred             ---HHHHHHHHHhcCC----CCeeeeeeeEEE--eCcEEEEEEecCCCCHHHHHhccCCCCC-----HHHHHHHHHHHHH
Q 021711          153 ---DFLSELGIMAHVD----HPNTAKLLGYGI--EGGMHIVLELSPNGSLASLLYGMKEKLK-----WGIRYKIALGVAE  218 (308)
Q Consensus       153 ---~~~~E~~~l~~l~----h~niv~l~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~l~-----~~~~~~i~~qi~~  218 (308)
                         +|.+|+..+.+++    +.+.+.+-..+.  ....+|||||+.|+.+.++-.......+     ...+..++.|+  
T Consensus       199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi--  276 (537)
T PRK04750        199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV--  276 (537)
T ss_pred             HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH--
Confidence               2344554444442    333333222111  2345799999999999875321112222     22222223333  


Q ss_pred             HHHHHHhCCCCCceecCCCCCCEEECCCC----cEEEeccccceecCCC
Q 021711          219 GLLYLHEGCQRRIIHRDIKAANILLTEDF----EPQICDFGLAKWLPEQ  263 (308)
Q Consensus       219 ~L~yLH~~~~~~iiHrDlKp~NILl~~~~----~~kl~DFGla~~~~~~  263 (308)
                           ..   .+++|+|+||.||+++.++    .+++.|||++..+.+.
T Consensus       277 -----f~---~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~  317 (537)
T PRK04750        277 -----FR---DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE  317 (537)
T ss_pred             -----Hh---CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence                 34   7999999999999999888    9999999999988654

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.46  E-value=1.5e-15  Score=141.22  Aligned_cols=120  Identities=22%  Similarity=0.261  Sum_probs=104.1

Q ss_pred             EEEEEEecCCCCHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccce
Q 021711          181 MHIVLELSPNGSLASLLYG--MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK  258 (308)
Q Consensus       181 ~~lv~e~~~~gsL~~~l~~--~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~  258 (308)
                      +|+.|++|...+|.+++..  .....++...+.++.|++.|+.|      ++.+|||+||.||+...+..+||.|||+..
T Consensus       331 lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl~t  404 (516)
T KOG1033|consen  331 LYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGLVT  404 (516)
T ss_pred             hhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhhee
Confidence            6789999999999999953  23457788889999999999998      478999999999999999999999999998


Q ss_pred             ecCCCCc----eeEeeceeccccccccccCchhhcCccceeEEEeeEEEeec
Q 021711          259 WLPEQWT----HHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLS  306 (308)
Q Consensus       259 ~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~  306 (308)
                      ......+    ....+.-.||..||+||.+.+..++.+.|||++|++|+||.
T Consensus       405 s~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~  456 (516)
T KOG1033|consen  405 SQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELL  456 (516)
T ss_pred             ecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHH
Confidence            7766541    12345678999999999999999999999999999999986

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.34  E-value=9.2e-12  Score=107.00  Aligned_cols=143  Identities=19%  Similarity=0.180  Sum_probs=107.0

Q ss_pred             ceeeccCceEEEEEEECCCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCC--CeeeeeeeEEEeC----cEEEEEEecC
Q 021711          116 NLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDH--PNTAKLLGYGIEG----GMHIVLELSP  189 (308)
Q Consensus       116 ~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~----~~~lv~e~~~  189 (308)
                      +.|+.|.++.||++...+|..+++|.............+.+|..++..+.+  .++.+++.+....    ..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            568999999999998876788999987554321124567889999999875  3456677765542    4589999999


Q ss_pred             CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------------
Q 021711          190 NGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC------------------------------------------  227 (308)
Q Consensus       190 ~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~------------------------------------------  227 (308)
                      |.++.+.+..  ..++......++.+++.+|..||+..                                          
T Consensus        84 G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (223)
T cd05154          84 GRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLL  161 (223)
T ss_pred             CEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHH
Confidence            9887665421  34666677777888888888887521                                          


Q ss_pred             -----------CCCceecCCCCCCEEECC--CCcEEEeccccceec
Q 021711          228 -----------QRRIIHRDIKAANILLTE--DFEPQICDFGLAKWL  260 (308)
Q Consensus       228 -----------~~~iiHrDlKp~NILl~~--~~~~kl~DFGla~~~  260 (308)
                                 ...++|+|+.|.||+++.  ++.+.|+||+.+..-
T Consensus       162 ~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g  207 (223)
T cd05154         162 RWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLG  207 (223)
T ss_pred             HHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccC
Confidence                       234799999999999998  567899999988753

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.31  E-value=5e-11  Score=100.79  Aligned_cols=136  Identities=15%  Similarity=0.065  Sum_probs=96.1

Q ss_pred             ceeeccCceEEEEEEECC-------CcEEEEEEeccCCh-----------H----------HHHH----HHHHHHHHHhc
Q 021711          116 NLIGKGGYAEVYKGRLRN-------GQLVAIKRLTRGTA-----------D----------EIIA----DFLSELGIMAH  163 (308)
Q Consensus       116 ~~LG~G~fg~Vy~~~~~~-------g~~vAvK~~~~~~~-----------~----------~~~~----~~~~E~~~l~~  163 (308)
                      ..||.|-=+.||.|...+       +..+|||+.+....           +          ....    ...+|...|.+
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            478999999999997543       47899997632110           0          0011    23379999988


Q ss_pred             CCC--CeeeeeeeEEEeCcEEEEEEecCCCCHHH-HHhccCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCceecCCCCC
Q 021711          164 VDH--PNTAKLLGYGIEGGMHIVLELSPNGSLAS-LLYGMKEKLKWGIRYKIALGVAEGLLYL-HEGCQRRIIHRDIKAA  239 (308)
Q Consensus       164 l~h--~niv~l~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~l~~~~~~~i~~qi~~~L~yL-H~~~~~~iiHrDlKp~  239 (308)
                      +..  -++.+++++   ..-++||||+.++.+.. .+.  ...++......+..+++.+|..| |.   .+|||+||++.
T Consensus        83 l~~~Gv~vP~pi~~---~~~~lvME~Ig~~~~~~~~Lk--d~~~~~~~~~~i~~~i~~~l~~l~H~---~glVHGDLs~~  154 (197)
T cd05146          83 MQKAGIPCPEVVVL---KKHVLVMSFIGDDQVPAPKLK--DAKLNDEEMKNAYYQVLSMMKQLYKE---CNLVHADLSEY  154 (197)
T ss_pred             HHHcCCCCCeEEEe---cCCEEEEEEcCCCCccchhhh--ccccCHHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHH
Confidence            853  455566654   44589999997654422 222  12344455667788999999998 77   89999999999


Q ss_pred             CEEECCCCcEEEeccccceec
Q 021711          240 NILLTEDFEPQICDFGLAKWL  260 (308)
Q Consensus       240 NILl~~~~~~kl~DFGla~~~  260 (308)
                      |||+.+ +.+.|+|||-+...
T Consensus       155 NIL~~~-~~v~iIDF~qav~~  174 (197)
T cd05146         155 NMLWHD-GKVWFIDVSQSVEP  174 (197)
T ss_pred             HEEEEC-CcEEEEECCCceeC
Confidence            999974 68999999988755

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.23  E-value=5.4e-12  Score=119.52  Aligned_cols=204  Identities=21%  Similarity=0.174  Sum_probs=145.5

Q ss_pred             CccccCHHH-HHhhcCCccccceeeccCceEEEEEEEC--CCcEEEEEEeccCChHHH-HHHHHHHHHHHhcC-CCCeee
Q 021711           96 PQKIFSLYE-LQSATNNFSFENLIGKGGYAEVYKGRLR--NGQLVAIKRLTRGTADEI-IADFLSELGIMAHV-DHPNTA  170 (308)
Q Consensus        96 ~~~~~~~~~-~~~~~~~~~~~~~LG~G~fg~Vy~~~~~--~g~~vAvK~~~~~~~~~~-~~~~~~E~~~l~~l-~h~niv  170 (308)
                      +.+++...+ ......+|.....||.|.|+.|+.+..+  ++..+++|.+.+...... ...-+.|+-+...+ .|.+++
T Consensus       250 p~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~  329 (524)
T KOG0601|consen  250 PANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSV  329 (524)
T ss_pred             hhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccC
Confidence            334444334 2233567888999999999999998744  577899998866543221 11224455555444 478888


Q ss_pred             eeee-EEEeCcEEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCC-Cc
Q 021711          171 KLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTED-FE  248 (308)
Q Consensus       171 ~l~~-~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~-~~  248 (308)
                      ..+. |......++-.||+.++++.... .....++...++.+..|++.++.++|+   ..++|+|+||+||++..+ +.
T Consensus       330 g~~~~W~~~r~~~ip~e~~~~~s~~l~~-~~~~~~d~~~~~~~~~q~~~~l~~i~s---~~~~~~d~~psni~i~~~~~~  405 (524)
T KOG0601|consen  330 GKNSSWSQLRQGYIPLEFCEGGSSSLRS-VTSQMLDEDPRLRLTAQILTALNVIHS---KLFVHLDVKPSNILISNDGFF  405 (524)
T ss_pred             CCCCCccccccccCchhhhcCcchhhhh-HHHHhcCcchhhhhHHHHHhccccccc---hhhhcccccccceeeccchhh
Confidence            8764 66666778899999999887665 234457777888899999999999998   999999999999999986 78


Q ss_pred             EEEeccccceecCCCCceeEeeceeccccc-cccccCchhhcCccceeEEEeeEEEeecc
Q 021711          249 PQICDFGLAKWLPEQWTHHTISKVEGTFGL-VKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       249 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y-~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      .++.|||.+..+.-.    ......++.-| .++.+.+......+.|++|||..+.+.+.
T Consensus       406 ~~~~~~~~~t~~~~~----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~  461 (524)
T KOG0601|consen  406 SKLGDFGCWTRLAFS----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAIT  461 (524)
T ss_pred             hhcccccccccccee----cccccccccccccchhhcccccccccccccccccccccccc
Confidence            899999998753221    11222233344 35666667778888999999988877654

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.21  E-value=2.8e-10  Score=93.92  Aligned_cols=132  Identities=23%  Similarity=0.249  Sum_probs=95.2

Q ss_pred             ceeeccCceEEEEEEECCCcEEEEEEeccC------ChHH-HHHHHHHHHHHHhcCCCCeeeeeeeEE-EeCcEEEEEEe
Q 021711          116 NLIGKGGYAEVYKGRLRNGQLVAIKRLTRG------TADE-IIADFLSELGIMAHVDHPNTAKLLGYG-IEGGMHIVLEL  187 (308)
Q Consensus       116 ~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~------~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~lv~e~  187 (308)
                      ..+++|+-+.+|.+.+. |..+++|.=.+.      .++. ...+-.+|+.++..++--.|....=|. ..+...++|||
T Consensus         2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            36789999999999764 444666643221      1111 245677899999888644443333333 33456799999


Q ss_pred             cCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceec
Q 021711          188 SPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL  260 (308)
Q Consensus       188 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~  260 (308)
                      ++|..|.+.+...        ...++..+-.-+.-||.   .+|+|+||.++||++..++ +.++||||+..-
T Consensus        81 I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~---~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s  141 (204)
T COG3642          81 IEGELLKDALEEA--------RPDLLREVGRLVGKLHK---AGIVHGDLTTSNIILSGGR-IYFIDFGLGEFS  141 (204)
T ss_pred             eCChhHHHHHHhc--------chHHHHHHHHHHHHHHh---cCeecCCCccceEEEeCCc-EEEEECCccccc
Confidence            9999888888543        24566677777788998   8999999999999999875 999999999854

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.20  E-value=2.7e-10  Score=93.71  Aligned_cols=142  Identities=23%  Similarity=0.228  Sum_probs=100.4

Q ss_pred             ccceeeccCceEEEEEEECCCcEEEEEEeccC------Ch-HHHHHHHHHHHHHHhcCCCCeeeeee-eEEEeCcEEEEE
Q 021711          114 FENLIGKGGYAEVYKGRLRNGQLVAIKRLTRG------TA-DEIIADFLSELGIMAHVDHPNTAKLL-GYGIEGGMHIVL  185 (308)
Q Consensus       114 ~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~------~~-~~~~~~~~~E~~~l~~l~h~niv~l~-~~~~~~~~~lv~  185 (308)
                      ...+|-||+-+.|+++.+. |+.+.||.-...      .+ .-...+.++|++.+.++.--.|.-.. -++....-.|+|
T Consensus        11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            4568899999999999884 777777753211      11 11356778899999887644443222 234444568999


Q ss_pred             EecCC-CCHHHHHhccCCCCC-HHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCC---cEEEecccccee
Q 021711          186 ELSPN-GSLASLLYGMKEKLK-WGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDF---EPQICDFGLAKW  259 (308)
Q Consensus       186 e~~~~-gsL~~~l~~~~~~l~-~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~---~~kl~DFGla~~  259 (308)
                      ||++| .++.+++...-..-. ......++..|-+.+.-||.   .+|||+||.++||++..++   .+.++|||++..
T Consensus        90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~---ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHD---NDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhh---CCeecccccccceEEecCCCcCceEEEeecchhc
Confidence            99977 467777754322222 22236788889999999998   8999999999999998665   458999999864

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.18  E-value=8e-12  Score=118.39  Aligned_cols=193  Identities=21%  Similarity=0.160  Sum_probs=145.1

Q ss_pred             Cccccceeec--cCceEEEEEEE--C-CCcEEEEEEeccCCh-HHHHHHHHHHHHHHhcCC-CCeeeeeeeEEEeC-cEE
Q 021711          111 NFSFENLIGK--GGYAEVYKGRL--R-NGQLVAIKRLTRGTA-DEIIADFLSELGIMAHVD-HPNTAKLLGYGIEG-GMH  182 (308)
Q Consensus       111 ~~~~~~~LG~--G~fg~Vy~~~~--~-~g~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~-~~~  182 (308)
                      .|...+-+|.  |.+|.||.+..  . ++..+|+|.-+.... .....+=++|+...+.++ |+|.++.+..+... ..+
T Consensus       115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf  194 (524)
T KOG0601|consen  115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF  194 (524)
T ss_pred             hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence            4566778999  99999999986  3 578899997543221 111223345666666664 99999977655554 456


Q ss_pred             EEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHH----HHHHHHhCCCCCceecCCCCCCEEECCC-CcEEEeccccc
Q 021711          183 IVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE----GLLYLHEGCQRRIIHRDIKAANILLTED-FEPQICDFGLA  257 (308)
Q Consensus       183 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~----~L~yLH~~~~~~iiHrDlKp~NILl~~~-~~~kl~DFGla  257 (308)
                      +-+|++ +.+|..+.+.....++....+....+...    ||.++|.   .+|+|-|+||+||++..+ ...+++|||+.
T Consensus       195 iqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs---~~~~~~~~kp~~i~~~~~~~s~~~~df~~v  270 (524)
T KOG0601|consen  195 IQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHS---NNIVHDDLKPANIFTTSDWTSCKLTDFGLV  270 (524)
T ss_pred             eeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCC---CcccccccchhheecccccceeecCCccee
Confidence            667766 57888888765555788888888888888    9999998   899999999999999999 88999999999


Q ss_pred             eecCCCCceeE---eeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          258 KWLPEQWTHHT---ISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       258 ~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ..+.+..-...   .-...|..-|++||.. +...+...|++++|.+.++.+++
T Consensus       271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~  323 (524)
T KOG0601|consen  271 SKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILG  323 (524)
T ss_pred             EEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhh
Confidence            98876542221   1233688899999986 45566677999999998887653

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.12  E-value=2.2e-09  Score=95.46  Aligned_cols=139  Identities=17%  Similarity=0.098  Sum_probs=97.3

Q ss_pred             eeeccCceEEEEEEECCCcEEEEEEeccCChHHHHH----------HHHHHHHHHhcCCCCee--eeeeeEEEe------
Q 021711          117 LIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIA----------DFLSELGIMAHVDHPNT--AKLLGYGIE------  178 (308)
Q Consensus       117 ~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~----------~~~~E~~~l~~l~h~ni--v~l~~~~~~------  178 (308)
                      ++-......|++..+ +|+.+.||........+..+          .+.+|...+..|...+|  +.++++...      
T Consensus        29 ~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~  107 (268)
T PRK15123         29 VFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT  107 (268)
T ss_pred             EEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence            444444445666665 57789999764433222122          37788888877743333  344555432      


Q ss_pred             CcEEEEEEecCCC-CHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECC-------CCcE
Q 021711          179 GGMHIVLELSPNG-SLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTE-------DFEP  249 (308)
Q Consensus       179 ~~~~lv~e~~~~g-sL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~-------~~~~  249 (308)
                      ...+||+|++++. +|.+++... ....+......++.+++..+.-||.   .||+|+|+++.|||++.       +..+
T Consensus       108 ~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~---~Gi~HgDL~~~NiLl~~~~~~~~~~~~~  184 (268)
T PRK15123        108 RTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHA---AGINHRDCYICHFLLHLPFPGREEDLKL  184 (268)
T ss_pred             ceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHH---CcCccCCCChhhEEEeccccCCCCCceE
Confidence            2357999999886 888887431 2344556677889999999999999   99999999999999985       4689


Q ss_pred             EEecccccee
Q 021711          250 QICDFGLAKW  259 (308)
Q Consensus       250 kl~DFGla~~  259 (308)
                      .++||+.++.
T Consensus       185 ~LIDl~r~~~  194 (268)
T PRK15123        185 SVIDLHRAQI  194 (268)
T ss_pred             EEEECCcccc
Confidence            9999998864

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.09  E-value=2.3e-10  Score=109.86  Aligned_cols=163  Identities=13%  Similarity=0.083  Sum_probs=116.6

Q ss_pred             CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeee-EEEeCcEEEEEEecCCCCHHHHHhccCCCCCHHHHHH
Q 021711          133 NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYK  211 (308)
Q Consensus       133 ~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~-~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~  211 (308)
                      ++.+|.|...+.... +......+-++.|+.++||||+++++ +..++..|+|+|-+.  .|..++....    ......
T Consensus        36 ~~~~vsVF~~~~~~~-~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~----~~~v~~  108 (690)
T KOG1243|consen   36 DGGPVSVFVYKRSNG-EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG----KEEVCL  108 (690)
T ss_pred             cCCceEEEEEeCCCc-hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH----HHHHHH
Confidence            578888888776555 44455667788899999999999997 556677999999875  5666664322    444555


Q ss_pred             HHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCceeEeeceeccccccccccCchhhcCc
Q 021711          212 IALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKR  291 (308)
Q Consensus       212 i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  291 (308)
                      -+.||+.||.|||+.  .+++|++|..+.|+++..|+.||++|-++.....-..  ......--..|..|+.+....  .
T Consensus       109 Gl~qIl~AL~FL~~d--~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~--~  182 (690)
T KOG1243|consen  109 GLFQILAALSFLNDD--CNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE--W  182 (690)
T ss_pred             HHHHHHHHHHHHhcc--CCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc--c
Confidence            688999999999963  6899999999999999999999999988754322110  001111223455665433221  4


Q ss_pred             cceeEEEeeEEEeeccC
Q 021711          292 CFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       292 ~~Di~s~g~~l~el~c~  308 (308)
                      ..|.|-||++++|++-|
T Consensus       183 s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  183 SIDSWGLGCLIEELFNG  199 (690)
T ss_pred             chhhhhHHHHHHHHhCc
Confidence            57999999999887643

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.07  E-value=1.4e-09  Score=91.52  Aligned_cols=127  Identities=24%  Similarity=0.226  Sum_probs=82.4

Q ss_pred             EEEEEEECCCcEEEEEEeccCCh-------------------------HHHHHHHHHHHHHHhcCCCC--eeeeeeeEEE
Q 021711          125 EVYKGRLRNGQLVAIKRLTRGTA-------------------------DEIIADFLSELGIMAHVDHP--NTAKLLGYGI  177 (308)
Q Consensus       125 ~Vy~~~~~~g~~vAvK~~~~~~~-------------------------~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~  177 (308)
                      .||.|...+|..+|+|+......                         ........+|.+.|..+..-  ++.+++++. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            48999988899999997643210                         11234567899999999755  456666542 


Q ss_pred             eCcEEEEEEecC--CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH-HHhCCCCCceecCCCCCCEEECCCCcEEEecc
Q 021711          178 EGGMHIVLELSP--NGSLASLLYGMKEKLKWGIRYKIALGVAEGLLY-LHEGCQRRIIHRDIKAANILLTEDFEPQICDF  254 (308)
Q Consensus       178 ~~~~~lv~e~~~--~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~y-LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DF  254 (308)
                        .-.+||||++  |..+..+....   ++......++.+++..+.. +|.   .+|+|+||.+.|||++++ .+.|+||
T Consensus        80 --~~~ivME~I~~~G~~~~~l~~~~---~~~~~~~~~~~~il~~~~~~~~~---~givHGDLs~~NIlv~~~-~~~iIDf  150 (188)
T PF01163_consen   80 --RNVIVMEYIGEDGVPLPRLKDVD---LSPEEPKELLEEILEEIIKMLHK---AGIVHGDLSEYNILVDDG-KVYIIDF  150 (188)
T ss_dssp             --TTEEEEE--EETTEEGGCHHHCG---GGGSTHHHHHHHHHHHHHHHHHC---TTEEESS-STTSEEEETT-CEEE--G
T ss_pred             --CCEEEEEecCCCccchhhHHhcc---ccchhHHHHHHHHHHHHHHHHHh---cCceecCCChhhEEeecc-eEEEEec
Confidence              3479999998  55454433211   1123345566777776655 466   899999999999999988 9999999


Q ss_pred             ccceecC
Q 021711          255 GLAKWLP  261 (308)
Q Consensus       255 Gla~~~~  261 (308)
                      |.+....
T Consensus       151 ~qav~~~  157 (188)
T PF01163_consen  151 GQAVDSS  157 (188)
T ss_dssp             TTEEETT
T ss_pred             CcceecC
Confidence            9987654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.99  E-value=9.3e-11  Score=103.99  Aligned_cols=145  Identities=18%  Similarity=0.193  Sum_probs=106.7

Q ss_pred             HhcCCCCeeeeeeeEEEeC------cEEEEEEecCCCCHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCc
Q 021711          161 MAHVDHPNTAKLLGYGIEG------GMHIVLELSPNGSLASLLYGM---KEKLKWGIRYKIALGVAEGLLYLHEGCQRRI  231 (308)
Q Consensus       161 l~~l~h~niv~l~~~~~~~------~~~lv~e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~i  231 (308)
                      +..+.|.|||+++.|+.+.      ...++.||+..|+|.++|+..   ...+......+++.||+.||.|||+ |...|
T Consensus       121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~Ppi  199 (458)
T KOG1266|consen  121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CDPPI  199 (458)
T ss_pred             HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cCCcc
Confidence            4455799999999876543      356899999999999999752   3446666777899999999999997 45789


Q ss_pred             eecCCCCCCEEECCCCcEEEeccccceecCCCCc--eeEeeceeccccccccccCchhhcCccceeEEEeeEEEeec
Q 021711          232 IHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT--HHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLS  306 (308)
Q Consensus       232 iHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~  306 (308)
                      +|+++..+-|++..+|-+||.---....-+.-..  ........|-++|.+||+=.-.....++|||+||+..+|++
T Consensus       200 ihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema  276 (458)
T KOG1266|consen  200 IHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA  276 (458)
T ss_pred             ccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence            9999999999999999888753211111000000  00112235678999999876667778899999998887765

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.85  E-value=2.7e-08  Score=86.89  Aligned_cols=135  Identities=23%  Similarity=0.196  Sum_probs=94.7

Q ss_pred             ccccceeeccCceEEEEEEECCCcEEEEEEeccCCh---------------------HHHHHHHHHHHHHHhcCCCC--e
Q 021711          112 FSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTA---------------------DEIIADFLSELGIMAHVDHP--N  168 (308)
Q Consensus       112 ~~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~---------------------~~~~~~~~~E~~~l~~l~h~--n  168 (308)
                      ..+.+.||-|--+.||.|....|..+|||.-.....                     .-.+....+|.++|.+|...  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            456789999999999999998999999996422110                     01234567899999998654  6


Q ss_pred             eeeeeeEEEeCcEEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCc
Q 021711          169 TAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFE  248 (308)
Q Consensus       169 iv~l~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~  248 (308)
                      +.+.+++.   .-.+|||++.|-.|...-      ++....-.++..|++-+.-+-.   .||||+|+.+=||+++++|.
T Consensus       173 VP~P~~~n---RHaVvMe~ieG~eL~~~r------~~~en~~~il~~il~~~~~~~~---~GiVHGDlSefNIlV~~dg~  240 (304)
T COG0478         173 VPKPIAWN---RHAVVMEYIEGVELYRLR------LDVENPDEILDKILEEVRKAYR---RGIVHGDLSEFNILVTEDGD  240 (304)
T ss_pred             CCCccccc---cceeeeehcccceeeccc------CcccCHHHHHHHHHHHHHHHHH---cCccccCCchheEEEecCCC
Confidence            66666652   236899999886554321      1222233344444444443334   79999999999999999999


Q ss_pred             EEEeccccce
Q 021711          249 PQICDFGLAK  258 (308)
Q Consensus       249 ~kl~DFGla~  258 (308)
                      +.++||--+.
T Consensus       241 ~~vIDwPQ~v  250 (304)
T COG0478         241 IVVIDWPQAV  250 (304)
T ss_pred             EEEEeCcccc
Confidence            9999995443

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.83  E-value=5.4e-08  Score=83.37  Aligned_cols=106  Identities=22%  Similarity=0.290  Sum_probs=81.0

Q ss_pred             HHHHHHHHHHhcCCCC--eeeeeeeEEEeC-----cEEEEEEecCCC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH
Q 021711          152 ADFLSELGIMAHVDHP--NTAKLLGYGIEG-----GMHIVLELSPNG-SLASLLYGMKEKLKWGIRYKIALGVAEGLLYL  223 (308)
Q Consensus       152 ~~~~~E~~~l~~l~h~--niv~l~~~~~~~-----~~~lv~e~~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yL  223 (308)
                      .+..+|...+..|...  ..++.+++....     ..+||+|++++. +|.+++..... .+......++.+++..+.-|
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~l  134 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAKL  134 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHHH
Confidence            4567787777766432  344555554432     247999999874 78888854222 56667778899999999999


Q ss_pred             HhCCCCCceecCCCCCCEEECCCC---cEEEeccccceecC
Q 021711          224 HEGCQRRIIHRDIKAANILLTEDF---EPQICDFGLAKWLP  261 (308)
Q Consensus       224 H~~~~~~iiHrDlKp~NILl~~~~---~~kl~DFGla~~~~  261 (308)
                      |.   .+|+|+|+++.|||++.+.   .+.++||+-++...
T Consensus       135 H~---~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~  172 (206)
T PF06293_consen  135 HD---AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP  172 (206)
T ss_pred             HH---CcCCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence            99   9999999999999999887   89999999888654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.74  E-value=6.6e-10  Score=111.24  Aligned_cols=197  Identities=15%  Similarity=0.086  Sum_probs=136.1

Q ss_pred             hcCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCCh--HHHHHHHHHHHHHHhcCCCCeeeeeeeE-EEeCcEEE
Q 021711          108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELGIMAHVDHPNTAKLLGY-GIEGGMHI  183 (308)
Q Consensus       108 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~-~~~~~~~l  183 (308)
                      ..+.+.+.+-+-+|.++.++.+.-. .|...++|.......  ....+...++-.+....++|.++...-- -.....+|
T Consensus       802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L  881 (1205)
T KOG0606|consen  802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL  881 (1205)
T ss_pred             CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence            4456777788889999999987644 354555554322110  0012223344444444556777655432 23345789


Q ss_pred             EEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCC-
Q 021711          184 VLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE-  262 (308)
Q Consensus       184 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~-  262 (308)
                      +++|+.+++|...++... ..+..-.......+..+++|||.   ..++|||++|.|+|...++..+++|||+...... 
T Consensus       882 ~~~~~~~~~~~Skl~~~~-~~saepaRs~i~~~vqs~e~L~s---~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~  957 (1205)
T KOG0606|consen  882 VGHYLNGGDLPSKLHNSG-CLSAEPARSPILERVQSLESLHS---SLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLI  957 (1205)
T ss_pred             hhHHhccCCchhhhhcCC-CcccccccchhHHHHhhhhcccc---chhhcccccccchhhcccCCcccCccccccccccc
Confidence            999999999999997644 33333334455667889999997   6699999999999999999999999984432210 


Q ss_pred             --------------------CCc---e-----eEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          263 --------------------QWT---H-----HTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       263 --------------------~~~---~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                                          ..+   .     .......||+.|.+||...+.......|.|+.|++++|.+||
T Consensus       958 ~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g 1031 (1205)
T KOG0606|consen  958 PPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTG 1031 (1205)
T ss_pred             cCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcC
Confidence                                000   0     012246799999999999999999999999999999999886

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.73  E-value=1.1e-07  Score=91.48  Aligned_cols=143  Identities=18%  Similarity=0.212  Sum_probs=93.5

Q ss_pred             ceeeccCceEEEEEEECCCcEEEEEEeccCChHHH-----------------------------H----------HHHHH
Q 021711          116 NLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEI-----------------------------I----------ADFLS  156 (308)
Q Consensus       116 ~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~-----------------------------~----------~~~~~  156 (308)
                      +.|+.++-|.||+|++++|+.||||+..++-.+..                             .          -++.+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            57999999999999999999999998765432110                             0          12344


Q ss_pred             HHHHHhcCC-----CCeeeee-eeEEEeCcEEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 021711          157 ELGIMAHVD-----HPNTAKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRR  230 (308)
Q Consensus       157 E~~~l~~l~-----h~niv~l-~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~  230 (308)
                      |+.-+.+++     .+++.-. +-+...+.-.|+|||+.|-.+.+.........+...+.....++.  +.-+-.   .+
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f--~~q~~~---dg  285 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAF--LRQLLR---DG  285 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHH--HHHHHh---cC
Confidence            555554442     2322111 111223445799999999988887543334555443332222221  122222   58


Q ss_pred             ceecCCCCCCEEECCCCcEEEeccccceecCCC
Q 021711          231 IIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ  263 (308)
Q Consensus       231 iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  263 (308)
                      ++|.|..|.||+++.+|.+.+.|||+...+.+.
T Consensus       286 ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~  318 (517)
T COG0661         286 FFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK  318 (517)
T ss_pred             ccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence            999999999999999999999999999877654

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.70  E-value=2.7e-08  Score=93.38  Aligned_cols=137  Identities=17%  Similarity=0.232  Sum_probs=103.7

Q ss_pred             ceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEE-----eCcEEEEEEecCC-CCHHH
Q 021711          123 YAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGI-----EGGMHIVLELSPN-GSLAS  195 (308)
Q Consensus       123 fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-----~~~~~lv~e~~~~-gsL~~  195 (308)
                      -.+.|++... +|..|++|+++...... ...-..-+++++++.|+|+|++.+.+.     +..+.+|++|.++ ++|.+
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~-~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d  367 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQS-TNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD  367 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccC-cccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence            3567888754 79999999994322111 111223467899999999999987543     3457899999875 57776


Q ss_pred             HHhc--------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecC
Q 021711          196 LLYG--------------MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP  261 (308)
Q Consensus       196 ~l~~--------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~  261 (308)
                      +...              .+...++..++.++.|+..||.++|+   .|+.-+-|.|.+||++.+.+++|+.-|+...+.
T Consensus       368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs---sGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~  444 (655)
T KOG3741|consen  368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS---SGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ  444 (655)
T ss_pred             HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh---cCceeecccHhHeEeeCcceEEEecccceeeec
Confidence            5432              12246778899999999999999999   898889999999999999899999888877665


Q ss_pred             CC
Q 021711          262 EQ  263 (308)
Q Consensus       262 ~~  263 (308)
                      ++
T Consensus       445 ~d  446 (655)
T KOG3741|consen  445 ED  446 (655)
T ss_pred             CC
Confidence            54

>PRK09902 hypothetical protein; Provisional

Probab=98.65  E-value=5.3e-07  Score=76.79  Aligned_cols=138  Identities=14%  Similarity=0.095  Sum_probs=98.0

Q ss_pred             eeccCceEEEEEEECCCcEEEEEEeccCCh-----HHHHHHHHHHHHHHhcCCCCe--eeeeeeEEE--eCc---EEEEE
Q 021711          118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTA-----DEIIADFLSELGIMAHVDHPN--TAKLLGYGI--EGG---MHIVL  185 (308)
Q Consensus       118 LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~-----~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~--~~~---~~lv~  185 (308)
                      -|+||-+.|+..... |+.+-+|+-.+...     +--...|.+|...+..|...+  +.++..+..  .+.   ..||+
T Consensus        26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT  104 (216)
T PRK09902         26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT  104 (216)
T ss_pred             cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence            366888899987764 45788887642211     112467899999988885322  444442211  111   46899


Q ss_pred             EecCC-CCHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCc--EEEecccccee
Q 021711          186 ELSPN-GSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFE--PQICDFGLAKW  259 (308)
Q Consensus       186 e~~~~-gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~--~kl~DFGla~~  259 (308)
                      |-+.+ -+|.+++... ..+.+......+..+++..+.-||.   .++.|+|+.+.|||++.++.  ++++||--++.
T Consensus       105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~---~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHS---VNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            98764 5888887442 2345667777899999999999999   99999999999999986666  99999977654

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.49  E-value=1.1e-06  Score=84.72  Aligned_cols=141  Identities=21%  Similarity=0.192  Sum_probs=93.0

Q ss_pred             ceeeccCceEEEEEEECCCcEEEEEEeccCChH------------------------------HHHH------HHHHHHH
Q 021711          116 NLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTAD------------------------------EIIA------DFLSELG  159 (308)
Q Consensus       116 ~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~------------------------------~~~~------~~~~E~~  159 (308)
                      +.||.-+.|.||+|++++|+.||||.-++...+                              +..+      +|.+|++
T Consensus       167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~  246 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK  246 (538)
T ss_pred             chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence            579999999999999999999999986554221                              1111      2445544


Q ss_pred             HHhcC----CCCe------eeeeeeEEEeCcEEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 021711          160 IMAHV----DHPN------TAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQR  229 (308)
Q Consensus       160 ~l~~l----~h~n------iv~l~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~  229 (308)
                      -..++    .|-+      |.+++- .....-.|+|||++|..+.++..-....++...+..-+.+...-+- ++    .
T Consensus       247 Nae~~~~~f~~~~~~~~V~VP~Vy~-~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~~qI-f~----~  320 (538)
T KOG1235|consen  247 NAERFRENFKDFSLLTYVLVPKVYW-DLSTKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYLEQI-FK----T  320 (538)
T ss_pred             hHHHHHHHHHhcccccceeCCeehh-hcCcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHHHHH-Hh----c
Confidence            43333    3444      223321 1223457999999998877665444555666655444444332222 23    5


Q ss_pred             CceecCCCCCCEEECC----CCcEEEeccccceecCC
Q 021711          230 RIIHRDIKAANILLTE----DFEPQICDFGLAKWLPE  262 (308)
Q Consensus       230 ~iiHrDlKp~NILl~~----~~~~kl~DFGla~~~~~  262 (308)
                      |++|.|-.|.||++..    ++.+.+-|||+.+.+..
T Consensus       321 GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  321 GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             CCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            8999999999999994    56899999999887654

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.46  E-value=5.7e-06  Score=71.15  Aligned_cols=142  Identities=18%  Similarity=0.162  Sum_probs=82.6

Q ss_pred             cceeeccCceEEEEEEECCCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCC--eeeeeeeEEEeC----cEEEEEEec
Q 021711          115 ENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHP--NTAKLLGYGIEG----GMHIVLELS  188 (308)
Q Consensus       115 ~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~~----~~~lv~e~~  188 (308)
                      .+.|+.|..+.||+....+ ..+++|.....   .....+.+|..++..+...  .+.+++.+....    ..+++|+++
T Consensus         2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~---~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i   77 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP---DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYI   77 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT-SEEEEEEESSH---HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEE
T ss_pred             CccCCCCCeeeEEEEEECC-cEEEEEEeCCC---CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEe
Confidence            3578999999999999876 58999987543   2345667888888777432  355666644332    257899999


Q ss_pred             CCCCHHH----------------HHh---ccC---CCCCHHH---------HHHH------------HHHHHH-HHHHHH
Q 021711          189 PNGSLAS----------------LLY---GMK---EKLKWGI---------RYKI------------ALGVAE-GLLYLH  224 (308)
Q Consensus       189 ~~gsL~~----------------~l~---~~~---~~l~~~~---------~~~i------------~~qi~~-~L~yLH  224 (308)
                      +|..+..                .+.   ...   .......         ....            ...+.. .+..++
T Consensus        78 ~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (239)
T PF01636_consen   78 PGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELE  157 (239)
T ss_dssp             SSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHH
Confidence            9987776                111   110   1111110         0000            011122 233333


Q ss_pred             h----CCCCCceecCCCCCCEEEC-CCCcEEEeccccceec
Q 021711          225 E----GCQRRIIHRDIKAANILLT-EDFEPQICDFGLAKWL  260 (308)
Q Consensus       225 ~----~~~~~iiHrDlKp~NILl~-~~~~~kl~DFGla~~~  260 (308)
                      .    .....++|+|+.|.|||++ .++.+-|+||+.+..-
T Consensus       158 ~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~~  198 (239)
T PF01636_consen  158 ALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGWG  198 (239)
T ss_dssp             HHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EEE
T ss_pred             hhhccCCCcEEEEeccccccceeeeccceeEEEecccceEC
Confidence            2    1235699999999999999 5566689999988764

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.40  E-value=7e-06  Score=71.36  Aligned_cols=137  Identities=18%  Similarity=0.205  Sum_probs=80.1

Q ss_pred             ceeeccCceEEEEEEECCCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCe--eeeeeeEEEeC-cEEEEEEecCCCC
Q 021711          116 NLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPN--TAKLLGYGIEG-GMHIVLELSPNGS  192 (308)
Q Consensus       116 ~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~-~~~lv~e~~~~gs  192 (308)
                      ..||+|..+.||+.   .|..+++|........   ....+|.+++..+..-.  +.+.+++...+ ...+|||+++|.+
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~~~---~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~   80 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGFDK---ETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR   80 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCCCH---HHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence            47899999999984   2445778887654322   34577888888875333  35556666544 3568999998863


Q ss_pred             -HHHH---------------------HhccC-CCCCHHHH-HHHHH----------HHHH-HHHHHHhC-CCCCceecCC
Q 021711          193 -LASL---------------------LYGMK-EKLKWGIR-YKIAL----------GVAE-GLLYLHEG-CQRRIIHRDI  236 (308)
Q Consensus       193 -L~~~---------------------l~~~~-~~l~~~~~-~~i~~----------qi~~-~L~yLH~~-~~~~iiHrDl  236 (308)
                       +...                     ++... ........ ..+-.          .+.. ...+|... ....++|+|+
T Consensus        81 ~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~  160 (226)
T TIGR02172        81 SFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF  160 (226)
T ss_pred             chhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence             2111                     11100 01111110 00100          0111 11222211 1235789999


Q ss_pred             CCCCEEECCCCcEEEecccccee
Q 021711          237 KAANILLTEDFEPQICDFGLAKW  259 (308)
Q Consensus       237 Kp~NILl~~~~~~kl~DFGla~~  259 (308)
                      .|.||++++++ +.|+||+.+..
T Consensus       161 ~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       161 QIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             CCCcEEEcCCC-cEEEechhcCc
Confidence            99999999988 99999998864

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.39  E-value=9.5e-06  Score=69.52  Aligned_cols=139  Identities=14%  Similarity=0.156  Sum_probs=88.7

Q ss_pred             hcCCccccceeeccCceEEEEEEECCCcEEEEEEeccCChH--HHHHHH------HHHHHHHhcCCC---Ceeeeeee--
Q 021711          108 ATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTAD--EIIADF------LSELGIMAHVDH---PNTAKLLG--  174 (308)
Q Consensus       108 ~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~--~~~~~~------~~E~~~l~~l~h---~niv~l~~--  174 (308)
                      ..++|...+++-......|.+-.. +|..+++|........  .....|      .+.+..+..++.   -..+.++.  
T Consensus        29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~  107 (229)
T PF06176_consen   29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA  107 (229)
T ss_pred             HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence            456888888888777777777665 4678899976543221  111111      233333333322   22222221  


Q ss_pred             ----EEEeCcEEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEE
Q 021711          175 ----YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQ  250 (308)
Q Consensus       175 ----~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~k  250 (308)
                          +.......++|||++|..|.+...     ++.    .++..+.+++.-||.   .|+.|+|..|.|++++.+ .++
T Consensus       108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH~---~G~~HGD~hpgNFlv~~~-~i~  174 (229)
T PF06176_consen  108 EKKIFRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLHK---HGFYHGDPHPGNFLVSNN-GIR  174 (229)
T ss_pred             eeeeccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHHH---cCCccCCCCcCcEEEECC-cEE
Confidence                112233458999999988766531     222    244567778999998   999999999999999966 599


Q ss_pred             Eeccccceec
Q 021711          251 ICDFGLAKWL  260 (308)
Q Consensus       251 l~DFGla~~~  260 (308)
                      ++||+..+..
T Consensus       175 iID~~~k~~~  184 (229)
T PF06176_consen  175 IIDTQGKRMS  184 (229)
T ss_pred             EEECcccccc
Confidence            9999887643

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=98.34  E-value=3.3e-08  Score=99.16  Aligned_cols=77  Identities=9%  Similarity=-0.047  Sum_probs=60.5

Q ss_pred             eecCCCCC-CEEECCCCcEEEeccccceecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          232 IHRDIKAA-NILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       232 iHrDlKp~-NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      .+++..|. |++++..+..++.|||.++...............||+.|+|||++.+..++.++|+||||++||||++|
T Consensus       499 ~~~~~~p~~~~~~~p~~~~~~~~~~~~~~~~~g~~~~~~~~~vGT~~Y~APE~l~~~~~~~~~DiwSlG~il~ElltG  576 (669)
T cd05610         499 PTQKPRPHGNLYQTPKQVKIGTPYRTPKSVRRGAAPVEGERILGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTG  576 (669)
T ss_pred             CCCCCCCCCceeECCccccccccCCCchhhhcccccccCCceeeCccccCHHHcCCCCCCcHHHHHHHHHHHHHHHHC
Confidence            44566666 667777777889999999876544333333457899999999998888889999999999999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.32  E-value=5.2e-07  Score=87.49  Aligned_cols=90  Identities=12%  Similarity=0.198  Sum_probs=72.0

Q ss_pred             HHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCC-------CceeEeeceeccccccccccCchh
Q 021711          215 GVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ-------WTHHTISKVEGTFGLVKLNLPPLV  287 (308)
Q Consensus       215 qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~-------~~~~~~~~~~gt~~y~aPE~~~~~  287 (308)
                      +++.||.|+|.  ..++||++|.|++|.++..+..||+.|+++......       +......-..-...|.|||+..+.
T Consensus       107 ~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~  184 (700)
T KOG2137|consen  107 NVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT  184 (700)
T ss_pred             cccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence            45589999997  368999999999999999999999999987654331       111111123445789999999998


Q ss_pred             hcCccceeEEEeeEEEeec
Q 021711          288 ILKRCFTCIFIGFSQLQLS  306 (308)
Q Consensus       288 ~~~~~~Di~s~g~~l~el~  306 (308)
                      ..+..+|++|+|+.+|-++
T Consensus       185 ~~~~~sd~fSlG~li~~i~  203 (700)
T KOG2137|consen  185 TNTPASDVFSLGVLIYTIY  203 (700)
T ss_pred             cccccccceeeeeEEEEEe
Confidence            8999999999999999887

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.26  E-value=8.6e-08  Score=92.15  Aligned_cols=182  Identities=20%  Similarity=0.160  Sum_probs=125.1

Q ss_pred             hhcCCccccceeeccCceEEEEEEECCCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCe-eeeeee-EEEeCcEEEE
Q 021711          107 SATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPN-TAKLLG-YGIEGGMHIV  184 (308)
Q Consensus       107 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~-~~~~~~~~lv  184 (308)
                      ..+..+...+-+++|++++++|.+....+....+.+...      ....-++++|.+++||| .+..++ +..+...+++
T Consensus       239 Dk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~  312 (829)
T KOG0576|consen  239 DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIP  312 (829)
T ss_pred             CCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc------hhhHHHHHHHHHccCCCCcccccccCCcccccchh
Confidence            344556666778999999999988654444445655433      22335788899999999 444444 3344456789


Q ss_pred             EEecCCC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCC
Q 021711          185 LELSPNG-SLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ  263 (308)
Q Consensus       185 ~e~~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  263 (308)
                      ++++.++ +-..........+...+...+.+.-+++++++|+   -.=+|||    ||+..+ +..+..||+....+...
T Consensus       313 ~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~---~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~  384 (829)
T KOG0576|consen  313 MRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHS---SYKVHRD----NILGSE-EEVKLLDFAVPPQLTRT  384 (829)
T ss_pred             hhhhcCCccccccCChhhHhhhhhhhhhhhhhhccccccccc---ccccCcc----cccccc-cccccccccCCcccCcc
Confidence            9998876 2211111111223334445566667789999997   4458998    777776 58999999999887665


Q ss_pred             CceeEeeceeccccccccccCchhhcCccceeEEEeeEEEee
Q 021711          264 WTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQL  305 (308)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el  305 (308)
                      .   ......+|+.++|||...+.....+-|.|+++....++
T Consensus       385 ~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~  423 (829)
T KOG0576|consen  385 M---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQM  423 (829)
T ss_pred             c---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhc
Confidence            3   34568899999999998888888888999998754443

>PLN02876 acyl-CoA dehydrogenase

Probab=98.24  E-value=1.5e-05  Score=81.95  Aligned_cols=78  Identities=12%  Similarity=0.181  Sum_probs=54.9

Q ss_pred             cceeeccCceEEEEEEECCC---cEEEEEEeccCChHHHHHHHHHHHHHHhcCC-CCee--eeeeeEEEeC----cEEEE
Q 021711          115 ENLIGKGGYAEVYKGRLRNG---QLVAIKRLTRGTADEIIADFLSELGIMAHVD-HPNT--AKLLGYGIEG----GMHIV  184 (308)
Q Consensus       115 ~~~LG~G~fg~Vy~~~~~~g---~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~-h~ni--v~l~~~~~~~----~~~lv  184 (308)
                      .+.++.|.+..+|+....++   ..+++|+............+.+|..+|+.+. |.++  .+++.++.+.    ..++|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            46788999999999876543   3677777543321112346779999999985 6665  6777777653    47899


Q ss_pred             EEecCCCC
Q 021711          185 LELSPNGS  192 (308)
Q Consensus       185 ~e~~~~gs  192 (308)
                      |||++|..
T Consensus       123 ME~v~G~~  130 (822)
T PLN02876        123 MEYLEGRI  130 (822)
T ss_pred             EEecCCcc
Confidence            99998754

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.19  E-value=7.7e-06  Score=69.00  Aligned_cols=101  Identities=24%  Similarity=0.170  Sum_probs=79.3

Q ss_pred             HHHHHHhcCCC-CeeeeeeeEEEeCcEEEEEEecCCCCHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCce
Q 021711          156 SELGIMAHVDH-PNTAKLLGYGIEGGMHIVLELSPNGSLASLLY--GMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRII  232 (308)
Q Consensus       156 ~E~~~l~~l~h-~niv~l~~~~~~~~~~lv~e~~~~gsL~~~l~--~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ii  232 (308)
                      .|.-++..+++ +++++++|+|-   -.+|.||...+++...-.  ..-...+|..+.+|+.++++.+.++++.....+.
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~CG---~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~   84 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSCG---RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFFY   84 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeECC---CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcEE
Confidence            47777888865 69999999883   378999998776642100  0113468999999999999999999975544577


Q ss_pred             ecCCCCCCEEECCCCcEEEecccccee
Q 021711          233 HRDIKAANILLTEDFEPQICDFGLAKW  259 (308)
Q Consensus       233 HrDlKp~NILl~~~~~~kl~DFGla~~  259 (308)
                      -.|++|+|+-+++++++|++|...+-.
T Consensus        85 lcDv~~~nfgv~~~~~lk~iDld~v~~  111 (188)
T PF12260_consen   85 LCDVSPDNFGVNDDGRLKLIDLDDVFV  111 (188)
T ss_pred             EeecchHHeEEeCCCcEEEEechhcch
Confidence            799999999999999999999987654

Proteins in this uncharacterised family are described as transmembrane proteins.

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.18  E-value=5.8e-05  Score=64.12  Aligned_cols=134  Identities=20%  Similarity=0.282  Sum_probs=88.2

Q ss_pred             cceeeccCceEEEEEEECCCcEEEEEEeccCC---------------hHHHHHHHHHHHHHHhcCC------CCeeeeee
Q 021711          115 ENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGT---------------ADEIIADFLSELGIMAHVD------HPNTAKLL  173 (308)
Q Consensus       115 ~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~---------------~~~~~~~~~~E~~~l~~l~------h~niv~l~  173 (308)
                      ...||+|+.-.||.-  .+.....||+.....               ......+..+|+.....+.      +.+|.+++
T Consensus         6 ~~~i~~G~~R~cy~H--P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~   83 (199)
T PF10707_consen    6 SDLIAQGGERDCYQH--PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY   83 (199)
T ss_pred             CcccccCCCceEEEC--CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence            357999999999963  334456788876544               0112345566666655554      88999999


Q ss_pred             eEEEe-CcEEEEEEecCC------CCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCC
Q 021711          174 GYGIE-GGMHIVLELSPN------GSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTED  246 (308)
Q Consensus       174 ~~~~~-~~~~lv~e~~~~------gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~  246 (308)
                      |+... -+.-+|+|.+..      .+|.+++..  ..++. ....   .+-+-..||-+   .+|+.+|++|.||++...
T Consensus        84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~--~~~~~-~~~~---~L~~f~~~l~~---~~Iv~~dl~~~NIv~~~~  154 (199)
T PF10707_consen   84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKE--GGLTE-ELRQ---ALDEFKRYLLD---HHIVIRDLNPHNIVVQRR  154 (199)
T ss_pred             EEEecCCceEEEEEEEECCCCCcCccHHHHHHc--CCccH-HHHH---HHHHHHHHHHH---cCCeecCCCcccEEEEec
Confidence            97655 468888887642      367888743  34554 2222   23334566776   789999999999999744


Q ss_pred             C----cEEEec-ccccee
Q 021711          247 F----EPQICD-FGLAKW  259 (308)
Q Consensus       247 ~----~~kl~D-FGla~~  259 (308)
                      .    .+.|+| ||-...
T Consensus       155 ~~~~~~lvlIDG~G~~~~  172 (199)
T PF10707_consen  155 DSGEFRLVLIDGLGEKEL  172 (199)
T ss_pred             CCCceEEEEEeCCCCccc
Confidence            2    577777 555444

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.18  E-value=2.8e-05  Score=68.13  Aligned_cols=138  Identities=16%  Similarity=0.142  Sum_probs=80.0

Q ss_pred             eeccCc-eEEEEEEECCCcEEEEEEeccCChHHHHHHHHHHHHHHhcCC-CCeeeeeeeEEEeC-cEEEEEEecCCCCHH
Q 021711          118 IGKGGY-AEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVD-HPNTAKLLGYGIEG-GMHIVLELSPNGSLA  194 (308)
Q Consensus       118 LG~G~f-g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~-~~~lv~e~~~~gsL~  194 (308)
                      |-.|.. ..||+.... +..+.+|+.....    ...+.+|+.++..+. +--+.+++++...+ ..++|||+++|.++.
T Consensus         6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~   80 (244)
T cd05150           6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA   80 (244)
T ss_pred             cCCCCCcCeEEEEcCC-CCcEEEEecCCCc----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence            444555 788998764 4678888875432    234557888877773 33355666665543 468999999987775


Q ss_pred             HHH-------------------hccCC---CCCHH--HHHHHHH--------------------HHHHHHHHHHh----C
Q 021711          195 SLL-------------------YGMKE---KLKWG--IRYKIAL--------------------GVAEGLLYLHE----G  226 (308)
Q Consensus       195 ~~l-------------------~~~~~---~l~~~--~~~~i~~--------------------qi~~~L~yLH~----~  226 (308)
                      ...                   +....   .+...  ....-..                    .+...+..|-.    .
T Consensus        81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  160 (244)
T cd05150          81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE  160 (244)
T ss_pred             HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence            431                   11000   11100  0000000                    01111122211    0


Q ss_pred             CCCCceecCCCCCCEEECCCCcEEEeccccceec
Q 021711          227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL  260 (308)
Q Consensus       227 ~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~  260 (308)
                      ....++|+|+.|.|||++.++.+.|+||+.|..-
T Consensus       161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~g  194 (244)
T cd05150         161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGVA  194 (244)
T ss_pred             CceEEECCCCCCccEEEeCCcEEEEEEccccccc
Confidence            1245899999999999999877889999988643

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.16  E-value=2.6e-05  Score=67.78  Aligned_cols=137  Identities=23%  Similarity=0.231  Sum_probs=87.0

Q ss_pred             eeeccCceEEEEEEECCCcEEEEEEeccCChHH-----------------------HHHHHHHHHHHHhcCC--CCeeee
Q 021711          117 LIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADE-----------------------IIADFLSELGIMAHVD--HPNTAK  171 (308)
Q Consensus       117 ~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~-----------------------~~~~~~~E~~~l~~l~--h~niv~  171 (308)
                      .|..|--+.||+|...++..+|+|+.......-                       ......+|..-|.++.  +-.+.+
T Consensus        55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~  134 (268)
T COG1718          55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE  134 (268)
T ss_pred             eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence            455677788999998789999999885432210                       1112334665565552  223333


Q ss_pred             eeeEEEeCcEEEEEEecCCCC-HHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEE
Q 021711          172 LLGYGIEGGMHIVLELSPNGS-LASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQ  250 (308)
Q Consensus       172 l~~~~~~~~~~lv~e~~~~gs-L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~k  250 (308)
                      .+++.   .-.|||||+.... -.-.|.  .-.+.......+..++++.+.-|-.  ..++||+||..=|||+. ++.+.
T Consensus       135 Pi~~~---~nVLvMEfIg~~g~pAP~Lk--Dv~~e~~e~~~~~~~~v~~~~~l~~--~a~LVHgDLSEyNiL~~-~~~p~  206 (268)
T COG1718         135 PIAFR---NNVLVMEFIGDDGLPAPRLK--DVPLELEEAEGLYEDVVEYMRRLYK--EAGLVHGDLSEYNILVH-DGEPY  206 (268)
T ss_pred             ceeec---CCeEEEEeccCCCCCCCCcc--cCCcCchhHHHHHHHHHHHHHHHHH--hcCcccccchhhheEEE-CCeEE
Confidence            33332   1258999986531 111111  1122333455667778888877664  26899999999999999 77999


Q ss_pred             EeccccceecC
Q 021711          251 ICDFGLAKWLP  261 (308)
Q Consensus       251 l~DFGla~~~~  261 (308)
                      |+|||=|....
T Consensus       207 iID~~QaV~~~  217 (268)
T COG1718         207 IIDVSQAVTID  217 (268)
T ss_pred             EEECccccccC
Confidence            99999887554

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.11  E-value=3.5e-05  Score=63.55  Aligned_cols=130  Identities=25%  Similarity=0.270  Sum_probs=88.0

Q ss_pred             cccceeeccCceEEEEEEECCCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeee-eeeeEEEeCcEEEEEEecCCC
Q 021711          113 SFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTA-KLLGYGIEGGMHIVLELSPNG  191 (308)
Q Consensus       113 ~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~lv~e~~~~g  191 (308)
                      +..+.|++|++|.||+|.+. |..+|+|.-..+..   +..+..|++++..++-.++. +++.|..+   .+.|||+.|-
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds~---r~~l~kEakiLeil~g~~~~p~vy~yg~~---~i~me~i~G~   97 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEWR-GGEVALKVRRRDSP---RRNLEKEAKILEILAGEGVTPEVYFYGED---FIRMEYIDGR   97 (201)
T ss_pred             hhhhhhhcccccEEEEeecc-CceEEEEEecCCcc---hhhHHHHHHHHHHhhhcCCCceEEEechh---hhhhhhhcCc
Confidence            45678999999999999996 55888887654433   46788999999988765554 34444322   4569999998


Q ss_pred             CHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCC-CCCEEECCCCcEEEeccccceec
Q 021711          192 SLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIK-AANILLTEDFEPQICDFGLAKWL  260 (308)
Q Consensus       192 sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlK-p~NILl~~~~~~kl~DFGla~~~  260 (308)
                      .|.+.-...    +..++.    .+++.---|-.   .+|-|..|. |...++..++.+-|+||--|+..
T Consensus        98 ~L~~~~~~~----~rk~l~----~vlE~a~~LD~---~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k  156 (201)
T COG2112          98 PLGKLEIGG----DRKHLL----RVLEKAYKLDR---LGIEHGELSRPWKNVLVNDRDVYIIDFDSATFK  156 (201)
T ss_pred             chhhhhhcc----cHHHHH----HHHHHHHHHHH---hccchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence            887765321    223333    34444222333   677777774 55556665669999999998854

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.03  E-value=7.9e-05  Score=63.14  Aligned_cols=125  Identities=22%  Similarity=0.337  Sum_probs=88.1

Q ss_pred             CCccccceeeccCc-eEEEEEEECCCcEEEEEEecc---CC--------hH---------HHHHHHHHHHHHHhcCC---
Q 021711          110 NNFSFENLIGKGGY-AEVYKGRLRNGQLVAIKRLTR---GT--------AD---------EIIADFLSELGIMAHVD---  165 (308)
Q Consensus       110 ~~~~~~~~LG~G~f-g~Vy~~~~~~g~~vAvK~~~~---~~--------~~---------~~~~~~~~E~~~l~~l~---  165 (308)
                      .+++..+.||.|.- |.||+++. +|+.+|+|....   ..        ..         ....-|..|.+...+|+   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~  115 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG  115 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence            68889999999999 99999998 478999999311   00        00         12345778888777764   


Q ss_pred             CCee--eeeeeEEEeC---------------c----EEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH
Q 021711          166 HPNT--AKLLGYGIEG---------------G----MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH  224 (308)
Q Consensus       166 h~ni--v~l~~~~~~~---------------~----~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH  224 (308)
                      +.++  |+++||..=.               .    .-||-||.+...          .+...    -+.+|.+-|..+|
T Consensus       116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~~~~----~~~~~~~dl~~~~  181 (207)
T PF13095_consen  116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PLQIR----DIPQMLRDLKILH  181 (207)
T ss_pred             ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------ccchh----HHHHHHHHHHHHH
Confidence            5566  8999975211               0    236777765532          12222    3456777888999


Q ss_pred             hCCCCCceecCCCCCCEEECCCCcEEEeccccc
Q 021711          225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLA  257 (308)
Q Consensus       225 ~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla  257 (308)
                      .   .+|+-+|+++.|..     .-||+|||.+
T Consensus       182 k---~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  182 K---LGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             H---CCeeeccCcccccc-----CCEEEecccC
Confidence            8   89999999999976     5689999865

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=97.96  E-value=2.6e-05  Score=72.25  Aligned_cols=183  Identities=14%  Similarity=0.098  Sum_probs=115.3

Q ss_pred             ccceeeccCceEEEEEEECCCcEEEEEEeccCChHHHHHHHHHHHHHHhc-CCCCeeeeeeeE------EEeC-c-EEEE
Q 021711          114 FENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAH-VDHPNTAKLLGY------GIEG-G-MHIV  184 (308)
Q Consensus       114 ~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~------~~~~-~-~~lv  184 (308)
                      ....||+|+-+.+|-.-.- +. .+.|+......... .+.   +..|.. -.||-+-.-+.|      .-+. . .-++
T Consensus        15 ~gr~LgqGgea~ly~l~e~-~d-~VAKIYh~Pppa~~-aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl   88 (637)
T COG4248          15 PGRPLGQGGEADLYTLGEV-RD-QVAKIYHAPPPAAQ-AQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL   88 (637)
T ss_pred             CCccccCCccceeeecchh-hc-hhheeecCCCchHH-HHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence            4578999999999965321 11 24477655433211 111   222333 246544331221      1111 1 3466


Q ss_pred             EEecCCCC-HHHHHhc-----cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccce
Q 021711          185 LELSPNGS-LASLLYG-----MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK  258 (308)
Q Consensus       185 ~e~~~~gs-L~~~l~~-----~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~  258 (308)
                      |..+.+.. ...++.-     .-....|...++.++.++.+..-||+   .|-+-+|+.++|+|+++++.+.|.|=.--.
T Consensus        89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~---~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq  165 (637)
T COG4248          89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE---HGHVVGDVNQNSFLVSDDSKVVLVDSDSFQ  165 (637)
T ss_pred             cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh---cCCcccccCccceeeecCceEEEEccccee
Confidence            66665542 2222211     12237899999999999999999998   899999999999999999999998743222


Q ss_pred             ecCCCCceeEeeceeccccccccccC-----chhhcCccceeEEEeeEEEeeccC
Q 021711          259 WLPEQWTHHTISKVEGTFGLVKLNLP-----PLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       259 ~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      .- ...+  ......|...|.+||.-     .+...+...|.+.+|+++++|+.|
T Consensus       166 i~-~ng~--~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~g  217 (637)
T COG4248         166 IN-ANGT--LHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFG  217 (637)
T ss_pred             ec-cCCc--eEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhc
Confidence            11 1222  23456789999999963     344456678999999999988754

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.95  E-value=6.5e-05  Score=65.48  Aligned_cols=31  Identities=23%  Similarity=0.351  Sum_probs=26.4

Q ss_pred             CCceecCCCCCCEEECCCCcEEEecccccee
Q 021711          229 RRIIHRDIKAANILLTEDFEPQICDFGLAKW  259 (308)
Q Consensus       229 ~~iiHrDlKp~NILl~~~~~~kl~DFGla~~  259 (308)
                      ..++|+|+.+.|||++.+...-|+||+.+..
T Consensus       164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~  194 (235)
T cd05155         164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV  194 (235)
T ss_pred             ceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence            4489999999999998776567999998764

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.75  E-value=0.00041  Score=60.23  Aligned_cols=73  Identities=19%  Similarity=0.150  Sum_probs=45.7

Q ss_pred             ceeeccCceEEEEEEECC--CcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCe-eeeeeeEEEeCcEEEEEEecCCCC
Q 021711          116 NLIGKGGYAEVYKGRLRN--GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPN-TAKLLGYGIEGGMHIVLELSPNGS  192 (308)
Q Consensus       116 ~~LG~G~fg~Vy~~~~~~--g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~lv~e~~~~gs  192 (308)
                      +.|..|-...+|+....+  +..+++|........  ..+..+|+.++..+...+ .+++++... +  .+++||++|.+
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~--~~d~~~E~~~~~~l~~~gl~P~v~~~~~-~--~~l~e~i~G~~   78 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL--IIDRERELRIHKLLSKHGLAPKLYATFQ-N--GLIYEFIPGRT   78 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc--eecHHHHHHHHHHHHhCCCCCeEEEEeC-C--cEEEEeeCCCc
Confidence            467778888999988664  578889976543211  112236788887774333 344444332 2  47999998866


Q ss_pred             H
Q 021711          193 L  193 (308)
Q Consensus       193 L  193 (308)
                      +
T Consensus        79 l   79 (235)
T cd05157          79 L   79 (235)
T ss_pred             C
Confidence            4

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PRK10593 hypothetical protein; Provisional

Probab=97.71  E-value=0.0013  Score=59.52  Aligned_cols=76  Identities=13%  Similarity=-0.017  Sum_probs=52.7

Q ss_pred             ccceeeccCceEEEEEEECCCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCC---CeeeeeeeEEEe----CcEEEEEE
Q 021711          114 FENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDH---PNTAKLLGYGIE----GGMHIVLE  186 (308)
Q Consensus       114 ~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~----~~~~lv~e  186 (308)
                      -.+.||.|..+.||.....++ .+.+|..+....   ...|..|...|+.|.-   -.+.++++++..    +..+||||
T Consensus        18 ~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~~~---~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE   93 (297)
T PRK10593         18 RVECISEQPYAALWALYDSQG-NPMPLMARSFST---PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE   93 (297)
T ss_pred             eeeecCCccceeEEEEEcCCC-CEEEEEeccccc---chHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence            346799999999999876555 466676443112   2467788888887742   356777776543    34799999


Q ss_pred             ecCCCCH
Q 021711          187 LSPNGSL  193 (308)
Q Consensus       187 ~~~~gsL  193 (308)
                      +++++++
T Consensus        94 ~i~G~~~  100 (297)
T PRK10593         94 RLRGVSV  100 (297)
T ss_pred             ccCCEec
Confidence            9998654

>PRK05231 homoserine kinase; Provisional

Probab=97.58  E-value=0.0035  Score=57.13  Aligned_cols=32  Identities=31%  Similarity=0.366  Sum_probs=27.3

Q ss_pred             CCCceecCCCCCCEEECCCCcEEEecccccee
Q 021711          228 QRRIIHRDIKAANILLTEDFEPQICDFGLAKW  259 (308)
Q Consensus       228 ~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~  259 (308)
                      +.+++|+|+.|.|||++.+...-|+||+.+..
T Consensus       186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             CcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence            46899999999999999765568999998863

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.50  E-value=0.00063  Score=60.05  Aligned_cols=136  Identities=13%  Similarity=0.049  Sum_probs=74.9

Q ss_pred             eeccCceEEEEEEECCCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCee-eeeeeEEEeCcEEEEEEecCCCCHHH-
Q 021711          118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT-AKLLGYGIEGGMHIVLELSPNGSLAS-  195 (308)
Q Consensus       118 LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~lv~e~~~~gsL~~-  195 (308)
                      +..|-...+|+... ++..+++|........ ..-+..+|..+++.+....+ .+++....   -++|+||++|..+.. 
T Consensus         4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~-~~~~r~~E~~~l~~l~~~g~~P~~i~~~~---~~~v~e~i~G~~~~~~   78 (256)
T TIGR02721         4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKA-LGVDRQREYQILQALSALGLAPKPILVNE---HWLLVEWLEGEVITLD   78 (256)
T ss_pred             CCCcCcCCeEEEEe-CCccEEEeeCCccccc-ccCcHHHHHHHHHHHHhcCCCCceEEEeC---CEEEEEeccCcccccc
Confidence            45677788998874 5667888875433211 10134678888888754333 33333321   368999998865431 


Q ss_pred             -------------H---HhccC---CCCCHHH-HHHHHHHH---------HHHHHHHHh-----CCCCCceecCCCCCCE
Q 021711          196 -------------L---LYGMK---EKLKWGI-RYKIALGV---------AEGLLYLHE-----GCQRRIIHRDIKAANI  241 (308)
Q Consensus       196 -------------~---l~~~~---~~l~~~~-~~~i~~qi---------~~~L~yLH~-----~~~~~iiHrDlKp~NI  241 (308)
                                   .   ++...   .+++... +..+..++         ..-+..+-.     ..+..++|+|+.|.||
T Consensus        79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni  158 (256)
T TIGR02721        79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL  158 (256)
T ss_pred             cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence                         1   11111   1112111 11111111         111121211     1123589999999999


Q ss_pred             EECCCCcEEEecccccee
Q 021711          242 LLTEDFEPQICDFGLAKW  259 (308)
Q Consensus       242 Ll~~~~~~kl~DFGla~~  259 (308)
                      +++.++ +.|+||..|..
T Consensus       159 l~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       159 VVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             EEeCCC-CEEEeccccCc
Confidence            999876 78999988764

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.46  E-value=0.0021  Score=60.44  Aligned_cols=76  Identities=16%  Similarity=0.084  Sum_probs=52.1

Q ss_pred             ceeeccCceEEEEEEECCC-cEEEEEEeccC-----Ch-HHHHHHHHHHHHHHhcCC---CCeeeeeeeEEEeCcEEEEE
Q 021711          116 NLIGKGGYAEVYKGRLRNG-QLVAIKRLTRG-----TA-DEIIADFLSELGIMAHVD---HPNTAKLLGYGIEGGMHIVL  185 (308)
Q Consensus       116 ~~LG~G~fg~Vy~~~~~~g-~~vAvK~~~~~-----~~-~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~lv~  185 (308)
                      +.||.|.+..||++...+| +.++||.-...     .. .-..+++..|.+.|..+.   ..++++++.+.. ...++||
T Consensus        32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~-~~~~lVM  110 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE-ELAVTVM  110 (401)
T ss_pred             eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC-CCCEEEE
Confidence            5789999999999998776 58999974311     10 112456777888887752   345667776633 4457999


Q ss_pred             EecCCCC
Q 021711          186 ELSPNGS  192 (308)
Q Consensus       186 e~~~~gs  192 (308)
                      |++++..
T Consensus       111 E~L~~~~  117 (401)
T PRK09550        111 EDLSDHK  117 (401)
T ss_pred             ecCCCcc
Confidence            9997643

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.38  E-value=0.0015  Score=59.13  Aligned_cols=140  Identities=25%  Similarity=0.291  Sum_probs=79.2

Q ss_pred             ceeeccCceEEEEEEECC-------CcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCee-eeeeeEEEeCcEEEEEEe
Q 021711          116 NLIGKGGYAEVYKGRLRN-------GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT-AKLLGYGIEGGMHIVLEL  187 (308)
Q Consensus       116 ~~LG~G~fg~Vy~~~~~~-------g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~lv~e~  187 (308)
                      +.|..|-...+|+....+       ++.+++|+.......  ..+..+|..++..+...++ .+++++.. +  .+|++|
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~--~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~--~~v~e~   78 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVEL--LIDRERELVVFARLSERNLGPKLYGIFP-N--GRIEEF   78 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcc--eechHHHHHHHHHHHhCCCCCceEEEeC-C--Cchhhe
Confidence            345566667889887654       578899986543321  2344577777777743333 34444433 2  357888


Q ss_pred             cCCCCHHHH-----------------HhccCCCC--------C--HHHHHH--------------------------HHH
Q 021711          188 SPNGSLASL-----------------LYGMKEKL--------K--WGIRYK--------------------------IAL  214 (308)
Q Consensus       188 ~~~gsL~~~-----------------l~~~~~~l--------~--~~~~~~--------------------------i~~  214 (308)
                      ++|..+...                 ++......        +  +.....                          +..
T Consensus        79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (302)
T cd05156          79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE  158 (302)
T ss_pred             eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence            887655321                 11111110        0  001100                          011


Q ss_pred             HHHHHHHHHHh------CCCCCceecCCCCCCEEECCC----CcEEEeccccceec
Q 021711          215 GVAEGLLYLHE------GCQRRIIHRDIKAANILLTED----FEPQICDFGLAKWL  260 (308)
Q Consensus       215 qi~~~L~yLH~------~~~~~iiHrDlKp~NILl~~~----~~~kl~DFGla~~~  260 (308)
                      .+..-+.++-.      .....++|+|+.+.|||++.+    +.+.++||..|..-
T Consensus       159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~~  214 (302)
T cd05156         159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASYN  214 (302)
T ss_pred             HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCCC
Confidence            12222333431      134568999999999999985    78999999988754

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.32  E-value=0.0026  Score=57.27  Aligned_cols=140  Identities=16%  Similarity=0.148  Sum_probs=80.0

Q ss_pred             cceeeccCceEEEEEEECCCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCe--eeeeeeE-------EEeCcEEEEE
Q 021711          115 ENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPN--TAKLLGY-------GIEGGMHIVL  185 (308)
Q Consensus       115 ~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~-------~~~~~~~lv~  185 (308)
                      .+.|..|....+|+....+ ..+++|......    ......|+.++..+.+.+  +.+++..       ...+..++|+
T Consensus        19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~   93 (296)
T cd05153          19 FEGISAGIENTNYFVTTDS-GRYVLTLFEKVS----AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALV   93 (296)
T ss_pred             eecccCccccceEEEEeCC-CcEEEEEcCCCC----hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEE
Confidence            3567778778999987644 468888875421    234556777777764322  3444321       1234467899


Q ss_pred             EecCCCCHHH-----------H---HhccCCC----------CCHHHHH----------HHHHHHHHHHHHHHh----CC
Q 021711          186 ELSPNGSLAS-----------L---LYGMKEK----------LKWGIRY----------KIALGVAEGLLYLHE----GC  227 (308)
Q Consensus       186 e~~~~gsL~~-----------~---l~~~~~~----------l~~~~~~----------~i~~qi~~~L~yLH~----~~  227 (308)
                      ++++|..+..           .   ++.....          ..|....          .....+...+.++..    ..
T Consensus        94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~  173 (296)
T cd05153          94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL  173 (296)
T ss_pred             EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence            9998865421           1   1110000          1111110          011112233444432    12


Q ss_pred             CCCceecCCCCCCEEECCCCcEEEecccccee
Q 021711          228 QRRIIHRDIKAANILLTEDFEPQICDFGLAKW  259 (308)
Q Consensus       228 ~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~  259 (308)
                      +.+++|+|+.|.|||++.++.+.|+||+.+..
T Consensus       174 ~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         174 PRGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             CCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence            35799999999999999987778999988764

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.30  E-value=0.00029  Score=63.64  Aligned_cols=133  Identities=20%  Similarity=0.215  Sum_probs=88.3

Q ss_pred             CccccceeeccCceEEEEEEECCCcEEEEEEeccC----------C-------hH----HHHHHHHHHHHHHhcCC-CC-
Q 021711          111 NFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRG----------T-------AD----EIIADFLSELGIMAHVD-HP-  167 (308)
Q Consensus       111 ~~~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~----------~-------~~----~~~~~~~~E~~~l~~l~-h~-  167 (308)
                      -+.+.+.||-|.-+.||.+-...|++.++|.-.-.          .       ..    -.+-...+|...|+.|. |. 
T Consensus        93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf  172 (465)
T KOG2268|consen   93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF  172 (465)
T ss_pred             hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence            46788999999999999999988999999843111          0       00    01223567888888874 22 


Q ss_pred             eeeeeeeEEEeCcEEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCC
Q 021711          168 NTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDF  247 (308)
Q Consensus       168 niv~l~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~  247 (308)
                      -+.+.+++   +.-++|||++.+-.|...-    .-.+.+.++.-+..+   +.-|-.   +|+||+|..-=||++.+++
T Consensus       173 pVPkpiD~---~RH~Vvmelv~g~Pl~~v~----~v~d~~~ly~~lm~~---Iv~la~---~GlIHgDFNEFNimv~dd~  239 (465)
T KOG2268|consen  173 PVPKPIDH---NRHCVVMELVDGYPLRQVR----HVEDPPTLYDDLMGL---IVRLAN---HGLIHGDFNEFNIMVKDDD  239 (465)
T ss_pred             CCCCcccc---cceeeHHHhhcccceeeee----ecCChHHHHHHHHHH---HHHHHH---cCceecccchheeEEecCC
Confidence            22333333   2336889999887776543    223344443333222   233444   8999999999999999999


Q ss_pred             cEEEecccc
Q 021711          248 EPQICDFGL  256 (308)
Q Consensus       248 ~~kl~DFGl  256 (308)
                      .++++||--
T Consensus       240 ~i~vIDFPQ  248 (465)
T KOG2268|consen  240 KIVVIDFPQ  248 (465)
T ss_pred             CEEEeechH
Confidence            999999953

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.12  E-value=0.02  Score=51.90  Aligned_cols=141  Identities=18%  Similarity=0.186  Sum_probs=78.4

Q ss_pred             cceeeccCceEEEEEEECCCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCC--eeeeeeeE-------EEeCcEEEEE
Q 021711          115 ENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHP--NTAKLLGY-------GIEGGMHIVL  185 (308)
Q Consensus       115 ~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~-------~~~~~~~lv~  185 (308)
                      .+.++.|....+|+....+| .+++|+.......   .....|.+++..|...  .+.+++..       ...+..++++
T Consensus        27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~~~---~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~  102 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRVKA---EELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLV  102 (307)
T ss_pred             ccccCCccccceEEEEeCCC-cEEEEEecCCCCH---HHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEE
Confidence            45677777789999876545 5778876543222   2233455666665321  23343321       1133467899


Q ss_pred             EecCCCCHH-----------HH---HhccCCC-----------CCHHHHHH------------HHHHHHHHHHHHHh---
Q 021711          186 ELSPNGSLA-----------SL---LYGMKEK-----------LKWGIRYK------------IALGVAEGLLYLHE---  225 (308)
Q Consensus       186 e~~~~gsL~-----------~~---l~~~~~~-----------l~~~~~~~------------i~~qi~~~L~yLH~---  225 (308)
                      +|++|..+.           ..   ++.....           ..|.....            ....+...+.++..   
T Consensus       103 e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~  182 (307)
T TIGR00938       103 EFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWP  182 (307)
T ss_pred             EeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhh
Confidence            999875421           11   1110010           01111000            01112334444432   


Q ss_pred             -CCCCCceecCCCCCCEEECCCCcEEEecccccee
Q 021711          226 -GCQRRIIHRDIKAANILLTEDFEPQICDFGLAKW  259 (308)
Q Consensus       226 -~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~  259 (308)
                       ..+.+++|+|+.+.||+++.++.+.|+||+.+..
T Consensus       183 ~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~  217 (307)
T TIGR00938       183 RDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT  217 (307)
T ss_pred             hcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence             2346899999999999999887778999998853

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.01  E-value=0.0085  Score=53.65  Aligned_cols=32  Identities=28%  Similarity=0.416  Sum_probs=26.5

Q ss_pred             CCceecCCCCCCEEECCCCc-EEEeccccceec
Q 021711          229 RRIIHRDIKAANILLTEDFE-PQICDFGLAKWL  260 (308)
Q Consensus       229 ~~iiHrDlKp~NILl~~~~~-~kl~DFGla~~~  260 (308)
                      ..++|+|+.|.|||++.++. .-|+||+.+..-
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG  217 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKVG  217 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence            34899999999999997555 569999998754

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.75  E-value=0.014  Score=53.97  Aligned_cols=73  Identities=14%  Similarity=0.143  Sum_probs=44.1

Q ss_pred             eeeccCceEEEEEEECCC-cEEEEEEecc-----C-ChHHHHHHHHHHHHHHhcCC--CC-eeeeeeeEEEeCcEEEEEE
Q 021711          117 LIGKGGYAEVYKGRLRNG-QLVAIKRLTR-----G-TADEIIADFLSELGIMAHVD--HP-NTAKLLGYGIEGGMHIVLE  186 (308)
Q Consensus       117 ~LG~G~fg~Vy~~~~~~g-~~vAvK~~~~-----~-~~~~~~~~~~~E~~~l~~l~--h~-niv~l~~~~~~~~~~lv~e  186 (308)
                      .||-|....||++...+| +.|+||.-..     . .-.-...+...|...|....  -| .+++++.| ......+|||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~-D~e~~~~vME   80 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF-DTEMAVTVME   80 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE-ccccceehHh
Confidence            478899999999997654 5899996421     1 10112344456777776553  24 34444443 3334458999


Q ss_pred             ecCC
Q 021711          187 LSPN  190 (308)
Q Consensus       187 ~~~~  190 (308)
                      +++.
T Consensus        81 dL~~   84 (370)
T TIGR01767        81 DLSH   84 (370)
T ss_pred             hCcc
Confidence            9854

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PLN02236 choline kinase

Probab=96.68  E-value=0.016  Score=53.63  Aligned_cols=140  Identities=19%  Similarity=0.241  Sum_probs=77.4

Q ss_pred             eeeccCceEEEEEEECC-----CcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeee-eeeeEEEeCcEEEEEEecCC
Q 021711          117 LIGKGGYAEVYKGRLRN-----GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTA-KLLGYGIEGGMHIVLELSPN  190 (308)
Q Consensus       117 ~LG~G~fg~Vy~~~~~~-----g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~lv~e~~~~  190 (308)
                      .|-.|-.-.+|++...+     +..|++|+...... ... +-.+|..++..+...++. ++++.+.. +  .|.+|+++
T Consensus        43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~-~~i-dR~~E~~~~~~l~~~gl~P~~~~~~~~-g--~v~efi~g  117 (344)
T PLN02236         43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVE-LFF-DRDDEIRTFECMSRHGQGPRLLGRFPN-G--RVEEFIHA  117 (344)
T ss_pred             EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCC-eee-chHHHHHHHHHHHHcCCCCceEEEECC-c--eEEEeeCC
Confidence            44457777889886532     36788887755432 212 225688887777533333 44454432 2  57888877


Q ss_pred             CCHHHH-----------------HhccCC-----CCCHHHHHHHHHHH-----------------HHHHHHH----Hh-C
Q 021711          191 GSLASL-----------------LYGMKE-----KLKWGIRYKIALGV-----------------AEGLLYL----HE-G  226 (308)
Q Consensus       191 gsL~~~-----------------l~~~~~-----~l~~~~~~~i~~qi-----------------~~~L~yL----H~-~  226 (308)
                      .+|...                 +|....     ...+..+..+..++                 ...+..|    .. .
T Consensus       118 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~  197 (344)
T PLN02236        118 RTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDD  197 (344)
T ss_pred             CCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccC
Confidence            665311                 111110     11122222222111                 1111122    11 1


Q ss_pred             CCCCceecCCCCCCEEECC-CCcEEEeccccceecC
Q 021711          227 CQRRIIHRDIKAANILLTE-DFEPQICDFGLAKWLP  261 (308)
Q Consensus       227 ~~~~iiHrDlKp~NILl~~-~~~~kl~DFGla~~~~  261 (308)
                      ....++|+|+++.|||+++ ++.+.++||..|..-.
T Consensus       198 ~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~~~  233 (344)
T PLN02236        198 QEIGFCHNDLQYGNIMIDEETRAITIIDYEYASYNP  233 (344)
T ss_pred             CCceEEeCCCCcCcEEEeCCCCcEEEEeehhccccc
Confidence            1246899999999999986 4689999999887543

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=96.55  E-value=0.031  Score=51.73  Aligned_cols=138  Identities=17%  Similarity=0.151  Sum_probs=89.0

Q ss_pred             cceeeccCceEEEEEEECCCcEEEEEEeccCC------------------------hHHH-HHHHHHHHHHHhcCCCCee
Q 021711          115 ENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGT------------------------ADEI-IADFLSELGIMAHVDHPNT  169 (308)
Q Consensus       115 ~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~------------------------~~~~-~~~~~~E~~~l~~l~h~ni  169 (308)
                      ...|..|--+.||.+...+|..+|||+.+..-                        +... .-....|++-|++|+...|
T Consensus       149 nGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGI  228 (520)
T KOG2270|consen  149 NGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGI  228 (520)
T ss_pred             ccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCC
Confidence            34677888899999998899999999864310                        0111 1123457777777754443


Q ss_pred             eeeeeEEEeCcEEEEEEecCCCCHHH-HHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCc
Q 021711          170 AKLLGYGIEGGMHIVLELSPNGSLAS-LLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFE  248 (308)
Q Consensus       170 v~l~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~  248 (308)
                      ...--.... .-.|||+|+....... .|  ....++...+..+-.|++.-|.-|..-  .++||.||.-=|+|+.+ |.
T Consensus       229 P~PePIlLk-~hVLVM~FlGrdgw~aPkL--Kd~~ls~~ka~~~Y~~~v~~MR~lY~~--c~LVHADLSEfN~Lyhd-G~  302 (520)
T KOG2270|consen  229 PCPEPILLK-NHVLVMEFLGRDGWAAPKL--KDASLSTSKARELYQQCVRIMRRLYQK--CRLVHADLSEFNLLYHD-GK  302 (520)
T ss_pred             CCCCceeee-cceEeeeeccCCCCcCccc--ccccCChHHHHHHHHHHHHHHHHHHHH--hceeccchhhhhheEEC-CE
Confidence            322111111 1258999986432211 12  233466666777777888888877662  68999999999999875 58


Q ss_pred             EEEeccccce
Q 021711          249 PQICDFGLAK  258 (308)
Q Consensus       249 ~kl~DFGla~  258 (308)
                      +.|+|-+-+.
T Consensus       303 lyiIDVSQSV  312 (520)
T KOG2270|consen  303 LYIIDVSQSV  312 (520)
T ss_pred             EEEEEccccc
Confidence            8999987654

>PRK06148 hypothetical protein; Provisional

Probab=96.44  E-value=0.077  Score=56.09  Aligned_cols=33  Identities=33%  Similarity=0.430  Sum_probs=27.4

Q ss_pred             CCCCceecCCCCCCEEECCCC--cEE-Eecccccee
Q 021711          227 CQRRIIHRDIKAANILLTEDF--EPQ-ICDFGLAKW  259 (308)
Q Consensus       227 ~~~~iiHrDlKp~NILl~~~~--~~k-l~DFGla~~  259 (308)
                      .+..+||.|+.+.|||++.++  .+. |+|||-+..
T Consensus       201 Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        201 LPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             CCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            346799999999999999875  555 999998764

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=96.34  E-value=0.0021  Score=66.47  Aligned_cols=150  Identities=23%  Similarity=0.162  Sum_probs=103.2

Q ss_pred             HHHHHHHHHHHhcCCCCeeeeeeeEEEeCc-----EEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh
Q 021711          151 IADFLSELGIMAHVDHPNTAKLLGYGIEGG-----MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHE  225 (308)
Q Consensus       151 ~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~  225 (308)
                      ......|+..+..+.|+|++.++.|..+.-     ..+..+++..-++...+. .....+......+..++.+||.|+|+
T Consensus       226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q-~v~~i~~~~~r~~~~~~~~GL~~~h~  304 (1351)
T KOG1035|consen  226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQ-SVGSIPLETLRILHQKLLEGLAYLHS  304 (1351)
T ss_pred             HHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHh-hccccCHHHHHHHHHHHhhhHHHHHH
Confidence            344456777888899999999998866532     124457888888888774 35567888888889999999999998


Q ss_pred             CCCCCceecCCCCC---CEEECCCCcEEEe--ccccceecCCCCceeEeeceeccccccccccCchhhcC--ccceeEEE
Q 021711          226 GCQRRIIHRDIKAA---NILLTEDFEPQIC--DFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPLVILK--RCFTCIFI  298 (308)
Q Consensus       226 ~~~~~iiHrDlKp~---NILl~~~~~~kl~--DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~--~~~Di~s~  298 (308)
                         ....|.-|..+   +--.+..+...++  ||+..+.++.....   ....-+..+.+||...+...+  +..|+|.+
T Consensus       305 ---~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~---~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~l  378 (1351)
T KOG1035|consen  305 ---LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS---FSDLLAEIRNADEDLKENTAKKSRLTDLWCL  378 (1351)
T ss_pred             ---hccceeEEecccccccccCccceeecchhhhcccccCCCcccc---hhhcCccccccccccccccchhhhhhHHHHH
Confidence               54555444444   3334455666766  99988877654321   223345566788877666554  44799999


Q ss_pred             eeEEEeecc
Q 021711          299 GFSQLQLSC  307 (308)
Q Consensus       299 g~~l~el~c  307 (308)
                      |.....+.+
T Consensus       379 gll~~~~~~  387 (1351)
T KOG1035|consen  379 GLLLLQLSQ  387 (1351)
T ss_pred             HHHHhhhhh
Confidence            987766554

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.32  E-value=0.051  Score=49.55  Aligned_cols=32  Identities=19%  Similarity=0.347  Sum_probs=28.6

Q ss_pred             CCceecCCCCCCEEECCCCcEEEeccccceec
Q 021711          229 RRIIHRDIKAANILLTEDFEPQICDFGLAKWL  260 (308)
Q Consensus       229 ~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~  260 (308)
                      ..++|+|+.+.|++++.++.+-|.||+++..-
T Consensus       198 ~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG  229 (321)
T COG3173         198 PVLVHGDYRPGNLIIDPGRPTGVLDWELATLG  229 (321)
T ss_pred             ceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence            45899999999999999988999999998753

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.21  E-value=0.061  Score=48.44  Aligned_cols=73  Identities=16%  Similarity=0.197  Sum_probs=42.7

Q ss_pred             ccceeeccCceEEEEEEECCCcEEEEEEeccCChHHHHHHHHHHHHHHhcC---CCCeeeeeeeEEEe-CcEEEEEEecC
Q 021711          114 FENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHV---DHPNTAKLLGYGIE-GGMHIVLELSP  189 (308)
Q Consensus       114 ~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~-~~~~lv~e~~~  189 (308)
                      -.+.++-|....+|+.. .+++.+.||.-....    ...|..|..-|+.|   .--.+.+++++... +..+||+||++
T Consensus        21 ~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~~~----~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~   95 (288)
T PF03881_consen   21 SIEPVSGGDINEAYRLD-TDGGSYFVKVNSESG----RDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLE   95 (288)
T ss_dssp             EEEEE--SSSSEEEEEE-TTS-EEEEEEEEGGG----CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE---
T ss_pred             eeEecCCCChhheEEEE-CCCccEEEEecChhh----HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeec
Confidence            34678889999999877 567889999876221    23455676666666   34567788887654 45689999987


Q ss_pred             CC
Q 021711          190 NG  191 (308)
Q Consensus       190 ~g  191 (308)
                      .+
T Consensus        96 ~~   97 (288)
T PF03881_consen   96 MG   97 (288)
T ss_dssp             --
T ss_pred             CC
Confidence            66

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.21  E-value=0.16  Score=47.95  Aligned_cols=74  Identities=11%  Similarity=0.005  Sum_probs=47.6

Q ss_pred             cceeeccCceEEEEEEECCCcEEEEEEeccCC---hH---HHHHHHHHHHHHHhcCC---CCeeeeeeeEEEeCcEEEEE
Q 021711          115 ENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGT---AD---EIIADFLSELGIMAHVD---HPNTAKLLGYGIEGGMHIVL  185 (308)
Q Consensus       115 ~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~---~~---~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~lv~  185 (308)
                      .+.||-|....||+.... +..++||.-....   .+   -...+-..|...|..+.   ..++.+++.++.+. ..++|
T Consensus        37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded~-~vlvM  114 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRTM-ALIGM  114 (418)
T ss_pred             EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCCC-CEEEE
Confidence            457899999999998864 5568899754111   00   01233445566665543   34777888877643 46789


Q ss_pred             EecCC
Q 021711          186 ELSPN  190 (308)
Q Consensus       186 e~~~~  190 (308)
                      |++++
T Consensus       115 E~L~~  119 (418)
T PLN02756        115 RYLEP  119 (418)
T ss_pred             eecCC
Confidence            99976

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=95.83  E-value=0.068  Score=49.13  Aligned_cols=140  Identities=19%  Similarity=0.227  Sum_probs=75.1

Q ss_pred             ceeeccCceEEEEEEECC----CcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCee-eeeeeEEEeCcEEEEEEecCC
Q 021711          116 NLIGKGGYAEVYKGRLRN----GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT-AKLLGYGIEGGMHIVLELSPN  190 (308)
Q Consensus       116 ~~LG~G~fg~Vy~~~~~~----g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~lv~e~~~~  190 (308)
                      +.|..|=...+|+....+    +..|++|........  .-+-.+|..+++.+..-++ .+++++. .++  +|.+|+++
T Consensus        20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~--~IdR~~E~~il~~l~~~gl~P~~l~~~-~~G--~i~~fi~g   94 (330)
T PLN02421         20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY--VIDRERELQAIKYLSAAGFGAKLLGVF-GNG--MIQSFINA   94 (330)
T ss_pred             EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCe--EechHHHHHHHHHHHhcCCCCceeEEe-CCc--EeehhhcC
Confidence            344446677888886543    237888877544321  1223467777777754444 3445544 333  47888876


Q ss_pred             CCHHH--------------H---HhccCCC----C-CHHHHHHHHHHH----------------------HHHHHHHHh-
Q 021711          191 GSLAS--------------L---LYGMKEK----L-KWGIRYKIALGV----------------------AEGLLYLHE-  225 (308)
Q Consensus       191 gsL~~--------------~---l~~~~~~----l-~~~~~~~i~~qi----------------------~~~L~yLH~-  225 (308)
                      .+|..              .   ++....+    . .+..+..+..++                      ..-+..+.. 
T Consensus        95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~  174 (330)
T PLN02421         95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI  174 (330)
T ss_pred             CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence            54421              1   1111101    1 122222222111                      111111111 


Q ss_pred             ----CCCCCceecCCCCCCEEECC-CCcEEEeccccceec
Q 021711          226 ----GCQRRIIHRDIKAANILLTE-DFEPQICDFGLAKWL  260 (308)
Q Consensus       226 ----~~~~~iiHrDlKp~NILl~~-~~~~kl~DFGla~~~  260 (308)
                          ..+.-+.|.|+-+.|||+++ ++.++++||..|..-
T Consensus       175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~n  214 (330)
T PLN02421        175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSYS  214 (330)
T ss_pred             hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCCC
Confidence                11123799999999999975 468999999988654

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=95.72  E-value=0.00052  Score=72.67  Aligned_cols=150  Identities=11%  Similarity=-0.095  Sum_probs=100.7

Q ss_pred             HHHHHHHHhcCCCCeeeeeeeEEE---eCcEEEEEEecCCCCHHHHHhccCCC---CCHHHHHHHHHHHHHHHHHHHhC-
Q 021711          154 FLSELGIMAHVDHPNTAKLLGYGI---EGGMHIVLELSPNGSLASLLYGMKEK---LKWGIRYKIALGVAEGLLYLHEG-  226 (308)
Q Consensus       154 ~~~E~~~l~~l~h~niv~l~~~~~---~~~~~lv~e~~~~gsL~~~l~~~~~~---l~~~~~~~i~~qi~~~L~yLH~~-  226 (308)
                      .+.|..-.+...|+++.....=..   ....+.+++|+.+|.+.+.+.+....   +...-+.....+...+..-+|.. 
T Consensus      1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred             hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence            344555556678998887654221   12357899999999999988653322   22222222222224444444431 


Q ss_pred             -CCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEee
Q 021711          227 -CQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQL  305 (308)
Q Consensus       227 -~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el  305 (308)
                       ..+-.+|++||+-|.++..+..+|++++|+.+.......  ......+++-|+.|+...+...+.++|+|..++.+|++
T Consensus      1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~s--f~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLS--FFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred             cCCccchhhhhhhhccceecCCcccccccccccccCchHh--hhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHH
Confidence             123478999999999999999999999999994433211  12346678889999999999999889999977776654

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=95.72  E-value=0.2  Score=45.42  Aligned_cols=33  Identities=15%  Similarity=0.275  Sum_probs=29.0

Q ss_pred             CCCceecCCCCCCEEECCCCcEEEeccccceec
Q 021711          228 QRRIIHRDIKAANILLTEDFEPQICDFGLAKWL  260 (308)
Q Consensus       228 ~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~  260 (308)
                      ..+++|+|+.+.|+|++.++.+.++||-.+..-
T Consensus       195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~d  227 (309)
T TIGR02904       195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASFA  227 (309)
T ss_pred             ceeeeCCCCcHHhEEEcCCCCEEEEEhhhcccC
Confidence            357999999999999999989999999887653

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=95.47  E-value=0.054  Score=50.08  Aligned_cols=54  Identities=19%  Similarity=0.182  Sum_probs=45.1

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceec
Q 021711          204 LKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL  260 (308)
Q Consensus       204 l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~  260 (308)
                      -.+.+.+.++.+.+.-+.-+..  .-..-|||+.-.||||+ +|++.|+||-++|.-
T Consensus       318 ~~~~e~lsff~s~~sil~~lek--kf~fehrnlt~~niLId-~GnvtLIDfklsRl~  371 (488)
T COG5072         318 DRSEEELSFFWSCISILDILEK--KFPFEHRNLTLDNILID-EGNVTLIDFKLSRLS  371 (488)
T ss_pred             ccHHHHHHHHHHHHHHHhhhhh--cCCcccccccccceeee-cCceEEEEeeeeecc
Confidence            4677888888887777776765  25689999999999999 899999999999943

>PRK12396 5-methylribose kinase; Reviewed

Probab=95.46  E-value=0.08  Score=49.71  Aligned_cols=75  Identities=15%  Similarity=0.078  Sum_probs=45.6

Q ss_pred             cceeeccCceEEEEEEECC-CcEEEEEEecc----CCh-HHHHHHHHHHHHHHhcCC--CC-eeeeeeeEEEeCcEEEEE
Q 021711          115 ENLIGKGGYAEVYKGRLRN-GQLVAIKRLTR----GTA-DEIIADFLSELGIMAHVD--HP-NTAKLLGYGIEGGMHIVL  185 (308)
Q Consensus       115 ~~~LG~G~fg~Vy~~~~~~-g~~vAvK~~~~----~~~-~~~~~~~~~E~~~l~~l~--h~-niv~l~~~~~~~~~~lv~  185 (308)
                      .+.||-|.-..||++...+ +..|+||.-..    ... .-..++...|.+.|+...  -| .+++++.| ......+||
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~-D~e~~~~vM  112 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF-DSVMNCCVM  112 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE-CcHHhhHHH
Confidence            3578999999999999753 56799986421    111 112455566777776652  23 44455543 333345788


Q ss_pred             EecCC
Q 021711          186 ELSPN  190 (308)
Q Consensus       186 e~~~~  190 (308)
                      |+++.
T Consensus       113 EdL~~  117 (409)
T PRK12396        113 EDLSD  117 (409)
T ss_pred             HhCcc
Confidence            88754

>PRK11768 serine/threonine protein kinase; Provisional

Probab=95.00  E-value=0.98  Score=41.36  Aligned_cols=30  Identities=30%  Similarity=0.434  Sum_probs=25.2

Q ss_pred             CCCceecCCCCCCEEECCCCcEEEecccccee
Q 021711          228 QRRIIHRDIKAANILLTEDFEPQICDFGLAKW  259 (308)
Q Consensus       228 ~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~  259 (308)
                      ..++||+|+.+.|||++ + .+.|+||+-+..
T Consensus       195 ~~~liHgD~h~~NvL~~-d-~~~iIDFDd~~~  224 (325)
T PRK11768        195 RLLRLHGDCHPGNILWR-D-GPHFVDLDDARM  224 (325)
T ss_pred             CccceecCCCchhcccc-C-CcEEEeCCCCCC
Confidence            35689999999999995 4 578999998764

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=94.21  E-value=0.01  Score=56.45  Aligned_cols=70  Identities=23%  Similarity=0.423  Sum_probs=58.5

Q ss_pred             hhcCCccccceeeccCceEEEEEEECC-CcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEE
Q 021711          107 SATNNFSFENLIGKGGYAEVYKGRLRN-GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYG  176 (308)
Q Consensus       107 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~-g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  176 (308)
                      ...++|.....+|.|+||+|+.+.... +..+|||.|..........+.++|..-+..+.|+++++++..+
T Consensus        46 r~a~~~e~~~~~~~~g~~~~~~~~n~~d~~~~avkritlkn~e~s~~rvl~~~~s~a~feh~g~~~~~ha~  116 (516)
T KOG1033|consen   46 REANDFEPGQCLGRGGFGVVFSAQNKADENKYAVKRITLKNREESRSRVLREVSSLAEFEHPGIKRYFHAW  116 (516)
T ss_pred             hhhccccccccccccCccccCCccccccchhhHHHHhcccchhhhhhhhhccccchhhhcccchhhheece
Confidence            334688899999999999999998774 5589999997766666678889999999999999999987633

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=94.11  E-value=0.32  Score=42.16  Aligned_cols=87  Identities=14%  Similarity=0.095  Sum_probs=57.0

Q ss_pred             HHHHHHHHHHhcCCCCeeeeeeeEEEeCcEEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCc
Q 021711          152 ADFLSELGIMAHVDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRI  231 (308)
Q Consensus       152 ~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~i  231 (308)
                      .-|..+.+++++++  .|+++..- ....+-+++|.|-....          ..    ..++.-=+..|.-.|+.. .+.
T Consensus       103 ~~y~nky~v~Armh--GilrL~ND-n~~~yGvIlE~Cy~~~i----------~~----~N~i~agi~~L~~fH~~~-~~~  164 (308)
T PF07387_consen  103 ALYFNKYRVFARMH--GILRLKND-NNYKYGVILERCYKIKI----------NF----SNFITAGIKDLMDFHSEN-QHC  164 (308)
T ss_pred             hhhhhhhhHHHHhh--heeEeecC-CCceeEEEEeeccCccc----------ch----hHHHHHhHHHHHHhhccC-CCe
Confidence            44667788888763  57777621 11134588898853211          00    111111135677788543 679


Q ss_pred             eecCCCCCCEEECCCCcEEEecccc
Q 021711          232 IHRDIKAANILLTEDFEPQICDFGL  256 (308)
Q Consensus       232 iHrDlKp~NILl~~~~~~kl~DFGl  256 (308)
                      +|+|-.|+||+-|..|.+||.|-+.
T Consensus       165 lHGD~np~NiM~D~~G~lKlVDP~~  189 (308)
T PF07387_consen  165 LHGDCNPDNIMCDKFGYLKLVDPVC  189 (308)
T ss_pred             ecCCCChhheeecCCCCEEecChhh
Confidence            9999999999999999999999774

The function of this family is unknown.

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=93.76  E-value=0.23  Score=46.69  Aligned_cols=58  Identities=17%  Similarity=0.147  Sum_probs=37.6

Q ss_pred             EEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEEC
Q 021711          183 IVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLT  244 (308)
Q Consensus       183 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~  244 (308)
                      ++=+|.+|-++..++...  ..++....+++.-.+.|+.-+-.  --+++|.|+.|.||++-
T Consensus       322 l~E~~~~Gl~v~~~v~~~--~~pe~l~kkva~lg~~AllkMl~--vDNFvHaDlHPGNVlir  379 (565)
T KOG1236|consen  322 LVETYERGLSVLRFVKWK--SQPEALVKKVAKLGVNALLKMLI--VDNFVHADLHPGNVLIR  379 (565)
T ss_pred             eeeeccccccHHhhhhcc--cChHHHHHHHHHHHHHHHHHHHH--hhcceecccCCCcEEEE
Confidence            555678888888888542  23444455555545555533322  15799999999999995

>PF03109 ABC1: ABC1 family; InterPro: IPR004147 This entry includes ABC1 from yeast [] and AarF from Escherichia coli []

Probab=93.67  E-value=0.034  Score=43.19  Aligned_cols=44  Identities=25%  Similarity=0.425  Sum_probs=33.4

Q ss_pred             ceeeccCceEEEEEEECCCcEEEEEEeccCChHHHHHHHHHHHHHHhc
Q 021711          116 NLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAH  163 (308)
Q Consensus       116 ~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~  163 (308)
                      +.||.|+.|.||+|++++|+.||||...+...    +.+...+.+|+.
T Consensus        17 ~PlasASiaQVh~a~l~~g~~VaVKV~rP~i~----~~i~~Dl~~l~~   60 (119)
T PF03109_consen   17 EPLASASIAQVHRARLKDGEEVAVKVQRPGIE----EQIEADLRILRR   60 (119)
T ss_pred             chhhheehhhheeeeecccchhhhhhcchHHH----HHHHHHHHHHHH
Confidence            67999999999999999999999999876543    334444444443

These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex [] and E. coli AarF is required for ubiquinone production []. It has been suggested that members of the ABC1 family are novel chaperonins []. These proteins are unrelated to the ABC transporter proteins.

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=93.15  E-value=0.21  Score=45.08  Aligned_cols=30  Identities=33%  Similarity=0.444  Sum_probs=26.2

Q ss_pred             CCceecCCCCCCEEECCCCcEEEecccccee
Q 021711          229 RRIIHRDIKAANILLTEDFEPQICDFGLAKW  259 (308)
Q Consensus       229 ~~iiHrDlKp~NILl~~~~~~kl~DFGla~~  259 (308)
                      .+++|+|+.+.||+++. +.+.|+||+.+..
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~  216 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCTI  216 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence            57999999999999998 5789999997654

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PRK10271 thiK thiamine kinase; Provisional

Probab=93.12  E-value=0.074  Score=44.67  Aligned_cols=29  Identities=21%  Similarity=0.266  Sum_probs=25.7

Q ss_pred             CceecCCCCCCEEECCCCcEEEecccccee
Q 021711          230 RIIHRDIKAANILLTEDFEPQICDFGLAKW  259 (308)
Q Consensus       230 ~iiHrDlKp~NILl~~~~~~kl~DFGla~~  259 (308)
                      -.+|+|+.|.|+++++++ ++|+||+.|..
T Consensus        78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~  106 (188)
T PRK10271         78 APLHMDVHAGNLVHSASG-LRLIDWEYAGD  106 (188)
T ss_pred             eeecCCCCCccEEEECCC-EEEEeCCcccC
Confidence            469999999999998877 89999998864

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=93.11  E-value=0.2  Score=45.99  Aligned_cols=29  Identities=34%  Similarity=0.626  Sum_probs=26.1

Q ss_pred             ceecCCCCCCEEECCCCc-EEEecccccee
Q 021711          231 IIHRDIKAANILLTEDFE-PQICDFGLAKW  259 (308)
Q Consensus       231 iiHrDlKp~NILl~~~~~-~kl~DFGla~~  259 (308)
                      +||+|+.|.||+++.+.. +.+.|||-+..
T Consensus       199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~  228 (331)
T COG2334         199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAGY  228 (331)
T ss_pred             eeecCCCccceeEcCCCCeeeEEEcccccc
Confidence            999999999999999875 88999998763

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	308
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		1e-33
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		4e-32
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		6e-25
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		7e-25
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		8e-25
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		1e-24
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		1e-24
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		1e-23
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		1e-18
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		5e-18
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		6e-18
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		6e-17
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		8e-17
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-16
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		5e-16
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		5e-16
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		6e-16
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-16
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-16
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		7e-16
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		9e-16
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-15
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		1e-15
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		1e-15
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		1e-15
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-15
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-15
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-15
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-15
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-15
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		5e-15
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		5e-15
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		5e-15
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		5e-15
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		5e-15
2pl0_A	289	Lck Bound To Imatinib Length = 289		5e-15
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		5e-15
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		6e-15
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		1e-14
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		1e-14
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-14
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		1e-14
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		1e-14
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-14
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-14
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		1e-14
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		1e-14
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-14
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-14
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		2e-14
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-14
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-14
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		2e-14
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-14
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		2e-14
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		2e-14
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-14
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-14
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-14
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-14
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-14
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-14
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		3e-14
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		3e-14
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		3e-14
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		3e-14
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-14
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		3e-14
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		3e-14
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		3e-14
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		3e-14
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		3e-14
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		3e-14
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		3e-14
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-14
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		3e-14
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		3e-14
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-14
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		3e-14
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		3e-14
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		3e-14
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		4e-14
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		4e-14
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		4e-14
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		4e-14
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		4e-14
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		4e-14
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		4e-14
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		4e-14
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		4e-14
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		4e-14
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		4e-14
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		5e-14
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		5e-14
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		6e-14
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-14
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		6e-14
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		7e-14
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		7e-14
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		7e-14
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		1e-13
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-13
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-13
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		1e-13
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		1e-13
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		1e-13
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		1e-13
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-13
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		2e-13
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		2e-13
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		2e-13
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		2e-13
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		2e-13
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		2e-13
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		2e-13
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		2e-13
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		2e-13
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		2e-13
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		2e-13
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		2e-13
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-13
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		2e-13
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		2e-13
1fvr_A	327	Tie2 Kinase Domain Length = 327		2e-13
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		3e-13
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		4e-13
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		4e-13
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		4e-13
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		4e-13
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		4e-13
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		4e-13
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		4e-13
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		5e-13
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		5e-13
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		5e-13
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		5e-13
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		5e-13
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		5e-13
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		6e-13
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		6e-13
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		6e-13
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		6e-13
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		6e-13
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		6e-13
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		6e-13
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		6e-13
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		7e-13
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		7e-13
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		7e-13
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		8e-13
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		8e-13
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		9e-13
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		9e-13
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		1e-12
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		1e-12
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		1e-12
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-12
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		1e-12
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-12
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-12
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-12
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		2e-12
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		2e-12
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-12
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-12
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		2e-12
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		2e-12
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		2e-12
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		2e-12
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		2e-12
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		2e-12
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-12
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		2e-12
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-12
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-12
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-12
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-12
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		2e-12
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		2e-12
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		3e-12
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		3e-12
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		3e-12
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		3e-12
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		3e-12
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		3e-12
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		3e-12
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		3e-12
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		3e-12
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		3e-12
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		3e-12
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		3e-12
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		4e-12
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		4e-12
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		4e-12
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		4e-12
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		4e-12
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		4e-12
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		4e-12
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		5e-12
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		6e-12
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		6e-12
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		6e-12
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		6e-12
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		6e-12
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		7e-12
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		7e-12
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		7e-12
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		7e-12
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		7e-12
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		8e-12
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		8e-12
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		8e-12
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		8e-12
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		8e-12
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		9e-12
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		9e-12
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		9e-12
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		9e-12
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		1e-11
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		1e-11
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		1e-11
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-11
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		1e-11
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		1e-11
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		1e-11
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		1e-11
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		1e-11
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		1e-11
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		1e-11
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		1e-11
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		1e-11
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-11
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		1e-11
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		1e-11
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-11
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		2e-11
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		2e-11
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		2e-11
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-11
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		2e-11
3a4o_X	286	Lyn Kinase Domain Length = 286		2e-11
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		2e-11
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		2e-11
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		2e-11
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		2e-11
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		2e-11
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-11
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		3e-11
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		3e-11
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-11
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		3e-11
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		3e-11
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		4e-11
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		4e-11
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		4e-11
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		4e-11
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		4e-11
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		5e-11
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		5e-11
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		5e-11
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		6e-11
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		6e-11
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		6e-11
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		6e-11
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		7e-11
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		7e-11
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		8e-11
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		8e-11
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		8e-11
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		8e-11
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		9e-11
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-10
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-10
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		1e-10
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		1e-10
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		1e-10
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		1e-10
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		1e-10
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		1e-10
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		1e-10
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		2e-10
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-10
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		2e-10
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		2e-10
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		3e-10
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		3e-10
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		3e-10
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		3e-10
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		4e-10
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		4e-10
3a7f_A	303	Human Mst3 Kinase Length = 303		4e-10
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-10
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		5e-10
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-10
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		6e-10
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		6e-10
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		6e-10
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		6e-10
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		6e-10
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		6e-10
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		6e-10
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-10
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		6e-10
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		6e-10
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		6e-10
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-10
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		7e-10
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		7e-10
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		7e-10
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		7e-10
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		7e-10
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		7e-10
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		7e-10
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		7e-10
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		7e-10
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		7e-10
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		7e-10
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		7e-10
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		7e-10
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		7e-10
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		7e-10
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		7e-10
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		7e-10
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		8e-10
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		8e-10
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		8e-10
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		8e-10
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		8e-10
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		8e-10
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		8e-10
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		8e-10
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		8e-10
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		8e-10
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		8e-10
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		8e-10
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		8e-10
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		8e-10
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		8e-10
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		9e-10
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		9e-10
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		9e-10
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		9e-10
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		9e-10
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		9e-10
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		1e-09
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		1e-09
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		1e-09
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-09
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-09
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		1e-09
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		1e-09
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-09
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-09
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-09
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		1e-09
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		1e-09
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		1e-09
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		1e-09
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		1e-09
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		1e-09
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		1e-09
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		1e-09
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		1e-09
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-09
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		1e-09
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		1e-09
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		2e-09
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-09
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		2e-09
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		2e-09
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		2e-09
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		2e-09
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-09
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		2e-09
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		2e-09
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		2e-09
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		2e-09
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-09
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		2e-09
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-09
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		2e-09
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		2e-09
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-09
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		2e-09
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-09
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-09
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		3e-09
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		3e-09
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		3e-09
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		3e-09
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		3e-09
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		3e-09
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		3e-09
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		3e-09
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-09
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		3e-09
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		3e-09
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		3e-09
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		3e-09
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		4e-09
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		4e-09
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		4e-09
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		4e-09
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		4e-09
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		4e-09
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		4e-09
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-09
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		4e-09
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		4e-09
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		4e-09
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		5e-09
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		5e-09
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		5e-09
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		5e-09
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		5e-09
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		5e-09
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		5e-09
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		5e-09
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		5e-09
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		6e-09
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-09
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		6e-09
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		6e-09
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		7e-09
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		7e-09
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		7e-09
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		7e-09
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		8e-09
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		9e-09
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		9e-09
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		9e-09
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		9e-09
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		9e-09
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		1e-08
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		1e-08
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		1e-08
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-08
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		1e-08
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		1e-08
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		1e-08
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		1e-08
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		1e-08
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-08
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		1e-08
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		1e-08
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		1e-08
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-08
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		2e-08
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		2e-08
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		2e-08
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-08
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		2e-08
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		2e-08
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		2e-08
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		2e-08
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		2e-08
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		2e-08
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		2e-08
4exu_A	371	Mapk13, Inactive Form Length = 371		2e-08
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-08
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-08
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-08
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		2e-08
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-08
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-08
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-08
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-08
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		2e-08
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		3e-08
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		3e-08
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-08
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		3e-08
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		3e-08
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-08
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		3e-08
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-08
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-08
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		4e-08
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		4e-08
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		4e-08
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		4e-08
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		4e-08
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		4e-08
3b2t_A	311	Structure Of Phosphotransferase Length = 311		4e-08
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		4e-08
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		4e-08
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		4e-08
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		4e-08
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		4e-08
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		4e-08
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		4e-08
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		4e-08
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		5e-08
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		5e-08
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		6e-08
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		6e-08
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		6e-08
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		7e-08
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		7e-08
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		8e-08
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		8e-08
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		9e-08
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		9e-08
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		9e-08
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		9e-08
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		1e-07
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-07
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-07
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		1e-07
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		1e-07
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		1e-07
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		1e-07
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-07
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		2e-07
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-07
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-07
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-07
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		2e-07
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		2e-07
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		2e-07
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-07
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		2e-07
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		2e-07
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-07
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-07
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		2e-07
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		3e-07
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		3e-07
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		3e-07
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		3e-07
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		4e-07
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		4e-07
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		4e-07
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		4e-07
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		4e-07
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		4e-07
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		4e-07
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		4e-07
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		5e-07
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		5e-07
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		5e-07
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		5e-07
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		5e-07
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		5e-07
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		5e-07
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		5e-07
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		5e-07
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		5e-07
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		5e-07
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		5e-07
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		5e-07
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		6e-07
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		6e-07
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		6e-07
3g51_A	325	Structural Diversity Of The Active Conformation Of		6e-07
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		6e-07
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		6e-07
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		7e-07
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		7e-07
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		7e-07
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		7e-07
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		7e-07
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		7e-07
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		7e-07
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		7e-07
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		7e-07
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		8e-07
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		8e-07
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		8e-07
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		8e-07
2oza_B	366	Structure Of P38alpha Complex Length = 366		8e-07
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		8e-07
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		8e-07
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		8e-07
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		9e-07
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		9e-07
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		9e-07
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		9e-07
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		1e-06
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		1e-06
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		1e-06
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		1e-06
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		1e-06
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		1e-06
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		1e-06
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		1e-06
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		1e-06
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		1e-06
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		1e-06
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		1e-06
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		1e-06
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		1e-06
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		1e-06
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		1e-06
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		1e-06
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		1e-06
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		1e-06
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		1e-06
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		1e-06
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		1e-06
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		1e-06
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-06
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		1e-06
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		1e-06
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		1e-06
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-06
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		1e-06
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		1e-06
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		1e-06
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		1e-06
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		1e-06
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-06
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		1e-06
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-06
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		1e-06
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-06
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		1e-06
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		1e-06
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		1e-06
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		1e-06
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		1e-06
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		1e-06
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-06
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		2e-06
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		2e-06
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		2e-06
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		2e-06
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		2e-06
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		2e-06
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		2e-06
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		2e-06
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		2e-06
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		2e-06
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		2e-06
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		2e-06
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		2e-06
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		2e-06
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		2e-06
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		2e-06
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		2e-06
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		2e-06
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		2e-06
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		2e-06
3hec_A	348	P38 In Complex With Imatinib Length = 348		2e-06
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		2e-06
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		2e-06
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		2e-06
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		2e-06
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		2e-06
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		2e-06
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		2e-06
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		2e-06
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		2e-06
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		2e-06
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		2e-06
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		2e-06
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		2e-06
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		2e-06
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		2e-06
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		2e-06
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		2e-06
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		3e-06
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		3e-06
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		3e-06
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		3e-06
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		3e-06
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		3e-06
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		3e-06
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-06
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		3e-06
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		3e-06
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		3e-06
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		3e-06
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-06
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		4e-06
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		4e-06
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		4e-06
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-06
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		4e-06
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		4e-06
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		4e-06
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		4e-06
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		4e-06
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		4e-06
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		5e-06
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		5e-06
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		7e-06
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		7e-06
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		7e-06
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		7e-06
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		7e-06
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		7e-06
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		7e-06
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		9e-06
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		9e-06
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		9e-06
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		1e-05
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		1e-05
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		1e-05
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		1e-05
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		1e-05
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		1e-05
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-05
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		1e-05
4fl3_A	635	Structural And Biophysical Characterization Of The		1e-05
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		1e-05
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-05
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		1e-05
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		1e-05
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		1e-05
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		1e-05
4fl2_A	636	Structural And Biophysical Characterization Of The		1e-05
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		1e-05
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-05
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		2e-05
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		2e-05
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-05
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		2e-05
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		2e-05
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-05
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		2e-05
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		2e-05
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		2e-05
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		2e-05
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-05
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		3e-05
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		3e-05
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		3e-05
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		3e-05
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		3e-05
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		3e-05
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		3e-05
4fie_A	423	Full-Length Human Pak4 Length = 423		3e-05
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		4e-05
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		4e-05
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		5e-05
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		5e-05
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		5e-05
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		5e-05
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		6e-05
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		7e-05
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		7e-05
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		7e-05
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		7e-05
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		8e-05
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		8e-05
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		8e-05
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		9e-05
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		9e-05
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		9e-05
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		9e-05
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		1e-04
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-04
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		1e-04
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		1e-04
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		1e-04
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		1e-04
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		1e-04
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		1e-04
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		1e-04
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		2e-04
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		2e-04
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-04
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		2e-04
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-04
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		2e-04
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-04
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		2e-04
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		2e-04
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		2e-04
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-04
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		2e-04
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		2e-04
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-04
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		3e-04
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		3e-04
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		3e-04
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		3e-04
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		3e-04
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		3e-04
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		3e-04
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-04
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		3e-04
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-04
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		3e-04
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		3e-04
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		3e-04
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		4e-04
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		4e-04
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		4e-04
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		4e-04
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		4e-04
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		4e-04
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		4e-04
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		4e-04
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		4e-04
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		4e-04
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		4e-04
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		5e-04
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		5e-04
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		5e-04
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		5e-04
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		5e-04
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		5e-04
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		5e-04
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		5e-04
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		5e-04
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		5e-04
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		5e-04
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		5e-04
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		5e-04
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		5e-04
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		5e-04
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		6e-04
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		6e-04
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		6e-04
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		6e-04
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		6e-04
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		6e-04
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		7e-04
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		7e-04
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		7e-04
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		8e-04
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		8e-04
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		8e-04
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		8e-04
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		9e-04
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		9e-04
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		9e-04
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		9e-04
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		9e-04
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		9e-04
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		9e-04
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		9e-04
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		9e-04
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		9e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  140 bits (352), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 86/205 (41%), Positives = 118/205 (57%), Gaps = 11/205 (5%)
Query: 83  PRNLFVNSYDSQSPQ------KIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQL 136
           P++ F +    + P+      K FSL ELQ A++NFS +N++G+GG+ +VYKGRL +G L
Sbjct: 5   PQDHFFDVPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTL 64
Query: 137 VAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHI-VLELSPNGSLAS 195
           VA+KRL           F +E+ +++   H N  +L G+ +     + V     NGS+AS
Sbjct: 65  VAVKRLKEERXQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVAS 124
Query: 196 LLYGMKEK---LKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQIC 252
            L    E    L W  R +IALG A GL YLH+ C  +IIHRD+KAANILL E+FE  + 
Sbjct: 125 CLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 184
Query: 253 DFGLAKWLPEQWTHHTISKVEGTFG 277
           DFGLAK L +    H    V GT G
Sbjct: 185 DFGLAK-LMDYKDXHVXXAVRGTIG 208

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  135 bits (339), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 81/184 (44%), Positives = 108/184 (58%), Gaps = 5/184 (2%)
Query: 98  KIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSE 157
           K FSL ELQ A++NF  +N++G+GG+ +VYKGRL +G LVA+KRL           F +E
Sbjct: 18  KRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQTE 77
Query: 158 LGIMAHVDHPNTAKLLGYGIEGGMHI-VLELSPNGSLASLLYGMKEK---LKWGIRYKIA 213
           + +++   H N  +L G+ +     + V     NGS+AS L    E    L W  R +IA
Sbjct: 78  VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA 137
Query: 214 LGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVE 273
           LG A GL YLH+ C  +IIHRD+KAANILL E+FE  + DFGLAK L +    H    V 
Sbjct: 138 LGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-LMDYKDXHVXXAVR 196
Query: 274 GTFG 277
           G  G
Sbjct: 197 GXIG 200

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  111 bits (277), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 75/188 (39%), Positives = 102/188 (54%), Gaps = 16/188 (8%)
Query: 100 FSLYELQSATNNFSFE------NLIGKGGYAEVYKGRLRNGQLVAIKRLTRG---TADEI 150
           FS YEL++ TNNF         N +G+GG+  VYKG + N   VA+K+L      T +E+
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEEL 73
Query: 151 IADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMK--EKLKWG 207
              F  E+ +MA   H N  +LLG+  +G  + +V    PNGSL   L  +     L W 
Sbjct: 74  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH 133
Query: 208 IRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH 267
           +R KIA G A G+ +LHE      IHRDIK+ANILL E F  +I DFGLA+   +     
Sbjct: 134 MRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190
Query: 268 TISKVEGT 275
             S++ GT
Sbjct: 191 MXSRIVGT 198

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  110 bits (276), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 72/171 (42%), Positives = 96/171 (56%), Gaps = 16/171 (9%)
Query: 100 FSLYELQSATNNFSFE------NLIGKGGYAEVYKGRLRNGQLVAIKRLTRG---TADEI 150
           FS YEL++ TNNF         N +G+GG+  VYKG + N   VA+K+L      T +E+
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEEL 73
Query: 151 IADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMK--EKLKWG 207
              F  E+ +MA   H N  +LLG+  +G  + +V    PNGSL   L  +     L W 
Sbjct: 74  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH 133
Query: 208 IRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           +R KIA G A G+ +LHE      IHRDIK+ANILL E F  +I DFGLA+
Sbjct: 134 MRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLAR 181

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  110 bits (276), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 72/171 (42%), Positives = 96/171 (56%), Gaps = 16/171 (9%)
Query: 100 FSLYELQSATNNFSFE------NLIGKGGYAEVYKGRLRNGQLVAIKRLTRG---TADEI 150
           FS YEL++ TNNF         N +G+GG+  VYKG + N   VA+K+L      T +E+
Sbjct: 9   FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEEL 67
Query: 151 IADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMK--EKLKWG 207
              F  E+ +MA   H N  +LLG+  +G  + +V    PNGSL   L  +     L W 
Sbjct: 68  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH 127
Query: 208 IRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           +R KIA G A G+ +LHE      IHRDIK+ANILL E F  +I DFGLA+
Sbjct: 128 MRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLAR 175

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  110 bits (274), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 73/182 (40%), Positives = 106/182 (58%), Gaps = 8/182 (4%)
Query: 102 LYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIM 161
           L +L+ ATNNF  + LIG G + +VYKG LR+G  VA+KR T  ++ + I +F +E+  +
Sbjct: 31  LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESS-QGIEEFETEIETL 89
Query: 162 AHVDHPNTAKLLGYGIE-GGMHIVLELSPNGSLASLLYGMK---EKLKWGIRYKIALGVA 217
           +   HP+   L+G+  E   M ++ +   NG+L   LYG       + W  R +I +G A
Sbjct: 90  SFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAA 149
Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFG 277
            GL YLH    R IIHRD+K+ NILL E+F P+I DFG++K   E    H    V+GT G
Sbjct: 150 RGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLG 206
Query: 278 LV 279
            +
Sbjct: 207 YI 208

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  109 bits (273), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 73/182 (40%), Positives = 106/182 (58%), Gaps = 8/182 (4%)
Query: 102 LYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIM 161
           L +L+ ATNNF  + LIG G + +VYKG LR+G  VA+KR T  ++ + I +F +E+  +
Sbjct: 31  LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESS-QGIEEFETEIETL 89
Query: 162 AHVDHPNTAKLLGYGIE-GGMHIVLELSPNGSLASLLYGMK---EKLKWGIRYKIALGVA 217
           +   HP+   L+G+  E   M ++ +   NG+L   LYG       + W  R +I +G A
Sbjct: 90  SFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAA 149
Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFG 277
            GL YLH    R IIHRD+K+ NILL E+F P+I DFG++K   E    H    V+GT G
Sbjct: 150 RGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLG 206
Query: 278 LV 279
            +
Sbjct: 207 YI 208

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 74/188 (39%), Positives = 99/188 (52%), Gaps = 16/188 (8%)
Query: 100 FSLYELQSATNNFSFE------NLIGKGGYAEVYKGRLRNGQLVAIKRLTRG---TADEI 150
           FS YEL++ TNNF         N  G+GG+  VYKG + N   VA+K+L      T +E+
Sbjct: 6   FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEEL 64
Query: 151 IADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMK--EKLKWG 207
              F  E+ + A   H N  +LLG+  +G  + +V    PNGSL   L  +     L W 
Sbjct: 65  KQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWH 124
Query: 208 IRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH 267
            R KIA G A G+ +LHE      IHRDIK+ANILL E F  +I DFGLA+   +     
Sbjct: 125 XRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXV 181
Query: 268 TISKVEGT 275
             S++ GT
Sbjct: 182 XXSRIVGT 189

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 60/181 (33%), Positives = 96/181 (53%), Gaps = 19/181 (10%)
Query: 108 ATNNFSFENLIGKGGYAEVYKGRL-RNGQLVAIKRLTRGTAD------EIIADFLSELGI 160
           A N   +E  IGKGG+  V+KGRL ++  +VAIK L  G ++      E   +F  E+ I
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 161 MAHVDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGL 220
           M++++HPN  KL G  +     +V+E  P G L   L      +KW ++ ++ L +A G+
Sbjct: 77  MSNLNHPNIVKLYGL-MHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGI 135
Query: 221 LYLHEGCQRRIIHRDIKAANILLTE-DFEPQIC----DFGLAKWLPEQWTHHTISKVEGT 275
            Y+ +     I+HRD+++ NI L   D    +C    DFGL+     Q + H++S + G 
Sbjct: 136 EYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS-----QQSVHSVSGLLGN 189
Query: 276 F 276
           F
Sbjct: 190 F 190

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 88.2 bits (217), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 59/181 (32%), Positives = 95/181 (52%), Gaps = 19/181 (10%)
Query: 108 ATNNFSFENLIGKGGYAEVYKGRL-RNGQLVAIKRLTRGTAD------EIIADFLSELGI 160
           A N   +E  IGKGG+  V+KGRL ++  +VAIK L  G ++      E   +F  E+ I
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 161 MAHVDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGL 220
           M++++HPN  KL G  +     +V+E  P G L   L      +KW ++ ++ L +A G+
Sbjct: 77  MSNLNHPNIVKLYGL-MHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGI 135
Query: 221 LYLHEGCQRRIIHRDIKAANILLTE-DFEPQIC----DFGLAKWLPEQWTHHTISKVEGT 275
            Y+ +     I+HRD+++ NI L   D    +C    DFG +     Q + H++S + G 
Sbjct: 136 EYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTS-----QQSVHSVSGLLGN 189
Query: 276 F 276
           F
Sbjct: 190 F 190

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 59/181 (32%), Positives = 95/181 (52%), Gaps = 19/181 (10%)
Query: 108 ATNNFSFENLIGKGGYAEVYKGRL-RNGQLVAIKRLTRGTAD------EIIADFLSELGI 160
           A N   +E  IGKGG+  V+KGRL ++  +VAIK L  G ++      E   +F  E+ I
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 161 MAHVDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGL 220
           M++++HPN  KL G  +     +V+E  P G L   L      +KW ++ ++ L +A G+
Sbjct: 77  MSNLNHPNIVKLYGL-MHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGI 135
Query: 221 LYLHEGCQRRIIHRDIKAANILLTE-DFEPQIC----DFGLAKWLPEQWTHHTISKVEGT 275
            Y+ +     I+HRD+++ NI L   D    +C    DF L+     Q + H++S + G 
Sbjct: 136 EYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLS-----QQSVHSVSGLLGN 189
Query: 276 F 276
           F
Sbjct: 190 F 190

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 84.7 bits (208), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 50/149 (33%), Positives = 83/149 (55%), Gaps = 8/149 (5%)
Query: 117 LIGKGGYAEVYKG-RLRNGQLV----AIKRLTRGTADEIIADFLSELGIMAHVDHPNTAK 171
           ++G G +  VYKG  +  G+ V    AIK L   T  +   +F+ E  IMA +DHP+  +
Sbjct: 22  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 81
Query: 172 LLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRI 231
           LLG  +   + +V +L P+G L   ++  K+ +   +     + +A+G++YL E   RR+
Sbjct: 82  LLGVCLSPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLEE---RRL 138
Query: 232 IHRDIKAANILLTEDFEPQICDFGLAKWL 260
           +HRD+ A N+L+      +I DFGLA+ L
Sbjct: 139 VHRDLAARNVLVKSPNHVKITDFGLARLL 167

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 84.3 bits (207), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 50/149 (33%), Positives = 83/149 (55%), Gaps = 8/149 (5%)
Query: 117 LIGKGGYAEVYKG-RLRNGQLV----AIKRLTRGTADEIIADFLSELGIMAHVDHPNTAK 171
           ++G G +  VYKG  +  G+ V    AIK L   T  +   +F+ E  IMA +DHP+  +
Sbjct: 45  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 104
Query: 172 LLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRI 231
           LLG  +   + +V +L P+G L   ++  K+ +   +     + +A+G++YL E   RR+
Sbjct: 105 LLGVCLSPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLEE---RRL 161
Query: 232 IHRDIKAANILLTEDFEPQICDFGLAKWL 260
           +HRD+ A N+L+      +I DFGLA+ L
Sbjct: 162 VHRDLAARNVLVKSPNHVKITDFGLARLL 190

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 57/182 (31%), Positives = 86/182 (47%), Gaps = 8/182 (4%)
Query: 87  FVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLR----NGQLVAIKRL 142
           FV+ +  + P +    +  +    N S + ++G G + EV  GRL+        VAIK L
Sbjct: 22  FVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL 81
Query: 143 TRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMK 201
             G  ++   DFL E  IM   DHPN  +L G   +   + IV E   NGSL S L    
Sbjct: 82  KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD 141
Query: 202 EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP 261
            +        +  G+A G+ YL +      +HRD+ A NIL+  +   ++ DFGLA+ L 
Sbjct: 142 AQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLARVLE 198
Query: 262 EQ 263
           + 
Sbjct: 199 DD 200

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 42/141 (29%), Positives = 79/141 (56%), Gaps = 4/141 (2%)
Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLL-GYG 176
           +G G + +VYK + +   ++A  ++    ++E + D++ E+ I+A  DHPN  KLL  + 
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 177 IEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDI 236
            E  + I++E    G++ +++  ++  L       +     + L YLH+    +IIHRD+
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDL 161
Query: 237 KAANILLTEDFEPQICDFGLA 257
           KA NIL T D + ++ DFG++
Sbjct: 162 KAGNILFTLDGDIKLADFGVS 182

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 42/141 (29%), Positives = 79/141 (56%), Gaps = 4/141 (2%)
Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLL-GYG 176
           +G G + +VYK + +   ++A  ++    ++E + D++ E+ I+A  DHPN  KLL  + 
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 177 IEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDI 236
            E  + I++E    G++ +++  ++  L       +     + L YLH+    +IIHRD+
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDL 161
Query: 237 KAANILLTEDFEPQICDFGLA 257
           KA NIL T D + ++ DFG++
Sbjct: 162 KAGNILFTLDGDIKLADFGVS 182

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 42/141 (29%), Positives = 79/141 (56%), Gaps = 4/141 (2%)
Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLL-GYG 176
           +G G + +VYK + +   ++A  ++    ++E + D++ E+ I+A  DHPN  KLL  + 
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 177 IEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDI 236
            E  + I++E    G++ +++  ++  L       +     + L YLH+    +IIHRD+
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDL 161
Query: 237 KAANILLTEDFEPQICDFGLA 257
           KA NIL T D + ++ DFG++
Sbjct: 162 KAGNILFTLDGDIKLADFGVS 182

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 56/182 (30%), Positives = 86/182 (47%), Gaps = 8/182 (4%)
Query: 87  FVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLR----NGQLVAIKRL 142
           FV+ +  + P +    +  +    N S + ++G G + EV  GRL+        VAIK L
Sbjct: 22  FVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL 81
Query: 143 TRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMK 201
             G  ++   DFL E  IM   DHPN  +L G   +   + IV E   NGSL S L    
Sbjct: 82  KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD 141
Query: 202 EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP 261
            +        +  G+A G+ YL +      +HRD+ A NIL+  +   ++ DFGL++ L 
Sbjct: 142 AQFTVIQLVGMLRGIASGMKYLSD---MGFVHRDLAARNILINSNLVCKVSDFGLSRVLE 198
Query: 262 EQ 263
           + 
Sbjct: 199 DD 200

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 56/182 (30%), Positives = 86/182 (47%), Gaps = 8/182 (4%)
Query: 87  FVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLR----NGQLVAIKRL 142
           FV+ +  + P +    +  +    N S + ++G G + EV  GRL+        VAIK L
Sbjct: 22  FVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL 81
Query: 143 TRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMK 201
             G  ++   DFL E  IM   DHPN  +L G   +   + IV E   NGSL S L    
Sbjct: 82  KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHD 141
Query: 202 EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP 261
            +        +  G+A G+ YL +      +HRD+ A NIL+  +   ++ DFGL++ L 
Sbjct: 142 AQFTVIQLVGMLRGIASGMKYLSD---MGAVHRDLAARNILINSNLVCKVSDFGLSRVLE 198
Query: 262 EQ 263
           + 
Sbjct: 199 DD 200

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 56/182 (30%), Positives = 86/182 (47%), Gaps = 8/182 (4%)
Query: 87  FVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLR----NGQLVAIKRL 142
           FV+ +  + P +    +  +    N S + ++G G + EV  GRL+        VAIK L
Sbjct: 22  FVDPHTYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL 81
Query: 143 TRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMK 201
             G  ++   DFL E  IM   DHPN  +L G   +   + IV E   NGSL S L    
Sbjct: 82  KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD 141
Query: 202 EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP 261
            +        +  G+A G+ YL +      +HRD+ A NIL+  +   ++ DFGL++ L 
Sbjct: 142 AQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLE 198
Query: 262 EQ 263
           + 
Sbjct: 199 DD 200

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 56/182 (30%), Positives = 86/182 (47%), Gaps = 8/182 (4%)
Query: 87  FVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLR----NGQLVAIKRL 142
           FV+ +  + P +    +  +    N S + ++G G + EV  GRL+        VAIK L
Sbjct: 22  FVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL 81
Query: 143 TRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMK 201
             G  ++   DFL E  IM   DHPN  +L G   +   + IV E   NGSL S L    
Sbjct: 82  KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD 141
Query: 202 EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP 261
            +        +  G+A G+ YL +      +HRD+ A NIL+  +   ++ DFGL++ L 
Sbjct: 142 AQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLE 198
Query: 262 EQ 263
           + 
Sbjct: 199 DD 200

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 56/182 (30%), Positives = 85/182 (46%), Gaps = 8/182 (4%)
Query: 87  FVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLR----NGQLVAIKRL 142
           FV+ +  + P +    +  +    N S + ++G G + EV  GRL+        VAIK L
Sbjct: 22  FVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL 81
Query: 143 TRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMK 201
             G  ++   DFL E  IM   DHPN  +L G   +   + IV E   NGSL S L    
Sbjct: 82  KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD 141
Query: 202 EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP 261
            +        +  G+A G+ YL +      +HRD+ A NIL+  +   ++ DFGL + L 
Sbjct: 142 AQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLGRVLE 198
Query: 262 EQ 263
           + 
Sbjct: 199 DD 200

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 56/194 (28%), Positives = 90/194 (46%), Gaps = 8/194 (4%)
Query: 86  LFVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLR----NGQLVAIKR 141
           +F++ +  + P +    +  +   +    E +IG G + EV  G L+        VAIK 
Sbjct: 9   IFIDPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKT 68
Query: 142 LTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGM 200
           L  G  ++   DFLSE  IM   DHPN   L G   +   + I+ E   NGSL S L   
Sbjct: 69  LKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQN 128
Query: 201 KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL 260
             +        +  G+A G+ YL +      +HRD+ A NIL+  +   ++ DFGL+++L
Sbjct: 129 DGQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFL 185
Query: 261 PEQWTHHTISKVEG 274
            +  +  T +   G
Sbjct: 186 EDDTSDPTYTSALG 199

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 43/141 (30%), Positives = 81/141 (57%), Gaps = 4/141 (2%)
Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLG-YG 176
           +G G + +VYK + +    +A  ++    ++E + D++ E+ I+A  DHP   KLLG Y 
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 177 IEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDI 236
            +G + I++E  P G++ +++  +   L       +   + E L +LH    +RIIHRD+
Sbjct: 87  HDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDL 143
Query: 237 KAANILLTEDFEPQICDFGLA 257
           KA N+L+T + + ++ DFG++
Sbjct: 144 KAGNVLMTLEGDIRLADFGVS 164

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 43/141 (30%), Positives = 81/141 (57%), Gaps = 4/141 (2%)
Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLG-YG 176
           +G G + +VYK + +    +A  ++    ++E + D++ E+ I+A  DHP   KLLG Y 
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 78
Query: 177 IEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDI 236
            +G + I++E  P G++ +++  +   L       +   + E L +LH    +RIIHRD+
Sbjct: 79  HDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDL 135
Query: 237 KAANILLTEDFEPQICDFGLA 257
           KA N+L+T + + ++ DFG++
Sbjct: 136 KAGNVLMTLEGDIRLADFGVS 156

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 55/182 (30%), Positives = 86/182 (47%), Gaps = 8/182 (4%)
Query: 87  FVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLR----NGQLVAIKRL 142
           +V+ +  + P +    +  +    N S + ++G G + EV  GRL+        VAIK L
Sbjct: 22  YVDPHTYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL 81
Query: 143 TRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMK 201
             G  ++   DFL E  IM   DHPN  +L G   +   + IV E   NGSL S L    
Sbjct: 82  KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD 141
Query: 202 EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP 261
            +        +  G+A G+ YL +      +HRD+ A NIL+  +   ++ DFGL++ L 
Sbjct: 142 AQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLE 198
Query: 262 EQ 263
           + 
Sbjct: 199 DD 200

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 55/182 (30%), Positives = 86/182 (47%), Gaps = 8/182 (4%)
Query: 87  FVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLR----NGQLVAIKRL 142
           +V+ +  + P +    +  +    N S + ++G G + EV  GRL+        VAIK L
Sbjct: 20  YVDPHTYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL 79
Query: 143 TRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMK 201
             G  ++   DFL E  IM   DHPN  +L G   +   + IV E   NGSL S L    
Sbjct: 80  KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD 139
Query: 202 EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP 261
            +        +  G+A G+ YL +      +HRD+ A NIL+  +   ++ DFGL++ L 
Sbjct: 140 AQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLE 196
Query: 262 EQ 263
           + 
Sbjct: 197 DD 198

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 55/182 (30%), Positives = 86/182 (47%), Gaps = 8/182 (4%)
Query: 87  FVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLR----NGQLVAIKRL 142
           +V+ +  + P +    +  +    N S + ++G G + EV  GRL+        VAIK L
Sbjct: 22  YVDPHTYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL 81
Query: 143 TRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMK 201
             G  ++   DFL E  IM   DHPN  +L G   +   + IV E   NGSL S L    
Sbjct: 82  KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHD 141
Query: 202 EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP 261
            +        +  G+A G+ YL +      +HRD+ A NIL+  +   ++ DFGL++ L 
Sbjct: 142 AQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLE 198
Query: 262 EQ 263
           + 
Sbjct: 199 DD 200

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 55/182 (30%), Positives = 86/182 (47%), Gaps = 8/182 (4%)
Query: 87  FVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLR----NGQLVAIKRL 142
           +V+ +  + P +    +  +    N S + ++G G + EV  GRL+        VAIK L
Sbjct: 22  YVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL 81
Query: 143 TRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMK 201
             G  ++   DFL E  IM   DHPN  +L G   +   + IV E   NGSL S L    
Sbjct: 82  KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD 141
Query: 202 EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP 261
            +        +  G+A G+ YL +      +HRD+ A NIL+  +   ++ DFGL++ L 
Sbjct: 142 AQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLE 198
Query: 262 EQ 263
           + 
Sbjct: 199 DD 200

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 53/172 (30%), Positives = 82/172 (47%), Gaps = 16/172 (9%)
Query: 93  SQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIA 152
           +Q PQK +   E +           +G G + EV+ G       VA+K L +G+      
Sbjct: 2   TQKPQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP--D 59
Query: 153 DFLSELGIMAHVDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKI 212
            FL+E  +M  + H    +L     +  ++I+ E   NGSL   L     K   GI+  I
Sbjct: 60  AFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFL-----KTPSGIKLTI 114
Query: 213 ------ALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
                 A  +AEG+ ++ E   R  IHRD++AANIL+++    +I DFGLA+
Sbjct: 115 NKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLAR 163

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 53/172 (30%), Positives = 82/172 (47%), Gaps = 16/172 (9%)
Query: 93  SQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIA 152
           +Q PQK +   E +           +G G + EV+ G       VA+K L +G+      
Sbjct: 2   TQKPQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP--D 59
Query: 153 DFLSELGIMAHVDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKI 212
            FL+E  +M  + H    +L     +  ++I+ E   NGSL   L     K   GI+  I
Sbjct: 60  AFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFL-----KTPSGIKLTI 114
Query: 213 ------ALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
                 A  +AEG+ ++ E   R  IHRD++AANIL+++    +I DFGLA+
Sbjct: 115 NKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLAR 163

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 53/172 (30%), Positives = 82/172 (47%), Gaps = 16/172 (9%)
Query: 93  SQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIA 152
           +Q PQK +   E +           +G G + EV+ G       VA+K L +G+      
Sbjct: 4   TQKPQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP--D 61
Query: 153 DFLSELGIMAHVDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKI 212
            FL+E  +M  + H    +L     +  ++I+ E   NGSL   L     K   GI+  I
Sbjct: 62  AFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFL-----KTPSGIKLTI 116
Query: 213 ------ALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
                 A  +AEG+ ++ E   R  IHRD++AANIL+++    +I DFGLA+
Sbjct: 117 NKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLAR 165

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 53/172 (30%), Positives = 82/172 (47%), Gaps = 16/172 (9%)
Query: 93  SQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIA 152
           +Q PQK +   E +           +G G + EV+ G       VA+K L +G+      
Sbjct: 1   TQKPQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP--D 58
Query: 153 DFLSELGIMAHVDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKI 212
            FL+E  +M  + H    +L     +  ++I+ E   NGSL   L     K   GI+  I
Sbjct: 59  AFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFL-----KTPSGIKLTI 113
Query: 213 ------ALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
                 A  +AEG+ ++ E   R  IHRD++AANIL+++    +I DFGLA+
Sbjct: 114 NKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLAR 162

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 48/143 (33%), Positives = 74/143 (51%), Gaps = 5/143 (3%)
Query: 118 IGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYG 176
           IG+G + EV+ GRLR +  LVA+K        ++ A FL E  I+    HPN  +L+G  
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 177 IEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRD 235
            +   ++IV+EL   G   + L     +L+     ++    A G+ YL   C    IHRD
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRD 238
Query: 236 IKAANILLTEDFEPQICDFGLAK 258
           + A N L+TE    +I DFG+++
Sbjct: 239 LAARNCLVTEKNVLKISDFGMSR 261

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 53/172 (30%), Positives = 82/172 (47%), Gaps = 16/172 (9%)
Query: 93  SQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIA 152
           +Q PQK +   E +           +G G + EV+ G       VA+K L +G+      
Sbjct: 6   TQKPQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP--D 63
Query: 153 DFLSELGIMAHVDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKI 212
            FL+E  +M  + H    +L     +  ++I+ E   NGSL   L     K   GI+  I
Sbjct: 64  AFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFL-----KTPSGIKLTI 118
Query: 213 ------ALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
                 A  +AEG+ ++ E   R  IHRD++AANIL+++    +I DFGLA+
Sbjct: 119 NKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLAR 167

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 48/143 (33%), Positives = 74/143 (51%), Gaps = 5/143 (3%)
Query: 118 IGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYG 176
           IG+G + EV+ GRLR +  LVA+K        ++ A FL E  I+    HPN  +L+G  
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 177 IEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRD 235
            +   ++IV+EL   G   + L     +L+     ++    A G+ YL   C    IHRD
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRD 238
Query: 236 IKAANILLTEDFEPQICDFGLAK 258
           + A N L+TE    +I DFG+++
Sbjct: 239 LAARNCLVTEKNVLKISDFGMSR 261

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 64/186 (34%), Positives = 93/186 (50%), Gaps = 22/186 (11%)
Query: 90  SYDSQSPQKIFS---LYELQSATNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRL-TR 144
           S  S SP +      L  L+     F    L+G G Y +VYKGR ++ GQL AIK +   
Sbjct: 1   SMASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT 60
Query: 145 GTADEIIADFLSELGIMAHVDHPNTAKLLGY-------GIEGGMHIVLELSPNGSLASLL 197
           G  +E I   ++ L   +H  H N A   G        G++  + +V+E    GS+  L+
Sbjct: 61  GDEEEEIKQEINMLKKYSH--HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI 118
Query: 198 YGMKE---KLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDF 254
              K    K +W I Y I   +  GL +LH   Q ++IHRDIK  N+LLTE+ E ++ DF
Sbjct: 119 KNTKGNTLKEEW-IAY-ICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDF 173
Query: 255 GLAKWL 260
           G++  L
Sbjct: 174 GVSAQL 179

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 54/182 (29%), Positives = 84/182 (46%), Gaps = 8/182 (4%)
Query: 87  FVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLR----NGQLVAIKRL 142
           FV+ +  + P +    +  +   +    E +IG G + EV  GRL+        VAIK L
Sbjct: 6   FVDPFTFEDPNQAVREFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTL 65
Query: 143 TRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLELSPNGSLASLLYGMK 201
             G  D+   DFLSE  IM   DHPN   L G   +   + I+ E   NGSL + L    
Sbjct: 66  KAGYTDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKND 125
Query: 202 EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP 261
            +        +  G+  G+ YL +      +HRD+ A NIL+  +   ++ DFG+++ L 
Sbjct: 126 GRFTVIQLVGMLRGIGSGMKYLSD---MSAVHRDLAARNILVNSNLVCKVSDFGMSRVLE 182
Query: 262 EQ 263
           + 
Sbjct: 183 DD 184

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 50/156 (32%), Positives = 80/156 (51%), Gaps = 8/156 (5%)
Query: 110 NNFSFENLIGKGGYAEVYKGR-LRNGQ----LVAIKRLTRGTADEIIADFLSELGIMAHV 164
             F    ++G G +  VYKG  +  G+     VAIK L   T+ +   + L E  +MA V
Sbjct: 12  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 71
Query: 165 DHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
           D+P+  +LLG  +   + ++ +L P G L   +   K+ +         + +AEG+ YL 
Sbjct: 72  DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAEGMNYLE 131
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL 260
           +   RR++HRD+ A N+L+      +I DFGLAK L
Sbjct: 132 D---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 164

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 49/156 (31%), Positives = 81/156 (51%), Gaps = 8/156 (5%)
Query: 110 NNFSFENLIGKGGYAEVYKGR-LRNGQ----LVAIKRLTRGTADEIIADFLSELGIMAHV 164
             F    ++G G +  VYKG  +  G+     VAIK L   T+ +   + L E  +MA V
Sbjct: 16  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 75
Query: 165 DHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
           D+P+  +LLG  +   + ++++L P G L   +   K+ +         + +A+G+ YL 
Sbjct: 76  DNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 135
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL 260
           +   RR++HRD+ A N+L+      +I DFGLAK L
Sbjct: 136 D---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 168

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 49/156 (31%), Positives = 81/156 (51%), Gaps = 8/156 (5%)
Query: 110 NNFSFENLIGKGGYAEVYKGR-LRNGQ----LVAIKRLTRGTADEIIADFLSELGIMAHV 164
             F    ++G G +  VYKG  +  G+     VAIK L   T+ +   + L E  +MA V
Sbjct: 19  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 78
Query: 165 DHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
           D+P+  +LLG  +   + ++++L P G L   +   K+ +         + +A+G+ YL 
Sbjct: 79  DNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 138
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL 260
           +   RR++HRD+ A N+L+      +I DFGLAK L
Sbjct: 139 D---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 171

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 50/152 (32%), Positives = 83/152 (54%), Gaps = 6/152 (3%)
Query: 111 NFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLT-RGTADEIIADFLSELGIMAHVDHPNT 169
           + + +  IG G +  V++    +G  VA+K L  +    E + +FL E+ IM  + HPN 
Sbjct: 38  DLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNI 96
Query: 170 AKLLGYGIEG-GMHIVLELSPNGSLASLLY--GMKEKLKWGIRYKIALGVAEGLLYLHEG 226
              +G   +   + IV E    GSL  LL+  G +E+L    R  +A  VA+G+ YLH  
Sbjct: 97  VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156
Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
               I+HRD+K+ N+L+ + +  ++CDFGL++
Sbjct: 157 -NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR 187

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 49/156 (31%), Positives = 81/156 (51%), Gaps = 8/156 (5%)
Query: 110 NNFSFENLIGKGGYAEVYKGR-LRNGQ----LVAIKRLTRGTADEIIADFLSELGIMAHV 164
             F    ++G G +  VYKG  +  G+     VAIK L   T+ +   + L E  +MA V
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 165 DHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
           D+P+  +LLG  +   + ++++L P G L   +   K+ +         + +A+G+ YL 
Sbjct: 75  DNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL 260
           +   RR++HRD+ A N+L+      +I DFGLAK L
Sbjct: 135 D---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 49/156 (31%), Positives = 81/156 (51%), Gaps = 8/156 (5%)
Query: 110 NNFSFENLIGKGGYAEVYKGR-LRNGQ----LVAIKRLTRGTADEIIADFLSELGIMAHV 164
             F    ++G G +  VYKG  +  G+     VAIK L   T+ +   + L E  +MA V
Sbjct: 16  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 75
Query: 165 DHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
           D+P+  +LLG  +   + ++++L P G L   +   K+ +         + +A+G+ YL 
Sbjct: 76  DNPHVCRLLGICLTSTVQLIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 135
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL 260
           +   RR++HRD+ A N+L+      +I DFGLAK L
Sbjct: 136 D---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 168

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 49/156 (31%), Positives = 81/156 (51%), Gaps = 8/156 (5%)
Query: 110 NNFSFENLIGKGGYAEVYKGR-LRNGQ----LVAIKRLTRGTADEIIADFLSELGIMAHV 164
             F    ++G G +  VYKG  +  G+     VAIK L   T+ +   + L E  +MA V
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 165 DHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
           D+P+  +LLG  +   + ++++L P G L   +   K+ +         + +A+G+ YL 
Sbjct: 77  DNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 136
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL 260
           +   RR++HRD+ A N+L+      +I DFGLAK L
Sbjct: 137 D---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 169

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 49/156 (31%), Positives = 81/156 (51%), Gaps = 8/156 (5%)
Query: 110 NNFSFENLIGKGGYAEVYKGR-LRNGQ----LVAIKRLTRGTADEIIADFLSELGIMAHV 164
             F    ++G G +  VYKG  +  G+     VAIK L   T+ +   + L E  +MA V
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 165 DHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
           D+P+  +LLG  +   + ++++L P G L   +   K+ +         + +A+G+ YL 
Sbjct: 78  DNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 137
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL 260
           +   RR++HRD+ A N+L+      +I DFGLAK L
Sbjct: 138 D---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 170

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/174 (32%), Positives = 83/174 (47%), Gaps = 9/174 (5%)
Query: 95  SPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLR----NGQLVAIKRLTRGTADEI 150
           S Q +    +   ATN  S + ++G G + EV  GRL+        VAIK L  G  ++ 
Sbjct: 2   STQTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ 60
Query: 151 IADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIR 209
             DFL E  IM   DHPN  +L G   +   + IV E   NGSL S L     +      
Sbjct: 61  RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQL 120
Query: 210 YKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ 263
             +  G+A G+ YL +      +HRD+ A NIL+  +   ++ DFGL++ L + 
Sbjct: 121 VGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD 171

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/174 (32%), Positives = 83/174 (47%), Gaps = 9/174 (5%)
Query: 95  SPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLR----NGQLVAIKRLTRGTADEI 150
           S Q +    +   ATN  S + ++G G + EV  GRL+        VAIK L  G  ++ 
Sbjct: 2   STQTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ 60
Query: 151 IADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIR 209
             DFL E  IM   DHPN  +L G   +   + IV E   NGSL S L     +      
Sbjct: 61  RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQL 120
Query: 210 YKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ 263
             +  G+A G+ YL +      +HRD+ A NIL+  +   ++ DFGL++ L + 
Sbjct: 121 VGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD 171

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/172 (31%), Positives = 86/172 (50%), Gaps = 10/172 (5%)
Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGI 177
           IG G +  VYKG+      V +  +T  T  ++ A F +E+G++    H N    +GY  
Sbjct: 21  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQA-FKNEVGVLRKTRHVNILLFMGYST 79
Query: 178 EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIK 237
           +  + IV +     SL   L+ ++ K +      IA   A+G+ YLH    + IIHRD+K
Sbjct: 80  KPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLK 136
Query: 238 AANILLTEDFEPQICDFGLAKWLPEQWT-HHTISKVEGTFGLVKLNLPPLVI 288
           + NI L ED   +I DFGLA  +  +W+  H   ++ G+     L + P VI
Sbjct: 137 SNNIFLHEDLTVKIGDFGLAT-VKSRWSGSHQFEQLSGSI----LWMAPEVI 183

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/174 (32%), Positives = 83/174 (47%), Gaps = 9/174 (5%)
Query: 95  SPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLR----NGQLVAIKRLTRGTADEI 150
           S Q +    +   ATN  S + ++G G + EV  GRL+        VAIK L  G  ++ 
Sbjct: 19  STQTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ 77
Query: 151 IADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIR 209
             DFL E  IM   DHPN  +L G   +   + IV E   NGSL S L     +      
Sbjct: 78  RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQL 137
Query: 210 YKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ 263
             +  G+A G+ YL +      +HRD+ A NIL+  +   ++ DFGL++ L + 
Sbjct: 138 VGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD 188

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/172 (31%), Positives = 86/172 (50%), Gaps = 10/172 (5%)
Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGI 177
           IG G +  VYKG+      V +  +T  T  ++ A F +E+G++    H N    +GY  
Sbjct: 21  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQA-FKNEVGVLRKTRHVNILLFMGYST 79
Query: 178 EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIK 237
           +  + IV +     SL   L+ ++ K +      IA   A+G+ YLH    + IIHRD+K
Sbjct: 80  KPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLK 136
Query: 238 AANILLTEDFEPQICDFGLAKWLPEQWT-HHTISKVEGTFGLVKLNLPPLVI 288
           + NI L ED   +I DFGLA  +  +W+  H   ++ G+     L + P VI
Sbjct: 137 SNNIFLHEDLTVKIGDFGLAT-VKSRWSGSHQFEQLSGSI----LWMAPEVI 183

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/189 (31%), Positives = 91/189 (48%), Gaps = 20/189 (10%)
Query: 114 FENLIGKGGYAEVYKGRLR----NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
            E +IG G + EV +GRL+        VAIK L  G  +    +FLSE  IM   +HPN 
Sbjct: 18  IEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNI 77
Query: 170 AKLLGYGIEGGMHIVL--ELSPNGSLASLLYGMKEKLKWGIRYKIAL-----GVAEGLLY 222
            +L G  +   M +++  E   NG+L S L     +L  G    I L     G+A G+ Y
Sbjct: 78  IRLEGV-VTNSMPVMILTEFMENGALDSFL-----RLNDGQFTVIQLVGMLRGIASGMRY 131
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLN 282
           L E      +HRD+ A NIL+  +   ++ DFGL+++L E  +  T +   G    ++  
Sbjct: 132 LAE---MSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWT 188
Query: 283 LPPLVILKR 291
            P  +  ++
Sbjct: 189 APEAIAFRK 197

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/172 (31%), Positives = 86/172 (50%), Gaps = 10/172 (5%)
Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGI 177
           IG G +  VYKG+      V +  +T  T  ++ A F +E+G++    H N    +GY  
Sbjct: 43  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQA-FKNEVGVLRKTRHVNILLFMGYST 101
Query: 178 EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIK 237
           +  + IV +     SL   L+ ++ K +      IA   A+G+ YLH    + IIHRD+K
Sbjct: 102 KPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLK 158
Query: 238 AANILLTEDFEPQICDFGLAKWLPEQWT-HHTISKVEGTFGLVKLNLPPLVI 288
           + NI L ED   +I DFGLA  +  +W+  H   ++ G+     L + P VI
Sbjct: 159 SNNIFLHEDLTVKIGDFGLAT-VKSRWSGSHQFEQLSGSI----LWMAPEVI 205

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/172 (31%), Positives = 86/172 (50%), Gaps = 10/172 (5%)
Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGI 177
           IG G +  VYKG+      V +  +T  T  ++ A F +E+G++    H N    +GY  
Sbjct: 18  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQA-FKNEVGVLRKTRHVNILLFMGYST 76
Query: 178 EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIK 237
           +  + IV +     SL   L+ ++ K +      IA   A+G+ YLH    + IIHRD+K
Sbjct: 77  KPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLK 133
Query: 238 AANILLTEDFEPQICDFGLAKWLPEQWT-HHTISKVEGTFGLVKLNLPPLVI 288
           + NI L ED   +I DFGLA  +  +W+  H   ++ G+     L + P VI
Sbjct: 134 SNNIFLHEDLTVKIGDFGLAT-VKSRWSGSHQFEQLSGSI----LWMAPEVI 180

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 51/164 (31%), Positives = 80/164 (48%), Gaps = 7/164 (4%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           +  +F   IG G +  V+ G   N   VAIK +  G   E   DF+ E  +M  + HP  
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE--EDFIEEAEVMMKLSHPKL 62
Query: 170 AKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQ 228
            +L G  +E   + +V E   +G L+  L   +          + L V EG+ YL E C 
Sbjct: 63  VQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC- 121
Query: 229 RRIIHRDIKAANILLTEDFEPQICDFGLAKW-LPEQWTHHTISK 271
             +IHRD+ A N L+ E+   ++ DFG+ ++ L +Q+T  T +K
Sbjct: 122 --VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTK 163

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/172 (31%), Positives = 86/172 (50%), Gaps = 10/172 (5%)
Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGI 177
           IG G +  VYKG+      V +  +T  T  ++ A F +E+G++    H N    +GY  
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQA-FKNEVGVLRKTRHVNILLFMGYST 102
Query: 178 EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIK 237
           +  + IV +     SL   L+ ++ K +      IA   A+G+ YLH    + IIHRD+K
Sbjct: 103 KPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLK 159
Query: 238 AANILLTEDFEPQICDFGLAKWLPEQWT-HHTISKVEGTFGLVKLNLPPLVI 288
           + NI L ED   +I DFGLA  +  +W+  H   ++ G+     L + P VI
Sbjct: 160 SNNIFLHEDLTVKIGDFGLAT-VKSRWSGSHQFEQLSGSI----LWMAPEVI 206

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/181 (31%), Positives = 82/181 (45%), Gaps = 8/181 (4%)
Query: 85  NLFVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLR-NGQL---VAIK 140
             +   +  + P +    +  +   +    E +IG G   EV  GRLR  GQ    VAIK
Sbjct: 24  QFYAEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIK 83
Query: 141 RLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMH-IVLELSPNGSLASLLYG 199
            L  G  +    DFLSE  IM   DHPN  +L G    G +  IV E   NGSL + L  
Sbjct: 84  ALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRT 143
Query: 200 MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKW 259
              +        +  GV  G+ YL +      +HRD+ A N+L+  +   ++ DFGL++ 
Sbjct: 144 HDGQFTIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRV 200
Query: 260 L 260
           L
Sbjct: 201 L 201

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/181 (31%), Positives = 82/181 (45%), Gaps = 8/181 (4%)
Query: 85  NLFVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLR-NGQL---VAIK 140
             +   +  + P +    +  +   +    E +IG G   EV  GRLR  GQ    VAIK
Sbjct: 24  QFYAEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIK 83
Query: 141 RLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMH-IVLELSPNGSLASLLYG 199
            L  G  +    DFLSE  IM   DHPN  +L G    G +  IV E   NGSL + L  
Sbjct: 84  ALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRT 143
Query: 200 MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKW 259
              +        +  GV  G+ YL +      +HRD+ A N+L+  +   ++ DFGL++ 
Sbjct: 144 HDGQFTIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRV 200
Query: 260 L 260
           L
Sbjct: 201 L 201

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/172 (31%), Positives = 84/172 (48%), Gaps = 10/172 (5%)
Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGI 177
           IG G +  VYKG+      V +  +T  T  ++ A F +E+G++    H N    +GY  
Sbjct: 20  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQA-FKNEVGVLRKTRHVNILLFMGYST 78
Query: 178 EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIK 237
           +  + IV +     SL   L+  + K +      IA   A G+ YLH    + IIHRD+K
Sbjct: 79  KPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLK 135
Query: 238 AANILLTEDFEPQICDFGLAKWLPEQWT-HHTISKVEGTFGLVKLNLPPLVI 288
           + NI L ED   +I DFGLA  +  +W+  H   ++ G+     L + P VI
Sbjct: 136 SNNIFLHEDNTVKIGDFGLAT-VKSRWSGSHQFEQLSGSI----LWMAPEVI 182

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/173 (31%), Positives = 84/173 (48%), Gaps = 10/173 (5%)
Query: 103 YELQSATNNFSFENLIGKGGYAEVYKGRLRN----GQLVAIKRLTRGTADEIIADFLSEL 158
           YE+Q           IG+G + +V++G   +       VAIK     T+D +   FL E 
Sbjct: 5   YEIQR--ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEA 62
Query: 159 GIMAHVDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE 218
             M   DHP+  KL+G   E  + I++EL   G L S L   K  L        A  ++ 
Sbjct: 63  LTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST 122
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK 271
            L YL     +R +HRDI A N+L++ +   ++ DFGL++++ E  T++  SK
Sbjct: 123 ALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASK 171

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 51/160 (31%), Positives = 81/160 (50%), Gaps = 6/160 (3%)
Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGI 177
           IG G +  VYKG+      V +  +T  T  ++ A F +E+G++    H N    +GY  
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQA-FKNEVGVLRKTRHVNILLFMGYST 74
Query: 178 EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIK 237
           +  + IV +     SL   L+ ++ K +      IA   A+G+ YLH    + IIHRD+K
Sbjct: 75  KPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLK 131
Query: 238 AANILLTEDFEPQICDFGLAKWLPEQWT-HHTISKVEGTF 276
           + NI L ED   +I DFGLA  +  +W+  H   ++ G+ 
Sbjct: 132 SNNIFLHEDLTVKIGDFGLAT-VKSRWSGSHQFEQLSGSI 170

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 49/156 (31%), Positives = 80/156 (51%), Gaps = 8/156 (5%)
Query: 110 NNFSFENLIGKGGYAEVYKGR-LRNGQ----LVAIKRLTRGTADEIIADFLSELGIMAHV 164
             F    ++G G +  VYKG  +  G+     VAIK L   T+ +   + L E  +MA V
Sbjct: 25  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 84
Query: 165 DHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
           D+P+  +LLG  +   + ++ +L P G L   +   K+ +         + +A+G+ YL 
Sbjct: 85  DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 144
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL 260
           +   RR++HRD+ A N+L+      +I DFGLAK L
Sbjct: 145 D---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 177

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 51/164 (31%), Positives = 80/164 (48%), Gaps = 7/164 (4%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           +  +F   IG G +  V+ G   N   VAIK +  G   E   DF+ E  +M  + HP  
Sbjct: 7   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE--EDFIEEAEVMMKLSHPKL 64
Query: 170 AKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQ 228
            +L G  +E   + +V E   +G L+  L   +          + L V EG+ YL E C 
Sbjct: 65  VQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC- 123
Query: 229 RRIIHRDIKAANILLTEDFEPQICDFGLAKW-LPEQWTHHTISK 271
             +IHRD+ A N L+ E+   ++ DFG+ ++ L +Q+T  T +K
Sbjct: 124 --VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTK 165

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 51/164 (31%), Positives = 81/164 (49%), Gaps = 7/164 (4%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           +  +F   IG G +  V+ G   N   VAIK +  G+  E   DF+ E  +M  + HP  
Sbjct: 27  SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIKEGSMSE--DDFIEEAEVMMKLSHPKL 84
Query: 170 AKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQ 228
            +L G  +E   + +V E   +G L+  L   +          + L V EG+ YL E C 
Sbjct: 85  VQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC- 143
Query: 229 RRIIHRDIKAANILLTEDFEPQICDFGLAKW-LPEQWTHHTISK 271
             +IHRD+ A N L+ E+   ++ DFG+ ++ L +Q+T  T +K
Sbjct: 144 --VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTK 185

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 54/173 (31%), Positives = 85/173 (49%), Gaps = 10/173 (5%)
Query: 103 YELQSATNNFSFENLIGKGGYAEVYKGRLRNGQ----LVAIKRLTRGTADEIIADFLSEL 158
           YE+Q           IG+G + +V++G   + +     VAIK     T+D +   FL E 
Sbjct: 7   YEIQR--ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEA 64
Query: 159 GIMAHVDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE 218
             M   DHP+  KL+G   E  + I++EL   G L S L   K  L        A  ++ 
Sbjct: 65  LTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST 124
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK 271
            L YL     +R +HRDI A N+L++ +   ++ DFGL++++ E  T++  SK
Sbjct: 125 ALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASK 173

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 54/173 (31%), Positives = 85/173 (49%), Gaps = 10/173 (5%)
Query: 103 YELQSATNNFSFENLIGKGGYAEVYKGRLRNGQ----LVAIKRLTRGTADEIIADFLSEL 158
           YE+Q           IG+G + +V++G   + +     VAIK     T+D +   FL E 
Sbjct: 8   YEIQR--ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEA 65
Query: 159 GIMAHVDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE 218
             M   DHP+  KL+G   E  + I++EL   G L S L   K  L        A  ++ 
Sbjct: 66  LTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST 125
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK 271
            L YL     +R +HRDI A N+L++ +   ++ DFGL++++ E  T++  SK
Sbjct: 126 ALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASK 174

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 54/173 (31%), Positives = 85/173 (49%), Gaps = 10/173 (5%)
Query: 103 YELQSATNNFSFENLIGKGGYAEVYKGRLRNGQ----LVAIKRLTRGTADEIIADFLSEL 158
           YE+Q           IG+G + +V++G   + +     VAIK     T+D +   FL E 
Sbjct: 2   YEIQR--ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEA 59
Query: 159 GIMAHVDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE 218
             M   DHP+  KL+G   E  + I++EL   G L S L   K  L        A  ++ 
Sbjct: 60  LTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST 119
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK 271
            L YL     +R +HRDI A N+L++ +   ++ DFGL++++ E  T++  SK
Sbjct: 120 ALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASK 168

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 54/173 (31%), Positives = 85/173 (49%), Gaps = 10/173 (5%)
Query: 103 YELQSATNNFSFENLIGKGGYAEVYKGRLRNGQ----LVAIKRLTRGTADEIIADFLSEL 158
           YE+Q           IG+G + +V++G   + +     VAIK     T+D +   FL E 
Sbjct: 5   YEIQR--ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEA 62
Query: 159 GIMAHVDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE 218
             M   DHP+  KL+G   E  + I++EL   G L S L   K  L        A  ++ 
Sbjct: 63  LTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST 122
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK 271
            L YL     +R +HRDI A N+L++ +   ++ DFGL++++ E  T++  SK
Sbjct: 123 ALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASK 171

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 82/177 (46%), Gaps = 8/177 (4%)
Query: 87  FVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLR----NGQLVAIKRL 142
           +++    + P +    +  +   +    E +IG G + EV  GRL+        VAIK L
Sbjct: 20  YIDPETYEDPNRAVHQFAKELDASCIKIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTL 79
Query: 143 TRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMK 201
             G  ++   DFL E  IM   DHPN   L G    G  + IV+E   NG+L + L    
Sbjct: 80  KVGYTEKQRRDFLCEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHD 139
Query: 202 EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
            +        +  G+A G+ YL +      +HRD+ A NIL+  +   ++ DFGL++
Sbjct: 140 GQFTVIQLVGMLRGIAAGMRYLAD---MGYVHRDLAARNILVNSNLVCKVSDFGLSR 193

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 54/173 (31%), Positives = 85/173 (49%), Gaps = 10/173 (5%)
Query: 103 YELQSATNNFSFENLIGKGGYAEVYKGRLRNGQ----LVAIKRLTRGTADEIIADFLSEL 158
           YE+Q           IG+G + +V++G   + +     VAIK     T+D +   FL E 
Sbjct: 33  YEIQR--ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEA 90
Query: 159 GIMAHVDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE 218
             M   DHP+  KL+G   E  + I++EL   G L S L   K  L        A  ++ 
Sbjct: 91  LTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST 150
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK 271
            L YL     +R +HRDI A N+L++ +   ++ DFGL++++ E  T++  SK
Sbjct: 151 ALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASK 199

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 52/169 (30%), Positives = 80/169 (47%), Gaps = 16/169 (9%)
Query: 96  PQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFL 155
           PQK +   E +           +G G + EV+ G       VA+K L +G+       FL
Sbjct: 8   PQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP--DAFL 65
Query: 156 SELGIMAHVDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKI--- 212
           +E  +M  + H    +L     +  ++I+ E   NGSL   L     K   GI+  I   
Sbjct: 66  AEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFL-----KTPSGIKLTINKL 120
Query: 213 ---ALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
              A  +AEG+ ++ E   R  IHRD++AANIL+++    +I DFGLA+
Sbjct: 121 LDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLAR 166

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 49/156 (31%), Positives = 80/156 (51%), Gaps = 8/156 (5%)
Query: 110 NNFSFENLIGKGGYAEVYKGR-LRNGQLV----AIKRLTRGTADEIIADFLSELGIMAHV 164
             F    ++G G +  VYKG  +  G+ V    AIK L   T+ +   + L E  +MA V
Sbjct: 9   TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 165 DHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
           D+P+  +LLG  +   + ++ +L P G L   +   K+ +         + +A+G+ YL 
Sbjct: 69  DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 128
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL 260
           +   RR++HRD+ A N+L+      +I DFGLAK L
Sbjct: 129 D---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 161

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 49/156 (31%), Positives = 80/156 (51%), Gaps = 8/156 (5%)
Query: 110 NNFSFENLIGKGGYAEVYKGR-LRNGQ----LVAIKRLTRGTADEIIADFLSELGIMAHV 164
             F    ++G G +  VYKG  +  G+     VAIK L   T+ +   + L E  +MA V
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 165 DHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
           D+P+  +LLG  +   + ++ +L P G L   +   K+ +         + +A+G+ YL 
Sbjct: 77  DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 136
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL 260
           +   RR++HRD+ A N+L+      +I DFGLAK L
Sbjct: 137 D---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 169

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 49/156 (31%), Positives = 80/156 (51%), Gaps = 8/156 (5%)
Query: 110 NNFSFENLIGKGGYAEVYKGR-LRNGQ----LVAIKRLTRGTADEIIADFLSELGIMAHV 164
             F    ++G G +  VYKG  +  G+     VAIK L   T+ +   + L E  +MA V
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 165 DHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
           D+P+  +LLG  +   + ++ +L P G L   +   K+ +         + +A+G+ YL 
Sbjct: 75  DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL 260
           +   RR++HRD+ A N+L+      +I DFGLAK L
Sbjct: 135 D---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 52/169 (30%), Positives = 80/169 (47%), Gaps = 16/169 (9%)
Query: 96  PQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFL 155
           PQK +   E +           +G G + EV+ G       VA+K L +G+       FL
Sbjct: 1   PQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP--DAFL 58
Query: 156 SELGIMAHVDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKI--- 212
           +E  +M  + H    +L     +  ++I+ E   NGSL   L     K   GI+  I   
Sbjct: 59  AEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFL-----KTPSGIKLTINKL 113
Query: 213 ---ALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
              A  +AEG+ ++ E   R  IHRD++AANIL+++    +I DFGLA+
Sbjct: 114 LDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLAR 159

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 49/156 (31%), Positives = 80/156 (51%), Gaps = 8/156 (5%)
Query: 110 NNFSFENLIGKGGYAEVYKGR-LRNGQ----LVAIKRLTRGTADEIIADFLSELGIMAHV 164
             F    ++G G +  VYKG  +  G+     VAIK L   T+ +   + L E  +MA V
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 165 DHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
           D+P+  +LLG  +   + ++ +L P G L   +   K+ +         + +A+G+ YL 
Sbjct: 78  DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 137
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL 260
           +   RR++HRD+ A N+L+      +I DFGLAK L
Sbjct: 138 D---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 170

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 49/156 (31%), Positives = 80/156 (51%), Gaps = 8/156 (5%)
Query: 110 NNFSFENLIGKGGYAEVYKGR-LRNGQ----LVAIKRLTRGTADEIIADFLSELGIMAHV 164
             F    ++G G +  VYKG  +  G+     VAIK L   T+ +   + L E  +MA V
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 165 DHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
           D+P+  +LLG  +   + ++ +L P G L   +   K+ +         + +A+G+ YL 
Sbjct: 75  DNPHVCRLLGICLTSTVQLITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL 260
           +   RR++HRD+ A N+L+      +I DFGLAK L
Sbjct: 135 D---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 49/156 (31%), Positives = 80/156 (51%), Gaps = 8/156 (5%)
Query: 110 NNFSFENLIGKGGYAEVYKGR-LRNGQ----LVAIKRLTRGTADEIIADFLSELGIMAHV 164
             F    ++G G +  VYKG  +  G+     VAIK L   T+ +   + L E  +MA V
Sbjct: 40  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 99
Query: 165 DHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
           D+P+  +LLG  +   + ++ +L P G L   +   K+ +         + +A+G+ YL 
Sbjct: 100 DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 159
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL 260
           +   RR++HRD+ A N+L+      +I DFGLAK L
Sbjct: 160 D---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 192

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/189 (31%), Positives = 91/189 (48%), Gaps = 20/189 (10%)
Query: 114 FENLIGKGGYAEVYKGRLR----NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
            E +IG G + EV +GRL+        VAIK L  G  +    +FLSE  IM   +HPN 
Sbjct: 20  IEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNI 79
Query: 170 AKLLGYGIEGGMHIVL--ELSPNGSLASLLYGMKEKLKWGIRYKIAL-----GVAEGLLY 222
            +L G  +   M +++  E   NG+L S L     +L  G    I L     G+A G+ Y
Sbjct: 80  IRLEGV-VTNSMPVMILTEFMENGALDSFL-----RLNDGQFTVIQLVGMLRGIASGMRY 133
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLN 282
           L E      +HRD+ A NIL+  +   ++ DFGL+++L E  +  T +   G    ++  
Sbjct: 134 LAE---MSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWT 190
Query: 283 LPPLVILKR 291
            P  +  ++
Sbjct: 191 APEAIAFRK 199

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 54/173 (31%), Positives = 85/173 (49%), Gaps = 10/173 (5%)
Query: 103 YELQSATNNFSFENLIGKGGYAEVYKGRLRNGQ----LVAIKRLTRGTADEIIADFLSEL 158
           YE+Q           IG+G + +V++G   + +     VAIK     T+D +   FL E 
Sbjct: 10  YEIQR--ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEA 67
Query: 159 GIMAHVDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE 218
             M   DHP+  KL+G   E  + I++EL   G L S L   K  L        A  ++ 
Sbjct: 68  LTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST 127
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK 271
            L YL     +R +HRDI A N+L++ +   ++ DFGL++++ E  T++  SK
Sbjct: 128 ALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASK 176

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 49/156 (31%), Positives = 80/156 (51%), Gaps = 8/156 (5%)
Query: 110 NNFSFENLIGKGGYAEVYKGR-LRNGQ----LVAIKRLTRGTADEIIADFLSELGIMAHV 164
             F    ++G G +  VYKG  +  G+     VAIK L   T+ +   + L E  +MA V
Sbjct: 22  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 165 DHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
           D+P+  +LLG  +   + ++ +L P G L   +   K+ +         + +A+G+ YL 
Sbjct: 82  DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 141
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL 260
           +   RR++HRD+ A N+L+      +I DFGLAK L
Sbjct: 142 D---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 174

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 49/156 (31%), Positives = 80/156 (51%), Gaps = 8/156 (5%)
Query: 110 NNFSFENLIGKGGYAEVYKGR-LRNGQ----LVAIKRLTRGTADEIIADFLSELGIMAHV 164
             F    ++G G +  VYKG  +  G+     VAIK L   T+ +   + L E  +MA V
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 165 DHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
           D+P+  +LLG  +   + ++ +L P G L   +   K+ +         + +A+G+ YL 
Sbjct: 78  DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 137
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL 260
           +   RR++HRD+ A N+L+      +I DFGLAK L
Sbjct: 138 D---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 170

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 49/156 (31%), Positives = 80/156 (51%), Gaps = 8/156 (5%)
Query: 110 NNFSFENLIGKGGYAEVYKGR-LRNGQ----LVAIKRLTRGTADEIIADFLSELGIMAHV 164
             F    ++G G +  VYKG  +  G+     VAIK L   T+ +   + L E  +MA V
Sbjct: 21  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 80
Query: 165 DHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
           D+P+  +LLG  +   + ++ +L P G L   +   K+ +         + +A+G+ YL 
Sbjct: 81  DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 140
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL 260
           +   RR++HRD+ A N+L+      +I DFGLAK L
Sbjct: 141 D---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 173

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 83/152 (54%), Gaps = 6/152 (3%)
Query: 111 NFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLT-RGTADEIIADFLSELGIMAHVDHPNT 169
           + + +  IG G +  V++    +G  VA+K L  +    E + +FL E+ IM  + HPN 
Sbjct: 38  DLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNI 96
Query: 170 AKLLGYGIEG-GMHIVLELSPNGSLASLLY--GMKEKLKWGIRYKIALGVAEGLLYLHEG 226
              +G   +   + IV E    GSL  LL+  G +E+L    R  +A  VA+G+ YLH  
Sbjct: 97  VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156
Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
               I+HR++K+ N+L+ + +  ++CDFGL++
Sbjct: 157 -NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSR 187

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 48/140 (34%), Positives = 72/140 (51%), Gaps = 4/140 (2%)
Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGI 177
           IG G +  VYKG+      V +  +T  T  ++ A F +E+G++    H N    +GY  
Sbjct: 36  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQA-FKNEVGVLRKTRHVNILLFMGYST 94
Query: 178 EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIK 237
           +  + IV +     SL   L+ ++ K +      IA   A+G+ YLH    + IIHRD+K
Sbjct: 95  KPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLK 151
Query: 238 AANILLTEDFEPQICDFGLA 257
           + NI L ED   +I DFGLA
Sbjct: 152 SNNIFLHEDLTVKIGDFGLA 171

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 49/156 (31%), Positives = 80/156 (51%), Gaps = 8/156 (5%)
Query: 110 NNFSFENLIGKGGYAEVYKGR-LRNGQ----LVAIKRLTRGTADEIIADFLSELGIMAHV 164
             F    ++G G +  VYKG  +  G+     VAIK L   T+ +   + L E  +MA V
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 165 DHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
           D+P+  +LLG  +   + ++ +L P G L   +   K+ +         + +A+G+ YL 
Sbjct: 78  DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 137
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL 260
           +   RR++HRD+ A N+L+      +I DFGLAK L
Sbjct: 138 D---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 170

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 51/164 (31%), Positives = 80/164 (48%), Gaps = 7/164 (4%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           +  +F   IG G +  V+ G   N   VAIK +  G   E   DF+ E  +M  + HP  
Sbjct: 10  SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE--EDFIEEAEVMMKLSHPKL 67
Query: 170 AKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQ 228
            +L G  +E   + +V E   +G L+  L   +          + L V EG+ YL E C 
Sbjct: 68  VQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC- 126
Query: 229 RRIIHRDIKAANILLTEDFEPQICDFGLAKW-LPEQWTHHTISK 271
             +IHRD+ A N L+ E+   ++ DFG+ ++ L +Q+T  T +K
Sbjct: 127 --VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTK 168

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 51/160 (31%), Positives = 80/160 (50%), Gaps = 6/160 (3%)
Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGI 177
           IG G +  VYKG+      V +  +T  T  ++ A F +E+G++    H N    +GY  
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQA-FKNEVGVLRKTRHVNILLFMGYST 74
Query: 178 EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIK 237
              + IV +     SL   L+ ++ K +      IA   A+G+ YLH    + IIHRD+K
Sbjct: 75  APQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLK 131
Query: 238 AANILLTEDFEPQICDFGLAKWLPEQWT-HHTISKVEGTF 276
           + NI L ED   +I DFGLA  +  +W+  H   ++ G+ 
Sbjct: 132 SNNIFLHEDLTVKIGDFGLAT-VKSRWSGSHQFEQLSGSI 170

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 48/140 (34%), Positives = 72/140 (51%), Gaps = 4/140 (2%)
Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGI 177
           IG G +  VYKG+      V +  +T  T  ++ A F +E+G++    H N    +GY  
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQA-FKNEVGVLRKTRHVNILLFMGYST 74
Query: 178 EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIK 237
           +  + IV +     SL   L+ ++ K +      IA   A+G+ YLH    + IIHRD+K
Sbjct: 75  KPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLK 131
Query: 238 AANILLTEDFEPQICDFGLA 257
           + NI L ED   +I DFGLA
Sbjct: 132 SNNIFLHEDLTVKIGDFGLA 151

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 49/156 (31%), Positives = 80/156 (51%), Gaps = 8/156 (5%)
Query: 110 NNFSFENLIGKGGYAEVYKGR-LRNGQLV----AIKRLTRGTADEIIADFLSELGIMAHV 164
             F    ++G G +  VYKG  +  G+ V    AIK L   T+ +   + L E  +MA V
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 165 DHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
           D+P+  +LLG  +   + ++ +L P G L   +   K+ +         + +A+G+ YL 
Sbjct: 75  DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL 260
           +   RR++HRD+ A N+L+      +I DFGLAK L
Sbjct: 135 D---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 48/140 (34%), Positives = 72/140 (51%), Gaps = 4/140 (2%)
Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGI 177
           IG G +  VYKG+      V +  +T  T  ++ A F +E+G++    H N    +GY  
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQA-FKNEVGVLRKTRHVNILLFMGYST 102
Query: 178 EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIK 237
           +  + IV +     SL   L+ ++ K +      IA   A+G+ YLH    + IIHRD+K
Sbjct: 103 KPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLK 159
Query: 238 AANILLTEDFEPQICDFGLA 257
           + NI L ED   +I DFGLA
Sbjct: 160 SNNIFLHEDLTVKIGDFGLA 179

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 51/164 (31%), Positives = 80/164 (48%), Gaps = 7/164 (4%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           +  +F   IG G +  V+ G   N   VAIK +  G   E   DF+ E  +M  + HP  
Sbjct: 8   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE--EDFIEEAEVMMKLSHPKL 65
Query: 170 AKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQ 228
            +L G  +E   + +V E   +G L+  L   +          + L V EG+ YL E C 
Sbjct: 66  VQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC- 124
Query: 229 RRIIHRDIKAANILLTEDFEPQICDFGLAKW-LPEQWTHHTISK 271
             +IHRD+ A N L+ E+   ++ DFG+ ++ L +Q+T  T +K
Sbjct: 125 --VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTK 166

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 51/158 (32%), Positives = 80/158 (50%), Gaps = 8/158 (5%)
Query: 118 IGKGGYAEVYKGRLRN----GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLL 173
           IG+G + +V++G   +       VAIK     T+D +   FL E   M   DHP+  KL+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 174 GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIH 233
           G   E  + I++EL   G L S L   K  L        A  ++  L YL     +R +H
Sbjct: 458 GVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFVH 514
Query: 234 RDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK 271
           RDI A N+L++ +   ++ DFGL++++ E  T++  SK
Sbjct: 515 RDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASK 551

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 54/171 (31%), Positives = 80/171 (46%), Gaps = 8/171 (4%)
Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGI 177
           IG G +  VYKG+      V +  +T  T  ++ A F +E+G++    H N    +GY  
Sbjct: 32  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQA-FKNEVGVLRKTRHVNILLFMGYST 90
Query: 178 EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIK 237
           +  + IV +     SL   L+  + K +      IA   A G+ YLH    + IIHRD+K
Sbjct: 91  KPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLK 147
Query: 238 AANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPLVI 288
           + NI L ED   +I DFGLA         H   ++ G+     L + P VI
Sbjct: 148 SNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSI----LWMAPEVI 194

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 54/173 (31%), Positives = 83/173 (47%), Gaps = 10/173 (5%)
Query: 103 YELQSATNNFSFENLIGKGGYAEVYKGRLRN----GQLVAIKRLTRGTADEIIADFLSEL 158
           YE+Q           IG+G + +V++G   +       VAIK     T+D +   FL E 
Sbjct: 5   YEIQR--ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEA 62
Query: 159 GIMAHVDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE 218
             M   DHP+  KL+G   E  + I++EL   G L S L   K  L        A  ++ 
Sbjct: 63  LTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLST 122
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK 271
            L YL     +R +HRDI A N+L++     ++ DFGL++++ E  T++  SK
Sbjct: 123 ALAYLE---SKRFVHRDIAARNVLVSATDCVKLGDFGLSRYM-EDSTYYKASK 171

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 80/156 (51%), Gaps = 8/156 (5%)
Query: 110 NNFSFENLIGKGGYAEVYKGR-LRNGQ----LVAIKRLTRGTADEIIADFLSELGIMAHV 164
             F    ++G G +  VYKG  +  G+     VAIK L   T+ +   + L E  +MA V
Sbjct: 19  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 78
Query: 165 DHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
           D+P+  +LLG  +   + ++++L P G L   +   K+ +         + +A+G+ YL 
Sbjct: 79  DNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 138
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL 260
           +   RR++HRD+ A N+L+      +I DFG AK L
Sbjct: 139 D---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLL 171

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 74.3 bits (181), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 80/156 (51%), Gaps = 8/156 (5%)
Query: 110 NNFSFENLIGKGGYAEVYKGR-LRNGQ----LVAIKRLTRGTADEIIADFLSELGIMAHV 164
             F    ++G G +  VYKG  +  G+     VAIK L   T+ +   + L E  +MA V
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 165 DHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
           D+P+  +LLG  +   + ++++L P G L   +   K+ +         + +A+G+ YL 
Sbjct: 77  DNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 136
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL 260
           +   RR++HRD+ A N+L+      +I DFG AK L
Sbjct: 137 D---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLL 169

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 74.3 bits (181), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 80/156 (51%), Gaps = 8/156 (5%)
Query: 110 NNFSFENLIGKGGYAEVYKGR-LRNGQ----LVAIKRLTRGTADEIIADFLSELGIMAHV 164
             F    ++G G +  VYKG  +  G+     VAIK L   T+ +   + L E  +MA V
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 165 DHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
           D+P+  +LLG  +   + ++++L P G L   +   K+ +         + +A+G+ YL 
Sbjct: 77  DNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 136
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL 260
           +   RR++HRD+ A N+L+      +I DFG AK L
Sbjct: 137 D---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLL 169

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 74.3 bits (181), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 80/156 (51%), Gaps = 8/156 (5%)
Query: 110 NNFSFENLIGKGGYAEVYKGR-LRNGQ----LVAIKRLTRGTADEIIADFLSELGIMAHV 164
             F    ++  G +  VYKG  +  G+     VAIK L   T+ +   + L E  +MA V
Sbjct: 22  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 165 DHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
           D+P+  +LLG  +   + ++++L P G L   +   K+ +         + +A+G+ YL 
Sbjct: 82  DNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 141
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL 260
           +   RR++HRD+ A N+L+      +I DFGLAK L
Sbjct: 142 D---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 174

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/162 (30%), Positives = 78/162 (48%), Gaps = 9/162 (5%)
Query: 103 YELQSATNNFSFENLIGKGGYAEVYKGRLRN----GQLVAIKRLTRGTADEIIADFLSEL 158
           YE+Q           IG+G + +V++G   +       VAIK     T+D +   FL E 
Sbjct: 5   YEIQR--ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEA 62
Query: 159 GIMAHVDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE 218
             M   DHP+  KL+G   E  + I++EL   G L S L   K  L        A  ++ 
Sbjct: 63  LTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLST 122
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL 260
            L YL     +R +HRDI A N+L++ +   ++ DFGL++++
Sbjct: 123 ALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 161

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/171 (31%), Positives = 79/171 (46%), Gaps = 8/171 (4%)
Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGI 177
           IG G +  VYKG+      V +  +T  T  ++ A F +E+G++    H N    +GY  
Sbjct: 32  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQA-FKNEVGVLRKTRHVNILLFMGYST 90
Query: 178 EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIK 237
              + IV +     SL   L+  + K +      IA   A G+ YLH    + IIHRD+K
Sbjct: 91  APQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLK 147
Query: 238 AANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPLVI 288
           + NI L ED   +I DFGLA         H   ++ G+     L + P VI
Sbjct: 148 SNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSI----LWMAPEVI 194

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/173 (31%), Positives = 83/173 (47%), Gaps = 10/173 (5%)
Query: 103 YELQSATNNFSFENLIGKGGYAEVYKGRLRN----GQLVAIKRLTRGTADEIIADFLSEL 158
           YE+Q           IG+G + +V++G   +       VAIK     T+D +   FL E 
Sbjct: 385 YEIQR--ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEA 442
Query: 159 GIMAHVDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE 218
             M   DHP+  KL+G   E  + I++EL   G L S L   K  L        A  ++ 
Sbjct: 443 LTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLST 502
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK 271
            L YL     +R +HRDI A N+L++     ++ DFGL++++ E  T++  SK
Sbjct: 503 ALAYLE---SKRFVHRDIAARNVLVSATDCVKLGDFGLSRYM-EDSTYYKASK 551

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/166 (31%), Positives = 78/166 (46%), Gaps = 8/166 (4%)
Query: 114 FENLIGKGGYAEVYKGRLR----NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
            E +IG G + EV  G L+        VAIK L  G  ++   DFLSE  IM   DHPN 
Sbjct: 11  IEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNV 70
Query: 170 AKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQ 228
             L G   +   + I+ E   NGSL S L     +        +  G+A G+ YL +   
Sbjct: 71  IHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLAD--- 127
Query: 229 RRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEG 274
              +HR + A NIL+  +   ++ DFGL+++L +  +  T +   G
Sbjct: 128 MNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALG 173

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 79/156 (50%), Gaps = 8/156 (5%)
Query: 110 NNFSFENLIGKGGYAEVYKGR-LRNGQ----LVAIKRLTRGTADEIIADFLSELGIMAHV 164
             F    ++G G +  VYKG  +  G+     VAI  L   T+ +   + L E  +MA V
Sbjct: 49  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASV 108
Query: 165 DHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
           D+P+  +LLG  +   + ++ +L P G L   +   K+ +         + +A+G+ YL 
Sbjct: 109 DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 168
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL 260
           +   RR++HRD+ A N+L+      +I DFGLAK L
Sbjct: 169 D---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 201

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 48/154 (31%), Positives = 81/154 (52%), Gaps = 6/154 (3%)
Query: 118 IGKGGYAEVYKG--RLRNGQL-VAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLG 174
           +G G +  V +G  R+R  Q+ VAIK L +GT      + + E  IM  +D+P   +L+G
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 175 YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHR 234
                 + +V+E++  G L   L G +E++      ++   V+ G+ YL E   +  +HR
Sbjct: 78  VCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KNFVHR 134
Query: 235 DIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT 268
           D+ A N+LL      +I DFGL+K L    +++T
Sbjct: 135 DLAARNVLLVNRHYAKISDFGLSKALGADDSYYT 168

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 79/156 (50%), Gaps = 8/156 (5%)
Query: 110 NNFSFENLIGKGGYAEVYKGR-LRNGQ----LVAIKRLTRGTADEIIADFLSELGIMAHV 164
             F    ++  G +  VYKG  +  G+     VAIK L   T+ +   + L E  +MA V
Sbjct: 15  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 165 DHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
           D+P+  +LLG  +   + ++ +L P G L   +   K+ +         + +A+G+ YL 
Sbjct: 75  DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL 260
           +   RR++HRD+ A N+L+      +I DFGLAK L
Sbjct: 135 D---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 84/179 (46%), Gaps = 13/179 (7%)
Query: 93  SQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIA 152
           S  PQK +     +    +   E  +G G + EV+         VA+K +  G+    + 
Sbjct: 165 SSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS--VE 222
Query: 153 DFLSELGIMAHVDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLY---GMKEKLKWGIR 209
            FL+E  +M  + H    KL     +  ++I+ E    GSL   L    G K+ L   I 
Sbjct: 223 AFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLID 282
Query: 210 YKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKW---LPEQWT 265
           +  +  +AEG+ ++    QR  IHRD++AANIL++     +I DFGLA+     P +WT
Sbjct: 283 F--SAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVGAKFPIKWT 336

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/160 (35%), Positives = 79/160 (49%), Gaps = 19/160 (11%)
Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGI 177
           IGKG + +V  G  R G  VA+K +     D     FL+E  +M  + H N  +LLG  +
Sbjct: 201 IGKGEFGDVMLGDYR-GNKVAVKCIKN---DATAQAFLAEASVMTQLRHSNLVQLLGVIV 256
Query: 178 E--GGMHIVLELSPNGSLASLLYGMKEKLKWG-IRYKIALGVAEGLLYLHEGCQRRIIHR 234
           E  GG++IV E    GSL   L      +  G    K +L V E + YL EG     +HR
Sbjct: 257 EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL-EG--NNFVHR 313
Query: 235 DIKAANILLTEDFEPQICDFGLAKW---------LPEQWT 265
           D+ A N+L++ED   ++ DFGL K          LP +WT
Sbjct: 314 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT 353

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 48/147 (32%), Positives = 74/147 (50%), Gaps = 16/147 (10%)
Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGI 177
           +G G + EV+ G       VA+K L +G+       FL+E  +M  + H    +L     
Sbjct: 22  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP--DAFLAEANLMKQLQHQRLVRLYAVVT 79
Query: 178 EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKI------ALGVAEGLLYLHEGCQRRI 231
           +  ++I+ E   NGSL   L     K   GI+  I      A  +AEG+ ++ E   R  
Sbjct: 80  QEPIYIITEYMENGSLVDFL-----KTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNY 131
Query: 232 IHRDIKAANILLTEDFEPQICDFGLAK 258
           IHRD++AANIL+++    +I DFGLA+
Sbjct: 132 IHRDLRAANILVSDTLSCKIADFGLAR 158

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 79/156 (50%), Gaps = 8/156 (5%)
Query: 110 NNFSFENLIGKGGYAEVYKGR-LRNGQ----LVAIKRLTRGTADEIIADFLSELGIMAHV 164
             F    ++  G +  VYKG  +  G+     VAIK L   T+ +   + L E  +MA V
Sbjct: 22  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 165 DHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
           D+P+  +LLG  +   + ++ +L P G L   +   K+ +         + +A+G+ YL 
Sbjct: 82  DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 141
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL 260
           +   RR++HRD+ A N+L+      +I DFGLAK L
Sbjct: 142 D---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 174

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 48/147 (32%), Positives = 74/147 (50%), Gaps = 16/147 (10%)
Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGI 177
           +G G + EV+ G       VA+K L +G+       FL+E  +M  + H    +L     
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP--DAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 178 EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKI------ALGVAEGLLYLHEGCQRRI 231
           +  ++I+ E   NGSL   L     K   GI+  I      A  +AEG+ ++ E   R  
Sbjct: 79  QEPIYIITEYMENGSLVDFL-----KTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNY 130
Query: 232 IHRDIKAANILLTEDFEPQICDFGLAK 258
           IHRD++AANIL+++    +I DFGLA+
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLAR 157

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 79/156 (50%), Gaps = 8/156 (5%)
Query: 110 NNFSFENLIGKGGYAEVYKGR-LRNGQ----LVAIKRLTRGTADEIIADFLSELGIMAHV 164
             F    ++G G +  VYKG  +  G+     VAIK L   T+ +   + L E  +MA V
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 165 DHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
           D+P+  +LLG  +   + ++ +L P G L   +   K+ +         + +A+G+ YL 
Sbjct: 75  DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL 260
           +   RR++HRD+ A N+L+      +I DFG AK L
Sbjct: 135 D---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLL 167

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 79/156 (50%), Gaps = 8/156 (5%)
Query: 110 NNFSFENLIGKGGYAEVYKGR-LRNGQ----LVAIKRLTRGTADEIIADFLSELGIMAHV 164
             F    ++G G +  VYKG  +  G+     VAIK L   T+ +   + L E  +MA V
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 165 DHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
           D+P+  +LLG  +   + ++ +L P G L   +   K+ +         + +A+G+ YL 
Sbjct: 77  DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 136
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL 260
           +   RR++HRD+ A N+L+      +I DFG AK L
Sbjct: 137 D---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLL 169

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 48/147 (32%), Positives = 74/147 (50%), Gaps = 16/147 (10%)
Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGI 177
           +G G + EV+ G       VA+K L +G+       FL+E  +M  + H    +L     
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP--DAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 178 EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKI------ALGVAEGLLYLHEGCQRRI 231
           +  ++I+ E   NGSL   L     K   GI+  I      A  +AEG+ ++ E   R  
Sbjct: 79  QEPIYIITEYMENGSLVDFL-----KTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNY 130
Query: 232 IHRDIKAANILLTEDFEPQICDFGLAK 258
           IHRD++AANIL+++    +I DFGLA+
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLAR 157

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/160 (35%), Positives = 79/160 (49%), Gaps = 19/160 (11%)
Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGI 177
           IGKG + +V  G  R G  VA+K +     D     FL+E  +M  + H N  +LLG  +
Sbjct: 29  IGKGEFGDVMLGDYR-GNKVAVKCIKN---DATAQAFLAEASVMTQLRHSNLVQLLGVIV 84
Query: 178 E--GGMHIVLELSPNGSLASLLYGMKEKLKWG-IRYKIALGVAEGLLYLHEGCQRRIIHR 234
           E  GG++IV E    GSL   L      +  G    K +L V E + YL EG     +HR
Sbjct: 85  EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL-EG--NNFVHR 141
Query: 235 DIKAANILLTEDFEPQICDFGLAKW---------LPEQWT 265
           D+ A N+L++ED   ++ DFGL K          LP +WT
Sbjct: 142 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT 181

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 48/147 (32%), Positives = 74/147 (50%), Gaps = 16/147 (10%)
Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGI 177
           +G G + EV+ G       VA+K L +G+       FL+E  +M  + H    +L     
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP--DAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 178 EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKI------ALGVAEGLLYLHEGCQRRI 231
           +  ++I+ E   NGSL   L     K   GI+  I      A  +AEG+ ++ E   R  
Sbjct: 79  QEPIYIITEYMENGSLVDFL-----KTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNY 130
Query: 232 IHRDIKAANILLTEDFEPQICDFGLAK 258
           IHRD++AANIL+++    +I DFGLA+
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLAR 157

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/160 (35%), Positives = 79/160 (49%), Gaps = 19/160 (11%)
Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGI 177
           IGKG + +V  G  R G  VA+K +     D     FL+E  +M  + H N  +LLG  +
Sbjct: 14  IGKGEFGDVMLGDYR-GNKVAVKCIKN---DATAQAFLAEASVMTQLRHSNLVQLLGVIV 69
Query: 178 E--GGMHIVLELSPNGSLASLLYGMKEKLKWG-IRYKIALGVAEGLLYLHEGCQRRIIHR 234
           E  GG++IV E    GSL   L      +  G    K +L V E + YL EG     +HR
Sbjct: 70  EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL-EG--NNFVHR 126
Query: 235 DIKAANILLTEDFEPQICDFGLAKW---------LPEQWT 265
           D+ A N+L++ED   ++ DFGL K          LP +WT
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT 166

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 48/147 (32%), Positives = 74/147 (50%), Gaps = 16/147 (10%)
Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGI 177
           +G G + EV+ G       VA+K L +G+       FL+E  +M  + H    +L     
Sbjct: 16  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP--DAFLAEANLMKQLQHQRLVRLYAVVT 73
Query: 178 EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKI------ALGVAEGLLYLHEGCQRRI 231
           +  ++I+ E   NGSL   L     K   GI+  I      A  +AEG+ ++ E   R  
Sbjct: 74  QEPIYIITEYMENGSLVDFL-----KTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNY 125
Query: 232 IHRDIKAANILLTEDFEPQICDFGLAK 258
           IHRD++AANIL+++    +I DFGLA+
Sbjct: 126 IHRDLRAANILVSDTLSCKIADFGLAR 152

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 84/169 (49%), Gaps = 23/169 (13%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQL---VAIKRLTRGTADEIIADFLSELGIMAHV-D 165
           N+  F+++IG+G + +V K R++   L    AIKR+    + +   DF  EL ++  +  
Sbjct: 15  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 74
Query: 166 HPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMK---------------EKLKWGIR 209
           HPN   LLG     G +++ +E +P+G+L   L   +                 L     
Sbjct: 75  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 134
Query: 210 YKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
              A  VA G+ YL    Q++ IHRD+ A NIL+ E++  +I DFGL++
Sbjct: 135 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR 180

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 84/173 (48%), Gaps = 13/173 (7%)
Query: 96  PQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADF 154
           P +IF   +L           ++GKG + +  K   R  G+++ +K L R   +E    F
Sbjct: 3   PHRIFRPSDLIHG-------EVLGKGCFGQAIKVTHRETGEVMVMKELIR-FDEETQRTF 54
Query: 155 LSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIA 213
           L E+ +M  ++HPN  K +G   +   ++ + E    G+L  ++  M  +  W  R   A
Sbjct: 55  LKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFA 114
Query: 214 LGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH 266
             +A G+ YLH      IIHRD+ + N L+ E+    + DFGLA+ + ++ T 
Sbjct: 115 KDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ 164

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 79/156 (50%), Gaps = 8/156 (5%)
Query: 110 NNFSFENLIGKGGYAEVYKGR-LRNGQ----LVAIKRLTRGTADEIIADFLSELGIMAHV 164
             F    ++G G +  VYKG  +  G+     VAIK L   T+ +   + L E  +MA V
Sbjct: 22  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 165 DHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
           D+P+  +LLG  +   + ++ +L P G L   +   K+ +         + +A+G+ YL 
Sbjct: 82  DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 141
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL 260
           +   RR++HRD+ A N+L+      +I DFG AK L
Sbjct: 142 D---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLL 174

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 98/198 (49%), Gaps = 21/198 (10%)
Query: 79  GIDM-PRNLFVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQL- 136
           G+D+   NL+  S D    ++            + + ++ +G G Y EVY G  +   L 
Sbjct: 11  GVDLGTENLYFQSMDKWEMER-----------TDITMKHKLGGGQYGEVYVGVWKKYSLT 59
Query: 137 VAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGY-GIEGGMHIVLELSPNGSLAS 195
           VA+K L   T +  + +FL E  +M  + HPN  +LLG   +E   +IV E  P G+L  
Sbjct: 60  VAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLD 117
Query: 196 LLYGM-KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDF 254
            L    +E++   +   +A  ++  + YL    ++  IHRD+ A N L+ E+   ++ DF
Sbjct: 118 YLRECNREEVTAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHVVKVADF 174
Query: 255 GLAKWLP-EQWTHHTISK 271
           GL++ +  + +T H  +K
Sbjct: 175 GLSRLMTGDTYTAHAGAK 192

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 84/169 (49%), Gaps = 23/169 (13%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQL---VAIKRLTRGTADEIIADFLSELGIMAHV-D 165
           N+  F+++IG+G + +V K R++   L    AIKR+    + +   DF  EL ++  +  
Sbjct: 25  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 84
Query: 166 HPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMK---------------EKLKWGIR 209
           HPN   LLG     G +++ +E +P+G+L   L   +                 L     
Sbjct: 85  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 210 YKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
              A  VA G+ YL    Q++ IHRD+ A NIL+ E++  +I DFGL++
Sbjct: 145 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR 190

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/160 (35%), Positives = 79/160 (49%), Gaps = 19/160 (11%)
Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGI 177
           IGKG + +V  G  R G  VA+K +     D     FL+E  +M  + H N  +LLG  +
Sbjct: 20  IGKGEFGDVMLGDYR-GNKVAVKCIKN---DATAQAFLAEASVMTQLRHSNLVQLLGVIV 75
Query: 178 E--GGMHIVLELSPNGSLASLLYGMKEKLKWG-IRYKIALGVAEGLLYLHEGCQRRIIHR 234
           E  GG++IV E    GSL   L      +  G    K +L V E + YL EG     +HR
Sbjct: 76  EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL-EG--NNFVHR 132
Query: 235 DIKAANILLTEDFEPQICDFGLAKW---------LPEQWT 265
           D+ A N+L++ED   ++ DFGL K          LP +WT
Sbjct: 133 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT 172

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 53/160 (33%), Positives = 81/160 (50%), Gaps = 9/160 (5%)
Query: 118 IGKGGYAEVYKGRLR--NGQLV--AIKRLTRG--TADEIIADFLSELGIMAHVDHPNTAK 171
           +G G +  V +G     +G+ V  A+K L     +  E + DF+ E+  M  +DH N  +
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 172 LLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRI 231
           L G  +   M +V EL+P GSL   L   +     G   + A+ VAEG+ YL     +R 
Sbjct: 80  LYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRF 136
Query: 232 IHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK 271
           IHRD+ A N+LL      +I DFGL + LP+   H+ + +
Sbjct: 137 IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE 176

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 46/140 (32%), Positives = 69/140 (49%), Gaps = 4/140 (2%)
Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGI 177
           IG G +  VYKG+      V I ++   T ++  A F +E+ ++    H N    +GY  
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQA-FRNEVAVLRKTRHVNILLFMGYMT 102
Query: 178 EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIK 237
           +  + IV +     SL   L+  + K +      IA   A+G+ YLH    + IIHRD+K
Sbjct: 103 KDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHA---KNIIHRDMK 159
Query: 238 AANILLTEDFEPQICDFGLA 257
           + NI L E    +I DFGLA
Sbjct: 160 SNNIFLHEGLTVKIGDFGLA 179

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 97/197 (49%), Gaps = 14/197 (7%)
Query: 81  DMPRNLFVNSYDSQSPQKIFSLYELQSATNNFSFENLI------GKGGYAEVYKG--RLR 132
           D PR + +++   +SP       EL+        +NL+      G G +  V +G  R+R
Sbjct: 303 DKPRPMPMDTSVFESP--FSDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMR 360
Query: 133 NGQL-VAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHIVLELSPNG 191
             Q+ VAIK L +GT      + + E  IM  +D+P   +L+G      + +V+E++  G
Sbjct: 361 KKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVMEMAGGG 420
Query: 192 SLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQI 251
            L   L G +E++      ++   V+ G+ YL E   +  +HR++ A N+LL      +I
Sbjct: 421 PLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRNLAARNVLLVNRHYAKI 477
Query: 252 CDFGLAKWLPEQWTHHT 268
            DFGL+K L    +++T
Sbjct: 478 SDFGLSKALGADDSYYT 494

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 53/160 (33%), Positives = 81/160 (50%), Gaps = 9/160 (5%)
Query: 118 IGKGGYAEVYKGRLR--NGQLV--AIKRLTRG--TADEIIADFLSELGIMAHVDHPNTAK 171
           +G G +  V +G     +G+ V  A+K L     +  E + DF+ E+  M  +DH N  +
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 172 LLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRI 231
           L G  +   M +V EL+P GSL   L   +     G   + A+ VAEG+ YL     +R 
Sbjct: 86  LYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRF 142
Query: 232 IHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK 271
           IHRD+ A N+LL      +I DFGL + LP+   H+ + +
Sbjct: 143 IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE 182

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 51/156 (32%), Positives = 74/156 (47%), Gaps = 8/156 (5%)
Query: 112 FSFENLIGKGGYAEVYKGRLR----NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHP 167
              E +IG G + EV  GRL+        VAIK L  G  D+   DFLSE  IM   DHP
Sbjct: 16  IKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHP 75
Query: 168 NTAKLLGYGIE-GGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEG 226
           N   L G   +   + I+ E   NGSL + L     +        +  G+  G+ YL + 
Sbjct: 76  NIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSD- 134
Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE 262
                +HRD+ A NIL+  +   ++ DFG+++ L +
Sbjct: 135 --MSYVHRDLAARNILVNSNLVCKVSDFGMSRVLED 168

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 51/155 (32%), Positives = 74/155 (47%), Gaps = 8/155 (5%)
Query: 114 FENLIGKGGYAEVYKGRLR----NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
            E +IG G + EV  GRL+        VAIK L  G  D+   DFLSE  IM   DHPN 
Sbjct: 12  IEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNI 71
Query: 170 AKLLGYGIE-GGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQ 228
             L G   +   + I+ E   NGSL + L     +        +  G+  G+ YL +   
Sbjct: 72  IHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSD--- 128
Query: 229 RRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ 263
              +HRD+ A NIL+  +   ++ DFG+++ L + 
Sbjct: 129 MSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDD 163

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 53/160 (33%), Positives = 81/160 (50%), Gaps = 9/160 (5%)
Query: 118 IGKGGYAEVYKGRLR--NGQLV--AIKRLTRG--TADEIIADFLSELGIMAHVDHPNTAK 171
           +G G +  V +G     +G+ V  A+K L     +  E + DF+ E+  M  +DH N  +
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 172 LLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRI 231
           L G  +   M +V EL+P GSL   L   +     G   + A+ VAEG+ YL     +R 
Sbjct: 80  LYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRF 136
Query: 232 IHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK 271
           IHRD+ A N+LL      +I DFGL + LP+   H+ + +
Sbjct: 137 IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE 176

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 80/169 (47%), Gaps = 10/169 (5%)
Query: 93  SQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIA 152
           S  PQK +     +    +   E  +G G + EV+         VA+K +  G+    + 
Sbjct: 171 SSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS--VE 228
Query: 153 DFLSELGIMAHVDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLY---GMKEKLKWGIR 209
            FL+E  +M  + H    KL     +  ++I+ E    GSL   L    G K+ L   I 
Sbjct: 229 AFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLID 288
Query: 210 YKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           +  +  +AEG+ ++    QR  IHRD++AANIL++     +I DFGLA+
Sbjct: 289 F--SAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLAR 332

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 53/160 (33%), Positives = 81/160 (50%), Gaps = 9/160 (5%)
Query: 118 IGKGGYAEVYKGRLR--NGQLV--AIKRLTRG--TADEIIADFLSELGIMAHVDHPNTAK 171
           +G G +  V +G     +G+ V  A+K L     +  E + DF+ E+  M  +DH N  +
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 172 LLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRI 231
           L G  +   M +V EL+P GSL   L   +     G   + A+ VAEG+ YL     +R 
Sbjct: 76  LYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRF 132
Query: 232 IHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK 271
           IHRD+ A N+LL      +I DFGL + LP+   H+ + +
Sbjct: 133 IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE 172

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 79/164 (48%), Gaps = 7/164 (4%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           +  +F   IG G +  V+ G   N   VAIK +  G   E   DF+ E  +M  + HP  
Sbjct: 7   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE--EDFIEEAEVMMKLSHPKL 64
Query: 170 AKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQ 228
            +L G  +E   + +V E   +G L+  L   +          + L V EG+ YL E   
Sbjct: 65  VQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA-- 122
Query: 229 RRIIHRDIKAANILLTEDFEPQICDFGLAKW-LPEQWTHHTISK 271
             +IHRD+ A N L+ E+   ++ DFG+ ++ L +Q+T  T +K
Sbjct: 123 -SVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTK 165

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 53/160 (33%), Positives = 81/160 (50%), Gaps = 9/160 (5%)
Query: 118 IGKGGYAEVYKGRLR--NGQLV--AIKRLTRG--TADEIIADFLSELGIMAHVDHPNTAK 171
           +G G +  V +G     +G+ V  A+K L     +  E + DF+ E+  M  +DH N  +
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 172 LLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRI 231
           L G  +   M +V EL+P GSL   L   +     G   + A+ VAEG+ YL     +R 
Sbjct: 76  LYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRF 132
Query: 232 IHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK 271
           IHRD+ A N+LL      +I DFGL + LP+   H+ + +
Sbjct: 133 IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE 172

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 50/151 (33%), Positives = 75/151 (49%), Gaps = 9/151 (5%)
Query: 114 FENLIGKGGYAEVYKGRL--RNGQLV--AIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           F  +IG+G +  VY G L   +G+ +  A+K L R T    ++ FL+E  IM    HPN 
Sbjct: 33  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 92
Query: 170 AKLLGYGI--EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
             LLG  +  EG   +VL    +G L + +                L VA+G+ YL    
Sbjct: 93  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---A 149
Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
            ++ +HRD+ A N +L E F  ++ DFGLA+
Sbjct: 150 SKKFVHRDLAARNCMLDEKFTVKVADFGLAR 180

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 49/150 (32%), Positives = 76/150 (50%), Gaps = 9/150 (6%)
Query: 115 ENLIGKGGYAEVYKG----RLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTA 170
           + +IGKG +  VY G    + +N    AIK L+R T  + +  FL E  +M  ++HPN  
Sbjct: 26  DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85
Query: 171 KLLGYGI--EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQ 228
            L+G  +  EG  H++L    +G L   +   +            L VA G+ YL E   
Sbjct: 86  ALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAE--- 142
Query: 229 RRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           ++ +HRD+ A N +L E F  ++ DFGLA+
Sbjct: 143 QKFVHRDLAARNCMLDESFTVKVADFGLAR 172

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 50/151 (33%), Positives = 75/151 (49%), Gaps = 9/151 (5%)
Query: 114 FENLIGKGGYAEVYKGRL--RNGQLV--AIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           F  +IG+G +  VY G L   +G+ +  A+K L R T    ++ FL+E  IM    HPN 
Sbjct: 34  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 93
Query: 170 AKLLGYGI--EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
             LLG  +  EG   +VL    +G L + +                L VA+G+ YL    
Sbjct: 94  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---A 150
Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
            ++ +HRD+ A N +L E F  ++ DFGLA+
Sbjct: 151 SKKFVHRDLAARNCMLDEKFTVKVADFGLAR 181

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 90/177 (50%), Gaps = 10/177 (5%)
Query: 96  PQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLT--RGTADEIIA 152
           PQK        +   NF  E  IG+G ++EVY+   L +G  VA+K++        +  A
Sbjct: 18  PQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARA 77
Query: 153 DFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEK---LKWGI 208
           D + E+ ++  ++HPN  K     IE   ++IVLEL+  G L+ ++   K++   +    
Sbjct: 78  DCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERT 137
Query: 209 RYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT 265
            +K  + +   L ++H    RR++HRDIK AN+ +T     ++ D GL ++   + T
Sbjct: 138 VWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 191

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 50/151 (33%), Positives = 75/151 (49%), Gaps = 9/151 (5%)
Query: 114 FENLIGKGGYAEVYKGRL--RNGQLV--AIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           F  +IG+G +  VY G L   +G+ +  A+K L R T    ++ FL+E  IM    HPN 
Sbjct: 26  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 85
Query: 170 AKLLGYGI--EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
             LLG  +  EG   +VL    +G L + +                L VA+G+ YL    
Sbjct: 86  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---A 142
Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
            ++ +HRD+ A N +L E F  ++ DFGLA+
Sbjct: 143 SKKFVHRDLAARNCMLDEKFTVKVADFGLAR 173

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 50/151 (33%), Positives = 75/151 (49%), Gaps = 9/151 (5%)
Query: 114 FENLIGKGGYAEVYKGRL--RNGQLV--AIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           F  +IG+G +  VY G L   +G+ +  A+K L R T    ++ FL+E  IM    HPN 
Sbjct: 53  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 112
Query: 170 AKLLGYGI--EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
             LLG  +  EG   +VL    +G L + +                L VA+G+ YL    
Sbjct: 113 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---A 169
Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
            ++ +HRD+ A N +L E F  ++ DFGLA+
Sbjct: 170 SKKFVHRDLAARNCMLDEKFTVKVADFGLAR 200

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 50/151 (33%), Positives = 75/151 (49%), Gaps = 9/151 (5%)
Query: 114 FENLIGKGGYAEVYKGRL--RNGQLV--AIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           F  +IG+G +  VY G L   +G+ +  A+K L R T    ++ FL+E  IM    HPN 
Sbjct: 32  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 91
Query: 170 AKLLGYGI--EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
             LLG  +  EG   +VL    +G L + +                L VA+G+ YL    
Sbjct: 92  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---A 148
Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
            ++ +HRD+ A N +L E F  ++ DFGLA+
Sbjct: 149 SKKFVHRDLAARNCMLDEKFTVKVADFGLAR 179

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 50/151 (33%), Positives = 75/151 (49%), Gaps = 9/151 (5%)
Query: 114 FENLIGKGGYAEVYKGRL--RNGQLV--AIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           F  +IG+G +  VY G L   +G+ +  A+K L R T    ++ FL+E  IM    HPN 
Sbjct: 33  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 92
Query: 170 AKLLGYGI--EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
             LLG  +  EG   +VL    +G L + +                L VA+G+ YL    
Sbjct: 93  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---A 149
Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
            ++ +HRD+ A N +L E F  ++ DFGLA+
Sbjct: 150 SKKFVHRDLAARNCMLDEKFTVKVADFGLAR 180

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 50/151 (33%), Positives = 75/151 (49%), Gaps = 9/151 (5%)
Query: 114 FENLIGKGGYAEVYKGRL--RNGQLV--AIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           F  +IG+G +  VY G L   +G+ +  A+K L R T    ++ FL+E  IM    HPN 
Sbjct: 31  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 90
Query: 170 AKLLGYGI--EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
             LLG  +  EG   +VL    +G L + +                L VA+G+ YL    
Sbjct: 91  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---A 147
Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
            ++ +HRD+ A N +L E F  ++ DFGLA+
Sbjct: 148 SKKFVHRDLAARNCMLDEKFTVKVADFGLAR 178

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 50/151 (33%), Positives = 75/151 (49%), Gaps = 9/151 (5%)
Query: 114 FENLIGKGGYAEVYKGRL--RNGQLV--AIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           F  +IG+G +  VY G L   +G+ +  A+K L R T    ++ FL+E  IM    HPN 
Sbjct: 34  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 93
Query: 170 AKLLGYGI--EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
             LLG  +  EG   +VL    +G L + +                L VA+G+ YL    
Sbjct: 94  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---A 150
Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
            ++ +HRD+ A N +L E F  ++ DFGLA+
Sbjct: 151 SKKFVHRDLAARNCMLDEKFTVKVADFGLAR 181

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 50/151 (33%), Positives = 75/151 (49%), Gaps = 9/151 (5%)
Query: 114 FENLIGKGGYAEVYKGRL--RNGQLV--AIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           F  +IG+G +  VY G L   +G+ +  A+K L R T    ++ FL+E  IM    HPN 
Sbjct: 29  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 88
Query: 170 AKLLGYGI--EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
             LLG  +  EG   +VL    +G L + +                L VA+G+ YL    
Sbjct: 89  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---A 145
Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
            ++ +HRD+ A N +L E F  ++ DFGLA+
Sbjct: 146 SKKFVHRDLAARNCMLDEKFTVKVADFGLAR 176

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 50/151 (33%), Positives = 75/151 (49%), Gaps = 9/151 (5%)
Query: 114 FENLIGKGGYAEVYKGRL--RNGQLV--AIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           F  +IG+G +  VY G L   +G+ +  A+K L R T    ++ FL+E  IM    HPN 
Sbjct: 52  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 111
Query: 170 AKLLGYGI--EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
             LLG  +  EG   +VL    +G L + +                L VA+G+ YL    
Sbjct: 112 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---A 168
Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
            ++ +HRD+ A N +L E F  ++ DFGLA+
Sbjct: 169 SKKFVHRDLAARNCMLDEKFTVKVADFGLAR 199

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 48/147 (32%), Positives = 73/147 (49%), Gaps = 16/147 (10%)
Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGI 177
           +G G   EV+ G       VA+K L +G+       FL+E  +M  + H    +L     
Sbjct: 21  LGAGQAGEVWMGYYNGHTKVAVKSLKQGSMSP--DAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 178 EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKI------ALGVAEGLLYLHEGCQRRI 231
           +  ++I+ E   NGSL   L     K   GI+  I      A  +AEG+ ++ E   R  
Sbjct: 79  QEPIYIITEYMENGSLVDFL-----KTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNY 130
Query: 232 IHRDIKAANILLTEDFEPQICDFGLAK 258
           IHRD++AANIL+++    +I DFGLA+
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLAR 157

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 70.9 bits (172), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 47/147 (31%), Positives = 74/147 (50%), Gaps = 16/147 (10%)
Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGI 177
           +G G + EV+ G       VA+K L +G+       FL+E  +M  + H    +L     
Sbjct: 17  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP--DAFLAEANLMKQLQHQRLVRLYAVVT 74
Query: 178 EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKI------ALGVAEGLLYLHEGCQRRI 231
           +  ++I+ E   NGSL   L     K   GI+  I      A  +AEG+ ++ E   R  
Sbjct: 75  QEPIYIITEYMENGSLVDFL-----KTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNY 126
Query: 232 IHRDIKAANILLTEDFEPQICDFGLAK 258
           IHR+++AANIL+++    +I DFGLA+
Sbjct: 127 IHRNLRAANILVSDTLSCKIADFGLAR 153

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 70.9 bits (172), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 84/169 (49%), Gaps = 23/169 (13%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQL---VAIKRLTRGTADEIIADFLSELGIMAHV-D 165
           N+  F+++IG+G + +V K R++   L    AIKR+    + +   DF  EL ++  +  
Sbjct: 22  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 81
Query: 166 HPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMK---------------EKLKWGIR 209
           HPN   LLG     G +++ +E +P+G+L   L   +                 L     
Sbjct: 82  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 141
Query: 210 YKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
              A  VA G+ YL    Q++ IHR++ A NIL+ E++  +I DFGL++
Sbjct: 142 LHFAADVARGMDYL---SQKQFIHRNLAARNILVGENYVAKIADFGLSR 187

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 53/160 (33%), Positives = 80/160 (50%), Gaps = 9/160 (5%)
Query: 118 IGKGGYAEVYKGRLR--NGQLV--AIKRLTRG--TADEIIADFLSELGIMAHVDHPNTAK 171
           +G G +  V +G     +G+ V  A+K L     +  E + DF+ E+  M  +DH N  +
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 172 LLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRI 231
           L G  +   M +V EL+P GSL   L   +     G   + A+ VAEG+ YL     +R 
Sbjct: 86  LYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRF 142
Query: 232 IHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK 271
           IHRD+ A N+LL      +I DFGL + LP+   H  + +
Sbjct: 143 IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQE 182

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 54/187 (28%), Positives = 81/187 (43%), Gaps = 9/187 (4%)
Query: 80  IDMPRNLFVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQ---- 135
           I    NL+        P +    +  +   +  + + +IG G + EVYKG L+       
Sbjct: 14  IPTTENLYFQGAMGSDPNQAVLKFTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKE 73
Query: 136 -LVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGY-GIEGGMHIVLELSPNGSL 193
             VAIK L  G  ++   DFL E GIM    H N  +L G       M I+ E   NG+L
Sbjct: 74  VPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGAL 133
Query: 194 ASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICD 253
              L     +        +  G+A G+ YL        +HRD+ A NIL+  +   ++ D
Sbjct: 134 DKFLREKDGEFSVLQLVGMLRGIAAGMKYL---ANMNYVHRDLAARNILVNSNLVCKVSD 190
Query: 254 FGLAKWL 260
           FGL++ L
Sbjct: 191 FGLSRVL 197

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/160 (33%), Positives = 80/160 (50%), Gaps = 9/160 (5%)
Query: 118 IGKGGYAEVYKGRLR--NGQLV--AIKRLTRG--TADEIIADFLSELGIMAHVDHPNTAK 171
           +G G +  V +G     +G+ V  A+K L     +  E + DF+ E+  M  +DH N  +
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 172 LLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRI 231
           L G  +   M +V EL+P GSL   L   +     G   + A+ VAEG+ YL     +R 
Sbjct: 76  LYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRF 132
Query: 232 IHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK 271
           IHRD+ A N+LL      +I DFGL + LP+   H  + +
Sbjct: 133 IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQE 172

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 48/150 (32%), Positives = 74/150 (49%), Gaps = 6/150 (4%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
            +   E  +G+G + EV+ G       VAIK L  GT       FL E  +M  + H   
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP--EAFLQEAQVMKKLRHEKL 75
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYG-MKEKLKWGIRYKIALGVAEGLLYLHEGCQ 228
            +L     E  ++IV+E    GSL   L G M + L+      +A  +A G+ Y+    +
Sbjct: 76  VQLYAVVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---R 132
Query: 229 RRIIHRDIKAANILLTEDFEPQICDFGLAK 258
              +HRD++AANIL+ E+   ++ DFGLA+
Sbjct: 133 MNYVHRDLRAANILVGENLVCKVADFGLAR 162

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 48/150 (32%), Positives = 74/150 (49%), Gaps = 6/150 (4%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
            +   E  +G+G + EV+ G       VAIK L  GT       FL E  +M  + H   
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP--EAFLQEAQVMKKLRHEKL 75
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYG-MKEKLKWGIRYKIALGVAEGLLYLHEGCQ 228
            +L     E  ++IV+E    GSL   L G M + L+      +A  +A G+ Y+    +
Sbjct: 76  VQLYAVVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---R 132
Query: 229 RRIIHRDIKAANILLTEDFEPQICDFGLAK 258
              +HRD++AANIL+ E+   ++ DFGLA+
Sbjct: 133 MNYVHRDLRAANILVGENLVCKVADFGLAR 162

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 75/151 (49%), Gaps = 9/151 (5%)
Query: 114 FENLIGKGGYAEVYKGRL--RNGQLV--AIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           F  +IG+G +  VY G L   +G+ +  A+K L R T    ++ FL+E  IM    HPN 
Sbjct: 32  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 91
Query: 170 AKLLGYGI--EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
             LLG  +  EG   +VL    +G L + +                L VA+G+ +L    
Sbjct: 92  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---A 148
Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
            ++ +HRD+ A N +L E F  ++ DFGLA+
Sbjct: 149 SKKFVHRDLAARNCMLDEKFTVKVADFGLAR 179

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 48/150 (32%), Positives = 73/150 (48%), Gaps = 6/150 (4%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
            +   E  +G+G + EV+ G       VAIK L  GT       FL E  +M  + H   
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP--EAFLQEAQVMKKIRHEKL 75
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYG-MKEKLKWGIRYKIALGVAEGLLYLHEGCQ 228
            +L     E  ++IV E    GSL   L G M + L+      +A  +A G+ Y+    +
Sbjct: 76  VQLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---R 132
Query: 229 RRIIHRDIKAANILLTEDFEPQICDFGLAK 258
              +HRD++AANIL+ E+   ++ DFGLA+
Sbjct: 133 MNYVHRDLRAANILVGENLVCKVADFGLAR 162

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 80/172 (46%), Gaps = 8/172 (4%)
Query: 94  QSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLR----NGQLVAIKRLTRGTADE 149
           + P +    +  +   +  + E +IG G + EV  GRL+        VAIK L  G  ++
Sbjct: 6   EDPNQAVHEFAKEIEASCITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEK 65
Query: 150 IIADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGI 208
              DFL E  IM   DHPN   L G   +   + IV E   NGSL + L     +     
Sbjct: 66  QRRDFLGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQ 125
Query: 209 RYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL 260
              +  G++ G+ YL +      +HRD+ A NIL+  +   ++ DFGL++ L
Sbjct: 126 LVGMLRGISAGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVL 174

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 75/151 (49%), Gaps = 9/151 (5%)
Query: 114 FENLIGKGGYAEVYKGRL--RNGQLV--AIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           F  +IG+G +  VY G L   +G+ +  A+K L R T    ++ FL+E  IM    HPN 
Sbjct: 35  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 94
Query: 170 AKLLGYGI--EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
             LLG  +  EG   +VL    +G L + +                L VA+G+ +L    
Sbjct: 95  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---A 151
Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
            ++ +HRD+ A N +L E F  ++ DFGLA+
Sbjct: 152 SKKFVHRDLAARNCMLDEKFTVKVADFGLAR 182

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 75/151 (49%), Gaps = 9/151 (5%)
Query: 114 FENLIGKGGYAEVYKGRL--RNGQLV--AIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           F  +IG+G +  VY G L   +G+ +  A+K L R T    ++ FL+E  IM    HPN 
Sbjct: 34  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 93
Query: 170 AKLLGYGI--EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
             LLG  +  EG   +VL    +G L + +                L VA+G+ +L    
Sbjct: 94  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---A 150
Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
            ++ +HRD+ A N +L E F  ++ DFGLA+
Sbjct: 151 SKKFVHRDLAARNCMLDEKFTVKVADFGLAR 181

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 96/187 (51%), Gaps = 13/187 (6%)
Query: 89  NSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQL-VAIKRLTRGTA 147
            S D  SP   +  +E++    + + ++ +G G Y EVY+G  +   L VA+K L   T 
Sbjct: 1   TSMDPSSPN--YDKWEMER--TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM 56
Query: 148 DEIIADFLSELGIMAHVDHPNTAKLLGYGI-EGGMHIVLELSPNGSLASLLYGM-KEKLK 205
           +  + +FL E  +M  + HPN  +LLG    E   +I++E    G+L   L    ++++ 
Sbjct: 57  E--VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVN 114
Query: 206 WGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP-EQW 264
             +   +A  ++  + YL    ++  IHRD+ A N L+ E+   ++ DFGL++ +  + +
Sbjct: 115 AVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 171
Query: 265 THHTISK 271
           T H  +K
Sbjct: 172 TAHAGAK 178

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 75/151 (49%), Gaps = 9/151 (5%)
Query: 114 FENLIGKGGYAEVYKGRL--RNGQLV--AIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           F  +IG+G +  VY G L   +G+ +  A+K L R T    ++ FL+E  IM    HPN 
Sbjct: 34  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 93
Query: 170 AKLLGYGI--EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
             LLG  +  EG   +VL    +G L + +                L VA+G+ +L    
Sbjct: 94  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---A 150
Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
            ++ +HRD+ A N +L E F  ++ DFGLA+
Sbjct: 151 SKKFVHRDLAARNCMLDEKFTVKVADFGLAR 181

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 75/151 (49%), Gaps = 9/151 (5%)
Query: 114 FENLIGKGGYAEVYKGRL--RNGQLV--AIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           F  +IG+G +  VY G L   +G+ +  A+K L R T    ++ FL+E  IM    HPN 
Sbjct: 93  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 152
Query: 170 AKLLGYGI--EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
             LLG  +  EG   +VL    +G L + +                L VA+G+ +L    
Sbjct: 153 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---A 209
Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
            ++ +HRD+ A N +L E F  ++ DFGLA+
Sbjct: 210 SKKFVHRDLAARNCMLDEKFTVKVADFGLAR 240

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 78/165 (47%), Gaps = 12/165 (7%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRL-----RNGQLVAIKRLTRGTADEIIADFLSELGI 160
           Q    +  F   +GKG +  V   R        G++VA+K+L   T +E + DF  E+ I
Sbjct: 9   QFEERHLKFLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEI 67
Query: 161 MAHVDHPNTAKLLGYGIEGG---MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVA 217
           +  + H N  K  G     G   + +++E  P GSL   L   KE++      +    + 
Sbjct: 68  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQIC 127
Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE 262
           +G+ YL     +R IHRD+   NIL+  +   +I DFGL K LP+
Sbjct: 128 KGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 169

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 75/151 (49%), Gaps = 9/151 (5%)
Query: 114 FENLIGKGGYAEVYKGRL--RNGQLV--AIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           F  +IG+G +  VY G L   +G+ +  A+K L R T    ++ FL+E  IM    HPN 
Sbjct: 35  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 94
Query: 170 AKLLGYGI--EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
             LLG  +  EG   +VL    +G L + +                L VA+G+ +L    
Sbjct: 95  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---A 151
Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
            ++ +HRD+ A N +L E F  ++ DFGLA+
Sbjct: 152 SKKFVHRDLAARNCMLDEKFTVKVADFGLAR 182

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 78/160 (48%), Gaps = 7/160 (4%)
Query: 108 ATNNFSFENLIGKGGYAEVYKGRLRNGQ----LVAIKRLTRGTADEIIADFLSELGIMAH 163
           A  +     ++G+G + EVY+G   N +     VA+K   +    +    F+SE  IM +
Sbjct: 6   AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKN 65
Query: 164 VDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYL 223
           +DHP+  KL+G   E    I++EL P G L   L   K  LK       +L + + + YL
Sbjct: 66  LDHPHIVKLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYL 125
Query: 224 HEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ 263
                   +HRDI   NIL+      ++ DFGL++++ ++
Sbjct: 126 E---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE 162

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 75/151 (49%), Gaps = 9/151 (5%)
Query: 114 FENLIGKGGYAEVYKGRL--RNGQLV--AIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           F  +IG+G +  VY G L   +G+ +  A+K L R T    ++ FL+E  IM    HPN 
Sbjct: 39  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 98
Query: 170 AKLLGYGI--EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
             LLG  +  EG   +VL    +G L + +                L VA+G+ +L    
Sbjct: 99  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---A 155
Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
            ++ +HRD+ A N +L E F  ++ DFGLA+
Sbjct: 156 SKKFVHRDLAARNCMLDEKFTVKVADFGLAR 186

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 48/150 (32%), Positives = 73/150 (48%), Gaps = 6/150 (4%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
            +   E  +G+G + EV+ G       VAIK L  GT       FL E  +M  + H   
Sbjct: 7   ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP--EAFLQEAQVMKKLRHEKL 64
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYG-MKEKLKWGIRYKIALGVAEGLLYLHEGCQ 228
            +L     E  ++IV E    GSL   L G M + L+      +A  +A G+ Y+    +
Sbjct: 65  VQLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---R 121
Query: 229 RRIIHRDIKAANILLTEDFEPQICDFGLAK 258
              +HRD++AANIL+ E+   ++ DFGLA+
Sbjct: 122 MNYVHRDLRAANILVGENLVCKVADFGLAR 151

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 48/150 (32%), Positives = 73/150 (48%), Gaps = 6/150 (4%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
            +   E  +G+G + EV+ G       VAIK L  GT       FL E  +M  + H   
Sbjct: 9   ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP--EAFLQEAQVMKKLRHEKL 66
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYG-MKEKLKWGIRYKIALGVAEGLLYLHEGCQ 228
            +L     E  ++IV E    GSL   L G M + L+      +A  +A G+ Y+    +
Sbjct: 67  VQLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---R 123
Query: 229 RRIIHRDIKAANILLTEDFEPQICDFGLAK 258
              +HRD++AANIL+ E+   ++ DFGLA+
Sbjct: 124 MNYVHRDLRAANILVGENLVCKVADFGLAR 153

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 78/160 (48%), Gaps = 7/160 (4%)
Query: 108 ATNNFSFENLIGKGGYAEVYKGRLRNGQ----LVAIKRLTRGTADEIIADFLSELGIMAH 163
           A  +     ++G+G + EVY+G   N +     VA+K   +    +    F+SE  IM +
Sbjct: 22  AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKN 81
Query: 164 VDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYL 223
           +DHP+  KL+G   E    I++EL P G L   L   K  LK       +L + + + YL
Sbjct: 82  LDHPHIVKLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYL 141
Query: 224 HEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ 263
                   +HRDI   NIL+      ++ DFGL++++ ++
Sbjct: 142 E---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE 178

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 78/165 (47%), Gaps = 12/165 (7%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRL-----RNGQLVAIKRLTRGTADEIIADFLSELGI 160
           Q    +  F   +GKG +  V   R        G++VA+K+L   T +E + DF  E+ I
Sbjct: 5   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEI 63
Query: 161 MAHVDHPNTAKLLGYGIEGG---MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVA 217
           +  + H N  K  G     G   + +++E  P GSL   L   KE++      +    + 
Sbjct: 64  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC 123
Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE 262
           +G+ YL     +R IHRD+   NIL+  +   +I DFGL K LP+
Sbjct: 124 KGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 165

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 78/160 (48%), Gaps = 7/160 (4%)
Query: 108 ATNNFSFENLIGKGGYAEVYKGRLRNGQ----LVAIKRLTRGTADEIIADFLSELGIMAH 163
           A  +     ++G+G + EVY+G   N +     VA+K   +    +    F+SE  IM +
Sbjct: 10  AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKN 69
Query: 164 VDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYL 223
           +DHP+  KL+G   E    I++EL P G L   L   K  LK       +L + + + YL
Sbjct: 70  LDHPHIVKLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYL 129
Query: 224 HEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ 263
                   +HRDI   NIL+      ++ DFGL++++ ++
Sbjct: 130 E---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE 166

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 92/195 (47%), Gaps = 23/195 (11%)
Query: 112 FSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEI---IADFLSELGIMAHVDHPN 168
            + E +IG GG+ +VY+     G  VA+K       ++I   I +   E  + A + HPN
Sbjct: 9   LTLEEIIGIGGFGKVYRA-FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPN 67
Query: 169 TAKLLGYGI-EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
              L G  + E  + +V+E +  G L  +L G  +++   I    A+ +A G+ YLH+  
Sbjct: 68  IIALRGVCLKEPNLCLVMEFARGGPLNRVLSG--KRIPPDILVNWAVQIARGMNYLHDEA 125
Query: 228 QRRIIHRDIKAANILLTEDFEP--------QICDFGLAKWLPEQWTHHTISKVEGTFGLV 279
              IIHRD+K++NIL+ +  E         +I DFGLA+    +W   T     G +   
Sbjct: 126 IVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR----EWHRTTKMSAAGAYAW- 180
Query: 280 KLNLPPLVILKRCFT 294
              + P VI    F+
Sbjct: 181 ---MAPEVIRASMFS 192

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 48/150 (32%), Positives = 73/150 (48%), Gaps = 6/150 (4%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
            +   E  +G+G + EV+ G       VAIK L  GT       FL E  +M  + H   
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP--EAFLQEAQVMKKLRHEKL 75
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYG-MKEKLKWGIRYKIALGVAEGLLYLHEGCQ 228
            +L     E  ++IV E    GSL   L G M + L+      +A  +A G+ Y+    +
Sbjct: 76  VQLYAVVSEEPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---R 132
Query: 229 RRIIHRDIKAANILLTEDFEPQICDFGLAK 258
              +HRD++AANIL+ E+   ++ DFGLA+
Sbjct: 133 MNYVHRDLRAANILVGENLVCKVADFGLAR 162

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 78/165 (47%), Gaps = 12/165 (7%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRL-----RNGQLVAIKRLTRGTADEIIADFLSELGI 160
           Q    +  F   +GKG +  V   R        G++VA+K+L   T +E + DF  E+ I
Sbjct: 6   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEI 64
Query: 161 MAHVDHPNTAKLLGYGIEGG---MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVA 217
           +  + H N  K  G     G   + +++E  P GSL   L   KE++      +    + 
Sbjct: 65  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC 124
Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE 262
           +G+ YL     +R IHRD+   NIL+  +   +I DFGL K LP+
Sbjct: 125 KGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 166

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 78/165 (47%), Gaps = 12/165 (7%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRL-----RNGQLVAIKRLTRGTADEIIADFLSELGI 160
           Q    +  F   +GKG +  V   R        G++VA+K+L   T +E + DF  E+ I
Sbjct: 4   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEI 62
Query: 161 MAHVDHPNTAKLLGYGIEGG---MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVA 217
           +  + H N  K  G     G   + +++E  P GSL   L   KE++      +    + 
Sbjct: 63  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC 122
Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE 262
           +G+ YL     +R IHRD+   NIL+  +   +I DFGL K LP+
Sbjct: 123 KGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 164

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 48/150 (32%), Positives = 73/150 (48%), Gaps = 6/150 (4%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
            +   E  +G+G + EV+ G       VAIK L  GT       FL E  +M  + H   
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP--EAFLQEAQVMKKLRHEKL 75
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYG-MKEKLKWGIRYKIALGVAEGLLYLHEGCQ 228
            +L     E  ++IV E    GSL   L G M + L+      +A  +A G+ Y+    +
Sbjct: 76  VQLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---R 132
Query: 229 RRIIHRDIKAANILLTEDFEPQICDFGLAK 258
              +HRD++AANIL+ E+   ++ DFGLA+
Sbjct: 133 MNYVHRDLRAANILVGENLVCKVADFGLAR 162

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 78/165 (47%), Gaps = 12/165 (7%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRL-----RNGQLVAIKRLTRGTADEIIADFLSELGI 160
           Q    +  F   +GKG +  V   R        G++VA+K+L   T +E + DF  E+ I
Sbjct: 11  QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEI 69
Query: 161 MAHVDHPNTAKLLGYGIEGG---MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVA 217
           +  + H N  K  G     G   + +++E  P GSL   L   KE++      +    + 
Sbjct: 70  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC 129
Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE 262
           +G+ YL     +R IHRD+   NIL+  +   +I DFGL K LP+
Sbjct: 130 KGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 171

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 78/165 (47%), Gaps = 12/165 (7%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRL-----RNGQLVAIKRLTRGTADEIIADFLSELGI 160
           Q    +  F   +GKG +  V   R        G++VA+K+L   T +E + DF  E+ I
Sbjct: 10  QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEI 68
Query: 161 MAHVDHPNTAKLLGYGIEGG---MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVA 217
           +  + H N  K  G     G   + +++E  P GSL   L   KE++      +    + 
Sbjct: 69  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC 128
Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE 262
           +G+ YL     +R IHRD+   NIL+  +   +I DFGL K LP+
Sbjct: 129 KGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 170

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 78/165 (47%), Gaps = 12/165 (7%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRL-----RNGQLVAIKRLTRGTADEIIADFLSELGI 160
           Q    +  F   +GKG +  V   R        G++VA+K+L   T +E + DF  E+ I
Sbjct: 6   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEI 64
Query: 161 MAHVDHPNTAKLLGYGIEGG---MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVA 217
           +  + H N  K  G     G   + +++E  P GSL   L   KE++      +    + 
Sbjct: 65  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC 124
Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE 262
           +G+ YL     +R IHRD+   NIL+  +   +I DFGL K LP+
Sbjct: 125 KGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 166

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 78/165 (47%), Gaps = 12/165 (7%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRL-----RNGQLVAIKRLTRGTADEIIADFLSELGI 160
           Q    +  F   +GKG +  V   R        G++VA+K+L   T +E + DF  E+ I
Sbjct: 9   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEI 67
Query: 161 MAHVDHPNTAKLLGYGIEGG---MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVA 217
           +  + H N  K  G     G   + +++E  P GSL   L   KE++      +    + 
Sbjct: 68  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC 127
Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE 262
           +G+ YL     +R IHRD+   NIL+  +   +I DFGL K LP+
Sbjct: 128 KGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 169

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 78/165 (47%), Gaps = 12/165 (7%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRL-----RNGQLVAIKRLTRGTADEIIADFLSELGI 160
           Q    +  F   +GKG +  V   R        G++VA+K+L   T +E + DF  E+ I
Sbjct: 13  QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEI 71
Query: 161 MAHVDHPNTAKLLGYGIEGG---MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVA 217
           +  + H N  K  G     G   + +++E  P GSL   L   KE++      +    + 
Sbjct: 72  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC 131
Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE 262
           +G+ YL     +R IHRD+   NIL+  +   +I DFGL K LP+
Sbjct: 132 KGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 173

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 78/165 (47%), Gaps = 12/165 (7%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRL-----RNGQLVAIKRLTRGTADEIIADFLSELGI 160
           Q    +  F   +GKG +  V   R        G++VA+K+L   T +E + DF  E+ I
Sbjct: 12  QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEI 70
Query: 161 MAHVDHPNTAKLLGYGIEGG---MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVA 217
           +  + H N  K  G     G   + +++E  P GSL   L   KE++      +    + 
Sbjct: 71  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC 130
Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE 262
           +G+ YL     +R IHRD+   NIL+  +   +I DFGL K LP+
Sbjct: 131 KGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 172

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 78/165 (47%), Gaps = 12/165 (7%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRL-----RNGQLVAIKRLTRGTADEIIADFLSELGI 160
           Q    +  F   +GKG +  V   R        G++VA+K+L   T +E + DF  E+ I
Sbjct: 37  QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEI 95
Query: 161 MAHVDHPNTAKLLGYGIEGG---MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVA 217
           +  + H N  K  G     G   + +++E  P GSL   L   KE++      +    + 
Sbjct: 96  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC 155
Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE 262
           +G+ YL     +R IHRD+   NIL+  +   +I DFGL K LP+
Sbjct: 156 KGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 197

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 78/165 (47%), Gaps = 12/165 (7%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRL-----RNGQLVAIKRLTRGTADEIIADFLSELGI 160
           Q    +  F   +GKG +  V   R        G++VA+K+L   T +E + DF  E+ I
Sbjct: 6   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEI 64
Query: 161 MAHVDHPNTAKLLGYGIEGG---MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVA 217
           +  + H N  K  G     G   + +++E  P GSL   L   KE++      +    + 
Sbjct: 65  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC 124
Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE 262
           +G+ YL     +R IHRD+   NIL+  +   +I DFGL K LP+
Sbjct: 125 KGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 166

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 78/165 (47%), Gaps = 12/165 (7%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRL-----RNGQLVAIKRLTRGTADEIIADFLSELGI 160
           Q    +  F   +GKG +  V   R        G++VA+K+L   T +E + DF  E+ I
Sbjct: 24  QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEI 82
Query: 161 MAHVDHPNTAKLLGYGIEGG---MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVA 217
           +  + H N  K  G     G   + +++E  P GSL   L   KE++      +    + 
Sbjct: 83  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC 142
Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE 262
           +G+ YL     +R IHRD+   NIL+  +   +I DFGL K LP+
Sbjct: 143 KGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 184

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 78/165 (47%), Gaps = 12/165 (7%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRL-----RNGQLVAIKRLTRGTADEIIADFLSELGI 160
           Q    +  F   +GKG +  V   R        G++VA+K+L   T +E + DF  E+ I
Sbjct: 24  QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEI 82
Query: 161 MAHVDHPNTAKLLGYGIEGG---MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVA 217
           +  + H N  K  G     G   + +++E  P GSL   L   KE++      +    + 
Sbjct: 83  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC 142
Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE 262
           +G+ YL     +R IHRD+   NIL+  +   +I DFGL K LP+
Sbjct: 143 KGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 184

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 76/149 (51%), Gaps = 11/149 (7%)
Query: 118 IGKGGYAEVYKGRL-----RNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKL 172
           +G+G + +V   R        G+ VA+K L   +    IAD   E+ I+ ++ H N  K 
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 173 LGYGIE---GGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQR 229
            G   E    G+ +++E  P+GSL   L   K K+    + K A+ + +G+ YL     R
Sbjct: 77  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG---SR 133
Query: 230 RIIHRDIKAANILLTEDFEPQICDFGLAK 258
           + +HRD+ A N+L+  + + +I DFGL K
Sbjct: 134 QYVHRDLAARNVLVESEHQVKIGDFGLTK 162

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 95/187 (50%), Gaps = 13/187 (6%)
Query: 89  NSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQL-VAIKRLTRGTA 147
            S D  SP   +  +E++    + + ++ +G G Y EVY+G  +   L VA+K L   T 
Sbjct: 1   TSMDPSSPN--YDKWEMER--TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM 56
Query: 148 DEIIADFLSELGIMAHVDHPNTAKLLGYGI-EGGMHIVLELSPNGSLASLLYGM-KEKLK 205
           +  + +FL E  +M  + HPN  +LLG    E   +I+ E    G+L   L    ++++ 
Sbjct: 57  E--VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVN 114
Query: 206 WGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP-EQW 264
             +   +A  ++  + YL    ++  IHRD+ A N L+ E+   ++ DFGL++ +  + +
Sbjct: 115 AVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 171
Query: 265 THHTISK 271
           T H  +K
Sbjct: 172 TAHAGAK 178

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 76/149 (51%), Gaps = 11/149 (7%)
Query: 118 IGKGGYAEVYKGRL-----RNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKL 172
           +G+G + +V   R        G+ VA+K L   +    IAD   E+ I+ ++ H N  K 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 173 LGYGIE---GGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQR 229
            G   E    G+ +++E  P+GSL   L   K K+    + K A+ + +G+ YL     R
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG---SR 145
Query: 230 RIIHRDIKAANILLTEDFEPQICDFGLAK 258
           + +HRD+ A N+L+  + + +I DFGL K
Sbjct: 146 QYVHRDLAARNVLVESEHQVKIGDFGLTK 174

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 47/150 (31%), Positives = 73/150 (48%), Gaps = 6/150 (4%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
            +   E  +G+G + EV+ G       VAIK L  GT       FL E  +M  + H   
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP--EAFLQEAQVMKKLRHEKL 75
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYG-MKEKLKWGIRYKIALGVAEGLLYLHEGCQ 228
            +L     E  ++IV+E    G L   L G M + L+      +A  +A G+ Y+    +
Sbjct: 76  VQLYAVVSEEPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---R 132
Query: 229 RRIIHRDIKAANILLTEDFEPQICDFGLAK 258
              +HRD++AANIL+ E+   ++ DFGLA+
Sbjct: 133 MNYVHRDLRAANILVGENLVCKVADFGLAR 162

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 74/151 (49%), Gaps = 10/151 (6%)
Query: 111 NFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTA 170
           +   E  +G G + EV+         VA+K +  G+    +  FL+E  +M  + H    
Sbjct: 16  SLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS--VEAFLAEANVMKTLQHDKLV 73
Query: 171 KLLGYGIEGGMHIVLELSPNGSLASLLY---GMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
           KL     +  ++I+ E    GSL   L    G K+ L   I +  +  +AEG+ ++    
Sbjct: 74  KLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDF--SAQIAEGMAFIE--- 128
Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           QR  IHRD++AANIL++     +I DFGLA+
Sbjct: 129 QRNYIHRDLRAANILVSASLVCKIADFGLAR 159

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 82/174 (47%), Gaps = 12/174 (6%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRL-----RNGQLVAIKRLTRGTADEIIADFLSELGI 160
           Q    +  F   +GKG +  V   R        G++VA+K+L   T +E + DF  E+ I
Sbjct: 7   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEI 65
Query: 161 MAHVDHPNTAKLLGYGIEGG---MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVA 217
           +  + H N  K  G     G   + +++E  P GSL   L   KE++      +    + 
Sbjct: 66  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC 125
Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK 271
           +G+ YL     +R IHR++   NIL+  +   +I DFGL K LP+   ++ + +
Sbjct: 126 KGMEYL---GTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKE 176

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 48/149 (32%), Positives = 72/149 (48%), Gaps = 6/149 (4%)
Query: 111 NFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTA 170
           +   E  +G+G + EV+ G       VAIK L  GT       FL E  +M  + H    
Sbjct: 185 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP--EAFLQEAQVMKKLRHEKLV 242
Query: 171 KLLGYGIEGGMHIVLELSPNGSLASLLYGMKEK-LKWGIRYKIALGVAEGLLYLHEGCQR 229
           +L     E  ++IV E    GSL   L G   K L+      +A  +A G+ Y+    + 
Sbjct: 243 QLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RM 299
Query: 230 RIIHRDIKAANILLTEDFEPQICDFGLAK 258
             +HRD++AANIL+ E+   ++ DFGLA+
Sbjct: 300 NYVHRDLRAANILVGENLVCKVADFGLAR 328

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 76/179 (42%), Gaps = 33/179 (18%)
Query: 110 NNFSFENLIGKGGYAEVYKGR------LRNGQLVAIKRLTRGTADEIIADFLSELGIMAH 163
           NN  +   IG+G +  V++ R           +VA+K L    + ++ ADF  E  +MA 
Sbjct: 47  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106
Query: 164 VDHPNTAKLLGYGIEG-GMHIVLELSPNGSLASLLYGMKEKLKWGIRYK----------- 211
            D+PN  KLLG    G  M ++ E    G L   L  M       + +            
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166
Query: 212 ------------IALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
                       IA  VA G+ YL E   R+ +HRD+   N L+ E+   +I DFGL++
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSR 222

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 48/150 (32%), Positives = 72/150 (48%), Gaps = 6/150 (4%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
            +   E  +G+G + EV+ G       VAIK L  GT       FL E  +M  + H   
Sbjct: 11  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP--EAFLQEAQVMKKLRHEKL 68
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEK-LKWGIRYKIALGVAEGLLYLHEGCQ 228
            +L     E  ++IV E    GSL   L G   K L+      +A  +A G+ Y+    +
Sbjct: 69  VQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---R 125
Query: 229 RRIIHRDIKAANILLTEDFEPQICDFGLAK 258
              +HRD++AANIL+ E+   ++ DFGLA+
Sbjct: 126 MNYVHRDLRAANILVGENLVCKVADFGLAR 155

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 48/149 (32%), Positives = 72/149 (48%), Gaps = 6/149 (4%)
Query: 111 NFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTA 170
           +   E  +G+G + EV+ G       VAIK L  GT       FL E  +M  + H    
Sbjct: 185 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP--EAFLQEAQVMKKLRHEKLV 242
Query: 171 KLLGYGIEGGMHIVLELSPNGSLASLLYGMKEK-LKWGIRYKIALGVAEGLLYLHEGCQR 229
           +L     E  ++IV E    GSL   L G   K L+      +A  +A G+ Y+    + 
Sbjct: 243 QLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RM 299
Query: 230 RIIHRDIKAANILLTEDFEPQICDFGLAK 258
             +HRD++AANIL+ E+   ++ DFGLA+
Sbjct: 300 NYVHRDLRAANILVGENLVCKVADFGLAR 328

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 48/150 (32%), Positives = 72/150 (48%), Gaps = 6/150 (4%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
            +   E  +G+G + EV+ G       VAIK L  GT       FL E  +M  + H   
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP--EAFLQEAQVMKKLRHEKL 75
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYG-MKEKLKWGIRYKIALGVAEGLLYLHEGCQ 228
            +L     E  ++IV E    GSL   L G M + L+      +A  +A G+ Y+    +
Sbjct: 76  VQLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---R 132
Query: 229 RRIIHRDIKAANILLTEDFEPQICDFGLAK 258
              +HRD+ AANIL+ E+   ++ DFGLA+
Sbjct: 133 MNYVHRDLAAANILVGENLVCKVADFGLAR 162

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 84/161 (52%), Gaps = 8/161 (4%)
Query: 101 SLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQL-VAIKRLTRGTADEIIADFLSELG 159
           SL + +    + + ++ +G G Y EVY+G  +   L VA+K L   T +  + +FL E  
Sbjct: 2   SLDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAA 59
Query: 160 IMAHVDHPNTAKLLGYGI-EGGMHIVLELSPNGSLASLLYGM-KEKLKWGIRYKIALGVA 217
           +M  + HPN  +LLG    E   +I++E    G+L   L    ++++   +   +A  ++
Sbjct: 60  VMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQIS 119
Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
             + YL    ++  IHRD+ A N L+ E+   ++ DFGL++
Sbjct: 120 SAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSR 157

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 79/164 (48%), Gaps = 7/164 (4%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
            +   E  +G+G + EV+ G       VAIK L  GT       FL E  +M  + H   
Sbjct: 15  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP--EAFLQEAQVMKKLRHEKL 72
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEK-LKWGIRYKIALGVAEGLLYLHEGCQ 228
            +L     E  ++IV E    GSL   L G   K L+      ++  +A G+ Y+    +
Sbjct: 73  VQLYAVVSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVE---R 129
Query: 229 RRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE-QWTHHTISK 271
              +HRD++AANIL+ E+   ++ DFGLA+ + + +WT    +K
Sbjct: 130 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAK 173

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 86/166 (51%), Gaps = 10/166 (6%)
Query: 96  PQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQL-VAIKRLTRGTADEIIADF 154
           P   +  +E++    + + ++ +G G Y EVY+G  +   L VA+K L   T +  + +F
Sbjct: 2   PSPNYDKWEMER--TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEF 57
Query: 155 LSELGIMAHVDHPNTAKLLGYGI-EGGMHIVLELSPNGSLASLLYGM-KEKLKWGIRYKI 212
           L E  +M  + HPN  +LLG    E   +I++E    G+L   L    ++++   +   +
Sbjct: 58  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYM 117
Query: 213 ALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           A  ++  + YL    ++  IHRD+ A N L+ E+   ++ DFGL++
Sbjct: 118 ATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSR 160

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 87/166 (52%), Gaps = 9/166 (5%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQL-VAIKRLTRGTADEIIADFLSELGIMAHVDHPN 168
            + + ++ +G G Y EVY+G  +   L VA+K L   T +  + +FL E  +M  + HPN
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPN 70
Query: 169 TAKLLGYGI-EGGMHIVLELSPNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEG 226
             +LLG    E   +I++E    G+L   L    ++++   +   +A  ++  + YL   
Sbjct: 71  LVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE-- 128
Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP-EQWTHHTISK 271
            ++  IHRD+ A N L+ E+   ++ DFGL++ +  + +T H  +K
Sbjct: 129 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK 173

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 53/150 (35%), Positives = 79/150 (52%), Gaps = 8/150 (5%)
Query: 112 FSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRG--TADEIIADFLSELGIMAHVDHPN 168
           FS    IG G +  VY  R +RN ++VAIK+++     ++E   D + E+  +  + HPN
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 169 TAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
           T +  G Y  E    +V+E    GS + LL   K+ L+      +  G  +GL YLH   
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH--- 132
Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLA 257
              +IHRD+KA NILL+E    ++ DFG A
Sbjct: 133 SHNMIHRDVKAGNILLSEPGLVKLGDFGSA 162

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 87/166 (52%), Gaps = 9/166 (5%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQL-VAIKRLTRGTADEIIADFLSELGIMAHVDHPN 168
            + + ++ +G G Y EVY+G  +   L VA+K L   T +  + +FL E  +M  + HPN
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPN 70
Query: 169 TAKLLGYGI-EGGMHIVLELSPNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEG 226
             +LLG    E   +I++E    G+L   L    ++++   +   +A  ++  + YL   
Sbjct: 71  LVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE-- 128
Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP-EQWTHHTISK 271
            ++  IHRD+ A N L+ E+   ++ DFGL++ +  + +T H  +K
Sbjct: 129 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK 173

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 77/165 (46%), Gaps = 12/165 (7%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRL-----RNGQLVAIKRLTRGTADEIIADFLSELGI 160
           Q    +  F   +GKG +  V   R        G++VA+K+L   T +E + DF  E+ I
Sbjct: 9   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEI 67
Query: 161 MAHVDHPNTAKLLGYGIEGG---MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVA 217
           +  + H N  K  G     G   + +++E  P GSL   L    E++      +    + 
Sbjct: 68  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQIC 127
Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE 262
           +G+ YL     +R IHRD+   NIL+  +   +I DFGL K LP+
Sbjct: 128 KGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 169

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 52/170 (30%), Positives = 81/170 (47%), Gaps = 20/170 (11%)
Query: 93  SQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEII 151
           ++ P+++F + E             +G+G Y  VYK      GQ+VAIK++     +  +
Sbjct: 24  TKQPEEVFDVLEK------------LGEGSYGSVYKAIHKETGQIVAIKQVP---VESDL 68
Query: 152 ADFLSELGIMAHVDHPNTAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRY 210
            + + E+ IM   D P+  K  G Y     + IV+E    GS++ ++    + L      
Sbjct: 69  QEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIA 128
Query: 211 KIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL 260
            I     +GL YLH     R IHRDIKA NILL  +   ++ DFG+A  L
Sbjct: 129 TILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQL 175

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 88/193 (45%), Gaps = 22/193 (11%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRLRNGQLV-AIKRLTRGTADE--IIADFLSELGIMA 162
           Q A  +F     +GKG +  VY  R +  + + A+K L +   ++  +      E+ I +
Sbjct: 9   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 68
Query: 163 HVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE--- 218
           H+ HPN  +L GY  +   ++++LE +P G +    Y   +KL      + A  + E   
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPRGEV----YKELQKLSKFDEQRTATYITELAN 124
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGL 278
            L Y H    +R+IHRDIK  N+LL    E +I DFG        W+ H  S    T   
Sbjct: 125 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG--------WSVHAPSSRRTTLCG 173
Query: 279 VKLNLPPLVILKR 291
               LPP +I  R
Sbjct: 174 TLDYLPPEMIEGR 186

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 48/149 (32%), Positives = 72/149 (48%), Gaps = 6/149 (4%)
Query: 111 NFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTA 170
           +   E  +G+G + EV+ G       VAIK L  GT       FL E  +M  + H    
Sbjct: 268 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP--EAFLQEAQVMKKLRHEKLV 325
Query: 171 KLLGYGIEGGMHIVLELSPNGSLASLLYGMKEK-LKWGIRYKIALGVAEGLLYLHEGCQR 229
           +L     E  ++IV E    GSL   L G   K L+      +A  +A G+ Y+    + 
Sbjct: 326 QLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RM 382
Query: 230 RIIHRDIKAANILLTEDFEPQICDFGLAK 258
             +HRD++AANIL+ E+   ++ DFGLA+
Sbjct: 383 NYVHRDLRAANILVGENLVCKVADFGLAR 411

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 94/184 (51%), Gaps = 13/184 (7%)
Query: 92  DSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQL-VAIKRLTRGTADEI 150
           D  SP   +  +E++    + + ++ +G G Y EVY+G  +   L VA+K L   T +  
Sbjct: 4   DPSSPN--YDKWEMER--TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-- 57
Query: 151 IADFLSELGIMAHVDHPNTAKLLGYGI-EGGMHIVLELSPNGSLASLLYGM-KEKLKWGI 208
           + +FL E  +M  + HPN  +LLG    E   +I+ E    G+L   L    ++++   +
Sbjct: 58  VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVV 117
Query: 209 RYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP-EQWTHH 267
              +A  ++  + YL    ++  IHRD+ A N L+ E+   ++ DFGL++ +  + +T H
Sbjct: 118 LLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 174
Query: 268 TISK 271
             +K
Sbjct: 175 AGAK 178

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 53/150 (35%), Positives = 79/150 (52%), Gaps = 8/150 (5%)
Query: 112 FSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRG--TADEIIADFLSELGIMAHVDHPN 168
           FS    IG G +  VY  R +RN ++VAIK+++     ++E   D + E+  +  + HPN
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 169 TAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
           T +  G Y  E    +V+E    GS + LL   K+ L+      +  G  +GL YLH   
Sbjct: 116 TIQYRGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH--- 171
Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLA 257
              +IHRD+KA NILL+E    ++ DFG A
Sbjct: 172 SHNMIHRDVKAGNILLSEPGLVKLGDFGSA 201

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 47/150 (31%), Positives = 72/150 (48%), Gaps = 6/150 (4%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
            +   E  +G+G + EV+ G       VAIK L  GT       FL E  +M  + H   
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP--EAFLQEAQVMKKLRHEKL 75
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYG-MKEKLKWGIRYKIALGVAEGLLYLHEGCQ 228
            +L     E  ++IV E    G L   L G M + L+      +A  +A G+ Y+    +
Sbjct: 76  VQLYAVVSEEPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---R 132
Query: 229 RRIIHRDIKAANILLTEDFEPQICDFGLAK 258
              +HRD++AANIL+ E+   ++ DFGLA+
Sbjct: 133 MNYVHRDLRAANILVGENLVCKVADFGLAR 162

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 94/184 (51%), Gaps = 13/184 (7%)
Query: 92  DSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQL-VAIKRLTRGTADEI 150
           D  SP   +  +E++    + + ++ +G G Y EVY+G  +   L VA+K L   T +  
Sbjct: 4   DPSSPN--YDKWEMER--TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-- 57
Query: 151 IADFLSELGIMAHVDHPNTAKLLGYGI-EGGMHIVLELSPNGSLASLLYGM-KEKLKWGI 208
           + +FL E  +M  + HPN  +LLG    E   +I+ E    G+L   L    ++++   +
Sbjct: 58  VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVV 117
Query: 209 RYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP-EQWTHH 267
              +A  ++  + YL    ++  IHRD+ A N L+ E+   ++ DFGL++ +  + +T H
Sbjct: 118 LLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 174
Query: 268 TISK 271
             +K
Sbjct: 175 AGAK 178

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 93/183 (50%), Gaps = 11/183 (6%)
Query: 93  SQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQL-VAIKRLTRGTADEII 151
           +  P   +  +E++    + + ++ +G G Y EVY+G  +   L VA+K L   T +  +
Sbjct: 2   AMDPSPNYDKWEMER--TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--V 57
Query: 152 ADFLSELGIMAHVDHPNTAKLLGYGI-EGGMHIVLELSPNGSLASLLYGM-KEKLKWGIR 209
            +FL E  +M  + HPN  +LLG    E   +I+ E    G+L   L    ++++   + 
Sbjct: 58  EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL 117
Query: 210 YKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP-EQWTHHT 268
             +A  ++  + YL    ++  IHRD+ A N L+ E+   ++ DFGL++ +  + +T H 
Sbjct: 118 LYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 174
Query: 269 ISK 271
            +K
Sbjct: 175 GAK 177

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 46/146 (31%), Positives = 81/146 (55%), Gaps = 8/146 (5%)
Query: 115 ENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLG 174
           E ++G+G +  V K + R  + VAIK++   +  +    F+ EL  ++ V+HPN  KL G
Sbjct: 14  EEVVGRGAFGVVCKAKWR-AKDVAIKQIESESERKA---FIVELRQLSRVNHPNIVKLYG 69
Query: 175 YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIA--LGVAEGLLYLHEGCQRRII 232
             +   + +V+E +  GSL ++L+G +    +   + ++  L  ++G+ YLH    + +I
Sbjct: 70  ACL-NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI 128
Query: 233 HRDIKAANILLTEDFEP-QICDFGLA 257
           HRD+K  N+LL       +ICDFG A
Sbjct: 129 HRDLKPPNLLLVAGGTVLKICDFGTA 154

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 48/150 (32%), Positives = 71/150 (47%), Gaps = 6/150 (4%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
            +   E  +G+G + EV+ G       VAIK L  GT       FL E  +M  + H   
Sbjct: 8   ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP--EAFLQEAQVMKKLRHEKL 65
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEK-LKWGIRYKIALGVAEGLLYLHEGCQ 228
            +L     E  + IV E    GSL   L G   K L+      +A  +A G+ Y+    +
Sbjct: 66  VQLYAVVSEEPIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---R 122
Query: 229 RRIIHRDIKAANILLTEDFEPQICDFGLAK 258
              +HRD++AANIL+ E+   ++ DFGLA+
Sbjct: 123 MNYVHRDLRAANILVGENLVCKVADFGLAR 152

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 46/146 (31%), Positives = 81/146 (55%), Gaps = 8/146 (5%)
Query: 115 ENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLG 174
           E ++G+G +  V K + R  + VAIK++   +  +    F+ EL  ++ V+HPN  KL G
Sbjct: 13  EEVVGRGAFGVVCKAKWR-AKDVAIKQIESESERKA---FIVELRQLSRVNHPNIVKLYG 68
Query: 175 YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIA--LGVAEGLLYLHEGCQRRII 232
             +   + +V+E +  GSL ++L+G +    +   + ++  L  ++G+ YLH    + +I
Sbjct: 69  ACL-NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI 127
Query: 233 HRDIKAANILLTEDFEP-QICDFGLA 257
           HRD+K  N+LL       +ICDFG A
Sbjct: 128 HRDLKPPNLLLVAGGTVLKICDFGTA 153

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 48/149 (32%), Positives = 72/149 (48%), Gaps = 6/149 (4%)
Query: 111 NFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTA 170
           +   E  +G+G + EV+ G       VAIK L  GT       FL E  +M  + H    
Sbjct: 185 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP--EAFLQEAQVMKKLRHEKLV 242
Query: 171 KLLGYGIEGGMHIVLELSPNGSLASLLYGMKEK-LKWGIRYKIALGVAEGLLYLHEGCQR 229
           +L     E  ++IV E    GSL   L G   K L+      +A  +A G+ Y+    + 
Sbjct: 243 QLYAVVSEEPIYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RM 299
Query: 230 RIIHRDIKAANILLTEDFEPQICDFGLAK 258
             +HRD++AANIL+ E+   ++ DFGLA+
Sbjct: 300 NYVHRDLRAANILVGENLVCKVADFGLAR 328

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 89/193 (46%), Gaps = 22/193 (11%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRLRNGQLV-AIKRLTRGTADE--IIADFLSELGIMA 162
           Q A  +F     +GKG +  VY  R +  + + A+K L +   ++  +      E+ I +
Sbjct: 5   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 64
Query: 163 HVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE--- 218
           H+ HPN  +L GY  +   ++++LE +P G++    Y   +KL      + A  + E   
Sbjct: 65  HLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELAN 120
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGL 278
            L Y H    +R+IHRDIK  N+LL    E +I DFG        W+ H  S    T   
Sbjct: 121 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG--------WSCHAPSSRRTTLSG 169
Query: 279 VKLNLPPLVILKR 291
               LPP +I  R
Sbjct: 170 TLDYLPPEMIEGR 182

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 95/187 (50%), Gaps = 13/187 (6%)
Query: 89  NSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQL-VAIKRLTRGTA 147
           N Y   SP   +  +E++    + + ++ +G G Y EVY+G  +   L VA+K L   T 
Sbjct: 9   NLYFQGSPN--YDKWEMER--TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM 64
Query: 148 DEIIADFLSELGIMAHVDHPNTAKLLGYGI-EGGMHIVLELSPNGSLASLLYGM-KEKLK 205
           +  + +FL E  +M  + HPN  +LLG    E   +I+ E    G+L   L    ++++ 
Sbjct: 65  E--VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVN 122
Query: 206 WGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP-EQW 264
             +   +A  ++  + YL    ++  IHRD+ A N L+ E+   ++ DFGL++ +  + +
Sbjct: 123 AVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 179
Query: 265 THHTISK 271
           T H  +K
Sbjct: 180 TAHAGAK 186

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 48/170 (28%), Positives = 87/170 (51%), Gaps = 12/170 (7%)
Query: 92  DSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQL-VAIKRLTRGTADEI 150
           D  SP   +  +E++    + + ++ +G G Y EVY+G  +   L VA+K L   T +  
Sbjct: 4   DPSSPN--YDKWEMER--TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-- 57
Query: 151 IADFLSELGIMAHVDHPNTAKLLGYGI-EGGMHIVLELSPNGSLASLLYGM-KEKLKWGI 208
           + +FL E  +M  + HPN  +LLG    E   +I+ E    G+L   L    ++++   +
Sbjct: 58  VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVV 117
Query: 209 RYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
              +A  ++  + YL    ++  IHRD+ A N L+ E+   ++ DFGL++
Sbjct: 118 LLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSR 164

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 83/162 (51%), Gaps = 8/162 (4%)
Query: 100 FSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQL-VAIKRLTRGTADEIIADFLSEL 158
            SL + +    + + ++ +G G Y EVY+G  +   L VA+K L   T +  + +FL E 
Sbjct: 1   MSLDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEA 58
Query: 159 GIMAHVDHPNTAKLLGYGI-EGGMHIVLELSPNGSLASLLYGM-KEKLKWGIRYKIALGV 216
            +M  + HPN  +LLG    E   +I+ E    G+L   L    ++++   +   +A  +
Sbjct: 59  AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQI 118
Query: 217 AEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           +  + YL    ++  IHRD+ A N L+ E+   ++ DFGL++
Sbjct: 119 SSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSR 157

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 89/193 (46%), Gaps = 22/193 (11%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRLRNGQLV-AIKRLTRGTADE--IIADFLSELGIMA 162
           Q A  +F     +GKG +  VY  R +  + + A+K L +   ++  +      E+ I +
Sbjct: 21  QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 80
Query: 163 HVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE--- 218
           H+ HPN  +L GY  +   ++++LE +P G++    Y   +KL      + A  + E   
Sbjct: 81  HLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELAN 136
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGL 278
            L Y H    +R+IHRDIK  N+LL    E +I DFG        W+ H  S    T   
Sbjct: 137 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG--------WSVHAPSSRRTTLCG 185
Query: 279 VKLNLPPLVILKR 291
               LPP +I  R
Sbjct: 186 TLDYLPPEMIEGR 198

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 89/193 (46%), Gaps = 22/193 (11%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRLRNGQLV-AIKRLTRGTADE--IIADFLSELGIMA 162
           Q A  +F     +GKG +  VY  R +  + + A+K L +   ++  +      E+ I +
Sbjct: 30  QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 89
Query: 163 HVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE--- 218
           H+ HPN  +L GY  +   ++++LE +P G++    Y   +KL      + A  + E   
Sbjct: 90  HLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELAN 145
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGL 278
            L Y H    +R+IHRDIK  N+LL    E +I DFG        W+ H  S    T   
Sbjct: 146 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG--------WSVHAPSSRRTTLCG 194
Query: 279 VKLNLPPLVILKR 291
               LPP +I  R
Sbjct: 195 TLDYLPPEMIEGR 207

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/147 (33%), Positives = 75/147 (51%), Gaps = 15/147 (10%)
Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGI 177
           +G G + EV+ G   N   VA+K L  GT    +  FL E  +M  + H    +L  Y +
Sbjct: 20  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS--VQAFLEEANLMKTLQHDKLVRL--YAV 75
Query: 178 ---EGGMHIVLELSPNGSLASLLY---GMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRI 231
              E  ++I+ E    GSL   L    G K  L   I +  +  +AEG+ Y+    ++  
Sbjct: 76  VTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDF--SAQIAEGMAYIE---RKNY 130
Query: 232 IHRDIKAANILLTEDFEPQICDFGLAK 258
           IHRD++AAN+L++E    +I DFGLA+
Sbjct: 131 IHRDLRAANVLVSESLMCKIADFGLAR 157

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 89/193 (46%), Gaps = 22/193 (11%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRLRNGQLV-AIKRLTRGTADE--IIADFLSELGIMA 162
           Q A  +F     +GKG +  VY  R +  + + A+K L +   ++  +      E+ I +
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 163 HVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE--- 218
           H+ HPN  +L GY  +   ++++LE +P G++    Y   +KL      + A  + E   
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELAN 122
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGL 278
            L Y H    +R+IHRDIK  N+LL    E +I DFG        W+ H  S    T   
Sbjct: 123 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG--------WSVHAPSSRRTTLCG 171
Query: 279 VKLNLPPLVILKR 291
               LPP +I  R
Sbjct: 172 TLDYLPPEMIEGR 184

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 89/193 (46%), Gaps = 22/193 (11%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRLRNGQLV-AIKRLTRGTADE--IIADFLSELGIMA 162
           Q A  +F     +GKG +  VY  R +  + + A+K L +   ++  +      E+ I +
Sbjct: 5   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 64
Query: 163 HVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE--- 218
           H+ HPN  +L GY  +   ++++LE +P G++    Y   +KL      + A  + E   
Sbjct: 65  HLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELAN 120
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGL 278
            L Y H    +R+IHRDIK  N+LL    E +I DFG        W+ H  S    T   
Sbjct: 121 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG--------WSVHAPSSRRDTLCG 169
Query: 279 VKLNLPPLVILKR 291
               LPP +I  R
Sbjct: 170 TLDYLPPEMIEGR 182

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 86/166 (51%), Gaps = 9/166 (5%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQL-VAIKRLTRGTADEIIADFLSELGIMAHVDHPN 168
            + + ++ +G G Y EVY+G  +   L VA+K L   T +  + +FL E  +M  + HPN
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPN 70
Query: 169 TAKLLGYGI-EGGMHIVLELSPNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEG 226
             +LLG    E   +I+ E    G+L   L    ++++   +   +A  ++  + YL   
Sbjct: 71  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE-- 128
Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP-EQWTHHTISK 271
            ++  IHRD+ A N L+ E+   ++ DFGL++ +  + +T H  +K
Sbjct: 129 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK 173

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 86/166 (51%), Gaps = 9/166 (5%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQL-VAIKRLTRGTADEIIADFLSELGIMAHVDHPN 168
            + + ++ +G G Y EVY+G  +   L VA+K L   T +  + +FL E  +M  + HPN
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPN 70
Query: 169 TAKLLGYGI-EGGMHIVLELSPNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEG 226
             +LLG    E   +I+ E    G+L   L    ++++   +   +A  ++  + YL   
Sbjct: 71  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE-- 128
Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP-EQWTHHTISK 271
            ++  IHRD+ A N L+ E+   ++ DFGL++ +  + +T H  +K
Sbjct: 129 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK 173

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 86/166 (51%), Gaps = 9/166 (5%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQL-VAIKRLTRGTADEIIADFLSELGIMAHVDHPN 168
            + + ++ +G G Y EVY+G  +   L VA+K L   T +  + +FL E  +M  + HPN
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPN 70
Query: 169 TAKLLGYGI-EGGMHIVLELSPNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEG 226
             +LLG    E   +I+ E    G+L   L    ++++   +   +A  ++  + YL   
Sbjct: 71  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE-- 128
Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP-EQWTHHTISK 271
            ++  IHRD+ A N L+ E+   ++ DFGL++ +  + +T H  +K
Sbjct: 129 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK 173

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 86/166 (51%), Gaps = 9/166 (5%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQL-VAIKRLTRGTADEIIADFLSELGIMAHVDHPN 168
            + + ++ +G G Y EVY+G  +   L VA+K L   T +  + +FL E  +M  + HPN
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPN 70
Query: 169 TAKLLGYGI-EGGMHIVLELSPNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEG 226
             +LLG    E   +I+ E    G+L   L    ++++   +   +A  ++  + YL   
Sbjct: 71  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE-- 128
Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP-EQWTHHTISK 271
            ++  IHRD+ A N L+ E+   ++ DFGL++ +  + +T H  +K
Sbjct: 129 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK 173

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 86/166 (51%), Gaps = 9/166 (5%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQL-VAIKRLTRGTADEIIADFLSELGIMAHVDHPN 168
            + + ++ +G G Y EVY+G  +   L VA+K L   T +  + +FL E  +M  + HPN
Sbjct: 15  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPN 72
Query: 169 TAKLLGYGI-EGGMHIVLELSPNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEG 226
             +LLG    E   +I+ E    G+L   L    ++++   +   +A  ++  + YL   
Sbjct: 73  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE-- 130
Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP-EQWTHHTISK 271
            ++  IHRD+ A N L+ E+   ++ DFGL++ +  + +T H  +K
Sbjct: 131 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK 175

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 86/166 (51%), Gaps = 9/166 (5%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQL-VAIKRLTRGTADEIIADFLSELGIMAHVDHPN 168
            + + ++ +G G Y EVY+G  +   L VA+K L   T +  + +FL E  +M  + HPN
Sbjct: 15  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPN 72
Query: 169 TAKLLGYGI-EGGMHIVLELSPNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEG 226
             +LLG    E   +I+ E    G+L   L    ++++   +   +A  ++  + YL   
Sbjct: 73  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE-- 130
Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP-EQWTHHTISK 271
            ++  IHRD+ A N L+ E+   ++ DFGL++ +  + +T H  +K
Sbjct: 131 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK 175

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 89/193 (46%), Gaps = 22/193 (11%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRLRNGQLV-AIKRLTRGTADE--IIADFLSELGIMA 162
           Q A  +F     +GKG +  VY  R +  + + A+K L +   ++  +      E+ I +
Sbjct: 9   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 68
Query: 163 HVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE--- 218
           H+ HPN  +L GY  +   ++++LE +P G++    Y   +KL      + A  + E   
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELAN 124
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGL 278
            L Y H    +R+IHRDIK  N+LL    E +I DFG        W+ H  S    T   
Sbjct: 125 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG--------WSVHAPSSRRTTLCG 173
Query: 279 VKLNLPPLVILKR 291
               LPP +I  R
Sbjct: 174 TLDYLPPEMIEGR 186

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 76/154 (49%), Gaps = 7/154 (4%)
Query: 111 NFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADE--IIADFLSELGIMAHVDHP 167
           +F   NL+GKG +A VY+   +  G  VAIK + +    +  ++    +E+ I   + HP
Sbjct: 12  DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHP 71
Query: 168 NTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEG 226
           +  +L  Y  +   +++VLE+  NG +   L    +             +  G+LYLH  
Sbjct: 72  SILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH-- 129
Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL 260
               I+HRD+  +N+LLT +   +I DFGLA  L
Sbjct: 130 -SHGILHRDLTLSNLLLTRNMNIKIADFGLATQL 162

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/150 (31%), Positives = 72/150 (48%), Gaps = 6/150 (4%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
            +   E  +G+G + EV+ G       VAIK L  GT       FL E  +M  + H   
Sbjct: 15  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP--EAFLQEAQVMKKLRHEKL 72
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEK-LKWGIRYKIALGVAEGLLYLHEGCQ 228
            +L     E  ++IV E    GSL   L G   K L+      ++  +A G+ Y+    +
Sbjct: 73  VQLYAVVSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVE---R 129
Query: 229 RRIIHRDIKAANILLTEDFEPQICDFGLAK 258
              +HRD++AANIL+ E+   ++ DFGLA+
Sbjct: 130 MNYVHRDLRAANILVGENLVCKVADFGLAR 159

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 79/152 (51%), Gaps = 8/152 (5%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQL-VAIKRLTRGTADEIIADFLSELGIMAHVDHPN 168
            + + ++ +G G Y EVY+G  +   L VA+K L   T +  + +FL E  +M  + HPN
Sbjct: 14  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPN 71
Query: 169 TAKLLGYGI-EGGMHIVLELSPNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEG 226
             +LLG    E   +I+ E    G+L   L    ++++   +   +A  ++  + YL   
Sbjct: 72  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE-- 129
Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
            ++  IHRD+ A N L+ E+   ++ DFGL++
Sbjct: 130 -KKNFIHRDLAARNCLVGENHLVKVADFGLSR 160

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 89/193 (46%), Gaps = 22/193 (11%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRLRNGQLV-AIKRLTRGTADE--IIADFLSELGIMA 162
           Q A  +F     +GKG +  VY  R +  + + A+K L +   ++  +      E+ I +
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 163 HVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE--- 218
           H+ HPN  +L GY  +   ++++LE +P G++    Y   +KL      + A  + E   
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELAN 119
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGL 278
            L Y H    +R+IHRDIK  N+LL    E +I DFG        W+ H  S    T   
Sbjct: 120 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG--------WSVHAPSSRRTTLCG 168
Query: 279 VKLNLPPLVILKR 291
               LPP +I  R
Sbjct: 169 TLDYLPPEMIEGR 181

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 79/152 (51%), Gaps = 8/152 (5%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQL-VAIKRLTRGTADEIIADFLSELGIMAHVDHPN 168
            + + ++ +G G Y EVY+G  +   L VA+K L   T +  + +FL E  +M  + HPN
Sbjct: 15  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPN 72
Query: 169 TAKLLGYGI-EGGMHIVLELSPNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEG 226
             +LLG    E   +I+ E    G+L   L    ++++   +   +A  ++  + YL   
Sbjct: 73  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE-- 130
Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
            ++  IHRD+ A N L+ E+   ++ DFGL++
Sbjct: 131 -KKNFIHRDLAARNCLVGENHLVKVADFGLSR 161

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/147 (31%), Positives = 74/147 (50%), Gaps = 9/147 (6%)
Query: 118 IGKGGYAEVYKGRLRN-GQLVAIKRLTRGTADEIIADF-LSELGIMAHVDHPNTAKLLG- 174
           IG+G Y  V+K R R+ GQ+VAIK+      D +I    L E+ ++  + HPN   LL  
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 175 YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRR-IIH 233
           +  +  +H+V E   +  L  L     ++ + G+   +   +    L     C +   IH
Sbjct: 71  FRRKRRLHLVFEYCDHTVLHEL-----DRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIH 125
Query: 234 RDIKAANILLTEDFEPQICDFGLAKWL 260
           RD+K  NIL+T+    ++CDFG A+ L
Sbjct: 126 RDVKPENILITKHSVIKLCDFGFARLL 152

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/147 (33%), Positives = 75/147 (51%), Gaps = 15/147 (10%)
Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGI 177
           +G G + EV+ G   N   VA+K L  GT    +  FL E  +M  + H    +L  Y +
Sbjct: 21  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS--VQAFLEEANLMKTLQHDKLVRL--YAV 76
Query: 178 ---EGGMHIVLELSPNGSLASLLY---GMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRI 231
              E  ++I+ E    GSL   L    G K  L   I +  +  +AEG+ Y+    ++  
Sbjct: 77  VTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDF--SAQIAEGMAYIE---RKNY 131
Query: 232 IHRDIKAANILLTEDFEPQICDFGLAK 258
           IHRD++AAN+L++E    +I DFGLA+
Sbjct: 132 IHRDLRAANVLVSESLMCKIADFGLAR 158

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/155 (30%), Positives = 79/155 (50%), Gaps = 20/155 (12%)
Query: 117 LIGKGGYAEVYKG-RLRNGQ----LVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAK 171
           ++G G +  VYKG  + +G+     VAIK L   T+ +   + L E  +MA V  P  ++
Sbjct: 24  VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVSR 83
Query: 172 LLGYGIEGGMHIVLELSPNGSLASLL------YGMKEKLKWGIRYKIALGVAEGLLYLHE 225
           LLG  +   + +V +L P G L   +       G ++ L W       + +A+G+ YL +
Sbjct: 84  LLGICLTSTVQLVTQLMPYGCLLDHVRENRGRLGSQDLLNW------CMQIAKGMSYLED 137
Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL 260
               R++HRD+ A N+L+      +I DFGLA+ L
Sbjct: 138 ---VRLVHRDLAARNVLVKSPNHVKITDFGLARLL 169

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 89/193 (46%), Gaps = 22/193 (11%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRLRNGQLV-AIKRLTRGTADE--IIADFLSELGIMA 162
           Q    +F     +GKG +  VY  R R  + + A+K L +   ++  +      E+ I +
Sbjct: 8   QWTLEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQS 67
Query: 163 HVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE--- 218
           H+ HPN  +L GY  +   ++++LE +P G++    Y   +KL      + A  + E   
Sbjct: 68  HLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSRFDEQRTATYITELAN 123
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGL 278
            L Y H    +R+IHRDIK  N+LL  + E +I DFG        W+ H  S    T   
Sbjct: 124 ALSYCH---SKRVIHRDIKPENLLLGSNGELKIADFG--------WSVHAPSSRRDTLCG 172
Query: 279 VKLNLPPLVILKR 291
               LPP +I  R
Sbjct: 173 TLDYLPPEMIEGR 185

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 89/193 (46%), Gaps = 22/193 (11%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRLRNGQLV-AIKRLTRGTADE--IIADFLSELGIMA 162
           Q A  +F     +GKG +  VY  R +  + + A+K L +   ++  +      E+ I +
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 163 HVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE--- 218
           H+ HPN  +L GY  +   ++++LE +P G++    Y   +KL      + A  + E   
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELAN 122
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGL 278
            L Y H    +R+IHRDIK  N+LL    E +I DFG        W+ H  S    T   
Sbjct: 123 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG--------WSVHAPSSRRTTLCG 171
Query: 279 VKLNLPPLVILKR 291
               LPP +I  R
Sbjct: 172 TLDYLPPEMIEGR 184

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 71/149 (47%), Gaps = 6/149 (4%)
Query: 111 NFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTA 170
           +   E  +G+G + EV+ G       VAIK L  G        FL E  +M  + H    
Sbjct: 186 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGNMSP--EAFLQEAQVMKKLRHEKLV 243
Query: 171 KLLGYGIEGGMHIVLELSPNGSLASLLYG-MKEKLKWGIRYKIALGVAEGLLYLHEGCQR 229
           +L     E  ++IV E    GSL   L G M + L+      +A  +A G+ Y+    + 
Sbjct: 244 QLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RM 300
Query: 230 RIIHRDIKAANILLTEDFEPQICDFGLAK 258
             +HRD++AANIL+ E+   ++ DFGL +
Sbjct: 301 NYVHRDLRAANILVGENLVCKVADFGLGR 329

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 89/193 (46%), Gaps = 22/193 (11%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRLRNGQLV-AIKRLTRGTADE--IIADFLSELGIMA 162
           Q A  +F     +GKG +  VY  R +  + + A+K L +   ++  +      E+ I +
Sbjct: 3   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 62
Query: 163 HVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE--- 218
           H+ HPN  +L GY  +   ++++LE +P G++    Y   +KL      + A  + E   
Sbjct: 63  HLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELAN 118
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGL 278
            L Y H    +R+IHRDIK  N+LL    E +I DFG        W+ H  S    T   
Sbjct: 119 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG--------WSVHAPSSRRTTLCG 167
Query: 279 VKLNLPPLVILKR 291
               LPP +I  R
Sbjct: 168 TLDYLPPEMIEGR 180

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 89/193 (46%), Gaps = 22/193 (11%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRLRNGQLV-AIKRLTRGTADE--IIADFLSELGIMA 162
           Q    +F     +GKG +  VY  R R  + + A+K L +   ++  +      E+ I +
Sbjct: 8   QWTLEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQS 67
Query: 163 HVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE--- 218
           H+ HPN  +L GY  +   ++++LE +P G++    Y   +KL      + A  + E   
Sbjct: 68  HLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSRFDEQRTATYITELAN 123
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGL 278
            L Y H    +R+IHRDIK  N+LL  + E +I DFG        W+ H  S    T   
Sbjct: 124 ALSYCH---SKRVIHRDIKPENLLLGSNGELKIADFG--------WSVHAPSSRRTTLCG 172
Query: 279 VKLNLPPLVILKR 291
               LPP +I  R
Sbjct: 173 TLDYLPPEMIEGR 185

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 87/193 (45%), Gaps = 22/193 (11%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRLRNGQLV-AIKRLTRGTADE--IIADFLSELGIMA 162
           Q A  +F     +GKG +  VY  R +  + + A+K L +   ++  +      E+ I +
Sbjct: 9   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 68
Query: 163 HVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE--- 218
           H+ HPN  +L GY  +   ++++LE +P G +    Y   +KL      + A  + E   
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPRGEV----YKELQKLSKFDEQRTATYITELAN 124
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGL 278
            L Y H    +R+IHRDIK  N+LL    E +I DFG        W+ H  S        
Sbjct: 125 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG--------WSVHAPSSRRXXLXG 173
Query: 279 VKLNLPPLVILKR 291
               LPP +I  R
Sbjct: 174 TLDYLPPEMIEGR 186

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 88/193 (45%), Gaps = 22/193 (11%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRLRNGQLV-AIKRLTRGTADE--IIADFLSELGIMA 162
           Q A  +F     +GKG +  VY  R +  + + A+K L +   ++  +      E+ I +
Sbjct: 9   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 68
Query: 163 HVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE--- 218
           H+ HPN  +L GY  +   ++++LE +P G++    Y   +KL      + A  + E   
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELAN 124
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGL 278
            L Y H    +R+IHRDIK  N+LL    E +I DFG        W+ H  S    T   
Sbjct: 125 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG--------WSVHAPSSRRTTLCG 173
Query: 279 VKLNLPPLVILKR 291
               LPP  I  R
Sbjct: 174 TLDYLPPEXIEGR 186

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 83/162 (51%), Gaps = 8/162 (4%)
Query: 100 FSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQL-VAIKRLTRGTADEIIADFLSEL 158
            SL + +    + + ++ +G G + EVY+G  +   L VA+K L   T +  + +FL E 
Sbjct: 1   MSLDKWEMERTDITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEA 58
Query: 159 GIMAHVDHPNTAKLLGYGI-EGGMHIVLELSPNGSLASLLYGM-KEKLKWGIRYKIALGV 216
            +M  + HPN  +LLG    E   +I+ E    G+L   L    ++++   +   +A  +
Sbjct: 59  AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQI 118
Query: 217 AEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           +  + YL    ++  IHRD+ A N L+ E+   ++ DFGL++
Sbjct: 119 SSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSR 157

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 81/160 (50%), Gaps = 12/160 (7%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPN 168
           +++  + +IG G  A V         + VAIKR+        + + L E+  M+   HPN
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 169 -TAKLLGYGIEGGMHIVLELSPNGSLASLLYGM--KEKLKWGIRYKIALG-----VAEGL 220
             +    + ++  + +V++L   GS+  ++  +  K + K G+  +  +      V EGL
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL 260
            YLH+  Q   IHRD+KA NILL ED   QI DFG++ +L
Sbjct: 135 EYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFL 171

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 89/193 (46%), Gaps = 22/193 (11%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRLRNGQLV-AIKRLTRGTADE--IIADFLSELGIMA 162
           Q A  +F     +GKG +  VY  R +  + + A+K L +   ++  +      E+ I +
Sbjct: 8   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 67
Query: 163 HVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE--- 218
           H+ HPN  +L GY  +   ++++LE +P G++    Y   +KL      + A  + E   
Sbjct: 68  HLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELAN 123
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGL 278
            L Y H    +R+IHRDIK  N+LL    E +I DFG        W+ H  S    T   
Sbjct: 124 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG--------WSVHAPSSRRTTLCG 172
Query: 279 VKLNLPPLVILKR 291
               LPP +I  R
Sbjct: 173 TLDYLPPEMIEGR 185

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 89/193 (46%), Gaps = 22/193 (11%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRLRNGQLV-AIKRLTRGTADE--IIADFLSELGIMA 162
           Q A  +F     +GKG +  VY  R +N + + A+K L +   ++  +      E+ I +
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 163 HVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE--- 218
           H+ HPN  +L GY  +   ++++LE +P G++    Y   +KL      + A  + E   
Sbjct: 64  HLRHPNILRLYGYFHDSTRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELAN 119
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGL 278
            L Y H    +++IHRDIK  N+LL    E +I DFG        W+ H  S        
Sbjct: 120 ALSYCH---SKKVIHRDIKPENLLLGSAGELKIADFG--------WSVHAPSSRRAALCG 168
Query: 279 VKLNLPPLVILKR 291
               LPP +I  R
Sbjct: 169 TLDYLPPEMIEGR 181

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 88/193 (45%), Gaps = 22/193 (11%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRLRNGQLV-AIKRLTRGTADE--IIADFLSELGIMA 162
           Q A  +F     +GKG +  VY  R +  + + A+K L +   ++  +      E+ I +
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 163 HVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE--- 218
           H+ HPN  +L GY  +   ++++LE +P G++    Y   +KL      + A  + E   
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELAN 122
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGL 278
            L Y H    +R+IHRDIK  N+LL    E +I DFG        W+ H  S        
Sbjct: 123 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG--------WSVHAPSSRRAALCG 171
Query: 279 VKLNLPPLVILKR 291
               LPP +I  R
Sbjct: 172 TLDYLPPEMIEGR 184

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 81/160 (50%), Gaps = 12/160 (7%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPN 168
           +++  + +IG G  A V         + VAIKR+        + + L E+  M+   HPN
Sbjct: 10  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 69
Query: 169 -TAKLLGYGIEGGMHIVLELSPNGSLASLLYGM--KEKLKWGIRYKIALG-----VAEGL 220
             +    + ++  + +V++L   GS+  ++  +  K + K G+  +  +      V EGL
Sbjct: 70  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 129
Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL 260
            YLH+  Q   IHRD+KA NILL ED   QI DFG++ +L
Sbjct: 130 EYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFL 166

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 88/193 (45%), Gaps = 22/193 (11%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRLRNGQLV-AIKRLTRGTADE--IIADFLSELGIMA 162
           Q A  +F     +GKG +  VY  R +  + + A+K L +   ++  +      E+ I +
Sbjct: 30  QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 89
Query: 163 HVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE--- 218
           H+ HPN  +L GY  +   ++++LE +P G++    Y   +KL      + A  + E   
Sbjct: 90  HLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELAN 145
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGL 278
            L Y H    +R+IHRDIK  N+LL    E +I DFG        W+ H  S        
Sbjct: 146 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG--------WSVHAPSSRRDDLCG 194
Query: 279 VKLNLPPLVILKR 291
               LPP +I  R
Sbjct: 195 TLDYLPPEMIEGR 207

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 52/165 (31%), Positives = 79/165 (47%), Gaps = 13/165 (7%)
Query: 99  IFSLYELQSATNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEI-IADFLS 156
           I S  + Q    N+     IGKG +A+V   R +  G+ VAIK + +   +   +     
Sbjct: 4   IASCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR 63
Query: 157 ELGIMAHVDHPNTAKLLGY-GIEGGMHIVLELSPNGSLASLLYG---MKEKLKWGIRYKI 212
           E+ IM  ++HPN  KL      E  +++++E +  G +   L     MKEK       +I
Sbjct: 64  EVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQI 123
Query: 213 ALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLA 257
              V     Y H   Q+RI+HRD+KA N+LL  D   +I DFG +
Sbjct: 124 VSAVQ----YCH---QKRIVHRDLKAENLLLDADMNIKIADFGFS 161

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 89/193 (46%), Gaps = 22/193 (11%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRLRNGQLV-AIKRLTRGTADE--IIADFLSELGIMA 162
           Q A  +F     +GKG +  VY  R +  + + A+K L +   ++  +      E+ I +
Sbjct: 6   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 65
Query: 163 HVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE--- 218
           H+ HPN  +L GY  +   ++++LE +P G++    Y   +KL      + A  + E   
Sbjct: 66  HLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELAN 121
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGL 278
            L Y H    +R+IHRDIK  N+LL    E +I +FG        W+ H  S    T   
Sbjct: 122 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIANFG--------WSVHAPSSRRTTLCG 170
Query: 279 VKLNLPPLVILKR 291
               LPP +I  R
Sbjct: 171 TLDYLPPEMIEGR 183

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 88/193 (45%), Gaps = 22/193 (11%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRLRNGQLV-AIKRLTRGTADE--IIADFLSELGIMA 162
           Q A  +F     +GKG +  VY  R +  + + A+K L +   ++  +      E+ I +
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 163 HVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE--- 218
           H+ HPN  +L GY  +   ++++LE +P G++    Y   +KL      + A  + E   
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELAN 119
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGL 278
            L Y H    +R+IHRDIK  N+LL    E +I DFG        W+ H  S        
Sbjct: 120 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG--------WSVHAPSSRRAALCG 168
Query: 279 VKLNLPPLVILKR 291
               LPP +I  R
Sbjct: 169 TLDYLPPEMIEGR 181

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 89/193 (46%), Gaps = 22/193 (11%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRLRNGQLV-AIKRLTRGTADE--IIADFLSELGIMA 162
           Q A  +F     +GKG +  VY  R +  + + A+K L +   ++  +      E+ I +
Sbjct: 1   QWALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQS 60
Query: 163 HVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE--- 218
           H+ HPN  +L GY  +   ++++LE +P G++    Y   +KL      + A  + E   
Sbjct: 61  HLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELAN 116
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGL 278
            L Y H    +R+IHRDIK  N+LL    E +I DFG        W+ H  S    T   
Sbjct: 117 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG--------WSVHAPSSRRTTLCG 165
Query: 279 VKLNLPPLVILKR 291
               LPP +I  R
Sbjct: 166 TLDYLPPEMIEGR 178

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 88/193 (45%), Gaps = 22/193 (11%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRLRNGQLV-AIKRLTRGTADE--IIADFLSELGIMA 162
           Q A  +F     +GKG +  VY  R +  + + A+K L +   ++  +      E+ I +
Sbjct: 6   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 65
Query: 163 HVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE--- 218
           H+ HPN  +L GY  +   ++++LE +P G++    Y   +KL      + A  + E   
Sbjct: 66  HLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELAN 121
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGL 278
            L Y H    +R+IHRDIK  N+LL    E +I DFG        W+ H  S        
Sbjct: 122 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG--------WSVHAPSSRRXXLCG 170
Query: 279 VKLNLPPLVILKR 291
               LPP +I  R
Sbjct: 171 TLDYLPPEMIEGR 183

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 50/158 (31%), Positives = 76/158 (48%), Gaps = 13/158 (8%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEI-IADFLSELGIMAH 163
           Q    N+     IGKG +A+V   R +  G+ VAIK + +   +   +     E+ IM  
Sbjct: 8   QPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKI 67
Query: 164 VDHPNTAKLLGY-GIEGGMHIVLELSPNGSLASLLYG---MKEKLKWGIRYKIALGVAEG 219
           ++HPN  KL      E  +++++E +  G +   L     MKEK       +I   V   
Sbjct: 68  LNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQ-- 125
Query: 220 LLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLA 257
             Y H   Q+RI+HRD+KA N+LL  D   +I DFG +
Sbjct: 126 --YCH---QKRIVHRDLKAENLLLDADMNIKIADFGFS 158

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 62/186 (33%), Positives = 95/186 (51%), Gaps = 25/186 (13%)
Query: 79  GIDM-PRNLFVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKG-RLRNGQL 136
           G+D+   NL+  S D   P+++F+  E             IGKG + EV+KG   R  ++
Sbjct: 10  GVDLGTENLYFQSMD---PEELFTKLEK------------IGKGSFGEVFKGIDNRTQKV 54
Query: 137 VAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLG-YGIEGGMHIVLELSPNGSLAS 195
           VAIK +    A++ I D   E+ +++  D P   K  G Y  +  + I++E    GS   
Sbjct: 55  VAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD 114
Query: 196 LLY-GMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDF 254
           LL  G  ++ +      I   + +GL YLH     + IHRDIKAAN+LL+E  E ++ DF
Sbjct: 115 LLEPGPLDETQIAT---ILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADF 168
Query: 255 GLAKWL 260
           G+A  L
Sbjct: 169 GVAGQL 174

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 88/193 (45%), Gaps = 22/193 (11%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRLRNGQLV-AIKRLTRGTADE--IIADFLSELGIMA 162
           Q A  +F     +GKG +  VY  R +  + + A+K L +   ++  +      E+ I +
Sbjct: 5   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 64
Query: 163 HVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE--- 218
           H+ HPN  +L GY  +   ++++LE +P G++    Y   +KL      + A  + E   
Sbjct: 65  HLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELAN 120
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGL 278
            L Y H    +R+IHRDIK  N+LL    E +I DFG        W+ H  S        
Sbjct: 121 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG--------WSVHAPSSRRTDLCG 169
Query: 279 VKLNLPPLVILKR 291
               LPP +I  R
Sbjct: 170 TLDYLPPEMIEGR 182

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 88/193 (45%), Gaps = 22/193 (11%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRLRNGQLV-AIKRLTRGTADE--IIADFLSELGIMA 162
           Q A  +F     +GKG +  VY  R +  + + A+K L +   ++  +      E+ I +
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 163 HVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE--- 218
           H+ HPN  +L GY  +   ++++LE +P G++    Y   +KL      + A  + E   
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELAN 119
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGL 278
            L Y H    +R+IHRDIK  N+LL    E +I DFG        W+ H  S        
Sbjct: 120 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG--------WSVHAPSSRRTELCG 168
Query: 279 VKLNLPPLVILKR 291
               LPP +I  R
Sbjct: 169 TLDYLPPEMIEGR 181

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 88/193 (45%), Gaps = 22/193 (11%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRLRNGQLV-AIKRLTRGTADE--IIADFLSELGIMA 162
           Q A  +F     +GKG +  VY  R +  + + A+K L +   ++  +      E+ I +
Sbjct: 9   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 68
Query: 163 HVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE--- 218
           H+ HPN  +L GY  +   ++++LE +P G++    Y   +KL      + A  + E   
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELAN 124
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGL 278
            L Y H    +R+IHRDIK  N+LL    E +I DFG        W+ H  S        
Sbjct: 125 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG--------WSVHAPSSRRTDLCG 173
Query: 279 VKLNLPPLVILKR 291
               LPP +I  R
Sbjct: 174 TLDYLPPEMIEGR 186

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 49/142 (34%), Positives = 66/142 (46%), Gaps = 6/142 (4%)
Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGI 177
           +G G + EV+ G       VAIK L  GT       FL E  IM  + H    +L     
Sbjct: 17  LGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSP--ESFLEEAQIMKKLKHDKLVQLYAVVS 74
Query: 178 EGGMHIVLELSPNGSLASLLY-GMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDI 236
           E  ++IV E    GSL   L  G    LK      +A  VA G+ Y+    +   IHRD+
Sbjct: 75  EEPIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDL 131
Query: 237 KAANILLTEDFEPQICDFGLAK 258
           ++ANIL+      +I DFGLA+
Sbjct: 132 RSANILVGNGLICKIADFGLAR 153

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 88/193 (45%), Gaps = 22/193 (11%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRLRNGQLV-AIKRLTRGTADE--IIADFLSELGIMA 162
           Q A  +F     +GKG +  VY  R +  + + A+K L +   ++  +      E+ I +
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 163 HVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE--- 218
           H+ HPN  +L GY  +   ++++LE +P G++    Y   +KL      + A  + E   
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELAN 119
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGL 278
            L Y H    +R+IHRDIK  N+LL    E +I DFG        W+ H  S        
Sbjct: 120 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG--------WSVHAPSSRRTDLCG 168
Query: 279 VKLNLPPLVILKR 291
               LPP +I  R
Sbjct: 169 TLDYLPPEMIEGR 181

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 89/193 (46%), Gaps = 22/193 (11%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRLRNGQLV-AIKRLTRGTADE--IIADFLSELGIMA 162
           Q A  +F     +GKG +  VY  R +  + + A+K L +   ++  +      E+ I +
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 163 HVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE--- 218
           H+ HPN  +L GY  +   ++++LE +P G++    Y   +KL      + A  + E   
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELAN 122
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGL 278
            L Y H    +R+IHRDIK  N+LL    E +I +FG        W+ H  S    T   
Sbjct: 123 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIANFG--------WSVHAPSSRRTTLCG 171
Query: 279 VKLNLPPLVILKR 291
               LPP +I  R
Sbjct: 172 TLDYLPPEMIEGR 184

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 88/193 (45%), Gaps = 22/193 (11%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRLRNGQLV-AIKRLTRGTADE--IIADFLSELGIMA 162
           Q A  +F     +GKG +  VY  R +  + + A+K L +   ++  +      E+ I +
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 163 HVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE--- 218
           H+ HPN  +L GY  +   ++++LE +P G++    Y   +KL      + A  + E   
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELAN 119
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGL 278
            L Y H    +R+IHRDIK  N+LL    E +I DFG        W+ H  S        
Sbjct: 120 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG--------WSVHAPSSRRTDLCG 168
Query: 279 VKLNLPPLVILKR 291
               LPP +I  R
Sbjct: 169 TLDYLPPEMIEGR 181

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 51/165 (30%), Positives = 79/165 (47%), Gaps = 13/165 (7%)
Query: 99  IFSLYELQSATNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEI-IADFLS 156
           I S  + Q    N+  +  IGKG +A+V   R +  G+ VA+K + +   +   +     
Sbjct: 4   ITSATDEQPHIGNYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFR 63
Query: 157 ELGIMAHVDHPNTAKLLGY-GIEGGMHIVLELSPNGSLASLLYG---MKEKLKWGIRYKI 212
           E+ IM  ++HPN  KL      E  +++V+E +  G +   L     MKEK       +I
Sbjct: 64  EVRIMKILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQI 123
Query: 213 ALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLA 257
              V     Y H   Q+ I+HRD+KA N+LL  D   +I DFG +
Sbjct: 124 VSAVQ----YCH---QKYIVHRDLKAENLLLDGDMNIKIADFGFS 161

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 86/165 (52%), Gaps = 9/165 (5%)
Query: 111 NFSFENLIGKGGYAEVYKGRLRNGQL-VAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           + + ++ +G G Y EVY+G  +   L VA+K L   T +  + +FL E  +M  + HPN 
Sbjct: 221 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNL 278
Query: 170 AKLLGYGI-EGGMHIVLELSPNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEGC 227
            +LLG    E   +I+ E    G+L   L    ++++   +   +A  ++  + YL    
Sbjct: 279 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--- 335
Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP-EQWTHHTISK 271
           ++  IHR++ A N L+ E+   ++ DFGL++ +  + +T H  +K
Sbjct: 336 KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK 380

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 86/165 (52%), Gaps = 9/165 (5%)
Query: 111 NFSFENLIGKGGYAEVYKGRLRNGQL-VAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           + + ++ +G G Y EVY+G  +   L VA+K L   T +  + +FL E  +M  + HPN 
Sbjct: 260 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNL 317
Query: 170 AKLLGYGI-EGGMHIVLELSPNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEGC 227
            +LLG    E   +I+ E    G+L   L    ++++   +   +A  ++  + YL    
Sbjct: 318 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--- 374
Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP-EQWTHHTISK 271
           ++  IHR++ A N L+ E+   ++ DFGL++ +  + +T H  +K
Sbjct: 375 KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK 419

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 88/193 (45%), Gaps = 22/193 (11%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRLRNGQLV-AIKRLTRGTADE--IIADFLSELGIMA 162
           Q A  +F     +GKG +  VY  R +  + + A+K L +   ++  +      E+ I +
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 163 HVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE--- 218
           H+ HPN  +L GY  +   ++++LE +P G++    Y   +KL      + A  + E   
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELAN 122
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGL 278
            L Y H    +R+IHRDIK  N+LL    E +I DFG        W+ H  S        
Sbjct: 123 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG--------WSVHAPSSRRXXLCG 171
Query: 279 VKLNLPPLVILKR 291
               LPP +I  R
Sbjct: 172 TLDYLPPEMIEGR 184

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 80/161 (49%), Gaps = 10/161 (6%)
Query: 104 ELQSATNNFSFENLIGKGGYAEVYKGRLRN-GQLVAIKRLTRG----TADEIIADFLSEL 158
           +++S    +   + +G+G +A VYK R +N  Q+VAIK++  G      D I    L E+
Sbjct: 4   DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63
Query: 159 GIMAHVDHPNTAKLL-GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVA 217
            ++  + HPN   LL  +G +  + +V +      L  ++      L         L   
Sbjct: 64  KLLQELSHPNIIGLLDAFGHKSNISLVFDFM-ETDLEVIIKDNSLVLTPSHIKAYMLMTL 122
Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           +GL YLH   Q  I+HRD+K  N+LL E+   ++ DFGLAK
Sbjct: 123 QGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAK 160

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 88/193 (45%), Gaps = 22/193 (11%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRLRNGQLV-AIKRLTRGTADE--IIADFLSELGIMA 162
           Q A  +F     +GKG +  VY  R +  + + A+K L +   ++  +      E+ I +
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 163 HVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE--- 218
           H+ HPN  +L GY  +   ++++LE +P G++    Y   +KL      + A  + E   
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELAN 122
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGL 278
            L Y H    +R+IHRDIK  N+LL    E +I DFG        W+ H  S        
Sbjct: 123 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG--------WSVHAPSSRRDDLCG 171
Query: 279 VKLNLPPLVILKR 291
               LPP +I  R
Sbjct: 172 TLDYLPPEMIEGR 184

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/152 (30%), Positives = 77/152 (50%), Gaps = 15/152 (9%)
Query: 118 IGKGGYAEVYKGRLR-NGQLVAIKR-LTRGTADEIIADFLSELGIMAHVDHPNTAKLLGY 175
           IG+G + EV+K R R  GQ VA+K+ L     +      L E+ I+  + H N   L+  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 176 ---------GIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEG 226
                      +G +++V +   +  LA LL  +  K       ++   +  GL Y+H  
Sbjct: 86  CRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH-- 142
Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
            + +I+HRD+KAAN+L+T D   ++ DFGLA+
Sbjct: 143 -RNKILHRDMKAANVLITRDGVLKLADFGLAR 173

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 88/193 (45%), Gaps = 22/193 (11%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRLRNGQLV-AIKRLTRGTADE--IIADFLSELGIMA 162
           Q A  +F     +GKG +  VY  R +  + + A+K L +   ++  +      E+ I +
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 163 HVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE--- 218
           H+ HPN  +L GY  +   ++++LE +P G++    Y   +KL      + A  + E   
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELAN 119
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGL 278
            L Y H    +R+IHRDIK  N+LL    E +I DFG        W+ H  S        
Sbjct: 120 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG--------WSVHAPSSRRXXLCG 168
Query: 279 VKLNLPPLVILKR 291
               LPP +I  R
Sbjct: 169 TLDYLPPEMIEGR 181

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 88/193 (45%), Gaps = 22/193 (11%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRLRNGQLV-AIKRLTRGTADE--IIADFLSELGIMA 162
           Q A  +F     +GKG +  VY  R +  + + A+K L +   ++  +      E+ I +
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 163 HVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE--- 218
           H+ HPN  +L GY  +   ++++LE +P G++    Y   +KL      + A  + E   
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELAN 119
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGL 278
            L Y H    +R+IHRDIK  N+LL    E +I DFG        W+ H  S        
Sbjct: 120 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG--------WSVHAPSSRRTXLCG 168
Query: 279 VKLNLPPLVILKR 291
               LPP +I  R
Sbjct: 169 TLDYLPPEMIEGR 181

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/154 (35%), Positives = 78/154 (50%), Gaps = 19/154 (12%)
Query: 117 LIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGY 175
           ++GKG Y  VY GR L N   +AIK +    +         E+ +  H+ H N  + LG 
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS-RYSQPLHEEIALHKHLKHKNIVQYLGS 87
Query: 176 GIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGI--RYKIALG-----VAEGLLYLHEGC 227
             E G + I +E  P GSL++LL     + KWG     +  +G     + EGL YLH+  
Sbjct: 88  FSENGFIKIFMEQVPGGSLSALL-----RSKWGPLKDNEQTIGFYTKQILEGLKYLHD-- 140
Query: 228 QRRIIHRDIKAANILL-TEDFEPQICDFGLAKWL 260
             +I+HRDIK  N+L+ T     +I DFG +K L
Sbjct: 141 -NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRL 173

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/152 (30%), Positives = 77/152 (50%), Gaps = 15/152 (9%)
Query: 118 IGKGGYAEVYKGRLR-NGQLVAIKR-LTRGTADEIIADFLSELGIMAHVDHPNTAKLLGY 175
           IG+G + EV+K R R  GQ VA+K+ L     +      L E+ I+  + H N   L+  
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 84
Query: 176 ---------GIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEG 226
                      +G +++V +   +  LA LL  +  K       ++   +  GL Y+H  
Sbjct: 85  CRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH-- 141
Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
            + +I+HRD+KAAN+L+T D   ++ DFGLA+
Sbjct: 142 -RNKILHRDMKAANVLITRDGVLKLADFGLAR 172

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/152 (30%), Positives = 77/152 (50%), Gaps = 15/152 (9%)
Query: 118 IGKGGYAEVYKGRLR-NGQLVAIKR-LTRGTADEIIADFLSELGIMAHVDHPNTAKLLGY 175
           IG+G + EV+K R R  GQ VA+K+ L     +      L E+ I+  + H N   L+  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 176 ---------GIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEG 226
                      +G +++V +   +  LA LL  +  K       ++   +  GL Y+H  
Sbjct: 86  CRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH-- 142
Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
            + +I+HRD+KAAN+L+T D   ++ DFGLA+
Sbjct: 143 -RNKILHRDMKAANVLITRDGVLKLADFGLAR 173

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/148 (35%), Positives = 80/148 (54%), Gaps = 9/148 (6%)
Query: 118 IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYG 176
           IGKG + EV+KG   R  Q+VAIK +    A++ I D   E+ +++  D     K  G  
Sbjct: 31  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVTKYYGSY 90
Query: 177 IEGG-MHIVLELSPNGSLASLL-YGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHR 234
           ++G  + I++E    GS   LL  G  ++ +     K  L   +GL YLH     + IHR
Sbjct: 91  LKGSKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEIL---KGLDYLHS---EKKIHR 144
Query: 235 DIKAANILLTEDFEPQICDFGLAKWLPE 262
           DIKAAN+LL+E  + ++ DFG+A  L +
Sbjct: 145 DIKAANVLLSEQGDVKLADFGVAGQLTD 172

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/173 (31%), Positives = 84/173 (48%), Gaps = 19/173 (10%)
Query: 87  FVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKG-RLRNGQLVAIKRLTRG 145
           F N +    P+++F+              + IGKG + EVYKG      ++VAIK +   
Sbjct: 8   FANQHSRVDPEELFTKL------------DRIGKGSFGEVYKGIDNHTKEVVAIKIIDLE 55
Query: 146 TADEIIADFLSELGIMAHVDHPNTAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKL 204
            A++ I D   E+ +++  D P   +  G Y     + I++E    GS   LL      L
Sbjct: 56  EAEDEIEDIQQEITVLSQCDSPYITRYFGSYLKSTKLWIIMEYLGGGSALDLL--KPGPL 113
Query: 205 KWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLA 257
           +      I   + +GL YLH     R IHRDIKAAN+LL+E  + ++ DFG+A
Sbjct: 114 EETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVA 163

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 79/172 (45%), Gaps = 16/172 (9%)
Query: 102 LYELQSAT----NNFSFENLIGKGGYAEVYKGRL-----RNGQLVAIKRLTRGTADEIIA 152
           LY  Q  T     +  + + +GKG +  V   R        G LVA+K+L     D+   
Sbjct: 11  LYACQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQ-R 69
Query: 153 DFLSELGIMA--HVDHPNTAKLLGYGI-EGGMHIVLELSPNGSLASLLYGMKEKLKWGIR 209
           DF  E+ I+   H D     + + YG     + +V+E  P+G L   L   + +L     
Sbjct: 70  DFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRL 129
Query: 210 YKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP 261
              +  + +G+ YL     RR +HRD+ A NIL+  +   +I DFGLAK LP
Sbjct: 130 LLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLP 178

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/154 (35%), Positives = 78/154 (50%), Gaps = 19/154 (12%)
Query: 117 LIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGY 175
           ++GKG Y  VY GR L N   +AIK +    +         E+ +  H+ H N  + LG 
Sbjct: 15  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS-RYSQPLHEEIALHKHLKHKNIVQYLGS 73
Query: 176 GIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGI--RYKIALG-----VAEGLLYLHEGC 227
             E G + I +E  P GSL++LL     + KWG     +  +G     + EGL YLH+  
Sbjct: 74  FSENGFIKIFMEQVPGGSLSALL-----RSKWGPLKDNEQTIGFYTKQILEGLKYLHD-- 126
Query: 228 QRRIIHRDIKAANILL-TEDFEPQICDFGLAKWL 260
             +I+HRDIK  N+L+ T     +I DFG +K L
Sbjct: 127 -NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRL 159

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 99/207 (47%), Gaps = 17/207 (8%)
Query: 68  LSIRRSSSMREGIDMPRNLFVNSYDSQSPQKIFSLYELQSATN-NFSF--ENL-----IG 119
           +S  +      G+ +P+  F     S +P +        S  N NF    ++L     +G
Sbjct: 1   MSQSKGKKRNPGLKIPKEAFEQPQTSSTPPRDLDSKACISIGNQNFEVKADDLEPIMELG 60
Query: 120 KGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLSELGI-MAHVDHPNTAKLLGYGI 177
           +G Y  V K R + +GQ++A+KR+      +     L +L I M  VD P T    G   
Sbjct: 61  RGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALF 120
Query: 178 -EGGMHIVLELSPNGSLASLLYGMKEK---LKWGIRYKIALGVAEGLLYLHEGCQRRIIH 233
            EG + I +EL  + SL      + +K   +   I  KIA+ + + L +LH   +  +IH
Sbjct: 121 REGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS--KLSVIH 177
Query: 234 RDIKAANILLTEDFEPQICDFGLAKWL 260
           RD+K +N+L+    + ++CDFG++ +L
Sbjct: 178 RDVKPSNVLINALGQVKMCDFGISGYL 204

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 52/143 (36%), Positives = 78/143 (54%), Gaps = 9/143 (6%)
Query: 118 IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLG-Y 175
           IGKG + EV+KG   R  ++VAIK +    A++ I D   E+ +++  D P   K  G Y
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 74
Query: 176 GIEGGMHIVLELSPNGSLASLLY-GMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHR 234
             +  + I++E    GS   LL  G  ++ +      I   + +GL YLH     + IHR
Sbjct: 75  LKDTKLWIIMEYLGGGSALDLLEPGPLDETQIAT---ILREILKGLDYLH---SEKKIHR 128
Query: 235 DIKAANILLTEDFEPQICDFGLA 257
           DIKAAN+LL+E  E ++ DFG+A
Sbjct: 129 DIKAANVLLSEHGEVKLADFGVA 151

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 52/143 (36%), Positives = 78/143 (54%), Gaps = 9/143 (6%)
Query: 118 IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLG-Y 175
           IGKG + EV+KG   R  ++VAIK +    A++ I D   E+ +++  D P   K  G Y
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 74
Query: 176 GIEGGMHIVLELSPNGSLASLLY-GMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHR 234
             +  + I++E    GS   LL  G  ++ +      I   + +GL YLH     + IHR
Sbjct: 75  LKDTKLWIIMEYLGGGSALDLLEPGPLDETQIAT---ILREILKGLDYLH---SEKKIHR 128
Query: 235 DIKAANILLTEDFEPQICDFGLA 257
           DIKAAN+LL+E  E ++ DFG+A
Sbjct: 129 DIKAANVLLSEHGEVKLADFGVA 151

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 52/143 (36%), Positives = 78/143 (54%), Gaps = 9/143 (6%)
Query: 118 IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLG-Y 175
           IGKG + EV+KG   R  ++VAIK +    A++ I D   E+ +++  D P   K  G Y
Sbjct: 30  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 89
Query: 176 GIEGGMHIVLELSPNGSLASLLY-GMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHR 234
             +  + I++E    GS   LL  G  ++ +      I   + +GL YLH     + IHR
Sbjct: 90  LKDTKLWIIMEYLGGGSALDLLEPGPLDETQIAT---ILREILKGLDYLH---SEKKIHR 143
Query: 235 DIKAANILLTEDFEPQICDFGLA 257
           DIKAAN+LL+E  E ++ DFG+A
Sbjct: 144 DIKAANVLLSEHGEVKLADFGVA 166

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 75/158 (47%), Gaps = 13/158 (8%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEI-IADFLSELGIMAH 163
           Q    N+     IGKG +A+V   R +  G+ VA+K + +   +   +     E+ IM  
Sbjct: 10  QPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKV 69
Query: 164 VDHPNTAKLLGY-GIEGGMHIVLELSPNGSLASLLYG---MKEKLKWGIRYKIALGVAEG 219
           ++HPN  KL      E  +++V+E +  G +   L     MKEK       +I   V   
Sbjct: 70  LNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ-- 127
Query: 220 LLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLA 257
             Y H   Q+ I+HRD+KA N+LL  D   +I DFG +
Sbjct: 128 --YCH---QKFIVHRDLKAENLLLDADMNIKIADFGFS 160

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 75/158 (47%), Gaps = 13/158 (8%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEI-IADFLSELGIMAH 163
           Q    N+     IGKG +A+V   R +  G+ VA+K + +   +   +     E+ IM  
Sbjct: 10  QPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKV 69
Query: 164 VDHPNTAKLLGY-GIEGGMHIVLELSPNGSLASLLYG---MKEKLKWGIRYKIALGVAEG 219
           ++HPN  KL      E  +++V+E +  G +   L     MKEK       +I   V   
Sbjct: 70  LNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ-- 127
Query: 220 LLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLA 257
             Y H   Q+ I+HRD+KA N+LL  D   +I DFG +
Sbjct: 128 --YCH---QKFIVHRDLKAENLLLDADMNIKIADFGFS 160

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 75/158 (47%), Gaps = 13/158 (8%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEI-IADFLSELGIMAH 163
           Q    N+     IGKG +A+V   R +  G+ VA+K + +   +   +     E+ IM  
Sbjct: 10  QPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKV 69
Query: 164 VDHPNTAKLLGY-GIEGGMHIVLELSPNGSLASLLYG---MKEKLKWGIRYKIALGVAEG 219
           ++HPN  KL      E  +++V+E +  G +   L     MKEK       +I   V   
Sbjct: 70  LNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ-- 127
Query: 220 LLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLA 257
             Y H   Q+ I+HRD+KA N+LL  D   +I DFG +
Sbjct: 128 --YCH---QKFIVHRDLKAENLLLDADMNIKIADFGFS 160

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 81/158 (51%), Gaps = 14/158 (8%)
Query: 108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADE-IIADFLSELGIMAHVD 165
           +  NF     IG+G Y  VYK R +  G++VA+K++   T  E + +  + E+ ++  ++
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 166 HPNTAKLLGY-GIEGGMHIVLELSP----NGSLASLLYGMKEKLKWGIRYKIALGVAEGL 220
           HPN  KLL     E  +++V E       +   AS L G+   L     +++     +GL
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLL----QGL 119
Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
            + H     R++HRD+K  N+L+  +   ++ DFGLA+
Sbjct: 120 AFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 154

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 89/178 (50%), Gaps = 21/178 (11%)
Query: 108 ATNNFSFENLIGKGGYAEVYKGRLRNGQL-VAIKRLTRGTADEI-IADFLSELGIMAHVD 165
             +N+  ++LIG+G Y  VY    +N +  VAIK++ R   D I     L E+ I+  + 
Sbjct: 24  VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLK 83
Query: 166 HPNTAKLLGYGIEGGM------HIVLELSPNGSLASL----LYGMKEKLKWGIRYKIALG 215
                +L    I   +      +IVLE++ +  L  L    ++  +E +K  I Y + LG
Sbjct: 84  SDYIIRLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTPIFLTEEHIK-TILYNLLLG 141
Query: 216 VAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVE 273
                 ++HE     IIHRD+K AN LL +D   ++CDFGLA+ +  +   + ++ +E
Sbjct: 142 EN----FIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLE 192

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 81/158 (51%), Gaps = 14/158 (8%)
Query: 108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADE-IIADFLSELGIMAHVD 165
           +  NF     IG+G Y  VYK R +  G++VA+K++   T  E + +  + E+ ++  ++
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 166 HPNTAKLLGY-GIEGGMHIVLELSP----NGSLASLLYGMKEKLKWGIRYKIALGVAEGL 220
           HPN  KLL     E  +++V E       +   AS L G+   L     +++     +GL
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLL----QGL 118
Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
            + H     R++HRD+K  N+L+  +   ++ DFGLA+
Sbjct: 119 AFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 153

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 48/168 (28%), Positives = 79/168 (47%), Gaps = 33/168 (19%)
Query: 118 IGKGGYAEVYKG------RLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHP-NTA 170
           +G+G + +V +       +    + VA+K L  G         +SEL I+ H+ H  N  
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 171 KLLGYGIEGG--MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIA--------------- 213
            LLG   + G  + +++E    G+L++ L   + +    + YK+A               
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEF---VPYKVAPEDLYKDFLTLEHLI 151
Query: 214 ---LGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
                VA+G+ +L     R+ IHRD+ A NILL+E    +ICDFGLA+
Sbjct: 152 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 196

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 48/168 (28%), Positives = 79/168 (47%), Gaps = 33/168 (19%)
Query: 118 IGKGGYAEVYKG------RLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHP-NTA 170
           +G+G + +V +       +    + VA+K L  G         +SEL I+ H+ H  N  
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 171 KLLGYGIEGG--MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIA--------------- 213
            LLG   + G  + +++E    G+L++ L   + +    + YK+A               
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEF---VPYKVAPEDLYKDFLTLEHLI 151
Query: 214 ---LGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
                VA+G+ +L     R+ IHRD+ A NILL+E    +ICDFGLA+
Sbjct: 152 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 196

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 81/162 (50%), Gaps = 18/162 (11%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADF---LSELGIMAHVD 165
           + +     IG G Y  V   R R  GQ VAIK++    A +++ +    L EL I+ H  
Sbjct: 55  DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIP--NAFDVVTNAKRTLRELKILKHFK 112
Query: 166 HPNTAKL-------LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE 218
           H N   +       + YG    +++VL+L     L  +++  +      +RY +   +  
Sbjct: 113 HDNIIAIKDILRPTVPYGEFKSVYVVLDLM-ESDLHQIIHSSQPLTLEHVRYFL-YQLLR 170
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL 260
           GL Y+H     ++IHRD+K +N+L+ E+ E +I DFG+A+ L
Sbjct: 171 GLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGL 209

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 81/158 (51%), Gaps = 14/158 (8%)
Query: 108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADE-IIADFLSELGIMAHVD 165
           +  NF     IG+G Y  VYK R +  G++VA+K++   T  E + +  + E+ ++  ++
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 166 HPNTAKLLGY-GIEGGMHIVLELS----PNGSLASLLYGMKEKLKWGIRYKIALGVAEGL 220
           HPN  KLL     E  +++V E       +   AS L G+   L     +++     +GL
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKDFMDASALTGIPLPLIKSYLFQLL----QGL 116
Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
            + H     R++HRD+K  N+L+  +   ++ DFGLA+
Sbjct: 117 AFCH---SHRVLHRDLKPENLLINTEGAIKLADFGLAR 151

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 48/168 (28%), Positives = 79/168 (47%), Gaps = 33/168 (19%)
Query: 118 IGKGGYAEVYKG------RLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHP-NTA 170
           +G+G + +V +       +    + VA+K L  G         +SEL I+ H+ H  N  
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 171 KLLGYGIEGG--MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIA--------------- 213
            LLG   + G  + +++E    G+L++ L   + +    + YK+A               
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEF---VPYKVAPEDLYKDFLTLEHLI 151
Query: 214 ---LGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
                VA+G+ +L     R+ IHRD+ A NILL+E    +ICDFGLA+
Sbjct: 152 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 196

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 80/158 (50%), Gaps = 14/158 (8%)
Query: 108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADE-IIADFLSELGIMAHVD 165
           +  NF     IG+G Y  VYK R +  G++VA+K++   T  E + +  + E+ ++  ++
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 166 HPNTAKLLGY-GIEGGMHIVLELSPNG----SLASLLYGMKEKLKWGIRYKIALGVAEGL 220
           HPN  KLL     E  +++V E           AS L G+   L     +++     +GL
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL----QGL 117
Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
            + H     R++HRD+K  N+L+  +   ++ DFGLA+
Sbjct: 118 AFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 152

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 80/158 (50%), Gaps = 14/158 (8%)
Query: 108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADE-IIADFLSELGIMAHVD 165
           +  NF     IG+G Y  VYK R +  G++VA+K++   T  E + +  + E+ ++  ++
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 166 HPNTAKLLGY-GIEGGMHIVLELSPNG----SLASLLYGMKEKLKWGIRYKIALGVAEGL 220
           HPN  KLL     E  +++V E           AS L G+   L     +++     +GL
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL----QGL 116
Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
            + H     R++HRD+K  N+L+  +   ++ DFGLA+
Sbjct: 117 AFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 151

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 80/158 (50%), Gaps = 14/158 (8%)
Query: 108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADE-IIADFLSELGIMAHVD 165
           +  NF     IG+G Y  VYK R +  G++VA+K++   T  E + +  + E+ ++  ++
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 166 HPNTAKLLGY-GIEGGMHIVLELSPNG----SLASLLYGMKEKLKWGIRYKIALGVAEGL 220
           HPN  KLL     E  +++V E           AS L G+   L     +++     +GL
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL----QGL 116
Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
            + H     R++HRD+K  N+L+  +   ++ DFGLA+
Sbjct: 117 AFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 151

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 48/168 (28%), Positives = 79/168 (47%), Gaps = 33/168 (19%)
Query: 118 IGKGGYAEVYKG------RLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHP-NTA 170
           +G+G + +V +       +    + VA+K L  G         +SEL I+ H+ H  N  
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 171 KLLGYGIEGG--MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIA--------------- 213
            LLG   + G  + +++E    G+L++ L   + +    + YK+A               
Sbjct: 86  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEF---VPYKVAPEDLYKDFLTLEHLI 142
Query: 214 ---LGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
                VA+G+ +L     R+ IHRD+ A NILL+E    +ICDFGLA+
Sbjct: 143 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 187

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 80/158 (50%), Gaps = 14/158 (8%)
Query: 108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADE-IIADFLSELGIMAHVD 165
           +  NF     IG+G Y  VYK R +  G++VA+K++   T  E + +  + E+ ++  ++
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 166 HPNTAKLLGY-GIEGGMHIVLELSPNG----SLASLLYGMKEKLKWGIRYKIALGVAEGL 220
           HPN  KLL     E  +++V E           AS L G+   L     +++     +GL
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL----QGL 116
Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
            + H     R++HRD+K  N+L+  +   ++ DFGLA+
Sbjct: 117 AFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 151

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 47/186 (25%), Positives = 88/186 (47%), Gaps = 13/186 (6%)
Query: 111 NFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTA 170
           + +F   +G G +  V  G+ R    VAIK +  G+  E   +F+ E  +M ++ H    
Sbjct: 5   DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE--DEFIEEAKVMMNLSHEKLV 62
Query: 171 KLLGYGI-EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQR 229
           +L G    +  + I+ E   NG L + L  M+ + +     ++   V E + YL     +
Sbjct: 63  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SK 119
Query: 230 RIIHRDIKAANILLTEDFEPQICDFGLAKW-LPEQWTHHTISKVEGTFGLVKLNLPPLVI 288
           + +HRD+ A N L+ +    ++ DFGL+++ L +++T    SK    +       PP V+
Sbjct: 120 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS------PPEVL 173
Query: 289 LKRCFT 294
           +   F+
Sbjct: 174 MYSKFS 179

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 80/158 (50%), Gaps = 14/158 (8%)
Query: 108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADE-IIADFLSELGIMAHVD 165
           +  NF     IG+G Y  VYK R +  G++VA+K++   T  E + +  + E+ ++  ++
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 166 HPNTAKLLGY-GIEGGMHIVLELSPNG----SLASLLYGMKEKLKWGIRYKIALGVAEGL 220
           HPN  KLL     E  +++V E           AS L G+   L     +++     +GL
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL----QGL 119
Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
            + H     R++HRD+K  N+L+  +   ++ DFGLA+
Sbjct: 120 AFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 154

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 80/158 (50%), Gaps = 14/158 (8%)
Query: 108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADE-IIADFLSELGIMAHVD 165
           +  NF     IG+G Y  VYK R +  G++VA+K++   T  E + +  + E+ ++  ++
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 166 HPNTAKLLGY-GIEGGMHIVLELSPNG----SLASLLYGMKEKLKWGIRYKIALGVAEGL 220
           HPN  KLL     E  +++V E           AS L G+   L     +++     +GL
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL----QGL 118
Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
            + H     R++HRD+K  N+L+  +   ++ DFGLA+
Sbjct: 119 AFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 153

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 47/179 (26%), Positives = 89/179 (49%), Gaps = 19/179 (10%)
Query: 89  NSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLV-AIKRLTRGTA 147
           N+  ++ P++ F++       ++F     +GKG +  VY  R +  + + A+K L +   
Sbjct: 1   NTALAEMPKRKFTI-------DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQL 53
Query: 148 DE--IIADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLL--YGMKE 202
           ++  +      E+ I +H+ HPN  ++  Y  +   ++++LE +P G L   L  +G  +
Sbjct: 54  EKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFD 113
Query: 203 KLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP 261
           + +          +A+ L Y HE   R++IHRDIK  N+L+    E +I DFG +   P
Sbjct: 114 EQRSAT---FMEELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAP 166

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 79/155 (50%), Gaps = 14/155 (9%)
Query: 111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADE-IIADFLSELGIMAHVDHPN 168
           NF     IG+G Y  VYK R +  G++VA+K++   T  E + +  + E+ ++  ++HPN
Sbjct: 8   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 67
Query: 169 TAKLLGY-GIEGGMHIVLELSPNG----SLASLLYGMKEKLKWGIRYKIALGVAEGLLYL 223
             KLL     E  +++V E           AS L G+   L     +++     +GL + 
Sbjct: 68  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL----QGLAFC 123
Query: 224 HEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           H     R++HRD+K  N+L+  +   ++ DFGLA+
Sbjct: 124 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 155

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 80/158 (50%), Gaps = 14/158 (8%)
Query: 108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADE-IIADFLSELGIMAHVD 165
           +  NF     IG+G Y  VYK R +  G++VA+K++   T  E + +  + E+ ++  ++
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 166 HPNTAKLLGY-GIEGGMHIVLELSPNG----SLASLLYGMKEKLKWGIRYKIALGVAEGL 220
           HPN  KLL     E  +++V E           AS L G+   L     +++     +GL
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL----QGL 116
Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
            + H     R++HRD+K  N+L+  +   ++ DFGLA+
Sbjct: 117 AFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 151

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 80/158 (50%), Gaps = 14/158 (8%)
Query: 108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADE-IIADFLSELGIMAHVD 165
           +  NF     IG+G Y  VYK R +  G++VA+K++   T  E + +  + E+ ++  ++
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 166 HPNTAKLLGY-GIEGGMHIVLELSPNG----SLASLLYGMKEKLKWGIRYKIALGVAEGL 220
           HPN  KLL     E  +++V E           AS L G+   L     +++     +GL
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL----QGL 118
Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
            + H     R++HRD+K  N+L+  +   ++ DFGLA+
Sbjct: 119 AFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 153

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 79/155 (50%), Gaps = 14/155 (9%)
Query: 111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADE-IIADFLSELGIMAHVDHPN 168
           NF     IG+G Y  VYK R +  G++VA+K++   T  E + +  + E+ ++  ++HPN
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 169 TAKLLGY-GIEGGMHIVLELSPNG----SLASLLYGMKEKLKWGIRYKIALGVAEGLLYL 223
             KLL     E  +++V E           AS L G+   L     +++     +GL + 
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL----QGLAFC 118
Query: 224 HEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           H     R++HRD+K  N+L+  +   ++ DFGLA+
Sbjct: 119 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 150

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 79/155 (50%), Gaps = 14/155 (9%)
Query: 111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADE-IIADFLSELGIMAHVDHPN 168
           NF     IG+G Y  VYK R +  G++VA+K++   T  E + +  + E+ ++  ++HPN
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 169 TAKLLGY-GIEGGMHIVLELSPNG----SLASLLYGMKEKLKWGIRYKIALGVAEGLLYL 223
             KLL     E  +++V E           AS L G+   L     +++     +GL + 
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL----QGLAFC 119
Query: 224 HEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           H     R++HRD+K  N+L+  +   ++ DFGLA+
Sbjct: 120 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 151

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 79/155 (50%), Gaps = 14/155 (9%)
Query: 111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADE-IIADFLSELGIMAHVDHPN 168
           NF     IG+G Y  VYK R +  G++VA+K++   T  E + +  + E+ ++  ++HPN
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 169 TAKLLGY-GIEGGMHIVLELSPNG----SLASLLYGMKEKLKWGIRYKIALGVAEGLLYL 223
             KLL     E  +++V E           AS L G+   L     +++     +GL + 
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL----QGLAFC 118
Query: 224 HEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           H     R++HRD+K  N+L+  +   ++ DFGLA+
Sbjct: 119 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 150

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 80/158 (50%), Gaps = 14/158 (8%)
Query: 108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADE-IIADFLSELGIMAHVD 165
           +  NF     IG+G Y  VYK R +  G++VA+K++   T  E + +  + E+ ++  ++
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 166 HPNTAKLLGY-GIEGGMHIVLELSPNG----SLASLLYGMKEKLKWGIRYKIALGVAEGL 220
           HPN  KLL     E  +++V E           AS L G+   L     +++     +GL
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL----QGL 118
Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
            + H     R++HRD+K  N+L+  +   ++ DFGLA+
Sbjct: 119 AFCH---SHRVLHRDLKPENLLINTEGAIKLADFGLAR 153

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 79/155 (50%), Gaps = 14/155 (9%)
Query: 111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADE-IIADFLSELGIMAHVDHPN 168
           NF     IG+G Y  VYK R +  G++VA+K++   T  E + +  + E+ ++  ++HPN
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 169 TAKLLGY-GIEGGMHIVLELSPNG----SLASLLYGMKEKLKWGIRYKIALGVAEGLLYL 223
             KLL     E  +++V E           AS L G+   L     +++     +GL + 
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL----QGLAFC 118
Query: 224 HEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           H     R++HRD+K  N+L+  +   ++ DFGLA+
Sbjct: 119 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 150

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 87/179 (48%), Gaps = 20/179 (11%)
Query: 107 SATNNFSFENL---------IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADE-IIADFLS 156
           S   N  F+ L         +G+G Y  VYK +   G++VA+KR+     DE I +  + 
Sbjct: 9   SGRENLYFQGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIR 68
Query: 157 ELGIMAHVDHPNTAKLLGY-GIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIAL- 214
           E+ ++  + HPN   L+     E  + +V E      L  +L   K  L+   + KI L 
Sbjct: 69  EISLLKELHHPNIVSLIDVIHSERCLTLVFEFM-EKDLKKVLDENKTGLQ-DSQIKIYLY 126
Query: 215 GVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKW--LP-EQWTHHTIS 270
            +  G+ + H   Q RI+HRD+K  N+L+  D   ++ DFGLA+   +P   +TH  ++
Sbjct: 127 QLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVT 182

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 80/158 (50%), Gaps = 14/158 (8%)
Query: 108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADE-IIADFLSELGIMAHVD 165
           +  NF     IG+G Y  VYK R +  G++VA+K++   T  E + +  + E+ ++  ++
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 166 HPNTAKLLGY-GIEGGMHIVLELSPNG----SLASLLYGMKEKLKWGIRYKIALGVAEGL 220
           HPN  KLL     E  +++V E           AS L G+   L     +++     +GL
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL----QGL 117
Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
            + H     R++HRD+K  N+L+  +   ++ DFGLA+
Sbjct: 118 AFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 152

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 87/179 (48%), Gaps = 20/179 (11%)
Query: 107 SATNNFSFENL---------IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADE-IIADFLS 156
           S   N  F+ L         +G+G Y  VYK +   G++VA+KR+     DE I +  + 
Sbjct: 9   SGRENLYFQGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIR 68
Query: 157 ELGIMAHVDHPNTAKLLGY-GIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIAL- 214
           E+ ++  + HPN   L+     E  + +V E      L  +L   K  L+   + KI L 
Sbjct: 69  EISLLKELHHPNIVSLIDVIHSERCLTLVFEFM-EKDLKKVLDENKTGLQ-DSQIKIYLY 126
Query: 215 GVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKW--LP-EQWTHHTIS 270
            +  G+ + H   Q RI+HRD+K  N+L+  D   ++ DFGLA+   +P   +TH  ++
Sbjct: 127 QLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVT 182

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 80/158 (50%), Gaps = 14/158 (8%)
Query: 108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADE-IIADFLSELGIMAHVD 165
           +  NF     IG+G Y  VYK R +  G++VA+K++   T  E + +  + E+ ++  ++
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 166 HPNTAKLLGY-GIEGGMHIVLELSPNG----SLASLLYGMKEKLKWGIRYKIALGVAEGL 220
           HPN  KLL     E  +++V E           AS L G+   L     +++     +GL
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQDLKTFMDASALTGIPLPLIKSYLFQLL----QGL 119
Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
            + H     R++HRD+K  N+L+  +   ++ DFGLA+
Sbjct: 120 AFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 154

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 72/152 (47%), Gaps = 12/152 (7%)
Query: 118 IGKGGYAEVYKGRL-----RNGQLVAIKRLTRGTADEIIADFLSELGIMA--HVDHPNTA 170
           +GKG +  V   R        G LVA+K+L     D+   DF  E+ I+   H D     
Sbjct: 18  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQ-RDFQREIQILKALHSDFIVKY 76
Query: 171 KLLGYGI-EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQR 229
           + + YG     + +V+E  P+G L   L   + +L        +  + +G+ YL     R
Sbjct: 77  RGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGS---R 133
Query: 230 RIIHRDIKAANILLTEDFEPQICDFGLAKWLP 261
           R +HRD+ A NIL+  +   +I DFGLAK LP
Sbjct: 134 RCVHRDLAARNILVESEAHVKIADFGLAKLLP 165

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 81/162 (50%), Gaps = 18/162 (11%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADF---LSELGIMAHVD 165
           + +     IG G Y  V   R R  GQ VAIK++    A +++ +    L EL I+ H  
Sbjct: 54  DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIP--NAFDVVTNAKRTLRELKILKHFK 111
Query: 166 HPNTAKL-------LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE 218
           H N   +       + YG    +++VL+L     L  +++  +      +RY +   +  
Sbjct: 112 HDNIIAIKDILRPTVPYGEFKSVYVVLDLM-ESDLHQIIHSSQPLTLEHVRYFL-YQLLR 169
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL 260
           GL Y+H     ++IHRD+K +N+L+ E+ E +I DFG+A+ L
Sbjct: 170 GLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGL 208

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 79/155 (50%), Gaps = 14/155 (9%)
Query: 111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADE-IIADFLSELGIMAHVDHPN 168
           NF     IG+G Y  VYK R +  G++VA+K++   T  E + +  + E+ ++  ++HPN
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 169 TAKLLGY-GIEGGMHIVLELSPNG----SLASLLYGMKEKLKWGIRYKIALGVAEGLLYL 223
             KLL     E  +++V E           AS L G+   L     +++     +GL + 
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL----QGLAFC 118
Query: 224 HEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           H     R++HRD+K  N+L+  +   ++ DFGLA+
Sbjct: 119 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 150

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 79/155 (50%), Gaps = 14/155 (9%)
Query: 111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADE-IIADFLSELGIMAHVDHPN 168
           NF     IG+G Y  VYK R +  G++VA+K++   T  E + +  + E+ ++  ++HPN
Sbjct: 11  NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 70
Query: 169 TAKLLGY-GIEGGMHIVLELSPNG----SLASLLYGMKEKLKWGIRYKIALGVAEGLLYL 223
             KLL     E  +++V E           AS L G+   L     +++     +GL + 
Sbjct: 71  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL----QGLAFC 126
Query: 224 HEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           H     R++HRD+K  N+L+  +   ++ DFGLA+
Sbjct: 127 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 158

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 80/158 (50%), Gaps = 14/158 (8%)
Query: 108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADE-IIADFLSELGIMAHVD 165
           +  NF     IG+G Y  VYK R +  G++VA+K++   T  E + +  + E+ ++  ++
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 64
Query: 166 HPNTAKLLGY-GIEGGMHIVLELSPNG----SLASLLYGMKEKLKWGIRYKIALGVAEGL 220
           HPN  KLL     E  +++V E           AS L G+   L     +++     +GL
Sbjct: 65  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL----QGL 120
Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
            + H     R++HRD+K  N+L+  +   ++ DFGLA+
Sbjct: 121 AFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 155

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 78/166 (46%), Gaps = 20/166 (12%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLR--NGQLV--AIKRLTRGT-ADEIIADFLSELGIMAHV 164
             F+   ++GKG +  V + +L+  +G  V  A+K L     A   I +FL E   M   
Sbjct: 23  QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF 82
Query: 165 DHPNTAKLLGYGI----EGGMHIVLELSP---NGSLASLLYGMKE-----KLKWGIRYKI 212
           DHP+ AKL+G  +    +G + I + + P   +G L + L   +       L      + 
Sbjct: 83  DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRF 142
Query: 213 ALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
            + +A G+ YL     R  IHRD+ A N +L ED    + DFGL++
Sbjct: 143 MVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSR 185

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 79/155 (50%), Gaps = 14/155 (9%)
Query: 111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADE-IIADFLSELGIMAHVDHPN 168
           NF     IG+G Y  VYK R +  G++VA+K++   T  E + +  + E+ ++  ++HPN
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 169 TAKLLGY-GIEGGMHIVLELSPNG----SLASLLYGMKEKLKWGIRYKIALGVAEGLLYL 223
             KLL     E  +++V E           AS L G+   L     +++     +GL + 
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL----QGLAFC 119
Query: 224 HEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           H     R++HRD+K  N+L+  +   ++ DFGLA+
Sbjct: 120 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 151

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 80/158 (50%), Gaps = 14/158 (8%)
Query: 108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADE-IIADFLSELGIMAHVD 165
           +  NF     IG+G Y  VYK R +  G++VA+K++   T  E + +  + E+ ++  ++
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 166 HPNTAKLLGY-GIEGGMHIVLELSPNG----SLASLLYGMKEKLKWGIRYKIALGVAEGL 220
           HPN  KLL     E  +++V E           AS L G+   L     +++     +GL
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL----QGL 117
Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
            + H     R++HRD+K  N+L+  +   ++ DFGLA+
Sbjct: 118 AFCH---SHRVLHRDLKPENLLINTEGAIKLADFGLAR 152

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 80/158 (50%), Gaps = 14/158 (8%)
Query: 108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADE-IIADFLSELGIMAHVD 165
           +  NF     IG+G Y  VYK R +  G++VA+K++   T  E + +  + E+ ++  ++
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 166 HPNTAKLLGY-GIEGGMHIVLELSPNG----SLASLLYGMKEKLKWGIRYKIALGVAEGL 220
           HPN  KLL     E  +++V E           AS L G+   L     +++     +GL
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL----QGL 119
Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
            + H     R++HRD+K  N+L+  +   ++ DFGLA+
Sbjct: 120 AFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 154

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 79/155 (50%), Gaps = 14/155 (9%)
Query: 111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADE-IIADFLSELGIMAHVDHPN 168
           NF     IG+G Y  VYK R +  G++VA+K++   T  E + +  + E+ ++  ++HPN
Sbjct: 5   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 64
Query: 169 TAKLLGY-GIEGGMHIVLELSPNG----SLASLLYGMKEKLKWGIRYKIALGVAEGLLYL 223
             KLL     E  +++V E           AS L G+   L     +++     +GL + 
Sbjct: 65  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL----QGLAFC 120
Query: 224 HEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           H     R++HRD+K  N+L+  +   ++ DFGLA+
Sbjct: 121 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 152

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 93/203 (45%), Gaps = 34/203 (16%)
Query: 118 IGKGGYAEVY--------KGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPN 168
           +G+G + +V         K +      VA+K L     ++ ++D +SE+ +M  +  H N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 169 TAKLLGYGIEGG-MHIVLELSPNGSLASLL---------------YGMKEKLKWGIRYKI 212
              LLG   + G +++++E +  G+L   L               +  +E+L        
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSC 155
Query: 213 ALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKV 272
           A  VA G+ YL     ++ IHRD+ A N+L+TED   +I DFGLA+ +     HH     
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI-----HHIDXXK 207
Query: 273 EGTFGLVKLN-LPPLVILKRCFT 294
           + T G + +  + P  +  R +T
Sbjct: 208 KTTNGRLPVKWMAPEALFDRIYT 230

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 75/158 (47%), Gaps = 13/158 (8%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEI-IADFLSELGIMAH 163
           Q    N+     IGKG +A+V   R +  G+ VA++ + +   +   +     E+ IM  
Sbjct: 10  QPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKV 69
Query: 164 VDHPNTAKLLGY-GIEGGMHIVLELSPNGSLASLLYG---MKEKLKWGIRYKIALGVAEG 219
           ++HPN  KL      E  +++V+E +  G +   L     MKEK       +I   V   
Sbjct: 70  LNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ-- 127
Query: 220 LLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLA 257
             Y H   Q+ I+HRD+KA N+LL  D   +I DFG +
Sbjct: 128 --YCH---QKFIVHRDLKAENLLLDADMNIKIADFGFS 160

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 83/158 (52%), Gaps = 14/158 (8%)
Query: 108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADE-IIADFLSELGIMAHVD 165
           +  NF     IG+G Y  VYK R +  G++VA+K++   T  E + +  + E+ ++  ++
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 166 HPNTAKLLGY-GIEGGMHIVLE-LSPNGSL---ASLLYGMKEKLKWGIRYKIALGVAEGL 220
           HPN  KLL     E  +++V E LS +      AS L G+   L     +++     +GL
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLL----QGL 119
Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
            + H     R++HRD+K  N+L+  +   ++ DFGLA+
Sbjct: 120 AFCH---SHRVLHRDLKPENLLINTEGAIKLADFGLAR 154

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 76/152 (50%), Gaps = 15/152 (9%)
Query: 118 IGKGGYAEVYKGRLR-NGQLVAIKR-LTRGTADEIIADFLSELGIMAHVDHPNTAKLLGY 175
           IG+G + EV+K R R  GQ VA+K+ L     +      L E+ I+  + H N   L+  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 176 ---------GIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEG 226
                      +  +++V +   +  LA LL  +  K       ++   +  GL Y+H  
Sbjct: 86  CRTKASPYNRCKASIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH-- 142
Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
            + +I+HRD+KAAN+L+T D   ++ DFGLA+
Sbjct: 143 -RNKILHRDMKAANVLITRDGVLKLADFGLAR 173

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 79/155 (50%), Gaps = 14/155 (9%)
Query: 111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADE-IIADFLSELGIMAHVDHPN 168
           NF     IG+G Y  VYK R +  G++VA+K++   T  E + +  + E+ ++  ++HPN
Sbjct: 11  NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 70
Query: 169 TAKLLGY-GIEGGMHIVLELSPNG----SLASLLYGMKEKLKWGIRYKIALGVAEGLLYL 223
             KLL     E  +++V E           AS L G+   L     +++     +GL + 
Sbjct: 71  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL----QGLAFC 126
Query: 224 HEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           H     R++HRD+K  N+L+  +   ++ DFGLA+
Sbjct: 127 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 158

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 83/158 (52%), Gaps = 14/158 (8%)
Query: 108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADE-IIADFLSELGIMAHVD 165
           +  NF     IG+G Y  VYK R +  G++VA+K++   T  E + +  + E+ ++  ++
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 166 HPNTAKLLGY-GIEGGMHIVLE-LSPNGSL---ASLLYGMKEKLKWGIRYKIALGVAEGL 220
           HPN  KLL     E  +++V E LS +      AS L G+   L     +++     +GL
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLL----QGL 117
Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
            + H     R++HRD+K  N+L+  +   ++ DFGLA+
Sbjct: 118 AFCH---SHRVLHRDLKPENLLINTEGAIKLADFGLAR 152

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 48/168 (28%), Positives = 79/168 (47%), Gaps = 33/168 (19%)
Query: 118 IGKGGYAEVYKG------RLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHP-NTA 170
           +G+G + +V +       +    + VA+K L  G         +SEL I+ H+ H  N  
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 131
Query: 171 KLLGYGIEGG--MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIA--------------- 213
            LLG   + G  + +++E    G+L++ L   + +    + YK+A               
Sbjct: 132 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEF---VPYKVAPEDLYKDFLTLEHLI 188
Query: 214 ---LGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
                VA+G+ +L     R+ IHRD+ A NILL+E    +ICDFGLA+
Sbjct: 189 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 233

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 79/155 (50%), Gaps = 14/155 (9%)
Query: 111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADE-IIADFLSELGIMAHVDHPN 168
           NF     IG+G Y  VYK R +  G++VA+K++   T  E + +  + E+ ++  ++HPN
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 169 TAKLLGY-GIEGGMHIVLELSPNG----SLASLLYGMKEKLKWGIRYKIALGVAEGLLYL 223
             KLL     E  +++V E           AS L G+   L     +++     +GL + 
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL----QGLAFC 119
Query: 224 HEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           H     R++HRD+K  N+L+  +   ++ DFGLA+
Sbjct: 120 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 151

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 47/186 (25%), Positives = 88/186 (47%), Gaps = 13/186 (6%)
Query: 111 NFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTA 170
           + +F   +G G +  V  G+ R    VAIK +  G+  E   +F+ E  +M ++ H    
Sbjct: 9   DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE--DEFIEEAKVMMNLSHEKLV 66
Query: 171 KLLGYGI-EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQR 229
           +L G    +  + I+ E   NG L + L  M+ + +     ++   V E + YL     +
Sbjct: 67  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SK 123
Query: 230 RIIHRDIKAANILLTEDFEPQICDFGLAKW-LPEQWTHHTISKVEGTFGLVKLNLPPLVI 288
           + +HRD+ A N L+ +    ++ DFGL+++ L +++T    SK    +       PP V+
Sbjct: 124 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS------PPEVL 177
Query: 289 LKRCFT 294
           +   F+
Sbjct: 178 MYSKFS 183

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 75/158 (47%), Gaps = 13/158 (8%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEI-IADFLSELGIMAH 163
           Q    N+     IGKG +A+V   R +  G+ VA++ + +   +   +     E+ IM  
Sbjct: 10  QPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKV 69
Query: 164 VDHPNTAKLLGY-GIEGGMHIVLELSPNGSLASLLYG---MKEKLKWGIRYKIALGVAEG 219
           ++HPN  KL      E  +++V+E +  G +   L     MKEK       +I   V   
Sbjct: 70  LNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ-- 127
Query: 220 LLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLA 257
             Y H   Q+ I+HRD+KA N+LL  D   +I DFG +
Sbjct: 128 --YCH---QKFIVHRDLKAENLLLDADMNIKIADFGFS 160

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 72/152 (47%), Gaps = 12/152 (7%)
Query: 118 IGKGGYAEVYKGRL-----RNGQLVAIKRLTRGTADEIIADFLSELGIMA--HVDHPNTA 170
           +GKG +  V   R        G LVA+K+L     D+   DF  E+ I+   H D     
Sbjct: 19  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQ-RDFQREIQILKALHSDFIVKY 77
Query: 171 KLLGYGI-EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQR 229
           + + YG     + +V+E  P+G L   L   + +L        +  + +G+ YL     R
Sbjct: 78  RGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGS---R 134
Query: 230 RIIHRDIKAANILLTEDFEPQICDFGLAKWLP 261
           R +HRD+ A NIL+  +   +I DFGLAK LP
Sbjct: 135 RCVHRDLAARNILVESEAHVKIADFGLAKLLP 166

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/174 (30%), Positives = 84/174 (48%), Gaps = 19/174 (10%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLRNG-QLVAIKRLTRGTADEI-IADFLSELGIMAHVDHP 167
           +N+  ++LIG+G Y  VY    +N  + VAIK++ R   D I     L E+ I+  +   
Sbjct: 28  DNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRLKSD 87
Query: 168 NTAKLLGYGIEGGM------HIVLELSPNGSLASLLYG---MKEKLKWGIRYKIALGVAE 218
              +L    I   +      +IVLE++ +  L  L      + E+    I Y + LG   
Sbjct: 88  YIIRLHDLIIPEDLLKFDELYIVLEIA-DSDLKKLFKTPIFLTEQHVKTILYNLLLGEK- 145
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKV 272
              ++HE     IIHRD+K AN LL +D   +ICDFGLA+ +      H ++ +
Sbjct: 146 ---FIHESG---IIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDL 193

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/153 (31%), Positives = 74/153 (48%), Gaps = 13/153 (8%)
Query: 111 NFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEI-IADFLSELGIMAHVDHPN 168
           N+     IGKG +A+V   R +  G+ VA+K + +   +   +     E+ IM  ++HPN
Sbjct: 8   NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 67
Query: 169 TAKLLGY-GIEGGMHIVLELSPNGSLASLLYG---MKEKLKWGIRYKIALGVAEGLLYLH 224
             KL      E  +++V+E +  G +   L     MKEK       +I   V     Y H
Sbjct: 68  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQ----YCH 123
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLA 257
              Q+ I+HRD+KA N+LL  D   +I DFG +
Sbjct: 124 ---QKFIVHRDLKAENLLLDADMNIKIADFGFS 153

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 87/175 (49%), Gaps = 19/175 (10%)
Query: 93  SQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLV-AIKRLTRGTADE-- 149
           ++ P++ F++       ++F     +GKG +  VY  R +  + + A+K L +   ++  
Sbjct: 4   AEMPKRKFTI-------DDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEG 56
Query: 150 IIADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLL--YGMKEKLKW 206
           +      E+ I +H+ HPN  ++  Y  +   ++++LE +P G L   L  +G  ++ + 
Sbjct: 57  VEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRS 116
Query: 207 GIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP 261
                    +A+ L Y HE   R++IHRDIK  N+L+    E +I DFG +   P
Sbjct: 117 AT---FMEELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAP 165

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/168 (28%), Positives = 78/168 (46%), Gaps = 33/168 (19%)
Query: 118 IGKGGYAEVYKG------RLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHP-NTA 170
           +G+G + +V +       +    + VA+K L  G         +SEL I+ H+ H  N  
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 171 KLLGYGIEGG--MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIA--------------- 213
            LLG   + G  + ++ E    G+L++ L   + +    + YK+A               
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEF---VPYKVAPEDLYKDFLTLEHLI 142
Query: 214 ---LGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
                VA+G+ +L     R+ IHRD+ A NILL+E    +ICDFGLA+
Sbjct: 143 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 187

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 79/155 (50%), Gaps = 14/155 (9%)
Query: 111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADE-IIADFLSELGIMAHVDHPN 168
           NF     IG+G Y  VYK R +  G++VA+K++   T  E + +  + E+ ++  ++HPN
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 169 TAKLLGY-GIEGGMHIVLELSPNG----SLASLLYGMKEKLKWGIRYKIALGVAEGLLYL 223
             KLL     E  +++V E           AS L G+   L     +++     +GL + 
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL----QGLSFC 119
Query: 224 HEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           H     R++HRD+K  N+L+  +   ++ DFGLA+
Sbjct: 120 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 151

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/188 (25%), Positives = 90/188 (47%), Gaps = 17/188 (9%)
Query: 111 NFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTA 170
           + +F   +G G +  V  G+ R    VAIK +  G+  E   +F+ E  +M ++ H    
Sbjct: 10  DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE--DEFIEEAKVMMNLSHEKLV 67
Query: 171 KLLGYGI---EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
           +L  YG+   +  + I+ E   NG L + L  M+ + +     ++   V E + YL    
Sbjct: 68  QL--YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE--- 122
Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAKW-LPEQWTHHTISKVEGTFGLVKLNLPPL 286
            ++ +HRD+ A N L+ +    ++ DFGL+++ L +++T    SK    +       PP 
Sbjct: 123 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS------PPE 176
Query: 287 VILKRCFT 294
           V++   F+
Sbjct: 177 VLMYSKFS 184

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 73/160 (45%), Gaps = 12/160 (7%)
Query: 110 NNFSFENLIGKGGYAEVYKGRL-----RNGQLVAIKRLTRGTADEIIADFLSELGIMAHV 164
            +  + + +GKG +  V   R        G LVA+K+L     D+   DF  E+ I+  +
Sbjct: 7   RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQ-RDFQREIQILKAL 65
Query: 165 DHPNTAKLLGYGIEGG---MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLL 221
                 K  G     G   + +V+E  P+G L   L   + +L        +  + +G+ 
Sbjct: 66  HSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGME 125
Query: 222 YLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP 261
           YL     RR +HRD+ A NIL+  +   +I DFGLAK LP
Sbjct: 126 YLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLP 162

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 79/161 (49%), Gaps = 23/161 (14%)
Query: 118 IGKGGYAEVYKG------RLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHP-NTA 170
           +G+G + +V +       +    + VA+K L  G         +SEL I+ H+ H  N  
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 171 KLLGYGIEGG--MHIVLELSPNGSLASLLYGMK-EKLKWGIRYK----------IALGVA 217
            LLG   + G  + +++E    G+L++ L   + E + +   YK           +  VA
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQVA 154
Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           +G+ +L     R+ IHRD+ A NILL+E    +ICDFGLA+
Sbjct: 155 KGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLAR 192

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/168 (28%), Positives = 78/168 (46%), Gaps = 33/168 (19%)
Query: 118 IGKGGYAEVYKG------RLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHP-NTA 170
           +G+G + +V +       +    + VA+K L  G         +SEL I+ H+ H  N  
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 171 KLLGYGIEGG--MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIA--------------- 213
            LLG   + G  + ++ E    G+L++ L   + +    + YK+A               
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEF---VPYKVAPEDLYKDFLTLEHLI 142
Query: 214 ---LGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
                VA+G+ +L     R+ IHRD+ A NILL+E    +ICDFGLA+
Sbjct: 143 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 187

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/168 (28%), Positives = 78/168 (46%), Gaps = 33/168 (19%)
Query: 118 IGKGGYAEVYKG------RLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHP-NTA 170
           +G+G + +V +       +    + VA+K L  G         +SEL I+ H+ H  N  
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 171 KLLGYGIEGG--MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIA--------------- 213
            LLG   + G  + ++ E    G+L++ L   + +    + YK+A               
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEF---VPYKVAPEDLYKDFLTLEHLI 142
Query: 214 ---LGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
                VA+G+ +L     R+ IHRD+ A NILL+E    +ICDFGLA+
Sbjct: 143 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 187

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 80/158 (50%), Gaps = 14/158 (8%)
Query: 108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADE-IIADFLSELGIMAHVD 165
           +  NF     IG+G Y  VYK R +  G++VA+K++   T  E + +  + E+ ++  ++
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 166 HPNTAKLLGY-GIEGGMHIVLELSPNG----SLASLLYGMKEKLKWGIRYKIALGVAEGL 220
           HPN  KLL     E  +++V E           AS L G+   L     +++     +GL
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEHVDQDLKKFMDASALTGIPLPLIKSYLFQLL----QGL 119
Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
            + H     R++HRD+K  N+L+  +   ++ DFGLA+
Sbjct: 120 AFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 154

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 79/155 (50%), Gaps = 14/155 (9%)
Query: 111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADE-IIADFLSELGIMAHVDHPN 168
           NF     IG+G Y  VYK R +  G++VA+K++   T  E + +  + E+ ++  ++HPN
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 169 TAKLLGY-GIEGGMHIVLELSPNG----SLASLLYGMKEKLKWGIRYKIALGVAEGLLYL 223
             KLL     E  +++V E           AS L G+   L     +++     +GL + 
Sbjct: 63  IVKLLDVIHTENKLYLVFEHVHQDLKTFMDASALTGIPLPLIKSYLFQLL----QGLAFC 118
Query: 224 HEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           H     R++HRD+K  N+L+  +   ++ DFGLA+
Sbjct: 119 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 150

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/188 (25%), Positives = 90/188 (47%), Gaps = 17/188 (9%)
Query: 111 NFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTA 170
           + +F   +G G +  V  G+ R    VAIK +  G+  E   +F+ E  +M ++ H    
Sbjct: 25  DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE--DEFIEEAKVMMNLSHEKLV 82
Query: 171 KLLGYGI---EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
           +L  YG+   +  + I+ E   NG L + L  M+ + +     ++   V E + YL    
Sbjct: 83  QL--YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE--- 137
Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAKW-LPEQWTHHTISKVEGTFGLVKLNLPPL 286
            ++ +HRD+ A N L+ +    ++ DFGL+++ L +++T    SK    +       PP 
Sbjct: 138 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS------PPE 191
Query: 287 VILKRCFT 294
           V++   F+
Sbjct: 192 VLMYSKFS 199

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/188 (25%), Positives = 90/188 (47%), Gaps = 17/188 (9%)
Query: 111 NFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTA 170
           + +F   +G G +  V  G+ R    VAIK +  G+  E   +F+ E  +M ++ H    
Sbjct: 16  DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE--DEFIEEAKVMMNLSHEKLV 73
Query: 171 KLLGYGI---EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
           +L  YG+   +  + I+ E   NG L + L  M+ + +     ++   V E + YL    
Sbjct: 74  QL--YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE--- 128
Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAKW-LPEQWTHHTISKVEGTFGLVKLNLPPL 286
            ++ +HRD+ A N L+ +    ++ DFGL+++ L +++T    SK    +       PP 
Sbjct: 129 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS------PPE 182
Query: 287 VILKRCFT 294
           V++   F+
Sbjct: 183 VLMYSKFS 190

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/158 (32%), Positives = 77/158 (48%), Gaps = 9/158 (5%)
Query: 110 NNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRL-TRGTADEIIADFLS-ELGIMAHVDH 166
            +F F  ++G+G ++ V   R L   +  AIK L  R    E    +++ E  +M+ +DH
Sbjct: 10  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 69
Query: 167 PNTAKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHE 225
           P   KL   +  +  ++  L  + NG L   +  +    +   R+  A  +   L YLH 
Sbjct: 70  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLH- 127
Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL-PE 262
              + IIHRD+K  NILL ED   QI DFG AK L PE
Sbjct: 128 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 163

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 93/203 (45%), Gaps = 34/203 (16%)
Query: 118 IGKGGYAEVY--------KGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPN 168
           +G+G + +V         K +      VA+K L     ++ ++D +SE+ +M  +  H N
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 169 TAKLLGYGIEGG-MHIVLELSPNGSLASLL---------------YGMKEKLKWGIRYKI 212
              LLG   + G +++++E +  G+L   L               +  +E+L        
Sbjct: 81  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 140
Query: 213 ALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKV 272
           A  VA G+ YL     ++ IHRD+ A N+L+TED   +I DFGLA+ +     HH     
Sbjct: 141 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI-----HHIDYYK 192
Query: 273 EGTFGLVKLN-LPPLVILKRCFT 294
           + T G + +  + P  +  R +T
Sbjct: 193 KTTNGRLPVKWMAPEALFDRIYT 215

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/158 (32%), Positives = 77/158 (48%), Gaps = 9/158 (5%)
Query: 110 NNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRL-TRGTADEIIADFLS-ELGIMAHVDH 166
            +F F  ++G+G ++ V   R L   +  AIK L  R    E    +++ E  +M+ +DH
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 167 PNTAKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHE 225
           P   KL   +  +  ++  L  + NG L   +  +    +   R+  A  +   L YLH 
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLH- 125
Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL-PE 262
              + IIHRD+K  NILL ED   QI DFG AK L PE
Sbjct: 126 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/158 (32%), Positives = 77/158 (48%), Gaps = 9/158 (5%)
Query: 110 NNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRL-TRGTADEIIADFLS-ELGIMAHVDH 166
            +F F  ++G+G ++ V   R L   +  AIK L  R    E    +++ E  +M+ +DH
Sbjct: 7   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 66
Query: 167 PNTAKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHE 225
           P   KL   +  +  ++  L  + NG L   +  +    +   R+  A  +   L YLH 
Sbjct: 67  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLH- 124
Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL-PE 262
              + IIHRD+K  NILL ED   QI DFG AK L PE
Sbjct: 125 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 160

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/158 (32%), Positives = 77/158 (48%), Gaps = 9/158 (5%)
Query: 110 NNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRL-TRGTADEIIADFLS-ELGIMAHVDH 166
            +F F  ++G+G ++ V   R L   +  AIK L  R    E    +++ E  +M+ +DH
Sbjct: 9   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 68
Query: 167 PNTAKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHE 225
           P   KL   +  +  ++  L  + NG L   +  +    +   R+  A  +   L YLH 
Sbjct: 69  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLH- 126
Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL-PE 262
              + IIHRD+K  NILL ED   QI DFG AK L PE
Sbjct: 127 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 162

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 79/158 (50%), Gaps = 9/158 (5%)
Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADE-IIADFLSELGIMAHVDHPNTAKLLGYG 176
           IG+G Y  VYK +   G+  A+K++     DE I +  + E+ I+  + H N  KL    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV- 68
Query: 177 IEGGMHIVLELSP-NGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRD 235
           I     +VL     +  L  LL   +  L+        L +  G+ Y H+   RR++HRD
Sbjct: 69  IHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRD 125
Query: 236 IKAANILLTEDFEPQICDFGLAKW--LP-EQWTHHTIS 270
           +K  N+L+  + E +I DFGLA+   +P  ++TH  ++
Sbjct: 126 LKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVT 163

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/149 (31%), Positives = 79/149 (53%), Gaps = 9/149 (6%)
Query: 118 IGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLSELGI-MAHVDHPNTAKLLGY 175
           +G+G Y  V K R + +GQ++A+KR+      +     L +L I M  VD P T    G 
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 176 GI-EGGMHIVLELSPNGSLASLLYGMKEK---LKWGIRYKIALGVAEGLLYLHEGCQRRI 231
              EG + I +EL  + SL      + +K   +   I  KIA+ + + L +LH   +  +
Sbjct: 75  LFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS--KLSV 131
Query: 232 IHRDIKAANILLTEDFEPQICDFGLAKWL 260
           IHRD+K +N+L+    + ++CDFG++ +L
Sbjct: 132 IHRDVKPSNVLINALGQVKMCDFGISGYL 160

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 93/203 (45%), Gaps = 34/203 (16%)
Query: 118 IGKGGYAEVY--------KGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPN 168
           +G+G + +V         K +      VA+K L     ++ ++D +SE+ +M  +  H N
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 169 TAKLLGYGIEGG-MHIVLELSPNGSLASLL---------------YGMKEKLKWGIRYKI 212
              LLG   + G +++++E +  G+L   L               +  +E+L        
Sbjct: 85  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 144
Query: 213 ALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKV 272
           A  VA G+ YL     ++ IHRD+ A N+L+TED   +I DFGLA+ +     HH     
Sbjct: 145 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI-----HHIDYYK 196
Query: 273 EGTFGLVKLN-LPPLVILKRCFT 294
           + T G + +  + P  +  R +T
Sbjct: 197 KTTNGRLPVKWMAPEALFDRIYT 219

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 93/203 (45%), Gaps = 34/203 (16%)
Query: 118 IGKGGYAEVY--------KGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPN 168
           +G+G + +V         K +      VA+K L     ++ ++D +SE+ +M  +  H N
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 169 TAKLLGYGIEGG-MHIVLELSPNGSLASLL---------------YGMKEKLKWGIRYKI 212
              LLG   + G +++++E +  G+L   L               +  +E+L        
Sbjct: 89  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 148
Query: 213 ALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKV 272
           A  VA G+ YL     ++ IHRD+ A N+L+TED   +I DFGLA+ +     HH     
Sbjct: 149 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI-----HHIDYYK 200
Query: 273 EGTFGLVKLN-LPPLVILKRCFT 294
           + T G + +  + P  +  R +T
Sbjct: 201 KTTNGRLPVKWMAPEALFDRIYT 223

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 93/203 (45%), Gaps = 34/203 (16%)
Query: 118 IGKGGYAEVY--------KGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPN 168
           +G+G + +V         K +      VA+K L     ++ ++D +SE+ +M  +  H N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 169 TAKLLGYGIEGG-MHIVLELSPNGSLASLL---------------YGMKEKLKWGIRYKI 212
              LLG   + G +++++E +  G+L   L               +  +E+L        
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 213 ALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKV 272
           A  VA G+ YL     ++ IHRD+ A N+L+TED   +I DFGLA+ +     HH     
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI-----HHIDYYK 207
Query: 273 EGTFGLVKLN-LPPLVILKRCFT 294
           + T G + +  + P  +  R +T
Sbjct: 208 KTTNGRLPVKWMAPEALFDRIYT 230

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 79/158 (50%), Gaps = 9/158 (5%)
Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADE-IIADFLSELGIMAHVDHPNTAKLLGYG 176
           IG+G Y  VYK +   G+  A+K++     DE I +  + E+ I+  + H N  KL    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV- 68
Query: 177 IEGGMHIVLELSP-NGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRD 235
           I     +VL     +  L  LL   +  L+        L +  G+ Y H+   RR++HRD
Sbjct: 69  IHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRD 125
Query: 236 IKAANILLTEDFEPQICDFGLAKW--LP-EQWTHHTIS 270
           +K  N+L+  + E +I DFGLA+   +P  ++TH  ++
Sbjct: 126 LKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVT 163

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/186 (25%), Positives = 88/186 (47%), Gaps = 13/186 (6%)
Query: 111 NFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTA 170
           + +F   +G G +  V  G+ R    VAIK +  G+  E   +F+ E  +M ++ H    
Sbjct: 10  DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE--DEFIEEAKVMMNLSHEKLV 67
Query: 171 KLLGYGI-EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQR 229
           +L G    +  + I+ E   NG L + L  M+ + +     ++   V E + YL     +
Sbjct: 68  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SK 124
Query: 230 RIIHRDIKAANILLTEDFEPQICDFGLAKW-LPEQWTHHTISKVEGTFGLVKLNLPPLVI 288
           + +HRD+ A N L+ +    ++ DFGL+++ L +++T    SK    +       PP V+
Sbjct: 125 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRWS------PPEVL 178
Query: 289 LKRCFT 294
           +   F+
Sbjct: 179 MYSKFS 184

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 93/203 (45%), Gaps = 34/203 (16%)
Query: 118 IGKGGYAEVY--------KGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPN 168
           +G+G + +V         K +      VA+K L     ++ ++D +SE+ +M  +  H N
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 169 TAKLLGYGIEGG-MHIVLELSPNGSLASLL---------------YGMKEKLKWGIRYKI 212
              LLG   + G +++++E +  G+L   L               +  +E+L        
Sbjct: 88  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 147
Query: 213 ALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKV 272
           A  VA G+ YL     ++ IHRD+ A N+L+TED   +I DFGLA+ +     HH     
Sbjct: 148 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI-----HHIDYYK 199
Query: 273 EGTFGLVKLN-LPPLVILKRCFT 294
           + T G + +  + P  +  R +T
Sbjct: 200 KTTNGRLPVKWMAPEALFDRIYT 222

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 93/203 (45%), Gaps = 34/203 (16%)
Query: 118 IGKGGYAEVY--------KGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPN 168
           +G+G + +V         K +      VA+K L     ++ ++D +SE+ +M  +  H N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 169 TAKLLGYGIEGG-MHIVLELSPNGSLASLL---------------YGMKEKLKWGIRYKI 212
              LLG   + G +++++E +  G+L   L               +  +E+L        
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 155
Query: 213 ALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKV 272
           A  VA G+ YL     ++ IHRD+ A N+L+TED   +I DFGLA+ +     HH     
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI-----HHIDYYK 207
Query: 273 EGTFGLVKLN-LPPLVILKRCFT 294
           + T G + +  + P  +  R +T
Sbjct: 208 KTTNGRLPVKWMAPEALFDRIYT 230

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 93/203 (45%), Gaps = 34/203 (16%)
Query: 118 IGKGGYAEVY--------KGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPN 168
           +G+G + +V         K +      VA+K L     ++ ++D +SE+ +M  +  H N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 169 TAKLLGYGIEGG-MHIVLELSPNGSLASLL---------------YGMKEKLKWGIRYKI 212
              LLG   + G +++++E +  G+L   L               +  +E+L        
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 213 ALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKV 272
           A  VA G+ YL     ++ IHRD+ A N+L+TED   +I DFGLA+ +     HH     
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI-----HHIDYYK 207
Query: 273 EGTFGLVKLN-LPPLVILKRCFT 294
           + T G + +  + P  +  R +T
Sbjct: 208 KTTNGRLPVKWMAPEALFDRIYT 230

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/189 (30%), Positives = 83/189 (43%), Gaps = 20/189 (10%)
Query: 89  NSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYK------GRLRNGQLVAIKRL 142
           NSY    P ++    + +   NN  F   +G G + +V +      G+      VA+K L
Sbjct: 25  NSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML 84
Query: 143 -TRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYG 199
            +   ADE  A  +SEL IM+H+  H N   LLG    GG + ++ E    G L + L  
Sbjct: 85  KSTAHADEKEA-LMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRR 143
Query: 200 MKEKLKWGIRYKIALGVAEGLLYLHEGCQ----------RRIIHRDIKAANILLTEDFEP 249
               L+    + IA   A     LH   Q          +  IHRD+ A N+LLT     
Sbjct: 144 KSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVA 203
Query: 250 QICDFGLAK 258
           +I DFGLA+
Sbjct: 204 KIGDFGLAR 212

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/180 (24%), Positives = 83/180 (46%), Gaps = 19/180 (10%)
Query: 95  SPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRN------GQLVAIKRLTRGTAD 148
           S   +F   E + A    +    +G+G +  VY+G  +          VAIK +    + 
Sbjct: 1   SAADVFVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM 60
Query: 149 EIIADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLK-- 205
               +FL+E  +M   +  +  +LLG   +G    +++EL   G L S L  ++ +++  
Sbjct: 61  RERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENN 120
Query: 206 -------WGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
                       ++A  +A+G+ YL+     + +HRD+ A N ++ EDF  +I DFG+ +
Sbjct: 121 PVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR 177

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 79/158 (50%), Gaps = 9/158 (5%)
Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADE-IIADFLSELGIMAHVDHPNTAKLLGYG 176
           IG+G Y  VYK +   G+  A+K++     DE I +  + E+ I+  + H N  KL    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV- 68
Query: 177 IEGGMHIVLELSP-NGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRD 235
           I     +VL     +  L  LL   +  L+        L +  G+ Y H+   RR++HRD
Sbjct: 69  IHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRD 125
Query: 236 IKAANILLTEDFEPQICDFGLAKW--LP-EQWTHHTIS 270
           +K  N+L+  + E +I DFGLA+   +P  ++TH  ++
Sbjct: 126 LKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVT 163

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/158 (32%), Positives = 77/158 (48%), Gaps = 9/158 (5%)
Query: 110 NNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRL-TRGTADEIIADFLS-ELGIMAHVDH 166
            +F F  ++G+G ++ V   R L   +  AIK L  R    E    +++ E  +M+ +DH
Sbjct: 14  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 73
Query: 167 PNTAKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHE 225
           P   KL   +  +  ++  L  + NG L   +  +    +   R+  A  +   L YLH 
Sbjct: 74  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLH- 131
Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL-PE 262
              + IIHRD+K  NILL ED   QI DFG AK L PE
Sbjct: 132 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 167

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/157 (33%), Positives = 77/157 (49%), Gaps = 9/157 (5%)
Query: 111 NFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRL-TRGTADEIIADFLS-ELGIMAHVDHP 167
           +F F  ++G+G ++ V   R L   +  AIK L  R    E    +++ E  +M+ +DHP
Sbjct: 30  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 89
Query: 168 NTAKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEG 226
              KL   +  +  ++  L  + NG L   +  +    +   R+  A  +   L YLH  
Sbjct: 90  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLH-- 146
Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL-PE 262
             + IIHRD+K  NILL ED   QI DFG AK L PE
Sbjct: 147 -GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 182

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/157 (33%), Positives = 77/157 (49%), Gaps = 9/157 (5%)
Query: 111 NFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRL-TRGTADEIIADFLS-ELGIMAHVDHP 167
           +F F  ++G+G ++ V   R L   +  AIK L  R    E    +++ E  +M+ +DHP
Sbjct: 30  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 89
Query: 168 NTAKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEG 226
              KL   +  +  ++  L  + NG L   +  +    +   R+  A  +   L YLH  
Sbjct: 90  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLH-- 146
Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL-PE 262
             + IIHRD+K  NILL ED   QI DFG AK L PE
Sbjct: 147 -GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 182

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/192 (30%), Positives = 86/192 (44%), Gaps = 26/192 (13%)
Query: 89  NSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYK------GRLRNGQLVAIKRL 142
           NSY    P ++    + +   NN  F   +G G + +V +      G+      VA+K L
Sbjct: 25  NSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML 84
Query: 143 -TRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYG 199
            +   ADE  A  +SEL IM+H+  H N   LLG    GG + ++ E    G L + L  
Sbjct: 85  KSTAHADEKEA-LMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRR 143
Query: 200 MKEKLKWGIRYKIALG-------------VAEGLLYLHEGCQRRIIHRDIKAANILLTED 246
               L+    + IA               VA+G+ +L     +  IHRD+ A N+LLT  
Sbjct: 144 KSRVLETDPAFAIANSTLSTRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNG 200
Query: 247 FEPQICDFGLAK 258
              +I DFGLA+
Sbjct: 201 HVAKIGDFGLAR 212

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 84/176 (47%), Gaps = 26/176 (14%)
Query: 137 VAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGIEGG-MHIVLELSPNGSLA 194
           VA+K L     ++ ++D +SE+ +M  +  H N   LLG   + G +++++E +  G+L 
Sbjct: 104 VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 163
Query: 195 SLL---------------YGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAA 239
             L               +  +E+L        A  VA G+ YL     ++ IHRD+ A 
Sbjct: 164 EYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAAR 220
Query: 240 NILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLN-LPPLVILKRCFT 294
           N+L+TED   +I DFGLA+ +     HH     + T G + +  + P  +  R +T
Sbjct: 221 NVLVTEDNVMKIADFGLARDI-----HHIDYYKKTTNGRLPVKWMAPEALFDRIYT 271

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/158 (32%), Positives = 77/158 (48%), Gaps = 9/158 (5%)
Query: 110 NNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRL-TRGTADEIIADFLS-ELGIMAHVDH 166
            +F F  ++G+G ++ V   R L   +  AIK L  R    E    +++ E  +M+ +DH
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 167 PNTAKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHE 225
           P   KL   +  +  ++  L  + NG L   +  +    +   R+  A  +   L YLH 
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLH- 147
Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL-PE 262
              + IIHRD+K  NILL ED   QI DFG AK L PE
Sbjct: 148 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 183

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/158 (32%), Positives = 77/158 (48%), Gaps = 9/158 (5%)
Query: 110 NNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRL-TRGTADEIIADFLS-ELGIMAHVDH 166
            +F F  ++G+G ++ V   R L   +  AIK L  R    E    +++ E  +M+ +DH
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 167 PNTAKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHE 225
           P   KL   +  +  ++  L  + NG L   +  +    +   R+  A  +   L YLH 
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLH- 149
Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL-PE 262
              + IIHRD+K  NILL ED   QI DFG AK L PE
Sbjct: 150 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/158 (32%), Positives = 77/158 (48%), Gaps = 9/158 (5%)
Query: 110 NNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRL-TRGTADEIIADFLS-ELGIMAHVDH 166
            +F F  ++G+G ++ V   R L   +  AIK L  R    E    +++ E  +M+ +DH
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 167 PNTAKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHE 225
           P   KL   +  +  ++  L  + NG L   +  +    +   R+  A  +   L YLH 
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLH- 147
Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL-PE 262
              + IIHRD+K  NILL ED   QI DFG AK L PE
Sbjct: 148 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 183

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/158 (32%), Positives = 77/158 (48%), Gaps = 9/158 (5%)
Query: 110 NNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRL-TRGTADEIIADFLS-ELGIMAHVDH 166
            +F F  ++G+G ++ V   R L   +  AIK L  R    E    +++ E  +M+ +DH
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 167 PNTAKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHE 225
           P   KL   +  +  ++  L  + NG L   +  +    +   R+  A  +   L YLH 
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLH- 147
Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL-PE 262
              + IIHRD+K  NILL ED   QI DFG AK L PE
Sbjct: 148 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 183

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/158 (32%), Positives = 77/158 (48%), Gaps = 9/158 (5%)
Query: 110 NNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRL-TRGTADEIIADFLS-ELGIMAHVDH 166
            +F F  ++G+G ++ V   R L   +  AIK L  R    E    +++ E  +M+ +DH
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 167 PNTAKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHE 225
           P   KL   +  +  ++  L  + NG L   +  +    +   R+  A  +   L YLH 
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLH- 150
Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL-PE 262
              + IIHRD+K  NILL ED   QI DFG AK L PE
Sbjct: 151 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 186

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/158 (32%), Positives = 77/158 (48%), Gaps = 9/158 (5%)
Query: 110 NNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRL-TRGTADEIIADFLS-ELGIMAHVDH 166
            +F F  ++G+G ++ V   R L   +  AIK L  R    E    +++ E  +M+ +DH
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 167 PNTAKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHE 225
           P   KL   +  +  ++  L  + NG L   +  +    +   R+  A  +   L YLH 
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLH- 150
Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL-PE 262
              + IIHRD+K  NILL ED   QI DFG AK L PE
Sbjct: 151 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 186

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/158 (32%), Positives = 77/158 (48%), Gaps = 9/158 (5%)
Query: 110 NNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRL-TRGTADEIIADFLS-ELGIMAHVDH 166
            +F F  ++G+G ++ V   R L   +  AIK L  R    E    +++ E  +M+ +DH
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 167 PNTAKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHE 225
           P   KL   +  +  ++  L  + NG L   +  +    +   R+  A  +   L YLH 
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLH- 149
Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL-PE 262
              + IIHRD+K  NILL ED   QI DFG AK L PE
Sbjct: 150 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 78/166 (46%), Gaps = 31/166 (18%)
Query: 118 IGKGGYAEVYKG------RLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHP-NTA 170
           +G+G + +V +       +    + VA+K L  G         +SEL I+ H+ H  N  
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 171 KLLGYGIEGG--MHIVLELSPNGSLASLLYGMKEKLKWGIRYK----------------I 212
            LLG   + G  + +++E    G+L++ L   + +    + YK                 
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEF---VPYKPEDLYKDFLTLEHLIXY 153
Query: 213 ALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           +  VA+G+ +L     R+ IHRD+ A NILL+E    +ICDFGLA+
Sbjct: 154 SFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLAR 196

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/158 (32%), Positives = 77/158 (48%), Gaps = 9/158 (5%)
Query: 110 NNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRL-TRGTADEIIADFLS-ELGIMAHVDH 166
            +F F  ++G+G ++ V   R L   +  AIK L  R    E    +++ E  +M+ +DH
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 167 PNTAKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHE 225
           P   KL   +  +  ++  L  + NG L   +  +    +   R+  A  +   L YLH 
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLH- 149
Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL-PE 262
              + IIHRD+K  NILL ED   QI DFG AK L PE
Sbjct: 150 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 40/153 (26%), Positives = 76/153 (49%), Gaps = 10/153 (6%)
Query: 111 NFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTA 170
           + +F   +G G +  V  G+ R    VAIK +  G+  E   +F+ E  +M ++ H    
Sbjct: 25  DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE--DEFIEEAKVMMNLSHEKLV 82
Query: 171 KLLGYGI---EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
           +L  YG+   +  + I+ E   NG L + L  M+ + +     ++   V E + YL    
Sbjct: 83  QL--YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE--- 137
Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAKWL 260
            ++ +HRD+ A N L+ +    ++ DFGL++++
Sbjct: 138 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV 170

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 78/167 (46%), Gaps = 32/167 (19%)
Query: 118 IGKGGYAEVYKG------RLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHP-NTA 170
           +G+G + +V +       +    + VA+K L  G         +SEL I+ H+ H  N  
Sbjct: 36  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 95
Query: 171 KLLGYGIEGG--MHIVLELSPNGSLASLLYGMKEKLKWGIRYKI---------------- 212
            LLG   + G  + +++E    G+L++ L   + +    + YK                 
Sbjct: 96  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEF---VPYKTPEDLYKDFLTLEHLIC 152
Query: 213 -ALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
            +  VA+G+ +L     R+ IHRD+ A NILL+E    +ICDFGLA+
Sbjct: 153 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 196

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/158 (32%), Positives = 77/158 (48%), Gaps = 9/158 (5%)
Query: 110 NNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRL-TRGTADEIIADFLS-ELGIMAHVDH 166
            +F F  ++G+G ++ V   R L   +  AIK L  R    E    +++ E  +M+ +DH
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 167 PNTAKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHE 225
           P   KL   +  +  ++  L  + NG L   +  +    +   R+  A  +   L YLH 
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTA-EIVSALEYLH- 149
Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL-PE 262
              + IIHRD+K  NILL ED   QI DFG AK L PE
Sbjct: 150 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/155 (29%), Positives = 78/155 (50%), Gaps = 14/155 (9%)
Query: 111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADE-IIADFLSELGIMAHVDHPN 168
           NF     IG+G Y  VYK R +  G++VA+ ++   T  E + +  + E+ ++  ++HPN
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 169 TAKLLGY-GIEGGMHIVLELSPNG----SLASLLYGMKEKLKWGIRYKIALGVAEGLLYL 223
             KLL     E  +++V E           AS L G+   L     +++     +GL + 
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL----QGLAFC 119
Query: 224 HEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           H     R++HRD+K  N+L+  +   ++ DFGLA+
Sbjct: 120 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 151

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/155 (29%), Positives = 78/155 (50%), Gaps = 14/155 (9%)
Query: 111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADE-IIADFLSELGIMAHVDHPN 168
           NF     IG+G Y  VYK R +  G++VA+ ++   T  E + +  + E+ ++  ++HPN
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 169 TAKLLGY-GIEGGMHIVLELSPNG----SLASLLYGMKEKLKWGIRYKIALGVAEGLLYL 223
             KLL     E  +++V E           AS L G+   L     +++     +GL + 
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL----QGLAFC 118
Query: 224 HEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           H     R++HRD+K  N+L+  +   ++ DFGLA+
Sbjct: 119 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 150

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 41/146 (28%), Positives = 69/146 (47%), Gaps = 10/146 (6%)
Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGI 177
           +G G +  V  G+ +    VA+K +  G+  E   +F  E   M  + HP   K   YG+
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE--DEFFQEAQTMMKLSHPKLVKF--YGV 71
Query: 178 ---EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHR 234
              E  ++IV E   NG L + L    + L+     ++   V EG+ +L      + IHR
Sbjct: 72  CSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHR 128
Query: 235 DIKAANILLTEDFEPQICDFGLAKWL 260
           D+ A N L+  D   ++ DFG+ +++
Sbjct: 129 DLAARNCLVDRDLCVKVSDFGMTRYV 154

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/158 (32%), Positives = 77/158 (48%), Gaps = 9/158 (5%)
Query: 110 NNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRL-TRGTADEIIADFLS-ELGIMAHVDH 166
            +F F  ++G+G ++ V   R L   +  AIK L  R    E    +++ E  +M+ +DH
Sbjct: 35  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 94
Query: 167 PNTAKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHE 225
           P   KL   +  +  ++  L  + NG L   +  +    +   R+  A  +   L YLH 
Sbjct: 95  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLH- 152
Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL-PE 262
              + IIHRD+K  NILL ED   QI DFG AK L PE
Sbjct: 153 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 188

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 81/178 (45%), Gaps = 8/178 (4%)
Query: 110 NNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRL-TRGTADEIIADFLS-ELGIMAHVDH 166
            +F F  ++G+G ++ V   R L   +  AIK L  R    E    +++ E  +M+ +DH
Sbjct: 37  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 96
Query: 167 PNTAKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHE 225
           P   KL   +  +  ++  L  + NG L   +  +    +   R+  A  +   L YLH 
Sbjct: 97  PFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLH- 154
Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNL 283
              + IIHRD+K  NILL ED   QI DFG AK L  +      +   GT   V   L
Sbjct: 155 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 210

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/158 (32%), Positives = 77/158 (48%), Gaps = 9/158 (5%)
Query: 110 NNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRL-TRGTADEIIADFLS-ELGIMAHVDH 166
            +F F  ++G+G ++ V   R L   +  AIK L  R    E    +++ E  +M+ +DH
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 167 PNTAKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHE 225
           P   KL   +  +  ++  L  + NG L   +  +    +   R+  A  +   L YLH 
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLH- 149
Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL-PE 262
              + IIHRD+K  NILL ED   QI DFG AK L PE
Sbjct: 150 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 84/182 (46%), Gaps = 19/182 (10%)
Query: 93  SQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRN------GQLVAIKRLTRGT 146
           S S   ++   E + A    +    +G+G +  VY+G  +          VAIK +    
Sbjct: 2   SFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA 61
Query: 147 ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLK 205
           +     +FL+E  +M   +  +  +LLG   +G    +++EL   G L S L  ++ +++
Sbjct: 62  SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEME 121
Query: 206 ---------WGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGL 256
                         ++A  +A+G+ YL+     + +HRD+ A N ++ EDF  +I DFG+
Sbjct: 122 NNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGM 178
Query: 257 AK 258
            +
Sbjct: 179 TR 180

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 48/168 (28%), Positives = 78/168 (46%), Gaps = 33/168 (19%)
Query: 118 IGKGGYAEVYKG------RLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHP-NTA 170
           +G+G + +V +       +    + VA+K L  G         +SEL I+ H+ H  N  
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 171 KLLGYGIEGG--MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIA--------------- 213
            LLG   + G  + +++E    G+L++ L   + +    + YK A               
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEF---VPYKEAPEDLYKDFLTLEHLI 153
Query: 214 ---LGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
                VA+G+ +L     R+ IHRD+ A NILL+E    +ICDFGLA+
Sbjct: 154 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 198

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 44/179 (24%), Positives = 85/179 (47%), Gaps = 19/179 (10%)
Query: 96  PQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRN---GQL---VAIKRLTRGTADE 149
           P  +F   E + +    +    +G+G +  VY+G  R+   G+    VA+K +    +  
Sbjct: 3   PSSVFVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLR 62
Query: 150 IIADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGI 208
              +FL+E  +M      +  +LLG   +G    +V+EL  +G L S L  ++ + +   
Sbjct: 63  ERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNP 122
Query: 209 ---------RYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
                      ++A  +A+G+ YL+    ++ +HRD+ A N ++  DF  +I DFG+ +
Sbjct: 123 GRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR 178

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 84/182 (46%), Gaps = 19/182 (10%)
Query: 93  SQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRN------GQLVAIKRLTRGT 146
           S S   ++   E + A    +    +G+G +  VY+G  +          VAIK +    
Sbjct: 2   SFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA 61
Query: 147 ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLK 205
           +     +FL+E  +M   +  +  +LLG   +G    +++EL   G L S L  ++ +++
Sbjct: 62  SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEME 121
Query: 206 ---------WGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGL 256
                         ++A  +A+G+ YL+     + +HRD+ A N ++ EDF  +I DFG+
Sbjct: 122 NNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGM 178
Query: 257 AK 258
            +
Sbjct: 179 TR 180

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/158 (32%), Positives = 77/158 (48%), Gaps = 9/158 (5%)
Query: 110 NNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRL-TRGTADEIIADFLS-ELGIMAHVDH 166
            +F F  ++G+G ++ V   R L   +  AIK L  R    E    +++ E  +M+ +DH
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 167 PNTAKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHE 225
           P   KL   +  +  ++  L  + NG L   +  +    +   R+  A  +   L YLH 
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLH- 149
Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL-PE 262
              + IIHRD+K  NILL ED   QI DFG AK L PE
Sbjct: 150 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 79/154 (51%), Gaps = 17/154 (11%)
Query: 118 IGKGGYAEVYKGR-LRNG-QLVAIKRLTRGTADE-IIADFLSELGIMAHVD---HPNTAK 171
           IG+G Y +V+K R L+NG + VA+KR+   T +E +    + E+ ++ H++   HPN  +
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 172 LLGYGI------EGGMHIVLELSPNGSLASLLYGMKEK-LKWGIRYKIALGVAEGLLYLH 224
           L           E  + +V E   +  L + L  + E  +       +   +  GL +LH
Sbjct: 79  LFDVCTVSRTDRETKLTLVFE-HVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 137
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
                R++HRD+K  NIL+T   + ++ DFGLA+
Sbjct: 138 ---SHRVVHRDLKPQNILVTSSGQIKLADFGLAR 168

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 44/179 (24%), Positives = 85/179 (47%), Gaps = 19/179 (10%)
Query: 96  PQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRN---GQL---VAIKRLTRGTADE 149
           P  +F   E + +    +    +G+G +  VY+G  R+   G+    VA+K +    +  
Sbjct: 3   PSSVFVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLR 62
Query: 150 IIADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGI 208
              +FL+E  +M      +  +LLG   +G    +V+EL  +G L S L  ++ + +   
Sbjct: 63  ERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNP 122
Query: 209 ---------RYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
                      ++A  +A+G+ YL+    ++ +HRD+ A N ++  DF  +I DFG+ +
Sbjct: 123 GRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR 178

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 44/179 (24%), Positives = 85/179 (47%), Gaps = 19/179 (10%)
Query: 96  PQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRN---GQL---VAIKRLTRGTADE 149
           P  +F   E + +    +    +G+G +  VY+G  R+   G+    VA+K +    +  
Sbjct: 3   PSSVFVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLR 62
Query: 150 IIADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGI 208
              +FL+E  +M      +  +LLG   +G    +V+EL  +G L S L  ++ + +   
Sbjct: 63  ERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNP 122
Query: 209 ---------RYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
                      ++A  +A+G+ YL+    ++ +HRD+ A N ++  DF  +I DFG+ +
Sbjct: 123 GRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR 178

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 43/180 (23%), Positives = 83/180 (46%), Gaps = 19/180 (10%)
Query: 95  SPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRN------GQLVAIKRLTRGTAD 148
           S   ++   E + A    +    +G+G +  VY+G  +          VAIK +    + 
Sbjct: 3   SAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM 62
Query: 149 EIIADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLK-- 205
               +FL+E  +M   +  +  +LLG   +G    +++EL   G L S L  ++ +++  
Sbjct: 63  RERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENN 122
Query: 206 -------WGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
                       ++A  +A+G+ YL+     + +HRD+ A N ++ EDF  +I DFG+ +
Sbjct: 123 PVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR 179

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 43/180 (23%), Positives = 83/180 (46%), Gaps = 19/180 (10%)
Query: 95  SPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRN------GQLVAIKRLTRGTAD 148
           S   ++   E + A    +    +G+G +  VY+G  +          VAIK +    + 
Sbjct: 3   SAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM 62
Query: 149 EIIADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLK-- 205
               +FL+E  +M   +  +  +LLG   +G    +++EL   G L S L  ++ +++  
Sbjct: 63  RERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENN 122
Query: 206 -------WGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
                       ++A  +A+G+ YL+     + +HRD+ A N ++ EDF  +I DFG+ +
Sbjct: 123 PVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR 179

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 43/180 (23%), Positives = 83/180 (46%), Gaps = 19/180 (10%)
Query: 95  SPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRN------GQLVAIKRLTRGTAD 148
           S   ++   E + A    +    +G+G +  VY+G  +          VAIK +    + 
Sbjct: 10  SAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM 69
Query: 149 EIIADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLK-- 205
               +FL+E  +M   +  +  +LLG   +G    +++EL   G L S L  ++ +++  
Sbjct: 70  RERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENN 129
Query: 206 -------WGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
                       ++A  +A+G+ YL+     + +HRD+ A N ++ EDF  +I DFG+ +
Sbjct: 130 PVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR 186

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 44/137 (32%), Positives = 69/137 (50%), Gaps = 16/137 (11%)
Query: 133 NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG---MHIVLELSP 189
            G++VA+K L  G   ++ + +  E+ I+  + H +  K  G   + G   + +V+E  P
Sbjct: 37  TGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVP 96
Query: 190 NGSLASLL----YGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTE 245
            GSL   L     G+ + L +      A  + EG+ YLH    +  IHR + A N+LL  
Sbjct: 97  LGSLRDYLPRHCVGLAQLLLF------AQQICEGMAYLH---AQHYIHRALAARNVLLDN 147
Query: 246 DFEPQICDFGLAKWLPE 262
           D   +I DFGLAK +PE
Sbjct: 148 DRLVKIGDFGLAKAVPE 164

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 86/196 (43%), Gaps = 32/196 (16%)
Query: 89  NSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYK------GRLRNGQLVAIKRL 142
           NSY    P ++    + +   NN  F   +G G + +V +      G+      VA+K L
Sbjct: 25  NSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML 84
Query: 143 -TRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGM 200
            +   ADE  A  +SEL IM+H+  H N   LLG    GG   VL ++       LL  +
Sbjct: 85  KSTAHADEKEA-LMSELKIMSHLGQHENIVNLLGACTHGGP--VLVITEYCCYGDLLNFL 141
Query: 201 KEKLKWGIRYK------------------IALGVAEGLLYLHEGCQRRIIHRDIKAANIL 242
           + K   G+ Y                    +  VA+G+ +L     +  IHRD+ A N+L
Sbjct: 142 RRKRPPGLEYSYNPSHNPEEQLSSRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVL 198
Query: 243 LTEDFEPQICDFGLAK 258
           LT     +I DFGLA+
Sbjct: 199 LTNGHVAKIGDFGLAR 214

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 51/162 (31%), Positives = 75/162 (46%), Gaps = 21/162 (12%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGI--MAHVDHP 167
           +N     LIG+G Y  VYKG L + + VA+K  +         +F++E  I  +  ++H 
Sbjct: 13  DNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ----NFINEKNIYRVPLMEHD 67
Query: 168 NTAKLL----GYGIEGGMH--IVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLL 221
           N A+ +        +G M   +V+E  PNGSL    Y       W    ++A  V  GL 
Sbjct: 68  NIARFIVGDERVTADGRMEYLLVMEYYPNGSLXK--YLSLHTSDWVSSCRLAHSVTRGLA 125
Query: 222 YLHEGCQR------RIIHRDIKAANILLTEDFEPQICDFGLA 257
           YLH    R       I HRD+ + N+L+  D    I DFGL+
Sbjct: 126 YLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLS 167

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 44/137 (32%), Positives = 69/137 (50%), Gaps = 16/137 (11%)
Query: 133 NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG---MHIVLELSP 189
            G++VA+K L  G   ++ + +  E+ I+  + H +  K  G   + G   + +V+E  P
Sbjct: 36  TGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVP 95
Query: 190 NGSLASLL----YGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTE 245
            GSL   L     G+ + L +      A  + EG+ YLH    +  IHR + A N+LL  
Sbjct: 96  LGSLRDYLPRHCVGLAQLLLF------AQQICEGMAYLH---AQHYIHRALAARNVLLDN 146
Query: 246 DFEPQICDFGLAKWLPE 262
           D   +I DFGLAK +PE
Sbjct: 147 DRLVKIGDFGLAKAVPE 163

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 43/180 (23%), Positives = 83/180 (46%), Gaps = 19/180 (10%)
Query: 95  SPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRN------GQLVAIKRLTRGTAD 148
           S   ++   E + A    +    +G+G +  VY+G  +          VAIK +    + 
Sbjct: 32  SAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM 91
Query: 149 EIIADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLK-- 205
               +FL+E  +M   +  +  +LLG   +G    +++EL   G L S L  ++ +++  
Sbjct: 92  RERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENN 151
Query: 206 -------WGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
                       ++A  +A+G+ YL+     + +HRD+ A N ++ EDF  +I DFG+ +
Sbjct: 152 PVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR 208

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 91/206 (44%), Gaps = 39/206 (18%)
Query: 83  PRNLFVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKG-----RLRNG-QL 136
           P +L V+++      KI    + +    N      +G+G + +V K      + R G   
Sbjct: 2   PLSLSVDAF------KILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTT 55
Query: 137 VAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGY-GIEGGMHIVLELSPNGSLAS 195
           VA+K L    +   + D LSE  ++  V+HP+  KL G    +G + +++E +  GSL  
Sbjct: 56  VAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRG 115
Query: 196 LL-----------------------YGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRII 232
            L                       +  +  L  G     A  +++G+ YL E    +++
Sbjct: 116 FLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLV 172
Query: 233 HRDIKAANILLTEDFEPQICDFGLAK 258
           HRD+ A NIL+ E  + +I DFGL++
Sbjct: 173 HRDLAARNILVAEGRKMKISDFGLSR 198

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 42/171 (24%), Positives = 80/171 (46%), Gaps = 19/171 (11%)
Query: 104 ELQSATNNFSFENLIGKGGYAEVYKGRLRN------GQLVAIKRLTRGTADEIIADFLSE 157
           E + A    +    +G+G +  VY+G  +          VAIK +    +     +FL+E
Sbjct: 6   EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 65
Query: 158 LGIMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLK---------WG 207
             +M   +  +  +LLG   +G    +++EL   G L S L  ++ +++           
Sbjct: 66  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 125
Query: 208 IRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
              ++A  +A+G+ YL+     + +HRD+ A N ++ EDF  +I DFG+ +
Sbjct: 126 KMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR 173

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 52/176 (29%), Positives = 82/176 (46%), Gaps = 30/176 (17%)
Query: 104 ELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTAD----EIIAD------ 153
           EL +  + ++ +  I  G Y  V  G    G  VAIKR+    +D     I++D      
Sbjct: 16  ELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKR 75
Query: 154 FLSELGIMAHVDHPNTAKLLGYGI---EGGMH---IVLELSPNGSLASLLYGMK-----E 202
            L E+ ++ H  HPN   L    +   E  MH   +V EL     LA +++  +     +
Sbjct: 76  VLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQ 134
Query: 203 KLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
            +++ + Y I LG    L  LHE     ++HRD+   NILL ++ +  ICDF LA+
Sbjct: 135 HIQYFM-YHILLG----LHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAR 182

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 42/171 (24%), Positives = 80/171 (46%), Gaps = 19/171 (11%)
Query: 104 ELQSATNNFSFENLIGKGGYAEVYKGRLRN------GQLVAIKRLTRGTADEIIADFLSE 157
           E + A    +    +G+G +  VY+G  +          VAIK +    +     +FL+E
Sbjct: 4   EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 63
Query: 158 LGIMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLK---------WG 207
             +M   +  +  +LLG   +G    +++EL   G L S L  ++ +++           
Sbjct: 64  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 123
Query: 208 IRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
              ++A  +A+G+ YL+     + +HRD+ A N ++ EDF  +I DFG+ +
Sbjct: 124 KMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR 171

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 81/166 (48%), Gaps = 28/166 (16%)
Query: 118 IGKGGYAEVY--------KGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPN 168
           +G+G + +V         K + +    VA+K L     +E ++D +SE+ +M  +  H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 169 TAKLLGYGIEGG-MHIVLELSPNGSLASLLY-----GMK----------EKLKWGIRYKI 212
              LLG   + G +++++E +  G+L   L      GM+          E++ +      
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 213 ALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
              +A G+ YL     ++ IHRD+ A N+L+TE+   +I DFGLA+
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 91/206 (44%), Gaps = 39/206 (18%)
Query: 83  PRNLFVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKG-----RLRNG-QL 136
           P +L V+++      KI    + +    N      +G+G + +V K      + R G   
Sbjct: 2   PLSLSVDAF------KILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTT 55
Query: 137 VAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGY-GIEGGMHIVLELSPNGSLAS 195
           VA+K L    +   + D LSE  ++  V+HP+  KL G    +G + +++E +  GSL  
Sbjct: 56  VAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRG 115
Query: 196 LL-----------------------YGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRII 232
            L                       +  +  L  G     A  +++G+ YL E    +++
Sbjct: 116 FLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLV 172
Query: 233 HRDIKAANILLTEDFEPQICDFGLAK 258
           HRD+ A NIL+ E  + +I DFGL++
Sbjct: 173 HRDLAARNILVAEGRKMKISDFGLSR 198

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 52/176 (29%), Positives = 82/176 (46%), Gaps = 30/176 (17%)
Query: 104 ELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTAD----EIIAD------ 153
           EL +  + ++ +  I  G Y  V  G    G  VAIKR+    +D     I++D      
Sbjct: 16  ELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKR 75
Query: 154 FLSELGIMAHVDHPNTAKLLGYGI---EGGMH---IVLELSPNGSLASLLYGMK-----E 202
            L E+ ++ H  HPN   L    +   E  MH   +V EL     LA +++  +     +
Sbjct: 76  VLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQ 134
Query: 203 KLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
            +++ + Y I LG    L  LHE     ++HRD+   NILL ++ +  ICDF LA+
Sbjct: 135 HIQYFM-YHILLG----LHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAR 182

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 51/158 (32%), Positives = 76/158 (48%), Gaps = 9/158 (5%)
Query: 110 NNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRL-TRGTADEIIADFLS-ELGIMAHVDH 166
            +F F  ++G+G ++     R L   +  AIK L  R    E    +++ E  +M+ +DH
Sbjct: 30  EDFKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 167 PNTAKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHE 225
           P   KL   +  +  ++  L  + NG L   +  +    +   R+  A  +   L YLH 
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLH- 147
Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL-PE 262
              + IIHRD+K  NILL ED   QI DFG AK L PE
Sbjct: 148 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 183

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 79/154 (51%), Gaps = 17/154 (11%)
Query: 118 IGKGGYAEVYKGR-LRNG-QLVAIKRLTRGTADE-IIADFLSELGIMAHVD---HPNTAK 171
           IG+G Y +V+K R L+NG + VA+KR+   T +E +    + E+ ++ H++   HPN  +
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 172 LLGYGI------EGGMHIVLELSPNGSLASLLYGMKEK-LKWGIRYKIALGVAEGLLYLH 224
           L           E  + +V E   +  L + L  + E  +       +   +  GL +LH
Sbjct: 79  LFDVCTVSRTDRETKLTLVFE-HVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 137
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
                R++HRD+K  NIL+T   + ++ DFGLA+
Sbjct: 138 ---SHRVVHRDLKPQNILVTSSGQIKLADFGLAR 168

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 44/160 (27%), Positives = 74/160 (46%), Gaps = 23/160 (14%)
Query: 117 LIGKGGYAEVYKGRLRNGQLVAIKRLTR-----GTADEIIADFLSELGIMAHVDHPNTAK 171
           ++G+G +  V +G L+     ++K   +      ++   I +FLSE   M    HPN  +
Sbjct: 41  ILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIR 100
Query: 172 LLGYGIEGGMH------IVLELSPNGSLASLLYGMKEKLKWGIRY-------KIALGVAE 218
           LLG  IE          ++L     G L +  Y +  +L+ G ++       K  + +A 
Sbjct: 101 LLGVCIEMSSQGIPKPMVILPFMKYGDLHT--YLLYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           G+ YL     R  +HRD+ A N +L +D    + DFGL+K
Sbjct: 159 GMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSK 195

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 79/154 (51%), Gaps = 17/154 (11%)
Query: 118 IGKGGYAEVYKGR-LRNG-QLVAIKRLTRGTADE-IIADFLSELGIMAHVD---HPNTAK 171
           IG+G Y +V+K R L+NG + VA+KR+   T +E +    + E+ ++ H++   HPN  +
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 172 LLGYGI------EGGMHIVLELSPNGSLASLLYGMKEK-LKWGIRYKIALGVAEGLLYLH 224
           L           E  + +V E   +  L + L  + E  +       +   +  GL +LH
Sbjct: 79  LFDVCTVSRTDRETKLTLVFE-HVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 137
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
                R++HRD+K  NIL+T   + ++ DFGLA+
Sbjct: 138 ---SHRVVHRDLKPQNILVTSSGQIKLADFGLAR 168

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 46/147 (31%), Positives = 75/147 (51%), Gaps = 10/147 (6%)
Query: 117 LIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA-DEIIADFLSELGIMAHVDHPNTAKLLG 174
           ++GKG + EV K + R   Q  A+K + + +A ++  +  L E+ ++  +DHPN  KL  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 175 YGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIH 233
              +    +IV EL   G L   +   K +       +I   V  G+ Y+H   +  I+H
Sbjct: 89  ILEDSSSFYIVGELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMH---KHNIVH 144
Query: 234 RDIKAANILL---TEDFEPQICDFGLA 257
           RD+K  NILL    +D + +I DFGL+
Sbjct: 145 RDLKPENILLESKEKDCDIKIIDFGLS 171

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 57/188 (30%), Positives = 85/188 (45%), Gaps = 22/188 (11%)
Query: 89  NSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYK------GRLRNGQLVAIKRL 142
           NSY    P ++    + +   NN  F   +G G + +V +      G+      VA+K L
Sbjct: 17  NSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML 76
Query: 143 -TRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYG 199
            +   ADE  A  +SEL IM+H+  H N   LLG    GG + ++ E    G L + L  
Sbjct: 77  KSTAHADEKEA-LMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRR 135
Query: 200 MKEK---------LKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQ 250
             E          L+       +  VA+G+ +L     +  IHRD+ A N+LLT     +
Sbjct: 136 KAEADLDKEDGRPLELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAK 192
Query: 251 ICDFGLAK 258
           I DFGLA+
Sbjct: 193 IGDFGLAR 200

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 43/180 (23%), Positives = 81/180 (45%), Gaps = 19/180 (10%)
Query: 95  SPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRN------GQLVAIKRLTRGTAD 148
           S   ++   E + A    +    +G+G +  VY+G  +          VAIK +    + 
Sbjct: 10  SAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM 69
Query: 149 EIIADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKL--- 204
               +FL+E  +M   +  +  +LLG   +G    +++EL   G L S L  ++  +   
Sbjct: 70  RERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANN 129
Query: 205 ------KWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
                       ++A  +A+G+ YL+     + +HRD+ A N ++ EDF  +I DFG+ +
Sbjct: 130 PVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR 186

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 57/188 (30%), Positives = 85/188 (45%), Gaps = 22/188 (11%)
Query: 89  NSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYK------GRLRNGQLVAIKRL 142
           NSY    P ++    + +   NN  F   +G G + +V +      G+      VA+K L
Sbjct: 25  NSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML 84
Query: 143 -TRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYG 199
            +   ADE  A  +SEL IM+H+  H N   LLG    GG + ++ E    G L + L  
Sbjct: 85  KSTAHADEKEA-LMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRR 143
Query: 200 MKEK---------LKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQ 250
             E          L+       +  VA+G+ +L     +  IHRD+ A N+LLT     +
Sbjct: 144 KAEADLDKEDGRPLELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAK 200
Query: 251 ICDFGLAK 258
           I DFGLA+
Sbjct: 201 IGDFGLAR 208

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 81/163 (49%), Gaps = 10/163 (6%)
Query: 101 SLYELQSATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA-DEIIADFLSEL 158
           +LY   +    ++   ++GKG + EV K + R   Q  A+K + + +A ++  +  L E+
Sbjct: 13  NLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREV 72
Query: 159 GIMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVA 217
            ++  +DHPN  KL     +    +IV EL   G L   +   K +       +I   V 
Sbjct: 73  ELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK-RFSEHDAARIIKQVF 131
Query: 218 EGLLYLHEGCQRRIIHRDIKAANILL---TEDFEPQICDFGLA 257
            G+ Y+H   +  I+HRD+K  NILL    +D + +I DFGL+
Sbjct: 132 SGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLS 171

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 94/199 (47%), Gaps = 24/199 (12%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEI-IADFLSELGIMAHVDHP 167
           + +   +LIG G Y  V +   +   ++VAIK++ R   D I     L E+ I+  ++H 
Sbjct: 53  DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHD 112
Query: 168 NTAKLLGYGIEGG------MHIVLELSPNGS---LASLLYGMKEKLKWGIRYKIALGVAE 218
           +  K+L   I         +++VLE++ +       + +Y  +  +K  + Y + +GV  
Sbjct: 113 HVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIK-TLLYNLLVGVK- 170
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL--PEQWTHH-TISKVEGT 275
              Y+H      I+HRD+K AN L+ +D   ++CDFGLA+ +  PE       IS  E  
Sbjct: 171 ---YVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDD 224
Query: 276 FGLVKLNLPPLVILKRCFT 294
             LV    P    LKR  T
Sbjct: 225 MNLV--TFPHTKNLKRQLT 241

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 81/163 (49%), Gaps = 10/163 (6%)
Query: 101 SLYELQSATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA-DEIIADFLSEL 158
           +LY   +    ++   ++GKG + EV K + R   Q  A+K + + +A ++  +  L E+
Sbjct: 13  NLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREV 72
Query: 159 GIMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVA 217
            ++  +DHPN  KL     +    +IV EL   G L   +   K +       +I   V 
Sbjct: 73  ELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK-RFSEHDAARIIKQVF 131
Query: 218 EGLLYLHEGCQRRIIHRDIKAANILL---TEDFEPQICDFGLA 257
            G+ Y+H   +  I+HRD+K  NILL    +D + +I DFGL+
Sbjct: 132 SGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLS 171

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/179 (24%), Positives = 85/179 (47%), Gaps = 19/179 (10%)
Query: 96  PQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRN---GQL---VAIKRLTRGTADE 149
           P  ++   E + +    +    +G+G +  VY+G  R+   G+    VA+K +    +  
Sbjct: 3   PSSVYVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLR 62
Query: 150 IIADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGI 208
              +FL+E  +M      +  +LLG   +G    +V+EL  +G L S L  ++ + +   
Sbjct: 63  ERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNP 122
Query: 209 ---------RYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
                      ++A  +A+G+ YL+    ++ +HRD+ A N ++  DF  +I DFG+ +
Sbjct: 123 GRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR 178

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 76/164 (46%), Gaps = 31/164 (18%)
Query: 113 SFENL--IGKGGYAEVYKGRLRN-GQLVAIKRLTRGTADEIIADF-LSELGIMAHVDHPN 168
            +ENL  +G+G Y  V K R ++ G++VAIK+      D+++    + E+ ++  + H N
Sbjct: 26  KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHEN 85
Query: 169 TAKLLGYG---------IEGGMHIVL---ELSPNGSLASLLYGMKEKLKWGIRYKIALGV 216
              LL             E   H +L   EL PNG            L + +  K    +
Sbjct: 86  LVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNG------------LDYQVVQKYLFQI 133
Query: 217 AEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL 260
             G+ + H      IIHRDIK  NIL+++    ++CDFG A+ L
Sbjct: 134 INGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTL 174

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 90/206 (43%), Gaps = 39/206 (18%)
Query: 83  PRNLFVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKG-----RLRNG-QL 136
           P +L V+++      KI    + +    N      +G+G + +V K      + R G   
Sbjct: 2   PLSLSVDAF------KILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTT 55
Query: 137 VAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGY-GIEGGMHIVLELSPNGSLAS 195
           VA+K L    +   + D LSE  ++  V+HP+  KL G    +G + +++E +  GSL  
Sbjct: 56  VAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRG 115
Query: 196 LL-----------------------YGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRII 232
            L                       +  +  L  G     A  +++G+ YL E     ++
Sbjct: 116 FLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMS---LV 172
Query: 233 HRDIKAANILLTEDFEPQICDFGLAK 258
           HRD+ A NIL+ E  + +I DFGL++
Sbjct: 173 HRDLAARNILVAEGRKMKISDFGLSR 198

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/168 (28%), Positives = 79/168 (47%), Gaps = 14/168 (8%)
Query: 105 LQSATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFL-SELGIMA 162
           + S   ++     IG G Y    K R + +G+++  K L  G+  E     L SE+ ++ 
Sbjct: 1   MPSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLR 60
Query: 163 HVDHPNTAKLLGYGIE---GGMHIVLELSPNGSLASLLY-GMKEKLKWGIRYKIALGVAE 218
            + HPN  +     I+     ++IV+E    G LAS++  G KE+    +  +  L V  
Sbjct: 61  ELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKER--QYLDEEFVLRVMT 118
Query: 219 GLLYLHEGCQRR------IIHRDIKAANILLTEDFEPQICDFGLAKWL 260
            L    + C RR      ++HRD+K AN+ L      ++ DFGLA+ L
Sbjct: 119 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL 166

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/168 (28%), Positives = 79/168 (47%), Gaps = 14/168 (8%)
Query: 105 LQSATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFL-SELGIMA 162
           + S   ++     IG G Y    K R + +G+++  K L  G+  E     L SE+ ++ 
Sbjct: 1   MPSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLR 60
Query: 163 HVDHPNTAKLLGYGIE---GGMHIVLELSPNGSLASLLY-GMKEKLKWGIRYKIALGVAE 218
            + HPN  +     I+     ++IV+E    G LAS++  G KE+    +  +  L V  
Sbjct: 61  ELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKER--QYLDEEFVLRVMT 118
Query: 219 GLLYLHEGCQRR------IIHRDIKAANILLTEDFEPQICDFGLAKWL 260
            L    + C RR      ++HRD+K AN+ L      ++ DFGLA+ L
Sbjct: 119 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL 166

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/171 (24%), Positives = 78/171 (45%), Gaps = 19/171 (11%)
Query: 104 ELQSATNNFSFENLIGKGGYAEVYKGRLRN------GQLVAIKRLTRGTADEIIADFLSE 157
           E + A    +    +G+G +  VY+G  +          VAIK +    +     +FL+E
Sbjct: 9   EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 68
Query: 158 LGIMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKL---------KWG 207
             +M   +  +  +LLG   +G    +++EL   G L S L  ++  +            
Sbjct: 69  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS 128
Query: 208 IRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
              ++A  +A+G+ YL+     + +HRD+ A N ++ EDF  +I DFG+ +
Sbjct: 129 KMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR 176

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/133 (31%), Positives = 65/133 (48%), Gaps = 8/133 (6%)
Query: 133 NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG---MHIVLELSP 189
            G++VA+K L      +  + +  E+ I+  + H +  K  G   + G   + +V+E  P
Sbjct: 59  TGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVP 118
Query: 190 NGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEP 249
            GSL   L   +  +        A  + EG+ YLH    +  IHRD+ A N+LL  D   
Sbjct: 119 LGSLRDYL--PRHSIGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLV 173
Query: 250 QICDFGLAKWLPE 262
           +I DFGLAK +PE
Sbjct: 174 KIGDFGLAKAVPE 186

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 79/159 (49%), Gaps = 8/159 (5%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGI-MAH 163
           Q+  N+      +G G   +V+K R R  G ++A+K++ R    E     L +L + +  
Sbjct: 21  QAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKS 80
Query: 164 VDHPNTAKLLGYGIEG-GMHIVLELSPNGSLASLLYG-MKEKLKWGIRYKIALGVAEGLL 221
            D P   +  G  I    + I +EL   G+ A  L   M+  +   I  K+ + + + L 
Sbjct: 81  HDCPYIVQCFGTFITNTDVFIAMELM--GTCAEKLKKRMQGPIPERILGKMTVAIVKALY 138
Query: 222 YLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL 260
           YL E  +  +IHRD+K +NILL E  + ++CDFG++  L
Sbjct: 139 YLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRL 175

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/168 (28%), Positives = 79/168 (47%), Gaps = 14/168 (8%)
Query: 105 LQSATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFL-SELGIMA 162
           + S   ++     IG G Y    K R + +G+++  K L  G+  E     L SE+ ++ 
Sbjct: 1   MPSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLR 60
Query: 163 HVDHPNTAKLLGYGIE---GGMHIVLELSPNGSLASLLY-GMKEKLKWGIRYKIALGVAE 218
            + HPN  +     I+     ++IV+E    G LAS++  G KE+    +  +  L V  
Sbjct: 61  ELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKER--QYLDEEFVLRVMT 118
Query: 219 GLLYLHEGCQRR------IIHRDIKAANILLTEDFEPQICDFGLAKWL 260
            L    + C RR      ++HRD+K AN+ L      ++ DFGLA+ L
Sbjct: 119 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL 166

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 78/164 (47%), Gaps = 18/164 (10%)
Query: 118 IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNTAKLL-- 173
           +G G Y  V      R+G+ VAIK+L+R    EI A     EL ++ H+ H N   LL  
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 91
Query: 174 ---GYGIEGGMHIVLELSPNGSLASLLYGMK---EKLKWGIRYKIALGVAEGLLYLHEGC 227
                 +       L +    +    + G+K   EK+++     +   + +GL Y+H   
Sbjct: 92  FTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQY-----LVYQMLKGLKYIHSAG 146
Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK 271
              ++HRD+K  N+ + ED E +I DFGLA+    + T + +++
Sbjct: 147 ---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR 187

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/171 (24%), Positives = 79/171 (46%), Gaps = 19/171 (11%)
Query: 104 ELQSATNNFSFENLIGKGGYAEVYKGRLRN------GQLVAIKRLTRGTADEIIADFLSE 157
           E + A    +    +G+G +  VY+G  +          VAIK +    +     +FL+E
Sbjct: 6   EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 65
Query: 158 LGIMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLK---------WG 207
             +M   +  +  +LLG   +G    +++EL   G L S L  ++ +++           
Sbjct: 66  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 125
Query: 208 IRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
              ++A  +A+G+ YL+     + +HRD+ A N  + EDF  +I DFG+ +
Sbjct: 126 KMIQMAGEIADGMAYLN---ANKFVHRDLAARNCXVAEDFTVKIGDFGMTR 173

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 96/209 (45%), Gaps = 18/209 (8%)
Query: 74  SSMREGIDMP---RNLFVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGR 130
           +S+   +D P   +N  ++++ ++  + +  +  LQ    ++    +IG+G + EV   R
Sbjct: 36  NSLVLDLDFPALRKNKNIDNFLNRYEKIVKKIRGLQMKAEDYDVVKVIGRGAFGEVQLVR 95
Query: 131 LRNGQLV-AIKRLTRGTADEII-----ADFLSELGIMAHVDHPNTAKLL-GYGIEGGMHI 183
            +  Q V A+K L++    E+I     A F  E  IMA  + P   +L   +  +  +++
Sbjct: 96  HKASQKVYAMKLLSKF---EMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM 152
Query: 184 VLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILL 243
           V+E  P G L +L+       KW   Y      AE +L L       +IHRD+K  N+LL
Sbjct: 153 VMEYMPGGDLVNLMSNYDVPEKWAKFY-----TAEVVLALDAIHSMGLIHRDVKPDNMLL 207
Query: 244 TEDFEPQICDFGLAKWLPEQWTHHTISKV 272
            +    ++ DFG    + E    H  + V
Sbjct: 208 DKHGHLKLADFGTCMKMDETGMVHCDTAV 236

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 75/148 (50%), Gaps = 14/148 (9%)
Query: 117 LIGKGGYAEVYK------GRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTA 170
            +GKGG+A+ Y+        +  G++V    L +    E ++   +E+ I   +D+P+  
Sbjct: 33  FLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMS---TEIAIHKSLDNPHVV 89
Query: 171 KLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQR 229
              G+  +   +++VLE+    SL  L    K   +   RY +   + +G+ YLH     
Sbjct: 90  GFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTI-QGVQYLHNN--- 145
Query: 230 RIIHRDIKAANILLTEDFEPQICDFGLA 257
           R+IHRD+K  N+ L +D + +I DFGLA
Sbjct: 146 RVIHRDLKLGNLFLNDDMDVKIGDFGLA 173

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 88/186 (47%), Gaps = 18/186 (9%)
Query: 80  IDMP---RNLFVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQL 136
           +D P   +N  ++++ S+    I  + +L+    ++    +IG+G + EV   R ++ + 
Sbjct: 41  LDFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRK 100
Query: 137 V-AIKRLTRGTADEII-----ADFLSELGIMAHVDHPNTAKLL-GYGIEGGMHIVLELSP 189
           V A+K L++    E+I     A F  E  IMA  + P   +L   +  +  +++V+E  P
Sbjct: 101 VYAMKLLSKF---EMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMP 157
Query: 190 NGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEP 249
            G L +L+       KW   Y      AE +L L        IHRD+K  N+LL +    
Sbjct: 158 GGDLVNLMSNYDVPEKWARFY-----TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHL 212
Query: 250 QICDFG 255
           ++ DFG
Sbjct: 213 KLADFG 218

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 75/149 (50%), Gaps = 9/149 (6%)
Query: 118 IGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLSELGIMAH-VDHPNTAKLLGY 175
           +G+G Y  V K R + +GQ+ A+KR+      +     L +L I    VD P T    G 
Sbjct: 42  LGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQKRLLXDLDISXRTVDCPFTVTFYGA 101
Query: 176 GI-EGGMHIVLELSPNGSLASLLYGMKEK---LKWGIRYKIALGVAEGLLYLHEGCQRRI 231
              EG + I  EL  + SL      + +K   +   I  KIA+ + + L +LH   +  +
Sbjct: 102 LFREGDVWICXELX-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH--SKLSV 158
Query: 232 IHRDIKAANILLTEDFEPQICDFGLAKWL 260
           IHRD+K +N+L+    + + CDFG++ +L
Sbjct: 159 IHRDVKPSNVLINALGQVKXCDFGISGYL 187

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 75/148 (50%), Gaps = 14/148 (9%)
Query: 117 LIGKGGYAEVYK------GRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTA 170
            +GKGG+A+ Y+        +  G++V    L +    E ++   +E+ I   +D+P+  
Sbjct: 49  FLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMS---TEIAIHKSLDNPHVV 105
Query: 171 KLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQR 229
              G+  +   +++VLE+    SL  L    K   +   RY +   + +G+ YLH     
Sbjct: 106 GFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTI-QGVQYLHNN--- 161
Query: 230 RIIHRDIKAANILLTEDFEPQICDFGLA 257
           R+IHRD+K  N+ L +D + +I DFGLA
Sbjct: 162 RVIHRDLKLGNLFLNDDMDVKIGDFGLA 189

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 75/148 (50%), Gaps = 14/148 (9%)
Query: 117 LIGKGGYAEVYK------GRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTA 170
            +GKGG+A+ Y+        +  G++V    L +    E ++   +E+ I   +D+P+  
Sbjct: 49  FLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMS---TEIAIHKSLDNPHVV 105
Query: 171 KLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQR 229
              G+  +   +++VLE+    SL  L    K   +   RY +   + +G+ YLH     
Sbjct: 106 GFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTI-QGVQYLHNN--- 161
Query: 230 RIIHRDIKAANILLTEDFEPQICDFGLA 257
           R+IHRD+K  N+ L +D + +I DFGLA
Sbjct: 162 RVIHRDLKLGNLFLNDDMDVKIGDFGLA 189

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 75/148 (50%), Gaps = 14/148 (9%)
Query: 117 LIGKGGYAEVYK------GRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTA 170
            +GKGG+A+ Y+        +  G++V    L +    E ++   +E+ I   +D+P+  
Sbjct: 49  FLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMS---TEIAIHKSLDNPHVV 105
Query: 171 KLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQR 229
              G+  +   +++VLE+    SL  L    K   +   RY +   + +G+ YLH     
Sbjct: 106 GFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTI-QGVQYLHNN--- 161
Query: 230 RIIHRDIKAANILLTEDFEPQICDFGLA 257
           R+IHRD+K  N+ L +D + +I DFGLA
Sbjct: 162 RVIHRDLKLGNLFLNDDMDVKIGDFGLA 189

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/189 (29%), Positives = 87/189 (46%), Gaps = 22/189 (11%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQ-LVAIKRLTRGTADE--IIADFLSELGIMAHVDH 166
           ++F     +GKG +  VY  R +    +VA+K L +   ++  +      E+ I AH+ H
Sbjct: 23  DDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHH 82
Query: 167 PNTAKLLGYGIEGG-MHIVLELSPNGSLASLLY---GMKEKLKWGIRYKIALGVAEGLLY 222
           PN  +L  Y  +   ++++LE +P G L   L       E+    I  ++A    + L+Y
Sbjct: 83  PNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTATIMEELA----DALMY 138
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLN 282
            H    +++IHRDIK  N+LL    E +I DFG        W+ H  S    T       
Sbjct: 139 CH---GKKVIHRDIKPENLLLGLKGELKIADFG--------WSVHAPSLRRKTMCGTLDY 187
Query: 283 LPPLVILKR 291
           LPP +I  R
Sbjct: 188 LPPEMIEGR 196

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 78/163 (47%), Gaps = 15/163 (9%)
Query: 118 IGKGGYAEV---YKGRLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNTAKLL 173
           +G G Y  V   Y  RLR  Q VA+K+L+R     I A     EL ++ H+ H N   LL
Sbjct: 28  VGSGAYGSVCSAYDARLR--QKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 85
Query: 174 -----GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQ 228
                   IE    + L  +  G+  + +   +      +++ +   +  GL Y+H    
Sbjct: 86  DVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQF-LVYQLLRGLKYIHSAG- 143
Query: 229 RRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK 271
             IIHRD+K +N+ + ED E +I DFGLA+   E+ T +  ++
Sbjct: 144 --IIHRDLKPSNVAVNEDCELRILDFGLARQADEEMTGYVATR 184

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 88/186 (47%), Gaps = 18/186 (9%)
Query: 80  IDMP---RNLFVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQL 136
           +D P   +N  ++++ S+    I  + +L+    ++    +IG+G + EV   R ++ + 
Sbjct: 36  LDFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRK 95
Query: 137 V-AIKRLTRGTADEII-----ADFLSELGIMAHVDHPNTAKLL-GYGIEGGMHIVLELSP 189
           V A+K L++    E+I     A F  E  IMA  + P   +L   +  +  +++V+E  P
Sbjct: 96  VYAMKLLSKF---EMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMP 152
Query: 190 NGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEP 249
            G L +L+       KW   Y      AE +L L        IHRD+K  N+LL +    
Sbjct: 153 GGDLVNLMSNYDVPEKWARFY-----TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHL 207
Query: 250 QICDFG 255
           ++ DFG
Sbjct: 208 KLADFG 213

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 81/166 (48%), Gaps = 28/166 (16%)
Query: 118 IGKGGYAEVY--------KGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPN 168
           +G+G + +V         K + +    VA+K L     ++ ++D +SE+ +M  +  H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 169 TAKLLGYGIEGG-MHIVLELSPNGSLASLLY-----GMK----------EKLKWGIRYKI 212
              LLG   + G +++++E +  G+L   L      GM+          E++ +      
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVSC 162
Query: 213 ALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
              +A G+ YL     ++ IHRD+ A N+L+TE+   +I DFGLA+
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 81/166 (48%), Gaps = 28/166 (16%)
Query: 118 IGKGGYAEVY--------KGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPN 168
           +G+G + +V         K + +    VA+K L     ++ ++D +SE+ +M  +  H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 169 TAKLLGYGIEGG-MHIVLELSPNGSLASLLY-----GMK----------EKLKWGIRYKI 212
              LLG   + G +++++E +  G+L   L      GM+          E++ +      
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 213 ALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
              +A G+ YL     ++ IHRD+ A N+L+TE+   +I DFGLA+
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 88/186 (47%), Gaps = 18/186 (9%)
Query: 80  IDMP---RNLFVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQL 136
           +D P   +N  ++++ S+    I  + +L+    ++    +IG+G + EV   R ++ + 
Sbjct: 41  LDFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRK 100
Query: 137 V-AIKRLTRGTADEII-----ADFLSELGIMAHVDHPNTAKLL-GYGIEGGMHIVLELSP 189
           V A+K L++    E+I     A F  E  IMA  + P   +L   +  +  +++V+E  P
Sbjct: 101 VYAMKLLSKF---EMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMP 157
Query: 190 NGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEP 249
            G L +L+       KW   Y      AE +L L        IHRD+K  N+LL +    
Sbjct: 158 GGDLVNLMSNYDVPEKWARFY-----TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHL 212
Query: 250 QICDFG 255
           ++ DFG
Sbjct: 213 KLADFG 218

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 78/164 (47%), Gaps = 18/164 (10%)
Query: 118 IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNTAKLL-- 173
           +G G Y  V      R+G+ VAIK+L+R    EI A     EL ++ H+ H N   LL  
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 109
Query: 174 ---GYGIEGGMHIVLELSPNGSLASLLYGMK---EKLKWGIRYKIALGVAEGLLYLHEGC 227
                 +       L +    +    + GM+   EK+++     +   + +GL Y+H   
Sbjct: 110 FTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQY-----LVYQMLKGLKYIHSAG 164
Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK 271
              ++HRD+K  N+ + ED E +I DFGLA+    + T + +++
Sbjct: 165 ---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR 205

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/180 (24%), Positives = 86/180 (47%), Gaps = 19/180 (10%)
Query: 99  IFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRN---GQL---VAIKRLTRGTADEIIA 152
           +F   E + +    +    +G+G +  VY+G  R+   G+    VA+K +    +     
Sbjct: 3   VFVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI 62
Query: 153 DFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGI--- 208
           +FL+E  +M      +  +LLG   +G    +V+EL  +G L S L  ++ + +      
Sbjct: 63  EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRP 122
Query: 209 ------RYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE 262
                   ++A  +A+G+ YL+    ++ +HRD+ A N ++  DF  +I DFG+ + + E
Sbjct: 123 PPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXE 179

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 71/155 (45%), Gaps = 7/155 (4%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEI-IADFLSELGIMAH 163
           Q    N+     IGKG +A+V   R +  G+ VA+K + +   +   +     E+ I   
Sbjct: 10  QPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKV 69
Query: 164 VDHPNTAKLLGY-GIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLY 222
           ++HPN  KL      E  +++V E +  G +   L       +   R K    +   + Y
Sbjct: 70  LNHPNIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFR-QIVSAVQY 128
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLA 257
            H   Q+ I+HRD+KA N+LL  D   +I DFG +
Sbjct: 129 CH---QKFIVHRDLKAENLLLDADXNIKIADFGFS 160

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 81/166 (48%), Gaps = 28/166 (16%)
Query: 118 IGKGGYAEVY--------KGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPN 168
           +G+G + +V         K + +    VA+K L     ++ ++D +SE+ +M  +  H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 169 TAKLLGYGIEGG-MHIVLELSPNGSLASLLY-----GMK----------EKLKWGIRYKI 212
              LLG   + G +++++E +  G+L   L      GM+          E++ +      
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 213 ALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
              +A G+ YL     ++ IHRD+ A N+L+TE+   +I DFGLA+
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 78/163 (47%), Gaps = 15/163 (9%)
Query: 118 IGKGGYAEV---YKGRLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNTAKLL 173
           +G G Y  V   Y  RLR  Q VA+K+L+R     I A     EL ++ H+ H N   LL
Sbjct: 36  VGSGAYGSVCSAYDARLR--QKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 174 -----GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQ 228
                   IE    + L  +  G+  + +   +      +++ +   +  GL Y+H    
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQF-LVYQLLRGLKYIHSAG- 151
Query: 229 RRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK 271
             IIHRD+K +N+ + ED E +I DFGLA+   E+ T +  ++
Sbjct: 152 --IIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYVATR 192

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 78/163 (47%), Gaps = 15/163 (9%)
Query: 118 IGKGGYAEV---YKGRLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNTAKLL 173
           +G G Y  V   Y  RLR  Q VA+K+L+R     I A     EL ++ H+ H N   LL
Sbjct: 36  VGSGAYGSVCSAYDARLR--QKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 174 -----GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQ 228
                   IE    + L  +  G+  + +   +      +++ +   +  GL Y+H    
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQF-LVYQLLRGLKYIHSAG- 151
Query: 229 RRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK 271
             IIHRD+K +N+ + ED E +I DFGLA+   E+ T +  ++
Sbjct: 152 --IIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYVATR 192

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 81/166 (48%), Gaps = 28/166 (16%)
Query: 118 IGKGGYAEVY--------KGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPN 168
           +G+G + +V         K + +    VA+K L     ++ ++D +SE+ +M  +  H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 169 TAKLLGYGIEGG-MHIVLELSPNGSLASLLY-----GMK----------EKLKWGIRYKI 212
              LLG   + G +++++E +  G+L   L      GM+          E++ +      
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 213 ALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
              +A G+ YL     ++ IHRD+ A N+L+TE+   +I DFGLA+
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMRIADFGLAR 205

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 83/161 (51%), Gaps = 14/161 (8%)
Query: 106 QSATNNFSFENLIGKGGYAEVY----KGRLRNGQLVAIKRLTRGT---ADEIIADFLSEL 158
           ++  ++F    ++G+G + +V+      R  +G L A+K L + T    D +      E 
Sbjct: 24  KADPSHFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKM--ER 81
Query: 159 GIMAHVDHPNTAKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVA 217
            I+A V+HP   KL   +  EG ++++L+    G L + L       +  +++ +A  +A
Sbjct: 82  DILADVNHPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-ELA 140
Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
            GL +LH      II+RD+K  NILL E+   ++ DFGL+K
Sbjct: 141 LGLDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSK 178

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 81/166 (48%), Gaps = 28/166 (16%)
Query: 118 IGKGGYAEVY--------KGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPN 168
           +G+G + +V         K + +    VA+K L     ++ ++D +SE+ +M  +  H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 169 TAKLLGYGIEGG-MHIVLELSPNGSLASLLY-----GMK----------EKLKWGIRYKI 212
              LLG   + G +++++E +  G+L   L      GM+          E++ +      
Sbjct: 103 IITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 213 ALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
              +A G+ YL     ++ IHRD+ A N+L+TE+   +I DFGLA+
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 76/164 (46%), Gaps = 19/164 (11%)
Query: 111 NFSFENLIGKGGYAEVYKGRLR------NGQLVAIKRLTRGTADEIIADFLSELGIMAHV 164
           N +    +G G + EVY+G++       +   VA+K L    +++   DFL E  I++ +
Sbjct: 32  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKL 91
Query: 165 DHPNTAKLLGYGIEG-GMHIVLELSPNGSLASLLYGMKEK------LKWGIRYKIALGVA 217
           +H N  + +G  ++     I+LEL   G L S L   + +      L       +A  +A
Sbjct: 92  NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 151
Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLT---EDFEPQICDFGLAK 258
            G  YL E      IHRDI A N LLT        +I DFG+A+
Sbjct: 152 CGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 192

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 90/202 (44%), Gaps = 28/202 (13%)
Query: 79  GIDMPRNLFVNSYDSQSPQKIF-----SLYELQSAT-NNFSFENLIGKGGYAEVYKGRLR 132
           GI    NL+   +   +P   F     S+ +L+     N +    +G G + EVY+G++ 
Sbjct: 11  GIPTTENLY---FQGSNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVS 67
Query: 133 ------NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVL 185
                 +   VA+K L    +++   DFL E  I++ ++H N  + +G  ++     I+L
Sbjct: 68  GMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVRCIGVSLQSLPRFILL 127
Query: 186 ELSPNGSLASLLYGMKEK------LKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAA 239
           EL   G L S L   + +      L       +A  +A G  YL E      IHRDI A 
Sbjct: 128 ELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAAR 184
Query: 240 NILLT---EDFEPQICDFGLAK 258
           N LLT        +I DFG+A+
Sbjct: 185 NCLLTCPGPGRVAKIGDFGMAR 206

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 78/161 (48%), Gaps = 23/161 (14%)
Query: 118 IGKGGYAEVYKG------RLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHP-NTA 170
           +G+G + +V +       +    + VA+K L  G         +SEL I+ H+ H  N  
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 171 KLLGYGIEGG--MHIVLELSPNGSLASLLYGMK-EKLKWGIRYK----------IALGVA 217
            LLG   + G  + +++E    G+L++ L   + E + +   YK           +  VA
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQVA 154
Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           +G+ +L     R+ IHRD+ A NILL+E    +I DFGLA+
Sbjct: 155 KGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLAR 192

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 81/166 (48%), Gaps = 28/166 (16%)
Query: 118 IGKGGYAEVY--------KGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPN 168
           +G+G + +V         K + +    VA+K L     ++ ++D +SE+ +M  +  H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 169 TAKLLGYGIEGG-MHIVLELSPNGSLASLLY-----GMK----------EKLKWGIRYKI 212
              LLG   + G +++++E +  G+L   L      GM+          E++ +      
Sbjct: 103 IIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 213 ALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
              +A G+ YL     ++ IHRD+ A N+L+TE+   +I DFGLA+
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/162 (32%), Positives = 79/162 (48%), Gaps = 15/162 (9%)
Query: 111 NFSFENL-----IGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEI-IADFLSELGI-MA 162
           +F+ E+L     IG+G Y  V K   + +GQ++A+KR+ R T DE      L +L + M 
Sbjct: 18  DFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRI-RSTVDEKEQKQLLMDLDVVMR 76
Query: 163 HVDHPNTAKLLGYGI-EGGMHIVLELSPNG--SLASLLYG-MKEKLKWGIRYKIALGVAE 218
             D P   +  G    EG   I +EL           +Y  + + +   I  KI L   +
Sbjct: 77  SSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVK 136
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL 260
            L +L E    +IIHRDIK +NILL      ++CDFG++  L
Sbjct: 137 ALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQL 176

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 75/164 (45%), Gaps = 19/164 (11%)
Query: 111 NFSFENLIGKGGYAEVYKGRLR------NGQLVAIKRLTRGTADEIIADFLSELGIMAHV 164
           N +    +G G + EVY+G++       +   VA+K L    +++   DFL E  I++  
Sbjct: 48  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 107
Query: 165 DHPNTAKLLGYGIEG-GMHIVLELSPNGSLASLLYGMKEK------LKWGIRYKIALGVA 217
           +H N  + +G  ++     I+LEL   G L S L   + +      L       +A  +A
Sbjct: 108 NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 167
Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLT---EDFEPQICDFGLAK 258
            G  YL E      IHRDI A N LLT        +I DFG+A+
Sbjct: 168 CGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 208

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 75/164 (45%), Gaps = 19/164 (11%)
Query: 111 NFSFENLIGKGGYAEVYKGRLR------NGQLVAIKRLTRGTADEIIADFLSELGIMAHV 164
           N +    +G G + EVY+G++       +   VA+K L    +++   DFL E  I++  
Sbjct: 58  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 117
Query: 165 DHPNTAKLLGYGIEG-GMHIVLELSPNGSLASLLYGMKEK------LKWGIRYKIALGVA 217
           +H N  + +G  ++     I+LEL   G L S L   + +      L       +A  +A
Sbjct: 118 NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 177
Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLT---EDFEPQICDFGLAK 258
            G  YL E      IHRDI A N LLT        +I DFG+A+
Sbjct: 178 CGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 218

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/112 (30%), Positives = 61/112 (54%), Gaps = 17/112 (15%)
Query: 157 ELGIMAHVDHPNTAKLL-GYGIEGGMHIVLELSPNGSL-------ASLLYGMKEKLKWGI 208
           E+ ++A++ HPN  +    +   G ++IV++    G L         +L+   + L W +
Sbjct: 73  EVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFV 132
Query: 209 RYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL 260
           +  +AL       ++H+   R+I+HRDIK+ NI LT+D   Q+ DFG+A+ L
Sbjct: 133 QICLALK------HVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVL 175

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 75/164 (45%), Gaps = 19/164 (11%)
Query: 111 NFSFENLIGKGGYAEVYKGRLR------NGQLVAIKRLTRGTADEIIADFLSELGIMAHV 164
           N +    +G G + EVY+G++       +   VA+K L    +++   DFL E  I++  
Sbjct: 32  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 91
Query: 165 DHPNTAKLLGYGIEG-GMHIVLELSPNGSLASLLYGMKEK------LKWGIRYKIALGVA 217
           +H N  + +G  ++     I+LEL   G L S L   + +      L       +A  +A
Sbjct: 92  NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 151
Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLT---EDFEPQICDFGLAK 258
            G  YL E      IHRDI A N LLT        +I DFG+A+
Sbjct: 152 CGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 192

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 75/164 (45%), Gaps = 19/164 (11%)
Query: 111 NFSFENLIGKGGYAEVYKGRLR------NGQLVAIKRLTRGTADEIIADFLSELGIMAHV 164
           N +    +G G + EVY+G++       +   VA+K L    +++   DFL E  I++  
Sbjct: 38  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 97
Query: 165 DHPNTAKLLGYGIEG-GMHIVLELSPNGSLASLLYGMKEK------LKWGIRYKIALGVA 217
           +H N  + +G  ++     I+LEL   G L S L   + +      L       +A  +A
Sbjct: 98  NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 157
Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLT---EDFEPQICDFGLAK 258
            G  YL E      IHRDI A N LLT        +I DFG+A+
Sbjct: 158 CGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 198

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 75/164 (45%), Gaps = 19/164 (11%)
Query: 111 NFSFENLIGKGGYAEVYKGRLR------NGQLVAIKRLTRGTADEIIADFLSELGIMAHV 164
           N +    +G G + EVY+G++       +   VA+K L    +++   DFL E  I++  
Sbjct: 31  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 90
Query: 165 DHPNTAKLLGYGIEG-GMHIVLELSPNGSLASLLYGMKEK------LKWGIRYKIALGVA 217
           +H N  + +G  ++     I+LEL   G L S L   + +      L       +A  +A
Sbjct: 91  NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 150
Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLT---EDFEPQICDFGLAK 258
            G  YL E      IHRDI A N LLT        +I DFG+A+
Sbjct: 151 CGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 81/166 (48%), Gaps = 28/166 (16%)
Query: 118 IGKGGYAEVY--------KGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPN 168
           +G+G + +V         K + +    VA+K L     ++ ++D +SE+ +M  +  H N
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 169 TAKLLGYGIEGG-MHIVLELSPNGSLASLLY-----GMK----------EKLKWGIRYKI 212
              LLG   + G +++++E +  G+L   L      GM+          E++ +      
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 213 ALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
              +A G+ YL     ++ IHRD+ A N+L+TE+   +I DFGLA+
Sbjct: 209 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 251

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 75/164 (45%), Gaps = 19/164 (11%)
Query: 111 NFSFENLIGKGGYAEVYKGRLR------NGQLVAIKRLTRGTADEIIADFLSELGIMAHV 164
           N +    +G G + EVY+G++       +   VA+K L    +++   DFL E  I++  
Sbjct: 49  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 108
Query: 165 DHPNTAKLLGYGIEG-GMHIVLELSPNGSLASLLYGMKEK------LKWGIRYKIALGVA 217
           +H N  + +G  ++     I+LEL   G L S L   + +      L       +A  +A
Sbjct: 109 NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 168
Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLT---EDFEPQICDFGLAK 258
            G  YL E      IHRDI A N LLT        +I DFG+A+
Sbjct: 169 CGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 209

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 75/164 (45%), Gaps = 19/164 (11%)
Query: 111 NFSFENLIGKGGYAEVYKGRLR------NGQLVAIKRLTRGTADEIIADFLSELGIMAHV 164
           N +    +G G + EVY+G++       +   VA+K L    +++   DFL E  I++  
Sbjct: 23  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 82
Query: 165 DHPNTAKLLGYGIEG-GMHIVLELSPNGSLASLLYGMKEK------LKWGIRYKIALGVA 217
           +H N  + +G  ++     I+LEL   G L S L   + +      L       +A  +A
Sbjct: 83  NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 142
Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLT---EDFEPQICDFGLAK 258
            G  YL E      IHRDI A N LLT        +I DFG+A+
Sbjct: 143 CGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 183

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 75/164 (45%), Gaps = 19/164 (11%)
Query: 111 NFSFENLIGKGGYAEVYKGRLR------NGQLVAIKRLTRGTADEIIADFLSELGIMAHV 164
           N +    +G G + EVY+G++       +   VA+K L    +++   DFL E  I++  
Sbjct: 72  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 131
Query: 165 DHPNTAKLLGYGIEG-GMHIVLELSPNGSLASLLYGMKEK------LKWGIRYKIALGVA 217
           +H N  + +G  ++     I+LEL   G L S L   + +      L       +A  +A
Sbjct: 132 NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 191
Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLT---EDFEPQICDFGLAK 258
            G  YL E      IHRDI A N LLT        +I DFG+A+
Sbjct: 192 CGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 232

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 42/179 (23%), Positives = 85/179 (47%), Gaps = 19/179 (10%)
Query: 96  PQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRN---GQL---VAIKRLTRGTADE 149
           P  ++   E + +    +    +G+G +  VY+G  R+   G+    VA+K +    +  
Sbjct: 4   PSSVYVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLR 63
Query: 150 IIADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGI 208
              +FL+E  +M      +  +LLG   +G    +V+EL  +G L S L  ++ + +   
Sbjct: 64  ERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNP 123
Query: 209 ---------RYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
                      ++A  +A+G+ YL+    ++ +HR++ A N ++  DF  +I DFG+ +
Sbjct: 124 GRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTR 179

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 81/166 (48%), Gaps = 28/166 (16%)
Query: 118 IGKGGYAEVY--------KGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPN 168
           +G+G + +V         K + +    VA+K L     ++ ++D +SE+ +M  +  H N
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 89
Query: 169 TAKLLGYGIEGG-MHIVLELSPNGSLASLLY-----GMK----------EKLKWGIRYKI 212
              LLG   + G +++++E +  G+L   L      GM+          E++ +      
Sbjct: 90  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 149
Query: 213 ALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
              +A G+ YL     ++ IHRD+ A N+L+TE+   +I DFGLA+
Sbjct: 150 TYQLARGMEYL---ASQKCIHRDLTARNVLVTENNVMKIADFGLAR 192

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 75/164 (45%), Gaps = 19/164 (11%)
Query: 111 NFSFENLIGKGGYAEVYKGRLR------NGQLVAIKRLTRGTADEIIADFLSELGIMAHV 164
           N +    +G G + EVY+G++       +   VA+K L    +++   DFL E  I++  
Sbjct: 32  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 91
Query: 165 DHPNTAKLLGYGIEG-GMHIVLELSPNGSLASLLYGMKEK------LKWGIRYKIALGVA 217
           +H N  + +G  ++     I+LEL   G L S L   + +      L       +A  +A
Sbjct: 92  NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 151
Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLT---EDFEPQICDFGLAK 258
            G  YL E      IHRDI A N LLT        +I DFG+A+
Sbjct: 152 CGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQ 192

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 42/179 (23%), Positives = 85/179 (47%), Gaps = 19/179 (10%)
Query: 96  PQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRN---GQL---VAIKRLTRGTADE 149
           P  ++   E + +    +    +G+G +  VY+G  R+   G+    VA+K +    +  
Sbjct: 3   PSSVYVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLR 62
Query: 150 IIADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGI 208
              +FL+E  +M      +  +LLG   +G    +V+EL  +G L S L  ++ + +   
Sbjct: 63  ERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNP 122
Query: 209 ---------RYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
                      ++A  +A+G+ YL+    ++ +HR++ A N ++  DF  +I DFG+ +
Sbjct: 123 GRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTR 178

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 79/161 (49%), Gaps = 19/161 (11%)
Query: 111 NFSFENLIGKGGYAEVYKGRL-RNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           +++   +IG G +  VY+ +L  +G+LVAIK++ +G A +       EL IM  +DH N 
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKN-----RELQIMRKLDHCNI 75
Query: 170 AKLLGYGIEGG-------MHIVLELSPNGSLASLLYGMKEKLKWGIRY-KIAL-GVAEGL 220
            +L  +    G       +++VL+  P        +  + K    + Y K+ +  +   L
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEP-QICDFGLAKWL 260
            Y+H      I HRDIK  N+LL  D    ++CDFG AK L
Sbjct: 136 AYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 78/157 (49%), Gaps = 19/157 (12%)
Query: 118 IGKGGYAEVYKGRLRN---GQL---VAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAK 171
           +G+G +  VY+G  R+   G+    VA+K +    +     +FL+E  +M      +  +
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 83
Query: 172 LLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGI---------RYKIALGVAEGLL 221
           LLG   +G    +V+EL  +G L S L  ++ + +              ++A  +A+G+ 
Sbjct: 84  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 143
Query: 222 YLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           YL+    ++ +HRD+ A N ++  DF  +I DFG+ +
Sbjct: 144 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR 177

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 79/161 (49%), Gaps = 19/161 (11%)
Query: 111 NFSFENLIGKGGYAEVYKGRL-RNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           +++   +IG G +  VY+ +L  +G+LVAIK++ +G A +       EL IM  +DH N 
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKN-----RELQIMRKLDHCNI 75
Query: 170 AKLLGYGIEGG-------MHIVLELSPNGSLASLLYGMKEKLKWGIRY-KIAL-GVAEGL 220
            +L  +    G       +++VL+  P        +  + K    + Y K+ +  +   L
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEP-QICDFGLAKWL 260
            Y+H      I HRDIK  N+LL  D    ++CDFG AK L
Sbjct: 136 AYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 81/166 (48%), Gaps = 28/166 (16%)
Query: 118 IGKGGYAEVY--------KGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPN 168
           +G+G + +V         K + +    VA+K L     ++ ++D +SE+ +M  +  H N
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 91
Query: 169 TAKLLGYGIEGG-MHIVLELSPNGSLASLLY-----GMK----------EKLKWGIRYKI 212
              LLG   + G +++++E +  G+L   L      GM+          E++ +      
Sbjct: 92  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 151
Query: 213 ALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
              +A G+ YL     ++ IHRD+ A N+L+TE+   +I DFGLA+
Sbjct: 152 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 194

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 81/166 (48%), Gaps = 28/166 (16%)
Query: 118 IGKGGYAEVY--------KGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPN 168
           +G+G + +V         K + +    VA+K L     ++ ++D +SE+ +M  +  H N
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 94
Query: 169 TAKLLGYGIEGG-MHIVLELSPNGSLASLLY-----GMK----------EKLKWGIRYKI 212
              LLG   + G +++++E +  G+L   L      GM+          E++ +      
Sbjct: 95  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 154
Query: 213 ALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
              +A G+ YL     ++ IHRD+ A N+L+TE+   +I DFGLA+
Sbjct: 155 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 197

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 65/133 (48%), Gaps = 8/133 (6%)
Query: 133 NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG---MHIVLELSP 189
            G++VA+K L      +  + +  E+ I+  + H +  K  G   + G   + +V+E  P
Sbjct: 42  TGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVP 101
Query: 190 NGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEP 249
            GSL   L   +  +        A  + EG+ YLH    +  IHR++ A N+LL  D   
Sbjct: 102 LGSLRDYL--PRHSIGLAQLLLFAQQICEGMAYLH---SQHYIHRNLAARNVLLDNDRLV 156
Query: 250 QICDFGLAKWLPE 262
           +I DFGLAK +PE
Sbjct: 157 KIGDFGLAKAVPE 169

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 75/164 (45%), Gaps = 19/164 (11%)
Query: 111 NFSFENLIGKGGYAEVYKGRLR------NGQLVAIKRLTRGTADEIIADFLSELGIMAHV 164
           N +    +G G + EVY+G++       +   VA+K L    +++   DFL E  I++  
Sbjct: 31  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 90
Query: 165 DHPNTAKLLGYGIEG-GMHIVLELSPNGSLASLLYGMKEK------LKWGIRYKIALGVA 217
           +H N  + +G  ++     I++EL   G L S L   + +      L       +A  +A
Sbjct: 91  NHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 150
Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLT---EDFEPQICDFGLAK 258
            G  YL E      IHRDI A N LLT        +I DFG+A+
Sbjct: 151 CGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 65/133 (48%), Gaps = 8/133 (6%)
Query: 133 NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG---MHIVLELSP 189
            G++VA+K L      +  + +  E+ I+  + H +  K  G   + G   + +V+E  P
Sbjct: 42  TGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVP 101
Query: 190 NGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEP 249
            GSL   L   +  +        A  + EG+ YLH    +  IHR++ A N+LL  D   
Sbjct: 102 LGSLRDYL--PRHSIGLAQLLLFAQQICEGMAYLH---AQHYIHRNLAARNVLLDNDRLV 156
Query: 250 QICDFGLAKWLPE 262
           +I DFGLAK +PE
Sbjct: 157 KIGDFGLAKAVPE 169

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 89/202 (44%), Gaps = 28/202 (13%)
Query: 79  GIDMPRNLFVNSYDSQSPQKIF-----SLYELQSAT-NNFSFENLIGKGGYAEVYKGRLR 132
           GI    NL+   +   +P   F     S+ +L+     N +    +G G + EVY+G++ 
Sbjct: 11  GIPTTENLY---FQGSNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVS 67
Query: 133 ------NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVL 185
                 +   VA+K L    +++   DFL E  I++  +H N  + +G  ++     I+L
Sbjct: 68  GMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILL 127
Query: 186 ELSPNGSLASLLYGMKEK------LKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAA 239
           EL   G L S L   + +      L       +A  +A G  YL E      IHRDI A 
Sbjct: 128 ELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAAR 184
Query: 240 NILLT---EDFEPQICDFGLAK 258
           N LLT        +I DFG+A+
Sbjct: 185 NCLLTCPGPGRVAKIGDFGMAR 206

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 79/161 (49%), Gaps = 19/161 (11%)
Query: 111 NFSFENLIGKGGYAEVYKGRL-RNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           +++   +IG G +  VY+ +L  +G+LVAIK++ +G A +       EL IM  +DH N 
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKN-----RELQIMRKLDHCNI 75
Query: 170 AKLLGYGIEGG-------MHIVLELSPNGSLASLLYGMKEKLKWGIRY-KIAL-GVAEGL 220
            +L  +    G       +++VL+  P        +  + K    + Y K+ +  +   L
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEP-QICDFGLAKWL 260
            Y+H      I HRDIK  N+LL  D    ++CDFG AK L
Sbjct: 136 AYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 89/202 (44%), Gaps = 28/202 (13%)
Query: 79  GIDMPRNLFVNSYDSQSPQKIF-----SLYELQSAT-NNFSFENLIGKGGYAEVYKGRLR 132
           GI    NL+   +   +P   F     S+ +L+     N +    +G G + EVY+G++ 
Sbjct: 11  GIPTTENLY---FQGSNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVS 67
Query: 133 ------NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVL 185
                 +   VA+K L    +++   DFL E  I++  +H N  + +G  ++     I++
Sbjct: 68  GMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILM 127
Query: 186 ELSPNGSLASLLYGMKEK------LKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAA 239
           EL   G L S L   + +      L       +A  +A G  YL E      IHRDI A 
Sbjct: 128 ELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAAR 184
Query: 240 NILLT---EDFEPQICDFGLAK 258
           N LLT        +I DFG+A+
Sbjct: 185 NCLLTCPGPGRVAKIGDFGMAR 206

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 54.3 bits (129), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 91/203 (44%), Gaps = 16/203 (7%)
Query: 112 FSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTA 170
           + F +++G G ++EV      R  +LVAIK + +   +       +E+ ++  + HPN  
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 171 KLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIR--YKIALGVAEGLLYLHEGC 227
            L   Y   G ++++++L   G L   +    EK  +  R   ++   V + + YLH+  
Sbjct: 80  ALDDIYESGGHLYLIMQLVSGGELFDRIV---EKGFYTERDASRLIFQVLDAVKYLHD-- 134
Query: 228 QRRIIHRDIKAANIL---LTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNLP 284
              I+HRD+K  N+L   L ED +  I DFGL+K    +     +S   GT G V   + 
Sbjct: 135 -LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAPEVL 190
Query: 285 PLVILKRCFTCIFIGFSQLQLSC 307
                 +   C  IG     L C
Sbjct: 191 AQKPYSKAVDCWSIGVIAYILLC 213

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 54.3 bits (129), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 77/154 (50%), Gaps = 13/154 (8%)
Query: 112 FSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTA 170
           + F +++G G ++EV      R  +LVAIK + +   +       +E+ ++  + HPN  
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 171 KLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIR--YKIALGVAEGLLYLHEGC 227
            L   Y   G ++++++L   G L   +    EK  +  R   ++   V + + YLH+  
Sbjct: 80  ALDDIYESGGHLYLIMQLVSGGELFDRIV---EKGFYTERDASRLIFQVLDAVKYLHD-- 134
Query: 228 QRRIIHRDIKAANIL---LTEDFEPQICDFGLAK 258
              I+HRD+K  N+L   L ED +  I DFGL+K
Sbjct: 135 -LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK 167

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 91/203 (44%), Gaps = 16/203 (7%)
Query: 112 FSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTA 170
           + F +++G G ++EV      R  +LVAIK + +   +       +E+ ++  + HPN  
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 171 KLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIR--YKIALGVAEGLLYLHEGC 227
            L   Y   G ++++++L   G L   +    EK  +  R   ++   V + + YLH+  
Sbjct: 80  ALDDIYESGGHLYLIMQLVSGGELFDRIV---EKGFYTERDASRLIFQVLDAVKYLHD-- 134
Query: 228 QRRIIHRDIKAANIL---LTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNLP 284
              I+HRD+K  N+L   L ED +  I DFGL+K    +     +S   GT G V   + 
Sbjct: 135 -LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAPEVL 190
Query: 285 PLVILKRCFTCIFIGFSQLQLSC 307
                 +   C  IG     L C
Sbjct: 191 AQKPYSKAVDCWSIGVIAYILLC 213

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 75/157 (47%), Gaps = 20/157 (12%)
Query: 117 LIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGY 175
           ++G+G + +V K R   + +  AIK++     +E ++  LSE+ ++A ++H    +    
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIRH--TEEKLSTILSEVMLLASLNHQYVVRYYAA 70
Query: 176 GIE--------------GGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLL 221
            +E                + I +E   NG+L  L++      +    +++   + E L 
Sbjct: 71  WLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALS 130
Query: 222 YLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           Y+H    + IIHRD+K  NI + E    +I DFGLAK
Sbjct: 131 YIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAK 164

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 75/161 (46%), Gaps = 14/161 (8%)
Query: 110 NNFSFENLIGKGGYAEV-YKGRLRNGQLVAIKRLTRGTADEI--IADFLSELGIMAHVDH 166
           ++F     IGKG + +V    +    ++ A+K + +    E   + +   EL IM  ++H
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 167 PNTAKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYK---IALGVAEGLLY 222
           P    L   +  E  M +V++L   G L       +  L+  + +K   + L + E ++ 
Sbjct: 75  PFLVNLWYSFQDEEDMFMVVDLLLGGDL-------RYHLQQNVHFKEETVKLFICELVMA 127
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ 263
           L     +RIIHRD+K  NILL E     I DF +A  LP +
Sbjct: 128 LDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 91/203 (44%), Gaps = 16/203 (7%)
Query: 112 FSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTA 170
           + F +++G G ++EV      R  +LVAIK + +   +       +E+ ++  + HPN  
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 171 KLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIR--YKIALGVAEGLLYLHEGC 227
            L   Y   G ++++++L   G L   +    EK  +  R   ++   V + + YLH+  
Sbjct: 80  ALDDIYESGGHLYLIMQLVSGGELFDRIV---EKGFYTERDASRLIFQVLDAVKYLHD-- 134
Query: 228 QRRIIHRDIKAANIL---LTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNLP 284
              I+HRD+K  N+L   L ED +  I DFGL+K    +     +S   GT G V   + 
Sbjct: 135 -LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAPEVL 190
Query: 285 PLVILKRCFTCIFIGFSQLQLSC 307
                 +   C  IG     L C
Sbjct: 191 AQKPYSKAVDCWSIGVIAYILLC 213

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 76/153 (49%), Gaps = 5/153 (3%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPN 168
           ++F   + +G G    V K + R   L+  ++L        I +  + EL ++   + P 
Sbjct: 16  DDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 75
Query: 169 TAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
                G +  +G + I +E    GSL  +L   K ++   I  K+++ V  GL YL E  
Sbjct: 76  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAK-RIPEEILGKVSIAVLRGLAYLRE-- 132
Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAKWL 260
           + +I+HRD+K +NIL+    E ++CDFG++  L
Sbjct: 133 KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 165

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 79/156 (50%), Gaps = 11/156 (7%)
Query: 109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEII--ADFLSELGIMAHVD 165
           ++ +  + ++GKG + EV   + +  GQ  A+K +++    +       L E+ ++  +D
Sbjct: 31  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 90
Query: 166 HPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
           HPN  KL  +  + G  ++V E+   G L   +   K +       +I   V  G+ Y+H
Sbjct: 91  HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK-RFSEVDAARIIRQVLSGITYMH 149
Query: 225 EGCQRRIIHRDIKAANILL---TEDFEPQICDFGLA 257
              + +I+HRD+K  N+LL   ++D   +I DFGL+
Sbjct: 150 ---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLS 182

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 80/172 (46%), Gaps = 14/172 (8%)
Query: 109 TNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPN 168
           ++ F  E+ +G+G  + VY+ + +  Q     ++ + T D+ I    +E+G++  + HPN
Sbjct: 52  SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVR--TEIGVLLRLSHPN 109
Query: 169 TAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIR--YKIALGVAEGLLYLHE 225
             KL   +     + +VLEL   G L   +    EK  +  R        + E + YLHE
Sbjct: 110 IIKLKEIFETPTEISLVLELVTGGELFDRIV---EKGYYSERDAADAVKQILEAVAYLHE 166
Query: 226 GCQRRIIHRDIKAANILLTE---DFEPQICDFGLAKWLPEQWTHHTISKVEG 274
                I+HRD+K  N+L      D   +I DFGL+K +  Q    T+    G
Sbjct: 167 NG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPG 215

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 80/166 (48%), Gaps = 28/166 (16%)
Query: 118 IGKGGYAEVY--------KGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPN 168
           +G+G + +V         K + +    VA+K L     ++ ++D +SE+ +M  +  H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 169 TAKLLGYGIEGG-MHIVLELSPNGSLASLLY-----GMK----------EKLKWGIRYKI 212
              LLG   + G +++++  +  G+L   L      GM+          E++ +      
Sbjct: 103 IINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 213 ALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
              +A G+ YL     ++ IHRD+ A N+L+TE+   +I DFGLA+
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 80/157 (50%), Gaps = 13/157 (8%)
Query: 109 TNNFSFENLIGKGGYAEVY--KGRLRNGQLVAIKRLTRGTADEII--ADFLSELGIMAHV 164
           ++ +  + ++GKG + EV   K ++  GQ  A+K +++    +       L E+ ++  +
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKI-TGQECAVKVISKRQVKQKTDKESLLREVQLLKQL 83
Query: 165 DHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYL 223
           DHPN  KL  +  + G  ++V E+   G L   +   K +       +I   V  G+ Y+
Sbjct: 84  DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK-RFSEVDAARIIRQVLSGITYM 142
Query: 224 HEGCQRRIIHRDIKAANILL---TEDFEPQICDFGLA 257
           H   + +I+HRD+K  N+LL   ++D   +I DFGL+
Sbjct: 143 H---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLS 176

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 87/203 (42%), Gaps = 39/203 (19%)
Query: 89  NSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYK------GRLRNGQLVAIKRL 142
           NSY    P ++    + +   NN  F   +G G + +V +      G+      VA+K L
Sbjct: 10  NSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML 69
Query: 143 -TRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGM 200
            +   ADE  A  +SEL IM+H+  H N   LLG    GG   VL ++       LL  +
Sbjct: 70  KSTAHADEKEA-LMSELKIMSHLGQHENIVNLLGACTHGGP--VLVITEYCCYGDLLNFL 126
Query: 201 KEKLKWGIRYKIALG-------------------------VAEGLLYLHEGCQRRIIHRD 235
           + K +  +   +A G                         VA+G+ +L     +  IHRD
Sbjct: 127 RRKAEAMLGPSLAPGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFL---ASKNCIHRD 183
Query: 236 IKAANILLTEDFEPQICDFGLAK 258
           + A N+LLT     +I DFGLA+
Sbjct: 184 VAARNVLLTNGHVAKIGDFGLAR 206

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 76/153 (49%), Gaps = 5/153 (3%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPN 168
           ++F   + +G G    V+K   +   LV  ++L        I +  + EL ++   + P 
Sbjct: 68  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 127
Query: 169 TAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
                G +  +G + I +E    GSL  +L     ++   I  K+++ V +GL YL E  
Sbjct: 128 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLRE-- 184
Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAKWL 260
           + +I+HRD+K +NIL+    E ++CDFG++  L
Sbjct: 185 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 217

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 76/153 (49%), Gaps = 5/153 (3%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPN 168
           ++F   + +G G    V+K   +   LV  ++L        I +  + EL ++   + P 
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 169 TAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
                G +  +G + I +E    GSL  +L     ++   I  K+++ V +GL YL E  
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLRE-- 122
Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAKWL 260
           + +I+HRD+K +NIL+    E ++CDFG++  L
Sbjct: 123 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 155

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 80/162 (49%), Gaps = 5/162 (3%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPN 168
           ++F   + +G G    V+K   +   LV  ++L        I +  + EL ++   + P 
Sbjct: 9   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 68
Query: 169 TAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
                G +  +G + I +E    GSL  +L     ++   I  K+++ V +GL YL E  
Sbjct: 69  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLRE-- 125
Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTI 269
           + +I+HRD+K +NIL+    E ++CDFG++  L ++  +  +
Sbjct: 126 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMANEFV 167

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 78/160 (48%), Gaps = 17/160 (10%)
Query: 103 YELQSATNNFSFENLIGKGGYAEVYKGRLRN-GQLVAIK--RLTRGTADEIIADFLSELG 159
           YE +   +  + +  +G+G + EV++ + +  G   A+K  RL     +E++A       
Sbjct: 51  YEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVA------- 103
Query: 160 IMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE 218
             A +  P    L G   EG  ++I +EL   GSL  L+  M    +    Y +   + E
Sbjct: 104 -CAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQAL-E 161
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTED-FEPQICDFGLA 257
           GL YLH    RRI+H D+KA N+LL+ D     +CDFG A
Sbjct: 162 GLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHA 198

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 78/160 (48%), Gaps = 17/160 (10%)
Query: 103 YELQSATNNFSFENLIGKGGYAEVYKGRLRN-GQLVAIK--RLTRGTADEIIADFLSELG 159
           YE +   +  + +  +G+G + EV++ + +  G   A+K  RL     +E++A       
Sbjct: 67  YEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVA------- 119
Query: 160 IMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE 218
             A +  P    L G   EG  ++I +EL   GSL  L+  M    +    Y +   + E
Sbjct: 120 -CAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQAL-E 177
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTED-FEPQICDFGLA 257
           GL YLH    RRI+H D+KA N+LL+ D     +CDFG A
Sbjct: 178 GLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHA 214

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 76/153 (49%), Gaps = 5/153 (3%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPN 168
           ++F   + +G G    V+K   +   LV  ++L        I +  + EL ++   + P 
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 169 TAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
                G +  +G + I +E    GSL  +L     ++   I  K+++ V +GL YL E  
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLRE-- 122
Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAKWL 260
           + +I+HRD+K +NIL+    E ++CDFG++  L
Sbjct: 123 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 155

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 76/153 (49%), Gaps = 5/153 (3%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPN 168
           ++F   + +G G    V+K   +   LV  ++L        I +  + EL ++   + P 
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92
Query: 169 TAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
                G +  +G + I +E    GSL  +L     ++   I  K+++ V +GL YL E  
Sbjct: 93  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLRE-- 149
Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAKWL 260
           + +I+HRD+K +NIL+    E ++CDFG++  L
Sbjct: 150 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 182

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 76/153 (49%), Gaps = 5/153 (3%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPN 168
           ++F   + +G G    V+K   +   LV  ++L        I +  + EL ++   + P 
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 169 TAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
                G +  +G + I +E    GSL  +L     ++   I  K+++ V +GL YL E  
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLRE-- 122
Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAKWL 260
           + +I+HRD+K +NIL+    E ++CDFG++  L
Sbjct: 123 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 155

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 76/153 (49%), Gaps = 5/153 (3%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPN 168
           ++F   + +G G    V+K   +   LV  ++L        I +  + EL ++   + P 
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 169 TAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
                G +  +G + I +E    GSL  +L     ++   I  K+++ V +GL YL E  
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLRE-- 122
Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAKWL 260
           + +I+HRD+K +NIL+    E ++CDFG++  L
Sbjct: 123 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 155

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 76/153 (49%), Gaps = 5/153 (3%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPN 168
           ++F   + +G G    V+K   +   LV  ++L        I +  + EL ++   + P 
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 169 TAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
                G +  +G + I +E    GSL  +L     ++   I  K+++ V +GL YL E  
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLRE-- 122
Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAKWL 260
           + +I+HRD+K +NIL+    E ++CDFG++  L
Sbjct: 123 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 155

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 80/157 (50%), Gaps = 13/157 (8%)
Query: 109 TNNFSFENLIGKGGYAEVY--KGRLRNGQLVAIKRLTRGTADEII--ADFLSELGIMAHV 164
           ++ +  + ++GKG + EV   K ++  GQ  A+K +++    +       L E+ ++  +
Sbjct: 48  SDRYKGQRVLGKGSFGEVILCKDKI-TGQECAVKVISKRQVKQKTDKESLLREVQLLKQL 106
Query: 165 DHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYL 223
           DHPN  KL  +  + G  ++V E+   G L   +   K +       +I   V  G+ Y+
Sbjct: 107 DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK-RFSEVDAARIIRQVLSGITYM 165
Query: 224 HEGCQRRIIHRDIKAANILL---TEDFEPQICDFGLA 257
           H   + +I+HRD+K  N+LL   ++D   +I DFGL+
Sbjct: 166 H---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLS 199

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 80/166 (48%), Gaps = 28/166 (16%)
Query: 118 IGKGGYAEVY--------KGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPN 168
           +G+G + +V         K + +    VA+K L     ++ ++D +SE+ +M  +  H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 169 TAKLLGYGIEGG-MHIVLELSPNGSLASLLY-----GMK----------EKLKWGIRYKI 212
              LLG   + G +++++  +  G+L   L      GM+          E++ +      
Sbjct: 103 IINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 213 ALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
              +A G+ YL     ++ IHRD+ A N+L+TE+   +I DFGLA+
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 80/157 (50%), Gaps = 13/157 (8%)
Query: 109 TNNFSFENLIGKGGYAEVY--KGRLRNGQLVAIKRLTRGTADEII--ADFLSELGIMAHV 164
           ++ +  + ++GKG + EV   K ++  GQ  A+K +++    +       L E+ ++  +
Sbjct: 49  SDRYKGQRVLGKGSFGEVILCKDKI-TGQECAVKVISKRQVKQKTDKESLLREVQLLKQL 107
Query: 165 DHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYL 223
           DHPN  KL  +  + G  ++V E+   G L   +   K +       +I   V  G+ Y+
Sbjct: 108 DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK-RFSEVDAARIIRQVLSGITYM 166
Query: 224 HEGCQRRIIHRDIKAANILL---TEDFEPQICDFGLA 257
           H   + +I+HRD+K  N+LL   ++D   +I DFGL+
Sbjct: 167 H---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLS 200

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/183 (27%), Positives = 86/183 (46%), Gaps = 13/183 (7%)
Query: 92  DSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKR--LTRGTAD 148
           D +  +K+ S+  +      ++    IG+G    VY    +  GQ VAI++  L +    
Sbjct: 2   DEEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK 61
Query: 149 EIIADFLSELGIMAHVDHPNTAKLL-GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWG 207
           E+I   ++E+ +M    +PN    L  Y +   + +V+E    GSL  ++   +  +  G
Sbjct: 62  ELI---INEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEG 116
Query: 208 IRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGL-AKWLPEQWTH 266
               +     + L +LH     ++IHRDIK+ NILL  D   ++ DFG  A+  PEQ   
Sbjct: 117 QIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 173
Query: 267 HTI 269
            T+
Sbjct: 174 STM 176

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 79/157 (50%), Gaps = 13/157 (8%)
Query: 109 TNNFSFENLIGKGGYAEVY--KGRLRNGQLVAIKRLTRGTADEII--ADFLSELGIMAHV 164
           ++ +  + ++GKG + EV   K ++  GQ  A+K +++    +       L E+ ++  +
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKI-TGQECAVKVISKRQVKQKTDKESLLREVQLLKQL 83
Query: 165 DHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYL 223
           DHPN  KL  +  + G  ++V E+   G L   +   K +       +I   V  G+ Y 
Sbjct: 84  DHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK-RFSEVDAARIIRQVLSGITYX 142
Query: 224 HEGCQRRIIHRDIKAANILL---TEDFEPQICDFGLA 257
           H   + +I+HRD+K  N+LL   ++D   +I DFGL+
Sbjct: 143 H---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLS 176

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 78/160 (48%), Gaps = 17/160 (10%)
Query: 103 YELQSATNNFSFENLIGKGGYAEVYKGRLRN-GQLVAIK--RLTRGTADEIIADFLSELG 159
           YE +   +  + +  +G+G + EV++ + +  G   A+K  RL     +E++A       
Sbjct: 65  YEYREEVHWMTHQPRLGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVA------- 117
Query: 160 IMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE 218
             A +  P    L G   EG  ++I +EL   GSL  L+  M    +    Y +   + E
Sbjct: 118 -CAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQAL-E 175
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTED-FEPQICDFGLA 257
           GL YLH    RRI+H D+KA N+LL+ D     +CDFG A
Sbjct: 176 GLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHA 212

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 76/153 (49%), Gaps = 5/153 (3%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPN 168
           ++F   + +G G    V+K   +   LV  ++L        I +  + EL ++   + P 
Sbjct: 25  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 84
Query: 169 TAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
                G +  +G + I +E    GSL  +L     ++   I  K+++ V +GL YL E  
Sbjct: 85  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLRE-- 141
Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAKWL 260
           + +I+HRD+K +NIL+    E ++CDFG++  L
Sbjct: 142 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 174

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 78/180 (43%), Gaps = 12/180 (6%)
Query: 109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHP 167
             ++     +G+G Y EV     R   + VA+K +    A +   +   E+ I A ++H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHE 65
Query: 168 NTAKLLGYGIEGGM-HIVLELSPNGSLASLL---YGMKEKLKWGIRYKIALGVAEGLLYL 223
           N  K  G+  EG + ++ LE    G L   +    GM E       +++  GV    +YL
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV----VYL 121
Query: 224 HEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNL 283
           H      I HRDIK  N+LL E    +I DFGLA           ++K+ GT   V   L
Sbjct: 122 H---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 75/160 (46%), Gaps = 26/160 (16%)
Query: 116 NLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTAD-------EIIADFLSELGIMAHVDHP 167
            ++G G +  V+KG  +  G+ + I    +   D       + + D +  +G    +DH 
Sbjct: 37  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIG---SLDHA 93
Query: 168 NTAKLLGYGIEGGMHIVLELSPNGSLASLL------YGMKEKLKWGIRYKIALGVAEGLL 221
           +  +LLG      + +V +  P GSL   +       G +  L WG++      +A+G+ 
Sbjct: 94  HIVRLLGLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQ------IAKGMY 147
Query: 222 YLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP 261
           YL E     ++HR++ A N+LL    + Q+ DFG+A  LP
Sbjct: 148 YLEE---HGMVHRNLAARNVLLKSPSQVQVADFGVADLLP 184

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 78/178 (43%), Gaps = 12/178 (6%)
Query: 111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           ++     +G+G Y EV     R   + VA+K +    A +   +   E+ I   ++H N 
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENV 66
Query: 170 AKLLGYGIEGGM-HIVLELSPNGSLASLL---YGMKEKLKWGIRYKIALGVAEGLLYLHE 225
            K  G+  EG + ++ LE    G L   +    GM E       +++  GV    +YLH 
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV----VYLH- 121
Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNL 283
           G    I HRDIK  N+LL E    +I DFGLA           ++K+ GT   V   L
Sbjct: 122 GIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPEL 177

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 75/160 (46%), Gaps = 26/160 (16%)
Query: 116 NLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTAD-------EIIADFLSELGIMAHVDHP 167
            ++G G +  V+KG  +  G+ + I    +   D       + + D +  +G    +DH 
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIG---SLDHA 75
Query: 168 NTAKLLGYGIEGGMHIVLELSPNGSLASLL------YGMKEKLKWGIRYKIALGVAEGLL 221
           +  +LLG      + +V +  P GSL   +       G +  L WG++      +A+G+ 
Sbjct: 76  HIVRLLGLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQ------IAKGMY 129
Query: 222 YLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP 261
           YL E     ++HR++ A N+LL    + Q+ DFG+A  LP
Sbjct: 130 YLEE---HGMVHRNLAARNVLLKSPSQVQVADFGVADLLP 166

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 84/177 (47%), Gaps = 13/177 (7%)
Query: 92  DSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKR--LTRGTAD 148
           D +  +K+ S+  +      ++    IG+G    VY    +  GQ VAI++  L +    
Sbjct: 2   DEEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK 61
Query: 149 EIIADFLSELGIMAHVDHPNTAKLL-GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWG 207
           E+I   ++E+ +M    +PN    L  Y +   + +V+E    GSL  ++   +  +  G
Sbjct: 62  ELI---INEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEG 116
Query: 208 IRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGL-AKWLPEQ 263
               +     + L +LH     ++IHRDIK+ NILL  D   ++ DFG  A+  PEQ
Sbjct: 117 QIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 84/177 (47%), Gaps = 13/177 (7%)
Query: 92  DSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKR--LTRGTAD 148
           D +  +K+ S+  +      ++    IG+G    VY    +  GQ VAI++  L +    
Sbjct: 2   DEEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK 61
Query: 149 EIIADFLSELGIMAHVDHPNTAKLL-GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWG 207
           E+I   ++E+ +M    +PN    L  Y +   + +V+E    GSL  ++   +  +  G
Sbjct: 62  ELI---INEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEG 116
Query: 208 IRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGL-AKWLPEQ 263
               +     + L +LH     ++IHRDIK+ NILL  D   ++ DFG  A+  PEQ
Sbjct: 117 QIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 78/178 (43%), Gaps = 12/178 (6%)
Query: 111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           ++     +G+G Y EV     R   + VA+K +    A +   +   E+ I   ++H N 
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 170 AKLLGYGIEGGM-HIVLELSPNGSLASLL---YGMKEKLKWGIRYKIALGVAEGLLYLHE 225
            K  G+  EG + ++ LE    G L   +    GM E       +++  GV    +YLH 
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV----VYLH- 121
Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNL 283
           G    I HRDIK  N+LL E    +I DFGLA           ++K+ GT   V   L
Sbjct: 122 GIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPEL 177

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 78/180 (43%), Gaps = 12/180 (6%)
Query: 109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHP 167
             ++     +G+G Y EV     R   + VA+K +    A +   +   E+ I   ++H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 65
Query: 168 NTAKLLGYGIEGGM-HIVLELSPNGSLASLL---YGMKEKLKWGIRYKIALGVAEGLLYL 223
           N  K  G+  EG + ++ LE    G L   +    GM E       +++  GV    +YL
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV----VYL 121
Query: 224 HEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNL 283
           H G    I HRDIK  N+LL E    +I DFGLA           ++K+ GT   V   L
Sbjct: 122 H-GIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPEL 178

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 84/177 (47%), Gaps = 13/177 (7%)
Query: 92  DSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKR--LTRGTAD 148
           D +  +K+ S+  +      ++    IG+G    VY    +  GQ VAI++  L +    
Sbjct: 3   DEEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK 62
Query: 149 EIIADFLSELGIMAHVDHPNTAKLL-GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWG 207
           E+I   ++E+ +M    +PN    L  Y +   + +V+E    GSL  ++   +  +  G
Sbjct: 63  ELI---INEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEG 117
Query: 208 IRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGL-AKWLPEQ 263
               +     + L +LH     ++IHRDIK+ NILL  D   ++ DFG  A+  PEQ
Sbjct: 118 QIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 171

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 79/162 (48%), Gaps = 17/162 (10%)
Query: 107 SATNNFSFENLIGKGGYAEVYKGRLRN-GQLVAIKRLTRGTADEIIADFLSELGIMAHVD 165
           S+++ F     +G G YA VYKG  +  G  VA+K +   + +   +  + E+ +M  + 
Sbjct: 2   SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELK 61
Query: 166 HPNTAKLLGY-GIEGGMHIVLELSPNG--------SLASLLYGMKEKLKWGIRYKIALGV 216
           H N  +L      E  + +V E   N         ++ +   G++  L   ++Y     +
Sbjct: 62  HENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNL---VKY-FQWQL 117
Query: 217 AEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
            +GL + HE    +I+HRD+K  N+L+ +  + ++ DFGLA+
Sbjct: 118 LQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLAR 156

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 79/161 (49%), Gaps = 19/161 (11%)
Query: 111 NFSFENLIGKGGYAEVYKGRL-RNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           +++   +IG G +  VY+ +L  +G+LVAIK++ +   D+   +   EL IM  +DH N 
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ---DKRFKN--RELQIMRKLDHCNI 109
Query: 170 AKLLGYGIEGG-------MHIVLELSPNGSLASLLYGMKEKLKWGIRY-KIAL-GVAEGL 220
            +L  +    G       +++VL+  P        +  + K    + Y K+ +  +   L
Sbjct: 110 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 169
Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEP-QICDFGLAKWL 260
            Y+H      I HRDIK  N+LL  D    ++CDFG AK L
Sbjct: 170 AYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 79/161 (49%), Gaps = 19/161 (11%)
Query: 111 NFSFENLIGKGGYAEVYKGRL-RNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           +++   +IG G +  VY+ +L  +G+LVAIK++ +   D+   +   EL IM  +DH N 
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ---DKRFKN--RELQIMRKLDHCNI 109
Query: 170 AKLLGYGIEGG-------MHIVLELSPNGSLASLLYGMKEKLKWGIRY-KIAL-GVAEGL 220
            +L  +    G       +++VL+  P        +  + K    + Y K+ +  +   L
Sbjct: 110 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 169
Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEP-QICDFGLAKWL 260
            Y+H      I HRDIK  N+LL  D    ++CDFG AK L
Sbjct: 170 AYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 79/161 (49%), Gaps = 19/161 (11%)
Query: 111 NFSFENLIGKGGYAEVYKGRL-RNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           +++   +IG G +  VY+ +L  +G+LVAIK++ +   D+   +   EL IM  +DH N 
Sbjct: 49  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ---DKRFKN--RELQIMRKLDHCNI 103
Query: 170 AKLLGYGIEGG-------MHIVLELSPNGSLASLLYGMKEKLKWGIRY-KIAL-GVAEGL 220
            +L  +    G       +++VL+  P        +  + K    + Y K+ +  +   L
Sbjct: 104 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 163
Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEP-QICDFGLAKWL 260
            Y+H      I HRDIK  N+LL  D    ++CDFG AK L
Sbjct: 164 AYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 201

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 79/161 (49%), Gaps = 19/161 (11%)
Query: 111 NFSFENLIGKGGYAEVYKGRL-RNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           +++   +IG G +  VY+ +L  +G+LVAIK++ +   D+   +   EL IM  +DH N 
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ---DKRFKN--RELQIMRKLDHCNI 75
Query: 170 AKLLGYGIEGG-------MHIVLELSPNGSLASLLYGMKEKLKWGIRY-KIAL-GVAEGL 220
            +L  +    G       +++VL+  P        +  + K    + Y K+ +  +   L
Sbjct: 76  VRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEP-QICDFGLAKWL 260
            Y+H      I HRDIK  N+LL  D    ++CDFG AK L
Sbjct: 136 AYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 78/180 (43%), Gaps = 12/180 (6%)
Query: 109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHP 167
             ++     +G+G Y EV     R   + VA+K +    A +   +   E+ I   ++H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 168 NTAKLLGYGIEGGM-HIVLELSPNGSLASLL---YGMKEKLKWGIRYKIALGVAEGLLYL 223
           N  K  G+  EG + ++ LE    G L   +    GM E       +++  GV    +YL
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV----VYL 120
Query: 224 HEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNL 283
           H G    I HRDIK  N+LL E    +I DFGLA           ++K+ GT   V   L
Sbjct: 121 H-GIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPEL 177

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 79/161 (49%), Gaps = 19/161 (11%)
Query: 111 NFSFENLIGKGGYAEVYKGRL-RNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           +++   +IG G +  VY+ +L  +G+LVAIK++ +   D+   +   EL IM  +DH N 
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ---DKRFKN--RELQIMRKLDHCNI 75
Query: 170 AKLLGYGIEGG-------MHIVLELSPNGSLASLLYGMKEKLKWGIRY-KIAL-GVAEGL 220
            +L  +    G       +++VL+  P        +  + K    + Y K+ +  +   L
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEP-QICDFGLAKWL 260
            Y+H      I HRDIK  N+LL  D    ++CDFG AK L
Sbjct: 136 AYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 78/178 (43%), Gaps = 12/178 (6%)
Query: 111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           ++     +G+G Y EV     R   + VA+K +    A +   +   E+ I   ++H N 
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 170 AKLLGYGIEGGM-HIVLELSPNGSLASLL---YGMKEKLKWGIRYKIALGVAEGLLYLHE 225
            K  G+  EG + ++ LE    G L   +    GM E       +++  GV    +YLH 
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV----VYLH- 121
Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNL 283
           G    I HRDIK  N+LL E    +I DFGLA           ++K+ GT   V   L
Sbjct: 122 GIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPEL 177

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 79/161 (49%), Gaps = 19/161 (11%)
Query: 111 NFSFENLIGKGGYAEVYKGRL-RNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           +++   +IG G +  VY+ +L  +G+LVAIK++ +   D+   +   EL IM  +DH N 
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ---DKRFKN--RELQIMRKLDHCNI 87
Query: 170 AKLLGYGIEGG-------MHIVLELSPNGSLASLLYGMKEKLKWGIRY-KIAL-GVAEGL 220
            +L  +    G       +++VL+  P        +  + K    + Y K+ +  +   L
Sbjct: 88  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 147
Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEP-QICDFGLAKWL 260
            Y+H      I HRDIK  N+LL  D    ++CDFG AK L
Sbjct: 148 AYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 185

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 79/161 (49%), Gaps = 19/161 (11%)
Query: 111 NFSFENLIGKGGYAEVYKGRL-RNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           +++   +IG G +  VY+ +L  +G+LVAIK++ +   D+   +   EL IM  +DH N 
Sbjct: 34  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ---DKRFKN--RELQIMRKLDHCNI 88
Query: 170 AKLLGYGIEGG-------MHIVLELSPNGSLASLLYGMKEKLKWGIRY-KIAL-GVAEGL 220
            +L  +    G       +++VL+  P        +  + K    + Y K+ +  +   L
Sbjct: 89  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 148
Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEP-QICDFGLAKWL 260
            Y+H      I HRDIK  N+LL  D    ++CDFG AK L
Sbjct: 149 AYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 186

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 79/161 (49%), Gaps = 19/161 (11%)
Query: 111 NFSFENLIGKGGYAEVYKGRL-RNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           +++   +IG G +  VY+ +L  +G+LVAIK++ +   D+   +   EL IM  +DH N 
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ---DKRFKN--RELQIMRKLDHCNI 75
Query: 170 AKLLGYGIEGG-------MHIVLELSPNGSLASLLYGMKEKLKWGIRY-KIAL-GVAEGL 220
            +L  +    G       +++VL+  P        +  + K    + Y K+ +  +   L
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEP-QICDFGLAKWL 260
            Y+H      I HRDIK  N+LL  D    ++CDFG AK L
Sbjct: 136 AYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 79/161 (49%), Gaps = 19/161 (11%)
Query: 111 NFSFENLIGKGGYAEVYKGRL-RNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           +++   +IG G +  VY+ +L  +G+LVAIK++ +   D+   +   EL IM  +DH N 
Sbjct: 22  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ---DKRFKN--RELQIMRKLDHCNI 76
Query: 170 AKLLGYGIEGG-------MHIVLELSPNGSLASLLYGMKEKLKWGIRY-KIAL-GVAEGL 220
            +L  +    G       +++VL+  P        +  + K    + Y K+ +  +   L
Sbjct: 77  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 136
Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEP-QICDFGLAKWL 260
            Y+H      I HRDIK  N+LL  D    ++CDFG AK L
Sbjct: 137 AYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 174

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 79/161 (49%), Gaps = 19/161 (11%)
Query: 111 NFSFENLIGKGGYAEVYKGRL-RNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           +++   +IG G +  VY+ +L  +G+LVAIK++ +   D+   +   EL IM  +DH N 
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ---DKRFKN--RELQIMRKLDHCNI 75
Query: 170 AKLLGYGIEGG-------MHIVLELSPNGSLASLLYGMKEKLKWGIRY-KIAL-GVAEGL 220
            +L  +    G       +++VL+  P        +  + K    + Y K+ +  +   L
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEP-QICDFGLAKWL 260
            Y+H      I HRDIK  N+LL  D    ++CDFG AK L
Sbjct: 136 AYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 79/161 (49%), Gaps = 19/161 (11%)
Query: 111 NFSFENLIGKGGYAEVYKGRL-RNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           +++   +IG G +  VY+ +L  +G+LVAIK++ +   D+   +   EL IM  +DH N 
Sbjct: 57  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ---DKRFKN--RELQIMRKLDHCNI 111
Query: 170 AKLLGYGIEGG-------MHIVLELSPNGSLASLLYGMKEKLKWGIRY-KIAL-GVAEGL 220
            +L  +    G       +++VL+  P        +  + K    + Y K+ +  +   L
Sbjct: 112 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 171
Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEP-QICDFGLAKWL 260
            Y+H      I HRDIK  N+LL  D    ++CDFG AK L
Sbjct: 172 AYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 209

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 79/161 (49%), Gaps = 19/161 (11%)
Query: 111 NFSFENLIGKGGYAEVYKGRL-RNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           +++   +IG G +  VY+ +L  +G+LVAIK++ +   D+   +   EL IM  +DH N 
Sbjct: 29  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ---DKRFKN--RELQIMRKLDHCNI 83
Query: 170 AKLLGYGIEGG-------MHIVLELSPNGSLASLLYGMKEKLKWGIRY-KIAL-GVAEGL 220
            +L  +    G       +++VL+  P        +  + K    + Y K+ +  +   L
Sbjct: 84  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 143
Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEP-QICDFGLAKWL 260
            Y+H      I HRDIK  N+LL  D    ++CDFG AK L
Sbjct: 144 AYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 181

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 79/161 (49%), Gaps = 19/161 (11%)
Query: 111 NFSFENLIGKGGYAEVYKGRL-RNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           +++   +IG G +  VY+ +L  +G+LVAIK++ +   D+   +   EL IM  +DH N 
Sbjct: 40  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ---DKRFKN--RELQIMRKLDHCNI 94
Query: 170 AKLLGYGIEGG-------MHIVLELSPNGSLASLLYGMKEKLKWGIRY-KIAL-GVAEGL 220
            +L  +    G       +++VL+  P        +  + K    + Y K+ +  +   L
Sbjct: 95  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 154
Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEP-QICDFGLAKWL 260
            Y+H      I HRDIK  N+LL  D    ++CDFG AK L
Sbjct: 155 AYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 192

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 79/161 (49%), Gaps = 19/161 (11%)
Query: 111 NFSFENLIGKGGYAEVYKGRL-RNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           +++   +IG G +  VY+ +L  +G+LVAIK++ +   D+   +   EL IM  +DH N 
Sbjct: 59  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ---DKRFKN--RELQIMRKLDHCNI 113
Query: 170 AKLLGYGIEGG-------MHIVLELSPNGSLASLLYGMKEKLKWGIRY-KIAL-GVAEGL 220
            +L  +    G       +++VL+  P        +  + K    + Y K+ +  +   L
Sbjct: 114 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 173
Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEP-QICDFGLAKWL 260
            Y+H      I HRDIK  N+LL  D    ++CDFG AK L
Sbjct: 174 AYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 211

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 79/161 (49%), Gaps = 19/161 (11%)
Query: 111 NFSFENLIGKGGYAEVYKGRL-RNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           +++   +IG G +  VY+ +L  +G+LVAIK++ +   D+   +   EL IM  +DH N 
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ---DKRFKN--RELQIMRKLDHCNI 87
Query: 170 AKLLGYGIEGG-------MHIVLELSPNGSLASLLYGMKEKLKWGIRY-KIAL-GVAEGL 220
            +L  +    G       +++VL+  P        +  + K    + Y K+ +  +   L
Sbjct: 88  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 147
Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEP-QICDFGLAKWL 260
            Y+H      I HRDIK  N+LL  D    ++CDFG AK L
Sbjct: 148 AYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 185

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 74/157 (47%), Gaps = 20/157 (12%)
Query: 117 LIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGY 175
           ++G+G + +V K R   + +  AIK++     +E ++  LSE+ ++A ++H    +    
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIRH--TEEKLSTILSEVMLLASLNHQYVVRYYAA 70
Query: 176 GIE--------------GGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLL 221
            +E                + I +E   N +L  L++      +    +++   + E L 
Sbjct: 71  WLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLFRQILEALS 130
Query: 222 YLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           Y+H    + IIHRD+K  NI + E    +I DFGLAK
Sbjct: 131 YIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAK 164

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 81/161 (50%), Gaps = 14/161 (8%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRLRNG----QLVAIKRLTRGT---ADEIIADFLSEL 158
           ++  + F    ++G+G + +V+  +  +G    QL A+K L + T    D +      E 
Sbjct: 20  KADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKM--ER 77
Query: 159 GIMAHVDHPNTAKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVA 217
            I+  V+HP   KL   +  EG ++++L+    G L + L       +  +++ +A  +A
Sbjct: 78  DILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-ELA 136
Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
             L +LH      II+RD+K  NILL E+   ++ DFGL+K
Sbjct: 137 LALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSK 174

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 79/161 (49%), Gaps = 19/161 (11%)
Query: 111 NFSFENLIGKGGYAEVYKGRL-RNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           +++   +IG G +  VY+ +L  +G+LVAIK++ +   D+   +   EL IM  +DH N 
Sbjct: 25  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ---DKRFKN--RELQIMRKLDHCNI 79
Query: 170 AKLLGYGIEGG-------MHIVLELSPNGSLASLLYGMKEKLKWGIRY-KIAL-GVAEGL 220
            +L  +    G       +++VL+  P        +  + K    + Y K+ +  +   L
Sbjct: 80  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 139
Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEP-QICDFGLAKWL 260
            Y+H      I HRDIK  N+LL  D    ++CDFG AK L
Sbjct: 140 AYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 177

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 79/161 (49%), Gaps = 19/161 (11%)
Query: 111 NFSFENLIGKGGYAEVYKGRL-RNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           +++   +IG G +  VY+ +L  +G+LVAIK++ +   D+   +   EL IM  +DH N 
Sbjct: 26  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ---DKRFKN--RELQIMRKLDHCNI 80
Query: 170 AKLLGYGIEGG-------MHIVLELSPNGSLASLLYGMKEKLKWGIRY-KIAL-GVAEGL 220
            +L  +    G       +++VL+  P        +  + K    + Y K+ +  +   L
Sbjct: 81  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 140
Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEP-QICDFGLAKWL 260
            Y+H      I HRDIK  N+LL  D    ++CDFG AK L
Sbjct: 141 AYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 178

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 79/161 (49%), Gaps = 19/161 (11%)
Query: 111 NFSFENLIGKGGYAEVYKGRL-RNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           +++   +IG G +  VY+ +L  +G+LVAIK++ +   D+   +   EL IM  +DH N 
Sbjct: 100 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ---DKRFKN--RELQIMRKLDHCNI 154
Query: 170 AKLLGYGIEGG-------MHIVLELSPNGSLASLLYGMKEKLKWGIRY-KIAL-GVAEGL 220
            +L  +    G       +++VL+  P        +  + K    + Y K+ +  +   L
Sbjct: 155 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 214
Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEP-QICDFGLAKWL 260
            Y+H      I HRDIK  N+LL  D    ++CDFG AK L
Sbjct: 215 AYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 252

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 42/167 (25%), Positives = 78/167 (46%), Gaps = 13/167 (7%)
Query: 101 SLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLV-AIKRLTRGTADEIIADFLSELG 159
           +LY   +  + F F+  +G G + +V+    R+  L   IK + +  +   +    +E+ 
Sbjct: 13  NLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIE 72
Query: 160 IMAHVDHPNTAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEK---LKWGIRYKIALG 215
           ++  +DHPN  K+   +     M+IV+E    G L   +   + +   L  G   ++   
Sbjct: 73  VLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQ 132
Query: 216 VAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEP----QICDFGLAK 258
           +   L Y H    + ++H+D+K  NIL  +D  P    +I DFGLA+
Sbjct: 133 MMNALAYFH---SQHVVHKDLKPENILF-QDTSPHSPIKIIDFGLAE 175

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 39/144 (27%), Positives = 69/144 (47%), Gaps = 7/144 (4%)
Query: 118 IGKGGYAEVYKGRLRNG-QLVAIKRLTRGTADE-IIADFLSELGIMAHVDHPNTAKLLGY 175
           IG+G Y  V+K + R   ++VA+KR+     DE + +  L E+ ++  + H N  +L   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 176 -GIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHR 234
              +  + +V E   +  L          L   I       + +GL + H    R ++HR
Sbjct: 70  LHSDKKLTLVFEFC-DQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHR 125
Query: 235 DIKAANILLTEDFEPQICDFGLAK 258
           D+K  N+L+  + E ++ DFGLA+
Sbjct: 126 DLKPQNLLINRNGELKLADFGLAR 149

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 76/169 (44%), Gaps = 17/169 (10%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMK-------EKLKWGIRYKIALGVAEGLLY 222
             LL           LE   +  L + L G         +KL       +   +  GL Y
Sbjct: 84  IGLLDVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK 271
           +H      IIHRD+K +N+ + ED E +I DFGLA+   ++ T +  ++
Sbjct: 141 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 186

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 78/178 (43%), Gaps = 12/178 (6%)
Query: 111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           ++     +G+G Y EV     R   + VA+K +    A +   +   E+ I   ++H N 
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 170 AKLLGYGIEGGM-HIVLELSPNGSLASLL---YGMKEKLKWGIRYKIALGVAEGLLYLHE 225
            K  G+  EG + ++ LE    G L   +    GM E       +++  GV    +YLH 
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV----VYLH- 122
Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNL 283
           G    I HRDIK  N+LL E    +I DFGLA           ++K+ GT   V   L
Sbjct: 123 GIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 76/169 (44%), Gaps = 17/169 (10%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 20  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 79
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMK-------EKLKWGIRYKIALGVAEGLLY 222
             LL           LE   +  L + L G         +KL       +   +  GL Y
Sbjct: 80  IGLLDVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 136
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK 271
           +H      IIHRD+K +N+ + ED E +I DFGLA+   ++ T +  ++
Sbjct: 137 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 182

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 78/178 (43%), Gaps = 12/178 (6%)
Query: 111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           ++     +G+G Y EV     R   + VA+K +    A +   +   E+ I   ++H N 
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENV 66
Query: 170 AKLLGYGIEGGM-HIVLELSPNGSLASLL---YGMKEKLKWGIRYKIALGVAEGLLYLHE 225
            K  G+  EG + ++ LE    G L   +    GM E       +++  GV    +YLH 
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV----VYLH- 121
Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNL 283
           G    I HRDIK  N+LL E    +I DFGLA           ++K+ GT   V   L
Sbjct: 122 GIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 76/169 (44%), Gaps = 17/169 (10%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 34  YQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 93
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMK-------EKLKWGIRYKIALGVAEGLLY 222
             LL           LE   +  L + L G         +KL       +   +  GL Y
Sbjct: 94  IGLLDVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 150
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK 271
           +H      IIHRD+K +N+ + ED E +I DFGLA+   ++ T +  ++
Sbjct: 151 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 196

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 76/169 (44%), Gaps = 17/169 (10%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  IG G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 29  YQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 88
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMK-------EKLKWGIRYKIALGVAEGLLY 222
             LL           LE   +  L + L G         +KL       +   +  GL Y
Sbjct: 89  IGLLDVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 145
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK 271
           +H      IIHRD+K +N+ + ED E +I DFGLA+   ++ T +  ++
Sbjct: 146 IHSA---DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR 191

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 78/178 (43%), Gaps = 12/178 (6%)
Query: 111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           ++     +G+G Y EV     R   + VA+K +    A +   +   E+ I   ++H N 
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 170 AKLLGYGIEGGM-HIVLELSPNGSLASLL---YGMKEKLKWGIRYKIALGVAEGLLYLHE 225
            K  G+  EG + ++ LE    G L   +    GM E       +++  GV    +YLH 
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV----VYLH- 121
Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNL 283
           G    I HRDIK  N+LL E    +I DFGLA           ++K+ GT   V   L
Sbjct: 122 GIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 76/154 (49%), Gaps = 10/154 (6%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDH 166
           N+F +  L+GKG + +V   R +  G+  A+K L +    A + +A  ++E  ++ +  H
Sbjct: 8   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 67
Query: 167 PN-TAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKI-ALGVAEGLLYLH 224
           P  TA    +     +  V+E +  G L    +  +E++    R +     +   L YLH
Sbjct: 68  PFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSALEYLH 125
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
               R +++RDIK  N++L +D   +I DFGL K
Sbjct: 126 ---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK 156

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 81/161 (50%), Gaps = 14/161 (8%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRLRNG----QLVAIKRLTRGT---ADEIIADFLSEL 158
           ++  + F    ++G+G + +V+  +  +G    QL A+K L + T    D +      E 
Sbjct: 20  KADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKM--ER 77
Query: 159 GIMAHVDHPNTAKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVA 217
            I+  V+HP   KL   +  EG ++++L+    G L + L       +  +++ +A  +A
Sbjct: 78  DILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-ELA 136
Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
             L +LH      II+RD+K  NILL E+   ++ DFGL+K
Sbjct: 137 LALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSK 174

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 50.8 bits (120), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 76/154 (49%), Gaps = 10/154 (6%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDH 166
           N+F +  L+GKG + +V   R +  G+  A+K L +    A + +A  ++E  ++ +  H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 167 PN-TAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKI-ALGVAEGLLYLH 224
           P  TA    +     +  V+E +  G L    +  +E++    R +     +   L YLH
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSALEYLH 122
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
               R +++RDIK  N++L +D   +I DFGL K
Sbjct: 123 ---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK 153

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 50.8 bits (120), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 76/169 (44%), Gaps = 17/169 (10%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 30  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 89
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMK-------EKLKWGIRYKIALGVAEGLLY 222
             LL           LE   +  L + L G         +KL       +   +  GL Y
Sbjct: 90  IGLLDVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 146
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK 271
           +H      IIHRD+K +N+ + ED E +I DFGLA+   ++ T +  ++
Sbjct: 147 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 192

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 50.8 bits (120), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 78/178 (43%), Gaps = 12/178 (6%)
Query: 111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           ++     +G+G Y EV     R   + VA+K +    A +   +   E+ I   ++H N 
Sbjct: 6   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 65
Query: 170 AKLLGYGIEGGM-HIVLELSPNGSLASLL---YGMKEKLKWGIRYKIALGVAEGLLYLHE 225
            K  G+  EG + ++ LE    G L   +    GM E       +++  GV    +YLH 
Sbjct: 66  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV----VYLH- 120
Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNL 283
           G    I HRDIK  N+LL E    +I DFGLA           ++K+ GT   V   L
Sbjct: 121 GIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 176

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 50.8 bits (120), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 81/161 (50%), Gaps = 14/161 (8%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRLRNG----QLVAIKRLTRGT---ADEIIADFLSEL 158
           ++  + F    ++G+G + +V+  +  +G    QL A+K L + T    D +      E 
Sbjct: 21  KADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKM--ER 78
Query: 159 GIMAHVDHPNTAKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVA 217
            I+  V+HP   KL   +  EG ++++L+    G L + L       +  +++ +A  +A
Sbjct: 79  DILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-ELA 137
Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
             L +LH      II+RD+K  NILL E+   ++ DFGL+K
Sbjct: 138 LALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSK 175

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 50.8 bits (120), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 44/172 (25%), Positives = 75/172 (43%), Gaps = 6/172 (3%)
Query: 86  LFVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRG 145
           L   S+  ++ Q    L E            LIGKG + +VY GR      + +  + R 
Sbjct: 9   LSARSFPRKASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHGEVAIRLIDIERD 68
Query: 146 TADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLELSPNGSLASLLYGMKEKL 204
             D++ A F  E+       H N    +G  +    + I+  L    +L S++   K  L
Sbjct: 69  NEDQLKA-FKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVL 127
Query: 205 KWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGL 256
                 +IA  + +G+ YLH    + I+H+D+K+ N+   ++ +  I DFGL
Sbjct: 128 DVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFY-DNGKVVITDFGL 175

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 78/178 (43%), Gaps = 12/178 (6%)
Query: 111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           ++     +G+G Y EV     R   + VA+K +    A +   +   E+ I   ++H N 
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 170 AKLLGYGIEGGM-HIVLELSPNGSLASLL---YGMKEKLKWGIRYKIALGVAEGLLYLHE 225
            K  G+  EG + ++ LE    G L   +    GM E       +++  GV    +YLH 
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV----VYLH- 121
Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNL 283
           G    I HRDIK  N+LL E    +I DFGLA           ++K+ GT   V   L
Sbjct: 122 GIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 76/154 (49%), Gaps = 10/154 (6%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDH 166
           N+F +  L+GKG + +V   R +  G+  A+K L +    A + +A  ++E  ++ +  H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 167 PN-TAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKI-ALGVAEGLLYLH 224
           P  TA    +     +  V+E +  G L    +  +E++    R +     +   L YLH
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSALEYLH 122
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
               R +++RDIK  N++L +D   +I DFGL K
Sbjct: 123 ---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK 153

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 76/169 (44%), Gaps = 17/169 (10%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 44  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 103
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMK-------EKLKWGIRYKIALGVAEGLLY 222
             LL           LE   +  L + L G         +KL       +   +  GL Y
Sbjct: 104 IGLLDVFTPAR---SLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 160
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK 271
           +H      IIHRD+K +N+ + ED E +I DFGLA+   ++ T +  ++
Sbjct: 161 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 206

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 46/167 (27%), Positives = 79/167 (47%), Gaps = 13/167 (7%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 170 AKLL-----GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
             LL        +E    + L     G+  + +   ++     +++ I   +  GL Y+H
Sbjct: 84  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLI-YQILRGLKYIH 142
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK 271
                 IIHRD+K +N+ + ED E +I DFGLA+   ++ T +  ++
Sbjct: 143 SA---DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR 186

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 78/180 (43%), Gaps = 12/180 (6%)
Query: 109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHP 167
             ++     +G+G Y EV     R   + VA+K +    A +   +   E+ I   ++H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 168 NTAKLLGYGIEGGM-HIVLELSPNGSLASLL---YGMKEKLKWGIRYKIALGVAEGLLYL 223
           N  K  G+  EG + ++ LE    G L   +    GM E       +++  GV    +YL
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV----VYL 121
Query: 224 HEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNL 283
           H G    I HRDIK  N+LL E    +I DFGLA           ++K+ GT   V   L
Sbjct: 122 H-GIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 81/195 (41%), Gaps = 28/195 (14%)
Query: 89  NSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKG------RLRNGQLVAIKRL 142
           N+Y    P ++   ++ +   N  SF   +G G + +V +       +      VA+K L
Sbjct: 25  NNYVYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML 84
Query: 143 TRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGIEGGMHIVL-ELSPNGSLASLLYGM 200
                       +SEL +++++ +H N   LLG    GG  +V+ E    G L + L   
Sbjct: 85  KPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRK 144
Query: 201 KEKL-----------------KWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILL 243
           ++                           +  VA+G+ +L     +  IHRD+ A NILL
Sbjct: 145 RDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILL 201
Query: 244 TEDFEPQICDFGLAK 258
           T     +ICDFGLA+
Sbjct: 202 THGRITKICDFGLAR 216

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 78/180 (43%), Gaps = 12/180 (6%)
Query: 109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHP 167
             ++     +G+G Y EV     R   + VA+K +    A +   +   E+ I   ++H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 168 NTAKLLGYGIEGGM-HIVLELSPNGSLASLL---YGMKEKLKWGIRYKIALGVAEGLLYL 223
           N  K  G+  EG + ++ LE    G L   +    GM E       +++  GV    +YL
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV----VYL 120
Query: 224 HEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNL 283
           H G    I HRDIK  N+LL E    +I DFGLA           ++K+ GT   V   L
Sbjct: 121 H-GIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 76/154 (49%), Gaps = 10/154 (6%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDH 166
           N+F +  L+GKG + +V   R +  G+  A+K L +    A + +A  ++E  ++ +  H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 167 PN-TAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKI-ALGVAEGLLYLH 224
           P  TA    +     +  V+E +  G L    +  +E++    R +     +   L YLH
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSALEYLH 122
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
               R +++RDIK  N++L +D   +I DFGL K
Sbjct: 123 ---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK 153

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 76/169 (44%), Gaps = 17/169 (10%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 43  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 102
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMK-------EKLKWGIRYKIALGVAEGLLY 222
             LL           LE   +  L + L G         +KL       +   +  GL Y
Sbjct: 103 IGLLDVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 159
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK 271
           +H      IIHRD+K +N+ + ED E +I DFGLA+   ++ T +  ++
Sbjct: 160 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 205

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 78/178 (43%), Gaps = 12/178 (6%)
Query: 111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           ++     +G+G Y EV     R   + VA+K +    A +   +   E+ I   ++H N 
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 170 AKLLGYGIEGGM-HIVLELSPNGSLASLL---YGMKEKLKWGIRYKIALGVAEGLLYLHE 225
            K  G+  EG + ++ LE    G L   +    GM E       +++  GV    +YLH 
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV----VYLH- 122
Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNL 283
           G    I HRDIK  N+LL E    +I DFGLA           ++K+ GT   V   L
Sbjct: 123 GIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 78/178 (43%), Gaps = 12/178 (6%)
Query: 111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           ++     +G+G Y EV     R   + VA+K +    A +   +   E+ I   ++H N 
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 170 AKLLGYGIEGGM-HIVLELSPNGSLASLL---YGMKEKLKWGIRYKIALGVAEGLLYLHE 225
            K  G+  EG + ++ LE    G L   +    GM E       +++  GV    +YLH 
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV----VYLH- 122
Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNL 283
           G    I HRDIK  N+LL E    +I DFGLA           ++K+ GT   V   L
Sbjct: 123 GIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 78/180 (43%), Gaps = 12/180 (6%)
Query: 109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHP 167
             ++     +G+G Y EV     R   + VA+K +    A +   +   E+ I   ++H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 168 NTAKLLGYGIEGGM-HIVLELSPNGSLASLL---YGMKEKLKWGIRYKIALGVAEGLLYL 223
           N  K  G+  EG + ++ LE    G L   +    GM E       +++  GV    +YL
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV----VYL 120
Query: 224 HEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNL 283
           H G    I HRDIK  N+LL E    +I DFGLA           ++K+ GT   V   L
Sbjct: 121 H-GIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 78/178 (43%), Gaps = 12/178 (6%)
Query: 111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           ++     +G+G Y EV     R   + VA+K +    A +   +   E+ I   ++H N 
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 170 AKLLGYGIEGGM-HIVLELSPNGSLASLL---YGMKEKLKWGIRYKIALGVAEGLLYLHE 225
            K  G+  EG + ++ LE    G L   +    GM E       +++  GV    +YLH 
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV----VYLH- 122
Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNL 283
           G    I HRDIK  N+LL E    +I DFGLA           ++K+ GT   V   L
Sbjct: 123 GIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 81/195 (41%), Gaps = 28/195 (14%)
Query: 89  NSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKG------RLRNGQLVAIKRL 142
           N+Y    P ++   ++ +   N  SF   +G G + +V +       +      VA+K L
Sbjct: 20  NNYVYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML 79
Query: 143 TRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGIEGGMHIVL-ELSPNGSLASLLYGM 200
                       +SEL +++++ +H N   LLG    GG  +V+ E    G L + L   
Sbjct: 80  KPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRK 139
Query: 201 KEKL-----------------KWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILL 243
           ++                           +  VA+G+ +L     +  IHRD+ A NILL
Sbjct: 140 RDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILL 196
Query: 244 TEDFEPQICDFGLAK 258
           T     +ICDFGLA+
Sbjct: 197 THGRITKICDFGLAR 211

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 76/154 (49%), Gaps = 10/154 (6%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDH 166
           N+F +  L+GKG + +V   R +  G+  A+K L +    A + +A  ++E  ++ +  H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 167 PN-TAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKI-ALGVAEGLLYLH 224
           P  TA    +     +  V+E +  G L    +  +E++    R +     +   L YLH
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSALEYLH 122
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
               R +++RDIK  N++L +D   +I DFGL K
Sbjct: 123 ---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK 153

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 70/153 (45%), Gaps = 14/153 (9%)
Query: 112 FSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIAD---FLSELGIMAHVDHPN 168
           ++ EN IG+G + EV K  ++ G    I+R  +      + D   F  E+ IM  +DHPN
Sbjct: 28  YTLENTIGRGSWGEV-KIAVQKG--TRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPN 84
Query: 169 TAKLL-GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
             +L   +     +++V+EL   G L   +   K   +     +I   V   + Y H   
Sbjct: 85  IIRLYETFEDNTDIYLVMELCTGGELFERVV-HKRVFRESDAARIMKDVLSAVAYCH--- 140
Query: 228 QRRIIHRDIKAANILL---TEDFEPQICDFGLA 257
           +  + HRD+K  N L    + D   ++ DFGLA
Sbjct: 141 KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLA 173

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 78/180 (43%), Gaps = 12/180 (6%)
Query: 109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHP 167
             ++     +G+G Y EV     R   + VA+K +    A +   +   E+ I   ++H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 168 NTAKLLGYGIEGGM-HIVLELSPNGSLASLL---YGMKEKLKWGIRYKIALGVAEGLLYL 223
           N  K  G+  EG + ++ LE    G L   +    GM E       +++  GV    +YL
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV----VYL 120
Query: 224 HEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNL 283
           H G    I HRDIK  N+LL E    +I DFGLA           ++K+ GT   V   L
Sbjct: 121 H-GIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 78/180 (43%), Gaps = 12/180 (6%)
Query: 109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHP 167
             ++     +G+G Y EV     R   + VA+K +    A +   +   E+ I   ++H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 168 NTAKLLGYGIEGGM-HIVLELSPNGSLASLL---YGMKEKLKWGIRYKIALGVAEGLLYL 223
           N  K  G+  EG + ++ LE    G L   +    GM E       +++  GV    +YL
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV----VYL 121
Query: 224 HEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNL 283
           H G    I HRDIK  N+LL E    +I DFGLA           ++K+ GT   V   L
Sbjct: 122 H-GIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 78/180 (43%), Gaps = 12/180 (6%)
Query: 109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHP 167
             ++     +G+G Y EV     R   + VA+K +    A +   +   E+ I   ++H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 168 NTAKLLGYGIEGGM-HIVLELSPNGSLASLL---YGMKEKLKWGIRYKIALGVAEGLLYL 223
           N  K  G+  EG + ++ LE    G L   +    GM E       +++  GV    +YL
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV----VYL 120
Query: 224 HEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNL 283
           H G    I HRDIK  N+LL E    +I DFGLA           ++K+ GT   V   L
Sbjct: 121 H-GIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 81/195 (41%), Gaps = 28/195 (14%)
Query: 89  NSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKG------RLRNGQLVAIKRL 142
           N+Y    P ++   ++ +   N  SF   +G G + +V +       +      VA+K L
Sbjct: 25  NNYVYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML 84
Query: 143 TRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGIEGGMHIVL-ELSPNGSLASLLYGM 200
                       +SEL +++++ +H N   LLG    GG  +V+ E    G L + L   
Sbjct: 85  KPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRK 144
Query: 201 KEKL-----------------KWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILL 243
           ++                           +  VA+G+ +L     +  IHRD+ A NILL
Sbjct: 145 RDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILL 201
Query: 244 TEDFEPQICDFGLAK 258
           T     +ICDFGLA+
Sbjct: 202 THGRITKICDFGLAR 216

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 81/195 (41%), Gaps = 28/195 (14%)
Query: 89  NSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKG------RLRNGQLVAIKRL 142
           N+Y    P ++   ++ +   N  SF   +G G + +V +       +      VA+K L
Sbjct: 2   NNYVYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML 61
Query: 143 TRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGIEGGMHIVL-ELSPNGSLASLLYGM 200
                       +SEL +++++ +H N   LLG    GG  +V+ E    G L + L   
Sbjct: 62  KPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRK 121
Query: 201 KEKL-----------------KWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILL 243
           ++                           +  VA+G+ +L     +  IHRD+ A NILL
Sbjct: 122 RDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILL 178
Query: 244 TEDFEPQICDFGLAK 258
           T     +ICDFGLA+
Sbjct: 179 THGRITKICDFGLAR 193

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 70/153 (45%), Gaps = 14/153 (9%)
Query: 112 FSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIAD---FLSELGIMAHVDHPN 168
           ++ EN IG+G + EV K  ++ G    I+R  +      + D   F  E+ IM  +DHPN
Sbjct: 11  YTLENTIGRGSWGEV-KIAVQKG--TRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPN 67
Query: 169 TAKLL-GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
             +L   +     +++V+EL   G L   +   K   +     +I   V   + Y H   
Sbjct: 68  IIRLYETFEDNTDIYLVMELCTGGELFERVV-HKRVFRESDAARIMKDVLSAVAYCH--- 123
Query: 228 QRRIIHRDIKAANILL---TEDFEPQICDFGLA 257
           +  + HRD+K  N L    + D   ++ DFGLA
Sbjct: 124 KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLA 156

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 76/169 (44%), Gaps = 17/169 (10%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 29  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 88
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMK-------EKLKWGIRYKIALGVAEGLLY 222
             LL           LE   +  L + L G         +KL       +   +  GL Y
Sbjct: 89  IGLLDVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 145
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK 271
           +H      IIHRD+K +N+ + ED E +I DFGLA+   ++ T +  ++
Sbjct: 146 IHSA---DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR 191

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 76/154 (49%), Gaps = 10/154 (6%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDH 166
           N+F +  L+GKG + +V   R +  G+  A+K L +    A + +A  ++E  ++ +  H
Sbjct: 10  NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 69
Query: 167 PN-TAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKI-ALGVAEGLLYLH 224
           P  TA    +     +  V+E +  G L    +  +E++    R +     +   L YLH
Sbjct: 70  PFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSALEYLH 127
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
               R +++RDIK  N++L +D   +I DFGL K
Sbjct: 128 ---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK 158

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 76/154 (49%), Gaps = 10/154 (6%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDH 166
           N+F +  L+GKG + +V   R +  G+  A+K L +    A + +A  ++E  ++ +  H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 167 PN-TAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKI-ALGVAEGLLYLH 224
           P  TA    +     +  V+E +  G L    +  +E++    R +     +   L YLH
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSALEYLH 122
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
               R +++RDIK  N++L +D   +I DFGL K
Sbjct: 123 ---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK 153

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 74/163 (45%), Gaps = 15/163 (9%)
Query: 118 IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNTAKLLGY 175
           +G G Y  V     +++G  +A+K+L+R     I A     EL ++ H+ H N   LL  
Sbjct: 59  VGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 118
Query: 176 GIEGGMHIVLELSPNGSLASLLYGMK-------EKLKWGIRYKIALGVAEGLLYLHEGCQ 228
                    LE   +  L + L G         +KL       +   +  GL Y+H    
Sbjct: 119 FTPA---TSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-- 173
Query: 229 RRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK 271
             IIHRD+K +N+ + ED E +I DFGLA+   ++ T +  ++
Sbjct: 174 -DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 215

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/161 (32%), Positives = 79/161 (49%), Gaps = 19/161 (11%)
Query: 103 YELQSATNNFSFENLIGKGGYAEVYKGRLRN-GQLVAIK--RLTRGTADEIIADFLSELG 159
           YE +   +  + +  +G+G + EV++   +  G   A+K  RL    A+E++A       
Sbjct: 86  YEYREEVHWATHQLRLGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRAEELMA------- 138
Query: 160 IMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVA- 217
             A +  P    L G   EG  ++I +EL   GSL  L+   ++      R    LG A 
Sbjct: 139 -CAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLV--KEQGCLPEDRALYYLGQAL 195
Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLTED-FEPQICDFGLA 257
           EGL YLH    RRI+H D+KA N+LL+ D     +CDFG A
Sbjct: 196 EGLEYLH---SRRILHGDVKADNVLLSSDGSHAALCDFGHA 233

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 70/148 (47%), Gaps = 14/148 (9%)
Query: 117 LIGKGGYAEVYK------GRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTA 170
            +GKGG+A+ ++        +  G++V    L +    E ++    E+ I   + H +  
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMS---MEISIHRSLAHQHVV 80
Query: 171 KLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQR 229
              G+  +   + +VLEL    SL  L    K   +   RY +   +  G  YLH   + 
Sbjct: 81  GFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-QIVLGCQYLH---RN 136
Query: 230 RIIHRDIKAANILLTEDFEPQICDFGLA 257
           R+IHRD+K  N+ L ED E +I DFGLA
Sbjct: 137 RVIHRDLKLGNLFLNEDLEVKIGDFGLA 164

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 70/148 (47%), Gaps = 14/148 (9%)
Query: 117 LIGKGGYAEVYK------GRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTA 170
            +GKGG+A+ ++        +  G++V    L +    E ++    E+ I   + H +  
Sbjct: 28  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMS---MEISIHRSLAHQHVV 84
Query: 171 KLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQR 229
              G+  +   + +VLEL    SL  L    K   +   RY +   +  G  YLH   + 
Sbjct: 85  GFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-QIVLGCQYLH---RN 140
Query: 230 RIIHRDIKAANILLTEDFEPQICDFGLA 257
           R+IHRD+K  N+ L ED E +I DFGLA
Sbjct: 141 RVIHRDLKLGNLFLNEDLEVKIGDFGLA 168

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 70/148 (47%), Gaps = 14/148 (9%)
Query: 117 LIGKGGYAEVYK------GRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTA 170
            +GKGG+A+ ++        +  G++V    L +    E ++    E+ I   + H +  
Sbjct: 22  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMS---MEISIHRSLAHQHVV 78
Query: 171 KLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQR 229
              G+  +   + +VLEL    SL  L    K   +   RY +   +  G  YLH   + 
Sbjct: 79  GFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-QIVLGCQYLH---RN 134
Query: 230 RIIHRDIKAANILLTEDFEPQICDFGLA 257
           R+IHRD+K  N+ L ED E +I DFGLA
Sbjct: 135 RVIHRDLKLGNLFLNEDLEVKIGDFGLA 162

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 84/196 (42%), Gaps = 25/196 (12%)
Query: 79  GIDM-PRNLFVNSYDSQSPQKIF------SLYELQSATNNFSFENLIGKGGYAEVYKG-R 130
           G+D+   NL+  S  SQ     +      +++E+     N S    +G G Y  V     
Sbjct: 10  GVDLGTENLYFQSNASQERPTFYRQELNKTIWEVPERYQNLS---PVGSGAYGSVCAAFD 66
Query: 131 LRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNTAKLLGYGIEGGMHIVLELSP 189
            + G  VA+K+L+R     I A     EL ++ H+ H N   LL           LE   
Sbjct: 67  TKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS---LEEFN 123
Query: 190 NGSLASLLYGMK-------EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANIL 242
           +  L + L G         +KL       +   +  GL Y+H      IIHRD+K +N+ 
Sbjct: 124 DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLA 180
Query: 243 LTEDFEPQICDFGLAK 258
           + ED E +I DFGLA+
Sbjct: 181 VNEDCELKILDFGLAR 196

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/167 (27%), Positives = 79/167 (47%), Gaps = 13/167 (7%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 170 AKLL-----GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
             LL        +E    + L     G+  + +   ++     +++ I   +  GL Y+H
Sbjct: 84  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLI-YQILRGLKYIH 142
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK 271
                 IIHRD+K +N+ + ED E +I DFGLA+   ++ T +  ++
Sbjct: 143 SA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 186

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 70/148 (47%), Gaps = 14/148 (9%)
Query: 117 LIGKGGYAEVYK------GRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTA 170
            +GKGG+A+ ++        +  G++V    L +    E ++    E+ I   + H +  
Sbjct: 46  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMS---MEISIHRSLAHQHVV 102
Query: 171 KLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQR 229
              G+  +   + +VLEL    SL  L    K   +   RY +   +  G  YLH   + 
Sbjct: 103 GFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-QIVLGCQYLH---RN 158
Query: 230 RIIHRDIKAANILLTEDFEPQICDFGLA 257
           R+IHRD+K  N+ L ED E +I DFGLA
Sbjct: 159 RVIHRDLKLGNLFLNEDLEVKIGDFGLA 186

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 76/169 (44%), Gaps = 17/169 (10%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 35  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 94
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMK-------EKLKWGIRYKIALGVAEGLLY 222
             LL           LE   +  L + L G         +KL       +   +  GL Y
Sbjct: 95  IGLLDVFTPAR---SLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 151
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK 271
           +H      IIHRD+K +N+ + ED E +I DFGLA+   ++ T +  ++
Sbjct: 152 IHSA---DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR 197

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 76/169 (44%), Gaps = 17/169 (10%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 31  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 90
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMK-------EKLKWGIRYKIALGVAEGLLY 222
             LL           LE   +  L + L G         +KL       +   +  GL Y
Sbjct: 91  IGLLDVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 147
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK 271
           +H      IIHRD+K +N+ + ED E +I DFGLA+   ++ T +  ++
Sbjct: 148 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATR 193

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 76/169 (44%), Gaps = 17/169 (10%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMK-------EKLKWGIRYKIALGVAEGLLY 222
             LL           LE   +  L + L G         +KL       +   +  GL Y
Sbjct: 84  IGLLDVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK 271
           +H      IIHRD+K +N+ + ED E +I DFGLA+   ++ T +  ++
Sbjct: 141 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 186

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 84/173 (48%), Gaps = 24/173 (13%)
Query: 106 QSATNN-FSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAH 163
           QS +N+ +   +++G+G  A V++GR +  G L AIK     +    +   + E  ++  
Sbjct: 4   QSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKK 63
Query: 164 VDHPNTAKLLGYGIEGGMH---IVLELSPNGSLASLL------YGMKEKLKWGIRYKIAL 214
           ++H N  KL     E       +++E  P GSL ++L      YG+ E       + I L
Sbjct: 64  LNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPES-----EFLIVL 118
Query: 215 -GVAEGLLYLHEGCQRRIIHRDIKAANIL--LTEDFEP--QICDFGLAKWLPE 262
             V  G+ +L E     I+HR+IK  NI+  + ED +   ++ DFG A+ L +
Sbjct: 119 RDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED 168

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 70/148 (47%), Gaps = 14/148 (9%)
Query: 117 LIGKGGYAEVYK------GRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTA 170
            +GKGG+A+ ++        +  G++V    L +    E ++    E+ I   + H +  
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMS---MEISIHRSLAHQHVV 80
Query: 171 KLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQR 229
              G+  +   + +VLEL    SL  L    K   +   RY +   +  G  YLH   + 
Sbjct: 81  GFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-QIVLGCQYLH---RN 136
Query: 230 RIIHRDIKAANILLTEDFEPQICDFGLA 257
           R+IHRD+K  N+ L ED E +I DFGLA
Sbjct: 137 RVIHRDLKLGNLFLNEDLEVKIGDFGLA 164

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 76/169 (44%), Gaps = 17/169 (10%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 31  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 90
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMK-------EKLKWGIRYKIALGVAEGLLY 222
             LL           LE   +  L + L G         +KL       +   +  GL Y
Sbjct: 91  IGLLDVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 147
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK 271
           +H      IIHRD+K +N+ + ED E +I DFGLA+   ++ T +  ++
Sbjct: 148 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATR 193

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/173 (25%), Positives = 77/173 (44%), Gaps = 36/173 (20%)
Query: 108 ATNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADE-IIADFLSELGIMAHVD 165
           AT+ +     IG G Y  VYK R   +G  VA+K +     +E +    + E+ ++  ++
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 166 ---HPNTAKLLGY-----------------GIEGGMHIVLELSPNGSLASLLYGMKEKLK 205
              HPN  +L+                    ++  +   L+ +P   L +    +K+ ++
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPA--ETIKDLMR 119
Query: 206 WGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
             +R         GL +LH  C   I+HRD+K  NIL+T     ++ DFGLA+
Sbjct: 120 QFLR---------GLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLAR 160

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 76/169 (44%), Gaps = 17/169 (10%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 31  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 90
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMK-------EKLKWGIRYKIALGVAEGLLY 222
             LL           LE   +  L + L G         +KL       +   +  GL Y
Sbjct: 91  IGLLDVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 147
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK 271
           +H      IIHRD+K +N+ + ED E +I DFGLA+   ++ T +  ++
Sbjct: 148 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATR 193

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/173 (25%), Positives = 77/173 (44%), Gaps = 36/173 (20%)
Query: 108 ATNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADE-IIADFLSELGIMAHVD 165
           AT+ +     IG G Y  VYK R   +G  VA+K +     +E +    + E+ ++  ++
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 166 ---HPNTAKLLGY-----------------GIEGGMHIVLELSPNGSLASLLYGMKEKLK 205
              HPN  +L+                    ++  +   L+ +P   L +    +K+ ++
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPA--ETIKDLMR 119
Query: 206 WGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
             +R         GL +LH  C   I+HRD+K  NIL+T     ++ DFGLA+
Sbjct: 120 QFLR---------GLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLAR 160

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 58/110 (52%), Gaps = 8/110 (7%)
Query: 151 IADFLSELGIMAHVDHPNTAKL---LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWG 207
           I     E+ I+  +DHPN  KL   L    E  +++V EL   G +  +   +K   +  
Sbjct: 80  IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-TLKPLSEDQ 138
Query: 208 IRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLA 257
            R+     + +G+ YLH    ++IIHRDIK +N+L+ ED   +I DFG++
Sbjct: 139 ARFYFQ-DLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVS 184

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 76/169 (44%), Gaps = 17/169 (10%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMK-------EKLKWGIRYKIALGVAEGLLY 222
             LL           LE   +  L + L G         +KL       +   +  GL Y
Sbjct: 84  IGLLDVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK 271
           +H      IIHRD+K +N+ + ED E +I DFGLA+   ++ T +  ++
Sbjct: 141 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 186

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 76/169 (44%), Gaps = 17/169 (10%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMK-------EKLKWGIRYKIALGVAEGLLY 222
             LL           LE   +  L + L G         +KL       +   +  GL Y
Sbjct: 84  IGLLDVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK 271
           +H      IIHRD+K +N+ + ED E +I DFGLA+   ++ T +  ++
Sbjct: 141 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 186

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 76/169 (44%), Gaps = 17/169 (10%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 30  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 89
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMK-------EKLKWGIRYKIALGVAEGLLY 222
             LL           LE   +  L + L G         +KL       +   +  GL Y
Sbjct: 90  IGLLDVFTPAR---SLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 146
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK 271
           +H      IIHRD+K +N+ + ED E +I DFGLA+   ++ T +  ++
Sbjct: 147 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 192

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 70/148 (47%), Gaps = 14/148 (9%)
Query: 117 LIGKGGYAEVYK------GRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTA 170
            +GKGG+A+ ++        +  G++V    L +    E ++    E+ I   + H +  
Sbjct: 48  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMS---MEISIHRSLAHQHVV 104
Query: 171 KLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQR 229
              G+  +   + +VLEL    SL  L    K   +   RY +   +  G  YLH   + 
Sbjct: 105 GFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-QIVLGCQYLH---RN 160
Query: 230 RIIHRDIKAANILLTEDFEPQICDFGLA 257
           R+IHRD+K  N+ L ED E +I DFGLA
Sbjct: 161 RVIHRDLKLGNLFLNEDLEVKIGDFGLA 188

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/161 (32%), Positives = 79/161 (49%), Gaps = 19/161 (11%)
Query: 103 YELQSATNNFSFENLIGKGGYAEVYKGRLRN-GQLVAIK--RLTRGTADEIIADFLSELG 159
           YE +   +  + +  +G+G + EV++   +  G   A+K  RL    A+E++A       
Sbjct: 67  YEYREEVHWATHQLRLGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRAEELMA------- 119
Query: 160 IMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVA- 217
             A +  P    L G   EG  ++I +EL   GSL  L+   ++      R    LG A 
Sbjct: 120 -CAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLV--KEQGCLPEDRALYYLGQAL 176
Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLTED-FEPQICDFGLA 257
           EGL YLH    RRI+H D+KA N+LL+ D     +CDFG A
Sbjct: 177 EGLEYLH---SRRILHGDVKADNVLLSSDGSHAALCDFGHA 214

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/173 (25%), Positives = 77/173 (44%), Gaps = 36/173 (20%)
Query: 108 ATNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADE-IIADFLSELGIMAHVD 165
           AT+ +     IG G Y  VYK R   +G  VA+K +     +E +    + E+ ++  ++
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 166 ---HPNTAKLLGY-----------------GIEGGMHIVLELSPNGSLASLLYGMKEKLK 205
              HPN  +L+                    ++  +   L+ +P   L +    +K+ ++
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPA--ETIKDLMR 119
Query: 206 WGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
             +R         GL +LH  C   I+HRD+K  NIL+T     ++ DFGLA+
Sbjct: 120 QFLR---------GLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLAR 160

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 76/169 (44%), Gaps = 17/169 (10%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMK-------EKLKWGIRYKIALGVAEGLLY 222
             LL           LE   +  L + L G         +KL       +   +  GL Y
Sbjct: 84  IGLLDVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK 271
           +H      IIHRD+K +N+ + ED E +I DFGLA+   ++ T +  ++
Sbjct: 141 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 186

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 76/169 (44%), Gaps = 17/169 (10%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMK-------EKLKWGIRYKIALGVAEGLLY 222
             LL           LE   +  L + L G         +KL       +   +  GL Y
Sbjct: 84  IGLLDVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK 271
           +H      IIHRD+K +N+ + ED E +I DFGLA+   ++ T +  ++
Sbjct: 141 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 186

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 70/156 (44%), Gaps = 17/156 (10%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMK-------EKLKWGIRYKIALGVAEGLLY 222
             LL           LE   +  L + L G         +KL       +   +  GL Y
Sbjct: 84  IGLLDVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           +H      IIHRD+K +N+ + ED E +I DFGLA+
Sbjct: 141 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 76/169 (44%), Gaps = 17/169 (10%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 36  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 95
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMK-------EKLKWGIRYKIALGVAEGLLY 222
             LL           LE   +  L + L G         +KL       +   +  GL Y
Sbjct: 96  IGLLDVFTPAR---SLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 152
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK 271
           +H      IIHRD+K +N+ + ED E +I DFGLA+   ++ T +  ++
Sbjct: 153 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 198

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 76/169 (44%), Gaps = 17/169 (10%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 36  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 95
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMK-------EKLKWGIRYKIALGVAEGLLY 222
             LL           LE   +  L + L G         +KL       +   +  GL Y
Sbjct: 96  IGLLDVFTPAR---SLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 152
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK 271
           +H      IIHRD+K +N+ + ED E +I DFGLA+   ++ T +  ++
Sbjct: 153 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 198

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 76/169 (44%), Gaps = 17/169 (10%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 29  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 88
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMK-------EKLKWGIRYKIALGVAEGLLY 222
             LL           LE   +  L + L G         +KL       +   +  GL Y
Sbjct: 89  IGLLDVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 145
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK 271
           +H      IIHRD+K +N+ + ED E +I DFGLA+   ++ T +  ++
Sbjct: 146 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 191

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 76/169 (44%), Gaps = 17/169 (10%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 30  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 89
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMK-------EKLKWGIRYKIALGVAEGLLY 222
             LL           LE   +  L + L G         +KL       +   +  GL Y
Sbjct: 90  IGLLDVFTPAR---SLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 146
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK 271
           +H      IIHRD+K +N+ + ED E +I DFGLA+   ++ T +  ++
Sbjct: 147 IHSA---DIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYVATR 192

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 76/169 (44%), Gaps = 17/169 (10%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 26  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 85
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMK-------EKLKWGIRYKIALGVAEGLLY 222
             LL           LE   +  L + L G         +KL       +   +  GL Y
Sbjct: 86  IGLLDVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 142
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK 271
           +H      IIHRD+K +N+ + ED E +I DFGLA+   ++ T +  ++
Sbjct: 143 IHSA---DIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYVATR 188

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 76/169 (44%), Gaps = 17/169 (10%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 23  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 82
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMK-------EKLKWGIRYKIALGVAEGLLY 222
             LL           LE   +  L + L G         +KL       +   +  GL Y
Sbjct: 83  IGLLDVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 139
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK 271
           +H      IIHRD+K +N+ + ED E +I DFGLA+   ++ T +  ++
Sbjct: 140 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 185

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 76/169 (44%), Gaps = 17/169 (10%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 31  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 90
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMK-------EKLKWGIRYKIALGVAEGLLY 222
             LL           LE   +  L + L G         +KL       +   +  GL Y
Sbjct: 91  IGLLDVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 147
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK 271
           +H      IIHRD+K +N+ + ED E +I DFGLA+   ++ T +  ++
Sbjct: 148 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 193

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 76/169 (44%), Gaps = 17/169 (10%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 35  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 94
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMK-------EKLKWGIRYKIALGVAEGLLY 222
             LL           LE   +  L + L G         +KL       +   +  GL Y
Sbjct: 95  IGLLDVFTPAR---SLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 151
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK 271
           +H      IIHRD+K +N+ + ED E +I DFGLA+   ++ T +  ++
Sbjct: 152 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 197

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 76/169 (44%), Gaps = 17/169 (10%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMK-------EKLKWGIRYKIALGVAEGLLY 222
             LL           LE   +  L + L G         +KL       +   +  GL Y
Sbjct: 84  IGLLDVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK 271
           +H      IIHRD+K +N+ + ED E +I DFGLA+   ++ T +  ++
Sbjct: 141 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 186

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 76/169 (44%), Gaps = 17/169 (10%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 29  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 88
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMK-------EKLKWGIRYKIALGVAEGLLY 222
             LL           LE   +  L + L G         +KL       +   +  GL Y
Sbjct: 89  IGLLDVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 145
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK 271
           +H      IIHRD+K +N+ + ED E +I DFGLA+   ++ T +  ++
Sbjct: 146 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 191

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 76/169 (44%), Gaps = 17/169 (10%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 26  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 85
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMK-------EKLKWGIRYKIALGVAEGLLY 222
             LL           LE   +  L + L G         +KL       +   +  GL Y
Sbjct: 86  IGLLDVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 142
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK 271
           +H      IIHRD+K +N+ + ED E +I DFGLA+   ++ T +  ++
Sbjct: 143 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 188

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 76/169 (44%), Gaps = 17/169 (10%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMK-------EKLKWGIRYKIALGVAEGLLY 222
             LL           LE   +  L + L G         +KL       +   +  GL Y
Sbjct: 84  IGLLDVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK 271
           +H      IIHRD+K +N+ + ED E +I DFGLA+   ++ T +  ++
Sbjct: 141 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 186

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/167 (27%), Positives = 78/167 (46%), Gaps = 13/167 (7%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 20  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 79
Query: 170 AKLL-----GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
             LL        +E    + L     G+  + +    +     +++ I   +  GL Y+H
Sbjct: 80  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQFLI-YQILRGLKYIH 138
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK 271
                 IIHRD+K +N+ + ED E +I DFGLA+   ++ T +  ++
Sbjct: 139 SA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 182

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 70/156 (44%), Gaps = 17/156 (10%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMK-------EKLKWGIRYKIALGVAEGLLY 222
             LL           LE   +  L + L G         +KL       +   +  GL Y
Sbjct: 84  IGLLDVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           +H      IIHRD+K +N+ + ED E +I DFGLA+
Sbjct: 141 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 76/169 (44%), Gaps = 17/169 (10%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 21  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 80
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMK-------EKLKWGIRYKIALGVAEGLLY 222
             LL           LE   +  L + L G         +KL       +   +  GL Y
Sbjct: 81  IGLLDVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 137
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK 271
           +H      IIHRD+K +N+ + ED E +I DFGLA+   ++ T +  ++
Sbjct: 138 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 183

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 76/169 (44%), Gaps = 17/169 (10%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 22  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 81
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMK-------EKLKWGIRYKIALGVAEGLLY 222
             LL           LE   +  L + L G         +KL       +   +  GL Y
Sbjct: 82  IGLLDVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 138
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK 271
           +H      IIHRD+K +N+ + ED E +I DFGLA+   ++ T +  ++
Sbjct: 139 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 184

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 76/169 (44%), Gaps = 17/169 (10%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 26  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 85
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMK-------EKLKWGIRYKIALGVAEGLLY 222
             LL           LE   +  L + L G         +KL       +   +  GL Y
Sbjct: 86  IGLLDVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 142
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK 271
           +H      IIHRD+K +N+ + ED E +I DFGLA+   ++ T +  ++
Sbjct: 143 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 188

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 76/169 (44%), Gaps = 17/169 (10%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 20  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 79
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMK-------EKLKWGIRYKIALGVAEGLLY 222
             LL           LE   +  L + L G         +KL       +   +  GL Y
Sbjct: 80  IGLLDVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 136
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK 271
           +H      IIHRD+K +N+ + ED E +I DFGLA+   ++ T +  ++
Sbjct: 137 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 182

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 76/169 (44%), Gaps = 17/169 (10%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 21  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 80
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMK-------EKLKWGIRYKIALGVAEGLLY 222
             LL           LE   +  L + L G         +KL       +   +  GL Y
Sbjct: 81  IGLLDVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 137
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK 271
           +H      IIHRD+K +N+ + ED E +I DFGLA+   ++ T +  ++
Sbjct: 138 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 183

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 76/169 (44%), Gaps = 17/169 (10%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 26  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 85
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMK-------EKLKWGIRYKIALGVAEGLLY 222
             LL           LE   +  L + L G         +KL       +   +  GL Y
Sbjct: 86  IGLLDVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 142
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK 271
           +H      IIHRD+K +N+ + ED E +I DFGLA+   ++ T +  ++
Sbjct: 143 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 188

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 76/169 (44%), Gaps = 17/169 (10%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 30  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 89
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMK-------EKLKWGIRYKIALGVAEGLLY 222
             LL           LE   +  L + L G         +KL       +   +  GL Y
Sbjct: 90  IGLLDVFTPAR---SLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 146
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK 271
           +H      IIHRD+K +N+ + ED E +I DFGLA+   ++ T +  ++
Sbjct: 147 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 192

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 76/169 (44%), Gaps = 17/169 (10%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 44  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 103
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMK-------EKLKWGIRYKIALGVAEGLLY 222
             LL           LE   +  L + L G         +KL       +   +  GL Y
Sbjct: 104 IGLLDVFTPAR---SLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 160
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK 271
           +H      IIHRD+K +N+ + ED E +I DFGLA+   ++ T +  ++
Sbjct: 161 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 206

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 76/169 (44%), Gaps = 17/169 (10%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMK-------EKLKWGIRYKIALGVAEGLLY 222
             LL           LE   +  L + L G         +KL       +   +  GL Y
Sbjct: 84  IGLLDVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK 271
           +H      IIHRD+K +N+ + ED E +I DFGLA+   ++ T +  ++
Sbjct: 141 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 186

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 70/156 (44%), Gaps = 17/156 (10%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 20  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 79
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMK-------EKLKWGIRYKIALGVAEGLLY 222
             LL           LE   +  L + L G         +KL       +   +  GL Y
Sbjct: 80  IGLLDVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 136
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           +H      IIHRD+K +N+ + ED E +I DFGLA+
Sbjct: 137 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR 169

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 76/169 (44%), Gaps = 17/169 (10%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 43  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 102
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMK-------EKLKWGIRYKIALGVAEGLLY 222
             LL           LE   +  L + L G         +KL       +   +  GL Y
Sbjct: 103 IGLLDVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 159
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK 271
           +H      IIHRD+K +N+ + ED E +I DFGLA+   ++ T +  ++
Sbjct: 160 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 205

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 84/173 (48%), Gaps = 24/173 (13%)
Query: 106 QSATNN-FSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLSELGIMAH 163
           QS +N+ +   +++G+G  A V++GR  + G L AIK     +    +   + E  ++  
Sbjct: 4   QSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKK 63
Query: 164 VDHPNTAKLLGYGIEGGMH---IVLELSPNGSLASLL------YGMKEKLKWGIRYKIAL 214
           ++H N  KL     E       +++E  P GSL ++L      YG+ E       + I L
Sbjct: 64  LNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPES-----EFLIVL 118
Query: 215 -GVAEGLLYLHEGCQRRIIHRDIKAANIL--LTEDFEP--QICDFGLAKWLPE 262
             V  G+ +L E     I+HR+IK  NI+  + ED +   ++ DFG A+ L +
Sbjct: 119 RDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED 168

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 76/157 (48%), Gaps = 13/157 (8%)
Query: 118 IGKGGYAEVYKGR-LRNGQLVAIKR--LTRGTADEIIADFLSELGIMAHVDHPNTAKLL- 173
           IG+G    VY    +  GQ VAI++  L +    E+I   ++E+ +M    +PN    L 
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI---INEILVMRENKNPNIVNYLD 85
Query: 174 GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIH 233
            Y +   + +V+E    GSL  ++   +  +  G    +     + L +LH     ++IH
Sbjct: 86  SYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLHSN---QVIH 140
Query: 234 RDIKAANILLTEDFEPQICDFGL-AKWLPEQWTHHTI 269
           R+IK+ NILL  D   ++ DFG  A+  PEQ    T+
Sbjct: 141 RNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM 177

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 76/169 (44%), Gaps = 17/169 (10%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 47  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 106
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMK-------EKLKWGIRYKIALGVAEGLLY 222
             LL           LE   +  L + L G         +KL       +   +  GL Y
Sbjct: 107 IGLLDVFTPAR---SLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 163
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK 271
           +H      IIHRD+K +N+ + ED E +I DFGLA+   ++ T +  ++
Sbjct: 164 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 209

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/149 (32%), Positives = 68/149 (45%), Gaps = 13/149 (8%)
Query: 118 IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNTAKLLGY 175
           +G G Y  V      R G  VAIK+L R    E+ A     EL ++ H+ H N   LL  
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 92
Query: 176 -----GIEGGMHIVLELSPNGS-LASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQR 229
                 ++      L +   G+ L  L+    EKL       +   + +GL Y+H     
Sbjct: 93  FTPDETLDDFTDFYLVMPFMGTDLGKLM--KHEKLGEDRIQFLVYQMLKGLRYIHAAG-- 148
Query: 230 RIIHRDIKAANILLTEDFEPQICDFGLAK 258
            IIHRD+K  N+ + ED E +I DFGLA+
Sbjct: 149 -IIHRDLKPGNLAVNEDCELKILDFGLAR 176

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 88/200 (44%), Gaps = 30/200 (15%)
Query: 93  SQSPQKIFSLYEL---------QSATNNFSFENLIGKGGYAEVYKGRLRNG------QLV 137
           S S  K+F  ++L         ++  + +     +G G   EV     R        +++
Sbjct: 123 SLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRII 182
Query: 138 AIKRLTRGTADEI--IADFLSELGIMAHVDHPNTAKLLGYGIEGGMHIVLELSPNGSLAS 195
           + ++   G+A E     +  +E+ I+  ++HP   K+  +      +IVLEL   G L  
Sbjct: 183 SKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFD 242
Query: 196 LLYG---MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLT---EDFEP 249
            + G   +KE       Y++ L V     YLHE     IIHRD+K  N+LL+   ED   
Sbjct: 243 KVVGNKRLKEATCKLYFYQMLLAVQ----YLHEN---GIIHRDLKPENVLLSSQEEDCLI 295
Query: 250 QICDFGLAKWLPEQWTHHTI 269
           +I DFG +K L E     T+
Sbjct: 296 KITDFGHSKILGETSLMRTL 315

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 78/164 (47%), Gaps = 12/164 (7%)
Query: 103 YELQSATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEI--IADFLSELG 159
           Y LQ    +F     +G G +  V+  R R NG+  A+K L +     +  +     E  
Sbjct: 3   YSLQ----DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERL 58
Query: 160 IMAHVDHPNTAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE 218
           +++ V HP   ++ G +     + ++++    G L SLL    ++    +    A  V  
Sbjct: 59  MLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLL-RKSQRFPNPVAKFYAAEVCL 117
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE 262
            L YLH    + II+RD+K  NILL ++   +I DFG AK++P+
Sbjct: 118 ALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 70/156 (44%), Gaps = 17/156 (10%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 44  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 103
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMK-------EKLKWGIRYKIALGVAEGLLY 222
             LL           LE   +  L + L G         +KL       +   +  GL Y
Sbjct: 104 IGLLDVFTPAR---SLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 160
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           +H      IIHRD+K +N+ + ED E +I DFGLA+
Sbjct: 161 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR 193

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 93/208 (44%), Gaps = 34/208 (16%)
Query: 58  KSLVTLYPLKLSIRRSSSMREGIDMPRNLFVNSYDSQSPQKIFSLYELQSATNNFSFENL 117
           +S+  L P ++S R  +S  E +  P       YD   P+  F          +F   + 
Sbjct: 21  QSMHQLQPRRVSFRGEAS--ETLQSP------GYDPSRPESFFQ--------QSFQRLSR 64
Query: 118 IGKGGYAEVYKGRLR-NGQLVAIKRLT---RGTADEIIADFLSELGIMAHV-DHPNTAKL 172
           +G G Y EV+K R + +G+L A+KR     RG  D   A  L+E+G    V  HP   +L
Sbjct: 65  LGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDR--ARKLAEVGSHEKVGQHPCCVRL 122
Query: 173 LGYGIEGG-MHIVLEL-SPNGSLASLLYG--MKEKLKWGIRYKIALGVAEGLLYLHEGCQ 228
                EGG +++  EL  P+       +G  + E   WG      L +A    +LH    
Sbjct: 123 EQAWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALA----HLHS--- 175
Query: 229 RRIIHRDIKAANILLTEDFEPQICDFGL 256
           + ++H D+K ANI L      ++ DFGL
Sbjct: 176 QGLVHLDVKPANIFLGPRGRCKLGDFGL 203

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 73/163 (44%), Gaps = 17/163 (10%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMK-------EKLKWGIRYKIALGVAEGLLY 222
             LL           LE   +  L + L G         +KL       +   +  GL Y
Sbjct: 84  IGLLDVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT 265
           +H      IIHRD+K +N+ + ED E +I DFGLA+   ++ T
Sbjct: 141 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT 180

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 88/200 (44%), Gaps = 30/200 (15%)
Query: 93  SQSPQKIFSLYEL---------QSATNNFSFENLIGKGGYAEVYKGRLRNG------QLV 137
           S S  K+F  ++L         ++  + +     +G G   EV     R        +++
Sbjct: 109 SLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRII 168
Query: 138 AIKRLTRGTADEI--IADFLSELGIMAHVDHPNTAKLLGYGIEGGMHIVLELSPNGSLAS 195
           + ++   G+A E     +  +E+ I+  ++HP   K+  +      +IVLEL   G L  
Sbjct: 169 SKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFD 228
Query: 196 LLYG---MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLT---EDFEP 249
            + G   +KE       Y++ L V     YLHE     IIHRD+K  N+LL+   ED   
Sbjct: 229 KVVGNKRLKEATCKLYFYQMLLAVQ----YLHEN---GIIHRDLKPENVLLSSQEEDCLI 281
Query: 250 QICDFGLAKWLPEQWTHHTI 269
           +I DFG +K L E     T+
Sbjct: 282 KITDFGHSKILGETSLMRTL 301

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 74/161 (45%), Gaps = 13/161 (8%)
Query: 105 LQSATNNFSFENLIGKGGYAEVY--KGRLRNGQLVAIKRLTRG--TADEIIADFLSELGI 160
            Q  ++ +     +G G Y EV   K +L  G   AIK + +   T        L E+ +
Sbjct: 16  FQGLSDRYQRVKKLGSGAYGEVLLCKDKL-TGAERAIKIIKKSSVTTTSNSGALLDEVAV 74
Query: 161 MAHVDHPNTAKLLGYGIEG-GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEG 219
           +  +DHPN  KL  +  +    ++V+E+   G L   +  +++K        I   V  G
Sbjct: 75  LKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEII-LRQKFSEVDAAVIMKQVLSG 133
Query: 220 LLYLHEGCQRRIIHRDIKAANILL---TEDFEPQICDFGLA 257
             YLH   +  I+HRD+K  N+LL   + D   +I DFGL+
Sbjct: 134 TTYLH---KHNIVHRDLKPENLLLESKSRDALIKIVDFGLS 171

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/175 (26%), Positives = 82/175 (46%), Gaps = 15/175 (8%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLRN-GQLVAIK-----RLTRGTADEIIADFLSELGIMAH 163
           N+FS   +IG+GG+ EVY  R  + G++ A+K     R+     + +  +    L +++ 
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 164 VDHPNTAKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLY 222
            D P    +   +     +  +L+L   G L   L       +  +R+  A  +  GL +
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF-YAAEIILGLEH 307
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFG 277
           +H    R +++RD+K ANILL E    +I D GLA    ++  H ++    GT G
Sbjct: 308 MH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHG 355

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/175 (26%), Positives = 82/175 (46%), Gaps = 15/175 (8%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLRN-GQLVAIK-----RLTRGTADEIIADFLSELGIMAH 163
           N+FS   +IG+GG+ EVY  R  + G++ A+K     R+     + +  +    L +++ 
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 164 VDHPNTAKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLY 222
            D P    +   +     +  +L+L   G L   L       +  +R+  A  +  GL +
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF-YAAEIILGLEH 307
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFG 277
           +H    R +++RD+K ANILL E    +I D GLA    ++  H ++    GT G
Sbjct: 308 MH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHG 355

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 43/164 (26%), Positives = 70/164 (42%), Gaps = 21/164 (12%)
Query: 118 IGKGGYAEVYKGRLRNGQL-VAIKRLTRGTADE------------IIADFLSELGIMAHV 164
           +G G Y EV   + +NG    AIK + +   D+               +  +E+ ++  +
Sbjct: 44  LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103
Query: 165 DHPNTAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYL 223
           DHPN  KL   +  +   ++V E    G L   +   + K        I   +  G+ YL
Sbjct: 104 DHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIIN-RHKFDECDAANIMKQILSGICYL 162
Query: 224 HEGCQRRIIHRDIKAANILLTED---FEPQICDFGLAKWLPEQW 264
           H   +  I+HRDIK  NILL         +I DFGL+ +  + +
Sbjct: 163 H---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY 203

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/175 (26%), Positives = 82/175 (46%), Gaps = 15/175 (8%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLRN-GQLVAIK-----RLTRGTADEIIADFLSELGIMAH 163
           N+FS   +IG+GG+ EVY  R  + G++ A+K     R+     + +  +    L +++ 
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 164 VDHPNTAKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLY 222
            D P    +   +     +  +L+L   G L   L       +  +R+  A  +  GL +
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF-YAAEIILGLEH 307
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFG 277
           +H    R +++RD+K ANILL E    +I D GLA    ++  H ++    GT G
Sbjct: 308 MH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHG 355

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/175 (26%), Positives = 82/175 (46%), Gaps = 15/175 (8%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLRN-GQLVAIK-----RLTRGTADEIIADFLSELGIMAH 163
           N+FS   +IG+GG+ EVY  R  + G++ A+K     R+     + +  +    L +++ 
Sbjct: 188 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 247
Query: 164 VDHPNTAKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLY 222
            D P    +   +     +  +L+L   G L   L       +  +R+  A  +  GL +
Sbjct: 248 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF-YAAEIILGLEH 306
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFG 277
           +H    R +++RD+K ANILL E    +I D GLA    ++  H ++    GT G
Sbjct: 307 MH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHG 354

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 89/194 (45%), Gaps = 15/194 (7%)
Query: 104 ELQSAT-NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADF--LSELG 159
           E Q  T N F    ++GKGG+ EV   ++R  G++ A K+L +    +   +   L+E  
Sbjct: 177 ERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQ 236
Query: 160 IMAHVDHPNTAKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKI-ALGVA 217
           I+  V+      L   Y  +  + +VL L   G L   +Y M +      R    A  + 
Sbjct: 237 ILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEIC 296
Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFG 277
            GL  LH   + RI++RD+K  NILL +    +I D GLA  +PE  T      ++G  G
Sbjct: 297 CGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT------IKGRVG 347
Query: 278 LVKLNLPPLVILKR 291
            V    P +V  +R
Sbjct: 348 TVGYMAPEVVKNER 361

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 73/157 (46%), Gaps = 20/157 (12%)
Query: 117 LIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGY 175
           ++G+G + +V K R   + +  AIK++     +E ++  LSE+ ++A ++H    +    
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIRH--TEEKLSTILSEVXLLASLNHQYVVRYYAA 70
Query: 176 GIE--------------GGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLL 221
            +E                + I  E   N +L  L++      +    +++   + E L 
Sbjct: 71  WLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLFRQILEALS 130
Query: 222 YLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           Y+H    + IIHR++K  NI + E    +I DFGLAK
Sbjct: 131 YIH---SQGIIHRNLKPXNIFIDESRNVKIGDFGLAK 164

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/144 (26%), Positives = 69/144 (47%), Gaps = 7/144 (4%)
Query: 118 IGKGGYAEVYKGRLRNG-QLVAIKRLTRGTADE-IIADFLSELGIMAHVDHPNTAKLLGY 175
           IG+G Y  V+K + R   ++VA+KR+     DE + +  L E+ ++  + H N  +L   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 176 -GIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHR 234
              +  + +V E   +  L          L   I       + +GL + H    R ++HR
Sbjct: 70  LHSDKKLTLVFEFC-DQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHR 125
Query: 235 DIKAANILLTEDFEPQICDFGLAK 258
           D+K  N+L+  + E ++ +FGLA+
Sbjct: 126 DLKPQNLLINRNGELKLANFGLAR 149

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/174 (30%), Positives = 80/174 (45%), Gaps = 21/174 (12%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLRNG-QLVAIKRLTR-----GTADEI--IADFLSELGIM 161
           + +     +G G   EV     R   + VAIK +++     G+A E     +  +E+ I+
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 162 AHVDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYG---MKEKLKWGIRYKIALGVAE 218
             ++HP   K+  +      +IVLEL   G L   + G   +KE       Y++ L V  
Sbjct: 70  KKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ- 128
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLT---EDFEPQICDFGLAKWLPEQWTHHTI 269
              YLHE     IIHRD+K  N+LL+   ED   +I DFG +K L E     T+
Sbjct: 129 ---YLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL 176

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/174 (30%), Positives = 80/174 (45%), Gaps = 21/174 (12%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLRNG-QLVAIKRLTR-----GTADEI--IADFLSELGIM 161
           + +     +G G   EV     R   + VAIK +++     G+A E     +  +E+ I+
Sbjct: 9   DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 68
Query: 162 AHVDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYG---MKEKLKWGIRYKIALGVAE 218
             ++HP   K+  +      +IVLEL   G L   + G   +KE       Y++ L V  
Sbjct: 69  KKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ- 127
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLT---EDFEPQICDFGLAKWLPEQWTHHTI 269
              YLHE     IIHRD+K  N+LL+   ED   +I DFG +K L E     T+
Sbjct: 128 ---YLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL 175

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 87/200 (43%), Gaps = 27/200 (13%)
Query: 104 ELQSAT-NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADF--LSELG 159
           E Q  T N F    ++GKGG+ EV   ++R  G++ A K+L +    +   +   L+E  
Sbjct: 177 ERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQ 236
Query: 160 IMAHVDHPNTAKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE 218
           I+  V+      L   Y  +  + +VL L   G L   +Y M +              A 
Sbjct: 237 ILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQ---------AGFPEAR 287
Query: 219 GLLYLHEGC-------QRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK 271
            + Y  E C       + RI++RD+K  NILL +    +I D GLA  +PE  T      
Sbjct: 288 AVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT------ 341
Query: 272 VEGTFGLVKLNLPPLVILKR 291
           ++G  G V    P +V  +R
Sbjct: 342 IKGRVGTVGYMAPEVVKNER 361

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/174 (30%), Positives = 80/174 (45%), Gaps = 21/174 (12%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLRNG-QLVAIKRLTR-----GTADEI--IADFLSELGIM 161
           + +     +G G   EV     R   + VAIK +++     G+A E     +  +E+ I+
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 162 AHVDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYG---MKEKLKWGIRYKIALGVAE 218
             ++HP   K+  +      +IVLEL   G L   + G   +KE       Y++ L V  
Sbjct: 70  KKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ- 128
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLT---EDFEPQICDFGLAKWLPEQWTHHTI 269
              YLHE     IIHRD+K  N+LL+   ED   +I DFG +K L E     T+
Sbjct: 129 ---YLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL 176

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 70/155 (45%), Gaps = 12/155 (7%)
Query: 112 FSFENLIGKGGYAEVYKGR----LRNGQLVAIKRLTRGTADEIIADFL---SELGIMAHV 164
           F    ++GKGGY +V++ R       G++ A+K L +        D     +E  I+  V
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 165 DHPNTAKLL-GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYL 223
            HP    L+  +   G ++++LE    G L   L    E+    +       +AE  + L
Sbjct: 79  KHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQL----EREGIFMEDTACFYLAEISMAL 134
Query: 224 HEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
               Q+ II+RD+K  NI+L      ++ DFGL K
Sbjct: 135 GHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCK 169

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/174 (30%), Positives = 80/174 (45%), Gaps = 21/174 (12%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLRNG-QLVAIKRLTR-----GTADEI--IADFLSELGIM 161
           + +     +G G   EV     R   + VAIK +++     G+A E     +  +E+ I+
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 162 AHVDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYG---MKEKLKWGIRYKIALGVAE 218
             ++HP   K+  +      +IVLEL   G L   + G   +KE       Y++ L V  
Sbjct: 70  KKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ- 128
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLT---EDFEPQICDFGLAKWLPEQWTHHTI 269
              YLHE     IIHRD+K  N+LL+   ED   +I DFG +K L E     T+
Sbjct: 129 ---YLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL 176

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 70/155 (45%), Gaps = 12/155 (7%)
Query: 112 FSFENLIGKGGYAEVYKGR----LRNGQLVAIKRLTRGTADEIIADFL---SELGIMAHV 164
           F    ++GKGGY +V++ R       G++ A+K L +        D     +E  I+  V
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 165 DHPNTAKLL-GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYL 223
            HP    L+  +   G ++++LE    G L   L    E+    +       +AE  + L
Sbjct: 79  KHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQL----EREGIFMEDTACFYLAEISMAL 134
Query: 224 HEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
               Q+ II+RD+K  NI+L      ++ DFGL K
Sbjct: 135 GHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCK 169

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 76/169 (44%), Gaps = 17/169 (10%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMK-------EKLKWGIRYKIALGVAEGLLY 222
             LL           LE   +  L + L G         +KL       +   +  GL Y
Sbjct: 84  IGLLDVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK 271
           +H      IIHRD+K +N+ + ED E +I D+GLA+   ++ T +  ++
Sbjct: 141 IHSA---DIIHRDLKPSNLAVNEDCELKILDYGLARHTDDEMTGYVATR 186

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 48/178 (26%), Positives = 75/178 (42%), Gaps = 33/178 (18%)
Query: 111 NFSFENLIGKGGYAEVYK----GRLRNGQ--LVAIKRLTRGTADEIIADFLSELGIMAHV 164
           N  F  ++G G + +V      G  + G    VA+K L            +SEL +M  +
Sbjct: 46  NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 105
Query: 165 -DHPNTAKLLGY-GIEGGMHIVLELSPNGSLASLLYGMKEKLKWG-IRYK---------- 211
             H N   LLG   + G ++++ E    G L + L   +EK     I Y+          
Sbjct: 106 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 165
Query: 212 -----------IALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
                       A  VA+G+ +L     +  +HRD+ A N+L+T     +ICDFGLA+
Sbjct: 166 LNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLAR 220

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 40/154 (25%), Positives = 76/154 (49%), Gaps = 9/154 (5%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHV-D 165
           +NF F  ++GKG + +V   R++  G L A+K L +     D+ +   ++E  I++   +
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN 82
Query: 166 HPNTAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
           HP   +L   +     +  V+E    G L   +   +   +   R+  A  +   L++LH
Sbjct: 83  HPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF-YAAEIISALMFLH 141
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           +   + II+RD+K  N+LL  +   ++ DFG+ K
Sbjct: 142 D---KGIIYRDLKLDNVLLDHEGHCKLADFGMCK 172

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 70/148 (47%), Gaps = 13/148 (8%)
Query: 118 IGKGGYAEVY--KGRLRNGQLVAIKRLTRG--TADEIIADFLSELGIMAHVDHPNTAKLL 173
           +G G Y EV   K +L  G   AIK + +   T        L E+ ++  +DHPN  KL 
Sbjct: 12  LGSGAYGEVLLCKDKL-TGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLY 70
Query: 174 GYGIEG-GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRII 232
            +  +    ++V+E+   G L   +  +++K        I   V  G  YLH   +  I+
Sbjct: 71  EFFEDKRNYYLVMEVYRGGELFDEII-LRQKFSEVDAAVIMKQVLSGTTYLH---KHNIV 126
Query: 233 HRDIKAANILL---TEDFEPQICDFGLA 257
           HRD+K  N+LL   + D   +I DFGL+
Sbjct: 127 HRDLKPENLLLESKSRDALIKIVDFGLS 154

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 79/167 (47%), Gaps = 13/167 (7%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L++     I A     EL ++ H+ H N 
Sbjct: 36  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLLKHMKHENV 95
Query: 170 AKLL-----GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
             LL        +E    + L     G+  + +   ++     +++ I   +  GL Y+H
Sbjct: 96  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH 154
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK 271
                 IIHRD+K +N+ + ED E +I DFGLA+   ++ T +  ++
Sbjct: 155 SA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 198

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 70/152 (46%), Gaps = 19/152 (12%)
Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHV--DHPNTAKLLGY 175
           IGKG Y EV+ G+ R G+ VA+K     T +E  A +  E  I   V   H N    +  
Sbjct: 45  IGKGRYGEVWMGKWR-GEKVAVKVFF--TTEE--ASWFRETEIYQTVLMRHENILGFIAA 99
Query: 176 GIEGG-----MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC--- 227
            I+G      ++++ +   NGSL   L       K  +  K+A     GL +LH      
Sbjct: 100 DIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSML--KLAYSSVSGLCHLHTEIFST 157
Query: 228 --QRRIIHRDIKAANILLTEDFEPQICDFGLA 257
             +  I HRD+K+ NIL+ ++    I D GLA
Sbjct: 158 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 189

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/174 (30%), Positives = 80/174 (45%), Gaps = 21/174 (12%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLRNG-QLVAIKRLTR-----GTADEI--IADFLSELGIM 161
           + +     +G G   EV     R   + VAIK +++     G+A E     +  +E+ I+
Sbjct: 16  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 75
Query: 162 AHVDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYG---MKEKLKWGIRYKIALGVAE 218
             ++HP   K+  +      +IVLEL   G L   + G   +KE       Y++ L V  
Sbjct: 76  KKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ- 134
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLT---EDFEPQICDFGLAKWLPEQWTHHTI 269
              YLHE     IIHRD+K  N+LL+   ED   +I DFG +K L E     T+
Sbjct: 135 ---YLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL 182

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 44/169 (26%), Positives = 76/169 (44%), Gaps = 27/169 (15%)
Query: 111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           +F    LIG GG+ +V+K + R +G+   IKR+              E+  +A +DH N 
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKA-----EREVKALAKLDHVNI 66
Query: 170 AKLLG------YGIEGG-----------MHIVLELSPNGSLASLLYGMK-EKLKWGIRYK 211
               G      Y  E             + I +E    G+L   +   + EKL   +  +
Sbjct: 67  VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALE 126
Query: 212 IALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL 260
           +   + +G+ Y+H    +++I+RD+K +NI L +  + +I DFGL   L
Sbjct: 127 LFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSL 172

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 72/174 (41%), Gaps = 28/174 (16%)
Query: 110 NNFSFENLIGKGGYAEVYKG------RLRNGQLVAIKRLTRGTADEIIADFLSELGIMAH 163
           N  SF   +G G + +V +       +      VA+K L            +SEL ++++
Sbjct: 39  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 98
Query: 164 V-DHPNTAKLLGYGIEGGMHIVL-ELSPNGSLASLLYGMKEKL----------------- 204
           + +H N   LLG    GG  +V+ E    G L + L   ++                   
Sbjct: 99  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 158
Query: 205 KWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
                   +  VA+G+ +L     +  IHRD+ A NILLT     +ICDFGLA+
Sbjct: 159 DLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR 209

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 74/154 (48%), Gaps = 14/154 (9%)
Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIAD--FLSELGIMAHVDHPNTAKLLGY 175
           +G G Y EV   R +   +    ++ R T+    ++   L E+ ++  +DHPN  KL  +
Sbjct: 45  LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF 104
Query: 176 GIEG-GMHIVLELSPNGSL-ASLLYGMK-EKLKWGIRYKIALGVAEGLLYLHEGCQRRII 232
             +    ++V+E    G L   +++ MK  ++   +  K  L    G+ YLH   +  I+
Sbjct: 105 FEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLS---GVTYLH---KHNIV 158
Query: 233 HRDIKAANILL---TEDFEPQICDFGLAKWLPEQ 263
           HRD+K  N+LL    +D   +I DFGL+     Q
Sbjct: 159 HRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ 192

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 75/169 (44%), Gaps = 17/169 (10%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMK-------EKLKWGIRYKIALGVAEGLLY 222
             LL           LE   +  L + L G         +KL       +   +  GL Y
Sbjct: 84  IGLLDVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK 271
           +H      IIHRD+K +N+ + ED E +I DF LA+   ++ T +  ++
Sbjct: 141 IHSA---DIIHRDLKPSNLAVNEDCELKILDFYLARHTDDEMTGYVATR 186

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 47.8 bits (112), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 39/164 (23%), Positives = 76/164 (46%), Gaps = 19/164 (11%)
Query: 109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHP 167
           +++F  ++L+G+G Y  V     +  G++VAIK++            L E+ I+ H  H 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 168 NTAKLLG------YGIEGGMHIVLELSPNGSLASLLYGM--KEKLKWGIRYKI-ALGVAE 218
           N   +        +     ++I+ EL        +   M   + +++ I   + A+ V  
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLH 129
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE 262
           G           +IHRD+K +N+L+  + + ++CDFGLA+ + E
Sbjct: 130 G---------SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDE 164

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 47.8 bits (112), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 39/164 (23%), Positives = 76/164 (46%), Gaps = 19/164 (11%)
Query: 109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHP 167
           +++F  ++L+G+G Y  V     +  G++VAIK++            L E+ I+ H  H 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 168 NTAKLLG------YGIEGGMHIVLELSPNG--SLASLLYGMKEKLKWGIRYKI-ALGVAE 218
           N   +        +     ++I+ EL       + S      + +++ I   + A+ V  
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLH 129
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE 262
           G           +IHRD+K +N+L+  + + ++CDFGLA+ + E
Sbjct: 130 G---------SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDE 164

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 47.8 bits (112), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 37/168 (22%), Positives = 75/168 (44%), Gaps = 19/168 (11%)
Query: 118 IGKGGYAEVYKGRLRNGQL-VAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYG 176
           +G+GG+  V++ + +      AIKR+     +      + E+  +A ++HP   +     
Sbjct: 13  LGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAW 72
Query: 177 IEGG-------------MHIVLELSPNGSLASLLYG--MKEKLKWGIRYKIALGVAEGLL 221
           +E               ++I ++L    +L   + G    E+ +  +   I L +AE + 
Sbjct: 73  LEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVE 132
Query: 222 YLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTI 269
           +LH    + ++HRD+K +NI  T D   ++ DFGL   + +     T+
Sbjct: 133 FLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 177

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 47.8 bits (112), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 78/167 (46%), Gaps = 13/167 (7%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 170 AKLL-----GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
             LL        +E    + L     G+  + +   ++     +++ I   +  GL Y+H
Sbjct: 84  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQFLI-YQILRGLKYIH 142
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK 271
                 IIHRD+K +N+ + ED E +I DFGL +   ++ T +  ++
Sbjct: 143 SA---DIIHRDLKPSNLAVNEDSELKILDFGLCRHTDDEMTGYVATR 186

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 47.8 bits (112), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 39/164 (23%), Positives = 76/164 (46%), Gaps = 19/164 (11%)
Query: 109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHP 167
           +++F  ++L+G+G Y  V     +  G++VAIK++            L E+ I+ H  H 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 168 NTAKLLG------YGIEGGMHIVLELSPNGSLASLLYGM--KEKLKWGIRYKI-ALGVAE 218
           N   +        +     ++I+ EL        +   M   + +++ I   + A+ V  
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLH 129
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE 262
           G           +IHRD+K +N+L+  + + ++CDFGLA+ + E
Sbjct: 130 G---------SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDE 164

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 37/147 (25%), Positives = 70/147 (47%), Gaps = 8/147 (5%)
Query: 118 IGKGGYAEVYKG--RLRNGQLVAIKRLTRGTADE--IIADFLSELGIMAHVDHPNTAKLL 173
           +G G +  V KG  +++        ++ +  A++  +  + L+E  +M  +D+P   +++
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 174 GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIH 233
           G        +V+E++  G L   L   +      I  ++   V+ G+ YL E      +H
Sbjct: 95  GICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNI-IELVHQVSMGMKYLEES---NFVH 150
Query: 234 RDIKAANILLTEDFEPQICDFGLAKWL 260
           RD+ A N+LL      +I DFGL+K L
Sbjct: 151 RDLAARNVLLVTQHYAKISDFGLSKAL 177

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 37/147 (25%), Positives = 70/147 (47%), Gaps = 8/147 (5%)
Query: 118 IGKGGYAEVYKG--RLRNGQLVAIKRLTRGTADE--IIADFLSELGIMAHVDHPNTAKLL 173
           +G G +  V KG  +++        ++ +  A++  +  + L+E  +M  +D+P   +++
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 174 GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIH 233
           G        +V+E++  G L   L   +      I  ++   V+ G+ YL E      +H
Sbjct: 95  GICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNI-IELVHQVSMGMKYLEES---NFVH 150
Query: 234 RDIKAANILLTEDFEPQICDFGLAKWL 260
           RD+ A N+LL      +I DFGL+K L
Sbjct: 151 RDLAARNVLLVTQHYAKISDFGLSKAL 177

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 51/178 (28%), Positives = 77/178 (43%), Gaps = 12/178 (6%)
Query: 111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           ++     +G+G   EV     R   + VA+K +    A +   +   E+ I   ++H N 
Sbjct: 7   DWDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 170 AKLLGYGIEGGM-HIVLELSPNGSLASLL---YGMKEKLKWGIRYKIALGVAEGLLYLHE 225
            K  G+  EG + ++ LE    G L   +    GM E       +++  GV    +YLH 
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV----VYLH- 121
Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNL 283
           G    I HRDIK  N+LL E    +I DFGLA           ++K+ GT   V   L
Sbjct: 122 GIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/154 (26%), Positives = 76/154 (49%), Gaps = 9/154 (5%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDH 166
           N F +  L+GKG + +V   + +  G+  A+K L +    A + +A  L+E  ++ +  H
Sbjct: 9   NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 68
Query: 167 PN-TAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKI-ALGVAEGLLYLH 224
           P  TA    +     +  V+E +  G L    +  +E++    R +     +   L YLH
Sbjct: 69  PFLTALKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIVSALDYLH 126
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
              ++ +++RD+K  N++L +D   +I DFGL K
Sbjct: 127 --SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK 158

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/147 (25%), Positives = 70/147 (47%), Gaps = 8/147 (5%)
Query: 118 IGKGGYAEVYKG--RLRNGQLVAIKRLTRGTADE--IIADFLSELGIMAHVDHPNTAKLL 173
           +G G +  V KG  +++        ++ +  A++  +  + L+E  +M  +D+P   +++
Sbjct: 33  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 92
Query: 174 GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIH 233
           G        +V+E++  G L   L   +      I  ++   V+ G+ YL E      +H
Sbjct: 93  GICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNI-IELVHQVSMGMKYLEES---NFVH 148
Query: 234 RDIKAANILLTEDFEPQICDFGLAKWL 260
           RD+ A N+LL      +I DFGL+K L
Sbjct: 149 RDLAARNVLLVTQHYAKISDFGLSKAL 175

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/154 (26%), Positives = 76/154 (49%), Gaps = 9/154 (5%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDH 166
           N F +  L+GKG + +V   + +  G+  A+K L +    A + +A  L+E  ++ +  H
Sbjct: 10  NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 69
Query: 167 PN-TAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKI-ALGVAEGLLYLH 224
           P  TA    +     +  V+E +  G L    +  +E++    R +     +   L YLH
Sbjct: 70  PFLTALKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIVSALDYLH 127
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
              ++ +++RD+K  N++L +D   +I DFGL K
Sbjct: 128 --SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK 159

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/154 (26%), Positives = 76/154 (49%), Gaps = 9/154 (5%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDH 166
           N F +  L+GKG + +V   + +  G+  A+K L +    A + +A  L+E  ++ +  H
Sbjct: 151 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 210
Query: 167 PN-TAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKI-ALGVAEGLLYLH 224
           P  TA    +     +  V+E +  G L    +  +E++    R +     +   L YLH
Sbjct: 211 PFLTALKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIVSALDYLH 268
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
              ++ +++RD+K  N++L +D   +I DFGL K
Sbjct: 269 --SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK 300

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/154 (26%), Positives = 76/154 (49%), Gaps = 9/154 (5%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDH 166
           N F +  L+GKG + +V   + +  G+  A+K L +    A + +A  L+E  ++ +  H
Sbjct: 8   NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 67
Query: 167 PN-TAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKI-ALGVAEGLLYLH 224
           P  TA    +     +  V+E +  G L    +  +E++    R +     +   L YLH
Sbjct: 68  PFLTALKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIVSALDYLH 125
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
              ++ +++RD+K  N++L +D   +I DFGL K
Sbjct: 126 --SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK 157

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/154 (26%), Positives = 76/154 (49%), Gaps = 9/154 (5%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDH 166
           N F +  L+GKG + +V   + +  G+  A+K L +    A + +A  L+E  ++ +  H
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207
Query: 167 PN-TAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKI-ALGVAEGLLYLH 224
           P  TA    +     +  V+E +  G L    +  +E++    R +     +   L YLH
Sbjct: 208 PFLTALKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIVSALDYLH 265
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
              ++ +++RD+K  N++L +D   +I DFGL K
Sbjct: 266 --SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK 297

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/147 (25%), Positives = 70/147 (47%), Gaps = 8/147 (5%)
Query: 118 IGKGGYAEVYKG--RLRNGQLVAIKRLTRGTADE--IIADFLSELGIMAHVDHPNTAKLL 173
           +G G +  V KG  +++        ++ +  A++  +  + L+E  +M  +D+P   +++
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 174 GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIH 233
           G        +V+E++  G L   L   +      I  ++   V+ G+ YL E      +H
Sbjct: 79  GICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNI-IELVHQVSMGMKYLEES---NFVH 134
Query: 234 RDIKAANILLTEDFEPQICDFGLAKWL 260
           RD+ A N+LL      +I DFGL+K L
Sbjct: 135 RDLAARNVLLVTQHYAKISDFGLSKAL 161

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 85/179 (47%), Gaps = 27/179 (15%)
Query: 105 LQSATNNFSFENL------IGKGGYAEVYKGRLR-NGQLVAIK--RLTRGTADEIIA--D 153
           L  A ++  FE++      IGKG ++ V +   R  GQ  A+K   + + T+   ++  D
Sbjct: 13  LDMADDDVLFEDVYELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTED 72
Query: 154 FLSELGIMAHVDHPNTAKLL-GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKI 212
              E  I   + HP+  +LL  Y  +G +++V E       A L + + ++   G  Y  
Sbjct: 73  LKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDG---ADLCFEIVKRADAGFVYSE 129
Query: 213 ALG------VAEGLLYLHEGCQRRIIHRDIKAANILLT--EDFEP-QICDFGLAKWLPE 262
           A+       + E L Y H+     IIHRD+K  N+LL   E+  P ++ DFG+A  L E
Sbjct: 130 AVASHYMRQILEALRYCHDN---NIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGE 185

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/147 (25%), Positives = 70/147 (47%), Gaps = 8/147 (5%)
Query: 118 IGKGGYAEVYKG--RLRNGQLVAIKRLTRGTADE--IIADFLSELGIMAHVDHPNTAKLL 173
           +G G +  V KG  +++        ++ +  A++  +  + L+E  +M  +D+P   +++
Sbjct: 377 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 436
Query: 174 GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIH 233
           G        +V+E++  G L   L   +      I  ++   V+ G+ YL E      +H
Sbjct: 437 GICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNI-IELVHQVSMGMKYLEES---NFVH 492
Query: 234 RDIKAANILLTEDFEPQICDFGLAKWL 260
           RD+ A N+LL      +I DFGL+K L
Sbjct: 493 RDLAARNVLLVTQHYAKISDFGLSKAL 519

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/147 (25%), Positives = 70/147 (47%), Gaps = 8/147 (5%)
Query: 118 IGKGGYAEVYKG--RLRNGQLVAIKRLTRGTADE--IIADFLSELGIMAHVDHPNTAKLL 173
           +G G +  V KG  +++        ++ +  A++  +  + L+E  +M  +D+P   +++
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 174 GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIH 233
           G        +V+E++  G L   L   +      I  ++   V+ G+ YL E      +H
Sbjct: 75  GICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNI-IELVHQVSMGMKYLEES---NFVH 130
Query: 234 RDIKAANILLTEDFEPQICDFGLAKWL 260
           RD+ A N+LL      +I DFGL+K L
Sbjct: 131 RDLAARNVLLVTQHYAKISDFGLSKAL 157

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/147 (25%), Positives = 70/147 (47%), Gaps = 8/147 (5%)
Query: 118 IGKGGYAEVYKG--RLRNGQLVAIKRLTRGTADE--IIADFLSELGIMAHVDHPNTAKLL 173
           +G G +  V KG  +++        ++ +  A++  +  + L+E  +M  +D+P   +++
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 174 GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIH 233
           G        +V+E++  G L   L   +      I  ++   V+ G+ YL E      +H
Sbjct: 79  GICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNI-IELVHQVSMGMKYLEES---NFVH 134
Query: 234 RDIKAANILLTEDFEPQICDFGLAKWL 260
           RD+ A N+LL      +I DFGL+K L
Sbjct: 135 RDLAARNVLLVTQHYAKISDFGLSKAL 161

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/147 (25%), Positives = 70/147 (47%), Gaps = 8/147 (5%)
Query: 118 IGKGGYAEVYKG--RLRNGQLVAIKRLTRGTADE--IIADFLSELGIMAHVDHPNTAKLL 173
           +G G +  V KG  +++        ++ +  A++  +  + L+E  +M  +D+P   +++
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 174 GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIH 233
           G        +V+E++  G L   L   +      I  ++   V+ G+ YL E      +H
Sbjct: 85  GICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNI-IELVHQVSMGMKYLEES---NFVH 140
Query: 234 RDIKAANILLTEDFEPQICDFGLAKWL 260
           RD+ A N+LL      +I DFGL+K L
Sbjct: 141 RDLAARNVLLVTQHYAKISDFGLSKAL 167

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/194 (27%), Positives = 84/194 (43%), Gaps = 22/194 (11%)
Query: 115 ENLIGKGGYAEVYK-GRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLL 173
           E   GK   AE Y     ++  LVA+K L +  +D    DF  E  ++ ++ H +  K  
Sbjct: 23  EGAFGKVFLAECYNLCPEQDKILVAVKTL-KDASDNARKDFHREAELLTNLQHEHIVKFY 81
Query: 174 GYGIEGG-MHIVLELSPNGSLASLLYG-------MKE-----KLKWGIRYKIALGVAEGL 220
           G  +EG  + +V E   +G L   L         M E     +L       IA  +A G+
Sbjct: 82  GVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGM 141
Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGLVK 280
           +YL     +  +HRD+   N L+ E+   +I DFG+++ +          +V G   L  
Sbjct: 142 VYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYST----DYYRVGGHTMLPI 194
Query: 281 LNLPPLVILKRCFT 294
             +PP  I+ R FT
Sbjct: 195 RWMPPESIMYRKFT 208

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 38/162 (23%), Positives = 74/162 (45%), Gaps = 13/162 (8%)
Query: 104 ELQSATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA---DEIIADFLSELG 159
           +++    +F    ++GKG + +V+    +   Q  AIK L +      D++    + +  
Sbjct: 12  QIKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV 71
Query: 160 IMAHVDHPNTAKLL-GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKI--ALGV 216
           +    +HP    +   +  +  +  V+E    G L   +Y ++   K+ +      A  +
Sbjct: 72  LSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDL---MYHIQSCHKFDLSRATFYAAEI 128
Query: 217 AEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
             GL +LH    + I++RD+K  NILL +D   +I DFG+ K
Sbjct: 129 ILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCK 167

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/147 (25%), Positives = 70/147 (47%), Gaps = 8/147 (5%)
Query: 118 IGKGGYAEVYKG--RLRNGQLVAIKRLTRGTADE--IIADFLSELGIMAHVDHPNTAKLL 173
           +G G +  V KG  +++        ++ +  A++  +  + L+E  +M  +D+P   +++
Sbjct: 13  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 72
Query: 174 GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIH 233
           G        +V+E++  G L   L   +      I  ++   V+ G+ YL E      +H
Sbjct: 73  GICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNI-IELVHQVSMGMKYLEES---NFVH 128
Query: 234 RDIKAANILLTEDFEPQICDFGLAKWL 260
           RD+ A N+LL      +I DFGL+K L
Sbjct: 129 RDLAARNVLLVTQHYAKISDFGLSKAL 155

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/147 (25%), Positives = 70/147 (47%), Gaps = 8/147 (5%)
Query: 118 IGKGGYAEVYKG--RLRNGQLVAIKRLTRGTADE--IIADFLSELGIMAHVDHPNTAKLL 173
           +G G +  V KG  +++        ++ +  A++  +  + L+E  +M  +D+P   +++
Sbjct: 378 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 437
Query: 174 GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIH 233
           G        +V+E++  G L   L   +      I  ++   V+ G+ YL E      +H
Sbjct: 438 GICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNI-IELVHQVSMGMKYLEES---NFVH 493
Query: 234 RDIKAANILLTEDFEPQICDFGLAKWL 260
           RD+ A N+LL      +I DFGL+K L
Sbjct: 494 RDLAARNVLLVTQHYAKISDFGLSKAL 520

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 75/169 (44%), Gaps = 17/169 (10%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMK-------EKLKWGIRYKIALGVAEGLLY 222
             LL           LE   +  L + L G         +KL       +   +  GL Y
Sbjct: 84  IGLLDVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK 271
           +H      IIHRD+K +N+ + ED E +I  FGLA+   ++ T +  ++
Sbjct: 141 IHSA---DIIHRDLKPSNLAVNEDCELKILGFGLARHTDDEMTGYVATR 186

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 76/182 (41%), Gaps = 40/182 (21%)
Query: 111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           +F    LIG GG+ +V+K + R +G+   I+R+              E+  +A +DH N 
Sbjct: 13  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKA-----EREVKALAKLDHVNI 67
Query: 170 AKLLG--------------------YGIEGG----------MHIVLELSPNGSLASLLYG 199
               G                    Y  E            + I +E    G+L   +  
Sbjct: 68  VHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEK 127
Query: 200 MK-EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
            + EKL   +  ++   + +G+ Y+H    +++IHRD+K +NI L +  + +I DFGL  
Sbjct: 128 RRGEKLDKVLALELFEQITKGVDYIH---SKKLIHRDLKPSNIFLVDTKQVKIGDFGLVT 184
Query: 259 WL 260
            L
Sbjct: 185 SL 186

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 75/169 (44%), Gaps = 17/169 (10%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMK-------EKLKWGIRYKIALGVAEGLLY 222
             LL           LE   +  L + L G         +KL       +   +  GL Y
Sbjct: 84  IGLLDVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK 271
           +H      IIHRD+K +N+ + ED E +I D GLA+   ++ T +  ++
Sbjct: 141 IHSA---DIIHRDLKPSNLAVNEDCELKILDAGLARHTDDEMTGYVATR 186

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/169 (26%), Positives = 73/169 (43%), Gaps = 24/169 (14%)
Query: 108 ATNNFSFENLI-------GKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGI 160
            T N  F+++         +G +  V+K +L N + VA+K            ++  E+  
Sbjct: 15  GTENLYFQSMPLQLLEVKARGRFGCVWKAQLLN-EYVAVKIFPIQDKQSWQNEY--EVYS 71
Query: 161 MAHVDHPNTAKLLGY-----GIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALG 215
           +  + H N  + +G       ++  + ++      GSL+  L      + W     IA  
Sbjct: 72  LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA--NVVSWNELCHIAET 129
Query: 216 VAEGLLYLHE-------GCQRRIIHRDIKAANILLTEDFEPQICDFGLA 257
           +A GL YLHE       G +  I HRDIK+ N+LL  +    I DFGLA
Sbjct: 130 MARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLA 178

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 75/169 (44%), Gaps = 17/169 (10%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMK-------EKLKWGIRYKIALGVAEGLLY 222
             LL           LE   +  L + L G         +KL       +   +  GL Y
Sbjct: 84  IGLLDVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK 271
           +H      IIHRD+K +N+ + ED E +I D GLA+   ++ T +  ++
Sbjct: 141 IHSA---DIIHRDLKPSNLAVNEDCELKILDRGLARHTDDEMTGYVATR 186

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/167 (25%), Positives = 69/167 (41%), Gaps = 25/167 (14%)
Query: 114 FENLIGKGGYAEVYKGRL------RNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHP 167
           F   +G+  + +VYKG L         Q VAIK L       +  +F  E  + A + HP
Sbjct: 30  FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHP 89
Query: 168 NTAKLLG-------------YGIEGGMHIVLEL-SPNGSLASL--LYGMKEKLKWGIRYK 211
           N   LLG             Y   G +H  L + SP+  + S      +K  L+      
Sbjct: 90  NVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 149
Query: 212 IALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           +   +A G+ YL       ++H+D+   N+L+ +    +I D GL +
Sbjct: 150 LVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR 193

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 76/156 (48%), Gaps = 13/156 (8%)
Query: 110 NNFSFENLIGKGGYAEVY-KGRLRNGQLVAIKRLTRGTA--DEIIADFLSELGIMAHVDH 166
            +F+F  ++GKG + +V    R    +L AIK L +     D+ +   + E  ++A +D 
Sbjct: 19  TDFNFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDK 78
Query: 167 PNTAKLLG--YGIEGGMHIVLELSPNGSLASLLYGMKE--KLKWGIRYKIALGVAEGLLY 222
           P     L   +     ++ V+E    G L   +Y +++  K K       A  ++ GL +
Sbjct: 79  PPFLTQLHSCFQTVDRLYFVMEYVNGGDL---MYHIQQVGKFKEPQAVFYAAEISIGLFF 135
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           LH   +R II+RD+K  N++L  +   +I DFG+ K
Sbjct: 136 LH---KRGIIYRDLKLDNVMLDSEGHIKIADFGMCK 168

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 38/143 (26%), Positives = 66/143 (46%), Gaps = 6/143 (4%)
Query: 118 IGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLG-Y 175
           +G+G YA VYKG+ +    LVA+K +     +      + E+ ++  + H N   L    
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 69
Query: 176 GIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRD 235
             E  + +V E   +  L   L      +           +  GL Y H   +++++HRD
Sbjct: 70  HTEKSLTLVFEYL-DKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH---RQKVLHRD 125
Query: 236 IKAANILLTEDFEPQICDFGLAK 258
           +K  N+L+ E  E ++ DFGLA+
Sbjct: 126 LKPQNLLINERGELKLADFGLAR 148

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 96/209 (45%), Gaps = 12/209 (5%)
Query: 52  FRNKSKKSLVTLYPLKLSIRRSSSMREGIDMPRNLFVNSYDSQSPQKIFSLYELQSATNN 111
           +RN+S  S+ TL  + + +    S      + R+ +V  +   +      + E+Q    +
Sbjct: 19  WRNESALSVETLLDVLVCLYTECSHSA---LRRDKYVAEFLEWAKPFTQLVKEMQLHRED 75
Query: 112 FSFENLIGKGGYAEVYKGRLRNGQ-LVAIKRLTRGTA--DEIIADFLSELGIMAHVD-HP 167
           F    +IG+G + EV   +++N + + A+K L +         A F  E  ++ + D   
Sbjct: 76  FEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQW 135
Query: 168 NTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGI-RYKIALGVAEGLLYLHEG 226
            TA    +  E  +++V++    G L +LL   ++KL   + R+ I     E +L +   
Sbjct: 136 ITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIG----EMVLAIDSI 191
Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFG 255
            Q   +HRDIK  N+LL  +   ++ DFG
Sbjct: 192 HQLHYVHRDIKPDNVLLDVNGHIRLADFG 220

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 38/162 (23%), Positives = 74/162 (45%), Gaps = 13/162 (8%)
Query: 104 ELQSATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA---DEIIADFLSELG 159
           +++    +F    ++GKG + +V+    +   Q  AIK L +      D++    + +  
Sbjct: 11  QIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV 70
Query: 160 IMAHVDHPNTAKLL-GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKI--ALGV 216
           +    +HP    +   +  +  +  V+E    G L   +Y ++   K+ +      A  +
Sbjct: 71  LSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDL---MYHIQSCHKFDLSRATFYAAEI 127
Query: 217 AEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
             GL +LH    + I++RD+K  NILL +D   +I DFG+ K
Sbjct: 128 ILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCK 166

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/176 (25%), Positives = 76/176 (43%), Gaps = 39/176 (22%)
Query: 108 ATNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRL----TRGTADEIIADFLSELGIMA 162
           AT+ +     IG G Y  VYK R   +G  VA+K +      G    +    + E+ ++ 
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 163 HVD---HPNTAKLLGY-----------------GIEGGMHIVLELSPNGSLASLLYGMKE 202
            ++   HPN  +L+                    ++  +   L+ +P   L +    +K+
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPA--ETIKD 124
Query: 203 KLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
            ++  +R         GL +LH  C   I+HRD+K  NIL+T     ++ DFGLA+
Sbjct: 125 LMRQFLR---------GLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLAR 168

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 71/143 (49%), Gaps = 12/143 (8%)
Query: 118 IGKGGYAEVYKGRLRN-GQLVAIKR--LTRGTADEIIADFLSELGIMAHVDHPNTAKLLG 174
           IG+G    V    +R+ G+LVA+K+  L +    E++    +E+ IM    H N  ++  
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELL---FNEVVIMRDYQHENVVEMYN 93
Query: 175 -YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIH 233
            Y +   + +V+E    G+L  ++     ++       + L V + L  LH    + +IH
Sbjct: 94  SYLVGDELWVVMEFLEGGALTDIV--THTRMNEEQIAAVCLAVLQALSVLHA---QGVIH 148
Query: 234 RDIKAANILLTEDFEPQICDFGL 256
           RDIK+ +ILLT D   ++ DFG 
Sbjct: 149 RDIKSDSILLTHDGRVKLSDFGF 171

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 75/169 (44%), Gaps = 17/169 (10%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMK-------EKLKWGIRYKIALGVAEGLLY 222
             LL           LE   +  L + L G         +KL       +   +  GL Y
Sbjct: 84  IGLLDVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK 271
           +H      IIHRD+K +N+ + ED E +I D GLA+   ++ T +  ++
Sbjct: 141 IHSA---DIIHRDLKPSNLAVNEDCELKILDGGLARHTDDEMTGYVATR 186

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 71/143 (49%), Gaps = 12/143 (8%)
Query: 118 IGKGGYAEVYKGRLRN-GQLVAIKR--LTRGTADEIIADFLSELGIMAHVDHPNTAKLLG 174
           IG+G    V    +R+ G+LVA+K+  L +    E++    +E+ IM    H N  ++  
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELL---FNEVVIMRDYQHENVVEMYN 84
Query: 175 -YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIH 233
            Y +   + +V+E    G+L  ++     ++       + L V + L  LH    + +IH
Sbjct: 85  SYLVGDELWVVMEFLEGGALTDIV--THTRMNEEQIAAVCLAVLQALSVLH---AQGVIH 139
Query: 234 RDIKAANILLTEDFEPQICDFGL 256
           RDIK+ +ILLT D   ++ DFG 
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGF 162

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 96/209 (45%), Gaps = 12/209 (5%)
Query: 52  FRNKSKKSLVTLYPLKLSIRRSSSMREGIDMPRNLFVNSYDSQSPQKIFSLYELQSATNN 111
           +RN+S  S+ TL  + + +    S      + R+ +V  +   +      + E+Q    +
Sbjct: 35  WRNESALSVETLLDVLVCLYTECSHSA---LRRDKYVAEFLEWAKPFTQLVKEMQLHRED 91
Query: 112 FSFENLIGKGGYAEVYKGRLRNGQ-LVAIKRLTRGTA--DEIIADFLSELGIMAHVD-HP 167
           F    +IG+G + EV   +++N + + A+K L +         A F  E  ++ + D   
Sbjct: 92  FEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQW 151
Query: 168 NTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGI-RYKIALGVAEGLLYLHEG 226
            TA    +  E  +++V++    G L +LL   ++KL   + R+ I     E +L +   
Sbjct: 152 ITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIG----EMVLAIDSI 207
Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFG 255
            Q   +HRDIK  N+LL  +   ++ DFG
Sbjct: 208 HQLHYVHRDIKPDNVLLDVNGHIRLADFG 236

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 43/167 (25%), Positives = 69/167 (41%), Gaps = 25/167 (14%)
Query: 114 FENLIGKGGYAEVYKGRL------RNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHP 167
           F   +G+  + +VYKG L         Q VAIK L       +  +F  E  + A + HP
Sbjct: 13  FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHP 72
Query: 168 NTAKLLG-------------YGIEGGMHIVLEL-SPNGSLASL--LYGMKEKLKWGIRYK 211
           N   LLG             Y   G +H  L + SP+  + S      +K  L+      
Sbjct: 73  NVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 132
Query: 212 IALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           +   +A G+ YL       ++H+D+   N+L+ +    +I D GL +
Sbjct: 133 LVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR 176

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 71/143 (49%), Gaps = 12/143 (8%)
Query: 118 IGKGGYAEVYKGRLRN-GQLVAIKR--LTRGTADEIIADFLSELGIMAHVDHPNTAKLLG 174
           IG+G    V    +R+ G+LVA+K+  L +    E++    +E+ IM    H N  ++  
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELL---FNEVVIMRDYQHENVVEMYN 88
Query: 175 -YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIH 233
            Y +   + +V+E    G+L  ++     ++       + L V + L  LH    + +IH
Sbjct: 89  SYLVGDELWVVMEFLEGGALTDIV--THTRMNEEQIAAVCLAVLQALSVLH---AQGVIH 143
Query: 234 RDIKAANILLTEDFEPQICDFGL 256
           RDIK+ +ILLT D   ++ DFG 
Sbjct: 144 RDIKSDSILLTHDGRVKLSDFGF 166

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 71/143 (49%), Gaps = 12/143 (8%)
Query: 118 IGKGGYAEVYKGRLRN-GQLVAIKR--LTRGTADEIIADFLSELGIMAHVDHPNTAKLLG 174
           IG+G    V    +R+ G+LVA+K+  L +    E++    +E+ IM    H N  ++  
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELL---FNEVVIMRDYQHENVVEMYN 95
Query: 175 -YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIH 233
            Y +   + +V+E    G+L  ++     ++       + L V + L  LH    + +IH
Sbjct: 96  SYLVGDELWVVMEFLEGGALTDIV--THTRMNEEQIAAVCLAVLQALSVLHA---QGVIH 150
Query: 234 RDIKAANILLTEDFEPQICDFGL 256
           RDIK+ +ILLT D   ++ DFG 
Sbjct: 151 RDIKSDSILLTHDGRVKLSDFGF 173

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 73/150 (48%), Gaps = 15/150 (10%)
Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGI 177
           +GKG Y EV++G L +G+ VA+K  +  + DE      +E+     + H N    +   +
Sbjct: 16  VGKGRYGEVWRG-LWHGESVAVKIFS--SRDEQSWFRETEIYNTVLLRHDNILGFIASDM 72
Query: 178 EG-----GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHE---GCQR 229
                   + ++     +GSL   L   ++ L+  +  ++A+  A GL +LH    G Q 
Sbjct: 73  TSRNSSTQLWLITHYHEHGSLYDFL--QRQTLEPHLALRLAVSAACGLAHLHVEIFGTQG 130
Query: 230 R--IIHRDIKAANILLTEDFEPQICDFGLA 257
           +  I HRD K+ N+L+  + +  I D GLA
Sbjct: 131 KPAIAHRDFKSRNVLVKSNLQCCIADLGLA 160

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 78/166 (46%), Gaps = 24/166 (14%)
Query: 118 IGKGGYAEVYKGRLRN-GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYG 176
           +G GG   V+     +  + VAIK++   T  + +   L E+ I+  +DH N  K+    
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVL-TDPQSVKHALREIKIIRRLDHDNIVKVFEIL 77
Query: 177 IEGGMHIVLELSPNGSLASL--LYGMKEKLKWGIRYKIALG-------------VAEGLL 221
              G  +  ++   GSL  L  +Y ++E ++  +   +  G             +  GL 
Sbjct: 78  GPSGSQLTDDV---GSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLLRGLK 134
Query: 222 YLHEGCQRRIIHRDIKAANILL-TEDFEPQICDFGLAKWLPEQWTH 266
           Y+H      ++HRD+K AN+ + TED   +I DFGLA+ +   ++H
Sbjct: 135 YIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSH 177

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 71/143 (49%), Gaps = 12/143 (8%)
Query: 118 IGKGGYAEVYKGRLRN-GQLVAIKR--LTRGTADEIIADFLSELGIMAHVDHPNTAKLLG 174
           IG+G    V    +R+ G+LVA+K+  L +    E++    +E+ IM    H N  ++  
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELL---FNEVVIMRDYQHENVVEMYN 215
Query: 175 -YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIH 233
            Y +   + +V+E    G+L  ++     ++       + L V + L  LH    + +IH
Sbjct: 216 SYLVGDELWVVMEFLEGGALTDIV--THTRMNEEQIAAVCLAVLQALSVLHA---QGVIH 270
Query: 234 RDIKAANILLTEDFEPQICDFGL 256
           RDIK+ +ILLT D   ++ DFG 
Sbjct: 271 RDIKSDSILLTHDGRVKLSDFGF 293

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 32/105 (30%), Positives = 52/105 (49%), Gaps = 4/105 (3%)
Query: 157 ELGIMAHVDHPNTAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALG 215
           E+ I++ V+H N  K+L  +  +G   +V+E   +G           +L   +   I   
Sbjct: 79  EIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQ 138
Query: 216 VAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL 260
           +   + YL     + IIHRDIK  NI++ EDF  ++ DFG A +L
Sbjct: 139 LVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL 180

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 72/157 (45%), Gaps = 13/157 (8%)
Query: 111 NFSFENLIGKGGYAEVYKGRL----RNGQLVAIKRLTRGT---ADEIIADFLSELGIMAH 163
           NF    ++G G Y +V+  R       G+L A+K L + T     +      +E  ++ H
Sbjct: 55  NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 114
Query: 164 VDHPNTAKLLGYGI--EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLL 221
           +        L Y    E  +H++L+    G L + L   +E+      +++ + V E +L
Sbjct: 115 IRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHL-SQRERF---TEHEVQIYVGEIVL 170
Query: 222 YLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
            L    +  II+RDIK  NILL  +    + DFGL+K
Sbjct: 171 ALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK 207

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 71/143 (49%), Gaps = 12/143 (8%)
Query: 118 IGKGGYAEVYKGRLRN-GQLVAIKR--LTRGTADEIIADFLSELGIMAHVDHPNTAKLLG 174
           IG+G    V    +R+ G+LVA+K+  L +    E++    +E+ IM    H N  ++  
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELL---FNEVVIMRDYQHENVVEMYN 138
Query: 175 -YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIH 233
            Y +   + +V+E    G+L  ++     ++       + L V + L  LH    + +IH
Sbjct: 139 SYLVGDELWVVMEFLEGGALTDIV--THTRMNEEQIAAVCLAVLQALSVLHA---QGVIH 193
Query: 234 RDIKAANILLTEDFEPQICDFGL 256
           RDIK+ +ILLT D   ++ DFG 
Sbjct: 194 RDIKSDSILLTHDGRVKLSDFGF 216

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 77/171 (45%), Gaps = 21/171 (12%)
Query: 101 SLYELQSATNNFSFENLIGKGGYAEVYKGRLRN------GQLVAIKRLT---RGTADEII 151
           S +  +   +++     +G G +A V K R +        + +  +RL+   RG + E I
Sbjct: 3   STFRQEDVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEI 62
Query: 152 ADFLSELGIMAHVDHPNTAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRY 210
                E+ I+  + HPN   L   +  +  + ++LEL   G L   L   KE L      
Sbjct: 63  E---REVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL-AEKESLTEDEAT 118
Query: 211 KIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEP----QICDFGLA 257
           +    + +G+ YLH    +RI H D+K  NI+L +   P    ++ DFG+A
Sbjct: 119 QFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA 166

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 64/152 (42%), Gaps = 18/152 (11%)
Query: 119 GKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPN-----TAKLL 173
            +G +  V+K +L N   VA+K       D+       E+     + H N      A+  
Sbjct: 24  ARGRFGCVWKAQLMN-DFVAVKIFP--LQDKQSWQSEREIFSTPGMKHENLLQFIAAEKR 80
Query: 174 GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHE-------- 225
           G  +E  + ++      GSL   L G    + W     +A  ++ GL YLHE        
Sbjct: 81  GSNLEVELWLITAFHDKGSLTDYLKG--NIITWNELCHVAETMSRGLSYLHEDVPWCRGE 138
Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLA 257
           G +  I HRD K+ N+LL  D    + DFGLA
Sbjct: 139 GHKPSIAHRDFKSKNVLLKSDLTAVLADFGLA 170

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 42/158 (26%), Positives = 74/158 (46%), Gaps = 20/158 (12%)
Query: 111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
            F F  ++G G ++EV+  + R  G+L A+K + +  A    +   +E+ ++  + H N 
Sbjct: 10  TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRD-SSLENEIAVLKKIKHENI 68
Query: 170 AKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYK-----IALGVAEGLLYL 223
             L   Y      ++V++L   G L   +      L+ G+  +     +   V   + YL
Sbjct: 69  VTLEDIYESTTHYYLVMQLVSGGELFDRI------LERGVYTEKDASLVIQQVLSAVKYL 122
Query: 224 HEGCQRRIIHRDIKAANILL---TEDFEPQICDFGLAK 258
           HE     I+HRD+K  N+L     E+ +  I DFGL+K
Sbjct: 123 HEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSK 157

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 44.7 bits (104), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 47/153 (30%), Positives = 74/153 (48%), Gaps = 21/153 (13%)
Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGY-- 175
           IGKG + EV++G+ R G+ VA+K  +         +  +E+     + H N   +LG+  
Sbjct: 12  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFRE--AEIYQTVMLRHEN---ILGFIA 65
Query: 176 ------GIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHE---G 226
                 G    + +V +   +GSL   L      ++  I  K+AL  A GL +LH    G
Sbjct: 66  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMI--KLALSTASGLAHLHMEIVG 123
Query: 227 CQRR--IIHRDIKAANILLTEDFEPQICDFGLA 257
            Q +  I HRD+K+ NIL+ ++    I D GLA
Sbjct: 124 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 156

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 76/162 (46%), Gaps = 16/162 (9%)
Query: 112 FSFENLIGKGGYAEVYKGRLRN-GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPN-- 168
           +  +  +G GG+  V +   ++ G+ VAIK+  +  + +    +  E+ IM  ++HPN  
Sbjct: 17  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 76
Query: 169 TAKLLGYGIEGGMH-----IVLELSPNGSLASLLYGMKE--KLKWGIRYKIALGVAEGLL 221
           +A+ +  G++         + +E    G L   L   +    LK G    +   ++  L 
Sbjct: 77  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALR 136
Query: 222 YLHEGCQRRIIHRDIKAANILLT---EDFEPQICDFGLAKWL 260
           YLHE    RIIHRD+K  NI+L    +    +I D G AK L
Sbjct: 137 YLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL 175

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 76/162 (46%), Gaps = 16/162 (9%)
Query: 112 FSFENLIGKGGYAEVYKGRLRN-GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPN-- 168
           +  +  +G GG+  V +   ++ G+ VAIK+  +  + +    +  E+ IM  ++HPN  
Sbjct: 16  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 75
Query: 169 TAKLLGYGIEGGMH-----IVLELSPNGSLASLLYGMKE--KLKWGIRYKIALGVAEGLL 221
           +A+ +  G++         + +E    G L   L   +    LK G    +   ++  L 
Sbjct: 76  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALR 135
Query: 222 YLHEGCQRRIIHRDIKAANILLT---EDFEPQICDFGLAKWL 260
           YLHE    RIIHRD+K  NI+L    +    +I D G AK L
Sbjct: 136 YLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL 174

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 47/153 (30%), Positives = 74/153 (48%), Gaps = 21/153 (13%)
Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGY-- 175
           IGKG + EV++G+ R G+ VA+K  +         +  +E+     + H N   +LG+  
Sbjct: 11  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFRE--AEIYQTVMLRHEN---ILGFIA 64
Query: 176 ------GIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHE---G 226
                 G    + +V +   +GSL   L      ++  I  K+AL  A GL +LH    G
Sbjct: 65  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMI--KLALSTASGLAHLHMEIVG 122
Query: 227 CQRR--IIHRDIKAANILLTEDFEPQICDFGLA 257
            Q +  I HRD+K+ NIL+ ++    I D GLA
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 68/153 (44%), Gaps = 24/153 (15%)
Query: 118 IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVD-HPNTAKLLG 174
           +GKG Y  V+K    R G++VA+K++     +   A     E+ I+  +  H N   LL 
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLN 76
Query: 175 YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLL---------YLHE 225
                    VL    +  +  +   M+  L   IR  I   V +  +         YLH 
Sbjct: 77  ---------VLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQLIKVIKYLHS 127
Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           G    ++HRD+K +NILL  +   ++ DFGL++
Sbjct: 128 GG---LLHRDMKPSNILLNAECHVKVADFGLSR 157

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 44.3 bits (103), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 47/153 (30%), Positives = 74/153 (48%), Gaps = 21/153 (13%)
Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGY-- 175
           IGKG + EV++G+ R G+ VA+K  +         +  +E+     + H N   +LG+  
Sbjct: 37  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFRE--AEIYQTVMLRHEN---ILGFIA 90
Query: 176 ------GIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHE---G 226
                 G    + +V +   +GSL   L      ++  I  K+AL  A GL +LH    G
Sbjct: 91  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMI--KLALSTASGLAHLHMEIVG 148
Query: 227 CQRR--IIHRDIKAANILLTEDFEPQICDFGLA 257
            Q +  I HRD+K+ NIL+ ++    I D GLA
Sbjct: 149 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 181

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 44.3 bits (103), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 47/153 (30%), Positives = 74/153 (48%), Gaps = 21/153 (13%)
Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGY-- 175
           IGKG + EV++G+ R G+ VA+K  +         +  +E+     + H N   +LG+  
Sbjct: 14  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFRE--AEIYQTVMLRHEN---ILGFIA 67
Query: 176 ------GIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHE---G 226
                 G    + +V +   +GSL   L      ++  I  K+AL  A GL +LH    G
Sbjct: 68  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMI--KLALSTASGLAHLHMEIVG 125
Query: 227 CQRR--IIHRDIKAANILLTEDFEPQICDFGLA 257
            Q +  I HRD+K+ NIL+ ++    I D GLA
Sbjct: 126 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 158

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 44.3 bits (103), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 47/153 (30%), Positives = 74/153 (48%), Gaps = 21/153 (13%)
Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGY-- 175
           IGKG + EV++G+ R G+ VA+K  +         +  +E+     + H N   +LG+  
Sbjct: 50  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFRE--AEIYQTVMLRHEN---ILGFIA 103
Query: 176 ------GIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHE---G 226
                 G    + +V +   +GSL   L      ++  I  K+AL  A GL +LH    G
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMI--KLALSTASGLAHLHMEIVG 161
Query: 227 CQRR--IIHRDIKAANILLTEDFEPQICDFGLA 257
            Q +  I HRD+K+ NIL+ ++    I D GLA
Sbjct: 162 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 194

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 47/153 (30%), Positives = 74/153 (48%), Gaps = 21/153 (13%)
Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGY-- 175
           IGKG + EV++G+ R G+ VA+K  +         +  +E+     + H N   +LG+  
Sbjct: 17  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFRE--AEIYQTVMLRHEN---ILGFIA 70
Query: 176 ------GIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHE---G 226
                 G    + +V +   +GSL   L      ++  I  K+AL  A GL +LH    G
Sbjct: 71  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMI--KLALSTASGLAHLHMEIVG 128
Query: 227 CQRR--IIHRDIKAANILLTEDFEPQICDFGLA 257
            Q +  I HRD+K+ NIL+ ++    I D GLA
Sbjct: 129 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 161

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 22/46 (47%), Positives = 31/46 (67%), Gaps = 3/46 (6%)
Query: 213 ALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           +  VA G+ +L     R+ IHRD+ A NILL+E+   +ICDFGLA+
Sbjct: 205 SFQVARGMEFL---SSRKCIHRDLAARNILLSENNVVKICDFGLAR 247

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 77/161 (47%), Gaps = 14/161 (8%)
Query: 109 TNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADE--IIADFLSELGIMAHVD 165
           ++ +    ++G GG +EV+  R LR+ + VA+K L    A +      F  E    A ++
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 166 HPNTAKLLGYG---IEGGM--HIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGV-AEG 219
           HP    +   G      G   +IV+E     +L  +++      +  +  K A+ V A+ 
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH-----TEGPMTPKRAIEVIADA 125
Query: 220 LLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL 260
              L+   Q  IIHRD+K ANIL++     ++ DFG+A+ +
Sbjct: 126 CQALNFSHQNGIIHRDVKPANILISATNAVKVVDFGIARAI 166

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/184 (23%), Positives = 88/184 (47%), Gaps = 17/184 (9%)
Query: 81  DMPRNLFVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAI 139
           ++ ++ +V  +   +   +  L E++   ++F    +IG+G ++EV   +++  GQ+ A+
Sbjct: 32  ELAQDKYVADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAM 91
Query: 140 K------RLTRGTADEIIADFLSELGIMAHVDHPNTAKL-LGYGIEGGMHIVLELSPNGS 192
           K       L RG     ++ F  E  ++ + D     +L   +  E  +++V+E    G 
Sbjct: 92  KIMNKWDMLKRGE----VSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGD 147
Query: 193 LASLLYGMKEKLKWGI-RYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQI 251
           L +LL    E++   + R+ +A    E ++ +    +   +HRDIK  NILL      ++
Sbjct: 148 LLTLLSKFGERIPAEMARFYLA----EIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRL 203
Query: 252 CDFG 255
            DFG
Sbjct: 204 ADFG 207

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 88/203 (43%), Gaps = 16/203 (7%)
Query: 112 FSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTA 170
           F F+  +G G ++EV     +  G+L A+K + +       +   +E+ ++  + H N  
Sbjct: 24  FEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIV 83
Query: 171 KLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIAL--GVAEGLLYLHEGC 227
            L   Y     +++V++L   G L   +    EK  +  +    L   V + + YLH   
Sbjct: 84  ALEDIYESPNHLYLVMQLVSGGELFDRIV---EKGFYTEKDASTLIRQVLDAVYYLH--- 137
Query: 228 QRRIIHRDIKAANIL-LTEDFEPQ--ICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNLP 284
           +  I+HRD+K  N+L  ++D E +  I DFGL+K    +     +S   GT G V   + 
Sbjct: 138 RMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKM---EGKGDVMSTACGTPGYVAPEVL 194
Query: 285 PLVILKRCFTCIFIGFSQLQLSC 307
                 +   C  IG     L C
Sbjct: 195 AQKPYSKAVDCWSIGVIAYILLC 217

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 71/158 (44%), Gaps = 26/158 (16%)
Query: 117 LIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYG 176
           +IG G +  V++ +L     VAIK++ +   D+   +   EL IM  V HPN   L  + 
Sbjct: 47  VIGNGSFGVVFQAKLVESDEVAIKKVLQ---DKRFKN--RELQIMRIVKHPNVVDLKAFF 101
Query: 177 IEGG-------MHIVLELSPNGSL-ASLLYG-MKEKLKWGIRYKIALGVAEGLLYLHEGC 227
              G       +++VLE  P     AS  Y  +K+ +   +       +   L Y+H   
Sbjct: 102 YSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG 161
Query: 228 QRRIIHRDIKAANILLTEDFEP-----QICDFGLAKWL 260
              I HRDIK  N+LL    +P     ++ DFG AK L
Sbjct: 162 ---ICHRDIKPQNLLL----DPPSGVLKLIDFGSAKIL 192

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 75/158 (47%), Gaps = 17/158 (10%)
Query: 109 TNNFSFENLIGKGG--YAEVYKGRLRNGQLVAIKR-LTRGTADEIIADFLSELGIMAHVD 165
             ++ F   +G+GG  Y ++ +G L +G   A+KR L     D   A    E  +    +
Sbjct: 28  NKHYLFIQKLGEGGFSYVDLVEG-LHDGHFYALKRILCHEQQDREEAQ--READMHRLFN 84
Query: 166 HPNTAKLLGYGIE--GGMH---IVLELSPNGSLASLLYGMKEKLKWGIRYKIA---LGVA 217
           HPN  +L+ Y +   G  H   ++L     G+L + +  +K+K  +    +I    LG+ 
Sbjct: 85  HPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGIC 144
Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFG 255
            GL  +H    +   HRD+K  NILL ++ +P + D G
Sbjct: 145 RGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLG 179

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/181 (24%), Positives = 85/181 (46%), Gaps = 16/181 (8%)
Query: 109 TNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADE--IIADFLSELGIMAHVD 165
           ++ +    ++G GG +EV+  R LR+ + VA+K L    A +      F  E    A ++
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 166 HPNTAKLLGYG---IEGGM--HIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGV-AEG 219
           HP    +   G      G   +IV+E     +L  +++      +  +  K A+ V A+ 
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH-----TEGPMTPKRAIEVIADA 125
Query: 220 LLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGLV 279
              L+   Q  IIHRD+K ANI+++     ++ DFG+A+ + +    +++++     G  
Sbjct: 126 CQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG--NSVTQTAAVIGTA 183
Query: 280 K 280
           +
Sbjct: 184 Q 184

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 41/153 (26%), Positives = 70/153 (45%), Gaps = 9/153 (5%)
Query: 111 NFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRG---TADEIIADFLSELGIMAHV-DH 166
           +F    +IG+G YA+V   RL+    +   R+ +      DE I    +E  +     +H
Sbjct: 53  DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNH 112
Query: 167 PNTAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHE 225
           P    L   +  E  +  V+E    G L   +   ++  +   R+  A  ++  L YLHE
Sbjct: 113 PFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNYLHE 171
Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
              R II+RD+K  N+LL  +   ++ D+G+ K
Sbjct: 172 ---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK 201

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 71/154 (46%), Gaps = 21/154 (13%)
Query: 118 IGKGGYAEVYKGRLRN------GQLVAIKRLT---RGTADEIIADFLSELGIMAHVDHPN 168
           +G G +A V K R +        + +  +RL+   RG + E I     E+ I+  + HPN
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIE---REVNILREIRHPN 69
Query: 169 TAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
              L   +  +  + ++LEL   G L   L   KE L      +    + +G+ YLH   
Sbjct: 70  IITLHDIFENKTDVVLILELVSGGELFDFL-AEKESLTEDEATQFLKQILDGVHYLH--- 125
Query: 228 QRRIIHRDIKAANILLTEDFEP----QICDFGLA 257
            +RI H D+K  NI+L +   P    ++ DFG+A
Sbjct: 126 SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA 159

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 81/176 (46%), Gaps = 28/176 (15%)
Query: 101 SLYELQSATNNFS----FENL--IGKGGYAEV---YKGRL-RNGQLVAIKRLTRGTADEI 150
             Y ++   + F+    ++NL  IG G    V   Y   L RN   VAIK+L+R   ++ 
Sbjct: 9   QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQT 65
Query: 151 IAD-FLSELGIMAHVDHPNTAKLLGYGIEG-------GMHIVLELSPNGSLASLLYGMKE 202
            A     EL +M  V+H N   LL              +++V+EL      A+L   ++ 
Sbjct: 66  HAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD----ANLXQVIQM 121
Query: 203 KLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           +L       +   +  G+ +LH      IIHRD+K +NI++  D   +I DFGLA+
Sbjct: 122 ELDHERMSYLLYQMLXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLAR 174

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/181 (24%), Positives = 85/181 (46%), Gaps = 16/181 (8%)
Query: 109 TNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADE--IIADFLSELGIMAHVD 165
           ++ +    ++G GG +EV+  R LR+ + VA+K L    A +      F  E    A ++
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 166 HPNTAKLLGYG---IEGGM--HIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGV-AEG 219
           HP    +   G      G   +IV+E     +L  +++      +  +  K A+ V A+ 
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH-----TEGPMTPKRAIEVIADA 125
Query: 220 LLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGLV 279
              L+   Q  IIHRD+K ANI+++     ++ DFG+A+ + +    +++++     G  
Sbjct: 126 CQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG--NSVTQTAAVIGTA 183
Query: 280 K 280
           +
Sbjct: 184 Q 184

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 83/198 (41%), Gaps = 29/198 (14%)
Query: 118 IGKGGYAEVYKGRLRN------GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAK 171
           +G+G + +V+     N        LVA+K L   + +    DF  E  ++  + H +  +
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTMLQHQHIVR 107
Query: 172 LLGYGIEG-GMHIVLELSPNGSL----------ASLLYGMKE----KLKWGIRYKIALGV 216
             G   EG  + +V E   +G L          A LL G ++     L  G    +A  V
Sbjct: 108 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 167
Query: 217 AEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTF 276
           A G++YL        +HRD+   N L+ +    +I DFG+++ +          +V G  
Sbjct: 168 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYST----DYYRVGGRT 220
Query: 277 GLVKLNLPPLVILKRCFT 294
            L    +PP  IL R FT
Sbjct: 221 MLPIRWMPPESILYRKFT 238

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 46/171 (26%), Positives = 76/171 (44%), Gaps = 21/171 (12%)
Query: 101 SLYELQSATNNFSFENLIGKGGYAEVYKGRLRN------GQLVAIKRLT---RGTADEII 151
           +LY      +++     +G G +A V K R +        + +  +RL    RG + E I
Sbjct: 17  NLYFQSMVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEI 76
Query: 152 ADFLSELGIMAHVDHPNTAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRY 210
                E+ I+  + HPN   L   +  +  + ++LEL   G L   L   KE L      
Sbjct: 77  E---REVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL-AEKESLTEDEAT 132
Query: 211 KIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEP----QICDFGLA 257
           +    + +G+ YLH    +RI H D+K  NI+L +   P    ++ DFG+A
Sbjct: 133 QFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA 180

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/131 (32%), Positives = 68/131 (51%), Gaps = 17/131 (12%)
Query: 137 VAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNTAKLLGY-----GIE--GGMHIVLEL- 187
           VAIK+L+R   ++  A     EL +M  V+H N   LL        +E    ++IV+EL 
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 188 SPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDF 247
             N S    +    E++ + + Y++ +G+     +LH      IIHRD+K +NI++  D 
Sbjct: 112 DANLSQVIQMELDHERMSY-LLYQMLVGIK----HLHSAG---IIHRDLKPSNIVVKSDA 163
Query: 248 EPQICDFGLAK 258
             +I DFGLA+
Sbjct: 164 TLKILDFGLAR 174

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 83/198 (41%), Gaps = 29/198 (14%)
Query: 118 IGKGGYAEVYKGRLRN------GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAK 171
           +G+G + +V+     N        LVA+K L   + +    DF  E  ++  + H +  +
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTMLQHQHIVR 78
Query: 172 LLGYGIEG-GMHIVLELSPNGSL----------ASLLYGMKE----KLKWGIRYKIALGV 216
             G   EG  + +V E   +G L          A LL G ++     L  G    +A  V
Sbjct: 79  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 138
Query: 217 AEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTF 276
           A G++YL        +HRD+   N L+ +    +I DFG+++ +          +V G  
Sbjct: 139 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYST----DYYRVGGRT 191
Query: 277 GLVKLNLPPLVILKRCFT 294
            L    +PP  IL R FT
Sbjct: 192 MLPIRWMPPESILYRKFT 209

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 22/43 (51%), Positives = 30/43 (69%), Gaps = 3/43 (6%)
Query: 216 VAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           VA+G+ +L     R+ IHRD+ A NILL+E    +ICDFGLA+
Sbjct: 200 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 239

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 83/198 (41%), Gaps = 29/198 (14%)
Query: 118 IGKGGYAEVYKGRLRN------GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAK 171
           +G+G + +V+     N        LVA+K L   + +    DF  E  ++  + H +  +
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTMLQHQHIVR 84
Query: 172 LLGYGIEG-GMHIVLELSPNGSL----------ASLLYGMKE----KLKWGIRYKIALGV 216
             G   EG  + +V E   +G L          A LL G ++     L  G    +A  V
Sbjct: 85  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 144
Query: 217 AEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTF 276
           A G++YL        +HRD+   N L+ +    +I DFG+++ +          +V G  
Sbjct: 145 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYST----DYYRVGGRT 197
Query: 277 GLVKLNLPPLVILKRCFT 294
            L    +PP  IL R FT
Sbjct: 198 MLPIRWMPPESILYRKFT 215

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 22/43 (51%), Positives = 30/43 (69%), Gaps = 3/43 (6%)
Query: 216 VAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           VA+G+ +L     R+ IHRD+ A NILL+E    +ICDFGLA+
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 241

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 52/176 (29%), Positives = 85/176 (48%), Gaps = 28/176 (15%)
Query: 101 SLYELQSATNNFS----FENL--IGKGGYAEV---YKGRLRNGQLVAIKRLTRGTADEII 151
           + Y ++   + F+    ++NL  IG G    V   Y   L     VAIK+L+R   ++  
Sbjct: 9   NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVVAAYDAILERN--VAIKKLSRPFQNQTH 66
Query: 152 AD-FLSELGIMAHVDHPNTAKLLGY-----GIE--GGMHIVLEL-SPNGSLASLLYGMKE 202
           A     EL +M  V+H N   LL        +E    ++IV+EL   N S    +    E
Sbjct: 67  AKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHE 126
Query: 203 KLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           ++ + + Y++ +G+     +LH      IIHRD+K +NI++  D   +I DFGLA+
Sbjct: 127 RMSY-LLYQMLVGIK----HLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLAR 174

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 52/176 (29%), Positives = 85/176 (48%), Gaps = 28/176 (15%)
Query: 101 SLYELQSATNNFS----FENL--IGKGGYAEV---YKGRLRNGQLVAIKRLTRGTADEII 151
           + Y ++   + F+    ++NL  IG G    V   Y   L     VAIK+L+R   ++  
Sbjct: 9   NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTH 66
Query: 152 AD-FLSELGIMAHVDHPNTAKLLGY-----GIE--GGMHIVLEL-SPNGSLASLLYGMKE 202
           A     EL +M  V+H N   LL        +E    ++IV+EL   N S    +    E
Sbjct: 67  AKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHE 126
Query: 203 KLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           ++ + + Y++ +G+     +LH      IIHRD+K +NI++  D   +I DFGLA+
Sbjct: 127 RMSY-LLYQMLVGIK----HLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLAR 174

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 22/43 (51%), Positives = 30/43 (69%), Gaps = 3/43 (6%)
Query: 216 VAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           VA+G+ +L     R+ IHRD+ A NILL+E    +ICDFGLA+
Sbjct: 207 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 246

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 22/43 (51%), Positives = 30/43 (69%), Gaps = 3/43 (6%)
Query: 216 VAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           VA+G+ +L     R+ IHRD+ A NILL+E    +ICDFGLA+
Sbjct: 209 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 248

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 79/176 (44%), Gaps = 28/176 (15%)
Query: 101 SLYELQSATNNFS----FENL--IGKGGYAEV---YKGRL-RNGQLVAIKRLTRGTADEI 150
             Y ++   + F+    ++NL  IG G    V   Y   L RN   VAIK+L+R   ++ 
Sbjct: 9   QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQT 65
Query: 151 IAD-FLSELGIMAHVDHPNTAKLLGYGIEG-------GMHIVLELSPNGSLASLLYGMKE 202
            A     EL +M  V+H N   LL              +++V+EL        +   +  
Sbjct: 66  HAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDH 125
Query: 203 KLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           +    + Y++  G+     +LH      IIHRD+K +NI++  D   +I DFGLA+
Sbjct: 126 ERMSYLLYQMLCGIK----HLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLAR 174

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 79/176 (44%), Gaps = 28/176 (15%)
Query: 101 SLYELQSATNNFS----FENL--IGKGGYAEV---YKGRL-RNGQLVAIKRLTRGTADEI 150
             Y ++   + F+    ++NL  IG G    V   Y   L RN   VAIK+L+R   ++ 
Sbjct: 9   QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQT 65
Query: 151 IAD-FLSELGIMAHVDHPNTAKLLGYGIEG-------GMHIVLELSPNGSLASLLYGMKE 202
            A     EL +M  V+H N   LL              +++V+EL        +   +  
Sbjct: 66  HAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDH 125
Query: 203 KLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           +    + Y++  G+     +LH      IIHRD+K +NI++  D   +I DFGLA+
Sbjct: 126 ERMSYLLYQMLCGIK----HLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLAR 174

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 36/127 (28%), Positives = 61/127 (48%), Gaps = 11/127 (8%)
Query: 133 NGQLVAIKR--LTRGTADEIIADFLSELGIMAHVDHPNTAKLLG-YGIEGGMHIVLELSP 189
            G+ VA+K+  L +    E++    +E+ IM    H N   +   Y +   + +V+E   
Sbjct: 69  TGKQVAVKKMDLRKQQRRELL---FNEVVIMRDYHHDNVVDMYSSYLVGDELWVVMEFLE 125
Query: 190 NGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEP 249
            G+L  ++     ++       + L V   L YLH    + +IHRDIK+ +ILLT D   
Sbjct: 126 GGALTDIV--THTRMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRI 180
Query: 250 QICDFGL 256
           ++ DFG 
Sbjct: 181 KLSDFGF 187

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 81/176 (46%), Gaps = 28/176 (15%)
Query: 101 SLYELQSATNNFS----FENL--IGKGGYAEV---YKGRL-RNGQLVAIKRLTRGTADEI 150
             Y ++   + F+    ++NL  IG G    V   Y   L RN   VAIK+L+R   ++ 
Sbjct: 9   QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQT 65
Query: 151 IAD-FLSELGIMAHVDHPNTAKLLGYGIEG-------GMHIVLELSPNGSLASLLYGMKE 202
            A     EL +M  V+H N   LL              +++V+EL      A+L   ++ 
Sbjct: 66  HAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD----ANLXQVIQM 121
Query: 203 KLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           +L       +   +  G+ +LH      IIHRD+K +NI++  D   +I DFGLA+
Sbjct: 122 ELDHERMSYLLYQMLXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLAR 174

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 51/181 (28%), Positives = 84/181 (46%), Gaps = 19/181 (10%)
Query: 117 LIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIA--DFLSELGIMAHVDHPNTAKLL 173
           ++G+GG+ EV+  +++  G+L A K+L +    +       + E  I+A V H      L
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-HSRFIVSL 250
Query: 174 GYGIEG--GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIAL----GVAEGLLYLHEGC 227
            Y  E    + +V+ +   G +   +Y + E    G +   A+     +  GL +LH   
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDED-NPGFQEPRAIFYTAQIVSGLEHLH--- 306
Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPLV 287
           QR II+RD+K  N+LL +D   +I D GLA  L    T     K +G  G      P L+
Sbjct: 307 QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT-----KTKGYAGTPGFMAPELL 361
Query: 288 I 288
           +
Sbjct: 362 L 362

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 81/176 (46%), Gaps = 28/176 (15%)
Query: 101 SLYELQSATNNFS----FENL--IGKGGYAEV---YKGRL-RNGQLVAIKRLTRGTADEI 150
             Y ++   + F+    ++NL  IG G    V   Y   L RN   VAIK+L+R   ++ 
Sbjct: 2   QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQT 58
Query: 151 IAD-FLSELGIMAHVDHPNTAKLLGYGIEG-------GMHIVLELSPNGSLASLLYGMKE 202
            A     EL +M  V+H N   LL              +++V+EL      A+L   ++ 
Sbjct: 59  HAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD----ANLXQVIQM 114
Query: 203 KLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           +L       +   +  G+ +LH      IIHRD+K +NI++  D   +I DFGLA+
Sbjct: 115 ELDHERMSYLLYQMLXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLAR 167

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 40/153 (26%), Positives = 70/153 (45%), Gaps = 9/153 (5%)
Query: 111 NFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRG---TADEIIADFLSELGIMAHV-DH 166
           +F    +IG+G YA+V   RL+    +   ++ +      DE I    +E  +     +H
Sbjct: 21  DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNH 80
Query: 167 PNTAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHE 225
           P    L   +  E  +  V+E    G L   +   ++  +   R+  A  ++  L YLHE
Sbjct: 81  PFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNYLHE 139
Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
              R II+RD+K  N+LL  +   ++ D+G+ K
Sbjct: 140 ---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK 169

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 37/149 (24%), Positives = 69/149 (46%), Gaps = 7/149 (4%)
Query: 111 NFSFENLIGKGGYAEVYKGRLRNGQLV-AIKRLTRGTA--DEIIADFLSELGIMAHVDHP 167
           +F    +IG+G + EV   +L+N   V A+K L +         A F  E  ++ + D  
Sbjct: 75  DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSK 134
Query: 168 NTAKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEG 226
               L   +  +  +++V++    G L +LL   +++L   +       +AE ++ +   
Sbjct: 135 WITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEM---ARFYLAEMVIAIDSV 191
Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFG 255
            Q   +HRDIK  NIL+  +   ++ DFG
Sbjct: 192 HQLHYVHRDIKPDNILMDMNGHIRLADFG 220

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 40/153 (26%), Positives = 70/153 (45%), Gaps = 9/153 (5%)
Query: 111 NFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRG---TADEIIADFLSELGIMAHV-DH 166
           +F    +IG+G YA+V   RL+    +   ++ +      DE I    +E  +     +H
Sbjct: 6   DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNH 65
Query: 167 PNTAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHE 225
           P    L   +  E  +  V+E    G L   +   ++  +   R+  A  ++  L YLHE
Sbjct: 66  PFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNYLHE 124
Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
              R II+RD+K  N+LL  +   ++ D+G+ K
Sbjct: 125 ---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK 154

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 56/177 (31%), Positives = 82/177 (46%), Gaps = 31/177 (17%)
Query: 106 QSATNNFSFENLIGKGGYAEV-YKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHV 164
           QS  N    E ++G G    V ++G  + G+ VA+KR+     D  IA  L E+ ++   
Sbjct: 11  QSLKNLVVSEKILGYGSSGTVVFQGSFQ-GRPVAVKRMLIDFCD--IA--LMEIKLLTES 65
Query: 165 D-HPNTAKLL-GYGIEGGMHIVLELSPNGSLASLLYGMK---EKLKWGIRYK-IAL--GV 216
           D HPN  +       +  ++I LEL  N +L  L+       E LK    Y  I+L   +
Sbjct: 66  DDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQI 124
Query: 217 AEGLLYLHEGCQRRIIHRDIKAANILLT-------------EDFEPQICDFGLAKWL 260
           A G+ +LH     +IIHRD+K  NIL++             E+    I DFGL K L
Sbjct: 125 ASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKL 178

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 44/150 (29%), Positives = 74/150 (49%), Gaps = 14/150 (9%)
Query: 117 LIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIA--DFLSELGIMAHVDHPNTAKLL 173
           ++G+GG+ EV+  +++  G+L A K+L +    +       + E  I+A V H      L
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-HSRFIVSL 250
Query: 174 GYGIEG--GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIAL----GVAEGLLYLHEGC 227
            Y  E    + +V+ +   G +   +Y + E    G +   A+     +  GL +LH   
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDED-NPGFQEPRAIFYTAQIVSGLEHLH--- 306
Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLA 257
           QR II+RD+K  N+LL +D   +I D GLA
Sbjct: 307 QRNIIYRDLKPENVLLDDDGNVRISDLGLA 336

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 44/150 (29%), Positives = 74/150 (49%), Gaps = 14/150 (9%)
Query: 117 LIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIA--DFLSELGIMAHVDHPNTAKLL 173
           ++G+GG+ EV+  +++  G+L A K+L +    +       + E  I+A V H      L
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-HSRFIVSL 250
Query: 174 GYGIEG--GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIAL----GVAEGLLYLHEGC 227
            Y  E    + +V+ +   G +   +Y + E    G +   A+     +  GL +LH   
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDED-NPGFQEPRAIFYTAQIVSGLEHLH--- 306
Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLA 257
           QR II+RD+K  N+LL +D   +I D GLA
Sbjct: 307 QRNIIYRDLKPENVLLDDDGNVRISDLGLA 336

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 44/150 (29%), Positives = 74/150 (49%), Gaps = 14/150 (9%)
Query: 117 LIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIA--DFLSELGIMAHVDHPNTAKLL 173
           ++G+GG+ EV+  +++  G+L A K+L +    +       + E  I+A V H      L
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-HSRFIVSL 250
Query: 174 GYGIEG--GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIAL----GVAEGLLYLHEGC 227
            Y  E    + +V+ +   G +   +Y + E    G +   A+     +  GL +LH   
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDED-NPGFQEPRAIFYTAQIVSGLEHLH--- 306
Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLA 257
           QR II+RD+K  N+LL +D   +I D GLA
Sbjct: 307 QRNIIYRDLKPENVLLDDDGNVRISDLGLA 336

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 56/177 (31%), Positives = 82/177 (46%), Gaps = 31/177 (17%)
Query: 106 QSATNNFSFENLIGKGGYAEV-YKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHV 164
           QS  N    E ++G G    V ++G  + G+ VA+KR+     D  IA  L E+ ++   
Sbjct: 11  QSLKNLVVSEKILGYGSSGTVVFQGSFQ-GRPVAVKRMLIDFCD--IA--LMEIKLLTES 65
Query: 165 D-HPNTAKLL-GYGIEGGMHIVLELSPNGSLASLLYGMK---EKLKWGIRYK-IAL--GV 216
           D HPN  +       +  ++I LEL  N +L  L+       E LK    Y  I+L   +
Sbjct: 66  DDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQI 124
Query: 217 AEGLLYLHEGCQRRIIHRDIKAANILLT-------------EDFEPQICDFGLAKWL 260
           A G+ +LH     +IIHRD+K  NIL++             E+    I DFGL K L
Sbjct: 125 ASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKL 178

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 78/175 (44%), Gaps = 26/175 (14%)
Query: 101 SLYELQSATNNFS----FENL--IGKGGYAEV---YKGRLRNGQLVAIKRLTRGTADEII 151
           + Y ++   + F+    ++NL  IG G    V   Y   L     VAIK+L+R   ++  
Sbjct: 9   NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTH 66
Query: 152 AD-FLSELGIMAHVDHPNTAKLLGYGIEG-------GMHIVLELSPNGSLASLLYGMKEK 203
           A     EL +M  V+H N   LL              ++IV+EL        +   +  +
Sbjct: 67  AKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHE 126
Query: 204 LKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
               + Y++  G+     +LH      IIHRD+K +NI++  D   +I DFGLA+
Sbjct: 127 RMSYLLYQMLCGIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 174

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 40/153 (26%), Positives = 70/153 (45%), Gaps = 9/153 (5%)
Query: 111 NFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRG---TADEIIADFLSELGIMAHV-DH 166
           +F    +IG+G YA+V   RL+    +   ++ +      DE I    +E  +     +H
Sbjct: 10  DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNH 69
Query: 167 PNTAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHE 225
           P    L   +  E  +  V+E    G L   +   ++  +   R+  A  ++  L YLHE
Sbjct: 70  PFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNYLHE 128
Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
              R II+RD+K  N+LL  +   ++ D+G+ K
Sbjct: 129 ---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK 158

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 23/61 (37%), Positives = 36/61 (59%), Gaps = 6/61 (9%)
Query: 216 VAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE---QWTHHTISKV 272
           + +G+ + H+    RI+HRDIK  NIL+  +   +I DFG+AK L E     T+H +  V
Sbjct: 120 ILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTV 176
Query: 273 E 273
           +
Sbjct: 177 Q 177

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 78/175 (44%), Gaps = 26/175 (14%)
Query: 101 SLYELQSATNNFS----FENL--IGKGGYAEV---YKGRLRNGQLVAIKRLTRGTADEII 151
           + Y ++   + F+    ++NL  IG G    V   Y   L     VAIK+L+R   ++  
Sbjct: 3   NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTH 60
Query: 152 AD-FLSELGIMAHVDHPNTAKLLGYGIEG-------GMHIVLELSPNGSLASLLYGMKEK 203
           A     EL +M  V+H N   LL              ++IV+EL        +   +  +
Sbjct: 61  AKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHE 120
Query: 204 LKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
               + Y++  G+     +LH      IIHRD+K +NI++  D   +I DFGLA+
Sbjct: 121 RMSYLLYQMLCGIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 168

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 73/162 (45%), Gaps = 15/162 (9%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVD 165
           ++   + +    +GKG Y EV++G  + G+ VA+K  +  + DE      +EL     + 
Sbjct: 4   RTVARDITLLECVGKGRYGEVWRGSWQ-GENVAVKIFS--SRDEKSWFRETELYNTVMLR 60
Query: 166 HPNTAKLLGYGIEG-----GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGL 220
           H N    +   +        + ++      GSL    Y     L      +I L +A GL
Sbjct: 61  HENILGFIASDMTSRHSSTQLWLITHYHEMGSLYD--YLQLTTLDTVSCLRIVLSIASGL 118
Query: 221 LYLHE---GCQRR--IIHRDIKAANILLTEDFEPQICDFGLA 257
            +LH    G Q +  I HRD+K+ NIL+ ++ +  I D GLA
Sbjct: 119 AHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA 160

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 78/175 (44%), Gaps = 26/175 (14%)
Query: 101 SLYELQSATNNFS----FENL--IGKGGYAEV---YKGRLRNGQLVAIKRLTRGTADEII 151
           + Y ++   + F+    ++NL  IG G    V   Y   L     VAIK+L+R   ++  
Sbjct: 9   NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTH 66
Query: 152 AD-FLSELGIMAHVDHPNTAKLLGYGIEG-------GMHIVLELSPNGSLASLLYGMKEK 203
           A     EL +M  V+H N   LL              ++IV+EL        +   +  +
Sbjct: 67  AKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHE 126
Query: 204 LKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
               + Y++  G+     +LH      IIHRD+K +NI++  D   +I DFGLA+
Sbjct: 127 RMSYLLYQMLCGIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 174

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 52/176 (29%), Positives = 84/176 (47%), Gaps = 28/176 (15%)
Query: 101 SLYELQSATNNFS----FENL--IGKGGYAEV---YKGRLRNGQLVAIKRLTRGTADEII 151
           + Y ++   + F+    ++NL  IG G    V   Y   L     VAIK+L+R   ++  
Sbjct: 9   NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTH 66
Query: 152 AD-FLSELGIMAHVDHPNTAKLLGY-----GIE--GGMHIVLEL-SPNGSLASLLYGMKE 202
           A     EL +M  V+H N   LL        +E    ++IV+EL   N S    +    E
Sbjct: 67  AKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHE 126
Query: 203 KLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           ++ + + Y++  G+     +LH      IIHRD+K +NI++  D   +I DFGLA+
Sbjct: 127 RMSY-LLYQMLCGIK----HLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLAR 174

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 78/175 (44%), Gaps = 26/175 (14%)
Query: 101 SLYELQSATNNFS----FENL--IGKGGYAEV---YKGRLRNGQLVAIKRLTRGTADEII 151
           + Y ++   + F+    ++NL  IG G    V   Y   L     VAIK+L+R   ++  
Sbjct: 14  NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTH 71
Query: 152 AD-FLSELGIMAHVDHPNTAKLLGYGIEG-------GMHIVLELSPNGSLASLLYGMKEK 203
           A     EL +M  V+H N   LL              ++IV+EL        +   +  +
Sbjct: 72  AKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHE 131
Query: 204 LKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
               + Y++  G+     +LH      IIHRD+K +NI++  D   +I DFGLA+
Sbjct: 132 RMSYLLYQMLCGIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 179

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 81/205 (39%), Gaps = 53/205 (25%)
Query: 101 SLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLV-AIKRLTRGTADEI----IADFL 155
           SL ELQ     +  +  IG+G Y  V        + + AIK + +    +I    +    
Sbjct: 20  SLLELQKK---YHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIK 76
Query: 156 SELGIMAHVDHPNTAKLLG-YGIEGGMHIVLELSPNGSLASLL----------------- 197
           +E+ +M  + HPN A+L   Y  E  + +V+EL   G L   L                 
Sbjct: 77  TEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVK 136
Query: 198 ------------------YGMKEKLKWGIRYK----IALGVAEGLLYLHEGCQRRIIHRD 235
                             +G +E L +  R K    I   +   L YLH    + I HRD
Sbjct: 137 TQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRD 193
Query: 236 IKAANILLTED--FEPQICDFGLAK 258
           IK  N L + +  FE ++ DFGL+K
Sbjct: 194 IKPENFLFSTNKSFEIKLVDFGLSK 218

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 44/181 (24%), Positives = 84/181 (46%), Gaps = 16/181 (8%)
Query: 109 TNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADE--IIADFLSELGIMAHVD 165
           ++ +    ++G GG +EV+  R LR  + VA+K L    A +      F  E    A ++
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 166 HPNTAKLLGYG---IEGGM--HIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGV-AEG 219
           HP    +   G      G   +IV+E     +L  +++      +  +  K A+ V A+ 
Sbjct: 71  HPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVH-----TEGPMTPKRAIEVIADA 125
Query: 220 LLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGLV 279
              L+   Q  IIHRD+K ANI+++     ++ DFG+A+ + +    +++++     G  
Sbjct: 126 CQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG--NSVTQTAAVIGTA 183
Query: 280 K 280
           +
Sbjct: 184 Q 184

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 73/162 (45%), Gaps = 15/162 (9%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVD 165
           ++  +  +    +GKG Y EV++G  + G+ VA+K  +  + DE      +EL     + 
Sbjct: 4   RTVAHQITLLECVGKGRYGEVWRGSWQ-GENVAVKIFS--SRDEKSWFRETELYNTVMLR 60
Query: 166 HPNTAKLLGYGIEG-----GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGL 220
           H N    +   +        + ++      GSL    Y     L      +I L +A GL
Sbjct: 61  HENILGFIASDMTSRHSSTQLWLITHYHEMGSLYD--YLQLTTLDTVSCLRIVLSIASGL 118
Query: 221 LYLHE---GCQRR--IIHRDIKAANILLTEDFEPQICDFGLA 257
            +LH    G Q +  I HRD+K+ NIL+ ++ +  I D GLA
Sbjct: 119 AHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA 160

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 79/175 (45%), Gaps = 28/175 (16%)
Query: 102 LYELQSATNNFS----FENL--IGKGGYAEV---YKGRL-RNGQLVAIKRLTRGTADEII 151
            Y ++   + F+    ++NL  IG G    V   Y   L RN   VAIK+L+R   ++  
Sbjct: 48  FYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTH 104
Query: 152 AD-FLSELGIMAHVDHPNTAKLLGYGIEG-------GMHIVLELSPNGSLASLLYGMKEK 203
           A     EL +M  V+H N   LL              +++V+EL        +   +  +
Sbjct: 105 AKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHE 164
Query: 204 LKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
               + Y++  G+     +LH      IIHRD+K +NI++  D   +I DFGLA+
Sbjct: 165 RMSYLLYQMLCGIK----HLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR 212

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 78/175 (44%), Gaps = 26/175 (14%)
Query: 101 SLYELQSATNNFS----FENL--IGKGGYAEV---YKGRLRNGQLVAIKRLTRGTADEII 151
           + Y ++   + F+    ++NL  IG G    V   Y   L     VAIK+L+R   ++  
Sbjct: 9   NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTH 66
Query: 152 AD-FLSELGIMAHVDHPNTAKLLGYGIEG-------GMHIVLELSPNGSLASLLYGMKEK 203
           A     EL +M  V+H N   LL              ++IV+EL        +   +  +
Sbjct: 67  AKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHE 126
Query: 204 LKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
               + Y++  G+     +LH      IIHRD+K +NI++  D   +I DFGLA+
Sbjct: 127 RMSYLLYQMLCGIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 174

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 79/176 (44%), Gaps = 28/176 (15%)
Query: 101 SLYELQSATNNFS----FENL--IGKGGYAEV---YKGRL-RNGQLVAIKRLTRGTADEI 150
             Y ++   + F+    ++NL  IG G    V   Y   L RN   VAIK+L+R   ++ 
Sbjct: 9   QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQT 65
Query: 151 IAD-FLSELGIMAHVDHPNTAKLLGYGIEG-------GMHIVLELSPNGSLASLLYGMKE 202
            A     EL +M  V+H N   LL              +++V+EL        +   +  
Sbjct: 66  HAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDH 125
Query: 203 KLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           +    + Y++  G+     +LH      IIHRD+K +NI++  D   +I DFGLA+
Sbjct: 126 ERMSYLLYQMLCGIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 174

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 78/175 (44%), Gaps = 26/175 (14%)
Query: 101 SLYELQSATNNFS----FENL--IGKGGYAEV---YKGRLRNGQLVAIKRLTRGTADEII 151
           + Y ++   + F+    ++NL  IG G    V   Y   L     VAIK+L+R   ++  
Sbjct: 9   NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTH 66
Query: 152 AD-FLSELGIMAHVDHPNTAKLLGYGIEG-------GMHIVLELSPNGSLASLLYGMKEK 203
           A     EL +M  V+H N   LL              ++IV+EL        +   +  +
Sbjct: 67  AKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHE 126
Query: 204 LKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
               + Y++  G+     +LH      IIHRD+K +NI++  D   +I DFGLA+
Sbjct: 127 RMSYLLYQMLCGIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 174

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 79/176 (44%), Gaps = 28/176 (15%)
Query: 101 SLYELQSATNNFS----FENL--IGKGGYAEV---YKGRL-RNGQLVAIKRLTRGTADEI 150
             Y ++   + F+    ++NL  IG G    V   Y   L RN   VAIK+L+R   ++ 
Sbjct: 9   QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQT 65
Query: 151 IAD-FLSELGIMAHVDHPNTAKLLGYGIEG-------GMHIVLELSPNGSLASLLYGMKE 202
            A     EL +M  V+H N   LL              +++V+EL        +   +  
Sbjct: 66  HAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDH 125
Query: 203 KLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           +    + Y++  G+     +LH      IIHRD+K +NI++  D   +I DFGLA+
Sbjct: 126 ERMSYLLYQMLCGIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 174

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 79/175 (45%), Gaps = 28/175 (16%)
Query: 102 LYELQSATNNFS----FENL--IGKGGYAEV---YKGRL-RNGQLVAIKRLTRGTADEII 151
            Y ++   + F+    ++NL  IG G    V   Y   L RN   VAIK+L+R   ++  
Sbjct: 48  FYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTH 104
Query: 152 AD-FLSELGIMAHVDHPNTAKLLGYGIEG-------GMHIVLELSPNGSLASLLYGMKEK 203
           A     EL +M  V+H N   LL              +++V+EL        +   +  +
Sbjct: 105 AKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHE 164
Query: 204 LKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
               + Y++  G+     +LH      IIHRD+K +NI++  D   +I DFGLA+
Sbjct: 165 RMSYLLYQMLCGIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 212

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 82/176 (46%), Gaps = 28/176 (15%)
Query: 101 SLYELQSATNNFS----FENL--IGKGGYAEV---YKGRLRNGQLVAIKRLTRGTADEII 151
           + Y ++   + F+    ++NL  IG G    V   Y   L     VAIK+L+R   ++  
Sbjct: 9   NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTH 66
Query: 152 AD-FLSELGIMAHVDHPNTAKLLGYGIEG-------GMHIVLEL-SPNGSLASLLYGMKE 202
           A     EL +M  V+H N   LL              ++IV+EL   N S    +    E
Sbjct: 67  AKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHE 126
Query: 203 KLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           ++ + + Y++  G+     +LH      IIHRD+K +NI++  D   +I DFGLA+
Sbjct: 127 RMSY-LLYQMLCGIK----HLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLAR 174

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 41.6 bits (96), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 79/176 (44%), Gaps = 28/176 (15%)
Query: 101 SLYELQSATNNFS----FENL--IGKGGYAEV---YKGRL-RNGQLVAIKRLTRGTADEI 150
             Y ++   + F+    ++NL  IG G    V   Y   L RN   VAIK+L+R   ++ 
Sbjct: 10  QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQT 66
Query: 151 IAD-FLSELGIMAHVDHPNTAKLLGYGIEG-------GMHIVLELSPNGSLASLLYGMKE 202
            A     EL +M  V+H N   LL              +++V+EL        +   +  
Sbjct: 67  HAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDH 126
Query: 203 KLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           +    + Y++  G+     +LH      IIHRD+K +NI++  D   +I DFGLA+
Sbjct: 127 ERMSYLLYQMLCGIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 175

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 41.6 bits (96), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 79/176 (44%), Gaps = 28/176 (15%)
Query: 101 SLYELQSATNNFS----FENL--IGKGGYAEV---YKGRL-RNGQLVAIKRLTRGTADEI 150
             Y ++   + F+    ++NL  IG G    V   Y   L RN   VAIK+L+R   ++ 
Sbjct: 10  QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQT 66
Query: 151 IAD-FLSELGIMAHVDHPNTAKLLGYGIEG-------GMHIVLELSPNGSLASLLYGMKE 202
            A     EL +M  V+H N   LL              +++V+EL        +   +  
Sbjct: 67  HAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDH 126
Query: 203 KLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           +    + Y++  G+     +LH      IIHRD+K +NI++  D   +I DFGLA+
Sbjct: 127 ERMSYLLYQMLCGIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 175

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 41.6 bits (96), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 56/177 (31%), Positives = 82/177 (46%), Gaps = 31/177 (17%)
Query: 106 QSATNNFSFENLIGKGGYAEV-YKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHV 164
           QS  N    E ++G G    V ++G  + G+ VA+KR+     D  IA  L E+ ++   
Sbjct: 29  QSLKNLVVSEKILGYGSSGTVVFQGSFQ-GRPVAVKRMLIDFCD--IA--LMEIKLLTES 83
Query: 165 D-HPNTAKLL-GYGIEGGMHIVLELSPNGSLASLLYGMK---EKLKWGIRYK-IAL--GV 216
           D HPN  +       +  ++I LEL  N +L  L+       E LK    Y  I+L   +
Sbjct: 84  DDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQI 142
Query: 217 AEGLLYLHEGCQRRIIHRDIKAANILLT-------------EDFEPQICDFGLAKWL 260
           A G+ +LH     +IIHRD+K  NIL++             E+    I DFGL K L
Sbjct: 143 ASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKL 196

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 41.6 bits (96), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 82/176 (46%), Gaps = 28/176 (15%)
Query: 101 SLYELQSATNNFS----FENL--IGKGGYAEV---YKGRLRNGQLVAIKRLTRGTADEII 151
           + Y ++   + F+    ++NL  IG G    V   Y   L     VAIK+L+R   ++  
Sbjct: 9   NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTH 66
Query: 152 AD-FLSELGIMAHVDHPNTAKLLGYGIEG-------GMHIVLEL-SPNGSLASLLYGMKE 202
           A     EL +M  V+H N   LL              ++IV+EL   N S    +    E
Sbjct: 67  AKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHE 126
Query: 203 KLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           ++ + + Y++  G+     +LH      IIHRD+K +NI++  D   +I DFGLA+
Sbjct: 127 RMSY-LLYQMLCGIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 174

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 41.6 bits (96), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 79/176 (44%), Gaps = 28/176 (15%)
Query: 101 SLYELQSATNNFS----FENL--IGKGGYAEV---YKGRL-RNGQLVAIKRLTRGTADEI 150
             Y ++   + F+    ++NL  IG G    V   Y   L RN   VAIK+L+R   ++ 
Sbjct: 8   QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQT 64
Query: 151 IAD-FLSELGIMAHVDHPNTAKLLGYGIEG-------GMHIVLELSPNGSLASLLYGMKE 202
            A     EL +M  V+H N   LL              +++V+EL        +   +  
Sbjct: 65  HAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDH 124
Query: 203 KLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           +    + Y++  G+     +LH      IIHRD+K +NI++  D   +I DFGLA+
Sbjct: 125 ERMSYLLYQMLCGIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 173

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 41.6 bits (96), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 78/175 (44%), Gaps = 26/175 (14%)
Query: 101 SLYELQSATNNFS----FENL--IGKGGYAEV---YKGRLRNGQLVAIKRLTRGTADEII 151
           + Y ++   + F+    ++NL  IG G    V   Y   L     VAIK+L+R   ++  
Sbjct: 9   NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTH 66
Query: 152 AD-FLSELGIMAHVDHPNTAKLLGYGIEG-------GMHIVLELSPNGSLASLLYGMKEK 203
           A     EL +M  V+H N   LL              ++IV+EL        +   +  +
Sbjct: 67  AKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHE 126
Query: 204 LKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
               + Y++  G+     +LH      IIHRD+K +NI++  D   +I DFGLA+
Sbjct: 127 RMSYLLYQMLCGIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 174

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 41.6 bits (96), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 56/177 (31%), Positives = 82/177 (46%), Gaps = 31/177 (17%)
Query: 106 QSATNNFSFENLIGKGGYAEV-YKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHV 164
           QS  N    E ++G G    V ++G  + G+ VA+KR+     D  IA  L E+ ++   
Sbjct: 29  QSLKNLVVSEKILGYGSSGTVVFQGSFQ-GRPVAVKRMLIDFCD--IA--LMEIKLLTES 83
Query: 165 D-HPNTAKLL-GYGIEGGMHIVLELSPNGSLASLLYGMK---EKLKWGIRYK-IAL--GV 216
           D HPN  +       +  ++I LEL  N +L  L+       E LK    Y  I+L   +
Sbjct: 84  DDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQI 142
Query: 217 AEGLLYLHEGCQRRIIHRDIKAANILLT-------------EDFEPQICDFGLAKWL 260
           A G+ +LH     +IIHRD+K  NIL++             E+    I DFGL K L
Sbjct: 143 ASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKL 196

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 41.6 bits (96), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 78/175 (44%), Gaps = 26/175 (14%)
Query: 101 SLYELQSATNNFS----FENL--IGKGGYAEV---YKGRLRNGQLVAIKRLTRGTADEII 151
           + Y ++   + F+    ++NL  IG G    V   Y   L     VAIK+L+R   ++  
Sbjct: 11  NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTH 68
Query: 152 AD-FLSELGIMAHVDHPNTAKLLGYGIEG-------GMHIVLELSPNGSLASLLYGMKEK 203
           A     EL +M  V+H N   LL              ++IV+EL        +   +  +
Sbjct: 69  AKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHE 128
Query: 204 LKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
               + Y++  G+     +LH      IIHRD+K +NI++  D   +I DFGLA+
Sbjct: 129 RMSYLLYQMLCGIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 176

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 41.6 bits (96), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 78/175 (44%), Gaps = 26/175 (14%)
Query: 101 SLYELQSATNNFS----FENL--IGKGGYAEV---YKGRLRNGQLVAIKRLTRGTADEII 151
           + Y ++   + F+    ++NL  IG G    V   Y   L     VAIK+L+R   ++  
Sbjct: 10  NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTH 67
Query: 152 AD-FLSELGIMAHVDHPNTAKLLGYGIEG-------GMHIVLELSPNGSLASLLYGMKEK 203
           A     EL +M  V+H N   LL              ++IV+EL        +   +  +
Sbjct: 68  AKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHE 127
Query: 204 LKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
               + Y++  G+     +LH      IIHRD+K +NI++  D   +I DFGLA+
Sbjct: 128 RMSYLLYQMLCGIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 175

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 41.6 bits (96), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 79/176 (44%), Gaps = 28/176 (15%)
Query: 101 SLYELQSATNNFS----FENL--IGKGGYAEV---YKGRL-RNGQLVAIKRLTRGTADEI 150
             Y ++   + F+    ++NL  IG G    V   Y   L RN   VAIK+L+R   ++ 
Sbjct: 2   QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQT 58
Query: 151 IAD-FLSELGIMAHVDHPNTAKLLGYGIEG-------GMHIVLELSPNGSLASLLYGMKE 202
            A     EL +M  V+H N   LL              +++V+EL        +   +  
Sbjct: 59  HAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDH 118
Query: 203 KLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           +    + Y++  G+     +LH      IIHRD+K +NI++  D   +I DFGLA+
Sbjct: 119 ERMSYLLYQMLCGIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 167

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 79/176 (44%), Gaps = 28/176 (15%)
Query: 101 SLYELQSATNNFS----FENL--IGKGGYAEV---YKGRL-RNGQLVAIKRLTRGTADEI 150
             Y ++   + F+    ++NL  IG G    V   Y   L RN   VAIK+L+R   ++ 
Sbjct: 3   QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQT 59
Query: 151 IAD-FLSELGIMAHVDHPNTAKLLGYGIEG-------GMHIVLELSPNGSLASLLYGMKE 202
            A     EL +M  V+H N   LL              +++V+EL        +   +  
Sbjct: 60  HAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDH 119
Query: 203 KLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           +    + Y++  G+     +LH      IIHRD+K +NI++  D   +I DFGLA+
Sbjct: 120 ERMSYLLYQMLCGIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 168

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 44/150 (29%), Positives = 69/150 (46%), Gaps = 15/150 (10%)
Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGI 177
           +GKG Y EV++G  + G+ VA+K  +  + DE      +EL     + H N    +   +
Sbjct: 45  VGKGRYGEVWRGSWQ-GENVAVKIFS--SRDEKSWFRETELYNTVMLRHENILGFIASDM 101
Query: 178 EG-----GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHE---GCQR 229
                   + ++      GSL    Y     L      +I L +A GL +LH    G Q 
Sbjct: 102 TSRHSSTQLWLITHYHEMGSLYD--YLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQG 159
Query: 230 R--IIHRDIKAANILLTEDFEPQICDFGLA 257
           +  I HRD+K+ NIL+ ++ +  I D GLA
Sbjct: 160 KPAIAHRDLKSKNILVKKNGQCCIADLGLA 189

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 79/176 (44%), Gaps = 28/176 (15%)
Query: 101 SLYELQSATNNFS----FENL--IGKGGYAEV---YKGRL-RNGQLVAIKRLTRGTADEI 150
             Y ++   + F+    ++NL  IG G    V   Y   L RN   VAIK+L+R   ++ 
Sbjct: 3   QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQT 59
Query: 151 IAD-FLSELGIMAHVDHPNTAKLLGYGIEG-------GMHIVLELSPNGSLASLLYGMKE 202
            A     EL +M  V+H N   LL              +++V+EL        +   +  
Sbjct: 60  HAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDH 119
Query: 203 KLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           +    + Y++  G+     +LH      IIHRD+K +NI++  D   +I DFGLA+
Sbjct: 120 ERMSYLLYQMLCGIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 168

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 18/43 (41%), Positives = 28/43 (65%), Gaps = 3/43 (6%)
Query: 216 VAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           +  GL Y+H      ++HRD+K +N+LL    + +ICDFGLA+
Sbjct: 133 ILRGLKYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLAR 172

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 18/43 (41%), Positives = 28/43 (65%), Gaps = 3/43 (6%)
Query: 216 VAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           +  GL Y+H      ++HRD+K +N+LL    + +ICDFGLA+
Sbjct: 153 ILRGLKYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLAR 192

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 41.2 bits (95), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 18/43 (41%), Positives = 28/43 (65%), Gaps = 3/43 (6%)
Query: 216 VAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           +  GL Y+H      ++HRD+K +N+LL    + +ICDFGLA+
Sbjct: 133 ILRGLKYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLAR 172

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 41.2 bits (95), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 18/43 (41%), Positives = 28/43 (65%), Gaps = 3/43 (6%)
Query: 216 VAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           +  GL Y+H      ++HRD+K +N+LL    + +ICDFGLA+
Sbjct: 137 ILRGLKYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLAR 176

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 41.2 bits (95), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 18/43 (41%), Positives = 28/43 (65%), Gaps = 3/43 (6%)
Query: 216 VAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           +  GL Y+H      ++HRD+K +N+LL    + +ICDFGLA+
Sbjct: 137 ILRGLKYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLAR 176

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 41.2 bits (95), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 44/181 (24%), Positives = 84/181 (46%), Gaps = 16/181 (8%)
Query: 109 TNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADE--IIADFLSELGIMAHVD 165
           ++ +    ++G GG +EV+  R LR  + VA+K L    A +      F  E    A ++
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 166 HPNTAKLLGYG---IEGGM--HIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGV-AEG 219
           HP    +   G      G   +IV+E     +L  +++      +  +  K A+ V A+ 
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH-----TEGPMTPKRAIEVIADA 125
Query: 220 LLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGLV 279
              L+   Q  IIHRD+K ANI+++     ++ DFG+A+ + +    +++++     G  
Sbjct: 126 CQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG--NSVTQTAAVIGTA 183
Query: 280 K 280
           +
Sbjct: 184 Q 184

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 41.2 bits (95), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 41/158 (25%), Positives = 76/158 (48%), Gaps = 29/158 (18%)
Query: 118 IGKGGYAEVYKGRLRN-GQLVAIKRLT-RGTADEIIADFLSELGIMA-----------HV 164
           +G+G +A V +   ++ GQ  A K L  R    +  A+ L E+ ++            H 
Sbjct: 37  LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 165 DHPNTAKLLGYGIEGGMHIVLELSPNGSLASL-LYGMKEKLKWGIRYKIALGVAEGLLYL 223
            + NT++++         ++LE +  G + SL L  + E +      ++   + EG+ YL
Sbjct: 97  VYENTSEII---------LILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYL 147
Query: 224 HEGCQRRIIHRDIKAANILLTEDF---EPQICDFGLAK 258
           H   Q  I+H D+K  NILL+  +   + +I DFG+++
Sbjct: 148 H---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSR 182

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 40.8 bits (94), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 18/43 (41%), Positives = 28/43 (65%), Gaps = 3/43 (6%)
Query: 216 VAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           +  GL Y+H      ++HRD+K +N+LL    + +ICDFGLA+
Sbjct: 135 ILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLAR 174

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 40.8 bits (94), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 18/43 (41%), Positives = 28/43 (65%), Gaps = 3/43 (6%)
Query: 216 VAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           +  GL Y+H      ++HRD+K +N+LL    + +ICDFGLA+
Sbjct: 135 ILRGLKYIHSA---NVLHRDLKPSNLLLNTTSDLKICDFGLAR 174

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 40.8 bits (94), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 18/43 (41%), Positives = 28/43 (65%), Gaps = 3/43 (6%)
Query: 216 VAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           +  GL Y+H      ++HRD+K +N+LL    + +ICDFGLA+
Sbjct: 135 ILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLAR 174

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 40.8 bits (94), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 44/181 (24%), Positives = 84/181 (46%), Gaps = 16/181 (8%)
Query: 109 TNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADE--IIADFLSELGIMAHVD 165
           ++ +    ++G GG +EV+  R LR  + VA+K L    A +      F  E    A ++
Sbjct: 28  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 87
Query: 166 HPNTAKLLGYG---IEGGM--HIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGV-AEG 219
           HP    +   G      G   +IV+E     +L  +++      +  +  K A+ V A+ 
Sbjct: 88  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH-----TEGPMTPKRAIEVIADA 142
Query: 220 LLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGLV 279
              L+   Q  IIHRD+K ANI+++     ++ DFG+A+ + +    +++++     G  
Sbjct: 143 CQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG--NSVTQTAAVIGTA 200
Query: 280 K 280
           +
Sbjct: 201 Q 201

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 40.8 bits (94), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 18/43 (41%), Positives = 28/43 (65%), Gaps = 3/43 (6%)
Query: 216 VAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           +  GL Y+H      ++HRD+K +N+LL    + +ICDFGLA+
Sbjct: 137 ILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLAR 176

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 40.8 bits (94), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 18/43 (41%), Positives = 28/43 (65%), Gaps = 3/43 (6%)
Query: 216 VAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           +  GL Y+H      ++HRD+K +N+LL    + +ICDFGLA+
Sbjct: 133 ILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLAR 172

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 40.8 bits (94), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 18/43 (41%), Positives = 28/43 (65%), Gaps = 3/43 (6%)
Query: 216 VAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           +  GL Y+H      ++HRD+K +N+LL    + +ICDFGLA+
Sbjct: 138 ILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLAR 177

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 40.8 bits (94), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 18/43 (41%), Positives = 28/43 (65%), Gaps = 3/43 (6%)
Query: 216 VAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           +  GL Y+H      ++HRD+K +N+LL    + +ICDFGLA+
Sbjct: 139 ILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLAR 178

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 40.8 bits (94), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 18/43 (41%), Positives = 28/43 (65%), Gaps = 3/43 (6%)
Query: 216 VAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           +  GL Y+H      ++HRD+K +N+LL    + +ICDFGLA+
Sbjct: 130 ILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLAR 169

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 40.8 bits (94), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 70/143 (48%), Gaps = 12/143 (8%)
Query: 118 IGKGGYAEVYKGRLRN-GQLVAIKR--LTRGTADEIIADFLSELGIMAHVDHPNTAKLL- 173
           IG+G    V   R ++ G+ VA+K   L +    E++    +E+ IM    H N  ++  
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELL---FNEVVIMRDYQHFNVVEMYK 109
Query: 174 GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIH 233
            Y +   + +++E    G+L  ++  ++  L       +   V + L YLH    + +IH
Sbjct: 110 SYLVGEELWVLMEFLQGGALTDIVSQVR--LNEEQIATVCEAVLQALAYLHA---QGVIH 164
Query: 234 RDIKAANILLTEDFEPQICDFGL 256
           RDIK+ +ILLT D   ++ DFG 
Sbjct: 165 RDIKSDSILLTLDGRVKLSDFGF 187

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 40.8 bits (94), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 18/43 (41%), Positives = 28/43 (65%), Gaps = 3/43 (6%)
Query: 216 VAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           +  GL Y+H      ++HRD+K +N+LL    + +ICDFGLA+
Sbjct: 137 ILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLAR 176

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 40.8 bits (94), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 38/145 (26%), Positives = 68/145 (46%), Gaps = 8/145 (5%)
Query: 118 IGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEI--IADFLSELGIMAHVDHPNTAKL-L 173
           +G G +  V   + +  G   A+K L +    ++  I   L+E  I+  V+ P   KL  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 174 GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIH 233
            +     +++V+E +P G + S L  +    +   R+  A  +     YLH      +I+
Sbjct: 109 SFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH---SLDLIY 164
Query: 234 RDIKAANILLTEDFEPQICDFGLAK 258
           RD+K  N+++ +    Q+ DFGLAK
Sbjct: 165 RDLKPENLMIDQQGYIQVTDFGLAK 189

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 40.8 bits (94), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 18/43 (41%), Positives = 28/43 (65%), Gaps = 3/43 (6%)
Query: 216 VAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           +  GL Y+H      ++HRD+K +N+LL    + +ICDFGLA+
Sbjct: 137 ILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLAR 176

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	308
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	7e-80
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	5e-68
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-67
3soc_A	322	Activin receptor type-2A; structural genomics cons	6e-50
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-45
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	2e-44
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	5e-44
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	4e-43
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	9e-43
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-42
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-41
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	6e-41
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	8e-41
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	6e-39
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	1e-37
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	4e-37
3q4u_A	301	Activin receptor type-1; structural genomics conso	9e-36
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	9e-36
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	3e-35
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	3e-35
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	3e-35
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	8e-35
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	2e-34
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	3e-34
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	4e-34
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	4e-34
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	5e-34
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	5e-34
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	6e-34
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-33
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	1e-33
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-33
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	3e-33
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	4e-33
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	4e-33
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	5e-33
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	6e-33
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	6e-33
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	7e-33
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	1e-32
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-32
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-32
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-32
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-32
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-32
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	3e-32
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	3e-32
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	7e-32
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	1e-31
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-31
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-31
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	3e-31
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	3e-31
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	4e-31
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	6e-31
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	8e-31
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	2e-30
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-30
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	4e-30
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	4e-30
3an0_A	340	Dual specificity mitogen-activated protein kinase;	8e-30
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	8e-30
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	8e-30
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	9e-30
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	1e-29
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-29
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	3e-29
3fme_A	290	Dual specificity mitogen-activated protein kinase;	3e-29
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	4e-29
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	5e-29
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	5e-29
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	7e-29
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	9e-29
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	1e-28
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	1e-28
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	1e-28
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-28
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	4e-28
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	4e-28
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	5e-28
4aoj_A	329	High affinity nerve growth factor receptor; transf	6e-28
2dyl_A	318	Dual specificity mitogen-activated protein kinase	1e-27
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	1e-27
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	1e-27
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-27
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	2e-27
2a19_B	284	Interferon-induced, double-stranded RNA-activated	3e-27
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	3e-27
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	3e-27
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	3e-27
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	4e-27
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-26
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-26
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-26
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	3e-26
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	4e-26
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	8e-26
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	1e-25
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	1e-25
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	1e-25
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	1e-25
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	4e-25
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	8e-25
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	2e-24
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	2e-24
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	3e-24
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	5e-24
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-23
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	3e-23
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-22
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-22
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	3e-22
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	4e-22
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	1e-21
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-21
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	1e-21
3ork_A	311	Serine/threonine protein kinase; structural genomi	2e-21
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	3e-21
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	1e-20
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-20
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-20
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	3e-20
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	3e-20
3niz_A	311	Rhodanese family protein; structural genomics, str	3e-20
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	4e-20
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	5e-20
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-19
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-19
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-19
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-19
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-19
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	3e-19
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	3e-19
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	4e-19
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	4e-19
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	5e-19
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	6e-19
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	9e-19
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-18
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-18
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	2e-18
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	2e-18
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	3e-18
3bhy_A	283	Death-associated protein kinase 3; death associate	3e-18
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	3e-18
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	4e-18
3rp9_A	458	Mitogen-activated protein kinase; structural genom	6e-18
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	6e-18
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	8e-18
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	1e-17
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-17
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	1e-17
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-17
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	3e-17
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	3e-17
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	3e-17
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	4e-17
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	5e-17
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	5e-17
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	9e-17
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-16
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	2e-16
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	2e-16
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-16
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	3e-16
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	3e-16
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	5e-16
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	5e-16
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	6e-16
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	8e-16
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	8e-16
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	8e-16
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	8e-16
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	9e-16
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	1e-15
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	1e-15
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	2e-15
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-15
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	2e-15
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	3e-15
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	3e-15
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	4e-15
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	4e-15
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	1e-14
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-14
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-14
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	2e-14
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-14
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	3e-14
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	3e-14
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	5e-14
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	5e-14
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	7e-14
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	8e-14
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	9e-14
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	1e-13
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	1e-13
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	4e-13
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	2e-12
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	2e-12
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	2e-12
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	3e-12
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	3e-12
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	6e-12
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	1e-11
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-11
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	2e-11
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	3e-11
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-10
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	2e-10
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	3e-10
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	1e-09
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	2e-09
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	3e-09
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	3e-09
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	4e-09
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	4e-08
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	5e-09
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	7e-09
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	1e-08
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	2e-08
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	3e-08
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	4e-08
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	7e-08
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	7e-08
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	8e-08
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	9e-08
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	1e-07
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	2e-07
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	4e-07
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	8e-07
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-06
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	3e-06
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	7e-06
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	1e-05

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  244 bits (625), Expect = 7e-80
 Identities = 84/184 (45%), Positives = 113/184 (61%), Gaps = 5/184 (2%)

Query: 98  KIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSE 157
           K FSL ELQ A++NFS +N++G+GG+ +VYKGRL +G LVA+KRL           F +E
Sbjct: 18  KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTE 77

Query: 158 LGIMAHVDHPNTAKLLGYGIEGGMHI-VLELSPNGSLASLLYGMKE---KLKWGIRYKIA 213
           + +++   H N  +L G+ +     + V     NGS+AS L    E    L W  R +IA
Sbjct: 78  VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA 137

Query: 214 LGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVE 273
           LG A GL YLH+ C  +IIHRD+KAANILL E+FE  + DFGLAK +  + TH T + V 
Sbjct: 138 LGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT-TAVR 196

Query: 274 GTFG 277
           GT G
Sbjct: 197 GTIG 200

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  213 bits (546), Expect = 5e-68
 Identities = 75/212 (35%), Positives = 109/212 (51%), Gaps = 14/212 (6%)

Query: 73  SSSMREGIDMPRNLFVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLR 132
            S   +  +   +   +SY          L +L+ ATNNF  + LIG G + +VYKG LR
Sbjct: 2   GSKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR 61

Query: 133 NGQLVAIKRLTRGT---ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHI-VLELS 188
           +G  VA+KR T  +    +E    F +E+  ++   HP+   L+G+  E    I + +  
Sbjct: 62  DGAKVALKRRTPESSQGIEE----FETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYM 117

Query: 189 PNGSLASLLYG---MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTE 245
            NG+L   LYG       + W  R +I +G A GL YLH      IIHRD+K+ NILL E
Sbjct: 118 ENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDE 174

Query: 246 DFEPQICDFGLAKWLPEQWTHHTISKVEGTFG 277
           +F P+I DFG++K   E    H  + V+GT G
Sbjct: 175 NFVPKITDFGISKKGTELDQTHLSTVVKGTLG 206

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  212 bits (542), Expect = 1e-67
 Identities = 73/192 (38%), Positives = 96/192 (50%), Gaps = 16/192 (8%)

Query: 98  KIFSLYELQSATNNFS------FENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEII 151
             FS YEL++ TNNF         N +G+GG+  VYKG + N   VA+K+L         
Sbjct: 13  HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTE 71

Query: 152 ---ADFLSELGIMAHVDHPNTAKLLGYGIEGGMHI-VLELSPNGSLASLLYGMKEK--LK 205
                F  E+ +MA   H N  +LLG+  +G     V    PNGSL   L  +     L 
Sbjct: 72  ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLS 131

Query: 206 WGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT 265
           W +R KIA G A G+ +LHE      IHRDIK+ANILL E F  +I DFGLA+   +   
Sbjct: 132 WHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 188

Query: 266 HHTISKVEGTFG 277
               S++ GT  
Sbjct: 189 TVMTSRIVGTTA 200

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  167 bits (424), Expect = 6e-50
 Identities = 45/190 (23%), Positives = 68/190 (35%), Gaps = 17/190 (8%)

Query: 100 FSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELG 159
                L   +       +  +G +  V+K +L   + VA+K                E+ 
Sbjct: 14  LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQS--WQNEYEVY 70

Query: 160 IMAHVDHPNTAKLLGYGIEGGMH-----IVLELSPNGSLASLLYGMKEKLKWGIRYKIAL 214
            +  + H N  + +G    G        ++      GSL+  L      + W     IA 
Sbjct: 71  SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK--ANVVSWNELCHIAE 128

Query: 215 GVAEGLLYLHE-------GCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH 267
            +A GL YLHE       G +  I HRDIK+ N+LL  +    I DFGLA       +  
Sbjct: 129 TMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAG 188

Query: 268 TISKVEGTFG 277
                 GT  
Sbjct: 189 DTHGQVGTRR 198

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  154 bits (391), Expect = 2e-45
 Identities = 57/179 (31%), Positives = 91/179 (50%), Gaps = 19/179 (10%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTAD------EIIADFLSELGIMA 162
           N   +E  IGKGG+  V+KGRL  +  +VAIK L  G ++      E   +F  E+ IM+
Sbjct: 19  NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78

Query: 163 HVDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLY 222
           +++HPN  KL G        +V+E  P G L   L      +KW ++ ++ L +A G+ Y
Sbjct: 79  NLNHPNIVKLYGLMHNP-PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEY 137

Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQ-----ICDFGLAKWLPEQWTHHTISKVEGTF 276
           +       I+HRD+++ NI L    E       + DFGL++      + H++S + G F
Sbjct: 138 MQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLGNF 190

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  153 bits (387), Expect = 2e-44
 Identities = 51/194 (26%), Positives = 75/194 (38%), Gaps = 21/194 (10%)

Query: 100 FSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELG 159
            +  E     +N     LIG+G Y  VYKG L   + VA+K  +          F++E  
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLD-ERPVAVKVFSFANRQN----FINEKN 57

Query: 160 I--MAHVDHPNTAKLLGYGIEGGMH------IVLELSPNGSLASLLYGMKEKLKWGIRYK 211
           I  +  ++H N A+ +               +V+E  PNGSL   L        W    +
Sbjct: 58  IYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS--LHTSDWVSSCR 115

Query: 212 IALGVAEGLLYLHE------GCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT 265
           +A  V  GL YLH         +  I HRD+ + N+L+  D    I DFGL+  L     
Sbjct: 116 LAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRL 175

Query: 266 HHTISKVEGTFGLV 279
                +       V
Sbjct: 176 VRPGEEDNAAISEV 189

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  151 bits (384), Expect = 5e-44
 Identities = 44/151 (29%), Positives = 76/151 (50%), Gaps = 6/151 (3%)

Query: 114 FENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKL 172
              ++GKG + +  K   R  G+++ +K L R   +E    FL E+ +M  ++HPN  K 
Sbjct: 14  HGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFD-EETQRTFLKEVKVMRCLEHPNVLKF 72

Query: 173 LGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRI 231
           +G   +   ++ + E    G+L  ++  M  +  W  R   A  +A G+ YLH      I
Sbjct: 73  IGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNI 129

Query: 232 IHRDIKAANILLTEDFEPQICDFGLAKWLPE 262
           IHRD+ + N L+ E+    + DFGLA+ + +
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVD 160

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  149 bits (377), Expect = 4e-43
 Identities = 49/171 (28%), Positives = 85/171 (49%), Gaps = 10/171 (5%)

Query: 101 SLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGI 160
           SL+ +         E ++G+G +  V K + R  + VAIK++    ++     F+ EL  
Sbjct: 1   SLHMIDY--KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIE---SESERKAFIVELRQ 54

Query: 161 MAHVDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMK--EKLKWGIRYKIALGVAE 218
           ++ V+HPN  KL G  +   + +V+E +  GSL ++L+G +              L  ++
Sbjct: 55  LSRVNHPNIVKLYGACLNP-VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQ 113

Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFE-PQICDFGLAKWLPEQWTHHT 268
           G+ YLH    + +IHRD+K  N+LL       +ICDFG A  +    T++ 
Sbjct: 114 GVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK 164

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  148 bits (375), Expect = 9e-43
 Identities = 49/163 (30%), Positives = 82/163 (50%), Gaps = 6/163 (3%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPN 168
            + + +  IG G +  V++     G  VA+K L       E + +FL E+ IM  + HPN
Sbjct: 37  CDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPN 95

Query: 169 TAKLLGYGIEGG-MHIVLELSPNGSLASLLY--GMKEKLKWGIRYKIALGVAEGLLYLHE 225
               +G   +   + IV E    GSL  LL+  G +E+L    R  +A  VA+G+ YLH 
Sbjct: 96  IVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH- 154

Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT 268
                I+HR++K+ N+L+ + +  ++CDFGL++     +    
Sbjct: 155 NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSK 197

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  146 bits (371), Expect = 2e-42
 Identities = 51/175 (29%), Positives = 83/175 (47%), Gaps = 19/175 (10%)

Query: 114 FENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEI---IADFLSELGIMAHVDHPNTA 170
            E +IG GG+ +VY+     G  VA+K       ++I   I +   E  + A + HPN  
Sbjct: 11  LEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69

Query: 171 KLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQR 229
            L G  ++   + +V+E +  G L  +L    +++   I    A+ +A G+ YLH+    
Sbjct: 70  ALRGVCLKEPNLCLVMEFARGGPLNRVLS--GKRIPPDILVNWAVQIARGMNYLHDEAIV 127

Query: 230 RIIHRDIKAANILLTEDFEPQ--------ICDFGLAKWLPEQWTHHTISKVEGTF 276
            IIHRD+K++NIL+ +  E          I DFGLA+    +W   T     G +
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR----EWHRTTKMSAAGAY 178

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  142 bits (361), Expect = 6e-41
 Identities = 50/167 (29%), Positives = 73/167 (43%), Gaps = 6/167 (3%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADE-IIADFLSELGIMAHVDHPN 168
              +    IG G +  VYKG+      VA+K L         +  F +E+G++    H N
Sbjct: 24  GQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 81

Query: 169 TAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQ 228
               +GY     + IV +     SL   L+  + K +      IA   A G+ YLH    
Sbjct: 82  ILLFMGYSTAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---A 138

Query: 229 RRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGT 275
           + IIHRD+K+ NI L ED   +I DFGLA         H   ++ G+
Sbjct: 139 KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGS 185

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  141 bits (359), Expect = 8e-41
 Identities = 34/154 (22%), Positives = 63/154 (40%), Gaps = 7/154 (4%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRL-TRGTADEIIADFLSELGIMAHVDHPN 168
              +F   + +    E++KGR + G  + +K L  R  +     DF  E   +    HPN
Sbjct: 10  KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPN 68

Query: 169 TAKLLGY---GIEGGMHIVLELSPNGSLASLLY-GMKEKLKWGIRYKIALGVAEGLLYLH 224
              +LG           ++    P GSL ++L+ G    +      K AL +A G+ +LH
Sbjct: 69  VLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH 128

Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
              +  I    + + ++++ ED   +I    +  
Sbjct: 129 -TLEPLIPRHALNSRSVMIDEDMTARISMADVKF 161

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  138 bits (350), Expect = 6e-39
 Identities = 41/147 (27%), Positives = 69/147 (46%), Gaps = 8/147 (5%)

Query: 114 FENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADE-IIADFLSELGIMAHVDHPNTAKL 172
              LIGKG + +VY GR   G+ VAI+ +     +E  +  F  E+       H N    
Sbjct: 37  IGELIGKGRFGQVYHGRWH-GE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLF 94

Query: 173 LGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRI 231
           +G  +    + I+  L    +L S++   K  L      +IA  + +G+ YLH    + I
Sbjct: 95  MGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGI 151

Query: 232 IHRDIKAANILLTEDFEPQICDFGLAK 258
           +H+D+K+ N+   ++ +  I DFGL  
Sbjct: 152 LHKDLKSKNVFY-DNGKVVITDFGLFS 177

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  136 bits (344), Expect = 1e-37
 Identities = 47/155 (30%), Positives = 76/155 (49%), Gaps = 5/155 (3%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPN 168
            +      IG+G + EV+ GRLR +  LVA+K        ++ A FL E  I+    HPN
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173

Query: 169 TAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
             +L+G   +   ++IV+EL   G   + L     +L+     ++    A G+ YL    
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLES-- 231

Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE 262
            +  IHRD+ A N L+TE    +I DFG+++   +
Sbjct: 232 -KCCIHRDLAARNCLVTEKNVLKISDFGMSREEAD 265

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  133 bits (338), Expect = 4e-37
 Identities = 48/159 (30%), Positives = 78/159 (49%), Gaps = 8/159 (5%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRNG-----QLVAIKRLTRGTADEIIADFLSELGIMAHV 164
             F    ++G G +  VYKG            VAIK L   T+ +   + L E  +MA V
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74

Query: 165 DHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
           D+P+  +LLG  +   + ++ +L P G L   +   K+ +         + +A+G+ YL 
Sbjct: 75  DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134

Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ 263
           +   RR++HRD+ A N+L+      +I DFGLAK L  +
Sbjct: 135 D---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  129 bits (327), Expect = 9e-36
 Identities = 39/157 (24%), Positives = 64/157 (40%), Gaps = 19/157 (12%)

Query: 114 FENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGI--MAHVDHPNTAK 171
               +GKG Y EV++G  + G+ VA+K  +          +  E  +     + H N   
Sbjct: 12  LLECVGKGRYGEVWRGSWQ-GENVAVKIFS----SRDEKSWFRETELYNTVMLRHENILG 66

Query: 172 LLGYGIEGG-----MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHE- 225
            +   +        + ++      GSL   L      L      +I L +A GL +LH  
Sbjct: 67  FIASDMTSRHSSTQLWLITHYHEMGSLYDYLQ--LTTLDTVSCLRIVLSIASGLAHLHIE 124

Query: 226 ----GCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
                 +  I HRD+K+ NIL+ ++ +  I D GLA 
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAV 161

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  130 bits (328), Expect = 9e-36
 Identities = 48/159 (30%), Positives = 79/159 (49%), Gaps = 8/159 (5%)

Query: 110 NNFSFENLIGKGGYAEVYKGRL-----RNGQLVAIKRLTRGTADEIIADFLSELGIMAHV 164
             F    ++G G +  VYKG       +    VAIK L   T+ +   + L E  +MA V
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74

Query: 165 DHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
           D+P+  +LLG  +   + ++ +L P G L   +   K+ +         + +A+G+ YL 
Sbjct: 75  DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134

Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ 263
           +   RR++HRD+ A N+L+      +I DFGLAK L  +
Sbjct: 135 D---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  129 bits (325), Expect = 3e-35
 Identities = 48/169 (28%), Positives = 70/169 (41%), Gaps = 19/169 (11%)

Query: 114 FENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGI--MAHVDHPNTAK 171
               IGKG Y EV+ G+ R G+ VA+K     T +E  A +  E  I     + H N   
Sbjct: 41  MVKQIGKGRYGEVWMGKWR-GEKVAVKVFF--TTEE--ASWFRETEIYQTVLMRHENILG 95

Query: 172 LLGYGIEGG-----MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHE- 225
            +   I+G      ++++ +   NGSL   L      L      K+A     GL +LH  
Sbjct: 96  FIAADIKGTGSWTQLYLITDYHENGSLYDYLK--STTLDAKSMLKLAYSSVSGLCHLHTE 153

Query: 226 ----GCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTIS 270
                 +  I HRD+K+ NIL+ ++    I D GLA           I 
Sbjct: 154 IFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIP 202

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  128 bits (324), Expect = 3e-35
 Identities = 38/170 (22%), Positives = 73/170 (42%), Gaps = 10/170 (5%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQL-----VAIKRLTRGTADEIIADFLSELGIMAHV 164
                  ++G G +  V+KG            V IK +   +  +        +  +  +
Sbjct: 13  TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL 72

Query: 165 DHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
           DH +  +LLG      + +V +  P GSL   +   +  L   +     + +A+G+ YL 
Sbjct: 73  DHAHIVRLLGLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE 132

Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP--EQWTHHTISKV 272
           E     ++HR++ A N+LL    + Q+ DFG+A  LP  ++   ++ +K 
Sbjct: 133 E---HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKT 179

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  126 bits (320), Expect = 8e-35
 Identities = 45/152 (29%), Positives = 75/152 (49%), Gaps = 6/152 (3%)

Query: 115 ENLIGKGGYAEVYKGRLRNGQ---LVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAK 171
           +  +G G +  V +G  R  +    VAIK L +GT      + + E  IM  +D+P   +
Sbjct: 15  DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74

Query: 172 LLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRI 231
           L+G      + +V+E++  G L   L G +E++      ++   V+ G+ YL E   +  
Sbjct: 75  LIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KNF 131

Query: 232 IHRDIKAANILLTEDFEPQICDFGLAKWLPEQ 263
           +HRD+ A N+LL      +I DFGL+K L   
Sbjct: 132 VHRDLAARNVLLVNRHYAKISDFGLSKALGAD 163

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  125 bits (315), Expect = 2e-34
 Identities = 45/154 (29%), Positives = 73/154 (47%), Gaps = 6/154 (3%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           +  +F   IG G +  V+ G   N   VAIK +  G   E   DF+ E  +M  + HP  
Sbjct: 8   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE--EDFIEEAEVMMKLSHPKL 65

Query: 170 AKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQ 228
            +L G  +E   + +V E   +G L+  L   +          + L V EG+ YL E   
Sbjct: 66  VQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE--- 122

Query: 229 RRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE 262
             +IHRD+ A N L+ E+   ++ DFG+ +++ +
Sbjct: 123 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 156

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  125 bits (317), Expect = 3e-34
 Identities = 46/161 (28%), Positives = 77/161 (47%), Gaps = 11/161 (6%)

Query: 110 NNFSFENLIGKGGYAEVYKGRL-----RNGQLVAIKRLTRGTADEIIADFLSELGIMAHV 164
                   +G+G + +V   R        G+ VA+K L   +    IAD   E+ I+ ++
Sbjct: 21  RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL 80

Query: 165 DHPNTAKLLGYGIEGG---MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLL 221
            H N  K  G   E G   + +++E  P+GSL   L   K K+    + K A+ + +G+ 
Sbjct: 81  YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMD 140

Query: 222 YLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE 262
           YL     R+ +HRD+ A N+L+  + + +I DFGL K +  
Sbjct: 141 YLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 178

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  124 bits (314), Expect = 4e-34
 Identities = 47/157 (29%), Positives = 75/157 (47%), Gaps = 7/157 (4%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRNG----QLVAIKRLTRGTADEIIADFLSELGIMAHVD 165
                   IG+G + +V++G   +       VAIK     T+D +   FL E   M   D
Sbjct: 15  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 74

Query: 166 HPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHE 225
           HP+  KL+G   E  + I++EL   G L S L   K  L        A  ++  L YL  
Sbjct: 75  HPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES 134

Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE 262
              +R +HRDI A N+L++ +   ++ DFGL++++ +
Sbjct: 135 ---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 168

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  125 bits (316), Expect = 4e-34
 Identities = 46/187 (24%), Positives = 78/187 (41%), Gaps = 18/187 (9%)

Query: 89  NSYDSQSPQKIFSLYELQSAT-----NNFSFENLIGKGGYAEVYKGRLRN-----GQLVA 138
           + +       +  L++                  +G+G + +V            G++VA
Sbjct: 5   HHHHHHHHGALEVLFQGPGDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVA 64

Query: 139 IKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG---MHIVLELSPNGSLAS 195
           +K L      +  + +  E+ I+  + H +  K  G   + G   + +V+E  P GSL  
Sbjct: 65  VKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRD 124

Query: 196 LLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFG 255
            L   +  +        A  + EG+ YLH    +  IHRD+ A N+LL  D   +I DFG
Sbjct: 125 YL--PRHSIGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFG 179

Query: 256 LAKWLPE 262
           LAK +PE
Sbjct: 180 LAKAVPE 186

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  126 bits (317), Expect = 5e-34
 Identities = 44/157 (28%), Positives = 70/157 (44%), Gaps = 19/157 (12%)

Query: 114 FENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGI--MAHVDHPNTAK 171
            +  IGKG + EV++G+ R G+ VA+K  +          +  E  I     + H N   
Sbjct: 46  LQESIGKGRFGEVWRGKWR-GEEVAVKIFS----SREERSWFREAEIYQTVMLRHENILG 100

Query: 172 LLGYGIEGG-----MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHE- 225
            +    +       + +V +   +GSL   L   +  +      K+AL  A GL +LH  
Sbjct: 101 FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN--RYTVTVEGMIKLALSTASGLAHLHME 158

Query: 226 --GCQRR--IIHRDIKAANILLTEDFEPQICDFGLAK 258
             G Q +  I HRD+K+ NIL+ ++    I D GLA 
Sbjct: 159 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 195

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  130 bits (327), Expect = 5e-34
 Identities = 60/258 (23%), Positives = 106/258 (41%), Gaps = 11/258 (4%)

Query: 14  LEDYFRSE-DSETCSSKEPCSETKPESKSNSRWHLF----YDLFRNKSKKSLVTLYPLKL 68
           L +Y + + D      KE C  +   + S +           L   + +   +       
Sbjct: 235 LVEYLKLKADGLIYCLKEACPNSSASNASGAAAPTLPAHPSTLTHPQRRIDTLNSDGYTP 294

Query: 69  SIRRSSSMREGIDMPRNLFVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYK 128
              R +S  +   MP +  V       P+++          N    +  +G G +  V +
Sbjct: 295 EPARITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQ 354

Query: 129 GRLR--NGQL-VAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHIVL 185
           G  R    Q+ VAIK L +GT      + + E  IM  +D+P   +L+G      + +V+
Sbjct: 355 GVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVM 414

Query: 186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTE 245
           E++  G L   L G +E++      ++   V+ G+ YL E   +  +HR++ A N+LL  
Sbjct: 415 EMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRNLAARNVLLVN 471

Query: 246 DFEPQICDFGLAKWLPEQ 263
               +I DFGL+K L   
Sbjct: 472 RHYAKISDFGLSKALGAD 489

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  124 bits (314), Expect = 6e-34
 Identities = 51/160 (31%), Positives = 74/160 (46%), Gaps = 9/160 (5%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLR----NGQLVAIKRLTRGTAD--EIIADFLSELGIMAH 163
            +      +G G +  V +G           VA+K L        E + DF+ E+  M  
Sbjct: 18  KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77

Query: 164 VDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYL 223
           +DH N  +L G  +   M +V EL+P GSL   L   +     G   + A+ VAEG+ YL
Sbjct: 78  LDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL 137

Query: 224 HEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ 263
                +R IHRD+ A N+LL      +I DFGL + LP+ 
Sbjct: 138 ES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 174

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  123 bits (311), Expect = 1e-33
 Identities = 39/154 (25%), Positives = 69/154 (44%), Gaps = 6/154 (3%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
              +    +G G +  V  G+ +    VA+K +  G+  E   +F  E   M  + HP  
Sbjct: 8   EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE--DEFFQEAQTMMKLSHPKL 65

Query: 170 AKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQ 228
            K  G   +   ++IV E   NG L + L    + L+     ++   V EG+ +L     
Sbjct: 66  VKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLES--- 122

Query: 229 RRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE 262
            + IHRD+ A N L+  D   ++ DFG+ +++ +
Sbjct: 123 HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD 156

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  124 bits (314), Expect = 1e-33
 Identities = 54/188 (28%), Positives = 82/188 (43%), Gaps = 9/188 (4%)

Query: 79  GIDMPRNLFVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNG---- 134
            I    NL+        P +    +  +   +  + + +IG G + EVYKG L+      
Sbjct: 13  DIPTTENLYFQGAMGSDPNQAVLKFTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKK 72

Query: 135 -QLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGS 192
              VAIK L  G  ++   DFL E GIM    H N  +L G   +   M I+ E   NG+
Sbjct: 73  EVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGA 132

Query: 193 LASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQIC 252
           L   L     +        +  G+A G+ YL        +HRD+ A NIL+  +   ++ 
Sbjct: 133 LDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVS 189

Query: 253 DFGLAKWL 260
           DFGL++ L
Sbjct: 190 DFGLSRVL 197

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  123 bits (311), Expect = 2e-33
 Identities = 47/161 (29%), Positives = 75/161 (46%), Gaps = 12/161 (7%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLR-----NGQLVAIKRLTRGTADEIIADFLSELGIMAHV 164
            +  F   +GKG +  V   R        G++VA+K+L   T + +  DF  E+ I+  +
Sbjct: 10  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL-RDFEREIEILKSL 68

Query: 165 DHPNTAKLLG---YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLL 221
            H N  K  G         + +++E  P GSL   L   KE++      +    + +G+ 
Sbjct: 69  QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGME 128

Query: 222 YLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE 262
           YL     +R IHRD+   NIL+  +   +I DFGL K LP+
Sbjct: 129 YLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 166

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  123 bits (310), Expect = 3e-33
 Identities = 50/185 (27%), Positives = 86/185 (46%), Gaps = 10/185 (5%)

Query: 85  NLFVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNG----QLVAIK 140
           ++ +++ + +  Q +     +  ++    F  +IG+G +  VY G L +        A+K
Sbjct: 1   HIDLSALNPELVQAV-QHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVK 59

Query: 141 RLTRGTADEIIADFLSELGIMAHVDHPNTAKLLG--YGIEGGMHIVLELSPNGSLASLLY 198
            L R T    ++ FL+E  IM    HPN   LLG     EG   +VL    +G L + + 
Sbjct: 60  SLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR 119

Query: 199 GMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
                          L VA+G+ YL     ++ +HRD+ A N +L E F  ++ DFGLA+
Sbjct: 120 NETHNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLAR 176

Query: 259 WLPEQ 263
            + ++
Sbjct: 177 DMYDK 181

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  122 bits (308), Expect = 4e-33
 Identities = 39/154 (25%), Positives = 75/154 (48%), Gaps = 6/154 (3%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
            + +F   +G G +  V  G+ R    VAIK +  G+  E   +F+ E  +M ++ H   
Sbjct: 24  KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE--DEFIEEAKVMMNLSHEKL 81

Query: 170 AKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQ 228
            +L G   +   + I+ E   NG L + L  M+ + +     ++   V E + YL     
Sbjct: 82  VQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES--- 138

Query: 229 RRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE 262
           ++ +HRD+ A N L+ +    ++ DFGL++++ +
Sbjct: 139 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 172

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  122 bits (308), Expect = 4e-33
 Identities = 46/158 (29%), Positives = 77/158 (48%), Gaps = 7/158 (4%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQL----VAIKRLTRGTADEIIADFLSELGIMAHVD 165
            +     ++G+G + EVY+G   N +     VA+K   +    +    F+SE  IM ++D
Sbjct: 12  EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD 71

Query: 166 HPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHE 225
           HP+  KL+G   E    I++EL P G L   L   K  LK       +L + + + YL  
Sbjct: 72  HPHIVKLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLES 131

Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ 263
                 +HRDI   NIL+      ++ DFGL++++ ++
Sbjct: 132 ---INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE 166

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  123 bits (310), Expect = 5e-33
 Identities = 58/216 (26%), Positives = 91/216 (42%), Gaps = 26/216 (12%)

Query: 69  SIRRSSSMREGIDMPRNLFVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYK 128
           S   +   R G +   N  V   +   P      YE +   +  + +  +G+G + EV++
Sbjct: 21  SSGSAKLQRLGPETEDNEGVLLTEKLKPVD----YEYREEVHWMTHQPRVGRGSFGEVHR 76

Query: 129 GR-LRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLE 186
            +  + G   A+K++       +    + EL   A +  P    L G   EG  ++I +E
Sbjct: 77  MKDKQTGFQCAVKKV------RLEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFME 130

Query: 187 LSPNGSLASLL--YG-MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILL 243
           L   GSL  L+   G + E       Y       EGL YLH    RRI+H D+KA N+LL
Sbjct: 131 LLEGGSLGQLIKQMGCLPEDR---ALY-YLGQALEGLEYLHT---RRILHGDVKADNVLL 183

Query: 244 TED-FEPQICDFGLAKWLPEQWTHHTISK---VEGT 275
           + D     +CDFG A  L       ++     + GT
Sbjct: 184 SSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGT 219

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  122 bits (309), Expect = 6e-33
 Identities = 47/161 (29%), Positives = 75/161 (46%), Gaps = 12/161 (7%)

Query: 110 NNFSFENLIGKGGYAEVYKGRL-----RNGQLVAIKRLTRGTADEIIADFLSELGIMAHV 164
            +  F   +GKG +  V   R        G++VA+K+L   T + +  DF  E+ I+  +
Sbjct: 41  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL-RDFEREIEILKSL 99

Query: 165 DHPNTAKLLG---YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLL 221
            H N  K  G         + +++E  P GSL   L   KE++      +    + +G+ 
Sbjct: 100 QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGME 159

Query: 222 YLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE 262
           YL     +R IHRD+   NIL+  +   +I DFGL K LP+
Sbjct: 160 YLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 197

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  122 bits (309), Expect = 6e-33
 Identities = 55/182 (30%), Positives = 80/182 (43%), Gaps = 8/182 (4%)

Query: 87  FVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLR----NGQLVAIKRL 142
           +   +  + P +    +  +   +    E +IG G   EV  GRLR        VAIK L
Sbjct: 26  YAEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKAL 85

Query: 143 TRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMK 201
             G  +    DFLSE  IM   DHPN  +L G    G    IV E   NGSL + L    
Sbjct: 86  KAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHD 145

Query: 202 EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP 261
            +        +  GV  G+ YL +      +HRD+ A N+L+  +   ++ DFGL++ L 
Sbjct: 146 GQFTIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202

Query: 262 EQ 263
           + 
Sbjct: 203 DD 204

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  123 bits (311), Expect = 7e-33
 Identities = 52/219 (23%), Positives = 94/219 (42%), Gaps = 11/219 (5%)

Query: 53  RNKSKKSLVTLYPLKLSIRRSSSMREGIDMPRNLFVNSYDSQSPQKIFSL--YELQSATN 110
            +     + ++  L  S+ + +          N       + +P+ + ++    +  ++ 
Sbjct: 30  GSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALNPELVQAVQHVVIGPSSL 89

Query: 111 NFSFENLIGKGGYAEVYKGRLRNG----QLVAIKRLTRGTADEIIADFLSELGIMAHVDH 166
              F  +IG+G +  VY G L +        A+K L R T    ++ FL+E  IM    H
Sbjct: 90  IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 149

Query: 167 PNTAKLLG--YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
           PN   LLG     EG   +VL    +G L + +                L VA+G+ +L 
Sbjct: 150 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA 209

Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ 263
               ++ +HRD+ A N +L E F  ++ DFGLA+ + ++
Sbjct: 210 S---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  124 bits (313), Expect = 1e-32
 Identities = 50/165 (30%), Positives = 78/165 (47%), Gaps = 7/165 (4%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
            +   E  +G+G + EV+ G       VAIK L  GT       FL E  +M  + H   
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP--EAFLQEAQVMKKLRHEKL 241

Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEK-LKWGIRYKIALGVAEGLLYLHEGCQ 228
            +L     E  ++IV E    GSL   L G   K L+      +A  +A G+ Y+     
Sbjct: 242 VQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER--- 298

Query: 229 RRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE-QWTHHTISKV 272
              +HRD++AANIL+ E+   ++ DFGLA+ + + ++T    +K 
Sbjct: 299 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF 343

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  124 bits (314), Expect = 2e-32
 Identities = 48/165 (29%), Positives = 77/165 (46%), Gaps = 7/165 (4%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
            +   E  +G+G + EV+ G       VAIK L  GT       FL E  +M  + H   
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP--EAFLQEAQVMKKLRHEKL 324

Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLY-GMKEKLKWGIRYKIALGVAEGLLYLHEGCQ 228
            +L     E  ++IV E    GSL   L     + L+      +A  +A G+ Y+     
Sbjct: 325 VQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER--- 381

Query: 229 RRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE-QWTHHTISKV 272
              +HRD++AANIL+ E+   ++ DFGLA+ + + ++T    +K 
Sbjct: 382 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF 426

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  120 bits (303), Expect = 2e-32
 Identities = 48/164 (29%), Positives = 79/164 (48%), Gaps = 7/164 (4%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
                   +G G + EV+ G       VA+K L +G+       FL+E  +M  + H   
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP--DAFLAEANLMKQLQHQRL 70

Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLL-YGMKEKLKWGIRYKIALGVAEGLLYLHEGCQ 228
            +L     +  ++I+ E   NGSL   L      KL       +A  +AEG+ ++ E   
Sbjct: 71  VRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE--- 127

Query: 229 RRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE-QWTHHTISK 271
           R  IHRD++AANIL+++    +I DFGLA+ + + ++T    +K
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAK 171

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  125 bits (316), Expect = 2e-32
 Identities = 51/215 (23%), Positives = 95/215 (44%), Gaps = 7/215 (3%)

Query: 53  RNKSKKSLVTLYPLKLSIRRSSSMREGIDMPRNLFVNSYDSQSPQKIFSLYELQSATNNF 112
           + + +++L ++  L  + ++            + +    D +    + S  + +      
Sbjct: 333 QKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYTMPSTRDYEIQRERI 392

Query: 113 SFENLIGKGGYAEVYKGRLRNG----QLVAIKRLTRGTADEIIADFLSELGIMAHVDHPN 168
                IG+G + +V++G   +       VAIK     T+D +   FL E   M   DHP+
Sbjct: 393 ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPH 452

Query: 169 TAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQ 228
             KL+G   E  + I++EL   G L S L   K  L        A  ++  L YL     
Sbjct: 453 IVKLIGVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLES--- 509

Query: 229 RRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ 263
           +R +HRDI A N+L++ +   ++ DFGL++++ + 
Sbjct: 510 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 544

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  121 bits (305), Expect = 2e-32
 Identities = 45/161 (27%), Positives = 73/161 (45%), Gaps = 12/161 (7%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLR-----NGQLVAIKRLTRGTADEIIADFLSELGIMAHV 164
            +  + + +GKG +  V   R        G LVA+K+L + +  +   DF  E+ I+  +
Sbjct: 23  RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL-QHSGPDQQRDFQREIQILKAL 81

Query: 165 DHPNTAKLLG---YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLL 221
                 K  G         + +V+E  P+G L   L   + +L        +  + +G+ 
Sbjct: 82  HSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGME 141

Query: 222 YLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE 262
           YL     RR +HRD+ A NIL+  +   +I DFGLAK LP 
Sbjct: 142 YLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPL 179

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  120 bits (304), Expect = 2e-32
 Identities = 48/167 (28%), Positives = 77/167 (46%), Gaps = 9/167 (5%)

Query: 103 YELQSATNNFSFENLIGKGGYAEVYKGRLRNG----QLVAIKRLTRGTADEIIADFLSEL 158
             +         + +IGKG +  VY G   +        AIK L+R T  + +  FL E 
Sbjct: 14  VLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREG 73

Query: 159 GIMAHVDHPNTAKLLG--YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGV 216
            +M  ++HPN   L+G     EG  H++L    +G L   +   +            L V
Sbjct: 74  LLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQV 133

Query: 217 AEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ 263
           A G+ YL E   ++ +HRD+ A N +L E F  ++ DFGLA+ + ++
Sbjct: 134 ARGMEYLAE---QKFVHRDLAARNCMLDESFTVKVADFGLARDILDR 177

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  122 bits (307), Expect = 3e-32
 Identities = 56/182 (30%), Positives = 85/182 (46%), Gaps = 8/182 (4%)

Query: 87  FVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNG----QLVAIKRL 142
           FV+ +  + P +    +  +    N S + ++G G + EV  GRL+        VAIK L
Sbjct: 22  FVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL 81

Query: 143 TRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMK 201
             G  ++   DFL E  IM   DHPN  +L G   +   + IV E   NGSL S L    
Sbjct: 82  KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD 141

Query: 202 EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP 261
            +        +  G+A G+ YL +      +HRD+ A NIL+  +   ++ DFGL + L 
Sbjct: 142 AQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLGRVLE 198

Query: 262 EQ 263
           + 
Sbjct: 199 DD 200

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  119 bits (301), Expect = 3e-32
 Identities = 51/170 (30%), Positives = 74/170 (43%), Gaps = 10/170 (5%)

Query: 92  DSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEII 151
            S + Q  F                 IGKG + +V  G    G  VA+K +      +  
Sbjct: 3   GSVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQ-- 59

Query: 152 ADFLSELGIMAHVDHPNTAKLLG--YGIEGGMHIVLELSPNGSLASLL-YGMKEKLKWGI 208
             FL+E  +M  + H N  +LLG     +GG++IV E    GSL   L    +  L    
Sbjct: 60  -AFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDC 118

Query: 209 RYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
             K +L V E + YL        +HRD+ A N+L++ED   ++ DFGL K
Sbjct: 119 LLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTK 165

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  122 bits (307), Expect = 7e-32
 Identities = 44/164 (26%), Positives = 76/164 (46%), Gaps = 7/164 (4%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
            +   E  +G G + EV+         VA+K +  G+       FL+E  +M  + H   
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSV--EAFLAEANVMKTLQHDKL 245

Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMK-EKLKWGIRYKIALGVAEGLLYLHEGCQ 228
            KL     +  ++I+ E    GSL   L   +  K         +  +AEG+ ++ +   
Sbjct: 246 VKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ--- 302

Query: 229 RRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE-QWTHHTISK 271
           R  IHRD++AANIL++     +I DFGLA+ + + ++T    +K
Sbjct: 303 RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAK 346

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  118 bits (299), Expect = 1e-31
 Identities = 57/169 (33%), Positives = 85/169 (50%), Gaps = 23/169 (13%)

Query: 96  PQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADF 154
           P+++F+  E             IGKG + EV+KG   R  ++VAIK +    A++ I D 
Sbjct: 20  PEELFTKLEK------------IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDI 67

Query: 155 LSELGIMAHVDHPNTAKLLG-YGIEGGMHIVLELSPNGSLASLL--YGMKEKLKWGIRYK 211
             E+ +++  D P   K  G Y  +  + I++E    GS   LL    + E     I   
Sbjct: 68  QQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQ---IAT- 123

Query: 212 IALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL 260
           I   + +GL YLH     + IHRDIKAAN+LL+E  E ++ DFG+A  L
Sbjct: 124 ILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQL 169

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  118 bits (299), Expect = 2e-31
 Identities = 51/178 (28%), Positives = 75/178 (42%), Gaps = 10/178 (5%)

Query: 90  SYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTAD 148
           S +S    KI           +      IG+G Y  V K     +GQ++A+KR+     +
Sbjct: 2   SIESSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDE 61

Query: 149 EIIADFLSELGI-MAHVDHPNTAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKW 206
           +     L +L + M   D P   +  G    EG   I +EL  + S       +   L  
Sbjct: 62  KEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDD 120

Query: 207 GIR----YKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL 260
            I      KI L   + L +L E    +IIHRDIK +NILL      ++CDFG++  L
Sbjct: 121 VIPEEILGKITLATVKALNHLKE--NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL 176

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  118 bits (297), Expect = 2e-31
 Identities = 50/179 (27%), Positives = 87/179 (48%), Gaps = 18/179 (10%)

Query: 93  SQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIK--RLTRGTADE 149
              PQK        +   NF  E  IG+G ++EVY+   L +G  VA+K  ++      +
Sbjct: 15  QFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAK 74

Query: 150 IIADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLK--- 205
             AD + E+ ++  ++HPN  K     IE   ++IVLEL+  G L+ ++   K++ +   
Sbjct: 75  ARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIP 134

Query: 206 ----WGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL 260
               W    ++       L ++H    RR++HRDIK AN+ +T     ++ D GL ++ 
Sbjct: 135 ERTVWKYFVQLCSA----LEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFF 186

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  120 bits (303), Expect = 3e-31
 Identities = 48/152 (31%), Positives = 70/152 (46%), Gaps = 10/152 (6%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
                   IGKG + +V  G    G  VA+K +      +    FL+E  +M  + H N 
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQ---AFLAEASVMTQLRHSNL 248

Query: 170 AKLLG--YGIEGGMHIVLELSPNGSLASLL-YGMKEKLKWGIRYKIALGVAEGLLYLHEG 226
            +LLG     +GG++IV E    GSL   L    +  L      K +L V E + YL   
Sbjct: 249 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG- 307

Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
                +HRD+ A N+L++ED   ++ DFGL K
Sbjct: 308 --NNFVHRDLAARNVLVSEDNVAKVSDFGLTK 337

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  117 bits (295), Expect = 3e-31
 Identities = 43/156 (27%), Positives = 78/156 (50%), Gaps = 8/156 (5%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQL-VAIKRLTRGTADEIIADFLSELGIMAHVDHPN 168
            + + ++ +G G Y EVY+G  +   L VA+K L   T +    +FL E  +M  + HPN
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPN 70

Query: 169 TAKLLGYGIEGG-MHIVLELSPNGSLAS-LLYGMKEKLKWGIRYKIALGVAEGLLYLHEG 226
             +LLG        +I+ E    G+L   L    ++++   +   +A  ++  + YL + 
Sbjct: 71  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK- 129

Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE 262
             +  IHRD+ A N L+ E+   ++ DFGL++ +  
Sbjct: 130 --KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 163

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  117 bits (295), Expect = 4e-31
 Identities = 47/149 (31%), Positives = 84/149 (56%), Gaps = 8/149 (5%)

Query: 112 FSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTA 170
           +     +G G + +VYK +    G L A K +   + +E+  D++ E+ I+A  DHP   
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELE-DYIVEIEILATCDHPYIV 79

Query: 171 KLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWG-IRYKIALGVAEGLLYLHEGCQ 228
           KLLG Y  +G + I++E  P G++ +++  +   L    I+  +   + E L +LH    
Sbjct: 80  KLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV-VCRQMLEALNFLH---S 135

Query: 229 RRIIHRDIKAANILLTEDFEPQICDFGLA 257
           +RIIHRD+KA N+L+T + + ++ DFG++
Sbjct: 136 KRIIHRDLKAGNVLMTLEGDIRLADFGVS 164

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  120 bits (302), Expect = 6e-31
 Identities = 44/167 (26%), Positives = 82/167 (49%), Gaps = 9/167 (5%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRN-GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPN 168
            + + ++ +G G Y EVY+G  +     VA+K L   T +    +FL E  +M  + HPN
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPN 277

Query: 169 TAKLLGYGIEGG-MHIVLELSPNGSLASLL-YGMKEKLKWGIRYKIALGVAEGLLYLHEG 226
             +LLG        +I+ E    G+L   L    ++++   +   +A  ++  + YL + 
Sbjct: 278 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK- 336

Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE-QWTHHTISKV 272
             +  IHR++ A N L+ E+   ++ DFGL++ +    +T H  +K 
Sbjct: 337 --KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF 381

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  116 bits (293), Expect = 8e-31
 Identities = 50/179 (27%), Positives = 77/179 (43%), Gaps = 19/179 (10%)

Query: 110 NNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPN 168
           +++  + +IG G  A V         + VAIKR+        + + L E+  M+   HPN
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74

Query: 169 TAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALG----------VA 217
                  + ++  + +V++L   GS+  +   +K  +  G      L           V 
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDI---IKHIVAKGEHKSGVLDESTIATILREVL 131

Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTF 276
           EGL YLH+      IHRD+KA NILL ED   QI DFG++ +L              TF
Sbjct: 132 EGLEYLHK---NGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKV-RKTF 186

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  115 bits (290), Expect = 2e-30
 Identities = 41/150 (27%), Positives = 70/150 (46%), Gaps = 8/150 (5%)

Query: 118 IGKGGYAEVYKGRLRNGQL---VAIKRLTRGTAD-EIIADFLSELGIMAHVDHPNTAKLL 173
           +G G +  V KG  +  ++   VA+K L     D  +  + L+E  +M  +D+P   +++
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84

Query: 174 GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIH 233
           G        +V+E++  G L   L      +K     ++   V+ G+ YL E      +H
Sbjct: 85  GICEAESWMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEE---SNFVH 140

Query: 234 RDIKAANILLTEDFEPQICDFGLAKWLPEQ 263
           RD+ A N+LL      +I DFGL+K L   
Sbjct: 141 RDLAARNVLLVTQHYAKISDFGLSKALRAD 170

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  115 bits (291), Expect = 2e-30
 Identities = 36/160 (22%), Positives = 67/160 (41%), Gaps = 19/160 (11%)

Query: 111 NFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           ++ F   +G+GG++ V     L +G   A+KR+      +   +   E  +    +HPN 
Sbjct: 30  HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDR-EEAQREADMHRLFNHPNI 88

Query: 170 AKLLGYGIEGG-----MHIVLELSPNGSLASLLYGMKEKLKWGIRY------KIALGVAE 218
            +L+ Y +          ++L     G+L +    ++     G          + LG+  
Sbjct: 89  LRLVAYCLRERGAKHEAWLLLPFFKRGTLWNE---IERLKDKGNFLTEDQILWLLLGICR 145

Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           GL  +H    +   HRD+K  NILL ++ +P + D G   
Sbjct: 146 GLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMN 182

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  115 bits (290), Expect = 4e-30
 Identities = 41/170 (24%), Positives = 74/170 (43%), Gaps = 10/170 (5%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADE-IIADFLSELGIMAHVDHPN 168
             +S    IG GG ++V++      Q+ AIK +    AD   +  + +E+  +  +   +
Sbjct: 9   RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68

Query: 169 TA--KLLGYGI-EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHE 225
               +L  Y I +  +++V+E   N  L S L   K+ +    R      + E +  +H 
Sbjct: 69  DKIIRLYDYEITDQYIYMVMECG-NIDLNSWL-KKKKSIDPWERKSYWKNMLEAVHTIH- 125

Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGT 275
             Q  I+H D+K AN L+ +    ++ DFG+A  +    T        GT
Sbjct: 126 --QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGT 172

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  114 bits (288), Expect = 4e-30
 Identities = 43/191 (22%), Positives = 80/191 (41%), Gaps = 12/191 (6%)

Query: 89  NSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTAD 148
           +  D  +    F    ++     +S    IG GG ++V++      Q+ AIK +    AD
Sbjct: 9   SGVDLGTENLYFQSMSVKG--RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEAD 66

Query: 149 E-IIADFLSELGIMAHVDHPNTA--KLLGYGI-EGGMHIVLELSPNGSLASLLYGMKEKL 204
              +  + +E+  +  +   +    +L  Y I +  +++V+E   N  L S L   K+ +
Sbjct: 67  NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWL-KKKKSI 124

Query: 205 KWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW 264
               R      + E +  +H   Q  I+H D+K AN L+ +    ++ DFG+A  +    
Sbjct: 125 DPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDT 180

Query: 265 THHTISKVEGT 275
           T        GT
Sbjct: 181 TSVVKDSQVGT 191

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  114 bits (287), Expect = 8e-30
 Identities = 49/169 (28%), Positives = 82/169 (48%), Gaps = 23/169 (13%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRNG---QLVAIKRLTRGTADEIIADFLSELGIMAHV-D 165
           N+  F+++IG+G + +V K R++        AIKR+    + +   DF  EL ++  +  
Sbjct: 25  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 84

Query: 166 HPNTAKLLGYGIEGG-MHIVLELSPNGSLASLL---------------YGMKEKLKWGIR 209
           HPN   LLG     G +++ +E +P+G+L   L                     L     
Sbjct: 85  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144

Query: 210 YKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
              A  VA G+ YL +   ++ IHRD+ A NIL+ E++  +I DFGL++
Sbjct: 145 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR 190

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  114 bits (287), Expect = 8e-30
 Identities = 46/168 (27%), Positives = 71/168 (42%), Gaps = 20/168 (11%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRNG----QLVAIKRLTRGTADEI-IADFLSELGIMAHV 164
             F+   ++GKG +  V + +L+        VA+K L         I +FL E   M   
Sbjct: 23  QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF 82

Query: 165 DHPNTAKLLG-------YGIEGGMHIVLELSPNGSLASLL-----YGMKEKLKWGIRYKI 212
           DHP+ AKL+G        G      ++L    +G L + L           L      + 
Sbjct: 83  DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRF 142

Query: 213 ALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL 260
            + +A G+ YL     R  IHRD+ A N +L ED    + DFGL++ +
Sbjct: 143 MVDIACGMEYLSS---RNFIHRDLAARNCMLAEDMTVCVADFGLSRKI 187

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  114 bits (288), Expect = 9e-30
 Identities = 43/160 (26%), Positives = 77/160 (48%), Gaps = 17/160 (10%)

Query: 110 NNFSFENLIGKGGYAEVYKGR-LRNGQLVAIK--RLTRGTADEIIADFLSELGIMAHVDH 166
             +     IG+G + +    +   +G+   IK   ++R ++ E   +   E+ ++A++ H
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKER-EESRREVAVLANMKH 82

Query: 167 PNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMK-----EKLKWGIRYKIALGVAEGL 220
           PN  +      E G ++IV++    G L   +   K     E        +I L     L
Sbjct: 83  PNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLA----L 138

Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL 260
            ++H+   R+I+HRDIK+ NI LT+D   Q+ DFG+A+ L
Sbjct: 139 KHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVL 175

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  114 bits (287), Expect = 1e-29
 Identities = 41/155 (26%), Positives = 78/155 (50%), Gaps = 9/155 (5%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPN 168
           ++F   + +G G    V+K   + +G ++A K +       I    + EL ++   + P 
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92

Query: 169 TAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRY--KIALGVAEGLLYLHE 225
                G +  +G + I +E    GSL  +   +K+  +   +   K+++ V +GL YL E
Sbjct: 93  IVGFYGAFYSDGEISICMEHMDGGSLDQV---LKKAGRIPEQILGKVSIAVIKGLTYLRE 149

Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL 260
             + +I+HRD+K +NIL+    E ++CDFG++  L
Sbjct: 150 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 182

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  113 bits (284), Expect = 2e-29
 Identities = 52/223 (23%), Positives = 81/223 (36%), Gaps = 23/223 (10%)

Query: 65  PLKLSIRRSSSMREGIDMPRNLFVNSYDSQSPQKIFSLYELQSAT----NNFSFENLIGK 120
              + +   +   + +   +   V+     S       Y+          +F   + +G 
Sbjct: 8   SSGVDLGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGH 67

Query: 121 GGYAEVYKGR-LRNGQLVAIKRLTRGTADEI-IADFLSELGIMAHV-DHPNTAKLLGYGI 177
           G Y EV+K R   +G+L A+KR           A  L+E+G    V  HP   +L     
Sbjct: 68  GSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWE 127

Query: 178 EGG-MHIVLELSPNGSLASLLY----GMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRII 232
           EGG +++  EL    SL          + E   WG      L     L +LH    + ++
Sbjct: 128 EGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLA----LAHLHS---QGLV 179

Query: 233 HRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGT 275
           H D+K ANI L      ++ DFGL   L            EG 
Sbjct: 180 HLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV---QEGD 219

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  112 bits (282), Expect = 3e-29
 Identities = 53/150 (35%), Positives = 74/150 (49%), Gaps = 11/150 (7%)

Query: 117 LIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGY 175
           ++GKG Y  VY GR L N   +AIK +    +         E+ +  H+ H N  + LG 
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQP-LHEEIALHKHLKHKNIVQYLGS 87

Query: 176 GIEGG-MHIVLELSPNGSLASLLYGMKEKLKWG---IRYKIALGVAEGLLYLHEGCQRRI 231
             E G + I +E  P GSL++LL      LK     I       + EGL YLH+    +I
Sbjct: 88  FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIG-FYTKQILEGLKYLHD---NQI 143

Query: 232 IHRDIKAANILL-TEDFEPQICDFGLAKWL 260
           +HRDIK  N+L+ T     +I DFG +K L
Sbjct: 144 VHRDIKGDNVLINTYSGVLKISDFGTSKRL 173

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  111 bits (281), Expect = 3e-29
 Identities = 47/157 (29%), Positives = 80/157 (50%), Gaps = 9/157 (5%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGI-MAHVDHP 167
           ++      +G+G Y  V K R   +GQ++A+KR+      +     L +L I M  VD P
Sbjct: 7   DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66

Query: 168 NTAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKW---GIRYKIALGVAEGLLYL 223
            T    G    EG + I +EL  + SL      + +K +     I  KIA+ + + L +L
Sbjct: 67  FTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHL 125

Query: 224 HEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL 260
           H   +  +IHRD+K +N+L+    + ++CDFG++ +L
Sbjct: 126 HS--KLSVIHRDVKPSNVLINALGQVKMCDFGISGYL 160

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  113 bits (285), Expect = 4e-29
 Identities = 37/178 (20%), Positives = 66/178 (37%), Gaps = 17/178 (9%)

Query: 93  SQSPQKIFSLYELQSATNNFSFENLIGKG--GYAEVYKGR-LRNGQLVAIKRLT-RGTAD 148
                    +         +    +IGKG      V   R    G+ V ++R+     ++
Sbjct: 8   HMENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSN 67

Query: 149 EIIADFLSELGIMAHVDHPNTAKLLG-YGIEGGMHIVLELSPNGSLASLL-----YGMKE 202
           E++     EL +    +HPN       +  +  + +V      GS   L+      GM E
Sbjct: 68  EMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNE 127

Query: 203 KLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL 260
                I Y I  GV + L Y+H       +HR +KA++IL++ D +  +        +
Sbjct: 128 LA---IAY-ILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSM 178

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  111 bits (280), Expect = 5e-29
 Identities = 39/170 (22%), Positives = 66/170 (38%), Gaps = 25/170 (14%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRNG------QLVAIKRLTRGTADEIIADFLSELGIMAH 163
           +   F   +G+  + +VYKG L         Q VAIK L       +  +F  E  + A 
Sbjct: 9   SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRAR 68

Query: 164 VDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLL---------------YGMKEKLKWG 207
           + HPN   LLG   +   + ++     +G L   L                 +K  L+  
Sbjct: 69  LQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128

Query: 208 IRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLA 257
               +   +A G+ YL       ++H+D+   N+L+ +    +I D GL 
Sbjct: 129 DFVHLVAQIAAGMEYLSS---HHVVHKDLATRNVLVYDKLNVKISDLGLF 175

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  113 bits (284), Expect = 5e-29
 Identities = 40/170 (23%), Positives = 73/170 (42%), Gaps = 10/170 (5%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADE-IIADFLSELGIMAHVDHPN 168
             +S    IG GG ++V++      Q+ AIK +    AD   +  + +E+  +  +   +
Sbjct: 56  RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115

Query: 169 TA--KLLGYGI-EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHE 225
               +L  Y I +  +++V+E   N  L S L   K+ +    R      + E +  +H 
Sbjct: 116 DKIIRLYDYEITDQYIYMVMECG-NIDLNSWLK-KKKSIDPWERKSYWKNMLEAVHTIH- 172

Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGT 275
             Q  I+H D+K AN L+ +    ++ DFG+A  +    T        G 
Sbjct: 173 --QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGA 219

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  111 bits (279), Expect = 7e-29
 Identities = 38/167 (22%), Positives = 74/167 (44%), Gaps = 19/167 (11%)

Query: 110 NNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPN 168
            +F     +G+GG+  V++ +   +    AIKR+     +      + E+  +A ++HP 
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64

Query: 169 -------------TAKLLGYGIEGGMHIVLELSPNGSLASLL--YGMKEKLKWGIRYKIA 213
                        T KL     +  ++I ++L    +L   +      E+ +  +   I 
Sbjct: 65  IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124

Query: 214 LGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL 260
           L +AE + +LH    + ++HRD+K +NI  T D   ++ DFGL   +
Sbjct: 125 LQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAM 168

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  111 bits (280), Expect = 9e-29
 Identities = 53/172 (30%), Positives = 83/172 (48%), Gaps = 19/172 (11%)

Query: 98  KIFSLYELQSATNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLS 156
               L  L+     F    L+G G Y +VYKGR ++ GQL AIK +      +   +   
Sbjct: 12  DEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD--VTGDEEEEIKQ 69

Query: 157 ELGIMAHV-DHPNTAKLLG-------YGIEGGMHIVLELSPNGSLASLLYGMKEKL---K 205
           E+ ++     H N A   G        G++  + +V+E    GS+  L+   K      +
Sbjct: 70  EINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEE 129

Query: 206 WGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLA 257
           W I Y I   +  GL +LH+    ++IHRDIK  N+LLTE+ E ++ DFG++
Sbjct: 130 W-IAY-ICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVS 176

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  111 bits (280), Expect = 1e-28
 Identities = 54/151 (35%), Positives = 79/151 (52%), Gaps = 10/151 (6%)

Query: 112 FSFENLIGKGGYAEVYKGR-LRNGQLVAIKR--LTRGTADEIIADFLSELGIMAHVDHPN 168
           FS    IG G +  VY  R +RN ++VAIK+   +   ++E   D + E+  +  + HPN
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115

Query: 169 TAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWG-IRYKIALGVAEGLLYLHEG 226
           T +  G Y  E    +V+E    GS + LL   K+ L+   I   +  G  +GL YLH  
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAA-VTHGALQGLAYLHS- 172

Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLA 257
               +IHRD+KA NILL+E    ++ DFG A
Sbjct: 173 --HNMIHRDVKAGNILLSEPGLVKLGDFGSA 201

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  111 bits (279), Expect = 1e-28
 Identities = 43/167 (25%), Positives = 70/167 (41%), Gaps = 19/167 (11%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRNG----QLVAIKRLTRGTADEI-IADFLSELGIMAHV 164
           N      ++G+G +  V +G L+        VA+K +    + +  I +FLSE   M   
Sbjct: 34  NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF 93

Query: 165 DHPNTAKLLG------YGIEGGMHIVLELSPNGSLASLL-----YGMKEKLKWGIRYKIA 213
            HPN  +LLG              ++L     G L + L         + +      K  
Sbjct: 94  SHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFM 153

Query: 214 LGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL 260
           + +A G+ YL     R  +HRD+ A N +L +D    + DFGL+K +
Sbjct: 154 VDIALGMEYLSN---RNFLHRDLAARNCMLRDDMTVCVADFGLSKKI 197

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  111 bits (279), Expect = 1e-28
 Identities = 43/184 (23%), Positives = 80/184 (43%), Gaps = 21/184 (11%)

Query: 91  YDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNG------QLVAIKRLTR 144
           Y S +   +   +E+       +    +G+G +  VY+G  +          VAIK +  
Sbjct: 8   YFSAADVYVPDEWEVAR--EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNE 65

Query: 145 GTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLL------ 197
             +     +FL+E  +M   +  +  +LLG   +G    +++EL   G L S L      
Sbjct: 66  AASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPA 125

Query: 198 ---YGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDF 254
                +          ++A  +A+G+ YL+     + +HRD+ A N ++ EDF  +I DF
Sbjct: 126 MANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDF 182

Query: 255 GLAK 258
           G+ +
Sbjct: 183 GMTR 186

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  110 bits (276), Expect = 2e-28
 Identities = 34/176 (19%), Positives = 73/176 (41%), Gaps = 23/176 (13%)

Query: 102 LYELQSATNNFSFENLIGKGGYAEVYKGRLRN--------GQLVAIKRLTRGTADEIIAD 153
            +++++   +  F   +G+G + +++KG  R            V +K L +   +     
Sbjct: 2   FHKIRN--EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSE-S 58

Query: 154 FLSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKI 212
           F     +M+ + H +     G  + G    +V E    GSL + L   K  +    + ++
Sbjct: 59  FFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEV 118

Query: 213 ALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQ--------ICDFGLAKWL 260
           A  +A  + +L E     +IH ++ A NILL  + + +        + D G++  +
Sbjct: 119 AKQLAAAMHFLEE---NTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV 171

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  110 bits (276), Expect = 4e-28
 Identities = 57/224 (25%), Positives = 91/224 (40%), Gaps = 35/224 (15%)

Query: 66  LKLSIRRSSSMREGIDMPRNLFVN-SYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYA 124
           ++ +    +++   + + R L  N  Y          L  L+   NN  +   IG+G + 
Sbjct: 3   MESAAVTLTTLPSELLLDR-LHPNPMYQRMPLLLNPKLLSLEYPRNNIEYVRDIGEGAFG 61

Query: 125 EVYKGRLRNG------QLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE 178
            V++ R           +VA+K L    + ++ ADF  E  +MA  D+PN  KLLG    
Sbjct: 62  RVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV 121

Query: 179 GG-MHIVLELSPNGSLASLLYGMKEKLKWGIRY-----------------------KIAL 214
           G  M ++ E    G L   L  M       + +                        IA 
Sbjct: 122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIAR 181

Query: 215 GVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
            VA G+ YL E   R+ +HRD+   N L+ E+   +I DFGL++
Sbjct: 182 QVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSR 222

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  109 bits (274), Expect = 4e-28
 Identities = 53/172 (30%), Positives = 79/172 (45%), Gaps = 14/172 (8%)

Query: 93  SQSPQKIFSLYELQSATNN----FSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTA 147
              P++     +  S T      F     +G+G Y  VYK      GQ+VAIK++     
Sbjct: 8   RNPPRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP---V 64

Query: 148 DEIIADFLSELGIMAHVDHPNTAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKW 206
           +  + + + E+ IM   D P+  K  G Y     + IV+E    GS++ ++    + L  
Sbjct: 65  ESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTE 124

Query: 207 G-IRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLA 257
             I   I     +GL YLH     R IHRDIKA NILL  +   ++ DFG+A
Sbjct: 125 DEIAT-ILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVA 172

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  109 bits (275), Expect = 5e-28
 Identities = 47/165 (28%), Positives = 72/165 (43%), Gaps = 19/165 (11%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRNG------QLVAIKRLTRGTADEIIADFLSELGIMAH 163
            N +    +G G + EVY+G++           VA+K L    +++   DFL E  I++ 
Sbjct: 30  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 89

Query: 164 VDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLL------YGMKEKLKWGIRYKIALGV 216
            +H N  + +G  ++     I++EL   G L S L            L       +A  +
Sbjct: 90  FNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149

Query: 217 AEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQIC---DFGLAK 258
           A G  YL E      IHRDI A N LLT     ++    DFG+A+
Sbjct: 150 ACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  109 bits (275), Expect = 6e-28
 Identities = 38/169 (22%), Positives = 65/169 (38%), Gaps = 25/169 (14%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRNG------QLVAIKRLTRGTADEIIADFLSELGIMAH 163
            +   +  +G+G + +V+     N        LVA+K L   +      DF  E  ++  
Sbjct: 41  RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQ-DFQREAELLTM 99

Query: 164 VDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLL--------------YGMKEKLKWGI 208
           + H +  +  G   EG  + +V E   +G L   L                    L  G 
Sbjct: 100 LQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQ 159

Query: 209 RYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLA 257
              +A  VA G++YL        +HRD+   N L+ +    +I DFG++
Sbjct: 160 LLAVASQVAAGMVYLAG---LHFVHRDLATRNCLVGQGLVVKIGDFGMS 205

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  108 bits (272), Expect = 1e-27
 Identities = 43/160 (26%), Positives = 76/160 (47%), Gaps = 6/160 (3%)

Query: 104 ELQSATNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLSELGI-M 161
             Q+  N+      +G G   +V+K R  + G ++A+K++ R    E     L +L + +
Sbjct: 19  RYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVL 78

Query: 162 AHVDHPNTAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGL 220
              D P   +  G +     + I +EL        L   M+  +   I  K+ + + + L
Sbjct: 79  KSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKAL 137

Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL 260
            YL E  +  +IHRD+K +NILL E  + ++CDFG++  L
Sbjct: 138 YYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRL 175

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  109 bits (274), Expect = 1e-27
 Identities = 53/226 (23%), Positives = 95/226 (42%), Gaps = 35/226 (15%)

Query: 65  PLKLSIRRSSSMREGIDMPRNLFVNSYDSQSPQKIF-SLYELQSAT------NNFSFENL 117
            + +S   SSSM     + R     S  + +P     S YEL          +  +    
Sbjct: 29  QVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVSEYELPEDPKWEFPRDKLTLGKP 88

Query: 118 IGKGGYAEVYKGRLR--------NGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPN 168
           +G+G + +V                  VA+K L     ++ ++D +SE+ +M  +  H N
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148

Query: 169 TAKLLGYGIEGG-MHIVLELSPNGSLASLL---------------YGMKEKLKWGIRYKI 212
              LLG   + G +++++E +  G+L   L                  +E++ +      
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208

Query: 213 ALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
              +A G+ YL     ++ IHRD+ A N+L+TE+   +I DFGLA+
Sbjct: 209 TYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLAR 251

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  107 bits (270), Expect = 1e-27
 Identities = 39/170 (22%), Positives = 68/170 (40%), Gaps = 26/170 (15%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRNG------QLVAIKRLTRGTADEIIADFLSELGIMAH 163
            +   +  +G+G + +V+     N        LVA+K L   T      DF  E  ++ +
Sbjct: 15  RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAAR-KDFQREAELLTN 73

Query: 164 VDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLL---------------YGMKEKLKWG 207
           + H +  K  G   +G  + +V E   +G L   L                  K +L   
Sbjct: 74  LQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLS 133

Query: 208 IRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLA 257
               IA  +A G++YL     +  +HRD+   N L+  +   +I DFG++
Sbjct: 134 QMLHIASQIASGMVYLAS---QHFVHRDLATRNCLVGANLLVKIGDFGMS 180

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  107 bits (270), Expect = 2e-27
 Identities = 43/193 (22%), Positives = 80/193 (41%), Gaps = 28/193 (14%)

Query: 109 TNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHP 167
            ++F    ++G+G + +V K R   + +  AIK++     +E ++  LSE+ ++A ++H 
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH--TEEKLSTILSEVMLLASLNHQ 62

Query: 168 NTAKLLGYGIEGG--------------MHIVLELSPNGSLASLLYGMK----EKLKWGIR 209
              +     +E                + I +E   NG+L  L++           W + 
Sbjct: 63  YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF 122

Query: 210 YKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTI 269
            +I   ++    Y+H    + IIHRD+K  NI + E    +I DFGLAK +        +
Sbjct: 123 RQILEALS----YIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKL 175

Query: 270 SKVEGTFGLVKLN 282
                      L 
Sbjct: 176 DSQNLPGSSDNLT 188

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  107 bits (270), Expect = 2e-27
 Identities = 47/173 (27%), Positives = 76/173 (43%), Gaps = 27/173 (15%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRN------GQLVAIKRLTRGTADEIIADFLSELGIMAH 163
           +       +G+G + +V +            + VA+K L  G         +SEL I+ H
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86

Query: 164 VD-HPNTAKLLGYGIEGG--MHIVLELSPNGSLASLL---------------YGMKEKLK 205
           +  H N   LLG   + G  + +++E    G+L++ L                  K+ L 
Sbjct: 87  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146

Query: 206 WGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
                  +  VA+G+ +L     R+ IHRD+ A NILL+E    +ICDFGLA+
Sbjct: 147 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLAR 196

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  106 bits (267), Expect = 3e-27
 Identities = 40/183 (21%), Positives = 72/183 (39%), Gaps = 35/183 (19%)

Query: 110 NNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPN 168
            +F    LIG GG+ +V+K +   +G+   IKR+              E+  +A +DH N
Sbjct: 11  MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKA-----EREVKALAKLDHVN 65

Query: 169 -----------------TAKLLGYGIEGGMHIVLELSPNGSLASLLYGMK-----EKLKW 206
                            ++K         + I +E    G+L   +   +     + L  
Sbjct: 66  IVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLAL 125

Query: 207 GIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH 266
            +  +I  G    + Y+H    +++I+RD+K +NI L +  + +I DFGL   L      
Sbjct: 126 ELFEQITKG----VDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR 178

Query: 267 HTI 269
              
Sbjct: 179 TRS 181

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  107 bits (269), Expect = 3e-27
 Identities = 45/179 (25%), Positives = 78/179 (43%), Gaps = 33/179 (18%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRNG------QLVAIKRLTRGTADEIIADFLSELGIMAH 163
            N      +G+G + +V K    +         VA+K L    +   + D LSE  ++  
Sbjct: 23  KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82

Query: 164 VDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLL-----------------------YG 199
           V+HP+  KL G   + G + +++E +  GSL   L                       + 
Sbjct: 83  VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142

Query: 200 MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
            +  L  G     A  +++G+ YL E    +++HRD+ A NIL+ E  + +I DFGL++
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLAE---MKLVHRDLAARNILVAEGRKMKISDFGLSR 198

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  106 bits (267), Expect = 3e-27
 Identities = 48/173 (27%), Positives = 70/173 (40%), Gaps = 20/173 (11%)

Query: 114 FENLIGKGGYAEVYKGR-LRNGQLVAIKRL-TRGTADEIIADFLSELGIMAHVDHPNTAK 171
           F+  IG+G +  VYKG        VA   L  R         F  E  ++  + HPN  +
Sbjct: 30  FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 89

Query: 172 LLGYGI-----EGGMHIVLELSPNGSLASLL--YG-MKEKLKWGIRYKIALGVAEGLLYL 223
                      +  + +V EL  +G+L + L  +  MK K+   +R      + +GL +L
Sbjct: 90  FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKV---LR-SWCRQILKGLQFL 145

Query: 224 HEGCQRRIIHRDIKAANILLT-EDFEPQICDFGLAKWLPEQWTHHTISKVEGT 275
           H      IIHRD+K  NI +T      +I D GLA              V GT
Sbjct: 146 HT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT----LKRASFAKAVIGT 193

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  107 bits (269), Expect = 3e-27
 Identities = 41/174 (23%), Positives = 78/174 (44%), Gaps = 28/174 (16%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLR--------NGQLVAIKRLTRGTADEIIADFLSELGIM 161
           +  +    +G+G + +V                  VA+K L     ++ ++D +SE+ +M
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94

Query: 162 AHV-DHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLL---------------YGMKEKL 204
             +  H N   LLG   + G +++++E +  G+L   L                  +E++
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154

Query: 205 KWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
            +         +A G+ YL     ++ IHRD+ A N+L+TE+   +I DFGLA+
Sbjct: 155 TFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLAR 205

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  107 bits (270), Expect = 4e-27
 Identities = 48/165 (29%), Positives = 72/165 (43%), Gaps = 19/165 (11%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRNG------QLVAIKRLTRGTADEIIADFLSELGIMAH 163
            N +    +G G + EVY+G++           VA+K L    +++   DFL E  I++ 
Sbjct: 71  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 130

Query: 164 VDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLL------YGMKEKLKWGIRYKIALGV 216
            +H N  + +G  ++     I+LEL   G L S L            L       +A  +
Sbjct: 131 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190

Query: 217 AEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQIC---DFGLAK 258
           A G  YL E      IHRDI A N LLT     ++    DFG+A+
Sbjct: 191 ACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 232

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  105 bits (265), Expect = 1e-26
 Identities = 46/169 (27%), Positives = 67/169 (39%), Gaps = 24/169 (14%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLR------NGQLVAIKRLTRGTADEIIADFLSELGIMAH 163
           NN  F   +G G + +V +              VA+K L      +     +SEL IM+H
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105

Query: 164 VD-HPNTAKLLGYGIEGG-MHIVLELSPNGSLASLL-------------YGMKEKLKWGI 208
           +  H N   LLG    GG + ++ E    G L + L                        
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165

Query: 209 RYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLA 257
               +  VA+G+ +L     +  IHRD+ A N+LLT     +I DFGLA
Sbjct: 166 LLHFSSQVAQGMAFLAS---KNCIHRDVAARNVLLTNGHVAKIGDFGLA 211

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  105 bits (263), Expect = 2e-26
 Identities = 46/173 (26%), Positives = 69/173 (39%), Gaps = 28/173 (16%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRN------GQLVAIKRLTRGTADEIIADFLSELGIMAH 163
           N  SF   +G G + +V +              VA+K L            +SEL ++++
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 164 V-DHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLL-----------------YGMKEKL 204
           + +H N   LLG    GG   ++ E    G L + L                    +  L
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 205 KWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLA 257
                   +  VA+G+ +L     +  IHRD+ A NILLT     +ICDFGLA
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLA 192

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  104 bits (261), Expect = 2e-26
 Identities = 41/150 (27%), Positives = 68/150 (45%), Gaps = 12/150 (8%)

Query: 112 FSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTA 170
           ++    IG+G    VY    +  GQ VAI+++      +     ++E+ +M    +PN  
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE-LIINEILVMRENKNPNIV 80

Query: 171 KLLG-YGIEGGMHIVLELSPNGSLASLL--YGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
             L  Y +   + +V+E    GSL  ++    M E     I   +     + L +LH   
Sbjct: 81  NYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQ---IAA-VCRECLQALEFLH--- 133

Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLA 257
             ++IHRDIK+ NILL  D   ++ DFG  
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFC 163

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  104 bits (261), Expect = 3e-26
 Identities = 41/170 (24%), Positives = 76/170 (44%), Gaps = 17/170 (10%)

Query: 106 QSATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHV 164
            ++ + +   +++G+G  A V++GR +  G L AIK     +    +   + E  ++  +
Sbjct: 5   STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64

Query: 165 DHPNTAKLLGY---GIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALG----VA 217
           +H N  KL             +++E  P GSL ++L   +    +G+     L     V 
Sbjct: 65  NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVL--EEPSNAYGLPESEFLIVLRDVV 122

Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQ----ICDFGLAKWLPEQ 263
            G+ +L E     I+HR+IK  NI+     + Q    + DFG A+ L + 
Sbjct: 123 GGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD 169

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  104 bits (261), Expect = 4e-26
 Identities = 44/192 (22%), Positives = 78/192 (40%), Gaps = 28/192 (14%)

Query: 71  RRSSSMREGIDMPR-NLFVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKG 129
            +S  +          + V+  D   P+ +   Y              IG+G    V   
Sbjct: 20  FQSGVVTHEQFKAALRMVVDQGD---PRLLLDSYVK------------IGEGSTGIVCLA 64

Query: 130 R-LRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLG-YGIEGGMHIVLEL 187
           R   +G+ VA+K +      +      +E+ IM    H N  ++   Y +   + +++E 
Sbjct: 65  REKHSGRQVAVKMMDL-RKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEF 123

Query: 188 SPNGSLASLLYG--MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTE 245
              G+L  ++    + E+    I   +   V + L YLH    + +IHRDIK+ +ILLT 
Sbjct: 124 LQGGALTDIVSQVRLNEEQ---IAT-VCEAVLQALAYLH---AQGVIHRDIKSDSILLTL 176

Query: 246 DFEPQICDFGLA 257
           D   ++ DFG  
Sbjct: 177 DGRVKLSDFGFC 188

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  102 bits (257), Expect = 8e-26
 Identities = 42/182 (23%), Positives = 67/182 (36%), Gaps = 19/182 (10%)

Query: 109 TNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADE-IIADFLSELGIMAHV-D 165
           T  F     IG G +  V+K     +G + AIKR  +  A      + L E+   A +  
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69

Query: 166 HPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRY------KIALGVAE 218
           H +  +      E   M I  E    GSLA  +    E  +    +       + L V  
Sbjct: 70  HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAI---SENYRIMSYFKEAELKDLLLQVGR 126

Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGL 278
           GL Y+H      ++H DIK +NI ++                 +  ++  + K+ G  G 
Sbjct: 127 GLRYIHS---MSLVHMDIKPSNIFISRT--SIPNAASEEGDEDDWASNKVMFKI-GDLGH 180

Query: 279 VK 280
           V 
Sbjct: 181 VT 182

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  106 bits (265), Expect = 1e-25
 Identities = 40/164 (24%), Positives = 64/164 (39%), Gaps = 24/164 (14%)

Query: 103 YELQSATNNFSFENLIGKGGYAEVYKGR-LR-NGQLVAIKRLTRGTADEIIADFLSELGI 160
           YE++           I  GG   +Y       NG+ V +K L      E  A  ++E   
Sbjct: 82  YEVKG---------CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQF 132

Query: 161 MAHVDHPNTAKLLGYGIEGGMH------IVLELSPNGSLASLLYGMKEKLKWGIRYKIAL 214
           +A V HP+  ++  +      H      IV+E     SL        +KL         L
Sbjct: 133 LAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK---GQKLPVAEAIAYLL 189

Query: 215 GVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
            +   L YLH      +++ D+K  NI+LTE+ + ++ D G   
Sbjct: 190 EILPALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAVS 229

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  104 bits (261), Expect = 1e-25
 Identities = 41/170 (24%), Positives = 76/170 (44%), Gaps = 17/170 (10%)

Query: 106 QSATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHV 164
            ++ + +   +++G+G  A V++GR +  G L AIK     +    +   + E  ++  +
Sbjct: 5   STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64

Query: 165 DHPNTAKLLGY---GIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALG----VA 217
           +H N  KL             +++E  P GSL ++L   +    +G+     L     V 
Sbjct: 65  NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVL--EEPSNAYGLPESEFLIVLRDVV 122

Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQ----ICDFGLAKWLPEQ 263
            G+ +L E     I+HR+IK  NI+     + Q    + DFG A+ L + 
Sbjct: 123 GGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD 169

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  102 bits (256), Expect = 1e-25
 Identities = 39/169 (23%), Positives = 71/169 (42%), Gaps = 20/169 (11%)

Query: 107 SATNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIK--RLTRGTADEIIADFLSELGIMAH 163
           S   ++     IG G Y    K R   +G+++  K       T  E     +SE+ ++  
Sbjct: 3   SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEK-QMLVSEVNLLRE 61

Query: 164 VDHPNTAKLLGYGIE---GGMHIVLELSPNGSLASLLYGMKEKLK-------WGIRYKIA 213
           + HPN  +     I+     ++IV+E    G LAS++    ++ +         +  ++ 
Sbjct: 62  LKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLT 121

Query: 214 LGVAEGLLYLHE--GCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL 260
           L +       H        ++HRD+K AN+ L      ++ DFGLA+ L
Sbjct: 122 LALK----ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL 166

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  103 bits (260), Expect = 1e-25
 Identities = 45/174 (25%), Positives = 78/174 (44%), Gaps = 28/174 (16%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRN--------GQLVAIKRLTRGTADEIIADFLSELGIM 161
           +       +G+G + +V                  VA+K L     ++ ++D +SE+ +M
Sbjct: 69  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 128

Query: 162 AHV-DHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLL---------------YGMKEKL 204
             +  H N   LLG   + G +++++E +  G+L   L               +  +E+L
Sbjct: 129 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188

Query: 205 KWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
                   A  VA G+ YL     ++ IHRD+ A N+L+TED   +I DFGLA+
Sbjct: 189 SSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLAR 239

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  101 bits (255), Expect = 4e-25
 Identities = 44/178 (24%), Positives = 67/178 (37%), Gaps = 33/178 (18%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRNG------QLVAIKRLTRGTADEIIADFLSELGIMAH 163
            N  F  ++G G + +V                VA+K L            +SEL +M  
Sbjct: 45  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104

Query: 164 V-DHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRY----------- 210
           +  H N   LLG     G ++++ E    G L + L   +EK                  
Sbjct: 105 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164

Query: 211 -----------KIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLA 257
                        A  VA+G+ +L     +  +HRD+ A N+L+T     +ICDFGLA
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLA 219

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  100 bits (252), Expect = 8e-25
 Identities = 43/155 (27%), Positives = 66/155 (42%), Gaps = 16/155 (10%)

Query: 111 NFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDHP 167
            +     +GKGG+A+ ++       ++ A K + +              E+ I   + H 
Sbjct: 42  RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ 101

Query: 168 NTAKLLGYGIEGGMHI--VLELSPNGSLASLLY---GMKEKLKWGIRYKIALGVAEGLLY 222
           +     G+  E    +  VLEL    SL  L      + E      RY +   +  G  Y
Sbjct: 102 HVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKRRKALTEPE---ARYYLR-QIVLGCQY 156

Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLA 257
           LH   + R+IHRD+K  N+ L ED E +I DFGLA
Sbjct: 157 LH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLA 188

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 99.2 bits (248), Expect = 2e-24
 Identities = 46/169 (27%), Positives = 73/169 (43%), Gaps = 19/169 (11%)

Query: 110 NNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDH 166
            +F     +GKG +  VY  R  ++  ++A+K L +       +      E+ I +H+ H
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68

Query: 167 PNTAKLLGYGIEGGMH------IVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGL 220
           PN  +L GY      H      ++LE +P G++   L  +  K            +A  L
Sbjct: 69  PNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANAL 122

Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTI 269
            Y H    +R+IHRDIK  N+LL    E +I DFG +   P       +
Sbjct: 123 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-RRTDL 167

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 99.2 bits (248), Expect = 2e-24
 Identities = 43/155 (27%), Positives = 66/155 (42%), Gaps = 16/155 (10%)

Query: 111 NFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDHP 167
            +     +GKGG+A+ ++       ++ A K + +              E+ I   + H 
Sbjct: 16  RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ 75

Query: 168 NTAKLLGYGIEGGMHI--VLELSPNGSLASLLYG---MKEKLKWGIRYKIALGVAEGLLY 222
           +     G+  E    +  VLEL    SL  L      + E      RY +   +  G  Y
Sbjct: 76  HVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKRRKALTEPE---ARYYLR-QIVLGCQY 130

Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLA 257
           LH   + R+IHRD+K  N+ L ED E +I DFGLA
Sbjct: 131 LH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLA 162

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 98.4 bits (246), Expect = 3e-24
 Identities = 46/158 (29%), Positives = 74/158 (46%), Gaps = 19/158 (12%)

Query: 110 NNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDH 166
            +F   NL+GKG +A VY+   +  G  VAIK + +       ++    +E+ I   + H
Sbjct: 11  EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70

Query: 167 PNTAKLLGYGIEGGMH------IVLELSPNGSLASLLYGMKEKLK-WGIRYKIALGVAEG 219
           P+  +L  Y             +VLE+  NG +   L    +       R+ +   +  G
Sbjct: 71  PSILELYNY-----FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMH-QIITG 124

Query: 220 LLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLA 257
           +LYLH      I+HRD+  +N+LLT +   +I DFGLA
Sbjct: 125 MLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLA 159

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 98.1 bits (245), Expect = 5e-24
 Identities = 38/160 (23%), Positives = 65/160 (40%), Gaps = 17/160 (10%)

Query: 103 YELQSATNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTAD--EIIADFLSELG 159
           Y++            +G GG + VY          VAIK +     +  E +  F  E+ 
Sbjct: 13  YKIVD---------KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVH 63

Query: 160 IMAHVDHPNTAKLLGYGIEGGMH-IVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE 218
             + + H N   ++    E   + +V+E     +L+  +      L           + +
Sbjct: 64  NSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYI-ESHGPLSVDTAINFTNQILD 122

Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           G+ + H     RI+HRDIK  NIL+  +   +I DFG+AK
Sbjct: 123 GIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAK 159

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 96.9 bits (242), Expect = 2e-23
 Identities = 34/166 (20%), Positives = 62/166 (37%), Gaps = 21/166 (12%)

Query: 103 YELQSATNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTAD--EIIADFLSELG 159
           Y L+          L+G+GG  +VY+       ++VA+K ++   +           E  
Sbjct: 36  YRLRR---------LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREAR 86

Query: 160 IMAHVDHPNTAKLLGYGIEGGMH-IVLELSPNGSLASLLYGMKEKLKWGIRY--KIALGV 216
               +  P+   +  +G   G   + + L     LA++L   + +          I   +
Sbjct: 87  TAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAML---RRQGPLAPPRAVAIVRQI 143

Query: 217 AEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE 262
              L   H        HRD+K  NIL++ D    + DFG+A    +
Sbjct: 144 GSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASATTD 186

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score = 97.9 bits (244), Expect = 3e-23
 Identities = 42/177 (23%), Positives = 71/177 (40%), Gaps = 20/177 (11%)

Query: 111 NFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVD-HPNT 169
           +F  ++++G G    +    + + + VA+KR+      E  +    E+ ++   D HPN 
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILP----ECFSFADREVQLLRESDEHPNV 80

Query: 170 AKLLGYGIE---GGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEG 226
            +   +  E      +I +EL    +L   +              +      GL +LH  
Sbjct: 81  IRY--FCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHS- 136

Query: 227 CQRRIIHRDIKAANILLTEDFEPQ-----ICDFGLAKWL-PEQWTHHTISKVEGTFG 277
               I+HRD+K  NIL++           I DFGL K L   + +    S V GT G
Sbjct: 137 --LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEG 191

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 94.8 bits (236), Expect = 1e-22
 Identities = 33/215 (15%), Positives = 79/215 (36%), Gaps = 38/215 (17%)

Query: 73  SSSMREGIDMPRNLFVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLR 132
             SM++ +    NL   +   +   K  + Y +            + +G + ++     +
Sbjct: 3   LGSMKDILSNYSNLIYLNKYVKEKDKYINDYRII---------RTLNQGKFNKIILCE-K 52

Query: 133 NGQLVAIKRLTRGTADEIIADFLS----------------ELGIMAHVDHPNTAKLLGYG 176
           + +  A+K+  +   ++      S                EL I+  + +       G  
Sbjct: 53  DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGI- 111

Query: 177 IEGGMHI--VLELSPNGSLASLL---YGMKEKLKWGIRYKIAL----GVAEGLLYLHEGC 227
           I     +  + E   N S+       + + +     I  ++       V     Y+H   
Sbjct: 112 ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN-- 169

Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE 262
           ++ I HRD+K +NIL+ ++   ++ DFG ++++ +
Sbjct: 170 EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVD 204

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 94.4 bits (235), Expect = 2e-22
 Identities = 41/180 (22%), Positives = 74/180 (41%), Gaps = 20/180 (11%)

Query: 111 NFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPN 168
                 ++ +GG+A VY+ + + +G+  A+KRL     ++     + E+  M  +  HPN
Sbjct: 29  RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKN-RAIIQEVCFMKKLSGHPN 87

Query: 169 TAKLLGYGIEGGMH--------IVLELSPNGSLASLLYGMKEKLKWG---IRYKIALGVA 217
             +       G           ++L     G L   L  M+ +       +  KI     
Sbjct: 88  IVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVL-KIFYQTC 146

Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL----PEQWTHHTISKVE 273
             + ++H   +  IIHRD+K  N+LL+     ++CDFG A  +       W+    + VE
Sbjct: 147 RAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVE 205

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score = 95.9 bits (238), Expect = 3e-22
 Identities = 45/170 (26%), Positives = 69/170 (40%), Gaps = 24/170 (14%)

Query: 111 NFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
            +  +  +G GG+  V +      G+ VAIK+  +  + +    +  E+ IM  ++HPN 
Sbjct: 15  PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74

Query: 170 AKLL-------GYGIEGGMHIVLELSPNGSLASLL------YGMKEKLKWGIRYKIALGV 216
                               + +E    G L   L       G+KE     IR  +   +
Sbjct: 75  VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGP---IR-TLLSDI 130

Query: 217 AEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQ---ICDFGLAKWLPEQ 263
           +  L YLHE    RIIHRD+K  NI+L    +     I D G AK L + 
Sbjct: 131 SSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG 177

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 92.7 bits (231), Expect = 4e-22
 Identities = 46/183 (25%), Positives = 81/183 (44%), Gaps = 25/183 (13%)

Query: 93  SQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGT--ADE 149
           ++ P++ F++       ++F     +GKG +  VY  R  +N  ++A+K L +     + 
Sbjct: 4   AEMPKRKFTI-------DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEG 56

Query: 150 IIADFLSELGIMAHVDHPNTAKLLGYGIEGGMH------IVLELSPNGSLASLLYGMKEK 203
           +      E+ I +H+ HPN  ++  Y      H      ++LE +P G L   L     +
Sbjct: 57  VEHQLRREIEIQSHLRHPNILRMYNY-----FHDRKRIYLMLEFAPRGELYKELQKHG-R 110

Query: 204 LKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ 263
                       +A+ L Y H   +R++IHRDIK  N+L+    E +I DFG +   P  
Sbjct: 111 FDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL 167

Query: 264 WTH 266
              
Sbjct: 168 RRR 170

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 94.0 bits (234), Expect = 1e-21
 Identities = 48/214 (22%), Positives = 80/214 (37%), Gaps = 29/214 (13%)

Query: 65  PLKLSIRRSSSMREGIDMPRNLFVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYA 124
               S R +   +  +     +F+ S        +  +Y+             +G G Y 
Sbjct: 5   HHHSSGRENLYFQGDLQATPGMFITS----KKGHLSEMYQ---------RVKKLGSGAYG 51

Query: 125 EVYKGRLR-NGQLVAIKRL-TRGTADEIIADFLSELGIMAHVDHPNTAKLLG-YGIEGGM 181
           EV   R +      AIK +     +    +  L E+ ++  +DHPN  KL   +  +   
Sbjct: 52  EVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNY 111

Query: 182 HIVLELSPNGSLASLLYGMK---EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKA 238
           ++V+E    G L   +       E     I  ++  GV     YLH   +  I+HRD+K 
Sbjct: 112 YLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVT----YLH---KHNIVHRDLKP 164

Query: 239 ANILLT---EDFEPQICDFGLAKWLPEQWTHHTI 269
            N+LL    +D   +I DFGL+     Q      
Sbjct: 165 ENLLLESKEKDALIKIVDFGLSAVFENQKKMKER 198

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 92.6 bits (231), Expect = 1e-21
 Identities = 48/161 (29%), Positives = 77/161 (47%), Gaps = 10/161 (6%)

Query: 104 ELQSATNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADF----LSEL 158
           +++S    +   + +G+G +A VYK R     Q+VAIK++  G   E         L E+
Sbjct: 4   DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63

Query: 159 GIMAHVDHPNTAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVA 217
            ++  + HPN   LL  +G +  + +V +      L  ++      L         L   
Sbjct: 64  KLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTL 122

Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           +GL YLH   Q  I+HRD+K  N+LL E+   ++ DFGLAK
Sbjct: 123 QGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAK 160

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 92.8 bits (230), Expect = 1e-21
 Identities = 18/227 (7%), Positives = 52/227 (22%), Gaps = 40/227 (17%)

Query: 71  RRSSSMREGIDMPRNLFVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGR 130
            R  +++E   M   +    +   +   + S   L            +  G  + V+  R
Sbjct: 25  CREEALKEPAAMVEAVTATVWPQNAETTVDS--LLSQGERKLKLVEPLRVGDRSVVFLVR 82

Query: 131 -LRNGQLVAIK--RLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHIVLEL 187
            +   +  A+K   +    +   +          A +   +  +             + +
Sbjct: 83  DVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAV 142

Query: 188 S--------------------------PNGSLASLLYGMKEKLKWG------IRYKIALG 215
                                       +  L  L   +     +         + +   
Sbjct: 143 QSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQ 202

Query: 216 VAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE 262
           +      L     + ++H      N+ +  D    + D      +  
Sbjct: 203 LIRLAANLQS---KGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT 246

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 91.2 bits (227), Expect = 2e-21
 Identities = 45/182 (24%), Positives = 77/182 (42%), Gaps = 22/182 (12%)

Query: 103 YELQSATNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTAD--EIIADFLSELG 159
           YEL           ++G GG +EV+  R LR+ + VA+K L    A        F  E  
Sbjct: 14  YELGE---------ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQ 64

Query: 160 IMAHVDHPNTAKLLGYGIEGGMH-----IVLELSPNGSLASLLYGMKEKLKWGIRYKIAL 214
             A ++HP    +   G           IV+E     +L  ++   +  +      ++  
Sbjct: 65  NAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV-HTEGPMTPKRAIEVIA 123

Query: 215 GVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTI-SKVE 273
              + L + H+     IIHRD+K ANI+++     ++ DFG+A+ + +     T  + V 
Sbjct: 124 DACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI 180

Query: 274 GT 275
           GT
Sbjct: 181 GT 182

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 92.4 bits (230), Expect = 3e-21
 Identities = 47/178 (26%), Positives = 78/178 (43%), Gaps = 16/178 (8%)

Query: 90  SYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRL-TRGTA 147
            +         +LY   +    ++   ++GKG + EV K + R   Q  A+K +      
Sbjct: 2   HHHHHHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK 61

Query: 148 DEIIADFLSELGIMAHVDHPNTAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMK---EK 203
           ++  +  L E+ ++  +DHPN  KL          +IV EL   G L   +   K   E 
Sbjct: 62  NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEH 121

Query: 204 LKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLT---EDFEPQICDFGLAK 258
               I  ++  G+     Y+H   +  I+HRD+K  NILL    +D + +I DFGL+ 
Sbjct: 122 DAARIIKQVFSGIT----YMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLST 172

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 90.9 bits (226), Expect = 1e-20
 Identities = 48/195 (24%), Positives = 83/195 (42%), Gaps = 30/195 (15%)

Query: 74  SSMREGIDMPRNLFVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLR- 132
            SM + +     +FV      S       Y+          + ++GKG + EV   + + 
Sbjct: 3   GSMMDHLHATPGMFVQH----STAIFSDRYK---------GQRVLGKGSFGEVILCKDKI 49

Query: 133 NGQLVAIKRL--TRGTADEIIADFLSELGIMAHVDHPNTAKLLG-YGIEGGMHIVLELSP 189
            GQ  A+K +   +          L E+ ++  +DHPN  KL   +  +G  ++V E+  
Sbjct: 50  TGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYT 109

Query: 190 NGSLASLLYGMK---EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLT-- 244
            G L   +   K   E     I  ++  G+     Y+H   + +I+HRD+K  N+LL   
Sbjct: 110 GGELFDEIISRKRFSEVDAARIIRQVLSGIT----YMH---KNKIVHRDLKPENLLLESK 162

Query: 245 -EDFEPQICDFGLAK 258
            +D   +I DFGL+ 
Sbjct: 163 SKDANIRIIDFGLST 177

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 88.1 bits (219), Expect = 2e-20
 Identities = 38/172 (22%), Positives = 69/172 (40%), Gaps = 17/172 (9%)

Query: 109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHP 167
            + F F+  +G G + +V+    R +G    IK + +  +   +    +E+ ++  +DHP
Sbjct: 21  DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80

Query: 168 NTAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRY------KIALGVAEGL 220
           N  K+   +     M+IV+E    G    LL  +      G         ++   +   L
Sbjct: 81  NIIKIFEVFEDYHNMYIVMETCEGG---ELLERIVSAQARGKALSEGYVAELMKQMMNAL 137

Query: 221 LYLHEGCQRRIIHRDIKAANILLT---EDFEPQICDFGLAKWLPEQWTHHTI 269
            Y H    + ++H+D+K  NIL          +I DFGLA+           
Sbjct: 138 AYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNA 186

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 87.9 bits (218), Expect = 2e-20
 Identities = 20/159 (12%), Positives = 46/159 (28%), Gaps = 19/159 (11%)

Query: 103 YELQSATNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIK--RLTRGTADEIIADFLSELG 159
           Y L             G     + ++       + VA+          D+++ + LS   
Sbjct: 33  YRLLI---------FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTL 83

Query: 160 IMAHVDHPNTAKLLGYGIEGGMH-IVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE 218
            ++ +D P  A++L          +V E    GSL  +              +    +A 
Sbjct: 84  RLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVA---DTSPSPVGAIRAMQSLAA 140

Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLA 257
                H   +  +       + + ++ D +  +      
Sbjct: 141 AADAAH---RAGVALSIDHPSRVRVSIDGDVVLAYPATM 176

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 88.4 bits (220), Expect = 3e-20
 Identities = 52/175 (29%), Positives = 84/175 (48%), Gaps = 21/175 (12%)

Query: 98  KIFSLYELQSATNNFSFENL--IGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADE---II 151
           K +   E         +E L  IG+G + EV+K R  + GQ VA+K++      E   I 
Sbjct: 3   KQYDSVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPIT 62

Query: 152 ADFLSELGIMAHVDHPNTAKLLG---------YGIEGGMHIVLELSPNGSLASLLYGMKE 202
           A  L E+ I+  + H N   L+             +G +++V +   +  LA LL  +  
Sbjct: 63  A--LREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLV 119

Query: 203 KLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLA 257
           K       ++   +  GL Y+H   + +I+HRD+KAAN+L+T D   ++ DFGLA
Sbjct: 120 KFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLA 171

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 88.5 bits (219), Expect = 3e-20
 Identities = 39/221 (17%), Positives = 74/221 (33%), Gaps = 27/221 (12%)

Query: 78  EGIDMPRNLFVNSYDSQSPQKIFSL-YELQSATNNFSFENLIGKGGYAEVYKGR------ 130
            G+  P + + N+++ Q          E Q  +      +L+G+G +A+VY+        
Sbjct: 32  SGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLND 91

Query: 131 LRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLG-YGIEGGMHIVLELSP 189
            +N Q   +K        E        +  +         K    +  + G  +V EL  
Sbjct: 92  AKNKQKFVLKVQKPANPWEFYI-GTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYS 150

Query: 190 NGSLASLLYGMKE----KLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTE 245
            G+L + +   K      +  G+    A+ +   +  +H+     IIH DIK  N +L  
Sbjct: 151 YGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGN 207

Query: 246 DFEP-----------QICDFGLAKWLPEQWTHHTISKVEGT 275
            F              + D G +  +         +    T
Sbjct: 208 GFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCET 248

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 87.6 bits (218), Expect = 3e-20
 Identities = 44/157 (28%), Positives = 72/157 (45%), Gaps = 10/157 (6%)

Query: 106 QSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADE---IIADFLSELGIMA 162
           Q     +     +G+G Y  VYK +   G++VA+KR+     DE     A  + E+ ++ 
Sbjct: 17  QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTA--IREISLLK 74

Query: 163 HVDHPNTAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLL 221
            + HPN   L+     E  + +V E      L  +L   K  L+          +  G+ 
Sbjct: 75  ELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVA 133

Query: 222 YLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           + H   Q RI+HRD+K  N+L+  D   ++ DFGLA+
Sbjct: 134 HCH---QHRILHRDLKPQNLLINSDGALKLADFGLAR 167

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 89.4 bits (222), Expect = 4e-20
 Identities = 48/218 (22%), Positives = 80/218 (36%), Gaps = 40/218 (18%)

Query: 72  RSSSMREGIDMPRNLFVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRL 131
           R +   +GI +   ++V     +   KI   Y              +G G Y EV   + 
Sbjct: 11  RENLYFQGIAINPGMYVR----KKEGKIGESYF---------KVRKLGSGAYGEVLLCKE 57

Query: 132 R-NGQLVAIKRL------------TRGTADEIIADFLSELGIMAHVDHPNTAKLLG-YGI 177
           +      AIK +                 ++   +  +E+ ++  +DHPN  KL   +  
Sbjct: 58  KNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFED 117

Query: 178 EGGMHIVLELSPNGSLASLLYGMK---EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHR 234
           +   ++V E    G L   +       E     I  +I  G+     YLH   +  I+HR
Sbjct: 118 KKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGIC----YLH---KHNIVHR 170

Query: 235 DIKAANILLT---EDFEPQICDFGLAKWLPEQWTHHTI 269
           DIK  NILL         +I DFGL+ +  + +     
Sbjct: 171 DIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDR 208

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 88.6 bits (220), Expect = 5e-20
 Identities = 50/194 (25%), Positives = 81/194 (41%), Gaps = 25/194 (12%)

Query: 84  RNLFVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRN-GQLVAIKRL 142
             +FV    +   Q ++     ++  + +     +G G   EV     R   + VAI+ +
Sbjct: 113 NKVFVFFDLTVDDQSVYP----KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRII 168

Query: 143 TR-------GTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHIVLELSPNGSLAS 195
           ++           +   +  +E+ I+  ++HP   K+  +      +IVLEL   G L  
Sbjct: 169 SKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFD 228

Query: 196 LLYGMK---EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQ-- 250
            + G K   E       Y++ L V     YLHE     IIHRD+K  N+LL+   E    
Sbjct: 229 KVVGNKRLKEATCKLYFYQMLLAVQ----YLHE---NGIIHRDLKPENVLLSSQEEDCLI 281

Query: 251 -ICDFGLAKWLPEQ 263
            I DFG +K L E 
Sbjct: 282 KITDFGHSKILGET 295

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 86.6 bits (215), Expect = 1e-19
 Identities = 50/187 (26%), Positives = 75/187 (40%), Gaps = 34/187 (18%)

Query: 93  SQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRN-GQLVAIKRLTR------- 144
           S  P+ +   Y +            +G G   EV     R   + VAIK +++       
Sbjct: 2   SVYPKALRDEYIM---------SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGS 52

Query: 145 GTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHIVLELSPNGSL-----ASLLYG 199
               +   +  +E+ I+  ++HP   K+  +      +IVLEL   G L      +    
Sbjct: 53  AREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRL- 111

Query: 200 MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQ---ICDFGL 256
            KE       Y++ L V     YLHE     IIHRD+K  N+LL+   E     I DFG 
Sbjct: 112 -KEATCKLYFYQMLLAVQ----YLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGH 163

Query: 257 AKWLPEQ 263
           +K L E 
Sbjct: 164 SKILGET 170

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 85.7 bits (213), Expect = 1e-19
 Identities = 44/172 (25%), Positives = 73/172 (42%), Gaps = 20/172 (11%)

Query: 109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRL-TRGTADEIIADFLSELGIMAHVDH 166
              ++   ++GKG + EV K + R   Q  A+K +      ++  +  L E+ ++  +DH
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80

Query: 167 PNTAKLLG-YGIEGGMHIVLELSPNGSL-----ASLLYGMKEKLKWGIRYKIALGVAEGL 220
           PN  KL          +IV EL   G L         +   E     I  ++  G+    
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRF--SEHDAARIIKQVFSGIT--- 135

Query: 221 LYLHEGCQRRIIHRDIKAANILLT---EDFEPQICDFGLAKWLPEQWTHHTI 269
            Y+H   +  I+HRD+K  NILL    +D + +I DFGL+    +       
Sbjct: 136 -YMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR 183

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 86.1 bits (214), Expect = 1e-19
 Identities = 42/151 (27%), Positives = 71/151 (47%), Gaps = 7/151 (4%)

Query: 110 NNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADF-LSELGIMAHVDHP 167
             +     IG+G Y  V+K R    GQ+VAIK+      D +I    L E+ ++  + HP
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62

Query: 168 NTAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEG 226
           N   LL  +  +  +H+V E   + ++   L   +  +   +   I     + + + H  
Sbjct: 63  NLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH-- 119

Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLA 257
            +   IHRD+K  NIL+T+    ++CDFG A
Sbjct: 120 -KHNCIHRDVKPENILITKHSVIKLCDFGFA 149

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 86.1 bits (214), Expect = 2e-19
 Identities = 42/153 (27%), Positives = 70/153 (45%), Gaps = 11/153 (7%)

Query: 110 NNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADE---IIADFLSELGIMAHVD 165
             +    L+G+G Y  V K R    G++VAIK+      D+    IA  + E+ ++  + 
Sbjct: 25  EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIA--MREIKLLKQLR 82

Query: 166 HPNTAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
           H N   LL     +   ++V E   + ++   L      L + +  K    +  G+ + H
Sbjct: 83  HENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIGFCH 141

Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLA 257
                 IIHRDIK  NIL+++    ++CDFG A
Sbjct: 142 ---SHNIIHRDIKPENILVSQSGVVKLCDFGFA 171

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 86.7 bits (215), Expect = 2e-19
 Identities = 49/197 (24%), Positives = 83/197 (42%), Gaps = 25/197 (12%)

Query: 71  RRSSSMREGIDMPRNLFVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGR 130
           +R+S++   I  P   F +   +     + S Y +           ++G G + +V+K  
Sbjct: 57  KRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSK-------TEILGGGRFGQVHKCE 109

Query: 131 LRN-GQLVAIKRL-TRGTADEIIADFLSELGIMAHVDHPNTAKLLG-YGIEGGMHIVLEL 187
               G  +A K + TRG  D    +  +E+ +M  +DH N  +L   +  +  + +V+E 
Sbjct: 110 ETATGLKLAAKIIKTRGMKD--KEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEY 167

Query: 188 SPNGSL----ASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILL 243
              G L        Y + E        +I     EG+ ++H   Q  I+H D+K  NIL 
Sbjct: 168 VDGGELFDRIIDESYNLTELDTILFMKQI----CEGIRHMH---QMYILHLDLKPENILC 220

Query: 244 TEDFEPQI--CDFGLAK 258
                 QI   DFGLA+
Sbjct: 221 VNRDAKQIKIIDFGLAR 237

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 84.9 bits (211), Expect = 3e-19
 Identities = 43/153 (28%), Positives = 69/153 (45%), Gaps = 10/153 (6%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADE---IIADFLSELGIMAHVDH 166
             +     IG+G Y  VYK +   G+  A+K++     DE        + E+ I+  + H
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTT--IREISILKELKH 59

Query: 167 PNTAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHE 225
            N  KL      +  + +V E      L  LL   +  L+        L +  G+ Y H 
Sbjct: 60  SNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH- 117

Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
              RR++HRD+K  N+L+  + E +I DFGLA+
Sbjct: 118 --DRRVLHRDLKPQNLLINREGELKIADFGLAR 148

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 85.3 bits (212), Expect = 3e-19
 Identities = 44/177 (24%), Positives = 67/177 (37%), Gaps = 21/177 (11%)

Query: 107 SATNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADF----LSELGIM 161
            AT+ +     IG G Y  VYK R   +G  VA+K +                + E+ ++
Sbjct: 6   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 65

Query: 162 ---AHVDHPNTAKLL------GYGIEGGMHIVLELSPNGSLASLLYGMKEK-LKWGIRYK 211
                 +HPN  +L+          E  + +V E      L + L       L       
Sbjct: 66  RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKD 124

Query: 212 IALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKW--LPEQWTH 266
           +      GL +LH      I+HRD+K  NIL+T     ++ DFGLA+        T 
Sbjct: 125 LMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTP 178

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 84.5 bits (210), Expect = 4e-19
 Identities = 46/189 (24%), Positives = 78/189 (41%), Gaps = 44/189 (23%)

Query: 109 TNNFSFENLIGKGGYAEVYKGRLRN-GQLVAIKRL-TRGTADEIIADFLSELGIMAHVDH 166
              F F  ++G G ++EV+  + R  G+L A+K +       +  +   +E+ ++  + H
Sbjct: 8   RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRD--SSLENEIAVLKKIKH 65

Query: 167 PNTAKLLG-YGIEGGMHIVLELSPNGSL--------------ASLLYGMKEKLKWGIRYK 211
            N   L   Y      ++V++L   G L              ASL+  +++         
Sbjct: 66  ENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLV--IQQ--------- 114

Query: 212 IALGVAEGLLYLHEGCQRRIIHRDIKAANILLT---EDFEPQICDFGLAKWLPEQWTHHT 268
               V   + YLHE     I+HRD+K  N+L     E+ +  I DFGL+K          
Sbjct: 115 ----VLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG----I 163

Query: 269 ISKVEGTFG 277
           +S   GT G
Sbjct: 164 MSTACGTPG 172

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 85.4 bits (212), Expect = 4e-19
 Identities = 41/166 (24%), Positives = 66/166 (39%), Gaps = 21/166 (12%)

Query: 112 FSFENLIGKGGYAEVYKGRLRN-GQLVAIK----RLTRGTADEIIADFLSELGIMAHVDH 166
           +    +IGKG ++ V +   R  GQ  A+K         +      D   E  I   + H
Sbjct: 26  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85

Query: 167 PNTAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRY------KIALGVAEG 219
           P+  +LL  Y  +G +++V E         L + + ++   G  Y           + E 
Sbjct: 86  PHIVELLETYSSDGMLYMVFEFMDGA---DLCFEIVKRADAGFVYSEAVASHYMRQILEA 142

Query: 220 LLYLHEGCQRRIIHRDIKAANILLT---EDFEPQICDFGLAKWLPE 262
           L Y H+     IIHRD+K   +LL         ++  FG+A  L E
Sbjct: 143 LRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGE 185

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 84.1 bits (209), Expect = 5e-19
 Identities = 38/181 (20%), Positives = 69/181 (38%), Gaps = 38/181 (20%)

Query: 109 TNNFSFENLIGKGGYAEVYKGRLRN-GQLVAIKRL-TRGTADEIIADFLSELGIMAHVDH 166
           ++N+  +  +GKG ++ V +   +  G   A K + T+  +         E  I   + H
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64

Query: 167 PNTAKLLG-YGIEGGMHIVLELSPNGSL--------------ASLLYGMKEKLKWGIRYK 211
           PN  +L      E   ++V +L   G L              AS    +++         
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHC--IQQ--------- 113

Query: 212 IALGVAEGLLYLHEGCQRRIIHRDIKAANILLT---EDFEPQICDFGLAKWLPEQWTHHT 268
               + E + Y H      I+HR++K  N+LL    +    ++ DFGLA  + +    H 
Sbjct: 114 ----ILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG 166

Query: 269 I 269
            
Sbjct: 167 F 167

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 85.6 bits (212), Expect = 6e-19
 Identities = 52/197 (26%), Positives = 78/197 (39%), Gaps = 35/197 (17%)

Query: 106 QSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVD 165
           QS  N    E ++G G    V       G+ VA+KR+     D      L E+ ++   D
Sbjct: 11  QSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIA----LMEIKLLTESD 66

Query: 166 -HPNTAKLLGYGIE---GGMHIVLELSPNGSLASLLYGMKEKLKWGIRY------KIALG 215
            HPN  +   Y  E     ++I LEL  N +L  L+       +            +   
Sbjct: 67  DHPNVIRY--YCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQ 123

Query: 216 VAEGLLYLHEGCQRRIIHRDIKAANILLT-------------EDFEPQICDFGLAKWLP- 261
           +A G+ +LH     +IIHRD+K  NIL++             E+    I DFGL K L  
Sbjct: 124 IASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS 180

Query: 262 -EQWTHHTISKVEGTFG 277
            +      ++   GT G
Sbjct: 181 GQSSFRTNLNNPSGTSG 197

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 85.1 bits (210), Expect = 9e-19
 Identities = 21/183 (11%), Positives = 46/183 (25%), Gaps = 39/183 (21%)

Query: 112 FSFENLIGKGGYAEVYKGR-LRNGQLVAIK--RLTRGTADEIIADFLSELGIMAH----- 163
                ++G+       +      G+   +     T       I     E+  +       
Sbjct: 80  LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139

Query: 164 -----------------VDHPNTAKLLGYGIEGGMHIVLEL-----SPNGSLASLLYGMK 201
                            V  P   K++   ++     VL           +L +    + 
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199

Query: 202 EKLKWG------IRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFG 255
                        R ++ L V   L  LH      ++H  ++  +I+L +     +  F 
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFE 256

Query: 256 LAK 258
              
Sbjct: 257 HLV 259

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 83.3 bits (207), Expect = 1e-18
 Identities = 38/154 (24%), Positives = 67/154 (43%), Gaps = 11/154 (7%)

Query: 110 NNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADE---IIADFLSELGIMAHVD 165
             +     IG+G Y  V+K +     ++VA+KR+     DE     A  L E+ ++  + 
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSA--LREICLLKELK 59

Query: 166 HPNTAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
           H N  +L      +  + +V E      L          L   I       + +GL + H
Sbjct: 60  HKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH 118

Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
               R ++HRD+K  N+L+  + E ++ +FGLA+
Sbjct: 119 ---SRNVLHRDLKPQNLLINRNGELKLANFGLAR 149

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 83.7 bits (207), Expect = 1e-18
 Identities = 44/200 (22%), Positives = 66/200 (33%), Gaps = 50/200 (25%)

Query: 109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIK----RLTRGTADEIIADFLSELGIMAH 163
              +  +  IG+G Y  V          + AIK       R    + +    +E+ +M  
Sbjct: 25  QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84

Query: 164 VDHPNTAKLLG-YGIEGGMHIVLELSPNGSL----------------------------- 193
           + HPN A+L   Y  E  + +V+EL   G L                             
Sbjct: 85  LHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPE 144

Query: 194 ----ASLLYGMKEKLKWGIRY------KIALGVAEGLLYLHEGCQRRIIHRDIKAANILL 243
               A        +              I   +   L YLH    + I HRDIK  N L 
Sbjct: 145 CNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLF 201

Query: 244 T--EDFEPQICDFGLAKWLP 261
           +  + FE ++ DFGL+K   
Sbjct: 202 STNKSFEIKLVDFGLSKEFY 221

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 83.2 bits (206), Expect = 2e-18
 Identities = 50/274 (18%), Positives = 96/274 (35%), Gaps = 45/274 (16%)

Query: 23  SETCSSKEPCSETKPESKSNSRWHLFYDLFRNKSKKSLVTLY--PLKLSIRRSSSMREGI 80
               SS       K   ++        +L R + +  + +L   P + +   + + +   
Sbjct: 4   HHHHSSGVDNKFNKERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLND 63

Query: 81  DMPRNLFVNSYDSQSPQKIFSLYELQSA-TNNFSFENLIGKGGYAEVYKGRLR-NGQLVA 138
             P+      + S  P+     +         +  +++IG+G  + V +   R  G   A
Sbjct: 64  AQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFA 123

Query: 139 IK-------RLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLG-YGIEGGMHIVLELSP 189
           +K       RL+    +E+      E  I+  V  HP+   L+  Y     M +V +L  
Sbjct: 124 VKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMR 183

Query: 190 NGSL--------------ASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRD 235
            G L                 +  M+              + E + +LH      I+HRD
Sbjct: 184 KGELFDYLTEKVALSEKETRSI--MRS-------------LLEAVSFLHA---NNIVHRD 225

Query: 236 IKAANILLTEDFEPQICDFGLAKWLPEQWTHHTI 269
           +K  NILL ++ + ++ DFG +  L        +
Sbjct: 226 LKPENILLDDNMQIRLSDFGFSCHLEPGEKLREL 259

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 83.1 bits (206), Expect = 2e-18
 Identities = 50/190 (26%), Positives = 83/190 (43%), Gaps = 43/190 (22%)

Query: 109 TNNFSFENLIGKGGYAEVYKGRLRN-GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHP 167
           ++ F  E+ +G+G  + VY+ + +   +  A+K L + T D+      +E+G++  + HP
Sbjct: 52  SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKK-TVDK--KIVRTEIGVLLRLSHP 108

Query: 168 NTAKLLG-YGIEGGMHIVLELSPNGSL--------------ASLLYGMKEKLKWGIRYKI 212
           N  KL   +     + +VLEL   G L              A+    +K+          
Sbjct: 109 NIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADA--VKQ---------- 156

Query: 213 ALGVAEGLLYLHEGCQRRIIHRDIKAANILLT---EDFEPQICDFGLAKWLPEQWTHHTI 269
              + E + YLHE     I+HRD+K  N+L      D   +I DFGL+K +  Q    T+
Sbjct: 157 ---ILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTV 210

Query: 270 SKVEGTFGLV 279
               GT G  
Sbjct: 211 C---GTPGYC 217

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 82.7 bits (205), Expect = 3e-18
 Identities = 40/175 (22%), Positives = 64/175 (36%), Gaps = 43/175 (24%)

Query: 109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIK-----RLTRGTADEIIADFLSELGIMA 162
            + +     +G G +A V K R +  G   A K     +           +   E+ I+ 
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70

Query: 163 HVDHPNTAKLLG-YGIEGGMHIVLELSPNGSL--------------ASLLYGMKEKLKWG 207
            V H N   L   Y     + ++LEL   G L              A+    +K+     
Sbjct: 71  QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF--IKQ----- 123

Query: 208 IRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQ----ICDFGLAK 258
                   + +G+ YLH    ++I H D+K  NI+L +   P     + DFGLA 
Sbjct: 124 --------ILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 81.8 bits (203), Expect = 3e-18
 Identities = 42/186 (22%), Positives = 72/186 (38%), Gaps = 43/186 (23%)

Query: 109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIK-----RLTRGTADEIIADFLSELGIMA 162
            +++     +G G +A V K R +  G+  A K     RL+         +   E+ I+ 
Sbjct: 4   EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63

Query: 163 HVDHPNTAKLLG-YGIEGGMHIVLELSPNGSL--------------ASLLYGMKEKLKWG 207
            + HPN   L   +  +  + ++LEL   G L              A+    +K+     
Sbjct: 64  EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQF--LKQ----- 116

Query: 208 IRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQ----ICDFGLAKWLPEQ 263
                   + +G+ YLH    +RI H D+K  NI+L +   P     + DFG+A  +   
Sbjct: 117 --------ILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG 165

Query: 264 WTHHTI 269
                I
Sbjct: 166 NEFKNI 171

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 82.7 bits (205), Expect = 3e-18
 Identities = 38/181 (20%), Positives = 69/181 (38%), Gaps = 38/181 (20%)

Query: 109 TNNFSFENLIGKGGYAEVYKGRLRN-GQLVAIKRL-TRGTADEIIADFLSELGIMAHVDH 166
           ++N+  +  +GKG ++ V +   +  G   A K + T+  +         E  I   + H
Sbjct: 28  SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87

Query: 167 PNTAKLLG-YGIEGGMHIVLELSPNGSL--------------ASLLYGMKEKLKWGIRYK 211
           PN  +L      E   ++V +L   G L              AS    +++         
Sbjct: 88  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHC--IQQ--------- 136

Query: 212 IALGVAEGLLYLHEGCQRRIIHRDIKAANILLT---EDFEPQICDFGLAKWLPEQWTHHT 268
               + E + Y H      I+HR++K  N+LL    +    ++ DFGLA  + +    H 
Sbjct: 137 ----ILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG 189

Query: 269 I 269
            
Sbjct: 190 F 190

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 81.9 bits (203), Expect = 4e-18
 Identities = 41/203 (20%), Positives = 70/203 (34%), Gaps = 52/203 (25%)

Query: 92  DSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRN-GQLVAIK--------RL 142
            S S    +  YE +          ++G+G  + V +   +   +  A+K          
Sbjct: 8   GSHSTHGFYENYEPK---------EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSF 58

Query: 143 TRGTADEIIADFLSELGIMAHVD-HPNTAKLLG-YGIEGGMHIVLELSPNGSL------- 193
           +     E+    L E+ I+  V  HPN  +L   Y       +V +L   G L       
Sbjct: 59  SAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK 118

Query: 194 -------ASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTED 246
                     +  M+              + E +  LH+     I+HRD+K  NILL +D
Sbjct: 119 VTLSEKETRKI--MRA-------------LLEVICALHK---LNIVHRDLKPENILLDDD 160

Query: 247 FEPQICDFGLAKWLPEQWTHHTI 269
              ++ DFG +  L        +
Sbjct: 161 MNIKLTDFGFSCQLDPGEKLREV 183

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 82.9 bits (205), Expect = 6e-18
 Identities = 48/207 (23%), Positives = 84/207 (40%), Gaps = 36/207 (17%)

Query: 69  SIRRSSSMREGIDMPRNLFVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYK 128
             + + S  +     R    +S  + S  +  S +++    + +   +LIG G Y  V +
Sbjct: 15  GTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQI---PDRYEIRHLIGTGSYGHVCE 71

Query: 129 GR-LRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNTAKLL------GYGIEGG 180
                  ++VAIK++ R   D I     L E+ I+  ++H +  K+L             
Sbjct: 72  AYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131

Query: 181 MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVA----------EGLLYLHEGCQRR 230
           +++VLE+                 K   R  + L              G+ Y+H      
Sbjct: 132 LYVVLEI------------ADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSA---G 176

Query: 231 IIHRDIKAANILLTEDFEPQICDFGLA 257
           I+HRD+K AN L+ +D   ++CDFGLA
Sbjct: 177 ILHRDLKPANCLVNQDCSVKVCDFGLA 203

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 82.0 bits (203), Expect = 6e-18
 Identities = 41/175 (23%), Positives = 65/175 (37%), Gaps = 43/175 (24%)

Query: 109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIK-----RLTRGTADEIIADFLSELGIMA 162
            + +     +G G +A V K R +  G   A K     +           +   E+ I+ 
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70

Query: 163 HVDHPNTAKLLG-YGIEGGMHIVLELSPNGSL--------------ASLLYGMKEKLKWG 207
            V HPN   L   Y     + ++LEL   G L              A+    +K+     
Sbjct: 71  QVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF--IKQ----- 123

Query: 208 IRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQ----ICDFGLAK 258
                   + +G+ YLH    ++I H D+K  NI+L +   P     + DFGLA 
Sbjct: 124 --------ILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 80.7 bits (200), Expect = 8e-18
 Identities = 41/168 (24%), Positives = 69/168 (41%), Gaps = 14/168 (8%)

Query: 109 TNNFSFENLIGKGGYAEVYKGRLRN-GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHP 167
              ++ EN IG+G + EV     +      A K++ +   +++   F  E+ IM  +DHP
Sbjct: 8   NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDV-DRFKQEIEIMKSLDHP 66

Query: 168 NTAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRY--KIALGVAEGLLYLH 224
           N  +L   +     +++V+EL   G    L   +  K  +      +I   V   + Y H
Sbjct: 67  NIIRLYETFEDNTDIYLVMELCTGG---ELFERVVHKRVFRESDAARIMKDVLSAVAYCH 123

Query: 225 EGCQRRIIHRDIKAANILLT---EDFEPQICDFGLAKWLPEQWTHHTI 269
              +  + HRD+K  N L      D   ++ DFGLA          T 
Sbjct: 124 ---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTK 168

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 81.7 bits (202), Expect = 1e-17
 Identities = 45/175 (25%), Positives = 73/175 (41%), Gaps = 43/175 (24%)

Query: 109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHP 167
             +++   +IG G +  VY+ +L  +G+LVAIK++ +    +       EL IM  +DH 
Sbjct: 53  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK-----NRELQIMRKLDHC 107

Query: 168 NTAKLLGYGIEGG-------MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALG----- 215
           N  +L  +    G       +++VL+             + E +    R+          
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDY------------VPETVYRVARHYSRAKQTLPV 155

Query: 216 ---------VAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEP-QICDFGLAKWL 260
                    +   L Y+H      I HRDIK  N+LL  D    ++CDFG AK L
Sbjct: 156 IYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score = 80.3 bits (199), Expect = 1e-17
 Identities = 44/155 (28%), Positives = 72/155 (46%), Gaps = 12/155 (7%)

Query: 110 NNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADE---IIADFLSELGIMAHVD 165
            NF     IG+G Y  VYK R    G++VA+K++   T  E     A  + E+ ++  ++
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA--IREISLLKELN 60

Query: 166 HPNTAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYK-IALGVAEGLLYL 223
           HPN  KLL     E  +++V E      L   +             K     + +GL + 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119

Query: 224 HEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           H     R++HRD+K  N+L+  +   ++ DFGLA+
Sbjct: 120 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 151

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 81.6 bits (202), Expect = 1e-17
 Identities = 39/189 (20%), Positives = 70/189 (37%), Gaps = 40/189 (21%)

Query: 109 TNNFSFENLIGKGGYAEVYKGRLRN-GQLVAIKRL-TRGTADEIIADFLSELGIMAHVDH 166
           T  +     +GKG ++ V +      GQ  A   + T+  +         E  I   + H
Sbjct: 10  TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69

Query: 167 PNTAKLLG-YGIEGGMHIVLELSPNGSL--------------ASLLYGMKEKLKWGIRYK 211
           PN  +L      EG  +++ +L   G L              AS    +++         
Sbjct: 70  PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHC--IQQ--------- 118

Query: 212 IALGVAEGLLYLHEGCQRRIIHRDIKAANILLT---EDFEPQICDFGLAKWLPEQWTHHT 268
               + E +L+ H+     ++HR++K  N+LL    +    ++ DFGLA  +  +     
Sbjct: 119 ----ILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE--QQA 169

Query: 269 ISKVEGTFG 277
                GT G
Sbjct: 170 WFGFAGTPG 178

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 80.8 bits (199), Expect = 2e-17
 Identities = 27/244 (11%), Positives = 66/244 (27%), Gaps = 39/244 (15%)

Query: 51  LFRNKSKKSLVTLYPLKLSIRRSSSMREGIDMPRNLFVNSYDSQSPQKIFSLYELQSATN 110
           L+       ++     ++      +  E +    +  V++    + Q      EL     
Sbjct: 14  LYFQGPGDVVIEELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPR 73

Query: 111 NFSFENLIGKGGYAEVYKGR-LRNGQLVAIK-----------------------RLTRGT 146
                 ++G+       +      G+   +                        RL RG 
Sbjct: 74  TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133

Query: 147 ADEIIA----DFLSELGIMAHVDHPNTAKLLGYGIEGGMH--IVLELSPNGSLASLL--- 197
            ++  A     F+    ++         ++     +  +     L      +L +     
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193

Query: 198 ---YGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDF 254
                  + L    R ++ L V   L  LH      ++H  ++  +I+L +     +  F
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGF 250

Query: 255 GLAK 258
               
Sbjct: 251 EHLV 254

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 80.0 bits (198), Expect = 3e-17
 Identities = 38/151 (25%), Positives = 67/151 (44%), Gaps = 6/151 (3%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPN 168
             +   + +G+G YA VYKG+ +    LVA+K +     +      + E+ ++  + H N
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61

Query: 169 TAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
              L      E  + +V E      L   L      +           +  GL Y H   
Sbjct: 62  IVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH--- 117

Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           +++++HRD+K  N+L+ E  E ++ DFGLA+
Sbjct: 118 RQKVLHRDLKPQNLLINERGELKLADFGLAR 148

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 80.5 bits (199), Expect = 3e-17
 Identities = 43/177 (24%), Positives = 67/177 (37%), Gaps = 42/177 (23%)

Query: 106 QSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVD 165
           +     ++   +IG G +  V++ +L     VAIK++ +    +       EL IM  V 
Sbjct: 36  EQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFK-----NRELQIMRIVK 90

Query: 166 HPNTAKLLGY-------GIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALG--- 215
           HPN   L  +         E  +++VLE             + E +    R+   L    
Sbjct: 91  HPNVVDLKAFFYSNGDKKDEVFLNLVLEY------------VPETVYRASRHYAKLKQTM 138

Query: 216 -----------VAEGLLYLHEGCQRRIIHRDIKAANILLTED-FEPQICDFGLAKWL 260
                      +   L Y+H      I HRDIK  N+LL       ++ DFG AK L
Sbjct: 139 PMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 80.0 bits (198), Expect = 3e-17
 Identities = 43/175 (24%), Positives = 65/175 (37%), Gaps = 43/175 (24%)

Query: 109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIK-----RLTRGTADEIIADFLSELGIMA 162
            + +     +G G +A V K R +  G   A K     R           D   E+ I+ 
Sbjct: 10  DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69

Query: 163 HVDHPNTAKLLG-YGIEGGMHIVLELSPNGSL--------------ASLLYGMKEKLKWG 207
            + HPN   L   Y  +  + ++LEL   G L              A+    +K+     
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEF--LKQ----- 122

Query: 208 IRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQ----ICDFGLAK 258
                   +  G+ YLH     +I H D+K  NI+L +   P+    I DFGLA 
Sbjct: 123 --------ILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 79.2 bits (196), Expect = 4e-17
 Identities = 47/202 (23%), Positives = 79/202 (39%), Gaps = 48/202 (23%)

Query: 92  DSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEI 150
           DS S  +   +Y+LQ        E+++G+G +A V         Q  A+K + +     I
Sbjct: 4   DSFSG-RFEDVYQLQ--------EDVLGEGAHARVQTCINLITSQEYAVKIIEK-QPGHI 53

Query: 151 IADFLSELGIMAHV-DHPNTAKLLG-YGIEGGMHIVLELSPNGSL--------------A 194
            +    E+ ++     H N  +L+  +  E   ++V E    GS+              A
Sbjct: 54  RSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEA 113

Query: 195 SLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLT---EDFEPQI 251
           S++  +++             VA  L +LH    + I HRD+K  NIL     +    +I
Sbjct: 114 SVV--VQD-------------VASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKI 155

Query: 252 CDFGLAKWLPEQWTHHTISKVE 273
           CDF L   +        IS  E
Sbjct: 156 CDFDLGSGIKLNGDCSPISTPE 177

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 79.2 bits (196), Expect = 5e-17
 Identities = 44/178 (24%), Positives = 75/178 (42%), Gaps = 19/178 (10%)

Query: 93  SQSPQKIFSLYELQSATNNFSFENL--IGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADE 149
                   S+    SAT+   +  +  +G+G Y EVYK       + VAIKR+     +E
Sbjct: 15  QTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEE 74

Query: 150 ---IIADFLSELGIMAHVDHPNTAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLK 205
                A  + E+ ++  + H N  +L         +H++ E + N  L   +    +   
Sbjct: 75  GVPGTA--IREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSM 131

Query: 206 WGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQ-----ICDFGLAK 258
             I+      +  G+ + H    RR +HRD+K  N+LL+     +     I DFGLA+
Sbjct: 132 RVIK-SFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 79.2 bits (196), Expect = 5e-17
 Identities = 45/180 (25%), Positives = 74/180 (41%), Gaps = 29/180 (16%)

Query: 107 SATNNFSFENLIGKGGYAEVYKGR--LRNGQLVAIKRLTRGTAD---------EIIADFL 155
            A   +     IG+G Y +V+K R     G+ VA+KR+   T +         E+     
Sbjct: 8   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREV----- 62

Query: 156 SELGIMAHVDHPNTAKLL------GYGIEGGMHIVLELSPNGSLASLLYGMKEK-LKWGI 208
           + L  +   +HPN  +L           E  + +V E      L + L  + E  +    
Sbjct: 63  AVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTET 121

Query: 209 RYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKW--LPEQWTH 266
              +   +  GL +LH     R++HRD+K  NIL+T   + ++ DFGLA+        T 
Sbjct: 122 IKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS 178

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 77.6 bits (192), Expect = 9e-17
 Identities = 46/158 (29%), Positives = 64/158 (40%), Gaps = 20/158 (12%)

Query: 111 NFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           ++     +G+G Y EV         + VA+K +    A +   +   E+ I   ++H N 
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67

Query: 170 AKLLGYG-IEGGMHI--VLELSPNGSLASLLY---GMKEKLKWGIRY--KIALGVAEGLL 221
            K   YG    G      LE    G L   +    GM E      R+  ++  GV     
Sbjct: 68  VKF--YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD--AQRFFHQLMAGVV---- 119

Query: 222 YLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKW 259
           YLH      I HRDIK  N+LL E    +I DFGLA  
Sbjct: 120 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATV 154

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 78.0 bits (193), Expect = 1e-16
 Identities = 40/158 (25%), Positives = 72/158 (45%), Gaps = 11/158 (6%)

Query: 107 SATNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVD 165
           S+++ F     +G G YA VYKG     G  VA+K +   + +   +  + E+ +M  + 
Sbjct: 2   SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELK 61

Query: 166 HPNTAKLLG-YGIEGGMHIVLELSPNGSLASLL-----YGMKEKLKWGIRYKIALGVAEG 219
           H N  +L      E  + +V E   N  L   +           L+  +       + +G
Sbjct: 62  HENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQG 120

Query: 220 LLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLA 257
           L + H   + +I+HRD+K  N+L+ +  + ++ DFGLA
Sbjct: 121 LAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLA 155

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 78.7 bits (194), Expect = 2e-16
 Identities = 32/154 (20%), Positives = 59/154 (38%), Gaps = 8/154 (5%)

Query: 109 TNNFSFENLIGKGGYAEVYKGRLRN-GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHP 167
            +++     +G G +  V++   R  G   A K +      +       E+  M+ + HP
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK-ETVRKEIQTMSVLRHP 214

Query: 168 NTAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEG 226
               L   +  +  M ++ E    G L   +     K+      +    V +GL ++HE 
Sbjct: 215 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE- 273

Query: 227 CQRRIIHRDIKAANILLTEDFEPQI--CDFGLAK 258
                +H D+K  NI+ T     ++   DFGL  
Sbjct: 274 --NNYVHLDLKPENIMFTTKRSNELKLIDFGLTA 305

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 77.4 bits (191), Expect = 2e-16
 Identities = 46/158 (29%), Positives = 64/158 (40%), Gaps = 20/158 (12%)

Query: 111 NFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           ++     +G+G Y EV         + VA+K +    A +   +   E+ I   ++H N 
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67

Query: 170 AKLLGYG-IEGGMHI--VLELSPNGSLASLLY---GMKEKLKWGIRY--KIALGVAEGLL 221
            K   YG    G      LE    G L   +    GM E      R+  ++  GV     
Sbjct: 68  VKF--YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD--AQRFFHQLMAGVV---- 119

Query: 222 YLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKW 259
           YLH      I HRDIK  N+LL E    +I DFGLA  
Sbjct: 120 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATV 154

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 77.4 bits (191), Expect = 2e-16
 Identities = 37/204 (18%), Positives = 64/204 (31%), Gaps = 36/204 (17%)

Query: 75  SMREGIDMPRNLFVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLR-N 133
           +            +          +   Y+L         + ++G G   +V +   R  
Sbjct: 2   AHHHHHHSSGLEVLFQGPEPKKYAVTDDYQLS--------KQVLGLGVNGKVLECFHRRT 53

Query: 134 GQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLG-----YGIEGGMHIVLEL 187
           GQ  A+K L              E+         P+   +L      +  +  + I++E 
Sbjct: 54  GQKCALKLLYD------SPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMEC 107

Query: 188 SPNGSL-----ASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANIL 242
              G L             E+    I   I   +     +LH      I HRD+K  N+L
Sbjct: 108 MEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQ----FLHS---HNIAHRDVKPENLL 160

Query: 243 LT---EDFEPQICDFGLAKWLPEQ 263
            T   +D   ++ DFG AK   + 
Sbjct: 161 YTSKEKDAVLKLTDFGFAKETTQN 184

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 77.1 bits (190), Expect = 3e-16
 Identities = 41/161 (25%), Positives = 67/161 (41%), Gaps = 22/161 (13%)

Query: 111 NFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTR-------GTADEIIADFLSELGIMA 162
            +S  + +G G +  V+        + V +K + +          D  +     E+ I++
Sbjct: 25  KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84

Query: 163 HVDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLL-Y-----GMKEKLKWGIRYKIALGV 216
            V+H N  K+L    E      L +  +GS   L  +      + E L   I  ++   V
Sbjct: 85  RVEHANIIKVLDI-FENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAV 143

Query: 217 AEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLA 257
                YL     + IIHRDIK  NI++ EDF  ++ DFG A
Sbjct: 144 G----YLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSA 177

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 76.6 bits (189), Expect = 3e-16
 Identities = 50/155 (32%), Positives = 77/155 (49%), Gaps = 17/155 (10%)

Query: 111 NFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLS-ELGIMAHVDHPN 168
           N+     IGKG +A+V   R +  G+ VAIK + +   +      L  E+ IM  ++HPN
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75

Query: 169 TAKLLGYGI---EGGMHIVLELSPNGSLASLLYG---MKEKLKWGIRYKIALGVAEGLLY 222
             KL  + +   E  +++++E +  G +   L     MKEK       +I   V     Y
Sbjct: 76  IVKL--FEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQ----Y 129

Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLA 257
            H   Q+RI+HRD+KA N+LL  D   +I DFG +
Sbjct: 130 CH---QKRIVHRDLKAENLLLDADMNIKIADFGFS 161

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 76.6 bits (189), Expect = 5e-16
 Identities = 42/185 (22%), Positives = 68/185 (36%), Gaps = 51/185 (27%)

Query: 106 QSATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADF------LSEL 158
           +   + F  E + G+G +  V  G+ +  G  VAIK+        +I D       L  +
Sbjct: 19  RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKK--------VIQDPRFRNRELQIM 70

Query: 159 GIMAHVDHPNTAKLLGYGIEGG--------MHIVLELSPNGSLASLLYGMKEKLKWGIRY 210
             +A + HPN  +L  Y    G        +++V+E             + + L    R 
Sbjct: 71  QDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEY------------VPDTLHRCCRN 118

Query: 211 KIALG--------------VAEGLLYLHEGCQRRIIHRDIKAANILL-TEDFEPQICDFG 255
                              +   +  LH      + HRDIK  N+L+   D   ++CDFG
Sbjct: 119 YYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN-VCHRDIKPHNVLVNEADGTLKLCDFG 177

Query: 256 LAKWL 260
            AK L
Sbjct: 178 SAKKL 182

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 77.1 bits (190), Expect = 5e-16
 Identities = 47/167 (28%), Positives = 69/167 (41%), Gaps = 33/167 (19%)

Query: 109 TNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDH 166
            +N+  ++LIG+G Y  VY        + VAIK++ R   D I     L E+ I+  +  
Sbjct: 25  PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKS 84

Query: 167 PNTAKLL------GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE-- 218
               +L              ++IVLE+                LK   +  I L      
Sbjct: 85  DYIIRLYDLIIPDDLLKFDELYIVLEI------------ADSDLKKLFKTPIFLTEEHIK 132

Query: 219 --------GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLA 257
                   G  ++HE     IIHRD+K AN LL +D   ++CDFGLA
Sbjct: 133 TILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLA 176

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 75.8 bits (187), Expect = 6e-16
 Identities = 37/164 (22%), Positives = 69/164 (42%), Gaps = 20/164 (12%)

Query: 111 NFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLS----ELGIMAHVD 165
            +   +L+G+G Y +V +          A+K L +     I  +  +    E+ ++  + 
Sbjct: 6   KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRI-PNGEANVKKEIQLLRRLR 64

Query: 166 HPNTAKL---LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLK--WGIRY--KIALGVAE 218
           H N  +L   L    +  M++V+E    G    L    +++        Y  ++  G+  
Sbjct: 65  HKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLE- 123

Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE 262
              YLH    + I+H+DIK  N+LLT     +I   G+A+ L  
Sbjct: 124 ---YLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHP 161

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 75.7 bits (187), Expect = 8e-16
 Identities = 28/161 (17%), Positives = 54/161 (33%), Gaps = 23/161 (14%)

Query: 109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHP 167
              +     +G+G +  V++     + +    K +     D        E+ I+    H 
Sbjct: 4   YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD--QVLVKKEISILNIARHR 61

Query: 168 NTAKLLG-YGIEGGMHIVLELSPNGSL----ASLLYGMKEKLKWGIRYKIALG---VAEG 219
           N   L   +     + ++ E      +     +  + + E+       +I      V E 
Sbjct: 62  NILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNER-------EIVSYVHQVCEA 114

Query: 220 LLYLHEGCQRRIIHRDIKAANILLTEDFEPQ--ICDFGLAK 258
           L +LH      I H DI+  NI+          I +FG A+
Sbjct: 115 LQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQAR 152

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 75.8 bits (187), Expect = 8e-16
 Identities = 38/185 (20%), Positives = 76/185 (41%), Gaps = 48/185 (25%)

Query: 99  IFSLYELQSATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSE 157
            +  Y+L         +  +G+G ++   K   + + Q  A+K +++     + A+   E
Sbjct: 6   FYQHYDLDLK------DKPLGEGSFSICRKCVHKKSNQAFAVKIISK----RMEANTQKE 55

Query: 158 LGIMAHVD-HPNTAKLLG-YGIEGGMHIVLELSPNGSL--------------ASLLYGMK 201
           +  +   + HPN  KL   +  +    +V+EL   G L              AS +  M+
Sbjct: 56  ITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYI--MR 113

Query: 202 EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLT---EDFEPQICDFGLAK 258
           +             +   + ++H+     ++HRD+K  N+L T   ++ E +I DFG A+
Sbjct: 114 K-------------LVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFAR 157

Query: 259 WLPEQ 263
             P  
Sbjct: 158 LKPPD 162

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 75.8 bits (187), Expect = 8e-16
 Identities = 44/177 (24%), Positives = 73/177 (41%), Gaps = 27/177 (15%)

Query: 94  QSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRL-TRGTADEII 151
           QS +   + Y L S          +G+G +A V +   +  GQ  A K L  R    +  
Sbjct: 21  QSMENFNNFYILTS--------KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCR 72

Query: 152 ADFLSELGIMAHVDH-PNTAKLLG-YGIEGGMHIVLELSPNGSL-----ASLLYGMKEKL 204
           A+ L E+ ++      P    L   Y     + ++LE +  G +       L   + E  
Sbjct: 73  AEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSEND 132

Query: 205 KWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILL---TEDFEPQICDFGLAK 258
              +  +I     EG+ YLH+     I+H D+K  NILL       + +I DFG+++
Sbjct: 133 VIRLIKQI----LEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSR 182

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 75.9 bits (187), Expect = 8e-16
 Identities = 39/162 (24%), Positives = 64/162 (39%), Gaps = 24/162 (14%)

Query: 109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRL-TRGTADEIIADFLSELGIMAHVDH 166
            + +     +G G +  V++   +  G++   K + T    D       +E+ IM  + H
Sbjct: 50  YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD--KYTVKNEISIMNQLHH 107

Query: 167 PNTAKLLG-YGIEGGMHIVLELSPNGSL----ASLLYGMKEKLKWGIRYKIALG---VAE 218
           P    L   +  +  M ++LE    G L    A+  Y M E        ++        E
Sbjct: 108 PKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEA-------EVINYMRQACE 160

Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQ--ICDFGLAK 258
           GL ++H   +  I+H DIK  NI+          I DFGLA 
Sbjct: 161 GLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLAT 199

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 76.0 bits (187), Expect = 9e-16
 Identities = 36/180 (20%), Positives = 68/180 (37%), Gaps = 40/180 (22%)

Query: 104 ELQSATNNFSFENL-IGKGGYAEVYKGRLR---NGQLVAIKRLTRGTADEIIADFLSELG 159
           E +   + F +E   +G+G Y  VYK + +   + +  A+K++       I      E+ 
Sbjct: 14  ERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEG---TGISMSACREIA 70

Query: 160 IMAHVDHPNTAKLLGYGIEGGMHIVLELSPNG----------SLASLLYGMKEKLKWGIR 209
           ++  + HPN   L          + L  +              L  ++   +        
Sbjct: 71  LLRELKHPNVISLQK--------VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKP 122

Query: 210 YKIALGVA--------EGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQ----ICDFGLA 257
            ++  G+         +G+ YLH      ++HRD+K ANIL+  +   +    I D G A
Sbjct: 123 VQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 179

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 75.4 bits (186), Expect = 1e-15
 Identities = 45/187 (24%), Positives = 69/187 (36%), Gaps = 53/187 (28%)

Query: 109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIA----DFLSELGIMAH 163
           T+ +  +  IG G Y+   +   +      A+K         II     D   E+ I+  
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVK---------IIDKSKRDPTEEIEILLR 71

Query: 164 -VDHPNTAKLLG-YGIEGGMHIVLELSPNGSL--------------ASLLYGMKEKLKWG 207
              HPN   L   Y     +++V EL   G L              AS +  +       
Sbjct: 72  YGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAV--LFT----- 124

Query: 208 IRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLT---EDFEP-QICDFGLAKWL-PE 262
                   + + + YLH    + ++HRD+K +NIL      + E  +ICDFG AK L  E
Sbjct: 125 --------ITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE 173

Query: 263 QWTHHTI 269
                T 
Sbjct: 174 NGLLMTP 180

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 74.6 bits (184), Expect = 1e-15
 Identities = 45/182 (24%), Positives = 71/182 (39%), Gaps = 38/182 (20%)

Query: 110 NNFSFENLIGKGGYAEVYKGR-LRNGQLVAIK-----RLTRGTADEIIADFLS------- 156
           N ++ ++ IGKG Y  V       +    A+K     +L R                   
Sbjct: 13  NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGG 72

Query: 157 -------------ELGIMAHVDHPNTAKL---LGYGIEGGMHIVLELSPNGSLASLLY-- 198
                        E+ I+  +DHPN  KL   L    E  +++V EL   G +  +    
Sbjct: 73  CIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK 132

Query: 199 GMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
            + E         +  G+     YLH    ++IIHRDIK +N+L+ ED   +I DFG++ 
Sbjct: 133 PLSEDQARFYFQDLIKGIE----YLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSN 185

Query: 259 WL 260
             
Sbjct: 186 EF 187

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 76.0 bits (187), Expect = 2e-15
 Identities = 53/251 (21%), Positives = 103/251 (41%), Gaps = 35/251 (13%)

Query: 34  ETKPESKSNSRWHLFYDLFRNKSKKSLVTLYPLKLSIRRSSSMREGIDMPRNLFVNSYDS 93
           +T  ++    +       +     +   +    +   R  +   +G+  P    V ++  
Sbjct: 96  DTADDALRPQKAQALRAAYLEPQAQLFCSFLDAETVARARAGAGDGLFQPLLRAVLAHLG 155

Query: 94  QSPQKIF--SLY----------ELQSAT-NNFSFENLIGKGGYAEVYKGRLRN-GQLVAI 139
           Q+P + F  SLY          E Q    + F    ++G+GG+ EV+  +++  G+L A 
Sbjct: 156 QAPFQEFLDSLYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYAC 215

Query: 140 KRLTRGTADEIIAD-----FLSELGIMAHVDHPNTAKLL-GYGIEGGMHIVLELSPNGSL 193
           K+L +     +         + E  I+A V       L   +  +  + +V+ +   G +
Sbjct: 216 KKLNK---KRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDI 272

Query: 194 ASLLYGMKEKLKWGIRYKIALGV---AE---GLLYLHEGCQRRIIHRDIKAANILLTEDF 247
              +Y + E       ++    +   A+   GL +LH+   R II+RD+K  N+LL +D 
Sbjct: 273 RYHIYNVDEDNP---GFQEPRAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDG 326

Query: 248 EPQICDFGLAK 258
             +I D GLA 
Sbjct: 327 NVRISDLGLAV 337

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 75.0 bits (185), Expect = 2e-15
 Identities = 44/166 (26%), Positives = 70/166 (42%), Gaps = 22/166 (13%)

Query: 109 TNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIAD-F---------LSEL 158
            + ++ +  I  G Y  V  G    G  VAIKR+    +D    +           L E+
Sbjct: 21  QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80

Query: 159 GIMAHVDHPNTAKLL------GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWG-IRYK 211
            ++ H  HPN   L              +++V EL     LA +++  +  +    I+Y 
Sbjct: 81  RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQY- 138

Query: 212 IALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLA 257
               +  GL  LHE     ++HRD+   NILL ++ +  ICDF LA
Sbjct: 139 FMYHILLGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLA 181

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 74.6 bits (184), Expect = 2e-15
 Identities = 47/167 (28%), Positives = 72/167 (43%), Gaps = 18/167 (10%)

Query: 109 TNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDH 166
              +     +G G Y  V      R+G+ VAIK+L+R    EI A     EL ++ H+ H
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQH 82

Query: 167 PNTAKLL-------GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWG-IRYKIALGVAE 218
            N   LL               ++V+          L   M  K     I+Y +   + +
Sbjct: 83  ENVIGLLDVFTPASSLRNFYDFYLVMPFMQ----TDLQKIMGLKFSEEKIQY-LVYQMLK 137

Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT 265
           GL Y+H      ++HRD+K  N+ + ED E +I DFGLA+    + T
Sbjct: 138 GLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMT 181

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 73.9 bits (182), Expect = 3e-15
 Identities = 37/188 (19%), Positives = 61/188 (32%), Gaps = 36/188 (19%)

Query: 86  LFVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTR 144
             V S        I   Y++           ++G G   +V +   +   +  A+K L  
Sbjct: 2   PHVKSGLQIKKNAIIDDYKV--------TSQVLGLGINGKVLQIFNKRTQEKFALKMLQD 53

Query: 145 GTADEIIADFLSELGIMAHV-DHPNTAKLLG-----YGIEGGMHIVLELSPNGSL----- 193
                       E+ +       P+  +++      Y     + IV+E    G L     
Sbjct: 54  ------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQ 107

Query: 194 ASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLT---EDFEPQ 250
                   E+    I   I   +     YLH      I HRD+K  N+L T    +   +
Sbjct: 108 DRGDQAFTEREASEIMKSIGEAIQ----YLHS---INIAHRDVKPENLLYTSKRPNAILK 160

Query: 251 ICDFGLAK 258
           + DFG AK
Sbjct: 161 LTDFGFAK 168

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 74.7 bits (184), Expect = 3e-15
 Identities = 49/174 (28%), Positives = 77/174 (44%), Gaps = 19/174 (10%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIAD-----FLSELGIMAH 163
           ++F     IGKG + +V   +     ++ A+K + +    + +          EL IM  
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNK---QKCVERNEVRNVFKELQIMQG 71

Query: 164 VDHPNTAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIA-LGVAEGLL 221
           ++HP    L   +  E  M +V++L   G L   L       +  ++  I  L +A  L 
Sbjct: 72  LEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMA--LD 129

Query: 222 YLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGT 275
           YL     +RIIHRD+K  NILL E     I DF +A  LP +    T++   GT
Sbjct: 130 YLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMA---GT 177

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 73.5 bits (181), Expect = 4e-15
 Identities = 42/195 (21%), Positives = 74/195 (37%), Gaps = 23/195 (11%)

Query: 83  PRNLFVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKR 141
           PR   +   +     K+    E +   + +    L+G GG+  VY G  + +   VAIK 
Sbjct: 16  PRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKH 75

Query: 142 LTRGTADEIIADFLS-----ELGIMAHVDH--PNTAKLLGYGIEGGMHIVLEL---SPNG 191
           + +    +            E+ ++  V        +LL +  E     VL L    P  
Sbjct: 76  VEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW-FERPDSFVLILERPEPVQ 134

Query: 192 SLASLLYG---MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILL-TEDF 247
            L   +     ++E+L     +++   V     + H      ++HRDIK  NIL+     
Sbjct: 135 DLFDFITERGALQEELARSFFWQVLEAVR----HCH---NCGVLHRDIKDENILIDLNRG 187

Query: 248 EPQICDFGLAKWLPE 262
           E ++ DFG    L +
Sbjct: 188 ELKLIDFGSGALLKD 202

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 74.4 bits (183), Expect = 4e-15
 Identities = 65/262 (24%), Positives = 104/262 (39%), Gaps = 35/262 (13%)

Query: 34  ETKPESKSNSRWHLFYDLFRNKSKKSLVTLYPLKLSIRRSSSMRE----GIDMPRNLFVN 89
           E  P+ K  +        F + +   L+   P +L    +  + +     +        +
Sbjct: 91  EVTPDDKRKACGRNLTQNFLSHTGPDLIPEVPRQLVTNCTQRLEQGPCKDLFQELTRLTH 150

Query: 90  SYDSQSPQKIF--SLY----------ELQSAT-NNFSFENLIGKGGYAEVYKGRLRN-GQ 135
            Y S +P   +  S+Y          E Q  T N F    ++GKGG+ EV   ++R  G+
Sbjct: 151 EYLSVAPFADYLDSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGK 210

Query: 136 LVAIKRLTRGTADEIIAD-----FLSELGIMAHVDHPNTAKLL-GYGIEGGMHIVLELSP 189
           + A K+L +     I         L+E  I+  V+      L   Y  +  + +VL L  
Sbjct: 211 MYACKKLEK---KRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMN 267

Query: 190 NGSLASLLYGMKE---KLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTED 246
            G L   +Y M +        + Y  A  +  GL  LH     RI++RD+K  NILL + 
Sbjct: 268 GGDLKFHIYHMGQAGFPEARAVFY--AAEICCGLEDLHR---ERIVYRDLKPENILLDDH 322

Query: 247 FEPQICDFGLAKWLPEQWTHHT 268
              +I D GLA  +PE  T   
Sbjct: 323 GHIRISDLGLAVHVPEGQTIKG 344

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 72.8 bits (179), Expect = 1e-14
 Identities = 43/188 (22%), Positives = 65/188 (34%), Gaps = 31/188 (16%)

Query: 82  MPRNLFVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIK 140
           M R                  Y+             IG G +      R     +LVA+K
Sbjct: 1   MDRAPVTTGPLDMPIMHDSDRYDF---------VKDIGSGNFGVARLMRDKLTKELVAVK 51

Query: 141 RLTRGTADEIIADFLS-ELGIMAHVDHPNTAKLLGYG-IEGGMHI--VLELSPNGSLASL 196
            + RG     I + +  E+     + HPN  +      I    H+  ++E +  G L   
Sbjct: 52  YIERG---AAIDENVQREIINHRSLRHPNIVRF--KEVILTPTHLAIIMEYASGGELYER 106

Query: 197 LY---GMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQ--I 251
           +       E        ++  GV+    Y H     +I HRD+K  N LL     P+  I
Sbjct: 107 ICNAGRFSEDEARFFFQQLLSGVS----YCH---SMQICHRDLKLENTLLDGSPAPRLKI 159

Query: 252 CDFGLAKW 259
           CDFG +K 
Sbjct: 160 CDFGYSKS 167

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 72.4 bits (178), Expect = 2e-14
 Identities = 45/210 (21%), Positives = 86/210 (40%), Gaps = 46/210 (21%)

Query: 87  FVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRN-GQLVAIKRLTRG 145
           F+   +    +    L E++   ++F    +IG+G ++EV   +++  GQ+ A+K + + 
Sbjct: 42  FLQWAEPIVVR----LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNK- 96

Query: 146 TADEIIAD-----FLSELGIMAHVDHP----------NTAKLLGYGIEGGMHIVLELSPN 190
              +++       F  E  ++ + D            +   L         ++V+E    
Sbjct: 97  --WDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYL---------YLVMEYYVG 145

Query: 191 GSLASLL--YGMKEKLKWGIRYKIALGVAE---GLLYLHEGCQRRIIHRDIKAANILLTE 245
           G L +LL  +G +   +    Y     +AE    +  +H   +   +HRDIK  NILL  
Sbjct: 146 GDLLTLLSKFGERIPAEMARFY-----LAEIVMAIDSVH---RLGYVHRDIKPDNILLDR 197

Query: 246 DFEPQICDFGLAKWLPEQWTHHTISKVEGT 275
               ++ DFG    L    T  ++  V GT
Sbjct: 198 CGHIRLADFGSCLKLRADGTVRSLVAV-GT 226

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 72.5 bits (178), Expect = 2e-14
 Identities = 43/201 (21%), Positives = 87/201 (43%), Gaps = 28/201 (13%)

Query: 87  FVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRG 145
           ++      + +    + +++    +F    +IG+G + EV   +L+   ++ A+K L + 
Sbjct: 55  YLEWAKPFTSK----VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNK- 109

Query: 146 TADEIIAD-----FLSELGIMAHVDHPNTAKLLG-YGIEGGMHIVLELSPNGSLASLLYG 199
              E++       F  E  ++ + D      L   +  +  +++V++    G L +LL  
Sbjct: 110 --WEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSK 167

Query: 200 MKEKL--KWGIRYKIALGVAE---GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDF 254
            +++L  +    Y     +AE    +  +H   Q   +HRDIK  NIL+  +   ++ DF
Sbjct: 168 FEDRLPEEMARFY-----LAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADF 219

Query: 255 GLAKWLPEQWTHHTISKVEGT 275
           G    L E  T  +   V GT
Sbjct: 220 GSCLKLMEDGTVQSSVAV-GT 239

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 72.2 bits (177), Expect = 2e-14
 Identities = 52/221 (23%), Positives = 93/221 (42%), Gaps = 32/221 (14%)

Query: 64  YPLKLSIRRSSSMREGIDMPRNL-FVNSYDSQSPQKI---FSLYELQSAT----NNFSFE 115
           Y  + ++    +  +G D   ++ ++  + + S  K+   F   E+  +T      +   
Sbjct: 8   YCSEPTLDVKIAFCQGFDKQVDVSYIAKHYNMSKSKVDNQFYSVEVGDSTFTVLKRYQNL 67

Query: 116 NLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNTAKLL 173
             IG G    V         + VAIK+L+R   ++  A     EL +M  V+H N   LL
Sbjct: 68  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 127

Query: 174 -------GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWG----IRYKIALGVAEGLLY 222
                         +++V+EL      A+L   ++ +L       + Y++  G    + +
Sbjct: 128 NVFTPQKTLEEFQDVYLVMELMD----ANLCQVIQMELDHERMSYLLYQMLCG----IKH 179

Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ 263
           LH      IIHRD+K +NI++  D   +I DFGLA+     
Sbjct: 180 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 217

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 71.5 bits (175), Expect = 2e-14
 Identities = 31/209 (14%), Positives = 62/209 (29%), Gaps = 58/209 (27%)

Query: 110 NNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPN 168
            +F     +G+GG+  V++ +   +    AIKR+     +      + E+  +A ++HP 
Sbjct: 6   TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65

Query: 169 TAKLLGYGIEGGMHIVLELSPNGSLASLLYGM------------------KEKLKWGIRY 210
             +     +E       E      L                                   
Sbjct: 66  IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125

Query: 211 KIALGVAEGLLYLH-EGCQRR--------------------------------------I 231
           ++     +  LY+  + C++                                       +
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGL 185

Query: 232 IHRDIKAANILLTEDFEPQICDFGLAKWL 260
           +HRD+K +NI  T D   ++ DFGL   +
Sbjct: 186 MHRDLKPSNIFFTMDDVVKVGDFGLVTAM 214

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 71.7 bits (176), Expect = 3e-14
 Identities = 38/200 (19%), Positives = 64/200 (32%), Gaps = 58/200 (29%)

Query: 96  PQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADF 154
              I   Y++           ++G G   +V +   +   +  A+K L            
Sbjct: 56  KNAIIDDYKV--------TSQVLGLGINGKVLQIFNKRTQEKFALKMLQD------CPKA 101

Query: 155 LSELGIMAHV-DHPNTAKLLG-----YGIEGGMHIVLELSPNGSL--------------- 193
             E+ +       P+  +++      Y     + IV+E    G L               
Sbjct: 102 RREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTER 161

Query: 194 -ASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLT---EDFEP 249
            AS +  MK              + E + YLH      I HRD+K  N+L T    +   
Sbjct: 162 EASEI--MKS-------------IGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAIL 203

Query: 250 QICDFGLAKWLPEQWTHHTI 269
           ++ DFG AK      +  T 
Sbjct: 204 KLTDFGFAKETTSHNSLTTP 223

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 72.2 bits (177), Expect = 3e-14
 Identities = 47/167 (28%), Positives = 77/167 (46%), Gaps = 17/167 (10%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIAD-----FLSELGIMAH 163
           N+FS   +IG+GG+ EVY  R    G++ A+K L +     I         L+E  +++ 
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDK---KRIKMKQGETLALNERIMLSL 245

Query: 164 V---DHPNTAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEG 219
           V   D P    +   +     +  +L+L   G L   L       +  +R+  A  +  G
Sbjct: 246 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAA-EIILG 304

Query: 220 LLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH 266
           L ++H    R +++RD+K ANILL E    +I D GLA    ++  H
Sbjct: 305 LEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH 348

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 70.9 bits (174), Expect = 5e-14
 Identities = 42/202 (20%), Positives = 72/202 (35%), Gaps = 57/202 (28%)

Query: 105 LQSATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADF---LSELGI 160
           L++++  +S    +G G +  V +     +G+  A+K+        ++ D      EL I
Sbjct: 2   LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKK--------VLQDPRYKNRELDI 53

Query: 161 MAHVDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYG--------------------- 199
           M  +DH N  KL+ Y    G        P      L                        
Sbjct: 54  MKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYL 113

Query: 200 ------MKEKLKWGIRYKIALG--------------VAEGLLYLHEGCQRRIIHRDIKAA 239
                 + + L   ++  I  G              +   + ++H      I HRDIK  
Sbjct: 114 NVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH---SLGICHRDIKPQ 170

Query: 240 NILL-TEDFEPQICDFGLAKWL 260
           N+L+ ++D   ++CDFG AK L
Sbjct: 171 NLLVNSKDNTLKLCDFGSAKKL 192

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 70.9 bits (174), Expect = 5e-14
 Identities = 48/199 (24%), Positives = 86/199 (43%), Gaps = 26/199 (13%)

Query: 87  FVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRG 145
           F++ Y     +    + +L+    ++    +IG+G + EV   R +   ++ A+K L++ 
Sbjct: 50  FLSRYKDTINK----IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSK- 104

Query: 146 TADEIIAD-----FLSELGIMAHVDHPNTAKLLG-YGIEGGMHIVLELSPNGSLASLLYG 199
              E+I       F  E  IMA  + P   +L   +  +  +++V+E  P G L +L+  
Sbjct: 105 --FEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN 162

Query: 200 MKEKLKWGIRYKIALGVAE---GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGL 256
                KW   Y      AE    L  +H       IHRD+K  N+LL +    ++ DFG 
Sbjct: 163 YDVPEKWARFY-----TAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGT 214

Query: 257 AKWLPEQWTHHTISKVEGT 275
              + ++      + V GT
Sbjct: 215 CMKMNKEGMVRCDTAV-GT 232

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 70.0 bits (172), Expect = 7e-14
 Identities = 46/179 (25%), Positives = 68/179 (37%), Gaps = 41/179 (22%)

Query: 109 TNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDH 166
              +     +G G Y  V      R G  VAIK+L R    E+ A     EL ++ H+ H
Sbjct: 24  RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRH 83

Query: 167 PNTAKLL-------GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIR---------- 209
            N   LL               ++V+              M   L   ++          
Sbjct: 84  ENVIGLLDVFTPDETLDDFTDFYLVMPF------------MGTDLGKLMKHEKLGEDRIQ 131

Query: 210 ---YKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT 265
              Y++     +GL Y+H      IIHRD+K  N+ + ED E +I DFGLA+    + T
Sbjct: 132 FLVYQML----KGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMT 183

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 69.6 bits (171), Expect = 8e-14
 Identities = 41/181 (22%), Positives = 68/181 (37%), Gaps = 32/181 (17%)

Query: 93  SQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIK-----RLTRGT 146
            +  +   + Y L           L+GKGG+  V+ G  L +   VAIK     R+   +
Sbjct: 23  GKDREAFEAEYRL---------GPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWS 73

Query: 147 ADEIIADFLSELGIMAHVD----HPNTAKLLG-YGIEGGMHIVLEL-SPNGSLASLLYG- 199
                     E+ ++  V     HP   +LL  +  + G  +VLE   P   L   +   
Sbjct: 74  PLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEK 133

Query: 200 --MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILL-TEDFEPQICDFGL 256
             + E        ++   +     + H    R ++HRDIK  NIL+       ++ DFG 
Sbjct: 134 GPLGEGPSRCFFGQVVAAIQ----HCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGS 186

Query: 257 A 257
            
Sbjct: 187 G 187

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 69.6 bits (171), Expect = 9e-14
 Identities = 49/160 (30%), Positives = 73/160 (45%), Gaps = 14/160 (8%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIAD-----FLSELGIMAH 163
            +F F  ++G+G ++ V   R     +  AIK L +     II +        E  +M+ 
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEK---RHIIKENKVPYVTRERDVMSR 86

Query: 164 VDHPNTAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLY 222
           +DHP   KL   +  +  ++  L  + NG L   +  +    +   R+  A  +   L Y
Sbjct: 87  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEY 145

Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE 262
           LH    + IIHRD+K  NILL ED   QI DFG AK L  
Sbjct: 146 LHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 182

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 69.7 bits (171), Expect = 1e-13
 Identities = 49/191 (25%), Positives = 82/191 (42%), Gaps = 25/191 (13%)

Query: 91  YDSQSPQKIFSLYELQSA----TNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRG 145
           +     +  F   EL          +   + +G G Y  V      + G  VA+K+L+R 
Sbjct: 6   HHHSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP 65

Query: 146 TADEIIAD-FLSELGIMAHVDHPNTAKLL-------GYGIEGGMHIVLELSPNGSLASLL 197
               I A     EL ++ H+ H N   LL              +++V  L     L +++
Sbjct: 66  FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIV 124

Query: 198 YGMK---EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDF 254
              K   + +++ + Y+I      GL Y+H      IIHRD+K +N+ + ED E +I DF
Sbjct: 125 KCQKLTDDHVQF-LIYQIL----RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDF 176

Query: 255 GLAKWLPEQWT 265
           GLA+   ++ T
Sbjct: 177 GLARHTADEMT 187

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 69.3 bits (170), Expect = 1e-13
 Identities = 45/168 (26%), Positives = 71/168 (42%), Gaps = 24/168 (14%)

Query: 109 TNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDH 166
              +     IG G    V         + VAIK+L+R   ++  A     EL +M  V+H
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 83

Query: 167 PNTAKLL-------GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWG----IRYKIALG 215
            N   LL              ++IV+EL      A+L   ++ +L       + Y++   
Sbjct: 84  KNIIGLLNVFTPQKSLEEFQDVYIVMELMD----ANLCQVIQMELDHERMSYLLYQML-- 137

Query: 216 VAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ 263
              G+ +LH      IIHRD+K +NI++  D   +I DFGLA+     
Sbjct: 138 --CGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 180

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 67.2 bits (165), Expect = 4e-13
 Identities = 38/159 (23%), Positives = 66/159 (41%), Gaps = 24/159 (15%)

Query: 111 NFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLS-----ELGIMAHV 164
           ++   + +G G + +V  G     G  VA+K L R    +I +  +      E+  +   
Sbjct: 12  HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNR---QKIRSLDVVGKIKREIQNLKLF 68

Query: 165 DHPNTAKLLGYGI---EGGMHIVLELSPNGSLASLLYG---MKEKLKWGIRYKIALGVAE 218
            HP+  KL  Y +        +V+E    G L   +     ++E     +  +I   V  
Sbjct: 69  RHPHIIKL--YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVD- 125

Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLA 257
              Y H   +  ++HRD+K  N+LL      +I DFGL+
Sbjct: 126 ---YCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLS 158

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 66.2 bits (162), Expect = 2e-12
 Identities = 43/202 (21%), Positives = 84/202 (41%), Gaps = 23/202 (11%)

Query: 72  RSSSMREGIDMPRNLFVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRL 131
              S++E +   +  F+  +++ S              + F     +G G +  V   + 
Sbjct: 11  EQESVKEFLAKAKEDFLKKWETPSQNTA--------QLDQFDRIKTLGTGSFGRVMLVKH 62

Query: 132 R-NGQLVAIKRLTRGTADEIIAD-----FLSELGIMAHVDHPNTAKLLG-YGIEGGMHIV 184
           + +G   A+K L +    +++        L+E  I+  V+ P   KL   +     +++V
Sbjct: 63  KESGNHYAMKILDK---QKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119

Query: 185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLT 244
           +E    G + S L  +    +   R+  A  +     YLH      +I+RD+K  N+L+ 
Sbjct: 120 MEYVAGGEMFSHLRRIGRFSEPHARFYAA-QIVLTFEYLHS---LDLIYRDLKPENLLID 175

Query: 245 EDFEPQICDFGLAKWLPEQ-WT 265
           +    Q+ DFG AK +  + WT
Sbjct: 176 QQGYIQVTDFGFAKRVKGRTWT 197

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 65.8 bits (161), Expect = 2e-12
 Identities = 36/165 (21%), Positives = 67/165 (40%), Gaps = 37/165 (22%)

Query: 109 TNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DH 166
            +++     +G+G Y+EV++   + N + V +K L      +I      E+ I+ ++   
Sbjct: 35  QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKI----KREIKILENLRGG 90

Query: 167 PNTAKLLGYGIEGGMHIVLELSPNGSLASLL--YGMKEKLKWGIR-----------YKIA 213
           PN   L          IV    P     +L+  +      K   +           Y+I 
Sbjct: 91  PNIITLA--------DIVK--DPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEIL 140

Query: 214 LGVAEGLLYLHEGCQRRIIHRDIKAANILL-TEDFEPQICDFGLA 257
               + L Y H      I+HRD+K  N+++  E  + ++ D+GLA
Sbjct: 141 ----KALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA 178

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 66.0 bits (161), Expect = 2e-12
 Identities = 41/157 (26%), Positives = 65/157 (41%), Gaps = 20/157 (12%)

Query: 111 NFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLS----ELGIMAHVD 165
           ++   + +G G + +V  G+    G  VA+K L R        D +     E+  +    
Sbjct: 17  HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRS--LDVVGKIRREIQNLKLFR 74

Query: 166 HPNTAKLLGYGIEGGMHI--VLELSPNGSLASLLYG---MKEKLKWGIRYKIALGVAEGL 220
           HP+  KL    I     I  V+E    G L   +     + EK    +  +I  GV    
Sbjct: 75  HPHIIKLYQV-ISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVD--- 130

Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLA 257
            Y H   +  ++HRD+K  N+LL      +I DFGL+
Sbjct: 131 -YCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLS 163

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 65.5 bits (160), Expect = 3e-12
 Identities = 40/168 (23%), Positives = 65/168 (38%), Gaps = 38/168 (22%)

Query: 109 TNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAH-VD 165
              +     +GKG Y  V+K    R G++VA+K++     +   A     E+ I+     
Sbjct: 8   LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSG 67

Query: 166 HPNTAKLLGYGIEGGMH---IVLELSPNGSLASLLYGMKEKLKWGIR------------- 209
           H N   LL            +V +             M+  L   IR             
Sbjct: 68  HENIVNLLNVLRADNDRDVYLVFDY------------METDLHAVIRANILEPVHKQYVV 115

Query: 210 YKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLA 257
           Y++       + YLH G    ++HRD+K +NILL  +   ++ DFGL+
Sbjct: 116 YQLIKV----IKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLS 156

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 64.6 bits (158), Expect = 6e-12
 Identities = 41/185 (22%), Positives = 73/185 (39%), Gaps = 45/185 (24%)

Query: 95  SPQKIF-SLYELQSATNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIA 152
            P+ +   ++++      ++  + IG+G Y  V       N   VAIK+++     +   
Sbjct: 14  GPEMVRGQVFDV---GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP-FEHQTYC 69

Query: 153 D-FLSELGIMAHVDHPNTAKLL------GYGIEGGMHIVLELSPNGSLASLLYGMKEKLK 205
              L E+ I+    H N   +              ++IV +L            M+  L 
Sbjct: 70  QRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDL------------METDLY 117

Query: 206 WGIR-------------YKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQIC 252
             ++             Y+I      GL Y+H      ++HRD+K +N+LL    + +IC
Sbjct: 118 KLLKTQHLSNDHICYFLYQIL----RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKIC 170

Query: 253 DFGLA 257
           DFGLA
Sbjct: 171 DFGLA 175

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 63.4 bits (153), Expect = 1e-11
 Identities = 31/200 (15%), Positives = 49/200 (24%), Gaps = 52/200 (26%)

Query: 108 ATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEI-------IADFLSELGI 160
            T        IG+G + EV++    +   VAIK +     D +         + L E+ I
Sbjct: 18  PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76

Query: 161 M---------AHVDHPNTAKLLGYGIEGG------------------------------- 180
                               L       G                               
Sbjct: 77  SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136

Query: 181 MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAAN 240
           + IVLE    G    L     +         I   +   L       +    HRD+   N
Sbjct: 137 LFIVLEFEFGGI--DLEQMRTKLSSLATAKSILHQLTASLAVAEASLR--FEHRDLHWGN 192

Query: 241 ILLTEDFEPQICDFGLAKWL 260
           +LL +    ++      K  
Sbjct: 193 VLLKKTSLKKLHYTLNGKSS 212

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 62.9 bits (154), Expect = 2e-11
 Identities = 46/170 (27%), Positives = 80/170 (47%), Gaps = 27/170 (15%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIAD-----FLSELGIMAH 163
            +F     +G G +  V+  R R NG+  A+K L +   + ++          E  +++ 
Sbjct: 6   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKK---EIVVRLKQVEHTNDERLMLSI 62

Query: 164 VDHPNTAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALG---VAE- 218
           V HP   ++ G +     + ++++    G L SLL   K +     R+   +     AE 
Sbjct: 63  VTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLR--KSQ-----RFPNPVAKFYAAEV 115

Query: 219 --GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ-WT 265
              L YLH    + II+RD+K  NILL ++   +I DFG AK++P+  +T
Sbjct: 116 CLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT 162

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 63.0 bits (154), Expect = 2e-11
 Identities = 41/189 (21%), Positives = 78/189 (41%), Gaps = 41/189 (21%)

Query: 109 TNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDH 166
           +++F  ++L+G+G Y  V        G++VAIK++       + A   L E+ I+ H  H
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKI-EPFDKPLFALRTLREIKILKHFKH 68

Query: 167 PNTAKLL------GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIR----------- 209
            N   +        +     ++I+ EL            M+  L   I            
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQEL------------MQTDLHRVISTQMLSDDHIQY 116

Query: 210 --YKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH 267
             Y+        +  LH      +IHRD+K +N+L+  + + ++CDFGLA+ + E    +
Sbjct: 117 FIYQTL----RAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADN 169

Query: 268 TISKVEGTF 276
           +    + + 
Sbjct: 170 SEPTGQQSG 178

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 62.3 bits (152), Expect = 3e-11
 Identities = 38/161 (23%), Positives = 69/161 (42%), Gaps = 19/161 (11%)

Query: 111 NFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADE--IIADFLSELGIMAHVDHP 167
            +     +G+G + +V      +  Q VA+K ++R    +  +      E+  +  + HP
Sbjct: 10  PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHP 69

Query: 168 NTAKLLGYG-IEGGMHI--VLELSPNGSLASLLYG---MKEKLKWGIRYKIALGVAEGLL 221
           +  KL  Y  I     I  V+E +  G L   +     M E        +I   +     
Sbjct: 70  HIIKL--YDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIE---- 122

Query: 222 YLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE 262
           Y H   + +I+HRD+K  N+LL ++   +I DFGL+  + +
Sbjct: 123 YCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 60.0 bits (146), Expect = 1e-10
 Identities = 40/185 (21%), Positives = 68/185 (36%), Gaps = 44/185 (23%)

Query: 109 TNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDH 166
            + +     +G GG   V+        + VAIK++     D       L E+ I+  +DH
Sbjct: 10  GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT--DPQSVKHALREIKIIRRLDH 67

Query: 167 PNTAKLLGYGIEGGMHIVLELSPNGSLASLLYG-----------MKEKLKWGIR------ 209
            N  K+          I+       +                  M+  L   +       
Sbjct: 68  DNIVKVF--------EILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLE 119

Query: 210 -------YKIALGVAEGLLYLHEGCQRRIIHRDIKAANILL-TEDFEPQICDFGLAKWLP 261
                  Y++      GL Y+H      ++HRD+K AN+ + TED   +I DFGLA+ + 
Sbjct: 120 EHARLFMYQLL----RGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMD 172

Query: 262 EQWTH 266
             ++H
Sbjct: 173 PHYSH 177

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 60.5 bits (147), Expect = 2e-10
 Identities = 41/156 (26%), Positives = 74/156 (47%), Gaps = 13/156 (8%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRN-GQLVAIKRLTRGTADEIIAD-----FLSELGIMAH 163
           N F +  L+GKG + +V   + +  G+  A+K L +   + I+A       L+E  ++ +
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKK---EVIVAKDEVAHTLTENRVLQN 204

Query: 164 VDHPNTAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLY 222
             HP    L   +     +  V+E +  G L   L   +   +   R+  A  +   L Y
Sbjct: 205 SRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGA-EIVSALDY 263

Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           LH   ++ +++RD+K  N++L +D   +I DFGL K
Sbjct: 264 LHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCK 297

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 59.5 bits (145), Expect = 3e-10
 Identities = 44/166 (26%), Positives = 74/166 (44%), Gaps = 34/166 (20%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIAD-----FLSELGIMAH 163
           N+F +  L+GKG + +V   R +  G+  A+K L +   + IIA       ++E  ++ +
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRK---EVIIAKDEVAHTVTESRVLQN 61

Query: 164 VDHP----------NTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKI- 212
             HP             +L           V+E +  G L   L   +E++    R +  
Sbjct: 62  TRHPFLTALKYAFQTHDRL---------CFVMEYANGGELFFHLS--RERVFTEERARFY 110

Query: 213 ALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
              +   L YLH    R +++RDIK  N++L +D   +I DFGL K
Sbjct: 111 GAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCK 153

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 57.2 bits (139), Expect = 1e-09
 Identities = 43/173 (24%), Positives = 70/173 (40%), Gaps = 46/173 (26%)

Query: 110 NNFSFENLIGKGGYAEVY----KGRLRNGQLVAIKRLTRGTADEIIAD----FLSELGIM 161
           + F    ++G+G + +V+           QL A+K L +     +          E  I+
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKK---ATLKVRDRVRTKMERDIL 80

Query: 162 AHVDHP----------NTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKL---KWGI 208
             V+HP             KL         +++L+    G L + L   KE +   +   
Sbjct: 81  VEVNHPFIVKLHYAFQTEGKL---------YLILDFLRGGDLFTRLS--KEVMFTEEDVK 129

Query: 209 RYKIALGVAE---GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
            Y     +AE    L +LH      II+RD+K  NILL E+   ++ DFGL+K
Sbjct: 130 FY-----LAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSK 174

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 56.8 bits (138), Expect = 2e-09
 Identities = 44/175 (25%), Positives = 71/175 (40%), Gaps = 48/175 (27%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRN----GQLVAIKRLTRGTADEIIADF------LSELG 159
             F    ++GKGGY +V++ R       G++ A+K L +     I+ +        +E  
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKK---AMIVRNAKDTAHTKAERN 73

Query: 160 IMAHVDHP----------NTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIR 209
           I+  V HP             KL         +++LE    G L   L   +E       
Sbjct: 74  ILEEVKHPFIVDLIYAFQTGGKL---------YLILEYLSGGELFMQLE--REG-----I 117

Query: 210 YKIALG---VAE---GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           +        +AE    L +LH+   + II+RD+K  NI+L      ++ DFGL K
Sbjct: 118 FMEDTACFYLAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCK 169

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 56.2 bits (136), Expect = 3e-09
 Identities = 43/178 (24%), Positives = 71/178 (39%), Gaps = 25/178 (14%)

Query: 110 NNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDH-P 167
            ++     IG+G +  +++G  L N Q VAIK   R +    + D   E      +    
Sbjct: 10  VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRD---EYRTYKLLAGCT 66

Query: 168 NTAKLLGYGIEGGMHI-VLE-LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLL---- 221
               +  +G EG  ++ V++ L P  SL  LL     K       K     A+ +L    
Sbjct: 67  GIPNVYYFGQEGLHNVLVIDLLGP--SLEDLLDLCGRKFS----VKTVAMAAKQMLARVQ 120

Query: 222 YLHEGCQRRIIHRDIKAANILLTEDFEPQ-----ICDFGLAKWLPEQWTHHTISKVEG 274
            +HE   + +++RDIK  N L+            + DFG+ K+  +  T   I   E 
Sbjct: 121 SIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREK 175

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 56.2 bits (136), Expect = 3e-09
 Identities = 44/178 (24%), Positives = 64/178 (35%), Gaps = 25/178 (14%)

Query: 110 NNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDH-P 167
            NF     IG G + E+  G+ L   + VAIK     +    +     E      +    
Sbjct: 9   PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHL---EYRFYKQLGSGD 65

Query: 168 NTAKLLGYGIEGGMHI-VLE-LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLL---- 221
              ++  +G  G  +  VLE L P  SL  L              K  L +A  L+    
Sbjct: 66  GIPQVYYFGPCGKYNAMVLELLGP--SLEDLFDLCDRTFS----LKTVLMIAIQLISRME 119

Query: 222 YLHEGCQRRIIHRDIKAANILLTEDFEPQ-----ICDFGLAKWLPEQWTHHTISKVEG 274
           Y+H    + +I+RD+K  N L+            I DF LAK   +  T   I   E 
Sbjct: 120 YVHS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREH 174

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 56.1 bits (135), Expect = 4e-09
 Identities = 23/97 (23%), Positives = 41/97 (42%), Gaps = 9/97 (9%)

Query: 110 NNFSFENLIGKGGYAEVYKGRL------RNGQLVAIKRLTRGTADEIIADFLSELGIMAH 163
           +       +G+G + +V +            + VA+K L  G         +SEL I+ H
Sbjct: 22  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81

Query: 164 VD-HPNTAKLLGY--GIEGGMHIVLELSPNGSLASLL 197
           +  H N   LLG      G + +++E    G+L++ L
Sbjct: 82  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 118

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 53.0 bits (127), Expect = 4e-08
 Identities = 22/48 (45%), Positives = 31/48 (64%), Gaps = 3/48 (6%)

Query: 211 KIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
             +  VA+G+ +L     R+ IHRD+ A NILL+E    +ICDFGLA+
Sbjct: 197 CYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLAR 241

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 55.9 bits (135), Expect = 5e-09
 Identities = 45/180 (25%), Positives = 74/180 (41%), Gaps = 40/180 (22%)

Query: 117 LIGKGGYAEVYKGR-LRNGQLVAIK------RLTRGTADEI-IADFLSELGIMA--HVDH 166
            +G G ++ V+  + + N   VA+K        T    DEI +   +++        +  
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 85

Query: 167 PNTAKLLG---YGIEGGMH--IVLE-LSPNGSLASLLYGMKEKLKWG------IRYKIAL 214
            +  KLL    +    G+H  +V E L  N      L  + +K +        ++ +I+ 
Sbjct: 86  NHILKLLDHFNHKGPNGVHVVMVFEVLGEN------LLALIKKYEHRGIPLIYVK-QISK 138

Query: 215 GVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQ------ICDFGLAKWLPEQWTHHT 268
            +  GL Y+H  C   IIH DIK  N+L+     P+      I D G A W  E   H+T
Sbjct: 139 QLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE---HYT 193

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 55.8 bits (134), Expect = 7e-09
 Identities = 40/158 (25%), Positives = 72/158 (45%), Gaps = 17/158 (10%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIAD-----FLSELGIMAH 163
            +F+F  ++GKG + +V     +   +L A+K L +   D +I D      + E  ++A 
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKK---DVVIQDDDVECTMVEKRVLAL 397

Query: 164 V-DHPNTAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKE-KLKWGIRYKIALGVAEGL 220
               P   +L   +     ++ V+E    G L   +  +   K    + Y  A  +A GL
Sbjct: 398 PGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFY--AAEIAIGL 455

Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
            +L     + II+RD+K  N++L  +   +I DFG+ K
Sbjct: 456 FFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCK 490

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 54.6 bits (132), Expect = 1e-08
 Identities = 43/173 (24%), Positives = 68/173 (39%), Gaps = 43/173 (24%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLR----NGQLVAIKRLTRGT---ADEIIADFLSELGIMA 162
            NF    ++G G Y +V+  R       G+L A+K L + T     +      +E  ++ 
Sbjct: 54  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113

Query: 163 HVDHP-----------NTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYK 211
           H+                 KL         H++L+    G L + L   + +     R+ 
Sbjct: 114 HIRQSPFLVTLHYAFQTETKL---------HLILDYINGGELFTHLS--QRE-----RFT 157

Query: 212 IALG---VAE---GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
                  V E    L +LH+     II+RDIK  NILL  +    + DFGL+K
Sbjct: 158 EHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSK 207

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 54.0 bits (130), Expect = 2e-08
 Identities = 32/209 (15%), Positives = 71/209 (33%), Gaps = 36/209 (17%)

Query: 78  EGIDMPRNLFVNSYDSQSPQKIFSLYELQSAT-NNFSFENLIGKGGYAEVYKGR------ 130
            G+D+          + S + + +   L   +   +  ++   +     +Y+        
Sbjct: 9   SGVDLGTENLYFQSMTTSLEALPTGTVLTDKSGRQWKLKSFQTRDNQGILYEAAPTSTLT 68

Query: 131 ---LRNGQLVAIKRLTRGTADEIIADF---------LSELGIMAHVDHPNTAKLLGYGIE 178
                  Q  ++K   +        +F         +++   +           +G+G+ 
Sbjct: 69  CDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVH 128

Query: 179 GGMH--IVLE-LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLL----YLHEGCQRRI 231
              +  +VL  L    SL S L    + +   +  +  L VA  LL    +LHE      
Sbjct: 129 QDKYRFLVLPSLGR--SLQSALDVSPKHV---LSERSVLQVACRLLDALEFLHE---NEY 180

Query: 232 IHRDIKAANILLTEDFEPQI--CDFGLAK 258
           +H ++ A NI +  + + Q+    +G A 
Sbjct: 181 VHGNVTAENIFVDPEDQSQVTLAGYGFAF 209

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 53.4 bits (129), Expect = 3e-08
 Identities = 43/170 (25%), Positives = 73/170 (42%), Gaps = 41/170 (24%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIAD-----FLSELGIMAH 163
           +NF F  ++GKG + +V   R++  G L A+K L +   D I+ D      ++E  I++ 
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKK---DVILQDDDVECTMTEKRILSL 79

Query: 164 V-DHP----------NTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKE-KLKWGIRYK 211
             +HP             +L           V+E    G L   +   +         Y 
Sbjct: 80  ARNHPFLTQLFCCFQTPDRL---------FFVMEFVNGGDLMFHIQKSRRFDEARARFY- 129

Query: 212 IALGVAE---GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
                AE    L++LH+   + II+RD+K  N+LL  +   ++ DFG+ K
Sbjct: 130 ----AAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCK 172

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 53.0 bits (128), Expect = 4e-08
 Identities = 40/167 (23%), Positives = 70/167 (41%), Gaps = 35/167 (20%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRN-GQLVAIKRLTRGTADEIIAD-----FLSELGIMAH 163
            +F+F  ++GKG + +V     +   +L A+K L +   D +I D      + E  ++A 
Sbjct: 20  TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKK---DVVIQDDDVECTMVEKRVLAL 76

Query: 164 VD-HP----------NTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKE-KLKWGIRYK 211
               P             +L         + V+E    G L   +  +   K    + Y 
Sbjct: 77  PGKPPFLTQLHSCFQTMDRL---------YFVMEYVNGGDLMYHIQQVGRFKEPHAVFY- 126

Query: 212 IALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
            A  +A GL +L     + II+RD+K  N++L  +   +I DFG+ K
Sbjct: 127 -AAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCK 169

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 52.2 bits (126), Expect = 7e-08
 Identities = 41/169 (24%), Positives = 72/169 (42%), Gaps = 39/169 (23%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIAD-----FLSELGIMAH 163
            +F    ++GKG + +V+    +   Q  AIK L +   D ++ D      + E  +++ 
Sbjct: 17  EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKK---DVVLMDDDVECTMVEKRVLSL 73

Query: 164 V-DHP----------NTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGI---R 209
             +HP              L           V+E    G L   +Y ++   K+ +    
Sbjct: 74  AWEHPFLTHMFCTFQTKENL---------FFVMEYLNGGDL---MYHIQSCHKFDLSRAT 121

Query: 210 YKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           +  A  +  GL +LH    + I++RD+K  NILL +D   +I DFG+ K
Sbjct: 122 FYAA-EIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCK 166

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 52.3 bits (126), Expect = 7e-08
 Identities = 44/172 (25%), Positives = 66/172 (38%), Gaps = 45/172 (26%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIAD-----FLSELGIMA- 162
           ++F F  +IGKG + +V   R +      A+K L +     I+        +SE  ++  
Sbjct: 38  SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQK---KAILKKKEEKHIMSERNVLLK 94

Query: 163 HVDHP----------NTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGI---- 208
           +V HP             KL         + VL+    G L   L       +       
Sbjct: 95  NVKHPFLVGLHFSFQTADKL---------YFVLDYINGGELFYHLQ------RERCFLEP 139

Query: 209 --RYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
             R+  A  +A  L YLH      I++RD+K  NILL       + DFGL K
Sbjct: 140 RARFYAA-EIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCK 187

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 52.0 bits (125), Expect = 8e-08
 Identities = 48/212 (22%), Positives = 84/212 (39%), Gaps = 43/212 (20%)

Query: 65  PLKLSIRRSSSMREGIDMPRNLFVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYA 124
           P   ++    +M  GI+      +N+ +S        L        +F    +IG+G YA
Sbjct: 15  PTTENLYFQGAMGSGIE-EEKEAMNTRESGKASSSLGL-------QDFDLLRVIGRGSYA 66

Query: 125 EVYKGRLRN-GQLVAIKRLTRGT--ADEIIADFLSELGIMAHV-DHP----------NTA 170
           +V   RL+   ++ A++ + +     DE I    +E  +     +HP            +
Sbjct: 67  KVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES 126

Query: 171 KLLGYGIEGGMHIVLELSPNGSLASLLYGMKE-KLKWGIRYKIALGVAE---GLLYLHEG 226
           +L           V+E    G L   +   ++   +    Y      AE    L YLHE 
Sbjct: 127 RL---------FFVIEYVNGGDLMFHMQRQRKLPEEHARFY-----SAEISLALNYLHE- 171

Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
             R II+RD+K  N+LL  +   ++ D+G+ K
Sbjct: 172 --RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK 201

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 51.8 bits (125), Expect = 9e-08
 Identities = 40/170 (23%), Positives = 70/170 (41%), Gaps = 41/170 (24%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIAD-----FLSELGIMAH 163
            +F    +IG+G YA+V   RL+   ++ A+K + +   + +  D       +E  +   
Sbjct: 9   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKK---ELVNDDEDIDWVQTEKHVFEQ 65

Query: 164 V-DHP----------NTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKE-KLKWGIRYK 211
             +HP            ++L           V+E    G L   +   ++   +    Y 
Sbjct: 66  ASNHPFLVGLHSCFQTESRL---------FFVIEYVNGGDLMFHMQRQRKLPEEHARFY- 115

Query: 212 IALGVAE---GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
                AE    L YLHE   R II+RD+K  N+LL  +   ++ D+G+ K
Sbjct: 116 ----SAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK 158

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 51.2 bits (123), Expect = 1e-07
 Identities = 44/174 (25%), Positives = 66/174 (37%), Gaps = 19/174 (10%)

Query: 110 NNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEII---ADFLSELGIMAHVD 165
           N +     IG G + ++Y G  +  G+ VAIK     T    +   +     +       
Sbjct: 9   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQ-----G 63

Query: 166 HPNTAKLLGYGIEGGMHI-VLE-LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYL 223
                 +   G EG  ++ V+E L P  SL  L      K        +A  +   + Y+
Sbjct: 64  GVGIPTIRWCGAEGDYNVMVMELLGP--SLEDLFNFCSRKFSLKTVLLLADQMISRIEYI 121

Query: 224 HEGCQRRIIHRDIKAANILL---TEDFEPQICDFGLAKWLPEQWTHHTISKVEG 274
           H    +  IHRD+K  N L+    +     I DFGLAK   +  TH  I   E 
Sbjct: 122 HS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYREN 172

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 50.8 bits (121), Expect = 2e-07
 Identities = 47/178 (26%), Positives = 71/178 (39%), Gaps = 27/178 (15%)

Query: 110 NNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEII---ADFLSELGIMAHVD 165
           N F     IG G + E+Y G  ++  + VAIK     T    +   +     L       
Sbjct: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQ-----G 61

Query: 166 HPNTAKLLGYGIEGGMHI-VLE-LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLL-- 221
                 +  +G+EG  ++ V++ L P  SL  L      KL      K  L +A+ ++  
Sbjct: 62  GTGIPNVRWFGVEGDYNVLVMDLLGP--SLEDLFNFCSRKLS----LKTVLMLADQMINR 115

Query: 222 --YLHEGCQRRIIHRDIKAANILLTEDFEPQ---ICDFGLAKWLPEQWTHHTISKVEG 274
             ++H    +  +HRDIK  N L+          I DFGLAK   +  TH  I   E 
Sbjct: 116 VEFVHS---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYREN 170

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 50.2 bits (120), Expect = 4e-07
 Identities = 28/173 (16%), Positives = 60/173 (34%), Gaps = 29/173 (16%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEI----------------IAD 153
             +     IG+GG+  +Y   + + + V          +                    +
Sbjct: 35  AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPE 94

Query: 154 FLSELGIMAHVDHPNTAKLLGYGIEGGMH-----IVLE-LSPNGSLASLLYGMKEKLKWG 207
            + +      + +    K  G G+          ++++       L  +     ++    
Sbjct: 95  QIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS--DLQKIYEANAKRFSRK 152

Query: 208 IRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQI--CDFGLAK 258
              +++L + + L Y+HE      +H DIKA+N+LL      Q+   D+GLA 
Sbjct: 153 TVLQLSLRILDILEYIHE---HEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 49.0 bits (117), Expect = 8e-07
 Identities = 48/162 (29%), Positives = 65/162 (40%), Gaps = 37/162 (22%)

Query: 117 LIGKGGYAEVYKGR-LRNGQLVAIK------RLTRGTADEIIADFLSELGIMAHVDHPNT 169
           +IGKG + +V K    +  Q VA+K      R  R  A+EI    L  L      +  N 
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEI--RILEHLRKQDKDNTMNV 161

Query: 170 AKLLGYGIEGGMH--IVLE-LSPNGSLASLLYGMKEKLKWG---------IRYKIALGVA 217
             +L        H  +  E LS N      LY   E +K           +R K A  + 
Sbjct: 162 IHMLENFTFRN-HICMTFELLSMN------LY---ELIKKNKFQGFSLPLVR-KFAHSIL 210

Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQI--CDFGLA 257
           + L  LH   + RIIH D+K  NILL +     I   DFG +
Sbjct: 211 QCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS 249

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 48.3 bits (114), Expect = 2e-06
 Identities = 63/388 (16%), Positives = 107/388 (27%), Gaps = 126/388 (32%)

Query: 3   KKEDSCSPVGVLEDYFRSEDSETCSSKEPCSETKPESKSNSRWHLFYDLFRNKSKK---- 58
                C  V   +D  +S       SKE          + S     +    +K ++    
Sbjct: 30  VDNFDCKDV---QDMPKS-----ILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQK 81

Query: 59  ----SLVTLY-----PLKLSIRRSSSMREGIDMPRNLFVNS------YDSQSPQKIF--- 100
                L   Y     P+K   R+ S M       R+   N       Y+    Q      
Sbjct: 82  FVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLR 141

Query: 101 -SLYELQSATNNFSFENLIGKGGY------AEVYKGRLRNGQLVAIKRLTRGTADEIIAD 153
            +L EL+ A N      + G  G        +V      +       ++      +I   
Sbjct: 142 QALLELRPAKNVL----IDGVLGSGKTWVALDV----CLS------YKVQCKMDFKI--- 184

Query: 154 F-LSELGIMAHVDHPNTA----KLLGYGIEGGMHIVLELSPNGSLA--SLLYGMKEKLKW 206
           F L+    + + + P T     + L Y I+       + S N  L   S+   ++  LK 
Sbjct: 185 FWLN----LKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKS 240

Query: 207 GIRYKIALGV------AEGLLYLHEGCQRRIIHRDIKAANIL----------------LT 244
              Y+  L V      A+     +  C+  +  R  +  + L                LT
Sbjct: 241 K-PYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLT 299

Query: 245 EDFEPQICDFGLAKW-------LPEQ-------------------------WTHHTISKV 272
            D    +    L K+       LP +                         W H    K+
Sbjct: 300 PDEVKSL----LLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKL 355

Query: 273 EGTFGLVKLNLPPLVILKRCFTCIFIGF 300
                     L P    ++ F  + + F
Sbjct: 356 TTIIESSLNVLEP-AEYRKMFDRLSV-F 381

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 47.0 bits (112), Expect = 3e-06
 Identities = 34/173 (19%), Positives = 63/173 (36%), Gaps = 32/173 (18%)

Query: 110 NNFSFENLIGKGGYAEVYKG-RLRNGQLVAIKRLTRGTAD------EI-------IADFL 155
           N +     IG GG+  +Y        +  A   +     +      E+         D +
Sbjct: 37  NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCI 96

Query: 156 SELGIMAHVDHPNTAKLLGYGIE---GGMH--IVLE-LSPNGSLASLLYGMKEKLKWGIR 209
            +      +D+       G G+    G  +  +V+E L     L  +     +   +   
Sbjct: 97  KKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGI--DLQKIS---GQNGTFKKS 151

Query: 210 --YKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQI--CDFGLAK 258
              ++ + + + L Y+HE      +H DIKAAN+LL      Q+   D+GL+ 
Sbjct: 152 TVLQLGIRMLDVLEYIHE---NEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 45.9 bits (109), Expect = 7e-06
 Identities = 43/170 (25%), Positives = 61/170 (35%), Gaps = 35/170 (20%)

Query: 109 TNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIK------RLTRGTADEIIADFLSELGIM 161
            + +  ++LIGKG + +V K       + VAIK              E+    L  +   
Sbjct: 53  MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEV--RLLELMNKH 110

Query: 162 AHVDHPNTAKLLGYGIEGGMH--IVLE-LSPNGSLASLLY---------GMKEKLKWGIR 209
                     L  + +    H  +V E LS N      LY         G+   L    R
Sbjct: 111 DTEMKYYIVHLKRHFMFRN-HLCLVFEMLSYN------LYDLLRNTNFRGVSLNL---TR 160

Query: 210 YKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQI--CDFGLA 257
            K A  +   LL+L    +  IIH D+K  NILL       I   DFG +
Sbjct: 161 -KFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 208

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 45.3 bits (107), Expect = 1e-05
 Identities = 40/143 (27%), Positives = 61/143 (42%), Gaps = 18/143 (12%)

Query: 118 IGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLSELGIMAHV-----DHPNTA- 170
           +G G ++ V+    ++  + VA+K +         A    E+ ++  V     + PN   
Sbjct: 45  LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALD--EIRLLKSVRNSDPNDPNREM 102

Query: 171 --KLLGY-GIEG--GMHIVLELSPNG-SLASLLYGMKEK-LKWGIRYKIALGVAEGLLYL 223
             +LL    I G  G HI +     G  L   +     + L      KI   V +GL YL
Sbjct: 103 VVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYL 162

Query: 224 HEGCQRRIIHRDIKAANILLTED 246
           H  C+  IIH DIK  NILL+ +
Sbjct: 163 HTKCR--IIHTDIKPENILLSVN 183

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	308
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	99.98
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.98
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.98
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	99.97
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.95
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.94
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.88
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.77
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.38
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.3
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.2
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.87
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.69
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.65
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.56
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.41
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.31
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.31
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.19
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.13
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.93
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.78
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.64
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.59
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.37
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.22
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.16
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.1
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.94
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.77
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.72
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.72
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.92
3mes_A	424	Choline kinase; malaria, structural genomics, stru	93.26
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	92.33
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	90.79
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	82.0
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	81.2

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=2.6e-51  Score=370.45  Aligned_cols=198  Identities=25%  Similarity=0.338  Sum_probs=168.2

Q ss_pred             HhhcCCccccceeeccCceEEEEEEECCCcEEEEEEeccC-ChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeCcEEEE
Q 021711          106 QSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRG-TADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHIV  184 (308)
Q Consensus       106 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~lv  184 (308)
                      +...+++.+.+.||+|+||+||+|++++  .||||.++.. ...+..+.|.+|+.+|++++|||||++++++.++.++||
T Consensus        32 ei~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~iV  109 (307)
T 3omv_A           32 EIEASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIV  109 (307)
T ss_dssp             BCCTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEE
T ss_pred             EEcHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEECCeEEEE
Confidence            3455788899999999999999998753  5999998643 334557889999999999999999999999998899999


Q ss_pred             EEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCC
Q 021711          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (308)
Q Consensus       185 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  264 (308)
                      ||||++|+|.+++......+++..++.|+.||+.||.|||+   ++||||||||+||||+.++.+||+|||+|+......
T Consensus       110 mEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~---~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~  186 (307)
T 3omv_A          110 TQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHA---KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS  186 (307)
T ss_dssp             EECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCSSSEEEETTEEEEECCCSSCBC-----
T ss_pred             EEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCccCHHHEEECCCCcEEEeeccCceecccCC
Confidence            99999999999998777789999999999999999999999   899999999999999999999999999999876543


Q ss_pred             ceeEeeceeccccccccccCch---hhcCccceeEEEeeEEEeeccC
Q 021711          265 THHTISKVEGTFGLVKLNLPPL---VILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      .........||+.|||||++..   ..++.++||||||++||||++|
T Consensus       187 ~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg  233 (307)
T 3omv_A          187 GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTG  233 (307)
T ss_dssp             -------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHS
T ss_pred             cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHC
Confidence            3334556789999999998753   3478899999999999999986

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=3.3e-50  Score=362.46  Aligned_cols=195  Identities=21%  Similarity=0.311  Sum_probs=170.0

Q ss_pred             cCCccccceeeccCceEEEEEEEC------CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR------NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GM  181 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~------~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~  181 (308)
                      .++|.+.+.||+|+||+||+|++.      ++..||||.++.... ...++|.+|+++|++++|||||++++++.++ .+
T Consensus        12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~-~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~   90 (299)
T 4asz_A           12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASD-NARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL   90 (299)
T ss_dssp             GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCH-HHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCCh-HHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence            357889999999999999999864      377899999976543 4567899999999999999999999988765 58


Q ss_pred             EEEEEecCCCCHHHHHhcc------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcE
Q 021711          182 HIVLELSPNGSLASLLYGM------------KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEP  249 (308)
Q Consensus       182 ~lv~e~~~~gsL~~~l~~~------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~  249 (308)
                      ++||||+++|+|.++|+..            ...+++..++.|+.||+.||.|||+   ++||||||||+|||++.++.+
T Consensus        91 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDlKp~NILl~~~~~~  167 (299)
T 4asz_A           91 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLV  167 (299)
T ss_dssp             EEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCE
T ss_pred             EEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccCHhhEEECCCCcE
Confidence            9999999999999999653            2469999999999999999999999   899999999999999999999


Q ss_pred             EEeccccceecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          250 QICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       250 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      ||+|||+|+...............||+.|||||.+.+..++.++||||||++||||++
T Consensus       168 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt  225 (299)
T 4asz_A          168 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT  225 (299)
T ss_dssp             EECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred             EECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHc
Confidence            9999999998765544334445789999999999988889999999999999999986

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=2.8e-50  Score=363.46  Aligned_cols=195  Identities=27%  Similarity=0.322  Sum_probs=173.1

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCC--hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVL  185 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~  185 (308)
                      ++|++.++||+|+||+||+|++. +|+.||||.+.+..  .....+.+.+|+++|+.++|||||++++++.++ .+|+||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            47999999999999999999976 69999999996432  122356789999999999999999999976654 589999


Q ss_pred             EecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCc
Q 021711          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (308)
Q Consensus       186 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~  265 (308)
                      ||++||+|.+++.. .+.+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+|+.+.....
T Consensus       112 Ey~~gG~L~~~i~~-~~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~  187 (311)
T 4aw0_A          112 SYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK  187 (311)
T ss_dssp             CCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred             ecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence            99999999999965 4579999999999999999999999   9999999999999999999999999999998865544


Q ss_pred             eeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          266 HHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      .......+||+.|||||.+.+..++.++|+||+|++||||+||
T Consensus       188 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G  230 (311)
T 4aw0_A          188 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG  230 (311)
T ss_dssp             CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHS
T ss_pred             cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhC
Confidence            4445678999999999999888899999999999999999987

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=3.3e-50  Score=363.97  Aligned_cols=195  Identities=21%  Similarity=0.272  Sum_probs=169.3

Q ss_pred             CCccccceeeccCceEEEEEEEC------CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR------NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMH  182 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~------~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~  182 (308)
                      .++++.+.||+|+||+||+|.+.      +++.||||.++........+.|.+|+.+|++++|||||+++|++.++ .++
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~  105 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS  105 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence            45677899999999999999863      46789999997655445567899999999999999999999988765 579


Q ss_pred             EEEEecCCCCHHHHHhcc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCC
Q 021711          183 IVLELSPNGSLASLLYGM---------------KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDF  247 (308)
Q Consensus       183 lv~e~~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~  247 (308)
                      +|||||++|+|.++|...               ...+++..++.|+.||+.||.|||+   ++||||||||+||||++++
T Consensus       106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLK~~NILl~~~~  182 (308)
T 4gt4_A          106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS---HHVVHKDLATRNVLVYDKL  182 (308)
T ss_dssp             EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGG
T ss_pred             EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCccccceEECCCC
Confidence            999999999999999642               2458999999999999999999999   8999999999999999999


Q ss_pred             cEEEeccccceecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          248 EPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       248 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      .+||+|||+|+.+.............||+.|||||.+....++.++||||||++||||++
T Consensus       183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t  242 (308)
T 4gt4_A          183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS  242 (308)
T ss_dssp             CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred             CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHh
Confidence            999999999997755433333456789999999999988889999999999999999986

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.6e-49  Score=362.51  Aligned_cols=194  Identities=20%  Similarity=0.296  Sum_probs=161.3

Q ss_pred             CCccccceeeccCceEEEEEEEC------CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR------NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMH  182 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~------~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~  182 (308)
                      ++|.+.+.||+|+||+||+|+++      +++.||||.++... ....++|.+|+++|++++|||||++++++.++ .++
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~  119 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL  119 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            46788899999999999999864      37899999997654 34568899999999999999999999998775 589


Q ss_pred             EEEEecCCCCHHHHHhccC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCc
Q 021711          183 IVLELSPNGSLASLLYGMK--------------EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFE  248 (308)
Q Consensus       183 lv~e~~~~gsL~~~l~~~~--------------~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~  248 (308)
                      +||||+++|+|.++++...              .++++..++.|+.||+.||.|||+   ++||||||||+||||+.++.
T Consensus       120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLKp~NILl~~~~~  196 (329)
T 4aoj_A          120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG---LHFVHRDLATRNCLVGQGLV  196 (329)
T ss_dssp             EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTE
T ss_pred             EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHhhEEECCCCc
Confidence            9999999999999996532              358999999999999999999999   89999999999999999999


Q ss_pred             EEEeccccceecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          249 PQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       249 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      +||+|||+|+.+.............||+.|||||.+.+..++.++||||||++||||++
T Consensus       197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt  255 (329)
T 4aoj_A          197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT  255 (329)
T ss_dssp             EEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHT
T ss_pred             EEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHc
Confidence            99999999998755444334456789999999999988889999999999999999986

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=8.5e-50  Score=365.87  Aligned_cols=195  Identities=21%  Similarity=0.258  Sum_probs=165.5

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCC-hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVL  185 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~  185 (308)
                      .++|++++.||+|+||+||+|++. +|+.||||.+.... .....+.+.+|+.+|+.|+|||||++++++.++ .+|+||
T Consensus        23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm  102 (350)
T 4b9d_A           23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM  102 (350)
T ss_dssp             CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence            368999999999999999999976 59999999997543 344578899999999999999999999977665 579999


Q ss_pred             EecCCCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCC
Q 021711          186 ELSPNGSLASLLYGMK-EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (308)
Q Consensus       186 e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  264 (308)
                      |||+||+|.+++...+ ..+++..+..|+.||+.||.|||+   ++||||||||+||||+.++.+||+|||+|+.+....
T Consensus       103 Ey~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~  179 (350)
T 4b9d_A          103 DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV  179 (350)
T ss_dssp             ECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred             eCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence            9999999999996543 457899999999999999999999   999999999999999999999999999999764321


Q ss_pred             ceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          265 THHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                        .......||+.|||||.+.+..++.++|+||+|++||||+||
T Consensus       180 --~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG  221 (350)
T 4b9d_A          180 --ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTL  221 (350)
T ss_dssp             --HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHS
T ss_pred             --ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHC
Confidence              122456899999999999888889999999999999999986

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=2.1e-49  Score=362.69  Aligned_cols=191  Identities=23%  Similarity=0.306  Sum_probs=169.1

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEEEe
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLEL  187 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~  187 (308)
                      ..|++.+.||+|+||+||+|+++ +|+.||||++...... ..+.+.+|+.+|+.++|||||++++++.++ .+||||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~-~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy  152 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ-RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF  152 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS-SGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh-HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence            46999999999999999999986 6999999999643222 235688999999999999999999976654 58999999


Q ss_pred             cCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCcee
Q 021711          188 SPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH  267 (308)
Q Consensus       188 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~  267 (308)
                      |+||+|.+++..  ..+++..+..++.||+.||.|||+   ++||||||||+||||+.++.+||+|||+|+.+.....  
T Consensus       153 ~~gg~L~~~l~~--~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~--  225 (346)
T 4fih_A          153 LEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--  225 (346)
T ss_dssp             CTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC--
T ss_pred             CCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEECCCCCEEEecCcCceecCCCCC--
Confidence            999999999854  569999999999999999999999   9999999999999999999999999999998765432  


Q ss_pred             EeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          268 TISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ......||+.|||||.+.+..++.++|+||+|++||||+||
T Consensus       226 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G  266 (346)
T 4fih_A          226 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG  266 (346)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHS
T ss_pred             cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHC
Confidence            23567899999999999888889999999999999999986

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=3e-48  Score=347.89  Aligned_cols=188  Identities=26%  Similarity=0.334  Sum_probs=162.6

Q ss_pred             ccccceeeccCceEEEEEEEC-CCcEEEEEEeccC-ChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEe-----CcEEEE
Q 021711          112 FSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRG-TADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-----GGMHIV  184 (308)
Q Consensus       112 ~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~~~lv  184 (308)
                      |++.+.||+|+||+||+|.+. ++..||+|.+... ......+.|.+|+.+|+.++|||||++++++..     ..+++|
T Consensus        28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv  107 (290)
T 3fpq_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV  107 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence            367788999999999999976 5899999999643 233456789999999999999999999997653     237899


Q ss_pred             EEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--ceecCCCCCCEEECC-CCcEEEeccccceecC
Q 021711          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRR--IIHRDIKAANILLTE-DFEPQICDFGLAKWLP  261 (308)
Q Consensus       185 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~--iiHrDlKp~NILl~~-~~~~kl~DFGla~~~~  261 (308)
                      ||||++|+|.+++.. ...+++..+..++.||+.||.|||+   ++  ||||||||+||||+. ++.+||+|||+|+...
T Consensus       108 mEy~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~ylH~---~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~  183 (290)
T 3fpq_A          108 TELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  183 (290)
T ss_dssp             EECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             EeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence            999999999999965 4579999999999999999999998   66  999999999999984 7899999999998654


Q ss_pred             CCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          262 EQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       262 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ..    ......||+.|||||.+.+ .++.++|+||+|++||||++|
T Consensus       184 ~~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg  225 (290)
T 3fpq_A          184 AS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATS  225 (290)
T ss_dssp             TT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHS
T ss_pred             CC----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHC
Confidence            33    2245789999999998865 578899999999999999986

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=2e-48  Score=351.11  Aligned_cols=194  Identities=21%  Similarity=0.325  Sum_probs=157.6

Q ss_pred             CccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeCc---------
Q 021711          111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG---------  180 (308)
Q Consensus       111 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---------  180 (308)
                      +|++.+.||+|+||+||+|+++ +|+.||||.+.....+...+.+.+|+.+|+.++|||||++++++.+.+         
T Consensus         6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~   85 (299)
T 4g31_A            6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSS   85 (299)
T ss_dssp             HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---------
T ss_pred             hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccC
Confidence            6899999999999999999976 689999999976655556778999999999999999999999765432         


Q ss_pred             ----EEEEEEecCCCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEecc
Q 021711          181 ----MHIVLELSPNGSLASLLYGMK--EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDF  254 (308)
Q Consensus       181 ----~~lv~e~~~~gsL~~~l~~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DF  254 (308)
                          +|+|||||++|+|.+++....  ...++..++.++.||+.||.|||+   ++||||||||+|||++.++.+||+||
T Consensus        86 ~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~---~~IiHRDlKp~NILl~~~~~vKl~DF  162 (299)
T 4g31_A           86 PKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDF  162 (299)
T ss_dssp             -CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC
T ss_pred             CCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHH---CcCccccCcHHHeEECCCCcEEEccC
Confidence                689999999999999996532  235667788999999999999999   99999999999999999999999999


Q ss_pred             ccceecCCCCcee----------EeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          255 GLAKWLPEQWTHH----------TISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       255 Gla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      |+|+.+.......          ......||+.|||||.+.+..++.++|+||+|+++|||++
T Consensus       163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~  225 (299)
T 4g31_A          163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY  225 (299)
T ss_dssp             CCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS
T ss_pred             ccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc
Confidence            9999875543211          1234679999999999988888999999999999999975

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.9e-48  Score=364.85  Aligned_cols=191  Identities=23%  Similarity=0.306  Sum_probs=169.7

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEEEe
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLEL  187 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~  187 (308)
                      +.|++.+.||+|+||.||+|++. +|+.||||++...... ..+.+.+|+.+|+.++|||||++++++..+ .+||||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~-~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy  229 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ-RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF  229 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCS-SGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchh-HHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence            56999999999999999999986 5999999999654322 245688999999999999999999976654 58999999


Q ss_pred             cCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCcee
Q 021711          188 SPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH  267 (308)
Q Consensus       188 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~  267 (308)
                      |+||+|.+++..  ..+++..+..++.||+.||.|||+   ++||||||||+||||+.+|.+||+|||+|+.+.....  
T Consensus       230 ~~gG~L~~~i~~--~~l~e~~~~~~~~qil~aL~ylH~---~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~--  302 (423)
T 4fie_A          230 LEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--  302 (423)
T ss_dssp             CTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC--
T ss_pred             CCCCcHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEecCccceECCCCCc--
Confidence            999999999854  569999999999999999999999   9999999999999999999999999999998755432  


Q ss_pred             EeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          268 TISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ......||+.|||||.+.+..++.++|+||+|+++|||+||
T Consensus       303 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G  343 (423)
T 4fie_A          303 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG  343 (423)
T ss_dssp             CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHS
T ss_pred             cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHC
Confidence            23567899999999999888899999999999999999987

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=3.1e-48  Score=357.06  Aligned_cols=204  Identities=23%  Similarity=0.311  Sum_probs=178.9

Q ss_pred             CHHHHHhhcCCccccceeeccCceEEEEEEECC------CcEEEEEEeccCChHHHHHHHHHHHHHHhcCCC-Ceeeeee
Q 021711          101 SLYELQSATNNFSFENLIGKGGYAEVYKGRLRN------GQLVAIKRLTRGTADEIIADFLSELGIMAHVDH-PNTAKLL  173 (308)
Q Consensus       101 ~~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~------g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~  173 (308)
                      ...+|+...++|++.+.||+|+||+||+|.+..      ++.||||.+.........+.|.+|+.+|.+++| ||||+++
T Consensus        55 ~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~  134 (353)
T 4ase_A           55 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL  134 (353)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence            445677778899999999999999999998642      368999999877666667889999999999965 8999999


Q ss_pred             eEEEeC--cEEEEEEecCCCCHHHHHhcc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCC
Q 021711          174 GYGIEG--GMHIVLELSPNGSLASLLYGM---------------KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDI  236 (308)
Q Consensus       174 ~~~~~~--~~~lv~e~~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDl  236 (308)
                      ++|.+.  .+++|||||++|+|.++|+..               ...+++..++.++.|||.||.|||+   ++||||||
T Consensus       135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~---~~iiHRDL  211 (353)
T 4ase_A          135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDL  211 (353)
T ss_dssp             EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCC
T ss_pred             EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh---CCeecCcc
Confidence            988653  479999999999999999652               2348899999999999999999999   99999999


Q ss_pred             CCCCEEECCCCcEEEeccccceecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          237 KAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       237 Kp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      ||+|||++.++.+||+|||+|+.+..+..........||+.|||||.+.+..++.++||||||++||||++
T Consensus       212 K~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t  282 (353)
T 4ase_A          212 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS  282 (353)
T ss_dssp             SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTT
T ss_pred             CccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHh
Confidence            99999999999999999999998866555445567889999999999988889999999999999999974

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=4.8e-48  Score=352.64  Aligned_cols=190  Identities=26%  Similarity=0.280  Sum_probs=163.2

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEEE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLE  186 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e  186 (308)
                      .+.|.+.++||+|+||.||+|+++ +|+.||||+++....      +.+|+.+|+.++|||||++++++.++ .+|||||
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmE  130 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFME  130 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            457888999999999999999976 599999999975432      24799999999999999999977665 5789999


Q ss_pred             ecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCC-cEEEeccccceecCCCCc
Q 021711          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDF-EPQICDFGLAKWLPEQWT  265 (308)
Q Consensus       187 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~-~~kl~DFGla~~~~~~~~  265 (308)
                      |++||+|.+++.. .+.+++..+..++.||+.||.|||+   ++||||||||+||||+.++ .+||+|||+|+.+.....
T Consensus       131 y~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~  206 (336)
T 4g3f_A          131 LLEGGSLGQLIKQ-MGCLPEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL  206 (336)
T ss_dssp             CCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred             ccCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence            9999999999965 4579999999999999999999998   9999999999999999987 699999999998765432


Q ss_pred             ee---EeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          266 HH---TISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       266 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ..   ......||+.|||||.+.+..++.++|+||+|++||||++|
T Consensus       207 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG  252 (336)
T 4g3f_A          207 GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG  252 (336)
T ss_dssp             -------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred             ccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHC
Confidence            21   22346899999999999888899999999999999999986

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1e-47  Score=341.79  Aligned_cols=191  Identities=19%  Similarity=0.321  Sum_probs=153.1

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCCh--HHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVL  185 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~  185 (308)
                      ++|++.+.||+|+||+||+|+.. +|+.||||.+.+...  .+....+.+|+.+|+.++|||||++++++.+. .+|+||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            68999999999999999999976 699999999975432  23356799999999999999999999977654 578999


Q ss_pred             EecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCc
Q 021711          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (308)
Q Consensus       186 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~  265 (308)
                      ||+ +|+|.+++.. ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+|+...... 
T Consensus        93 Ey~-~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~-  166 (275)
T 3hyh_A           93 EYA-GNELFDYIVQ-RDKMSEQEARRFFQQIISAVEYCHR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN-  166 (275)
T ss_dssp             ECC-CEEHHHHHHH-SCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred             eCC-CCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCChHHeEECCCCCEEEeecCCCeecCCCC-
Confidence            999 6899999865 5679999999999999999999999   999999999999999999999999999998765432 


Q ss_pred             eeEeeceeccccccccccCchhhc-CccceeEEEeeEEEeeccC
Q 021711          266 HHTISKVEGTFGLVKLNLPPLVIL-KRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~s~g~~l~el~c~  308 (308)
                        ......||+.|||||.+.+..+ +.++|+||+|+++|||++|
T Consensus       167 --~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg  208 (275)
T 3hyh_A          167 --FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCR  208 (275)
T ss_dssp             ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHS
T ss_pred             --ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHC
Confidence              2345789999999999876654 6789999999999999986

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.1e-48  Score=352.63  Aligned_cols=193  Identities=22%  Similarity=0.200  Sum_probs=160.6

Q ss_pred             CCccccceeeccCceEEEEEEEC----CCcEEEEEEeccCCh-HHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR----NGQLVAIKRLTRGTA-DEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHI  183 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~----~g~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l  183 (308)
                      ++|++.+.||+|+||+||+|+..    +++.||||.+..... .....++.+|+.+|+.++|||||++++++.++ .+|+
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            47999999999999999999863    478999999865321 11234678999999999999999999977654 5899


Q ss_pred             EEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCC
Q 021711          184 VLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ  263 (308)
Q Consensus       184 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  263 (308)
                      ||||++||+|.+++.. ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+|+.....
T Consensus       104 vmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~  179 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH  179 (304)
T ss_dssp             EECCCTTCEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred             EEEcCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHeEEcCCCCEEecccccceeccCC
Confidence            9999999999999965 4579999999999999999999999   99999999999999999999999999999976443


Q ss_pred             CceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          264 WTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ..  ......||+.|||||.+.+..++.++|+||+|++||||+||
T Consensus       180 ~~--~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG  222 (304)
T 3ubd_A          180 EK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG  222 (304)
T ss_dssp             -C--CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHS
T ss_pred             Cc--cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhC
Confidence            22  23467899999999999888889999999999999999986

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.3e-47  Score=346.48  Aligned_cols=194  Identities=22%  Similarity=0.236  Sum_probs=157.1

Q ss_pred             CCccccceeeccCceEEEEEEECCCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-----cEEEE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-----GMHIV  184 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~lv  184 (308)
                      ++|.+.+.||+|+||+||+|++ +|+.||||++......+  ..+..|+..+..++|||||++++++.++     .++||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~~--~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV   79 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERS--WFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV   79 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHHH--HHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhh--HHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence            3578889999999999999998 58999999996543221  2234566667789999999999988754     36899


Q ss_pred             EEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCceecCCCCCCEEECCCCcEEEecccccee
Q 021711          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC-----QRRIIHRDIKAANILLTEDFEPQICDFGLAKW  259 (308)
Q Consensus       185 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~-----~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~  259 (308)
                      |||+++|+|.++++.  ..+++..+..++.|++.||.|||+.+     ..+||||||||+||||+.++.+||+|||+|+.
T Consensus        80 ~Ey~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~  157 (303)
T 3hmm_A           80 SDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR  157 (303)
T ss_dssp             EECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             ecCCCCCcHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence            999999999999964  56899999999999999999999721     13899999999999999999999999999998


Q ss_pred             cCCCCcee--EeeceeccccccccccCchh------hcCccceeEEEeeEEEeeccC
Q 021711          260 LPEQWTHH--TISKVEGTFGLVKLNLPPLV------ILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       260 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ........  ......||+.|||||++.+.      .++.++||||||++||||++|
T Consensus       158 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg  214 (303)
T 3hmm_A          158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR  214 (303)
T ss_dssp             EETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHT
T ss_pred             ccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHC
Confidence            75543321  12346899999999987543      356789999999999999864

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.5e-45  Score=340.62  Aligned_cols=194  Identities=24%  Similarity=0.314  Sum_probs=165.8

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCC-hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEe-------Cc
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-------GG  180 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-------~~  180 (308)
                      ++|++.+.||+|+||+||+|++. +|+.||||++.... .....+.+++|+.+|+.++|||||++++++..       +.
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            57999999999999999999976 69999999997543 23446788999999999999999999997643       45


Q ss_pred             EEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceec
Q 021711          181 MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL  260 (308)
Q Consensus       181 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~  260 (308)
                      +|+||||+. |+|.+++.. ...+++..+..++.||+.||.|||+   ++||||||||+|||++.++.+||+|||+|+.+
T Consensus       134 ~~ivmE~~~-g~L~~~i~~-~~~l~~~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~  208 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIHS-SQPLTLEHVRYFLYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMARGL  208 (398)
T ss_dssp             EEEEEECCS-EEHHHHHTS-SSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCBCC
T ss_pred             EEEEEeCCC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CcCcCCCcCccccccCCCCCEEEeecceeeec
Confidence            899999996 689998864 5679999999999999999999999   99999999999999999999999999999976


Q ss_pred             CCCCc--eeEeeceeccccccccccCchh-hcCccceeEEEeeEEEeeccC
Q 021711          261 PEQWT--HHTISKVEGTFGLVKLNLPPLV-ILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       261 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~s~g~~l~el~c~  308 (308)
                      .....  ........||+.|||||.+.+. .++.++|+||+|+++|||++|
T Consensus       209 ~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G  259 (398)
T 4b99_A          209 CTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLAR  259 (398)
T ss_dssp             -------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHT
T ss_pred             ccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHC
Confidence            44321  1234567999999999987664 468899999999999999986

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=6.8e-44  Score=329.52  Aligned_cols=192  Identities=20%  Similarity=0.253  Sum_probs=161.2

Q ss_pred             hhcCCccccceeeccCceEEEEEEEC----CCcEEEEEEeccCChHHHHHHHHHHHHHHhcC-CCCeeeeeeeEEEeC-c
Q 021711          107 SATNNFSFENLIGKGGYAEVYKGRLR----NGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGIEG-G  180 (308)
Q Consensus       107 ~~~~~~~~~~~LG~G~fg~Vy~~~~~----~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~  180 (308)
                      ...++|++.+.||+|+||+||+|+.+    +++.||+|.+.....   ..++.+|+++|+.+ +|||||++++++.+. .
T Consensus        18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~---~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~   94 (361)
T 4f9c_A           18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH---PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH   94 (361)
T ss_dssp             GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC---HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred             CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC---HHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence            34578999999999999999999864    468899999865543   24678999999988 699999999966654 5


Q ss_pred             EEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCC-CcEEEecccccee
Q 021711          181 MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTED-FEPQICDFGLAKW  259 (308)
Q Consensus       181 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~-~~~kl~DFGla~~  259 (308)
                      +|+||||+++|+|.+++.    .+++..+..++.||+.||.|||+   ++|+||||||+|||++.+ +.+||+|||+|+.
T Consensus        95 ~~lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH~---~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~  167 (361)
T 4f9c_A           95 VVIAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIHQ---FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQG  167 (361)
T ss_dssp             EEEEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEEEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence            889999999999999883    58999999999999999999999   999999999999999877 7999999999987


Q ss_pred             cCCCCc--------------------------eeEeeceeccccccccccCchh-hcCccceeEEEeeEEEeeccC
Q 021711          260 LPEQWT--------------------------HHTISKVEGTFGLVKLNLPPLV-ILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       260 ~~~~~~--------------------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ......                          ........||++|+|||.+.+. .++.+.|+||+|+++|||++|
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G  243 (361)
T 4f9c_A          168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSG  243 (361)
T ss_dssp             CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHT
T ss_pred             cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHC
Confidence            643211                          1123456899999999987665 478899999999999999986

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=6.3e-44  Score=349.17  Aligned_cols=192  Identities=25%  Similarity=0.299  Sum_probs=164.9

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCC-----hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEe-CcE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT-----ADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGM  181 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~  181 (308)
                      .++|++.++||+|+||+||+|+.+ +|+.||||.+.+..     ..........++.+++.++|||||++++++.+ +.+
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l  267 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL  267 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence            468999999999999999999976 59999999996421     12223334455777888999999999996655 468


Q ss_pred             EEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecC
Q 021711          182 HIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP  261 (308)
Q Consensus       182 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~  261 (308)
                      |+||||++||+|.+++.. .+.+++..+..++.||+.||.|||+   ++||||||||+||||+.+|.+||+|||+|+.+.
T Consensus       268 ylVmEy~~GGdL~~~l~~-~~~l~E~~a~~y~~qIl~aL~yLH~---~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~  343 (689)
T 3v5w_A          268 SFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFS  343 (689)
T ss_dssp             EEEECCCCSCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             EEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHeEEeCCCCEEecccceeeecC
Confidence            999999999999999965 4679999999999999999999998   999999999999999999999999999999876


Q ss_pred             CCCceeEeeceeccccccccccCch-hhcCccceeEEEeeEEEeeccC
Q 021711          262 EQWTHHTISKVEGTFGLVKLNLPPL-VILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       262 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ...    ....+||+.|||||.+.. ..++.++|+||+|++||||+||
T Consensus       344 ~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG  387 (689)
T 3v5w_A          344 KKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG  387 (689)
T ss_dssp             SCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred             CCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhC
Confidence            542    245789999999998864 4688999999999999999987

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=2e-43  Score=344.61  Aligned_cols=192  Identities=20%  Similarity=0.250  Sum_probs=171.3

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEEEe
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLEL  187 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~  187 (308)
                      ++|++.+.||+|+||.||+|+.+ +|+.||+|.+...... ..+.+.+|+.+|+.++|||||++++++.+. .+|+||||
T Consensus       157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~-~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~  235 (573)
T 3uto_A          157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHES-DKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  235 (573)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH-HHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchh-hHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence            58999999999999999999976 6999999999765433 356788999999999999999999977655 58999999


Q ss_pred             cCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCC--CcEEEeccccceecCCCCc
Q 021711          188 SPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTED--FEPQICDFGLAKWLPEQWT  265 (308)
Q Consensus       188 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~--~~~kl~DFGla~~~~~~~~  265 (308)
                      |.||+|.+++......+++..+..++.||+.||.|||+   ++|+||||||+|||++.+  +.+||+|||+|+.+.... 
T Consensus       236 ~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~-  311 (573)
T 3uto_A          236 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ-  311 (573)
T ss_dssp             CCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS-
T ss_pred             cCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhccccCCCCCCEEEeeccceeEccCCC-
Confidence            99999999997666779999999999999999999999   999999999999999854  799999999999886553 


Q ss_pred             eeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          266 HHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                        ......||+.|||||.+.+..++.++|+||+|++||||++|
T Consensus       312 --~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G  352 (573)
T 3uto_A          312 --SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG  352 (573)
T ss_dssp             --EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHS
T ss_pred             --ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHC
Confidence              33456899999999999888889999999999999999886

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=5.8e-41  Score=317.42  Aligned_cols=203  Identities=20%  Similarity=0.224  Sum_probs=173.1

Q ss_pred             HHHHHhhcCCccccceeeccCceEEEEEEECC-CcEEEEEEeccCChH--HHHHHHHHHHHHHhcCCCCeeeeeeeEEEe
Q 021711          102 LYELQSATNNFSFENLIGKGGYAEVYKGRLRN-GQLVAIKRLTRGTAD--EIIADFLSELGIMAHVDHPNTAKLLGYGIE  178 (308)
Q Consensus       102 ~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~-g~~vAvK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  178 (308)
                      ..++....++|++.++||+|+||+||+|++.. ++.||+|++......  .....+.+|..++..++||||+++++++.+
T Consensus        66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~  145 (437)
T 4aw2_A           66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD  145 (437)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred             hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence            34455667899999999999999999999874 889999998642211  112347889999999999999999997766


Q ss_pred             C-cEEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccc
Q 021711          179 G-GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLA  257 (308)
Q Consensus       179 ~-~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla  257 (308)
                      . .+++||||+++|+|.+++......+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+|
T Consensus       146 ~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILl~~~g~vkL~DFGla  222 (437)
T 4aw2_A          146 DNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSC  222 (437)
T ss_dssp             SSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeeEcCCCCEEEcchhhh
Confidence            5 5789999999999999997656789999999999999999999999   99999999999999999999999999999


Q ss_pred             eecCCCCceeEeeceeccccccccccCc-----hhhcCccceeEEEeeEEEeeccC
Q 021711          258 KWLPEQWTHHTISKVEGTFGLVKLNLPP-----LVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      +.+...... ......||+.|+|||++.     ...++.++|+||+|+++|||++|
T Consensus       223 ~~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG  277 (437)
T 4aw2_A          223 LKLMEDGTV-QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYG  277 (437)
T ss_dssp             EECCTTSCE-ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHS
T ss_pred             hhcccCCCc-ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhC
Confidence            887654332 334578999999999876     34578899999999999999876

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=7.8e-40  Score=295.24  Aligned_cols=196  Identities=24%  Similarity=0.415  Sum_probs=169.7

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEEE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLE  186 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e  186 (308)
                      .++|.+.++||+|+||.||+|.+. +++.||+|.+.... ....+.|.+|+.+++.++||||+++++++.++ ..++|||
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   87 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFD-EETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITE   87 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEE
Confidence            457899999999999999999976 58999999986543 34567899999999999999999999987765 4789999


Q ss_pred             ecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCce
Q 021711          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH  266 (308)
Q Consensus       187 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~  266 (308)
                      |+++|+|.+++......+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++........
T Consensus        88 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  164 (310)
T 3s95_A           88 YIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ  164 (310)
T ss_dssp             CCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEECTTSCEEECCCTTCEECC-----
T ss_pred             ecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCcCeEEECCCCCEEEeecccceeccccccc
Confidence            999999999998767789999999999999999999999   89999999999999999999999999999977543221


Q ss_pred             e------------EeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          267 H------------TISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       267 ~------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      .            ......||+.|+|||.+.+..++.++|+||+|+++|||++|
T Consensus       165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g  218 (310)
T 3s95_A          165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGR  218 (310)
T ss_dssp             ---------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHT
T ss_pred             ccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcC
Confidence            1            11146799999999999888889999999999999999764

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.7e-40  Score=301.39  Aligned_cols=211  Identities=40%  Similarity=0.592  Sum_probs=179.8

Q ss_pred             ccccCHHHHHhhcCCccccceeeccCceEEEEEEECCCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEE
Q 021711           97 QKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYG  176 (308)
Q Consensus        97 ~~~~~~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  176 (308)
                      ...++..++....++|++.+.||+|+||.||+|...+|+.||||.+...........+.+|+.+++.++||||+++++++
T Consensus        17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~   96 (326)
T 3uim_A           17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC   96 (326)
T ss_dssp             CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred             cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence            45678889999999999999999999999999998789999999997654333234688999999999999999999987


Q ss_pred             EeC-cEEEEEEecCCCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEe
Q 021711          177 IEG-GMHIVLELSPNGSLASLLYGMK---EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQIC  252 (308)
Q Consensus       177 ~~~-~~~lv~e~~~~gsL~~~l~~~~---~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~  252 (308)
                      ... ..++||||+++|+|.+++....   ..+++..+..++.|++.||.|||+.+..+|+||||||+|||++.++.+||+
T Consensus        97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~  176 (326)
T 3uim_A           97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG  176 (326)
T ss_dssp             CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred             ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence            664 5789999999999999997533   348999999999999999999999222299999999999999999999999


Q ss_pred             ccccceecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          253 DFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       253 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      |||+++........ ......||+.|+|||.+.....+.++|+||+|+++|+|++|
T Consensus       177 Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g  231 (326)
T 3uim_A          177 DFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITG  231 (326)
T ss_dssp             CCSSCEECCSSSSC-EECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHC
T ss_pred             cCccccccCccccc-ccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhC
Confidence            99999987654332 33456799999999998888889999999999999999875

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=4.5e-40  Score=298.33  Aligned_cols=196  Identities=21%  Similarity=0.318  Sum_probs=165.6

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeCc--------
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG--------  180 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--------  180 (308)
                      ++|++.+.||+|+||.||+|++. +|+.||||++.........+.+.+|+.+++.++||||+++++++.+..        
T Consensus         6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   85 (332)
T 3qd2_B            6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM   85 (332)
T ss_dssp             HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred             hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence            47899999999999999999987 699999999976554455688999999999999999999999765432        


Q ss_pred             --------------------------------------------------EEEEEEecCCCCHHHHHhccC--CCCCHHH
Q 021711          181 --------------------------------------------------MHIVLELSPNGSLASLLYGMK--EKLKWGI  208 (308)
Q Consensus       181 --------------------------------------------------~~lv~e~~~~gsL~~~l~~~~--~~l~~~~  208 (308)
                                                                        .++||||+++++|.+++....  ...++..
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~  165 (332)
T 3qd2_B           86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV  165 (332)
T ss_dssp             HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHH
T ss_pred             hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHH
Confidence                                                              689999999999999996532  2356667


Q ss_pred             HHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCce----------eEeeceeccccc
Q 021711          209 RYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH----------HTISKVEGTFGL  278 (308)
Q Consensus       209 ~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~----------~~~~~~~gt~~y  278 (308)
                      ++.++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++........          .......||+.|
T Consensus       166 ~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y  242 (332)
T 3qd2_B          166 CLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY  242 (332)
T ss_dssp             HHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGG
T ss_pred             HHHHHHHHHHHHHHHHh---CCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCc
Confidence            88999999999999999   89999999999999999999999999999987654321          112346799999


Q ss_pred             cccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          279 VKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       279 ~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      +|||...+..++.++|+||+|+++|||++|
T Consensus       243 ~aPE~~~~~~~~~~~Di~slG~il~el~~~  272 (332)
T 3qd2_B          243 MSPEQIHGNNYSHKVDIFSLGLILFELLYS  272 (332)
T ss_dssp             SCHHHHHCCCCCTHHHHHHHHHHHHHHHSC
T ss_pred             cChHHhcCCCCcchhhHHHHHHHHHHHHHc
Confidence            999998887889999999999999999875

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=2.8e-40  Score=306.35  Aligned_cols=197  Identities=21%  Similarity=0.309  Sum_probs=170.5

Q ss_pred             hcCCccccceeeccCceEEEEEEEC--------CCcEEEEEEeccCChHHHHHHHHHHHHHHhcC-CCCeeeeeeeEEEe
Q 021711          108 ATNNFSFENLIGKGGYAEVYKGRLR--------NGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGIE  178 (308)
Q Consensus       108 ~~~~~~~~~~LG~G~fg~Vy~~~~~--------~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  178 (308)
                      ..++|.+.+.||+|+||.||+|.+.        ++..||||.+.........+.+.+|+.+++.+ +||||+++++++..
T Consensus        79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~  158 (370)
T 2psq_A           79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ  158 (370)
T ss_dssp             CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred             cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence            3468999999999999999999862        35679999998766666678899999999999 89999999998765


Q ss_pred             C-cEEEEEEecCCCCHHHHHhccC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEE
Q 021711          179 G-GMHIVLELSPNGSLASLLYGMK---------------EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANIL  242 (308)
Q Consensus       179 ~-~~~lv~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NIL  242 (308)
                      . .+++||||+++|+|.+++....               ..+++..++.++.||+.||.|||+   ++|+||||||+|||
T Consensus       159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIl  235 (370)
T 2psq_A          159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVL  235 (370)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEE
T ss_pred             CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchhhEE
Confidence            4 5799999999999999997533               347899999999999999999999   89999999999999


Q ss_pred             ECCCCcEEEeccccceecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          243 LTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       243 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      ++.++.+||+|||+++.+.............||+.|+|||.+.+..++.++|+||||+++|||++
T Consensus       236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt  300 (370)
T 2psq_A          236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT  300 (370)
T ss_dssp             ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHT
T ss_pred             ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHc
Confidence            99999999999999997765433222334567889999999888888999999999999999986

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.8e-40  Score=301.10  Aligned_cols=203  Identities=37%  Similarity=0.607  Sum_probs=175.9

Q ss_pred             HHHHHhhcCCccccceeeccCceEEEEEEECCCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-c
Q 021711          102 LYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-G  180 (308)
Q Consensus       102 ~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~  180 (308)
                      ..++...+++|++.+.||+|+||.||+|.+++|+.||||.+..... ...+.+.+|+.+++.++||||+++++++... .
T Consensus        31 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  109 (321)
T 2qkw_B           31 LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESS-QGIEEFETEIETLSFCRHPHLVSLIGFCDERNE  109 (321)
T ss_dssp             CSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCS-SHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTC
T ss_pred             HHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccCh-HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCe
Confidence            3445567789999999999999999999988899999999876543 2357899999999999999999999987664 5


Q ss_pred             EEEEEEecCCCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccc
Q 021711          181 MHIVLELSPNGSLASLLYGMK---EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLA  257 (308)
Q Consensus       181 ~~lv~e~~~~gsL~~~l~~~~---~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla  257 (308)
                      .++||||+++|+|.+++....   ..+++..++.++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++
T Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~  186 (321)
T 2qkw_B          110 MILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGIS  186 (321)
T ss_dssp             CEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCSTTEEECTTCCEEECCCTTC
T ss_pred             EEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcC---CCeecCCCCHHHEEECCCCCEEEeecccc
Confidence            789999999999999886532   358999999999999999999999   89999999999999999999999999999


Q ss_pred             eecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          258 KWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      +...............||+.|+|||.+.+..++.++|+||+|+++|||++|
T Consensus       187 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g  237 (321)
T 2qkw_B          187 KKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCA  237 (321)
T ss_dssp             EECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHC
T ss_pred             cccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhC
Confidence            876543333333456799999999998888889999999999999999875

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=5.7e-40  Score=300.74  Aligned_cols=194  Identities=24%  Similarity=0.299  Sum_probs=168.4

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCC--hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIV  184 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv  184 (308)
                      .++|++.+.||+|+||.||+|+.. +|+.||+|.+....  .......+.+|+.+++.++||||+++++++... ..++|
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv   83 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence            358999999999999999999976 58999999986432  112346788999999999999999999977654 57899


Q ss_pred             EEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCC
Q 021711          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (308)
Q Consensus       185 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  264 (308)
                      |||+++|+|..++.. ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++......
T Consensus        84 ~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~  159 (337)
T 1o6l_A           84 MEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG  159 (337)
T ss_dssp             EECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred             EeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCCHHHEEECCCCCEEEeeccchhhcccCC
Confidence            999999999998864 4578999999999999999999999   899999999999999999999999999998643332


Q ss_pred             ceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          265 THHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      .  ......||+.|+|||.+.+..++.++|+||+|+++|||++|
T Consensus       160 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g  201 (337)
T 1o6l_A          160 A--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG  201 (337)
T ss_dssp             C--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHS
T ss_pred             C--cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcC
Confidence            2  23467899999999999888889999999999999999876

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=2e-40  Score=311.57  Aligned_cols=204  Identities=20%  Similarity=0.214  Sum_probs=173.9

Q ss_pred             CHHHHHhhcCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCCh--HHHHHHHHHHHHHHhcCCCCeeeeeeeEEE
Q 021711          101 SLYELQSATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELGIMAHVDHPNTAKLLGYGI  177 (308)
Q Consensus       101 ~~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  177 (308)
                      .+.++....++|++.++||+|+||.||+|+.+ +|+.||+|++.+...  ....+.+.+|..++..++||||+++++++.
T Consensus        52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~  131 (412)
T 2vd5_A           52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ  131 (412)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred             hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence            34455566789999999999999999999986 699999999964321  112345789999999999999999999776


Q ss_pred             eC-cEEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEecccc
Q 021711          178 EG-GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGL  256 (308)
Q Consensus       178 ~~-~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGl  256 (308)
                      +. .+|+||||+++|+|.+++......+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+
T Consensus       132 ~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILld~~g~vkL~DFGl  208 (412)
T 2vd5_A          132 DENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGS  208 (412)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             eCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccCHHHeeecCCCCEEEeechh
Confidence            65 5789999999999999997656679999999999999999999999   9999999999999999999999999999


Q ss_pred             ceecCCCCceeEeeceeccccccccccCch-------hhcCccceeEEEeeEEEeeccC
Q 021711          257 AKWLPEQWTHHTISKVEGTFGLVKLNLPPL-------VILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       257 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ++.+...... ......||+.|+|||.+..       ..++.++|+||+|+++|||++|
T Consensus       209 a~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG  266 (412)
T 2vd5_A          209 CLKLRADGTV-RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYG  266 (412)
T ss_dssp             CEECCTTSCE-ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHS
T ss_pred             heeccCCCcc-ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhC
Confidence            9987654332 2245689999999998863       3578899999999999999876

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=6.2e-40  Score=302.90  Aligned_cols=196  Identities=17%  Similarity=0.179  Sum_probs=167.5

Q ss_pred             HhhcCCccccceeeccCceEEEEEE------ECCCcEEEEEEeccCChHHHHHHHHHHHHHHhcCC---CCeeeeeeeEE
Q 021711          106 QSATNNFSFENLIGKGGYAEVYKGR------LRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVD---HPNTAKLLGYG  176 (308)
Q Consensus       106 ~~~~~~~~~~~~LG~G~fg~Vy~~~------~~~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~  176 (308)
                      ....++|.+.+.||+|+||.||+|.      ..+++.||||.+.....    ..+.+|+.++..++   |+||+++++++
T Consensus        61 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~e~~~~~~l~~~~~~~iv~~~~~~  136 (365)
T 3e7e_A           61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP----WEFYIGTQLMERLKPSMQHMFMKFYSAH  136 (365)
T ss_dssp             ECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCH----HHHHHHHHHHHHSCGGGGGGBCCEEEEE
T ss_pred             EECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCCh----hHHHHHHHHHHHhhhhhhhhhhhhheee
Confidence            3456789999999999999999994      33588999999976543    45667777777776   99999999977


Q ss_pred             Ee-CcEEEEEEecCCCCHHHHHhc----cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECC------
Q 021711          177 IE-GGMHIVLELSPNGSLASLLYG----MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTE------  245 (308)
Q Consensus       177 ~~-~~~~lv~e~~~~gsL~~~l~~----~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~------  245 (308)
                      .. +..++||||+++|+|.+++..    ....+++..++.++.||+.||.|||+   ++|+||||||+|||++.      
T Consensus       137 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~---~~ivHrDiKp~NIll~~~~~~~~  213 (365)
T 3e7e_A          137 LFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQD  213 (365)
T ss_dssp             ECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECGGGTCC-
T ss_pred             ecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEecccccCcc
Confidence            65 568999999999999999964    34569999999999999999999998   89999999999999998      


Q ss_pred             -----CCcEEEeccccceecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          246 -----DFEPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       246 -----~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                           ++.+||+|||+|+.+.............||++|+|||.+.+..++.++|+||+|+++|||++|
T Consensus       214 ~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg  281 (365)
T 3e7e_A          214 DEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFG  281 (365)
T ss_dssp             -----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHS
T ss_pred             ccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhC
Confidence                 899999999999876533333455677899999999999888889999999999999999886

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=5.6e-40  Score=302.61  Aligned_cols=195  Identities=23%  Similarity=0.351  Sum_probs=164.1

Q ss_pred             hcCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCC--hHHHHHHHHHHHHHHhcC-CCCeeeeeeeEEEeC-cEE
Q 021711          108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHV-DHPNTAKLLGYGIEG-GMH  182 (308)
Q Consensus       108 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~~~  182 (308)
                      ..++|++.++||+|+||.||+|+.. +|+.||||.+....  .....+.+.+|..++..+ +||||+++++++... .++
T Consensus        21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~  100 (353)
T 3txo_A           21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF  100 (353)
T ss_dssp             --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence            3478999999999999999999976 58999999997532  122356788999999988 799999999977665 578


Q ss_pred             EEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCC
Q 021711          183 IVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE  262 (308)
Q Consensus       183 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~  262 (308)
                      +||||+++|+|..++.. ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+|+....
T Consensus       101 lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~  176 (353)
T 3txo_A          101 FVMEFVNGGDLMFHIQK-SRRFDEARARFYAAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC  176 (353)
T ss_dssp             EEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             EEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence            99999999999999865 4569999999999999999999999   8999999999999999999999999999986433


Q ss_pred             CCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          263 QWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       263 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ..  .......||+.|+|||.+.+..++.++|+||+|+++|||++|
T Consensus       177 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G  220 (353)
T 3txo_A          177 NG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCG  220 (353)
T ss_dssp             -----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHS
T ss_pred             CC--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhC
Confidence            22  233467899999999999888899999999999999999876

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=2.5e-40  Score=301.33  Aligned_cols=196  Identities=27%  Similarity=0.405  Sum_probs=165.0

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCc----EEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeCcEEE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQ----LVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHI  183 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~----~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l  183 (308)
                      .++|++.+.||+|+||.||+|.+. +++    .||+|.+.........+.|.+|+.+++.++||||+++++++..+..++
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   93 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQL   93 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSSEEE
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEE
Confidence            357999999999999999999865 344    468888765444444678999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCC
Q 021711          184 VLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ  263 (308)
Q Consensus       184 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  263 (308)
                      |+||+.+|+|.+++......+++..++.++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+|+.+...
T Consensus        94 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~  170 (327)
T 3poz_A           94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE  170 (327)
T ss_dssp             EEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTT
T ss_pred             EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCChheEEECCCCCEEEccCcceeEccCC
Confidence            999999999999998777789999999999999999999999   89999999999999999999999999999987665


Q ss_pred             CceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          264 WTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      ..........||+.|+|||.+.+..++.++|+||+|+++|||++
T Consensus       171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt  214 (327)
T 3poz_A          171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT  214 (327)
T ss_dssp             CC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred             cccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHh
Confidence            44444455677899999999988888999999999999999886

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.1e-39  Score=296.90  Aligned_cols=196  Identities=29%  Similarity=0.383  Sum_probs=168.7

Q ss_pred             cCCccccceeeccCceEEEEEEEC----CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR----NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHI  183 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~----~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l  183 (308)
                      .++|++.+.||+|+||.||+|.+.    .+..||||.+.........+.|.+|+.+++.++||||+++++++..+ ..++
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  127 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI  127 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence            468999999999999999999975    34569999998765666678899999999999999999999988765 4789


Q ss_pred             EEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCC
Q 021711          184 VLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ  263 (308)
Q Consensus       184 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  263 (308)
                      ||||+++|+|.+++......+++..++.++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++.+...
T Consensus       128 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  204 (325)
T 3kul_A          128 VTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD  204 (325)
T ss_dssp             EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCSSCEECC--
T ss_pred             EeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEECCCCCEEECCCCcccccccC
Confidence            999999999999997766789999999999999999999999   89999999999999999999999999999987654


Q ss_pred             Cce-eEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          264 WTH-HTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       264 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      ... .......+|+.|+|||.+....++.++|+||+|+++|||++
T Consensus       205 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~  249 (325)
T 3kul_A          205 PDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA  249 (325)
T ss_dssp             --CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHT
T ss_pred             ccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHc
Confidence            322 22334567889999999988888999999999999999876

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=2.1e-40  Score=307.77  Aligned_cols=199  Identities=24%  Similarity=0.333  Sum_probs=172.4

Q ss_pred             HhhcCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEE
Q 021711          106 QSATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHI  183 (308)
Q Consensus       106 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l  183 (308)
                      ....++|.+.+.||+|+||.||+|.+. +++.||||.+......+..+.|.+|+.+|+.++||||+++++++... ..++
T Consensus       110 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  189 (377)
T 3cbl_A          110 VLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYI  189 (377)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             EEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEE
Confidence            344568999999999999999999987 68999999997665555567899999999999999999999988764 5799


Q ss_pred             EEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCC
Q 021711          184 VLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ  263 (308)
Q Consensus       184 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  263 (308)
                      ||||+++|+|.+++......+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++.....
T Consensus       190 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~  266 (377)
T 3cbl_A          190 VMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADG  266 (377)
T ss_dssp             EEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred             EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence            999999999999997766679999999999999999999999   89999999999999999999999999999876543


Q ss_pred             CceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          264 WTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      ..........+++.|+|||.+....++.++|+||||+++|||++
T Consensus       267 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t  310 (377)
T 3cbl_A          267 VYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFS  310 (377)
T ss_dssp             EEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHT
T ss_pred             ceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHh
Confidence            22111123356788999999887788999999999999999986

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-39  Score=294.84  Aligned_cols=192  Identities=15%  Similarity=0.096  Sum_probs=170.2

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEEE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLE  186 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e  186 (308)
                      .++|++.+.||+|+||.||+|... +++.||+|.+.....  ....+.+|+.+++.++||||+++++++.+. ..++|||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   81 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT--DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE   81 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH--HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcc--cHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence            468999999999999999999976 588999999875443  346788999999999999999999977664 5789999


Q ss_pred             ecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECC--CCcEEEeccccceecCCCC
Q 021711          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTE--DFEPQICDFGLAKWLPEQW  264 (308)
Q Consensus       187 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~--~~~~kl~DFGla~~~~~~~  264 (308)
                      |+++|+|.+++......+++..+..++.|++.||.|||+   ++|+||||||+|||++.  ++.+||+|||+++.+....
T Consensus        82 ~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~  158 (321)
T 1tki_A           82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD  158 (321)
T ss_dssp             CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred             eCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC
Confidence            999999999997666679999999999999999999999   89999999999999997  7899999999999876543


Q ss_pred             ceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          265 THHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                         ......||+.|+|||...+...+.++|+||+|+++|+|++|
T Consensus       159 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g  199 (321)
T 1tki_A          159 ---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSG  199 (321)
T ss_dssp             ---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHS
T ss_pred             ---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhC
Confidence               33456899999999998877788999999999999999886

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.2e-39  Score=293.05  Aligned_cols=192  Identities=22%  Similarity=0.297  Sum_probs=168.2

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEEE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLE  186 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e  186 (308)
                      .++|++.+.||+|+||.||+|.+. +|+.||||.+...... ..+.+.+|+.+++.++||||+++++++..+ ..++|||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   97 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   97 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCS-CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccccc-HHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence            458999999999999999999965 6899999998643322 246788999999999999999999977654 5789999


Q ss_pred             ecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCce
Q 021711          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH  266 (308)
Q Consensus       187 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~  266 (308)
                      |+++|+|.+++..  ..+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++....... 
T Consensus        98 ~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  171 (297)
T 3fxz_A           98 YLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-  171 (297)
T ss_dssp             CCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred             CCCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc-
Confidence            9999999999954  468999999999999999999999   8999999999999999999999999999988765433 


Q ss_pred             eEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          267 HTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                       ......||+.|+|||.+.+..++.++|+||+|+++|||++|
T Consensus       172 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g  212 (297)
T 3fxz_A          172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG  212 (297)
T ss_dssp             -CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHS
T ss_pred             -ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhC
Confidence             23456899999999998888889999999999999999875

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=7.3e-40  Score=298.91  Aligned_cols=194  Identities=24%  Similarity=0.332  Sum_probs=169.5

Q ss_pred             hcCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCC-hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEE
Q 021711          108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIV  184 (308)
Q Consensus       108 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv  184 (308)
                      ..++|++.+.||+|+||.||+|.+. +|+.||||++.... .....+.+.+|+.+++.++||||+++++++... ..++|
T Consensus        13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   92 (328)
T 3fe3_A           13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI   92 (328)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence            3568999999999999999999975 69999999996542 334567889999999999999999999987665 57899


Q ss_pred             EEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCC
Q 021711          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (308)
Q Consensus       185 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  264 (308)
                      |||+++|+|.+++.. ...+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++......
T Consensus        93 ~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  168 (328)
T 3fe3_A           93 MEYASGGEVFDYLVA-HGRMKEKEARSKFRQIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG  168 (328)
T ss_dssp             ECCCTTCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC
T ss_pred             EECCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC
Confidence            999999999999865 4569999999999999999999999   899999999999999999999999999998765442


Q ss_pred             ceeEeeceeccccccccccCchhhc-CccceeEEEeeEEEeeccC
Q 021711          265 THHTISKVEGTFGLVKLNLPPLVIL-KRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~s~g~~l~el~c~  308 (308)
                         ......||+.|+|||.+.+... +.++|+||+|+++|+|++|
T Consensus       169 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g  210 (328)
T 3fe3_A          169 ---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG  210 (328)
T ss_dssp             ---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHS
T ss_pred             ---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhC
Confidence               2345689999999999876665 4789999999999999876

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=3.7e-40  Score=302.89  Aligned_cols=205  Identities=22%  Similarity=0.315  Sum_probs=176.5

Q ss_pred             cCHHHHHhhcCCccccceeeccCceEEEEEEEC------CCcEEEEEEeccCChHHHHHHHHHHHHHHhcC-CCCeeeee
Q 021711          100 FSLYELQSATNNFSFENLIGKGGYAEVYKGRLR------NGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKL  172 (308)
Q Consensus       100 ~~~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~------~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l  172 (308)
                      +....+....++|++.+.||+|+||.||+|++.      +++.||||.+.........+.+.+|+.++.++ +||||+++
T Consensus        12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~   91 (359)
T 3vhe_A           12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   91 (359)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence            345566777889999999999999999999742      36899999998766555667899999999999 79999999


Q ss_pred             eeEEEeC--cEEEEEEecCCCCHHHHHhccCC------------------------------------------------
Q 021711          173 LGYGIEG--GMHIVLELSPNGSLASLLYGMKE------------------------------------------------  202 (308)
Q Consensus       173 ~~~~~~~--~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------  202 (308)
                      ++++.+.  ..++||||+++|+|.+++.....                                                
T Consensus        92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (359)
T 3vhe_A           92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK  171 (359)
T ss_dssp             EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred             eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence            9987764  37899999999999999965322                                                


Q ss_pred             -----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCc
Q 021711          203 -----------------KLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (308)
Q Consensus       203 -----------------~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~  265 (308)
                                       .+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++.+.....
T Consensus       172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~  248 (359)
T 3vhe_A          172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD  248 (359)
T ss_dssp             ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred             ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence                             18889999999999999999999   8999999999999999999999999999997765544


Q ss_pred             eeEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          266 HHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      ........||+.|+|||.+.+..++.++|+||+|+++|||++
T Consensus       249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt  290 (359)
T 3vhe_A          249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS  290 (359)
T ss_dssp             CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTT
T ss_pred             chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHh
Confidence            445556789999999999888888999999999999999986

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=3.5e-40  Score=309.71  Aligned_cols=201  Identities=21%  Similarity=0.234  Sum_probs=170.6

Q ss_pred             HHHHHhhcCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChH--HHHHHHHHHHHHHhcCCCCeeeeeeeEEEe
Q 021711          102 LYELQSATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTAD--EIIADFLSELGIMAHVDHPNTAKLLGYGIE  178 (308)
Q Consensus       102 ~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  178 (308)
                      +.++....++|++.++||+|+||.||+|+.. +++.||+|.+......  ...+.+.+|+.++..++||||+++++++.+
T Consensus        61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~  140 (410)
T 3v8s_A           61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD  140 (410)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence            3445566789999999999999999999987 5899999998642111  112347889999999999999999997776


Q ss_pred             C-cEEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccc
Q 021711          179 G-GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLA  257 (308)
Q Consensus       179 ~-~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla  257 (308)
                      . .+++||||+++|+|.+++..  ..+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+|
T Consensus       141 ~~~~~lV~E~~~gg~L~~~l~~--~~~~e~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFG~a  215 (410)
T 3v8s_A          141 DRYLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTC  215 (410)
T ss_dssp             SSEEEEEECCCTTEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CCEEEEEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeeECCCCCEEEecccee
Confidence            5 47899999999999999854  468999999999999999999999   99999999999999999999999999999


Q ss_pred             eecCCCCceeEeeceeccccccccccCchhh----cCccceeEEEeeEEEeeccC
Q 021711          258 KWLPEQWTHHTISKVEGTFGLVKLNLPPLVI----LKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Di~s~g~~l~el~c~  308 (308)
                      +.+..... .......||+.|+|||.+....    ++.++|+||+|++||||++|
T Consensus       216 ~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G  269 (410)
T 3v8s_A          216 MKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG  269 (410)
T ss_dssp             EECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHS
T ss_pred             EeeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhC
Confidence            98765432 2334678999999999876554    67899999999999999886

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=5.4e-40  Score=298.43  Aligned_cols=193  Identities=23%  Similarity=0.305  Sum_probs=165.9

Q ss_pred             hcCCccccceeeccCceEEEEEEECCCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeCc-----EE
Q 021711          108 ATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG-----MH  182 (308)
Q Consensus       108 ~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~  182 (308)
                      ..++|++.++||+|+||.||+|++. ++.||||++.....  ....+.+|+.++..++||||+++++++....     ++
T Consensus        22 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   98 (322)
T 3soc_A           22 QSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDK--QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLW   98 (322)
T ss_dssp             TTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGH--HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred             chhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCch--HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEE
Confidence            4468999999999999999999875 78999999865432  2345667999999999999999999876543     68


Q ss_pred             EEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCC----------CceecCCCCCCEEECCCCcEEEe
Q 021711          183 IVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQR----------RIIHRDIKAANILLTEDFEPQIC  252 (308)
Q Consensus       183 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~----------~iiHrDlKp~NILl~~~~~~kl~  252 (308)
                      +||||+++|+|.+++..  ..+++..+..++.|++.||.|||+   .          +|+||||||+|||++.++.+||+
T Consensus        99 lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~al~~LH~---~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~  173 (322)
T 3soc_A           99 LITAFHEKGSLSDFLKA--NVVSWNELCHIAETMARGLAYLHE---DIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA  173 (322)
T ss_dssp             EEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHTC---CEEEETTEEECEEECSCCSGGGEEECTTCCEEEC
T ss_pred             EEEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHh---hccccccccCCCEEeCCCChHhEEECCCCeEEEc
Confidence            99999999999999954  458999999999999999999998   7          99999999999999999999999


Q ss_pred             ccccceecCCCCceeEeeceeccccccccccCch-----hhcCccceeEEEeeEEEeeccC
Q 021711          253 DFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPL-----VILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       253 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      |||+++.+.............||+.|+|||.+.+     ...+.++|+||+|+++|||++|
T Consensus       174 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg  234 (322)
T 3soc_A          174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASR  234 (322)
T ss_dssp             CCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             cCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhC
Confidence            9999998766544333445789999999998765     3556678999999999999875

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=5.6e-40  Score=298.81  Aligned_cols=196  Identities=24%  Similarity=0.296  Sum_probs=166.9

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeCc-EEEEEE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLE  186 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e  186 (308)
                      .++|++.+.||+|+||.||+|.+. +++.||+|.+.........+.+.+|+.+++.++||||+++++++.++. .++|||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            368999999999999999999977 689999999875544444567889999999999999999999887754 689999


Q ss_pred             ecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCce
Q 021711          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH  266 (308)
Q Consensus       187 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~  266 (308)
                      |+++|+|.+++.. ...+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++.+......
T Consensus        86 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  161 (323)
T 3tki_A           86 YCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  161 (323)
T ss_dssp             CCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             cCCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence            9999999998853 4568999999999999999999999   99999999999999999999999999999876544333


Q ss_pred             eEeeceeccccccccccCchhhc-CccceeEEEeeEEEeeccC
Q 021711          267 HTISKVEGTFGLVKLNLPPLVIL-KRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~s~g~~l~el~c~  308 (308)
                      .......||+.|+|||.+.+... +.++|+||+|+++|+|++|
T Consensus       162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g  204 (323)
T 3tki_A          162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG  204 (323)
T ss_dssp             CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHS
T ss_pred             cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhC
Confidence            34456789999999999866554 6789999999999999875

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=2.6e-40  Score=300.74  Aligned_cols=196  Identities=21%  Similarity=0.322  Sum_probs=168.0

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCc----EEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeCcEEE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQ----LVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHI  183 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~----~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l  183 (308)
                      .++|++.+.||+|+||.||+|.+. +++    .||+|.+...........+.+|+.++..++||||+++++++.++..++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   91 (325)
T 3kex_A           12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQL   91 (325)
T ss_dssp             TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECBSSEEE
T ss_pred             HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCccEE
Confidence            468999999999999999999875 344    388888754433333456778999999999999999999998888999


Q ss_pred             EEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCC
Q 021711          184 VLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ  263 (308)
Q Consensus       184 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  263 (308)
                      ||||+++|+|.+++......+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++.+...
T Consensus        92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~  168 (325)
T 3kex_A           92 VTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEE---HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD  168 (325)
T ss_dssp             EEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHH---TTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCC
T ss_pred             EEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHh---CCCCCCccchheEEECCCCeEEECCCCcccccCcc
Confidence            999999999999997666678999999999999999999999   89999999999999999999999999999988665


Q ss_pred             CceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          264 WTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      ..........||..|+|||.+....++.++|+||+|+++|||++
T Consensus       169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~  212 (325)
T 3kex_A          169 DKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT  212 (325)
T ss_dssp             TTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred             cccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHh
Confidence            54444556788999999999988888999999999999999887

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=3.2e-39  Score=298.47  Aligned_cols=193  Identities=25%  Similarity=0.303  Sum_probs=168.9

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChH-----HHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTAD-----EIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GM  181 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~  181 (308)
                      .++|++.+.||+|+||.||+|... +|+.||+|.+......     ...+.+.+|+.+++.++||||+++++++.+. ..
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            468999999999999999999976 5899999999754321     1246788999999999999999999987765 57


Q ss_pred             EEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCC----cEEEeccccc
Q 021711          182 HIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDF----EPQICDFGLA  257 (308)
Q Consensus       182 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~----~~kl~DFGla  257 (308)
                      ++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.++    .+||+|||++
T Consensus        91 ~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a  166 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA  166 (361)
T ss_dssp             EEEEECCCSCBHHHHHTT-CSCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred             EEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence            899999999999999954 4579999999999999999999999   8999999999999998877    7999999999


Q ss_pred             eecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          258 KWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      +.+....   ......||+.|+|||.+....++.++|+||+|+++|+|+||
T Consensus       167 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g  214 (361)
T 2yab_A          167 HEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG  214 (361)
T ss_dssp             EECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred             eEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhC
Confidence            9876542   23456799999999998877788999999999999999886

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=3.5e-39  Score=289.49  Aligned_cols=195  Identities=23%  Similarity=0.320  Sum_probs=164.5

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccC--ChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeCc-EEEE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRG--TADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIV  184 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv  184 (308)
                      .++|++.+.||+|+||.||+|++. +++.||+|.+...  ...+..+.+.+|+.++..++||||+++++++..++ .++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            468999999999999999999976 5899999998543  23455678999999999999999999999877654 7899


Q ss_pred             EEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCC
Q 021711          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (308)
Q Consensus       185 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  264 (308)
                      |||+++++|.+++.. ...+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++.+....
T Consensus        90 ~e~~~g~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  165 (294)
T 4eqm_A           90 MEYIEGPTLSEYIES-HGPLSVDTAINFTNQILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS  165 (294)
T ss_dssp             EECCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCSSSTTC----
T ss_pred             EeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEEeCCCcccccccc
Confidence            999999999999965 4578999999999999999999999   899999999999999999999999999998764432


Q ss_pred             ceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          265 THHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      . .......||+.|+|||.+.+...+.++|+||+|+++|+|++|
T Consensus       166 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g  208 (294)
T 4eqm_A          166 L-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVG  208 (294)
T ss_dssp             ----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHS
T ss_pred             c-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhC
Confidence            2 123456799999999998888888999999999999999875

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.5e-39  Score=303.99  Aligned_cols=194  Identities=23%  Similarity=0.274  Sum_probs=166.4

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCC--hHHHHHHHHHHHHHHhcC-CCCeeeeeeeEEEeC-cEEE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHV-DHPNTAKLLGYGIEG-GMHI  183 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~~~l  183 (308)
                      .++|++.++||+|+||.||+|+.+ +++.||+|.+.+..  ..+....+.+|..++..+ +||||+++++++... .+++
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            468999999999999999999977 58899999997542  222345678899999876 899999999977665 5789


Q ss_pred             EEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCC
Q 021711          184 VLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ  263 (308)
Q Consensus       184 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  263 (308)
                      ||||+++|+|..++.. ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+|+.....
T Consensus       131 V~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~  206 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP  206 (396)
T ss_dssp             EEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             EEEcCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEECCCCCEEEeecceeeecccC
Confidence            9999999999999864 4579999999999999999999999   89999999999999999999999999999864332


Q ss_pred             CceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          264 WTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ..  ......||+.|+|||.+.+..++.++|+||+|+++|||++|
T Consensus       207 ~~--~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G  249 (396)
T 4dc2_A          207 GD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAG  249 (396)
T ss_dssp             TC--CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHS
T ss_pred             CC--ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhC
Confidence            21  23567899999999999888889999999999999999876

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=4e-39  Score=296.02  Aligned_cols=193  Identities=24%  Similarity=0.278  Sum_probs=168.2

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCC--hHHHHHHHHHHHHHHhcC-CCCeeeeeeeEEEeC-cEEEE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHV-DHPNTAKLLGYGIEG-GMHIV  184 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~~~lv  184 (308)
                      ++|++.+.||+|+||.||+|+.. +++.||+|.+....  .....+.+.+|..++..+ +||||+++++++... ..++|
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   88 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   88 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence            57999999999999999999986 58999999997542  334567788999999987 899999999977654 57899


Q ss_pred             EEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCC
Q 021711          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (308)
Q Consensus       185 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  264 (308)
                      |||+++|+|.+++.. ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++......
T Consensus        89 ~e~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~  164 (345)
T 3a8x_A           89 IEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG  164 (345)
T ss_dssp             ECCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT
T ss_pred             EeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEEeccccccccCCC
Confidence            999999999999864 3569999999999999999999999   899999999999999999999999999998643322


Q ss_pred             ceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          265 THHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      .  ......||+.|+|||.+.+..++.++|+||+|+++|||++|
T Consensus       165 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g  206 (345)
T 3a8x_A          165 D--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAG  206 (345)
T ss_dssp             C--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHS
T ss_pred             C--cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhC
Confidence            1  23467899999999998887889999999999999999876

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=3.5e-39  Score=291.75  Aligned_cols=191  Identities=26%  Similarity=0.299  Sum_probs=161.1

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCC-hHHHHHHHHHHHHHHhcC-CCCeeeeeeeEEEeCc-EEEEE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT-ADEIIADFLSELGIMAHV-DHPNTAKLLGYGIEGG-MHIVL  185 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~-~~lv~  185 (308)
                      ++|++.+.||+|+||+||+|++. +|+.||||++.... .......+..|+..+..+ +||||+++++++.+++ .++||
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~  136 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT  136 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence            57999999999999999999987 69999999986543 233345566676666555 8999999999887664 78999


Q ss_pred             EecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCc
Q 021711          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (308)
Q Consensus       186 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~  265 (308)
                      ||+ +++|.+++......+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++...... 
T Consensus       137 e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~-  211 (311)
T 3p1a_A          137 ELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG-  211 (311)
T ss_dssp             ECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECGGGCEEECCCTTCEECC----
T ss_pred             ecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEccceeeeecccCC-
Confidence            999 679999987767789999999999999999999999   899999999999999999999999999998775432 


Q ss_pred             eeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          266 HHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                        ......||++|+|||.+.+ .++.++|+||+|+++|||+||
T Consensus       212 --~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g  251 (311)
T 3p1a_A          212 --AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACN  251 (311)
T ss_dssp             -----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHT
T ss_pred             --CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhC
Confidence              2345679999999998865 678899999999999999886

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-39  Score=296.68  Aligned_cols=200  Identities=27%  Similarity=0.363  Sum_probs=172.0

Q ss_pred             HHhhcCCccccceeeccCceEEEEEEEC------CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEe
Q 021711          105 LQSATNNFSFENLIGKGGYAEVYKGRLR------NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE  178 (308)
Q Consensus       105 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~------~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  178 (308)
                      +....++|++.+.||+|+||.||+|.+.      +++.||+|.+......+..+.+.+|+.+++.++||||+++++++..
T Consensus        42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~  121 (343)
T 1luf_A           42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV  121 (343)
T ss_dssp             TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence            3455678999999999999999999875      3478999999876666667889999999999999999999998765


Q ss_pred             C-cEEEEEEecCCCCHHHHHhccC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceec
Q 021711          179 G-GMHIVLELSPNGSLASLLYGMK-----------------------EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHR  234 (308)
Q Consensus       179 ~-~~~lv~e~~~~gsL~~~l~~~~-----------------------~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHr  234 (308)
                      + ..++||||+++|+|.+++....                       ..+++..++.++.||+.||.|||+   ++|+||
T Consensus       122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~---~~ivH~  198 (343)
T 1luf_A          122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHR  198 (343)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCS
T ss_pred             CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecC
Confidence            4 5799999999999999996532                       568999999999999999999999   899999


Q ss_pred             CCCCCCEEECCCCcEEEeccccceecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          235 DIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       235 DlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      ||||+|||++.++.+||+|||+++...............||+.|+|||.+.....+.++|+||+|+++|||++
T Consensus       199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t  271 (343)
T 1luf_A          199 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS  271 (343)
T ss_dssp             CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred             CCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHh
Confidence            9999999999999999999999987654332223345678999999999887788999999999999999986

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.2e-39  Score=290.05  Aligned_cols=197  Identities=25%  Similarity=0.348  Sum_probs=161.6

Q ss_pred             hhcCCccccceeeccCceEEEEEEECC----CcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeCcEE
Q 021711          107 SATNNFSFENLIGKGGYAEVYKGRLRN----GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMH  182 (308)
Q Consensus       107 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~----g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  182 (308)
                      ...++|++.+.||+|+||.||+|.+..    +..||+|.+.........+.+.+|+.+++.++||||+++++++.++..+
T Consensus        12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   91 (281)
T 1mp8_A           12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVW   91 (281)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSCE
T ss_pred             EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEccCccE
Confidence            345689999999999999999998753    4579999987766566678899999999999999999999998888899


Q ss_pred             EEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCC
Q 021711          183 IVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE  262 (308)
Q Consensus       183 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~  262 (308)
                      +||||+++++|.+++......+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++....
T Consensus        92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  168 (281)
T 1mp8_A           92 IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  168 (281)
T ss_dssp             EEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred             EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHEEECCCCCEEECccccccccCc
Confidence            9999999999999997666679999999999999999999999   8999999999999999999999999999987754


Q ss_pred             CCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          263 QWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       263 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      ... .......+|+.|+|||......++.++|+||+|+++|||++
T Consensus       169 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~  212 (281)
T 1mp8_A          169 STY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM  212 (281)
T ss_dssp             -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHT
T ss_pred             ccc-cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHh
Confidence            322 12234567889999999887778899999999999999874

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1.8e-39  Score=293.63  Aligned_cols=197  Identities=27%  Similarity=0.419  Sum_probs=160.5

Q ss_pred             HhhcCCccccceeeccCceEEEEEEECCCcEEEEEEeccCC-hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEE
Q 021711          106 QSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHI  183 (308)
Q Consensus       106 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l  183 (308)
                      ....++|++.+.||+|+||.||+|+. +|+.||||.+.... ..+..+.+.+|+.+++.++||||+++++++... ..++
T Consensus        33 ~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l  111 (309)
T 3p86_A           33 DIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSI  111 (309)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEE
T ss_pred             cCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEE
Confidence            34557899999999999999999987 58899999986543 344567899999999999999999999987665 5799


Q ss_pred             EEEecCCCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCC--ceecCCCCCCEEECCCCcEEEecccccee
Q 021711          184 VLELSPNGSLASLLYGMK--EKLKWGIRYKIALGVAEGLLYLHEGCQRR--IIHRDIKAANILLTEDFEPQICDFGLAKW  259 (308)
Q Consensus       184 v~e~~~~gsL~~~l~~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~~~~--iiHrDlKp~NILl~~~~~~kl~DFGla~~  259 (308)
                      ||||+++|+|.+++....  ..+++..++.++.|++.||.|||+   .+  |+||||||+|||++.++.+||+|||+++.
T Consensus       112 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~  188 (309)
T 3p86_A          112 VTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN---RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL  188 (309)
T ss_dssp             EEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHT---SSSCCCCTTCCGGGEEECTTCCEEECCCC----
T ss_pred             EEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHc---CCCCEECCCCChhhEEEeCCCcEEECCCCCCcc
Confidence            999999999999996532  238999999999999999999998   78  99999999999999999999999999986


Q ss_pred             cCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          260 LPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       260 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ......  ......||+.|+|||.+.+...+.++|+||+|+++|||++|
T Consensus       189 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg  235 (309)
T 3p86_A          189 KASTFL--SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATL  235 (309)
T ss_dssp             ---------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHC
T ss_pred             cccccc--ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhC
Confidence            544321  23456899999999998888889999999999999999875

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=5.1e-39  Score=290.76  Aligned_cols=196  Identities=21%  Similarity=0.293  Sum_probs=166.7

Q ss_pred             hhcCCccccceeeccCceEEEEEEECCCcEEEEEEeccCCh-HHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEE
Q 021711          107 SATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTA-DEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIV  184 (308)
Q Consensus       107 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv  184 (308)
                      ...++|++.+.||+|+||.||+|.+.+|+.||+|.+..... ......+.+|+.+++.++||||+++++++... ..++|
T Consensus        18 ~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   97 (311)
T 3niz_A           18 GLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLV   97 (311)
T ss_dssp             CSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEE
T ss_pred             chHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEE
Confidence            44578999999999999999999998899999999865432 23457789999999999999999999987654 57899


Q ss_pred             EEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCC
Q 021711          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (308)
Q Consensus       185 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  264 (308)
                      |||+++ +|.+.+......+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++......
T Consensus        98 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~  173 (311)
T 3niz_A           98 FEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPV  173 (311)
T ss_dssp             EECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred             EcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence            999985 8888887766779999999999999999999999   899999999999999999999999999999875432


Q ss_pred             ceeEeeceeccccccccccCch-hhcCccceeEEEeeEEEeeccC
Q 021711          265 THHTISKVEGTFGLVKLNLPPL-VILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      .  ......||+.|+|||.+.+ ..++.++|+||+|+++|+|++|
T Consensus       174 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g  216 (311)
T 3niz_A          174 R--SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITG  216 (311)
T ss_dssp             C-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHS
T ss_pred             c--cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhC
Confidence            2  2345678999999998765 4578899999999999999875

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=2.3e-39  Score=297.70  Aligned_cols=196  Identities=21%  Similarity=0.286  Sum_probs=167.6

Q ss_pred             hhcCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCCh--HHHHHHHHHHHHHHhcC-CCCeeeeeeeEEEeC-cE
Q 021711          107 SATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELGIMAHV-DHPNTAKLLGYGIEG-GM  181 (308)
Q Consensus       107 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~~  181 (308)
                      ...++|.+.++||+|+||.||+|+.+ +|+.||||.+.....  ......+.+|..++..+ +||||+++++++.+. ..
T Consensus        14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~   93 (345)
T 1xjd_A           14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL   93 (345)
T ss_dssp             --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence            45679999999999999999999986 589999999965321  12245678899999876 999999999977654 57


Q ss_pred             EEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecC
Q 021711          182 HIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP  261 (308)
Q Consensus       182 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~  261 (308)
                      ++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++...
T Consensus        94 ~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~  169 (345)
T 1xjd_A           94 FFVMEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENM  169 (345)
T ss_dssp             EEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCChhhEEECCCCCEEEeEChhhhhcc
Confidence            899999999999999864 3568999999999999999999999   899999999999999999999999999998654


Q ss_pred             CCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          262 EQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       262 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ....  ......||+.|+|||.+.+..++.++|+||+|+++|||++|
T Consensus       170 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g  214 (345)
T 1xjd_A          170 LGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIG  214 (345)
T ss_dssp             CTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHS
T ss_pred             cCCC--cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcC
Confidence            3222  23467899999999998888889999999999999999876

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=3e-39  Score=300.93  Aligned_cols=193  Identities=25%  Similarity=0.322  Sum_probs=167.4

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCCh--HHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIV  184 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv  184 (308)
                      .++|++.+.||+|+||.||+|... +++.||+|.+.....  ......+.+|+.+++.++|||||++++++.+. ..++|
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   93 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV   93 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            368999999999999999999976 589999999864321  12346788999999999999999999977664 57899


Q ss_pred             EEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCC
Q 021711          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (308)
Q Consensus       185 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  264 (308)
                      |||+.+|+|..++.. ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++.+....
T Consensus        94 ~e~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~  169 (384)
T 4fr4_A           94 VDLLLGGDLRYHLQQ-NVHFKEETVKLFICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET  169 (384)
T ss_dssp             ECCCTTEEHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred             EecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEECCCCCEEEeccceeeeccCCC
Confidence            999999999999864 4579999999999999999999999   899999999999999999999999999999876542


Q ss_pred             ceeEeeceeccccccccccCch---hhcCccceeEEEeeEEEeeccC
Q 021711          265 THHTISKVEGTFGLVKLNLPPL---VILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Di~s~g~~l~el~c~  308 (308)
                         ......||+.|+|||.+..   ..++.++|+||+|+++|||++|
T Consensus       170 ---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG  213 (384)
T 4fr4_A          170 ---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRG  213 (384)
T ss_dssp             ---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHS
T ss_pred             ---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhC
Confidence               2356789999999998763   3478899999999999999876

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=2.3e-39  Score=300.62  Aligned_cols=196  Identities=28%  Similarity=0.389  Sum_probs=159.0

Q ss_pred             cCCccccceeeccCceEEEEEEEC----CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR----NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHI  183 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~----~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l  183 (308)
                      .++|++.+.||+|+||.||+|++.    ++..||||.+.........+.|.+|+.+++.++||||+++++++... ..++
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI  123 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence            458999999999999999999865    46789999998765555678899999999999999999999988765 4789


Q ss_pred             EEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCC
Q 021711          184 VLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ  263 (308)
Q Consensus       184 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  263 (308)
                      ||||+++|+|.+++......+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++.+...
T Consensus       124 v~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  200 (373)
T 2qol_A          124 VTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD  200 (373)
T ss_dssp             EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred             EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEEcCCCCEEECcCccccccccC
Confidence            999999999999997766679999999999999999999999   89999999999999999999999999999977554


Q ss_pred             Cce-eEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          264 WTH-HTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       264 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      ... .......+|+.|+|||.+....++.++|+||||+++|||++
T Consensus       201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt  245 (373)
T 2qol_A          201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS  245 (373)
T ss_dssp             -------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred             CccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHh
Confidence            221 11223456788999999888888999999999999999765

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=9.4e-39  Score=290.38  Aligned_cols=189  Identities=22%  Similarity=0.291  Sum_probs=166.0

Q ss_pred             ccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEEEecC
Q 021711          112 FSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLELSP  189 (308)
Q Consensus       112 ~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~~  189 (308)
                      |...+.||+|+||.||+|+.. +|+.||||.+...... ..+.+.+|+.+++.++||||+++++++... ..++||||++
T Consensus        47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  125 (321)
T 2c30_A           47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ-RRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQ  125 (321)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-SHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred             hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchh-HHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCC
Confidence            677789999999999999987 6999999998754332 246788999999999999999999977664 5789999999


Q ss_pred             CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCceeEe
Q 021711          190 NGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTI  269 (308)
Q Consensus       190 ~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  269 (308)
                      +++|.+++.  ...+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++.+.....  ..
T Consensus       126 ~~~L~~~l~--~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~~  198 (321)
T 2c30_A          126 GGALTDIVS--QVRLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KR  198 (321)
T ss_dssp             SCBHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC--CB
T ss_pred             CCCHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc--cc
Confidence            999999985  3569999999999999999999999   8999999999999999999999999999988755432  22


Q ss_pred             eceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          270 SKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       270 ~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ....||+.|+|||......++.++|+||+|+++|||++|
T Consensus       199 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g  237 (321)
T 2c30_A          199 KSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDG  237 (321)
T ss_dssp             CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHS
T ss_pred             ccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhC
Confidence            456899999999998888888999999999999999875

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=4.6e-39  Score=291.50  Aligned_cols=194  Identities=23%  Similarity=0.306  Sum_probs=167.2

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC---cEEEE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG---GMHIV  184 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---~~~lv  184 (308)
                      .++|.+.++||+|+||.||+|.+. +|+.||||.+.........+.+.+|+.+++.++||||+++++++...   ..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence            457999999999999999999987 48999999997544333457788999999999999999999987654   46899


Q ss_pred             EEecCCCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEE----CCCCcEEEeccccce
Q 021711          185 LELSPNGSLASLLYGMK--EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILL----TEDFEPQICDFGLAK  258 (308)
Q Consensus       185 ~e~~~~gsL~~~l~~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl----~~~~~~kl~DFGla~  258 (308)
                      |||+++++|.+++....  ..+++..+..++.|++.||.|||+   .+|+||||||+|||+    +.++.+||+|||+++
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~  164 (319)
T 4euu_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (319)
T ss_dssp             EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred             EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence            99999999999997533  238999999999999999999999   899999999999999    777889999999999


Q ss_pred             ecCCCCceeEeeceeccccccccccCc--------hhhcCccceeEEEeeEEEeeccC
Q 021711          259 WLPEQWTHHTISKVEGTFGLVKLNLPP--------LVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       259 ~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      .+.....   .....||+.|+|||.+.        ...++.++|+||+|+++|||++|
T Consensus       165 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g  219 (319)
T 4euu_A          165 ELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATG  219 (319)
T ss_dssp             ECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHS
T ss_pred             ecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhC
Confidence            8765432   23567999999999875        35577889999999999999875

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=5.6e-39  Score=283.44  Aligned_cols=194  Identities=20%  Similarity=0.306  Sum_probs=171.3

Q ss_pred             hcCCccccceeeccCceEEEEEEECCCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEEE
Q 021711          108 ATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLE  186 (308)
Q Consensus       108 ~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e  186 (308)
                      ..++|++.+.||+|+||.||+|.+.++..||+|.+......  .+.+.+|+.++..++||||+++++++... ..++|||
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (268)
T 3sxs_A            6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS--EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTE   83 (268)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBC--HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCc--HHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEE
Confidence            45689999999999999999999988889999999765433  25688999999999999999999987665 5789999


Q ss_pred             ecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCce
Q 021711          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH  266 (308)
Q Consensus       187 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~  266 (308)
                      |+++++|.+++......+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++....... 
T Consensus        84 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-  159 (268)
T 3sxs_A           84 YISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLES---HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY-  159 (268)
T ss_dssp             CCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE-
T ss_pred             ccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCcceEEECCCCCEEEccCccceecchhhh-
Confidence            999999999997766679999999999999999999999   8999999999999999999999999999998765432 


Q ss_pred             eEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          267 HTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      .......+|+.|+|||.......+.++|+||+|+++|+|++
T Consensus       160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~  200 (268)
T 3sxs_A          160 VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFS  200 (268)
T ss_dssp             EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHT
T ss_pred             hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHc
Confidence            23345667788999999888788999999999999999986

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=3.2e-39  Score=293.45  Aligned_cols=191  Identities=24%  Similarity=0.347  Sum_probs=167.5

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChH--HHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTAD--EIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIV  184 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv  184 (308)
                      .++|++.+.||+|+||.||+|+.. +|+.||+|.+......  ...+.+.+|+.+++.++||||+++++++.+. ..++|
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv   84 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   84 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence            357999999999999999999976 6899999998653211  2246778999999999999999999977665 57899


Q ss_pred             EEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCC
Q 021711          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (308)
Q Consensus       185 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  264 (308)
                      |||+++|+|.+++.. ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++..... 
T Consensus        85 ~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~-  159 (318)
T 1fot_A           85 MDYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-  159 (318)
T ss_dssp             ECCCCSCBHHHHHHH-TSSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred             EeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChheEEEcCCCCEEEeecCcceecCCc-
Confidence            999999999999965 4568999999999999999999998   89999999999999999999999999999976543 


Q ss_pred             ceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          265 THHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                          .....||+.|+|||.+.+..++.++|+||+|+++|||++|
T Consensus       160 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g  199 (318)
T 1fot_A          160 ----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAG  199 (318)
T ss_dssp             ----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHS
T ss_pred             ----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhC
Confidence                2346899999999998888889999999999999999876

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.6e-39  Score=299.93  Aligned_cols=198  Identities=23%  Similarity=0.299  Sum_probs=172.5

Q ss_pred             hhcCCccccceeeccCceEEEEEEEC--------CCcEEEEEEeccCChHHHHHHHHHHHHHHhcC-CCCeeeeeeeEEE
Q 021711          107 SATNNFSFENLIGKGGYAEVYKGRLR--------NGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGI  177 (308)
Q Consensus       107 ~~~~~~~~~~~LG~G~fg~Vy~~~~~--------~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  177 (308)
                      ...++|.+.+.||+|+||.||+|.+.        .+..||||++...........+.+|+.+++.+ +||||+++++++.
T Consensus        66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~  145 (382)
T 3tt0_A           66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT  145 (382)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence            44578999999999999999999863        23579999998766666678899999999999 9999999999877


Q ss_pred             eC-cEEEEEEecCCCCHHHHHhccC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCE
Q 021711          178 EG-GMHIVLELSPNGSLASLLYGMK---------------EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANI  241 (308)
Q Consensus       178 ~~-~~~lv~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NI  241 (308)
                      .. ..++||||+++|+|.+++....               ..+++..++.++.|++.||.|||+   .+|+||||||+||
T Consensus       146 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NI  222 (382)
T 3tt0_A          146 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNV  222 (382)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGE
T ss_pred             cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCcceE
Confidence            65 5799999999999999997543               358999999999999999999999   8999999999999


Q ss_pred             EECCCCcEEEeccccceecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          242 LLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       242 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      |++.++.+||+|||+++...............||+.|+|||.+.+...+.++|+||+|+++|||++
T Consensus       223 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt  288 (382)
T 3tt0_A          223 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT  288 (382)
T ss_dssp             EECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHT
T ss_pred             EEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHh
Confidence            999999999999999987755433333445678999999999888888999999999999999986

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=1.3e-38  Score=284.89  Aligned_cols=193  Identities=21%  Similarity=0.292  Sum_probs=166.2

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCC-hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEEE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLE  186 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e  186 (308)
                      ++|++.+.||+|+||.||+|.+. +|+.||+|.+.... .......+.+|+.+++.++||||+++++++.++ ..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            57999999999999999999986 58999999996543 233457889999999999999999999987665 4789999


Q ss_pred             ecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCce
Q 021711          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH  266 (308)
Q Consensus       187 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~  266 (308)
                      |+.+ +|.+.+......+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++....... 
T Consensus        82 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~---~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  156 (292)
T 3o0g_A           82 FCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-  156 (292)
T ss_dssp             CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS-
T ss_pred             cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecCCccc-
Confidence            9975 6666665656789999999999999999999999   8999999999999999999999999999998754322 


Q ss_pred             eEeeceeccccccccccCchhh-cCccceeEEEeeEEEeeccC
Q 021711          267 HTISKVEGTFGLVKLNLPPLVI-LKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~s~g~~l~el~c~  308 (308)
                       ......||+.|+|||...+.. ++.++|+||+|+++|||++|
T Consensus       157 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~  198 (292)
T 3o0g_A          157 -CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANA  198 (292)
T ss_dssp             -CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTT
T ss_pred             -cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHc
Confidence             234568899999999876554 78899999999999999864

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=3.4e-39  Score=290.80  Aligned_cols=199  Identities=24%  Similarity=0.340  Sum_probs=172.5

Q ss_pred             HhhcCCccccceeeccCceEEEEEEEC------CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC
Q 021711          106 QSATNNFSFENLIGKGGYAEVYKGRLR------NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG  179 (308)
Q Consensus       106 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~------~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  179 (308)
                      ....++|.+.+.||+|+||.||+|...      ++..||+|.+.........+.+.+|+.+++.++||||+++++++...
T Consensus        19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   98 (314)
T 2ivs_A           19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQD   98 (314)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             ccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecC
Confidence            344578999999999999999999862      35789999998766556678899999999999999999999987654


Q ss_pred             -cEEEEEEecCCCCHHHHHhccC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecC
Q 021711          180 -GMHIVLELSPNGSLASLLYGMK-----------------------EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRD  235 (308)
Q Consensus       180 -~~~lv~e~~~~gsL~~~l~~~~-----------------------~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrD  235 (308)
                       ..++||||+++++|.+++....                       ..+++..++.++.|++.||.|||+   ++|+|||
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~d  175 (314)
T 2ivs_A           99 GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLVHRD  175 (314)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH---TTEECCC
T ss_pred             CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH---CCCcccc
Confidence             5789999999999999996532                       237889999999999999999999   8999999


Q ss_pred             CCCCCEEECCCCcEEEeccccceecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          236 IKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       236 lKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      |||+|||++.++.+||+|||+++...............+|+.|+|||...+...+.++|+||+|+++|||++
T Consensus       176 ikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t  247 (314)
T 2ivs_A          176 LAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT  247 (314)
T ss_dssp             CSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHT
T ss_pred             cchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHh
Confidence            999999999999999999999998766544333445678899999999888788999999999999999986

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.4e-39  Score=294.99  Aligned_cols=199  Identities=23%  Similarity=0.283  Sum_probs=169.1

Q ss_pred             HhhcCCccccceeeccCceEEEEEEEC------CCcEEEEEEeccCChHHHHHHHHHHHHHHhcC-CCCeeeeeeeEEEe
Q 021711          106 QSATNNFSFENLIGKGGYAEVYKGRLR------NGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGIE  178 (308)
Q Consensus       106 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~------~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  178 (308)
                      ....++|.+.+.||+|+||.||+|.+.      ++..||+|.+.........+.+.+|+.++..+ +||||+++++++..
T Consensus        41 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  120 (344)
T 1rjb_A           41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL  120 (344)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             ccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence            345678999999999999999999862      35689999997654444567899999999999 89999999998765


Q ss_pred             C-cEEEEEEecCCCCHHHHHhccCC----------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecC
Q 021711          179 G-GMHIVLELSPNGSLASLLYGMKE----------------------KLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRD  235 (308)
Q Consensus       179 ~-~~~lv~e~~~~gsL~~~l~~~~~----------------------~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrD  235 (308)
                      . ..++||||+++|+|.+++.....                      .+++..++.++.||+.||.|||+   ++|+|||
T Consensus       121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~D  197 (344)
T 1rjb_A          121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRD  197 (344)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETT
T ss_pred             CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCcccCC
Confidence            4 57899999999999999975432                      37889999999999999999999   8999999


Q ss_pred             CCCCCEEECCCCcEEEeccccceecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          236 IKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       236 lKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      |||+|||++.++.+||+|||+++.+.............||+.|+|||.+.+..++.++|+||+|+++|||++
T Consensus       198 ikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t  269 (344)
T 1rjb_A          198 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS  269 (344)
T ss_dssp             CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTT
T ss_pred             CChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHc
Confidence            999999999999999999999987765544444456778999999999888888999999999999999986

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=2.9e-39  Score=289.38  Aligned_cols=197  Identities=26%  Similarity=0.373  Sum_probs=165.7

Q ss_pred             hcCCccccceeeccCceEEEEEEEC-----CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEe---C
Q 021711          108 ATNNFSFENLIGKGGYAEVYKGRLR-----NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE---G  179 (308)
Q Consensus       108 ~~~~~~~~~~LG~G~fg~Vy~~~~~-----~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---~  179 (308)
                      ..++|++.+.||+|+||.||+|++.     +++.||||.+..... ...+.+.+|+.+++.++||||+++++++..   .
T Consensus         8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   86 (295)
T 3ugc_A            8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE-EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR   86 (295)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCH-HHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHT
T ss_pred             CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence            3468999999999999999999842     588999999976543 446789999999999999999999998754   3


Q ss_pred             cEEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEecccccee
Q 021711          180 GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKW  259 (308)
Q Consensus       180 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~  259 (308)
                      ..++||||+++|+|.+++......+++..++.++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++.
T Consensus        87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~  163 (295)
T 3ugc_A           87 NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKV  163 (295)
T ss_dssp             SCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred             ceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHhhEEEcCCCeEEEccCccccc
Confidence            4799999999999999997766679999999999999999999999   9999999999999999999999999999998


Q ss_pred             cCCCCce-eEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          260 LPEQWTH-HTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       260 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ....... .......||..|+|||.+.+..++.++|+||+|+++|||++|
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g  213 (295)
T 3ugc_A          164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTY  213 (295)
T ss_dssp             ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHT
T ss_pred             ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhc
Confidence            7554322 122345678889999998888889999999999999999874

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1.4e-39  Score=309.45  Aligned_cols=199  Identities=22%  Similarity=0.325  Sum_probs=173.0

Q ss_pred             HHHHhhcCCccccceeeccCceEEEEEEECCCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeCcEE
Q 021711          103 YELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMH  182 (308)
Q Consensus       103 ~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  182 (308)
                      .++....++|++.+.||+|+||.||+|.+.++..||||.++.....  .+.|.+|+.+|+.++||||+++++++.....+
T Consensus       181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~  258 (454)
T 1qcf_A          181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS--VEAFLAEANVMKTLQHDKLVKLHAVVTKEPIY  258 (454)
T ss_dssp             TCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBC--HHHHHHHHHHHTTCCCTTBCCEEEEECSSSCE
T ss_pred             cceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCcc--HHHHHHHHHHHhhCCCCCEeeEEEEEeCCccE
Confidence            4455667789999999999999999999988889999999765432  57899999999999999999999998888899


Q ss_pred             EEEEecCCCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecC
Q 021711          183 IVLELSPNGSLASLLYGMK-EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP  261 (308)
Q Consensus       183 lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~  261 (308)
                      +||||+++|+|.+++.... ..+++..++.++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++...
T Consensus       259 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~  335 (454)
T 1qcf_A          259 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIE  335 (454)
T ss_dssp             EEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTCCEEECSTTGGGGBC
T ss_pred             EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEECCCCcEEEeeCCCceEcC
Confidence            9999999999999996532 368899999999999999999999   899999999999999999999999999998765


Q ss_pred             CCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          262 EQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       262 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      .... .......+|+.|+|||.+....++.++|+||||++||||++
T Consensus       336 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t  380 (454)
T 1qcf_A          336 DNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVT  380 (454)
T ss_dssp             CHHH-HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred             CCce-eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHh
Confidence            4211 11223457889999999887788999999999999999986

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=4.9e-39  Score=296.34  Aligned_cols=195  Identities=21%  Similarity=0.255  Sum_probs=167.7

Q ss_pred             hcCCccccceeeccCceEEEEEEECC-CcEEEEEEeccCCh--HHHHHHHHHHHHHHhcC-CCCeeeeeeeEEEeC-cEE
Q 021711          108 ATNNFSFENLIGKGGYAEVYKGRLRN-GQLVAIKRLTRGTA--DEIIADFLSELGIMAHV-DHPNTAKLLGYGIEG-GMH  182 (308)
Q Consensus       108 ~~~~~~~~~~LG~G~fg~Vy~~~~~~-g~~vAvK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~~~  182 (308)
                      ..++|++.++||+|+||.||+|+... |+.||||.+.....  ....+.+.+|..++..+ +||||+++++++... .++
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~   97 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY   97 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence            45789999999999999999999874 88999999865321  12346788999999988 799999999977664 578


Q ss_pred             EEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCC
Q 021711          183 IVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE  262 (308)
Q Consensus       183 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~  262 (308)
                      +||||+++|+|.+++.. ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++....
T Consensus        98 lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  173 (353)
T 2i0e_A           98 FVMEYVNGGDLMYHIQQ-VGRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW  173 (353)
T ss_dssp             EEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence            99999999999999864 3569999999999999999999999   8999999999999999999999999999986433


Q ss_pred             CCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          263 QWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       263 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ...  ......||+.|+|||.+.+..++.++|+||+|+++|||++|
T Consensus       174 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G  217 (353)
T 2i0e_A          174 DGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAG  217 (353)
T ss_dssp             TTC--CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHS
T ss_pred             CCc--ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcC
Confidence            221  23467899999999998888889999999999999999876

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=7.5e-39  Score=288.39  Aligned_cols=200  Identities=24%  Similarity=0.291  Sum_probs=173.9

Q ss_pred             HHhhcCCccccceeeccCceEEEEEEE------CCCcEEEEEEeccCChHHHHHHHHHHHHHHhcC-CCCeeeeeeeEEE
Q 021711          105 LQSATNNFSFENLIGKGGYAEVYKGRL------RNGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGI  177 (308)
Q Consensus       105 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~------~~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  177 (308)
                      +....++|++.+.||+|+||.||+|.+      .+++.||+|.+.........+.+.+|+.++..+ +||||+++++++.
T Consensus        18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   97 (313)
T 1t46_A           18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT   97 (313)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEe
Confidence            344557899999999999999999985      246899999998765555568899999999999 9999999999876


Q ss_pred             eC-cEEEEEEecCCCCHHHHHhccCC-----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCC
Q 021711          178 EG-GMHIVLELSPNGSLASLLYGMKE-----------------KLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAA  239 (308)
Q Consensus       178 ~~-~~~lv~e~~~~gsL~~~l~~~~~-----------------~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~  239 (308)
                      .+ ..++||||+++|+|.+++.....                 .+++..++.++.|++.||.|||+   ++|+||||||+
T Consensus        98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~  174 (313)
T 1t46_A           98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAAR  174 (313)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGG
T ss_pred             cCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccc
Confidence            54 57899999999999999975432                 48999999999999999999999   89999999999


Q ss_pred             CEEECCCCcEEEeccccceecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          240 NILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       240 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      |||++.++.+||+|||+++...............||+.|+|||.+.....+.++|+||+|+++|||++
T Consensus       175 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt  242 (313)
T 1t46_A          175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS  242 (313)
T ss_dssp             GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred             eEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHh
Confidence            99999999999999999998766544444456678899999999888888999999999999999986

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-38  Score=296.16  Aligned_cols=193  Identities=21%  Similarity=0.215  Sum_probs=169.2

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEEE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLE  186 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e  186 (308)
                      .++|++.+.||+|+||.||+|... +|+.||+|.+...... ....+.+|+.+++.++||||+++++++.+. ..++|||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~-~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E  128 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL-DKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE  128 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH-HHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchh-hHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEE
Confidence            358999999999999999999976 5899999998765433 346788999999999999999999987665 5789999


Q ss_pred             ecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECC--CCcEEEeccccceecCCCC
Q 021711          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTE--DFEPQICDFGLAKWLPEQW  264 (308)
Q Consensus       187 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~--~~~~kl~DFGla~~~~~~~  264 (308)
                      |+.+|+|.+++......+++..+..++.||+.||.|||+   ++|+||||||+|||++.  ++.+||+|||+++.+....
T Consensus       129 ~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~  205 (387)
T 1kob_A          129 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE  205 (387)
T ss_dssp             CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred             cCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccchHHeEEecCCCCceEEEecccceecCCCc
Confidence            999999999997656679999999999999999999999   89999999999999974  4689999999999876543


Q ss_pred             ceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          265 THHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      .   .....||+.|+|||.+.....+.++|+||+|+++|||++|
T Consensus       206 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg  246 (387)
T 1kob_A          206 I---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG  246 (387)
T ss_dssp             C---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHS
T ss_pred             c---eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhC
Confidence            2   2345799999999998887788999999999999999876

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=8.1e-39  Score=287.03  Aligned_cols=193  Identities=24%  Similarity=0.332  Sum_probs=161.6

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChH-------------------------HHHHHHHHHHHHHh
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTAD-------------------------EIIADFLSELGIMA  162 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~-------------------------~~~~~~~~E~~~l~  162 (308)
                      .++|++.+.||+|+||.||+|... +++.||||.+......                         ...+.+.+|+.+++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            468999999999999999999976 5889999998654211                         12356899999999


Q ss_pred             cCCCCeeeeeeeEEEe---CcEEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCC
Q 021711          163 HVDHPNTAKLLGYGIE---GGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAA  239 (308)
Q Consensus       163 ~l~h~niv~l~~~~~~---~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~  239 (308)
                      .++||||+++++++..   ...++||||+++++|.+++  ....+++..+..++.|++.||.|||+   ++|+||||||+
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~  166 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP--TLKPLSEDQARFYFQDLIKGIEYLHY---QKIIHRDIKPS  166 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS--CSSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGG
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHH
Confidence            9999999999998775   3478999999999998765  34579999999999999999999999   89999999999


Q ss_pred             CEEECCCCcEEEeccccceecCCCCceeEeeceeccccccccccCchhh---cCccceeEEEeeEEEeeccC
Q 021711          240 NILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPLVI---LKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       240 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Di~s~g~~l~el~c~  308 (308)
                      |||++.++.+||+|||+++.+.....  ......||+.|+|||.+.+..   .+.++|+||+|+++|+|++|
T Consensus       167 Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g  236 (298)
T 2zv2_A          167 NLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFG  236 (298)
T ss_dssp             GEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHS
T ss_pred             HEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHC
Confidence            99999999999999999998755432  334568999999999886554   36788999999999999875

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=6.4e-39  Score=295.21  Aligned_cols=190  Identities=21%  Similarity=0.238  Sum_probs=167.3

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCCh--HHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVL  185 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~  185 (308)
                      ++|++.+.||+|+||.||+|+.. +|+.||+|.+.....  ....+.+.+|+.+++.++||||+++++++.+. ..++||
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  120 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            57999999999999999999976 589999999864321  12356788999999999999999999977654 578999


Q ss_pred             EecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCc
Q 021711          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (308)
Q Consensus       186 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~  265 (308)
                      ||+++|+|.+++.. ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++.....  
T Consensus       121 e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~--  194 (350)
T 1rdq_E          121 EYVAGGEMFSHLRR-IGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--  194 (350)
T ss_dssp             ECCTTCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred             cCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCccceEEECCCCCEEEcccccceeccCC--
Confidence            99999999999965 3568999999999999999999999   99999999999999999999999999999977543  


Q ss_pred             eeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          266 HHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                         .....||+.|+|||.+.+..++.++|+||+|+++|||++|
T Consensus       195 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g  234 (350)
T 1rdq_E          195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAG  234 (350)
T ss_dssp             ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHS
T ss_pred             ---cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhC
Confidence               2346899999999998888889999999999999999876

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=6.4e-39  Score=292.20  Aligned_cols=194  Identities=24%  Similarity=0.284  Sum_probs=157.8

Q ss_pred             cCCccccceeeccCceEEEEEEE----CCCcEEEEEEeccCCh---HHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-c
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRL----RNGQLVAIKRLTRGTA---DEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-G  180 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~----~~g~~vAvK~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~  180 (308)
                      .++|++.+.||+|+||.||+|+.    .+|+.||+|.+.....   ......+.+|+.+++.++||||+++++++... .
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            46899999999999999999987    3689999999975431   22345688999999999999999999977654 5


Q ss_pred             EEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceec
Q 021711          181 MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL  260 (308)
Q Consensus       181 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~  260 (308)
                      .++||||+++++|.+++.. ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++..
T Consensus        96 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~  171 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLER-EGIFMEDTACFYLAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKES  171 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred             EEEEEeCCCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHh---CCEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence            8999999999999999864 4568899999999999999999999   89999999999999999999999999999865


Q ss_pred             CCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          261 PEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       261 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      .....  ......||+.|+|||.+.+...+.++|+||+|+++|||++|
T Consensus       172 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g  217 (327)
T 3a62_A          172 IHDGT--VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTG  217 (327)
T ss_dssp             ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHS
T ss_pred             ccCCc--cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHC
Confidence            43321  23456899999999998877788999999999999999875

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1e-38  Score=295.06  Aligned_cols=193  Identities=21%  Similarity=0.254  Sum_probs=168.1

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCC-hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVL  185 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~  185 (308)
                      .++|++.+.||+|+||.||+|... +|+.||+|.+.... .....+.+.+|+.+++.++||||+++++++.+. ..++||
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~  107 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF  107 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            357999999999999999999976 58999999997543 334467899999999999999999999987765 478999


Q ss_pred             EecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCC---cEEEeccccceecCC
Q 021711          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDF---EPQICDFGLAKWLPE  262 (308)
Q Consensus       186 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~---~~kl~DFGla~~~~~  262 (308)
                      ||+++|+|.+.+.. ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.++   .+||+|||+++....
T Consensus       108 e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~  183 (362)
T 2bdw_A          108 DLVTGGELFEDIVA-REFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND  183 (362)
T ss_dssp             CCCCSCBHHHHHTT-CSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTT
T ss_pred             ecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEeecCcceEecC
Confidence            99999999998854 4568999999999999999999999   8999999999999998654   599999999987754


Q ss_pred             CCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          263 QWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       263 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ..   ......||+.|+|||.+.+..++.++|+||+|+++|+|++|
T Consensus       184 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g  226 (362)
T 2bdw_A          184 SE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG  226 (362)
T ss_dssp             CC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred             Cc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHC
Confidence            32   23456899999999998877788999999999999999886

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=3.9e-39  Score=284.78  Aligned_cols=194  Identities=23%  Similarity=0.355  Sum_probs=170.0

Q ss_pred             hcCCccccceeeccCceEEEEEEECCCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEEE
Q 021711          108 ATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLE  186 (308)
Q Consensus       108 ~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e  186 (308)
                      ..++|++.+.||+|+||.||+|.+.+++.||+|.+......  .+++.+|+.+++.++||||+++++++.+. ..++|||
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (269)
T 4hcu_A            8 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE   85 (269)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBC--HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             ChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccC--HHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEE
Confidence            34689999999999999999999988899999999765433  25789999999999999999999987664 5789999


Q ss_pred             ecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCce
Q 021711          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH  266 (308)
Q Consensus       187 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~  266 (308)
                      |+++++|.+++......+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.+||+|||+++....... 
T Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  161 (269)
T 4hcu_A           86 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-  161 (269)
T ss_dssp             CCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH-
T ss_pred             eCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHh---CCeecCCcchheEEEcCCCCEEecccccccccccccc-
Confidence            999999999997766779999999999999999999999   8999999999999999999999999999987654321 


Q ss_pred             eEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          267 HTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      .......||+.|+|||.......+.++|+||+|+++|+|++
T Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~  202 (269)
T 4hcu_A          162 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFS  202 (269)
T ss_dssp             HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred             ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhc
Confidence            12234567889999999888888999999999999999986

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.4e-39  Score=293.99  Aligned_cols=196  Identities=27%  Similarity=0.405  Sum_probs=162.9

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCc----EEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeCcEEE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQ----LVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHI  183 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~----~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l  183 (308)
                      .++|++.+.||+|+||.||+|.+. +++    .||+|.+...........+.+|+.+++.++||||+++++++..+..++
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   93 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQL   93 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSSEEE
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCCceE
Confidence            468999999999999999999975 344    367887765444344578899999999999999999999999989999


Q ss_pred             EEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCC
Q 021711          184 VLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ  263 (308)
Q Consensus       184 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  263 (308)
                      |+||+.+|+|.+++......+++..++.++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++.+...
T Consensus        94 v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~  170 (327)
T 3lzb_A           94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE  170 (327)
T ss_dssp             EECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTC-------
T ss_pred             EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh---CCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCc
Confidence            999999999999998777789999999999999999999999   89999999999999999999999999999987654


Q ss_pred             CceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          264 WTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      ..........||+.|+|||.+.+..++.++|+||+|+++|||++
T Consensus       171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~  214 (327)
T 3lzb_A          171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT  214 (327)
T ss_dssp             ---------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred             cccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHH
Confidence            44334445667889999999988888999999999999999886

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=6.6e-39  Score=286.40  Aligned_cols=193  Identities=23%  Similarity=0.300  Sum_probs=163.1

Q ss_pred             CCccccceeeccCceEEEEEEECCCcEEEEEEeccCChH-HHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEEEe
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTAD-EIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLEL  187 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~  187 (308)
                      ++|++.+.||+|+||.||+|+..+|+.||+|.+...... .....+.+|+.+++.++||||+++++++... ..++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            579999999999999999999988999999998654332 2346788999999999999999999977654 57899999


Q ss_pred             cCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCcee
Q 021711          188 SPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH  267 (308)
Q Consensus       188 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~  267 (308)
                      +.+ +|.+++......+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++.......  
T Consensus        82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--  155 (288)
T 1ob3_A           82 LDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR--  155 (288)
T ss_dssp             CSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred             cCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEeECccccccCcccc--
Confidence            975 9999987666789999999999999999999999   8999999999999999999999999999987654322  


Q ss_pred             EeeceeccccccccccCchh-hcCccceeEEEeeEEEeeccC
Q 021711          268 TISKVEGTFGLVKLNLPPLV-ILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ......||+.|+|||.+.+. ..+.++|+||+|+++|||++|
T Consensus       156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g  197 (288)
T 1ob3_A          156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG  197 (288)
T ss_dssp             ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHS
T ss_pred             ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhC
Confidence            23456789999999987653 478899999999999999875

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.6e-39  Score=300.83  Aligned_cols=196  Identities=26%  Similarity=0.295  Sum_probs=167.0

Q ss_pred             cCCccccceeeccCceEEEEEEEC------CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR------NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GM  181 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~------~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~  181 (308)
                      .++|++.+.||+|+||.||+|.+.      +++.||||.+...........+.+|+.+++.++||||+++++++... ..
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  149 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  149 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            468999999999999999999853      36789999997665555567899999999999999999999987665 57


Q ss_pred             EEEEEecCCCCHHHHHhccC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCC---cEEEe
Q 021711          182 HIVLELSPNGSLASLLYGMK------EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDF---EPQIC  252 (308)
Q Consensus       182 ~lv~e~~~~gsL~~~l~~~~------~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~---~~kl~  252 (308)
                      ++||||+++|+|.+++....      ..+++..++.++.||+.||.|||+   ++|+||||||+|||++.++   .+||+
T Consensus       150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kL~  226 (367)
T 3l9p_A          150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIG  226 (367)
T ss_dssp             EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEEecCCCCceEEEC
Confidence            89999999999999997533      358999999999999999999999   8999999999999999554   59999


Q ss_pred             ccccceecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          253 DFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       253 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      |||+++.+.............||+.|+|||.+.+..++.++|+||+|+++|||++
T Consensus       227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt  281 (367)
T 3l9p_A          227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS  281 (367)
T ss_dssp             CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred             CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHh
Confidence            9999986533222122234678999999999888888999999999999999986

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=4.5e-38  Score=282.99  Aligned_cols=208  Identities=37%  Similarity=0.553  Sum_probs=178.4

Q ss_pred             CccccCHHHHHhhcCCcccc------ceeeccCceEEEEEEECCCcEEEEEEeccCC---hHHHHHHHHHHHHHHhcCCC
Q 021711           96 PQKIFSLYELQSATNNFSFE------NLIGKGGYAEVYKGRLRNGQLVAIKRLTRGT---ADEIIADFLSELGIMAHVDH  166 (308)
Q Consensus        96 ~~~~~~~~~~~~~~~~~~~~------~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~---~~~~~~~~~~E~~~l~~l~h  166 (308)
                      ....|++.++...+++|...      +.||+|+||.||+|.. +++.||+|.+....   ..+..+.+.+|+.+++.++|
T Consensus        11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h   89 (307)
T 2nru_A           11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH   89 (307)
T ss_dssp             CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred             CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence            34577888999988888776      8999999999999987 58899999986432   23456789999999999999


Q ss_pred             CeeeeeeeEEEeC-cEEEEEEecCCCCHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEE
Q 021711          167 PNTAKLLGYGIEG-GMHIVLELSPNGSLASLLYGM--KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILL  243 (308)
Q Consensus       167 ~niv~l~~~~~~~-~~~lv~e~~~~gsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl  243 (308)
                      |||+++++++... ..++||||+++++|.+++...  ...+++..++.++.|++.||.|||+   ++|+||||||+|||+
T Consensus        90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nili  166 (307)
T 2nru_A           90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANILL  166 (307)
T ss_dssp             TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEE
T ss_pred             CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecCCCCHHHEEE
Confidence            9999999987654 579999999999999998642  3468999999999999999999999   899999999999999


Q ss_pred             CCCCcEEEeccccceecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          244 TEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       244 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      +.++.+||+|||+++...............||+.|+|||...+ ..+.++|+||+|+++|+|++|
T Consensus       167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g  230 (307)
T 2nru_A          167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITG  230 (307)
T ss_dssp             CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHC
T ss_pred             cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHC
Confidence            9999999999999998765444334455789999999998754 467889999999999999875

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1e-38  Score=293.75  Aligned_cols=194  Identities=21%  Similarity=0.213  Sum_probs=165.3

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCCh----HHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA----DEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHI  183 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l  183 (308)
                      ++|++.+.||+|+||.||+|... +|+.||||.+.....    ....+.+.+|+.+++.++||||+++++++... ..++
T Consensus        24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  103 (351)
T 3c0i_A           24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM  103 (351)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            47999999999999999999976 589999999853211    11246789999999999999999999977665 5789


Q ss_pred             EEEecCCCCHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCc---EEEeccccc
Q 021711          184 VLELSPNGSLASLLYGM---KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFE---PQICDFGLA  257 (308)
Q Consensus       184 v~e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~---~kl~DFGla  257 (308)
                      ||||+++++|.+.+...   ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.   +||+|||++
T Consensus       104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a  180 (351)
T 3c0i_A          104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVA  180 (351)
T ss_dssp             EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred             EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChHHeEEecCCCCCcEEEecCcce
Confidence            99999999998877542   3358999999999999999999999   89999999999999987654   999999999


Q ss_pred             eecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          258 KWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      +.+.....  ......||+.|+|||.+....++.++|+||+|+++|+|++|
T Consensus       181 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g  229 (351)
T 3c0i_A          181 IQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG  229 (351)
T ss_dssp             EECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHS
T ss_pred             eEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHC
Confidence            98765432  23456799999999998877789999999999999999876

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=7.2e-39  Score=290.41  Aligned_cols=194  Identities=22%  Similarity=0.309  Sum_probs=152.2

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEEE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLE  186 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e  186 (308)
                      .++|++.+.||+|+||.||+|... +|+.||+|.+...........+.+|+.+++.++||||+++++++... ..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            468999999999999999999876 58999999997554333346788999999999999999999987665 5789999


Q ss_pred             ecCCCCHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecC
Q 021711          187 LSPNGSLASLLYGMK-----EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP  261 (308)
Q Consensus       187 ~~~~gsL~~~l~~~~-----~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~  261 (308)
                      |++ |+|.+++....     ..+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++...
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            998 59999886432     458999999999999999999999   899999999999999999999999999999875


Q ss_pred             CCCceeEeeceeccccccccccCchh-hcCccceeEEEeeEEEeeccC
Q 021711          262 EQWTHHTISKVEGTFGLVKLNLPPLV-ILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       262 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ....  ......||+.|+|||.+.+. .++.++|+||+|+++|||++|
T Consensus       160 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g  205 (317)
T 2pmi_A          160 IPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITG  205 (317)
T ss_dssp             SCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHS
T ss_pred             CCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhC
Confidence            4322  23456799999999987653 578899999999999999875

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=1.5e-38  Score=301.52  Aligned_cols=194  Identities=20%  Similarity=0.208  Sum_probs=167.5

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCC-hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVL  185 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~  185 (308)
                      .++|++.+.||+|+||.||+|... +|+.+|+|.+.... .....+.+.+|+.+++.++||||+++++++.+. ..++||
T Consensus        10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~   89 (444)
T 3soa_A           10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF   89 (444)
T ss_dssp             HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence            457999999999999999999876 68999999997543 334467789999999999999999999977765 478999


Q ss_pred             EecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEEC---CCCcEEEeccccceecCC
Q 021711          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLT---EDFEPQICDFGLAKWLPE  262 (308)
Q Consensus       186 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~---~~~~~kl~DFGla~~~~~  262 (308)
                      ||+.+|+|.+.+.. ...+++..+..++.||+.||.|||+   ++|+||||||+|||++   .++.+||+|||+++....
T Consensus        90 E~~~gg~L~~~i~~-~~~~~e~~~~~i~~qil~aL~~lH~---~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~  165 (444)
T 3soa_A           90 DLVTGGELFEDIVA-REYYSEADASHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG  165 (444)
T ss_dssp             CCCBCCBHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCT
T ss_pred             EeCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEeccCCCCcEEEccCceeEEecC
Confidence            99999999998865 4569999999999999999999999   8999999999999998   457899999999987755


Q ss_pred             CCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          263 QWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       263 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ...  ......||+.|+|||.+....++.++|+||+|+++|+|++|
T Consensus       166 ~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G  209 (444)
T 3soa_A          166 EQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVG  209 (444)
T ss_dssp             TCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHS
T ss_pred             CCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhC
Confidence            422  23457899999999998887889999999999999999886

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=6e-39  Score=286.83  Aligned_cols=197  Identities=26%  Similarity=0.360  Sum_probs=158.2

Q ss_pred             hhcCCccccceeeccCceEEEEEEECCCcEEEEEEeccCC-hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeCcEEEEE
Q 021711          107 SATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHIVL  185 (308)
Q Consensus       107 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~lv~  185 (308)
                      ...++|++.+.||+|+||.||+|.+.  ..||+|.+.... .....+.|.+|+.+++.++||||+++++++.....++||
T Consensus        21 i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~lv~   98 (289)
T 3og7_A           21 IPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVT   98 (289)
T ss_dssp             CCTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEE
T ss_pred             cCccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccCCccEEEE
Confidence            44578999999999999999999864  359999986543 334567899999999999999999999998888899999


Q ss_pred             EecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCc
Q 021711          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (308)
Q Consensus       186 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~  265 (308)
                      ||+.+++|.+++......+++..++.++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++.......
T Consensus        99 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  175 (289)
T 3og7_A           99 QWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG  175 (289)
T ss_dssp             ECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEECCCC----------
T ss_pred             EecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEECCCCCEEEccceeccccccccc
Confidence            9999999999997767779999999999999999999999   8999999999999999999999999999987654333


Q ss_pred             eeEeeceeccccccccccCc---hhhcCccceeEEEeeEEEeeccC
Q 021711          266 HHTISKVEGTFGLVKLNLPP---LVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ........||+.|+|||.+.   ...++.++|+||+|+++|+|++|
T Consensus       176 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g  221 (289)
T 3og7_A          176 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTG  221 (289)
T ss_dssp             --------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHS
T ss_pred             cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHC
Confidence            33445678999999999875   44567789999999999999875

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1e-38  Score=287.93  Aligned_cols=204  Identities=23%  Similarity=0.312  Sum_probs=176.3

Q ss_pred             CHHHHHhhcCCccccceeeccCceEEEEEEE------CCCcEEEEEEeccCChHHHHHHHHHHHHHHhcC-CCCeeeeee
Q 021711          101 SLYELQSATNNFSFENLIGKGGYAEVYKGRL------RNGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLL  173 (308)
Q Consensus       101 ~~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~------~~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~  173 (308)
                      ...++....++|++.+.||+|+||.||+|.+      .+++.||||.+.........+.+.+|+.++..+ +||||++++
T Consensus        18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~   97 (316)
T 2xir_A           18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL   97 (316)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence            3445566678999999999999999999984      246899999998766555667899999999999 799999999


Q ss_pred             eEEEeC--cEEEEEEecCCCCHHHHHhccCC---------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCC
Q 021711          174 GYGIEG--GMHIVLELSPNGSLASLLYGMKE---------------KLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDI  236 (308)
Q Consensus       174 ~~~~~~--~~~lv~e~~~~gsL~~~l~~~~~---------------~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDl  236 (308)
                      +++...  ..++||||+++|+|.+++.....               .+++..+..++.|++.||.|||+   ++|+||||
T Consensus        98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~di  174 (316)
T 2xir_A           98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDL  174 (316)
T ss_dssp             EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH---TTCCCSCC
T ss_pred             EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh---CCcccccC
Confidence            987654  37899999999999999975432               27889999999999999999999   89999999


Q ss_pred             CCCCEEECCCCcEEEeccccceecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          237 KAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       237 Kp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      ||+|||++.++.+||+|||+++.+.............||+.|+|||.+.....+.++|+||+|+++|+|++
T Consensus       175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t  245 (316)
T 2xir_A          175 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS  245 (316)
T ss_dssp             SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred             ccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHh
Confidence            99999999999999999999998765544444556788999999999888788999999999999999986

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=5.2e-39  Score=290.29  Aligned_cols=196  Identities=20%  Similarity=0.264  Sum_probs=161.0

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCC--hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeCc-----
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG-----  180 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----  180 (308)
                      .++|++.+.||+|+||.||+|++. +++.||||.+....  .......+.+|+.++..++||||+++++++....     
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            468999999999999999999975 68999999997543  3345678999999999999999999999765432     


Q ss_pred             EEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceec
Q 021711          181 MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL  260 (308)
Q Consensus       181 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~  260 (308)
                      .++||||+++++|.+++.. ...+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++.+
T Consensus        91 ~~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  166 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAI  166 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEETTSCEEECCCSCC---
T ss_pred             cEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEcCCCCEEEeeccCcccc
Confidence            4899999999999999964 4568999999999999999999999   89999999999999999999999999999876


Q ss_pred             CCCCce-eEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          261 PEQWTH-HTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       261 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ...... .......||+.|+|||.+.+...+.++|+||+|+++|||++|
T Consensus       167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g  215 (311)
T 3ork_A          167 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG  215 (311)
T ss_dssp             ---------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHS
T ss_pred             cccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhC
Confidence            543222 122346799999999998888888999999999999999875

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.2e-38  Score=285.97  Aligned_cols=196  Identities=24%  Similarity=0.336  Sum_probs=168.3

Q ss_pred             CCccccceeeccCceEEEEEEE-----CCCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC---cE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRL-----RNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG---GM  181 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~-----~~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---~~  181 (308)
                      +.|++.+.||+|+||.||+|++     .+++.||+|.+.........+.+.+|+.+++.++||||+++++++...   ..
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  100 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI  100 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence            4688999999999999999984     258899999997654444457889999999999999999999987653   47


Q ss_pred             EEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecC
Q 021711          182 HIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP  261 (308)
Q Consensus       182 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~  261 (308)
                      ++||||+++|+|.+++......+++..++.++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++...
T Consensus       101 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~  177 (302)
T 4e5w_A          101 KLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE  177 (302)
T ss_dssp             EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred             EEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhc---CCcccCCCchheEEEcCCCCEEECccccccccc
Confidence            89999999999999997767789999999999999999999999   999999999999999999999999999999876


Q ss_pred             CCCce-eEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          262 EQWTH-HTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       262 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ..... .......||..|+|||.+.+...+.++|+||+|+++|+|++|
T Consensus       178 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g  225 (302)
T 4e5w_A          178 TDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTY  225 (302)
T ss_dssp             TTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTT
T ss_pred             CCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHc
Confidence            55432 223356788999999998888888899999999999999874

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=4.3e-39  Score=291.56  Aligned_cols=202  Identities=22%  Similarity=0.331  Sum_probs=172.7

Q ss_pred             HHHHhhcCCccccceeeccCceEEEEEEEC------CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEE
Q 021711          103 YELQSATNNFSFENLIGKGGYAEVYKGRLR------NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYG  176 (308)
Q Consensus       103 ~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~------~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  176 (308)
                      .++....++|++.+.||+|+||.||+|.+.      +++.||+|.+...........+.+|+.+++.++||||+++++++
T Consensus        18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   97 (322)
T 1p4o_A           18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV   97 (322)
T ss_dssp             CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred             hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence            344566789999999999999999999764      36789999997665555567899999999999999999999987


Q ss_pred             EeC-cEEEEEEecCCCCHHHHHhccC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCC
Q 021711          177 IEG-GMHIVLELSPNGSLASLLYGMK---------EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTED  246 (308)
Q Consensus       177 ~~~-~~~lv~e~~~~gsL~~~l~~~~---------~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~  246 (308)
                      ..+ ..++||||+++|+|.+++....         ..+++..++.++.|++.||.|||+   ++|+||||||+|||++.+
T Consensus        98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~NIli~~~  174 (322)
T 1p4o_A           98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAED  174 (322)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTT
T ss_pred             ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCCccCCCccceEEEcCC
Confidence            664 5789999999999999986422         457899999999999999999999   899999999999999999


Q ss_pred             CcEEEeccccceecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          247 FEPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       247 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      +.+||+|||+++...............||+.|+|||.+.+...+.++|+||+|+++|+|++
T Consensus       175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~  235 (322)
T 1p4o_A          175 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT  235 (322)
T ss_dssp             CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHH
T ss_pred             CeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHh
Confidence            9999999999987654332222334567899999999887788999999999999999986

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=7.4e-39  Score=291.64  Aligned_cols=193  Identities=22%  Similarity=0.236  Sum_probs=167.4

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcC-CCCeeeeeeeEEEeCc-EEEEE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGIEGG-MHIVL  185 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~-~~lv~  185 (308)
                      .++|++.+.||+|+||.||+|... +|+.||||.+......   +.+.+|+.+++.+ +||||+++++++..+. .++||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~   84 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA---PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVL   84 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS---CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch---HHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEE
Confidence            468999999999999999999974 6899999998654322   3577899999999 9999999999877765 68999


Q ss_pred             EecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCc-----EEEeccccceec
Q 021711          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFE-----PQICDFGLAKWL  260 (308)
Q Consensus       186 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~-----~kl~DFGla~~~  260 (308)
                      ||+ +++|.+++......+++..++.++.|++.||.|||+   .+|+||||||+|||++.++.     +||+|||+++.+
T Consensus        85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~  160 (330)
T 2izr_A           85 ELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY  160 (330)
T ss_dssp             ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred             EeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence            999 999999997666789999999999999999999999   89999999999999998887     999999999986


Q ss_pred             CCCCcee-----EeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          261 PEQWTHH-----TISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       261 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      .......     ......||+.|+|||.+.+..++.++|+||||+++|||++|
T Consensus       161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g  213 (330)
T 2izr_A          161 IDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRG  213 (330)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHS
T ss_pred             ecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcC
Confidence            5433211     12467899999999998888889999999999999999876

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=3e-38  Score=287.66  Aligned_cols=192  Identities=26%  Similarity=0.296  Sum_probs=167.6

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChH-----HHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTAD-----EIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMH  182 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~  182 (308)
                      ++|.+.+.||+|+||.||+|... +|+.||+|.+......     ...+.+.+|+.+++.++||||+++++++... ..+
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   90 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   90 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            47899999999999999999976 5899999998654321     1256789999999999999999999977765 578


Q ss_pred             EEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCC----cEEEeccccce
Q 021711          183 IVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDF----EPQICDFGLAK  258 (308)
Q Consensus       183 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~----~~kl~DFGla~  258 (308)
                      +||||+++++|.+++.. ...+++..+..++.|++.||.|||+   .+|+||||||+|||++.++    .+||+|||+++
T Consensus        91 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~  166 (326)
T 2y0a_A           91 LILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH  166 (326)
T ss_dssp             EEEECCCSCBHHHHHTT-SSCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred             EEEEcCCCCCHHHHHHh-cCCcCHHHHHHHHHHHHHHHHHHHH---CCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence            99999999999999954 4578999999999999999999999   8999999999999999887    89999999999


Q ss_pred             ecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          259 WLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       259 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      .+.....   .....||+.|+|||.+....++.++|+||+|+++|+|++|
T Consensus       167 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g  213 (326)
T 2y0a_A          167 KIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG  213 (326)
T ss_dssp             ECCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred             ECCCCCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHC
Confidence            8754422   2456799999999998877788999999999999999875

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.3e-38  Score=281.53  Aligned_cols=196  Identities=24%  Similarity=0.345  Sum_probs=171.8

Q ss_pred             cCCccccc-eeeccCceEEEEEEEC---CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeCcEEEE
Q 021711          109 TNNFSFEN-LIGKGGYAEVYKGRLR---NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHIV  184 (308)
Q Consensus       109 ~~~~~~~~-~LG~G~fg~Vy~~~~~---~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~lv  184 (308)
                      .++|.+.+ .||+|+||.||+|.+.   ++..||+|.+.........+.+.+|+.+++.++||||+++++++..+..++|
T Consensus         8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~lv   87 (287)
T 1u59_A            8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLV   87 (287)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEE
T ss_pred             HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEecCCCcEEE
Confidence            35666766 9999999999999864   5788999999876655667889999999999999999999999987889999


Q ss_pred             EEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCC
Q 021711          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (308)
Q Consensus       185 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  264 (308)
                      |||+++++|.+++......+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++......
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~  164 (287)
T 1u59_A           88 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD  164 (287)
T ss_dssp             EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred             EEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCchheEEEcCCCCEEECcccceeeeccCc
Confidence            99999999999997666779999999999999999999999   899999999999999999999999999999876543


Q ss_pred             cee-EeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          265 THH-TISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       265 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      ... ......||+.|+|||.......+.++|+||+|+++|||++
T Consensus       165 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt  208 (287)
T 1u59_A          165 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALS  208 (287)
T ss_dssp             CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHT
T ss_pred             ceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHc
Confidence            321 1234567899999999887778899999999999999986

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1.4e-38  Score=282.89  Aligned_cols=196  Identities=24%  Similarity=0.338  Sum_probs=169.1

Q ss_pred             hcCCccccceeeccCceEEEEEEECC----CcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeCcEEE
Q 021711          108 ATNNFSFENLIGKGGYAEVYKGRLRN----GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHI  183 (308)
Q Consensus       108 ~~~~~~~~~~LG~G~fg~Vy~~~~~~----g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l  183 (308)
                      ..++|.+.+.||+|+||.||+|.+.+    +..||+|.+.........+.+.+|+.+++.++||||+++++++.++..++
T Consensus        10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   89 (281)
T 3cc6_A           10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEPTWI   89 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSSSCEE
T ss_pred             cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCEE
Confidence            45689999999999999999998643    34699999987655556788999999999999999999999988888899


Q ss_pred             EEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCC
Q 021711          184 VLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ  263 (308)
Q Consensus       184 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  263 (308)
                      ||||+++++|.+++......+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++.....
T Consensus        90 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  166 (281)
T 3cc6_A           90 IMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE  166 (281)
T ss_dssp             EEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEEETTEEEECCCCGGGCC---
T ss_pred             EEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEECCCCcEEeCccCCCcccccc
Confidence            999999999999997766779999999999999999999999   89999999999999999999999999999876543


Q ss_pred             CceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          264 WTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      .. .......+|+.|+|||.......+.++|+||+|+++|||++
T Consensus       167 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt  209 (281)
T 3cc6_A          167 DY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILS  209 (281)
T ss_dssp             -------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred             cc-cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHh
Confidence            22 12344567899999999877778899999999999999986

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=2e-38  Score=289.25  Aligned_cols=198  Identities=21%  Similarity=0.307  Sum_probs=171.0

Q ss_pred             hhcCCccccceeeccCceEEEEEEEC--------CCcEEEEEEeccCChHHHHHHHHHHHHHHhcC-CCCeeeeeeeEEE
Q 021711          107 SATNNFSFENLIGKGGYAEVYKGRLR--------NGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGI  177 (308)
Q Consensus       107 ~~~~~~~~~~~LG~G~fg~Vy~~~~~--------~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  177 (308)
                      ...++|++.+.||+|+||.||+|.+.        ++..||+|.+...........+.+|+.+++.+ +||||+++++++.
T Consensus        32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  111 (334)
T 2pvf_A           32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT  111 (334)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             CCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence            34578999999999999999999863        46789999998766556678899999999999 8999999999876


Q ss_pred             eC-cEEEEEEecCCCCHHHHHhccC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCE
Q 021711          178 EG-GMHIVLELSPNGSLASLLYGMK---------------EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANI  241 (308)
Q Consensus       178 ~~-~~~lv~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NI  241 (308)
                      .. ..++||||+++|+|.+++....               ..+++..++.++.|++.||.|||+   .+|+||||||+||
T Consensus       112 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NI  188 (334)
T 2pvf_A          112 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNV  188 (334)
T ss_dssp             SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGE
T ss_pred             cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCccceE
Confidence            65 5789999999999999997533               248899999999999999999999   8999999999999


Q ss_pred             EECCCCcEEEeccccceecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          242 LLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       242 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      |++.++.+||+|||+++...............+|+.|+|||.+.+...+.++|+||+|+++|||++
T Consensus       189 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt  254 (334)
T 2pvf_A          189 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT  254 (334)
T ss_dssp             EECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHT
T ss_pred             EEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHh
Confidence            999999999999999998766543333445678899999999887778899999999999999986

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=2.1e-38  Score=283.92  Aligned_cols=190  Identities=22%  Similarity=0.302  Sum_probs=159.7

Q ss_pred             cCCccccceeeccCceEEEEEEECCCcEEEEEEeccCChHHHHHHHHHHHHHHhc--CCCCeeeeeeeEEEe-----CcE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAH--VDHPNTAKLLGYGIE-----GGM  181 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~-----~~~  181 (308)
                      .++|++.+.||+|+||.||+|.+ +|+.||||++....    ...+.+|.+++..  ++||||+++++++..     ...
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~----~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~   81 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD----EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL   81 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGG----HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecccc----chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence            46899999999999999999988 68999999986532    2445667777666  799999999997543     237


Q ss_pred             EEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCceecCCCCCCEEECCCCcEEEec
Q 021711          182 HIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH--------EGCQRRIIHRDIKAANILLTEDFEPQICD  253 (308)
Q Consensus       182 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH--------~~~~~~iiHrDlKp~NILl~~~~~~kl~D  253 (308)
                      ++||||+++|+|.+++.  ...+++..++.++.|++.||.|||        +   ++|+||||||+|||++.++.+||+|
T Consensus        82 ~lv~e~~~~g~L~~~l~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~ivH~Dlkp~Nill~~~~~~kl~D  156 (301)
T 3q4u_A           82 WLITHYHEMGSLYDYLQ--LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGK---PAIAHRDLKSKNILVKKNGQCCIAD  156 (301)
T ss_dssp             EEEECCCTTCBHHHHHT--TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCB---CEEECSCCCGGGEEECTTSCEEECC
T ss_pred             EEehhhccCCCHHHHHh--hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCC---CCeecCCCChHhEEEcCCCCEEEee
Confidence            89999999999999994  457999999999999999999999        7   8999999999999999999999999


Q ss_pred             cccceecCCCCceeE--eeceeccccccccccCchh------hcCccceeEEEeeEEEeeccC
Q 021711          254 FGLAKWLPEQWTHHT--ISKVEGTFGLVKLNLPPLV------ILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       254 FGla~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~------~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ||+++..........  .....||+.|+|||.+.+.      ..+.++|+||+|+++|||++|
T Consensus       157 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg  219 (301)
T 3q4u_A          157 LGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR  219 (301)
T ss_dssp             CTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             CCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhh
Confidence            999987755433221  2345899999999987665      445789999999999999875

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1.2e-38  Score=283.02  Aligned_cols=197  Identities=24%  Similarity=0.351  Sum_probs=171.7

Q ss_pred             HHhhcCCccccceeeccCceEEEEEEECCCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeCcEEEE
Q 021711          105 LQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHIV  184 (308)
Q Consensus       105 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~lv  184 (308)
                      +....++|++.+.||+|+||.||+|...++..||+|.+......  .+.+.+|+.+++.++||||+++++++.++..++|
T Consensus         8 ~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v   85 (279)
T 1qpc_A            8 WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS--PDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYII   85 (279)
T ss_dssp             TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC--HHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEE
T ss_pred             cccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCccc--HHHHHHHHHHHHhCCCcCcceEEEEEcCCCcEEE
Confidence            34455789999999999999999999888889999998755432  4678999999999999999999999888889999


Q ss_pred             EEecCCCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCC
Q 021711          185 LELSPNGSLASLLYGMK-EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ  263 (308)
Q Consensus       185 ~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  263 (308)
                      |||+++++|.+++.... ..+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++.....
T Consensus        86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  162 (279)
T 1qpc_A           86 TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN  162 (279)
T ss_dssp             EECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred             EecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHhhEEEcCCCCEEECCCcccccccCc
Confidence            99999999999986432 268999999999999999999999   89999999999999999999999999999987554


Q ss_pred             CceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          264 WTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      .. .......+|..|+|||.......+.++|+||+|++++||++
T Consensus       163 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~  205 (279)
T 1qpc_A          163 EY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT  205 (279)
T ss_dssp             CE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHT
T ss_pred             cc-ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHh
Confidence            22 22234567889999999887778889999999999999986

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.8e-38  Score=288.90  Aligned_cols=200  Identities=24%  Similarity=0.294  Sum_probs=172.9

Q ss_pred             HHhhcCCccccceeeccCceEEEEEEECC-C-----cEEEEEEeccCChHHHHHHHHHHHHHHhcC-CCCeeeeeeeEEE
Q 021711          105 LQSATNNFSFENLIGKGGYAEVYKGRLRN-G-----QLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGI  177 (308)
Q Consensus       105 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~-g-----~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  177 (308)
                      +....++|++.+.||+|+||.||+|.+.. +     ..||+|.+.........+.+.+|+.++..+ +||||+++++++.
T Consensus        41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~  120 (333)
T 2i1m_A           41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT  120 (333)
T ss_dssp             GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence            44556899999999999999999998753 2     489999998766555678899999999999 8999999999876


Q ss_pred             eC-cEEEEEEecCCCCHHHHHhcc-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEE
Q 021711          178 EG-GMHIVLELSPNGSLASLLYGM-------------KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILL  243 (308)
Q Consensus       178 ~~-~~~lv~e~~~~gsL~~~l~~~-------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl  243 (308)
                      .+ ..++||||+++|+|.+++...             ...+++..++.++.|++.||.|||+   ++|+||||||+|||+
T Consensus       121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~  197 (333)
T 2i1m_A          121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVLL  197 (333)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGCEE
T ss_pred             cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCcccceEEE
Confidence            64 578999999999999998643             2457899999999999999999999   899999999999999


Q ss_pred             CCCCcEEEeccccceecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          244 TEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       244 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      +.++.+||+|||+++...............||+.|+|||.+.+...+.++|+||+|+++|||++
T Consensus       198 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t  261 (333)
T 2i1m_A          198 TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS  261 (333)
T ss_dssp             EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTT
T ss_pred             CCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHc
Confidence            9999999999999987655444334445678899999999888788999999999999999986

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=9.4e-39  Score=296.54  Aligned_cols=194  Identities=25%  Similarity=0.261  Sum_probs=158.4

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCCh--HHHHHHHHHHHHH-HhcCCCCeeeeeeeEEEeC-cEEE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELGI-MAHVDHPNTAKLLGYGIEG-GMHI  183 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~--~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~-~~~l  183 (308)
                      .++|++.++||+|+||.||+|+.+ +++.||+|.+.....  ......+.+|..+ ++.++||||+++++++... .+|+
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            358999999999999999999987 588999999965421  2234566778777 5778999999999977654 5789


Q ss_pred             EEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCC
Q 021711          184 VLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ  263 (308)
Q Consensus       184 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  263 (308)
                      ||||+++|+|.+++.. ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++.....
T Consensus       117 v~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~  192 (373)
T 2r5t_A          117 VLDYINGGELFYHLQR-ERCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH  192 (373)
T ss_dssp             EEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred             EEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence            9999999999999864 4568899999999999999999999   99999999999999999999999999999864332


Q ss_pred             CceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          264 WTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ..  ......||+.|+|||.+.+..++.++|+||+|+++|||++|
T Consensus       193 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G  235 (373)
T 2r5t_A          193 NS--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG  235 (373)
T ss_dssp             CC--CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred             CC--ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcC
Confidence            21  23467899999999998888889999999999999999876

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=1.3e-38  Score=288.77  Aligned_cols=199  Identities=24%  Similarity=0.364  Sum_probs=153.5

Q ss_pred             HhhcCCccccceeeccCceEEEEEEECC-C---cEEEEEEeccCC-hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeCc
Q 021711          106 QSATNNFSFENLIGKGGYAEVYKGRLRN-G---QLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG  180 (308)
Q Consensus       106 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~-g---~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  180 (308)
                      ....++|++.+.||+|+||.||+|.+.. +   ..||||.+.... .....+.+.+|+.+++.++||||+++++++....
T Consensus        19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   98 (323)
T 3qup_A           19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSR   98 (323)
T ss_dssp             BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred             ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence            3456789999999999999999998764 3   279999987542 2234678999999999999999999999876543


Q ss_pred             -------EEEEEEecCCCCHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCc
Q 021711          181 -------MHIVLELSPNGSLASLLYGMK-----EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFE  248 (308)
Q Consensus       181 -------~~lv~e~~~~gsL~~~l~~~~-----~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~  248 (308)
                             .++||||+.+|+|.+++....     ..+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.
T Consensus        99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~Dikp~NIli~~~~~  175 (323)
T 3qup_A           99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS---RNFIHRDLAARNCMLAEDMT  175 (323)
T ss_dssp             ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSC
T ss_pred             cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc---CCcccCCCCcceEEEcCCCC
Confidence                   289999999999999985422     258999999999999999999999   89999999999999999999


Q ss_pred             EEEeccccceecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          249 PQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       249 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      +||+|||+++...............+|+.|+|||...+..++.++|+||+|+++|||++
T Consensus       176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~  234 (323)
T 3qup_A          176 VCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT  234 (323)
T ss_dssp             EEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred             EEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHh
Confidence            99999999987755433333345667889999999888888999999999999999877

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=4.2e-38  Score=282.01  Aligned_cols=197  Identities=26%  Similarity=0.363  Sum_probs=168.0

Q ss_pred             cCCccccceeeccCceEEEEEEECC----CcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEe--CcEE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLRN----GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE--GGMH  182 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~~----g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~  182 (308)
                      ..+|++.+.||+|+||.||+|.+.+    +..||+|.+.........+.+.+|+.+++.++||||+++++++..  +..+
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  103 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  103 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence            3478899999999999999998643    236899999876666667889999999999999999999998654  3578


Q ss_pred             EEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCC
Q 021711          183 IVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE  262 (308)
Q Consensus       183 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~  262 (308)
                      +||||+++|+|.+++......+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++.+..
T Consensus       104 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~  180 (298)
T 3f66_A          104 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD  180 (298)
T ss_dssp             EEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred             EEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEECCCCCEEECcccccccccc
Confidence            9999999999999997766778999999999999999999999   8999999999999999999999999999987654


Q ss_pred             CCc--eeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          263 QWT--HHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       263 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ...  ........||+.|+|||.......+.++|+||+|+++|+|++|
T Consensus       181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~  228 (298)
T 3f66_A          181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTR  228 (298)
T ss_dssp             GGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred             cchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhC
Confidence            322  1223456788999999998888889999999999999998873

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=6.5e-39  Score=285.22  Aligned_cols=195  Identities=20%  Similarity=0.316  Sum_probs=167.5

Q ss_pred             hhcCCccccceeeccCceEEEEEEECCCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEE
Q 021711          107 SATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVL  185 (308)
Q Consensus       107 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~  185 (308)
                      ...++|++.+.||+|+||.||+|.+.++..||+|.+......  .+.+.+|+.++..++||||+++++++... ..++||
T Consensus        21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   98 (283)
T 3gen_A           21 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT   98 (283)
T ss_dssp             CCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBC--HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred             CCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCC--HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEE
Confidence            445689999999999999999999988889999999765433  25788999999999999999999987664 578999


Q ss_pred             EecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCc
Q 021711          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (308)
Q Consensus       186 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~  265 (308)
                      ||+++++|.+++......+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++.......
T Consensus        99 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~  175 (283)
T 3gen_A           99 EYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY  175 (283)
T ss_dssp             CCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH
T ss_pred             eccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCccceEEEcCCCCEEEcccccccccccccc
Confidence            9999999999997766779999999999999999999999   8999999999999999999999999999987644321


Q ss_pred             eeEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          266 HHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                       .......+|+.|+|||.......+.++|+||+|+++|+|++
T Consensus       176 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t  216 (283)
T 3gen_A          176 -TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS  216 (283)
T ss_dssp             -HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHT
T ss_pred             -ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHh
Confidence             12234567889999999887788999999999999999986

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=7.5e-39  Score=303.66  Aligned_cols=196  Identities=23%  Similarity=0.292  Sum_probs=158.7

Q ss_pred             hcCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccC--ChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEE
Q 021711          108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRG--TADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHI  183 (308)
Q Consensus       108 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l  183 (308)
                      ..++|++.+.||+|+||.||+|... +|+.||||.+...  ........+.+|+.+++.++||||+++++++... .+++
T Consensus       146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l  225 (446)
T 4ejn_A          146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF  225 (446)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred             ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence            3468999999999999999999976 5899999998643  1223356788999999999999999999977665 5789


Q ss_pred             EEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCC
Q 021711          184 VLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ  263 (308)
Q Consensus       184 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  263 (308)
                      ||||+++|+|.+++.. ...+++..+..++.||+.||.|||+  .++|+||||||+|||++.++.+||+|||+|+.....
T Consensus       226 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~--~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  302 (446)
T 4ejn_A          226 VMEYANGGELFFHLSR-ERVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD  302 (446)
T ss_dssp             EECCCSSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHH--HTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred             EEeeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhh--cCCEEECCCCHHHEEECCCCCEEEccCCCceeccCC
Confidence            9999999999998864 4578999999999999999999995  168999999999999999999999999999865433


Q ss_pred             CceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          264 WTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ..  ......||+.|+|||.+.+..++.++|+||+|+++|||++|
T Consensus       303 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g  345 (446)
T 4ejn_A          303 GA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG  345 (446)
T ss_dssp             ------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHS
T ss_pred             Cc--ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhC
Confidence            22  33567899999999999888889999999999999999875

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=2.2e-38  Score=307.81  Aligned_cols=195  Identities=27%  Similarity=0.310  Sum_probs=169.3

Q ss_pred             hcCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCCh--HHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEE
Q 021711          108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHI  183 (308)
Q Consensus       108 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l  183 (308)
                      ..++|++.++||+|+||.||+|+.. +|+.||+|.+.....  ......+.+|+.+|..++||||+++++++.+. .+++
T Consensus       182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l  261 (576)
T 2acx_A          182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL  261 (576)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence            3467999999999999999999986 699999999864321  12245688999999999999999999976654 5789


Q ss_pred             EEEecCCCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCC
Q 021711          184 VLELSPNGSLASLLYGMK-EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE  262 (308)
Q Consensus       184 v~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~  262 (308)
                      ||||+++|+|.+++.... ..+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+|+.+..
T Consensus       262 VmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~---~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~  338 (576)
T 2acx_A          262 VLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE  338 (576)
T ss_dssp             EECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCchheEEEeCCCCeEEEecccceeccc
Confidence            999999999999986533 348999999999999999999999   8999999999999999999999999999998765


Q ss_pred             CCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          263 QWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       263 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ...   .....||+.|+|||.+.+..++.++|+||+|+++|||++|
T Consensus       339 ~~~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG  381 (576)
T 2acx_A          339 GQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAG  381 (576)
T ss_dssp             TCC---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHS
T ss_pred             Ccc---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhC
Confidence            432   2446899999999998887889999999999999999876

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.4e-38  Score=293.67  Aligned_cols=194  Identities=20%  Similarity=0.299  Sum_probs=155.7

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCC-hHHHHHHHHHHHHHHhcCC-CCeeeeeeeEEEeC---cEE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVD-HPNTAKLLGYGIEG---GMH  182 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~---~~~  182 (308)
                      .++|++.+.||+|+||.||+|.+. +|+.||||++.... ......++.+|+.++..+. ||||+++++++...   .++
T Consensus         8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~   87 (388)
T 3oz6_A            8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY   87 (388)
T ss_dssp             HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred             cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence            468999999999999999999976 68999999986432 2344677889999999997 99999999987643   479


Q ss_pred             EEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCC
Q 021711          183 IVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE  262 (308)
Q Consensus       183 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~  262 (308)
                      +||||+. ++|..++..  ..+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+|+.+..
T Consensus        88 lv~e~~~-~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  161 (388)
T 3oz6_A           88 LVFDYME-TDLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVN  161 (388)
T ss_dssp             EEEECCS-EEHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEESSS
T ss_pred             EEecccC-cCHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHeEEcCCCCEEecCCcccccccc
Confidence            9999997 589998854  578999999999999999999999   8999999999999999999999999999987643


Q ss_pred             CC-------------------ceeEeeceeccccccccccCch-hhcCccceeEEEeeEEEeeccC
Q 021711          263 QW-------------------THHTISKVEGTFGLVKLNLPPL-VILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       263 ~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ..                   .........||+.|+|||.+.+ ..++.++|+||+|++++||++|
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g  227 (388)
T 3oz6_A          162 IRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCG  227 (388)
T ss_dssp             CCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHS
T ss_pred             cccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhC
Confidence            11                   1112345789999999998765 5678899999999999999876

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1.7e-38  Score=290.77  Aligned_cols=192  Identities=18%  Similarity=0.288  Sum_probs=165.0

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChH--HHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTAD--EIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIV  184 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv  184 (308)
                      .++|.+.+.||+|+||.||+|.+. +++.||+|.+......  +....+.+|+.+++.++||||+++++++... ..++|
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   87 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV   87 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            468999999999999999999975 6899999998643211  1235788999999999999999999987665 57899


Q ss_pred             EEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCC
Q 021711          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (308)
Q Consensus       185 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  264 (308)
                      |||+ +|+|.+++.. ...+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++......
T Consensus        88 ~E~~-~g~l~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~  162 (336)
T 3h4j_B           88 IEYA-GGELFDYIVE-KKRMTEDEGRRFFQQIICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN  162 (336)
T ss_dssp             ECCC-CEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHH---HTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB
T ss_pred             EECC-CCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc
Confidence            9999 7899988854 4579999999999999999999999   899999999999999999999999999998765542


Q ss_pred             ceeEeeceeccccccccccCchhhc-CccceeEEEeeEEEeeccC
Q 021711          265 THHTISKVEGTFGLVKLNLPPLVIL-KRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~s~g~~l~el~c~  308 (308)
                      .   .....||+.|+|||.+.+... +.++|+||+|+++|+|++|
T Consensus       163 ~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g  204 (336)
T 3h4j_B          163 F---LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVG  204 (336)
T ss_dssp             T---TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHS
T ss_pred             c---cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhC
Confidence            2   245679999999999876665 6889999999999999876

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=9.5e-39  Score=303.60  Aligned_cols=197  Identities=25%  Similarity=0.336  Sum_probs=166.3

Q ss_pred             HHhhcCCccccceeeccCceEEEEEEECCCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeCcEEEE
Q 021711          105 LQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHIV  184 (308)
Q Consensus       105 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~lv  184 (308)
                      +....++|++.+.||+|+||.||+|.+.++..||||.+......  .+.|.+|+.+|+.++||||+++++++.++..++|
T Consensus       179 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~iv  256 (452)
T 1fmk_A          179 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIV  256 (452)
T ss_dssp             SBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC--HHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEE
T ss_pred             cccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCC--HHHHHHHHHHHHhCCCCCEeeEEEEEcCCceEEE
Confidence            44556789999999999999999999988888999999765432  3678999999999999999999999988889999


Q ss_pred             EEecCCCCHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCC
Q 021711          185 LELSPNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ  263 (308)
Q Consensus       185 ~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  263 (308)
                      |||+++|+|.+++... ...+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++.....
T Consensus       257 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  333 (452)
T 1fmk_A          257 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDN  333 (452)
T ss_dssp             ECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred             ehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEECCCCCEEECCCccceecCCC
Confidence            9999999999999653 3568999999999999999999999   89999999999999999999999999999876543


Q ss_pred             CceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          264 WTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      .. .......+|..|+|||.+....++.++|+||||++||||++
T Consensus       334 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t  376 (452)
T 1fmk_A          334 EY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT  376 (452)
T ss_dssp             ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred             ce-ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHh
Confidence            21 12234567889999999887788999999999999999987

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=2.9e-38  Score=300.42  Aligned_cols=194  Identities=24%  Similarity=0.310  Sum_probs=153.0

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCC-hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEe------Cc
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGIE------GG  180 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~  180 (308)
                      .++|++.++||+|+||.||+|.+. +|+.||||++.... .....+++.+|+.+|+.++||||+++++++..      ..
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            468999999999999999999876 68999999986543 23346789999999999999999999998743      24


Q ss_pred             EEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceec
Q 021711          181 MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL  260 (308)
Q Consensus       181 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~  260 (308)
                      +|+||||+ +++|.+++.. ...+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+|+.+
T Consensus       132 ~~lv~e~~-~~~L~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~---~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~  206 (458)
T 3rp9_A          132 LYVVLEIA-DSDFKKLFRT-PVYLTELHIKTLLYNLLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLARTV  206 (458)
T ss_dssp             EEEEECCC-SEEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCBCT
T ss_pred             EEEEEecc-ccchhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCcCCCCCChhhEEECCCCCEeecccccchhc
Confidence            79999987 5789998854 4579999999999999999999999   89999999999999999999999999999976


Q ss_pred             CCCCce-------------------------eEeeceeccccccccccC-chhhcCccceeEEEeeEEEeecc
Q 021711          261 PEQWTH-------------------------HTISKVEGTFGLVKLNLP-PLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       261 ~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      ......                         .......||+.|+|||.+ ....++.++|+||+|++||||++
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ellt  279 (458)
T 3rp9_A          207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN  279 (458)
T ss_dssp             TSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHT
T ss_pred             cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHH
Confidence            432210                         123457889999999975 45568899999999999999986

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=2e-38  Score=292.88  Aligned_cols=197  Identities=18%  Similarity=0.262  Sum_probs=163.7

Q ss_pred             hcCCccccceeeccCceEEEEEEECC------CcEEEEEEeccCChHHH----------HHHHHHHHHHHhcCCCCeeee
Q 021711          108 ATNNFSFENLIGKGGYAEVYKGRLRN------GQLVAIKRLTRGTADEI----------IADFLSELGIMAHVDHPNTAK  171 (308)
Q Consensus       108 ~~~~~~~~~~LG~G~fg~Vy~~~~~~------g~~vAvK~~~~~~~~~~----------~~~~~~E~~~l~~l~h~niv~  171 (308)
                      ..++|++.+.||+|+||.||+|.+..      ++.||||.+........          ...+..|+..+..++||||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            45689999999999999999998764      47899999876543210          123455677788889999999


Q ss_pred             eeeEEEeC-----cEEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEEC--
Q 021711          172 LLGYGIEG-----GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLT--  244 (308)
Q Consensus       172 l~~~~~~~-----~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~--  244 (308)
                      +++++...     ..++||||+ +++|.+++......+++..++.++.||+.||.|||+   ++|+||||||+|||++  
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~---~~iiHrDlkp~Nill~~~  188 (364)
T 3op5_A          113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHE---HEYVHGDIKASNLLLNYK  188 (364)
T ss_dssp             EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEESS
T ss_pred             EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeEEecCCHHHEEEecC
Confidence            99977653     268999999 999999997766789999999999999999999999   8999999999999999  


Q ss_pred             CCCcEEEeccccceecCCCCceeE-----eeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          245 EDFEPQICDFGLAKWLPEQWTHHT-----ISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       245 ~~~~~kl~DFGla~~~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      .++.+||+|||+++.+........     .....||+.|+|||.+.+..++.++|+||||+++|||++|
T Consensus       189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g  257 (364)
T 3op5_A          189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTG  257 (364)
T ss_dssp             CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHS
T ss_pred             CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhC
Confidence            889999999999988754322211     1345699999999998888889999999999999999876

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=3.7e-38  Score=305.09  Aligned_cols=195  Identities=23%  Similarity=0.298  Sum_probs=169.3

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChH--HHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTAD--EIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIV  184 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv  184 (308)
                      .++|.+.++||+|+||.||+|+.. +|+.||+|.+......  .....+.+|+.+++.++||||+++++++... .+++|
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  263 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV  263 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence            367999999999999999999986 5999999999643211  2246788999999999999999999976654 58999


Q ss_pred             EEecCCCCHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecC
Q 021711          185 LELSPNGSLASLLYGM---KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP  261 (308)
Q Consensus       185 ~e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~  261 (308)
                      |||++||+|.+++...   ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++.+.
T Consensus       264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~---~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~  340 (543)
T 3c4z_A          264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELK  340 (543)
T ss_dssp             ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHH---cCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence            9999999999998653   3468999999999999999999999   899999999999999999999999999999876


Q ss_pred             CCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          262 EQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       262 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ....  ......||+.|+|||.+.+..++.++|+||+|+++|||++|
T Consensus       341 ~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG  385 (543)
T 3c4z_A          341 AGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAA  385 (543)
T ss_dssp             TTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHS
T ss_pred             CCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhC
Confidence            5432  22346899999999998888889999999999999999876

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.4e-38  Score=288.99  Aligned_cols=195  Identities=21%  Similarity=0.256  Sum_probs=160.5

Q ss_pred             hcCCccccceeeccCceEEEEEEECCCcEEEEEEeccCC-hHHHHHHHHHHHHHHhcCCC--CeeeeeeeEEEeCc-EEE
Q 021711          108 ATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDH--PNTAKLLGYGIEGG-MHI  183 (308)
Q Consensus       108 ~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~-~~l  183 (308)
                      ..++|++.+.||+|+||.||+|...+++.||||.+.... .....+.+.+|+.++..++|  |||+++++++..+. .++
T Consensus         7 ~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l   86 (343)
T 3dbq_A            7 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM   86 (343)
T ss_dssp             SSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             ecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence            456799999999999999999998889999999986543 33456789999999999976  99999999887654 678


Q ss_pred             EEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCC
Q 021711          184 VLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ  263 (308)
Q Consensus       184 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  263 (308)
                      ||| +.+++|.+++.. ...+++..+..++.|++.||.|||+   ++|+||||||+|||++ ++.+||+|||+++.+...
T Consensus        87 v~e-~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~---~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~  160 (343)
T 3dbq_A           87 VME-CGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD  160 (343)
T ss_dssp             EEC-CCSEEHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred             EEe-CCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence            999 568899999965 4578999999999999999999999   8999999999999997 578999999999987655


Q ss_pred             CceeEeeceeccccccccccCch-----------hhcCccceeEEEeeEEEeeccC
Q 021711          264 WTHHTISKVEGTFGLVKLNLPPL-----------VILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ..........||+.|+|||.+.+           ..++.++|+||+|+++|||++|
T Consensus       161 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g  216 (343)
T 3dbq_A          161 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYG  216 (343)
T ss_dssp             ---------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHS
T ss_pred             cccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhC
Confidence            43333446789999999999765           5577889999999999999876

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=9.5e-38  Score=290.62  Aligned_cols=198  Identities=18%  Similarity=0.220  Sum_probs=168.6

Q ss_pred             hcCCccccceeecc--CceEEEEEEEC-CCcEEEEEEeccCC-hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEE
Q 021711          108 ATNNFSFENLIGKG--GYAEVYKGRLR-NGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMH  182 (308)
Q Consensus       108 ~~~~~~~~~~LG~G--~fg~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~  182 (308)
                      ..++|++.+.||+|  +||.||+|+.. +|+.||||.+.... ..+..+.+.+|+.+++.++|||||++++++... ..+
T Consensus        23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  102 (389)
T 3gni_B           23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW  102 (389)
T ss_dssp             CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence            34689999999999  99999999987 69999999996543 334567888999999999999999999977665 578


Q ss_pred             EEEEecCCCCHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecC
Q 021711          183 IVLELSPNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP  261 (308)
Q Consensus       183 lv~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~  261 (308)
                      +||||+++|+|.+++... ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||++....
T Consensus       103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~  179 (389)
T 3gni_B          103 VVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMI  179 (389)
T ss_dssp             EEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred             EEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence            999999999999998653 3568999999999999999999999   899999999999999999999999999987653


Q ss_pred             CCCce-----eEeeceeccccccccccCch--hhcCccceeEEEeeEEEeeccC
Q 021711          262 EQWTH-----HTISKVEGTFGLVKLNLPPL--VILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       262 ~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      .....     .......||+.|+|||.+.+  ..++.++|+||+|+++|||++|
T Consensus       180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g  233 (389)
T 3gni_B          180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANG  233 (389)
T ss_dssp             ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHS
T ss_pred             cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHC
Confidence            32211     11123579999999998876  4678899999999999999875

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.8e-38  Score=311.00  Aligned_cols=196  Identities=24%  Similarity=0.341  Sum_probs=164.6

Q ss_pred             cCCccccc-eeeccCceEEEEEEEC---CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeCcEEEE
Q 021711          109 TNNFSFEN-LIGKGGYAEVYKGRLR---NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHIV  184 (308)
Q Consensus       109 ~~~~~~~~-~LG~G~fg~Vy~~~~~---~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~lv  184 (308)
                      .+++.+.+ .||+|+||.||+|.++   ++..||||.++........+.|.+|+.+|+.++|||||++++++..+..++|
T Consensus       334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~lv  413 (613)
T 2ozo_A          334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLV  413 (613)
T ss_dssp             TTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEESSSEEEE
T ss_pred             ccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEeccCCeEEE
Confidence            34555555 7999999999999864   4567999999765444446789999999999999999999999988889999


Q ss_pred             EEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCC
Q 021711          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (308)
Q Consensus       185 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  264 (308)
                      |||+++|+|.+++......+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++.+....
T Consensus       414 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~  490 (613)
T 2ozo_A          414 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADD  490 (613)
T ss_dssp             EECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC---
T ss_pred             EEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCC
Confidence            99999999999997766779999999999999999999999   899999999999999999999999999998765432


Q ss_pred             cee-EeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          265 THH-TISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       265 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      ... ......+|+.|+|||.+....++.++|+||||++||||++
T Consensus       491 ~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt  534 (613)
T 2ozo_A          491 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALS  534 (613)
T ss_dssp             -----------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred             ceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHH
Confidence            211 1223456789999999988888999999999999999986

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=9.4e-38  Score=295.05  Aligned_cols=194  Identities=26%  Similarity=0.297  Sum_probs=162.6

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCC-hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC------c
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG------G  180 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~  180 (308)
                      .++|++.+.||+|+||.||+|.+. +++.||||++.... .....+++.+|+.+++.++||||+++++++...      .
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            468999999999999999999976 58899999997543 233467899999999999999999999987654      4


Q ss_pred             EEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceec
Q 021711          181 MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL  260 (308)
Q Consensus       181 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~  260 (308)
                      .++||||+. ++|.+++.. ...+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+|+..
T Consensus       105 ~~lv~e~~~-~~L~~~~~~-~~~l~~~~~~~i~~qil~aL~~LH~---~givHrDlkp~NILl~~~~~~kL~DFGla~~~  179 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFKT-PIFLTEEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLARTI  179 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEEecCC-cCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHeEECCCCCEEEccCCCcccc
Confidence            799999986 599999854 4569999999999999999999999   89999999999999999999999999999987


Q ss_pred             CCCCce--------------------eEeeceeccccccccccC-chhhcCccceeEEEeeEEEeecc
Q 021711          261 PEQWTH--------------------HTISKVEGTFGLVKLNLP-PLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       261 ~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      ......                    .......||+.|+|||.+ ....++.++|+||+|+++|||++
T Consensus       180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~  247 (432)
T 3n9x_A          180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLN  247 (432)
T ss_dssp             -------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHT
T ss_pred             cccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHh
Confidence            543221                    123567899999999975 45568889999999999999985

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=4.4e-38  Score=292.02  Aligned_cols=187  Identities=20%  Similarity=0.229  Sum_probs=159.0

Q ss_pred             cceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEEEecCCCC
Q 021711          115 ENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLELSPNGS  192 (308)
Q Consensus       115 ~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~~~gs  192 (308)
                      .+.||+|+||.||+|... +|+.||+|.+..... ...+.+.+|+.+++.++||||+++++++... ..++||||+++++
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~  172 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM-KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE  172 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCSH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence            578999999999999975 589999999976543 3357899999999999999999999987765 4789999999999


Q ss_pred             HHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEE--CCCCcEEEeccccceecCCCCceeEee
Q 021711          193 LASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILL--TEDFEPQICDFGLAKWLPEQWTHHTIS  270 (308)
Q Consensus       193 L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl--~~~~~~kl~DFGla~~~~~~~~~~~~~  270 (308)
                      |.+++......+++..+..++.||+.||.|||+   .+|+||||||+|||+  +.++.+||+|||+++.+.....   ..
T Consensus       173 L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~---~~  246 (373)
T 2x4f_A          173 LFDRIIDESYNLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK---LK  246 (373)
T ss_dssp             EHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB---CC
T ss_pred             HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc---cc
Confidence            999887656679999999999999999999999   899999999999999  5678999999999998765432   23


Q ss_pred             ceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          271 KVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       271 ~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ...||+.|+|||.+.....+.++|+||+|+++|||++|
T Consensus       247 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg  284 (373)
T 2x4f_A          247 VNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG  284 (373)
T ss_dssp             CCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHS
T ss_pred             cccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhC
Confidence            45799999999998877788899999999999999875

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=4.4e-38  Score=289.35  Aligned_cols=191  Identities=26%  Similarity=0.352  Sum_probs=151.4

Q ss_pred             hcCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEE
Q 021711          108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVL  185 (308)
Q Consensus       108 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~  185 (308)
                      ..++|++.+.||+|+||.||+|.+. +++.||||.+.....   .+.+.+|+.+++.++||||+++++++... ..++||
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  127 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVD---KKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVL  127 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-------------CHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchh---HHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEE
Confidence            3468999999999999999999987 488999999975432   35678999999999999999999987765 478999


Q ss_pred             EecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECC---CCcEEEeccccceecCC
Q 021711          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTE---DFEPQICDFGLAKWLPE  262 (308)
Q Consensus       186 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~---~~~~kl~DFGla~~~~~  262 (308)
                      ||+++|+|.+++.. ...+++..+..++.|++.||.|||+   .+|+||||||+|||++.   ++.+||+|||+++....
T Consensus       128 e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~  203 (349)
T 2w4o_A          128 ELVTGGELFDRIVE-KGYYSERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH  203 (349)
T ss_dssp             CCCCSCBHHHHHTT-CSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESSSSTTCCEEECCCC-------
T ss_pred             EeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCcccEEEecCCCCCCEEEccCccccccCc
Confidence            99999999999864 4568999999999999999999999   89999999999999975   78999999999987644


Q ss_pred             CCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          263 QWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       263 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ..   ......||+.|+|||.+.+..++.++|+||+|+++|||++|
T Consensus       204 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g  246 (349)
T 2w4o_A          204 QV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCG  246 (349)
T ss_dssp             ------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred             cc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhC
Confidence            32   23456799999999998887889999999999999999876

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=9e-38  Score=287.27  Aligned_cols=189  Identities=29%  Similarity=0.365  Sum_probs=164.5

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCC--hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVL  185 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~  185 (308)
                      +.|+..+.||+|+||.||+|+.. +|+.||||.+....  ..+..+.+.+|+.+++.++||||+++++++... ..++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            45889999999999999999974 68999999986542  334567899999999999999999999977665 578999


Q ss_pred             EecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCc
Q 021711          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (308)
Q Consensus       186 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~  265 (308)
                      ||+. |+|.+++......+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++.....  
T Consensus       134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~--  207 (348)
T 1u5q_A          134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--  207 (348)
T ss_dssp             ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB--
T ss_pred             ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC--
Confidence            9997 68888886666789999999999999999999999   89999999999999999999999999999876432  


Q ss_pred             eeEeeceeccccccccccCc---hhhcCccceeEEEeeEEEeeccC
Q 021711          266 HHTISKVEGTFGLVKLNLPP---LVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                          ....||+.|+|||.+.   ...++.++|+||+|+++|||++|
T Consensus       208 ----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g  249 (348)
T 1u5q_A          208 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER  249 (348)
T ss_dssp             ----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHS
T ss_pred             ----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhC
Confidence                3457999999999874   45578889999999999999875

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=2.8e-38  Score=297.55  Aligned_cols=194  Identities=25%  Similarity=0.321  Sum_probs=158.0

Q ss_pred             hcCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCC-------hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC
Q 021711          108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT-------ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG  179 (308)
Q Consensus       108 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  179 (308)
                      ..++|.+.+.||+|+||.||+|... +++.||||.+....       .......+.+|+.+|+.++||||+++++++...
T Consensus       133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  212 (419)
T 3i6u_A          133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE  212 (419)
T ss_dssp             HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEESS
T ss_pred             hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence            4578999999999999999999876 58999999986432       112234588999999999999999999998888


Q ss_pred             cEEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCC---cEEEecccc
Q 021711          180 GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDF---EPQICDFGL  256 (308)
Q Consensus       180 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~---~~kl~DFGl  256 (308)
                      ..++||||+++|+|.+++.. ...+++..+..++.|++.||.|||+   ++|+||||||+|||++.++   .+||+|||+
T Consensus       213 ~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~  288 (419)
T 3i6u_A          213 DYYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGH  288 (419)
T ss_dssp             EEEEEEECCTTCBGGGGTSS-SCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSSSCCEEECCSST
T ss_pred             ceEEEEEcCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCCCcceEEEeeccc
Confidence            89999999999999988754 4579999999999999999999999   8999999999999997544   599999999


Q ss_pred             ceecCCCCceeEeeceeccccccccccCch---hhcCccceeEEEeeEEEeeccC
Q 021711          257 AKWLPEQWTHHTISKVEGTFGLVKLNLPPL---VILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       257 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      |+.+....   ......||+.|+|||.+..   ..++.++|+||+|+++|+|++|
T Consensus       289 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg  340 (419)
T 3i6u_A          289 SKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG  340 (419)
T ss_dssp             TTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHS
T ss_pred             ceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHC
Confidence            98765432   2345789999999998753   4567789999999999999875

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.8e-38  Score=293.29  Aligned_cols=194  Identities=26%  Similarity=0.370  Sum_probs=157.1

Q ss_pred             CccccceeeccCceEEEEEEEC--C--CcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEe--CcEEEE
Q 021711          111 NFSFENLIGKGGYAEVYKGRLR--N--GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE--GGMHIV  184 (308)
Q Consensus       111 ~~~~~~~LG~G~fg~Vy~~~~~--~--g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~lv  184 (308)
                      .|++.+.||+|+||.||+|.+.  +  +..||+|.+.........+.|.+|+.+++.++||||+++++++..  +..++|
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv  169 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  169 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence            5778899999999999999864  2  246899998765554557889999999999999999999998653  357899


Q ss_pred             EEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCC
Q 021711          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (308)
Q Consensus       185 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  264 (308)
                      |||+++|+|.+++......+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++.+....
T Consensus       170 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~  246 (373)
T 3c1x_A          170 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE  246 (373)
T ss_dssp             EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred             EECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCccchheEEECCCCCEEEeeccccccccccc
Confidence            99999999999997766778999999999999999999999   899999999999999999999999999998764432


Q ss_pred             ce--eEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          265 TH--HTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       265 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      ..  .......+|+.|+|||.+....++.++|+||||+++|||++
T Consensus       247 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt  291 (373)
T 3c1x_A          247 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT  291 (373)
T ss_dssp             -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred             cccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHh
Confidence            21  12234567889999999888888999999999999999987

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=5.4e-38  Score=293.01  Aligned_cols=194  Identities=20%  Similarity=0.252  Sum_probs=160.5

Q ss_pred             cCCccccceeeccCceEEEEEEECCCcEEEEEEeccCC-hHHHHHHHHHHHHHHhcCC--CCeeeeeeeEEEeCc-EEEE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVD--HPNTAKLLGYGIEGG-MHIV  184 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~-~~lv  184 (308)
                      .++|++.+.||+|+||.||+|...+++.||||.+.... .....+.+.+|+.++..++  ||||+++++++.... +++|
T Consensus        55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv  134 (390)
T 2zmd_A           55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV  134 (390)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence            34699999999999999999998889999999986543 3445678999999999996  599999999877654 7899


Q ss_pred             EEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCC
Q 021711          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (308)
Q Consensus       185 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  264 (308)
                      || +.+++|.+++.. ...+++..+..++.||+.||.|||+   .+|+||||||+|||++ ++.+||+|||+++.+....
T Consensus       135 ~E-~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~  208 (390)
T 2zmd_A          135 ME-CGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT  208 (390)
T ss_dssp             EE-CCSEEHHHHHHH-CSSCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred             Ee-cCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence            99 678899999965 4478898999999999999999998   8999999999999996 5799999999999876543


Q ss_pred             ceeEeeceeccccccccccCch-----------hhcCccceeEEEeeEEEeeccC
Q 021711          265 THHTISKVEGTFGLVKLNLPPL-----------VILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      .........||+.|+|||.+.+           ..++.++|+||+|++||||++|
T Consensus       209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G  263 (390)
T 2zmd_A          209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYG  263 (390)
T ss_dssp             -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHS
T ss_pred             ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHC
Confidence            3333446789999999998754           3577889999999999999876

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=9.1e-38  Score=278.34  Aligned_cols=192  Identities=30%  Similarity=0.504  Sum_probs=165.0

Q ss_pred             hcCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChH---HH---HHHHHHHHHHHhcCCCCeeeeeeeEEEeCc
Q 021711          108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTAD---EI---IADFLSELGIMAHVDHPNTAKLLGYGIEGG  180 (308)
Q Consensus       108 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~---~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  180 (308)
                      ..++|++.+.||+|+||.||+|.+. +++.||+|.+......   ..   .+.+.+|+.+++.++||||+++++++.+..
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   96 (287)
T 4f0f_A           17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP   96 (287)
T ss_dssp             CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT
T ss_pred             hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC
Confidence            3468999999999999999999975 6899999998643321   11   267899999999999999999999876555


Q ss_pred             EEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--ceecCCCCCCEEECCCCc-----EEEec
Q 021711          181 MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRR--IIHRDIKAANILLTEDFE-----PQICD  253 (308)
Q Consensus       181 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~--iiHrDlKp~NILl~~~~~-----~kl~D  253 (308)
                       ++||||+++|+|.+.+......+++..+..++.|++.||.|||+   ++  |+||||||+|||++.++.     +||+|
T Consensus        97 -~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D  172 (287)
T 4f0f_A           97 -RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQN---QNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD  172 (287)
T ss_dssp             -EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred             -eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHh---CCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence             79999999999999987767789999999999999999999998   78  999999999999988776     99999


Q ss_pred             cccceecCCCCceeEeeceeccccccccccC--chhhcCccceeEEEeeEEEeeccC
Q 021711          254 FGLAKWLPEQWTHHTISKVEGTFGLVKLNLP--PLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       254 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ||+++.....     .....||+.|+|||.+  .....+.++|+||+|+++|||++|
T Consensus       173 fg~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g  224 (287)
T 4f0f_A          173 FGLSQQSVHS-----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTG  224 (287)
T ss_dssp             CTTCBCCSSC-----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHS
T ss_pred             CCcccccccc-----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcC
Confidence            9999854332     3456899999999987  444567889999999999999875

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.1e-38  Score=296.19  Aligned_cols=194  Identities=23%  Similarity=0.305  Sum_probs=166.9

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC---cEEEE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG---GMHIV  184 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---~~~lv  184 (308)
                      .++|.+.++||+|+||.||+|++. +|+.||||.+.........+.+.+|+.+++.++||||+++++++...   ..++|
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv   87 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence            457999999999999999999987 48999999997544333456788999999999999999999987654   46899


Q ss_pred             EEecCCCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEE----CCCCcEEEeccccce
Q 021711          185 LELSPNGSLASLLYGMK--EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILL----TEDFEPQICDFGLAK  258 (308)
Q Consensus       185 ~e~~~~gsL~~~l~~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl----~~~~~~kl~DFGla~  258 (308)
                      |||+++|+|.+++....  ..+++..++.++.|++.||.|||+   .+|+||||||+|||+    +.++.+||+|||+++
T Consensus        88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~  164 (396)
T 4eut_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (396)
T ss_dssp             ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred             EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence            99999999999996533  238999999999999999999999   899999999999999    777889999999999


Q ss_pred             ecCCCCceeEeeceeccccccccccCch--------hhcCccceeEEEeeEEEeeccC
Q 021711          259 WLPEQWTHHTISKVEGTFGLVKLNLPPL--------VILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       259 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      .......   .....||+.|+|||.+..        ..++.++|+||+|+++|||++|
T Consensus       165 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg  219 (396)
T 4eut_A          165 ELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATG  219 (396)
T ss_dssp             ECCCGGG---SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHS
T ss_pred             EccCCCc---cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHC
Confidence            8755432   234679999999998765        4567889999999999999876

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=2e-37  Score=280.96  Aligned_cols=193  Identities=24%  Similarity=0.299  Sum_probs=167.8

Q ss_pred             CccccceeeccCceEEEEEEEC-----CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC---cEE
Q 021711          111 NFSFENLIGKGGYAEVYKGRLR-----NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG---GMH  182 (308)
Q Consensus       111 ~~~~~~~LG~G~fg~Vy~~~~~-----~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---~~~  182 (308)
                      .|++.+.||+|+||.||++.+.     +++.||||.+.........+.+.+|+.+++.++||||+++++++.+.   .++
T Consensus        32 ~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  111 (318)
T 3lxp_A           32 YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQ  111 (318)
T ss_dssp             GEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEE
T ss_pred             HHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEE
Confidence            3489999999999999998753     57899999998766556678899999999999999999999988763   478


Q ss_pred             EEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCC
Q 021711          183 IVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE  262 (308)
Q Consensus       183 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~  262 (308)
                      +||||+++|+|.+++..  ..+++..++.++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++....
T Consensus       112 lv~e~~~~~~L~~~l~~--~~~~~~~~~~i~~~l~~~l~~LH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~  186 (318)
T 3lxp_A          112 LVMEYVPLGSLRDYLPR--HSIGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE  186 (318)
T ss_dssp             EEECCCTTCBHHHHGGG--SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECCT
T ss_pred             EEEecccCCcHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEEcCCCCEEECCccccccccc
Confidence            99999999999999954  458999999999999999999999   8999999999999999999999999999998866


Q ss_pred             CCcee-EeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          263 QWTHH-TISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       263 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ..... ......||..|+|||.+.+...+.++|+||+|+++|+|++|
T Consensus       187 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g  233 (318)
T 3lxp_A          187 GHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTH  233 (318)
T ss_dssp             TCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTT
T ss_pred             cccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhC
Confidence            53322 23356788999999998888888999999999999999875

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=5.1e-38  Score=290.26  Aligned_cols=192  Identities=21%  Similarity=0.258  Sum_probs=156.2

Q ss_pred             hcCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEE
Q 021711          108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVL  185 (308)
Q Consensus       108 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~  185 (308)
                      ..++|++.+.||+|+||.||+++.. +++.||||.+......  .+.+.+|+.+++.++||||+++++++... ..++||
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~   95 (361)
T 3uc3_A           18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI--DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIM   95 (361)
T ss_dssp             CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS--CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc--cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEE
Confidence            3468999999999999999999987 6899999999764432  25678999999999999999999987665 578999


Q ss_pred             EecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCc--EEEeccccceecCCC
Q 021711          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFE--PQICDFGLAKWLPEQ  263 (308)
Q Consensus       186 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~--~kl~DFGla~~~~~~  263 (308)
                      ||+.+|+|.+++.. ...+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.  +||+|||+++.....
T Consensus        96 e~~~~~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~---~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~  171 (361)
T 3uc3_A           96 EYASGGELYERICN-AGRFSEDEARFFFQQLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  171 (361)
T ss_dssp             ECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred             EeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence            99999999999864 4569999999999999999999999   99999999999999987765  999999999854332


Q ss_pred             CceeEeeceeccccccccccCchhhcC-ccceeEEEeeEEEeeccC
Q 021711          264 WTHHTISKVEGTFGLVKLNLPPLVILK-RCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~s~g~~l~el~c~  308 (308)
                      .   ......||+.|+|||.+.+.... .++|+||+|+++|+|++|
T Consensus       172 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g  214 (361)
T 3uc3_A          172 S---QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVG  214 (361)
T ss_dssp             ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHS
T ss_pred             C---CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhC
Confidence            1   23456799999999988766654 448999999999999876

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=2e-38  Score=288.41  Aligned_cols=193  Identities=21%  Similarity=0.281  Sum_probs=157.7

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEEEe
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLEL  187 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~  187 (308)
                      ++|.+.+.||+|+||.||+|... +++.||+|.+...........+.+|+.+++.++||||+++++++... ..++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            57999999999999999999986 68999999987544333333566899999999999999999987654 57899999


Q ss_pred             cCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCcee
Q 021711          188 SPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH  267 (308)
Q Consensus       188 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~  267 (308)
                      +. |+|.+++......+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++.......  
T Consensus        82 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~--  155 (324)
T 3mtl_A           82 LD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK--  155 (324)
T ss_dssp             CS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred             cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCcCHHHEEECCCCCEEEccCcccccccCCcc--
Confidence            97 58999987766779999999999999999999999   8999999999999999999999999999986643322  


Q ss_pred             EeeceeccccccccccCch-hhcCccceeEEEeeEEEeeccC
Q 021711          268 TISKVEGTFGLVKLNLPPL-VILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ......||+.|+|||.+.+ ..++.++|+||+|+++|+|++|
T Consensus       156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g  197 (324)
T 3mtl_A          156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATG  197 (324)
T ss_dssp             -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHS
T ss_pred             ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhC
Confidence            2345678999999998765 4578899999999999999875

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.2e-37  Score=276.31  Aligned_cols=196  Identities=26%  Similarity=0.382  Sum_probs=149.7

Q ss_pred             hcCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCCh--HHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeCc-EEE
Q 021711          108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHI  183 (308)
Q Consensus       108 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~l  183 (308)
                      ..++|++.+.||+|+||.||+|... +|+.||+|.+.....  ....+.+.+|+.++..++||||+++++++.... .++
T Consensus         9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   88 (278)
T 3cok_A            9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL   88 (278)
T ss_dssp             SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred             ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence            3467999999999999999999975 689999999864321  122467899999999999999999999877654 689


Q ss_pred             EEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCC
Q 021711          184 VLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ  263 (308)
Q Consensus       184 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  263 (308)
                      ||||+++++|.+++......+++..+..++.|++.||.|||+   ++|+||||||+||+++.++.+||+|||++......
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~  165 (278)
T 3cok_A           89 VLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP  165 (278)
T ss_dssp             EEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred             EEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence            999999999999997766779999999999999999999999   89999999999999999999999999999877543


Q ss_pred             CceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          264 WTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ..  ......||+.|+|||...+...+.++|+||+|+++|+|++|
T Consensus       166 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g  208 (278)
T 3cok_A          166 HE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIG  208 (278)
T ss_dssp             ----------------------------CTHHHHHHHHHHHHHHS
T ss_pred             CC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhC
Confidence            22  22346799999999999888888999999999999999875

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=5.8e-38  Score=299.20  Aligned_cols=190  Identities=23%  Similarity=0.214  Sum_probs=158.5

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCC-hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-------
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-------  179 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-------  179 (308)
                      .++|++.+.||+|+||.||+|.+. +|+.||||++.... .....+++.+|+.+++.++||||+++++++...       
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            478999999999999999999876 58999999997542 234467889999999999999999999987543       


Q ss_pred             cEEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEecccccee
Q 021711          180 GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKW  259 (308)
Q Consensus       180 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~  259 (308)
                      ..++||||+.+ +|.+.+.   ..+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+|+.
T Consensus       141 ~~~lv~E~~~~-~l~~~~~---~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~  213 (464)
T 3ttj_A          141 DVYLVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART  213 (464)
T ss_dssp             EEEEEEECCSE-EHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCCC--
T ss_pred             eEEEEEeCCCC-CHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChHhEEEeCCCCEEEEEEEeeee
Confidence            36899999976 4666663   358999999999999999999999   8999999999999999999999999999987


Q ss_pred             cCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          260 LPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       260 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      .....   ......||+.|+|||.+.+..++.++|+||+|+++|||++|
T Consensus       214 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g  259 (464)
T 3ttj_A          214 AGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH  259 (464)
T ss_dssp             ---CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHS
T ss_pred             cCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhC
Confidence            65432   23457899999999998888889999999999999999875

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=8.7e-38  Score=296.83  Aligned_cols=189  Identities=26%  Similarity=0.363  Sum_probs=164.2

Q ss_pred             hhcCCccccceeeccCceEEEEEEECCCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC--cEEEE
Q 021711          107 SATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG--GMHIV  184 (308)
Q Consensus       107 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~lv  184 (308)
                      ...++|++.+.||+|+||.||+|.+. |+.||||.++...   ..+.|.+|+.+|+.++||||+++++++.+.  ..++|
T Consensus       190 i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv  265 (450)
T 1k9a_A          190 LNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV  265 (450)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT---TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEE
T ss_pred             cChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch---HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEE
Confidence            44568999999999999999999985 7899999997654   246789999999999999999999987654  58999


Q ss_pred             EEecCCCCHHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCC
Q 021711          185 LELSPNGSLASLLYGMKE-KLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ  263 (308)
Q Consensus       185 ~e~~~~gsL~~~l~~~~~-~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  263 (308)
                      |||+++|+|.+++..... .+++..++.++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++.....
T Consensus       266 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  342 (450)
T 1k9a_A          266 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  342 (450)
T ss_dssp             EECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc
Confidence            999999999999976443 37899999999999999999999   89999999999999999999999999999865332


Q ss_pred             CceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          264 WTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                           .....+|+.|+|||.+....++.++|+||||++||||++
T Consensus       343 -----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t  381 (450)
T 1k9a_A          343 -----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS  381 (450)
T ss_dssp             ---------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHT
T ss_pred             -----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHh
Confidence                 123467899999999888888999999999999999986

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=9.4e-38  Score=283.84  Aligned_cols=196  Identities=25%  Similarity=0.342  Sum_probs=170.5

Q ss_pred             cCCccccceeeccCceEEEEEEE-----CCCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEe---Cc
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRL-----RNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE---GG  180 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~-----~~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---~~  180 (308)
                      .++|++.+.||+|+||.||+|++     .+++.||||.+..... ...+.+.+|+.+++.++||||+++++++..   ..
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~  100 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGP-DQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQS  100 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCH-HHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCE
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCH-HHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCce
Confidence            36899999999999999999984     2588999999976543 345779999999999999999999997753   34


Q ss_pred             EEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceec
Q 021711          181 MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL  260 (308)
Q Consensus       181 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~  260 (308)
                      .++||||+++++|.+++......+++..++.++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++..
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~  177 (327)
T 3lxl_A          101 LRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLL  177 (327)
T ss_dssp             EEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred             EEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChhhEEECCCCCEEEcccccceec
Confidence            789999999999999997656679999999999999999999999   89999999999999999999999999999987


Q ss_pred             CCCCcee-EeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          261 PEQWTHH-TISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       261 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ....... ......||..|+|||.+.+..++.++|+||+|+++|+|++|
T Consensus       178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g  226 (327)
T 3lxl_A          178 PLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTY  226 (327)
T ss_dssp             CTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTT
T ss_pred             ccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhC
Confidence            6543322 22346788999999998888889999999999999999875

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.9e-37  Score=290.34  Aligned_cols=187  Identities=20%  Similarity=0.226  Sum_probs=153.2

Q ss_pred             CCcccc-ceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHH-hcCCCCeeeeeeeEEEe-----CcE
Q 021711          110 NNFSFE-NLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIM-AHVDHPNTAKLLGYGIE-----GGM  181 (308)
Q Consensus       110 ~~~~~~-~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~-----~~~  181 (308)
                      ++|.+. ++||+|+||.||+|.+. +|+.||||++...      ..+.+|+.++ +..+||||+++++++..     ..+
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~  134 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL  134 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence            467666 78999999999999976 5899999998642      3456788887 45589999999997653     347


Q ss_pred             EEEEEecCCCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECC---CCcEEEeccccc
Q 021711          182 HIVLELSPNGSLASLLYGMK-EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTE---DFEPQICDFGLA  257 (308)
Q Consensus       182 ~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~---~~~~kl~DFGla  257 (308)
                      ++||||+++|+|.+++.... ..+++..+..++.||+.||.|||+   ++|+||||||+|||++.   ++.+||+|||++
T Consensus       135 ~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a  211 (400)
T 1nxk_A          135 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA  211 (400)
T ss_dssp             EEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred             EEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCcceEEEecCCCCccEEEEecccc
Confidence            89999999999999997543 458999999999999999999999   89999999999999997   789999999999


Q ss_pred             eecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          258 KWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      +......   ......||+.|+|||.+....++.++|+||+|+++|||++|
T Consensus       212 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g  259 (400)
T 1nxk_A          212 KETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG  259 (400)
T ss_dssp             EECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHS
T ss_pred             cccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhC
Confidence            9765432   23467899999999999888889999999999999999886

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=3.5e-38  Score=281.11  Aligned_cols=190  Identities=20%  Similarity=0.294  Sum_probs=164.6

Q ss_pred             cCCccccceeeccCceEEEEEEECC-C-------cEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLRN-G-------QLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-  179 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~~-g-------~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-  179 (308)
                      .++|.+.+.||+|+||.||+|.+.. +       ..||+|.+..... ...+.+.+|+.+++.++||||+++++++..+ 
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   85 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHR-NYSESFFEAASMMSKLSHKHLVLNYGVCVCGD   85 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGG-GGHHHHHHHHHHHHTSCCTTBCCEEEEECCTT
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccH-HHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCC
Confidence            4689999999999999999998653 3       4799999865432 3357899999999999999999999987664 


Q ss_pred             cEEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCc--------EEE
Q 021711          180 GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFE--------PQI  251 (308)
Q Consensus       180 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~--------~kl  251 (308)
                      ..++||||+++|+|.+++......+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.        +||
T Consensus        86 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl  162 (289)
T 4fvq_A           86 ENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEE---NTLIHGNVCAKNILLIREEDRKTGNPPFIKL  162 (289)
T ss_dssp             CCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred             CCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhh---CCeECCCcCcceEEEecCCcccccccceeee
Confidence            5789999999999999997766669999999999999999999999   89999999999999998876        999


Q ss_pred             eccccceecCCCCceeEeeceeccccccccccCch-hhcCccceeEEEeeEEEeeccC
Q 021711          252 CDFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPL-VILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       252 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      +|||+++.....      ....||+.|+|||.+.+ ...+.++|+||+|+++|||++|
T Consensus       163 ~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g  214 (289)
T 4fvq_A          163 SDPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSG  214 (289)
T ss_dssp             CCCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTT
T ss_pred             ccCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcC
Confidence            999999755332      34568999999998876 5688899999999999999874

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=6.4e-38  Score=277.41  Aligned_cols=195  Identities=25%  Similarity=0.298  Sum_probs=168.4

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeCc-EEEEEEe
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLEL  187 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~  187 (308)
                      ++|++.+.||+|+||.||+|... +++.||+|.+.........+.+.+|+.+++.++||||+++++++.++. .++||||
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (276)
T 2yex_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   86 (276)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence            57899999999999999999976 689999999865443344678899999999999999999999877654 6899999


Q ss_pred             cCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCcee
Q 021711          188 SPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH  267 (308)
Q Consensus       188 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~  267 (308)
                      +++++|.+++.. ...+++..+..++.|++.||.|||+   ++|+||||||+||+++.++.+||+|||++..+.......
T Consensus        87 ~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~  162 (276)
T 2yex_A           87 CSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER  162 (276)
T ss_dssp             CTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred             cCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchh
Confidence            999999998853 4568999999999999999999999   899999999999999999999999999998765443333


Q ss_pred             EeeceeccccccccccCchhhc-CccceeEEEeeEEEeeccC
Q 021711          268 TISKVEGTFGLVKLNLPPLVIL-KRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~s~g~~l~el~c~  308 (308)
                      ......||+.|+|||...+... +.++|+||+|+++|+|++|
T Consensus       163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g  204 (276)
T 2yex_A          163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG  204 (276)
T ss_dssp             CBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHS
T ss_pred             cccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhC
Confidence            3456789999999999876554 6789999999999999875

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.5e-37  Score=278.58  Aligned_cols=193  Identities=25%  Similarity=0.308  Sum_probs=161.3

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCCh-HHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEEE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA-DEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLE  186 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e  186 (308)
                      ++|++.+.||+|+||.||+|.+. +|+.||+|.+..... ....+.+.+|+.+++.++||||+++++++... ..++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            68999999999999999999986 489999999865443 34467788999999999999999999987765 4789999


Q ss_pred             ecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCce
Q 021711          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH  266 (308)
Q Consensus       187 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~  266 (308)
                      |+++++|.+++.. ...+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++....... 
T Consensus        83 ~~~~~~l~~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  157 (311)
T 4agu_A           83 YCDHTVLHELDRY-QRGVPEHLVKSITWQTLQAVNFCHK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD-  157 (311)
T ss_dssp             CCSEEHHHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred             eCCCchHHHHHhh-hcCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc-
Confidence            9999999888754 4568999999999999999999999   8999999999999999999999999999988754322 


Q ss_pred             eEeeceeccccccccccCch-hhcCccceeEEEeeEEEeeccC
Q 021711          267 HTISKVEGTFGLVKLNLPPL-VILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~s~g~~l~el~c~  308 (308)
                       ......||..|+|||.+.+ ...+.++|+||+|+++|+|++|
T Consensus       158 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g  199 (311)
T 4agu_A          158 -YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSG  199 (311)
T ss_dssp             ---------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHS
T ss_pred             -ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhC
Confidence             2345689999999998765 4568899999999999999875

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=8e-38  Score=298.83  Aligned_cols=193  Identities=20%  Similarity=0.339  Sum_probs=167.9

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChH--HHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTAD--EIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIV  184 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv  184 (308)
                      .++|.+.+.||+|+||.||+|.+. +|+.||||++......  +....+.+|+.+++.++||||+++++++... ..++|
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv   94 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV   94 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            468999999999999999999986 6999999998643211  2356789999999999999999999977664 57899


Q ss_pred             EEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCC
Q 021711          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (308)
Q Consensus       185 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  264 (308)
                      |||+++|+|.+++.. ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++......
T Consensus        95 ~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~  170 (476)
T 2y94_A           95 MEYVSGGELFDYICK-NGRLDEKESRRLFQQILSGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE  170 (476)
T ss_dssp             EECCSSEEHHHHTTS-SSSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC
T ss_pred             EeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcccccHHHEEEecCCCeEEEeccchhhccccc
Confidence            999999999999864 4579999999999999999999998   899999999999999999999999999999875542


Q ss_pred             ceeEeeceeccccccccccCchhhc-CccceeEEEeeEEEeeccC
Q 021711          265 THHTISKVEGTFGLVKLNLPPLVIL-KRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~s~g~~l~el~c~  308 (308)
                         ......||+.|+|||.+.+... +.++|+||+|+++|+|+||
T Consensus       171 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG  212 (476)
T 2y94_A          171 ---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCG  212 (476)
T ss_dssp             ---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHS
T ss_pred             ---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhC
Confidence               2345689999999998876654 6789999999999999886

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=3.5e-38  Score=303.02  Aligned_cols=196  Identities=21%  Similarity=0.362  Sum_probs=170.0

Q ss_pred             HhhcCCccccceeeccCceEEEEEEECC-CcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEE
Q 021711          106 QSATNNFSFENLIGKGGYAEVYKGRLRN-GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHI  183 (308)
Q Consensus       106 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~-g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l  183 (308)
                      .....+|++.+.||+|+||.||+|.+.. +..||||.+......  .+.|.+|+.+|+.++||||+++++++... ..++
T Consensus       216 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l  293 (495)
T 1opk_A          216 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI  293 (495)
T ss_dssp             BCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSC--HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             ccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccc--hHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEE
Confidence            3445678899999999999999999874 889999999765432  46799999999999999999999988765 5799


Q ss_pred             EEEecCCCCHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCC
Q 021711          184 VLELSPNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE  262 (308)
Q Consensus       184 v~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~  262 (308)
                      ||||+++|+|.+++... ...+++..++.++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++.+..
T Consensus       294 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  370 (495)
T 1opk_A          294 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG  370 (495)
T ss_dssp             EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEECCTTCEECCTT
T ss_pred             EEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChhhEEECCCCcEEEeecccceeccC
Confidence            99999999999999753 3568999999999999999999999   8999999999999999999999999999998754


Q ss_pred             CCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          263 QWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       263 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      ... .......+|+.|+|||.+....++.++|+||||++||||++
T Consensus       371 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t  414 (495)
T 1opk_A          371 DTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT  414 (495)
T ss_dssp             CCE-ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHT
T ss_pred             Cce-eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHh
Confidence            321 22234567789999999888888999999999999999986

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.7e-37  Score=285.67  Aligned_cols=195  Identities=17%  Similarity=0.153  Sum_probs=167.6

Q ss_pred             HHHHhhcCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCC-----CCeeeeeeeEE
Q 021711          103 YELQSATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVD-----HPNTAKLLGYG  176 (308)
Q Consensus       103 ~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l~~~~  176 (308)
                      .+.....++|++.+.||+|+||.||+|++. +++.||||.+...  ......+.+|+.++..++     ||||+++++++
T Consensus        28 ~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~  105 (360)
T 3llt_A           28 KKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI--KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKF  105 (360)
T ss_dssp             CTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC--HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEE
T ss_pred             ecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc--hhhhhhhHHHHHHHHHhcccCCCCCCeeccccee
Confidence            334455689999999999999999999975 6899999998743  233567788999999986     99999999977


Q ss_pred             EeC-cEEEEEEecCCCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECC---------
Q 021711          177 IEG-GMHIVLELSPNGSLASLLYGMK-EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTE---------  245 (308)
Q Consensus       177 ~~~-~~~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~---------  245 (308)
                      ... ..++||||+ +++|.+++.... ..+++..+..++.||+.||.|||+   ++|+||||||+|||++.         
T Consensus       106 ~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~~~  181 (360)
T 3llt_A          106 MYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRK---MSLTHTDLKPENILLDDPYFEKSLIT  181 (360)
T ss_dssp             EETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCTTCCEEEEE
T ss_pred             eECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCcccEEEccccccccccc
Confidence            664 578999999 899999996543 358999999999999999999999   99999999999999975         


Q ss_pred             ----------------CCcEEEeccccceecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          246 ----------------DFEPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       246 ----------------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                                      ++.+||+|||+|+......     ....||+.|+|||.+.+..++.++|+||+|+++|+|++|
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g  255 (360)
T 3llt_A          182 VRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTG  255 (360)
T ss_dssp             EECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHS
T ss_pred             hhcccccccccccccCCCCEEEEeccCceecCCCC-----cCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHC
Confidence                            7899999999998764432     356799999999998888889999999999999999875

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.8e-37  Score=277.51  Aligned_cols=194  Identities=21%  Similarity=0.243  Sum_probs=167.2

Q ss_pred             hcCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcC-CCCeeeeeeeEEEeCc-EEEE
Q 021711          108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGIEGG-MHIV  184 (308)
Q Consensus       108 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~-~~lv  184 (308)
                      ..++|++.+.||+|+||.||+|... +|+.||||.+......   ..+.+|+.++..+ +|+|++++++++.... .++|
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   84 (298)
T 1csn_A            8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA---PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV   84 (298)
T ss_dssp             ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS---CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc---HHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEE
Confidence            3468999999999999999999964 6899999998654322   4577899999999 7999999999877654 6899


Q ss_pred             EEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCc-----EEEecccccee
Q 021711          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFE-----PQICDFGLAKW  259 (308)
Q Consensus       185 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~-----~kl~DFGla~~  259 (308)
                      |||+ +++|.+++......+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.     +||+|||+++.
T Consensus        85 ~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~  160 (298)
T 1csn_A           85 IDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  160 (298)
T ss_dssp             EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             EEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence            9999 999999997766679999999999999999999998   89999999999999987765     99999999998


Q ss_pred             cCCCCce-----eEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          260 LPEQWTH-----HTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       260 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      .......     .......||+.|+|||.+.+...+.++|+||+|+++|||++|
T Consensus       161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g  214 (298)
T 1csn_A          161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRG  214 (298)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHS
T ss_pred             cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcC
Confidence            7654322     123456799999999998887789999999999999999875

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-37  Score=278.27  Aligned_cols=195  Identities=26%  Similarity=0.339  Sum_probs=167.7

Q ss_pred             CccccceeeccCceEEEEEEECC----CcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-c-EEEE
Q 021711          111 NFSFENLIGKGGYAEVYKGRLRN----GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-G-MHIV  184 (308)
Q Consensus       111 ~~~~~~~LG~G~fg~Vy~~~~~~----g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~-~~lv  184 (308)
                      .|...++||+|+||.||+|.+.+    +..||+|.+.........+.+.+|+.+++.++||||+++++++... . .++|
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            46667999999999999998542    2379999998766656678899999999999999999999987654 3 4899


Q ss_pred             EEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCC
Q 021711          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (308)
Q Consensus       185 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  264 (308)
                      |||+.+|+|.+++......+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++.+....
T Consensus       102 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  178 (298)
T 3pls_A          102 LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAE---QKFVHRDLAARNCMLDESFTVKVADFGLARDILDRE  178 (298)
T ss_dssp             ECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred             EecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence            99999999999997767779999999999999999999999   899999999999999999999999999998664432


Q ss_pred             c--eeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          265 T--HHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       265 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      .  ........||..|+|||...+...+.++|+||+|+++|+|++|
T Consensus       179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g  224 (298)
T 3pls_A          179 YYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTR  224 (298)
T ss_dssp             GGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHT
T ss_pred             ccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhC
Confidence            1  1123356789999999998888889999999999999999873

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1e-37  Score=284.85  Aligned_cols=197  Identities=27%  Similarity=0.356  Sum_probs=162.6

Q ss_pred             hcCCccccceeeccCceEEEEEEECC-----CcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cE
Q 021711          108 ATNNFSFENLIGKGGYAEVYKGRLRN-----GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GM  181 (308)
Q Consensus       108 ~~~~~~~~~~LG~G~fg~Vy~~~~~~-----g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~  181 (308)
                      ..++|.+.+.||+|+||.||+|.+..     +..||+|.+...........+.+|+.+++.++||||+++++++... ..
T Consensus        42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  121 (333)
T 1mqb_A           42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM  121 (333)
T ss_dssp             CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred             ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCc
Confidence            44688899999999999999998653     2469999998765555667899999999999999999999987664 57


Q ss_pred             EEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecC
Q 021711          182 HIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP  261 (308)
Q Consensus       182 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~  261 (308)
                      ++||||+++|+|.+++......+++..++.++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++...
T Consensus       122 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~  198 (333)
T 1mqb_A          122 MIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  198 (333)
T ss_dssp             EEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             EEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence            89999999999999997766789999999999999999999999   899999999999999999999999999998775


Q ss_pred             CCCce-eEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          262 EQWTH-HTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       262 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      ..... .......+|+.|+|||.+.....+.++|+||+|+++|||++
T Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt  245 (333)
T 1mqb_A          199 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMT  245 (333)
T ss_dssp             ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHT
T ss_pred             cccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHc
Confidence            43221 12233456889999999877778889999999999999876

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1.1e-37  Score=280.85  Aligned_cols=194  Identities=24%  Similarity=0.307  Sum_probs=160.1

Q ss_pred             hcCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCCh----HHHHHHHHHHHHHHhcC---CCCeeeeeeeEEEeC
Q 021711          108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA----DEIIADFLSELGIMAHV---DHPNTAKLLGYGIEG  179 (308)
Q Consensus       108 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~----~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~  179 (308)
                      ..++|++.+.||+|+||.||+|++. +|+.||||.+.....    ......+.+|+.+++.+   +||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            3579999999999999999999975 689999999863221    11123455677766665   599999999987654


Q ss_pred             c------EEEEEEecCCCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEe
Q 021711          180 G------MHIVLELSPNGSLASLLYGMK-EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQIC  252 (308)
Q Consensus       180 ~------~~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~  252 (308)
                      .      .++||||+. ++|.+++.... ..+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~  162 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKLA  162 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCTTTEEECTTSCEEEC
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEEe
Confidence            3      689999997 59999986543 348999999999999999999999   899999999999999999999999


Q ss_pred             ccccceecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          253 DFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       253 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      |||+++......   ......||+.|+|||.+.+..++.++|+||+|+++|||++|
T Consensus       163 Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g  215 (308)
T 3g33_A          163 DFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRR  215 (308)
T ss_dssp             SCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTS
T ss_pred             eCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhC
Confidence            999998765432   23467899999999998888889999999999999999875

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=3.4e-37  Score=274.01  Aligned_cols=193  Identities=21%  Similarity=0.266  Sum_probs=168.0

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCC-hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeCc-EEEEE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIVL  185 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~  185 (308)
                      .++|++.+.||+|+||.||+|.+. +|+.||+|.+.... .....+.+.+|+.+++.++||||+++++++.... .++||
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            478999999999999999999976 58999999986532 3344678899999999999999999999877654 68999


Q ss_pred             EecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCc---EEEeccccceecCC
Q 021711          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFE---PQICDFGLAKWLPE  262 (308)
Q Consensus       186 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~---~kl~DFGla~~~~~  262 (308)
                      ||+++++|.+.+.. ...+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.   +||+|||++.....
T Consensus        85 e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~  160 (284)
T 3kk8_A           85 DLVTGGELFEDIVA-REFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND  160 (284)
T ss_dssp             CCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred             ecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence            99999999988864 4568999999999999999999999   89999999999999987655   99999999987755


Q ss_pred             CCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          263 QWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       263 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ..   ......||+.|+|||.+.....+.++|+||+|+++|+|++|
T Consensus       161 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g  203 (284)
T 3kk8_A          161 SE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG  203 (284)
T ss_dssp             SC---BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHS
T ss_pred             Cc---cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHC
Confidence            42   22456799999999998888889999999999999999875

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=2e-37  Score=282.21  Aligned_cols=184  Identities=21%  Similarity=0.260  Sum_probs=143.1

Q ss_pred             cceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCC-CCeeeeeeeEEEeC-cEEEEEEecCCC
Q 021711          115 ENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVD-HPNTAKLLGYGIEG-GMHIVLELSPNG  191 (308)
Q Consensus       115 ~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~-~~~lv~e~~~~g  191 (308)
                      .+.||+|+||.||+|.+. +++.||||.+....    ...+.+|+.+++.+. ||||+++++++.+. ..++||||+++|
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~   91 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM----EANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGG   91 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGGG----HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChhh----hhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCC
Confidence            378999999999999986 58999999986532    356778999999997 99999999987765 478999999999


Q ss_pred             CHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCC---cEEEeccccceecCCCCceeE
Q 021711          192 SLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDF---EPQICDFGLAKWLPEQWTHHT  268 (308)
Q Consensus       192 sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~---~~kl~DFGla~~~~~~~~~~~  268 (308)
                      +|.+++.. ...+++..+..++.|++.||.|||+   ++|+||||||+|||++.++   .+||+|||+++.......  .
T Consensus        92 ~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~--~  165 (325)
T 3kn6_A           92 ELFERIKK-KKHFSETEASYIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ--P  165 (325)
T ss_dssp             BHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred             cHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC--c
Confidence            99999965 4579999999999999999999999   8999999999999998765   899999999997655432  2


Q ss_pred             eeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          269 ISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       269 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      .....||+.|+|||.+.+..++.++|+||+|+++|+|++|
T Consensus       166 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g  205 (325)
T 3kn6_A          166 LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSG  205 (325)
T ss_dssp             ------------------CCCCHHHHHHHHHHHHHHHHHS
T ss_pred             ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhC
Confidence            3456789999999999888889999999999999999875

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=2.4e-38  Score=306.93  Aligned_cols=197  Identities=25%  Similarity=0.336  Sum_probs=171.1

Q ss_pred             HHhhcCCccccceeeccCceEEEEEEECCCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeCcEEEE
Q 021711          105 LQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHIV  184 (308)
Q Consensus       105 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~lv  184 (308)
                      +....++|++.+.||+|+||.||+|.+.++..||||.+......  .+.|.+|+.+|+.++||||+++++++.+...++|
T Consensus       262 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~lv  339 (535)
T 2h8h_A          262 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIV  339 (535)
T ss_dssp             SBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSC--HHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEE
T ss_pred             eecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCC--HHHHHHHHHHHHhCCCCCEeeEEEEEeeccceEe
Confidence            44556788999999999999999999988888999999765432  3678999999999999999999999988889999


Q ss_pred             EEecCCCCHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCC
Q 021711          185 LELSPNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ  263 (308)
Q Consensus       185 ~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  263 (308)
                      |||+.+|+|.+++... ...+++..++.++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++.+...
T Consensus       340 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  416 (535)
T 2h8h_A          340 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDN  416 (535)
T ss_dssp             ECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCH
T ss_pred             eehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEEcCCCcEEEcccccceecCCC
Confidence            9999999999999653 3568999999999999999999999   89999999999999999999999999999876432


Q ss_pred             CceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          264 WTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      .. .......+|..|+|||.+....++.++|+||||++||||++
T Consensus       417 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t  459 (535)
T 2h8h_A          417 EY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT  459 (535)
T ss_dssp             HH-HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTT
T ss_pred             ce-ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHh
Confidence            11 11123457789999999888888999999999999999987

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=4.1e-38  Score=277.30  Aligned_cols=194  Identities=23%  Similarity=0.349  Sum_probs=169.2

Q ss_pred             hcCCccccceeeccCceEEEEEEECCCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEEE
Q 021711          108 ATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLE  186 (308)
Q Consensus       108 ~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e  186 (308)
                      ..++|++.+.||+|+||.||+|.+.+++.||+|.+......  .+.+.+|+.+++.++||||+++++++... ..++|||
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (267)
T 3t9t_A            6 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTE   83 (267)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBC--HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEC
T ss_pred             chhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCC--HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEe
Confidence            34689999999999999999999988889999999765433  36788999999999999999999987664 5789999


Q ss_pred             ecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCce
Q 021711          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH  266 (308)
Q Consensus       187 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~  266 (308)
                      |+++++|.+++......+++..+..++.|++.||.|||+   ++|+||||||+||+++.++.+||+|||+++....... 
T Consensus        84 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~-  159 (267)
T 3t9t_A           84 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-  159 (267)
T ss_dssp             CCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH-
T ss_pred             CCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEECCCCCEEEcccccccccccccc-
Confidence            999999999997766779999999999999999999999   8999999999999999999999999999987643211 


Q ss_pred             eEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          267 HTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      .......||..|+|||.......+.++|+||+|+++|+|++
T Consensus       160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~  200 (267)
T 3t9t_A          160 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFS  200 (267)
T ss_dssp             HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred             cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhc
Confidence            11234567889999999887778899999999999999986

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-37  Score=287.17  Aligned_cols=189  Identities=24%  Similarity=0.288  Sum_probs=159.6

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCC-hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-------
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-------  179 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-------  179 (308)
                      .++|++.+.||+|+||.||+|.+. +|+.||||.+.... .....+++.+|+.+++.++||||+++++++...       
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            468999999999999999999975 69999999986543 334467899999999999999999999987654       


Q ss_pred             cEEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEecccccee
Q 021711          180 GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKW  259 (308)
Q Consensus       180 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~  259 (308)
                      ..++||||+ +++|.+++..  ..+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++.
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  177 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQ  177 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             eEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCHHHEEEcCCCCEEEEeeecccc
Confidence            358999999 8899999864  568999999999999999999999   8999999999999999999999999999997


Q ss_pred             cCCCCceeEeeceeccccccccccCch-hhcCccceeEEEeeEEEeeccC
Q 021711          260 LPEQWTHHTISKVEGTFGLVKLNLPPL-VILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       260 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ....     .....||+.|+|||.+.+ ..++.++|+||+|++++||++|
T Consensus       178 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g  222 (367)
T 1cm8_A          178 ADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITG  222 (367)
T ss_dssp             CCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHS
T ss_pred             cccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhC
Confidence            6543     245679999999998776 5678899999999999999875

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1.5e-37  Score=276.13  Aligned_cols=193  Identities=25%  Similarity=0.386  Sum_probs=163.7

Q ss_pred             hcCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChH--HHHHHHHHHHHHHhcCCCCeeeeeeeEEEeCc-EEE
Q 021711          108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTAD--EIIADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHI  183 (308)
Q Consensus       108 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~l  183 (308)
                      ..++|++.+.||+|+||.||+|.+. +++.||+|.+......  .....+.+|+.+++.++||||+++++++.+.. .++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   86 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL   86 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence            3468999999999999999999876 4789999998643221  22467889999999999999999999887654 789


Q ss_pred             EEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCC
Q 021711          184 VLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ  263 (308)
Q Consensus       184 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  263 (308)
                      ||||+++++|.+++.. ...+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||++......
T Consensus        87 v~e~~~~~~l~~~l~~-~~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~  162 (279)
T 3fdn_A           87 ILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS  162 (279)
T ss_dssp             EECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHT---TTCEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred             EEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence            9999999999999865 3568999999999999999999998   89999999999999999999999999999765443


Q ss_pred             CceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          264 WTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                          ......||+.|+|||.+.+...+.++|+||+|+++|+|++|
T Consensus       163 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g  203 (279)
T 3fdn_A          163 ----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG  203 (279)
T ss_dssp             ---------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHS
T ss_pred             ----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHC
Confidence                22456799999999998888888999999999999999875

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=1.1e-37  Score=309.67  Aligned_cols=195  Identities=21%  Similarity=0.260  Sum_probs=168.0

Q ss_pred             hcCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCC--hHHHHHHHHHHHHHHhcC-CCCeeeeeeeEEEe-CcEE
Q 021711          108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHV-DHPNTAKLLGYGIE-GGMH  182 (308)
Q Consensus       108 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-~~~~  182 (308)
                      ..++|++.++||+|+||.||+|+.. +++.||||++....  .....+.+..|..++..+ +||||+++++++.+ +.+|
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~  418 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY  418 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence            3568999999999999999999976 58899999986432  112346788899999987 79999999987665 4578


Q ss_pred             EEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCC
Q 021711          183 IVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE  262 (308)
Q Consensus       183 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~  262 (308)
                      +||||+++|+|.+++.. ...+++..+..++.||+.||.|||+   ++|+||||||+||||+.++.+||+|||+|+....
T Consensus       419 lV~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~---~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~  494 (674)
T 3pfq_A          419 FVMEYVNGGDLMYHIQQ-VGRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW  494 (674)
T ss_dssp             EEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TSEECCCCCSTTEEECSSSCEEECCCTTCEECCC
T ss_pred             EEEeCcCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeccCChhhEEEcCCCcEEEeecceeecccc
Confidence            99999999999999965 3569999999999999999999999   8999999999999999999999999999997543


Q ss_pred             CCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          263 QWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       263 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ...  ......||+.|+|||++....++.++|+||+|++||||++|
T Consensus       495 ~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG  538 (674)
T 3pfq_A          495 DGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAG  538 (674)
T ss_dssp             TTC--CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHS
T ss_pred             CCc--ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcC
Confidence            322  23567899999999999888889999999999999999876

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1.7e-37  Score=281.64  Aligned_cols=192  Identities=24%  Similarity=0.289  Sum_probs=167.5

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChH-----HHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTAD-----EIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMH  182 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~  182 (308)
                      ++|++.+.||+|+||.||+|... +|+.||+|.+......     ...+.+.+|+.+++.++||||+++++++... ..+
T Consensus        12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   91 (321)
T 2a2a_A           12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV   91 (321)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence            57999999999999999999976 5899999998654321     1256789999999999999999999987765 478


Q ss_pred             EEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCC----cEEEeccccce
Q 021711          183 IVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDF----EPQICDFGLAK  258 (308)
Q Consensus       183 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~----~~kl~DFGla~  258 (308)
                      +||||+++++|.+++.. ...+++..+..++.|++.||.|||+   .+|+||||||+|||++.++    .+||+|||+++
T Consensus        92 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~---~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~  167 (321)
T 2a2a_A           92 LILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH  167 (321)
T ss_dssp             EEECCCCSCBHHHHHHT-CSCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCTTCE
T ss_pred             EEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChHHEEEecCCCCcCCEEEccCccce
Confidence            99999999999999964 4568999999999999999999999   8999999999999999887    79999999999


Q ss_pred             ecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          259 WLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       259 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      .......   .....||+.|+|||.......+.++|+||+|+++|+|++|
T Consensus       168 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g  214 (321)
T 2a2a_A          168 EIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG  214 (321)
T ss_dssp             ECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred             ecCcccc---ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHC
Confidence            8765422   2456799999999998877788999999999999999875

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=2.2e-37  Score=285.08  Aligned_cols=200  Identities=23%  Similarity=0.268  Sum_probs=163.3

Q ss_pred             HHHHHhhcCCccccceeeccCceEEEEEEECCCcEEEEEEeccCCh----------HHHHHHHHHHHHHHhcCCCCeeee
Q 021711          102 LYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTA----------DEIIADFLSELGIMAHVDHPNTAK  171 (308)
Q Consensus       102 ~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~----------~~~~~~~~~E~~~l~~l~h~niv~  171 (308)
                      ..++....++|++.+.||+|+||.||+|...+|+.||||++.....          ....+.+.+|+.+++.++||||++
T Consensus        14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~   93 (362)
T 3pg1_A           14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG   93 (362)
T ss_dssp             HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence            4567778899999999999999999999988899999999854221          223578999999999999999999


Q ss_pred             eeeEEEeC------cEEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECC
Q 021711          172 LLGYGIEG------GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTE  245 (308)
Q Consensus       172 l~~~~~~~------~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~  245 (308)
                      +++++...      ..++||||+. |+|.+.+......+++..+..++.||+.||.|||+   ++|+||||||+|||++.
T Consensus        94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~  169 (362)
T 3pg1_A           94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHE---AGVVHRDLHPGNILLAD  169 (362)
T ss_dssp             CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECT
T ss_pred             eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CcCEecCCChHHEEEcC
Confidence            99976432      3689999997 68888887666679999999999999999999999   89999999999999999


Q ss_pred             CCcEEEeccccceecCCCCceeEeeceeccccccccccCch-hhcCccceeEEEeeEEEeeccC
Q 021711          246 DFEPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPL-VILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       246 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ++.+||+|||+++......   ......||+.|+|||...+ ...+.++|+||+|+++|+|++|
T Consensus       170 ~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g  230 (362)
T 3pg1_A          170 NNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNR  230 (362)
T ss_dssp             TCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHS
T ss_pred             CCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhC
Confidence            9999999999998654432   2345679999999998765 5678899999999999999875

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=2.7e-37  Score=285.29  Aligned_cols=194  Identities=22%  Similarity=0.274  Sum_probs=166.8

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC------cE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG------GM  181 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~  181 (308)
                      .++|++.+.||+|+||.||+|... +++.||||.+.........+.+.+|+.++..++||||+++++++...      ..
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            468999999999999999999976 58899999997655555668899999999999999999999987643      47


Q ss_pred             EEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecC
Q 021711          182 HIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP  261 (308)
Q Consensus       182 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~  261 (308)
                      ++||||+. |+|.+++..  ..+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++...
T Consensus       106 ~iv~e~~~-~~L~~~l~~--~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~  179 (364)
T 3qyz_A          106 YIVQDLME-TDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD  179 (364)
T ss_dssp             EEEEECCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEcccC-cCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChHhEEECCCCCEEEEeCcceEecC
Confidence            89999997 589998854  569999999999999999999999   899999999999999999999999999999775


Q ss_pred             CCCcee-EeeceeccccccccccCchh-hcCccceeEEEeeEEEeeccC
Q 021711          262 EQWTHH-TISKVEGTFGLVKLNLPPLV-ILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       262 ~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ...... ......||+.|+|||.+.+. ..+.++|+||+|+++|+|++|
T Consensus       180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g  228 (364)
T 3qyz_A          180 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN  228 (364)
T ss_dssp             GGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHS
T ss_pred             CCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHC
Confidence            432211 12456899999999976544 478899999999999999875

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=3e-37  Score=273.65  Aligned_cols=191  Identities=24%  Similarity=0.313  Sum_probs=165.4

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeCc-EEEEEE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLE  186 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e  186 (308)
                      .++|++.+.||+|+||.||+|... ++..||+|.+...... ..+.+.+|+.+++.++||||+++++++.... .++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE-DVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME   86 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCS-CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccc-hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence            357999999999999999999976 4789999998654322 2467889999999999999999999877654 789999


Q ss_pred             ecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEE---CCCCcEEEeccccceecCCC
Q 021711          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILL---TEDFEPQICDFGLAKWLPEQ  263 (308)
Q Consensus       187 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl---~~~~~~kl~DFGla~~~~~~  263 (308)
                      |+++++|.+++.. ...+++..+..++.|++.||.|||+   ++|+||||||+|||+   +.++.+||+|||++..+...
T Consensus        87 ~~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~  162 (277)
T 3f3z_A           87 LCTGGELFERVVH-KRVFRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG  162 (277)
T ss_dssp             CCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT
T ss_pred             ccCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc
Confidence            9999999998864 4568999999999999999999999   899999999999999   78889999999999887654


Q ss_pred             CceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          264 WTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      .   ......||+.|+|||.+.+. .+.++|+||+|+++|+|++|
T Consensus       163 ~---~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g  203 (277)
T 3f3z_A          163 K---MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCG  203 (277)
T ss_dssp             S---CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHS
T ss_pred             c---chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHC
Confidence            3   22456799999999987654 78899999999999999875

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=7.7e-38  Score=288.05  Aligned_cols=192  Identities=23%  Similarity=0.346  Sum_probs=168.0

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEEE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLE  186 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e  186 (308)
                      .++|++.+.||+|+||.||+|.+. +++.||+|.+.........+.+.+|+.+++.++||||+++++++..+ ..++|||
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  111 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME  111 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence            457999999999999999999986 58999999998765566678899999999999999999999977665 4789999


Q ss_pred             ecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCC-CceecCCCCCCEEECCCCcEEEeccccceecCCCCc
Q 021711          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQR-RIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (308)
Q Consensus       187 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~-~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~  265 (308)
                      |+++++|.+++.. ...+++..+..++.|++.||.|||+   . +|+||||||+|||++.++.+||+|||+++.+...  
T Consensus       112 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lh~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--  185 (360)
T 3eqc_A          112 HMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLRE---KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  185 (360)
T ss_dssp             CCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred             CCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---hCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc--
Confidence            9999999999965 3468999999999999999999997   5 8999999999999999999999999999765322  


Q ss_pred             eeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          266 HHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                        ......||+.|+|||.+.+..++.++|+||+|+++|+|++|
T Consensus       186 --~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g  226 (360)
T 3eqc_A          186 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG  226 (360)
T ss_dssp             --C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHT
T ss_pred             --cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhC
Confidence              22346899999999998888889999999999999999875

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=4.6e-37  Score=276.02  Aligned_cols=193  Identities=29%  Similarity=0.379  Sum_probs=169.3

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEEE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLE  186 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e  186 (308)
                      .+.|++.+.||+|+||.||+|... +++.||+|.+.........+.+.+|+.+++.++||||+++++++... ..++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  100 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME  100 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence            357899999999999999999875 58999999997654444467899999999999999999999977665 5789999


Q ss_pred             ecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCce
Q 021711          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH  266 (308)
Q Consensus       187 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~  266 (308)
                      |+++++|.+++.  ...+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.+||+|||++..+..... 
T Consensus       101 ~~~~~~L~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  174 (303)
T 3a7i_A          101 YLGGGSALDLLE--PGPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-  174 (303)
T ss_dssp             CCTTEEHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC-
T ss_pred             eCCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChheEEECCCCCEEEeecccceecCcccc-
Confidence            999999999985  3578999999999999999999999   8999999999999999999999999999987754322 


Q ss_pred             eEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          267 HTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                       ......||+.|+|||...+...+.++|+||+|+++|+|++|
T Consensus       175 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g  215 (303)
T 3a7i_A          175 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARG  215 (303)
T ss_dssp             -CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHS
T ss_pred             -ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccC
Confidence             22456799999999998887888899999999999999875

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=4.8e-38  Score=291.70  Aligned_cols=191  Identities=12%  Similarity=0.137  Sum_probs=157.1

Q ss_pred             hcCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccC--ChHHHHHHHHHHH---HHHhcCCCCeeeeee-------e
Q 021711          108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRG--TADEIIADFLSEL---GIMAHVDHPNTAKLL-------G  174 (308)
Q Consensus       108 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~--~~~~~~~~~~~E~---~~l~~l~h~niv~l~-------~  174 (308)
                      ..++|++.+.||+|+||.||+|.+. +|+.||||.+...  ......+.+.+|+   .+++.++|||||+++       +
T Consensus        71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~  150 (377)
T 3byv_A           71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD  150 (377)
T ss_dssp             CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred             CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence            3468999999999999999999964 6999999998643  2223467889999   455566899999998       5


Q ss_pred             EEEeC------------------cEEEEEEecCCCCHHHHHhccCC------CCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 021711          175 YGIEG------------------GMHIVLELSPNGSLASLLYGMKE------KLKWGIRYKIALGVAEGLLYLHEGCQRR  230 (308)
Q Consensus       175 ~~~~~------------------~~~lv~e~~~~gsL~~~l~~~~~------~l~~~~~~~i~~qi~~~L~yLH~~~~~~  230 (308)
                      ++...                  ..++||||+ +|+|.+++.....      .+++..++.++.||+.||.|||+   ++
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~  226 (377)
T 3byv_A          151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YG  226 (377)
T ss_dssp             EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH---TT
T ss_pred             hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh---CC
Confidence            44433                  268999999 6899999965321      12357888899999999999999   89


Q ss_pred             ceecCCCCCCEEECCCCcEEEeccccceecCCCCceeEeeceeccccccccccCchh-----------hcCccceeEEEe
Q 021711          231 IIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPLV-----------ILKRCFTCIFIG  299 (308)
Q Consensus       231 iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~Di~s~g  299 (308)
                      |+||||||+|||++.++.+||+|||+|+....     ......| +.|+|||.+.+.           .++.++|+||||
T Consensus       227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG  300 (377)
T 3byv_A          227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALG  300 (377)
T ss_dssp             EECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHH
T ss_pred             eecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHH
Confidence            99999999999999999999999999996433     2345677 999999998877           789999999999


Q ss_pred             eEEEeeccC
Q 021711          300 FSQLQLSCS  308 (308)
Q Consensus       300 ~~l~el~c~  308 (308)
                      +++|||++|
T Consensus       301 ~il~elltg  309 (377)
T 3byv_A          301 LVIYWIWCA  309 (377)
T ss_dssp             HHHHHHHHS
T ss_pred             HHHHHHHHC
Confidence            999999876

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=4.9e-38  Score=287.45  Aligned_cols=193  Identities=23%  Similarity=0.324  Sum_probs=165.5

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCCh-------HHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeCc
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA-------DEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG  180 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~-------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  180 (308)
                      .++|++.+.||+|+||.||+|.+. +++.||||.+.....       ......+.+|+.+++.++||||+++++++...+
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~  102 (335)
T 3dls_A           23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG  102 (335)
T ss_dssp             HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence            468999999999999999999975 589999999875431       112345778999999999999999999877654


Q ss_pred             -EEEEEEecCCC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccce
Q 021711          181 -MHIVLELSPNG-SLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK  258 (308)
Q Consensus       181 -~~lv~e~~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~  258 (308)
                       .++||||+.+| +|.+++.. ...+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++
T Consensus       103 ~~~lv~e~~~~g~~l~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~  178 (335)
T 3dls_A          103 FFQLVMEKHGSGLDLFAFIDR-HPRLDEPLASYIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAA  178 (335)
T ss_dssp             EEEEEEECCTTSCBHHHHHHT-CCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EEEEEEEeCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEEeccCHHHEEEcCCCcEEEeecccce
Confidence             68999998776 99998854 4569999999999999999999999   899999999999999999999999999999


Q ss_pred             ecCCCCceeEeeceeccccccccccCchhhc-CccceeEEEeeEEEeeccC
Q 021711          259 WLPEQWTHHTISKVEGTFGLVKLNLPPLVIL-KRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       259 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~s~g~~l~el~c~  308 (308)
                      .+.....   .....||+.|+|||.+.+... +.++|+||+|+++|+|++|
T Consensus       179 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g  226 (335)
T 3dls_A          179 YLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFE  226 (335)
T ss_dssp             ECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHS
T ss_pred             ECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhC
Confidence            8765432   234679999999998876665 7789999999999999875

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.5e-37  Score=277.43  Aligned_cols=192  Identities=22%  Similarity=0.306  Sum_probs=160.0

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEEEe
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLEL  187 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~  187 (308)
                      ++|.+.+.||+|+||.||+|... ++..||+|.+.........+.+.+|+.+++.++||||+++++++... ..++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  101 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET  101 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence            57999999999999999999976 58899999987544333357789999999999999999999987765 47899999


Q ss_pred             cCCCCHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEE---CCCCcEEEeccccceecC
Q 021711          188 SPNGSLASLLYG---MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILL---TEDFEPQICDFGLAKWLP  261 (308)
Q Consensus       188 ~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl---~~~~~~kl~DFGla~~~~  261 (308)
                      +++|+|.+++..   ....+++..+..++.|++.||.|||+   .+|+||||||+|||+   +.++.+||+|||+++.+.
T Consensus       102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~  178 (285)
T 3is5_A          102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK  178 (285)
T ss_dssp             CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred             CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence            999999998854   23679999999999999999999999   899999999999999   456789999999998765


Q ss_pred             CCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          262 EQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       262 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ...   ......||+.|+|||.+. ...+.++|+||+|+++|||++|
T Consensus       179 ~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g  221 (285)
T 3is5_A          179 SDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTG  221 (285)
T ss_dssp             -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHS
T ss_pred             Ccc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhC
Confidence            432   234567999999999875 4567889999999999999865

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=8.6e-38  Score=278.43  Aligned_cols=196  Identities=22%  Similarity=0.357  Sum_probs=171.3

Q ss_pred             HhhcCCccccceeeccCceEEEEEEECC-CcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEE
Q 021711          106 QSATNNFSFENLIGKGGYAEVYKGRLRN-GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHI  183 (308)
Q Consensus       106 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~-g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l  183 (308)
                      ....++|++.+.||+|+||.||+|.+.. +..||+|.+.....  ..+.+.+|+.+++.++||||+++++++... ..++
T Consensus         9 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   86 (288)
T 3kfa_A            9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI   86 (288)
T ss_dssp             BCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCST--HHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEE
T ss_pred             cccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEE
Confidence            3456789999999999999999999874 88999999976543  357889999999999999999999987664 5789


Q ss_pred             EEEecCCCCHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCC
Q 021711          184 VLELSPNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE  262 (308)
Q Consensus       184 v~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~  262 (308)
                      ||||+++++|.+++... ...+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.+||+|||+++....
T Consensus        87 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~  163 (288)
T 3kfa_A           87 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG  163 (288)
T ss_dssp             EEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHH---HTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCS
T ss_pred             EEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHH---CCccCCCCCcceEEEcCCCCEEEccCccceeccC
Confidence            99999999999999653 3458999999999999999999999   8999999999999999999999999999987755


Q ss_pred             CCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          263 QWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       263 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      ... .......+|+.|+|||.......+.++|+||+|+++|+|++
T Consensus       164 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~  207 (288)
T 3kfa_A          164 DTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT  207 (288)
T ss_dssp             SSS-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred             Ccc-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHh
Confidence            432 23456678899999999888888999999999999999987

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=5e-37  Score=272.45  Aligned_cols=191  Identities=23%  Similarity=0.247  Sum_probs=162.6

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCCh-HHHHHHHHHHHHHHhcC-CCCeeeeeeeEEEeC-cEEEE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA-DEIIADFLSELGIMAHV-DHPNTAKLLGYGIEG-GMHIV  184 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~~~lv  184 (308)
                      .++|++.+.||+|+||.||+|... +++.||+|.+..... ......+.+|+..+..+ +||||+++++++.+. ..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv   89 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ   89 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence            357999999999999999999986 689999999875432 23457788999999999 999999999987765 47899


Q ss_pred             EEecCCCCHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCC---------------
Q 021711          185 LELSPNGSLASLLYGM---KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTED---------------  246 (308)
Q Consensus       185 ~e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~---------------  246 (308)
                      |||+++++|.+++...   ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.+               
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~  166 (289)
T 1x8b_A           90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDW  166 (289)
T ss_dssp             EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEC-----------------
T ss_pred             EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence            9999999999999653   2568999999999999999999999   899999999999999844               


Q ss_pred             ----CcEEEeccccceecCCCCceeEeeceeccccccccccCchh-hcCccceeEEEeeEEEeeccC
Q 021711          247 ----FEPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPLV-ILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       247 ----~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~s~g~~l~el~c~  308 (308)
                          ..+||+|||++.......      ...||+.|+|||.+.+. ..+.++|+||+|+++|+|+++
T Consensus       167 ~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~  227 (289)
T 1x8b_A          167 ASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGA  227 (289)
T ss_dssp             ---CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTC
T ss_pred             cCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcC
Confidence                479999999999875542      23599999999987655 456789999999999999764

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=6.9e-37  Score=273.75  Aligned_cols=194  Identities=23%  Similarity=0.275  Sum_probs=169.0

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccC--ChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeCc-EEEE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRG--TADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIV  184 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv  184 (308)
                      .++|.+.+.||+|+||.||+|... +++.||+|.+...  ......+.+.+|+.+++.++||||+++++++...+ .++|
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV   93 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence            357999999999999999999987 4889999998653  23345678899999999999999999999887654 7899


Q ss_pred             EEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCC
Q 021711          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (308)
Q Consensus       185 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  264 (308)
                      |||+++++|.+++.. ...+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++......
T Consensus        94 ~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  169 (294)
T 2rku_A           94 LELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG  169 (294)
T ss_dssp             EECCTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             EecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEcCCCCEEEEeccCceecccCc
Confidence            999999999998854 4578999999999999999999999   899999999999999999999999999999875432


Q ss_pred             ceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          265 THHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      .  ......||+.|+|||.......+.++|+||+|+++|+|++|
T Consensus       170 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g  211 (294)
T 2rku_A          170 E--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVG  211 (294)
T ss_dssp             C--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHS
T ss_pred             c--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhC
Confidence            2  22346799999999998877788899999999999999875

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.6e-37  Score=280.23  Aligned_cols=199  Identities=23%  Similarity=0.343  Sum_probs=157.7

Q ss_pred             HhhcCCccccceeeccCceEEEEEEEC----CCcEEEEEEeccCC-hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeCc
Q 021711          106 QSATNNFSFENLIGKGGYAEVYKGRLR----NGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG  180 (308)
Q Consensus       106 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~----~g~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  180 (308)
                      ....++|.+.+.||+|+||.||+|.+.    ++..||+|.+.... .....+.+.+|+.+++.++||||+++++++....
T Consensus        30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  109 (313)
T 3brb_A           30 VIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMS  109 (313)
T ss_dssp             BCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC--
T ss_pred             ccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecc
Confidence            345678999999999999999999764    24589999987543 3345678999999999999999999999876532


Q ss_pred             ------EEEEEEecCCCCHHHHHhc-----cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcE
Q 021711          181 ------MHIVLELSPNGSLASLLYG-----MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEP  249 (308)
Q Consensus       181 ------~~lv~e~~~~gsL~~~l~~-----~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~  249 (308)
                            .++||||+++|+|.+++..     ....+++..++.++.|++.||.|||+   ++|+||||||+|||++.++.+
T Consensus       110 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~  186 (313)
T 3brb_A          110 SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN---RNFLHRDLAARNCMLRDDMTV  186 (313)
T ss_dssp             -----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCSGGGEEECTTSCE
T ss_pred             ccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcE
Confidence                  4899999999999999843     23568999999999999999999998   899999999999999999999


Q ss_pred             EEeccccceecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          250 QICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       250 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      ||+|||+++.+.............+++.|+|||.......+.++|+||+|+++|+|++
T Consensus       187 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~  244 (313)
T 3brb_A          187 CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT  244 (313)
T ss_dssp             EECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHT
T ss_pred             EEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHh
Confidence            9999999987755433233345678899999999888788899999999999999987

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=7.8e-38  Score=285.91  Aligned_cols=199  Identities=23%  Similarity=0.269  Sum_probs=161.0

Q ss_pred             hhcCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCC----hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeCc-
Q 021711          107 SATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT----ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG-  180 (308)
Q Consensus       107 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-  180 (308)
                      ...++|++.+.||+|+||.||+|... ++..||+|.+....    .....+.+.+|+.+++.++||||+++++++.+.. 
T Consensus        23 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  102 (345)
T 3hko_A           23 ELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQY  102 (345)
T ss_dssp             HHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             hhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCe
Confidence            44568999999999999999999975 58899999986431    2234678999999999999999999999887654 


Q ss_pred             EEEEEEecCCCCHHHHHhcc---------------------------------------CCCCCHHHHHHHHHHHHHHHH
Q 021711          181 MHIVLELSPNGSLASLLYGM---------------------------------------KEKLKWGIRYKIALGVAEGLL  221 (308)
Q Consensus       181 ~~lv~e~~~~gsL~~~l~~~---------------------------------------~~~l~~~~~~~i~~qi~~~L~  221 (308)
                      .++||||+++|+|.+++...                                       ...+++..+..++.|++.||.
T Consensus       103 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~  182 (345)
T 3hko_A          103 ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALH  182 (345)
T ss_dssp             EEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHH
Confidence            78999999999999998421                                       111356677889999999999


Q ss_pred             HHHhCCCCCceecCCCCCCEEECCCC--cEEEeccccceecCCCCce--eEeeceeccccccccccCch--hhcCcccee
Q 021711          222 YLHEGCQRRIIHRDIKAANILLTEDF--EPQICDFGLAKWLPEQWTH--HTISKVEGTFGLVKLNLPPL--VILKRCFTC  295 (308)
Q Consensus       222 yLH~~~~~~iiHrDlKp~NILl~~~~--~~kl~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di  295 (308)
                      |||+   .+|+||||||+|||++.++  .+||+|||+++.+......  .......||+.|+|||.+..  ..++.++|+
T Consensus       183 ~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di  259 (345)
T 3hko_A          183 YLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDA  259 (345)
T ss_dssp             HHHH---TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHH
T ss_pred             HHHH---CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHH
Confidence            9999   8999999999999998776  8999999999876432221  12346789999999998754  557889999


Q ss_pred             EEEeeEEEeeccC
Q 021711          296 IFIGFSQLQLSCS  308 (308)
Q Consensus       296 ~s~g~~l~el~c~  308 (308)
                      ||+|+++|||++|
T Consensus       260 wslG~il~el~~g  272 (345)
T 3hko_A          260 WSAGVLLHLLLMG  272 (345)
T ss_dssp             HHHHHHHHHHHHS
T ss_pred             HHHHHHHHHHHHC
Confidence            9999999999875

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=5.2e-37  Score=280.26  Aligned_cols=194  Identities=23%  Similarity=0.275  Sum_probs=169.3

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccC--ChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeCc-EEEE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRG--TADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIV  184 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv  184 (308)
                      .++|.+.+.||+|+||.||++.+. +++.||+|.+...  ......+.+.+|+.+++.++||||+++++++.+.+ .++|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            357999999999999999999986 4889999998643  23345678999999999999999999999887654 7899


Q ss_pred             EEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCC
Q 021711          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (308)
Q Consensus       185 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  264 (308)
                      |||+.+++|.+++.. ...+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++......
T Consensus       120 ~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  195 (335)
T 2owb_A          120 LELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG  195 (335)
T ss_dssp             ECCCTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             EecCCCCCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCCEecCCCchhEEEcCCCCEEEeeccCceecccCc
Confidence            999999999998854 4578999999999999999999999   899999999999999999999999999999875432


Q ss_pred             ceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          265 THHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      .  ......||..|+|||.+.+...+.++|+||+|+++|+|++|
T Consensus       196 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g  237 (335)
T 2owb_A          196 E--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVG  237 (335)
T ss_dssp             C--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHS
T ss_pred             c--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHC
Confidence            2  22456799999999998887788899999999999999875

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=3.4e-37  Score=272.24  Aligned_cols=191  Identities=26%  Similarity=0.425  Sum_probs=155.1

Q ss_pred             hcCCccccceeeccCceEEEEEEECCCcEEEEEEeccCChH---HHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEE
Q 021711          108 ATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTAD---EIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHI  183 (308)
Q Consensus       108 ~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l  183 (308)
                      ..++|++.+.||+|+||.||+|.+. |+.||||.+......   ...+.+.+|+.+++.++||||+++++++..+ ..++
T Consensus         5 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (271)
T 3dtc_A            5 DFAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL   83 (271)
T ss_dssp             CTTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEE
T ss_pred             chhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence            3468999999999999999999975 889999998654322   2356789999999999999999999987665 4789


Q ss_pred             EEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC---ceecCCCCCCEEECC--------CCcEEEe
Q 021711          184 VLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRR---IIHRDIKAANILLTE--------DFEPQIC  252 (308)
Q Consensus       184 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~---iiHrDlKp~NILl~~--------~~~~kl~  252 (308)
                      ||||+++++|.+++.  ...+++..+..++.|++.||.|||+   ++   |+||||||+|||++.        ++.+||+
T Consensus        84 v~e~~~~~~L~~~~~--~~~~~~~~~~~i~~~l~~~l~~lH~---~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~  158 (271)
T 3dtc_A           84 VMEFARGGPLNRVLS--GKRIPPDILVNWAVQIARGMNYLHD---EAIVPIIHRDLKSSNILILQKVENGDLSNKILKIT  158 (271)
T ss_dssp             EEECCTTEEHHHHHT--SSCCCHHHHHHHHHHHHHHHHHHHH---SSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEEC
T ss_pred             EEEcCCCCCHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCCCceeecCCchHHEEEecccccccccCcceEEc
Confidence            999999999999984  4579999999999999999999999   67   999999999999986        6789999


Q ss_pred             ccccceecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          253 DFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       253 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      |||+++......    .....||+.|+|||.+.+..++.++|+||+|+++|+|++|
T Consensus       159 Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g  210 (271)
T 3dtc_A          159 DFGLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTG  210 (271)
T ss_dssp             CCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHC
T ss_pred             cCCccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhC
Confidence            999998765432    2345799999999998888889999999999999999875

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-37  Score=284.33  Aligned_cols=196  Identities=26%  Similarity=0.308  Sum_probs=159.7

Q ss_pred             hhcCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChH----HHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-c
Q 021711          107 SATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTAD----EIIADFLSELGIMAHVDHPNTAKLLGYGIEG-G  180 (308)
Q Consensus       107 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~  180 (308)
                      ...++|++.+.||+|+||.||+|.+. +|+.||||.+......    .....+.+|+.+++.++||||+++++++... .
T Consensus         7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (346)
T 1ua2_A            7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN   86 (346)
T ss_dssp             ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred             HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence            34578999999999999999999976 5899999998653221    1234688999999999999999999977654 5


Q ss_pred             EEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceec
Q 021711          181 MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL  260 (308)
Q Consensus       181 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~  260 (308)
                      .++||||+.+ +|..++......+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++.+
T Consensus        87 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~  162 (346)
T 1ua2_A           87 ISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSF  162 (346)
T ss_dssp             CEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred             eEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCCHHHEEEcCCCCEEEEecccceec
Confidence            7899999986 8998887666678899999999999999999999   89999999999999999999999999999876


Q ss_pred             CCCCceeEeeceeccccccccccCchh-hcCccceeEEEeeEEEeeccC
Q 021711          261 PEQWTHHTISKVEGTFGLVKLNLPPLV-ILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       261 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~s~g~~l~el~c~  308 (308)
                      .....  ......||+.|+|||...+. .++.++|+||+|+++|||++|
T Consensus       163 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g  209 (346)
T 1ua2_A          163 GSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLR  209 (346)
T ss_dssp             TSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHS
T ss_pred             cCCcc--cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHC
Confidence            54322  23456799999999987543 468889999999999999875

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=5.8e-37  Score=276.81  Aligned_cols=195  Identities=21%  Similarity=0.264  Sum_probs=158.2

Q ss_pred             cCCcccc-ceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcC-CCCeeeeeeeEEEeC-cEEEE
Q 021711          109 TNNFSFE-NLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGIEG-GMHIV  184 (308)
Q Consensus       109 ~~~~~~~-~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~~~lv  184 (308)
                      .+.|++. +.||+|+||.||+|... +++.||||.+..... .....+.+|+.++.++ +||||+++++++.+. ..++|
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv   89 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG-HIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLV   89 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS-CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc-hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence            3578874 78999999999999965 689999999975432 2346788999999885 799999999987665 57899


Q ss_pred             EEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCc---EEEeccccceecC
Q 021711          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFE---PQICDFGLAKWLP  261 (308)
Q Consensus       185 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~---~kl~DFGla~~~~  261 (308)
                      |||+++|+|.+++.. ...+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.   +||+|||+++...
T Consensus        90 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~  165 (316)
T 2ac3_A           90 FEKMRGGSILSHIHK-RRHFNELEASVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK  165 (316)
T ss_dssp             EECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred             EEcCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence            999999999999965 3568999999999999999999999   89999999999999998775   9999999998764


Q ss_pred             CCCce-----eEeeceeccccccccccCch-----hhcCccceeEEEeeEEEeeccC
Q 021711          262 EQWTH-----HTISKVEGTFGLVKLNLPPL-----VILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       262 ~~~~~-----~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      .....     .......||+.|+|||.+..     ..++.++|+||+|+++|||++|
T Consensus       166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g  222 (316)
T 2ac3_A          166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSG  222 (316)
T ss_dssp             ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHS
T ss_pred             cCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHC
Confidence            32211     12234569999999998764     4578899999999999999875

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=2.8e-37  Score=281.16  Aligned_cols=191  Identities=27%  Similarity=0.401  Sum_probs=155.1

Q ss_pred             hcCCccccceeeccCceEEEEEEECCCcEEEEEEeccCChHHHHHHHHHHHHH--HhcCCCCeeeeeeeEEEe------C
Q 021711          108 ATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGI--MAHVDHPNTAKLLGYGIE------G  179 (308)
Q Consensus       108 ~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~l~~~~~~------~  179 (308)
                      ..++|++.+.||+|+||.||+|+. +++.||||.+.....    ..+..|.++  +..++||||+++++++..      .
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~----~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~   85 (336)
T 3g2f_A           11 DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR----QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRM   85 (336)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGH----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCE
T ss_pred             ChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccch----hhHHHHHHHHHHHhccCcchhhheecccccccCCCc
Confidence            457899999999999999999987 689999999875432    334444444  456899999999975432      1


Q ss_pred             cEEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCC---------CceecCCCCCCEEECCCCcEE
Q 021711          180 GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQR---------RIIHRDIKAANILLTEDFEPQ  250 (308)
Q Consensus       180 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~---------~iiHrDlKp~NILl~~~~~~k  250 (308)
                      .+++||||+++|+|.+++..  ...++..+..++.||+.||.|||+   .         +|+||||||+|||++.++.+|
T Consensus        86 ~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~~L~~LH~---~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k  160 (336)
T 3g2f_A           86 EYLLVMEYYPNGSLXKYLSL--HTSDWVSSCRLAHSVTRGLAYLHT---ELPRGDHYKPAISHRDLNSRNVLVKNDGTCV  160 (336)
T ss_dssp             EEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHC---CBCCGGGCBCCEECSSCSGGGEEECTTSCEE
T ss_pred             eEEEEEecCCCCcHHHHHhh--cccchhHHHHHHHHHHHHHHHHHh---hhccccccccceeecccccceEEEcCCCcEE
Confidence            35799999999999999954  345888999999999999999998   6         999999999999999999999


Q ss_pred             EeccccceecCCCCc------eeEeeceeccccccccccCch-------hhcCccceeEEEeeEEEeeccC
Q 021711          251 ICDFGLAKWLPEQWT------HHTISKVEGTFGLVKLNLPPL-------VILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       251 l~DFGla~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      |+|||+++.+.....      ........||+.|+|||.+.+       ...+.++|+||+|+++|||++|
T Consensus       161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g  231 (336)
T 3g2f_A          161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMR  231 (336)
T ss_dssp             ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhc
Confidence            999999998754321      112234579999999998765       4566789999999999999865

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=9.8e-37  Score=275.27  Aligned_cols=195  Identities=17%  Similarity=0.214  Sum_probs=158.1

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCC--hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIV  184 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv  184 (308)
                      .++|++.+.||+|+||.||+|... +++.||+|.+....  .....+.+.+|+.++..++||||+++++++..+ ..++|
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD  112 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence            478999999999999999999976 68899999986542  233467899999999999999999999987765 47899


Q ss_pred             EEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCC
Q 021711          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (308)
Q Consensus       185 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  264 (308)
                      +||+++++|.+++.. ...+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++......
T Consensus       113 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  188 (309)
T 2h34_A          113 MRLINGVDLAAMLRR-QGPLAPPRAVAIVRQIGSALDAAHA---AGATHRDVKPENILVSADDFAYLVDFGIASATTDEK  188 (309)
T ss_dssp             EECCCCEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSCCC--------
T ss_pred             EEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CcCCcCCCChHHEEEcCCCCEEEecCccCccccccc
Confidence            999999999999864 3568999999999999999999999   899999999999999999999999999998765432


Q ss_pred             ceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          265 THHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      . .......||+.|+|||.+.+...+.++|+||+|+++|||++|
T Consensus       189 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g  231 (309)
T 2h34_A          189 L-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTG  231 (309)
T ss_dssp             ---------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHS
T ss_pred             c-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHC
Confidence            2 223456799999999999888888999999999999999875

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=3e-37  Score=278.54  Aligned_cols=190  Identities=25%  Similarity=0.393  Sum_probs=157.1

Q ss_pred             cCCccccceeeccCceEEEEEEECCCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeCcEEEEEEec
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHIVLELS  188 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~lv~e~~  188 (308)
                      .++|++.+.||+|+||.||+|.+. ++.||+|.+....   ..+.|.+|+.+++.++||||+++++++. +..++||||+
T Consensus         7 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~-~~~~lv~e~~   81 (307)
T 2eva_A            7 YKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESES---ERKAFIVELRQLSRVNHPNIVKLYGACL-NPVCLVMEYA   81 (307)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSSTT---HHHHHHHHHHHHHHCCCTTBCCEEEBCT-TTTEEEEECC
T ss_pred             HhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecChh---HHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCcEEEEEcC
Confidence            357889999999999999999985 7889999986543   3468899999999999999999999776 4578999999


Q ss_pred             CCCCHHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCc-EEEeccccceecCCCCc
Q 021711          189 PNGSLASLLYGMKE--KLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFE-PQICDFGLAKWLPEQWT  265 (308)
Q Consensus       189 ~~gsL~~~l~~~~~--~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~-~kl~DFGla~~~~~~~~  265 (308)
                      ++|+|.+++.....  .++...++.++.|++.||.|||+.+.++|+||||||+|||++.++. +||+|||+++.....  
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--  159 (307)
T 2eva_A           82 EGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--  159 (307)
T ss_dssp             TTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---------
T ss_pred             CCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc--
Confidence            99999999975432  4788899999999999999999744468999999999999998886 799999999865432  


Q ss_pred             eeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          266 HHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                         .....||+.|+|||...+...+.++|+||+|+++|||++|
T Consensus       160 ---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g  199 (307)
T 2eva_A          160 ---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITR  199 (307)
T ss_dssp             --------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHT
T ss_pred             ---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHC
Confidence               2345699999999998877888999999999999999875

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.8e-37  Score=279.36  Aligned_cols=192  Identities=26%  Similarity=0.337  Sum_probs=157.4

Q ss_pred             hhcCCccccceeeccCceEEEEEEECCCcEEEEEEeccCChHHHHHHHHHHHHHHhcC--CCCeeeeeeeEEEeC-----
Q 021711          107 SATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHV--DHPNTAKLLGYGIEG-----  179 (308)
Q Consensus       107 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~-----  179 (308)
                      ...++|++.+.||+|+||.||+|++. ++.||||.+.....    ..+.+|.+++..+  +||||+++++++...     
T Consensus        34 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~----~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~  108 (337)
T 3mdy_A           34 TIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEE----ASWFRETEIYQTVLMRHENILGFIAADIKGTGSWT  108 (337)
T ss_dssp             THHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGGH----HHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGC
T ss_pred             ccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecccc----chhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCC
Confidence            34468999999999999999999985 89999999864322    3445566666554  899999999987664     


Q ss_pred             cEEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCC--------CceecCCCCCCEEECCCCcEEE
Q 021711          180 GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQR--------RIIHRDIKAANILLTEDFEPQI  251 (308)
Q Consensus       180 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~--------~iiHrDlKp~NILl~~~~~~kl  251 (308)
                      ..++||||+++|+|.+++..  ..+++..++.++.|++.||.|||+   .        +|+||||||+|||++.++.+||
T Consensus       109 ~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl  183 (337)
T 3mdy_A          109 QLYLITDYHENGSLYDYLKS--TTLDAKSMLKLAYSSVSGLCHLHT---EIFSTQGKPAIAHRDLKSKNILVKKNGTCCI  183 (337)
T ss_dssp             EEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHS---CBCSTTCBCCEECSCCCGGGEEECTTSCEEE
T ss_pred             ceEEEEeccCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHH---hhhhhccCCCEEecccchHHEEECCCCCEEE
Confidence            47899999999999999954  468999999999999999999998   6        9999999999999999999999


Q ss_pred             eccccceecCCCCceeE--eeceeccccccccccCchhhcCcc------ceeEEEeeEEEeeccC
Q 021711          252 CDFGLAKWLPEQWTHHT--ISKVEGTFGLVKLNLPPLVILKRC------FTCIFIGFSQLQLSCS  308 (308)
Q Consensus       252 ~DFGla~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~------~Di~s~g~~l~el~c~  308 (308)
                      +|||+++.+........  .....||+.|+|||.+.+......      +|+||+|+++|||++|
T Consensus       184 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg  248 (337)
T 3mdy_A          184 ADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARR  248 (337)
T ss_dssp             CCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhc
Confidence            99999987755432211  224679999999998876655554      8999999999999875

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=3e-37  Score=275.89  Aligned_cols=197  Identities=21%  Similarity=0.288  Sum_probs=166.0

Q ss_pred             hhcCCccccc-eeeccCceEEEEEEEC---CCcEEEEEEeccCCh-HHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeCcE
Q 021711          107 SATNNFSFEN-LIGKGGYAEVYKGRLR---NGQLVAIKRLTRGTA-DEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGM  181 (308)
Q Consensus       107 ~~~~~~~~~~-~LG~G~fg~Vy~~~~~---~g~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  181 (308)
                      ...++|.+.+ .||+|+||.||+|.+.   .++.||||.+..... ....+.+.+|+.+++.++||||+++++++..+..
T Consensus        13 ~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   92 (291)
T 1xbb_A           13 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESW   92 (291)
T ss_dssp             CCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSSE
T ss_pred             ecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEECCCCc
Confidence            3446788888 9999999999999643   368899999975432 2346789999999999999999999999977889


Q ss_pred             EEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecC
Q 021711          182 HIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP  261 (308)
Q Consensus       182 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~  261 (308)
                      ++||||+++++|.+++.. ...+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++...
T Consensus        93 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~  168 (291)
T 1xbb_A           93 MLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALR  168 (291)
T ss_dssp             EEEEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred             EEEEEeCCCCCHHHHHHh-CcCCCHHHHHHHHHHHHHHHHHHHh---CCeEcCCCCcceEEEeCCCcEEEccCCcceeec
Confidence            999999999999999965 4568999999999999999999999   899999999999999999999999999999876


Q ss_pred             CCCcee-EeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          262 EQWTHH-TISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       262 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      ...... ......+|+.|+|||.......+.++|+||+|+++|+|++
T Consensus       169 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~  215 (291)
T 1xbb_A          169 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS  215 (291)
T ss_dssp             TTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHT
T ss_pred             cCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHh
Confidence            543322 1233456789999999887778889999999999999986

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=1.4e-37  Score=285.30  Aligned_cols=189  Identities=22%  Similarity=0.293  Sum_probs=161.3

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcC-CCCeeeeeeeEEEeC-cEEEEE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGIEG-GMHIVL  185 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~~~lv~  185 (308)
                      .++|++.+.||+|+||.||+|..+ +|+.||+|.+.....     .+.+|++++.++ +||||+++++++.++ ..++||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~   95 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT   95 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence            357999999999999999999986 589999999975432     234688888877 799999999987765 478999


Q ss_pred             EecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCC----CcEEEeccccceecC
Q 021711          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTED----FEPQICDFGLAKWLP  261 (308)
Q Consensus       186 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~----~~~kl~DFGla~~~~  261 (308)
                      ||+++|+|.+++.. ...+++..+..++.||+.||.|||+   ++|+||||||+|||+..+    +.+||+|||+++.+.
T Consensus        96 E~~~gg~L~~~i~~-~~~~~~~~~~~~~~qi~~al~~lH~---~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~  171 (342)
T 2qr7_A           96 ELMKGGELLDKILR-QKFFSEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR  171 (342)
T ss_dssp             CCCCSCBHHHHHHT-CTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred             eCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence            99999999999864 4568999999999999999999999   899999999999998543    359999999999775


Q ss_pred             CCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          262 EQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       262 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ....  ......||+.|+|||.+.+..++.++|+||+|+++|||++|
T Consensus       172 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g  216 (342)
T 2qr7_A          172 AENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTG  216 (342)
T ss_dssp             CTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHS
T ss_pred             CCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcC
Confidence            4422  23456899999999998887788899999999999999876

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.1e-38  Score=289.44  Aligned_cols=194  Identities=24%  Similarity=0.277  Sum_probs=162.5

Q ss_pred             CCccccceeeccCceEEEEEEE----CCCcEEEEEEeccCC---hHHHHHHHHHHHHHHhcC-CCCeeeeeeeEEEeC-c
Q 021711          110 NNFSFENLIGKGGYAEVYKGRL----RNGQLVAIKRLTRGT---ADEIIADFLSELGIMAHV-DHPNTAKLLGYGIEG-G  180 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~----~~g~~vAvK~~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~  180 (308)
                      ++|++.+.||+|+||.||+|+.    .+++.||||.+....   .....+.+.+|+.++..+ +||||+++++++... .
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  133 (355)
T 1vzo_A           54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  133 (355)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence            5899999999999999999987    368999999986432   111235567899999999 699999999977665 5


Q ss_pred             EEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceec
Q 021711          181 MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL  260 (308)
Q Consensus       181 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~  260 (308)
                      .++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++.+
T Consensus       134 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~  209 (355)
T 1vzo_A          134 LHLILDYINGGELFTHLSQ-RERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEF  209 (355)
T ss_dssp             EEEEECCCCSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred             EEEEeecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCcEEEeeCCCCeec
Confidence            7899999999999999965 3568999999999999999999999   89999999999999999999999999999876


Q ss_pred             CCCCceeEeeceeccccccccccCch--hhcCccceeEEEeeEEEeeccC
Q 021711          261 PEQWTHHTISKVEGTFGLVKLNLPPL--VILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       261 ~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ...... ......||+.|+|||.+.+  ...+.++|+||+|+++|||++|
T Consensus       210 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g  258 (355)
T 1vzo_A          210 VADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTG  258 (355)
T ss_dssp             CGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHS
T ss_pred             ccCCCC-cccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHC
Confidence            543222 2235679999999998764  3467889999999999999875

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1.8e-37  Score=281.96  Aligned_cols=197  Identities=25%  Similarity=0.297  Sum_probs=163.5

Q ss_pred             hcCCccccceeeccCceEEEEEEEC------CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-c
Q 021711          108 ATNNFSFENLIGKGGYAEVYKGRLR------NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-G  180 (308)
Q Consensus       108 ~~~~~~~~~~LG~G~fg~Vy~~~~~------~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~  180 (308)
                      ..++|++.+.||+|+||.||+|.+.      +++.||||.+..........++.+|+.+++.++||||+++++++... .
T Consensus        28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  107 (327)
T 2yfx_A           28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP  107 (327)
T ss_dssp             CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence            3468999999999999999999842      47799999997665555567899999999999999999999987765 5


Q ss_pred             EEEEEEecCCCCHHHHHhccC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECC---CCcEEE
Q 021711          181 MHIVLELSPNGSLASLLYGMK------EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTE---DFEPQI  251 (308)
Q Consensus       181 ~~lv~e~~~~gsL~~~l~~~~------~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~---~~~~kl  251 (308)
                      .++||||+++++|.+++....      ..+++..++.++.|++.||.|||+   .+|+||||||+|||++.   +..+||
T Consensus       108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~i~H~dlkp~NIli~~~~~~~~~kl  184 (327)
T 2yfx_A          108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKI  184 (327)
T ss_dssp             CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeecCcCCHhHEEEecCCCcceEEE
Confidence            789999999999999997543      348899999999999999999999   89999999999999994   446999


Q ss_pred             eccccceecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          252 CDFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       252 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      +|||+++...............||+.|+|||.+....++.++|+||+|+++|+|++
T Consensus       185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt  240 (327)
T 2yfx_A          185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS  240 (327)
T ss_dssp             CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred             CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHc
Confidence            99999986544332223345678999999999888788999999999999999986

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=2.9e-37  Score=283.23  Aligned_cols=196  Identities=24%  Similarity=0.313  Sum_probs=165.5

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCCh-HHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-------
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA-DEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-------  179 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-------  179 (308)
                      .++|++.+.||+|+||.||+|+.. +|+.||+|.+..... ......+.+|+.+++.++||||+++++++...       
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            358999999999999999999985 689999999854432 22345678999999999999999999977653       


Q ss_pred             --cEEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccc
Q 021711          180 --GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLA  257 (308)
Q Consensus       180 --~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla  257 (308)
                        ..++||||+.+ +|.+.+......+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++
T Consensus        96 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a  171 (351)
T 3mi9_A           96 KGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLA  171 (351)
T ss_dssp             -CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCCEEEccchhc
Confidence              37899999975 8888887666779999999999999999999999   89999999999999999999999999999


Q ss_pred             eecCCCCc--eeEeeceeccccccccccCch-hhcCccceeEEEeeEEEeeccC
Q 021711          258 KWLPEQWT--HHTISKVEGTFGLVKLNLPPL-VILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       258 ~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      +.+.....  ........||+.|+|||.+.+ ..++.++|+||+|+++|||++|
T Consensus       172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g  225 (351)
T 3mi9_A          172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR  225 (351)
T ss_dssp             EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHS
T ss_pred             ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhC
Confidence            97753322  122345678999999998765 4468899999999999999875

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.9e-37  Score=279.13  Aligned_cols=196  Identities=26%  Similarity=0.370  Sum_probs=169.6

Q ss_pred             cCCccccceeeccCceEEEEEEE-----CCCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC---c
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRL-----RNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG---G  180 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~-----~~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---~  180 (308)
                      .++|++.+.||+|+||.||+|++     .+|+.||+|.+..... +..+.+.+|+.+++.++||||+++++++...   .
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  118 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE-EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN  118 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCS-HHHHHHHHHHHHHHTCCCTTBCCEEEEECC----C
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCH-HHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCc
Confidence            45789999999999999999984     2588999999976543 3467899999999999999999999976543   5


Q ss_pred             EEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceec
Q 021711          181 MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL  260 (308)
Q Consensus       181 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~  260 (308)
                      .++||||+++++|.+++......+++..++.++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++..
T Consensus       119 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~  195 (326)
T 2w1i_A          119 LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVL  195 (326)
T ss_dssp             CEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             eEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEEcCCCcEEEecCcchhhc
Confidence            789999999999999997766779999999999999999999999   89999999999999999999999999999987


Q ss_pred             CCCCceeE-eeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          261 PEQWTHHT-ISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       261 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ........ .....+|..|+|||...+...+.++|+||+|+++|||++|
T Consensus       196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg  244 (326)
T 2w1i_A          196 PQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTY  244 (326)
T ss_dssp             CSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHT
T ss_pred             cccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhc
Confidence            65433221 2345678889999998877788999999999999999874

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=3.8e-37  Score=304.97  Aligned_cols=199  Identities=25%  Similarity=0.347  Sum_probs=170.5

Q ss_pred             HHhhcCCccccceeeccCceEEEEEEECC----CcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeCc
Q 021711          105 LQSATNNFSFENLIGKGGYAEVYKGRLRN----GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG  180 (308)
Q Consensus       105 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~----g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  180 (308)
                      +....++|++.+.||+|+||.||+|.+..    +..||+|.+.........+.|.+|+.+++.++||||+++++++.++.
T Consensus       385 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~  464 (656)
T 2j0j_A          385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENP  464 (656)
T ss_dssp             TBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             cccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCc
Confidence            34455789999999999999999998752    46799999877665666788999999999999999999999998888


Q ss_pred             EEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceec
Q 021711          181 MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL  260 (308)
Q Consensus       181 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~  260 (308)
                      .++||||+++|+|.+++......+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++..
T Consensus       465 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDikp~NILl~~~~~vkL~DFG~a~~~  541 (656)
T 2j0j_A          465 VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM  541 (656)
T ss_dssp             CEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred             eEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchHhEEEeCCCCEEEEecCCCeec
Confidence            999999999999999997666679999999999999999999999   89999999999999999999999999999877


Q ss_pred             CCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          261 PEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       261 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      ..... .......||+.|+|||.+....++.++|+||+|+++|||++
T Consensus       542 ~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt  587 (656)
T 2j0j_A          542 EDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM  587 (656)
T ss_dssp             CC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred             CCCcc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHH
Confidence            54322 22334567889999999887788999999999999999875

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=5.6e-37  Score=270.17  Aligned_cols=189  Identities=18%  Similarity=0.196  Sum_probs=162.8

Q ss_pred             cCCccccceeeccCceEEEEEEECCCcEEEEEEeccCC-hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC---cEEEE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG---GMHIV  184 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---~~~lv  184 (308)
                      .++|++.+.||+|+||.||+|.++ ++.||+|.+.... .....+.+.+|+.+++.++||||+++++++...   ..++|
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI   87 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred             HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence            458999999999999999999985 8899999997543 334567899999999999999999999987764   47899


Q ss_pred             EEecCCCCHHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCC--ceecCCCCCCEEECCCCcEEEeccccceecC
Q 021711          185 LELSPNGSLASLLYGMKE-KLKWGIRYKIALGVAEGLLYLHEGCQRR--IIHRDIKAANILLTEDFEPQICDFGLAKWLP  261 (308)
Q Consensus       185 ~e~~~~gsL~~~l~~~~~-~l~~~~~~~i~~qi~~~L~yLH~~~~~~--iiHrDlKp~NILl~~~~~~kl~DFGla~~~~  261 (308)
                      |||+++|+|.+++..... .+++..+..++.|++.||.|||+   ++  |+||||||+|||++.++.++|+|||++....
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~  164 (271)
T 3kmu_A           88 THWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT---LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ  164 (271)
T ss_dssp             EECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTT---SSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred             ecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhc---CCCceecCCCccceEEEcCCcceeEEeccceeeec
Confidence            999999999999976433 58999999999999999999998   78  9999999999999999999999999876533


Q ss_pred             CCCceeEeeceeccccccccccCchhhcCc---cceeEEEeeEEEeeccC
Q 021711          262 EQWTHHTISKVEGTFGLVKLNLPPLVILKR---CFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       262 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~Di~s~g~~l~el~c~  308 (308)
                      .       ....||+.|+|||.+.+...+.   ++|+||+|+++|||++|
T Consensus       165 ~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g  207 (271)
T 3kmu_A          165 S-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTR  207 (271)
T ss_dssp             C-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHC
T ss_pred             c-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhC
Confidence            2       2347899999999886554443   69999999999999875

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=9.5e-37  Score=275.15  Aligned_cols=193  Identities=27%  Similarity=0.403  Sum_probs=164.2

Q ss_pred             hcCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEE
Q 021711          108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVL  185 (308)
Q Consensus       108 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~  185 (308)
                      ..++|++.+.||+|+||.||+|.+. +|+.||+|.+.....   .+.+.+|+.++..++||||+++++++... ..++||
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  103 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD---LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM  103 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC---CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH---HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence            3568999999999999999999976 589999999975432   35688999999999999999999977665 578999


Q ss_pred             EecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCc
Q 021711          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (308)
Q Consensus       186 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~  265 (308)
                      ||+++++|.+++......+++..+..++.|++.||.|||+   .+|+|+||||+||+++.++.+||+|||++........
T Consensus       104 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~  180 (314)
T 3com_A          104 EYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA  180 (314)
T ss_dssp             ECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS
T ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc
Confidence            9999999999997666789999999999999999999999   8999999999999999999999999999987654322


Q ss_pred             eeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          266 HHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                        ......||+.|+|||.+.+...+.++|+||+|+++|+|++|
T Consensus       181 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g  221 (314)
T 3com_A          181 --KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEG  221 (314)
T ss_dssp             --CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHS
T ss_pred             --ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhC
Confidence              22456799999999998887888999999999999999875

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=5.4e-37  Score=274.34  Aligned_cols=193  Identities=24%  Similarity=0.377  Sum_probs=159.6

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEe----------
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE----------  178 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----------  178 (308)
                      ++|++.+.||+|+||.||+|... +|+.||||.+...  ....+.+.+|+.+++.++||||+++++++.+          
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (303)
T 1zy4_A            6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT--EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA   83 (303)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred             ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc--HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence            57899999999999999999975 6899999998643  3345789999999999999999999997643          


Q ss_pred             ----CcEEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEecc
Q 021711          179 ----GGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDF  254 (308)
Q Consensus       179 ----~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DF  254 (308)
                          ...++||||+++|+|.+++......+++..++.++.|++.||.|||+   ++|+||||||+|||++.++.+||+||
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dlkp~Nil~~~~~~~kl~df  160 (303)
T 1zy4_A           84 VKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDF  160 (303)
T ss_dssp             --CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCC
T ss_pred             cccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHh---CCeecccCCHHhEEEcCCCCEEEeeC
Confidence                34689999999999999997656668889999999999999999999   89999999999999999999999999


Q ss_pred             ccceecCCCCc------------eeEeeceeccccccccccCchh-hcCccceeEEEeeEEEeecc
Q 021711          255 GLAKWLPEQWT------------HHTISKVEGTFGLVKLNLPPLV-ILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       255 Gla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~s~g~~l~el~c  307 (308)
                      |+++.......            ........||+.|+|||.+.+. ..+.++|+||+|+++|||++
T Consensus       161 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~  226 (303)
T 1zy4_A          161 GLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY  226 (303)
T ss_dssp             CCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS
T ss_pred             cchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh
Confidence            99987643211            1123456799999999987654 57889999999999999875

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=8.4e-37  Score=293.88  Aligned_cols=192  Identities=24%  Similarity=0.365  Sum_probs=163.1

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChH------------HHHHHHHHHHHHHhcCCCCeeeeeeeE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTAD------------EIIADFLSELGIMAHVDHPNTAKLLGY  175 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~------------~~~~~~~~E~~~l~~l~h~niv~l~~~  175 (308)
                      .++|.+.+.||+|+||.||+|... +++.||+|.+......            ...+.+.+|+.+++.++||||++++++
T Consensus        35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  114 (504)
T 3q5i_A           35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV  114 (504)
T ss_dssp             GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            468999999999999999999976 5889999998654311            235678999999999999999999998


Q ss_pred             EEeCc-EEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCC---cEEE
Q 021711          176 GIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDF---EPQI  251 (308)
Q Consensus       176 ~~~~~-~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~---~~kl  251 (308)
                      +.+.. .++||||+++|+|.+.+.. ...+++..+..++.||+.||.|||+   .+|+||||||+|||++.++   .+||
T Consensus       115 ~~~~~~~~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl  190 (504)
T 3q5i_A          115 FEDKKYFYLVTEFYEGGELFEQIIN-RHKFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKI  190 (504)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESSTTCCSSEEE
T ss_pred             EEcCCEEEEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCcHHHEEEecCCCCccEEE
Confidence            77654 7899999999999998865 4569999999999999999999999   8999999999999999776   6999


Q ss_pred             eccccceecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          252 CDFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       252 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      +|||+++......   ......||+.|+|||.+.. .++.++|+||+|+++|+|+||
T Consensus       191 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g  243 (504)
T 3q5i_A          191 VDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCG  243 (504)
T ss_dssp             CCCTTCEECCTTS---CBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHS
T ss_pred             EECCCCEEcCCCC---ccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhC
Confidence            9999999876543   2345679999999998764 578889999999999999886

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=3.1e-37  Score=285.50  Aligned_cols=190  Identities=10%  Similarity=0.078  Sum_probs=147.5

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCC--hHHHHHHHHHHH---HHHhcCCCCeeeeee-------eE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSEL---GIMAHVDHPNTAKLL-------GY  175 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~~E~---~~l~~l~h~niv~l~-------~~  175 (308)
                      ..+|.+.+.||+|+||.||+|.+. +|+.||||.+....  .....+.+.+|+   .+|.. +||||++++       ++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~  139 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDA  139 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehh
Confidence            346899999999999999999976 68999999997654  233456777785   45555 799988754       33


Q ss_pred             EEe------------------CcEEEEEEecCCCCHHHHHhccCCCCCHHHH------HHHHHHHHHHHHHHHhCCCCCc
Q 021711          176 GIE------------------GGMHIVLELSPNGSLASLLYGMKEKLKWGIR------YKIALGVAEGLLYLHEGCQRRI  231 (308)
Q Consensus       176 ~~~------------------~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~------~~i~~qi~~~L~yLH~~~~~~i  231 (308)
                      +..                  ...++||||++ |+|.+++......+++..+      ..++.||+.||.|||+   ++|
T Consensus       140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~---~~i  215 (371)
T 3q60_A          140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQS---KGL  215 (371)
T ss_dssp             EEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHH---TTE
T ss_pred             eecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHH---CCC
Confidence            322                  23689999998 8999999765444555555      6788999999999999   899


Q ss_pred             eecCCCCCCEEECCCCcEEEeccccceecCCCCceeEeeceeccccccccccCch--hhcCccceeEEEeeEEEeeccC
Q 021711          232 IHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPL--VILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       232 iHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      +||||||+|||++.++.+||+|||+|+.....     .....||+.|+|||.+.+  ..++.++|+||+|++||||++|
T Consensus       216 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg  289 (371)
T 3q60_A          216 VHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL  289 (371)
T ss_dssp             EETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred             ccCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence            99999999999999999999999999976432     224567799999999876  6789999999999999999876

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=6.7e-37  Score=280.56  Aligned_cols=195  Identities=22%  Similarity=0.323  Sum_probs=164.9

Q ss_pred             hcCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEe------Cc
Q 021711          108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE------GG  180 (308)
Q Consensus       108 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~  180 (308)
                      ..++|++.+.||+|+||.||+|.+. +|+.||||.+...........+.+|+.+++.++||||+++++++..      ..
T Consensus         9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   88 (353)
T 2b9h_A            9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE   88 (353)
T ss_dssp             SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred             cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence            3578999999999999999999976 5899999999765555556788999999999999999999997654      34


Q ss_pred             EEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceec
Q 021711          181 MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL  260 (308)
Q Consensus       181 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~  260 (308)
                      .++||||+. ++|.+++..  ..+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++.+
T Consensus        89 ~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~  162 (353)
T 2b9h_A           89 VYIIQELMQ-TDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARII  162 (353)
T ss_dssp             EEEEECCCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEEeccC-ccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence            789999997 589998854  568999999999999999999999   89999999999999999999999999999987


Q ss_pred             CCCCcee--------EeeceeccccccccccCch-hhcCccceeEEEeeEEEeeccC
Q 021711          261 PEQWTHH--------TISKVEGTFGLVKLNLPPL-VILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       261 ~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      .......        ......||+.|+|||.+.. ...+.++|+||+|+++|+|++|
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g  219 (353)
T 2b9h_A          163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLR  219 (353)
T ss_dssp             C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHS
T ss_pred             ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhC
Confidence            5432211        1234678999999997654 5678899999999999999875

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=2e-37  Score=276.21  Aligned_cols=196  Identities=28%  Similarity=0.413  Sum_probs=160.5

Q ss_pred             cCCccccceeeccCceEEEEEEEC--CCc--EEEEEEeccCC--hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeCcEE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR--NGQ--LVAIKRLTRGT--ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMH  182 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~--~g~--~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  182 (308)
                      .++|++.+.||+|+||.||+|.+.  +++  .||+|.+....  ..+..+.+.+|+.+++.++||||+++++++.....+
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   96 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK   96 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCE
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCCce
Confidence            458999999999999999999864  233  68999886542  234567899999999999999999999999888899


Q ss_pred             EEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCC
Q 021711          183 IVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE  262 (308)
Q Consensus       183 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~  262 (308)
                      +|+||+++++|.+++......+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++....
T Consensus        97 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  173 (291)
T 1u46_A           97 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ  173 (291)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred             eeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEEcCCCCEEEccccccccccc
Confidence            9999999999999997766679999999999999999999999   8999999999999999999999999999998765


Q ss_pred             CCceeE-eeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          263 QWTHHT-ISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       263 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      ...... .....+|+.|+|||.......+.++|+||+|+++|+|++
T Consensus       174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~  219 (291)
T 1u46_A          174 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT  219 (291)
T ss_dssp             -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHT
T ss_pred             cccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHh
Confidence            443222 234568889999999887778889999999999999986

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1.8e-36  Score=270.49  Aligned_cols=190  Identities=25%  Similarity=0.339  Sum_probs=162.7

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCC-hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEe-----CcEE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-----GGMH  182 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~~~  182 (308)
                      +.|.+.+.||+|+||.||+|.+. ++..||+|.+.... .....+.+.+|+.+++.++||||+++++++..     ..++
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  105 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV  105 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence            45888899999999999999876 58899999986532 33456789999999999999999999997654     2378


Q ss_pred             EEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--ceecCCCCCCEEEC-CCCcEEEecccccee
Q 021711          183 IVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRR--IIHRDIKAANILLT-EDFEPQICDFGLAKW  259 (308)
Q Consensus       183 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~--iiHrDlKp~NILl~-~~~~~kl~DFGla~~  259 (308)
                      +||||+++++|.+++.. ...+++..+..++.|++.||.|||+   .+  |+||||||+|||++ .++.+||+|||++..
T Consensus       106 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~  181 (290)
T 1t4h_A          106 LVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  181 (290)
T ss_dssp             EEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             EEEEecCCCCHHHHHHH-ccCCCHHHHHHHHHHHHHHHHHHHc---CCCCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence            99999999999999964 3568999999999999999999998   77  99999999999998 788999999999976


Q ss_pred             cCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          260 LPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       260 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      .....    .....||+.|+|||.+.+ ..+.++|+||+|+++|+|++|
T Consensus       182 ~~~~~----~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g  225 (290)
T 1t4h_A          182 KRASF----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATS  225 (290)
T ss_dssp             CCTTS----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHS
T ss_pred             ccccc----cccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhC
Confidence            54432    234579999999998764 478889999999999999875

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=8.3e-37  Score=271.39  Aligned_cols=192  Identities=24%  Similarity=0.322  Sum_probs=163.7

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChH-----HHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTAD-----EIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMH  182 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~  182 (308)
                      ++|++.+.||+|+||.||+|... +|+.||+|.+......     ...+.+.+|+.+++.++||||+++++++... ..+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            46899999999999999999987 5899999998654221     1256789999999999999999999987765 478


Q ss_pred             EEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCC----cEEEeccccce
Q 021711          183 IVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDF----EPQICDFGLAK  258 (308)
Q Consensus       183 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~----~~kl~DFGla~  258 (308)
                      +||||+++++|.+++.. ...+++..+..++.|++.||.|||+   ++|+||||||+||+++.++    .+||+|||+++
T Consensus        85 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~  160 (283)
T 3bhy_A           85 LILELVSGGELFDFLAE-KESLTEDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH  160 (283)
T ss_dssp             EEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred             EEEeecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence            99999999999999864 4568999999999999999999999   8999999999999999877    89999999998


Q ss_pred             ecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          259 WLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       259 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ......   ......||+.|+|||.......+.++|+||+|+++|+|++|
T Consensus       161 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g  207 (283)
T 3bhy_A          161 KIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG  207 (283)
T ss_dssp             ECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred             eccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHC
Confidence            775432   22456799999999998877788899999999999999875

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.4e-37  Score=278.69  Aligned_cols=200  Identities=26%  Similarity=0.326  Sum_probs=148.6

Q ss_pred             HhhcCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEe-CcEEE
Q 021711          106 QSATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHI  183 (308)
Q Consensus       106 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~l  183 (308)
                      ....++|++.+.||+|+||.||+|... +++.||||.+.........+.+.+|+.++..++||||+++++++.. +..++
T Consensus        11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   90 (303)
T 2vwi_A           11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWL   90 (303)
T ss_dssp             --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEE
T ss_pred             ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEE
Confidence            455689999999999999999999865 6899999998655434446778999999999999999999997765 45789


Q ss_pred             EEEecCCCCHHHHHhc-------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEecccc
Q 021711          184 VLELSPNGSLASLLYG-------MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGL  256 (308)
Q Consensus       184 v~e~~~~gsL~~~l~~-------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGl  256 (308)
                      ||||+++++|.+++..       ....+++..+..++.|++.||.|||+   ++|+||||||+||+++.++.+||+|||+
T Consensus        91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~  167 (303)
T 2vwi_A           91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK---NGQIHRDVKAGNILLGEDGSVQIADFGV  167 (303)
T ss_dssp             EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred             EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCCChhhEEEcCCCCEEEEeccc
Confidence            9999999999999863       23458999999999999999999999   8999999999999999999999999999


Q ss_pred             ceecCCCCce---eEeeceeccccccccccCch-hhcCccceeEEEeeEEEeeccC
Q 021711          257 AKWLPEQWTH---HTISKVEGTFGLVKLNLPPL-VILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       257 a~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ++.+......   .......||+.|+|||.... ...+.++|+||+|+++|||++|
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g  223 (303)
T 2vwi_A          168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATG  223 (303)
T ss_dssp             HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHS
T ss_pred             hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhC
Confidence            9876543211   12235679999999998865 4478899999999999999875

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=8.1e-37  Score=282.96  Aligned_cols=190  Identities=24%  Similarity=0.211  Sum_probs=155.3

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCC-hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-------
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-------  179 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-------  179 (308)
                      .++|++.+.||+|+||.||+|... +++.||||.+.... .......+.+|+.+++.++||||+++++++...       
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            468999999999999999999876 58899999997543 334567889999999999999999999987643       


Q ss_pred             cEEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEecccccee
Q 021711          180 GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKW  259 (308)
Q Consensus       180 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~  259 (308)
                      ..++||||+.+ +|.+.+.   ..+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++.
T Consensus       104 ~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~  176 (371)
T 2xrw_A          104 DVYIVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART  176 (371)
T ss_dssp             EEEEEEECCSE-EHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred             ceEEEEEcCCC-CHHHHHh---hccCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEEEeecccc
Confidence            46899999975 7888774   358999999999999999999999   8999999999999999999999999999987


Q ss_pred             cCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          260 LPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       260 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      .....   ......||+.|+|||.+.+..++.++|+||+|+++|||++|
T Consensus       177 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g  222 (371)
T 2xrw_A          177 AGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG  222 (371)
T ss_dssp             ----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHS
T ss_pred             ccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhC
Confidence            64431   23456899999999998887888999999999999999875

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=4.2e-37  Score=272.99  Aligned_cols=188  Identities=24%  Similarity=0.371  Sum_probs=164.6

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEe----------
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE----------  178 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----------  178 (308)
                      ++|++.+.||+|+||.||+|.+. +|+.||+|.+....     +.+.+|+.+++.++||||+++++++..          
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   85 (284)
T 2a19_B           11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK   85 (284)
T ss_dssp             HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred             cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence            47999999999999999999986 68999999997543     245689999999999999999997643          


Q ss_pred             -------CcEEEEEEecCCCCHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEE
Q 021711          179 -------GGMHIVLELSPNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQ  250 (308)
Q Consensus       179 -------~~~~lv~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~k  250 (308)
                             ...++||||+++++|.+++... ...+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+|
T Consensus        86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~k  162 (284)
T 2a19_B           86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVK  162 (284)
T ss_dssp             ---CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEE
T ss_pred             cccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHEEEcCCCCEE
Confidence                   2368999999999999999653 3578999999999999999999999   8999999999999999999999


Q ss_pred             EeccccceecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          251 ICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       251 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      |+|||+++.......   .....||+.|+|||.......+.++|+||+|+++|+|++|
T Consensus       163 l~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~  217 (284)
T 2a19_B          163 IGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHV  217 (284)
T ss_dssp             ECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSC
T ss_pred             ECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhc
Confidence            999999998765432   2345799999999998877788999999999999999864

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=2.8e-37  Score=280.15  Aligned_cols=193  Identities=26%  Similarity=0.334  Sum_probs=162.7

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCCh-------HHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeCc
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA-------DEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG  180 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~-------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  180 (308)
                      .++|.+.+.||+|+||.||+|.+. +++.||||.+.....       ......+.+|+.+++.++||||+++++++....
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   88 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED   88 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence            357999999999999999999976 588999999865321       122346889999999999999999999998888


Q ss_pred             EEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCc---EEEeccccc
Q 021711          181 MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFE---PQICDFGLA  257 (308)
Q Consensus       181 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~---~kl~DFGla  257 (308)
                      .++||||+++++|.+++.. ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.   +||+|||++
T Consensus        89 ~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~  164 (322)
T 2ycf_A           89 YYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHS  164 (322)
T ss_dssp             EEEEEECCTTEETHHHHST-TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSSSCCEEECCCTTC
T ss_pred             eEEEEecCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEecCCCCCeEEEccCccc
Confidence            9999999999999998854 4578999999999999999999999   89999999999999987654   999999999


Q ss_pred             eecCCCCceeEeeceeccccccccccCc---hhhcCccceeEEEeeEEEeeccC
Q 021711          258 KWLPEQWTHHTISKVEGTFGLVKLNLPP---LVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      +......   ......||+.|+|||.+.   ...++.++|+||+|+++|+|++|
T Consensus       165 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g  215 (322)
T 2ycf_A          165 KILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG  215 (322)
T ss_dssp             EECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHS
T ss_pred             eeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhC
Confidence            9875432   223467999999999863   34567889999999999999875

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=3.5e-37  Score=280.70  Aligned_cols=194  Identities=20%  Similarity=0.271  Sum_probs=155.2

Q ss_pred             hcCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCCh-HHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEE
Q 021711          108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA-DEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIV  184 (308)
Q Consensus       108 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv  184 (308)
                      ..++|++.+.||+|+||.||+|... +++.||||.+..... ......+.+|+.+++.++||||+++++++..+ ..++|
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  111 (329)
T 3gbz_A           32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI  111 (329)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred             chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence            3468999999999999999999876 689999999975433 23456788999999999999999999987665 47899


Q ss_pred             EEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEEC-----CCCcEEEecccccee
Q 021711          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLT-----EDFEPQICDFGLAKW  259 (308)
Q Consensus       185 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~-----~~~~~kl~DFGla~~  259 (308)
                      |||+. |+|.+++.. ...+++..+..++.||+.||.|||+   ++|+||||||+|||++     .++.+||+|||+++.
T Consensus       112 ~e~~~-~~L~~~~~~-~~~~~~~~~~~i~~ql~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~  186 (329)
T 3gbz_A          112 FEYAE-NDLKKYMDK-NPDVSMRVIKSFLYQLINGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA  186 (329)
T ss_dssp             EECCS-EEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHH
T ss_pred             EecCC-CCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCEECCCCCHHHEEEecCCCCccceEEECcCCCccc
Confidence            99997 499999865 4468999999999999999999999   8999999999999994     455699999999987


Q ss_pred             cCCCCceeEeeceeccccccccccCchhh-cCccceeEEEeeEEEeeccC
Q 021711          260 LPEQWTHHTISKVEGTFGLVKLNLPPLVI-LKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       260 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~s~g~~l~el~c~  308 (308)
                      +.....  ......||+.|+|||.+.+.. ++.++|+||+|+++|||++|
T Consensus       187 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g  234 (329)
T 3gbz_A          187 FGIPIR--QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMK  234 (329)
T ss_dssp             HC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHS
T ss_pred             cCCccc--ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHC
Confidence            654322  234567899999999886644 78899999999999999875

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=7e-37  Score=272.40  Aligned_cols=192  Identities=24%  Similarity=0.378  Sum_probs=166.5

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCCh--HHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIV  184 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv  184 (308)
                      .++|++.+.||+|+||.||+|... +++.||+|.+.....  ......+.+|+.+++.++||||+++++++.+. ..++|
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   92 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM   92 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence            357999999999999999999976 578999999864321  11246788999999999999999999987765 47899


Q ss_pred             EEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCC
Q 021711          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (308)
Q Consensus       185 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  264 (308)
                      |||+++++|.+++.. ...+++..+..++.|++.||.|||+   ++|+||||||+||+++.++.+||+|||++.......
T Consensus        93 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~  168 (284)
T 2vgo_A           93 LEFAPRGELYKELQK-HGRFDEQRSATFMEELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR  168 (284)
T ss_dssp             ECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC
T ss_pred             EEeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEEcCCCCEEEecccccccCcccc
Confidence            999999999999865 3468999999999999999999998   899999999999999999999999999998765432


Q ss_pred             ceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          265 THHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                          .....||+.|+|||.+.+...+.++|+||+|+++|+|++|
T Consensus       169 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g  208 (284)
T 2vgo_A          169 ----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVG  208 (284)
T ss_dssp             ----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHS
T ss_pred             ----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHC
Confidence                2346799999999998887888999999999999999875

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=4.5e-37  Score=285.72  Aligned_cols=191  Identities=22%  Similarity=0.254  Sum_probs=158.3

Q ss_pred             HhhcCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-----
Q 021711          106 QSATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-----  179 (308)
Q Consensus       106 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----  179 (308)
                      ....++|++.+.||+|+||.||+|.+. +|+.||||++.....     ...+|+.+++.++||||+++++++...     
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~   77 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEP   77 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-----SCCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-----hHHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence            455679999999999999999999875 689999999865432     123799999999999999999976432     


Q ss_pred             ----------------------------------cEEEEEEecCCCCHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHH
Q 021711          180 ----------------------------------GMHIVLELSPNGSLASLLYG---MKEKLKWGIRYKIALGVAEGLLY  222 (308)
Q Consensus       180 ----------------------------------~~~lv~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~y  222 (308)
                                                        ..++||||++ |+|.+.+..   ....+++..+..++.||+.||.|
T Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~  156 (383)
T 3eb0_A           78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF  156 (383)
T ss_dssp             --------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence                                              1679999998 588777653   35679999999999999999999


Q ss_pred             HHhCCCCCceecCCCCCCEEEC-CCCcEEEeccccceecCCCCceeEeeceeccccccccccCchh-hcCccceeEEEee
Q 021711          223 LHEGCQRRIIHRDIKAANILLT-EDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPLV-ILKRCFTCIFIGF  300 (308)
Q Consensus       223 LH~~~~~~iiHrDlKp~NILl~-~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~s~g~  300 (308)
                      ||+   .+|+||||||+|||++ .++.+||+|||+|+.+.....   .....||+.|+|||.+.+. .++.++|+||+|+
T Consensus       157 LH~---~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~  230 (383)
T 3eb0_A          157 IHS---LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSIDLWSIGC  230 (383)
T ss_dssp             HHT---TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHH
T ss_pred             HHH---CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcchhhhhHHH
Confidence            998   8999999999999998 688999999999998755432   2456789999999987654 4788999999999


Q ss_pred             EEEeeccC
Q 021711          301 SQLQLSCS  308 (308)
Q Consensus       301 ~l~el~c~  308 (308)
                      ++|||++|
T Consensus       231 il~ell~g  238 (383)
T 3eb0_A          231 VFGELILG  238 (383)
T ss_dssp             HHHHHHHS
T ss_pred             HHHHHHhC
Confidence            99999876

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=7.2e-37  Score=278.58  Aligned_cols=194  Identities=23%  Similarity=0.322  Sum_probs=161.3

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCCh-HHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeCc-EEEEE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA-DEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIVL  185 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~  185 (308)
                      .++|++.+.||+|+||.||+|+.. +|+.||+|.+..... ....+.+.+|+.+++.++||||+++++++.... .++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  103 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF  103 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence            358999999999999999999986 489999999865433 344567889999999999999999999877654 78999


Q ss_pred             EecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCc
Q 021711          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (308)
Q Consensus       186 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~  265 (308)
                      ||+.+++|..++. ....+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++.+.....
T Consensus       104 e~~~~~~l~~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  179 (331)
T 4aaa_A          104 EFVDHTILDDLEL-FPNGLDYQVVQKYLFQIINGIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE  179 (331)
T ss_dssp             ECCSEEHHHHHHH-STTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred             ecCCcchHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHHH---CCEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc
Confidence            9999988888764 34569999999999999999999999   8999999999999999999999999999987654322


Q ss_pred             eeEeeceeccccccccccCchh-hcCccceeEEEeeEEEeeccC
Q 021711          266 HHTISKVEGTFGLVKLNLPPLV-ILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~s~g~~l~el~c~  308 (308)
                        ......||+.|+|||.+.+. ..+.++|+||+|+++|+|++|
T Consensus       180 --~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g  221 (331)
T 4aaa_A          180 --VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMG  221 (331)
T ss_dssp             ------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHS
T ss_pred             --ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhC
Confidence              23456799999999987654 578899999999999999875

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=1.6e-36  Score=273.44  Aligned_cols=195  Identities=26%  Similarity=0.364  Sum_probs=156.6

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccC--ChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRG--TADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIV  184 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv  184 (308)
                      .++|++.+.||+|+||.||+|... +|+.||+|.+...  ........+.+|+.+++.++||||+++++++... ..++|
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv  110 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV  110 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence            357999999999999999999975 6899999998743  2344567899999999999999999999977665 57899


Q ss_pred             EEecCCCCHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecC
Q 021711          185 LELSPNGSLASLLYG---MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP  261 (308)
Q Consensus       185 ~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~  261 (308)
                      |||+.+++|.+++..   ....+++..++.++.|++.||.|||+   .+|+||||||+||+++.++.+||+|||+++...
T Consensus       111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~  187 (310)
T 2wqm_A          111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFS  187 (310)
T ss_dssp             EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred             EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence            999999999998864   34568999999999999999999999   899999999999999999999999999998765


Q ss_pred             CCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          262 EQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       262 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ....  ......||+.|+|||...+...+.++|+||+|+++|+|++|
T Consensus       188 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g  232 (310)
T 2wqm_A          188 SKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAAL  232 (310)
T ss_dssp             -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHS
T ss_pred             CCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhC
Confidence            4322  22356799999999998877888999999999999999875

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=8.5e-37  Score=275.85  Aligned_cols=197  Identities=19%  Similarity=0.260  Sum_probs=163.5

Q ss_pred             hcCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEe-----CcE
Q 021711          108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-----GGM  181 (308)
Q Consensus       108 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~~  181 (308)
                      ..++|++.+.||+|+||.||+|... +|+.||||.+..... ...+.+.+|+.+++.++||||+++++++..     ...
T Consensus        27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  105 (317)
T 2buj_A           27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQ-QDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA  105 (317)
T ss_dssp             TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSH-HHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred             CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCH-HHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence            4568999999999999999999974 689999999865433 346789999999999999999999997752     247


Q ss_pred             EEEEEecCCCCHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccce
Q 021711          182 HIVLELSPNGSLASLLYG---MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK  258 (308)
Q Consensus       182 ~lv~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~  258 (308)
                      ++||||+++|+|.+++..   ....+++..++.++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++
T Consensus       106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~  182 (317)
T 2buj_A          106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMN  182 (317)
T ss_dssp             EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred             EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCCEEEEecCcch
Confidence            899999999999999865   35679999999999999999999999   899999999999999999999999999998


Q ss_pred             ecCCCCce-------eEeeceeccccccccccCchh---hcCccceeEEEeeEEEeeccC
Q 021711          259 WLPEQWTH-------HTISKVEGTFGLVKLNLPPLV---ILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       259 ~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~---~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ........       .......||+.|+|||.+...   .++.++|+||+|+++|||++|
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g  242 (317)
T 2buj_A          183 QACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFG  242 (317)
T ss_dssp             ESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHS
T ss_pred             hcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhC
Confidence            65421110       001234579999999987543   357899999999999999875

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.8e-37  Score=277.98  Aligned_cols=197  Identities=27%  Similarity=0.392  Sum_probs=160.5

Q ss_pred             HHhhcCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcC-CCCeeeeeeeEEEe----
Q 021711          105 LQSATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGIE----  178 (308)
Q Consensus       105 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----  178 (308)
                      +....++|++.+.||+|+||.||+|.+. +|+.||||.+......  ...+.+|+.+++.+ +||||+++++++..    
T Consensus        19 l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~   96 (326)
T 2x7f_A           19 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE--EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP   96 (326)
T ss_dssp             CCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST--THHHHHHHHHHHHHCCSTTBCCEEEEEEECC--
T ss_pred             ccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc--HHHHHHHHHHHHhccCCCCeeeeeeEEeeccCc
Confidence            3455679999999999999999999975 6899999998654332  36788999999998 79999999997764    


Q ss_pred             ---CcEEEEEEecCCCCHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEecc
Q 021711          179 ---GGMHIVLELSPNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDF  254 (308)
Q Consensus       179 ---~~~~lv~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DF  254 (308)
                         ...++||||+++++|.+++... ...+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+||
T Consensus        97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~kl~Df  173 (326)
T 2x7f_A           97 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDF  173 (326)
T ss_dssp             CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCC
T ss_pred             cccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCcHHHEEEcCCCCEEEeeC
Confidence               3578999999999999999753 3568999999999999999999999   89999999999999999999999999


Q ss_pred             ccceecCCCCceeEeeceeccccccccccCc-----hhhcCccceeEEEeeEEEeeccC
Q 021711          255 GLAKWLPEQWTHHTISKVEGTFGLVKLNLPP-----LVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       255 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      |++..+.....  ......||+.|+|||.+.     ....+.++|+||+|+++|+|++|
T Consensus       174 g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g  230 (326)
T 2x7f_A          174 GVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG  230 (326)
T ss_dssp             TTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHS
T ss_pred             cCceecCcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhC
Confidence            99987643321  224567999999999875     45678889999999999999875

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=3.1e-37  Score=282.81  Aligned_cols=195  Identities=21%  Similarity=0.269  Sum_probs=158.4

Q ss_pred             cCCccccceeeccCceEEEEEEEC----CCcEEEEEEeccCChHH----------HHHHHHHHHHHHhcCCCCeeeeeee
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR----NGQLVAIKRLTRGTADE----------IIADFLSELGIMAHVDHPNTAKLLG  174 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~----~g~~vAvK~~~~~~~~~----------~~~~~~~E~~~l~~l~h~niv~l~~  174 (308)
                      .++|.+.+.||+|+||.||+|.+.    ++..+|+|.+.......          ....+.+|+.++..++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            468999999999999999999976    47889999987553211          1134678899999999999999999


Q ss_pred             EEEe-----CcEEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCC--
Q 021711          175 YGIE-----GGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDF--  247 (308)
Q Consensus       175 ~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~--  247 (308)
                      ++..     ...++||||+ +++|.+++.... .+++..++.++.||+.||.|||+   ++|+||||||+|||++.++  
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~  190 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIHE---NEYVHGDIKAANLLLGYKNPD  190 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEESSSTT
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCcCHHHEEEccCCCC
Confidence            7765     3478999999 999999986543 79999999999999999999999   8999999999999999887  


Q ss_pred             cEEEeccccceecCCCCcee-----EeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          248 EPQICDFGLAKWLPEQWTHH-----TISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       248 ~~kl~DFGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      .+||+|||+++.+.......     ......||+.|+|||.+.+..++.++|+||+|+++|||++|
T Consensus       191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g  256 (345)
T 2v62_A          191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCG  256 (345)
T ss_dssp             SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHS
T ss_pred             cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhC
Confidence            99999999998875432211     11356899999999998888889999999999999999875

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=5.6e-37  Score=302.68  Aligned_cols=188  Identities=22%  Similarity=0.296  Sum_probs=158.9

Q ss_pred             ceeeccCceEEEEEEEC---CCcEEEEEEeccCCh-HHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeCcEEEEEEecCCC
Q 021711          116 NLIGKGGYAEVYKGRLR---NGQLVAIKRLTRGTA-DEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHIVLELSPNG  191 (308)
Q Consensus       116 ~~LG~G~fg~Vy~~~~~---~g~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~lv~e~~~~g  191 (308)
                      +.||+|+||.||+|.+.   .++.||||+++.... ....+.+.+|+.+|+.++|||||++++++.....++||||+++|
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~lv~E~~~~g  454 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELG  454 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEEECCTTE
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEEEccCCC
Confidence            47999999999999653   467899999975432 23457899999999999999999999999888899999999999


Q ss_pred             CHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCce-eEee
Q 021711          192 SLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH-HTIS  270 (308)
Q Consensus       192 sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~-~~~~  270 (308)
                      +|.+++.. ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+|+.+...... ....
T Consensus       455 ~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~---~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~  530 (635)
T 4fl3_A          455 PLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT  530 (635)
T ss_dssp             EHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC---------
T ss_pred             CHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccccc
Confidence            99999964 4578999999999999999999999   89999999999999999999999999999987554321 1223


Q ss_pred             ceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          271 KVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       271 ~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      ...||+.|+|||.+....++.++|+||||++||||++
T Consensus       531 ~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt  567 (635)
T 4fl3_A          531 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS  567 (635)
T ss_dssp             ----CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred             CCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHh
Confidence            4567889999999988889999999999999999986

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=4.2e-37  Score=294.32  Aligned_cols=191  Identities=23%  Similarity=0.345  Sum_probs=165.4

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCCh--HHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVL  185 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~  185 (308)
                      ++|++.++||+|+||.||+|... +|+.||||.+.....  ....+.+.+|+.+++.++||||+++++++... ..++||
T Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  105 (484)
T 3nyv_A           26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVG  105 (484)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            57999999999999999999986 689999999864321  22357789999999999999999999987765 478999


Q ss_pred             EecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEE---CCCCcEEEeccccceecCC
Q 021711          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILL---TEDFEPQICDFGLAKWLPE  262 (308)
Q Consensus       186 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl---~~~~~~kl~DFGla~~~~~  262 (308)
                      ||+.+|+|.+.+.. ...+++..+..++.||+.||.|||+   ++|+||||||+|||+   +.++.+||+|||+++.+..
T Consensus       106 e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~  181 (484)
T 3nyv_A          106 EVYTGGELFDEIIS-RKRFSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA  181 (484)
T ss_dssp             CCCCSCBHHHHHHT-CSCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCC
T ss_pred             ecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccc
Confidence            99999999998864 4568999999999999999999999   899999999999999   4678999999999987755


Q ss_pred             CCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          263 QWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       263 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ..   ......||+.|+|||.+.+ .++.++|+||+|+++|+|++|
T Consensus       182 ~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g  223 (484)
T 3nyv_A          182 SK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSG  223 (484)
T ss_dssp             CC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHS
T ss_pred             cc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHC
Confidence            42   2245679999999998765 578889999999999999886

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=2.7e-37  Score=273.95  Aligned_cols=195  Identities=23%  Similarity=0.327  Sum_probs=165.0

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCC-hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEe---CcEEE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGIE---GGMHI  183 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---~~~~l  183 (308)
                      .++|++.+.||+|+||.||+|... +|+.||+|.+.... .....+.+.+|+.+++.++||||+++++++..   ...++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            468999999999999999999976 68999999997543 33456789999999999999999999997653   34789


Q ss_pred             EEEecCCCCHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-----ceecCCCCCCEEECCCCcEEEeccc
Q 021711          184 VLELSPNGSLASLLYGM---KEKLKWGIRYKIALGVAEGLLYLHEGCQRR-----IIHRDIKAANILLTEDFEPQICDFG  255 (308)
Q Consensus       184 v~e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~-----iiHrDlKp~NILl~~~~~~kl~DFG  255 (308)
                      ||||+++++|.+++...   ...+++..++.++.|++.||.|||+   .+     |+||||||+|||++.++.+||+|||
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg  161 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR---RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG  161 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhc---ccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence            99999999999998652   3458999999999999999999998   77     9999999999999999999999999


Q ss_pred             cceecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          256 LAKWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       256 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      +++.......  ......||..|+|||.......+.++|+||+|+++|+|++|
T Consensus       162 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g  212 (279)
T 2w5a_A          162 LARILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCAL  212 (279)
T ss_dssp             HHHHC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHS
T ss_pred             hheeeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHC
Confidence            9987654321  12345789999999998877788999999999999999875

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=2.3e-36  Score=279.49  Aligned_cols=195  Identities=23%  Similarity=0.304  Sum_probs=167.6

Q ss_pred             hhcCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCCh-------HHHHHHHHHHHHHHhcC-CCCeeeeeeeEEE
Q 021711          107 SATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA-------DEIIADFLSELGIMAHV-DHPNTAKLLGYGI  177 (308)
Q Consensus       107 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~-------~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  177 (308)
                      ...++|++.+.||+|+||.||+|.+. +|+.||||.+.....       .+..+.+.+|+.++..+ +||||+++++++.
T Consensus        91 ~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  170 (365)
T 2y7j_A           91 EFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYE  170 (365)
T ss_dssp             HHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEe
Confidence            34467999999999999999999986 699999999865431       23356788999999999 7999999999876


Q ss_pred             eC-cEEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEecccc
Q 021711          178 EG-GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGL  256 (308)
Q Consensus       178 ~~-~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGl  256 (308)
                      .. ..++||||+++++|.+++.. ...+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+
T Consensus       171 ~~~~~~lv~e~~~g~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~---~gi~H~Dlkp~NIl~~~~~~ikl~DfG~  246 (365)
T 2y7j_A          171 SSSFMFLVFDLMRKGELFDYLTE-KVALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGF  246 (365)
T ss_dssp             BSSEEEEEECCCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             eCCEEEEEEEeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEEecCc
Confidence            65 47899999999999999864 4568999999999999999999999   8999999999999999999999999999


Q ss_pred             ceecCCCCceeEeeceeccccccccccCchh------hcCccceeEEEeeEEEeeccC
Q 021711          257 AKWLPEQWTHHTISKVEGTFGLVKLNLPPLV------ILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       257 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~Di~s~g~~l~el~c~  308 (308)
                      +..+.....   .....||+.|+|||.+...      .++.++|+||+|+++|+|++|
T Consensus       247 ~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g  301 (365)
T 2y7j_A          247 SCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG  301 (365)
T ss_dssp             CEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHS
T ss_pred             ccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHC
Confidence            998765432   3457899999999987533      467789999999999999875

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=5.8e-37  Score=293.67  Aligned_cols=191  Identities=26%  Similarity=0.374  Sum_probs=162.4

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCCh-HHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEEE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA-DEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLE  186 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e  186 (308)
                      ++|++.+.||+|+||.||+|... +++.||||.+..... ......+.+|+.+++.++||||+++++++... ..++|||
T Consensus        22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  101 (486)
T 3mwu_A           22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE  101 (486)
T ss_dssp             HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence            57999999999999999999976 689999999853211 11246788999999999999999999987765 4789999


Q ss_pred             ecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEEC---CCCcEEEeccccceecCCC
Q 021711          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLT---EDFEPQICDFGLAKWLPEQ  263 (308)
Q Consensus       187 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~---~~~~~kl~DFGla~~~~~~  263 (308)
                      |+.+|+|.+.+.. ...+++..+..++.||+.||.|||+   ++|+||||||+|||++   .++.+||+|||+++.+...
T Consensus       102 ~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~  177 (486)
T 3mwu_A          102 LYTGGELFDEIIK-RKRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN  177 (486)
T ss_dssp             CCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC
T ss_pred             cCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC
Confidence            9999999998865 3578999999999999999999999   8999999999999995   4567999999999876543


Q ss_pred             CceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          264 WTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      .   ......||+.|+|||.+.+ .++.++|+||+|+++|+|++|
T Consensus       178 ~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g  218 (486)
T 3mwu_A          178 T---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSG  218 (486)
T ss_dssp             -------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHS
T ss_pred             C---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhC
Confidence            2   2345679999999999865 478889999999999999876

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1.6e-36  Score=276.73  Aligned_cols=192  Identities=23%  Similarity=0.284  Sum_probs=163.0

Q ss_pred             hhcCCccccceeeccCceEEEEEEECCCcEEEEEEeccCChHHHHHHHHHHHHHHhc--CCCCeeeeeeeEEEeC-----
Q 021711          107 SATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAH--VDHPNTAKLLGYGIEG-----  179 (308)
Q Consensus       107 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~-----  179 (308)
                      ...++|.+.+.||+|+||.||+|.+ +|+.||||.+....    ...+.+|++++..  ++||||+++++++...     
T Consensus        39 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~----~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~  113 (342)
T 1b6c_B           39 TIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT  113 (342)
T ss_dssp             HHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGGG----HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred             cccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCchh----HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence            4456899999999999999999998 58999999986432    3567788888887  7899999999987765     


Q ss_pred             cEEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCceecCCCCCCEEECCCCcEEE
Q 021711          180 GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH--------EGCQRRIIHRDIKAANILLTEDFEPQI  251 (308)
Q Consensus       180 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH--------~~~~~~iiHrDlKp~NILl~~~~~~kl  251 (308)
                      ..++||||+++|+|.+++..  ..+++..++.++.|++.||.|||        +   .+|+||||||+|||++.++.+||
T Consensus       114 ~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~ivH~Dlkp~NIll~~~~~~kL  188 (342)
T 1b6c_B          114 QLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGK---PAIAHRDLKSKNILVKKNGTCCI  188 (342)
T ss_dssp             CEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCB---CEEECSCCSGGGEEECTTSCEEE
T ss_pred             eeEEEEeecCCCcHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHHHHhhhccc---CCeeeCCCCHHHEEECCCCCEEE
Confidence            57899999999999999954  46899999999999999999999        6   89999999999999999999999


Q ss_pred             eccccceecCCCCcee--EeeceeccccccccccCchh------hcCccceeEEEeeEEEeeccC
Q 021711          252 CDFGLAKWLPEQWTHH--TISKVEGTFGLVKLNLPPLV------ILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       252 ~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~Di~s~g~~l~el~c~  308 (308)
                      +|||+++.........  ......||+.|+|||.+.+.      ..+.++|+||+|+++|||++|
T Consensus       189 ~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg  253 (342)
T 1b6c_B          189 ADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR  253 (342)
T ss_dssp             CCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhc
Confidence            9999998775543321  22456799999999987654      233678999999999999875

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=9e-37  Score=277.36  Aligned_cols=192  Identities=26%  Similarity=0.424  Sum_probs=159.5

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcE--EEEEEeccCChHHHHHHHHHHHHHHhcC-CCCeeeeeeeEEEeC-cEEEE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQL--VAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGIEG-GMHIV  184 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~--vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~~~lv  184 (308)
                      ++|++.+.||+|+||.||+|++. ++..  +|+|.+.........+.+.+|+.++..+ +||||+++++++... ..++|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  104 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA  104 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence            58999999999999999999865 4654  4999987654444567789999999999 899999999987765 47899


Q ss_pred             EEecCCCCHHHHHhccC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcE
Q 021711          185 LELSPNGSLASLLYGMK---------------EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEP  249 (308)
Q Consensus       185 ~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~  249 (308)
                      |||+++|+|.+++....               ..+++..++.++.|++.||.|||+   ++|+||||||+|||++.++.+
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~  181 (327)
T 1fvr_A          105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA  181 (327)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCE
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCccceEEEcCCCeE
Confidence            99999999999996532               468999999999999999999999   999999999999999999999


Q ss_pred             EEeccccceecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          250 QICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       250 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      ||+|||+++.....   .......+|+.|+|||.+.....+.++|+||+|+++|||++
T Consensus       182 kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt  236 (327)
T 1fvr_A          182 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS  236 (327)
T ss_dssp             EECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHT
T ss_pred             EEcccCcCcccccc---ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHc
Confidence            99999999853321   11233467889999999887778899999999999999985

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=5e-37  Score=284.29  Aligned_cols=189  Identities=24%  Similarity=0.302  Sum_probs=146.8

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCC-hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEe-------C
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-------G  179 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-------~  179 (308)
                      .++|++.+.||+|+||.||+|.+. +|+.||||++.... ......++.+|+.+++.++||||+++++++..       .
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            468999999999999999999865 58999999986543 23446788999999999999999999998754       3


Q ss_pred             cEEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEecccccee
Q 021711          180 GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKW  259 (308)
Q Consensus       180 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~  259 (308)
                      ..++|+|++ +++|.+++..  ..+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++.
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kL~DFG~a~~  181 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH  181 (367)
T ss_dssp             CCEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECC------
T ss_pred             eEEEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHhhEEECCCCCEEEeecccccc
Confidence            468999998 7899888853  579999999999999999999999   8999999999999999999999999999987


Q ss_pred             cCCCCceeEeeceeccccccccccCch-hhcCccceeEEEeeEEEeeccC
Q 021711          260 LPEQWTHHTISKVEGTFGLVKLNLPPL-VILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       260 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ....     .....||+.|+|||.+.+ ..++.++|+||+|++++||++|
T Consensus       182 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g  226 (367)
T 2fst_X          182 TADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG  226 (367)
T ss_dssp             --------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHS
T ss_pred             cccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhC
Confidence            5432     245689999999998765 5678899999999999999876

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=2.8e-36  Score=273.89  Aligned_cols=186  Identities=18%  Similarity=0.228  Sum_probs=162.2

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCC-CCeeeeeeeEEEe---CcEEE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVD-HPNTAKLLGYGIE---GGMHI  183 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~---~~~~l  183 (308)
                      .++|++.+.||+|+||.||+|... +++.||||.+....    .+.+.+|+.+++.++ ||||+++++++..   ...++
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~l  110 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL  110 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc----hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEE
Confidence            368999999999999999999875 68999999987543    356889999999997 9999999998875   34789


Q ss_pred             EEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCC-cEEEeccccceecCC
Q 021711          184 VLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDF-EPQICDFGLAKWLPE  262 (308)
Q Consensus       184 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~-~~kl~DFGla~~~~~  262 (308)
                      ||||+.+++|.+++.    .++...+..++.|++.||.|||+   ++|+||||||+|||++.++ .+||+|||+++....
T Consensus       111 v~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~  183 (330)
T 3nsz_A          111 VFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  183 (330)
T ss_dssp             EEECCCCCCHHHHGG----GCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred             EEeccCchhHHHHHH----hCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence            999999999999873    38889999999999999999999   8999999999999999776 899999999998765


Q ss_pred             CCceeEeeceeccccccccccCch-hhcCccceeEEEeeEEEeeccC
Q 021711          263 QWTHHTISKVEGTFGLVKLNLPPL-VILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       263 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ...   .....||..|+|||.+.+ ...+.++|+||+|+++|+|++|
T Consensus       184 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g  227 (330)
T 3nsz_A          184 GQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFR  227 (330)
T ss_dssp             TCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHT
T ss_pred             CCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhC
Confidence            432   345679999999998766 5578899999999999999875

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=2.5e-36  Score=271.17  Aligned_cols=196  Identities=20%  Similarity=0.238  Sum_probs=164.4

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCCh---HHHHHHHHHHHHHHhcCCCCeeeeeeeEEEe---CcE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA---DEIIADFLSELGIMAHVDHPNTAKLLGYGIE---GGM  181 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---~~~  181 (308)
                      .++|++.+.||+|+||.||+|... +++.||+|.+.....   ......+.+|+.+++.++||||+++++++..   ...
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            368999999999999999999975 588999999864321   1235779999999999999999999997642   357


Q ss_pred             EEEEEecCCCCHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceec
Q 021711          182 HIVLELSPNGSLASLLYG-MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL  260 (308)
Q Consensus       182 ~lv~e~~~~gsL~~~l~~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~  260 (308)
                      ++||||+.++ |.+++.. ....+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++...
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~  159 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEAL  159 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEcCCCcEEeecccccccc
Confidence            9999999876 7666654 34568999999999999999999999   89999999999999999999999999999987


Q ss_pred             CCCCceeEeeceeccccccccccCchhh--cCccceeEEEeeEEEeeccC
Q 021711          261 PEQWTHHTISKVEGTFGLVKLNLPPLVI--LKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       261 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Di~s~g~~l~el~c~  308 (308)
                      .............||+.|+|||...+..  .+.++|+||+|+++|||++|
T Consensus       160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g  209 (305)
T 2wtk_C          160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTG  209 (305)
T ss_dssp             CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHS
T ss_pred             CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhC
Confidence            6543333445678999999999876433  36789999999999999875

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=1.6e-36  Score=291.17  Aligned_cols=191  Identities=25%  Similarity=0.307  Sum_probs=159.9

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCCh-HHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEEE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA-DEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLE  186 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e  186 (308)
                      ++|++.+.||+|+||.||+|+.. ++..||+|.+..... ......+.+|+.+++.++||||+++++++... ..++|||
T Consensus        37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  116 (494)
T 3lij_A           37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME  116 (494)
T ss_dssp             HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence            47999999999999999999986 588999999875432 12246788999999999999999999987765 4789999


Q ss_pred             ecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCC---CcEEEeccccceecCCC
Q 021711          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTED---FEPQICDFGLAKWLPEQ  263 (308)
Q Consensus       187 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~---~~~kl~DFGla~~~~~~  263 (308)
                      |+++|+|.+.+.. ...+++..+..++.||+.||.|||+   ++|+||||||+|||++..   +.+||+|||+++.....
T Consensus       117 ~~~~g~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~  192 (494)
T 3lij_A          117 CYKGGELFDEIIH-RMKFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ  192 (494)
T ss_dssp             CCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT
T ss_pred             cCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC
Confidence            9999999998854 4568999999999999999999999   899999999999999764   45999999999987554


Q ss_pred             CceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          264 WTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      .   ......||+.|+|||.+. ..++.++|+||+|+++|+|++|
T Consensus       193 ~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g  233 (494)
T 3lij_A          193 K---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAG  233 (494)
T ss_dssp             B---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHS
T ss_pred             c---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhC
Confidence            2   234567999999999875 4578889999999999999876

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.5e-36  Score=271.15  Aligned_cols=193  Identities=24%  Similarity=0.289  Sum_probs=164.8

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEE-EeC-cEEEEE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYG-IEG-GMHIVL  185 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~-~~~lv~  185 (308)
                      .++|++.+.||+|+||.||+|++. +|+.||||.+......   ..+.+|+.+++.++|++++..+.++ ..+ ..++||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH---PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC---CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch---hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence            478999999999999999999974 6899999998654332   3578999999999998887777654 333 468999


Q ss_pred             EecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEEC---CCCcEEEeccccceecCC
Q 021711          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLT---EDFEPQICDFGLAKWLPE  262 (308)
Q Consensus       186 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~---~~~~~kl~DFGla~~~~~  262 (308)
                      ||+ +++|.+++......+++..+..++.|++.||.|||+   ++|+||||||+|||++   .++.+||+|||+++....
T Consensus        85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~  160 (296)
T 3uzp_A           85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  160 (296)
T ss_dssp             ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred             Eec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence            999 899999997666789999999999999999999999   8999999999999994   788999999999998765


Q ss_pred             CCcee-----EeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          263 QWTHH-----TISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       263 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      .....     ......||+.|+|||...+...+.++|+||+|+++|||++|
T Consensus       161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g  211 (296)
T 3uzp_A          161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLG  211 (296)
T ss_dssp             TTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHS
T ss_pred             cccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhC
Confidence            43321     12456899999999998888889999999999999999875

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=8.8e-37  Score=287.46  Aligned_cols=187  Identities=26%  Similarity=0.281  Sum_probs=155.9

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-------cE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-------GM  181 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-------~~  181 (308)
                      .+|++.++||+|+||.||+|++. +|+.||||++.....     .+.+|+.+|+.++||||+++++++...       .+
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~  128 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL  128 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence            46889999999999999999986 589999999865432     234799999999999999999876431       15


Q ss_pred             EEEEEecCCCCHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCC-CcEEEeccccc
Q 021711          182 HIVLELSPNGSLASLLYG---MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTED-FEPQICDFGLA  257 (308)
Q Consensus       182 ~lv~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~-~~~kl~DFGla  257 (308)
                      ++||||+++ +|.+.+..   ....+++..+..++.||+.||.|||+   ++|+||||||+|||++.+ +.+||+|||++
T Consensus       129 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NILl~~~~~~~kl~DFG~a  204 (420)
T 1j1b_A          129 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSA  204 (420)
T ss_dssp             EEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             Eeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChhhEEEeCCCCeEEeccchhh
Confidence            689999986 66665532   35679999999999999999999998   899999999999999965 57899999999


Q ss_pred             eecCCCCceeEeeceeccccccccccCchh-hcCccceeEEEeeEEEeeccC
Q 021711          258 KWLPEQWTHHTISKVEGTFGLVKLNLPPLV-ILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~s~g~~l~el~c~  308 (308)
                      +.+.....   .....||+.|+|||.+.+. .++.++|+||+|++||||++|
T Consensus       205 ~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G  253 (420)
T 1j1b_A          205 KQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG  253 (420)
T ss_dssp             EECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHS
T ss_pred             hhcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhC
Confidence            98754422   2356799999999987654 678899999999999999886

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=9.9e-37  Score=271.63  Aligned_cols=194  Identities=23%  Similarity=0.278  Sum_probs=149.6

Q ss_pred             hcCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHH-HHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEE
Q 021711          108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEI-IADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIV  184 (308)
Q Consensus       108 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv  184 (308)
                      ..++|++.+.||+|+||.||+|... +|+.||+|.+........ .+.+.++...++.++||||+++++++... ..++|
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv   84 (290)
T 3fme_A            5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC   84 (290)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred             cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence            4568999999999999999999975 689999999976543333 33444555557888999999999977655 58899


Q ss_pred             EEecCCCCHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCC-CceecCCCCCCEEECCCCcEEEeccccceec
Q 021711          185 LELSPNGSLASLLYG---MKEKLKWGIRYKIALGVAEGLLYLHEGCQR-RIIHRDIKAANILLTEDFEPQICDFGLAKWL  260 (308)
Q Consensus       185 ~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~-~iiHrDlKp~NILl~~~~~~kl~DFGla~~~  260 (308)
                      |||++ |+|.+++..   ....+++..+..++.|++.||.|||+   + +|+||||||+|||++.++.+||+|||+++..
T Consensus        85 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  160 (290)
T 3fme_A           85 MELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS---KLSVIHRDVKPSNVLINALGQVKMCDFGISGYL  160 (290)
T ss_dssp             EECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred             Eehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence            99997 488777643   45679999999999999999999998   7 9999999999999999999999999999876


Q ss_pred             CCCCceeEeeceeccccccccccC----chhhcCccceeEEEeeEEEeeccC
Q 021711          261 PEQWTHHTISKVEGTFGLVKLNLP----PLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       261 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      .....   .....||+.|+|||.+    .....+.++|+||+|+++|+|++|
T Consensus       161 ~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g  209 (290)
T 3fme_A          161 VDDVA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAIL  209 (290)
T ss_dssp             ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHT
T ss_pred             ccccc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHC
Confidence            55422   2345799999999984    455678899999999999999865

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1.1e-36  Score=271.84  Aligned_cols=194  Identities=24%  Similarity=0.285  Sum_probs=161.4

Q ss_pred             hcCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEE-EeC-cEEEE
Q 021711          108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYG-IEG-GMHIV  184 (308)
Q Consensus       108 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~-~~~lv  184 (308)
                      ..++|++.+.||+|+||.||+|.+. +++.||||.+.....   ...+.+|+.++..++|++++..+.++ ..+ ..++|
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   83 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV   83 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc---chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence            3478999999999999999999974 689999998754332   23577899999999998888877754 333 46899


Q ss_pred             EEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEE---CCCCcEEEeccccceecC
Q 021711          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILL---TEDFEPQICDFGLAKWLP  261 (308)
Q Consensus       185 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl---~~~~~~kl~DFGla~~~~  261 (308)
                      |||+ +++|.+++......+++..+..++.|++.||.|||+   ++|+||||||+|||+   +.++.+||+|||+++...
T Consensus        84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~  159 (296)
T 4hgt_A           84 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  159 (296)
T ss_dssp             EECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             EEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence            9999 999999997666789999999999999999999999   899999999999999   788999999999999875


Q ss_pred             CCCcee-----EeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          262 EQWTHH-----TISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       262 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ......     ......||+.|+|||...+...+.++|+||+|+++|+|++|
T Consensus       160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g  211 (296)
T 4hgt_A          160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLG  211 (296)
T ss_dssp             CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHS
T ss_pred             CcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcC
Confidence            543321     22356899999999998888889999999999999999875

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.1e-36  Score=273.96  Aligned_cols=191  Identities=26%  Similarity=0.387  Sum_probs=163.5

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEEE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLE  186 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e  186 (308)
                      .++|.+.+.||+|+||.||+|+.. +|+.||+|.+...... ..+.+.+|+.+++.++||||+++++++... ..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAF-RDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ   86 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccccc-chHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence            357999999999999999999976 6899999999754322 245688999999999999999999987665 4789999


Q ss_pred             ecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEE---CCCCcEEEeccccceecCCC
Q 021711          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILL---TEDFEPQICDFGLAKWLPEQ  263 (308)
Q Consensus       187 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl---~~~~~~kl~DFGla~~~~~~  263 (308)
                      |+++++|.+++.. ...+++..+..++.|++.||.|||+   .+|+||||||+|||+   +.++.+||+|||+++.....
T Consensus        87 ~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~  162 (304)
T 2jam_A           87 LVSGGELFDRILE-RGVYTEKDASLVIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG  162 (304)
T ss_dssp             CCCSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB
T ss_pred             cCCCccHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC
Confidence            9999999998854 3568999999999999999999999   899999999999999   77889999999999865432


Q ss_pred             CceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          264 WTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                          ......||+.|+|||.+.+..++.++|+||+|+++|+|++|
T Consensus       163 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g  203 (304)
T 2jam_A          163 ----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCG  203 (304)
T ss_dssp             ----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHS
T ss_pred             ----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHC
Confidence                12345799999999998887888999999999999999875

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.6e-36  Score=268.62  Aligned_cols=194  Identities=19%  Similarity=0.310  Sum_probs=158.7

Q ss_pred             hcCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCCh--HHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEE
Q 021711          108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHI  183 (308)
Q Consensus       108 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l  183 (308)
                      ..++|++.+.||+|+||.||+|.+. +|+.||+|.+.....  .+..+.+.+|+.+++.++||||+++++++... ..++
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   88 (276)
T 2h6d_A            9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM   88 (276)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence            3468999999999999999999986 689999999864321  12356788999999999999999999987665 4789


Q ss_pred             EEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCC
Q 021711          184 VLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ  263 (308)
Q Consensus       184 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  263 (308)
                      ||||+++++|.+++.. ...+++..+..++.|++.||.|||+   ++|+||||||+||+++.++.+||+|||++......
T Consensus        89 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~  164 (276)
T 2h6d_A           89 VMEYVSGGELFDYICK-HGRVEEMEARRLFQQILSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG  164 (276)
T ss_dssp             EEECCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHH---HCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred             EEeccCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence            9999999999999865 3568999999999999999999999   89999999999999999999999999999876543


Q ss_pred             CceeEeeceeccccccccccCchhhc-CccceeEEEeeEEEeeccC
Q 021711          264 WTHHTISKVEGTFGLVKLNLPPLVIL-KRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~s~g~~l~el~c~  308 (308)
                      .   ......||+.|+|||...+... +.++|+||+|+++|+|++|
T Consensus       165 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g  207 (276)
T 2h6d_A          165 E---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCG  207 (276)
T ss_dssp             ---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHS
T ss_pred             c---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhC
Confidence            2   2234679999999999876554 6789999999999999875

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.3e-37  Score=284.27  Aligned_cols=190  Identities=18%  Similarity=0.252  Sum_probs=161.6

Q ss_pred             cCCccccceeeccCceEEEEEEECC---------CcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeee--------
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLRN---------GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAK--------  171 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~~---------g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~--------  171 (308)
                      .++|++.+.||+|+||.||+|.+..         ++.||+|.+...      +.+.+|+.++..++||||++        
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~  114 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD------GRLFNEQNFFQRAAKPLQVNKWKKLYST  114 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT------STHHHHHHHHHHHCCHHHHHHHHHHTTC
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc------chHHHHHHHHHHhcccchhhhhhhhccC
Confidence            4689999999999999999998763         789999998754      35778999999999999988        


Q ss_pred             -------eeeEEEe--CcEEEEEEecCCCCHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCE
Q 021711          172 -------LLGYGIE--GGMHIVLELSPNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANI  241 (308)
Q Consensus       172 -------l~~~~~~--~~~~lv~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NI  241 (308)
                             +++++..  ...++||||+ +++|.+++... ...+++..++.++.||+.||.|||+   ++|+||||||+||
T Consensus       115 ~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NI  190 (352)
T 2jii_A          115 PLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHE---NEYVHGNVTAENI  190 (352)
T ss_dssp             TTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCGGGE
T ss_pred             CccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHE
Confidence                   5666654  4578999999 99999999754 3679999999999999999999999   8999999999999


Q ss_pred             EECCCC--cEEEeccccceecCCCCcee-----EeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          242 LLTEDF--EPQICDFGLAKWLPEQWTHH-----TISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       242 Ll~~~~--~~kl~DFGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      |++.++  .+||+|||+++.+.......     ......||+.|+|||.+.+...+.++|+||+|++||||++|
T Consensus       191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g  264 (352)
T 2jii_A          191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYG  264 (352)
T ss_dssp             EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHS
T ss_pred             EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhC
Confidence            999998  89999999998765432211     12345899999999998887889999999999999999875

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=4.3e-37  Score=275.75  Aligned_cols=195  Identities=24%  Similarity=0.388  Sum_probs=162.0

Q ss_pred             hcCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEE
Q 021711          108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVL  185 (308)
Q Consensus       108 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~  185 (308)
                      ..++|++.+.||+|+||.||+|.+. +++.||+|.+..... ...+.+.+|+.+++.++||||+++++++... ..++||
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   95 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSE-EELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMI   95 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEE
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCH-HHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEE
Confidence            3468999999999999999999986 589999999865432 2357889999999999999999999977654 578999


Q ss_pred             EecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCc
Q 021711          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (308)
Q Consensus       186 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~  265 (308)
                      ||+++++|.+++......+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||++....... 
T Consensus        96 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  171 (302)
T 2j7t_A           96 EFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL-  171 (302)
T ss_dssp             ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH-
T ss_pred             EeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEECCCCCEEEEECCCCccccccc-
Confidence            9999999999987666779999999999999999999999   899999999999999999999999999986432211 


Q ss_pred             eeEeeceeccccccccccCc-----hhhcCccceeEEEeeEEEeeccC
Q 021711          266 HHTISKVEGTFGLVKLNLPP-----LVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                       .......||+.|+|||...     ....+.++|+||+|+++|+|++|
T Consensus       172 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g  218 (302)
T 2j7t_A          172 -QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQI  218 (302)
T ss_dssp             -HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHS
T ss_pred             -cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcC
Confidence             1123457999999999873     44567889999999999999875

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1.8e-36  Score=281.37  Aligned_cols=189  Identities=22%  Similarity=0.253  Sum_probs=160.6

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCC--------CCeeeeeeeEEE--
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVD--------HPNTAKLLGYGI--  177 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~~~~~--  177 (308)
                      .++|++.+.||+|+||.||+|+.. +++.||||.+...  ....+.+.+|+.+++.++        |+||+++++++.  
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~  113 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA--EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS  113 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC--CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeec
Confidence            468999999999999999999875 5889999998743  334577889999999885        788999999765  


Q ss_pred             ---eCcEEEEEEecCCCCHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCC-CceecCCCCCCEEECCCC-----
Q 021711          178 ---EGGMHIVLELSPNGSLASLLYG-MKEKLKWGIRYKIALGVAEGLLYLHEGCQR-RIIHRDIKAANILLTEDF-----  247 (308)
Q Consensus       178 ---~~~~~lv~e~~~~gsL~~~l~~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~-~iiHrDlKp~NILl~~~~-----  247 (308)
                         ....++||||+ +++|.+.+.. ....+++..+..++.||+.||.|||+   + +|+||||||+|||++.++     
T Consensus       114 ~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~givHrDikp~NIll~~~~~~~~~  189 (397)
T 1wak_A          114 GVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHT---KCRIIHTDIKPENILLSVNEQYIRR  189 (397)
T ss_dssp             ETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECCCCSGGGEEECCCHHHHHH
T ss_pred             CCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHeeEeccchhhhh
Confidence               23478999999 5566666544 33569999999999999999999998   7 999999999999999775     


Q ss_pred             --------------------------------------------cEEEeccccceecCCCCceeEeeceecccccccccc
Q 021711          248 --------------------------------------------EPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNL  283 (308)
Q Consensus       248 --------------------------------------------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~  283 (308)
                                                                  .+||+|||+++.....     .....||+.|+|||.
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~  264 (397)
T 1wak_A          190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEV  264 (397)
T ss_dssp             HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHH
T ss_pred             hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChh
Confidence                                                        7999999999987543     234579999999999


Q ss_pred             CchhhcCccceeEEEeeEEEeeccC
Q 021711          284 PPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       284 ~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      +.+..++.++|+||+|++||||++|
T Consensus       265 ~~~~~~~~~~DiwslG~il~elltg  289 (397)
T 1wak_A          265 LIGSGYNTPADIWSTACMAFELATG  289 (397)
T ss_dssp             HHTSCCCTHHHHHHHHHHHHHHHHS
T ss_pred             hcCCCCCcHHHHHHHHHHHHHHhhC
Confidence            8888889999999999999999875

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=6.8e-36  Score=266.86  Aligned_cols=193  Identities=26%  Similarity=0.343  Sum_probs=160.4

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEEEe
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLEL  187 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~  187 (308)
                      ++|....+||+|+||.||+|.+. +++.||+|.+..... ...+.+.+|+.+++.++||||+++++++... ..++||||
T Consensus        22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  100 (295)
T 2clq_A           22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS-RYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQ  100 (295)
T ss_dssp             CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC----HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCch-HHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEe
Confidence            34555569999999999999975 588999999876543 3457789999999999999999999987765 47899999


Q ss_pred             cCCCCHHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECC-CCcEEEeccccceecCCCC
Q 021711          188 SPNGSLASLLYGMKE--KLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTE-DFEPQICDFGLAKWLPEQW  264 (308)
Q Consensus       188 ~~~gsL~~~l~~~~~--~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~-~~~~kl~DFGla~~~~~~~  264 (308)
                      +++++|.+++.....  .+++..+..++.|++.||.|||+   ++|+||||||+|||++. ++.+||+|||+++......
T Consensus       101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~  177 (295)
T 2clq_A          101 VPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD---NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN  177 (295)
T ss_dssp             CSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC--
T ss_pred             CCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHh---CCEEccCCChhhEEEECCCCCEEEeecccccccCCCC
Confidence            999999999975432  45688889999999999999999   89999999999999987 8899999999998775432


Q ss_pred             ceeEeeceeccccccccccCchhh--cCccceeEEEeeEEEeeccC
Q 021711          265 THHTISKVEGTFGLVKLNLPPLVI--LKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Di~s~g~~l~el~c~  308 (308)
                      .  ......||+.|+|||......  .+.++|+||+|+++|+|++|
T Consensus       178 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g  221 (295)
T 2clq_A          178 P--CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATG  221 (295)
T ss_dssp             -----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHT
T ss_pred             C--cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHC
Confidence            1  234567999999999886543  67899999999999999875

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=8e-36  Score=266.98  Aligned_cols=194  Identities=24%  Similarity=0.276  Sum_probs=166.5

Q ss_pred             hcCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCCh--------HHHHHHHHHHHHHHhcCC-CCeeeeeeeEEE
Q 021711          108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--------DEIIADFLSELGIMAHVD-HPNTAKLLGYGI  177 (308)
Q Consensus       108 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~--------~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~  177 (308)
                      ..++|++.+.||+|+||.||+|.+. +|+.||||.+.....        ....+.+.+|+.+++.+. ||||+++++++.
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   94 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence            3578999999999999999999986 589999999865421        234567889999999995 999999999877


Q ss_pred             eCc-EEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEecccc
Q 021711          178 EGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGL  256 (308)
Q Consensus       178 ~~~-~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGl  256 (308)
                      .+. .++||||+++++|.+++.. ...+++..+..++.|++.||.|||+   ++|+||||||+||+++.++.+||+|||+
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~  170 (298)
T 1phk_A           95 TNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGF  170 (298)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             cCCeEEEEEeccCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEcCCCcEEEecccc
Confidence            654 7899999999999999965 4578999999999999999999999   8999999999999999999999999999


Q ss_pred             ceecCCCCceeEeeceeccccccccccCch------hhcCccceeEEEeeEEEeeccC
Q 021711          257 AKWLPEQWTHHTISKVEGTFGLVKLNLPPL------VILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       257 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      +..+.....   .....||+.|+|||.+..      ...+.++|+||+|+++|+|++|
T Consensus       171 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g  225 (298)
T 1phk_A          171 SCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG  225 (298)
T ss_dssp             CEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHS
T ss_pred             hhhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHC
Confidence            988755422   245679999999998752      3457789999999999999875

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=4.6e-37  Score=272.77  Aligned_cols=189  Identities=26%  Similarity=0.361  Sum_probs=157.3

Q ss_pred             hhcCCccccceeeccCceEEEEEEECCCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC--cEEEE
Q 021711          107 SATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG--GMHIV  184 (308)
Q Consensus       107 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~lv  184 (308)
                      ...++|++.+.||+|+||.||+|... |+.||+|.+....   ..+.+.+|+.+++.++||||+++++++.+.  ..++|
T Consensus        18 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv   93 (278)
T 1byg_A           18 LNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV   93 (278)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEE
T ss_pred             CChhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh---HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEE
Confidence            34568999999999999999999874 8899999987543   346789999999999999999999976543  57999


Q ss_pred             EEecCCCCHHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCC
Q 021711          185 LELSPNGSLASLLYGMKE-KLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ  263 (308)
Q Consensus       185 ~e~~~~gsL~~~l~~~~~-~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  263 (308)
                      |||+++++|.+++..... .+++..+..++.|++.||.|||+   ++|+||||||+||+++.++.+||+|||+++.....
T Consensus        94 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  170 (278)
T 1byg_A           94 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  170 (278)
T ss_dssp             ECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred             EecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHh---CCccccCCCcceEEEeCCCcEEEeecccccccccc
Confidence            999999999999965332 37889999999999999999999   89999999999999999999999999999865433


Q ss_pred             CceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          264 WTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      .     ....+|+.|+|||...+...+.++|+||+|+++|+|++
T Consensus       171 ~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t  209 (278)
T 1byg_A          171 Q-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS  209 (278)
T ss_dssp             ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred             c-----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHh
Confidence            1     23467899999999887778899999999999999986

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.1e-36  Score=301.07  Aligned_cols=186  Identities=23%  Similarity=0.279  Sum_probs=161.0

Q ss_pred             cCCccccceeeccCceEEEEEEEC--CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeCc------
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR--NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG------  180 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  180 (308)
                      .++|++.+.||+|+||.||+|.+.  +|+.||||.+......+....+.+|+.++..++||||+++++++...+      
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~  158 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV  158 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence            478999999999999999999976  589999999876555556778999999999999999999999876543      


Q ss_pred             EEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceec
Q 021711          181 MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL  260 (308)
Q Consensus       181 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~  260 (308)
                      .|+||||+++++|.+++..   .+++..++.++.||+.||.|||+   ++|+||||||+|||++.+ .+||+|||+++..
T Consensus       159 ~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~---~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~  231 (681)
T 2pzi_A          159 GYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI  231 (681)
T ss_dssp             EEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSS-CEEECCCTTCEET
T ss_pred             eEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHH---CCCeecccChHHeEEeCC-cEEEEecccchhc
Confidence            5899999999999987743   79999999999999999999999   899999999999999986 8999999999987


Q ss_pred             CCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          261 PEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       261 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ...      ....||++|+|||.+... .+.++|+||||+++++|++|
T Consensus       232 ~~~------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g  272 (681)
T 2pzi_A          232 NSF------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLD  272 (681)
T ss_dssp             TCC------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSC
T ss_pred             ccC------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhC
Confidence            543      345799999999987554 37789999999999999875

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.4e-36  Score=275.77  Aligned_cols=197  Identities=21%  Similarity=0.274  Sum_probs=150.9

Q ss_pred             hhcCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCC-CCeeeeeeeEEEe------
Q 021711          107 SATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVD-HPNTAKLLGYGIE------  178 (308)
Q Consensus       107 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~------  178 (308)
                      ....+|++.++||+|+||.||+|.+. +++.||||.+..... .....+.+|+.++..+. ||||+++++++..      
T Consensus        25 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~  103 (337)
T 3ll6_A           25 LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEE-EKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESD  103 (337)
T ss_dssp             ETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSH-HHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTST
T ss_pred             ccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCch-HHHHHHHHHHHHHHHhccCCChhhccccccccccccc
Confidence            34468999999999999999999976 689999999865543 34577899999999996 9999999997742      


Q ss_pred             ---CcEEEEEEecCCCCHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--ceecCCCCCCEEECCCCcEEE
Q 021711          179 ---GGMHIVLELSPNGSLASLLYG--MKEKLKWGIRYKIALGVAEGLLYLHEGCQRR--IIHRDIKAANILLTEDFEPQI  251 (308)
Q Consensus       179 ---~~~~lv~e~~~~gsL~~~l~~--~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~--iiHrDlKp~NILl~~~~~~kl  251 (308)
                         ...++||||+. |+|.+++..  ....+++..++.++.||+.||.|||+   .+  |+||||||+|||++.++.+||
T Consensus       104 ~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~~~ivH~Dikp~NIl~~~~~~~kl  179 (337)
T 3ll6_A          104 TGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR---QKPPIIHRDLKVENLLLSNQGTIKL  179 (337)
T ss_dssp             TSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCCCCCGGGCEECTTSCEEB
T ss_pred             cCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCEEEccCCcccEEECCCCCEEE
Confidence               12678999996 799988854  34569999999999999999999998   78  999999999999999999999


Q ss_pred             eccccceecCCCCcee----------EeeceeccccccccccC---chhhcCccceeEEEeeEEEeeccC
Q 021711          252 CDFGLAKWLPEQWTHH----------TISKVEGTFGLVKLNLP---PLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       252 ~DFGla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      +|||+++.........          ......||+.|+|||.+   .....+.++|+||+|+++|+|++|
T Consensus       180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g  249 (337)
T 3ll6_A          180 CDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFR  249 (337)
T ss_dssp             CCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHS
T ss_pred             ecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhC
Confidence            9999998765432211          11245699999999987   455678899999999999999875

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=5.3e-36  Score=282.93  Aligned_cols=190  Identities=21%  Similarity=0.209  Sum_probs=162.4

Q ss_pred             hcCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcC------CCCeeeeeeeEEEeC-
Q 021711          108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHV------DHPNTAKLLGYGIEG-  179 (308)
Q Consensus       108 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~~~~~~~-  179 (308)
                      ...+|++.+.||+|+||.||+|.+. +++.||||.+....  .....+.+|+.++..+      +|+||+++++++... 
T Consensus        95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~  172 (429)
T 3kvw_A           95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK--RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRN  172 (429)
T ss_dssp             ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETT
T ss_pred             ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc--chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCC
Confidence            3468999999999999999999876 48999999997542  3346677888887776      578999999977654 


Q ss_pred             cEEEEEEecCCCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCc--EEEecccc
Q 021711          180 GMHIVLELSPNGSLASLLYGMK-EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFE--PQICDFGL  256 (308)
Q Consensus       180 ~~~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~--~kl~DFGl  256 (308)
                      ..++||||+. ++|.+++.... ..+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.  +||+|||+
T Consensus       173 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NILl~~~~~~~vkL~DFG~  248 (429)
T 3kvw_A          173 HICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGS  248 (429)
T ss_dssp             EEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---HTEECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred             eEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEccCCCcceEEeeccc
Confidence            5789999996 68998886543 458999999999999999999999   89999999999999999887  99999999


Q ss_pred             ceecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          257 AKWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       257 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      |+.....     .....||+.|+|||.+.+..++.++|+||+|++||||++|
T Consensus       249 a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG  295 (429)
T 3kvw_A          249 SCYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTG  295 (429)
T ss_dssp             CEETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHS
T ss_pred             ceecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhC
Confidence            9875443     2346899999999998888889999999999999999876

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=2.3e-36  Score=282.31  Aligned_cols=188  Identities=24%  Similarity=0.245  Sum_probs=155.8

Q ss_pred             CCccccceeeccCceEEEEEEECCCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeCc-------EE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG-------MH  182 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-------~~  182 (308)
                      .+|++.++||+|+||.||+|++..+..||+|++......     ..+|+.+++.++||||+++++++....       ++
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~-----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~  114 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF-----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN  114 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS-----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred             ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch-----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence            479999999999999999999887777999988654321     236999999999999999999764322       67


Q ss_pred             EEEEecCCCCHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEEC-CCCcEEEecccccee
Q 021711          183 IVLELSPNGSLASLLY--GMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLT-EDFEPQICDFGLAKW  259 (308)
Q Consensus       183 lv~e~~~~gsL~~~l~--~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~-~~~~~kl~DFGla~~  259 (308)
                      +||||++++.+.....  .....+++..+..++.||+.||.|||+   ++|+||||||+|||++ .++.+||+|||+|+.
T Consensus       115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~  191 (394)
T 4e7w_A          115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKI  191 (394)
T ss_dssp             EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence            9999998754433322  235679999999999999999999999   8999999999999999 789999999999998


Q ss_pred             cCCCCceeEeeceeccccccccccCchh-hcCccceeEEEeeEEEeeccC
Q 021711          260 LPEQWTHHTISKVEGTFGLVKLNLPPLV-ILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       260 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~s~g~~l~el~c~  308 (308)
                      +.....   .....||+.|+|||.+.+. .++.++|+||+|+++|||++|
T Consensus       192 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g  238 (394)
T 4e7w_A          192 LIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQG  238 (394)
T ss_dssp             CCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHS
T ss_pred             ccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhC
Confidence            754432   2356789999999987554 478899999999999999876

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=1.2e-36  Score=277.66  Aligned_cols=179  Identities=19%  Similarity=0.147  Sum_probs=149.1

Q ss_pred             cCCccccceeeccCceEEEEEEECCCcEEEEEEeccCCh-------HHHHHHHHHHHHHHhcCC---------CCeeeee
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTA-------DEIIADFLSELGIMAHVD---------HPNTAKL  172 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~-------~~~~~~~~~E~~~l~~l~---------h~niv~l  172 (308)
                      .++|++.+.||+|+||.||+|++ +|+.||||.+.....       ....+.+.+|+.+++.++         ||||+++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            45789999999999999999998 689999999975421       223467888988888875         7777777


Q ss_pred             eeEEE-------------------------------eCcEEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q 021711          173 LGYGI-------------------------------EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLL  221 (308)
Q Consensus       173 ~~~~~-------------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~  221 (308)
                      .+.+.                               .+..++||||+++|++.+.+.  ...+++..+..++.||+.||.
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~--~~~~~~~~~~~i~~qi~~aL~  175 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR--TKLSSLATAKSILHQLTASLA  175 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT--TTCCCHHHHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH--hcCCCHHHHHHHHHHHHHHHH
Confidence            66432                               456899999999997766663  356899999999999999999


Q ss_pred             HHH-hCCCCCceecCCCCCCEEECCCC--------------------cEEEeccccceecCCCCceeEeeceeccccccc
Q 021711          222 YLH-EGCQRRIIHRDIKAANILLTEDF--------------------EPQICDFGLAKWLPEQWTHHTISKVEGTFGLVK  280 (308)
Q Consensus       222 yLH-~~~~~~iiHrDlKp~NILl~~~~--------------------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~a  280 (308)
                      ||| +   ++|+||||||+|||++.++                    .+||+|||+|+.....       ...||+.|+|
T Consensus       176 ~lH~~---~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y~a  245 (336)
T 2vuw_A          176 VAEAS---LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVSMD  245 (336)
T ss_dssp             HHHHH---HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCCTTC
T ss_pred             HHHHh---CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeecccC
Confidence            999 8   8999999999999999887                    8999999999977543       3479999999


Q ss_pred             cccCchhhcCccceeEEEeeE
Q 021711          281 LNLPPLVILKRCFTCIFIGFS  301 (308)
Q Consensus       281 PE~~~~~~~~~~~Di~s~g~~  301 (308)
                      ||.+.+.. +.++|+||++.+
T Consensus       246 PE~~~g~~-~~~~Diwsl~~~  265 (336)
T 2vuw_A          246 EDLFTGDG-DYQFDIYRLMKK  265 (336)
T ss_dssp             SGGGCCCS-SHHHHHHHHHHH
T ss_pred             hhhhcCCC-ccceehhhhhCC
Confidence            99987665 788999998665

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=5e-36  Score=277.63  Aligned_cols=188  Identities=21%  Similarity=0.305  Sum_probs=159.4

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCC-hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeCc------
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG------  180 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  180 (308)
                      .++|.+.+.||+|+||.||+|.+. +|+.||||.+.... .......+.+|+.+++.++||||+++++++....      
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            468999999999999999999976 58999999997543 3345678899999999999999999999876543      


Q ss_pred             -EEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEecccccee
Q 021711          181 -MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKW  259 (308)
Q Consensus       181 -~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~  259 (308)
                       .++||||+. ++|.+++   ...+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++.
T Consensus       121 ~~~lv~e~~~-~~l~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~  193 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIM---GMEFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARH  193 (371)
T ss_dssp             CCEEEEECCC-EEHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECSTTCC--
T ss_pred             eEEEEEcccc-ccHHHHh---hcCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCcCHHHeEECCCCCEEEEecCcccc
Confidence             389999997 5888877   3458999999999999999999999   8999999999999999999999999999986


Q ss_pred             cCCCCceeEeeceeccccccccccCch-hhcCccceeEEEeeEEEeeccC
Q 021711          260 LPEQWTHHTISKVEGTFGLVKLNLPPL-VILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       260 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ....     .....||+.|+|||.+.+ ...+.++|+||+|+++|+|++|
T Consensus       194 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g  238 (371)
T 4exu_A          194 ADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTG  238 (371)
T ss_dssp             -----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHS
T ss_pred             cccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhC
Confidence            5432     245678999999998766 5678899999999999999876

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=3.2e-36  Score=273.55  Aligned_cols=195  Identities=24%  Similarity=0.328  Sum_probs=145.3

Q ss_pred             hhcCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHH-HHhcCCCCeeeeeeeEEEeC-cEEE
Q 021711          107 SATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELG-IMAHVDHPNTAKLLGYGIEG-GMHI  183 (308)
Q Consensus       107 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~-~~~l  183 (308)
                      ...++|++.+.||+|+||.||+|... +|+.||||.+...........+.+|+. +++.++||||+++++++... ..++
T Consensus        19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~l   98 (327)
T 3aln_A           19 FTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWI   98 (327)
T ss_dssp             CCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEE
T ss_pred             cCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEE
Confidence            34578999999999999999999986 689999999976655444566677776 67778999999999977665 4789


Q ss_pred             EEEecCCCCHHHHHhc----cCCCCCHHHHHHHHHHHHHHHHHHHhCCCC-CceecCCCCCCEEECCCCcEEEeccccce
Q 021711          184 VLELSPNGSLASLLYG----MKEKLKWGIRYKIALGVAEGLLYLHEGCQR-RIIHRDIKAANILLTEDFEPQICDFGLAK  258 (308)
Q Consensus       184 v~e~~~~gsL~~~l~~----~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~-~iiHrDlKp~NILl~~~~~~kl~DFGla~  258 (308)
                      ||||+.+ +|.+++..    ....+++..+..++.|++.||.|||+   . +|+||||||+|||++.++.+||+|||+++
T Consensus        99 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~  174 (327)
T 3aln_A           99 CMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE---NLKIIHRDIKPSNILLDRSGNIKLCDFGISG  174 (327)
T ss_dssp             EECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH---HHSCCCSCCCGGGEEEETTTEEEECCCSSSC
T ss_pred             EEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc---cCCEeECCCCHHHEEEcCCCCEEEccCCCce
Confidence            9999985 78777642    25678999999999999999999998   7 99999999999999999999999999998


Q ss_pred             ecCCCCceeEeeceeccccccccccC----chhhcCccceeEEEeeEEEeeccC
Q 021711          259 WLPEQWTHHTISKVEGTFGLVKLNLP----PLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       259 ~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      .+....   ......||+.|+|||..    .....+.++|+||+|+++|+|++|
T Consensus       175 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g  225 (327)
T 3aln_A          175 QLVDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATG  225 (327)
T ss_dssp             C---------------------------------CCSHHHHHHHHHHHHHHHHS
T ss_pred             eccccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHC
Confidence            765432   22345799999999997    345578899999999999999875

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=2.1e-36  Score=275.37  Aligned_cols=195  Identities=22%  Similarity=0.303  Sum_probs=162.0

Q ss_pred             hcCCcccc-ceeeccCceEEEEEEEC-CCcEEEEEEeccCCh-HHHHHHHHHHHHHHhcCC-CCeeeeeeeEEEeC-cEE
Q 021711          108 ATNNFSFE-NLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA-DEIIADFLSELGIMAHVD-HPNTAKLLGYGIEG-GMH  182 (308)
Q Consensus       108 ~~~~~~~~-~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~-~~~  182 (308)
                      ..+.|.+. +.||+|+||.||+|... +|+.||+|.+..... ......+.+|+.++..++ ||||+++++++... ..+
T Consensus        26 ~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~  105 (327)
T 3lm5_A           26 FNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEII  105 (327)
T ss_dssp             HHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             hhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEE
Confidence            34567776 89999999999999976 589999999865322 223567889999999994 69999999987765 478


Q ss_pred             EEEEecCCCCHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECC---CCcEEEeccccce
Q 021711          183 IVLELSPNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTE---DFEPQICDFGLAK  258 (308)
Q Consensus       183 lv~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~---~~~~kl~DFGla~  258 (308)
                      +||||+++|+|.+++... ...+++..+..++.|++.||.|||+   ++|+||||||+|||++.   ++.+||+|||+++
T Consensus       106 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~---~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~  182 (327)
T 3lm5_A          106 LILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSR  182 (327)
T ss_dssp             EEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESCBTTBCCEEECCGGGCE
T ss_pred             EEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCChHHEEEecCCCCCcEEEeeCcccc
Confidence            999999999999988542 3568999999999999999999999   89999999999999998   7899999999999


Q ss_pred             ecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          259 WLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       259 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ......   ......||+.|+|||.+....++.++|+||+|+++|+|++|
T Consensus       183 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g  229 (327)
T 3lm5_A          183 KIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTH  229 (327)
T ss_dssp             EC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred             ccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhC
Confidence            875432   23456799999999998888888999999999999999875

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.2e-36  Score=283.08  Aligned_cols=191  Identities=22%  Similarity=0.334  Sum_probs=145.0

Q ss_pred             Cccc-cceeeccCceEEEEEEEC---CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEe---CcEEE
Q 021711          111 NFSF-ENLIGKGGYAEVYKGRLR---NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE---GGMHI  183 (308)
Q Consensus       111 ~~~~-~~~LG~G~fg~Vy~~~~~---~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---~~~~l  183 (308)
                      .|.+ .++||+|+||.||+|++.   +++.||||.+......   ..+.+|+.+|+.++||||+++++++..   ...++
T Consensus        21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l   97 (405)
T 3rgf_A           21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS---MSACREIALLRELKHPNVISLQKVFLSHADRKVWL   97 (405)
T ss_dssp             HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC---HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred             hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC---HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence            4555 458999999999999975   4789999999754332   467899999999999999999998754   34789


Q ss_pred             EEEecCCCCHHHHHhcc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEE----CCCCcEEE
Q 021711          184 VLELSPNGSLASLLYGM--------KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILL----TEDFEPQI  251 (308)
Q Consensus       184 v~e~~~~gsL~~~l~~~--------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl----~~~~~~kl  251 (308)
                      ||||+. |+|.+++...        ...+++..+..++.||+.||.|||+   ++|+||||||+|||+    +.++.+||
T Consensus        98 v~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl  173 (405)
T 3rgf_A           98 LFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKI  173 (405)
T ss_dssp             EEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred             EEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeCCCcCHHHeEEecCCCCCCcEEE
Confidence            999996 4788777431        1248999999999999999999999   899999999999999    67789999


Q ss_pred             eccccceecCCCCce-eEeeceeccccccccccCchh-hcCccceeEEEeeEEEeeccC
Q 021711          252 CDFGLAKWLPEQWTH-HTISKVEGTFGLVKLNLPPLV-ILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       252 ~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~s~g~~l~el~c~  308 (308)
                      +|||+|+.+...... .......||+.|+|||.+.+. .++.++|+||+|+++|||++|
T Consensus       174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g  232 (405)
T 3rgf_A          174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS  232 (405)
T ss_dssp             CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHS
T ss_pred             EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhC
Confidence            999999877543221 223457899999999987664 478899999999999999875

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=1.9e-36  Score=273.43  Aligned_cols=198  Identities=20%  Similarity=0.250  Sum_probs=159.8

Q ss_pred             HHhhcCCccccceeeccCceEEEEEEECCCcEEEEEEeccCC-hHHHHHHHHHHHHHHhcCC--CCeeeeeeeEEEeCc-
Q 021711          105 LQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVD--HPNTAKLLGYGIEGG-  180 (308)
Q Consensus       105 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~-  180 (308)
                      +....++|++.+.||+|+||.||+|...+++.||+|.+.... .....+.+.+|+.++..++  ||||+++++++.... 
T Consensus        23 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~  102 (313)
T 3cek_A           23 MSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY  102 (313)
T ss_dssp             EEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSE
T ss_pred             eeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCE
Confidence            334556899999999999999999998889999999986543 3445678999999999997  599999999877654 


Q ss_pred             EEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceec
Q 021711          181 MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL  260 (308)
Q Consensus       181 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~  260 (308)
                      .++||| +.+++|.+++.. ...+++..+..++.|++.||.|||+   ++|+||||||+|||+++ +.+||+|||+++.+
T Consensus       103 ~~lv~e-~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~  176 (313)
T 3cek_A          103 IYMVME-CGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIVD-GMLKLIDFGIANQM  176 (313)
T ss_dssp             EEEEEC-CCSEEHHHHHHH-CSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEET-TEEEECCCSSSCC-
T ss_pred             EEEEEe-cCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEEEC-CeEEEeeccccccc
Confidence            678999 668899999965 4578999999999999999999999   89999999999999975 79999999999877


Q ss_pred             CCCCceeEeeceeccccccccccCch-----------hhcCccceeEEEeeEEEeeccC
Q 021711          261 PEQWTHHTISKVEGTFGLVKLNLPPL-----------VILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       261 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      .............||+.|+|||.+..           ...+.++|+||+|+++|||++|
T Consensus       177 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g  235 (313)
T 3cek_A          177 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYG  235 (313)
T ss_dssp             -------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHS
T ss_pred             cCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhC
Confidence            55433323345679999999998754           3567789999999999999875

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=6.2e-36  Score=269.70  Aligned_cols=193  Identities=23%  Similarity=0.278  Sum_probs=155.8

Q ss_pred             cCCccccceeeccCceEEEEEEECC-CcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEE----------
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLRN-GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGI----------  177 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~~-g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~----------  177 (308)
                      .++|++.+.||+|+||.||+|.... |+.||+|.+.... ....+.+.+|+.+++.++||||+++++++.          
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   88 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD-PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDV   88 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC--
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC-hHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccc
Confidence            4689999999999999999999874 8999999987554 344678999999999999999999998763          


Q ss_pred             -----eCcEEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEEC-CCCcEEE
Q 021711          178 -----EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLT-EDFEPQI  251 (308)
Q Consensus       178 -----~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~-~~~~~kl  251 (308)
                           ....++||||+. |+|.+++.  ...+++..+..++.|++.||.|||+   ++|+||||||+|||++ .++.+||
T Consensus        89 ~~~~~~~~~~lv~e~~~-~~L~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~kl  162 (320)
T 2i6l_A           89 GSLTELNSVYIVQEYME-TDLANVLE--QGPLLEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKI  162 (320)
T ss_dssp             --CCSCSEEEEEEECCS-EEHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTTEEEE
T ss_pred             ccccccCceeEEeeccC-CCHHHHhh--cCCccHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCeEEE
Confidence                 234789999997 69999985  3568999999999999999999999   8999999999999997 5679999


Q ss_pred             eccccceecCCCCce-eEeeceeccccccccccCch-hhcCccceeEEEeeEEEeeccC
Q 021711          252 CDFGLAKWLPEQWTH-HTISKVEGTFGLVKLNLPPL-VILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       252 ~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      +|||+++........ .......||..|+|||.... ...+.++|+||+|+++|||++|
T Consensus       163 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g  221 (320)
T 2i6l_A          163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG  221 (320)
T ss_dssp             CCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHS
T ss_pred             ccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhC
Confidence            999999876543221 12234567999999997654 5678899999999999999875

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=5.1e-36  Score=275.37  Aligned_cols=195  Identities=22%  Similarity=0.228  Sum_probs=150.6

Q ss_pred             HHhhcCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-c--
Q 021711          105 LQSATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-G--  180 (308)
Q Consensus       105 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~--  180 (308)
                      .....++|++.+.||+|+||.||+|.+. +|+.||||.+......  ...+.+++..+..++||||+++++++... .  
T Consensus        18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~   95 (360)
T 3e3p_A           18 SRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF--RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD   95 (360)
T ss_dssp             HHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC--CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred             chhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc--cHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence            4455689999999999999999999986 5899999998654322  24566788888999999999999976542 1  


Q ss_pred             -----EEEEEEecCCCCHHHHHh---ccCCCCCHHHHHHHHHHHHHHHHHHH--hCCCCCceecCCCCCCEEECC-CCcE
Q 021711          181 -----MHIVLELSPNGSLASLLY---GMKEKLKWGIRYKIALGVAEGLLYLH--EGCQRRIIHRDIKAANILLTE-DFEP  249 (308)
Q Consensus       181 -----~~lv~e~~~~gsL~~~l~---~~~~~l~~~~~~~i~~qi~~~L~yLH--~~~~~~iiHrDlKp~NILl~~-~~~~  249 (308)
                           .++||||+++ +|...+.   .....+++..+..++.|++.||.|||  +   ++|+||||||+|||++. ++.+
T Consensus        96 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~ivH~Dlkp~NIll~~~~~~~  171 (360)
T 3e3p_A           96 RRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPS---VNVCHRDIKPHNVLVNEADGTL  171 (360)
T ss_dssp             TTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTT---TCCBCSCCCGGGEEEETTTTEE
T ss_pred             ccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCC---CCeecCcCCHHHEEEeCCCCcE
Confidence                 6799999986 5554443   24556889999999999999999999  7   89999999999999997 8999


Q ss_pred             EEeccccceecCCCCceeEeeceeccccccccccCchhh-cCccceeEEEeeEEEeeccC
Q 021711          250 QICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPLVI-LKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       250 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~s~g~~l~el~c~  308 (308)
                      ||+|||+++.+.....   .....||+.|+|||.+.+.. ++.++|+||+|+++|||++|
T Consensus       172 kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g  228 (360)
T 3e3p_A          172 KLCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLG  228 (360)
T ss_dssp             EECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHS
T ss_pred             EEeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhC
Confidence            9999999997755432   23567899999999875544 78899999999999999875

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=8.1e-36  Score=285.44  Aligned_cols=193  Identities=25%  Similarity=0.318  Sum_probs=162.9

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeee-eeeeEEEeCc-EEEEE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTA-KLLGYGIEGG-MHIVL  185 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~-~~lv~  185 (308)
                      .++|++.++||+|+||.||+|.+. +++.||||++......   ..+.+|+.++..++|++.+ .+..++.... .++||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvm   82 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVM   82 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS---CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc---HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEE
Confidence            468999999999999999999975 6899999988654332   3577899999999875544 4445555544 67999


Q ss_pred             EecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEE---CCCCcEEEeccccceecCC
Q 021711          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILL---TEDFEPQICDFGLAKWLPE  262 (308)
Q Consensus       186 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl---~~~~~~kl~DFGla~~~~~  262 (308)
                      ||+ +++|.+++......+++..++.++.||+.||.|||+   ++|+||||||+|||+   +.++.+||+|||+++.+..
T Consensus        83 e~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~  158 (483)
T 3sv0_A           83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD  158 (483)
T ss_dssp             ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred             ECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence            999 999999997667789999999999999999999999   899999999999999   5788999999999998765


Q ss_pred             CCcee-----EeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          263 QWTHH-----TISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       263 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      .....     ......||+.|+|||.+.+..++.++|+||||++||||++|
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG  209 (483)
T 3sv0_A          159 TSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRG  209 (483)
T ss_dssp             TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHS
T ss_pred             CccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhC
Confidence            43321     12367899999999999888899999999999999999875

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=2.1e-35  Score=268.08  Aligned_cols=189  Identities=19%  Similarity=0.265  Sum_probs=162.0

Q ss_pred             cCCccccceeeccCceEEEEEEE-C-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCC------eeeeeeeEEEeC-
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRL-R-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHP------NTAKLLGYGIEG-  179 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~-~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~------niv~l~~~~~~~-  179 (308)
                      .++|++.+.||+|+||.||+|.. . +++.||||.+...  ....+.+.+|+.++..++|+      +++++++++... 
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~   90 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV--DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG   90 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS--HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC--CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC
Confidence            46899999999999999999987 3 5889999998653  23457788999999888665      499999977665 


Q ss_pred             cEEEEEEecCCCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECC-------------
Q 021711          180 GMHIVLELSPNGSLASLLYGMK-EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTE-------------  245 (308)
Q Consensus       180 ~~~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~-------------  245 (308)
                      ..++||||+ +++|.+++.... ..+++..+..++.|++.||.|||+   ++|+||||||+|||++.             
T Consensus        91 ~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~  166 (339)
T 1z57_A           91 HICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKR  166 (339)
T ss_dssp             EEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCCCEEEEEC----C
T ss_pred             cEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeccccccccCCcccc
Confidence            578999999 889999986543 368899999999999999999999   89999999999999987             


Q ss_pred             ------CCcEEEeccccceecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          246 ------DFEPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       246 ------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                            ++.+||+|||+++.....     .....||+.|+|||.+.+..++.++|+||+|+++|||++|
T Consensus       167 ~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g  230 (339)
T 1z57_A          167 DERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLG  230 (339)
T ss_dssp             EEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHS
T ss_pred             ccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhC
Confidence                  668999999999876543     2346799999999998887889999999999999999875

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=4.9e-36  Score=271.70  Aligned_cols=194  Identities=24%  Similarity=0.362  Sum_probs=160.6

Q ss_pred             hcCCccccceeeccCceEEEEEEEC--CCcEEEEEEeccCChH-HHHHHHHHHHHHHhcC---CCCeeeeeeeEEE----
Q 021711          108 ATNNFSFENLIGKGGYAEVYKGRLR--NGQLVAIKRLTRGTAD-EIIADFLSELGIMAHV---DHPNTAKLLGYGI----  177 (308)
Q Consensus       108 ~~~~~~~~~~LG~G~fg~Vy~~~~~--~g~~vAvK~~~~~~~~-~~~~~~~~E~~~l~~l---~h~niv~l~~~~~----  177 (308)
                      ..++|++.+.||+|+||.||+|.+.  +|+.||+|.+...... .....+.+|+.+++.+   +||||+++++++.    
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            4468999999999999999999983  5889999998643211 1123455677766655   8999999999775    


Q ss_pred             --eCcEEEEEEecCCCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEecc
Q 021711          178 --EGGMHIVLELSPNGSLASLLYGMK-EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDF  254 (308)
Q Consensus       178 --~~~~~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DF  254 (308)
                        ....++||||+. |+|.+++.... ..+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+||
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~gi~H~dlkp~Nili~~~~~~kl~Df  164 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADF  164 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHHHeEEcCCCCEEEecC
Confidence              234789999998 69999986543 358999999999999999999999   89999999999999999999999999


Q ss_pred             ccceecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          255 GLAKWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       255 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      |+++......   ......||..|+|||.+.....+.++|+||+|+++|+|++|
T Consensus       165 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g  215 (326)
T 1blx_A          165 GLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRR  215 (326)
T ss_dssp             CSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred             cccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcC
Confidence            9998764332   23456799999999998877888999999999999999875

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=3.4e-36  Score=275.34  Aligned_cols=193  Identities=18%  Similarity=0.286  Sum_probs=165.1

Q ss_pred             cCCccccceeeccCceEEEEEEECCCcEEEEEEeccCChH----------------HHHHHHHHHHHHHhcCCCCeeeee
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTAD----------------EIIADFLSELGIMAHVDHPNTAKL  172 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~----------------~~~~~~~~E~~~l~~l~h~niv~l  172 (308)
                      .++|++.+.||+|+||.||+|.. +|+.||+|.+......                ...+.+.+|+.++..++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            46899999999999999999999 8999999998643111                112788999999999999999999


Q ss_pred             eeEEEeC-cEEEEEEecCCCCHHHH------Hhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEEC
Q 021711          173 LGYGIEG-GMHIVLELSPNGSLASL------LYGM-KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLT  244 (308)
Q Consensus       173 ~~~~~~~-~~~lv~e~~~~gsL~~~------l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~  244 (308)
                      ++++... ..++||||+++|+|.++      +... ...+++..+..++.|++.||.|||+  .++|+||||||+|||++
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~~i~H~dl~p~Nil~~  186 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMD  186 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHH--TSCEECCCCCGGGEEEC
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhc--cCCEeecCCChHhEEEc
Confidence            9987765 47899999999999988      5332 4678999999999999999999996  26899999999999999


Q ss_pred             CCCcEEEeccccceecCCCCceeEeeceeccccccccccCchh-hcCc-cceeEEEeeEEEeeccC
Q 021711          245 EDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPLV-ILKR-CFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       245 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~Di~s~g~~l~el~c~  308 (308)
                      .++.+||+|||+++.....    ......||..|+|||...+. ..+. ++|+||+|+++|||++|
T Consensus       187 ~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g  248 (348)
T 2pml_X          187 KNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYN  248 (348)
T ss_dssp             TTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHS
T ss_pred             CCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhC
Confidence            9999999999999986543    33567899999999988766 4444 89999999999999875

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1.2e-35  Score=272.94  Aligned_cols=188  Identities=22%  Similarity=0.302  Sum_probs=158.7

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCC-hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeCc------
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG------  180 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  180 (308)
                      .++|.+.+.||+|+||.||+|.+. +|+.||||.+.... .......+.+|+.+++.++||||+++++++....      
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            468999999999999999999976 58999999996543 3344678899999999999999999999876543      


Q ss_pred             -EEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEecccccee
Q 021711          181 -MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKW  259 (308)
Q Consensus       181 -~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~  259 (308)
                       .++||||+. ++|.+++.   ..+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++.
T Consensus       103 ~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~  175 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMG---LKFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARH  175 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTT---SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTCCEEECSTTCTTC
T ss_pred             eEEEEecccc-CCHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEeECCCCcEEEeecccccC
Confidence             489999997 58877663   358999999999999999999999   8999999999999999999999999999986


Q ss_pred             cCCCCceeEeeceeccccccccccCch-hhcCccceeEEEeeEEEeeccC
Q 021711          260 LPEQWTHHTISKVEGTFGLVKLNLPPL-VILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       260 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ....     .....||+.|+|||.+.+ ...+.++|+||+|+++|+|++|
T Consensus       176 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g  220 (353)
T 3coi_A          176 ADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTG  220 (353)
T ss_dssp             -------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHS
T ss_pred             CCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhC
Confidence            5432     234678999999998765 5678899999999999999875

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=6.6e-35  Score=271.05  Aligned_cols=192  Identities=21%  Similarity=0.262  Sum_probs=161.0

Q ss_pred             hcCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCC-CC-----eeeeeeeEEEe-C
Q 021711          108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVD-HP-----NTAKLLGYGIE-G  179 (308)
Q Consensus       108 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~~~~~-~  179 (308)
                      ..++|++.+.||+|+||.||+|... +++.||||.+...  ......+.+|+.++..++ |+     +|+++++++.. +
T Consensus        52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~  129 (382)
T 2vx3_A           52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK--KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN  129 (382)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS--HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred             eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc--HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence            3579999999999999999999976 5889999999753  233566778888888774 44     49999987665 4


Q ss_pred             cEEEEEEecCCCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEEC--CCCcEEEecccc
Q 021711          180 GMHIVLELSPNGSLASLLYGMK-EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLT--EDFEPQICDFGL  256 (308)
Q Consensus       180 ~~~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~--~~~~~kl~DFGl  256 (308)
                      ..++||||+. |+|.+++.... ..+++..+..++.|++.||.|||.. ..+|+||||||+|||++  .++.+||+|||+
T Consensus       130 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~  207 (382)
T 2vx3_A          130 HLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGS  207 (382)
T ss_dssp             EEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTT
T ss_pred             ceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccC
Confidence            5789999996 59999987643 4689999999999999999999941 26899999999999995  467899999999


Q ss_pred             ceecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          257 AKWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       257 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ++.....     .....||+.|+|||.+.+..++.++|+||+|+++|||++|
T Consensus       208 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg  254 (382)
T 2vx3_A          208 SCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTG  254 (382)
T ss_dssp             CEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred             ceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhC
Confidence            9987543     2356899999999998888889999999999999999876

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=5.3e-35  Score=267.27  Aligned_cols=188  Identities=20%  Similarity=0.222  Sum_probs=138.8

Q ss_pred             cCCcccc-ceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEe-----CcE
Q 021711          109 TNNFSFE-NLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-----GGM  181 (308)
Q Consensus       109 ~~~~~~~-~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~~  181 (308)
                      .++|.+. ++||+|+||.||+|.+. +|+.||||++....  ....   .....+..++||||+++++++..     ...
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~---e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~  101 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP--KARQ---EVDHHWQASGGPHIVCILDVYENMHHGKRCL  101 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH--HHHH---HHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH--HHHH---HHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence            4688885 57999999999999987 68999999986532  1112   22233566799999999997654     237


Q ss_pred             EEEEEecCCCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCC---CcEEEeccccc
Q 021711          182 HIVLELSPNGSLASLLYGMK-EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTED---FEPQICDFGLA  257 (308)
Q Consensus       182 ~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~---~~~kl~DFGla  257 (308)
                      ++||||+++|+|.+++.... ..+++..+..++.|++.||.|||+   ++|+||||||+|||++.+   +.+||+|||++
T Consensus       102 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~---~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~  178 (336)
T 3fhr_A          102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA  178 (336)
T ss_dssp             EEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEEecCCCceEEEeccccc
Confidence            89999999999999997543 469999999999999999999999   899999999999999864   55999999999


Q ss_pred             eecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          258 KWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      +.....    ......||+.|+|||.+....++.++|+||+|+++|+|++|
T Consensus       179 ~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g  225 (336)
T 3fhr_A          179 KETTQN----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG  225 (336)
T ss_dssp             EEC--------------------------CHHHHHHHHHHHHHHHHHHHHS
T ss_pred             eecccc----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHC
Confidence            876543    23456789999999999888888899999999999999875

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=6.2e-36  Score=271.44  Aligned_cols=196  Identities=20%  Similarity=0.283  Sum_probs=163.4

Q ss_pred             HHhhcCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChH-----HHHHHHHHHHHHHhcCC--CCeeeeeeeEE
Q 021711          105 LQSATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTAD-----EIIADFLSELGIMAHVD--HPNTAKLLGYG  176 (308)
Q Consensus       105 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~-----~~~~~~~~E~~~l~~l~--h~niv~l~~~~  176 (308)
                      .....++|++.+.||+|+||.||+|... +++.||||.+......     .....+.+|+.+++.++  ||||+++++++
T Consensus        38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~  117 (320)
T 3a99_A           38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF  117 (320)
T ss_dssp             --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred             cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence            3445678999999999999999999865 6899999998643211     11245678999999996  59999999987


Q ss_pred             EeC-cEEEEEEecCC-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEEC-CCCcEEEec
Q 021711          177 IEG-GMHIVLELSPN-GSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLT-EDFEPQICD  253 (308)
Q Consensus       177 ~~~-~~~lv~e~~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~-~~~~~kl~D  253 (308)
                      ... ..++|+|++.+ ++|.+++.. ...+++..+..++.|++.||.|||+   .+|+||||||+|||++ .++.+||+|
T Consensus       118 ~~~~~~~lv~e~~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~kL~D  193 (320)
T 3a99_A          118 ERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLID  193 (320)
T ss_dssp             ECSSEEEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECC
T ss_pred             ecCCcEEEEEEcCCCCccHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCcEeCCCCHHHEEEeCCCCCEEEee
Confidence            765 47899999976 899999865 4578999999999999999999999   8999999999999999 778999999


Q ss_pred             cccceecCCCCceeEeeceeccccccccccCchhhc-CccceeEEEeeEEEeeccC
Q 021711          254 FGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPLVIL-KRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       254 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~s~g~~l~el~c~  308 (308)
                      ||+++......    .....||+.|+|||.+..... +.++|+||+|+++|||++|
T Consensus       194 fg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g  245 (320)
T 3a99_A          194 FGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG  245 (320)
T ss_dssp             CTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHS
T ss_pred             Ccccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHC
Confidence            99999876432    235679999999998766554 6788999999999999875

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.8e-36  Score=273.75  Aligned_cols=201  Identities=22%  Similarity=0.321  Sum_probs=161.4

Q ss_pred             HHHHHhhcCCccccceeeccCceEEEEEEECCCcEEEEEEeccCCh-HHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-
Q 021711          102 LYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTA-DEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-  179 (308)
Q Consensus       102 ~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-  179 (308)
                      ..++....++|++.+.||+|+||.||+|.+..  .+|+|.+..... ....+.+.+|+.+++.++||||+++++++... 
T Consensus        25 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  102 (319)
T 2y4i_B           25 LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP  102 (319)
T ss_dssp             GGGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS
T ss_pred             cccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence            34445567899999999999999999999754  499999864322 22235677899999999999999999987765 


Q ss_pred             cEEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEecccccee
Q 021711          180 GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKW  259 (308)
Q Consensus       180 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~  259 (308)
                      ..++||||+++++|.+++......+++..+..++.|++.||.|||+   ++|+||||||+|||++ ++.+||+|||+++.
T Consensus       103 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~  178 (319)
T 2y4i_B          103 HLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSI  178 (319)
T ss_dssp             CEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHH---TTCCCCCCCSTTEEEC---CCEECCCSCCC-
T ss_pred             ceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChhhEEEe-CCCEEEeecCCccc
Confidence            5789999999999999997666679999999999999999999999   8999999999999998 67999999999876


Q ss_pred             cCCCCc---eeEeeceeccccccccccCch---------hhcCccceeEEEeeEEEeeccC
Q 021711          260 LPEQWT---HHTISKVEGTFGLVKLNLPPL---------VILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       260 ~~~~~~---~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ......   ........||+.|+|||....         ..++.++|+||+|+++|||++|
T Consensus       179 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g  239 (319)
T 2y4i_B          179 SGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAR  239 (319)
T ss_dssp             ---------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHS
T ss_pred             cccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhC
Confidence            532211   112234569999999998754         3357789999999999999875

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=2.2e-35  Score=272.17  Aligned_cols=189  Identities=20%  Similarity=0.211  Sum_probs=161.3

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCC-----------CCeeeeeeeEE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVD-----------HPNTAKLLGYG  176 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~  176 (308)
                      .++|++.+.||+|+||.||+|.+. +++.||||.+....  .....+.+|+.++..++           ||||+++++++
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~   95 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK--VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF   95 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc--cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHh
Confidence            468999999999999999999975 68999999987532  23467888999988876           89999999976


Q ss_pred             EeC-----cEEEEEEecCCCCHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCC-CceecCCCCCCEEEC-----
Q 021711          177 IEG-----GMHIVLELSPNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEGCQR-RIIHRDIKAANILLT-----  244 (308)
Q Consensus       177 ~~~-----~~~lv~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~-~iiHrDlKp~NILl~-----  244 (308)
                      ...     ..++|||++ +++|.+++... ...+++..+..++.||+.||.|||+   + +|+||||||+|||++     
T Consensus        96 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~~ivH~Dikp~NIll~~~~~~  171 (373)
T 1q8y_A           96 NHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR---RCGIIHTDIKPENVLMEIVDSP  171 (373)
T ss_dssp             EEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECSCCSGGGEEEEEEETT
T ss_pred             hccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHh---cCCEEecCCChHHeEEeccCCC
Confidence            643     467899999 88999998653 3458999999999999999999998   7 999999999999994     


Q ss_pred             -CCCcEEEeccccceecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          245 -EDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       245 -~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                       ..+.+||+|||+++.....     .....||+.|+|||.+.+..++.++|+||+|+++|||++|
T Consensus       172 ~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g  231 (373)
T 1q8y_A          172 ENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITG  231 (373)
T ss_dssp             TTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred             cCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhC
Confidence             4458999999999887543     2345799999999998888889999999999999999875

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=5.4e-35  Score=267.24  Aligned_cols=189  Identities=17%  Similarity=0.210  Sum_probs=159.4

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CC-cEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCe------eeeeeeEEEe-C
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NG-QLVAIKRLTRGTADEIIADFLSELGIMAHVDHPN------TAKLLGYGIE-G  179 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g-~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~-~  179 (308)
                      .++|++.+.||+|+||.||+|... ++ +.||+|.+...  ....+.+.+|+.+++.++|++      ++.+++++.. +
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~   95 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV--GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG   95 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETT
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc--ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCC
Confidence            468999999999999999999975 34 78999998753  234567888999999887665      8888887665 4


Q ss_pred             cEEEEEEecCCCCHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEE---------------
Q 021711          180 GMHIVLELSPNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILL---------------  243 (308)
Q Consensus       180 ~~~lv~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl---------------  243 (308)
                      ..++||||+ +++|.+.+... ...+++..+..++.||+.||.|||+   ++|+||||||+|||+               
T Consensus        96 ~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~  171 (355)
T 2eu9_A           96 HMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSC  171 (355)
T ss_dssp             EEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred             eEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecccccccccccccc
Confidence            578999999 56777766543 3569999999999999999999998   899999999999999               


Q ss_pred             ----CCCCcEEEeccccceecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          244 ----TEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       244 ----~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                          +.++.+||+|||+++......     ....||+.|+|||.+.+..++.++|+||+|+++|||++|
T Consensus       172 ~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g  235 (355)
T 2eu9_A          172 EEKSVKNTSIRVADFGSATFDHEHH-----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRG  235 (355)
T ss_dssp             CEEEESCCCEEECCCTTCEETTSCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred             cccccCCCcEEEeecCccccccccc-----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhC
Confidence                567899999999998754432     346799999999998888889999999999999999876

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=4.3e-35  Score=261.38  Aligned_cols=192  Identities=25%  Similarity=0.366  Sum_probs=163.2

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCCh-HHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA-DEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVL  185 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~  185 (308)
                      .++|++.+.||+|+||.||+|... +++.||+|.+..... ....+.+.+|+.+++.++||||+++++++... ..++|+
T Consensus        21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  100 (287)
T 2wei_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (287)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence            468999999999999999999986 689999999864322 22356789999999999999999999987765 478999


Q ss_pred             EecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCC---CcEEEeccccceecCC
Q 021711          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTED---FEPQICDFGLAKWLPE  262 (308)
Q Consensus       186 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~---~~~kl~DFGla~~~~~  262 (308)
                      ||+++++|.+.+.. ...+++..+..++.|++.||.|||+   ++|+||||||+||+++.+   +.+||+|||+++....
T Consensus       101 e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~  176 (287)
T 2wei_A          101 ELYTGGELFDEIIK-RKRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ  176 (287)
T ss_dssp             CCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCC
T ss_pred             EccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChhhEEEecCCCcccEEEeccCcceeecC
Confidence            99999999998864 3468999999999999999999999   899999999999999764   4799999999987654


Q ss_pred             CCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          263 QWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       263 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ...   .....||+.|+|||.+.+. .+.++|+||+|+++|+|++|
T Consensus       177 ~~~---~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g  218 (287)
T 2wei_A          177 NTK---MKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSG  218 (287)
T ss_dssp             CSS---CSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHS
T ss_pred             CCc---cccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhC
Confidence            322   2345699999999987653 77889999999999999875

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=5.3e-35  Score=263.77  Aligned_cols=194  Identities=24%  Similarity=0.344  Sum_probs=145.3

Q ss_pred             hcCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHH-HHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEE
Q 021711          108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEI-IADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIV  184 (308)
Q Consensus       108 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv  184 (308)
                      ..++|++.+.||+|+||.||+|.+. +|+.||||.+........ .+.+..+..+++.++||||+++++++... ..++|
T Consensus        23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv  102 (318)
T 2dyl_A           23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA  102 (318)
T ss_dssp             CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence            3468899999999999999999986 689999999976544333 33444455567888999999999987765 47899


Q ss_pred             EEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCC-CceecCCCCCCEEECCCCcEEEeccccceecCCC
Q 021711          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQR-RIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ  263 (308)
Q Consensus       185 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~-~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  263 (308)
                      |||+ ++.+..+.......+++..+..++.|++.||.|||+   . +|+||||||+|||++.++.+||+|||+++.+...
T Consensus       103 ~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  178 (318)
T 2dyl_A          103 MELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKE---KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD  178 (318)
T ss_dssp             ECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH---HHCCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred             Eecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHh---hCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence            9999 566666665556779999999999999999999997   5 8999999999999999999999999999876543


Q ss_pred             CceeEeeceeccccccccccCc-----hhhcCccceeEEEeeEEEeeccC
Q 021711          264 WTHHTISKVEGTFGLVKLNLPP-----LVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      .   ......||+.|+|||.+.     ....+.++|+||+|+++|||++|
T Consensus       179 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g  225 (318)
T 2dyl_A          179 K---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATG  225 (318)
T ss_dssp             -----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHS
T ss_pred             c---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhC
Confidence            2   223467999999999873     44567889999999999999875

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.7e-35  Score=266.93  Aligned_cols=194  Identities=24%  Similarity=0.305  Sum_probs=157.9

Q ss_pred             hhcCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChH-----HHHHHHHHHHHHHhcC----CCCeeeeeeeEE
Q 021711          107 SATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTAD-----EIIADFLSELGIMAHV----DHPNTAKLLGYG  176 (308)
Q Consensus       107 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~-----~~~~~~~~E~~~l~~l----~h~niv~l~~~~  176 (308)
                      ...++|++.+.||+|+||.||+|... +++.||||.+......     .....+.+|+.++..+    +||||+++++++
T Consensus        28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~  107 (312)
T 2iwi_A           28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF  107 (312)
T ss_dssp             -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred             hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence            44578999999999999999999875 6889999999654321     1234466799999888    899999999976


Q ss_pred             Ee-CcEEEEEEe-cCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEEC-CCCcEEEec
Q 021711          177 IE-GGMHIVLEL-SPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLT-EDFEPQICD  253 (308)
Q Consensus       177 ~~-~~~~lv~e~-~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~-~~~~~kl~D  253 (308)
                      .. +..++|+|+ +.+++|.+++.. ...+++..+..++.|++.||.|||+   ++|+||||||+||+++ .++.+||+|
T Consensus       108 ~~~~~~~~v~e~~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~kl~d  183 (312)
T 2iwi_A          108 ETQEGFMLVLERPLPAQDLFDYITE-KGPLGEGPSRCFFGQVVAAIQHCHS---RGVVHRDIKDENILIDLRRGCAKLID  183 (312)
T ss_dssp             -----CEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHH---HTEECCCCSGGGEEEETTTTEEEECC
T ss_pred             ecCCeEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChhhEEEeCCCCeEEEEE
Confidence            55 457899999 789999999965 4568999999999999999999999   8999999999999999 789999999


Q ss_pred             cccceecCCCCceeEeeceeccccccccccCchhhc-CccceeEEEeeEEEeeccC
Q 021711          254 FGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPLVIL-KRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       254 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~s~g~~l~el~c~  308 (308)
                      ||+++......    .....||..|+|||....... +.++|+||+|+++|||++|
T Consensus       184 fg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g  235 (312)
T 2iwi_A          184 FGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCG  235 (312)
T ss_dssp             CSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHS
T ss_pred             cchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHC
Confidence            99999876542    245679999999998766555 4479999999999999875

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=5.9e-35  Score=275.99  Aligned_cols=192  Identities=21%  Similarity=0.226  Sum_probs=151.2

Q ss_pred             hcCCccccceeeccCceEEEEEEECCCcEEEEEEeccCChHHHHHHHHHHHHHHhcC-CCCeeeeeeeEEEeCc-EEEEE
Q 021711          108 ATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGIEGG-MHIVL  185 (308)
Q Consensus       108 ~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~-~~lv~  185 (308)
                      ...+|.+.++||+|+||+|+.....+|+.||||++.....    ..+.+|+.+++.+ +|||||++++++.+.. .++||
T Consensus        22 ~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~----~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~   97 (432)
T 3p23_A           22 GKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF----SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAI   97 (432)
T ss_dssp             TTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE----EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH----HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEE
Confidence            3457899999999999997655556799999999865432    2345799999999 7999999999877654 68999


Q ss_pred             EecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECC-----CCcEEEeccccceec
Q 021711          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTE-----DFEPQICDFGLAKWL  260 (308)
Q Consensus       186 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~-----~~~~kl~DFGla~~~  260 (308)
                      ||+. |+|.+++......+....+..++.||+.||.|||+   ++|+||||||+|||++.     ...+||+|||+|+.+
T Consensus        98 E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~  173 (432)
T 3p23_A           98 ELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL  173 (432)
T ss_dssp             ECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHH---TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred             ECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHH---CcCEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence            9996 59999997655555555667899999999999999   89999999999999953     236889999999987


Q ss_pred             CCCCce-eEeeceeccccccccccCch---hhcCccceeEEEeeEEEeecc
Q 021711          261 PEQWTH-HTISKVEGTFGLVKLNLPPL---VILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       261 ~~~~~~-~~~~~~~gt~~y~aPE~~~~---~~~~~~~Di~s~g~~l~el~c  307 (308)
                      ...... .......||++|+|||.+.+   ...+.++|+||+|+++|||++
T Consensus       174 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt  224 (432)
T 3p23_A          174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVIS  224 (432)
T ss_dssp             ------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHT
T ss_pred             cCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHc
Confidence            543221 22345789999999998863   445678999999999999987

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=3e-35  Score=289.25  Aligned_cols=193  Identities=24%  Similarity=0.304  Sum_probs=166.4

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEe-------CcE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-------GGM  181 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-------~~~  181 (308)
                      ++|++.+.||+|+||.||+|.+. +|+.||||.+.........+.+.+|+.+++.++||||+++++++..       +..
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~   93 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP   93 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred             CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence            68999999999999999999875 5899999998766555667889999999999999999999987533       346


Q ss_pred             EEEEEecCCCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCc---EEEecccc
Q 021711          182 HIVLELSPNGSLASLLYGMK--EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFE---PQICDFGL  256 (308)
Q Consensus       182 ~lv~e~~~~gsL~~~l~~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~---~kl~DFGl  256 (308)
                      ++||||+++|+|.+++....  ..+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.   +||+|||+
T Consensus        94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs---~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~  170 (676)
T 3qa8_A           94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGY  170 (676)
T ss_dssp             CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHH---TTBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred             EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEeecCCCceeEEEccccc
Confidence            89999999999999997533  258888999999999999999999   89999999999999997764   99999999


Q ss_pred             ceecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          257 AKWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       257 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ++......   ......||+.|+|||.+.+..++.++|+||+|+++|+|++|
T Consensus       171 a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG  219 (676)
T 3qa8_A          171 AKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITG  219 (676)
T ss_dssp             CCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSS
T ss_pred             cccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHC
Confidence            99875542   22456899999999999888889999999999999999886

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=1.3e-34  Score=273.71  Aligned_cols=190  Identities=26%  Similarity=0.293  Sum_probs=146.4

Q ss_pred             CCccccceeeccCceEEEEEEECCCcEEEEEEeccCChHHHHHHHHHHHHHHhcC-CCCeeeeeeeEEEeCc-EEEEEEe
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGIEGG-MHIVLEL  187 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~-~~lv~e~  187 (308)
                      +.|...++||+|+||+||.+...+|+.||||.+....    .+.+.+|+.++..+ +||||+++++++.... .++||||
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~----~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~   90 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF----CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALEL   90 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG----HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred             heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH----HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEec
Confidence            4556678999999999987766689999999986532    34577899999876 8999999999877654 7899999


Q ss_pred             cCCCCHHHHHhccCCC------CCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCC-------------Cc
Q 021711          188 SPNGSLASLLYGMKEK------LKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTED-------------FE  248 (308)
Q Consensus       188 ~~~gsL~~~l~~~~~~------l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~-------------~~  248 (308)
                      +. |+|.+++......      ..+..++.++.||+.||.|||+   ++|+||||||+|||++.+             +.
T Consensus        91 ~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~  166 (434)
T 2rio_A           91 CN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLR  166 (434)
T ss_dssp             CS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred             CC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCcccccccccCCCceE
Confidence            96 6999999653221      1222356799999999999999   899999999999999754             48


Q ss_pred             EEEeccccceecCCCCcee--EeeceeccccccccccCch-------hhcCccceeEEEeeEEEeecc
Q 021711          249 PQICDFGLAKWLPEQWTHH--TISKVEGTFGLVKLNLPPL-------VILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       249 ~kl~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~~~~~Di~s~g~~l~el~c  307 (308)
                      +||+|||+++.+.......  ......||++|+|||.+.+       ...+.++|+||+|+++|||++
T Consensus       167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt  234 (434)
T 2rio_A          167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS  234 (434)
T ss_dssp             EEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHT
T ss_pred             EEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHh
Confidence            9999999999876543211  2235689999999998754       457888999999999999987

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.98  E-value=6.4e-33  Score=248.13  Aligned_cols=165  Identities=14%  Similarity=0.047  Sum_probs=142.4

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCCh--HHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIV  184 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv  184 (308)
                      .++|++.+.||+|+||.||+|.+. +|+.||||.+.....  .+..+.+.+|+.++..++||||+++++++... ..++|
T Consensus        30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  109 (286)
T 3uqc_A           30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV  109 (286)
T ss_dssp             TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence            368999999999999999999986 489999999975432  44568899999999999999999999987765 57899


Q ss_pred             EEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCC
Q 021711          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (308)
Q Consensus       185 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  264 (308)
                      |||+++++|.+++..  . .....+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+++|         
T Consensus       110 ~e~~~g~~L~~~l~~--~-~~~~~~~~i~~ql~~aL~~lH~---~givH~Dikp~NIll~~~g~~kl~~~~---------  174 (286)
T 3uqc_A          110 AEWIRGGSLQEVADT--S-PSPVGAIRAMQSLAAAADAAHR---AGVALSIDHPSRVRVSIDGDVVLAYPA---------  174 (286)
T ss_dssp             EECCCEEEHHHHHTT--C-CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEETTSCEEECSCC---------
T ss_pred             EEecCCCCHHHHHhc--C-CChHHHHHHHHHHHHHHHHHHH---CCCccCCCCcccEEEcCCCCEEEEecc---------
Confidence            999999999999843  2 4556788899999999999999   899999999999999999999998543         


Q ss_pred             ceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          265 THHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                                   |++|       .+.++|+||+|+++|||++|
T Consensus       175 -------------~~~~-------~~~~~Di~slG~il~elltg  198 (286)
T 3uqc_A          175 -------------TMPD-------ANPQDDIRGIGASLYALLVN  198 (286)
T ss_dssp             -------------CCTT-------CCHHHHHHHHHHHHHHHHHS
T ss_pred             -------------ccCC-------CCchhHHHHHHHHHHHHHHC
Confidence                         3443       46789999999999999876

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.98  E-value=6.3e-33  Score=270.36  Aligned_cols=182  Identities=15%  Similarity=0.112  Sum_probs=127.7

Q ss_pred             eeeccCceEEEEEE-ECCCcEEEEEEeccCC---------hHHHHHHHHHHHHHHhcC-CCCeeeeeeeEEEeC-cEEEE
Q 021711          117 LIGKGGYAEVYKGR-LRNGQLVAIKRLTRGT---------ADEIIADFLSELGIMAHV-DHPNTAKLLGYGIEG-GMHIV  184 (308)
Q Consensus       117 ~LG~G~fg~Vy~~~-~~~g~~vAvK~~~~~~---------~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~~~lv  184 (308)
                      ..+.|++|.+..++ ...|+.+|+|.+....         .+...++|.+|+++|+++ .|+||+++++++.++ ..|||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            35667777666654 3358899999986532         122456799999999999 799999999988765 58999


Q ss_pred             EEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCC
Q 021711          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (308)
Q Consensus       185 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  264 (308)
                      |||++|++|.+++.. .+.++..   .|+.||+.||.|+|+   ++||||||||+|||++.+|.+||+|||+|+.+....
T Consensus       321 MEyv~G~~L~d~i~~-~~~l~~~---~I~~QIl~AL~ylH~---~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~  393 (569)
T 4azs_A          321 MEKLPGRLLSDMLAA-GEEIDRE---KILGSLLRSLAALEK---QGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC  393 (569)
T ss_dssp             EECCCSEEHHHHHHT-TCCCCHH---HHHHHHHHHHHHHHH---TTCEESCCCGGGEEECTTSCEEECCCTTEESCC---
T ss_pred             EecCCCCcHHHHHHh-CCCCCHH---HHHHHHHHHHHHHHH---CCceeccCchHhEEECCCCCEEEeecccCeeCCCCC
Confidence            999999999999964 4556654   478999999999999   999999999999999999999999999999876543


Q ss_pred             ceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          265 THHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      .  ......||++|||||.+.+. .....|+||+|++++++.++
T Consensus       394 ~--~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~  434 (569)
T 4azs_A          394 S--WPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQP  434 (569)
T ss_dssp             C--CSHHHHHHHHHHHHHHC------------------CCCCTT
T ss_pred             c--cccCceechhhccHHHhCCC-CCCcccccccccchhhhccc
Confidence            2  23467899999999998754 45567999999999988653

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.98  E-value=8.8e-34  Score=266.42  Aligned_cols=192  Identities=12%  Similarity=0.111  Sum_probs=146.4

Q ss_pred             hhcCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChH--HHHHHHHHHHHHHhcCCC-Cee-------------
Q 021711          107 SATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTAD--EIIADFLSELGIMAHVDH-PNT-------------  169 (308)
Q Consensus       107 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~--~~~~~~~~E~~~l~~l~h-~ni-------------  169 (308)
                      ....+|...++||+|+||.||+|.+. +|+.||||++......  ...+.+.+|+.++..++| +|.             
T Consensus        75 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~  154 (413)
T 3dzo_A           75 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF  154 (413)
T ss_dssp             SCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCC
T ss_pred             CCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccch
Confidence            34456888899999999999999965 6999999998743322  225678899999999977 211             


Q ss_pred             --eee------eeEEEe------CcEEEEEEecCCCCHHHHHhc------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 021711          170 --AKL------LGYGIE------GGMHIVLELSPNGSLASLLYG------MKEKLKWGIRYKIALGVAEGLLYLHEGCQR  229 (308)
Q Consensus       170 --v~l------~~~~~~------~~~~lv~e~~~~gsL~~~l~~------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~  229 (308)
                        +.+      ..+...      ...+++|++ .+++|.+++..      ....+++..++.++.|++.||.|||+   +
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~  230 (413)
T 3dzo_A          155 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPR-MQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---Y  230 (413)
T ss_dssp             EEEECCC---------------CCSEEEEEEC-CSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---T
T ss_pred             hhcccCCCCccccccCCCccccccceEEEeeh-hcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh---C
Confidence              111      111111      123455554 46899998842      23447788889999999999999999   9


Q ss_pred             CceecCCCCCCEEECCCCcEEEeccccceecCCCCceeEeeceeccccccccccC----------chhhcCccceeEEEe
Q 021711          230 RIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNLP----------PLVILKRCFTCIFIG  299 (308)
Q Consensus       230 ~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~Di~s~g  299 (308)
                      +|+||||||+|||++.++.+||+|||+++.....     .....| +.|+|||.+          ....++.++|+||||
T Consensus       231 ~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlG  304 (413)
T 3dzo_A          231 GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLG  304 (413)
T ss_dssp             TEECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHH
T ss_pred             CcccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHH
Confidence            9999999999999999999999999999875432     345677 999999988          444567799999999


Q ss_pred             eEEEeeccC
Q 021711          300 FSQLQLSCS  308 (308)
Q Consensus       300 ~~l~el~c~  308 (308)
                      +++|||++|
T Consensus       305 vil~elltg  313 (413)
T 3dzo_A          305 LAIYWIWCA  313 (413)
T ss_dssp             HHHHHHHHS
T ss_pred             HHHHHHHHC
Confidence            999999876

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=99.97  E-value=8e-32  Score=241.82  Aligned_cols=166  Identities=21%  Similarity=0.279  Sum_probs=141.4

Q ss_pred             CCcccc-ceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHH-hcCCCCeeeeeeeEEEe-----CcE
Q 021711          110 NNFSFE-NLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIM-AHVDHPNTAKLLGYGIE-----GGM  181 (308)
Q Consensus       110 ~~~~~~-~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~-----~~~  181 (308)
                      ++|.+. ++||+|+||.||+|... +++.||+|.+...      ..+.+|+.++ +.++||||+++++++..     ...
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   90 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   90 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence            567776 78999999999999975 6899999998642      3456788887 66699999999997654     347


Q ss_pred             EEEEEecCCCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECC---CCcEEEeccccc
Q 021711          182 HIVLELSPNGSLASLLYGMK-EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTE---DFEPQICDFGLA  257 (308)
Q Consensus       182 ~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~---~~~~kl~DFGla  257 (308)
                      ++||||+++|+|.+++.... ..+++..+..++.|++.||.|||+   ++|+||||||+|||++.   ++.+||+|||++
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a  167 (299)
T 3m2w_A           91 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA  167 (299)
T ss_dssp             EEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred             EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence            89999999999999997643 469999999999999999999999   89999999999999998   788999999999


Q ss_pred             eecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          258 KWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      +....                        ..++.++|+||+|+++|||++|
T Consensus       168 ~~~~~------------------------~~~~~~~DiwslG~il~el~tg  194 (299)
T 3m2w_A          168 KETTG------------------------EKYDKSCDMWSLGVIMYILLCG  194 (299)
T ss_dssp             EECTT------------------------CGGGGHHHHHHHHHHHHHHHHS
T ss_pred             ccccc------------------------ccCCchhhHHHHHHHHHHHHHC
Confidence            76432                        2245678999999999999875

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.95  E-value=2e-29  Score=244.29  Aligned_cols=173  Identities=19%  Similarity=0.134  Sum_probs=131.3

Q ss_pred             cccceeeccCceEEEEEEECCCcEEEEEEeccCCh--H-----HHHHHHHHHHHHHhcCCCCeeeeeeeEEE-eCcEEEE
Q 021711          113 SFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTA--D-----EIIADFLSELGIMAHVDHPNTAKLLGYGI-EGGMHIV  184 (308)
Q Consensus       113 ~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~--~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~lv  184 (308)
                      ...++||+|+||.||+|.. .+..+|+|.......  .     ...+++.+|+.++++++||||+++..++. ....++|
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            3457899999999999954 578889998643221  1     12456899999999999999996554443 4457999


Q ss_pred             EEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCC
Q 021711          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (308)
Q Consensus       185 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  264 (308)
                      |||+++++|.+++..         +..++.|++.||.|||+   ++|+||||||+|||++.  .+||+|||+|+......
T Consensus       418 mE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~---~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~  483 (540)
T 3en9_A          418 MSYINGKLAKDVIED---------NLDIAYKIGEIVGKLHK---NDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDE  483 (540)
T ss_dssp             EECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHH---TTEECTTCCTTSEEESS--SEEECCCTTCEECCCHH
T ss_pred             EECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHH---CcCccCCCCHHHEEECC--eEEEEECccCEECCCcc
Confidence            999999999999854         45789999999999999   89999999999999999  99999999999876532


Q ss_pred             cee-----EeeceeccccccccccCch--hhcCccceeEEEee
Q 021711          265 THH-----TISKVEGTFGLVKLNLPPL--VILKRCFTCIFIGF  300 (308)
Q Consensus       265 ~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~s~g~  300 (308)
                      ...     ......||+.|||||++..  ..++..+|.|+.++
T Consensus       484 ~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl  526 (540)
T 3en9_A          484 DKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIIL  526 (540)
T ss_dssp             HHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHH
T ss_pred             ccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHH
Confidence            211     1236789999999999877  34667788887654

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.94  E-value=1.2e-26  Score=207.16  Aligned_cols=143  Identities=16%  Similarity=0.122  Sum_probs=116.7

Q ss_pred             HHHHhhcCCccccceeeccCceEEEEEEECCCcEEEEEEeccCChH-----------------HHHHHHHHHHHHHhcCC
Q 021711          103 YELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTAD-----------------EIIADFLSELGIMAHVD  165 (308)
Q Consensus       103 ~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~-----------------~~~~~~~~E~~~l~~l~  165 (308)
                      ..+......|.+.+.||+|+||.||+|.+.+|+.||+|.+......                 .....+.+|+.+++.++
T Consensus        83 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~  162 (282)
T 1zar_A           83 HRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ  162 (282)
T ss_dssp             HHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc
Confidence            3444556678888999999999999999977999999998643211                 13567899999999998


Q ss_pred             CCeeeeeeeEEEeCcEEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECC
Q 021711          166 HPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTE  245 (308)
Q Consensus       166 h~niv~l~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~  245 (308)
                        | +++.+++..+..++||||+++++|.+ +..       .....++.|++.||.|||+   .+|+||||||+|||++ 
T Consensus       163 --~-~~v~~~~~~~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH~---~giiHrDlkp~NILl~-  227 (282)
T 1zar_A          163 --G-LAVPKVYAWEGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVS-  227 (282)
T ss_dssp             --T-SSSCCEEEEETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEE-
T ss_pred             --C-CCcCeEEeccceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHHH---CCCEeCCCCHHHEEEE-
Confidence              4 66666666677899999999999987 421       2234689999999999999   9999999999999999 


Q ss_pred             CCcEEEeccccceec
Q 021711          246 DFEPQICDFGLAKWL  260 (308)
Q Consensus       246 ~~~~kl~DFGla~~~  260 (308)
                      ++.+||+|||+|+..
T Consensus       228 ~~~vkl~DFG~a~~~  242 (282)
T 1zar_A          228 EEGIWIIDFPQSVEV  242 (282)
T ss_dssp             TTEEEECCCTTCEET
T ss_pred             CCcEEEEECCCCeEC
Confidence            999999999999743

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.88  E-value=3.3e-23  Score=182.39  Aligned_cols=141  Identities=20%  Similarity=0.178  Sum_probs=108.7

Q ss_pred             CCccccceeeccCceEEEEEEE-CCCcE--EEEEEeccCChH-----------------------HHHHHHHHHHHHHhc
Q 021711          110 NNFSFENLIGKGGYAEVYKGRL-RNGQL--VAIKRLTRGTAD-----------------------EIIADFLSELGIMAH  163 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~-~~g~~--vAvK~~~~~~~~-----------------------~~~~~~~~E~~~l~~  163 (308)
                      .-|.+.+.||+|+||.||+|.+ .+|+.  ||||.+......                       .....+.+|+.++..
T Consensus        47 ~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~  126 (258)
T 1zth_A           47 YITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLER  126 (258)
T ss_dssp             SEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHH
T ss_pred             CchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHH
Confidence            3467889999999999999998 57888  999987543110                       112468899999999


Q ss_pred             CCCCee--eeeeeEEEeCcEEEEEEecCC-C----CHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCceecC
Q 021711          164 VDHPNT--AKLLGYGIEGGMHIVLELSPN-G----SLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH-EGCQRRIIHRD  235 (308)
Q Consensus       164 l~h~ni--v~l~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH-~~~~~~iiHrD  235 (308)
                      ++|+++  +.++++   ...++||||+.+ |    +|.+....    .++..+..++.|++.||.||| +   .+|+|||
T Consensus       127 l~~~~i~~p~~~~~---~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~---~givHrD  196 (258)
T 1zth_A          127 AKEAGVSVPQPYTY---MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQE---AELVHAD  196 (258)
T ss_dssp             HHHTTCCCCCEEEE---ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHT---SCEECSS
T ss_pred             HHhCCCCCCeEEEc---CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHH---CCEEeCC
Confidence            988764  333332   356899999942 3    77766532    223456788999999999999 8   8999999


Q ss_pred             CCCCCEEECCCCcEEEeccccceecCC
Q 021711          236 IKAANILLTEDFEPQICDFGLAKWLPE  262 (308)
Q Consensus       236 lKp~NILl~~~~~~kl~DFGla~~~~~  262 (308)
                      |||+|||++.  .++|+|||+|.....
T Consensus       197 lkp~NILl~~--~~~liDFG~a~~~~~  221 (258)
T 1zth_A          197 LSEYNIMYID--KVYFIDMGQAVTLRH  221 (258)
T ss_dssp             CSTTSEEESS--SEEECCCTTCEETTS
T ss_pred             CCHHHEEEcC--cEEEEECcccccCCC
Confidence            9999999998  999999999987643

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.77  E-value=6.5e-19  Score=162.67  Aligned_cols=147  Identities=16%  Similarity=0.146  Sum_probs=102.0

Q ss_pred             HHHHhhcCCccccceeeccCceEEEEEEECCCcEEEEEEeccCCh-------------H----H----HHHHHHHHHHHH
Q 021711          103 YELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTA-------------D----E----IIADFLSELGIM  161 (308)
Q Consensus       103 ~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~-------------~----~----~~~~~~~E~~~l  161 (308)
                      +.+.....-|++...||+|+||.||+|...+|+.||||+++....             .    .    ......+|...|
T Consensus        88 ~~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL  167 (397)
T 4gyi_A           88 HTHAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFM  167 (397)
T ss_dssp             HHHHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHH
Confidence            334444445899999999999999999988899999998743210             0    0    011123455566


Q ss_pred             hcCCCCeeeeeeeEEEeCcEEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCE
Q 021711          162 AHVDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANI  241 (308)
Q Consensus       162 ~~l~h~niv~l~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NI  241 (308)
                      .++.+.++....-+.. ...+|||||+.|++|..+..     .  .....++.|++.+|.|||.   .+||||||||.||
T Consensus       168 ~rL~~~gv~vp~p~~~-~~~~LVME~i~G~~L~~l~~-----~--~~~~~l~~qll~~l~~lH~---~gIVHrDLKp~NI  236 (397)
T 4gyi_A          168 KALYEEGFPVPEPIAQ-SRHTIVMSLVDALPMRQVSS-----V--PDPASLYADLIALILRLAK---HGLIHGDFNEFNI  236 (397)
T ss_dssp             HHHHHTTCSCCCEEEE-ETTEEEEECCSCEEGGGCCC-----C--SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSE
T ss_pred             HHHHhcCCCCCeeeec-cCceEEEEecCCccHhhhcc-----c--HHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHE
Confidence            6654433322111222 23379999999988765431     1  1234678999999999998   8999999999999


Q ss_pred             EECCCC----------cEEEeccccceec
Q 021711          242 LLTEDF----------EPQICDFGLAKWL  260 (308)
Q Consensus       242 Ll~~~~----------~~kl~DFGla~~~  260 (308)
                      |+++++          .+.|+||+-+...
T Consensus       237 Ll~~dgd~~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          237 LIREEKDAEDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             EEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred             EEeCCCCcccccccccceEEEEeCCcccC
Confidence            998876          3899999977643

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.38  E-value=2.2e-12  Score=112.70  Aligned_cols=145  Identities=14%  Similarity=0.054  Sum_probs=108.8

Q ss_pred             hcCCccccceeeccCceEEEEEEECCCcEEEEEEeccCChHHHHHHHHHHHHHHhcCC-CCeeeeeeeEEEeC-cEEEEE
Q 021711          108 ATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVD-HPNTAKLLGYGIEG-GMHIVL  185 (308)
Q Consensus       108 ~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~-~~~lv~  185 (308)
                      ....|.+...++.|+.+.||++... ++.+++|........ ....+.+|+.+++.+. +..+.++++++... ..++||
T Consensus        12 ~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~-~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~   89 (263)
T 3tm0_A           12 LIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKG-TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM   89 (263)
T ss_dssp             HHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTT-STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred             HhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCC-CHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEE
Confidence            3457888888999999999999754 688999998642111 1235778999998884 67788888877665 468999


Q ss_pred             EecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---------------------------------------
Q 021711          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEG---------------------------------------  226 (308)
Q Consensus       186 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~---------------------------------------  226 (308)
                      |+++|.+|.+.+.      +......++.+++.+|..||+.                                       
T Consensus        90 e~i~G~~l~~~~~------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (263)
T 3tm0_A           90 SEADGVLCSEEYE------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP  163 (263)
T ss_dssp             ECCSSEEHHHHCC------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred             EecCCeehhhccC------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence            9999999987631      1112346788899999999971                                       


Q ss_pred             -----------------CCCCceecCCCCCCEEECCCCcEEEeccccceec
Q 021711          227 -----------------CQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL  260 (308)
Q Consensus       227 -----------------~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~  260 (308)
                                       ....++|+|++|.|||++++..+.|+||+.+..-
T Consensus       164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~g  214 (263)
T 3tm0_A          164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRA  214 (263)
T ss_dssp             SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred             CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcccC
Confidence                             0134899999999999987656679999988654

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.30  E-value=6e-12  Score=109.18  Aligned_cols=139  Identities=15%  Similarity=0.111  Sum_probs=97.9

Q ss_pred             CCccccceeeccCceEEEEEEECCCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCe--eeeeeeEEEeC-cEEEEEE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPN--TAKLLGYGIEG-GMHIVLE  186 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~-~~~lv~e  186 (308)
                      .++.+..+.+.|..+.||++...+|..+++|......    ...+.+|+.+++.+.+.+  +.+++++...+ ..++|||
T Consensus        20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~----~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e   95 (264)
T 1nd4_A           20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLG   95 (264)
T ss_dssp             TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCT----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEE
T ss_pred             CCCceEecccCCCCceEEEEecCCCCeEEEEeCCccc----chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEE
Confidence            3455544444566799999987677889999876542    234668888888885444  45577766554 5789999


Q ss_pred             ecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------
Q 021711          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC---------------------------------------  227 (308)
Q Consensus       187 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~---------------------------------------  227 (308)
                      |++|.+|.  ..    ....   ..++.+++..|..||...                                       
T Consensus        96 ~i~G~~l~--~~----~~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (264)
T 1nd4_A           96 EVPGQDLL--SS----HLAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLA  166 (264)
T ss_dssp             CCSSEETT--TS----CCCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCC
T ss_pred             ecCCcccC--cC----cCCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCcc
Confidence            99998874  21    1121   245677777888888621                                       


Q ss_pred             ----------------CCCceecCCCCCCEEECCCCcEEEeccccceecC
Q 021711          228 ----------------QRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP  261 (308)
Q Consensus       228 ----------------~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~  261 (308)
                                      ...++|+|++|.|||++.++.+.|+|||.+...+
T Consensus       167 ~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~g~  216 (264)
T 1nd4_A          167 PAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVAD  216 (264)
T ss_dssp             HHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEEE
T ss_pred             HHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcccCC
Confidence                            1129999999999999877667799999987654

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.20  E-value=4.7e-11  Score=109.22  Aligned_cols=142  Identities=13%  Similarity=0.091  Sum_probs=103.5

Q ss_pred             cceeeccCceEEEEEEECCCcEEEEEEec--cCChHHHHHHHHHHHHHHhcCC--CCeeeeeeeEEEeC----cEEEEEE
Q 021711          115 ENLIGKGGYAEVYKGRLRNGQLVAIKRLT--RGTADEIIADFLSELGIMAHVD--HPNTAKLLGYGIEG----GMHIVLE  186 (308)
Q Consensus       115 ~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~--~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~----~~~lv~e  186 (308)
                      .+.|+.|.++.||+.... +..+++|+..  ..........+.+|..+++.+.  +..+++++.++.+.    ..++|||
T Consensus        43 ~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme  121 (359)
T 3dxp_A           43 VEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME  121 (359)
T ss_dssp             EEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred             EEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence            467899999999998875 4578888765  3321122356778999999886  45577888877654    2689999


Q ss_pred             ecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------
Q 021711          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC---------------------------------------  227 (308)
Q Consensus       187 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~---------------------------------------  227 (308)
                      +++|..+.+..   ...++......++.+++..|..||...                                       
T Consensus       122 ~v~G~~l~~~~---~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  198 (359)
T 3dxp_A          122 FVSGRVLWDQS---LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMD  198 (359)
T ss_dssp             CCCCBCCCCTT---CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHH
T ss_pred             ecCCeecCCCc---cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHH
Confidence            99987764311   234677788889999999999999721                                       


Q ss_pred             ----------------CCCceecCCCCCCEEECCCCc--EEEeccccceec
Q 021711          228 ----------------QRRIIHRDIKAANILLTEDFE--PQICDFGLAKWL  260 (308)
Q Consensus       228 ----------------~~~iiHrDlKp~NILl~~~~~--~kl~DFGla~~~  260 (308)
                                      ...++|+|++|.|||++.++.  +.|+||+.+..-
T Consensus       199 ~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g  249 (359)
T 3dxp_A          199 SLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG  249 (359)
T ss_dssp             HHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred             HHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence                            246999999999999997753  689999998753

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.69  E-value=3.5e-08  Score=87.94  Aligned_cols=137  Identities=19%  Similarity=0.176  Sum_probs=96.2

Q ss_pred             cceeeccCceEEEEEEECCCcEEEEEEeccCChHHHHHHHHHHHHHHhcCC-CCe--eeeeeeEEEeCc----EEEEEEe
Q 021711          115 ENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVD-HPN--TAKLLGYGIEGG----MHIVLEL  187 (308)
Q Consensus       115 ~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~l~~~~~~~~----~~lv~e~  187 (308)
                      .+.++.|....||+..    ..+++|.....   .....+.+|..++..+. +..  +.+++.+.....    .|+||++
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~---~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~   97 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKHS---RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK   97 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESSH---HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCCc---chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence            3568999999999864    45888875432   33567889999998873 332  334444433322    3789999


Q ss_pred             cCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC-----------------------------------------
Q 021711          188 SPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEG-----------------------------------------  226 (308)
Q Consensus       188 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~-----------------------------------------  226 (308)
                      ++|.+|.....   ..++......++.+++..|..||..                                         
T Consensus        98 i~G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  174 (304)
T 3sg8_A           98 IKGVPLTPLLL---NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD  174 (304)
T ss_dssp             CCCEECCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred             cCCeECCcccc---ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence            99988765332   2356666777788888888888751                                         


Q ss_pred             --------------CCCCceecCCCCCCEEECC--CCcEEEeccccceecC
Q 021711          227 --------------CQRRIIHRDIKAANILLTE--DFEPQICDFGLAKWLP  261 (308)
Q Consensus       227 --------------~~~~iiHrDlKp~NILl~~--~~~~kl~DFGla~~~~  261 (308)
                                    ....++|+|++|.||+++.  ...+.|+||+.+..-.
T Consensus       175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~  225 (304)
T 3sg8_A          175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISD  225 (304)
T ss_dssp             HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEEC
T ss_pred             HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCC
Confidence                          0134799999999999998  4567899999987643

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.65  E-value=3.6e-07  Score=81.68  Aligned_cols=136  Identities=17%  Similarity=0.100  Sum_probs=89.8

Q ss_pred             ceeeccCceEEEEEEECCCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCC---eeeeeeeEEE--eCcEEEEEEecCC
Q 021711          116 NLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHP---NTAKLLGYGI--EGGMHIVLELSPN  190 (308)
Q Consensus       116 ~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~--~~~~~lv~e~~~~  190 (308)
                      +.++.|....||+.    |..+++|+-..   ......+.+|..+|..+.+.   .+.+++.++.  .+..++||++++|
T Consensus        25 ~~l~~G~~n~v~~v----g~~~VlR~~~~---~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G   97 (306)
T 3tdw_A           25 ESLGEGFRNYAILV----NGDWVFRFPKS---QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG   97 (306)
T ss_dssp             EEEEECSSEEEEEE----TTTEEEEEESS---HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred             eecCCCcceeEEEE----CCEEEEEecCC---chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence            56788888899987    45678887422   23456788999999998642   3455666654  2347899999999


Q ss_pred             CCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC--------------------------------------------
Q 021711          191 GSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEG--------------------------------------------  226 (308)
Q Consensus       191 gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~--------------------------------------------  226 (308)
                      .++.....   ..++......++.+++..|..||..                                            
T Consensus        98 ~~l~~~~~---~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~  174 (306)
T 3tdw_A           98 QILGEDGM---AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTL  174 (306)
T ss_dssp             EECHHHHH---TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHH
T ss_pred             eECchhhh---hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHH
Confidence            87765321   1223333334444444444444431                                            


Q ss_pred             -------------CCCCceecCCCCCCEEECC---CCc-EEEeccccceecC
Q 021711          227 -------------CQRRIIHRDIKAANILLTE---DFE-PQICDFGLAKWLP  261 (308)
Q Consensus       227 -------------~~~~iiHrDlKp~NILl~~---~~~-~kl~DFGla~~~~  261 (308)
                                   .+..++|+|++|.|||++.   ++. +.|+||+.+..-.
T Consensus       175 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd  226 (306)
T 3tdw_A          175 RFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISD  226 (306)
T ss_dssp             HHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEEC
T ss_pred             HHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCC
Confidence                         1235799999999999997   455 4899999887643

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.31  E-value=1e-05  Score=70.25  Aligned_cols=135  Identities=14%  Similarity=0.057  Sum_probs=89.7

Q ss_pred             eeeccCce-EEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCC-CCeeeeeeeEEEeC-cEEEEEEecCCCC
Q 021711          117 LIGKGGYA-EVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVD-HPNTAKLLGYGIEG-GMHIVLELSPNGS  192 (308)
Q Consensus       117 ~LG~G~fg-~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~-~~~lv~e~~~~gs  192 (308)
                      .+..|..| .||+.... ++..+++|.-...    ....+.+|..+|+.+. +--+.++++++.++ ..++|||+++|.+
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~  106 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS----VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT  106 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETH----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCC----CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence            34445544 68987765 4567888976432    2356778988888774 33356777777665 4689999999988


Q ss_pred             HHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------------
Q 021711          193 LASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC---------------------------------------------  227 (308)
Q Consensus       193 L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~---------------------------------------------  227 (308)
                      +.+.....     ......++.+++..|.-||...                                             
T Consensus       107 ~~~~~~~~-----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  181 (272)
T 4gkh_A          107 AFQVLEEY-----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK  181 (272)
T ss_dssp             HHHHHHHC-----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred             ccccccCC-----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence            77654221     1112234455555555555310                                             


Q ss_pred             ----------CCCceecCCCCCCEEECCCCcEEEeccccceec
Q 021711          228 ----------QRRIIHRDIKAANILLTEDFEPQICDFGLAKWL  260 (308)
Q Consensus       228 ----------~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~  260 (308)
                                ...++|+|+.+.|||++.++.+-|+||+.+..-
T Consensus       182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~g  224 (272)
T 4gkh_A          182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIA  224 (272)
T ss_dssp             HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred             HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccccC
Confidence                      112799999999999998777789999998764

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.31  E-value=1.6e-06  Score=80.06  Aligned_cols=76  Identities=14%  Similarity=0.063  Sum_probs=48.3

Q ss_pred             cceeeccCceEEEEEEEC-CCcEEEEEEeccCCh---H---HHHHHHHHHHHHHhcCCC--Ce-eeeeeeEEEeCcEEEE
Q 021711          115 ENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA---D---EIIADFLSELGIMAHVDH--PN-TAKLLGYGIEGGMHIV  184 (308)
Q Consensus       115 ~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~---~---~~~~~~~~E~~~l~~l~h--~n-iv~l~~~~~~~~~~lv  184 (308)
                      .+.||.|.++.||++... +++.+++|.......   +   ....++..|.+++..+..  +. +.+++.+ .....++|
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~-d~~~~~lv  113 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS-DTEMAVTV  113 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE-ETTTTEEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE-cCCccEEE
Confidence            467999999999999754 467899998643211   0   012456678888877632  33 4455544 34456899


Q ss_pred             EEecCCC
Q 021711          185 LELSPNG  191 (308)
Q Consensus       185 ~e~~~~g  191 (308)
                      ||++++.
T Consensus       114 mE~l~g~  120 (397)
T 2olc_A          114 MEDLSHL  120 (397)
T ss_dssp             ECCCTTS
T ss_pred             EEeCCCc
Confidence            9999763

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.19  E-value=1.8e-05  Score=70.91  Aligned_cols=33  Identities=21%  Similarity=0.289  Sum_probs=29.2

Q ss_pred             CCCceecCCCCCCEEECCCCcEEEeccccceec
Q 021711          228 QRRIIHRDIKAANILLTEDFEPQICDFGLAKWL  260 (308)
Q Consensus       228 ~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~  260 (308)
                      +..++|+|+++.|||++.++.+.|+||+.+..-
T Consensus       221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~g  253 (346)
T 2q83_A          221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTVSFD  253 (346)
T ss_dssp             SCCEECSSCSTTSEEECGGGCEEECCCTTCEEC
T ss_pred             cCceecCCCCcccEEEeCCCcEEEEehhhcccC
Confidence            367999999999999988888999999988654

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.13  E-value=7.5e-06  Score=74.25  Aligned_cols=79  Identities=9%  Similarity=-0.027  Sum_probs=50.9

Q ss_pred             ccee-eccCceEEEEEEEC-------CCcEEEEEEeccCCh--HHHHHHHHHHHHHHhcCC-C--CeeeeeeeEEEeC--
Q 021711          115 ENLI-GKGGYAEVYKGRLR-------NGQLVAIKRLTRGTA--DEIIADFLSELGIMAHVD-H--PNTAKLLGYGIEG--  179 (308)
Q Consensus       115 ~~~L-G~G~fg~Vy~~~~~-------~g~~vAvK~~~~~~~--~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~--  179 (308)
                      .+.| +.|....+|+....       ++..+++|.......  ......+.+|..+++.+. +  -.+.+++.++.+.  
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence            3567 78888999988754       256788887643220  000134567777777764 2  3466777776554  


Q ss_pred             --cEEEEEEecCCCCH
Q 021711          180 --GMHIVLELSPNGSL  193 (308)
Q Consensus       180 --~~~lv~e~~~~gsL  193 (308)
                        ..++|||+++|..+
T Consensus       105 ~g~~~~v~e~l~G~~l  120 (357)
T 3ats_A          105 LGTPFFLMDYVEGVVP  120 (357)
T ss_dssp             TSSCEEEEECCCCBCC
T ss_pred             cCCceEEEEecCCCCh
Confidence              35899999988654

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.93  E-value=4.3e-05  Score=67.20  Aligned_cols=78  Identities=13%  Similarity=0.172  Sum_probs=53.9

Q ss_pred             CccccceeeccCceEEEEEEECCCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCC---CeeeeeeeEEEeCcEEEEEEe
Q 021711          111 NFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDH---PNTAKLLGYGIEGGMHIVLEL  187 (308)
Q Consensus       111 ~~~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~~~~~lv~e~  187 (308)
                      ...-.+.+|.|..+.||+....+|+.|.+|+....... ....|.+|...|+.|.-   --+.+++++   +..++|||+
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~-~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~---~~~~lv~e~   91 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPA-LDGLFRAEALGLDWLGRSFGSPVPQVAGW---DDRTLAMEW   91 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCC-CTTHHHHHHHHHHHHTCSTTCCSCCEEEE---ETTEEEEEC
T ss_pred             CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcc-hhhHHHHHHHHHHHHHhhCCCCcceEEec---cCceEEEEe
Confidence            44556789999999999999999999999986543221 12346688888887742   123444443   234789999


Q ss_pred             cCCCC
Q 021711          188 SPNGS  192 (308)
Q Consensus       188 ~~~gs  192 (308)
                      +.++.
T Consensus        92 l~~~~   96 (288)
T 3f7w_A           92 VDERP   96 (288)
T ss_dssp             CCCCC
T ss_pred             ecccC
Confidence            87654

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.78  E-value=0.00015  Score=67.28  Aligned_cols=32  Identities=25%  Similarity=0.507  Sum_probs=28.6

Q ss_pred             CCceecCCCCCCEEECCCCcEEEeccccceecC
Q 021711          229 RRIIHRDIKAANILLTEDFEPQICDFGLAKWLP  261 (308)
Q Consensus       229 ~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~  261 (308)
                      ..++|+|++|.|||++.++ +.|+||+.+.+-+
T Consensus       232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~  263 (420)
T 2pyw_A          232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGP  263 (420)
T ss_dssp             CEEECSCCSGGGEEECSSC-EEECCCTTCEEEC
T ss_pred             CeEEecCCCCCcEEEeCCC-CEEEeCcccccCc
Confidence            6799999999999999876 9999999988653

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.64  E-value=0.00036  Score=62.32  Aligned_cols=135  Identities=19%  Similarity=0.191  Sum_probs=86.0

Q ss_pred             cceeeccCceEEEEEEECCCcEEEEEEeccCChHHHHHHHHHHHHHHhcCC---CCeeeeeeeEEEeC-cEEEEEEecCC
Q 021711          115 ENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVD---HPNTAKLLGYGIEG-GMHIVLELSPN  190 (308)
Q Consensus       115 ~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~-~~~lv~e~~~~  190 (308)
                      .+.|+.|....+|+... ++..+++|......    ...+.+|...|+.|.   ...+++++.++... ..++|||++++
T Consensus        41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~~----~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G  115 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLIND-EVQTVFVKINERSY----RSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK  115 (312)
T ss_dssp             EEEECCSSSSEEEEEES-SSCEEEEEEEEGGG----HHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred             eEEeCCccceeeeEEEE-CCCeEEEEeCCccc----HHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence            45789999999999876 46778889865431    356778888888773   35677888876543 47899999998


Q ss_pred             CCH--------HHH---HhccCC--C-------------------CCHHHHH---HHH----------------HHHHHH
Q 021711          191 GSL--------ASL---LYGMKE--K-------------------LKWGIRY---KIA----------------LGVAEG  219 (308)
Q Consensus       191 gsL--------~~~---l~~~~~--~-------------------l~~~~~~---~i~----------------~qi~~~  219 (308)
                      ..+        ...   |+....  .                   -+|....   ++.                ..++..
T Consensus       116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~  195 (312)
T 3jr1_A          116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI  195 (312)
T ss_dssp             CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred             CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence            753        111   222111  0                   1343321   111                111222


Q ss_pred             H-HHHHh-CCCCCceecCCCCCCEEECCCCcEEEeccc
Q 021711          220 L-LYLHE-GCQRRIIHRDIKAANILLTEDFEPQICDFG  255 (308)
Q Consensus       220 L-~yLH~-~~~~~iiHrDlKp~NILl~~~~~~kl~DFG  255 (308)
                      + ..|.. .....++|+|+.+.|++++.++ +.|.||.
T Consensus       196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            2 23321 1135699999999999999887 8999984

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.59  E-value=0.00023  Score=63.78  Aligned_cols=35  Identities=29%  Similarity=0.336  Sum_probs=29.4

Q ss_pred             CCCceecCCCCCCEEECCC----CcEEEeccccceecCC
Q 021711          228 QRRIIHRDIKAANILLTED----FEPQICDFGLAKWLPE  262 (308)
Q Consensus       228 ~~~iiHrDlKp~NILl~~~----~~~kl~DFGla~~~~~  262 (308)
                      ...++|+|+.+.|||++.+    +.+.|+||+.+..-+.
T Consensus       182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~~  220 (333)
T 3csv_A          182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGHR  220 (333)
T ss_dssp             CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEECT
T ss_pred             CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCCC
Confidence            3579999999999999874    6799999999876543

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.37  E-value=0.00056  Score=60.36  Aligned_cols=138  Identities=12%  Similarity=0.020  Sum_probs=72.6

Q ss_pred             cceeeccCceEEEEEEECCCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCee-eeeeeEEEeCcEEEEEEec-CCCC
Q 021711          115 ENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT-AKLLGYGIEGGMHIVLELS-PNGS  192 (308)
Q Consensus       115 ~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~lv~e~~-~~gs  192 (308)
                      .+.|+.|....+|+.     ..+++|+.......  ..+..+|..+++.+...++ .+++++. ...-++++||+ ++.+
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~--~~~r~~E~~~l~~l~~~g~~P~~~~~~-~~~~~~v~e~i~~g~~   94 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE--YINRANEAVAAREAAKAGVSPEVLHVD-PATGVMVTRYIAGAQT   94 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC------CCCHHHHHHHHHHHHHTTSSCCEEEEC-TTTCCEEEECCTTCEE
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCccc--eeCHHHHHHHHHHHHHcCCCCceEEEE-CCCCEEEEeecCCCcc
Confidence            567889999999998     45788876543211  1122356666665532222 4555443 22346899999 5543


Q ss_pred             HHH------------------HHhccCCCC----CH-HHHHHHHH--------------HHHHHHH----HHHh-CCCCC
Q 021711          193 LAS------------------LLYGMKEKL----KW-GIRYKIAL--------------GVAEGLL----YLHE-GCQRR  230 (308)
Q Consensus       193 L~~------------------~l~~~~~~l----~~-~~~~~i~~--------------qi~~~L~----yLH~-~~~~~  230 (308)
                      +..                  .++.....+    .. .....+..              .+...+.    .+.. ..+..
T Consensus        95 l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~  174 (301)
T 3dxq_A           95 MSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLA  174 (301)
T ss_dssp             CCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCE
T ss_pred             CCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCce
Confidence            321                  011111111    11 11111110              0111111    1111 12245


Q ss_pred             ceecCCCCCCEEECCCCcEEEeccccceecC
Q 021711          231 IIHRDIKAANILLTEDFEPQICDFGLAKWLP  261 (308)
Q Consensus       231 iiHrDlKp~NILl~~~~~~kl~DFGla~~~~  261 (308)
                      ++|+|+.+.||+ ..++.+.|+||..+..-+
T Consensus       175 l~HgDl~~~Nil-~~~~~~~lID~e~a~~g~  204 (301)
T 3dxq_A          175 ACHCDPLCENFL-DTGERMWIVDWEYSGMND  204 (301)
T ss_dssp             EECSCCCGGGEE-ECSSCEEECCCTTCEEEC
T ss_pred             eeccCCCcCCEE-ECCCCEEEEecccccCCC
Confidence            899999999999 556678999999887543

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.22  E-value=0.0036  Score=55.39  Aligned_cols=140  Identities=16%  Similarity=0.186  Sum_probs=75.4

Q ss_pred             ceeeccCceEEEEEEECCCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCe--eeeeeeE-------EEeCcEEEEEE
Q 021711          116 NLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPN--TAKLLGY-------GIEGGMHIVLE  186 (308)
Q Consensus       116 ~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~-------~~~~~~~lv~e  186 (308)
                      +.|+.|....+|+....+| .+++|........   ..+..|+.++..+...+  +.+++..       ...+..+++++
T Consensus        28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~~~---~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~  103 (322)
T 2ppq_A           28 KGIAEGVENSNFLLHTTKD-PLILTLYEKRVEK---NDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALIS  103 (322)
T ss_dssp             EEECC---EEEEEEEESSC-CEEEEEECC---C---CHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEE
T ss_pred             eccCCCcccceEEEEeCCc-cEEEEEeCCCCCH---HHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEE
Confidence            4567788889999987655 5778987652111   23445666666653111  2333311       12344678999


Q ss_pred             ecCCCCHH-----------H---HHhccCCC--------CC---HHHHHH------------HHHHHHHHHHHHHhC---
Q 021711          187 LSPNGSLA-----------S---LLYGMKEK--------LK---WGIRYK------------IALGVAEGLLYLHEG---  226 (308)
Q Consensus       187 ~~~~gsL~-----------~---~l~~~~~~--------l~---~~~~~~------------i~~qi~~~L~yLH~~---  226 (308)
                      +++|..+.           .   .++.....        ..   |...+.            +...+...+.++...   
T Consensus       104 ~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~  183 (322)
T 2ppq_A          104 FLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPK  183 (322)
T ss_dssp             CCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCC
T ss_pred             eCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcc
Confidence            99875421           1   11211000        11   211100            001133445555431   


Q ss_pred             -CCCCceecCCCCCCEEECCCCcEEEecccccee
Q 021711          227 -CQRRIIHRDIKAANILLTEDFEPQICDFGLAKW  259 (308)
Q Consensus       227 -~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~  259 (308)
                       .+..++|+|+.+.|||++.++.+.|+||+.+..
T Consensus       184 ~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          184 DLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             SSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             cCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence             135699999999999999876568999998764

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.16  E-value=0.0025  Score=56.58  Aligned_cols=141  Identities=16%  Similarity=0.117  Sum_probs=77.4

Q ss_pred             ceeeccCceEEEEEEECCCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCC--eeeeeeeE------EEeCcEEEEEEe
Q 021711          116 NLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHP--NTAKLLGY------GIEGGMHIVLEL  187 (308)
Q Consensus       116 ~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~------~~~~~~~lv~e~  187 (308)
                      ..|+ |....||+....+|+.+++|........  ...+..|..++..+...  .+++++..      ...+..++++++
T Consensus        32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~--~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~  108 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERWT--ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPS  108 (328)
T ss_dssp             EEEC-CSSSEEEEECCTTCCCEEEEEECTTTSC--HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEEC
T ss_pred             Eeec-CcccceEEEEcCCCCEEEEEEcCCCCCC--HHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEe
Confidence            3566 7788999887766778999998643211  23455677777666311  23334332      123345689999


Q ss_pred             cCCCCHH-----------HH---Hhcc--C------CCCCHHHH----HHHH---------------HHHHHHHHHHHh-
Q 021711          188 SPNGSLA-----------SL---LYGM--K------EKLKWGIR----YKIA---------------LGVAEGLLYLHE-  225 (308)
Q Consensus       188 ~~~gsL~-----------~~---l~~~--~------~~l~~~~~----~~i~---------------~qi~~~L~yLH~-  225 (308)
                      ++|..+.           ..   ++..  .      ....+...    ..+.               ..+...+..+.. 
T Consensus       109 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~  188 (328)
T 1zyl_A          109 VGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAH  188 (328)
T ss_dssp             CCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHH
T ss_pred             cCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHH
Confidence            9874321           11   1110  0      01122111    0010               011112222221 


Q ss_pred             ---CCCCCceecCCCCCCEEECCCCcEEEeccccceecC
Q 021711          226 ---GCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP  261 (308)
Q Consensus       226 ---~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~  261 (308)
                         ..+..++|+|+++.|||++ + .+.|+||+.+..-+
T Consensus       189 ~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g~  225 (328)
T 1zyl_A          189 WREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARNGP  225 (328)
T ss_dssp             CCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCEEC
T ss_pred             hhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCcCc
Confidence               1235689999999999999 4 89999998877543

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.10  E-value=0.0012  Score=61.48  Aligned_cols=71  Identities=17%  Similarity=0.127  Sum_probs=46.0

Q ss_pred             cceeeccCceEEEEEEECC--------CcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCee-eeeeeEEEeCcEEEEE
Q 021711          115 ENLIGKGGYAEVYKGRLRN--------GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT-AKLLGYGIEGGMHIVL  185 (308)
Q Consensus       115 ~~~LG~G~fg~Vy~~~~~~--------g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~lv~  185 (308)
                      .+.|+.|....+|++...+        +..+++|+......   ...+.+|..++..+...++ .++++.+.+   .+|+
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~---g~v~  151 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET---ESHLVAESVIFTLLSERHLGPKLYGIFSG---GRLE  151 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC---HHHHHHHHHHHHHHHHTTSSSCEEEEETT---EEEE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC---CEEE
Confidence            3567888889999998653        47889998743222   1344578888877743333 456654432   3889


Q ss_pred             EecCCC
Q 021711          186 ELSPNG  191 (308)
Q Consensus       186 e~~~~g  191 (308)
                      ||++|.
T Consensus       152 e~l~G~  157 (429)
T 1nw1_A          152 EYIPSR  157 (429)
T ss_dssp             CCCCEE
T ss_pred             EEeCCc
Confidence            998763

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.94  E-value=0.0026  Score=58.26  Aligned_cols=140  Identities=16%  Similarity=0.187  Sum_probs=78.9

Q ss_pred             ceeeccCceEEEEEEEC--------CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCC-CCeeeeeeeEEEeCcEEEEEE
Q 021711          116 NLIGKGGYAEVYKGRLR--------NGQLVAIKRLTRGTADEIIADFLSELGIMAHVD-HPNTAKLLGYGIEGGMHIVLE  186 (308)
Q Consensus       116 ~~LG~G~fg~Vy~~~~~--------~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~lv~e  186 (308)
                      +.|..|-...+|++...        +++.+++|+.....  .......+|..+++.|. +.-..++++++.+   .+|+|
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~--~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~---g~v~e  130 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL--QGVDSLVLESVMFAILAERSLGPQLYGVFPE---GRLEQ  130 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT---EEEEE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc--chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC---ccEEE
Confidence            45666777888998764        24688888853321  11345568888887774 2223556655433   38999


Q ss_pred             ecCCCCHH--------------HH---HhccC----CCCC--HHHHHHHHHHHHH-------------------HHHHHH
Q 021711          187 LSPNGSLA--------------SL---LYGMK----EKLK--WGIRYKIALGVAE-------------------GLLYLH  224 (308)
Q Consensus       187 ~~~~gsL~--------------~~---l~~~~----~~l~--~~~~~~i~~qi~~-------------------~L~yLH  224 (308)
                      |++|.+|.              ..   |+...    ....  +..+.++..++..                   .+..|.
T Consensus       131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~  210 (379)
T 3feg_A          131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR  210 (379)
T ss_dssp             CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred             EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence            99875432              11   12111    1122  3444444433321                   223332


Q ss_pred             ----h-CCCCCceecCCCCCCEEECCC----CcEEEeccccceec
Q 021711          225 ----E-GCQRRIIHRDIKAANILLTED----FEPQICDFGLAKWL  260 (308)
Q Consensus       225 ----~-~~~~~iiHrDlKp~NILl~~~----~~~kl~DFGla~~~  260 (308)
                          . .....++|+|+.+.|||++.+    +.+.|+||..|..-
T Consensus       211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~~  255 (379)
T 3feg_A          211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSYN  255 (379)
T ss_dssp             HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEEE
T ss_pred             HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCcC
Confidence                1 122458999999999999876    68999999988743

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.77  E-value=0.007  Score=56.86  Aligned_cols=72  Identities=15%  Similarity=0.034  Sum_probs=44.5

Q ss_pred             ceeeccCceEEEEEEECC-CcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCee-eeeeeEEEeCcEEEEEEecCCCC
Q 021711          116 NLIGKGGYAEVYKGRLRN-GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT-AKLLGYGIEGGMHIVLELSPNGS  192 (308)
Q Consensus       116 ~~LG~G~fg~Vy~~~~~~-g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~lv~e~~~~gs  192 (308)
                      +.|+.|-...+|++...+ +..+++|+....... . -+-.+|..++..|...++ .++++.+ .+  .+|+||++|.+
T Consensus       114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~-idR~~E~~vl~~L~~~gl~P~ll~~~-~~--G~v~e~I~G~~  187 (458)
T 2qg7_A          114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-I-INREREKKISCILYNKNIAKKIYVFF-TN--GRIEEFMDGYA  187 (458)
T ss_dssp             EEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-C-SCHHHHHHHHHHHTTSSSBCCEEEEE-TT--EEEEECCCSEE
T ss_pred             EEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-h-cCHHHHHHHHHHHHhcCCCCCEEEEe-CC--eEEEEeeCCcc
Confidence            568888889999998764 477888876432211 1 111478888888864444 4566655 22  35999998643

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.72  E-value=0.0095  Score=53.50  Aligned_cols=33  Identities=27%  Similarity=0.367  Sum_probs=28.9

Q ss_pred             CCceecCCCCCCEEECCCCcEEEeccccceecC
Q 021711          229 RRIIHRDIKAANILLTEDFEPQICDFGLAKWLP  261 (308)
Q Consensus       229 ~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~  261 (308)
                      ..++|+|+.+.||+++.++.+.|+||+.+..-+
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~~  238 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLAP  238 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEEEC
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeCC
Confidence            469999999999999988889999998887643

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.72  E-value=0.0017  Score=59.01  Aligned_cols=72  Identities=14%  Similarity=0.116  Sum_probs=40.7

Q ss_pred             ceeeccCceEEEEEEECC---------CcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCe-eeeeeeEEEeCcEEEEE
Q 021711          116 NLIGKGGYAEVYKGRLRN---------GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPN-TAKLLGYGIEGGMHIVL  185 (308)
Q Consensus       116 ~~LG~G~fg~Vy~~~~~~---------g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~lv~  185 (308)
                      +.|+.|....+|+....+         +..+++|+...... . ..+...|..++..+...+ ..++++..  . -++|+
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~-~~~v~  113 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-E-LYNTISEFEVYKTMSKYKIAPQLLNTF--N-GGRIE  113 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-G-TSCHHHHHHHHHHHHHTTSSCCEEEEE--T-TEEEE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-c-eecHHHHHHHHHHHHhcCCCCceEEec--C-CcEEE
Confidence            467778888999988653         26788887644321 1 112346777777664223 34555433  2 26899


Q ss_pred             EecCCCC
Q 021711          186 ELSPNGS  192 (308)
Q Consensus       186 e~~~~gs  192 (308)
                      +|++|.+
T Consensus       114 e~i~G~~  120 (369)
T 3c5i_A          114 EWLYGDP  120 (369)
T ss_dssp             ECCCSEE
T ss_pred             EEecCCc
Confidence            9998743

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=93.26  E-value=0.17  Score=46.92  Aligned_cols=72  Identities=10%  Similarity=0.031  Sum_probs=43.7

Q ss_pred             ceeeccCceEEEEEEECC--------CcEEEEEEeccCChHHHHHHHHHHHHHHhcCC-CCeeeeeeeEEEeCcEEEEEE
Q 021711          116 NLIGKGGYAEVYKGRLRN--------GQLVAIKRLTRGTADEIIADFLSELGIMAHVD-HPNTAKLLGYGIEGGMHIVLE  186 (308)
Q Consensus       116 ~~LG~G~fg~Vy~~~~~~--------g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~lv~e  186 (308)
                      +.|..|-...+|+....+        +..+++++.......  .-+..+|..+++.+. +.-..++++.+  . -++|++
T Consensus        76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~--~idR~~E~~~l~~L~~~gi~P~l~~~~--~-~~~I~e  150 (424)
T 3mes_A           76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK--FYDSKVELDVFRYLSNINIAPNIIADF--P-EGRIEE  150 (424)
T ss_dssp             EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C--CCCHHHHHHHHHHHHHTTSSCCEEEEE--T-TEEEEE
T ss_pred             EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch--hcCHHHHHHHHHHHHhcCCCCCEEEEc--C-CCEEEE
Confidence            457778888999998753        578898886443211  112246777776663 22234455432  2 268999


Q ss_pred             ecCCCC
Q 021711          187 LSPNGS  192 (308)
Q Consensus       187 ~~~~gs  192 (308)
                      |++|.+
T Consensus       151 fI~G~~  156 (424)
T 3mes_A          151 FIDGEP  156 (424)
T ss_dssp             CCCSEE
T ss_pred             EeCCcc
Confidence            998854

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=92.33  E-value=0.013  Score=55.00  Aligned_cols=61  Identities=8%  Similarity=0.188  Sum_probs=17.6

Q ss_pred             ccceeeccCceEEEEEEECC-CcEEEE------EEeccCC-hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEE
Q 021711          114 FENLIGKGGYAEVYKGRLRN-GQLVAI------KRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGI  177 (308)
Q Consensus       114 ~~~~LG~G~fg~Vy~~~~~~-g~~vAv------K~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  177 (308)
                      +.+.||   ||.||+|.+.. ...||+      |..+... ..+....|.+|..++..++|||+++.++|..
T Consensus       146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~  214 (463)
T 3cxl_A          146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV  214 (463)
T ss_dssp             STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred             ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence            445666   99999998764 467888      7665432 2234567899999999999999999988654

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=90.79  E-value=0.084  Score=44.32  Aligned_cols=96  Identities=16%  Similarity=0.022  Sum_probs=59.6

Q ss_pred             CCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCceeEee
Q 021711          191 GSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTIS  270 (308)
Q Consensus       191 gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~  270 (308)
                      -+|.++|...+.++++.+++.++.|.+.+|.-+-..  ..-..+=+-|..|++..+|.|.+.+ +.+.            
T Consensus        33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~--~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------   97 (229)
T 2yle_A           33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARR--RQPRHRVRSAAQIRVWRDGAVTLAP-AADD------------   97 (229)
T ss_dssp             EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCSGGGEEEETTSCEEECC-C---------------
T ss_pred             ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhc--ccCCceecCCcceEEecCCceeccc-cccc------------
Confidence            389999988899999999999999999988765210  1111223346889999999887764 1111            


Q ss_pred             ceeccccccccccCchhhcCccceeEEEeeEEEe
Q 021711          271 KVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQ  304 (308)
Q Consensus       271 ~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~e  304 (308)
                        .....+.+||..+ ...+.+.-|||+|++||.
T Consensus        98 --~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~  128 (229)
T 2yle_A           98 --AGEPPPVAGKLGY-SQCMETEVIESLGIIIYK  128 (229)
T ss_dssp             -----------CCSS-SSSCHHHHHHHHHHHHHH
T ss_pred             --ccccCCCChhhcc-ccchHHHHHHHHHHHHHH
Confidence              1123455777653 223445678888888764

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=82.00  E-value=2.7  Score=35.03  Aligned_cols=87  Identities=16%  Similarity=0.216  Sum_probs=56.6

Q ss_pred             CCCeeeeeeeEEEeCcEEEEEEecCCC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHH-HHHhCCCCCceecCCCCCCEE
Q 021711          165 DHPNTAKLLGYGIEGGMHIVLELSPNG-SLASLLYGMKEKLKWGIRYKIALGVAEGLL-YLHEGCQRRIIHRDIKAANIL  242 (308)
Q Consensus       165 ~h~niv~l~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~-yLH~~~~~~iiHrDlKp~NIL  242 (308)
                      .||++..-+. ..++.+.+.++.-+++ ++.. +    ..++...+++++.+|+.-.. +++     .-+|--|.|+||+
T Consensus        48 ~~~~f~~~I~-~~eD~~~i~y~~~~~~~~f~~-i----~~~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l~P~NL~  116 (219)
T 4ano_A           48 VDPCIVRDID-VSEDEVKVVIKPPSSFLTFAA-I----RKTTLLSRIRAAIHLVSKVKHHSA-----RRLIFIVCPENLM  116 (219)
T ss_dssp             SCSSSEEEEE-ECSSEEEEEEECCTTCEEHHH-H----HTSCHHHHHHHHHHHHHHHSSCCS-----SSEECCCCGGGEE
T ss_pred             cCCCCCeEEE-EeCCEEEEEEEcCcccCcHHH-H----HhcCHHHHHHHHHHHHHHHHHhhh-----CceeEEEeCceEE
Confidence            5787722222 3334445555544332 3333 2    34677888888888876655 444     3567778899999


Q ss_pred             ECCCCcEEEeccccceecCC
Q 021711          243 LTEDFEPQICDFGLAKWLPE  262 (308)
Q Consensus       243 l~~~~~~kl~DFGla~~~~~  262 (308)
                      ++.++.++|.-.|+-..+++
T Consensus       117 f~~~~~p~i~hRGi~~~lpP  136 (219)
T 4ano_A          117 FNRALEPFFLHVGVKESLPP  136 (219)
T ss_dssp             ECTTCCEEESCCEETTTBSS
T ss_pred             EeCCCcEEEEEcCCcccCCC
Confidence            99999999999998665544

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=81.20  E-value=0.79  Score=41.81  Aligned_cols=29  Identities=31%  Similarity=0.534  Sum_probs=24.7

Q ss_pred             ceecCCCCCCEEE------CCCCcEEEecccccee
Q 021711          231 IIHRDIKAANILL------TEDFEPQICDFGLAKW  259 (308)
Q Consensus       231 iiHrDlKp~NILl------~~~~~~kl~DFGla~~  259 (308)
                      ++|+|+.+.|||+      +++..+.++||-.|..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            6799999999999      4456799999988864

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	308
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	3e-49
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	6e-46
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	3e-45
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	5e-44
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-43
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-42
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	4e-42
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	5e-41
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	3e-40
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	4e-40
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	1e-39
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	1e-39
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-39
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-39
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	3e-39
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	5e-39
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	6e-39
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	7e-39
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	8e-39
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-38
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	3e-38
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	8e-38
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	5e-37
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	9e-37
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	3e-36
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	4e-36
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	5e-36
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	6e-36
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	1e-35
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	4e-35
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	1e-34
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-33
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	6e-33
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	6e-33
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	7e-33
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	9e-32
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	3e-31
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	5e-31
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	6e-31
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	1e-30
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	1e-30
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-30
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-30
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	9e-30
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	1e-29
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	5e-29
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	8e-29
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	1e-28
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	1e-27
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-27
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	4e-27
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	1e-26
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	2e-26
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	9e-26
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	1e-25
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-25
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	2e-25
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	1e-24
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	2e-23
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	8e-22
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	4e-21
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	8e-20
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	5e-17

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (412), Expect = 3e-49
 Identities = 50/169 (29%), Positives = 76/169 (44%), Gaps = 6/169 (3%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTAD-EIIADFLSELGIMAHVDHPN 168
              +    IG G +  VYKG+      VA+K L       + +  F +E+G++    H N
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65

Query: 169 TAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQ 228
               +GY     + IV +     SL   L+ ++ K +      IA   A+G+ YLH    
Sbjct: 66  ILLFMGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---A 122

Query: 229 RRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFG 277
           + IIHRD+K+ NI L ED   +I DFGLA         H   ++ G+  
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 171

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (394), Expect = 6e-46
 Identities = 42/167 (25%), Positives = 80/167 (47%), Gaps = 5/167 (2%)

Query: 105 LQSATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAH 163
           ++   ++F   + +G G    V+K   + +G ++A K +       I    + EL ++  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60

Query: 164 VDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLY 222
            + P      G     G + I +E    GSL  +L     ++   I  K+++ V +GL Y
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTY 119

Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTI 269
           L E  + +I+HRD+K +NIL+    E ++CDFG++  L +   +  +
Sbjct: 120 LRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV 164

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (387), Expect = 3e-45
 Identities = 47/179 (26%), Positives = 84/179 (46%), Gaps = 8/179 (4%)

Query: 104 ELQSATNNFSFENL-IGKGGYAEVYKGRLR---NGQLVAIKRLTRGTADEIIADFLSELG 159
           +L    +N    ++ +G G +  V +G  R       VAIK L +GT      + + E  
Sbjct: 2   KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 61

Query: 160 IMAHVDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEG 219
           IM  +D+P   +L+G      + +V+E++  G L   L G +E++      ++   V+ G
Sbjct: 62  IMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMG 121

Query: 220 LLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK-VEGTFG 277
           + YL    ++  +HRD+ A N+LL      +I DFGL+K L    +++T     +    
Sbjct: 122 MKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 177

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  150 bits (379), Expect = 5e-44
 Identities = 58/200 (29%), Positives = 87/200 (43%), Gaps = 17/200 (8%)

Query: 100 FSLYELQSATNNFS---------FENLIGKGGYAEVYKGRLR----NGQLVAIKRLTRGT 146
           F+  +   A   F+          E +IG G + EV  G L+        VAIK L  G 
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 147 ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLK 205
            ++   DFLSE  IM   DHPN   L G   +   + I+ E   NGSL S L     +  
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 126

Query: 206 WGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT 265
                 +  G+A G+ YL        +HRD+ A NIL+  +   ++ DFGL+++L +  +
Sbjct: 127 VIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183

Query: 266 HHTISKVEGTFGLVKLNLPP 285
             T +   G    ++   P 
Sbjct: 184 DPTYTSALGGKIPIRWTAPE 203

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (374), Expect = 2e-43
 Identities = 46/169 (27%), Positives = 76/169 (44%), Gaps = 7/169 (4%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
                   +G G + EV+ G       VA+K L +G+       FL+E  +M  + H   
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP--DAFLAEANLMKQLQHQRL 70

Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMK-EKLKWGIRYKIALGVAEGLLYLHEGCQ 228
            +L     +  ++I+ E   NGSL   L      KL       +A  +AEG+ ++ E   
Sbjct: 71  VRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE--- 127

Query: 229 RRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFG 277
           R  IHRD++AANIL+++    +I DFGLA+ + +   +      +    
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN-EYTAREGAKFPIK 175

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (366), Expect = 1e-42
 Identities = 39/169 (23%), Positives = 77/169 (45%), Gaps = 7/169 (4%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
            + +F   +G G +  V  G+ R    VAIK +  G+  E   +F+ E  +M ++ H   
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE--DEFIEEAKVMMNLSHEKL 61

Query: 170 AKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQ 228
            +L G   +   + I+ E   NG L + L  M+ + +     ++   V E + YL     
Sbjct: 62  VQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---S 118

Query: 229 RRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFG 277
           ++ +HRD+ A N L+ +    ++ DFGL++++ +     ++        
Sbjct: 119 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSK-FPVR 166

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (365), Expect = 4e-42
 Identities = 43/162 (26%), Positives = 78/162 (48%), Gaps = 6/162 (3%)

Query: 109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHP 167
            + +     +G G + +VYK + +    L A K +   + +E+  D++ E+ I+A  DHP
Sbjct: 11  EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEEL-EDYMVEIDILASCDHP 69

Query: 168 NTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEG 226
           N  KLL        + I++E    G++ +++  ++  L       +     + L YLH+ 
Sbjct: 70  NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD- 128

Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT 268
              +IIHRD+KA NIL T D + ++ DFG++           
Sbjct: 129 --NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRD 168

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (356), Expect = 5e-41
 Identities = 42/169 (24%), Positives = 72/169 (42%), Gaps = 7/169 (4%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           +  +F   IG G +  V+ G   N   VAIK +  G   E   DF+ E  +M  + HP  
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE--EDFIEEAEVMMKLSHPKL 62

Query: 170 AKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQ 228
            +L G  +E   + +V E   +G L+  L   +          + L V EG   +    +
Sbjct: 63  VQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEG---MAYLEE 119

Query: 229 RRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFG 277
             +IHRD+ A N L+ E+   ++ DFG+ +++ +     +         
Sbjct: 120 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTK-FPVK 167

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  140 bits (353), Expect = 3e-40
 Identities = 58/224 (25%), Positives = 87/224 (38%), Gaps = 37/224 (16%)

Query: 101 SLYELQSATNNFSFENLIGKGGYAEVYKGRLRN------GQLVAIKRLTRGTADEIIADF 154
            L  L+   NN  +   IG+G +  V++ R           +VA+K L    + ++ ADF
Sbjct: 4   KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63

Query: 155 LSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGM------------- 200
             E  +MA  D+PN  KLLG    G  M ++ E    G L   L  M             
Sbjct: 64  QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123

Query: 201 ----------KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQ 250
                        L    +  IA  VA G+ YL E   R+ +HRD+   N L+ E+   +
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVK 180

Query: 251 ICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFT 294
           I DFGL++ +     +                +PP  I    +T
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIPIR----WMPPESIFYNRYT 220

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (352), Expect = 4e-40
 Identities = 47/169 (27%), Positives = 73/169 (43%), Gaps = 7/169 (4%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
            +   E  +G+G + EV+ G       VAIK L  GT       FL E  +M  + H   
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP--EAFLQEAQVMKKLRHEKL 74

Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLK-WGIRYKIALGVAEGLLYLHEGCQ 228
            +L     E  ++IV E    GSL   L G   K         +A  +A G+ Y+    +
Sbjct: 75  VQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---R 131

Query: 229 RRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFG 277
              +HRD++AANIL+ E+   ++ DFGLA+ + +          +    
Sbjct: 132 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR-QGAKFPIK 179

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (347), Expect = 1e-39
 Identities = 56/193 (29%), Positives = 85/193 (44%), Gaps = 14/193 (7%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLR----NGQLVAIKRLTRGTA--DEIIADFLSELGIMAH 163
            +      +G G +  V +G           VA+K L        E + DF+ E+  M  
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67

Query: 164 VDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYL 223
           +DH N  +L G  +   M +V EL+P GSL   L   +     G   + A+ VAEG+ YL
Sbjct: 68  LDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL 127

Query: 224 HEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK-VEGTFGLVKLN 282
                +R IHRD+ A N+LL      +I DFGL + LP+   H+ + +  +  F      
Sbjct: 128 ES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA----W 180

Query: 283 LPPLVILKRCFTC 295
             P  +  R F+ 
Sbjct: 181 CAPESLKTRTFSH 193

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (351), Expect = 1e-39
 Identities = 45/198 (22%), Positives = 72/198 (36%), Gaps = 33/198 (16%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRN------GQLVAIKRLTRGTADEIIADFLSELGIMAH 163
            N  F  ++G G + +V                VA+K L            +SEL +M  
Sbjct: 37  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96

Query: 164 V-DHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEK------------------ 203
           +  H N   LLG     G ++++ E    G L + L   +EK                  
Sbjct: 97  LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156

Query: 204 ----LKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKW 259
               L +      A  VA+G+ +L     +  +HRD+ A N+L+T     +ICDFGLA+ 
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARD 213

Query: 260 LPEQWTHHTISKVEGTFG 277
           +     +           
Sbjct: 214 IMSDSNYVVRGNARLPVK 231

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (346), Expect = 2e-39
 Identities = 52/179 (29%), Positives = 83/179 (46%), Gaps = 10/179 (5%)

Query: 103 YELQSATNNFSFENLIGKGGYAEVYKGRLRN----GQLVAIKRLTRGTADEIIADFLSEL 158
           YE+Q           IG+G + +V++G   +       VAIK     T+D +   FL E 
Sbjct: 2   YEIQ--RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEA 59

Query: 159 GIMAHVDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE 218
             M   DHP+  KL+G   E  + I++EL   G L S L   K  L        A  ++ 
Sbjct: 60  LTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST 119

Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFG 277
            L YL     +R +HRDI A N+L++ +   ++ DFGL++++ +   +   SK +    
Sbjct: 120 ALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA-SKGKLPIK 174

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (346), Expect = 2e-39
 Identities = 41/172 (23%), Positives = 74/172 (43%), Gaps = 10/172 (5%)

Query: 107 SATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEI-IADFLSELGIMAHV 164
           S   ++     IG G Y    K R + +G+++  K L  G+  E      +SE+ ++  +
Sbjct: 1   SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL 60

Query: 165 DHPNTAKLLGYGIE---GGMHIVLELSPNGSLASLLYG---MKEKLKWGIRYKIALGVAE 218
            HPN  +     I+     ++IV+E    G LAS++      ++ L      ++   +  
Sbjct: 61  KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 120

Query: 219 GLLYLHE--GCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT 268
            L   H        ++HRD+K AN+ L      ++ DFGLA+ L    +   
Sbjct: 121 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAK 172

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (347), Expect = 3e-39
 Identities = 49/214 (22%), Positives = 82/214 (38%), Gaps = 28/214 (13%)

Query: 89  NSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLR------NGQLVAIKRL 142
           N+Y    P ++   ++ +   N  SF   +G G + +V +              VA+K L
Sbjct: 2   NNYVYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML 61

Query: 143 TRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGM 200
                       +SEL +++++ +H N   LLG    GG   ++ E    G L + L   
Sbjct: 62  KPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRK 121

Query: 201 KE-----------------KLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILL 243
           ++                  L        +  VA+G+ +L     +  IHRD+ A NILL
Sbjct: 122 RDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILL 178

Query: 244 TEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFG 277
           T     +ICDFGLA+ +     +           
Sbjct: 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVK 212

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (343), Expect = 5e-39
 Identities = 45/170 (26%), Positives = 71/170 (41%), Gaps = 6/170 (3%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPN 168
            ++     +G+G Y EV     R   + VA+K +    A +   +   E+ I   ++H N
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 169 TAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
             K  G+  EG   ++ LE    G L   +      +      +    +  G++YLH   
Sbjct: 65  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHG-- 121

Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFG 277
              I HRDIK  N+LL E    +I DFGLA           ++K+ GT  
Sbjct: 122 -IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 170

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (346), Expect = 6e-39
 Identities = 52/188 (27%), Positives = 85/188 (45%), Gaps = 12/188 (6%)

Query: 112 FSFENLIGKGGYAEVYKGRLRN-----GQLVAIKRLTRGTADEIIADFLSELGIMAHVDH 166
           F    ++G G +  VYKG            VAIK L   T+ +   + L E  +MA VD+
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70

Query: 167 PNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEG 226
           P+  +LLG  +   + ++ +L P G L   +   K+ +         + +A+G+ YL   
Sbjct: 71  PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL--- 127

Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPL 286
             RR++HRD+ A N+L+      +I DFGLAK L  +   +     +         +   
Sbjct: 128 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW----MALE 183

Query: 287 VILKRCFT 294
            IL R +T
Sbjct: 184 SILHRIYT 191

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  137 bits (345), Expect = 7e-39
 Identities = 48/159 (30%), Positives = 76/159 (47%), Gaps = 8/159 (5%)

Query: 112 FSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTA--DEIIADFLSELGIMAHVDHPN 168
           FS    IG G +  VY  R +RN ++VAIK+++      +E   D + E+  +  + HPN
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 169 TAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
           T +  G  +      +V+E     +   L    K+ L+      +  G  +GL YLH   
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHS-- 133

Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH 266
              +IHRD+KA NILL+E    ++ DFG A  +    + 
Sbjct: 134 -HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSF 171

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (341), Expect = 8e-39
 Identities = 51/164 (31%), Positives = 72/164 (43%), Gaps = 10/164 (6%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
                   IGKG + +V  G  R G  VA+K +     D     FL+E  +M  + H N 
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKN---DATAQAFLAEASVMTQLRHSNL 62

Query: 170 AKLLGYGIE--GGMHIVLELSPNGSLASLLYGMKEK-LKWGIRYKIALGVAEGLLYLHEG 226
            +LLG  +E  GG++IV E    GSL   L       L      K +L V E + YL   
Sbjct: 63  VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE-- 120

Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTIS 270
                +HRD+ A N+L++ED   ++ DFGL K          + 
Sbjct: 121 -GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP 163

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (341), Expect = 1e-38
 Identities = 40/168 (23%), Positives = 73/168 (43%), Gaps = 9/168 (5%)

Query: 115 ENLIGKGGYAEVYKGRLRN---GQLVAIKRLTRGTADE-IIADFLSELGIMAHVDHPNTA 170
           +  +G G +  V KG  +     + VA+K L     D  +  + L+E  +M  +D+P   
Sbjct: 12  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71

Query: 171 KLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRR 230
           +++G        +V+E++  G L   L      +K     ++   V+ G+ YL    +  
Sbjct: 72  RMIGICEAESWMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLE---ESN 127

Query: 231 IIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK-VEGTFG 277
            +HRD+ A N+LL      +I DFGL+K L     ++      +    
Sbjct: 128 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK 175

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (337), Expect = 3e-38
 Identities = 45/164 (27%), Positives = 74/164 (45%), Gaps = 8/164 (4%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELGIMAHVDH 166
            +F     +GKG +  VY  R + +  ++A+K L +       +      E+ I +H+ H
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 167 PNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHE 225
           PN  +L GY  +   ++++LE +P G++   L  +  K            +A  L Y H 
Sbjct: 66  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCHS 124

Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTI 269
              +R+IHRDIK  N+LL    E +I DFG +   P        
Sbjct: 125 ---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC 165

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  133 bits (336), Expect = 8e-38
 Identities = 46/180 (25%), Positives = 86/180 (47%), Gaps = 12/180 (6%)

Query: 92  DSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRN-GQLVAIKRLTRGTADEI 150
           D  SP   +  +E++    + + ++ +G G Y EVY+G  +     VA+K L   T +  
Sbjct: 3   DPSSPN--YDKWEME--RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-- 56

Query: 151 IADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLY-GMKEKLKWGI 208
           + +FL E  +M  + HPN  +LLG        +I+ E    G+L   L    ++++   +
Sbjct: 57  VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVV 116

Query: 209 RYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT 268
              +A  ++  + YL    ++  IHRD+ A N L+ E+   ++ DFGL++ +        
Sbjct: 117 LLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 173

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (332), Expect = 5e-37
 Identities = 49/172 (28%), Positives = 76/172 (44%), Gaps = 11/172 (6%)

Query: 114 FENLIGKGGYAEVYKGRLRN----GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           F  +IG+G +  VY G L +        A+K L R T    ++ FL+E  IM    HPN 
Sbjct: 31  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 90

Query: 170 AKLLGYGI--EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
             LLG  +  EG   +VL    +G L + +                L VA+G+       
Sbjct: 91  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGM---KFLA 147

Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP--EQWTHHTISKVEGTFG 277
            ++ +HRD+ A N +L E F  ++ DFGLA+ +   E  + H  +  +    
Sbjct: 148 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK 199

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (328), Expect = 9e-37
 Identities = 52/175 (29%), Positives = 79/175 (45%), Gaps = 10/175 (5%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQ-----LVAIKRLTRGTADEIIADFLSELGIMAHV 164
           +  + + +IG G + EVYKG L+         VAIK L  G  ++   DFL E GIM   
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66

Query: 165 DHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYL 223
            H N  +L G   +   M I+ E   NG+L   L     +        +  G+A G+ YL
Sbjct: 67  SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL 126

Query: 224 HEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH-HTISKVEGTFG 277
                   +HRD+ A NIL+  +   ++ DFGL++ L +     +T S  +    
Sbjct: 127 AN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR 178

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  130 bits (329), Expect = 3e-36
 Identities = 32/164 (19%), Positives = 60/164 (36%), Gaps = 8/164 (4%)

Query: 110 NNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPN 168
           +++     +G G +  V++      G   A K +      +       E+  M+ + HP 
Sbjct: 26  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK-ETVRKEIQTMSVLRHPT 84

Query: 169 TAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
              L     +   M ++ E    G L   +     K+      +    V +GL ++HE  
Sbjct: 85  LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE-- 142

Query: 228 QRRIIHRDIKAANILLTEDFEPQI--CDFGLAKWLPEQWTHHTI 269
               +H D+K  NI+ T     ++   DFGL   L  + +    
Sbjct: 143 -NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT 185

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (325), Expect = 4e-36
 Identities = 42/179 (23%), Positives = 80/179 (44%), Gaps = 8/179 (4%)

Query: 92  DSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEI 150
           D +  +K+ S+  +      ++    IG+G    VY    +  GQ VAI+++      + 
Sbjct: 2   DEEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK 61

Query: 151 IADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIR 209
               ++E+ +M    +PN    L   + G  + +V+E    GSL  ++   +  +  G  
Sbjct: 62  -ELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQI 118

Query: 210 YKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT 268
             +     + L +LH     ++IHRDIK+ NILL  D   ++ DFG    +  + +  +
Sbjct: 119 AAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 174

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (324), Expect = 5e-36
 Identities = 48/171 (28%), Positives = 74/171 (43%), Gaps = 8/171 (4%)

Query: 111 NFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTA--DEIIADFLSELGIMAHVDHP 167
           +F F  ++G+G ++ V   R L   +  AIK L +     +  +     E  +M+ +DHP
Sbjct: 9   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68

Query: 168 NTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEG 226
              KL     +   ++  L  + NG L   +  +    +   R+  A    E +  L   
Sbjct: 69  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA----EIVSALEYL 124

Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFG 277
             + IIHRD+K  NILL ED   QI DFG AK L  +      +   GT  
Sbjct: 125 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 175

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (322), Expect = 6e-36
 Identities = 46/174 (26%), Positives = 68/174 (39%), Gaps = 14/174 (8%)

Query: 112 FSFENLIGKGGYAEVYKGRLR-NGQLVAIKRL-TRGTADEIIADFLSELGIMAHVDHPNT 169
             F+  IG+G +  VYKG        VA   L  R         F  E  ++  + HPN 
Sbjct: 11  LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70

Query: 170 AKLLGYGI-----EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
            +           +  + +V EL  +G+L + L   K  +K  +       + +GL +LH
Sbjct: 71  VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLH 129

Query: 225 EGCQRRIIHRDIKAANILLT-EDFEPQICDFGLAKWLPEQWTHHTISKVEGTFG 277
                 IIHRD+K  NI +T      +I D GLA      +    I    GT  
Sbjct: 130 TRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVI----GTPE 178

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (323), Expect = 1e-35
 Identities = 42/167 (25%), Positives = 70/167 (41%), Gaps = 15/167 (8%)

Query: 114 FENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLL 173
            +  IGKG + EV++G+ R G+ VA+K  +            +E+     + H N    +
Sbjct: 7   LQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWF--REAEIYQTVMLRHENILGFI 63

Query: 174 GYGIEGG-----MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC- 227
               +       + +V +   +GSL   L   +  +      K+AL  A GL +LH    
Sbjct: 64  AADNKDNGTWTQLWLVSDYHEHGSLFDYLN--RYTVTVEGMIKLALSTASGLAHLHMEIV 121

Query: 228 ----QRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTIS 270
               +  I HRD+K+ NIL+ ++    I D GLA           I+
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIA 168

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (319), Expect = 4e-35
 Identities = 51/179 (28%), Positives = 83/179 (46%), Gaps = 23/179 (12%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQL---VAIKRLTRGTADEIIADFLSELGIMAHV-D 165
           N+  F+++IG+G + +V K R++   L    AIKR+    + +   DF  EL ++  +  
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 166 HPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYG---------------MKEKLKWGIR 209
           HPN   LLG     G +++ +E +P+G+L   L                     L     
Sbjct: 70  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 210 YKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT 268
              A  VA G+ YL    Q++ IHRD+ A NIL+ E++  +I DFGL++          
Sbjct: 130 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM 185

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  127 bits (319), Expect = 1e-34
 Identities = 44/166 (26%), Positives = 75/166 (45%), Gaps = 11/166 (6%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTAD-----EIIADFLSELGIMAH 163
           N+FS   +IG+GG+ EVY  R    G++ A+K L +          +  +    L +++ 
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 164 VDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLY 222
            D P    +         +  +L+L   G L   L       +  +R+  A  +  GL +
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF-YAAEIILGLEH 122

Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT 268
           +H    R +++RD+K ANILL E    +I D GLA    ++  H +
Sbjct: 123 MH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS 165

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  123 bits (310), Expect = 2e-33
 Identities = 35/162 (21%), Positives = 58/162 (35%), Gaps = 8/162 (4%)

Query: 110 NNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPN 168
           + +     +G G +  V++      G++   K +      +      +E+ IM  + HP 
Sbjct: 29  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD-KYTVKNEISIMNQLHHPK 87

Query: 169 TAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
              L     +   M ++LE    G L   +     K+             EGL ++HE  
Sbjct: 88  LINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE-- 145

Query: 228 QRRIIHRDIKAANILLTEDFEPQI--CDFGLAKWLPEQWTHH 267
              I+H DIK  NI+        +   DFGLA  L       
Sbjct: 146 -HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK 186

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (304), Expect = 6e-33
 Identities = 42/184 (22%), Positives = 77/184 (41%), Gaps = 19/184 (10%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRN------GQLVAIKRLTRGTADEIIADFLSELGIMAH 163
              +    +G+G +  VY+G  +          VAIK +    +     +FL+E  +M  
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79

Query: 164 VDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKE---------KLKWGIRYKIA 213
            +  +  +LLG   +G    +++EL   G L S L  ++                  ++A
Sbjct: 80  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139

Query: 214 LGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVE 273
             +A+G+ YL      + +HRD+ A N ++ EDF  +I DFG+ + + E   +    K  
Sbjct: 140 GEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196

Query: 274 GTFG 277
               
Sbjct: 197 LPVR 200

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (303), Expect = 6e-33
 Identities = 46/192 (23%), Positives = 78/192 (40%), Gaps = 27/192 (14%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLR------NGQLVAIKRLTRGTADEIIADFLSELGIMAH 163
           +       +G+G + +V +            + VA+K L  G         +SEL I+ H
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 164 -VDHPNTAKLLGYGIEGG--MHIVLELSPNGSLASLLYGMKEK---------------LK 205
              H N   LLG   + G  + +++E    G+L++ L   + +               L 
Sbjct: 73  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 206 WGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT 265
                  +  VA+G+ +L     R+ IHRD+ A NILL+E    +ICDFGLA+ + +   
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189

Query: 266 HHTISKVEGTFG 277
           +           
Sbjct: 190 YVRKGDARLPLK 201

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  121 bits (304), Expect = 7e-33
 Identities = 40/162 (24%), Positives = 69/162 (42%), Gaps = 6/162 (3%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELGIMAHVDH 166
            +F     +G G +  V+  R R NG+  A+K L +      + +     E  +++ V H
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 167 PNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEG 226
           P   ++ G   +     ++     G     L    ++    +    A  V   L YLH  
Sbjct: 64  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS- 122

Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT 268
             + II+RD+K  NILL ++   +I DFG AK++P+      
Sbjct: 123 --KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLC 162

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  117 bits (294), Expect = 9e-32
 Identities = 41/170 (24%), Positives = 67/170 (39%), Gaps = 15/170 (8%)

Query: 111 NFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTAD--------EIIADFLSELGIM 161
           N+  + ++G+G  + V +       +  A+K +              E+    L E+ I+
Sbjct: 4   NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63

Query: 162 AHV-DHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEG 219
             V  HPN  +L           +V +L   G L   L   K  L      KI   + E 
Sbjct: 64  RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEV 122

Query: 220 LLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTI 269
           +  LH+     I+HRD+K  NILL +D   ++ DFG +  L        +
Sbjct: 123 ICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREV 169

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  116 bits (291), Expect = 3e-31
 Identities = 44/196 (22%), Positives = 79/196 (40%), Gaps = 17/196 (8%)

Query: 109 TNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTA--DEIIADFLSELGIMAHVD 165
           ++ +    ++G GG +EV+  R LR  + VA+K L    A        F  E    A ++
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 166 HPNTAKLLGYGIE-----GGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGL 220
           HP    +   G          +IV+E     +L  +++     +      ++     + L
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQAL 124

Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK-VEGTFGLV 279
            + H+     IIHRD+K ANI+++     ++ DFG+A+ + +     T +  V GT    
Sbjct: 125 NFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY- 180

Query: 280 KLNLPPLVILKRCFTC 295
              L P          
Sbjct: 181 ---LSPEQARGDSVDA 193

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (292), Expect = 5e-31
 Identities = 28/163 (17%), Positives = 54/163 (33%), Gaps = 9/163 (5%)

Query: 111 NFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
            +     +G+G +  V++     + +    K +     D+++     E+ I+    H N 
Sbjct: 6   KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL--VKKEISILNIARHRNI 63

Query: 170 AKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQ 228
             L         + ++ E      +   +     +L           V E L +LH    
Sbjct: 64  LHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS--- 120

Query: 229 RRIIHRDIKAANILLTEDFEPQ--ICDFGLAKWLPEQWTHHTI 269
             I H DI+  NI+          I +FG A+ L        +
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL 163

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  115 bits (290), Expect = 6e-31
 Identities = 42/166 (25%), Positives = 75/166 (45%), Gaps = 9/166 (5%)

Query: 109 TNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHP 167
            + + F +++G G ++EV      R  +LVAIK + +   +       +E+ ++  + HP
Sbjct: 8   RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67

Query: 168 NTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEG 226
           N   L      GG ++++++L   G L   +   K         ++   V + + YLH+ 
Sbjct: 68  NIVALDDIYESGGHLYLIMQLVSGGELFDRIV-EKGFYTERDASRLIFQVLDAVKYLHDL 126

Query: 227 CQRRIIHRDIKAANILLT---EDFEPQICDFGLAKWLPEQWTHHTI 269
               I+HRD+K  N+L     ED +  I DFGL+K         T 
Sbjct: 127 G---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTA 169

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (287), Expect = 1e-30
 Identities = 45/193 (23%), Positives = 80/193 (41%), Gaps = 28/193 (14%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLR--------NGQLVAIKRLTRGTADEIIADFLSELGIM 161
           +       +G+G + +V                  VA+K L     ++ ++D +SE+ +M
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72

Query: 162 AHV-DHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMK---------------EKL 204
             +  H N   LLG   + G +++++E +  G+L   L   +               E+L
Sbjct: 73  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132

Query: 205 KWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW 264
                   A  VA G+ YL     ++ IHRD+ A N+L+TED   +I DFGLA+ +    
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189

Query: 265 THHTISKVEGTFG 277
            +   +       
Sbjct: 190 YYKKTTNGRLPVK 202

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (290), Expect = 1e-30
 Identities = 46/169 (27%), Positives = 73/169 (43%), Gaps = 19/169 (11%)

Query: 111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           +++   +IG G +  VY+ +L  +G+LVAIK++ +            EL IM  +DH N 
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNI 75

Query: 170 AKLLGYGIEGG-------MHIVLELSPNGSLASLLYGMKEK--LKWGIRYKIALGVAEGL 220
            +L  +    G       +++VL+  P        +  + K  L           +   L
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135

Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEPQ-ICDFGLAKWLPEQWTHHT 268
            Y+H      I HRDIK  N+LL  D     +CDFG AK L     + +
Sbjct: 136 AYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 181

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  114 bits (285), Expect = 2e-30
 Identities = 42/159 (26%), Positives = 72/159 (45%), Gaps = 4/159 (2%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADE-IIADFLSELGIMAHVDHPN 168
             +     IG+G Y  VYK +   G+  A+K++     DE I +  + E+ I+  + H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61

Query: 169 TAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQ 228
             KL          +++    +  L  LL   +  L+        L +  G+ Y H+   
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD--- 118

Query: 229 RRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH 267
           RR++HRD+K  N+L+  + E +I DFGLA+        +
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY 157

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (288), Expect = 2e-30
 Identities = 38/166 (22%), Positives = 62/166 (37%), Gaps = 11/166 (6%)

Query: 109 TNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHP 167
              ++  + IG+G Y  V       N   VAIK+++           L E+ I+    H 
Sbjct: 7   GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66

Query: 168 NTAKLLGYGIEGGMH-----IVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLY 222
           N   +        +       ++       L  LL    + L           +  GL Y
Sbjct: 67  NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLK--TQHLSNDHICYFLYQILRGLKY 124

Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT 268
           +H      ++HRD+K +N+LL    + +ICDFGLA+       H  
Sbjct: 125 IHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTG 167

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (282), Expect = 9e-30
 Identities = 38/164 (23%), Positives = 66/164 (40%), Gaps = 9/164 (5%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELGIMAHV-D 165
            +F    ++GKG + +V+    +   Q  AIK L +     D+ +   + E  +++   +
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 166 HPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
           HP    +         +  V+E    G L   +     K         A  +  GL +LH
Sbjct: 62  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLH 120

Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT 268
               + I++RD+K  NILL +D   +I DFG+ K          
Sbjct: 121 S---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTN 161

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (280), Expect = 1e-29
 Identities = 41/161 (25%), Positives = 75/161 (46%), Gaps = 6/161 (3%)

Query: 111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADE-IIADFLSELGIMAHVDHPN 168
           NF     IG+G Y  VYK R +  G++VA+K++   T  E + +  + E+ ++  ++HPN
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62

Query: 169 TAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
             KLL        +++V E         +       +   +       + +GL + H   
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS-- 120

Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT 268
             R++HRD+K  N+L+  +   ++ DFGLA+        +T
Sbjct: 121 -HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT 160

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  111 bits (278), Expect = 5e-29
 Identities = 39/196 (19%), Positives = 73/196 (37%), Gaps = 14/196 (7%)

Query: 74  SSMREGIDMPRNLFVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGR-LR 132
            S++E +   +  F+  +++ S Q    L       + F     +G G +  V   +   
Sbjct: 13  ESVKEFLAKAKEDFLKKWETPS-QNTAQL-------DQFDRIKTLGTGSFGRVMLVKHKE 64

Query: 133 NGQLVAIKRLTRGTADEI--IADFLSELGIMAHVDHPNTAKLLGYGIEGGMHIVLELSPN 190
           +G   A+K L +    ++  I   L+E  I+  V+ P   KL     +     ++     
Sbjct: 65  SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVA 124

Query: 191 GSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQ 250
           G           +         A  +     YLH      +I+RD+K  N+L+ +    Q
Sbjct: 125 GGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQ 181

Query: 251 ICDFGLAKWLPEQWTH 266
           + DFG AK +  +   
Sbjct: 182 VTDFGFAKRVKGRTWT 197

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (274), Expect = 8e-29
 Identities = 47/159 (29%), Positives = 73/159 (45%), Gaps = 10/159 (6%)

Query: 116 NLIGKGGYAEVYKGRLRN-GQLVAIKRLTRG----TADEIIADFLSELGIMAHVDHPNTA 170
           + +G+G +A VYK R +N  Q+VAIK++  G      D I    L E+ ++  + HPN  
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 171 KLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQR 229
            LL        + +V +         ++      L         L   +GL YLH+    
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLE-VIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW-- 120

Query: 230 RIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT 268
            I+HRD+K  N+LL E+   ++ DFGLAK        +T
Sbjct: 121 -ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYT 158

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (275), Expect = 1e-28
 Identities = 41/162 (25%), Positives = 70/162 (43%), Gaps = 8/162 (4%)

Query: 110 NNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRG--TADEIIADFLSELGIMAHVDH 166
           N+F +  L+GKG + +V   R    G+  A+K L +    A + +A  ++E  ++ +  H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 167 PNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHE 225
           P    L         +  V+E +  G L   L   +   +   R+  A    E +  L  
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGA----EIVSALEY 120

Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH 267
              R +++RDIK  N++L +D   +I DFGL K         
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM 162

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (266), Expect = 1e-27
 Identities = 49/202 (24%), Positives = 83/202 (41%), Gaps = 22/202 (10%)

Query: 105 LQSATNNFSFENLIGKGGYAEVYKGRLR--NGQLVAIKRLTRGTADEIIA-DFLSELGIM 161
           L  A   +     IG+G Y +V+K R     G+ VA+KR+   T +E +    + E+ ++
Sbjct: 2   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 61

Query: 162 AH---VDHPNTAKLLGYGIEGG------MHIVLELSPNGSLASLLYGMKEKLKWGIRYKI 212
            H    +HPN  +L              + +V E         L    +  +       +
Sbjct: 62  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDM 121

Query: 213 ALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKV 272
              +  GL +LH     R++HRD+K  NIL+T   + ++ DFGLA+    Q    +   V
Sbjct: 122 MFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS---V 175

Query: 273 EGTFGLVKLNLPPLVILKRCFT 294
             T         P V+L+  + 
Sbjct: 176 VVTLWY----RAPEVLLQSSYA 193

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (264), Expect = 2e-27
 Identities = 36/161 (22%), Positives = 69/161 (42%), Gaps = 5/161 (3%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADE-IIADFLSELGIMAHVDHP 167
             +     IG+G Y  V+K + R   ++VA+KR+     DE + +  L E+ ++  + H 
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 168 NTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
           N  +L           ++    +  L          L   I       + +GL + H   
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH--- 118

Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT 268
            R ++HRD+K  N+L+  + E ++ +FGLA+        ++
Sbjct: 119 SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYS 159

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (263), Expect = 4e-27
 Identities = 43/181 (23%), Positives = 77/181 (42%), Gaps = 17/181 (9%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADE-IIADFLSELGIMAHVDHP 167
           + +     IG+G + EV+K R R  GQ VA+K++      E      L E+ I+  + H 
Sbjct: 10  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69

Query: 168 NTAKLLGYGI---------EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE 218
           N   L+             +G +++V +   +         +   L      +I   +  
Sbjct: 70  NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGL----LSNVLVKFTLSEIKRVMQM 125

Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL--PEQWTHHTISKVEGTF 276
            L  L+   + +I+HRD+KAAN+L+T D   ++ DFGLA+     +    +  +    T 
Sbjct: 126 LLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTL 185

Query: 277 G 277
            
Sbjct: 186 W 186

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  104 bits (259), Expect = 1e-26
 Identities = 36/166 (21%), Positives = 66/166 (39%), Gaps = 11/166 (6%)

Query: 110 NNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPN 168
            ++     IG+G +  +++G  L N Q VAIK   R +    + D      ++A      
Sbjct: 5   VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIP 64

Query: 169 TAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQ 228
              +  +G EG  ++++      SL  LL     K         A  +   +  +H   +
Sbjct: 65  --NVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---E 119

Query: 229 RRIIHRDIKAANILLTEDFEPQ-----ICDFGLAKWLPEQWTHHTI 269
           + +++RDIK  N L+            + DFG+ K+  +  T   I
Sbjct: 120 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHI 165

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (259), Expect = 2e-26
 Identities = 41/168 (24%), Positives = 69/168 (41%), Gaps = 13/168 (7%)

Query: 110 NNFSFENLIGKGGYAEVYKGRL----RNGQLVAIKRLTRGTA---DEIIADFLSELGIMA 162
            NF    ++G G Y +V+  R       G+L A+K L + T     +      +E  ++ 
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 163 HVDH-PNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGL 220
           H+   P    L         +H++L+    G L + L   +   +  ++  +     E +
Sbjct: 84  HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVG----EIV 139

Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT 268
           L L    +  II+RDIK  NILL  +    + DFGL+K      T   
Sbjct: 140 LALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERA 187

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (252), Expect = 9e-26
 Identities = 34/170 (20%), Positives = 61/170 (35%), Gaps = 13/170 (7%)

Query: 110 NNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTAD-----EIIADFLSELGIMAH 163
           + +    L+G GG+  VY G  + +   VAIK + +                 E+ ++  
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63

Query: 164 VD--HPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGL 220
           V        +LL +        ++LE              +  L+  +       V E +
Sbjct: 64  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123

Query: 221 LYLHEGCQRRIIHRDIKAANILLTED-FEPQICDFGLAKWLPEQWTHHTI 269
            + H      ++HRDIK  NIL+  +  E ++ DFG    L +       
Sbjct: 124 RHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD 170

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (254), Expect = 1e-25
 Identities = 34/166 (20%), Positives = 59/166 (35%), Gaps = 20/166 (12%)

Query: 115 ENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKL 172
             ++G G   +V +    R  +  A+K L              E+ +       P+  ++
Sbjct: 17  SQVLGLGINGKVLQIFNKRTQEKFALKMLQD------CPKARREVELHWRASQCPHIVRI 70

Query: 173 LGYG-----IEGGMHIVLELSPNGSLASLLYGMKEK-LKWGIRYKIALGVAEGLLYLHEG 226
           +            + IV+E    G L S +    ++        +I   + E + YLH  
Sbjct: 71  VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS- 129

Query: 227 CQRRIIHRDIKAANILLTEDFEP---QICDFGLAKWLPEQWTHHTI 269
               I HRD+K  N+L T        ++ DFG AK      +  T 
Sbjct: 130 --INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP 173

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (254), Expect = 2e-25
 Identities = 50/180 (27%), Positives = 71/180 (39%), Gaps = 15/180 (8%)

Query: 100 FSLYELQSAT----NNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIAD- 153
           F   E+          +     +G G Y  V      R G  VAIK+L R    E+ A  
Sbjct: 4   FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63

Query: 154 FLSELGIMAHVDHPNTAKLLGYGIEGG-----MHIVLELSPNGSLASLLYGMKEKLKWGI 208
              EL ++ H+ H N   LL                L +   G+    L    EKL    
Sbjct: 64  AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLM-KHEKLGEDR 122

Query: 209 RYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT 268
              +   + +GL Y+H      IIHRD+K  N+ + ED E +I DFGLA+    + T + 
Sbjct: 123 IQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYV 179

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  100 bits (250), Expect = 2e-25
 Identities = 41/165 (24%), Positives = 62/165 (37%), Gaps = 11/165 (6%)

Query: 110 NNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPN 168
           N +     IG G + ++Y G  +  G+ VAIK     T          E  I   +    
Sbjct: 7   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP---QLHIESKIYKMMQGGV 63

Query: 169 TAKLLGY-GIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
               + + G EG  ++++      SL  L      K        +A  +   + Y+H   
Sbjct: 64  GIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS-- 121

Query: 228 QRRIIHRDIKAANILLTE---DFEPQICDFGLAKWLPEQWTHHTI 269
            +  IHRD+K  N L+          I DFGLAK   +  TH  I
Sbjct: 122 -KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHI 165

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.7 bits (245), Expect = 1e-24
 Identities = 40/180 (22%), Positives = 67/180 (37%), Gaps = 15/180 (8%)

Query: 101 SLYELQSATNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADE-----IIADF 154
           +++  ++  + +     +G G +A V K R    G   A K + +             D 
Sbjct: 1   TVFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDI 60

Query: 155 LSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIA 213
             E+ I+  + HPN   L         + ++LEL   G L       KE L      +  
Sbjct: 61  EREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFD-FLAEKESLTEEEATEFL 119

Query: 214 LGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQ----ICDFGLAKWLPEQWTHHTI 269
             +  G   ++     +I H D+K  NI+L +   P+    I DFGLA  +        I
Sbjct: 120 KQILNG---VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI 176

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score = 95.7 bits (237), Expect = 2e-23
 Identities = 33/166 (19%), Positives = 67/166 (40%), Gaps = 17/166 (10%)

Query: 110 NNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHP 167
           +++     +G+G Y+EV++   + N + V +K L      +       E+ I+ ++   P
Sbjct: 35  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKK----IKREIKILENLRGGP 90

Query: 168 NTAKLLGYG---IEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
           N   L       +     +V E   N     L     + L           + + L Y H
Sbjct: 91  NIITLADIVKDPVSRTPALVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCH 146

Query: 225 EGCQRRIIHRDIKAANILLT-EDFEPQICDFGLAKWLPEQWTHHTI 269
                 I+HRD+K  N+++  E  + ++ D+GLA++      ++  
Sbjct: 147 ---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR 189

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 91.9 bits (227), Expect = 8e-22
 Identities = 44/170 (25%), Positives = 72/170 (42%), Gaps = 13/170 (7%)

Query: 109 TNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDH 166
              +   + +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H
Sbjct: 17  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76

Query: 167 PNTAKLLGYGI------EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGL 220
            N   LL          E     ++       L ++     +KL       +   +  GL
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI--VKCQKLTDDHVQFLIYQILRGL 134

Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTIS 270
            Y+H      IIHRD+K +N+ + ED E +I DFGLA+   ++ T +  +
Sbjct: 135 KYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT 181

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 90.0 bits (222), Expect = 4e-21
 Identities = 38/167 (22%), Positives = 64/167 (38%), Gaps = 16/167 (9%)

Query: 110 NNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADE-IIADFLSELGIMAHVDHP 167
             +     IG G    V         + VAIK+L+R   ++        EL +M  V+H 
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76

Query: 168 NTAKLLGYGIEGG-------MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGL 220
           N   LL              +++V+EL        +   +  +        +   +  G+
Sbjct: 77  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMS----YLLYQMLCGI 132

Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH 267
            +LH       IHRD+K +NI++  D   +I DFGLA+     +   
Sbjct: 133 KHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMT 176

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 83.3 bits (205), Expect = 8e-20
 Identities = 25/160 (15%), Positives = 51/160 (31%), Gaps = 26/160 (16%)

Query: 113 SFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTA---------DEIIADFLSELGIMAH 163
           +   L+G+G  + V+           +K    G           D     F       A 
Sbjct: 3   AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSAR 62

Query: 164 VDHPNTAKLLGYGIE-----GGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE 218
            +     KL G  +       G  +++EL               +++     ++   + E
Sbjct: 63  NEFRALQKLQGLAVPKVYAWEGNAVLMELID--------AKELYRVRVENPDEVLDMILE 114

Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
            +   +    R I+H D+   N+L++ +    I DF  + 
Sbjct: 115 EVAKFY---HRGIVHGDLSQYNVLVS-EEGIWIIDFPQSV 150

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 78.2 bits (191), Expect = 5e-17
 Identities = 32/184 (17%), Positives = 61/184 (33%), Gaps = 22/184 (11%)

Query: 112 FSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTA 170
           +     +G G ++ V+  + + N   VA+K +              E+ ++  V+  +  
Sbjct: 15  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG--DKVYTEAAEDEIKLLQRVNDADNT 72

Query: 171 KLLGYGIEG----------------GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIAL 214
           K    G                    + +V E+     LA +       +      +I+ 
Sbjct: 73  KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISK 132

Query: 215 GVAEGLLYLHEGCQRRIIHRDIKAANILLT-EDFEPQICDFGLAKWLPEQWTHHTISKVE 273
            +  GL Y+H   +  IIH DIK  N+L+   D    +    +A      W     +   
Sbjct: 133 QLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI 190

Query: 274 GTFG 277
            T  
Sbjct: 191 QTRE 194

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	308
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.98
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.92
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.48
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.02
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.56
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.09
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.88
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.01

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-49  Score=350.26  Aligned_cols=195  Identities=25%  Similarity=0.298  Sum_probs=168.2

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeCc-EEEEEEe
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLEL  187 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~  187 (308)
                      ++|++.+.||+|+||+||+|+++ +|+.||||.+......+..+.+.+|+.+|+.++|||||++++++.+++ .|+||||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy   84 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   84 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence            57999999999999999999986 689999999976554445577999999999999999999999777654 7899999


Q ss_pred             cCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCcee
Q 021711          188 SPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH  267 (308)
Q Consensus       188 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~  267 (308)
                      +++|+|.+++.. ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+|+.+.......
T Consensus        85 ~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~al~ylH~---~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~  160 (271)
T d1nvra_          85 CSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER  160 (271)
T ss_dssp             CTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred             cCCCcHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH---cCCccCcccHHHEEECCCCCEEEccchhheeeccCCccc
Confidence            999999998853 4579999999999999999999999   999999999999999999999999999999876554444


Q ss_pred             EeeceeccccccccccCchhhc-CccceeEEEeeEEEeeccC
Q 021711          268 TISKVEGTFGLVKLNLPPLVIL-KRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~s~g~~l~el~c~  308 (308)
                      ......||+.|||||.+.+..+ +.++|+||+|+++|||++|
T Consensus       161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G  202 (271)
T d1nvra_         161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG  202 (271)
T ss_dssp             CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHS
T ss_pred             cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhC
Confidence            4567789999999999876654 6789999999999999876

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-49  Score=352.02  Aligned_cols=198  Identities=26%  Similarity=0.376  Sum_probs=167.2

Q ss_pred             HhhcCCccccceeeccCceEEEEEEECCCcEEEEEEeccCC-hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeCcEEEE
Q 021711          106 QSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHIV  184 (308)
Q Consensus       106 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~lv  184 (308)
                      +...++|++.+.||+|+||+||+|+++  ..||||.++... ..+..+.|.+|+.+|++++|||||++++++.++.+++|
T Consensus         4 ei~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~lv   81 (276)
T d1uwha_           4 EIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIV   81 (276)
T ss_dssp             BCCTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEE
T ss_pred             ccccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEeccEEEEE
Confidence            345678999999999999999999864  359999986432 33456889999999999999999999999988889999


Q ss_pred             EEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCC
Q 021711          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (308)
Q Consensus       185 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  264 (308)
                      |||+++|+|.+++......+++..++.++.||+.||.|||+   ++||||||||+|||++.++.+||+|||+|+......
T Consensus        82 ~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~---~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~  158 (276)
T d1uwha_          82 TQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS  158 (276)
T ss_dssp             EECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred             EecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhc---CCEeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence            99999999999997767789999999999999999999999   899999999999999999999999999998876544


Q ss_pred             ceeEeeceeccccccccccCch---hhcCccceeEEEeeEEEeeccC
Q 021711          265 THHTISKVEGTFGLVKLNLPPL---VILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      .........||+.|||||.+..   ..++.++||||||++||||++|
T Consensus       159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg  205 (276)
T d1uwha_         159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTG  205 (276)
T ss_dssp             -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHS
T ss_pred             CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHC
Confidence            4444567789999999998743   2367889999999999999876

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-48  Score=346.35  Aligned_cols=198  Identities=24%  Similarity=0.346  Sum_probs=174.5

Q ss_pred             HHhhcCCccccceeeccCceEEEEEEECCCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeCcEEEE
Q 021711          105 LQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHIV  184 (308)
Q Consensus       105 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~lv  184 (308)
                      ++...++|++.+.||+|+||.||+|.+++++.||||.+......  .+.|.+|+.+|.+++|||||++++++.++..++|
T Consensus         8 wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~--~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~iv   85 (272)
T d1qpca_           8 WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS--PDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYII   85 (272)
T ss_dssp             TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC--HHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEE
T ss_pred             eecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCC--HHHHHHHHHHHHhCCCCCEeEEEeeeccCCeEEE
Confidence            33445689999999999999999999988889999999765433  3679999999999999999999999988889999


Q ss_pred             EEecCCCCHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCC
Q 021711          185 LELSPNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ  263 (308)
Q Consensus       185 ~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  263 (308)
                      |||+++|+|.+++... ...+++..++.++.||+.||.|||+   ++|+||||||+||||+.++.+||+|||+|+.+...
T Consensus        86 ~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~---~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~  162 (272)
T d1qpca_          86 TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN  162 (272)
T ss_dssp             EECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred             EEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccchhheeeecccceeeccccceEEccCC
Confidence            9999999999987543 2358999999999999999999999   89999999999999999999999999999987654


Q ss_pred             CceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          264 WTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      .. .......||+.|+|||.+....++.++||||||+++|||+++
T Consensus       163 ~~-~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~  206 (272)
T d1qpca_         163 EY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTH  206 (272)
T ss_dssp             CE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTT
T ss_pred             cc-ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhC
Confidence            32 233467899999999998888889999999999999999874

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.4e-48  Score=338.66  Aligned_cols=193  Identities=23%  Similarity=0.360  Sum_probs=161.5

Q ss_pred             cCCccccceeeccCceEEEEEEECCCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEe-CcEEEEEEe
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLEL  187 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~lv~e~  187 (308)
                      .++|++.+.||+|+||.||+|++.+++.||||.+......  .++|.+|+.++++++|||||++++++.. +..++||||
T Consensus         4 p~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~--~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~   81 (263)
T d1sm2a_           4 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF   81 (263)
T ss_dssp             CSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSC--HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             hHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCc--HHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEe
Confidence            3579999999999999999999988899999999765433  3679999999999999999999998775 468999999


Q ss_pred             cCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCcee
Q 021711          188 SPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH  267 (308)
Q Consensus       188 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~  267 (308)
                      +++|+|.+++......+++..++.++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+|+.+...... 
T Consensus        82 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~-  157 (263)
T d1sm2a_          82 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-  157 (263)
T ss_dssp             CTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred             cCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhc---cceeecccchhheeecCCCCeEecccchheeccCCCce-
Confidence            99999999997777789999999999999999999999   89999999999999999999999999999987554332 


Q ss_pred             EeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          268 TISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      ......||+.|+|||.+.+..++.++||||||+++|||++
T Consensus       158 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t  197 (263)
T d1sm2a_         158 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFS  197 (263)
T ss_dssp             -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHT
T ss_pred             eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHH
Confidence            2345679999999999988889999999999999999986

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-47  Score=339.72  Aligned_cols=196  Identities=24%  Similarity=0.355  Sum_probs=173.4

Q ss_pred             cCCccccce-eeccCceEEEEEEEC---CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeCcEEEE
Q 021711          109 TNNFSFENL-IGKGGYAEVYKGRLR---NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHIV  184 (308)
Q Consensus       109 ~~~~~~~~~-LG~G~fg~Vy~~~~~---~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~lv  184 (308)
                      .++|.+.+. ||+|+||.||+|.++   ++..||||.++........++|.+|+.+|++++|||||++++++..+.+++|
T Consensus         7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~lv   86 (285)
T d1u59a_           7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLV   86 (285)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEE
T ss_pred             ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccCeEEEE
Confidence            356777775 999999999999865   3558999999876666667889999999999999999999999988889999


Q ss_pred             EEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCC
Q 021711          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (308)
Q Consensus       185 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  264 (308)
                      |||+++|+|.+++...+..+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+|+.+....
T Consensus        87 mE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~  163 (285)
T d1u59a_          87 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD  163 (285)
T ss_dssp             EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred             EEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCcCchhheeeccCCceeeccchhhhcccccc
Confidence            99999999999987767789999999999999999999999   899999999999999999999999999999886644


Q ss_pred             cee-EeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          265 THH-TISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       265 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      ... ......||+.|+|||.+....++.++||||||+++|||++
T Consensus       164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt  207 (285)
T d1u59a_         164 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALS  207 (285)
T ss_dssp             CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHT
T ss_pred             cccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHh
Confidence            322 2335678999999999988888999999999999999865

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-47  Score=340.38  Aligned_cols=191  Identities=23%  Similarity=0.298  Sum_probs=168.6

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEEEe
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLEL  187 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~  187 (308)
                      ++|++.+.||+|+||+||+|.+. +|+.||||.+...... ..+.+.+|+.+|+.++|||||++++++..+ .+|+||||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy   98 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS-CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh-HHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence            47999999999999999999975 6999999998654322 246789999999999999999999977665 57899999


Q ss_pred             cCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCcee
Q 021711          188 SPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH  267 (308)
Q Consensus       188 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~  267 (308)
                      +++|+|.+++..  ..+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+|+.+.....  
T Consensus        99 ~~gg~L~~~~~~--~~l~~~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~--  171 (293)
T d1yhwa1          99 LAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--  171 (293)
T ss_dssp             CTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--
T ss_pred             cCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCcHHHeEECCCCcEeeccchhheeeccccc--
Confidence            999999998754  569999999999999999999999   9999999999999999999999999999998755432  


Q ss_pred             EeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          268 TISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ......||+.|+|||.+.+..++.++|+||+|+++|||++|
T Consensus       172 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG  212 (293)
T d1yhwa1         172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG  212 (293)
T ss_dssp             CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHS
T ss_pred             cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhC
Confidence            23466899999999999888889999999999999999876

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-47  Score=336.72  Aligned_cols=191  Identities=25%  Similarity=0.380  Sum_probs=168.7

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCCh--HHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVL  185 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~  185 (308)
                      ++|++.+.||+|+||+||+|+++ +|+.||+|.+.....  ....+.+.+|+.+++.++|||||++++++.++ .+++||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            47999999999999999999986 589999999864321  12356788999999999999999999987765 478999


Q ss_pred             EecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCc
Q 021711          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (308)
Q Consensus       186 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~  265 (308)
                      ||+++|+|.+++.. ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+|+...... 
T Consensus        86 Ey~~~g~L~~~l~~-~~~l~e~~~~~i~~qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~-  160 (263)
T d2j4za1          86 EYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-  160 (263)
T ss_dssp             ECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC-
T ss_pred             eecCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeeeeccccceecCCCCEeecccceeeecCCCc-
Confidence            99999999999864 4579999999999999999999999   999999999999999999999999999998775542 


Q ss_pred             eeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          266 HHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                         .....||+.|||||.+.+..++.++|+||+|++||||++|
T Consensus       161 ---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G  200 (263)
T d2j4za1         161 ---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG  200 (263)
T ss_dssp             ---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHS
T ss_pred             ---ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcC
Confidence               2356899999999999888889999999999999999876

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-48  Score=353.08  Aligned_cols=194  Identities=23%  Similarity=0.340  Sum_probs=170.2

Q ss_pred             hcCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEE
Q 021711          108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVL  185 (308)
Q Consensus       108 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~  185 (308)
                      ..++|++.+.||+|+||+||+|++. +|+.||+|.++........+.+.+|+.+|+.++|||||++++++.+. .+++||
T Consensus         4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm   83 (322)
T d1s9ja_           4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM   83 (322)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            4578999999999999999999976 68999999997655555567899999999999999999999977665 589999


Q ss_pred             EecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCc
Q 021711          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (308)
Q Consensus       186 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~  265 (308)
                      ||+++|+|.+++.. ...+++..+..++.|++.||.|||+  .++|+||||||+|||++.++.+||+|||+|+.+.... 
T Consensus        84 Ey~~gg~L~~~l~~-~~~l~~~~~~~~~~qil~aL~yLH~--~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~-  159 (322)
T d1s9ja_          84 EHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-  159 (322)
T ss_dssp             ECCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT-
T ss_pred             EcCCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHH--hCCEEccccCHHHeeECCCCCEEEeeCCCccccCCCc-
Confidence            99999999999965 4569999999999999999999996  1489999999999999999999999999999764322 


Q ss_pred             eeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          266 HHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                         .....||+.|+|||.+.+..++.++|+||+|+++|||++|
T Consensus       160 ---~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G  199 (322)
T d1s9ja_         160 ---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG  199 (322)
T ss_dssp             ---C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHS
T ss_pred             ---cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHC
Confidence               2356899999999999888899999999999999999886

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-47  Score=338.96  Aligned_cols=197  Identities=22%  Similarity=0.314  Sum_probs=158.8

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCC-hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEe---CcEEEE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGIE---GGMHIV  184 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---~~~~lv  184 (308)
                      ++|++.+.||+|+||+||+|+.+ +|+.||||.+.... .+...+.+.+|+++|++++|||||++++++.+   +.+|+|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            57999999999999999999976 68999999997543 34456789999999999999999999997753   347999


Q ss_pred             EEecCCCCHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCceecCCCCCCEEECCCCcEEEecccccee
Q 021711          185 LELSPNGSLASLLYG---MKEKLKWGIRYKIALGVAEGLLYLHEGC--QRRIIHRDIKAANILLTEDFEPQICDFGLAKW  259 (308)
Q Consensus       185 ~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~yLH~~~--~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~  259 (308)
                      |||+++|+|.+++..   ....+++..++.++.||+.||.|||+..  ..+|+||||||+|||++.++.+||+|||+|+.
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~  163 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  163 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence            999999999999854   3467999999999999999999999821  12499999999999999999999999999998


Q ss_pred             cCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          260 LPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       260 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      +.....  ......||+.|||||.+.+..++.++|+||+|+++|||++|
T Consensus       164 ~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg  210 (269)
T d2java1         164 LNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCAL  210 (269)
T ss_dssp             C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHS
T ss_pred             cccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhC
Confidence            754322  23467899999999999888889999999999999999876

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-47  Score=341.39  Aligned_cols=195  Identities=27%  Similarity=0.322  Sum_probs=166.8

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCC--hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVL  185 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~  185 (308)
                      ++|++.+.||+|+||+||+|++. +|+.||||.+....  .....+.+.+|+.+|++++|||||++++++.+. .+|+||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            57999999999999999999986 68999999986432  122356789999999999999999999977665 578999


Q ss_pred             EecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCc
Q 021711          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (308)
Q Consensus       186 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~  265 (308)
                      ||+++|+|.+++.. .+.+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+|+.+.....
T Consensus        88 Ey~~gg~L~~~~~~-~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~  163 (288)
T d1uu3a_          88 SYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK  163 (288)
T ss_dssp             CCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             EccCCCCHHHhhhc-cCCCCHHHHHHHHHHHHHHHHhhcc---ccEEcCcCCccccccCCCceEEecccccceecccCCc
Confidence            99999999998864 4679999999999999999999999   9999999999999999999999999999998865444


Q ss_pred             eeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          266 HHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ........||+.|+|||.+.+..++.++|+||+|++||||++|
T Consensus       164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g  206 (288)
T d1uu3a_         164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG  206 (288)
T ss_dssp             ------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHS
T ss_pred             ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhC
Confidence            3344567899999999999888889999999999999999886

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.4e-47  Score=341.71  Aligned_cols=198  Identities=22%  Similarity=0.352  Sum_probs=173.6

Q ss_pred             HHhhcCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEE
Q 021711          105 LQSATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMH  182 (308)
Q Consensus       105 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~  182 (308)
                      |+...++|++.+.||+|+||+||+|.+. +|+.||||.++.....  .++|.+|+.+|++++|||||++++++.++ ..+
T Consensus        12 wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~--~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   89 (287)
T d1opja_          12 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY   89 (287)
T ss_dssp             TBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC--HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             cEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch--HHHHHHHHHHHHhCCCCCEecCCccEeeCCeeE
Confidence            3445578999999999999999999986 5889999998765433  46799999999999999999999987764 588


Q ss_pred             EEEEecCCCCHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecC
Q 021711          183 IVLELSPNGSLASLLYG-MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP  261 (308)
Q Consensus       183 lv~e~~~~gsL~~~l~~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~  261 (308)
                      +||||+++|+|.+++.. ....+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+|+...
T Consensus        90 iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~  166 (287)
T d1opja_          90 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMT  166 (287)
T ss_dssp             EEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCCTTTCC
T ss_pred             EEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHH---CCcccCccccCeEEECCCCcEEEccccceeecC
Confidence            99999999999999865 34578999999999999999999999   899999999999999999999999999999776


Q ss_pred             CCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          262 EQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       262 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      .... .......||+.|+|||.+.+..++.++||||||+++|||+++
T Consensus       167 ~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~  212 (287)
T d1opja_         167 GDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATY  212 (287)
T ss_dssp             SSSS-EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTT
T ss_pred             CCCc-eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhC
Confidence            5433 344567799999999998888899999999999999999874

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-47  Score=340.93  Aligned_cols=193  Identities=23%  Similarity=0.357  Sum_probs=167.4

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEEEe
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLEL  187 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~  187 (308)
                      +.|++.+.||+|+||.||+|++. +|+.||||.+...... ..+.+.+|+++|+.++|||||++++++.++ .+++||||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy   90 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEE-ELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF   90 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSG-GGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHH-HHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEec
Confidence            46899999999999999999976 5899999999765433 356789999999999999999999977664 57899999


Q ss_pred             cCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCcee
Q 021711          188 SPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH  267 (308)
Q Consensus       188 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~  267 (308)
                      +++|+|.+++......+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+|+......  .
T Consensus        91 ~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~---~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~--~  165 (288)
T d2jfla1          91 CAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--Q  165 (288)
T ss_dssp             CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH--H
T ss_pred             CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEEEeecChhheeECCCCCEEEEechhhhccCCCc--c
Confidence            99999999987666779999999999999999999999   999999999999999999999999999998753321  1


Q ss_pred             EeeceeccccccccccCc-----hhhcCccceeEEEeeEEEeeccC
Q 021711          268 TISKVEGTFGLVKLNLPP-----LVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ......||+.|+|||.+.     +..++.++|+||+|+++|||++|
T Consensus       166 ~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg  211 (288)
T d2jfla1         166 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEI  211 (288)
T ss_dssp             HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHS
T ss_pred             cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhC
Confidence            223578999999999863     33467889999999999999886

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=5e-47  Score=339.98  Aligned_cols=196  Identities=28%  Similarity=0.401  Sum_probs=159.6

Q ss_pred             cCCccccceeeccCceEEEEEEECC-C---cEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLRN-G---QLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHI  183 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~~-g---~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l  183 (308)
                      .++|++.++||+|+||+||+|.++. +   ..||||.+.........+.|.+|+.+|++++|||||++++++..+ .+++
T Consensus        25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i  104 (299)
T d1jpaa_          25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI  104 (299)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            3578889999999999999998753 3   368999987766666678899999999999999999999988664 5899


Q ss_pred             EEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCC
Q 021711          184 VLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ  263 (308)
Q Consensus       184 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  263 (308)
                      ||||+++|+|.+++......+++..++.++.||+.||.|||+   ++|+||||||+||||+.++.+||+|||+|+.+...
T Consensus       105 v~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~  181 (299)
T d1jpaa_         105 ITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD  181 (299)
T ss_dssp             EEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred             EEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhh---CCCccCccccceEEECCCCcEEECCcccceEccCC
Confidence            999999999999987767789999999999999999999999   99999999999999999999999999999987654


Q ss_pred             CceeE---eeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          264 WTHHT---ISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       264 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      .....   .....||+.|||||.+....++.++||||||++||||++
T Consensus       182 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t  228 (299)
T d1jpaa_         182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS  228 (299)
T ss_dssp             --------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHT
T ss_pred             CCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHh
Confidence            33222   223568999999999888888999999999999999975

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-46  Score=334.86  Aligned_cols=197  Identities=27%  Similarity=0.361  Sum_probs=164.2

Q ss_pred             cCCccccceeeccCceEEEEEEECCC-----cEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEe-CcEE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLRNG-----QLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMH  182 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~~g-----~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~  182 (308)
                      .+.|+..++||+|+||.||+|.++.+     ..||||.+.....+....+|++|+.+|++++|||||+++|++.+ +..+
T Consensus         6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~   85 (283)
T d1mqba_           6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM   85 (283)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence            35788999999999999999987632     47999999776666666789999999999999999999998875 4578


Q ss_pred             EEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCC
Q 021711          183 IVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE  262 (308)
Q Consensus       183 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~  262 (308)
                      +||||+.++++.+++......+++..++.++.||+.||.|||+   ++|+||||||+||||+.++.+||+|||+|+.+..
T Consensus        86 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~  162 (283)
T d1mqba_          86 IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  162 (283)
T ss_dssp             EEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred             EEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccc---cccccCccccceEEECCCCeEEEcccchhhcccC
Confidence            9999999999999887777789999999999999999999999   8999999999999999999999999999998755


Q ss_pred             CCce-eEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          263 QWTH-HTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       263 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      .... .......||+.|+|||.+.+..++.++||||||+++|||+++
T Consensus       163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~  209 (283)
T d1mqba_         163 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTY  209 (283)
T ss_dssp             -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTT
T ss_pred             CCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhC
Confidence            4322 223456789999999998888889999999999999999873

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-46  Score=328.59  Aligned_cols=188  Identities=26%  Similarity=0.347  Sum_probs=161.9

Q ss_pred             ccccceeeccCceEEEEEEEC-CCcEEEEEEeccCC-hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEe-----CcEEEE
Q 021711          112 FSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-----GGMHIV  184 (308)
Q Consensus       112 ~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~~~lv  184 (308)
                      |++.+.||+|+||+||+|.+. +++.||+|.+.... .....+.|.+|+++|++++|||||++++++..     ..+++|
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv   90 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV   90 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence            467788999999999999976 58899999986542 34456789999999999999999999997653     237899


Q ss_pred             EEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--ceecCCCCCCEEEC-CCCcEEEeccccceecC
Q 021711          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRR--IIHRDIKAANILLT-EDFEPQICDFGLAKWLP  261 (308)
Q Consensus       185 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~--iiHrDlKp~NILl~-~~~~~kl~DFGla~~~~  261 (308)
                      |||+++|+|.+++.. ...+++..+..++.||+.||.|||+   ++  |+||||||+|||++ +++.+||+|||+|+...
T Consensus        91 mE~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~gl~yLH~---~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~  166 (270)
T d1t4ha_          91 TELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  166 (270)
T ss_dssp             EECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             EeCCCCCcHHHHHhc-cccccHHHHHHHHHHHHHHHHHHHH---CCCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence            999999999999964 4578999999999999999999998   66  99999999999997 57899999999998654


Q ss_pred             CCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          262 EQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       262 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ...    .....||+.|||||.+.+ .++.++|+||+|+++|||++|
T Consensus       167 ~~~----~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g  208 (270)
T d1t4ha_         167 ASF----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATS  208 (270)
T ss_dssp             TTS----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHS
T ss_pred             CCc----cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHC
Confidence            432    235689999999998865 478899999999999999886

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-46  Score=338.92  Aligned_cols=195  Identities=27%  Similarity=0.407  Sum_probs=167.6

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCc----EEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeCcEEEE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQ----LVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHIV  184 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~----~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~lv  184 (308)
                      .+|++.++||+|+||+||+|.+. +|+    .||+|.+......+..+.|.+|+.++++++|||||++++++.++..+++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~v   88 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLI   88 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeeEE
Confidence            47999999999999999999875 343    6899988765544456789999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCC
Q 021711          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (308)
Q Consensus       185 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  264 (308)
                      +|++.+|+|.+.+......+++..++.++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+|+.+....
T Consensus        89 ~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~---~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~  165 (317)
T d1xkka_          89 TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE  165 (317)
T ss_dssp             EECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTC
T ss_pred             EEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHH---cCcccCcchhhcceeCCCCCeEeeccccceeccccc
Confidence            99999999999988777889999999999999999999999   899999999999999999999999999999886655


Q ss_pred             ceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          265 THHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      .........||+.|+|||.+.+..++.++|+||||++||||++
T Consensus       166 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t  208 (317)
T d1xkka_         166 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT  208 (317)
T ss_dssp             C--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred             ccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHH
Confidence            5444556789999999999988889999999999999999986

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-46  Score=339.23  Aligned_cols=198  Identities=22%  Similarity=0.282  Sum_probs=168.3

Q ss_pred             hhcCCccccceeeccCceEEEEEEECC-C-----cEEEEEEeccCChHHHHHHHHHHHHHHhcC-CCCeeeeeeeEEEeC
Q 021711          107 SATNNFSFENLIGKGGYAEVYKGRLRN-G-----QLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGIEG  179 (308)
Q Consensus       107 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~-g-----~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  179 (308)
                      ...++|++.++||+|+||+||+|++.. +     ..||+|.+...........+.+|+.+|.++ +|||||++++++.+.
T Consensus        34 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~  113 (325)
T d1rjba_          34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS  113 (325)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             CCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence            445689999999999999999998653 2     369999987655555567899999999998 899999999987654


Q ss_pred             -cEEEEEEecCCCCHHHHHhccC----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCC
Q 021711          180 -GMHIVLELSPNGSLASLLYGMK----------------------EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDI  236 (308)
Q Consensus       180 -~~~lv~e~~~~gsL~~~l~~~~----------------------~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDl  236 (308)
                       .+++||||+++|+|.+++....                      ..+++..++.++.||+.||.|||+   ++||||||
T Consensus       114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~---~~IiHRDl  190 (325)
T d1rjba_         114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDL  190 (325)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTC
T ss_pred             CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccC
Confidence             5899999999999999996543                      247889999999999999999999   89999999


Q ss_pred             CCCCEEECCCCcEEEeccccceecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          237 KAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       237 Kp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      ||+|||++.++.+||+|||+|+...............||+.|||||.+.+..++.++||||||++||||++
T Consensus       191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt  261 (325)
T d1rjba_         191 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS  261 (325)
T ss_dssp             SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTT
T ss_pred             chhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHh
Confidence            99999999999999999999998766555445567789999999999988889999999999999999874

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-46  Score=335.52  Aligned_cols=195  Identities=25%  Similarity=0.341  Sum_probs=166.5

Q ss_pred             hcCCccccceeeccCceEEEEEEECCCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeCcEEEEEEe
Q 021711          108 ATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHIVLEL  187 (308)
Q Consensus       108 ~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~lv~e~  187 (308)
                      ..++|++.+.||+|+||.||+|++++++.||||.+......  .+.|.+|+.+|++++|||||++++++.++..++||||
T Consensus        15 ~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~--~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~lv~Ey   92 (285)
T d1fmka3          15 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEY   92 (285)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC--HHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEECC
T ss_pred             CHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCC--HHHHHHHHHHHHhcccCCEeEEEEEEecCCeEEEEEe
Confidence            34689999999999999999999988888999999755433  3679999999999999999999999988889999999


Q ss_pred             cCCCCHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCce
Q 021711          188 SPNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH  266 (308)
Q Consensus       188 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~  266 (308)
                      +++|+|..++... ...+++..++.++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+|+.+..... 
T Consensus        93 ~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~---~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~-  168 (285)
T d1fmka3          93 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-  168 (285)
T ss_dssp             CTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred             cCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhh---hheecccccceEEEECCCCcEEEcccchhhhccCCCc-
Confidence            9999999888653 4569999999999999999999999   8999999999999999999999999999987754432 


Q ss_pred             eEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          267 HTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      .......||+.|+|||++.....+.++||||||+++|||+|+
T Consensus       169 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~  210 (285)
T d1fmka3         169 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTK  210 (285)
T ss_dssp             -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred             eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhC
Confidence            233456799999999999888899999999999999999874

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-46  Score=326.44  Aligned_cols=193  Identities=20%  Similarity=0.323  Sum_probs=173.1

Q ss_pred             cCCccccceeeccCceEEEEEEECCCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEEEe
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLEL  187 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~  187 (308)
                      .++|++.++||+|+||+||+|++++++.||||.++.....  .+.|++|+.++++++|||||++++++.++ .+++||||
T Consensus         3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~--~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey   80 (258)
T d1k2pa_           3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY   80 (258)
T ss_dssp             CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSC--HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEEC
T ss_pred             hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCC--HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEc
Confidence            3689999999999999999999988889999999765443  36799999999999999999999988764 68999999


Q ss_pred             cCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCcee
Q 021711          188 SPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH  267 (308)
Q Consensus       188 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~  267 (308)
                      +++|+|..++......+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+|+.+..... .
T Consensus        81 ~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~---~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~-~  156 (258)
T d1k2pa_          81 MANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-T  156 (258)
T ss_dssp             CTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH---TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC-C
T ss_pred             cCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhh---cCcccccccceeEEEcCCCcEEECcchhheeccCCCc-e
Confidence            99999999987777789999999999999999999999   8999999999999999999999999999987765433 2


Q ss_pred             EeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          268 TISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      ......||+.|+|||.+.+..++.++|+||||+++|||++
T Consensus       157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t  196 (258)
T d1k2pa_         157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS  196 (258)
T ss_dssp             CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred             eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHh
Confidence            3345779999999999988889999999999999999976

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.6e-46  Score=337.75  Aligned_cols=193  Identities=25%  Similarity=0.402  Sum_probs=152.2

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEEE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLE  186 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e  186 (308)
                      .+.|++.+.||+|+||+||+|+++ +|+.||||.+...........+.+|+.+|+.++|||||++++++.++ .+|+|||
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE   87 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ   87 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            457999999999999999999976 58999999997655444456788999999999999999999977665 4789999


Q ss_pred             ecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEEC---CCCcEEEeccccceecCCC
Q 021711          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLT---EDFEPQICDFGLAKWLPEQ  263 (308)
Q Consensus       187 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~---~~~~~kl~DFGla~~~~~~  263 (308)
                      |++||+|.+++.. ...+++..+..++.||+.||.|||+   ++|+||||||+|||+.   +++.+||+|||+|+.....
T Consensus        88 ~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~  163 (307)
T d1a06a_          88 LVSGGELFDRIVE-KGFYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG  163 (307)
T ss_dssp             CCCSCBHHHHHHT-CSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred             ccCCCcHHHhhhc-ccCCCHHHHHHHHHHHHHHHHhhhh---ceeeeEEecccceeecccCCCceEEEeccceeEEccCC
Confidence            9999999999964 5679999999999999999999999   9999999999999995   4789999999999876544


Q ss_pred             CceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          264 WTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      .   ......||+.|||||.+.+..++.++|+||+|++||||++|
T Consensus       164 ~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g  205 (307)
T d1a06a_         164 S---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG  205 (307)
T ss_dssp             ------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred             C---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhC
Confidence            2   23457899999999998888889999999999999999886

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=7.3e-46  Score=339.13  Aligned_cols=192  Identities=20%  Similarity=0.250  Sum_probs=170.9

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEEEe
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLEL  187 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~  187 (308)
                      ++|++.+.||+|+||.||+|++. +|+.||||.+...... ..+.+.+|+.+|+.++|||||++++++.+. .+++||||
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  104 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHES-DKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  104 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHH-HHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchh-hHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            58999999999999999999976 6899999999765433 357889999999999999999999977665 58899999


Q ss_pred             cCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECC--CCcEEEeccccceecCCCCc
Q 021711          188 SPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTE--DFEPQICDFGLAKWLPEQWT  265 (308)
Q Consensus       188 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~--~~~~kl~DFGla~~~~~~~~  265 (308)
                      +++|+|.+++......+++..+..++.||+.||.|||+   ++||||||||+|||++.  ++.+||+|||+|+.+.....
T Consensus       105 ~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~  181 (350)
T d1koaa2         105 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS  181 (350)
T ss_dssp             CCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSC
T ss_pred             CCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh---cCCeeeeechhHeeeccCCCCeEEEeecchheecccccc
Confidence            99999999997666779999999999999999999999   99999999999999964  57899999999998765532


Q ss_pred             eeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          266 HHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                         .....||+.|||||.+.+..++.++|+||+|+++|||++|
T Consensus       182 ---~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G  221 (350)
T d1koaa2         182 ---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG  221 (350)
T ss_dssp             ---EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHS
T ss_pred             ---cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhC
Confidence               3457899999999999888888999999999999999886

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-46  Score=337.98  Aligned_cols=194  Identities=24%  Similarity=0.294  Sum_probs=170.8

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCCh--HHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIV  184 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv  184 (308)
                      .++|++.+.||+|+||.||+|+.+ +|+.||||++.+...  ....+.+.+|+.+|+.++||||+++++++.+. .+|+|
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv   83 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence            367999999999999999999975 699999999965321  12356789999999999999999999977665 57899


Q ss_pred             EEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCC
Q 021711          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (308)
Q Consensus       185 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  264 (308)
                      |||+++|+|.+++.. ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.+|.+||+|||+|+......
T Consensus        84 ~ey~~gg~L~~~~~~-~~~~~e~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~  159 (337)
T d1o6la_          84 MEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG  159 (337)
T ss_dssp             EECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred             eeccCCCchhhhhhc-ccCCcHHHHHHHHHHHhhhhhhhhh---cCccccccCHHHeEecCCCCEEEeecccccccccCC
Confidence            999999999999865 4578999999999999999999999   999999999999999999999999999999765432


Q ss_pred             ceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          265 THHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      .  ......||+.|+|||.+.+..++.++|+||+|+++|||++|
T Consensus       160 ~--~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G  201 (337)
T d1o6la_         160 A--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG  201 (337)
T ss_dssp             C--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHS
T ss_pred             c--ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHC
Confidence            2  33567899999999999888899999999999999999986

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-46  Score=329.26  Aligned_cols=188  Identities=22%  Similarity=0.291  Sum_probs=161.9

Q ss_pred             ceeeccCceEEEEEEECC---CcEEEEEEeccCC-hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeCcEEEEEEecCCC
Q 021711          116 NLIGKGGYAEVYKGRLRN---GQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHIVLELSPNG  191 (308)
Q Consensus       116 ~~LG~G~fg~Vy~~~~~~---g~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~lv~e~~~~g  191 (308)
                      +.||+|+||.||+|.+++   ++.||||.++... .....++|.+|+.+|++++|||||++++++..+..++||||+++|
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~~~~lvmE~~~~g   92 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELG   92 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSSEEEEEECCTTE
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccCCEEEEEEcCCCC
Confidence            579999999999998653   5689999996543 234467899999999999999999999999888899999999999


Q ss_pred             CHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCcee-Eee
Q 021711          192 SLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH-TIS  270 (308)
Q Consensus       192 sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~-~~~  270 (308)
                      +|.+++.. ...+++..++.++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+|+.+....... ...
T Consensus        93 ~L~~~l~~-~~~l~~~~~~~i~~qi~~gl~ylH~---~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~  168 (277)
T d1xbba_          93 PLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT  168 (277)
T ss_dssp             EHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC--
T ss_pred             cHHHHHhh-ccCCCHHHHHHHHHHHHHHHhhHHh---CCcccCCCcchhhcccccCcccccchhhhhhcccccccccccc
Confidence            99999864 4579999999999999999999999   899999999999999999999999999999876554432 233


Q ss_pred             ceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          271 KVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       271 ~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      ...||+.|+|||.+....++.++||||||+++|||++
T Consensus       169 ~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt  205 (277)
T d1xbba_         169 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS  205 (277)
T ss_dssp             --CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHT
T ss_pred             ccCCCceecCchhhcCCCCCchhhhccchhhhhHHhh
Confidence            5679999999999988888999999999999999875

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.2e-46  Score=334.67  Aligned_cols=188  Identities=27%  Similarity=0.344  Sum_probs=164.0

Q ss_pred             CccccceeeccCceEEEEEEEC-CCcEEEEEEeccCC--hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEEE
Q 021711          111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLE  186 (308)
Q Consensus       111 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e  186 (308)
                      .|+..+.||+|+||+||+|++. +|+.||||.+....  ..+..+.+.+|+.+|++++|||||++++++.++ .+++|||
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E   95 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence            4889999999999999999976 68999999986543  344567899999999999999999999987665 5889999


Q ss_pred             ecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCce
Q 021711          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH  266 (308)
Q Consensus       187 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~  266 (308)
                      |+.+|+|..++. ....+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+|+.....   
T Consensus        96 ~~~~g~l~~~~~-~~~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~---  168 (309)
T d1u5ra_          96 YCLGSASDLLEV-HKKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---  168 (309)
T ss_dssp             CCSEEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---
T ss_pred             ecCCCchHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEECCCCCEEEeecccccccCCC---
Confidence            999998876654 45679999999999999999999999   99999999999999999999999999999876432   


Q ss_pred             eEeeceeccccccccccCch---hhcCccceeEEEeeEEEeeccC
Q 021711          267 HTISKVEGTFGLVKLNLPPL---VILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~---~~~~~~~Di~s~g~~l~el~c~  308 (308)
                         ....||+.|||||.+..   ..++.++|+||+|+++|||++|
T Consensus       169 ---~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g  210 (309)
T d1u5ra_         169 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER  210 (309)
T ss_dssp             ---CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHS
T ss_pred             ---CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHC
Confidence               34679999999998743   3467889999999999999886

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1.4e-45  Score=337.59  Aligned_cols=192  Identities=21%  Similarity=0.221  Sum_probs=171.2

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEEEe
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLEL  187 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~  187 (308)
                      ++|++.+.||+|+||.||+|+.. +|+.||||.+...... ....+.+|+.+|+.++|||||++++++.++ .+|+||||
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  107 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL-DKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  107 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH-HHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchh-HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            57999999999999999999975 6999999999765433 356788999999999999999999977664 57899999


Q ss_pred             cCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEEC--CCCcEEEeccccceecCCCCc
Q 021711          188 SPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLT--EDFEPQICDFGLAKWLPEQWT  265 (308)
Q Consensus       188 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~--~~~~~kl~DFGla~~~~~~~~  265 (308)
                      +++|+|.+.+.....++++..+..++.||+.||.|||+   ++|+||||||+|||++  .++.+||+|||+|+.+.....
T Consensus       108 ~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~  184 (352)
T d1koba_         108 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI  184 (352)
T ss_dssp             CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred             CCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccccccccccccCCCeEEEeecccceecCCCCc
Confidence            99999999887666679999999999999999999999   9999999999999998  568999999999998866532


Q ss_pred             eeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          266 HHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                         .....||+.|+|||.+.+..++.++|+||+|+++|||+||
T Consensus       185 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG  224 (352)
T d1koba_         185 ---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG  224 (352)
T ss_dssp             ---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHS
T ss_pred             ---eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhC
Confidence               3457899999999999888889999999999999999986

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-46  Score=330.75  Aligned_cols=197  Identities=25%  Similarity=0.348  Sum_probs=163.3

Q ss_pred             hhcCCccccceeeccCceEEEEEEECC----CcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeCcEE
Q 021711          107 SATNNFSFENLIGKGGYAEVYKGRLRN----GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMH  182 (308)
Q Consensus       107 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~----g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  182 (308)
                      ...++|++.+.||+|+||.||+|++..    +..||||.+.....+...+.|.+|+.+|+.++|||||++++++.++.++
T Consensus         4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~   83 (273)
T d1mp8a_           4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVW   83 (273)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSCE
T ss_pred             cCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCeEE
Confidence            345689999999999999999998753    3579999987666666678899999999999999999999999888899


Q ss_pred             EEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCC
Q 021711          183 IVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE  262 (308)
Q Consensus       183 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~  262 (308)
                      +||||+++|+|.+++......+++..++.++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+|+.+..
T Consensus        84 iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~  160 (273)
T d1mp8a_          84 IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  160 (273)
T ss_dssp             EEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred             EEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcc---cCeeccccchhheeecCCCcEEEccchhheeccC
Confidence            9999999999999887777789999999999999999999999   9999999999999999999999999999997654


Q ss_pred             CCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          263 QWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       263 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      ... .......||+.|+|||.+.+..++.++|+||||+++|||++
T Consensus       161 ~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt  204 (273)
T d1mp8a_         161 STY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM  204 (273)
T ss_dssp             -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHT
T ss_pred             Ccc-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHh
Confidence            322 23345678999999999988889999999999999999876

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=9.4e-46  Score=331.92  Aligned_cols=203  Identities=27%  Similarity=0.355  Sum_probs=175.2

Q ss_pred             HHHHhhcCCccccceeeccCceEEEEEEEC------CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEE
Q 021711          103 YELQSATNNFSFENLIGKGGYAEVYKGRLR------NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYG  176 (308)
Q Consensus       103 ~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~------~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  176 (308)
                      .+++...++|++.+.||+|+||+||+|+++      +++.||||++......+..++|.+|+.+|++++||||+++++++
T Consensus         6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~   85 (301)
T d1lufa_           6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC   85 (301)
T ss_dssp             HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence            345556788999999999999999999864      35789999998766666678899999999999999999999977


Q ss_pred             EeC-cEEEEEEecCCCCHHHHHhccC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCce
Q 021711          177 IEG-GMHIVLELSPNGSLASLLYGMK-----------------------EKLKWGIRYKIALGVAEGLLYLHEGCQRRII  232 (308)
Q Consensus       177 ~~~-~~~lv~e~~~~gsL~~~l~~~~-----------------------~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ii  232 (308)
                      ... ..+++|||+++|+|.+++....                       ..+++..++.++.|++.||.|||+   ++||
T Consensus        86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~---~~iv  162 (301)
T d1lufa_          86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFV  162 (301)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCC
T ss_pred             ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc---CCeE
Confidence            654 5889999999999999986421                       247889999999999999999999   9999


Q ss_pred             ecCCCCCCEEECCCCcEEEeccccceecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          233 HRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       233 HrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ||||||+|||++.++.+||+|||+|+.+.............||+.|+|||...+..++.++||||||++||||+|+
T Consensus       163 HrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~  238 (301)
T d1lufa_         163 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSY  238 (301)
T ss_dssp             CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred             eeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHcc
Confidence            9999999999999999999999999977665444444567899999999999888899999999999999999875

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2e-45  Score=331.89  Aligned_cols=190  Identities=24%  Similarity=0.344  Sum_probs=167.8

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCCh--HHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVL  185 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~  185 (308)
                      ++|++.+.||+|+||+||+|+++ +|+.||||++.....  ....+.+.+|+.+|+.++|||||++++++.++ .+|+||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            47999999999999999999976 599999999864321  12356789999999999999999999977665 578999


Q ss_pred             EecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCc
Q 021711          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (308)
Q Consensus       186 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~  265 (308)
                      ||+.||+|..++.. ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+|+...... 
T Consensus        84 E~~~gg~l~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~-  158 (316)
T d1fota_          84 DYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT-  158 (316)
T ss_dssp             CCCCSCBHHHHHHH-TSSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB-
T ss_pred             eecCCccccccccc-cccccccHHHHHHHHHHHhhhhhcc---CcEEccccCchheeEcCCCCEEEecCccceEecccc-
Confidence            99999999998854 5568888889999999999999998   999999999999999999999999999999875532 


Q ss_pred             eeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          266 HHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                          ....||+.|||||.+.+..++.++|+||+|++||||++|
T Consensus       159 ----~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG  197 (316)
T d1fota_         159 ----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAG  197 (316)
T ss_dssp             ----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHS
T ss_pred             ----ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhC
Confidence                356899999999998888889999999999999999886

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-45  Score=325.55  Aligned_cols=193  Identities=25%  Similarity=0.293  Sum_probs=169.0

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCCh-----HHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA-----DEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GM  181 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~  181 (308)
                      .++|++.+.||+|+||+||+|+++ +|+.||||.+.....     ....+.+.+|+.+|++++|||||++++++.+. .+
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   88 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            357999999999999999999985 699999999864321     12357899999999999999999999977665 47


Q ss_pred             EEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCC----cEEEeccccc
Q 021711          182 HIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDF----EPQICDFGLA  257 (308)
Q Consensus       182 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~----~~kl~DFGla  257 (308)
                      ++||||+++|+|.+++.. ...+++..+..++.|++.||.|||+   ++|+||||||+|||++.++    .+||+|||+|
T Consensus        89 ~iv~E~~~gg~L~~~i~~-~~~l~~~~~~~~~~qi~~al~yLH~---~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a  164 (293)
T d1jksa_          89 ILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA  164 (293)
T ss_dssp             EEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             EEEEEcCCCccccchhcc-ccccchhHHHHHHHHHHHHHHhhhh---cceeecccccceEEEecCCCcccceEecchhhh
Confidence            899999999999999865 4579999999999999999999999   9999999999999999876    5999999999


Q ss_pred             eecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          258 KWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      +.+....   ......||+.|+|||.+.+..++.++|+||+|+++|||++|
T Consensus       165 ~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g  212 (293)
T d1jksa_         165 HKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG  212 (293)
T ss_dssp             EECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHS
T ss_pred             hhcCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcC
Confidence            9876543   23456899999999999888889999999999999999876

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-45  Score=327.92  Aligned_cols=204  Identities=23%  Similarity=0.308  Sum_probs=164.9

Q ss_pred             HHHHHhhcCCccccceeeccCceEEEEEEEC------CCcEEEEEEeccCChHHHHHHHHHHHHHHhcC-CCCeeeeeee
Q 021711          102 LYELQSATNNFSFENLIGKGGYAEVYKGRLR------NGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLG  174 (308)
Q Consensus       102 ~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~------~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~  174 (308)
                      ..+++...++|++.+.||+|+||.||+|.+.      +++.||||.++........+.+.+|..++.++ +|+||+.+++
T Consensus         5 ~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~   84 (299)
T d1ywna1           5 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG   84 (299)
T ss_dssp             HHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             CccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeee
Confidence            3445555678999999999999999999864      24689999997665555567888898888777 6899999999


Q ss_pred             EEEeC--cEEEEEEecCCCCHHHHHhcc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCC
Q 021711          175 YGIEG--GMHIVLELSPNGSLASLLYGM---------------KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIK  237 (308)
Q Consensus       175 ~~~~~--~~~lv~e~~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlK  237 (308)
                      ++...  .+++||||+++|+|.+++...               ...+++..++.++.||+.||.|||+   ++|||||||
T Consensus        85 ~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~ivHrDlK  161 (299)
T d1ywna1          85 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLA  161 (299)
T ss_dssp             EECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCC
T ss_pred             eeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh---CCCcCCcCC
Confidence            77654  478999999999999999643               2348899999999999999999999   999999999


Q ss_pred             CCCEEECCCCcEEEeccccceecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          238 AANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       238 p~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      |+|||++.++.+||+|||+|+...............||+.|+|||.+.+..++.++||||||+++|||+++
T Consensus       162 p~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~  232 (299)
T d1ywna1         162 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL  232 (299)
T ss_dssp             GGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred             ccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhC
Confidence            99999999999999999999987655444444567899999999999888889999999999999998763

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.1e-44  Score=331.36  Aligned_cols=190  Identities=21%  Similarity=0.238  Sum_probs=168.2

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCCh--HHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVL  185 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~  185 (308)
                      ++|++.+.||+|+||.||+|+++ +|+.||||++.....  ....+.+++|+.+|+.++|||||++++++... ..++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            47999999999999999999986 699999999864321  12356789999999999999999999977665 478999


Q ss_pred             EecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCc
Q 021711          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (308)
Q Consensus       186 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~  265 (308)
                      ||+.+|+|..++.. ...+++..+..++.||+.||.|||+   ++||||||||+|||++.++.+||+|||+|+.+...  
T Consensus       121 e~~~~g~l~~~l~~-~~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~--  194 (350)
T d1rdqe_         121 EYVAGGEMFSHLRR-IGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--  194 (350)
T ss_dssp             ECCTTCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred             ccccccchhhhHhh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCcCCHHHcccCCCCCEEeeeceeeeecccc--
Confidence            99999999999865 4579999999999999999999999   99999999999999999999999999999987543  


Q ss_pred             eeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          266 HHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                         .....||+.|||||.+.+..++.++|+||+|+++|||++|
T Consensus       195 ---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG  234 (350)
T d1rdqe_         195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAG  234 (350)
T ss_dssp             ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHS
T ss_pred             ---cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhC
Confidence               2356899999999999888889999999999999999886

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-44  Score=322.97  Aligned_cols=192  Identities=16%  Similarity=0.114  Sum_probs=169.7

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEe-CcEEEEEE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLE  186 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~lv~e  186 (308)
                      .++|++.+.||+|+||+||+|.+. +|+.||||.+.....+  ...+.+|+.+|+.++|||||++++++.+ +.+|+|||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~--~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE   81 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD--QVLVKKEISILNIARHRNILHLHESFESMEELVMIFE   81 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH--HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc--HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence            468999999999999999999986 5889999999765543  3568899999999999999999997665 56899999


Q ss_pred             ecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCC--CcEEEeccccceecCCCC
Q 021711          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTED--FEPQICDFGLAKWLPEQW  264 (308)
Q Consensus       187 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~--~~~kl~DFGla~~~~~~~  264 (308)
                      |++||+|.+++......+++..+..++.||+.||.|||+   ++|+||||||+|||++.+  ..+||+|||+++......
T Consensus        82 ~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~---~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~  158 (321)
T d1tkia_          82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD  158 (321)
T ss_dssp             CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred             cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---cCCCcccccccceeecCCCceEEEEcccchhhccccCC
Confidence            999999999997666679999999999999999999999   999999999999999854  489999999999875542


Q ss_pred             ceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          265 THHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                         ......||+.|+|||...+..++.++|+||+|+++|+|++|
T Consensus       159 ---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G  199 (321)
T d1tkia_         159 ---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSG  199 (321)
T ss_dssp             ---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHS
T ss_pred             ---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhC
Confidence               23456899999999998888889999999999999999876

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=3.9e-44  Score=329.31  Aligned_cols=192  Identities=25%  Similarity=0.294  Sum_probs=163.7

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCCh-----HHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA-----DEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GM  181 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~  181 (308)
                      .++|++.++||+|+||.||+|++. +|+.||||.+.....     ........+|+.+++.++|||||++++++... .+
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~   82 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL   82 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence            468999999999999999999976 599999999854221     11223334557788889999999999977665 58


Q ss_pred             EEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecC
Q 021711          182 HIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP  261 (308)
Q Consensus       182 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~  261 (308)
                      |+||||+++|+|.+++.. ...+++..+..++.||+.||.|||+   ++||||||||+|||++.++.+||+|||+|+.+.
T Consensus        83 ~ivmE~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~aL~ylH~---~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~  158 (364)
T d1omwa3          83 SFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFS  158 (364)
T ss_dssp             EEEECCCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred             EEEEEecCCCcHHHHHHh-cccccHHHHHHHHHHHHHHHHHHHH---CCccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence            999999999999999965 4568999999999999999999999   999999999999999999999999999999876


Q ss_pred             CCCceeEeeceeccccccccccCch-hhcCccceeEEEeeEEEeeccC
Q 021711          262 EQWTHHTISKVEGTFGLVKLNLPPL-VILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       262 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ...    .....||+.|+|||.+.. ..++.++|+||+|++||||++|
T Consensus       159 ~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG  202 (364)
T d1omwa3         159 KKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG  202 (364)
T ss_dssp             SSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred             CCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhC
Confidence            542    245689999999998764 4578899999999999999886

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=4.6e-44  Score=317.08  Aligned_cols=196  Identities=20%  Similarity=0.255  Sum_probs=162.5

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCC--hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeCc-----
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG-----  180 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----  180 (308)
                      .++|++.+.||+|+||.||+|++. +|+.||||.+....  ..+....|.+|+.+++.++|||||++++++....     
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            467999999999999999999975 69999999997543  2345678999999999999999999999765432     


Q ss_pred             EEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceec
Q 021711          181 MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL  260 (308)
Q Consensus       181 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~  260 (308)
                      +|+||||++|++|.+++.. ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.++|+|||+++..
T Consensus        86 ~~lvmE~~~g~~L~~~~~~-~~~l~~~~~~~i~~qi~~al~~lH~---~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~  161 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAI  161 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred             EEEEEECCCCCEehhhhcc-cCCCCHHHHHHHHHHHHHHHHHHHh---CCccCccccCcccccCccccceeehhhhhhhh
Confidence            6899999999999998854 4579999999999999999999999   99999999999999999999999999999876


Q ss_pred             CCCCce-eEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          261 PEQWTH-HTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       261 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ...... .......||+.|+|||.+.+..++.++|+||+|+++|||++|
T Consensus       162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG  210 (277)
T d1o6ya_         162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG  210 (277)
T ss_dssp             C----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHS
T ss_pred             ccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhC
Confidence            543222 234467899999999998888889999999999999999986

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-44  Score=320.06  Aligned_cols=196  Identities=28%  Similarity=0.408  Sum_probs=162.1

Q ss_pred             cCCccccceeeccCceEEEEEEEC--CC--cEEEEEEeccCC--hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeCcEE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR--NG--QLVAIKRLTRGT--ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMH  182 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~--~g--~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  182 (308)
                      .++|++.+.||+|+||.||+|++.  ++  ..||||.+....  .++..++|.+|+.+|+.++|||||++++++.++..+
T Consensus         7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~~~~   86 (273)
T d1u46a_           7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK   86 (273)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeecchh
Confidence            357999999999999999999864  23  378999986542  234567899999999999999999999999888899


Q ss_pred             EEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCC
Q 021711          183 IVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE  262 (308)
Q Consensus       183 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~  262 (308)
                      +||||+++|++.+.+......+++..++.++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++.+..
T Consensus        87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~  163 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ  163 (273)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred             eeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhh---CCEeeeeecHHHhccccccceeeccchhhhhccc
Confidence            9999999999999887767779999999999999999999999   8999999999999999999999999999998866


Q ss_pred             CCceeE-eeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          263 QWTHHT-ISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       263 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      ...... .....||+.|+|||...+..++.++|+||||+++|||++
T Consensus       164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt  209 (273)
T d1u46a_         164 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT  209 (273)
T ss_dssp             -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHT
T ss_pred             CCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHh
Confidence            544332 234568899999999988889999999999999999986

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-44  Score=322.82  Aligned_cols=193  Identities=21%  Similarity=0.292  Sum_probs=167.3

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCC--hHHHHHHHHHHHHHHh-cCCCCeeeeeeeEEEeC-cEEEE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMA-HVDHPNTAKLLGYGIEG-GMHIV  184 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~-~~~lv  184 (308)
                      ++|.+.+.||+|+||+||+|++. +|+.||||++.+..  ..+..+.+.+|..++. .++|||||++++++.++ .+|+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            58999999999999999999986 58999999996432  1122456777877765 68999999999987765 48899


Q ss_pred             EEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCC
Q 021711          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (308)
Q Consensus       185 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  264 (308)
                      |||+++|+|.+++.. ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+|+......
T Consensus        82 mEy~~~g~L~~~i~~-~~~~~e~~~~~~~~qi~~al~ylH~---~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~  157 (320)
T d1xjda_          82 MEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD  157 (320)
T ss_dssp             EECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred             EeecCCCcHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCcccceeecCCCceeccccchhhhccccc
Confidence            999999999999964 4568999999999999999999999   899999999999999999999999999998765433


Q ss_pred             ceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          265 THHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      .  ......||+.|+|||.+.+..++.++|+||+|+++|||++|
T Consensus       158 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG  199 (320)
T d1xjda_         158 A--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIG  199 (320)
T ss_dssp             C--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHS
T ss_pred             c--cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhC
Confidence            2  33457899999999999888899999999999999999986

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-43  Score=319.04  Aligned_cols=191  Identities=26%  Similarity=0.358  Sum_probs=167.1

Q ss_pred             cceeeccCceEEEEEEECC----CcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEe--CcEEEEEEec
Q 021711          115 ENLIGKGGYAEVYKGRLRN----GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE--GGMHIVLELS  188 (308)
Q Consensus       115 ~~~LG~G~fg~Vy~~~~~~----g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~lv~e~~  188 (308)
                      .++||+|+||+||+|++.+    ...||||.+.........++|.+|+++|++++|||||+++|++.+  +..++||||+
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            5789999999999998753    236899999765556667899999999999999999999998765  3578999999


Q ss_pred             CCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCcee-
Q 021711          189 PNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH-  267 (308)
Q Consensus       189 ~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~-  267 (308)
                      ++|+|.+++......+++..++.++.|++.||.|||+   .+|+||||||+|||+++++.+||+|||+++.+....... 
T Consensus       112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~---~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~  188 (311)
T d1r0pa_         112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV  188 (311)
T ss_dssp             TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred             ecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcc---cCcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence            9999999998777778899999999999999999999   899999999999999999999999999999875543221 


Q ss_pred             -EeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          268 -TISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       268 -~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                       ......||+.|+|||.......+.++||||||+++|||+|+
T Consensus       189 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~  230 (311)
T d1r0pa_         189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTR  230 (311)
T ss_dssp             TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred             eecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHC
Confidence             22346799999999998888899999999999999999874

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=2.3e-43  Score=312.62  Aligned_cols=192  Identities=24%  Similarity=0.281  Sum_probs=167.3

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCCh--------HHHHHHHHHHHHHHhcCC-CCeeeeeeeEEEeC
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--------DEIIADFLSELGIMAHVD-HPNTAKLLGYGIEG  179 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~--------~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~  179 (308)
                      ++|++.+.||+|+||+||+|+.. +|+.||||++.....        ....+.+.+|+.++++++ |||||++++++.++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            68999999999999999999975 689999999865421        224567899999999997 99999999987765


Q ss_pred             -cEEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccce
Q 021711          180 -GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK  258 (308)
Q Consensus       180 -~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~  258 (308)
                       .+|+||||+++|+|.+++.. ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+|+
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~  158 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSC  158 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             cceEEEEEcCCCchHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---cCCcccccccceEEEcCCCCeEEccchhee
Confidence             47899999999999999965 4579999999999999999999999   899999999999999999999999999999


Q ss_pred             ecCCCCceeEeeceeccccccccccCchh------hcCccceeEEEeeEEEeeccC
Q 021711          259 WLPEQWTHHTISKVEGTFGLVKLNLPPLV------ILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       259 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~Di~s~g~~l~el~c~  308 (308)
                      .+.....   .....||+.|+|||.....      ..+.++|+||+|+++|||++|
T Consensus       159 ~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g  211 (277)
T d1phka_         159 QLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG  211 (277)
T ss_dssp             ECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHS
T ss_pred             EccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccC
Confidence            8866432   2457899999999987533      246789999999999999876

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-43  Score=319.86  Aligned_cols=200  Identities=24%  Similarity=0.280  Sum_probs=176.4

Q ss_pred             HHhhcCCccccceeeccCceEEEEEEEC------CCcEEEEEEeccCChHHHHHHHHHHHHHHhcC-CCCeeeeeeeEEE
Q 021711          105 LQSATNNFSFENLIGKGGYAEVYKGRLR------NGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGI  177 (308)
Q Consensus       105 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~------~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  177 (308)
                      ++...++|++.++||+|+||.||+|++.      ++..||||+++..........|.+|+.+++++ +|||||++++++.
T Consensus        18 ~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~   97 (311)
T d1t46a_          18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT   97 (311)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEe
Confidence            4445578999999999999999999853      35789999998766555677899999999999 6999999999887


Q ss_pred             eC-cEEEEEEecCCCCHHHHHhccC-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCC
Q 021711          178 EG-GMHIVLELSPNGSLASLLYGMK-----------------EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAA  239 (308)
Q Consensus       178 ~~-~~~lv~e~~~~gsL~~~l~~~~-----------------~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~  239 (308)
                      +. ..++||||+++|+|.+++....                 ..+++..+..++.||+.||.|||+   ++||||||||+
T Consensus        98 ~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~---~~ivHrDLKp~  174 (311)
T d1t46a_          98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAAR  174 (311)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGG
T ss_pred             eCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccccc
Confidence            65 4799999999999999986432                 258899999999999999999999   99999999999


Q ss_pred             CEEECCCCcEEEeccccceecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          240 NILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       240 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      |||++.++.+||+|||+++...............||+.|+|||.+.+...+.++|+||||+++|||++
T Consensus       175 NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt  242 (311)
T d1t46a_         175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS  242 (311)
T ss_dssp             GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred             cccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHh
Confidence            99999999999999999998876655555567899999999999988889999999999999999986

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-43  Score=319.67  Aligned_cols=187  Identities=20%  Similarity=0.226  Sum_probs=161.5

Q ss_pred             CCcccc-ceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhc-CCCCeeeeeeeEEEe-----CcE
Q 021711          110 NNFSFE-NLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAH-VDHPNTAKLLGYGIE-----GGM  181 (308)
Q Consensus       110 ~~~~~~-~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~-----~~~  181 (308)
                      ++|.+. ++||+|+||.||+|++. +|+.||||.+...      ..+.+|+.++.+ .+|||||++++++.+     ..+
T Consensus        11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~   84 (335)
T d2ozaa1          11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   84 (335)
T ss_dssp             GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence            578876 46999999999999975 6899999998643      346689998755 589999999997653     347


Q ss_pred             EEEEEecCCCCHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECC---CCcEEEeccccc
Q 021711          182 HIVLELSPNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTE---DFEPQICDFGLA  257 (308)
Q Consensus       182 ~lv~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~---~~~~kl~DFGla  257 (308)
                      |+|||||+||+|.+++... ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.   .+.+||+|||+|
T Consensus        85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~---~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a  161 (335)
T d2ozaa1          85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA  161 (335)
T ss_dssp             EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHH---cCCcccccccccccccccccccccccccccee
Confidence            8999999999999999754 3469999999999999999999999   99999999999999986   457999999999


Q ss_pred             eecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          258 KWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      +.......   .....||+.|+|||.+.+..++.++|+||+|++||+|++|
T Consensus       162 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg  209 (335)
T d2ozaa1         162 KETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG  209 (335)
T ss_dssp             EECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTS
T ss_pred             eeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhC
Confidence            98765432   3457899999999999988899999999999999999986

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-44  Score=320.40  Aligned_cols=201  Identities=21%  Similarity=0.315  Sum_probs=174.0

Q ss_pred             HHhhcCCccccceeeccCceEEEEEEEC------CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEe
Q 021711          105 LQSATNNFSFENLIGKGGYAEVYKGRLR------NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE  178 (308)
Q Consensus       105 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~------~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  178 (308)
                      |+...++|++.+.||+|+||.||+|.+.      ++..||||+++..........|.+|+.++++++|||||++++++..
T Consensus        15 ~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~   94 (308)
T d1p4oa_          15 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ   94 (308)
T ss_dssp             TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred             eeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec
Confidence            3445578999999999999999999864      2578999999866555566789999999999999999999998765


Q ss_pred             -CcEEEEEEecCCCCHHHHHhccC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCc
Q 021711          179 -GGMHIVLELSPNGSLASLLYGMK---------EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFE  248 (308)
Q Consensus       179 -~~~~lv~e~~~~gsL~~~l~~~~---------~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~  248 (308)
                       ...++||||+++|+|.+++....         ..+++..+..++.|++.||.|||+   ++|+||||||+|||++.+++
T Consensus        95 ~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~---~~ivHrDlk~~NiLld~~~~  171 (308)
T d1p4oa_          95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFT  171 (308)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCC
T ss_pred             CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeeceEcCCceeecCCce
Confidence             46899999999999999886421         347889999999999999999999   89999999999999999999


Q ss_pred             EEEeccccceecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          249 PQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       249 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      +||+|||+|+.+.............||+.|+|||...+...+.++|+||||+++|||+++
T Consensus       172 ~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~  231 (308)
T d1p4oa_         172 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATL  231 (308)
T ss_dssp             EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHT
T ss_pred             EEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhC
Confidence            999999999987665444444566899999999999888889999999999999998753

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-43  Score=316.23  Aligned_cols=194  Identities=22%  Similarity=0.311  Sum_probs=162.8

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChH-HHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEEE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTAD-EIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLE  186 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e  186 (308)
                      ++|++.+.||+|+||+||+|.+. +|+.||||++...... ...+.+.+|+.+|++++|||||++++++.++ .+++|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            68999999999999999999975 6999999999654322 2356889999999999999999999977765 5789999


Q ss_pred             ecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCce
Q 021711          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH  266 (308)
Q Consensus       187 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~  266 (308)
                      |+.++.+..........+++..+..++.||+.||.|||+   ++||||||||+|||++.++.+||+|||+|+....... 
T Consensus        82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~---~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~-  157 (298)
T d1gz8a_          82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-  157 (298)
T ss_dssp             CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB-
T ss_pred             ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhc---CCEEccccCchheeecccCcceeccCCcceeccCCcc-
Confidence            997654444444456679999999999999999999999   9999999999999999999999999999987755432 


Q ss_pred             eEeeceeccccccccccCchhh-cCccceeEEEeeEEEeeccC
Q 021711          267 HTISKVEGTFGLVKLNLPPLVI-LKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~s~g~~l~el~c~  308 (308)
                       ......||+.|+|||...... .+.++|+||+|+++|+|++|
T Consensus       158 -~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G  199 (298)
T d1gz8a_         158 -TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR  199 (298)
T ss_dssp             -CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHS
T ss_pred             -cceeecccceeeehhhhccccCCCccccccccchhhhHHhhC
Confidence             334568999999999765544 57889999999999999886

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-43  Score=317.88  Aligned_cols=193  Identities=26%  Similarity=0.425  Sum_probs=162.2

Q ss_pred             CCccccceeeccCceEEEEEEECC-Cc--EEEEEEeccCChHHHHHHHHHHHHHHhcC-CCCeeeeeeeEEEeCc-EEEE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLRN-GQ--LVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGIEGG-MHIV  184 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~~-g~--~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~-~~lv  184 (308)
                      ++|++.++||+|+||.||+|.+++ |.  .||||.+......+..+.|.+|+.+|.++ +|||||++++++.+.+ +++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            688999999999999999998763 44  57888886655555567899999999998 7999999999887664 7899


Q ss_pred             EEecCCCCHHHHHhcc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcE
Q 021711          185 LELSPNGSLASLLYGM---------------KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEP  249 (308)
Q Consensus       185 ~e~~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~  249 (308)
                      |||+++|+|.+++...               ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~---~~iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc---CCccccccccceEEEcCCCce
Confidence            9999999999998642               3579999999999999999999999   899999999999999999999


Q ss_pred             EEeccccceecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          250 QICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       250 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ||+|||+|+......   ......||..|+|||.+.+..++.++|+||||+++|||++|
T Consensus       167 kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~  222 (309)
T d1fvra_         167 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSL  222 (309)
T ss_dssp             EECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTT
T ss_pred             EEccccccccccccc---cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhc
Confidence            999999998654332   22345799999999999888899999999999999999864

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9e-44  Score=312.84  Aligned_cols=188  Identities=27%  Similarity=0.381  Sum_probs=158.3

Q ss_pred             hcCCccccceeeccCceEEEEEEECCCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEe--CcEEEEE
Q 021711          108 ATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE--GGMHIVL  185 (308)
Q Consensus       108 ~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~lv~  185 (308)
                      ..++|++.+.||+|+||.||+|.++ |..||||.++...   ..+.|.+|+.++++++|||||+++|++.+  +.+++||
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~---~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~   80 (262)
T d1byga_           5 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT   80 (262)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred             CHHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHH---HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEE
Confidence            3457889999999999999999985 7889999997543   24678999999999999999999998864  3479999


Q ss_pred             EecCCCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCC
Q 021711          186 ELSPNGSLASLLYGMK-EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (308)
Q Consensus       186 e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  264 (308)
                      ||+++|+|.+++.... ..+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++..... 
T Consensus        81 ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~-  156 (262)
T d1byga_          81 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-  156 (262)
T ss_dssp             CCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred             eccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhcccccc---CceeccccchHhheecCCCCEeecccccceecCCC-
Confidence            9999999999996532 358999999999999999999999   89999999999999999999999999999875432 


Q ss_pred             ceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          265 THHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                          .....+|..|+|||.+.+..++.++||||||+++|||+|
T Consensus       157 ----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t  195 (262)
T d1byga_         157 ----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS  195 (262)
T ss_dssp             ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred             ----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHH
Confidence                234578999999999988889999999999999999986

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-43  Score=316.82  Aligned_cols=198  Identities=24%  Similarity=0.313  Sum_probs=168.9

Q ss_pred             hhcCCccccceeeccCceEEEEEEECC--------CcEEEEEEeccCChHHHHHHHHHHHHHHhcC-CCCeeeeeeeEEE
Q 021711          107 SATNNFSFENLIGKGGYAEVYKGRLRN--------GQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGI  177 (308)
Q Consensus       107 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~--------g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  177 (308)
                      ...++|.+.+.||+|+||.||+|+...        +..||||.+...........+.+|...+.++ +|||||++++++.
T Consensus        10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~   89 (299)
T d1fgka_          10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT   89 (299)
T ss_dssp             CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence            445689999999999999999998542        2479999998776666678899999999888 8999999999887


Q ss_pred             eCc-EEEEEEecCCCCHHHHHhccC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCE
Q 021711          178 EGG-MHIVLELSPNGSLASLLYGMK---------------EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANI  241 (308)
Q Consensus       178 ~~~-~~lv~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NI  241 (308)
                      +++ .++||||+.+|+|.+++....               ..+++..++.++.||+.||.|||+   ++||||||||+||
T Consensus        90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~---~~ivHrDiKp~Ni  166 (299)
T d1fgka_          90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNV  166 (299)
T ss_dssp             SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGE
T ss_pred             cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh---CCEEeeeecccce
Confidence            654 899999999999999996532               358999999999999999999999   9999999999999


Q ss_pred             EECCCCcEEEeccccceecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeecc
Q 021711          242 LLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSC  307 (308)
Q Consensus       242 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c  307 (308)
                      |++.++.+||+|||+++...............||+.|+|||.+.+..++.++|+||||+++|||+|
T Consensus       167 Ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~  232 (299)
T d1fgka_         167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT  232 (299)
T ss_dssp             EECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred             eecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhcc
Confidence            999999999999999998766554444556789999999999988889999999999999999986

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-43  Score=315.42  Aligned_cols=194  Identities=22%  Similarity=0.232  Sum_probs=156.7

Q ss_pred             CCccccceeeccCceEEEEEEECCCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-----cEEEE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-----GMHIV  184 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~lv  184 (308)
                      ++|.+.+.||+|+||.||+|++ +|+.||||.+......  ...+.+|+..+..++|||||++++++.+.     .+++|
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~--~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv   79 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER--SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV   79 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHH--HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh--HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence            4678889999999999999997 5889999998644321  12223455555678999999999988754     36899


Q ss_pred             EEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCceecCCCCCCEEECCCCcEEEecccccee
Q 021711          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC-----QRRIIHRDIKAANILLTEDFEPQICDFGLAKW  259 (308)
Q Consensus       185 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~-----~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~  259 (308)
                      |||+++|+|.+++..  ..+++..++.++.|++.||.|||+..     .++|+||||||+||||+.++.+||+|||+++.
T Consensus        80 ~Ey~~~g~L~~~l~~--~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~  157 (303)
T d1vjya_          80 SDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR  157 (303)
T ss_dssp             EECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             EecccCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccc
Confidence            999999999999964  46899999999999999999999621     25899999999999999999999999999998


Q ss_pred             cCCCCcee--EeeceeccccccccccCchh------hcCccceeEEEeeEEEeeccC
Q 021711          260 LPEQWTHH--TISKVEGTFGLVKLNLPPLV------ILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       260 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ........  ......||+.|+|||++.+.      ..+.++||||||++||||++|
T Consensus       158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg  214 (303)
T d1vjya_         158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR  214 (303)
T ss_dssp             EETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHT
T ss_pred             ccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhC
Confidence            76543322  23457899999999987543      256678999999999999875

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-43  Score=315.58  Aligned_cols=189  Identities=25%  Similarity=0.278  Sum_probs=156.9

Q ss_pred             ccceeeccCceEEEEEEEC-CCcEEEEEEeccCChH----HHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEEEe
Q 021711          114 FENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTAD----EIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLEL  187 (308)
Q Consensus       114 ~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~  187 (308)
                      .+++||+|+||+||+|++. +|+.||||++......    ...+.+.+|+.+|+.++|||||++++++..+ ..++||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            3578999999999999976 5999999998644321    2235789999999999999999999977665 58999999


Q ss_pred             cCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCcee
Q 021711          188 SPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH  267 (308)
Q Consensus       188 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~  267 (308)
                      +.++++..+. .....+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+|+.......  
T Consensus        82 ~~~~~~~~~~-~~~~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~--  155 (299)
T d1ua2a_          82 METDLEVIIK-DNSLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR--  155 (299)
T ss_dssp             CSEEHHHHHT-TCCSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC--
T ss_pred             hcchHHhhhh-hcccCCCHHHHHHHHHHHHHHHHHhhc---cceecccCCcceEEecCCCccccccCccccccCCCcc--
Confidence            9887766554 445678889999999999999999999   9999999999999999999999999999987655432  


Q ss_pred             EeeceeccccccccccCch-hhcCccceeEEEeeEEEeeccC
Q 021711          268 TISKVEGTFGLVKLNLPPL-VILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ......||+.|+|||.+.. ..++.++|+||+|+++|||++|
T Consensus       156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g  197 (299)
T d1ua2a_         156 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLR  197 (299)
T ss_dssp             CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHS
T ss_pred             cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhC
Confidence            2345689999999998754 4568899999999999999876

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-42  Score=312.74  Aligned_cols=195  Identities=21%  Similarity=0.240  Sum_probs=163.9

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeCc-----EE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG-----MH  182 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~  182 (308)
                      +++|++.+.||+|+||+||+|.+. +|+.||||++.........+.+++|+.+|+.++||||+++++++....     .+
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            457999999999999999999875 799999999976555556778999999999999999999999876542     35


Q ss_pred             EEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCC
Q 021711          183 IVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE  262 (308)
Q Consensus       183 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~  262 (308)
                      ++++++.+|+|.+++..  ..+++..+..++.|++.||.|||+   ++||||||||+|||++.++.+||+|||+|+....
T Consensus        87 ~l~~~~~~g~L~~~l~~--~~l~~~~i~~i~~qil~al~yLH~---~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~  161 (345)
T d1pmea_          87 YLVTHLMGADLYKLLKT--QHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP  161 (345)
T ss_dssp             EEEEECCCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred             EEEEeecCCchhhhhhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCcceEEECCCCCEEEcccCceeeccC
Confidence            66677889999999954  469999999999999999999999   9999999999999999999999999999987654


Q ss_pred             CCce-eEeeceeccccccccccCc-hhhcCccceeEEEeeEEEeeccC
Q 021711          263 QWTH-HTISKVEGTFGLVKLNLPP-LVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       263 ~~~~-~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      .... .......||+.|+|||.+. ....+.++|+||+|+++|||++|
T Consensus       162 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g  209 (345)
T d1pmea_         162 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN  209 (345)
T ss_dssp             GGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHS
T ss_pred             CCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhC
Confidence            3222 1234567999999999874 44568889999999999999875

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-43  Score=309.45  Aligned_cols=192  Identities=21%  Similarity=0.286  Sum_probs=160.7

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChH-----HHHHHHHHHHHHHhcCC--CCeeeeeeeEEEeC-
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTAD-----EIIADFLSELGIMAHVD--HPNTAKLLGYGIEG-  179 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~-----~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~-  179 (308)
                      .++|++.++||+|+||+||+|++. +|+.||||.+......     ....++.+|+.+|++++  |||||++++++.++ 
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~   82 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD   82 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence            358999999999999999999976 6899999998643211     11234678999999986  89999999977665 


Q ss_pred             cEEEEEEecCC-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECC-CCcEEEeccccc
Q 021711          180 GMHIVLELSPN-GSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTE-DFEPQICDFGLA  257 (308)
Q Consensus       180 ~~~lv~e~~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~-~~~~kl~DFGla  257 (308)
                      ..++||||+.+ +++.+++.. ...+++..+..++.||+.||.|||+   ++|+||||||+|||++. ++.+||+|||+|
T Consensus        83 ~~~lv~e~~~~~~~l~~~~~~-~~~l~e~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NIll~~~~~~vkl~DFG~a  158 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSG  158 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             eEEEEEEeccCcchHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCCccccCcccceEEecCCCeEEECccccc
Confidence            57899999976 677777754 4679999999999999999999999   99999999999999985 479999999999


Q ss_pred             eecCCCCceeEeeceeccccccccccCchhh-cCccceeEEEeeEEEeeccC
Q 021711          258 KWLPEQWTHHTISKVEGTFGLVKLNLPPLVI-LKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~s~g~~l~el~c~  308 (308)
                      +.....    ......||+.|+|||.+.+.. .+.++|+||+|+++|||++|
T Consensus       159 ~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g  206 (273)
T d1xwsa_         159 ALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG  206 (273)
T ss_dssp             EECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHS
T ss_pred             eecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhC
Confidence            876543    234578999999999886554 46778999999999999876

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-42  Score=310.04  Aligned_cols=194  Identities=23%  Similarity=0.325  Sum_probs=161.4

Q ss_pred             cCCccccceeeccCceEEEEEEEC-C-CcEEEEEEeccCCh-HHHHHHHHHHHHHHhcC---CCCeeeeeeeEEEe----
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-N-GQLVAIKRLTRGTA-DEIIADFLSELGIMAHV---DHPNTAKLLGYGIE----  178 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~-g~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~----  178 (308)
                      .++|++.+.||+|+||+||+|++. + ++.||||++..... +.....+.+|+.+|+.|   +||||+++++++..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            468999999999999999999974 4 67899999864321 11123455677766655   89999999997642    


Q ss_pred             --CcEEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEecccc
Q 021711          179 --GGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGL  256 (308)
Q Consensus       179 --~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGl  256 (308)
                        ...++++||+.++.+..........+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~---~~ivHrDiKp~NILi~~~~~~kl~dfg~  162 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGL  162 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred             cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecCCCccEEEEcCCCCeeecchhh
Confidence              24689999999887766665566779999999999999999999999   9999999999999999999999999999


Q ss_pred             ceecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          257 AKWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       257 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ++......   ......||+.|+|||.+.+..++.++|+||+|+++|||++|
T Consensus       163 ~~~~~~~~---~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g  211 (305)
T d1blxa_         163 ARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRR  211 (305)
T ss_dssp             CCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred             hhhhcccc---cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHC
Confidence            98654432   23467899999999999888899999999999999999876

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=8.6e-42  Score=303.62  Aligned_cols=193  Identities=22%  Similarity=0.269  Sum_probs=161.5

Q ss_pred             CCccccceeeccCceEEEEEEECCCcEEEEEEeccCCh-HHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-cEEEEEEe
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTA-DEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLEL  187 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~  187 (308)
                      ++|++.+.||+|+||+||+|++++|+.||||.+..... +...+++.+|+.+|++++|||||++++++..+ ..++++|+
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            58999999999999999999998999999999965433 22357899999999999999999999977665 57889999


Q ss_pred             cCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCcee
Q 021711          188 SPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH  267 (308)
Q Consensus       188 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~  267 (308)
                      +.++.+..+. .....+++..+..++.||+.||+|||+   .+||||||||+|||++.++.+||+|||+|........  
T Consensus        82 ~~~~~~~~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~--  155 (286)
T d1ob3a_          82 LDQDLKKLLD-VCEGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR--  155 (286)
T ss_dssp             CSEEHHHHHH-TSTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred             ehhhhHHHHH-hhcCCcchhhhHHHHHHHHHHHHHhcc---CcEEecCCCCceeeEcCCCCEEecccccceecccCcc--
Confidence            8776555554 456789999999999999999999999   8999999999999999999999999999987654322  


Q ss_pred             EeeceeccccccccccCchh-hcCccceeEEEeeEEEeeccC
Q 021711          268 TISKVEGTFGLVKLNLPPLV-ILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ......||+.|+|||..... ..+.++|+||+|+++|||++|
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G  197 (286)
T d1ob3a_         156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG  197 (286)
T ss_dssp             ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHS
T ss_pred             ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHC
Confidence            23455799999999987654 468899999999999999886

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=6.7e-41  Score=299.08  Aligned_cols=193  Identities=21%  Similarity=0.240  Sum_probs=163.6

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCC-CeeeeeeeEEEeCc-EEEEE
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDH-PNTAKLLGYGIEGG-MHIVL  185 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~-~~lv~  185 (308)
                      .++|++.+.||+|+||+||+|++. +|+.||||.+......   ..+.+|+++++.++| +|++.+++++..+. .++||
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vm   80 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA---PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI   80 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS---CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc---HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEE
Confidence            368999999999999999999976 6899999988654332   345678888888865 89999999877765 57889


Q ss_pred             EecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECC-----CCcEEEeccccceec
Q 021711          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTE-----DFEPQICDFGLAKWL  260 (308)
Q Consensus       186 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~-----~~~~kl~DFGla~~~  260 (308)
                      ||+ +++|.+++......++...+..++.|++.||.|||+   ++|+||||||+|||++.     ++.+||+|||+|+.+
T Consensus        81 e~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~---~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~  156 (293)
T d1csna_          81 DLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY  156 (293)
T ss_dssp             ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred             Eec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHH---CCceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence            988 789999987767789999999999999999999998   99999999999999974     568999999999987


Q ss_pred             CCCCce-----eEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          261 PEQWTH-----HTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       261 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ......     .......||+.|||||.+.+..++.++|+||+|+++|||++|
T Consensus       157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg  209 (293)
T d1csna_         157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRG  209 (293)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHS
T ss_pred             ccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhC
Confidence            543221     123356899999999999888899999999999999999875

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-41  Score=306.04  Aligned_cols=189  Identities=24%  Similarity=0.284  Sum_probs=158.8

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCC-hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-------
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-------  179 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-------  179 (308)
                      .++|++.+.||+|+||+||+|.+. +|+.||||++.... .+...+.+.+|+.+|+.++|||||++++++...       
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            468999999999999999999976 59999999997543 334567899999999999999999999987654       


Q ss_pred             cEEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEecccccee
Q 021711          180 GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKW  259 (308)
Q Consensus       180 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~  259 (308)
                      .+++||||+ +.+|..+..  ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+|+.
T Consensus        97 ~~~lv~e~~-~~~l~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~---~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~  170 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMK--HEKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQ  170 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             eEEEEEecc-cccHHHHHH--hccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCcchhhcccccccccccccceec
Confidence            368999999 567877764  3579999999999999999999999   9999999999999999999999999999998


Q ss_pred             cCCCCceeEeeceeccccccccccCchh-hcCccceeEEEeeEEEeeccC
Q 021711          260 LPEQWTHHTISKVEGTFGLVKLNLPPLV-ILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       260 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ....     .....||+.|+|||.+.+. ..+.++|+||+|+++|||++|
T Consensus       171 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g  215 (346)
T d1cm8a_         171 ADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITG  215 (346)
T ss_dssp             CCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHS
T ss_pred             cCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHC
Confidence            7543     2456899999999987654 468899999999999999876

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-41  Score=301.63  Aligned_cols=195  Identities=24%  Similarity=0.301  Sum_probs=160.1

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCC-hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEe---------
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGIE---------  178 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---------  178 (308)
                      ++|++.+.||+|+||+||+|++. +|+.||||++.... .+....++.+|+.+|++++||||+++++++..         
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~   89 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   89 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred             CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence            68999999999999999999975 69999999985432 22335678899999999999999999986543         


Q ss_pred             CcEEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccce
Q 021711          179 GGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK  258 (308)
Q Consensus       179 ~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~  258 (308)
                      +.+++||||+.++.+... ......++...+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++
T Consensus        90 ~~~~iv~e~~~~~~~~~~-~~~~~~~~~~~~~~i~~qil~~l~~lH~---~~ivHrDlKp~NILl~~~~~~kl~dfg~~~  165 (318)
T d3blha1          90 GSIYLVFDFCEHDLAGLL-SNVLVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLAR  165 (318)
T ss_dssp             -CEEEEEECCCEEHHHHH-TCTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             ceEEEEEeccCCCccchh-hhcccccccHHHHHHHHHHHHHHHHhcc---CCEEecCcCchheeecCCCcEEeeecceee
Confidence            347899999987665544 3456678999999999999999999999   999999999999999999999999999998


Q ss_pred             ecCCCCce--eEeeceeccccccccccCchh-hcCccceeEEEeeEEEeeccC
Q 021711          259 WLPEQWTH--HTISKVEGTFGLVKLNLPPLV-ILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       259 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~s~g~~l~el~c~  308 (308)
                      .+......  .......||+.|+|||.+... .++.++|+||+|+++|||++|
T Consensus       166 ~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g  218 (318)
T d3blha1         166 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR  218 (318)
T ss_dssp             ECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHS
T ss_pred             ecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhC
Confidence            77643221  122346799999999987644 578899999999999999875

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.1e-40  Score=298.19  Aligned_cols=192  Identities=25%  Similarity=0.299  Sum_probs=159.8

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeee-EEEeCc-EEEEEE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLG-YGIEGG-MHIVLE  186 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~-~~~~~~-~~lv~e  186 (308)
                      ++|++.+.||+|+||.||+|++. +|+.||||.+......   .++.+|+++++.++|+|++..+. +..++. .++|||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme   83 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH---PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   83 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS---CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC---HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence            57999999999999999999975 5899999998754332   35778999999998887666654 445544 567888


Q ss_pred             ecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECC---CCcEEEeccccceecCCC
Q 021711          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTE---DFEPQICDFGLAKWLPEQ  263 (308)
Q Consensus       187 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~---~~~~kl~DFGla~~~~~~  263 (308)
                      |+ +++|...+......+++..+..++.|++.||+|||+   ++|+||||||+|||++.   +..+||+|||+|+.+...
T Consensus        84 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~  159 (299)
T d1ckia_          84 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  159 (299)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred             Ec-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence            88 567777776667789999999999999999999999   99999999999999864   457999999999987654


Q ss_pred             Ccee-----EeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          264 WTHH-----TISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       264 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ....     ......||+.|+|||.+.+..++.++|+||||+++|||++|
T Consensus       160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg  209 (299)
T d1ckia_         160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLG  209 (299)
T ss_dssp             TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHS
T ss_pred             ccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhC
Confidence            3321     23456899999999999888899999999999999999876

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-41  Score=306.22  Aligned_cols=187  Identities=26%  Similarity=0.276  Sum_probs=156.3

Q ss_pred             CccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-------cEE
Q 021711          111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-------GMH  182 (308)
Q Consensus       111 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-------~~~  182 (308)
                      +|+..++||+|+||+||+|++. +|+.||||++.....     .+.+|+.+|++++||||+++++++...       .++
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~   95 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN   95 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEE
Confidence            6888999999999999999986 599999999975432     224799999999999999999976532       268


Q ss_pred             EEEEecCCCCHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCC-cEEEecccccee
Q 021711          183 IVLELSPNGSLASLLY--GMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDF-EPQICDFGLAKW  259 (308)
Q Consensus       183 lv~e~~~~gsL~~~l~--~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~-~~kl~DFGla~~  259 (308)
                      +||||++++.+..+..  .....+++..+..++.||+.||.|||+   ++|+||||||+|||++.++ .+||+|||+++.
T Consensus        96 lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~---~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~  172 (350)
T d1q5ka_          96 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ  172 (350)
T ss_dssp             EEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred             EEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHh---cCCcccCCCcceEEEecCCCceeEecccchhh
Confidence            9999998764444332  245579999999999999999999998   9999999999999999775 899999999998


Q ss_pred             cCCCCceeEeeceeccccccccccCc-hhhcCccceeEEEeeEEEeeccC
Q 021711          260 LPEQWTHHTISKVEGTFGLVKLNLPP-LVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       260 ~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      +.....   .....||..|+|||... ...++.++|+||+|+++|||++|
T Consensus       173 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g  219 (350)
T d1q5ka_         173 LVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG  219 (350)
T ss_dssp             CCTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHT
T ss_pred             ccCCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhC
Confidence            755432   24568999999999765 45678999999999999999876

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-40  Score=291.89  Aligned_cols=193  Identities=20%  Similarity=0.276  Sum_probs=166.4

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCC-hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEeCc-EEEEEE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLE  186 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~lv~e  186 (308)
                      ++|++.+.||+|+||+||+|++. +|+.||||+++... .+....++.+|+.+|++++||||+++++++.... .++|++
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            58999999999999999999976 68999999986543 2345688999999999999999999999777654 678999


Q ss_pred             ecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceecCCCCce
Q 021711          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH  266 (308)
Q Consensus       187 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~  266 (308)
                      ++.+++|..++. ....+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||.|+....... 
T Consensus        82 ~~~~~~l~~~~~-~~~~~~~~~~~~~~~q~~~aL~~lH~---~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~-  156 (292)
T d1unla_          82 FCDQDLKKYFDS-CNGDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-  156 (292)
T ss_dssp             CCSEEHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS-
T ss_pred             eccccccccccc-cccccchhHHHHHHHHHHHHHHHhhc---CCEeeecccCcccccccCCceeeeecchhhcccCCCc-
Confidence            999988887764 45678999999999999999999999   9999999999999999999999999999998765433 


Q ss_pred             eEeeceeccccccccccCchh-hcCccceeEEEeeEEEeeccC
Q 021711          267 HTISKVEGTFGLVKLNLPPLV-ILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~s~g~~l~el~c~  308 (308)
                       ......++..|+|||.+... ..+.++|+||+|+++|||++|
T Consensus       157 -~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g  198 (292)
T d1unla_         157 -CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANA  198 (292)
T ss_dssp             -CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTT
T ss_pred             -cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhC
Confidence             22345688899999986554 468899999999999999875

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=3.6e-40  Score=298.61  Aligned_cols=185  Identities=18%  Similarity=0.236  Sum_probs=159.6

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCC-CCeeeeeeeEEEe---CcEEEE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVD-HPNTAKLLGYGIE---GGMHIV  184 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~---~~~~lv  184 (308)
                      ++|++.++||+|+||+||+|++. +|+.||||+++...    .+++.+|+.+|+.++ ||||+++++++..   ..+++|
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v  110 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  110 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence            57999999999999999999975 68999999997644    356789999999995 9999999998763   248899


Q ss_pred             EEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCC-cEEEeccccceecCCC
Q 021711          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDF-EPQICDFGLAKWLPEQ  263 (308)
Q Consensus       185 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~-~~kl~DFGla~~~~~~  263 (308)
                      |||+.+++|..+.    +.+++..+..++.||+.||.|||+   ++|+||||||+|||++.++ .+||+|||+|+.....
T Consensus       111 ~e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH~---~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~  183 (328)
T d3bqca1         111 FEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG  183 (328)
T ss_dssp             EECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred             EeecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHhh---cccccccccccceEEcCCCCeeeecccccceeccCC
Confidence            9999999986643    468999999999999999999999   9999999999999998655 6999999999987654


Q ss_pred             CceeEeeceeccccccccccCchh-hcCccceeEEEeeEEEeeccC
Q 021711          264 WTHHTISKVEGTFGLVKLNLPPLV-ILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ..   .....||+.|+|||..... .++.++|+||+|++++|+++|
T Consensus       184 ~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g  226 (328)
T d3bqca1         184 QE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFR  226 (328)
T ss_dssp             CC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHT
T ss_pred             Cc---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccC
Confidence            32   3456899999999986654 468899999999999999875

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.6e-40  Score=297.93  Aligned_cols=190  Identities=23%  Similarity=0.253  Sum_probs=160.0

Q ss_pred             cCCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCC-hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEe------Cc
Q 021711          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGIE------GG  180 (308)
Q Consensus       109 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~  180 (308)
                      .++|++.+.||+|+||+||+|++. +|+.||||++.... .....+++.+|+.+|+.++|||||++++++..      ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            468999999999999999999975 69999999997543 23345678999999999999999999997643      23


Q ss_pred             EEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceec
Q 021711          181 MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL  260 (308)
Q Consensus       181 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~  260 (308)
                      .+++++|+.+|+|.+++.  ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+|++|||+|...
T Consensus        97 ~~~i~~~~~gg~L~~~~~--~~~l~e~~~~~i~~qil~aL~~LH~---~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~  171 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHT  171 (348)
T ss_dssp             CCEEEEECCSEEHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC----CC
T ss_pred             eEEEEEeecCCchhhhcc--cccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCCccccccccccccccccchhccc
Confidence            467788889999999984  3579999999999999999999999   99999999999999999999999999999865


Q ss_pred             CCCCceeEeeceeccccccccccCchh-hcCccceeEEEeeEEEeeccC
Q 021711          261 PEQWTHHTISKVEGTFGLVKLNLPPLV-ILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       261 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ...     .....||+.|+|||...+. ..+.++|+||+|+++|+|++|
T Consensus       172 ~~~-----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g  215 (348)
T d2gfsa1         172 DDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG  215 (348)
T ss_dssp             TGG-----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHS
T ss_pred             Ccc-----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhC
Confidence            432     2456899999999976554 468899999999999999876

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-40  Score=298.18  Aligned_cols=194  Identities=24%  Similarity=0.270  Sum_probs=162.2

Q ss_pred             CCccccceeeccCceEEEEEEEC----CCcEEEEEEeccCC---hHHHHHHHHHHHHHHhcCCC-CeeeeeeeEEEeC-c
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR----NGQLVAIKRLTRGT---ADEIIADFLSELGIMAHVDH-PNTAKLLGYGIEG-G  180 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~----~g~~vAvK~~~~~~---~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~-~  180 (308)
                      ++|++.+.||+|+||+||+|+..    +|+.||||.+....   .....+.+.+|+.++++++| |||+++++++.+. .
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            57999999999999999999852    47899999986432   11224568899999999976 8999999977654 5


Q ss_pred             EEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceec
Q 021711          181 MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL  260 (308)
Q Consensus       181 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~  260 (308)
                      .+++|||+.+|+|.+++.. ...++...+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+|+.+
T Consensus       104 ~~~v~e~~~~~~L~~~i~~-~~~~~e~~~~~~~~Qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~  179 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQ-RERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEF  179 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred             eeeeeecccccHHHHHHHh-cccccHHHHHHHHHHHHHHHHHhhc---CCEEeccCCccceeecCCCCEEEeeccchhhh
Confidence            7899999999999999865 4467788889999999999999999   89999999999999999999999999999987


Q ss_pred             CCCCceeEeeceeccccccccccCchh--hcCccceeEEEeeEEEeeccC
Q 021711          261 PEQWTHHTISKVEGTFGLVKLNLPPLV--ILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       261 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ...... ......||+.|+|||.+...  ..+.++||||+|++||||++|
T Consensus       180 ~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG  228 (322)
T d1vzoa_         180 VADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTG  228 (322)
T ss_dssp             CGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHS
T ss_pred             cccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhC
Confidence            554322 23467899999999987543  467789999999999999876

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-39  Score=294.67  Aligned_cols=189  Identities=23%  Similarity=0.222  Sum_probs=152.6

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCC-hHHHHHHHHHHHHHHhcCCCCeeeeeeeEEEe-------Cc
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-------GG  180 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-------~~  180 (308)
                      ++|++.++||+|+||+||+|++. +|+.||||++.... ......++.+|+.+++.++|||||++++++..       ..
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            68999999999999999999986 59999999997543 23445678999999999999999999997743       35


Q ss_pred             EEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeccccceec
Q 021711          181 MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL  260 (308)
Q Consensus       181 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~  260 (308)
                      +|+||||+.++ +.+.+   ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+|++|||+++..
T Consensus        97 ~~iv~Ey~~~~-l~~~~---~~~~~~~~i~~~~~qil~gl~~LH~---~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~  169 (355)
T d2b1pa1          97 VYLVMELMDAN-LCQVI---QMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  169 (355)
T ss_dssp             EEEEEECCSEE-HHHHH---TSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             eEEEEeccchH-HHHhh---hcCCCHHHHHHHHHHHHHHHHHhhh---cccccccCCccccccccccceeeechhhhhcc
Confidence            78999999765 44444   2468999999999999999999999   99999999999999999999999999999876


Q ss_pred             CCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          261 PEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       261 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                      ....   ......||+.|+|||.+.+..++.++|+||+|++++||++|
T Consensus       170 ~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g  214 (355)
T d2b1pa1         170 GTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH  214 (355)
T ss_dssp             --------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHS
T ss_pred             cccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhC
Confidence            5432   33466899999999998888889999999999999999875

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.98  E-value=5.2e-34  Score=260.73  Aligned_cols=190  Identities=21%  Similarity=0.209  Sum_probs=152.2

Q ss_pred             CCccccceeeccCceEEEEEEEC-CCcEEEEEEeccCChHHHHHHHHHHHHHHhcCC-----------CCeeeeeeeEEE
Q 021711          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVD-----------HPNTAKLLGYGI  177 (308)
Q Consensus       110 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~  177 (308)
                      ++|++.++||+|+||+||+|+.. +|+.||||++....  ...+.+.+|+.+++.++           |+||+++++++.
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~--~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~   90 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK--VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   90 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc--cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEee
Confidence            45999999999999999999975 69999999997543  23466788888888775           578999988664


Q ss_pred             e---CcEEEEEEecCCCC-HHHHH-hccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCC-----
Q 021711          178 E---GGMHIVLELSPNGS-LASLL-YGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDF-----  247 (308)
Q Consensus       178 ~---~~~~lv~e~~~~gs-L~~~l-~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~-----  247 (308)
                      .   ...+++++++..+. ..... ......++...+..++.||+.||.|||+  ..+|+||||||+|||++.++     
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~~  168 (362)
T d1q8ya_          91 HKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENL  168 (362)
T ss_dssp             EEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTTE
T ss_pred             eccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCccccc
Confidence            3   23566777665443 22222 2344568899999999999999999997  27899999999999998665     


Q ss_pred             -cEEEeccccceecCCCCceeEeeceeccccccccccCchhhcCccceeEEEeeEEEeeccC
Q 021711          248 -EPQICDFGLAKWLPEQWTHHTISKVEGTFGLVKLNLPPLVILKRCFTCIFIGFSQLQLSCS  308 (308)
Q Consensus       248 -~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~g~~l~el~c~  308 (308)
                       .++++|||.|+.....     .....||+.|+|||......++.++|+||+|+++++|++|
T Consensus       169 ~~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g  225 (362)
T d1q8ya_         169 IQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITG  225 (362)
T ss_dssp             EEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred             ceeeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHC
Confidence             4999999999876443     2456899999999998888889999999999999999875

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.92  E-value=2.7e-25  Score=185.03  Aligned_cols=137  Identities=18%  Similarity=0.206  Sum_probs=107.6

Q ss_pred             ccccceeeccCceEEEEEEECCCcEEEEEEeccCCh-----------------HHHHHHHHHHHHHHhcCCCCeeeeeee
Q 021711          112 FSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTA-----------------DEIIADFLSELGIMAHVDHPNTAKLLG  174 (308)
Q Consensus       112 ~~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~-----------------~~~~~~~~~E~~~l~~l~h~niv~l~~  174 (308)
                      +.+.+.||+|+||.||+|.+.+|+.||||.+.....                 ........+|...+..+.|++++..++
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~   81 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA   81 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred             chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence            346789999999999999988899999998643211                 111234567889999999999998876


Q ss_pred             EEEeCcEEEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEecc
Q 021711          175 YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDF  254 (308)
Q Consensus       175 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DF  254 (308)
                      +.   ..+++|||+++..+..        ++......++.|++.+|.|||+   ++|+||||||+|||++++ .++|+||
T Consensus        82 ~~---~~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH~---~giiHrDiKP~NILv~~~-~~~liDF  146 (191)
T d1zara2          82 WE---GNAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVSEE-GIWIIDF  146 (191)
T ss_dssp             EE---TTEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEETT-EEEECCC
T ss_pred             ec---CCEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHHhh---CCEEEccCChhheeeeCC-CEEEEEC
Confidence            53   2379999998765432        3334456789999999999999   999999999999999975 5899999


Q ss_pred             ccceecCCC
Q 021711          255 GLAKWLPEQ  263 (308)
Q Consensus       255 Gla~~~~~~  263 (308)
                      |+|+....+
T Consensus       147 G~a~~~~~~  155 (191)
T d1zara2         147 PQSVEVGEE  155 (191)
T ss_dssp             TTCEETTST
T ss_pred             CCcccCCCC
Confidence            999876533

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.48  E-value=3.2e-07  Score=77.42  Aligned_cols=149  Identities=15%  Similarity=0.089  Sum_probs=93.0

Q ss_pred             HHHhhcCCccccceeeccCceEEEEEEECCCcEEEEEEeccCChHHHHHHHHHHHHHHhcCC-CCeeeeeeeEEEeC-cE
Q 021711          104 ELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVD-HPNTAKLLGYGIEG-GM  181 (308)
Q Consensus       104 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~-~~  181 (308)
                      ++......|+..+..+-++.+.||+... +++.+.+|+........ ...+.+|...+..+. +--+.+++.+...+ ..
T Consensus         8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~-~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~   85 (263)
T d1j7la_           8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGT-TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS   85 (263)
T ss_dssp             HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTS-TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred             HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccc-hhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence            3444445777666544455678998865 45567788775432211 234567777776663 33356667766554 46


Q ss_pred             EEEEEecCCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------
Q 021711          182 HIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC----------------------------------  227 (308)
Q Consensus       182 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~----------------------------------  227 (308)
                      ++||++++|.++.+....   ...   ...++.+++..+..||+..                                  
T Consensus        86 ~lv~~~l~G~~~~~~~~~---~~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (263)
T d1j7la_          86 NLLMSEADGVLCSEEYED---EQS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE  159 (263)
T ss_dssp             EEEEECCSSEEHHHHTTT---CSC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGS
T ss_pred             EEEEEecccccccccccc---ccc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccc
Confidence            899999999887654321   111   1223444455555555311                                  


Q ss_pred             ----------------------CCCceecCCCCCCEEECCCCcEEEeccccceec
Q 021711          228 ----------------------QRRIIHRDIKAANILLTEDFEPQICDFGLAKWL  260 (308)
Q Consensus       228 ----------------------~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~  260 (308)
                                            ...++|+|+.|.|||+++++.+-|+||+.+..-
T Consensus       160 ~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~g  214 (263)
T d1j7la_         160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRA  214 (263)
T ss_dssp             TTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred             ccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcccC
Confidence                                  122789999999999998766679999988753

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.02  E-value=1e-05  Score=67.45  Aligned_cols=140  Identities=17%  Similarity=0.101  Sum_probs=79.3

Q ss_pred             eeeccC-ceEEEEEEECCCcEEEEEEeccCChHHHHHHHHHHHHHHhcCC--CCeeeeeeeEEEeC-cEEEEEEecCCCC
Q 021711          117 LIGKGG-YAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVD--HPNTAKLLGYGIEG-GMHIVLELSPNGS  192 (308)
Q Consensus       117 ~LG~G~-fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~-~~~lv~e~~~~gs  192 (308)
                      .+..|. .+.||+....++..+.+|.-.....    ..+..|...++.+.  .-.+.+++.+..++ ..++||++++|.+
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~----~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~   92 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL----NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQD   92 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT----SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEE
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH----hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccc
Confidence            344444 4689999887788889998654432    23456666666553  23356667765554 4689999998755


Q ss_pred             HHH--------------HHhc-c-----CCCC--CHHHHHHHHH--------------------HHHHHHHHHHhCC---
Q 021711          193 LAS--------------LLYG-M-----KEKL--KWGIRYKIAL--------------------GVAEGLLYLHEGC---  227 (308)
Q Consensus       193 L~~--------------~l~~-~-----~~~l--~~~~~~~i~~--------------------qi~~~L~yLH~~~---  227 (308)
                      +.+              .+.. +     ...+  .......-..                    .....+..+....   
T Consensus        93 ~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  172 (255)
T d1nd4a_          93 LLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDG  172 (255)
T ss_dssp             TTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSS
T ss_pred             cccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCcc
Confidence            421              1110 0     0000  0000000000                    0111222222211   


Q ss_pred             -CCCceecCCCCCCEEECCCCcEEEeccccceec
Q 021711          228 -QRRIIHRDIKAANILLTEDFEPQICDFGLAKWL  260 (308)
Q Consensus       228 -~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~  260 (308)
                       +..++|+|+.|.|||++.+..+-|+||+.+..-
T Consensus       173 ~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~g  206 (255)
T d1nd4a_         173 EDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA  206 (255)
T ss_dssp             CCEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred             CCceEEeCCCCCcceEEeCCceEEEEEchhcccC
Confidence             123799999999999998766789999998764

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.56  E-value=0.00011  Score=65.62  Aligned_cols=76  Identities=13%  Similarity=0.005  Sum_probs=45.6

Q ss_pred             ceeeccCceEEEEEEECC-CcEEEEEEeccC------ChHHHHHHHHHHHHHHhcCC---CCeeeeeeeEEEeCcEEEEE
Q 021711          116 NLIGKGGYAEVYKGRLRN-GQLVAIKRLTRG------TADEIIADFLSELGIMAHVD---HPNTAKLLGYGIEGGMHIVL  185 (308)
Q Consensus       116 ~~LG~G~fg~Vy~~~~~~-g~~vAvK~~~~~------~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~lv~  185 (308)
                      +.||.|....||+....+ ++.+++|.-...      .-.....+...|...|..+.   ...+++++.+. .....+||
T Consensus        32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d-~~~~~lvm  110 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD-TEMAVTVM  110 (392)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE-TTTTEEEE
T ss_pred             EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc-CCCCEEEE
Confidence            468999999999998654 678999964321      00011233456777776552   23455566553 34457899


Q ss_pred             EecCCCC
Q 021711          186 ELSPNGS  192 (308)
Q Consensus       186 e~~~~gs  192 (308)
                      |++.+..
T Consensus       111 E~L~~~~  117 (392)
T d2pula1         111 EDLSHLK  117 (392)
T ss_dssp             CCCTTSE
T ss_pred             eccCCcc
Confidence            9997643

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.09  E-value=0.002  Score=55.44  Aligned_cols=133  Identities=14%  Similarity=0.112  Sum_probs=71.6

Q ss_pred             eEEEEEEECCCcEEEEEEeccCChHHHHHHHHHHHHHHhcCCCCee-----eeeee---EEEeCcEEEEEEecCCCCH--
Q 021711          124 AEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT-----AKLLG---YGIEGGMHIVLELSPNGSL--  193 (308)
Q Consensus       124 g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-----v~l~~---~~~~~~~~lv~e~~~~gsL--  193 (308)
                      -.||++...+|+.+++|+.......  .+.+..|...+..|...++     +..-+   +...+..+.++++++|..+  
T Consensus        36 N~vy~v~~~dg~~~VlK~~rp~~~s--~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~  113 (325)
T d1zyla1          36 NRVYQFQDEDRRRFVVKFYRPERWT--ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA  113 (325)
T ss_dssp             SEEEEECCTTCCCEEEEEECTTTSC--HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred             ceeEEEEcCCCCEEEEEEeCCCCCC--HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence            4799999989999999987654221  2445567777766632221     11111   2223335678888865321  


Q ss_pred             ---HH------H---Hhc--c------CCCCCHH----------------------HHHHHHHHHHHHHHHH-HhCCCCC
Q 021711          194 ---AS------L---LYG--M------KEKLKWG----------------------IRYKIALGVAEGLLYL-HEGCQRR  230 (308)
Q Consensus       194 ---~~------~---l~~--~------~~~l~~~----------------------~~~~i~~qi~~~L~yL-H~~~~~~  230 (308)
                         ..      .   ++.  .      ....+..                      .....+.++...+.-. ....+.+
T Consensus       114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~  193 (325)
T d1zyla1         114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL  193 (325)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred             CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence               11      1   111  0      0111111                      1111222222222211 1222356


Q ss_pred             ceecCCCCCCEEECCCCcEEEeccccceec
Q 021711          231 IIHRDIKAANILLTEDFEPQICDFGLAKWL  260 (308)
Q Consensus       231 iiHrDlKp~NILl~~~~~~kl~DFGla~~~  260 (308)
                      +||+|+.+.|||++++  ..++||+-+..-
T Consensus       194 liHgDlh~~NvL~~~~--~~~IDFdd~~~g  221 (325)
T d1zyla1         194 RLHGDCHAGNILWRDG--PMFVDLDDARNG  221 (325)
T ss_dssp             ECCSSCSGGGEEESSS--EEECCCTTCCEE
T ss_pred             eecCCCCcccEEEeCC--ceEEechhcccC
Confidence            8999999999999743  458999988754

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.88  E-value=0.0062  Score=51.70  Aligned_cols=32  Identities=25%  Similarity=0.293  Sum_probs=28.1

Q ss_pred             CCCceecCCCCCCEEECCCCcEEEecccccee
Q 021711          228 QRRIIHRDIKAANILLTEDFEPQICDFGLAKW  259 (308)
Q Consensus       228 ~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~  259 (308)
                      +.++||+|+.+.||+++.+...-|.||+.+..
T Consensus       182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         182 PAGVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             CEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             ccccccCCcchhhhhcccccceeEeccccccc
Confidence            46799999999999999887778999998763

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.01  E-value=0.016  Score=50.92  Aligned_cols=71  Identities=17%  Similarity=0.123  Sum_probs=44.6

Q ss_pred             ceeeccCceEEEEEEECC--------CcEEEEEEeccCChHHHHHHHHHHHHHHhcCC-CCeeeeeeeEEEeCcEEEEEE
Q 021711          116 NLIGKGGYAEVYKGRLRN--------GQLVAIKRLTRGTADEIIADFLSELGIMAHVD-HPNTAKLLGYGIEGGMHIVLE  186 (308)
Q Consensus       116 ~~LG~G~fg~Vy~~~~~~--------g~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~lv~e  186 (308)
                      +.|+-|-.-.+|++...+        .+.|.+++.-....   ..+..+|..+++.+. +.-..++++++.+   .+|+|
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~---~idr~~E~~i~~~ls~~gl~Pkll~~~~~---g~I~e  121 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET---ESHLVAESVIFTLLSERHLGPKLYGIFSG---GRLEE  121 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC---HHHHHHHHHHHHHHHHTTSSSCEEEEETT---EEEEC
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcch---hhHHHHHHHHHHHHHhCCCCCeEEEEcCC---ceEEE
Confidence            567878888999998653        24566666542222   123457888888774 3333466666532   57888


Q ss_pred             ecCCCC
Q 021711          187 LSPNGS  192 (308)
Q Consensus       187 ~~~~gs  192 (308)
                      |++|.+
T Consensus       122 fi~g~~  127 (395)
T d1nw1a_         122 YIPSRP  127 (395)
T ss_dssp             CCCEEE
T ss_pred             Eecccc
Confidence            887643